PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ley, S; Weigert, A; Weichand, B; Henke, N; Mille-Baker, B; Janssen, RAJ; Brune, B				Ley, S.; Weigert, A.; Weichand, B.; Henke, N.; Mille-Baker, B.; Janssen, R. A. J.; Bruene, B.			The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages	ONCOGENE			English	Article						immunity; sphingolipids; cancer; nerve growth factor; trafficking	NERVE GROWTH-FACTOR; HUMAN MONOCYTES; BREAST-CANCER; RECEPTORS; SPHINGOSINE-1-PHOSPHATE; EXPRESSION; TRANSACTIVATION; INTERLEUKIN-10; PROGRESSION; DISEASE	Tumor-associated macrophages (TAMs) are a major supportive component within neoplasms. Mechanisms of macrophage (M(1)) attraction and differentiation to a tumor-promoting phenotype, which is characterized by pronounced interleukin (IL)-10 production, are under investigation. We report that supernatants of dying cancer cells induced substantial IL-10 release from primary human MOs, dependent on signaling through tyrosine kinase receptor A (TRKA or neurotrophic tyrosine kinase receptor type 1 (NTRK1)). Mechanistically, sphingosine-1-phosphate (SIP) release from apoptotic cancer cells triggered src-dependent shuttling of cytosolic TRKA to the plasma membrane via S1P receptor signaling. Plasma membrane-associated TRKA, which was activated by constitutively autocrine secreted nerve growth factor, used phosphatidylinositol 3-kinase (PI3K)/AKT and p38 mitogen-activated protein kinase (MAPK) signaling to induce IL-10. Interestingly, TRKA-dependent signaling was required for cytokine production by TAMs isolated from primary murine breast cancer tissue. Besides IL-10, this pathway initiated secretion of IL-6, tumor necrosis factor-alpha (TNF-alpha) and monocyte chemotactic protein-1 (MCP-1), indicating relevance in cancer-associated inflammation. Our findings highlight a fine-tuned regulatory system including S1P-dependent TRKA trafficking for executing TAM-like cell function in vitro as well as in vivo. Oncogene (2013) 32, 631-640; doi:10.1038/onc.2012.77; published online 12 March 2012	[Ley, S.; Weigert, A.; Weichand, B.; Henke, N.; Bruene, B.] Goethe Univ Frankfurt, Inst Biochem, I ZAFES, D-60590 Frankfurt, Germany; [Mille-Baker, B.] BioFocus Ltd, Leiden, Netherlands; [Janssen, R. A. J.] Galapagos BV, Leiden, Netherlands	Goethe University Frankfurt; Galapagos NV	Brune, B (corresponding author), Goethe Univ Frankfurt, Inst Biochem, I ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	bruene@pathobiochemie1.de	Weigert, Andreas/E-6540-2010	Weigert, Andreas/0000-0002-7529-1952	DFG [Br999, FOG 784, GRK 757]; Sander Foundation [2007.070.2]; Deutsche Krebshilfe [109599]	DFG(German Research Foundation (DFG)); Sander Foundation; Deutsche Krebshilfe(Deutsche Krebshilfe)	The work was supported by DFG (Br999, FOG 784, GRK 757), Sander Foundation (2007.070.2) and Deutsche Krebshilfe (109599). We are grateful to Yves-Alain Barde for sharing the HA-TRKA expression plasmid and thank Franz Josef Streb, Magarethe Wiebe and Karina Pfister for excellent technical assistance.	Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Barra V, 2011, CELL MOL LIFE SCI, V68, P1815, DOI 10.1007/s00018-010-0537-x; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bracci-Laudiero L, 2005, BLOOD, V106, P3507, DOI 10.1182/blood-2004-10-4055; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; EHRHARD PB, 1993, P NATL ACAD SCI USA, V90, P5423, DOI 10.1073/pnas.90.12.5423; El Zein N, 2010, CELL SIGNAL, V22, P1437, DOI 10.1016/j.cellsig.2010.05.012; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Herr B, 2009, BLOOD, V114, P2140, DOI 10.1182/blood-2009-01-201889; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Jung EJ, 2008, EXP MOL MED, V40, P276, DOI 10.3858/emm.2008.40.3.276; Karkoulias G, 2007, CELL SIGNAL, V19, P945, DOI 10.1016/j.cellsig.2006.11.003; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Koh E, 2007, CELL SIGNAL, V19, P1328, DOI 10.1016/j.cellsig.2007.01.005; Kruttgen A, 2006, BRAIN PATHOL, V16, P304, DOI 10.1111/j.1750-3639.2006.00037.x; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Long JS, 2010, J BIOL CHEM, V285, P35957, DOI 10.1074/jbc.M110.117945; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Moises T, 2007, MOL NEUROBIOL, V35, P151, DOI 10.1007/s12035-007-8000-1; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Noga O, 2007, CLIN EXP ALLERGY, V37, P1701, DOI 10.1111/j.1365-2222.2007.02832.x; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; Toman RE, 2004, J CELL BIOL, V166, P381, DOI 10.1083/jcb.200402016; Tsuruda A, 2004, FEBS LETT, V560, P215, DOI 10.1016/S0014-5793(04)00115-2; van Es HHG, 2005, DRUG DISCOV TODAY, V10, P1385, DOI 10.1016/S1359-6446(05)03590-7; Wang WG, 2005, FASEB J, V19, P1731, DOI 10.1096/fj.05-3730fje; Weigert A, 2007, MOL BIOL CELL, V18, P3810, DOI 10.1091/mbc.E06-12-1096; Weigert A, 2010, BLOOD, V115, P3531, DOI 10.1182/blood-2009-10-243444; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; Wetter JA, 2009, J BIOMOL SCREEN, V14, P1134, DOI 10.1177/1087057109343809; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	40	27	30	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 31	2013	32	5					631	640		10.1038/onc.2012.77	http://dx.doi.org/10.1038/onc.2012.77			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22410777				2022-12-25	WOS:000316164700010
J	Calve, S; Simon, HG				Calve, Sarah; Simon, Hans-Georg			Biochemical and mechanical environment cooperatively regulate skeletal muscle regeneration	FASEB JOURNAL			English	Article						extracellular matrix; polydimethylsiloxane; live cell imaging; newt; tenascin-C	EXTRACELLULAR-MATRIX; LIMB REGENERATION; BIOMECHANICAL PROPERTIES; PERSISTENCE LENGTH; GROWTH-FACTORS; NEWT LIMB; CELLS; HYALURONAN; ELASTICITY; BEHAVIOR	During forelimb regeneration in the newt Notophthalmus viridescens, the dynamic expression of a transitional matrix rich in hyaluronic acid, tenascin-C, and fibronectin controls muscle cell behavior in vivo and in vitro. However, the influence of extracellular matrix (ECM) remodeling on tissue stiffness and the cellular response to mechanical variations during regeneration was unknown. By measuring the transverse stiffness of tissues in situ, we found undifferentiated regenerative blastemas were less stiff than differentiated stump muscle (13.3 +/- 1.6 vs. 16.6 +/- 1.2 kPa). To directly determine how ECM and stiffness combine to affect skeletal muscle fragmentation, migration, and fusion, we coated silicone-based substrates ranging from 2 to 100 kPa with matrices representative of transitional (tenascin-C and fibronectin) and differentiated environments (laminin and Matrigel). Using live-cell imaging, we found softer tenascin-C-coated substrates significantly enhanced migration and fragmentation of primary newt muscle cells. In contrast, stiffer substrates coated with laminin, Matrigel, or fibronectin increased differentiation while suppressing migration and fragmentation. These data support our in vivo observations that a transitional matrix of reduced stiffness regulates muscle plasticity and progenitor cell recruitment into the regenerative blastema. These new findings will enable the determination of how biochemical and mechanical cues from the ECM control genetic pathways that drive regeneration.-Calve, S., Simon, H.-G. Biochemical and mechanical environment cooperatively regulate skeletal muscle regeneration. FASEB J. 26, 2538-2545 (2012). www.fasebj.org	[Calve, Sarah; Simon, Hans-Georg] Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Dept Pediat, Chicago, IL 60614 USA	Northwestern University; Feinberg School of Medicine	Simon, HG (corresponding author), Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Dept Pediat, 2300 Childrens Plaza,M-C 204, Chicago, IL 60614 USA.	hgsimon@northwestern.edu			U.S. Defense Advanced Research Projects Agency [BAA04-12 Addendum B]; Chicago Community Trust; U.S. National Institutes of Health	U.S. Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Chicago Community Trust; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. K. Shull and K. Otim (Department of Materials Science and Engineering, Northwestern University) for assistance with mechanical testing. The authors also thank all members of the H.-G. S. laboratory for helpful discussions. The authors are grateful to Dr. C. Huppenbauer and M. Tjepkema (W. Nuhsbaum Inc., McHenry, IL, USA) for expert technical support. This work was supported by the U.S. Defense Advanced Research Projects Agency, Restorative Injury Repair BAA04-12 Addendum B (to H.-G. S.), Searle Funds at The Chicago Community Trust (to H.-G. S.), and the U.S. National Institutes of Health T90 Regenerative Medicine Training	Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009; Bosboom EMH, 2001, J BIOMECH, V34, P1365, DOI 10.1016/S0021-9290(01)00083-5; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Calve S, 2010, IUTAM BOOKSER, V16, P257, DOI 10.1007/978-90-481-3348-2_22; Calve S, 2011, DEV DYNAM, V240, P1233, DOI 10.1002/dvdy.22530; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Candiello J, 2007, FEBS J, V274, P2897, DOI 10.1111/j.1742-4658.2007.05823.x; CHALKLEY DT, 1954, J MORPHOL, V94, P21, DOI 10.1002/jmor.1050940103; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Darling EM, 2010, BIOPHYS J, V98, P2848, DOI 10.1016/j.bpj.2010.03.037; Defranchi E, 2005, MICROSC RES TECHNIQ, V67, P27, DOI 10.1002/jemt.20177; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Grounds Miranda D., 2008, V3, P269; Hakim CH, 2011, J APPL PHYSIOL, V110, P1656, DOI 10.1152/japplphysiol.01425.2010; Han L, 2011, ANNU REV MATER RES, V41, P133, DOI 10.1146/annurev-matsci-062910-100431; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Jarvinen TAH, 2003, J CELL SCI, V116, P857, DOI 10.1242/jcs.00303; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kumar A, 2007, NAT PROTOC, V2, P939, DOI 10.1038/nprot.2007.134; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Luo ZP, 2004, BIORHEOLOGY, V41, P247; Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x; Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; MALEY MAL, 1995, EXP CELL RES, V219, P169, DOI 10.1006/excr.1995.1217; MESCHER AL, 1988, DIFFERENTIATION, V38, P161, DOI 10.1111/j.1432-0436.1988.tb00210.x; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Ogneva IV, 2010, BIOPHYS J, V98, P418, DOI 10.1016/j.bpj.2009.10.028; Okita M, 2004, J MUSCLE RES CELL M, V25, P159, DOI 10.1023/B:JURE.0000035851.12800.39; Ren KF, 2010, ACTA BIOMATER, V6, P4238, DOI 10.1016/j.actbio.2010.06.014; REPESH LA, 1982, DIFFERENTIATION, V22, P125, DOI 10.1111/j.1432-0436.1982.tb01236.x; ROWE DA, 1982, J EMBRYOL EXP MORPH, V68, P1; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; Shull KR, 2002, MAT SCI ENG R, V36, P1, DOI 10.1016/S0927-796X(01)00039-0; Sivakumar L, 2010, BIOMATERIALS, V31, P4802, DOI 10.1016/j.biomaterials.2010.02.070; Tassava Roy A., 1996, Wound Repair and Regeneration, V4, P75, DOI 10.1046/j.1524-475X.1996.40113.x; TOOLE BP, 1971, DEV BIOL, V25, P57, DOI 10.1016/0012-1606(71)90019-4; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; Walthall JC, 2006, ANAT REC PART A, V288A, P46, DOI 10.1002/ar.a.20279	48	60	60	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2538	2545		10.1096/fj.11-200162	http://dx.doi.org/10.1096/fj.11-200162			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415307	Green Published, Green Submitted			2022-12-25	WOS:000305017200030
J	Weber, M; Lambeck, S; Ding, N; Henken, S; Kohl, M; Deigner, HP; Enot, DP; Igwe, EI; Frappart, L; Kiehntopf, M; Claus, RA; Kamradt, T; Weih, D; Vodovotz, Y; Briles, DE; Ogunniyi, AD; Paton, JC; Maus, UA; Bauer, M				Weber, Martina; Lambeck, Sandro; Ding, Nadine; Henken, Stefanie; Kohl, Matthias; Deigner, Hans P.; Enot, David P.; Igwe, Emeka I.; Frappart, Lucien; Kiehntopf, Michael; Claus, Ralf A.; Kamradt, Thomas; Weih, Debra; Vodovotz, Yoram; Briles, David E.; Ogunniyi, Abiodun D.; Paton, James C.; Maus, Ulrich A.; Bauer, Michael			Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia	FASEB JOURNAL			English	Article						sepsis; pneumolysin; pathogen-host interaction	COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; PULMONARY INFECTION; HOST-DEFENSE; PNEUMOLYSIN; METABOLISM; SEPSIS; PATHOGENESIS; MACROPHAGES; INJURY	Community-acquired pneumonia presents a spectrum of clinical phenotypes, from lobar pneumonia to septic shock, while mechanisms underlying progression are incompletely understood. In a transcriptomic and metabolomic study across tissues, we examined serotype-specific regulation of signaling and metabolic pathways in C57BL/6 mice intratracheally instilled with either serotype 19F Streptococcus pneumoniae (S19; causing lobar pneumonia), or serotype 2 S. pneumoniae (S2; causing septic pneumococcal disease,) or vehicle (Todd-Hewitt broth). Samples of lung, liver, and blood were collected at 6 and 24 h postinfection and subjected to microarray analysis and mass spectrometry. Results comprise a preferential induction of cholesterol biosynthesis in lobar pneumonia at low-infection doses (105 colony forming units/mouse) leading to increased plasma cholesterol (vehicle: 1.8 +/- 0.12 mM, S2: 2.3 +/- 0.10 mM, S19: 2.9 +/- 0.15 mM; P<0.05, comparing S19 to vehicle and S2). This induction was pneumolysin dependent, as a pneumolysin-deficient strain of serotype 19F failed to induce cholesterol biosynthesis (S19 Delta PLY: 1.9 +/- 0.03 mM). Preincubation of pneumolysin with purified cholesterol or plasma from hypercholesterolemic mice prior to intratracheal instillation protected against lung barrier dysfunction and alveolar macrophage necrosis. Cholesterol may attenuate disease severity by neutralizing pneumolysin in the alveolar compartment and thus prevent septic disease progression.-Weber, M., Lambeck, S., Ding, N., Henken, S., Kohl, M., Deigner, H. P., Enot, D. P., Igwe, E. I., Frappart, L., Kiehntopf, M., Claus, R. A., Kamradt, T., Weih, D., Vodovotz, Y., Briles, D. E., Ogunniyi, A. D., Paton, J. C., Maus, U. A., Bauer, M. Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia. FASEB J. 26, 2424-2436 (2012). www.fasebj.org	[Lambeck, Sandro; Claus, Ralf A.; Bauer, Michael] Jena Univ Hosp, Ctr Sepsis Control & Care, D-07747 Jena, Germany; [Weber, Martina; Kohl, Matthias; Claus, Ralf A.; Bauer, Michael] Jena Univ Hosp, Dept Anaesthesiol & Intens Care Therapy, D-07747 Jena, Germany; [Kiehntopf, Michael] Jena Univ Hosp, Inst Clin Chem & Lab Med, D-07747 Jena, Germany; [Kamradt, Thomas] Jena Univ Hosp, Inst Immunol, D-07747 Jena, Germany; [Ding, Nadine; Henken, Stefanie; Maus, Ulrich A.] Hannover Med Sch, Dept Expt Pneumol, D-3000 Hannover, Germany; [Deigner, Hans P.; Enot, David P.; Igwe, Emeka I.] Biocrates Life Sci AG, Innsbruck, Austria; [Frappart, Lucien] Univ Lyon 1, Dept Pathol, F-69365 Lyon, France; [Frappart, Lucien] INSERM, U590, F-69008 Lyon, France; [Weih, Debra] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Vodovotz, Yoram] McGowan Inst Regenerat Med, Ctr Inflammat Regenerat Modeling, Pittsburgh, PA USA; [Briles, David E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Ogunniyi, Abiodun D.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Hannover Medical School; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; University of Adelaide	Bauer, M (corresponding author), Jena Univ Hosp, Ctr Sepsis Control & Care, Erlanger Allee 101, D-07747 Jena, Germany.	michael.bauer@med.uni-jena.de	Kamradt, Thomas/E-9971-2018; Kohl, Matthias/R-6096-2019; Paton, James C/A-9920-2008; Claus, Ralf A./Q-4035-2016	Kohl, Matthias/0000-0001-9514-8910; Bauer, Michael/0000-0002-1521-3514; Kamradt, Thomas/0000-0001-8443-5893; Ogunniyi, Abiodun/0000-0001-9308-5629; Claus, Ralf A./0000-0001-7232-4088	Federal Ministry of Education and Research (BMBF) [01KI07111, 01EO1002]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors acknowledge expert technical support by Brigitte Specht, Edith Walther, Maik Balduf, Dr. Elke Grunow, Dr. Karen Felsmann, and Kay Stotzer. This work was funded by the Federal Ministry of Education and Research (BMBF; 01KI07111 to M. B. and U. A. M.; 01EO1002 to M. B., R. A. C., and S. L. for the Center for Sepsis Control and Care) and was performed within the framework of the Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Sepsis (PROGRESS). U. A. M. and M. B. share senior authorship.	Balachandran P, 2001, J BACTERIOL, V183, P3108, DOI 10.1128/JB.183.10.3108-3116.2001; BENTON KA, 1995, INFECT IMMUN, V63, P448, DOI 10.1128/IAI.63.2.448-455.1995; Bergeron Y, 1998, INFECT IMMUN, V66, P912, DOI 10.1128/IAI.66.3.912-922.1998; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; Chung TP, 2002, CRIT CARE MED, V30, pS51, DOI 10.1097/00003246-200201001-00007; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Cobb JP, 2004, LANCET, V363, P2076, DOI 10.1016/S0140-6736(04)16460-X; DAVIS CC, 1991, J INFECT DIS, V163, P799, DOI 10.1093/infdis/163.4.799; de Lima-Salgado Thais Martins, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P258; dos Santos CC, 2010, CRIT CARE MED, V38, P894, DOI 10.1097/CCM.0b013e3181ce4e50; Dremsizov T, 2006, CHEST, V129, P968, DOI 10.1378/chest.129.4.968; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunham CM, 2003, CRIT CARE, V7, pR145, DOI 10.1186/cc2382; Ewig Santiago, 2002, Curr Opin Crit Care, V8, P453, DOI 10.1097/00075198-200210000-00014; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonnert FA, 2011, J SURG RES, V170, pE123, DOI 10.1016/j.jss.2011.05.019; Gordon BR, 2001, CRIT CARE MED, V29, P1563, DOI 10.1097/00003246-200108000-00011; Harvey RM, 2011, INFECT IMMUN, V79, P4122, DOI 10.1128/IAI.05418-11; Henken S, 2010, ANTIMICROB AGENTS CH, V54, P707, DOI 10.1128/AAC.00943-09; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JOHNSTON RB, 1991, REV INFECT DIS, V13, pS509; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; LEROY O, 1995, INTENS CARE MED, V21, P24, DOI 10.1007/BF02425150; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Marquart ME, 2007, INVEST OPHTH VIS SCI, V48, P2661, DOI 10.1167/iovs.07-0017; Martin-Ponce E, 2010, CLIN NUTR, V29, P501, DOI 10.1016/j.clnu.2009.12.009; Maus UA, 2004, J IMMUNOL, V173, P1307, DOI 10.4049/jimmunol.173.2.1307; Maus UA, 2003, J IMMUNOL, V170, P3273, DOI 10.4049/jimmunol.170.6.3273; Maus UA, 2002, AM J PHYSIOL-LUNG C, V282, pL1245, DOI 10.1152/ajplung.00453.2001; Maus UA, 2007, AM J RESP CRIT CARE, V175, P958, DOI 10.1164/rccm.200610-1533OC; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; MELLENCAMP MA, 1991, J INFECT DIS, V163, P102, DOI 10.1093/infdis/163.1.102; MOINE P, 1995, SCAND J INFECT DIS, V27, P201, DOI 10.3109/00365549509019009; Nes WD, 2000, ENDOCRINOLOGY, V141, P953, DOI 10.1210/en.141.3.953; Nollmann M, 2004, BIOPHYS J, V86, P3141, DOI 10.1016/S0006-3495(04)74362-3; Ortqvist A, 2005, SEMIN RESP CRIT CARE, V26, P563, DOI 10.1055/s-2005-925523; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; PATON JC, 1983, INFECT IMMUN, V40, P548, DOI 10.1128/IAI.40.2.548-552.1983; QUISTORFF B, 1976, ANAL BIOCHEM, V73, P236, DOI 10.1016/0003-2697(76)90162-7; Rubins JB, 1998, J LAB CLIN MED, V131, P21, DOI 10.1016/S0022-2143(98)90073-7; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Santos-Sierra S, 2006, J ENDOTOXIN RES, V12, P307, DOI 10.1179/096805106X118762; Scanu AM, 2008, FASEB J, V22, P4044, DOI 10.1096/fj.08-117150; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; SIMON RH, 1995, J LAB CLIN MED, V126, P108; Takashima K, 1997, INFECT IMMUN, V65, P257, DOI 10.1128/IAI.65.1.257-260.1997; TUOMANEN EI, 1995, NEW ENGL J MED, V332, P1280, DOI 10.1056/NEJM199505113321907; Unterwurzacher I, 2008, CLIN CHEM LAB MED, V46, P1589, DOI 10.1515/CCLM.2008.323; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Vermont CL, 2005, CRIT CARE MED, V33, P1610, DOI 10.1097/01.CCM.0000171272.50888.AD; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Winter C, 2007, J IMMUNOL, V178, P5828, DOI 10.4049/jimmunol.178.9.5828; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82; Yoshimura A, 1999, J IMMUNOL, V163, P1	58	32	33	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2424	2436		10.1096/fj.11-191957	http://dx.doi.org/10.1096/fj.11-191957			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415311				2022-12-25	WOS:000305017200020
J	Anjem, A; Imlay, JA				Anjem, Adil; Imlay, James A.			Mononuclear Iron Enzymes Are Primary Targets of Hydrogen Peroxide Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-THREONINE DEHYDROGENASE; PROTEIN-TYROSINE PHOSPHATASES; ESCHERICHIA-COLI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; TRANSCRIPTION FACTOR; CATALYTIC MECHANISM; CYTOSINE DEAMINASE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; OXIDATIVE STRESS	This study tested whether nonredox metalloenzymes are commonly charged with iron in vivo and are primary targets of oxidative stress because of it. Indeed, three sample mononuclear enzymes, peptide deformylase, threonine dehydrogenase, and cytosine deaminase, were rapidly damaged by micromolar hydrogen peroxide in vitro and in live Escherichia coli. The first two enzymes use a cysteine residue to coordinate the catalytic metal atom; it was quantitatively oxidized by the radical generated by the Fenton reaction. Because oxidized cysteine can be repaired by cellular reductants, the effect was to avoid irreversible damage to other active-site residues. Nevertheless, protracted H2O2 exposure gradually inactivated these enzymes, consistent with the overoxidation of the cysteine residue to sulfinic or sulfonic forms. During H2O2 stress, E. coli defended all three proteins by inducing MntH, a manganese importer, and Dps, an iron-sequestration protein. These proteins appeared to collaborate in replacing the iron atom with nonoxidizable manganese. The implication is that mononuclear metalloproteins are common targets of H2O2 and that both structural and metabolic arrangements exist to protect them.	[Anjem, Adil; Imlay, James A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Imlay, JA (corresponding author), Univ Illinois, Dept Microbiol, 601 S Goodwin Ave, Urbana, IL 61801 USA.	jimlay@illinois.edu			National Institutes of Health [GM049640]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049640, R01GM049640, R01GM071041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049640.	ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ARCHIBALD F, 1986, CRC CR REV MICROBIOL, V13, P63, DOI 10.3109/10408418609108735; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Becker A, 1998, NAT STRUCT BIOL, V5, P1053, DOI 10.1038/4162; BERTHIER F, 1993, LETT APPL MICROBIOL, V16, P150, DOI 10.1111/j.1472-765X.1993.tb01381.x; BOYLAN SA, 1981, J BIOL CHEM, V256, P1809; Chan MK, 1997, BIOCHEMISTRY-US, V36, P13904, DOI 10.1021/bi9711543; CHANG EC, 1989, J BIOL CHEM, V264, P12172; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; DUGGLEBY RG, 1974, J BIOL CHEM, V249, P167; EPPERLY BR, 1991, J BIOL CHEM, V266, P6086; Forman HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC246, DOI 10.1152/ajpcell.00516.2003; GIACHETTI E, 1984, EXPERIENTIA, V40, P227, DOI 10.1007/BF01963614; Gort AS, 1998, J BACTERIOL, V180, P1402, DOI 10.1128/JB.180.6.1402-1410.1998; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Hall RS, 2011, BIOCHEMISTRY-US, V50, P5077, DOI 10.1021/bi200483k; Helmann JD, 2003, J BACTERIOL, V185, P243, DOI 10.1128/JB.185.1.243-253.2003; Higashi N, 2008, J BIOCHEM, V144, P77, DOI 10.1093/jb/mvn041; Inaoka T, 1999, J BACTERIOL, V181, P1939, DOI 10.1128/JB.181.6.1939-1943.1999; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; Ishikawa K, 2007, J MOL BIOL, V366, P857, DOI 10.1016/j.jmb.2006.11.060; Jain RK, 2005, J AM CHEM SOC, V127, P4558, DOI 10.1021/ja0503074; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Johnson AR, 1998, ARCH BIOCHEM BIOPHYS, V358, P211, DOI 10.1006/abbi.1998.0845; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Lazennec C, 1997, ANAL BIOCHEM, V244, P180, DOI 10.1006/abio.1996.9910; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; Miller J. H., 1972, EXPT MOL GENETICS, P431; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; PORTER DJT, 1993, J BIOL CHEM, V268, P24005; Porter DJT, 2000, BBA-PROTEIN STRUCT M, V1476, P239, DOI 10.1016/S0167-4838(99)00246-0; Rajagopalan PTR, 1998, J BIOL CHEM, V273, P22305, DOI 10.1074/jbc.273.35.22305; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Rowe JL, 2005, J BACTERIOL, V187, P6317, DOI 10.1128/JB.187.18.6317-6323.2005; Sanchez RJ, 2005, J BIOL INORG CHEM, V10, P913, DOI 10.1007/s00775-005-0044-y; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Smith KJ, 2003, PROTEIN SCI, V12, P349, DOI 10.1110/ps.0229303; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Takanishi CL, 2007, BIOCHEMISTRY-US, V46, P14725, DOI 10.1021/bi701625s; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	61	151	153	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15544	15556		10.1074/jbc.M111.330365	http://dx.doi.org/10.1074/jbc.M111.330365			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411989	Green Published, hybrid			2022-12-25	WOS:000304006300035
J	Jacques, C; Holzenberger, M; Mladenovic, Z; Salvat, C; Pecchi, E; Berenbaum, F; Gosset, M				Jacques, Claire; Holzenberger, Martin; Mladenovic, Zvezdana; Salvat, Colette; Pecchi, Emilie; Berenbaum, Francis; Gosset, Marjolaine			Proinflammatory Actions of Visfatin/Nicotinamide Phosphoribosyltransferase (Nampt) Involve Regulation of Insulin Signaling Pathway and Nampt Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-ENHANCING FACTOR; PROSTAGLANDIN-E SYNTHASE-1; GROWTH-FACTOR-I; ARTICULAR CHONDROCYTES; RHEUMATOID-ARTHRITIS; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; PRIMARY CULTURE; BETA-CELLS; IGF-I	Visfatin (also termed pre-B-cell colony-enhancing factor (PBEF) or nicotinamide phosphoribosyltransferase (Nampt)) is a pleiotropic mediator acting on many inflammatory processes including osteoarthritis. Visfatin exhibits both an intracellular enzymatic activity (nicotinamide phosphoribosyltransferase, Nampt) leading to NAD synthesis and a cytokine function via the binding to its hypothetical receptor. We recently reported the role of visfatin in prostaglandin E-2 (PGE(2)) synthesis in chondrocytes. Here, our aim was to characterize the signaling pathways involved in this response in exploring both the insulin receptor (IR) signaling pathway and Nampt activity. IR was expressed in human and murine chondrocytes, and visfatin triggered Akt phosphorylation in murine chondrocytes. Blocking IR expression with siRNA or activity using the hydroxy-2-naphthalenyl methyl phosphonic acid tris acetoxymethyl ester (HNMPA-(AM)(3)) inhibitor diminished visfatin-induced PGE(2) release in chondrocytes. Moreover, visfatin-induced IGF-1R(-/-) chondrocytes released higher concentration of PGE(2) than IGF-1R (+/+) cells, a finding confirmed with an antibody that blocked IGF-1R. Using RT-PCR, we found that visfatin did not regulate IR expression and that an increased insulin release was also unlikely to be involved because insulin was unable to increase PGE(2) release. Inhibition of Nampt activity using the APO866 inhibitor gradually decreased PGE(2) release, whereas the addition of exogenous nicotinamide increased it. We conclude that the proinflammatory actions of visfatin in chondrocytes involve regulation of IR signaling pathways, possibly through the control of Nampt enzymatic activity.	[Berenbaum, Francis] Univ Paris 06, UR 4, Aging Stress & Inflammat Lab, F-75252 Paris 5, France; [Holzenberger, Martin] Pierre & Marie Curie Fac Med, INSERM, U938, F-75571 Paris, France; [Berenbaum, Francis] Hop St Antoine, Dept Rheumatol, AP HP, F-75571 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Berenbaum, F (corresponding author), Univ Paris 06, UR 4, Aging Stress & Inflammat Lab, 7 Quai St Bernard, F-75252 Paris 5, France.	francis.berenbaum@sat.aphp.fr	Holzenberger, Martin/N-9732-2018; Berenbaum, Francis/AAO-5690-2020; Gosset, Marjolaine/ACE-0183-2022	Berenbaum, Francis/0000-0001-8252-7815; Gosset, Marjolaine/0000-0002-4875-7892; JACQUES, Claire/0000-0002-2741-5340; Holzenberger, Martin/0000-0003-4869-725X	Fondation Arthritis; French Society of Rheumatology	Fondation Arthritis; French Society of Rheumatology	This work was supported by the Fondation Arthritis and the French Society of Rheumatology.	Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Aigner T, 2006, ADV DRUG DELIVER REV, V58, P128, DOI 10.1016/j.addr.2006.01.020; Albrecht C, 2009, INT J MOL MED, V23, P347, DOI 10.3892/ijmm_00000138; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Bao JP, 2009, J INT MED RES, V37, P1655, DOI 10.1177/147323000903700601; Bi TQ, 2010, CANCER BIOL THER, V10, P119, DOI 10.4161/cbt.10.2.12581; Blaise R, 2009, ARTHRITIS RHEUM-US, V60, P428, DOI 10.1002/art.24250; Boini KM, 2010, BBA-MOL CELL BIOL L, V1801, P1294, DOI 10.1016/j.bbalip.2010.09.001; Brentano F, 2007, ARTHRITIS RHEUM, V56, P2829, DOI 10.1002/art.22833; Brown JEP, 2010, J MOL ENDOCRINOL, V44, P171, DOI 10.1677/JME-09-0071; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Chabane N, 2008, OSTEOARTHR CARTILAGE, V16, P1267, DOI 10.1016/j.joca.2008.03.009; Chan SJ, 1997, P NATL ACAD SCI USA, V94, P12446, DOI 10.1073/pnas.94.23.12446; Claassen H, 2011, ANN ANAT, V193, P23, DOI 10.1016/j.aanat.2010.09.005; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001; DORE S, 1995, ARTHRITIS RHEUM, V38, P413, DOI 10.1002/art.1780380319; Ekenstedt KJ, 2006, ARTHRITIS RHEUM-US, V54, P3850, DOI 10.1002/art.22254; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gosset M, 2008, ARTHRITIS RHEUM-US, V58, P1399, DOI 10.1002/art.23431; Jacques C, 1997, J CLIN INVEST, V99, P1864, DOI 10.1172/JCI119353; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kim JJ, 2002, GROWTH HORM IGF RES, V12, P84, DOI 10.1054/ghir.2002.0265; Kim MK, 2006, J MOL BIOL, V362, P66, DOI 10.1016/j.jmb.2006.06.082; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Kralisch S, 2005, AM J PHYSIOL-ENDOC M, V289, pE586, DOI 10.1152/ajpendo.00090.2005; Li XF, 2005, J RHEUMATOL, V32, P887; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Masuko-Hongo K, 2004, ARTHRITIS RHEUM-US, V50, P2829, DOI 10.1002/art.20437; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Remacle-Bonnet M, 2005, AM J PATHOL, V167, P761, DOI 10.1016/S0002-9440(10)62049-4; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Romacho T, 2009, DIABETOLOGIA, V52, P2455, DOI 10.1007/s00125-009-1509-2; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Rosa SC, 2011, OSTEOARTHR CARTILAGE, V19, P719, DOI 10.1016/j.joca.2011.02.004; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011; Sun Q, 2009, ANN MED, V41, P311, DOI 10.1080/07853890902729760; Xie H, 2007, CALCIFIED TISSUE INT, V80, P201, DOI 10.1007/s00223-006-0155-7; Yammani RR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3705; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	51	54	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15100	15108		10.1074/jbc.M112.350215	http://dx.doi.org/10.1074/jbc.M112.350215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399297	Green Published, hybrid			2022-12-25	WOS:000304003200071
J	Selway, J; Rigatti, R; Storey, N; Lu, J; Willars, GB; Herbert, TP				Selway, Joanne; Rigatti, Roberto; Storey, Nina; Lu, Jing; Willars, Gary B.; Herbert, Terence P.			Evidence That Ca2+ within the Microdomain of the L-Type Voltage Gated Ca2+ Channel Activates ERK in MIN6 Cells in Response to Glucagon-Like Peptide-1	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INSULIN-SECRETION; ENDOPLASMIC-RETICULUM; REGULATED KINASES; PROTEIN-KINASES; CALCIUM; GLUCOSE; LINE; PHOSPHORYLATION; NUCLEUS	Glucagon like peptide-1 (GLP-1) is released from intestinal L-cells in response to nutrient ingestion and acts upon pancreatic beta-cells potentiating glucose-stimulated insulin secretion and stimulating beta-cell proliferation, differentiation, survival and gene transcription. These effects are mediated through the activation of multiple signal transduction pathways including the extracellular regulated kinase (ERK) pathway. We have previously reported that GLP-1 activates ERK through a mechanism dependent upon the influx of extracellular Ca2+ through L-type voltage gated Ca2+ channels (VGCC). However, the mechanism by which L-type VGCCs couple to the ERK signalling pathway in pancreatic beta-cells is poorly understood. In this report, we characterise the relationship between L-type VGCC mediated changes in intracellular Ca2+ concentration ([Ca2+](i)) and the activation of ERK, and demonstrate that the sustained activation of ERK (up to 30 min) in response to GLP-1 requires the continual activation of the L-type VGCC yet does not require a sustained increase in global [Ca2+](i) or Ca2+ efflux from the endoplasmic reticulum. Moreover, sustained elevation of [Ca2+](i) induced by ionomycin is insufficient to stimulate the prolonged activation of ERK. Using the cell permeant Ca2+ chelators, EGTA-AM and BAPTA-AM, to determine the spatial dynamics of L-type VGCC-dependent Ca2+ signalling to ERK, we provide evidence that a sustained increase in Ca2+ within the microdomain of the L-type VGCC is sufficient for signalling to ERK and that this plays an important role in GLP-1-stimulated ERK activation.	[Selway, Joanne; Rigatti, Roberto; Storey, Nina; Lu, Jing; Willars, Gary B.; Herbert, Terence P.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Selway, J (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England.	tph4@le.ac.uk		Herbert, Terence/0000-0001-5402-0814	Diabetes UK [BDA:RD04/2980]	Diabetes UK(Diabetes UK)	This work was supported by a Diabetes UK(http://www.diabetes.org.uk/) studentship BDA:RD04/2980 awarded to TPH for JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER EM, 1991, J NEUROSCI, V11, P1496; Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Benes C, 1999, BIOCHEM J, V340, P219, DOI 10.1042/0264-6021:3400219; Benes C, 1998, J BIOL CHEM, V273, P15507, DOI 10.1074/jbc.273.25.15507; Bhatt HS, 2000, BIOCHEM PHARMACOL, V60, P1655, DOI 10.1016/S0006-2952(00)00483-4; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Duan LL, 2010, P NATL ACAD SCI USA, V107, P22314, DOI 10.1073/pnas.1016630108; Gautam D, 2007, DIABETES OBES METAB, V9, P158, DOI 10.1111/j.1463-1326.2007.00781.x; Gibson TB, 2006, DIABETES, V55, P1066, DOI 10.2337/diabetes.55.04.06.db05-1266; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Gomez E, 2008, BIOCHEM J, V410, P485, DOI 10.1042/BJ20071367; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Maechler P, 1999, J BIOL CHEM, V274, P12583, DOI 10.1074/jbc.274.18.12583; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; NEHER E, 1986, EMBO J, V5, P51, DOI 10.1002/j.1460-2075.1986.tb04176.x; Perfetti R, 2000, EUR J ENDOCRINOL, V143, P717, DOI 10.1530/eje.0.1430717; Quoyer J, 2009, J BIOL CHEM; ROBERT A, 1993, THERAPIE, V48, P345; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Varadi A, 2002, DIABETES, V51, pS190, DOI 10.2337/diabetes.51.2007.S190	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33004	10.1371/journal.pone.0033004	http://dx.doi.org/10.1371/journal.pone.0033004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412973	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000303060800074
J	El-Sabaawi, RW; Kohler, TJ; Zandona, E; Travis, J; Marshall, MC; Thomas, SA; Reznick, DN; Walsh, M; Gilliam, JF; Pringle, C; Flecker, AS				El-Sabaawi, Rana W.; Kohler, Tyler J.; Zandona, Eugenia; Travis, Joseph; Marshall, Michael C.; Thomas, Steven A.; Reznick, David N.; Walsh, Matthew; Gilliam, James F.; Pringle, Catherine; Flecker, Alexander S.			Environmental and Organismal Predictors of Intraspecific Variation in the Stoichiometry of a Neotropical Freshwater Fish	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; RESOURCE AVAILABILITY; PHOSPHORUS-CONTENT; TROPICAL STREAM; RIVULUS-HARTII; NITROGEN; GROWTH; CARBON; PREDATORS; COMMUNITY	The elemental composition of animals, or their organismal stoichiometry, is thought to constrain their contribution to nutrient recycling, their interactions with other animals, and their demographic rates. Factors that affect organismal stoichiometry are generally poorly understood, but likely reflect elemental investments in morphological features and life history traits, acting in concert with the environmental availability of elements. We assessed the relative contribution of organismal traits and environmental variability to the stoichiometry of an insectivorous Neotropical stream fish, Rivulus hartii. We characterized the influence of body size, life history phenotype, stage of maturity, and environmental variability on organismal stoichiometry in 6 streams that differ in a broad suite of environmental variables. The elemental composition of R. hartii was variable, and overlapped with the wide range of elemental composition documented across freshwater fish taxa. Average %P composition was similar to 3.2%(+/- 0.6), average %N similar to 10.7%(+/- 0.9), and average % C similar to 41.7%(+/- 3.1). Streams were the strongest predictor of organismal stoichiometry, and explained up to 18% of the overall variance. This effect appeared to be largely explained by variability in quality of basal resources such as epilithon N:P and benthic organic matter C:N, along with variability in invertebrate standing stocks, an important food source for R. hartii. Organismal traits were weak predictors of organismal stoichiometry in this species, explaining when combined up to 7% of the overall variance in stoichiometry. Body size was significantly and positively correlated with % P, and negatively with N:P, and C:P, and life history phenotype was significantly correlated with % C, % P, C: P and C:N. Our study suggests that spatial variability in elemental availability is more strongly correlated with organismal stoichiometry than organismal traits, and suggests that the stoichiometry of carnivores may not be completely buffered from environmental variability. We discuss the relevance of these findings to ecological stoichiometry theory.	[El-Sabaawi, Rana W.; Flecker, Alexander S.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Kohler, Tyler J.; Thomas, Steven A.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA; [Zandona, Eugenia] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Travis, Joseph; Pringle, Catherine] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Marshall, Michael C.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Reznick, David N.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Walsh, Matthew] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Gilliam, James F.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	Cornell University; University of Nebraska System; University of Nebraska Lincoln; Drexel University; State University System of Florida; Florida State University; University System of Georgia; University of Georgia; University of California System; University of California Riverside; Yale University; University of North Carolina; North Carolina State University	El-Sabaawi, RW (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	rana@uvic.ca	Zandona, Eugenia/ABG-8207-2020; Pringle, Catherine M/I-1841-2012; Zandona, Eugenia/GQH-9518-2022; Zandona, Eugenia/B-3449-2013; Kohler, Tyler/I-5472-2016; Gilliam, James F/D-5605-2013	Zandona, Eugenia/0000-0003-4754-5326; Zandona, Eugenia/0000-0003-4754-5326; Zandona, Eugenia/0000-0003-4754-5326; Kohler, Tyler/0000-0001-5137-4844; Marshall, Michael/0000-0002-1270-9717; reznick, david/0000-0002-1144-0568	National Science Foundation (NSF) [DEB-0623632]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by a National Science Foundation Frontiers in Integrative Biological Research Grant to DNR (NSF-FIBR, DEB-0623632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Bertram SM, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2601; Binderup AJ, 2011, ISOLATING TOP DOWN E; Cross WF, 2003, ECOL LETT, V6, P721, DOI 10.1046/j.1461-0248.2003.00481.x; Dantas MC, 2007, J FISH BIOL, V70, P100, DOI 10.1111/j.1095-8649.2006.01277.x; de Villemereuil PB, 2011, ECOL MODEL, V222, P419, DOI 10.1016/j.ecolmodel.2010.10.011; DeMott WR, 1998, LIMNOL OCEANOGR, V43, P1147, DOI 10.4319/lo.1998.43.6.1147; Dickman EM, 2008, P NATL ACAD SCI USA, V105, P18408, DOI 10.1073/pnas.0805566105; Dodds WK, 2004, OECOLOGIA, V140, P458, DOI 10.1007/s00442-004-1599-y; Evans-White MA, 2006, ECOL LETT, V9, P1186, DOI 10.1111/j.1461-0248.2006.00971.x; Furness AI, 2011, CONVERGENCE LIFE HIS; GILLIAM JF, 1993, ECOLOGY, V74, P1856, DOI 10.2307/1939943; Gonzalez AL, 2011, OIKOS, V120, P1247, DOI 10.1111/j.1600-0706.2010.19151.x; Grether GF, 2001, ECOLOGY, V82, P1546, DOI 10.1890/0012-9658(2001)082[1546:RFCCRA]2.0.CO;2; Hall SR, 2009, ANNU REV ECOL EVOL S, V40, P503, DOI 10.1146/annurev.ecolsys.39.110707.173518; Hamback PA, 2009, OIKOS, V118, P615, DOI 10.1111/j.1600-0706.2009.17177.x; Hendrixson HA, 2007, J FISH BIOL, V70, P121, DOI 10.1111/j.1095-8649.2006.01280.x; Hood JM, 2010, AM NAT, V176, P651, DOI 10.1086/656489; KITCHELL JF, 1979, BIOSCIENCE, V29, P28, DOI 10.2307/1307570; Kohler T. J., 2010, INFLUENCE CANOPY COV; Magurran AE, 2005, EVOLUTIONARY ECOLOGY, Vxi; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; McIntyre PB, 2010, AM FISH S S, V73, P539; Moe SJ, 2005, OIKOS, V109, P29, DOI 10.1111/j.0030-1299.2005.14056.x; Nakazawa T, 2011, ECOL RES, V26, P209, DOI 10.1007/s11284-010-0752-9; Owens DC, 2010, SEASONAL VARIATION T; Palkovacs EP, 2009, ECOLOGY, V90, P300, DOI 10.1890/08-1673.1; Parsons TR, 1984, MANUAL CHEM BIOL MET, Vxiv; Pilati A, 2007, OIKOS, V116, P1663, DOI 10.1111/j.2007.0030-1299.15970.x; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; Schatz GS, 2007, OECOLOGIA, V153, P1021, DOI 10.1007/s00442-007-0793-0; Schindler DE, 1997, ECOLOGY, V78, P1816; SHEARER KD, 1984, CAN J FISH AQUAT SCI, V41, P1592, DOI 10.1139/f84-197; Small GE, 2010, OECOLOGIA, V162, P581, DOI 10.1007/s00442-009-1489-4; Sokal RR, 1995, BIOMETRY PRINCIPLES, Vxix; Sterner R. W., 2002, ECOLOGICAL STOICHIOM, VXXI; Sterner RW, 2000, ECOLOGY, V81, P127, DOI 10.1890/0012-9658(2000)081[0127:CNAPSO]2.0.CO;2; Sweeting CJ, 2006, RAPID COMMUN MASS SP, V20, P595, DOI 10.1002/rcm.2347; Tanner DK, 2000, CAN J FISH AQUAT SCI, V57, P1243, DOI 10.1139/cjfas-57-6-1243; Van Ham EH, 2003, AQUACULTURE, V217, P547, DOI 10.1016/S0044-8486(02)00411-8; Vanni MJ, 2002, ECOL LETT, V5, P285, DOI 10.1046/j.1461-0248.2002.00314.x; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Vrede T, 2011, OIKOS, V120, P886, DOI 10.1111/j.1600-0706.2010.18939.x; Walsh MR, 2008, P NATL ACAD SCI USA, V105, P594, DOI 10.1073/pnas.0710051105; Walsh MR, 2011, EVOLUTION, V65, P1021, DOI 10.1111/j.1558-5646.2010.01188.x; Walsh MR, 2010, EVOLUTION, V64, P1583, DOI 10.1111/j.1558-5646.2009.00922.x; Walsh MR, 2009, EVOLUTION, V63, P3201, DOI 10.1111/j.1558-5646.2009.00785.x; Walter RP, 2011, MOL ECOL, V20, P601, DOI 10.1111/j.1365-294X.2010.04968.x	49	41	41	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32713	10.1371/journal.pone.0032713	http://dx.doi.org/10.1371/journal.pone.0032713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412911	Green Published, gold			2022-12-25	WOS:000303021100024
J	Noto, R; Santangelo, MG; Ricagno, S; Mangione, MR; Levantino, M; Pezzullo, M; Martorana, V; Cupane, A; Bolognesi, M; Manno, M				Noto, Rosina; Santangelo, Maria Grazia; Ricagno, Stefano; Mangione, Maria Rosalia; Levantino, Matteo; Pezzullo, Margherita; Martorana, Vincenzo; Cupane, Antonio; Bolognesi, Martino; Manno, Mauro			The Tempered Polymerization of Human Neuroserpin	PLOS ONE			English	Article							SERPIN STRUCTURE; MOLECULAR-BASIS; REACTIVE LOOP; MECHANISM; POLYMERS; KINETICS; PROTEIN; BETA; AGGREGATION; ACCUMULATION	Neuroserpin, a member of the serpin protein superfamily, is an inhibitor of proteolytic activity that is involved in pathologies such as ischemia, Alzheimer's disease, and Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB). The latter belongs to a class of conformational diseases, known as serpinopathies, which are related to the aberrant polymerization of serpin mutants. Neuroserpin is known to polymerize, even in its wild type form, under thermal stress. Here, we study the mechanism of neuroserpin polymerization over a wide range of temperatures by different techniques. Our experiments show how the onset of polymerization is dependent on the formation of an intermediate monomeric conformer, which then associates with a native monomer to yield a dimeric species. After the formation of small polymers, the aggregation proceeds via monomer addition as well as polymer-polymer association. No further secondary mechanism takes place up to very high temperatures, thus resulting in the formation of neuroserpin linear polymeric chains. Most interesting, the overall aggregation is tuned by the co-occurrence of monomer inactivation (i.e. the formation of latent neuroserpin) and by a mechanism of fragmentation. The polymerization kinetics exhibit a unique modulation of the average mass and size of polymers, which might suggest synchronization among the different processes involved. Thus, fragmentation would control and temper the aggregation process, instead of enhancing it, as typically observed (e.g.) for amyloid fibrillation.	[Noto, Rosina; Mangione, Maria Rosalia; Martorana, Vincenzo; Manno, Mauro] Natl Res Council Italy, Inst Biophys, Palermo, Italy; [Santangelo, Maria Grazia; Levantino, Matteo; Cupane, Antonio] Univ Palermo, Dept Phys, I-90123 Palermo, Italy; [Ricagno, Stefano; Pezzullo, Margherita; Bolognesi, Martino] Univ Milan, Inst Biophys CNR, Dept Biomol Sci & Biotechnol, Milan, Italy; [Ricagno, Stefano; Pezzullo, Margherita; Bolognesi, Martino] Univ Milan, CIMAINA, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan	Noto, R (corresponding author), Natl Res Council Italy, Inst Biophys, Palermo, Italy.	mauro.manno@cnr.it	Ricagno, Stefano/G-1456-2015; Levantino, Matteo/C-2433-2008; Ricagno, Stefano/AAH-9763-2020; Bolognesi, Martino/B-7924-2017; Manno, Mauro/F-1385-2010; Levantino, Matteo/ABE-5904-2020	Ricagno, Stefano/0000-0001-6678-5873; Levantino, Matteo/0000-0002-1224-4809; Ricagno, Stefano/0000-0001-6678-5873; Bolognesi, Martino/0000-0002-9253-5170; Manno, Mauro/0000-0001-9843-0428; Levantino, Matteo/0000-0002-1224-4809; Martorana, Vincenzo/0000-0001-7092-6077; Noto, Rosina/0000-0001-6818-7981; Mangione, Maria Rosalia/0000-0002-3466-2569	Fondazione Cariplo, Milano, Italy (NOBEL); Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) (Bando Futuro in Ricerca [FIRB]) [RBLA03B3KC_005]; Telethon - Italy [GGP11057]	Fondazione Cariplo, Milano, Italy (NOBEL); Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) (Bando Futuro in Ricerca [FIRB]); Telethon - Italy(Fondazione Telethon)	SR MP and MB acknowledge the financial support from Fondazione Cariplo, Milano, Italy (NOBEL project Transcriptomics and Proteomics Approaches to Diseases of High Socio-medical Impact: a Technology Integrated Network), from the Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) (Bando Futuro in Ricerca [FIRB] contract RBLA03B3KC_005) and by the financial support of Telethon - Italy (Grant no. GGP11057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CB, 2009, BIOPHYS J, V96, P1529, DOI 10.1016/j.bpj.2008.11.024; Andrews JM, 2007, J PHYS CHEM B, V111, P7897, DOI 10.1021/jp070212j; Barker-Carlson K, 2002, J BIOL CHEM, V277, P46852, DOI 10.1074/jbc.M207740200; Belorgey D, 2004, EUR J BIOCHEM, V271, P3360, DOI 10.1111/j.1432-1033.2004.04270.x; Belorgey D, 2002, J BIOL CHEM, V277, P17367, DOI 10.1074/jbc.M200680200; Belorgey D., 2010, METHODS, V53, P255; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; Cabrita LD, 2004, EUR BIOPHYS J BIOPHY, V33, P83, DOI 10.1007/s00249-003-0356-1; Caccia Sonia, 2010, Biomol Concepts, V1, P117, DOI 10.1515/bmc.2010.019; CARLIER MF, 1987, P NATL ACAD SCI USA, V84, P5257, DOI 10.1073/pnas.84.15.5257; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 2002, NATURE, V407, P923; Carrotta R, 2005, J BIOL CHEM, V280, P30001, DOI 10.1074/jbc.M500052200; Carrotta R, 2009, PHYS CHEM CHEM PHYS, V11, P4007, DOI 10.1039/b818687a; CHEN YD, 1987, P NATL ACAD SCI USA, V84, P8419, DOI 10.1073/pnas.84.23.8419; Chiou A, 2009, BIOPHYS J, V97, P2306, DOI 10.1016/j.bpj.2009.07.057; Cipelletti L, 2000, PHYS REV LETT, V84, P2275, DOI 10.1103/PhysRevLett.84.2275; D'Amico M, 2011, J PHYS CHEM B, V115, P4078, DOI 10.1021/jp106748g; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Davies MJ, 2009, J BIOL CHEM, V284, P18202, DOI 10.1074/jbc.M109.010744; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Davis RL, 2002, LANCET, V359, P2242, DOI 10.1016/S0140-6736(02)09293-0; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Flyvbjerg H, 1996, P NATL ACAD SCI USA, V93, P5975, DOI 10.1073/pnas.93.12.5975; Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jobs E, 1997, PHYS REV LETT, V79, P519, DOI 10.1103/PhysRevLett.79.519; Kinghorn KJ, 2006, J BIOL CHEM, V281, P29268, DOI 10.1074/jbc.M600690200; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Krishnan B, 2011, NAT STRUCT MOL BIOL, V18, P222, DOI 10.1038/nsmb.1976; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Manno M, 2006, BIOPHYS J, V90, P4585, DOI 10.1529/biophysj.105.077636; MARX A, 1994, EUR BIOPHYS J BIOPHY, V22, P405, DOI 10.1007/BF00180162; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2006, CELL MOL LIFE SCI, V63, P709, DOI 10.1007/s00018-005-5077-4; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; OLIVIER BJ, 1990, PHYS REV A, V41, P2093, DOI 10.1103/PhysRevA.41.2093; Onda M, 2005, J BIOL CHEM, V280, P13735; Oosawa F., 1975, THERMODYNAMICS POLYM; Purkayastha P, 2005, BIOCHEMISTRY-US, V44, P2642, DOI 10.1021/bi048662e; Ricagno S, 2010, BIOPHYS J, V99, P3402, DOI 10.1016/j.bpj.2010.09.021; Ricagno S, 2009, J MOL BIOL, V388, P109, DOI 10.1016/j.jmb.2009.02.056; Santangelo MG, 2012, PROTEINS, V80, P8, DOI 10.1002/prot.23197; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sivasothy P, 2000, J BIOL CHEM, V275, P33663, DOI 10.1074/jbc.M004054200; SORENSEN CM, 1987, PHYS REV LETT, V59, P363, DOI 10.1103/PhysRevLett.59.363; TAYLOR TW, 1987, PHYS REV A, V36, P5415, DOI 10.1103/PhysRevA.36.5415; Tsutsui Y, 2008, J BIOL CHEM, V283, P30804, DOI 10.1074/jbc.M804048200; VIGIL RD, 1989, J COLLOID INTERF SCI, V133, P257, DOI 10.1016/0021-9797(89)90300-7; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171	62	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32444	10.1371/journal.pone.0032444	http://dx.doi.org/10.1371/journal.pone.0032444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412873	Green Published, Green Submitted, gold			2022-12-25	WOS:000303021100017
J	Bernal, M; Sanchez-Romero, MA; Salas-Pino, S; Daga, RR				Bernal, Manuel; Antonia Sanchez-Romero, Maria; Salas-Pino, Silvia; Daga, Rafael R.			Regulation of Fission Yeast Morphogenesis by PP2A Activator pta2	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; CELL-DIVISION CYCLE; FORMIN FOR3P; ACTIN CABLES; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; POLARIZED GROWTH; CDC42 ACTIVATION; LOCALIZATION; CYTOSKELETON	Cell polarization is key for the function of most eukaryotic cells, and regulates cell shape, migration and tissue architecture. Fission yeast, Schizosaccharomyces pombe cells are cylindrical and polarize cell growth to one or both cell tips dependent on the cell cycle stage. Whereas microtubule cytoskeleton contributes to the positioning of the growth sites by delivering polarity factors to the cell ends, the Cdc42 GTPase polarizes secretion via actin-dependent delivery and tethering of secretory vesicles to plasma membrane. How growth is restricted to cell tips and how re-initiation of tip growth is regulated in the cell cycle remains poorly understood. In this work we investigated the function of protein phosphatase type 2A (PP2A) in S. pombe morphogenesis by deleting the evolutionary conserved PTPA-type regulatory subunit that we named pta2. pta2-deleted cells showed morphological defects and altered growth pattern. Consistent with this, actin patches and active Cdc42 were mislocalized in the pta2 deletion. These defects were additive to the lack of Cdc42-GAP Rga4. pta2D cells show upregulated Cdc42 activity and pta2 interacts genetically with polarisome components Tea1, Tea4 and For3 leading to complete loss of cell polarity and rounded morphology. Thus, regulation of polarity by PP2A requires the polarisome and involves Pta2-dependent control of Cdc42 activity.	[Bernal, Manuel; Antonia Sanchez-Romero, Maria; Salas-Pino, Silvia; Daga, Rafael R.] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Bernal, M (corresponding author), Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.	rroddag@upo.es	Romero, María Antonia Sánchez-/L-3437-2014; Manuel, Bernal/AAT-9161-2020; salas-pino, silvia/T-7800-2017; Sánchez-Romero, María Antonia/O-4038-2019; Daga, Rafael/P-8340-2014	Romero, María Antonia Sánchez-/0000-0003-3098-1033; salas-pino, silvia/0000-0003-2713-0123; Sánchez-Romero, María Antonia/0000-0003-3098-1033; Daga, Rafael/0000-0001-5726-761X; Bernal, Manuel/0000-0003-0412-3035	Spanish Ministerio de Ciencia e Inovacion from La Junta de Andalucia [BFU2010-21310, P09-CTS-4697]; Spanish Ministerio de Educacion (FPI) [BES-2008-004018]	Spanish Ministerio de Ciencia e Inovacion from La Junta de Andalucia; Spanish Ministerio de Educacion (FPI)(German Research Foundation (DFG)National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants to RRD from the Spanish Ministerio de Ciencia e Inovacion BFU2010-21310 and P09-CTS-4697 (PROYECTO DE EXCELENCIA) from La Junta de Andalucia. MB was supported by Spanish Ministerio de Educacion (FPI Fellowship, BES-2008-004018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bendezu FO, 2011, MOL BIOL CELL, V22, P44, DOI 10.1091/mbc.E10-08-0720; CAYLA X, 1990, BIOCHEMISTRY-US, V29, P658, DOI 10.1021/bi00455a010; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Chang F, 2003, NAT CELL BIOL, V5, P294, DOI 10.1038/ncb0403-294; Chang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001347; CLARKE PR, 1993, MOL BIOL CELL, V4, P397, DOI 10.1091/mbc.4.4.397; Coll PM, 2003, MOL BIOL CELL, V14, P313, DOI 10.1091/mbc.E02-07-0400; Das M, 2007, MOL BIOL CELL, V18, P2090, DOI 10.1091/mbc.E06-09-0883; Das M, 2009, CURR BIOL, V19, P1314, DOI 10.1016/j.cub.2009.06.057; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Estravis M, 2011, TRAFFIC, V12, P1744, DOI 10.1111/j.1600-0854.2011.01275.x; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; Feierbach B, 2004, J CELL BIOL, V165, P697, DOI 10.1083/jcb.200403090; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Ge WZ, 2005, MOL BIOL CELL, V16, P4124, DOI 10.1091/mbc.e04-11-0976; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; HAGAN IM, 1988, J CELL SCI, V89, P343; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Hirota K, 2003, MOL BIOL CELL, V14, P3617, DOI 10.1091/mbc.E02-10-0665; Hoffman GR, 2000, CELL, V102, P403, DOI 10.1016/S0092-8674(00)00045-3; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huisman SM, 2011, SEMIN CELL DEV BIOL, V22, P799, DOI 10.1016/j.semcdb.2011.07.013; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiang W, 2000, GENETICS, V154, P1025; JIMENEZ J, 1994, MOL GEN GENET, V245, P86, DOI 10.1007/BF00279754; Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kelly FD, 2011, MOL BIOL CELL, V22, P3801, DOI 10.1091/mbc.E11-01-0057; Kinoshita K, 1996, GENES CELLS, V1, P29, DOI 10.1046/j.1365-2443.1996.02002.x; KINOSHITA N, 1993, GENE DEV, V7, P1059, DOI 10.1101/gad.7.6.1059; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; Kume K, 2011, NAT CELL BIOL, V13, P234, DOI 10.1038/ncb2166; Lahoz A, 2010, GENETICS, V186, P1261, DOI 10.1534/genetics.110.121368; Le Goff X, 2001, FEBS LETT, V508, P136, DOI 10.1016/S0014-5793(01)03047-2; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; LIN FC, 1995, EMBO J, V14, P2745, DOI 10.1002/j.1460-2075.1995.tb07275.x; MARKS J, 1985, EUR J CELL BIOL, V39, P27; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2005, CELL CYCLE, V4, P1046, DOI 10.4161/cc.4.8.1853; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MAY JW, 1995, CAN J MICROBIOL, V41, P273, DOI 10.1139/m95-037; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Mitchell DA, 2001, MOL CELL BIOL, V21, P488, DOI 10.1128/MCB.21.2.488-500.2001; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moseley JB, 2009, CURR OPIN CELL BIOL, V21, P82, DOI 10.1016/j.ceb.2008.12.005; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Pal G, 2008, J CELL BIOL, V180, P931, DOI 10.1083/jcb.200711014; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Rempola B, 2000, MOL GEN GENET, V262, P1081, DOI 10.1007/PL00008651; Rincon S, 2007, CELL CYCLE, V6, P1687, DOI 10.4161/cc.6.14.4481; Rincon SA, 2009, MOL BIOL CELL, V20, P4390, DOI 10.1091/mbc.E09-03-0207; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; SHIMANUKI M, 1993, MOL BIOL CELL, V4, P303, DOI 10.1091/mbc.4.3.303; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Tatebe H, 2005, CURR BIOL, V15, P1006, DOI 10.1016/j.cub.2005.04.061; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Van Hoof C, 2005, BIOCHEM J, V386, P93, DOI 10.1042/BJ20040887; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Yoshida S, 2008, EMBO REP, V9, P39, DOI 10.1038/sj.embor.7401142	73	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32823	10.1371/journal.pone.0032823	http://dx.doi.org/10.1371/journal.pone.0032823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403715	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700112
J	Ceacero, F; Garcia, AJ; Landete-Castillejos, T; Bartosova, J; Bartos, L; Gallego, L				Ceacero, Francisco; Garcia, Andres J.; Landete-Castillejos, Tomas; Bartosova, Jitka; Bartos, Ludek; Gallego, Laureano			Benefits for Dominant Red Deer Hinds under a Competitive Feeding System: Food Access Behavior, Diet and Nutrient Selection	PLOS ONE			English	Article							WHITE-TAILED DEER; FEMALE MOUNTAIN GOATS; SOCIAL RANK; CERVUS-ELAPHUS; REPRODUCTIVE SUCCESS; BREEDING SUCCESS; PLANT PHENOLOGY; SEX-RATIOS; AGGRESSIVENESS; RUMINANTS	Social dominance is widely known to facilitate access to food resources in many animal species such as deer. However, research has paid little attention to dominance in ad libitum access to food because it was thought not to result in any benefit for dominant individuals. In this study we assessed if, even under ad libitum conditions, social rank may allow dominant hinds to consume the preferred components of food. Forty-four red deer hinds (Cervus elaphus) were allowed to consume ad libitum meal consisting of pellets of sunflower, lucerne and orange, and seeds of cereals, corn, cotton, and carob tree. The meal was placed only in one feeder, which reduced accessibility to a few individuals simultaneously. During seven days, feeding behavior (order of access, time to first feeding bout, total time spent feeding, and time per feeding bout) were assessed during the first hour. The relative abundance of each meal component was assessed at times 0, 1 and 5 h, as well as its nutritional composition. Social rank was positively related to the amount of time spent feeding during the 1st h (P = 0.048). Selection indices were positively correlated with energy (P = 0.018 during the 1st h and P = 0.047 from 1st to 5th) and fat (only during the 1st h; P = 0.036), but also negatively with certain minerals. Thus, dominant hinds could select high energy meal components for longer time under an ad libitum but restricted food access setting. Selection indices showed a higher selectivity when food availability was higher (1st hour respect to 1st to 5th). Finally, high and low ranking hinds had longer time per feeding bout than mid ones (P = 0.011), suggesting complex behavioral feeding tactics of low ranking social ungulates.	[Ceacero, Francisco; Garcia, Andres J.; Landete-Castillejos, Tomas; Gallego, Laureano] Univ Castilla La Mancha, ETSIA, Dept Ciencia & Tecnol Agroforestal & Genet, Albacete, Spain; [Ceacero, Francisco; Bartosova, Jitka; Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Garcia, Andres J.; Landete-Castillejos, Tomas] Univ Castilla La Mancha, IDR, Secc Recursos Cineget, Albacete, Spain; [Garcia, Andres J.; Landete-Castillejos, Tomas] IREC Sec Albacete, Anim Sci Techniques Appl Wildlife Management Res, Albacete, Spain	Universidad de Castilla-La Mancha; Czech Research Institute of Animal Science; Universidad de Castilla-La Mancha	Ceacero, F (corresponding author), Univ Castilla La Mancha, ETSIA, Dept Ciencia & Tecnol Agroforestal & Genet, Albacete, Spain.	francisco.ceacero@uclm.es	Ceacero, Francisco/C-1088-2009; Bartosova, Jitka/U-7255-2019; Bartosova, Jitka/A-4908-2019; Garcia Diaz, Andres Jose/A-9162-2012; Gallego, Laureano/G-9715-2015	Ceacero, Francisco/0000-0001-9014-147X; Bartosova, Jitka/0000-0002-4675-3310; Garcia Diaz, Andres Jose/0000-0002-4662-2185; Gallego, Laureano/0000-0001-8219-087X; Landete Castillejos, Tomas/0000-0001-9753-5295	JCCM [CPA-034/08, 2009-18072]; Czech Science Foundation [523/08/P301]; Junta de Comunidades de Castilla-La Mancha, Spain [POII10-0129-0562]; Ministerio de Ciencia e Innovacion, Spain [CGL2011-24811/BOS]; Ministry of Agriculture, Czech Republic [MZe 0002701404]	JCCM; Czech Science Foundation(Grant Agency of the Czech Republic); Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Agriculture, Czech Republic(Ministry of Agriculture, Czech Republic)	FC was supported by a research contract (CPA-034/08) and post-doc funding (2009-18072) by JCCM. JB was supported by the Czech Science Foundation (project No. 523/08/P301). This study was supported by projects POII10-0129-0562 (Junta de Comunidades de Castilla-La Mancha, Spain), CGL2011-24811/BOS (Ministerio de Ciencia e Innovacion, Spain), and MZe 0002701404 (Ministry of Agriculture, Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALADOS CL, 1992, ETHOL ECOL EVOL, V4, P151, DOI 10.1080/08927014.1992.9525336; ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; APPLEBY MC, 1980, BEHAVIOUR, V74, P294, DOI 10.1163/156853980X00519; Asher GW, 2011, LIVEST SCI, V140, P8, DOI 10.1016/j.livsci.2011.02.002; Atienza Juan Carlos, 1994, Ardeola, V41, P173; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; BARRETTE C, 1986, BEHAVIOUR, V97, P118, DOI 10.1163/156853986X00342; Barroso FG, 2000, APPL ANIM BEHAV SCI, V69, P35, DOI 10.1016/S0168-1591(00)00113-1; Baumgardt BR, 1970, PHYSL DIGESTION META, P235; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P105, DOI 10.1016/0040-5809(78)90007-2; Berteaux D, 1998, OECOLOGIA, V115, P84, DOI 10.1007/s004420050494; Cassinello J, 2002, ZOO BIOL, V21, P597, DOI 10.1002/zoo.10062; Ceacero F, 2007, ETHOLOGY, V113, P1133, DOI 10.1111/j.1439-0310.2007.01427.x; Ceacero F, 2010, PHYSIOL BEHAV, V100, P122, DOI 10.1016/j.physbeh.2010.02.008; Ceacero F, 2010, BRIT J NUTR, V103, P617, DOI 10.1017/S0007114509992091; Ceacero F, 2009, LIVEST SCI, V122, P345, DOI 10.1016/j.livsci.2008.08.002; Chevallier-Redor N, 2001, ANIM RES, V50, P57, DOI 10.1051/animres:2001116; CLUTTONBROCK TH, 1986, ANIM BEHAV, V34, P460, DOI 10.1016/S0003-3472(86)80115-4; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; COPPOCK CE, 1981, J DAIRY SCI, V64, P1230, DOI 10.3168/jds.S0022-0302(81)82698-7; Cote SD, 2000, ETHOLOGY, V106, P945, DOI 10.1046/j.1439-0310.2000.00606.x; Cote SD, 2001, ANIM BEHAV, V62, P173, DOI 10.1006/anbe.2001.1719; Cote SD, 2000, BEHAVIOUR, V137, P1541, DOI 10.1163/156853900502718; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; Dennehy JJ, 2001, BEHAV ECOL, V12, P177, DOI 10.1093/beheco/12.2.177; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Devries TJ, 2009, J DAIRY SCI, V92, P1161, DOI 10.3168/jds.2008-1314; DeVries TJ, 2004, J DAIRY SCI, V87, P1432, DOI 10.3168/jds.S0022-0302(04)73293-2; DINIUS DA, 1970, J DAIRY SCI, V53, P311, DOI 10.3168/jds.S0022-0302(70)86202-6; Dubuc C, 2007, INT J PRIMATOL, V28, P357, DOI 10.1007/s10764-007-9118-8; FESTABIANCHET M, 1991, ANIM BEHAV, V42, P71, DOI 10.1016/S0003-3472(05)80607-4; Forbes JM, 2007, NUTR RES REV, V20, P132, DOI 10.1017/S0954422407797834; Forbes J. Michael, 2007, P1, DOI [10.1079/9781845932794.0341, 10.1079/9781845932794.0041, 10.1079/9781845932794.0310, 10.1079/9781845932794.0365, 10.1079/9781845932794.0243, 10.1079/9781845932794.0000]; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; GRASMAN BT, 1993, ECOLOGY, V74, P2279, DOI 10.2307/1939581; HALL MJ, 1983, Z TIERPSYCHOL, V61, P250; JIANG Z, 1993, EVOL ECOL, V7, P488, DOI 10.1007/BF01237643; Kelly R. W., 1975, Applied Animal Ethology, V1, P293, DOI 10.1016/0304-3762(75)90022-X; Landete-Castillejos T, 2010, J DAIRY RES, V77, P77, DOI 10.1017/S0022029909990392; Loudon ASI, 1984, S ZOOL SOC LOND, V51, P233; Lovari S., 1985, P102; Manly B.F.J., 2002, RESOURCE SELECTION A; MASTELLER MA, 1988, CAN J ZOOL, V66, P2585, DOI 10.1139/z88-381; MURDEN SB, 1993, ECOL APPL, V3, P497, DOI 10.2307/1941918; Mysterud A, 2001, J ANIM ECOL, V70, P915, DOI 10.1046/j.0021-8790.2001.00559.x; National Research Council, 2007, NUTR REQ SMALL RUM S, DOI [10.17226/11654, DOI 10.17226/11654]; Oftedal O.T., 1985, P215; OWENSMITH N, 1982, AM NAT, V119, P151, DOI 10.1086/283902; OZOGA JJ, 1972, J WILDLIFE MANAGE, V36, P861, DOI 10.2307/3799441; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; POPPI DP, 1995, J ANIM SCI, V73, P278; PRINS HHT, 1989, ETHOLOGY, V81, P47, DOI 10.1111/j.1439-0310.1989.tb00757.x; Provenza FD, 2006, FEEDING IN DOMESTIC VERTEBRATES: FROM STRUCTURE TO BEHAVIOUR, P210, DOI 10.1079/9781845930639.0210; PROVENZA FD, 1987, APPL ANIM BEHAV SCI, V18, P211, DOI 10.1016/0168-1591(87)90218-8; REINHARDT V, 1983, BEHAVIOUR, V87, P1, DOI 10.1163/156853983X00093; Rodriguez-Berrocal J, 1993, UTILIZACION RECURSOS; RUTBERG AT, 1986, BEHAVIOUR, V96, P62, DOI 10.1163/156853986X00225; Schmidt KT, 1999, ETHOLOGY, V105, P349, DOI 10.1046/j.1439-0310.1999.00385.x; SYME LA, 1975, ANIM BEHAV, V23, P609, DOI 10.1016/0003-3472(75)90138-4; Taillon J, 2007, ANIM BEHAV, V74, P265, DOI 10.1016/j.anbehav.2006.11.018; THOULESS CR, 1986, ANIM BEHAV, V34, P1166, DOI 10.1016/S0003-3472(86)80176-2; THOULESS CR, 1990, ANIM BEHAV, V40, P105, DOI 10.1016/S0003-3472(05)80669-4; Val-Laillet D, 2008, APPL ANIM BEHAV SCI, V111, P158, DOI 10.1016/j.applanim.2007.06.001; Val-Laillet D, 2009, APPL ANIM BEHAV SCI, V116, P141, DOI 10.1016/j.applanim.2008.08.005; vanWieren SE, 1996, FOREST ECOL MANAG, V88, P149, DOI 10.1016/S0378-1127(96)03877-7; Veiberg V, 2004, OECOLOGIA, V138, P135, DOI 10.1007/s00442-003-1399-9; Verheyden-Tixier H, 2008, OECOLOGIA, V156, P715, DOI 10.1007/s00442-008-1020-3; Weckerly FW, 1999, CAN J ZOOL, V77, P1379, DOI 10.1139/cjz-77-9-1379; Zebeli Q, 2010, LIVEST SCI, V127, P1, DOI 10.1016/j.livsci.2009.09.003	72	44	44	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32780	10.1371/journal.pone.0032780	http://dx.doi.org/10.1371/journal.pone.0032780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403707	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700104
J	Covaceuszach, S; Marinelli, S; Krastanova, I; Ugolini, G; Pavone, F; Lamba, D; Cattaneo, A				Covaceuszach, Sonia; Marinelli, Sara; Krastanova, Ivet; Ugolini, Gabriele; Pavone, Flaminia; Lamba, Doriano; Cattaneo, Antonino			Single Cycle Structure-Based Humanization of an Anti-Nerve Growth Factor Therapeutic Antibody	PLOS ONE			English	Article							MURINE MONOCLONAL-ANTIBODIES; RESHAPING HUMAN-ANTIBODIES; BASAL FOREBRAIN; CRYSTAL-STRUCTURES; TYROSINE KINASE; PAIN; TRKA; RECEPTOR; DOMAIN; NEUROTROPHINS	Most forms of chronic pain are inadequately treated by present therapeutic options. Compelling evidence has accumulated, demonstrating that Nerve Growth Factor (NGF) is a key modulator of inflammatory and nociceptive responses, and is a promising target for the treatment of human pathologies linked to chronic and inflammatory pain. There is therefore a growing interest in the development of therapeutic molecules antagonising the NGF pathway and its nociceptor sensitization actions, among which function-blocking anti-NGF antibodies are particularly relevant candidates. In this respect, the rat anti-NGF alpha D11 monoclonal antibody (mAb) is a potent antagonist, able to effectively antagonize rodent and human NGF in a variety of in vitro and in vivo systems. Here we show that mAb alpha D11 displays a significant analgesic effect in two different models of persistent pain in mice, with a remarkable long-lasting activity. In order to advance alpha D11 mAb towards its clinical application in man, anti-NGF alpha D11 mAb was humanized by applying a novel single cycle strategy based on the a priori experimental determination of the crystal and molecular structure of the parental Fragment antigen-binding (Fab). The humanized antibody (hum-alpha D11) was tested in vitro and in vivo, showing that the binding mode and the NGF neutralizing biological activities of the parental antibody are fully preserved, with even a significant affinity improvement. The results firmly establish hum-alpha D11 as a lead candidate for clinical applications in a therapeutic area with a severe unmet medical need. More generally, the single-cycle structure-based humanization method represents a considerable improvement over the standard humanization methods, which are intrinsically empirical and require several refinement cycles.	[Covaceuszach, Sonia; Ugolini, Gabriele] SpA, Lay Line Genom, Rome, Italy; [Covaceuszach, Sonia; Pavone, Flaminia] CNR, Ist Cristallog, Trieste, Italy; [Marinelli, Sara] CNR, Ist Biol Cellulare & Neurobiol, Rome, Italy; [Krastanova, Ivet] Sincrotrone Trieste SCpA, Struct Biol Lab, Trieste, Italy; [Cattaneo, Antonino] European Brain Res Inst, Rome, Italy; [Cattaneo, Antonino] Scuola Normale Super Pisa, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Elettra Sincrotrone Trieste; Scuola Normale Superiore di Pisa	Covaceuszach, S (corresponding author), SpA, Lay Line Genom, Rome, Italy.	antonino.cattaneo@sns.it	Marinelli, Sara/L-7738-2019; Cattaneo, Antonino/AAA-7252-2019; Covaceuszach, Sonia/AAA-4116-2021; Lamba, Doriano/L-9808-2018; Cattaneo, Antonino/K-4471-2016; Lamba, Doriano/B-2961-2011	Marinelli, Sara/0000-0001-5393-4796; Lamba, Doriano/0000-0001-6859-7868; Cattaneo, Antonino/0000-0002-6975-8923; Lamba, Doriano/0000-0001-6859-7868; Pavone, Flaminia/0000-0001-5189-2748	Ministero Italiano dell'Universita e Ricerca Scientifica "Progetti di Ricerca di Interesse Nazionale" (PRIN) [2007LP44TW]	Ministero Italiano dell'Universita e Ricerca Scientifica "Progetti di Ricerca di Interesse Nazionale" (PRIN)(Ministry of Education, Universities and Research (MIUR))	The research was sponsored by the Ministero Italiano dell'Universita e Ricerca Scientifica "Progetti di Ricerca di Interesse Nazionale'' (PRIN 2007LP44TW). No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdiche YN, 2008, PROTEIN SCI, V17, P1326, DOI 10.1110/ps.035402.108; ALOE L, 1992, ARTHRITIS RHEUM, V35, P351, DOI 10.1002/art.1780350315; Banfield MJ, 1997, PROTEINS, V29, P161, DOI 10.1002/(SICI)1097-0134(199710)29:2<161::AID-PROT4>3.0.CO;2-G; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; BERARDI N, 1994, P NATL ACAD SCI USA, V91, P684, DOI 10.1073/pnas.91.2.684; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capsoni S, 2010, P NATL ACAD SCI USA, V107, P12299, DOI 10.1073/pnas.1007181107; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Carvalho OP, 2011, J MED GENET, V48, P131, DOI 10.1136/jmg.2010.081455; CATTANEO A, 1988, J NEUROCHEM, V50, P1003, DOI 10.1111/j.1471-4159.1988.tb10565.x; Cattaneo A, 1999, J NEUROSCI, V19, P9687; Cattaneo A, 2005, Patent, Patent No. [WO/2005/061540, 2005061540]; Cattaneo A, 2010, CURR OPIN MOL THER, V12, P94; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHEVALIER S, 1994, BLOOD, V83, P1479; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; CO MS, 1991, P NATL ACAD SCI USA, V88, P2869, DOI 10.1073/pnas.88.7.2869; Covaceuszach S, 2005, PROTEINS, V58, P717, DOI 10.1002/prot.20366; Covaceuszach S, 2004, ACTA CRYSTALLOGR D, V60, P1323, DOI 10.1107/S0907444904011485; Covaceuszach S, 2008, J MOL BIOL, V381, P881, DOI 10.1016/j.jmb.2008.06.008; Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158, DOI 10.2174/156720509787602870; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIEDERICHS K, 1995, PROTEINS, V23, P187, DOI 10.1002/prot.340230208; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; Faelber K, 2001, J MOL BIOL, V313, P83, DOI 10.1006/jmbi.2001.5036; Fan ZC, 1999, J MOL RECOGNIT, V12, P19, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<19::AID-JMR445>3.0.CO;2-Y; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Garaci E, 2003, P NATL ACAD SCI USA, V100, P8927, DOI 10.1073/pnas.1332627100; GORMAN SD, 1991, P NATL ACAD SCI USA, V88, P4181, DOI 10.1073/pnas.88.10.4181; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haidar JN, 2012, PROTEINS, V80, P896, DOI 10.1002/prot.23246; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Hefti FF, 2006, TRENDS PHARMACOL SCI, V27, P85, DOI 10.1016/j.tips.2005.12.001; HOLLAND DR, 1994, J MOL BIOL, V239, P385, DOI 10.1006/jmbi.1994.1380; Indo Y, 2001, HUM MUTAT, V18, P462, DOI 10.1002/humu.1224; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat E. A., 1991, NIH PUBLICATION; KOLBINGER F, 1993, PROTEIN ENG, V6, P971, DOI 10.1093/protein/6.8.971; Kruttgen A, 2006, BRAIN PATHOL, V16, P304, DOI 10.1111/j.1750-3639.2006.00037.x; Kuroda D, 2008, PROTEINS, V73, P608, DOI 10.1002/prot.22087; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; LEVIMONTALCINI R, 1964, SCIENCE, V143, P105, DOI 10.1126/science.143.3602.105; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LeviMontalcini R, 1996, TRENDS NEUROSCI, V19, P514, DOI 10.1016/S0166-2236(96)10058-8; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; Makabe K, 2008, J BIOL CHEM, V283, P1156, DOI 10.1074/jbc.M706190200; Miller LJ, 2002, UROLOGY, V59, P603, DOI 10.1016/S0090-4295(01)01597-7; Molnar M, 1998, EUR J NEUROSCI, V10, P3127, DOI 10.1046/j.1460-9568.1998.00314.x; Molnar M, 1997, NEUROREPORT, V8, P575, DOI 10.1097/00001756-199701200-00039; Morea V, 1998, J MOL BIOL, V275, P269, DOI 10.1006/jmbi.1997.1442; Nicol GD, 2007, MOL INTERV, V7, P26, DOI 10.1124/mi.7.1.6; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; PEDERSEN JT, 1994, J MOL BIOL, V235, P959, DOI 10.1006/jmbi.1994.1050; Persic L, 1997, GENE, V187, P9, DOI 10.1016/S0378-1119(96)00628-2; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; RIECHMANN L, 1992, J MOL BIOL, V224, P913, DOI 10.1016/0022-2836(92)90459-W; Roguska MA, 1996, PROTEIN ENG, V9, P895, DOI 10.1093/protein/9.10.895; ROGUSKA MA, 1994, P NATL ACAD SCI USA, V91, P969, DOI 10.1073/pnas.91.3.969; RUBERTI F, 1993, CELL MOL NEUROBIOL, V13, P559, DOI 10.1007/BF00711464; Shirai H, 1999, FEBS LETT, V455, P188, DOI 10.1016/S0014-5793(99)00821-2; Shirai H, 1996, FEBS LETT, V399, P1, DOI 10.1016/S0014-5793(96)01252-5; Svensson P, 2003, PAIN, V104, P241, DOI 10.1016/S0304-3959(03)00012-5; TEMPEST PR, 1991, BIO-TECHNOL, V9, P266, DOI 10.1038/nbt0391-266; Ugolini G, 2007, P NATL ACAD SCI USA, V104, P2985, DOI 10.1073/pnas.0611253104; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; Watson JJ, 2008, BIODRUGS, V22, P349, DOI 10.2165/0063030-200822060-00002; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wood JN, 2010, NEW ENGL J MED, V363, P1572, DOI 10.1056/NEJMe1004416; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	78	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32212	10.1371/journal.pone.0032212	http://dx.doi.org/10.1371/journal.pone.0032212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403636	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700033
J	Hoffmann, BR; Liu, YY; Mosher, DF				Hoffmann, Brian R.; Liu, Yuanyuan; Mosher, Deane F.			Modification of EGF-Like Module 1 of Thrombospondin-1, an Animal Extracellular Protein, by O-Linked N-Acetylglucosamine	PLOS ONE			English	Article							C-MANNOSYLATION; FUCOSYLATION; DOMAIN; GLCNACYLATION; LOCALIZATION; SECRETION; REPEATS; CALCIUM; SITES; NOTCH	Thrombospondin-1 (TSP-1) is known to be subject to three unusual carbohydrate modifications: C-mannosylation, O-fucosylation, and O-glucosylation. We now describe a fourth: O-beta-N-acetylglucosaminylation. Previously, O-beta-N-acetylglucosamine (O-beta-GlcNAc) was found on a threonine in the loop between the fifth and sixth cysteines of the 20th epidermal growth factor (EGF)-like module of Drosophila Notch. A BLAST search based on the Drosophila Notch loop sequence identified a number of human EGF-like modules that contain a similar sequence, including EGF-like module 1 of TSP-1 and its homolog, TSP-2. TSP-1, which has a potentially modifiable serine in the loop, reacted in immuno-blots with the CTD110.6 anti-O-GlcNAc antibody. Antibody reactivity was diminished by treatment of TSP-1 with beta-N-acetylhexosaminidase. TSP-2, which lacks a potentially modifiable serine/threonine in the loop, did not react with CTD110.6. Analysis of tandem modules of TSP-1 localized reactivity of CTD110.6 to EGF-like module 1. Top-down mass spectrometric analysis of EGF-like module 1 demonstrated the expected modifications with glucose (+ 162 Da) and xylose (+ 132 Da) separately from modification with N-acetyl hexosamine (+ 203 Da). Mass spectrometric sequence analysis localized the + 203-Da modification to Ser580 in the sequence (575)CPPGYSGNGIQC(586). These results demonstrate that O-beta-N-acetylglucosaminylation can occur on secreted extracellular matrix proteins as well as on cell surface proteins.	[Hoffmann, Brian R.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hoffmann, BR (corresponding author), Univ Wisconsin, Dept Med, Madison, WI 53706 USA.	dfm1@medicine.edu	Liu, Yuanyuan/E-9439-2013		National Institutes of Health [RO1HL054462, T32-HL007899]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054462, T32HL007899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [RO1HL054462 to DFM; T32-HL007899 to BRH] (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Adams JC, 2000, DEV DYNAM, V218, P280; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; Bentley AA, 2010, MOL BIOL EVOL, V27, P2187, DOI 10.1093/molbev/msq107; CAPASSO JM, 1988, J BIOL CHEM, V263, P19778; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Furmanek A, 2000, ACTA BIOCHIM POL, V47, P781, DOI 10.18388/abp.2000_3996; Goletz S, 1997, GLYCOBIOLOGY, V7, P881, DOI 10.1093/glycob/7.7.881; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; LAWLER J, 1982, J BIOL CHEM, V257, P2257; Liu YY, 2009, J BIOL CHEM, V284, P28563, DOI 10.1074/jbc.M109.035089; Liu YY, 2009, J BIOL CHEM, V284, P22206, DOI 10.1074/jbc.M109.026120; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MURPHYULLRICH JE, 1985, BLOOD, V66, P1098; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wang JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-91; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32762	10.1371/journal.pone.0032762	http://dx.doi.org/10.1371/journal.pone.0032762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403705	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700102
J	Mathew, A; Fukuda, T; Nagaoka, Y; Hasumura, T; Morimoto, H; Yoshida, Y; Maekawa, T; Venugopal, K; Kumar, DS				Mathew, Anila; Fukuda, Takahiro; Nagaoka, Yutaka; Hasumura, Takashi; Morimoto, Hisao; Yoshida, Yasuhiko; Maekawa, Toru; Venugopal, Kizhikkilot; Kumar, D. Sakthi			Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; AMYLOID PATHOLOGY; OXIDATIVE DAMAGE; CANCER-THERAPY; FORMULATION; DELIVERY; VITRO; BIOAVAILABILITY	Alzheimer's disease is a growing concern in the modern world. As the currently available medications are not very promising, there is an increased need for the fabrication of newer drugs. Curcumin is a plant derived compound which has potential activities beneficial for the treatment of Alzheimer's disease. Anti-amyloid activity and anti-oxidant activity of curcumin is highly beneficial for the treatment of Alzheimer's disease. The insolubility of curcumin in water restricts its use to a great extend, which can be overcome by the synthesis of curcumin nanoparticles. In our work, we have successfully synthesized water-soluble PLGA coated-curcumin nanoparticles and characterized it using different techniques. As drug targeting to diseases of cerebral origin are difficult due to the stringency of blood-brain barrier, we have coupled the nanoparticle with Tet-1 peptide, which has the affinity to neurons and possess retrograde transportation properties. Our results suggest that curcumin encapsulated-PLGA nanoparticles are able to destroy amyloid aggregates, exhibit anti-oxidative property and are non-cytotoxic. The encapsulation of the curcumin in PLGA does not destroy its inherent properties and so, the PLGA-curcumin nanoparticles can be used as a drug with multiple functions in treating Alzheimer's disease proving it to be a potential therapeutic tool against this dreaded disease.	[Mathew, Anila; Fukuda, Takahiro; Nagaoka, Yutaka; Hasumura, Takashi; Morimoto, Hisao; Yoshida, Yasuhiko; Maekawa, Toru; Kumar, D. Sakthi] Toyo Univ, Grad Sch Interdisciplinary New Sci, Bio Nano Elect Res Ctr, Kawagoe, Saitama, Japan; [Venugopal, Kizhikkilot] Sooriya Hosp, Dept Resp Med, Madras, Tamil Nadu, India	Toyo University	Mathew, A (corresponding author), Toyo Univ, Grad Sch Interdisciplinary New Sci, Bio Nano Elect Res Ctr, Kawagoe, Saitama, Japan.	sakthi@toyo.jp		Kumar, Sakthi/0000-0003-4624-7327	Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [22560209] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Anila Mathew sincerely acknowledges her receipt of the Monbukagakusho Scholarship from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2011, NATURE, V475, pS2, DOI 10.1038/475S2a; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Balasubramanian K, 2006, J AGR FOOD CHEM, V54, P3512, DOI 10.1021/jf0603533; Bartczak D, 2011, LANGMUIR, V27, P10119, DOI 10.1021/la2022177; Bisht Savita, 2007, Journal of Nanobiotechnology, V5, P3, DOI 10.1186/1477-3155-5-3; Cartiera MS, 2010, MOL PHARMACEUT, V7, P86, DOI 10.1021/mp900138a; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Fujisawa S, 2004, ANTICANCER RES, V24, P563; Gao XL, 2006, BIOMATERIALS, V27, P3482, DOI 10.1016/j.biomaterials.2006.01.038; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Hanz S, 2004, NEUROSCIENTIST, V10, P404, DOI 10.1177/1073858404267884; Iqbal K, 2007, CELL MOL LIFE SCI, V64, P2234, DOI 10.1007/s00018-007-7221-9; Li JW, 2011, BIOMATERIALS, V32, P4943, DOI 10.1016/j.biomaterials.2011.03.031; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Liu JK, 2005, NEUROBIOL DIS, V19, P407, DOI 10.1016/j.nbd.2005.01.022; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Mohorko N, 2010, J NEUROPATH EXP NEUR, V69, P405, DOI 10.1097/NEN.0b013e3181d709eb; Mondalek Fadee G., 2010, Journal of Nanobiotechnology, V8, P17, DOI 10.1186/1477-3155-8-17; Mourtas S, 2011, BIOMATERIALS, V32, P1635, DOI 10.1016/j.biomaterials.2010.10.027; Mukerjee A, 2009, ANTICANCER RES, V29, P3867; Noga DE, 2008, BIOMACROMOLECULES, V9, P2056, DOI [10.1021/bm800292z, 10.1021/bm800292Z]; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Park IK, 2007, J GENE MED, V9, P691, DOI 10.1002/jgm.1062; Park SY, 2008, FOOD CHEM TOXICOL, V46, P2881, DOI 10.1016/j.fct.2008.05.030; Rafii MS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-7; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Shaikh J, 2009, EUR J PHARM SCI, V37, P223, DOI 10.1016/j.ejps.2009.02.019; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Shive MS, 1997, ADV DRUG DELIV REV, V28, P5; Taylor M, 2011, NANOMED-NANOTECHNOL, V7, P541, DOI 10.1016/j.nano.2011.06.015; Tosi G, 2007, J CONTROL RELEASE, V122, P1, DOI 10.1016/j.jconrel.2007.05.022; Tsai YM, 2011, INT J PHARMACEUT, V416, P331, DOI 10.1016/j.ijpharm.2011.06.030; Vergoni AV, 2009, NANOMED-NANOTECHNOL, V5, P369, DOI 10.1016/j.nano.2009.02.005; Yanagisawa D, 2010, BIOMATERIALS, V31, P4179, DOI 10.1016/j.biomaterials.2010.01.142; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Youdim MBH, 2005, J NEURAL TRANSM, V112, P519, DOI 10.1007/s00702-004-0214-z	43	259	264	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32616	10.1371/journal.pone.0032616	http://dx.doi.org/10.1371/journal.pone.0032616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403681	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700078
J	Hsu, ACY; Parsons, K; Barr, I; Lowther, S; Middleton, D; Hansbro, PM; Wark, PAB				Hsu, Alan C-Y.; Parsons, Kristy; Barr, Ian; Lowther, Sue; Middleton, Deborah; Hansbro, Philip M.; Wark, Peter A. B.			Critical Role of Constitutive Type I Interferon Response in Bronchial Epithelial Cell to Influenza Infection	PLOS ONE			English	Article							VIRUS NS1 PROTEIN; CYCLOHEXIMIDE-INDUCED APOPTOSIS; A VIRUS; RIG-I; AVIAN INFLUENZA; RNA VIRUSES; KINASE PKR; POLY(A)-BINDING PROTEIN; TRANSCRIPTION FACTORS; RECEPTOR SPECIFICITY	Innate antiviral responses in bronchial epithelial cells (BECs) provide the first line of defense against respiratory viral infection and the effectiveness of this response is critically dependent on the type I interferons (IFNs). However the importance of the antiviral responses in BECs during influenza infection is not well understood. We profiled the innate immune response to infection with H3N2 and H5N1 virus using Calu-3 cells and primary BECs to model proximal airway cells. The susceptibility of BECs to influenza infection was not solely dependent on the sialic acid-bearing glycoprotein, and antiviral responses that occurred after viral endocytosis was more important in limiting viral replication. The early antiviral response and apoptosis correlated with the ability to limit viral replication. Both viruses reduced RIG-I associated antiviral responses and subsequent induction of IFN-beta. However it was found that there was constitutive release of IFN-beta by BECs and this was critical in inducing late antiviral signaling via type I IFN receptors, and was crucial in limiting viral infection. This study characterizes anti-influenza virus responses in airway epithelial cells and shows that constitutive IFN-beta release plays a more important role in initiating protective late IFN-stimulated responses during human influenza infection in bronchial epithelial cells.	[Hsu, Alan C-Y.; Parsons, Kristy; Hansbro, Philip M.; Wark, Peter A. B.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Barr, Ian] World Hlth Org, Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia; [Lowther, Sue; Middleton, Deborah] Australian Anim Hlth Lab, Commonwealth Sci & Ind Res Org CSIRO, Geelong, Vic, Australia; [Wark, Peter A. B.] John Hunter Hosp, Dept Resp & Sleep Med, Newcastle, NSW, Australia	University of Newcastle; World Health Organization; Commonwealth Scientific & Industrial Research Organisation (CSIRO); John Hunter Hospital	Hsu, ACY (corresponding author), Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia.	Alan.Hsu@uon.edu.au	Hansbro, Phil/G-7486-2013; Wark, Peter/G-7037-2013; Hsu, Alan/A-3144-2012	Hansbro, Phil/0000-0002-4741-3035; Wark, Peter/0000-0001-5676-6126; Hsu, Alan/0000-0002-6640-0846; Barr, Ian/0000-0002-7351-418X	National Health and Medical Research Council (NHMRC) [G47767]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council (NHMRC G47767; www.nhmrc.gov.au). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessenko AV, 1997, FEBS LETT, V416, P113, DOI 10.1016/S0014-5793(97)01161-7; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; BOCCI V, 1985, LYMPHOKINE RES, V4, P151; BOCCI V, 1985, MICROBIOLOGICA, V8, P405; Bornholdt ZA, 2008, NATURE; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Clemens MJ, 2003, J INTERF CYTOK RES, V23, P277, DOI 10.1089/107999003766628124; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; DEMAEYERGUIGNARD J, 1988, ANN INST PASTEUR VIR, V139, P51, DOI 10.1016/S0769-2617(88)80005-4; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fraser C, 2009, PANDEMIC POTENTIAL S; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garcia-Sastre A, 2006, EMERG INFECT DIS, V12, P44, DOI 10.3201/eid1201.051186; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hsu AC, 2010, AM J RESP CELL MOL B; Hsu ACY, 2011, AM J RESP CELL MOL, V44, P906, DOI 10.1165/rcmb.2010-0157OC; HUPRIKAR J, 1980, J VIROL METHODS, V1, P117, DOI 10.1016/0166-0934(80)90020-8; HURD SZ, 1991, J ALLERGY CLIN IMMUN, V88, P808; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Matsukura S, 2007, INT ARCH ALLERGY IMM, V143, P80, DOI 10.1159/000101411; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Oshansky CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021183; Phipps-Yonas H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000193; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ranjan P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-102; RINGOLD GM, 1984, P NATL ACAD SCI-BIOL, V81, P3964, DOI 10.1073/pnas.81.13.3964; Ryan-Poirier K, 1998, VIRUS RES, V56, P169, DOI 10.1016/S0168-1702(98)00067-7; Saedisomeolia A, 2009, BRIT J NUTR, V101, P533, DOI 10.1017/S0007114508025798; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Suzuki Y, 1998, Tanpakushitsu Kakusan Koso, V43, P2559; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Watanabe A, 2011, J BIOL CHEM, V286, P10702, DOI 10.1074/jbc.M110.185793; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhu QY, 2008, J VIROL, V82, P220, DOI 10.1128/JVI.00978-07	69	62	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32947	10.1371/journal.pone.0032947	http://dx.doi.org/10.1371/journal.pone.0032947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396801	Green Published, gold			2022-12-25	WOS:000303006500037
J	Lever, M; George, PM; Atkinson, W; Elmslie, JL; Slow, S; Molyneux, SL; Troughton, RW; Richards, AM; Frampton, CM; Chambers, ST				Lever, Michael; George, Peter M.; Atkinson, Wendy; Elmslie, Jane L.; Slow, Sandy; Molyneux, Sarah L.; Troughton, Richard W.; Richards, A. Mark; Frampton, Christopher M.; Chambers, Stephen T.			The Contrasting Relationships between Betaine and Homocysteine in Two Clinical Cohorts are Associated with Plasma Lipids and Drug Treatments	PLOS ONE			English	Article							GLYCINE BETAINE; CARDIOVASCULAR EVENTS; EXCRETION; CHOLINE; DERIVATIVES; METABOLISM; RISK	Background: Urinary betaine excretion positively correlated with plasma homocysteine in outpatients attending a lipid disorders clinic (lipid clinic study). We aimed to confirm this in subjects with established vascular disease. Methods: The correlation between betaine excretion and homocysteine was compared in samples collected from subjects 4 months after hospitalization for an acute coronary episode (ACS study, 415 urine samples) and from 158 sequential patients visiting a lipid disorders clinic. Principal findings: In contrast to the lipid clinic study, betaine excretion and plasma homocysteine did not correlate in the total ACS cohort. Differences between the patient groups included age, non-HDL cholesterol and medication. In ACS subjects with below median betaine excretion, excretion correlated (using log transformed data) negatively with plasma homocysteine (r = -20.17, p = 0.019, n = 199), with no correlation in the corresponding subset of the lipid clinic subjects. In ACS subjects with above median betaine excretion a positive trend (r = +0.10) between betaine excretion and homocysteine was not significant; the corresponding correlation in lipid clinic subjects was r = +0.42 (p = 0.0001). In ACS subjects, correlations were stronger when plasma non-HDL cholesterol and betaine excretion were above the median, r = +0.20 (p = 0.045); in subjects above median non-HDL cholesterol and below median betaine excretion, r = -20.26 (p = 0.012). ACS subjects taking diuretics or proton pump inhibitors had stronger correlations, negative with lower betaine excretion and positive with higher betaine excretion. Conclusions: Betaine excretion correlates with homocysteine in subjects with elevated blood lipids.	[Lever, Michael; George, Peter M.; Atkinson, Wendy; Elmslie, Jane L.; Slow, Sandy; Molyneux, Sarah L.] Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand; [Lever, Michael; George, Peter M.; Slow, Sandy; Chambers, Stephen T.] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand; [Troughton, Richard W.; Richards, A. Mark; Frampton, Christopher M.] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Med, Christchurch, New Zealand	Canterbury Health Laboratories; University of Otago; University of Otago	Lever, M (corresponding author), Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand.	michael.lever@otago.ac.nz	George, Peter M/A-1315-2013	George, Peter M/0000-0001-9100-3466; Troughton, Richard/0000-0001-7484-4036; Chambers, Stephen/0000-0002-0698-3285; Molyneux, Sarah/0000-0001-6816-5619	National Heart Foundation of New Zealand [1090]; Paykel Trust; Neurological Foundation of New Zealand	National Heart Foundation of New Zealand; Paykel Trust; Neurological Foundation of New Zealand	This work was supported by the National Heart Foundation of New Zealand Grant 1090. http://www.heartfoundation.org.nz/. Supplemented by grants from the Paykel Trust and the Neurological Foundation of New Zealand. http://www.paykeltrust.co.nz/, http://www.neurological.org.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Dellow WJ, 1999, DIABETES RES CLIN PR, V43, P91, DOI 10.1016/S0168-8227(98)00115-6; Herrmann W, 2007, CURR DRUG METAB, V8, P17, DOI 10.2174/138920007779315008; Holm PI, 2004, ARTERIOSCL THROM VAS, V24, P301, DOI 10.1161/01.ATV.0000114569.54976.31; Kim SH, 2009, ANAL BIOANAL CHEM, V395, P1117, DOI 10.1007/s00216-009-3054-8; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; LEVER M, 1994, CLIN CHIM ACTA, V230, P69, DOI 10.1016/0009-8981(94)90090-6; Lever M, 2005, METABOLISM, V54, P1, DOI 10.1016/j.metabol.2004.07.007; Lever M, 2007, CLIN BIOCHEM, V40, P1225, DOI 10.1016/j.clinbiochem.2007.05.021; Lever M, 2007, CLIN BIOCHEM, V40, P447, DOI 10.1016/j.clinbiochem.2006.10.029; Lever M, 2012, CLIN BIOCHEM, V45, P154, DOI 10.1016/j.clinbiochem.2011.10.021; Lever M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021666; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lever M, 2009, CARDIOVASC DRUG THER, V23, P395, DOI 10.1007/s10557-009-6188-1; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Smulders YM, 2011, J INHERIT METAB DIS, V34, P93, DOI 10.1007/s10545-010-9151-1; Storer MK, 2006, J CHROMATOGR A, V1104, P263, DOI 10.1016/j.chroma.2005.11.123; Storer MK, 2006, ANAL CHIM ACTA, V558, P319, DOI 10.1016/j.aca.2005.10.060; Storer MK, 2006, THESIS U OTAGO DUNED; Strakova J, 2010, NUTR RES, V30, P492, DOI 10.1016/j.nutres.2010.06.017; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Ueland PM, 2007, CLIN CHEM, V53, P807, DOI 10.1373/clinchem.2007.085480; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; Wald DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016473	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32460	10.1371/journal.pone.0032460	http://dx.doi.org/10.1371/journal.pone.0032460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396767	Green Published, Green Submitted, gold			2022-12-25	WOS:000303006500019
J	Weng, H; Yoo, CY; Gosney, MJ; Hasegawa, PM; Mickelbart, MV				Weng, Hua; Yoo, Chan Yul; Gosney, Michael J.; Hasegawa, Paul M.; Mickelbart, Michael V.			Poplar GTL1 Is a Ca2+/Calmodulin-Binding Transcription Factor that Functions in Plant Water Use Efficiency and Drought Tolerance	PLOS ONE			English	Article							DNA-BINDING DOMAINS; ARABIDOPSIS-THALIANA; POPULUS-DELTOIDES; STOMATAL DENSITY; GENE-EXPRESSION; ABIOTIC-STRESS; G-PROTEIN; CALCIUM; TRANSPIRATION; SYSTEM	Diminishing global fresh water availability has focused research to elucidate mechanisms of water use in poplar, an economically important species. A GT-2 family trihelix transcription factor that is a determinant of water use efficiency (WUE), PtaGTL1 (GT-2 like 1), was identified in Populus tremula6P. alba (clone 717-IB4). Like other GT-2 family members, PtaGTL1 contains both N- and C-terminal trihelix DNA binding domains. PtaGTL1 expression, driven by the Arabidopsis thaliana AtGTL1 promoter, suppressed the higher WUE and drought tolerance phenotypes of an Arabidopsis GTL1 loss-of-function mutation (gtl1-4). Genetic suppression of gtl1-4 was associated with increased stomatal density due to repression of Arabidopsis STOMATAL DENSITY AND DISTRIBUTION1 (AtSDD1), a negative regulator of stomatal development. Electrophoretic mobility shift assays (EMSA) indicated that a PtaGTL1 C-terminal DNA trihelix binding fragment (PtaGTL1-C) interacted with an AtSDD1 promoter fragment containing the GT3 box (GGTAAA), and this GT3 box was necessary for binding. PtaGTL1-C also interacted with a PtaSDD1 promoter fragment via the GT2 box (GGTAAT). PtaSDD1 encodes a protein with 60% primary sequence identity with AtSDD1. In vitro molecular interaction assays were used to determine that Ca2+-loaded calmodulin (CaM) binds to PtaGTL1-C, which was predicted to have a CaM-interaction domain in the first helix of the C-terminal trihelix DNA binding domain. These results indicate that, in Arabidopsis and poplar, GTL1 and SDD1 are fundamental components of stomatal lineage. In addition, PtaGTL1 is a Ca2+-CaM binding protein, which infers a mechanism by which environmental stimuli can induce Ca2+ signatures that would modulate stomatal development and regulate plant water use.	[Weng, Hua; Yoo, Chan Yul; Gosney, Michael J.; Hasegawa, Paul M.; Mickelbart, Michael V.] Purdue Univ, Dept Hort & Landscape Architecture, Ctr Plant Environm Stress Physiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Weng, H (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, Ctr Plant Environm Stress Physiol, W Lafayette, IN 47907 USA.	mickelbart@purdue.edu	Barickman, Thomas/I-6993-2012; YOO, CHAN YUL/D-8399-2017	YOO, CHAN YUL/0000-0001-6159-7443	National Science Foundation [MCB-0424850]; Binational Agricultural Research and Development Awards [103314]	National Science Foundation(National Science Foundation (NSF)); Binational Agricultural Research and Development Awards	This study was supported by National Science Foundation Award MCB-0424850 and Binational Agricultural Research and Development Awards 103314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PLANT PHYSL 5 EDITIO; ARAZI T, 1995, PLANT PHYSIOL, V108, P551, DOI 10.1104/pp.108.2.551; Bacon M. A., 2004, Water use efficiency in plant biology; Balatinecz J.J., 2001, POPLAR CULTURE N AM, P277; Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; BRAATNE JH, 1992, TREE PHYSIOL, V11, P325, DOI 10.1093/treephys/11.4.325; Breuer C, 2009, PLANT CELL, V21, P2307, DOI 10.1105/tpc.109.068387; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Casson SA, 2010, CURR OPIN PLANT BIOL, V13, P90, DOI 10.1016/j.pbi.2009.08.005; Casson SA, 2009, CURR BIOL, V19, P229, DOI 10.1016/j.cub.2008.12.046; Choi MS, 2005, J BIOL CHEM, V280, P40820, DOI 10.1074/jbc.M504616200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; DEHESH K, 1992, EMBO J, V11, P4131, DOI 10.1002/j.1460-2075.1992.tb05506.x; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Finkler A, 2007, FEBS LETT, V581, P3893, DOI 10.1016/j.febslet.2007.07.051; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; Harfouche A, 2011, TRENDS BIOTECHNOL, V29, P9, DOI 10.1016/j.tibtech.2010.09.003; HONG YY, 2008, MOL PLANT, V1, P262, DOI DOI 10.1093/mp/ssm025; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Jeong YM, 2006, PLANT PHYSIOL, V140, P196, DOI 10.1104/pp.105.071316; Jing ZP, 2004, NEW PHYTOL, V164, P137, DOI 10.1111/j.1469-8137.2004.01173.x; Kaiser H, 2006, J EXP BOT, V57, P2087, DOI 10.1093/jxb/erj165; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Kim HS, 2007, J BIOL CHEM, V282, P36292, DOI 10.1074/jbc.M705217200; Kim HS, 2008, TREE PHYSIOL, V28, P559, DOI 10.1093/treephys/28.4.559; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; KUHN RM, 1993, PLANT MOL BIOL, V23, P337, DOI 10.1007/BF00029009; Lake JA, 2008, NEW PHYTOL, V179, P397, DOI 10.1111/j.1469-8137.2008.02485.x; Lampard GR, 2009, PLANT CELL, V21, P3506, DOI 10.1105/tpc.109.070110; Li B, 1996, THEOR APPL GENET, V93, P380, DOI 10.1007/BF00223180; Luoni L, 2000, FEBS LETT, V482, P225, DOI 10.1016/S0014-5793(00)02065-2; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; Monclus R, 2005, NEW PHYTOL, V167, P53, DOI 10.1111/j.1469-8137.2005.01407.x; Morello L, 2011, J EXP BOT, V62, P533, DOI 10.1093/jxb/erq273; Ni M, 1996, PLANT CELL, V8, P1041, DOI 10.1105/tpc.8.6.1041; Nilson SE, 2010, PLANT PHYSIOL, V152, P2067, DOI 10.1104/pp.109.148262; Nobel P., 1999, PHYSICOCHEMICAL ENV, V2nd; Pauly N, 2001, CELL CALCIUM, V30, P413, DOI 10.1054/ceca.2001.0250; Pearce DW, 2006, TREE PHYSIOL, V26, P211, DOI 10.1093/treephys/26.2.211; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; Song WY, 2008, INT J BIOL SCI, V4, P116; Souch CA, 1998, TREE PHYSIOL, V18, P829; Takezawa D, 2003, J BIOL CHEM, V278, P38076, DOI 10.1074/jbc.M301369200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vanderbeld B, 2007, PLANT MOL BIOL, V64, P683, DOI 10.1007/s11103-007-9189-0; Xing HT, 2011, PLANTA, V234, P229, DOI 10.1007/s00425-011-1389-9; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Yoo CY, 2010, PLANT CELL, V22, P4128, DOI 10.1105/tpc.110.078691; Yoo CY, 2009, CRIT REV PLANT SCI, V28, P410, DOI 10.1080/07352680903173175; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Zhou DX, 1999, TRENDS PLANT SCI, V4, P210, DOI 10.1016/S1360-1385(99)01418-1	62	36	53	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32925	10.1371/journal.pone.0032925	http://dx.doi.org/10.1371/journal.pone.0032925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396800	gold, Green Submitted, Green Published			2022-12-25	WOS:000303006500036
J	Diep, CH; Zucker, KM; Hostetter, G; Watanabe, A; Hu, CC; Munoz, RM; Von Hoff, DD; Han, HY				Diep, Caroline H.; Zucker, Kelly M.; Hostetter, Galen; Watanabe, Aprill; Hu, Chengcheng; Munoz, Ruben M.; Von Hoff, Daniel D.; Han, Haiyong			Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells	PLOS ONE			English	Article							ORGAN SIZE CONTROL; HIPPO SIGNALING PATHWAY; TUMOR-SUPPRESSOR; LIVER-CANCER; TRANSCRIPTIONAL COACTIVATOR; PROMOTER HYPERMETHYLATION; CANDIDATE ONCOGENE; CONTACT INHIBITION; YAP ONCOPROTEIN; LATS1	Background: The Hippo pathway regulates organ size by inhibiting cell proliferation and promoting cell apoptosis upon its activation. The Yes Associated Protein 1 (YAP1) is a nuclear effector of the Hippo pathway that promotes cell growth as a transcription co-activator. In human cancer, the YAP1 gene was reported as amplified and over-expressed in several tumor types. Methods: Immunohistochemical staining of YAP1 protein was used to assess the expression of YAP1 in pancreatic tumor tissues. siRNA oligonucleotides were used to knockdown the expression of YAP1 and their effects on pancreatic cancer cells were investigated using cell proliferation, apoptosis, and anchorage-independent growth assays. The Wilcoxon signed-rank, Pearson correlation coefficient, Kendall's Tau, Spearman's Rho, and an independent two-sample t (two-tailed) test were used to determine the statistical significance of the data. Results: Immunohistochemistry studies in pancreatic tumor tissues revealed YAP1 staining intensities were moderate to strong in the nucleus and cytoplasm of the tumor cells, whereas the adjacent normal epithelial showed negative to weak staining. In cultured cells, YAP1 expression and localization was modulated by cell density. YAP1 total protein expression increased in the nuclear fractions in BxPC-3 and PANC-1, while it declined in HPDE6 as cell density increased. Additionally, treatment of pancreatic cancer cell lines, BxPC-3 and PANC-1, with YAP1-targeting siRNA oligonucleotides significantly reduced their proliferation in vitro. Furthermore, treatment with YAP1 siRNA oligonucleotides diminished the anchorage-independent growth on soft agar of pancreatic cancer cells, suggesting a role of YAP1 in pancreatic cancer tumorigenesis. Conclusions: YAP1 is overexpressed in pancreatic cancer tissues and potentially plays an important role in the clonogenicity and growth of pancreatic cancer cells.	[Diep, Caroline H.; Zucker, Kelly M.; Munoz, Ruben M.; Von Hoff, Daniel D.; Han, Haiyong] Translat Genom Res Inst, Clin Translat Div, Scottsdale, AZ USA; [Hostetter, Galen; Watanabe, Aprill] Translat Genom Res Inst, Integrated Canc Genom Div, Scottsdale, AZ USA; [Hu, Chengcheng] Univ Arizona, Coll Publ Hlth, Epidemiol & Biostat Div, Tucson, AZ USA	Translational Genomics Research Institute; Translational Genomics Research Institute; University of Arizona	Diep, CH (corresponding author), Translat Genom Res Inst, Clin Translat Div, Scottsdale, AZ USA.	hhan@tgen.org	Hu, Chengcheng/A-8391-2017	Diep, Ph.D., Caroline/0000-0001-9011-6450; Hu, Chengcheng/0000-0001-8525-0356	National Foundation for Cancer Research; Katz family; Helios Scholars Program	National Foundation for Cancer Research; Katz family; Helios Scholars Program	The work was supported by National Foundation for Cancer Research, the Katz family, and the Helios Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Balagurunathan Y, 2008, MOL CANCER THER, V7, P3071, DOI 10.1158/1535-7163.MCT-08-0402; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Diep CH, 2011, CLIN CANCER RES, V17, P2744, DOI 10.1158/1078-0432.CCR-10-2214; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Furukawa T, 1996, AM J PATHOL, V148, P1763; Gilbert MM, 2011, DEV CELL, V20, P700, DOI 10.1016/j.devcel.2011.04.012; Guo JC, 2006, INT J MOL MED, V17, P761; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hisaoka M, 2002, LAB INVEST, V82, P1427, DOI 10.1097/01.LAB.0000032381.68634.CA; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Jiang Z, 2006, NEUROSCI RES, V56, P450, DOI 10.1016/j.neures.2006.09.006; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morinaga N, 2000, INT J ONCOL, V17, P1125; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Oh H, 2009, DEV BIOL, V335, P188, DOI 10.1016/j.ydbio.2009.08.026; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	46	70	80	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32783	10.1371/journal.pone.0032783	http://dx.doi.org/10.1371/journal.pone.0032783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396793	Green Submitted, Green Published, gold			2022-12-25	WOS:000303005000037
J	Qi, JP; Zhang, K; Zhang, Q; Sun, Y; Fu, T; Li, GH; Chen, JF				Qi, JunPeng; Zhang, Kun; Zhang, Qiao; Sun, Yi; Fu, Ting; Li, GuoHui; Chen, JianFeng			Identification, Characterization, and Epitope Mapping of Human Monoclonal Antibody J19 That Specifically Recognizes Activated Integrin alpha(4)beta(7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-I DOMAIN; AVIDITY REGULATION; OVERLAP EXTENSION; STRUCTURAL BASIS; FIRM ADHESION; OUTSIDE-IN; AFFINITY; BINDING; CONFORMATION; ECTODOMAIN	Integrin alpha(4)beta(7) is a lymphocyte homing receptor that mediates both rolling and firm adhesion of lymphocytes on vascular endothelium, two of the critical steps in lymphocyte migration and tissue-specific homing. The rolling and firm adhesions of lymphocytes rely on the dynamic shift between the inactive and active states of integrin alpha(4)beta(7), which is associated with the conformational rearrangement of integrin molecules. Activation-specific antibodies, which specifically recognize the activated integrins, have been used as powerful tools in integrin studies, whereas there is no well characterized activation-specific antibody to integrin alpha(4)beta(7). Here, we report the identification, characterization, and epitope mapping of an activation-specific human mAb J19 against integrin alpha(4)beta(7). J19 was discovered by screening a human single-chain variable fragment phage library using an activated alpha(4)beta(7) mutant as target. J19 IgG specifically bound to the high affinity alpha(4)beta(7) induced by Mn2+, DTT, ADP, or CXCL12, but not to the low affinity integrin. Moreover, J19 IgG did not interfere with alpha(4)beta(7)-MAdCAM-1 interaction. The epitope of J19 IgG was mapped to Ser-331, Ala-332, and Ala-333 of beta(7) I domain and a seven-residue segment from 184 to 190 of alpha(4)beta-propeller domain, which are buried in low affinity integrin with bent conformation and only exposed in the high affinity extended conformation. Taken together, J19 is a potentially powerful tool for both studies on alpha(4)beta(7) activation mechanism and development of novel therapeutics targeting the activated lymphocyte expressing high affinity alpha(4)beta(7).	[Qi, JunPeng; Zhang, Kun; Zhang, Qiao; Sun, Yi; Chen, JianFeng] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Fu, Ting; Li, GuoHui] Chinese Acad Sci, Lab Mol Modeling & Design, State Key Lab Mol React Dynam, Dalian Inst Chem Phys, Dalian 116023, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Chen, JF (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai Inst Biol Sci, 320 YueYang Rd, Shanghai 200031, Peoples R China.	jfchen@sibs.ac.cn	Qi, Junpeng/AAH-5525-2020; Qi, Junpeng/G-6949-2019		National Basic Research Program of China [2010CB529703]; National Natural Science Foundation of China [31190061, 30970604, 30700119]; Science and Technology Commission of Shanghai Municipality [11JC1414200]; Novo Nordisk-CAS Research Foundation [NN-CAS 2008-1]; Shanghai Pujiang Program [08PJ14106]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Novo Nordisk-CAS Research Foundation(Novo Nordisk Foundation); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by National Basic Research Program of China Grant 2010CB529703; National Natural Science Foundation of China Grants 31190061, 30970604, and 30700119; Science and Technology Commission of Shanghai Municipality Grant 11JC1414200; Novo Nordisk-CAS Research Foundation Grant NN-CAS 2008-1; and Shanghai Pujiang Program Grant 08PJ14106.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; DAVIS GE, 1993, J IMMUNOL, V151, P7138; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; EDWARDS BS, 1995, BLOOD, V86, P2288, DOI 10.1182/blood.V86.6.2288.bloodjournal8662288; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; LAZAROVITS AI, 1984, J IMMUNOL, V133, P1857; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; MURGO AJ, 1992, J PHARMACOL EXP THER, V261, P580; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Pan YP, 2010, P NATL ACAD SCI USA, V107, P21388, DOI 10.1073/pnas.1015487107; Park EJ, 2007, J CLIN INVEST, V117, P2526, DOI 10.1172/JCI31570; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Stefanelli T, 2008, AUTOIMMUN REV, V7, P364, DOI 10.1016/j.autrev.2008.01.002; Sun DS, 2005, J BIOMED SCI, V12, P937, DOI 10.1007/s11373-005-9016-z; Sun H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208900; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; TEIXIDO J, 1992, J BIOL CHEM, V267, P1786; Tidswell M, 1997, J IMMUNOL, V159, P1497; Weitz-Schmidt G, 2011, J BIOL CHEM, V286, P42115, DOI 10.1074/jbc.M111.282830; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2004, P NATL ACAD SCI USA, V101, P15422, DOI 10.1073/pnas.0406680101; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Yamamoto M, 1998, J IMMUNOL, V160, P2188; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	47	7	9	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15749	15759		10.1074/jbc.M112.341263	http://dx.doi.org/10.1074/jbc.M112.341263			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418441	Green Published, hybrid			2022-12-25	WOS:000304006300053
J	Singha, UK; Hamilton, V; Duncan, MR; Weems, E; Tripathi, MK; Chaudhuri, M				Singha, Ujjal K.; Hamilton, VaNae; Duncan, Melanie R.; Weems, Ebony; Tripathi, Manish K.; Chaudhuri, Minu			Protein Translocase of Mitochondrial Inner Membrane in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA IMPORT; PREPROTEIN TRANSLOCASE; OUTER-MEMBRANE; INDUCIBLE EXPRESSION; ALTERNATIVE OXIDASE; DOWN-REGULATION; INSERTION; COMPLEX; IDENTIFICATION; BIOGENESIS	Translocases of mitochondrial inner membrane (TIMs) are multiprotein complexes. The only Tim component so far characterized in kinetoplastid parasites such as Trypanosoma brucei is Tim17 (TbTim17), which is essential for cell survival and mitochondrial protein import. Here, we report that TbTim17 is present in a protein complex of about 1,100 kDa, which is much larger than the TIM complexes found in fungi and mammals. Depletion of TbTim17 in T. brucei impairs the mitochondrial import of cytochrome oxidase subunit IV, an N-terminal signal-containing protein. Pretreatment of isolated mitoplasts with the anti-TbTim17 antibody inhibited import of cytochrome oxidase subunit IV, indicating a direct involvement of the TbTim17 in the import process. Purification of the TbTim17-containing protein complex from the mitochondrial membrane of T. brucei by tandem affinity chromatography revealed that TbTim17 associates with seven unique as well as a few known T. brucei mitochondrial proteins. Depletion of three of these novel proteins, i.e. TbTim47, TbTim54, and TbTim62, significantly decreased mitochondrial protein import in vitro. In vivo targeting of a newly synthesized mitochondrial matrix protein, MRP2, was also inhibited due to depletion of TbTim17, TbTim54, and TbTim62. Co-precipitation analysis confirmed the interaction of TbTim54 and TbTim62 with TbTim17 in vivo. Overall, our data reveal that TbTim17, the single homolog of Tim17/22/23 family proteins, is present in a unique TIM complex consisting of novel proteins in T. brucei and is critical for mitochondrial protein import.	[Singha, Ujjal K.; Hamilton, VaNae; Duncan, Melanie R.; Weems, Ebony; Chaudhuri, Minu] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Tripathi, Manish K.] Vanderbilt Univ, Dept Surg Oncol, Nashville, TN 37232 USA	Meharry Medical College; Vanderbilt University	Chaudhuri, M (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, W Basic Sci Bldg,Rm 4105, Nashville, TN 37208 USA.	mchaudhuri@mmc.edu			National Center for Research Resources [U54RR026140]; National Institute for Minority Health and Health Disparities [U54MD07593]; National Institutes of Health [G12RR003032, 2SC1GM081146]; National Institute for Heart, Lung, and Blood [T32HL007737]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140, G12RR003032] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM081146] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Heart, Lung, and Blood; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Core facilities are supported by Grants U54RR026140 from National Center for Research Resources, U54MD07593 from National Institute for Minority Health and Health Disparities, and G12RR003032 from National Institutes of Health. V. H., E. W., and M. R. D. are supported by training Grant T32HL007737 from National Institute for Heart, Lung, and Blood. M. C. is supported by Grant 2SC1GM081146 from the National Institutes of Health.	Acestor N, 2009, PROTEOMICS, V9, P5497, DOI 10.1002/pmic.200900354; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Bagos PG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-189; Bains G, 1999, BIOESSAYS, V21, P1; Bauer MF, 1999, J MOL BIOL, V289, P69, DOI 10.1006/jmbi.1999.2751; Becker T, 2008, BBA-BIOENERGETICS, V1777, P557, DOI 10.1016/j.bbabio.2008.03.017; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Chaudhuri M, 1996, MOL BIOCHEM PARASIT, V83, P125, DOI 10.1016/S0166-6851(96)02754-5; Chaudhuri M, 2001, GENE, V266, P1, DOI 10.1016/S0378-1119(01)00367-5; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Gunzl Arthur, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1919s55; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hausler T, 1997, EUR J CELL BIOL, V73, P240; Hewitt V, 2011, BBA-BIOMEMBRANES, V1808, P947, DOI 10.1016/j.bbamem.2010.07.019; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247; Lithgow T, 2010, PHILOS T R SOC B, V365, P799, DOI 10.1098/rstb.2009.0167; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2007, METHOD ENZYMOL, V424, P3, DOI 10.1016/S0076-6879(07)24001-7; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Paris Z, 2011, MOL BIOCHEM PARASIT, V176, P116, DOI 10.1016/j.molbiopara.2010.12.010; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Rehling P, 2003, J MOL BIOL, V326, P639, DOI 10.1016/S0022-2836(02)01440-7; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; Schneider A, 2008, TRENDS CELL BIOL, V18, P12, DOI 10.1016/j.tcb.2007.09.009; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Sharma S, 2010, MOL BIOCHEM PARASIT, V174, P89, DOI 10.1016/j.molbiopara.2010.07.003; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Singha UK, 2009, EUKARYOT CELL, V8, P1418, DOI 10.1128/EC.00132-09; Sternberg JM, 2010, PARASITOLOGY, V137, P2007, DOI 10.1017/S0031182010000946; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Williams S, 2008, EXP PARASITOL, V118, P420, DOI 10.1016/j.exppara.2007.10.008; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WOODS A, 1989, J CELL SCI, V93, P491; World Health Organization, 2006, REP INF DIS; Zhang XB, 2010, NUCLEIC ACIDS RES, V38, P7378, DOI 10.1093/nar/gkq618; Zikova A, 2006, MOL BIOCHEM PARASIT, V149, P65, DOI 10.1016/j.molbiopara.2006.04.007; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	61	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14480	14493		10.1074/jbc.M111.322925	http://dx.doi.org/10.1074/jbc.M111.322925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22408251	Green Published, hybrid			2022-12-25	WOS:000304003200015
J	Chen, X; Gorlov, IP; Ying, J; Merriman, KW; Kimmel, M; Lu, C; Reyes-Gibby, CC; Gorlova, OY				Chen, Xing; Gorlov, Ivan P.; Ying, Jun; Merriman, Kelly W.; Kimmel, Marek; Lu, Charles; Reyes-Gibby, Cielito C.; Gorlova, Olga Y.			Initial Medical Attention on Patients with Early-Stage Non-Small Cell Lung Cancer	PLOS ONE			English	Article							OVARIAN-CANCER; SURVIVAL; SYMPTOMS; DIAGNOSIS; DELAY; TIME; CARE	Background: Detection of early stage non-small cell lung cancer (NSCLC) is commonly believed to be incidental. Understanding the reasons that caused initial detection of these patients is important for early diagnosis. However, these reasons are not well studied. Methods: We retrospectively reviewed medical records of patients diagnosed with stage I or II NSCLC between 2000 and 2009 at UT MD Anderson Cancer Center. Information on suggestive LC-symptoms or other reasons that caused detection were extracted from patients' medical records. We applied univariate and multivariate analyses to evaluate the association of suggestive LC-symptoms with tumor size and patient survival. Results: Of the 1396 early stage LC patients, 733 (52.5%) presented with suggestive LC-symptoms as chief complaint. 347 (24.9%) and 287 (20.6%) were diagnosed because of regular check-ups and evaluations for other diseases, respectively. The proportion of suggestive LC-symptom-caused detection had a linear relationship with the tumor size (correlation 0.96; with p,. 0001). After age, gender, race, smoking status, therapy, and stage adjustment, the symptom-caused detection showed no significant difference in overall and LC-specific survival when compared with the other (non-symptom-caused) detection. Conclusion: Symptoms suggestive of LC are the number one reason that led to detection in early NSCLC. They were also associated with tumor size at diagnosis, suggesting early stage LC patients are developing symptoms. Presence of symptoms in early stages did not compromise survival. A symptom-based alerting system or guidelines may be worth of further study to benefit NSCLC high risk individuals.	[Chen, Xing; Ying, Jun; Merriman, Kelly W.; Reyes-Gibby, Cielito C.; Gorlova, Olga Y.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Gorlov, Ivan P.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Kimmel, Marek] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Lu, Charles] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Rice University; University of Texas System; UTMD Anderson Cancer Center	Chen, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	cnxingchen@gmail.com			Cancer Intervention and Surveillance Modeling Network (CISNET) [5 U01 CA097431]; Prevent Cancer Foundation; National Institutes of Health (NIH) [R03CA1338885, R03128025, CA55769, R01 CA149462]; NATIONAL CANCER INSTITUTE [U01CA097431, R01CA149462, R01CA055769] Funding Source: NIH RePORTER	Cancer Intervention and Surveillance Modeling Network (CISNET); Prevent Cancer Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Cancer Intervention and Surveillance Modeling Network (CISNET) (http://cisnet.cancer.gov/) 5 U01 CA097431 to MK and OG, Prevent Cancer Foundation grant (http://preventcancer.org/prevention/preventable-cancers/lung-cancer/) to OG, National Institutes of Health (NIH)(http://grants.nih.gov/grants/oer.htm) R03CA1338885 and R03128025 to IG, and CA55769 to MRS. XC, JY, and OG were supported in part by the NIH grant R01 CA149462. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowen EF, 2002, LUNG CANCER-J IASLC, V37, P227, DOI 10.1016/S0169-5002(02)00143-5; Campbell M, 2007, BRIT J GEN PRACT, V57, P410; Chen E, 2011, EXPERT REV PHARM OUT, V11, P433, DOI [10.1586/erp.11.56, 10.1586/ERP.11.56]; Corner J, 2006, SOC SCI MED, V62, P1381, DOI 10.1016/j.socscimed.2005.08.012; Corner J, 2005, THORAX, V60, P314, DOI 10.1136/thx.2004.029264; Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705, DOI 10.1001/jama.291.22.2705; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127; Hauptmann M, 2000, STAT MED, V19, P2185, DOI 10.1002/1097-0258(20000830)19:16<2185::AID-SIM528>3.0.CO;2-I; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kesson E, 1998, BRIT J CANCER, V78, P1391, DOI 10.1038/bjc.1998.690; Koyi H, 2002, LUNG CANCER-J IASLC, V36, P9, DOI 10.1016/S0169-5002(01)00451-2; NARUKE T, 1993, SEMIN SURG ONCOL, V9, P80, DOI 10.1002/ssu.2980090204; Raz DJ, 2007, J THORAC ONCOL, V2, P125, DOI 10.1097/JTO.0b013e31802f1cb1; Rineer J, 2010, CHEST, V137, P362, DOI 10.1378/chest.09-0868; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Smith SM, 2009, THORAX, V64, P523, DOI 10.1136/thx.2008.096560; SOBUE T, 1992, CANCER, V69, P685, DOI 10.1002/1097-0142(19920201)69:3<685::AID-CNCR2820690315>3.0.CO;2-W; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3	20	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32644	10.1371/journal.pone.0032644	http://dx.doi.org/10.1371/journal.pone.0032644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412901	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800038
J	Pester, D; Milcevicova, R; Schaffer, J; Wilhelm, E; Blumel, S				Pester, Doris; Milcevicova, Renata; Schaffer, Johann; Wilhelm, Eva; Bluemel, Sylvia			Erwinia amylovora Expresses Fast and Simultaneously hrp/dsp Virulence Genes during Flower Infection on Apple Trees	PLOS ONE			English	Article							III PROTEIN SECRETION; PLANT-PATHOGENIC BACTERIA; SYRINGAE PV. PHASEOLICOLA; FIRE BLIGHT; PSEUDOMONAS-SYRINGAE; BIOLOGICAL-CONTROL; HRP MUTANTS; HOST APPLE; HARPIN; IDENTIFICATION	Background: Pathogen entry through host blossoms is the predominant infection pathway of the Gram-negative bacterium Erwinia amylovora leading to manifestation of the disease fire blight. Like in other economically important plant pathogens, E. amylovora pathogenicity depends on a type III secretion system encoded by hrp genes. However, timing and transcriptional order of hrp gene expression during flower infections are unknown. Methodology/Principal Findings: Using quantitative real-time PCR analyses, we addressed the questions of how fast, strong and uniform key hrp virulence genes and the effector dspA/E are expressed when bacteria enter flowers provided with the full defense mechanism of the apple plant. In non-invasive bacterial inoculations of apple flowers still attached to the tree, E. amylovora activated expression of key type III secretion genes in a narrow time window, mounting in a single expression peak of all investigated hrp/dspA/E genes around 24-48 h post inoculation (hpi). This single expression peak coincided with a single depression in the plant PR-1 expression at 24 hpi indicating transient manipulation of the salicylic acid pathway as one target of E. amylovora type III effectors. Expression of hrp/dspA/E genes was highly correlated to expression of the regulator hrpL and relative transcript abundances followed the ratio: hrpA. hrpN. hrpL. dspA/E. Acidic conditions (pH 4) in flower infections led to reduced virulence/effector gene expression without the typical expression peak observed under natural conditions (pH 7). Conclusion/Significance: The simultaneous expression of hrpL, hrpA, hrpN, and the effector dspA/E during early floral infection indicates that speed and immediate effector transmission is important for successful plant invasion. When this delicate balance is disturbed, e. g., by acidic pH during infection, virulence gene expression is reduced, thus partly explaining the efficacy of acidification in fire blight control on a molecular level.	[Pester, Doris; Schaffer, Johann; Bluemel, Sylvia] Austrian Agcy Hlth & Food Safety AGES, Inst Plant Hlth, Vienna, Austria; [Milcevicova, Renata; Wilhelm, Eva] Austrian Inst Technol AIT, Seibersdorf, Austria	Austrian Institute of Technology (AIT)	Pester, D (corresponding author), Austrian Agcy Hlth & Food Safety AGES, Inst Plant Hlth, Vienna, Austria.	Dorisct@gmx.de			Austrian Federal Ministry of Agriculture, Forestry, Environment and Water in cooperation; Austrian Federal States; Austrian Agency of Health and Food Safety (DAFNE) [100448]	Austrian Federal Ministry of Agriculture, Forestry, Environment and Water in cooperation; Austrian Federal States; Austrian Agency of Health and Food Safety (DAFNE)	This study was granted by the Austrian Federal Ministry of Agriculture, Forestry, Environment and Water in cooperation with the Austrian Federal States and the Austrian Agency of Health and Food Safety (DAFNE no 100448; www.dafne.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-1; BARNY MA, 1995, EUR J PLANT PATHOL, V101, P333, DOI 10.1007/BF01874789; BARNY MA, 1990, MOL MICROBIOL, V4, P777, DOI 10.1111/j.1365-2958.1990.tb00648.x; Blachinsky D, 2006, EUR J PLANT PATHOL, V116, P315, DOI 10.1007/s10658-006-9062-z; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Bocsanczy AM, 2008, MOL PLANT PATHOL, V9, P425, DOI 10.1111/J.1364-3703.2008.00471.X; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325; Bogdanove AJ, 2000, FIRE BLIGHT, P163, DOI 10.1079/9780851992945.0163; Bonasera JM, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-23; Boureau T, 2006, MOL PLANT MICROBE IN, V19, P16, DOI 10.1094/MPMI-19-0016; Boureau T, 2002, MOL PLANT PATHOL, V3, P451, DOI 10.1046/j.1364-3703.2002.00139.x; Boureau T, 2011, MOL PLANT MICROBE IN, V24, P577, DOI 10.1094/MPMI-09-10-0212; Buban T, 2003, PLANT SYST EVOL, V238, P183, DOI 10.1007/s00606-002-0266-1; Buttner D, 2009, PLANT PHYSIOL, V150, P1656, DOI 10.1104/pp.109.139089; BUGERT P, 1995, MOL MICROBIOL, V15, P917, DOI 10.1111/j.1365-2958.1995.tb02361.x; Cabrefiga J, 2005, PHYTOPATHOLOGY, V95, P1430, DOI 10.1094/PHYTO-95-1430; Cesbron S, 2006, FEMS MICROBIOL LETT, V257, P221, DOI 10.1111/j.1574-6968.2006.00172.x; Chang S, 1993, PLANT MOL BIOL REP, V11, P113, DOI DOI 10.1007/BF02670468; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Engelhardt S, 2009, PLANT J, V57, P706, DOI 10.1111/j.1365-313X.2008.03723.x; Faize M, 1999, FEMS MICROBIOL LETT, V171, P173, DOI 10.1111/j.1574-6968.1999.tb13429.x; Faize M, 2006, BIOL PLANTARUM, V50, P667, DOI 10.1007/s10535-006-0104-3; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; GRIGNON C, 1991, ANNU REV PLANT PHYS, V42, P103, DOI 10.1146/annurev.pp.42.060191.000535; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Jin QL, 2003, MICROBES INFECT, V5, P301, DOI 10.1016/S1286-4579(03)00032-7; Jin QL, 2001, MOL MICROBIOL, V40, P1129, DOI 10.1046/j.1365-2958.2001.02455.x; Johnson KB, 2009, PHYTOPATHOLOGY, V99, P128, DOI 10.1094/PHYTO-99-2-0128; Kim JF, 1997, J BACTERIOL, V179, P1690, DOI 10.1128/jb.179.5.1690-1697.1997; Kunz S, 2005, 1 S BIOC BACT PLANT, V408, P249; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Meng XD, 2006, MOL PLANT MICROBE IN, V19, P53, DOI 10.1094/MPMI-19-0053; Milcevicova R, 2009, THESIS U NATURAL RES, P109; Milcevicova R, 2010, PLANT SCI, V179, P60, DOI 10.1016/j.plantsci.2010.04.013; Momol MT, 2000, FIRE BLIGHT, P55, DOI 10.1079/9780851992945.0055; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Nakka S, 2010, MICROBIOL RES, V165, P665, DOI 10.1016/j.micres.2009.11.013; Nissinen RM, 2007, MOL PLANT PATHOL, V8, P55, DOI 10.1111/j.1364-3703.2006.00370.x; Norelli JL, 2009, TREE GENET GENOMES, V5, P27, DOI 10.1007/s11295-008-0164-y; Oh CS, 2005, FEMS MICROBIOL LETT, V253, P185, DOI 10.1016/j.femsle.2005.09.051; Oh CS, 2005, MOL PLANT PATHOL, V6, P125, DOI 10.1111/j.1364-3703.2005.00269.x; Oh J, 2007, J BIOL CHEM, V282, P13601, DOI 10.1074/jbc.M602576200; Perino C, 1999, CELL MICROBIOL, V1, P131; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Philion V, 2011, ACTA HORTIC, V896, P307, DOI 10.17660/ActaHortic.2011.896.43; Psallidas PG, 2000, FIRE BLIGHT, P199, DOI 10.1079/9780851992945.0199; Pusey PL, 2008, PHYTOPATHOLOGY, V98, P1136, DOI 10.1094/PHYTO-98-10-1136; Pusey PL, 1999, PHYTOPATHOLOGY, V89, P39, DOI 10.1094/PHYTO.1999.89.1.39; Pusey PL, 1997, PHYTOPATHOLOGY, V87, P1096, DOI 10.1094/PHYTO.1997.87.11.1096; Reboutier D, 2007, MOL PLANT MICROBE IN, V20, P94, DOI 10.1094/MPMI-20-0094; Sarowar S, 2011, J EXP BOT, V62, P4851, DOI 10.1093/jxb/err147; Smith TJ, 2011, ACTA HORTIC, V896, P331, DOI 10.17660/ActaHortic.2011.896.45; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; THARAUD M, 1994, MICROBIOL-UK, V140, P659, DOI 10.1099/00221287-140-3-659; THOMSON SV, 1986, PHYTOPATHOLOGY, V76, P476, DOI 10.1094/Phyto-76-476; Thomson SV, 2003, PLANT DIS, V87, P502, DOI 10.1094/PDIS.2003.87.5.502; Thwaites R, 2004, MOL PLANT MICROBE IN, V17, P1250, DOI 10.1094/MPMI.2004.17.11.1250; van der Zwet T., 1979, FIRE BLIGHT BACTERIA; Venisse JS, 2003, FEBS LETT, V537, P198, DOI 10.1016/S0014-5793(03)00123-6; Venisse JS, 2002, MOL PLANT MICROBE IN, V15, P1204, DOI 10.1094/MPMI.2002.15.12.1204; Wang DP, 2010, PHYTOPATHOLOGY, V100, P192, DOI 10.1094/PHYTO-100-2-0192; WEI ZM, 1992, J BACTERIOL, V174, P1875, DOI 10.1128/jb.174.6.1875-1882.1992; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; WEI ZM, 1995, J BACTERIOL, V177, P6201, DOI 10.1128/jb.177.21.6201-6210.1995; Zhao YF, 2005, J BACTERIOL, V187, P8088, DOI 10.1128/JB.187.23.8088-8103.2005	66	20	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32583	10.1371/journal.pone.0032583	http://dx.doi.org/10.1371/journal.pone.0032583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412891	gold, Green Published, Green Submitted			2022-12-25	WOS:000303021100019
J	Cao, SH; Xu, WT; Zhang, N; Wang, Y; Luo, YB; He, XY; Huang, KL				Cao, Sishuo; Xu, Wentao; Zhang, Nan; Wang, Yan; Luo, Yunbo; He, Xiaoyun; Huang, Kunlun			A Mitochondria-Dependent Pathway Mediates the Apoptosis of GSE-Induced Yeast	PLOS ONE			English	Article							GRAPEFRUIT-SEED-EXTRACT; ANTIBACTERIAL AGENT; PROTEOME ANALYSIS; REACTIVE OXYGEN; ACID; PHOSPHORYLATION; ACTIVATION; CARCINOMA; DEATH; CELLS	Grapefruit seed extract (GSE), which has powerful anti-fungal activity, can induce apoptosis in S. cerevisiae. The yeast cells underwent apoptosis as determined by testing for apoptotic markers of DNA cleavage and typical chromatin condensation by Terminal Deoxynucleotidyl Transferase-mediated dUTP Nick End Labeling (TUNEL) and 4,69-diaminidino-2-phenylindole (DAPI) staining and electron microscopy. The changes of Delta Psi mt (mitochondrial transmembrane potential) and ROS (reactive oxygen species) indicated that the mitochondria took part in the apoptotic process. Changes in this process detected by metabonomics and proteomics revealed that the yeast cells tenaciously resisted adversity. Proteins related to redox, cellular structure, membrane, energy and DNA repair were significantly increased. In this study, the relative changes in the levels of proteins and metabolites showed the tenacious resistance of yeast cells. However, GSE induced apoptosis in the yeast cells by destruction of the mitochondrial 60 S ribosomal protein, L14-A, and prevented the conversion of pantothenic acid to coenzyme A (CoA). The relationship between the proteins and metabolites was analyzed by orthogonal projections to latent structures (OPLS). We found that the changes of the metabolites and the protein changes had relevant consistency.	[Cao, Sishuo; Xu, Wentao; Wang, Yan; Luo, Yunbo; He, Xiaoyun; Huang, Kunlun] China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Safety & Mol Biol, Beijing 100094, Peoples R China; [Xu, Wentao; Zhang, Nan; Luo, Yunbo; Huang, Kunlun] Minist Agr, Supervis Inspect & Testing Ctr Genetically Modifi, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Cao, SH (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Safety & Mol Biol, Beijing 100094, Peoples R China.	xuwentaoboy@sina.com; hkl009@163.com		Kunlun, Huang/0000-0002-2350-5859	Ministry of Science and Technology of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the Fundamental Research Funds for the Central Universities of the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2006, MOL CANCER THER, V5, P3294, DOI 10.1158/1535-7163.MCT-06-0483; Almeida B, 2009, PROTEOMICS, V9, P720, DOI 10.1002/pmic.200700816; Altmann Katrin, 2007, Methods Mol Biol, V372, P81, DOI 10.1007/978-1-59745-365-3_6; Andersen G, 2007, FEBS J, V274, P1804, DOI 10.1111/j.1742-4658.2007.05729.x; Ashkenazi A, 2007, SCIENCE, V281, P1303; Bach B, 2009, APPL ENVIRON MICROB, V75, P4231, DOI 10.1128/AEM.00051-09; Bundy JG, 2007, GENOME RES, V17, P510, DOI 10.1101/gr.5662207; BYERS B, 1991, METHOD ENZYMOL, V194, P602; Cvetnic Zdenka, 2004, Acta Pharmaceutica (Zagreb), V54, P243; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; Heggers JP, 2002, J ALTERN COMPLEM MED, V8, P333, DOI 10.1089/10755530260128023; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hu Y, 2003, ELECTROPHORESIS, V24, P1458, DOI 10.1002/elps.200390188; Ignacio C, 2005, COMP ANAL ANTIFUNGAL; Ionescu G, 1990, J ORTHOMOLECULAR MED, V5, P155; Kaur M, 2009, PHARM RES-DORDR, V26, P2133, DOI 10.1007/s11095-009-9926-y; Keun HC, 2003, ANAL CHIM ACTA, V490, P265, DOI 10.1016/S0003-2670(03)00094-1; Kissova I, 2000, FEBS LETT, V471, P113, DOI 10.1016/S0014-5793(00)01379-X; Kitagaki H, 2007, FEBS LETT, V581, P2935, DOI 10.1016/j.febslet.2007.05.048; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; Krajewska-Kulak E, 2003, J EUR ACAD DERMATOL, V17, P486, DOI 10.1046/j.1468-3083.2003.00614_12.x; Laun P, 2005, FEMS YEAST RES, V5, P1261, DOI 10.1016/j.femsyr.2005.07.006; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Longo VD, 2005, NAT REV GENET, V6, DOI 10.1038/nrg1706; Lutz NW, 2005, METABOLOMICS, V1, P251, DOI 10.1007/s11306-005-0005-z; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Mazzoni C, 2007, FEBS LETT, V581, P4836, DOI 10.1016/j.febslet.2007.09.009; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Pham NA, 2000, CYTOMETRY, V41, P245, DOI 10.1002/1097-0320(20001201)41:4<245::AID-CYTO2>3.0.CO;2-#; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Raina K, 2008, MOL CANCER THER, V7, P1258, DOI 10.1158/1535-7163.MCT-07-2220; RAMOS F, 1985, EUR J BIOCHEM, V149, P401, DOI 10.1111/j.1432-1033.1985.tb08939.x; Reagor L, 2002, J ALTERN COMPLEM MED, V8, P325, DOI 10.1089/10755530260128014; Roe S, 2004, United States Patent Application Publication, Patent No. [2004/0247714A1, 20040247714]; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Saito M, 1998, J AGR FOOD CHEM, V46, P1460, DOI 10.1021/jf9709156; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; SODA T, 1953, J BIOCHEM-TOKYO, V40, P421, DOI 10.1093/oxfordjournals.jbchem.a126383; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P446, DOI 10.1016/S0753-3322(02)00285-8; Tirillini B, 2000, FITOTERAPIA, V71, pS29, DOI 10.1016/S0367-326X(00)00176-3; Wei L, 2008, TOXICOL APPL PHARM, V227, P417, DOI 10.1016/j.taap.2007.11.015; Weinberger M, 2005, J CELL SCI, V118, P3543, DOI 10.1242/jcs.02477; Westman E, 2007, NEUROBIOL DIS, V26, P221, DOI 10.1016/j.nbd.2006.12.012; Wilk S, 2005, SCIENCE, ptr16; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P131, DOI 10.1016/S0169-7439(01)00156-3; Xu WT, 2007, POSTHARVEST BIOL TEC, V46, P86, DOI 10.1016/j.postharvbio.2007.03.019; Xu WT, 2007, POSTHARVEST BIOL TEC, V45, P126, DOI 10.1016/j.postharvbio.2006.11.019; Zhang XQ, 2006, PROTEOMICS, V6, P5260, DOI 10.1002/pmic.200600006	53	11	11	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32943	10.1371/journal.pone.0032943	http://dx.doi.org/10.1371/journal.pone.0032943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403727	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700124
J	Matos, RG; Fialho, AM; Giloh, M; Schuster, G; Arraiano, CM				Matos, Rute G.; Fialho, Arsenio M.; Giloh, Mordechai; Schuster, Gadi; Arraiano, Cecilia M.			The rnb Gene of Synechocystis PCC6803 Encodes a RNA Hydrolase Displaying RNase II and Not RNase R Enzymatic Properties	PLOS ONE			English	Article							ESCHERICHIA-COLI; RIBONUCLEASE-II; MESSENGER-RNA; POLYNUCLEOTIDE PHOSPHORYLASE; SWISS-MODEL; PHYLOGENETIC ANALYSIS; REACTION-MECHANISM; QUALITY-CONTROL; DEGRADATION; CLEAVAGE	Cyanobacteria are photosynthetic prokaryotic organisms that share characteristics with bacteria and chloroplasts regarding mRNA degradation. Synechocystis sp. PCC6803 is a model organism for cyanobacteria, but not much is known about the mechanism of RNA degradation. Only one member of the RNase II-family is present in the genome of Synechocystis sp PCC6803. This protein was shown to be essential for its viability, which indicates that it may have a crucial role in the metabolism of Synechocystis RNA. The aim of this work was to characterize the activity of the RNase II/R homologue present in Synechocystis sp. PCC6803. The results showed that as expected, it displayed hydrolytic activity and released nucleoside monophosphates. When compared to two E. coli counterparts, the activity assays showed that the Synechocystis protein displays RNase II, and not RNase R characteristics. This is the first reported case where when only one member of the RNase II/R family exists it displays RNase II and not RNase R characteristics.	[Matos, Rute G.; Arraiano, Cecilia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Fialho, Arsenio M.] Inst Super Tecn, Ctr Biol & Chem Engn, IBB, Lisbon, Portugal; [Giloh, Mordechai; Schuster, Gadi] Technion Israel Inst Technol, Fac Biol, Haifa, Israel	Universidade Nova de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Technion Israel Institute of Technology	Matos, RG (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	cecilia@itqb.unl.pt	Schuster, Gadi/AAE-2010-2019; Fialho, Arsenio/A-6246-2008; Matos, Rute/J-4983-2013; AM, Fialho/AAB-5715-2021	Fialho, Arsenio/0000-0002-8066-5787; AM, Fialho/0000-0002-8066-5787; Matos Luis, Rute/0000-0002-9788-7562; Arraiano, Cecilia/0000-0003-1934-9301	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011]; BARD foundation; BSF(Binational Science Foundation)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); BARD foundation; BSF(Binational Science Foundation)(US-Israel Binational Science Foundation)	Work at ITQB was supported by grants from Fundacao para a Ciencia e a Tecnologia (FCT) and grant PEst-OE/EQB/LA0004/2011, also from FCT. Work at IBB/IST had financial support from FCT. Work in GS's lab was supported by grants from the BARD (Binational Agricultural Research and Development Fund) and BSF(Binational Science Foundation) foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amblar M, 2005, FEBS J, V272, P363, DOI 10.1111/j.1742-4658.2004.04477.x; Amblar M, 2007, RNA, V13, P317, DOI 10.1261/rna.220407; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arraiano CM, 2010, RNA BIOL, V7, P276, DOI 10.4161/rna.7.3.11490; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Arraiano CM, 2008, METHOD ENZYMOL, V447, P131, DOI 10.1016/S0076-6879(08)02208-8; Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; Barbas A, 2008, J BIOL CHEM, V283, P13070, DOI 10.1074/jbc.M709989200; Barbas A, 2009, J BIOL CHEM, V284, P20486, DOI 10.1074/jbc.M109.020693; Cairrao F, 2003, MOL MICROBIOL, V50, P1349, DOI 10.1046/j.1365-2958.2003.03766.x; Cannistraro VJ, 1999, BBA-PROTEIN STRUCT M, V1433, P170, DOI 10.1016/S0167-4838(99)00136-3; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Cannistraro VJ, 2001, METHOD ENZYMOL, V342, P309, DOI 10.1016/S0076-6879(01)42555-9; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charpentier X, 2008, J BACTERIOL, V190, P8126, DOI 10.1128/JB.01035-08; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Conrad C, 1998, NUCLEIC ACIDS RES, V26, P4446, DOI 10.1093/nar/26.19.4446; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DEUTSCHER MP, 1991, P NATL ACAD SCI USA, V88, P3277, DOI 10.1073/pnas.88.8.3277; Domingues S, 2009, BIOCHEMISTRY-US, V48, P11848, DOI 10.1021/bi901105n; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Horie Y, 2007, MOL GENET GENOMICS, V278, P331, DOI 10.1007/s00438-007-0254-9; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lalonde MS, 2007, RNA, V13, P1957, DOI 10.1261/rna.706207; Lisitsky I, 1997, J BIOL CHEM, V272, P17648, DOI 10.1074/jbc.272.28.17648; Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Matos RG, 2011, PROTEINS, V79, P1853, DOI 10.1002/prot.23010; Matos RG, 2009, BIOCHEM J, V423, P291, DOI 10.1042/BJ20090839; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mohanty BK, 2003, MOL MICROBIOL, V50, P645, DOI 10.1046/j.1365-2958.2003.03724.x; Portnoy V, 2006, NUCLEIC ACIDS RES, V34, P5923, DOI 10.1093/nar/gkl763; Rott R, 2003, J BIOL CHEM, V278, P15771, DOI 10.1074/jbc.M211571200; Rowland JG, 2011, J PROTEOME RES, V10, P3674, DOI 10.1021/pr200299t; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001	44	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32690	10.1371/journal.pone.0032690	http://dx.doi.org/10.1371/journal.pone.0032690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403697	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700094
J	Perez-Redondo, R; Rodriguez-Garcia, A; Botas, A; Santamarta, I; Martin, JF; Liras, P				Perez-Redondo, Rosario; Rodriguez-Garcia, Antonio; Botas, Alma; Santamarta, Irene; Martin, Juan F.; Liras, Paloma			ArgR of Streptomyces coelicolor Is a Versatile Regulator	PLOS ONE			English	Article							ESCHERICHIA-COLI; ARGININE-BIOSYNTHESIS; TRANSCRIPTOME ANALYSIS; ANTIBIOTIC PRODUCTION; BACILLUS-SUBTILIS; OPERATOR INTERACTIONS; NITROGEN-METABOLISM; GLOBAL REGULATORS; GENE-EXPRESSION; CROSS-TALK	ArgR is the regulator of arginine biosynthesis genes in Streptomyces species. Transcriptomic comparison by microarrays has been made between Streptomyces coelicolor M145 and its mutant S. coelicolor Delta argR under control, unsupplemented conditions, and in the presence of arginine. Expression of 459 genes was different in transcriptomic assays, but only 27 genes were affected by arginine supplementation. Arginine and pyrimidine biosynthesis genes were derepressed by the lack of ArgR, while no strong effect on expression resulted on arginine supplementation. Several nitrogen metabolism genes expression as glnK, glnA and glnII, were downregulated in S. coelicolor DargR. In addition, downregulation of genes for the yellow type I polyketide CPK antibiotic and for the antibiotic regulatory genes afsS and scbR was observed. The transcriptomic data were validated by either reverse transcription-PCR, expression of the gene-promoter coupled to the luciferase gene, proteomic or by electrophoresis mobility shift assay (EMSA) using pure Strep-tagged ArgR. Two ARG-boxes in the arginine operon genes suggest that these genes are more tightly controlled. Other genes, including genes encoding regulatory proteins, possess a DNA sequence formed by a single ARG-box which responds to ArgR, as validated by EMSA.	[Perez-Redondo, Rosario; Rodriguez-Garcia, Antonio; Botas, Alma; Santamarta, Irene; Martin, Juan F.; Liras, Paloma] Univ Leon, Fac Ciencias Biol & Ambientales, Area Microbiol, E-24071 Leon, Spain; [Perez-Redondo, Rosario; Rodriguez-Garcia, Antonio; Botas, Alma; Santamarta, Irene; Martin, Juan F.; Liras, Paloma] Inst Biotecnol, Leon, Spain	Universidad de Leon	Perez-Redondo, R (corresponding author), Univ Leon, Fac Ciencias Biol & Ambientales, Area Microbiol, E-24071 Leon, Spain.	paloma.liras@unileon.es	SANTAMARTA, IRENE/L-4534-2014; Rodríguez-García, Antonio/A-9461-2011; Redondo, Rosario Perez/I-7037-2016	SANTAMARTA, IRENE/0000-0001-9139-7805; Rodríguez-García, Antonio/0000-0001-8118-9762; Redondo, Rosario Perez/0000-0002-8782-8796	Spanish Comision Interministerial de Ciencia y Tecnologia [GEN2003-20245, BIO2009-09820]; Ministry of Science and Innovation;  [LSHM-CT-2004-005224]	Spanish Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	This work was supported by Grants from the Spanish Comision Interministerial de Ciencia y Tecnologia GEN2003-20245, BIO2009-09820, and by the European Project LSHM-CT-2004-005224. AB received a fellowship from the Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borovok I, 2006, J BACTERIOL, V188, P2512, DOI 10.1128/JB.188.7.2512-2520.2006; Caldara M, 2007, J MOL BIOL, V373, P251, DOI 10.1016/j.jmb.2007.08.013; Caldara M, 2006, MICROBIOL-SGM, V152, P3343, DOI 10.1099/mic.0.29088-0; Castro-Melchor M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-578; Charlier D, 2004, BIOCHEM SOC T, V32, P310, DOI 10.1042/BST0320310; CHARLIER D, 1992, J MOL BIOL, V226, P367, DOI 10.1016/0022-2836(92)90953-H; Claessen D, 2004, MOL MICROBIOL, V53, P433, DOI 10.1111/j.1365-2958.2004.04143.x; CUNIN R, 1983, NUCLEIC ACIDS RES, V11, P5007, DOI 10.1093/nar/11.15.5007; CZAPLEWSKI LG, 1992, MOL MICROBIOL, V6, P267, DOI 10.1111/j.1365-2958.1992.tb02008.x; DELAFUENTE A, 1994, GENE, V139, P83, DOI 10.1016/0378-1119(94)90527-4; delaFuente JL, 1996, BIOCHEM J, V320, P173, DOI 10.1042/bj3200173; FERNANDEZMORENO MA, 1991, CELL, V66, P769, DOI 10.1016/0092-8674(91)90120-N; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Garnett JA, 2008, J MOL BIOL, V379, P284, DOI 10.1016/j.jmb.2008.03.007; Gottelt M, 2010, MICROBIOL-SGM, V156, P2343, DOI 10.1099/mic.0.038281-0; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hara H, 2007, MICROBIOLOGY, V155, P2197; HORNEMANN U, 1975, J ANTIBIOT, V28, P841, DOI 10.7164/antibiotics.28.841; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kiupakis AK, 2002, J BACTERIOL, V184, P2940, DOI 10.1128/JB.184.11.2940-2950.2002; Larsen R, 2008, APPL ENVIRON MICROB, V74, P4768, DOI 10.1128/AEM.00117-08; Lee SY, 2011, APPL ENVIRON MICROB, V77, P711, DOI 10.1128/AEM.01610-10; Lee SY, 2010, APPL MICROBIOL BIOT, V86, P235, DOI 10.1007/s00253-009-2264-5; Lee SY, 2009, CURR MICROBIOL, V59, P483, DOI 10.1007/s00284-009-9467-y; Lu CD, 1999, J BACTERIOL, V181, P1934, DOI 10.1128/JB.181.6.1934-1938.1999; Lu CD, 2004, J BACTERIOL, V186, P3855, DOI 10.1128/JB.186.12.3855-3861.2004; LUDOVICE M, 1992, J BACTERIOL, V174, P4606, DOI 10.1128/JB.174.14.4606-4613.1992; MAAS WK, 1994, MICROBIOL REV, V58, P631, DOI 10.1128/MMBR.58.4.631-640.1994; Makarova KS, 2001, GENOME BIOL, V2; Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714; Martin JF, 2011, MICROB BIOTECHNOL, V4, P165, DOI 10.1111/j.1751-7915.2010.00235.x; MARTINKUS KJ, 1983, TETRAHEDRON, V39, P3493, DOI 10.1016/S0040-4020(01)88659-2; Mehra S, 2006, J IND MICROBIOL BIOT, V33, P159, DOI 10.1007/s10295-005-0034-7; Miller CM, 1997, MOL MICROBIOL, V26, P37, DOI 10.1046/j.1365-2958.1997.5441907.x; NORTH AK, 1989, GENE, V80, P29, DOI 10.1016/0378-1119(89)90247-3; Park SM, 1997, J BACTERIOL, V179, P5300, DOI 10.1128/jb.179.17.5300-5308.1997; Paul L, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-2; Reuther J, 2007, J MOL MICROB BIOTECH, V12, P139, DOI 10.1159/000096469; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Rodriguez-Garcia A, 2000, J MOL MICROB BIOTECH, V2, P543; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; Rodriguez-Garcia A, 2009, NUCLEIC ACIDS RES, V37, P3230, DOI 10.1093/nar/gkp162; RodriguezGarcia A, 1997, MOL MICROBIOL, V25, P219, DOI 10.1046/j.1365-2958.1997.4511815.x; ROMERO J, 1986, APPL ENVIRON MICROB, V52, P892, DOI 10.1128/AEM.52.4.892-897.1986; Santamarta I, 2011, MOL MICROBIOL, V81, P968, DOI 10.1111/j.1365-2958.2011.07743.x; Santos-Beneit F, 2008, MICROBIOL-SGM, V154, P2356, DOI 10.1099/mic.0.2008/019539-0; Santos-Beneit F, 2009, MOL MICROBIOL, V72, P53, DOI 10.1111/j.1365-2958.2009.06624.x; Sartor M, 2004, BIOTECHNIQUES, V36, P790, DOI 10.2144/04365ST02; Schneider TD, 1997, J THEOR BIOL, V189, P427, DOI 10.1006/jtbi.1997.0540; Schneider TD, 1996, METHOD ENZYMOL, V274, P445; SMITH MCM, 1989, MOL MICROBIOL, V3, P23, DOI 10.1111/j.1365-2958.1989.tb00099.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Soutar A, 1996, MOL GEN GENET, V251, P245; Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x; Thomas MG, 2002, CHEM BIOL, V9, P171, DOI 10.1016/S1074-5521(02)00100-X; TIAN GL, 1992, J MOL BIOL, V226, P387, DOI 10.1016/0022-2836(92)90954-I; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; VANPILSUM JF, 1956, J BIOL CHEM, V222, P225; Walker J B, 1975, Methods Enzymol, V43, P429; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-191; Yang Z, 2007, J BACTERIOL, V189, P3945, DOI 10.1128/JB.00261-07	66	26	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32697	10.1371/journal.pone.0032697	http://dx.doi.org/10.1371/journal.pone.0032697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403700	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700097
J	Zhang, TY; Fu, XJ; Ma, S; Xiao, GX; Wong, LS; Kwoh, CK; Lees, M; Lee, GKK; Hung, T				Zhang, Tianyou; Fu, Xiuju; Ma, Stefan; Xiao, Gaoxi; Wong, Limsoon; Kwoh, Chee Keong; Lees, Michael; Lee, Gary Kee Khoon; Hung, Terence			Evaluating Temporal Factors in Combined Interventions of Workforce Shift and School Closure for Mitigating the Spread of Influenza	PLOS ONE			English	Article							INFECTIOUS-DISEASES; PANDEMIC INFLUENZA; MODEL; TRANSMISSION; STRATEGIES	Background: It is believed that combined interventions may be more effective than individual interventions in mitigating epidemic. However there is a lack of quantitative studies on performance of the combination of individual interventions under different temporal settings. Methodology/Principal Findings: To better understand the problem, we develop an individual-based simulation model running on top of contact networks based on real-life contact data in Singapore. We model and evaluate the spread of influenza epidemic with intervention strategies of workforce shift and its combination with school closure, and examine the impacts of temporal factors, namely the trigger threshold and the duration of an intervention. By comparing simulation results for intervention scenarios with different temporal factors, we find that combined interventions do not always outperform individual interventions and are more effective only when the duration is longer than 6 weeks or school closure is triggered at the 5% threshold; combined interventions may be more effective if school closure starts first when the duration is less than 4 weeks or workforce shift starts first when the duration is longer than 4 weeks. Conclusions/Significance: We therefore conclude that identifying the appropriate timing configuration is crucial for achieving optimal or near optimal performance in mitigating the spread of influenza epidemic. The results of this study are useful to policy makers in deliberating and planning individual and combined interventions.	[Zhang, Tianyou; Fu, Xiuju; Lee, Gary Kee Khoon; Hung, Terence] ASTAR, Inst High Performance Comp, Singapore, Singapore; [Xiao, Gaoxi; Kwoh, Chee Keong; Lees, Michael] Nanyang Technol Univ, Singapore, Singapore; [Wong, Limsoon] Natl Univ Singapore, Singapore 117548, Singapore; [Ma, Stefan] Minist Hlth, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Ministry of Health-Singapore	Zhang, TY (corresponding author), ASTAR, Inst High Performance Comp, Singapore, Singapore.	fuxj@ihpc.a-star.edu.sg	Wong, Limsoon/W-3611-2019; Xiao, Gaoxi/A-5095-2011; zhang, tian/GZK-6001-2022; Wong, Limsoon/E-5033-2010	Wong, Limsoon/0000-0003-1241-5441; Xiao, Gaoxi/0000-0002-4171-6799; Wong, Limsoon/0000-0003-1241-5441	Biomedical Research Council of Singapore A-STAR [06/1/21/19/457]	Biomedical Research Council of Singapore A-STAR	This work was supported in part by Biomedical Research Council of Singapore A-STAR (http://www.a-star.edu.sg/AboutASTAR/BiomedicalResearchCouncil/tabid/64/Default.aspx) under Grant 06/1/21/19/457. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26; Cauchemez S, P NATL ACAD SCI; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cowling BJ, 2008, EMERG INFECT DIS, V14, P1660, DOI 10.3201/eid1410.080646; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Department of Statistics Singapore Statistics Singapore - Census of Population, 2000, CENS POP 2000 STAT R; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Duerr HP, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-76; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halder N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-168; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Nishiura H, 2009, EUROSURVEILLANCE, V14; Rizzo C, 2008, EPIDEMIOL INFECT, V136, P1650, DOI 10.1017/S095026880800037X; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135; Zhang T, 2010, EFFECTS TEMPORAL FAC	26	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32203	10.1371/journal.pone.0032203	http://dx.doi.org/10.1371/journal.pone.0032203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403634	Green Published, gold			2022-12-25	WOS:000303017700031
J	Plaideau, C; Liu, JM; Hartleib-Geschwindner, J; Bastin-Coyette, L; Bontemps, F; Oscarsson, J; Hue, L; Rider, MH				Plaideau, Catheline; Liu, Jianming; Hartleib-Geschwindner, Judith; Bastin-Coyette, Laurent; Bontemps, Francoise; Oscarsson, Jan; Hue, Louis; Rider, Mark H.			Overexpression of AMP-metabolizing enzymes controls adenine nucleotide levels and AMPK activation in HEK293T cells	FASEB JOURNAL			English	Article						adenylate energy charge; cN-1A; control coefficient	PROTEIN-KINASE; ADENYLATE DEAMINASE; SKELETAL-MUSCLE; ENERGY-CHARGE; YEAST SNF1; PHOSPHORYLATION; INSULIN; CONTRACTION; EXERCISE; HEART	We investigated whether overexpression of AMP-metabolizing enzymes in intact cells would modulate oligomycin-induced AMPK activation. Human embryonic kidney (HEK) 293T cells were transiently transfected with increasing amounts of plasmid vectors to obtain a graded increase in overexpression of AMP-deaminase (AMPD) 1, AMPD2, and soluble 5'-nucleotidase IA (cN-IA) for measurements of AMPK activation and total intracellular adenine nucleotide levels induced by oligomycin treatment. Overexpression of AMPD1 and AMPD2 slightly decreased AMP levels and oligomycin-induced AMPK activation. Increased overexpression of cN-IA led to reductions in the oligomycin-induced increases in AMP and ADP concentrations by similar to 70 and 50%, respectively, concomitant with a 50% decrease in AMPK activation. The results support the view that a rise in ADP as well as AMP is important for activation of AMPK, which can thus be regulated by the adenylate energy charge. The control coefficient of cN-IA on AMP was 0.3-0.7, whereas the values for AMPD1 and AMPD2 were <0.1, suggesting that in this model cN-IA exerts a large proportion of control over intracellular AMP. Therefore, small molecule inhibition of cN-IA could be a strategy for AMPK activation.-Plaideau, C., Liu, J., Hartleib-Geschwindner, J., Bastin-Coyette, L., Bontemps, F., Oscarsson, J., Hue, L., Rider, M. H. Overexpression of AMP-metabolizing enzymes controls adenine nucleotide levels and AMPK activation in HEK293T cells. FASEB J. 26, 2685-2694 (2012). www.fasebj.org	[Plaideau, Catheline; Bastin-Coyette, Laurent; Bontemps, Francoise; Hue, Louis; Rider, Mark H.] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Liu, Jianming; Hartleib-Geschwindner, Judith; Oscarsson, Jan] AstraZeneca Res & Dev, Molndal, Sweden	Universite Catholique Louvain; AstraZeneca	Rider, MH (corresponding author), Catholic Univ Louvain, Duve Inst, Ave Hippocrate 75,Bte B1-74-02, B-1200 Brussels, Belgium.	mark.rider@uclouvain.be			Interuniversity Attraction Poles Program-Belgian Science Policy [P6/28]; Directorate General Higher Education and Scientific Research, French Community of Belgium; Fund for Medical Scientific Research (Belgium); EXGENESIS from European Commission [LSHM-CT-2004-005272]; Fund for Scientific Research in Industry and Agriculture (FRIA; Belgium)	Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office); Directorate General Higher Education and Scientific Research, French Community of Belgium; Fund for Medical Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS); EXGENESIS from European Commission; Fund for Scientific Research in Industry and Agriculture (FRIA; Belgium)(Fonds de la Recherche Scientifique - FNRS)	The authors thank Roxane Jacobs for her expert technical assistance. This work was supported by the Interuniversity Attraction Poles Program-Belgian Science Policy (P6/28), the Directorate General Higher Education and Scientific Research, French Community of Belgium, the Fund for Medical Scientific Research (Belgium), and the EXGENESIS Integrated Project (LSHM-CT-2004-005272) from the European Commission. C. P. was supported by the Fund for Scientific Research in Industry and Agriculture (FRIA; Belgium).	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; BAUSCHJURKEN MT, 1995, ARCH BIOCHEM BIOPHYS, V321, P372, DOI 10.1006/abbi.1995.1407; BELSHAM GJ, 1980, BIOCHEM J, V192, P457, DOI 10.1042/bj1920457; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Bontemps F, 2000, BIOCHEM PHARMACOL, V59, P1237, DOI 10.1016/S0006-2952(00)00258-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabarcas SM, 2010, CURR MOL MED, V10, P741; CHAPMAN AG, 1973, J BIOL CHEM, V248, P8309; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]; Frederich M, 2002, J BIOL CHEM, V277, P1928, DOI 10.1074/jbc.M107128200; Haas AL, 2003, BIOCHEM BIOPH RES CO, V305, P421, DOI 10.1016/S0006-291X(03)00787-3; HALFMAN CJ, 1982, BIOCHEM J, V203, P339, DOI 10.1042/bj2030339; Hancock CR, 2006, J APPL PHYSIOL, V100, P406, DOI 10.1152/japplphysiol.00885.2005; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kulkarni SS, 2011, J BIOL CHEM, V286, P34567, DOI 10.1074/jbc.M111.268292; Lai YC, 2010, J APPL PHYSIOL, V108, P1106, DOI 10.1152/japplphysiol.00401.2009; Mahnke-Zizelman DK, 1998, J BIOL CHEM, V273, P35118, DOI 10.1074/jbc.273.52.35118; MahnkeZizelman DK, 1997, BIOCHEM J, V326, P521, DOI 10.1042/bj3260521; Mantovani J, 2011, FEBS LETT, V585, P967, DOI 10.1016/j.febslet.2010.12.015; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; MCGILVERY RW, 1974, J BIOL CHEM, V249, P5845; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; MORISAKI T, 1990, J BIOL CHEM, V265, P11482; Neumann D., 2007, MOL SYSTEMS BIOENERG, P303; NEWBY AC, 1988, BIOCHEM J, V253, P123, DOI 10.1042/bj2530123; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; OGASAWARA N, 1975, FEBS LETT, V58, P245, DOI 10.1016/0014-5793(75)80270-5; OGASAWARA N, 1978, EUR J BIOCHEM, V87, P297, DOI 10.1111/j.1432-1033.1978.tb12378.x; REN JM, 1990, J APPL PHYSIOL, V69, P919, DOI 10.1152/jappl.1990.69.3.919; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; RUNDELL KW, 1992, AM J PHYSIOL, V263, pC287, DOI 10.1152/ajpcell.1992.263.2.C287; RUNDELL KW, 1992, AM J PHYSIOL, V263, pC294, DOI 10.1152/ajpcell.1992.263.2.C294; Rush JWE, 1998, AM J PHYSIOL-CELL PH, V274, pC465, DOI 10.1152/ajpcell.1998.274.2.C465; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; SAHLIN K, 1990, INT J SPORTS MED, V11, pS62, DOI 10.1055/s-2007-1024856; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Sitte HH, 2001, MOL PHARMACOL, V59, P1129, DOI 10.1124/mol.59.5.1129; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Teijeira S, 2009, CLIN NEUROPATHOL, V28, P136; Tullson P C, 1991, Exerc Sport Sci Rev, V19, P507; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wegener G, 1996, EXPERIENTIA, V52, P404, DOI 10.1007/BF01919307; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; ZENG CB, 1995, J BIOL CHEM, V270, P10509, DOI 10.1074/jbc.270.18.10509; Zhang SJ, 2008, ACTA PHYSIOL, V192, P413, DOI 10.1111/j.1748-1716.2007.01767.x	58	21	22	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2685	2694		10.1096/fj.11-198168	http://dx.doi.org/10.1096/fj.11-198168			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415305				2022-12-25	WOS:000305017200044
J	Cheng, AC; Wu, HL; Shi, GY; Tsai, IH				Cheng, An-Chun; Wu, Hua-Lin; Shi, Guey-Yueh; Tsai, Inn-Ho			A Novel Heparin-dependent Inhibitor of Activated Protein C That Potentiates Consumptive Coagulopathy in Russell's Viper Envenomation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-X ACTIVATOR; ANTITHROMBIN-III; MAST-CELLS; FACTOR-VA; IN-VIVO; VENOM; COAGULATION; MECHANISM; THROMBIN; SNAKE	The activation of coagulation factors V and X by Russell's viper venom (RVV) has been implicated in the development of consumptive coagulopathies in severely envenomed patients. However, factor Va is prone to inactivation by activated protein C (APC), an important serine protease that negatively regulates blood coagulation. It is therefore hypothesized that APC may be down-regulated by some of the venom components. In this study, we managed to isolate a potent Kunitz-type APC inhibitor, named DrKIn-I. Using chromogenic substrate, DrKIn-I dose-dependently inhibited the activity of APC. Heparin potentiated the inhibition and reduced the IC50 of DrKIn-I by 25-fold. DrKIn-I, together with heparin, also protected factor Va from APC-mediated inactivation. Using surface plasmon resonance, DrKIn-I exhibited fast binding kinetics with APC (association rate constant = 1.7 x 10(7) M-1 s(-1)). Direct binding assays and kinetic studies revealed that this inhibition (K-i = 53 pM) is due to the tight binding interactions of DrKIn-I with both heparin and APC. DrKIn-I also effectively reversed the anticoagulant activity of APC and completely restored the thrombin generation in APC-containing plasma. Furthermore, although the injection of either DrKIn-I or RVV-X (the venom factor X-activator) into ICR mice did not significantly deplete the plasma fibrinogen concentration, co-administration of DrKIn-I with RVV-X resulted in complete fibrinogen consumption and the deposition of fibrin thrombi in the glomerular capillaries. Our results provide new insights into the pathogenesis of RVV-induced coagulopathies and indicate that DrKIn-I is a novel APC inhibitor that is associated with potentially fatal thrombotic complications in Russell's viper envenomation.	[Cheng, An-Chun; Tsai, Inn-Ho] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Wu, Hua-Lin; Shi, Guey-Yueh] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Coll Med, Tainan 70101, Taiwan; [Wu, Hua-Lin; Shi, Guey-Yueh] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Tsai, Inn-Ho] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University; National Taiwan University	Tsai, IH (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	bc201@gate.sinica.edu.tw			Academia Sinica; National Science Council [NSC 99-2311-B-001-016-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica and from the National Science Council (NSC 99-2311-B-001-016-MY3).	Alirol E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000603; BAUER KA, 1991, SEMIN HEMATOL, V28, P10; Bombeli T, 1997, THROMB HAEMOSTASIS, V77, P408; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CAVARI S, 1992, THROMB RES, V67, P157, DOI 10.1016/0049-3848(92)90135-W; Chen HS, 2008, FEBS J, V275, P3944, DOI 10.1111/j.1742-4658.2008.06540.x; Cheng YC, 2005, BBA-PROTEINS PROTEOM, V1747, P213, DOI 10.1016/j.bbapap.2004.11.006; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Dahlback B, 2005, J INTERN MED, V257, P209, DOI 10.1111/j.1365-2796.2004.01444.x; Engelberg H, 2001, ATHEROSCLEROSIS, V159, P253, DOI 10.1016/S0021-9150(01)00650-5; Esmon CT, 2001, CRIT CARE, V5, pS7, DOI 10.1186/cc1333; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; Friedrich U, 2001, J BIOL CHEM, V276, P24122, DOI 10.1074/jbc.M011567200; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x; GRIFFITH MJ, 1982, J BIOL CHEM, V257, P7360; Gupta A, 2007, AM J PHYSIOL-RENAL, V293, pF245, DOI 10.1152/ajprenal.00477.2006; HEEB MJ, 1988, J BIOL CHEM, V263, P11613; HIGGINBOTHAM RD, 1965, J IMMUNOL, V95, P867; Hirsh J, 2001, ARTERIOSCL THROM VAS, V21, P1094, DOI 10.1161/hq0701.093686; Hung DZ, 2002, PHARMACOL TOXICOL, V91, P106, DOI 10.1034/j.1600-0773.2002.910303.x; IHRCKE NS, 1993, IMMUNOL TODAY, V14, P500, DOI 10.1016/0167-5699(93)90265-M; Kang HM, 2005, THROMB RES, V115, P327, DOI 10.1016/j.thromres.2004.09.015; Knoebl Paul N, 2008, Biologics, V2, P285; LIU LB, 1995, THROMB HAEMOSTASIS, V73, P405; Mann KG, 2003, J THROMB HAEMOST, V1, P1504, DOI 10.1046/j.1538-7836.2003.00298.x; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; NESHEIM ME, 1982, J BIOL CHEM, V257, P1443; Nielsen VG, 2001, J CRIT CARE, V16, P64, DOI 10.1053/jcrc.2001.26292; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Petaja J, 1997, J CLIN INVEST, V99, P2655, DOI 10.1172/JCI119454; Rapaport SI, 1997, ARTERIOSCL THROM VAS, V17, P409, DOI 10.1161/01.ATV.17.2.409; RATCLIFFE PJ, 1989, AM J TROP MED HYG, V40, P312, DOI 10.4269/ajtmh.1989.40.312; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; Smith OP, 1999, BRIT J HAEMATOL, V104, P202, DOI 10.1046/j.1365-2141.1999.01186.x; Sugimoto M, 1997, THROMB HAEMOSTASIS, V77, P1223; Suntravat M, 2011, TOXICON, V58, P230, DOI 10.1016/j.toxicon.2011.05.007; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; THANTHAN, 1989, ACTA TROP, V46, P23, DOI 10.1016/0001-706X(89)90013-2; THANTHAN, 1988, BRIT J HAEMATOL, V69, P513, DOI 10.1111/j.1365-2141.1988.tb02408.x; TINNUSWE, 1993, T ROY SOC TROP MED H, V87, P678, DOI 10.1016/0035-9203(93)90290-7; van Holde KE, 2002, BIOPHYS CHEM, V101, P249, DOI 10.1016/S0301-4622(02)00176-X; WARRELL DA, 1989, T ROY SOC TROP MED H, V83, P732, DOI 10.1016/0035-9203(89)90311-8; Win-Aung, 1998, T ROY SOC TROP MED H, V92, P322, DOI 10.1016/S0035-9203(98)91031-8; Yegneswaran S, 2009, THROMB HAEMOSTASIS, V101, P55, DOI 10.1160/TH08-07-0491; YOSHIKAWA T, 1981, RES EXP MED, V179, P223, DOI 10.1007/BF01851619; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	49	14	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15739	15748		10.1074/jbc.M111.323063	http://dx.doi.org/10.1074/jbc.M111.323063			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416129	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000304006300052
J	Ding, BX; Sun, Y; Huang, JT				Ding, Boxiao; Sun, Yin; Huang, Jiaoti			Overexpression of SKI Oncoprotein Leads to p53 Degradation through Regulation of MDM2 Protein Sumoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING-GROWTH-FACTOR; TRANSCRIPTIONAL REPRESSION; SKELETAL-MUSCLE; LIGASE ACTIVITY; CO-REPRESSOR; TUMOR-GROWTH; RAR-ALPHA; IN-VIVO; UBIQUITINATION; PATHWAY	Protooncogene Ski was identified based on its ability to transform avian fibroblasts in vitro. In support of its oncogenic activity, SKI was found to be overexpressed in a variety of human cancers, although the exact molecular mechanism(s) responsible for its oncogenic activity is not fully understood. We found that SKI can negatively regulate p53 by decreasing its level through up-regulation of MDM2 activity, which is mediated by the ability of SKI to enhance sumoylation of MDM2. This stimulation of MDM2 sumoylation is accomplished through a direct interaction of SKI with SUMO-conjugating enzyme E2, Ubc9, resulting in enhanced thioester bond formation and mono-sumoylation of Ubc9. A mutant SKI defective in transformation fails to increase p53 ubiquitination and is unable to increase MDM2 levels and to increase mono-sumoylation of Ubc9, suggesting that the ability of SKI to enhance Ubc9 activity is essential for its transforming function. These results established a detailed molecular mechanism that underlies the ability of SKI to cause cellular transformation while unraveling a novel connection between sumoylation and tumorigenesis, providing potential new therapeutic targets for cancer.	[Ding, Boxiao; Sun, Yin; Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sun, Y (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	yinsun@mednet.ucla.edu; jiaotihuang@mednet.ucla.edu	Ding, Boxiao/C-1017-2011	Huang, Jiaoti/0000-0003-1195-1998	National Institutes of Health [RO1 CA093848, 1R01CA158627]; Department of Defense [PC1001008]; UCLA SPORE in Prostate Cancer; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA158627, R01CA093848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); UCLA SPORE in Prostate Cancer; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA093848 (to Y. S.).; Supported by Department of Defense Prostate Cancer Research Program Grant PC1001008, UCLA SPORE in Prostate Cancer (to R. Reiter), a challenge award from the Prostate Cancer Foundation (to O. Witte), a creativity award from Prostate Cancer Foundation (to M. Rettig), and National Institutes of Health Grant 1R01CA158627 (to L. Marks). To whom correspondence may be addressed. E-mail: jiaotihuang@mednet.ucla.edu.	Akagi T, 2004, TRENDS MOL MED, V10, P542, DOI 10.1016/j.molmed.2004.09.001; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Barkas A., 1986, THESIS NEW YORK U; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Buess M, 2004, NEOPLASIA, V6, P207, DOI 10.1593/neo.03442; Buschmann T, 2001, J BIOL CHEM, V276, P40389, DOI 10.1074/jbc.M103786200; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Chen DH, 2009, PIGM CELL MELANOMA R, V22, P761, DOI 10.1111/j.1755-148X.2009.00603.x; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; COLMENARES C, 1991, MOL CELL BIOL, V11, P1167, DOI 10.1128/MCB.11.2.1167; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Ferrand N, 2010, CANCER RES, V70, P8457, DOI 10.1158/0008-5472.CAN-09-4088; Fukuchi M, 2004, INT J CANCER, V108, P818, DOI 10.1002/ijc.11651; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Heider TR, 2007, ANN SURG, V246, P61, DOI 10.1097/SLA.0b013e318070cafa; Hock A, 2010, INT J BIOCHEM CELL B, V42, P1618, DOI 10.1016/j.biocel.2010.06.011; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Inoue Y, 2011, J BIOL CHEM, V286, P6311, DOI 10.1074/jbc.M110.177683; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee MH, 2006, NAT CELL BIOL, V8, P1424, DOI 10.1038/ncb1512; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Medrano EE, 2003, ONCOGENE, V22, P3123, DOI 10.1038/sj.onc.1206452; Miyauchi Y, 2002, J BIOL CHEM, V277, P50131, DOI 10.1074/jbc.M208319200; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Pelisch F, 2010, P NATL ACAD SCI USA, V107, P16119, DOI 10.1073/pnas.1004653107; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Sun Y, 2011, J BIOL CHEM, V286, P18623, DOI 10.1074/jbc.M110.176693; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Takahata M, 2009, J BIOL CHEM, V284, P3334, DOI 10.1074/jbc.M808989200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tokitou F, 1999, J BIOL CHEM, V274, P4485, DOI 10.1074/jbc.274.8.4485; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	54	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14621	14630		10.1074/jbc.M111.301523	http://dx.doi.org/10.1074/jbc.M111.301523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22411991	Green Published, hybrid			2022-12-25	WOS:000304003200029
J	Mahat, DB; Brennan-Laun, SE; Fialcowitz-White, EJ; Kishor, A; Ross, CR; Pozharskaya, T; Rawn, JD; Blackshear, PJ; Hassel, BA; Wilson, GM				Mahat, Dig B.; Brennan-Laun, Sarah E.; Fialcowitz-White, Elizabeth J.; Kishor, Aparna; Ross, Christina R.; Pozharskaya, Tatyana; Rawn, J. David; Blackshear, Perry J.; Hassel, Bret A.; Wilson, Gerald M.			Coordinated Expression of Tristetraprolin Post-Transcriptionally Attenuates Mitogenic Induction of the Oncogenic Ser/Thr Kinase Pim-1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; MESSENGER-RNA DECAY; ELEMENT-BINDING PROTEIN; ZINC-FINGER PROTEINS; AU-RICH ELEMENTS; POSTTRANSLATIONAL MODIFICATION; DEPENDENT PHOSPHORYLATION; C-MYC; HUR	The serine/threonine kinase Pim-1 directs selected signaling events that promote cell growth and survival and is overexpressed in diverse human cancers. Pim-1 expression is tightly controlled through multiple mechanisms, including regulation of mRNA turnover. In several cultured cell models, mitogenic stimulation rapidly induced and stabilized PIM1 mRNA, however, vigorous destabilization 4-6 hours later helped restore basal expression levels. Acceleration of PIM1 mRNA turnover coincided with accumulation of tristetraprolin (TTP), an mRNA-destabilizing protein that targets transcripts containing AU-rich elements. TTP binds PIM1 mRNA in cells, and suppresses its expression by accelerating mRNA decay. Reporter mRNA decay assays localized the TTP-regulated mRNA decay element to a discrete AU-rich sequence in the distal 3'-untranslated region that binds TTP. These data suggest that coordinated stimulation of TTP and PIM1 expression limits the magnitude and duration of PIM1 mRNA accumulation by accelerating its degradation as TTP protein levels increase. Consistent with this model, PIM1 and TTP mRNA levels were well correlated across selected human tissue panels, and PIM1 mRNA was induced to significantly higher levels in mitogen-stimulated fibroblasts from TTP-deficient mice. Together, these data support a model whereby induction of TTP mediates a negative feedback circuit to limit expression of selected mitogen-activated genes.	[Mahat, Dig B.; Brennan-Laun, Sarah E.; Fialcowitz-White, Elizabeth J.; Kishor, Aparna; Ross, Christina R.; Pozharskaya, Tatyana; Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Hassel, Bret A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Hassel, Bret A.; Wilson, Gerald M.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Rawn, J. David] Towson Univ, Dept Chem, Baltimore, MD 21204 USA; [Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; Towson University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Mahat, DB (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	gwils001@umaryland.edu	Wilson, Gerald/AAF-3874-2019; Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529; Wilson, Gerald/0000-0002-1273-7507	American Cancer Society [RSG-07-293-01-GMC]; National Institutes of Heatlh [CA102428]; VA Merit Review Award; NATIONAL CANCER INSTITUTE [R56CA102428, R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Heatlh; VA Merit Review Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were supported by American Cancer Society grant RSG-07-293-01-GMC and National Institutes of Heatlh grant CA102428 (to GMW) and by a VA Merit Review Award (to BAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli L, 2005, J CLIN ONCOL, V23, P7296, DOI 10.1200/JCO.2005.01.3870; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Al-Souhibani N, 2010, ONCOGENE, V29, P4205, DOI 10.1038/onc.2010.168; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Borg KE, 1999, ENDOCRINOLOGY, V140, P5659, DOI 10.1210/en.140.12.5659; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; BUCKLEY AR, 1995, ENDOCRINOLOGY, V136, P5252, DOI 10.1210/en.136.12.5252; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gu JJ, 2009, ONCOGENE, V28, P4261, DOI 10.1038/onc.2009.276; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hoover DS, 1997, CELL GROWTH DIFFER, V8, P1371; Ionov Y, 2003, ANTICANCER RES, V23, P167; Jaster R, 1999, CELL SIGNAL, V11, P769, DOI 10.1016/S0898-6568(99)00050-9; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Krishnan N, 2003, ENDOCRINE, V20, P123, DOI 10.1385/ENDO:20:1-2:123; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 1998, J BIOL CHEM, V273, P506, DOI 10.1074/jbc.273.1.506; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Ma J, 2007, ONCOGENE, V26, P5145, DOI 10.1038/sj.onc.1210323; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Mizuno K, 2001, BIOCHEM BIOPH RES CO, V281, P663, DOI 10.1006/bbrc.2001.4405; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Phillips K, 2004, P NATL ACAD SCI USA, V101, P2011, DOI 10.1073/pnas.0400148101; Prives C, 2008, CELL CYCLE, V7, P3840, DOI 10.4161/cc.7.24.7243; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Rohwer F, 1996, J IMMUNOL, V157, P643; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Toba G, 2008, NUCLEIC ACIDS RES, V36, P1390, DOI 10.1093/nar/gkm1168; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang WG, 2004, J BIOL CHEM, V279, P48376, DOI 10.1074/jbc.M409014200; Warnecke-Eberz U, 2009, ANTICANCER RES, V29, P4451; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; WINGETT D, 1991, J IMMUNOL, V147, P3653; Ysla RM, 2008, METHOD ENZYMOL, V449, P47, DOI 10.1016/S0076-6879(08)02403-8; Yu K, 2006, CLIN CANCER RES, V12, P3288, DOI 10.1158/1078-0432.CCR-05-1530; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618; Zou TT, 2006, J BIOL CHEM, V281, P19387, DOI 10.1074/jbc.M602344200; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182	80	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33194	10.1371/journal.pone.0033194	http://dx.doi.org/10.1371/journal.pone.0033194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413002	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000036
J	Nowell, VJ; Kropinski, AM; Songer, JG; MacInnes, JI; Parreira, VR; Prescott, JF				Nowell, Victoria J.; Kropinski, Andrew M.; Songer, J. Glenn; MacInnes, Janet I.; Parreira, Valeria R.; Prescott, John F.			Genome Sequencing and Analysis of a Type A Clostridium perfringens Isolate from a Case of Bovine Clostridial Abomasitis	PLOS ONE			English	Article							OF-THE-LITERATURE; BETA2 TOXIN; ENTEROTOXIN GENE; PLASMID; CALVES; VIRULENCE; DISEASE; SYSTEM; IDENTIFICATION; TRANSCRIPTION	Clostridium perfringens is a common inhabitant of the avian and mammalian gastrointestinal tracts and can behave commensally or pathogenically. Some enteric diseases caused by type A C. perfringens, including bovine clostridial abomasitis, remain poorly understood. To investigate the potential basis of virulence in strains causing this disease, we sequenced the genome of a type A C. perfringens isolate (strain F262) from a case of bovine clostridial abomasitis. The similar to 3.34 Mbp chromosome of C. perfringens F262 is predicted to contain 3163 protein-coding genes, 76 tRNA genes, and an integrated plasmid sequence, Cfrag (similar to 18 kb). In addition, sequences of two complete circular plasmids, pF262C (4.8 kb) and pF262D (9.1 kb), and two incomplete plasmid fragments, pF262A (48.5 kb) and pF262B (50.0 kb), were identified. Comparison of the chromosome sequence of C. perfringens F262 to complete C. perfringens chromosomes, plasmids and phages revealed 261 unique genes. No novel toxin genes related to previously described clostridial toxins were identified: 60% of the 261 unique genes were hypothetical proteins. There was a two base pair deletion in virS, a gene reported to encode the main sensor kinase involved in virulence gene activation. Despite this frameshift mutation, C. perfringens F262 expressed perfringolysin O, alpha-toxin and the beta2-toxin, suggesting that another regulation system might contribute to the pathogenicity of this strain. Two complete plasmids, pF262C (4.8 kb) and pF262D (9.1 kb), unique to this strain of C. perfringens were identified.	[Nowell, Victoria J.; MacInnes, Janet I.; Parreira, Valeria R.; Prescott, John F.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Kropinski, Andrew M.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Songer, J. Glenn] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA	University of Guelph; Public Health Agency of Canada; University of Guelph; Iowa State University	Nowell, VJ (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	prescott@uoguelph.ca	Kropinski, Andrew M/H-7130-2016	Kropinski, Andrew M/0000-0002-6871-6799	Natural Sciences and Engineering Research Council; Ontario Graduate Scholarship; Animal Health Strategic Initiative of the Ontario Ministry of Agriculture, Food and Rural Affairs	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Animal Health Strategic Initiative of the Ontario Ministry of Agriculture, Food and Rural Affairs	This work was supported by the Natural Sciences and Engineering Research Council, the Ontario Graduate Scholarship and the Animal Health Strategic Initiative of the Ontario Ministry of Agriculture, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; BaThein W, 1996, J BACTERIOL, V178, P2514, DOI 10.1128/jb.178.9.2514-2520.1996; Bueschel DM, 2003, VET MICROBIOL, V94, P121, DOI 10.1016/S0378-1135(03)00081-6; Ceci L, 2006, J VET MED A, V53, P518, DOI 10.1111/j.1439-0442.2006.00884.x; Cheung JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005849; Cheung JK, 2000, MICROBIOL-UK, V146, P517, DOI 10.1099/00221287-146-2-517; COHEN A, 1985, PLASMID, V13, P41, DOI 10.1016/0147-619X(85)90054-X; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Ferrarezi MC, 2008, ANAEROBE, V14, P328, DOI 10.1016/j.anaerobe.2008.12.001; Flores-Diaz M, 2003, TOXICON, V42, P979, DOI 10.1016/j.toxicon.2003.11.013; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; GALIZZI A, 1981, MOL GEN GENET, V182, P99, DOI 10.1007/BF00422774; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; Grant KA, 2008, FOODBORNE PATHOG DIS, V5, P629, DOI 10.1089/fpd.2007.0066; Gurjar A, 2010, INFECT IMMUN, V78, P4860, DOI 10.1128/IAI.00715-10; Hiscox TJ, 2011, INFECT IMMUN, V79, P2145, DOI 10.1128/IAI.00060-11; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Lebrun M, 2007, VET MICROBIOL, V120, P151, DOI 10.1016/j.vetmic.2006.10.020; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; Li JH, 2011, INFECT IMMUN, V79, P2451, DOI 10.1128/IAI.00169-11; Lindstrom M, 2011, FOOD MICROBIOL, V28, P192, DOI 10.1016/j.fm.2010.03.020; Manteca C, 2002, VET MICROBIOL, V86, P191, DOI 10.1016/S0378-1135(02)00008-1; Miyamoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020376; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nariya H, 2011, APPL MICROBIOL BIOT, V90, P1973, DOI 10.1007/s00253-011-3253-z; Obana N, 2011, J BACTERIOL, V193, P4417, DOI 10.1128/JB.00262-11; Ohtani K, 2003, FEMS MICROBIOL LETT, V222, P137, DOI 10.1016/S0378-1097(03)00255-6; Ohtani K, 2009, J BACTERIOL, V191, P3919, DOI 10.1128/JB.01455-08; Okumura K, 2008, J BACTERIOL, V190, P7719, DOI 10.1128/JB.01573-07; ROEDER BL, 1987, J AM VET MED ASSOC, V190, P1550; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Smedley JG, 2005, REV PHYSIOL BIOCH P, V152, P183, DOI 10.1007/s10254-004-0036-2; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Songer JG, 2005, ANAEROBE, V11, P290, DOI 10.1016/j.anaerobe.2004.12.004; Songer JG, 2004, ANAEROBE, V10, P239, DOI 10.1016/j.anaerobe.2004.05.001; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Uzal FA, 2011, VET MICROBIOL, V153, P37, DOI 10.1016/j.vetmic.2011.02.048; Van Kruiningen HJ, 2009, CAN VET J, V50, P857; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	47	22	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32271	10.1371/journal.pone.0032271	http://dx.doi.org/10.1371/journal.pone.0032271			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412860	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062000008
J	Olori, JC; Bell, CJ				Olori, Jennifer C.; Bell, Christopher J.			Comparative Skull Morphology of Uropeltid Snakes (Alethinophidia: Uropeltidae) with Special Reference to Disarticulated Elements and Variation	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; SKELETAL MORPHOLOGY; CRANIAL OSTEOLOGY; BODY-SIZE; MINIATURIZATION; SERPENTES; EVOLUTION; REPTILIA; AMPHIBIA; ANATOMY	Uropeltids form a diverse clade of highly derived, fossorial snakes that, because of their phylogenetic position among other alethinophidian lineages, may play a key role in understanding the early evolution of cranial morphology in snakes. We include detailed osteological descriptions of crania and mandibles for eight uropeltid species from three nominal genera (Uropeltis, Rhinophis, and Brachyophidium) and emphasize disarticulated elements and the impact of intraspecific variation on previously proposed morphological characters used for phylogenetic analysis. Preliminary analysis of phylogenetic relationships strongly supports a clade composed exclusively of species of Plectrurus, Uropeltis, and Rhinophis. However, monophyly of each of those genera and Melanophidium is not upheld. There is moderate support that Sri Lankan species (e.g., Rhinophis and Uropeltis melanogaster) are monophyletic with respect to Indian uropeltids. Previously proposed characters that are phylogenetically informative include the shape of the nasals, length of the occipital condyle, level of development of the posteroventral process of the dentary, and participation of the parietal in the optic foramen. Additionally, thirty new features that may be systematically informative are identified and described, but were not verified for their utility. Such verification must await availability of additional disarticulated cranial material from a larger sample of taxa. All characters require further testing through increased focus on sources and patterns of intraspecific variation, inclusion of broader taxonomic samples in comparative studies, and exploration of skeletal development, sexual dimorphism, and biogeographic patterns. Additionally, trends in the relative enlargement of the sensory capsules, reduction in cranial ossification and dentition, fusion of elements, and the appearance of novel morphological conditions, such as the structure and location of the suspensorium, may be related to fossoriality and miniaturization in some uropeltid taxa, and may complicate analysis of relationships within Uropeltidae and among alethinophidian snakes.	[Olori, Jennifer C.; Bell, Christopher J.] Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX USA	University of Texas System; University of Texas Austin	Olori, JC (corresponding author), SUNY Coll Oswego, Dept Biol Sci, Oswego, NY USA.	jennifer.olori@oswego.edu		Olori, Jennifer/0000-0003-0479-6264	Jackson School of Geosciences, The University of Texas at Austin; NSF [EF-0334961]; Division Of Earth Sciences [0948842] Funding Source: National Science Foundation	Jackson School of Geosciences, The University of Texas at Austin; NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the Jackson School of Geosciences, The University of Texas at Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank O. Rieppel and D. Cundall for sharing their thoughts on the anatomy of uropeltid snakes. We are grateful to K. Claeson and E. Ekdale for discussion and comments on early drafts of the manuscript. All specimens were collected by C. Gans and colleagues in India and Sri Lanka, and our work would not have been possible without their earlier research on uropeltid biology and taxonomy, and Carl's generous donation of skeletons to the TMM. We also thank L. Murray (TMM), C. McCarthy (BMNH), J. Vindum (CAS), P. Holroyd (UCMP), and Deep Scaly: Squamate Tree of Life (NSF grant EF-0334961 to M. Kearney and O. Rieppel) for specimen access, as well as R. Ketcham, M. Colbert, and R. Racicot for CT scanning and X-ray reconstruction. Editor A. Farke and reviewers D. Cundall and D. Gower provided critical comments for the improvement of the manuscript. Any errors remain our own, but our presentation was improved greatly by their thoughtful review.	Baumeister K. L., 1908, ZOOL JB ABT ANAT, V26, P423; Beddome R. H., 1867, Madras Quart. Journ. Med. Sc., P14; Bell Christopher J., 2009, Records of the Western Australian Museum, V25, P201; Bellairs A.d'A., 1981, Biology of Reptilia, V11, P1; BELLAIRS AD, 1951, BIOL REV, V26, P193, DOI 10.1111/j.1469-185X.1951.tb00646.x; Bellairs ADA, 1949, ZOOL J LINN SOC-LOND, V41, P482, DOI 10.1111/j.1096-3642.1940.tb02418.x; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; Boulenger G. A., 1893, CATALOGUE SNAKES BRI, VI; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; CADLE JE, 1990, BIOL J LINN SOC, V40, P293, DOI 10.1111/j.1095-8312.1990.tb00541.x; CARROLL RL, 1990, PALAEONTOLOGY, V33, P893; Comeaux RS, 2010, ZOOL J LINN SOC-LOND, V160, P118, DOI 10.1111/j.1096-3642.2009.00595.x; CUNDALL D, 1993, ZOOL J LINN SOC-LOND, V109, P235, DOI 10.1006/zjls.1993.1038; CUNDALL D, 1993, ZOOL J LINN SOC-LOND, V109, P275, DOI 10.1006/zjls.1993.1039; Cundall David, 2008, Contributions to Herpetology, V23, P349; DUMERIL A. M., 1853, MEMOIRES LACADEMIE S, VXXIII, P399, DOI DOI 10.5962/BHL.TITLE.60463; Estes R., 1988, P119; FRAZZETTA TH, 1966, J MORPHOL, V118, P217, DOI 10.1002/jmor.1051180206; Gans C., 1966, Tierreich, V84, P1; Gans C., 1976, Linnean Soc Symp Ser, V3, P191; GANS C, 1978, SCIENCE, V199, P189, DOI 10.1126/science.199.4325.189; GANS C, 1973, ENDEAVOUR, V32, P60, DOI 10.1016/0160-9327(73)90004-5; GANS C, 1986, Journal of the Bombay Natural History Society, V83, P152; Gans C, 1993, P INT INT S EC LANDS, P189; Gower David J., 2008, Hamadryad, V33, P64; Gower DJ, 2005, J ZOOL SYST EVOL RES, V43, P315, DOI 10.1111/j.1439-0469.2005.00315.x; Gower DJ, 2003, J MORPHOL, V258, P249, DOI 10.1002/jmor.10147; GROOMBRIDGE B, 1979, J ZOOL, V189, P559; GROOMBRIDGE BC, 1979, J NAT HIST, V13, P477, DOI 10.1080/00222937900770371; GROOMBRIDGE BC, 1979, J NAT HIST, V13, P447, DOI 10.1080/00222937900770361; Hall B., 1993, BONE, V7, P79; HANKEN J, 1983, J MORPHOL, V177, P255, DOI 10.1002/jmor.1051770304; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; HANKEN J, 1984, BIOL J LINN SOC, V23, P55, DOI 10.1111/j.1095-8312.1984.tb00806.x; HEISE PJ, 1995, MOL BIOL EVOL, V12, P259; Hoffstetter R., 1969, P201; Lawson R, 2004, J ZOOL, V263, P285, DOI 10.1017/S0952836904005278; Lee MSY, 2007, SYST BIODIVERS, V5, P371, DOI 10.1017/S1477200007002290; Lee MSY, 2002, BIOL REV, V77, P333, DOI 10.1017/S1464793102005924; Maddin HC, 2011, J MORPHOL, V272, P722, DOI 10.1002/jmor.10946; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; Maglia AM, 2007, J MORPHOL, V268, P194, DOI 10.1002/jmor.10508; Mahendra B.C., 1984, Annals of Zoology (Agra), V22, pi; Mahendra B.C, 1984, ANN ZOOLOGY, V22, P1; Mahendra BC., 1938, ANAT ANZEIGER, V86, P347; McDiarmid R. W., 1999, TAXONOMIC GEOAND, V1; Nopcsa Baron F., 1928, Palaeobiologica Wien, V1, P163; Olori JC, 2010, COPEIA, P14, DOI 10.1643/CH-09-082; Peters GCH, 1861, SERPENTUM FAMILIA UR; Rajendran M.V., 1979, Journal of Madurai Kamaraj University Series B Sciences, V8, P97; Rajendran MV, 1978, REPTILE RES, V1, P17; Rajendran MV, 1985, MADURAI KAMARAJ U PU; Rieppel O, 2007, ZOOL J LINN SOC-LOND, V149, P671, DOI 10.1111/j.1096-3642.2007.00276.x; Rieppel O, 1996, SYM ZOOL S, P47; RIEPPEL O, 1978, Z ZOOL SYST EVOL, V16, P14; RIEPPEL O, 1988, EVOL BIOL, V22, P37; RIEPPEL O, 1979, ZOOL J LINN SOC-LOND, V66, P411, DOI 10.1111/j.1096-3642.1979.tb01915.x; Rieppel O., 1984, Symposia of the Zoological Society of London, P503; Rieppel O., 1980, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V103, P551; Rieppel O, 1983, Z ZOOL SYST EVOL, V21, P81; Rieppel O., 2000, FIELDIANA GEOL, V43, P1; Rieppel O, 1977, J ZOOL LOND, V18, P145; Rieppel Olivier, 2002, Bulletin of the Natural History Museum Zoology Series, V68, P123; Scanlon JD, 2000, NATURE, V403, P416, DOI 10.1038/35000188; Slowinski JB, 2002, MOL PHYLOGENET EVOL, V24, P194, DOI 10.1016/S1055-7903(02)00239-7; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TAYLOR EDWARD H., 1953, UNIV KANSAS SCI BULL, V35, P1615; Tchernov E, 2000, SCIENCE, V287, P2010, DOI 10.1126/science.287.5460.2010; Underwood G., 1967, CONTRIBUTION CLASSIF; Vidal N, 2004, P ROY SOC B-BIOL SCI, V271, pS226, DOI 10.1098/rsbl.2003.0151; Vidal N, 2002, CR BIOL, V325, P977, DOI 10.1016/S1631-0691(02)01510-X; WAKE MH, 1986, J MORPHOL, V189, P1, DOI 10.1002/jmor.1051890102; WEVER EG, 1978, REPTILE EAR; White ME, 2002, ECOLOGY EVOLUTION TR, P156; Wickramasinghe LJM, 2009, ZOOTAXA, P1; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; WILLIAMS ERNEST E., 1959, BREVIORA MUS COMP ZOOL [HARVARD], V106, P1; Yeh J, 2002, EVOLUTION, V56, P628	78	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32450	10.1371/journal.pone.0032450	http://dx.doi.org/10.1371/journal.pone.0032450			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412874	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000010
J	Sharif, T; Alhosin, M; Auger, C; Minker, C; Kim, JH; Etienne-Selloum, N; Bories, P; Gronemeyer, H; Lobstein, A; Bronner, C; Fuhrmann, G; Schini-Kerth, VB				Sharif, Tanveer; Alhosin, Mahmoud; Auger, Cyril; Minker, Carole; Kim, Jong-Hun; Etienne-Selloum, Nelly; Bories, Pierre; Gronemeyer, Hinrich; Lobstein, Annelise; Bronner, Christian; Fuhrmann, Guy; Schini-Kerth, Valerie B.			Aronia melanocarpa Juice Induces a Redox-Sensitive p73-Related Caspase 3-Dependent Apoptosis in Human Leukemia Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; BREAST-CANCER CELLS; COLON-CANCER; LYMPHOBLASTIC-LEUKEMIA; SRA DOMAIN; IN-VITRO; INDUCTION; EXTRACTS; PATHWAY; PROTEIN	Polyphenols are natural compounds widely present in fruits and vegetables, which have antimutagenic and anticancer properties. The aim of the present study was to determine the anticancer effect of a polyphenol-rich Aronia melanocarpa juice (AMJ) containing 7.15 g/L of polyphenols in the acute lymphoblastic leukemia Jurkat cell line, and, if so, to clarify the underlying mechanism and to identify the active polyphenols involved. AMJ inhibited cell proliferation, which was associated with cell cycle arrest in G(2)/M phase, and caused the induction of apoptosis. These effects were associated with an upregulation of the expression of tumor suppressor p73 and active caspase 3, and a downregulation of the expression of cyclin B1 and the epigenetic integrator UHRF1. AMJ significantly increased the formation of reactive oxygen species (ROS), decreased the mitochondrial membrane potential and caused the release of cytochrome c into the cytoplasm. Treatment with intracellular ROS scavengers prevented the AMJ-induced apoptosis and upregulation of the expression of p73 and active caspase 3. The fractionation of the AMJ and the use of identified isolated compounds indicated that the anticancer activity was associated predominantly with chlorogenic acids, some cyanidin glycosides, and derivatives of quercetin. AMJ treatment also induced apoptosis of different human lymphoblastic leukemia cells (HSB-2, Molt-4 and CCRF-CEM). In addition, AMJ exerted a strong pro-apoptotic effect in human primary lymphoblastic leukemia cells but not in human normal primary T-lymphocytes. Thus, the present findings indicate that AMJ exhibits strong anticancer activity through a redox-sensitive mechanism in the p53-deficient Jurkat cells and that this effect involves several types of polyphenols. They further suggest that AMJ has chemotherapeutic properties against acute lymphoblastic leukemia by selectively targeting lymphoblast-derived tumor cells.	[Sharif, Tanveer; Alhosin, Mahmoud; Auger, Cyril; Kim, Jong-Hun; Etienne-Selloum, Nelly; Bronner, Christian; Fuhrmann, Guy; Schini-Kerth, Valerie B.] Univ Strasbourg, CNRS, UMR 7213, Lab Biophoton & Pharmacol,Fac Pharm, Illkirch Graffenstaden, France; [Minker, Carole; Lobstein, Annelise] Univ Strasbourg, CNRS, UMR 7200, Lab Innovat Therapeut,Fac Pharm, Illkirch Graffenstaden, France; [Bories, Pierre; Gronemeyer, Hinrich] Univ Strasbourg, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire,UMR 7104,U964, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sharif, T (corresponding author), Univ Strasbourg, CNRS, UMR 7213, Lab Biophoton & Pharmacol,Fac Pharm, Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Bronner, Christian/R-8488-2016; Alhosin, Mahmoud/H-8101-2017; Gronemeyer, Hinrich/AAH-5575-2019; Gronemeyer, Hinrich/H-7002-2016; Alhosin, Mahmoud/AAD-5782-2020; Gronemeyer, Hinrich/G-6240-2011; Auger, Cyril/N-4702-2016	Bronner, Christian/0000-0002-3101-9279; Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Alhosin, Mahmoud/0000-0003-2147-1445; Gronemeyer, Hinrich/0000-0001-9454-2449; Bories, Pierre/0000-0002-2252-0395; Sharif, Tanveer/0000-0003-3269-8100	Higher Education Commission of Pakistan; Association pour la Recherche sur le Cancer (ARC); Syrian Higher Education Ministry	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Syrian Higher Education Ministry	TS is supported by a fellowship from the Higher Education Commission of Pakistan and from the Association pour la Recherche sur le Cancer (ARC). MA is supported by a fellowship from the Syrian Higher Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Aiyer HS, 2010, CANCER PREV RES, V3, P727, DOI 10.1158/1940-6207.CAPR-09-0260; Alhosin M, 2010, BIOCHEM PHARMACOL, V79, P1251, DOI 10.1016/j.bcp.2009.12.015; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Azam S, 2004, TOXICOL IN VITRO, V18, P555, DOI 10.1016/j.tiv.2003.12.012; Bermudez-Soto MJ, 2004, EUR FOOD RES TECHNOL, V219, P133, DOI 10.1007/s00217-004-0940-3; Bermundez-Soto MJ, 2007, J NUTR BIOCHEM, V18, P259, DOI 10.1016/j.jnutbio.2006.05.003; Boominathan L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-27; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Chen W, 2008, FREE RADICAL BIO MED, V45, P60, DOI 10.1016/j.freeradbiomed.2008.03.013; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Chung FL, 2003, J NUTR, V133, p3268S, DOI 10.1093/jn/133.10.3268S; Das A, 2010, CANCER-AM CANCER SOC, V116, P164, DOI 10.1002/cncr.24699; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041; Juan ME, 2008, J AGR FOOD CHEM, V56, P4813, DOI 10.1021/jf800175a; Feng RT, 2007, J BIOL CHEM, V282, P13468, DOI 10.1074/jbc.M610616200; Fuhrmann G, 1999, CELL MOL BIOL, V45, P717; Gusman J, 2001, CARCINOGENESIS, V22, P1111, DOI 10.1093/carcin/22.8.1111; Hakimuddin F, 2006, J AGR FOOD CHEM, V54, P7912, DOI 10.1021/jf060834m; HSIAO MH, 1994, BLOOD, V83, P2922, DOI 10.1182/blood.V83.10.2922.2922; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Jeong JC, 2010, NUTR CANCER, V62, P402, DOI 10.1080/01635580903441287; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kulling SE, 2008, PLANTA MED, V74, P1625, DOI 10.1055/s-0028-1088306; Kwan ML, 2004, AM J EPIDEMIOL, V160, P1098, DOI 10.1093/aje/kwh317; Lala G, 2006, NUTR CANCER, V54, P84, DOI 10.1207/s15327914nc5401_10; Li GX, 2010, CARCINOGENESIS, V31, P902, DOI 10.1093/carcin/bgq039; Liu CY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-15; Malik M, 2003, NUTR CANCER, V46, P186, DOI 10.1207/S15327914NC4602_12; Miller PE, 2010, NUTR CANCER, V62, P413, DOI 10.1080/01635580903407114; Misikangas M, 2007, J NUTR, V137, P2285, DOI 10.1093/jn/137.10.2285; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Murias M, 2008, TOXICOL IN VITRO, V22, P1361, DOI 10.1016/j.tiv.2008.03.002; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; Rigas B, 2008, BRIT J CANCER, V98, P1157, DOI 10.1038/sj.bjc.6604225; Sanchez-Duffhues G, 2009, BIOCHEM PHARMACOL, V77, P1401, DOI 10.1016/j.bcp.2009.01.004; Sharif T, 2011, INVEST NEW DRUG, V29, P239, DOI 10.1007/s10637-009-9352-3; Sharif T, 2010, EUR J CANCER, V46, P983, DOI 10.1016/j.ejca.2009.12.029; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Skupien K, 2008, PHYTOTHER RES, V22, P689, DOI 10.1002/ptr.2411; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Tien AL, 2011, BIOCHEM J, V435, P175, DOI 10.1042/BJ20100840; Walter A, 2010, FASEB J, V24, P3360, DOI 10.1096/fj.09-149419; Warburg O., 1925, KLIN WOCHENSCHR, V4, P534, DOI DOI 10.1007/BF01726151	48	41	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32526	10.1371/journal.pone.0032526	http://dx.doi.org/10.1371/journal.pone.0032526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412883	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062000012
J	Green, SJ; Akins, JL; Maljkovic, A; Cote, IM				Green, Stephanie J.; Akins, John L.; Maljkovic, Aleksandra; Cote, Isabelle M.			Invasive Lionfish Drive Atlantic Coral Reef Fish Declines	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH	Indo-Pacific lionfish (Pterois volitans and P. miles) have spread swiftly across the Western Atlantic, producing a marine predator invasion of unparalleled speed and magnitude. There is growing concern that lionfish will affect the structure and function of invaded marine ecosystems, however detrimental impacts on natural communities have yet to be measured. Here we document the response of native fish communities to predation by lionfish populations on nine coral reefs off New Providence Island, Bahamas. We assessed lionfish diet through stomach contents analysis, and quantified changes in fish biomass through visual surveys of lionfish and native fishes at the sites over time. Lionfish abundance increased rapidly between 2004 and 2010, by which time lionfish comprised nearly 40% of the total predator biomass in the system. The increase in lionfish abundance coincided with a 65% decline in the biomass of the lionfish's 42 Atlantic prey fishes in just two years. Without prompt action to control increasing lionfish populations, similar effects across the region may have long-term negative implications for the structure of Atlantic marine communities, as well as the societies and economies that depend on them.	[Green, Stephanie J.; Maljkovic, Aleksandra; Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Akins, John L.] Reef Environm Educ Fdn, Key Largo, FL USA	Simon Fraser University	Green, SJ (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	stephanie.green@sfu.ca	Cote, Isabelle/ABD-5898-2021; Petersen, Carsten T/G-2078-2014; Green, Stephanie/AGE-1160-2022	Petersen, Carsten T/0000-0001-7574-0351; Green, Stephanie/0000-0003-4705-7859	NSERC Canada; NSERC	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work came from an NSERC Canada Graduate Fellowship to S. Green and NSERC Discovery Grant to I. Cote (www.nserc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins JL, 2011, BEST PRACTICES LIONF; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; [Anonymous], 2011, GLOB INV SPEC DAT; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Betancur-R R, 2011, J BIOGEOGR, V38, P1281, DOI 10.1111/j.1365-2699.2011.02496.x; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Froese R, FISHBASE 2000 CONCEP; Green SJ, 2011, MAR ECOL PROG SER, V433, P159, DOI 10.3354/meps09208; Lettieri L, 2010, J EVOLUTION BIOL, V23, P2289, DOI 10.1111/j.1420-9101.2010.02098.x; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Randall J. E, 1967, STUD TROP OCEANOGR U, V5, P665; Schmitt EF, 1996, B MAR SCI, V59, P404; Stepath C.M, 2005, P NATL MARINE ED ASS; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Vose D., 2008, RISK ANAL QUANTITATI; Zuur Alain F., 2009, P1	17	254	267	6	426	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32596	10.1371/journal.pone.0032596	http://dx.doi.org/10.1371/journal.pone.0032596			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412895	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800033
J	Kasam, M; Yang, B; Strong, R; Schaar, K; Misra, V; Xi, XP; Grotta, JC; Aronowski, J; Savitz, SI				Kasam, Mallikarjunarao; Yang, Bing; Strong, Roger; Schaar, Krystal; Misra, Vivek; Xi, Xiaopei; Grotta, James C.; Aronowski, Jaroslaw; Savitz, Sean I.			Nitric Oxide Facilitates Delivery and Mediates Improved Outcome of Autologous Bone Marrow Mononuclear Cells in a Rodent Stroke Model	PLOS ONE			English	Article							MIDDLE-AGED RATS; FOCAL ISCHEMIA; BRAIN-INJURY; CEREBRAL-ISCHEMIA; TRANSPLANTATION; REPERFUSION; HYPOXIA; DAMAGE	Background: Bone marrow mononuclear cells (MNC) represent an investigational treatment for stroke. The objective of this study was to determine the relevance of vasoactive mediators, generated in response to MNC injection, as factors regulating cerebral perfusion (CP), the biodistribution of MNC, and outcome in stroke. Methods: Long Evans rats underwent transient middle cerebral artery occlusion. MNC were extracted from the bone marrow at 22 hrs and injected via the internal carotid artery or the femoral vein 2 hours later. CP was measured with MRI or continuous laser Doppler flowmetry. Serum samples were collected to measure vasoactive mediators. Animals were treated with the Nitric Oxide (NO) inhibitor, L-NAME, to establish the relevance of NO-signaling to the effect of MNC. Lesion size, MNC biodistribution, and neurological deficits were assessed. Results: CP transiently increased in the peri-infarct region within 30 min after injecting MNC compared to saline or fibroblast control. This CP increase corresponded temporarily to serum NO elevation and was abolished by L-NAME. Pre-treatment with L-NAME reduced brain penetration of MNC and prevented MNC from reducing infarct lesion size and neurological deficits. Conclusions: NO generation in response to MNC may represent a mechanism underlying how MNC enter the brain, reduce lesion size, and improve outcome in ischemic stroke.	[Kasam, Mallikarjunarao; Yang, Bing; Strong, Roger; Schaar, Krystal; Misra, Vivek; Xi, Xiaopei; Grotta, James C.; Aronowski, Jaroslaw; Savitz, Sean I.] Univ Texas Houston, Sch Med, Stroke Team, Dept Neurol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Kasam, M (corresponding author), Univ Texas Houston, Sch Med, Stroke Team, Dept Neurol, Houston, TX 77030 USA.	sean.i.savitz@uth.tmc.edu	Grotta, James/AAH-7423-2021; Yang, Bing/E-2903-2012	kasam, Mallikarjuna Rao Kasam/0000-0001-8115-5271; grotta, james/0000-0002-3667-4248	Howard Hughes Medical Institute; United States National Institutes of Health (NIH) [R21]; American Heart Association; Notsew Orm Sands Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Notsew Orm Sands Foundation	This work was supported by the Howard Hughes Medical Institute, United States National Institutes of Health (NIH) R21, American Heart Association, and the Notsew Orm Sands Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Baker AH, 2007, P NATL ACAD SCI USA, V104, P3597, DOI 10.1073/pnas.0611112104; Bockhorst KH, 2010, J NEUROSCI RES, V88, P1146, DOI 10.1002/jnr.22273; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Fujita Y, 2010, STROKE, V41, P2938, DOI 10.1161/STROKEAHA.110.596379; Holotnakova T, 2008, PFLUG ARCH EUR J PHY, V456, P323, DOI 10.1007/s00424-007-0400-6; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kamiya N, 2008, LIFE SCI, V83, P433, DOI 10.1016/j.lfs.2008.07.018; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lindner MD, 2003, J NEUROSCI, V23, P10913; Yanamoto H, 1999, STROKE, V30, P2720, DOI 10.1161/01.STR.30.12.2720; Yang B, 2011, J NEUROSCI RES, V89, P833, DOI 10.1002/jnr.22614; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	16	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32793	10.1371/journal.pone.0032793	http://dx.doi.org/10.1371/journal.pone.0032793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412926	Green Submitted, gold, Green Published			2022-12-25	WOS:000303060800052
J	Liu, W; Shaver, TM; Balasa, A; Ljungberg, MC; Wang, XL; Wen, S; Nguyen, H; Van den Veyver, IB				Liu, Wei; Shaver, Timothy M.; Balasa, Alfred; Ljungberg, M. Cecilia; Wang, Xiaoling; Wen, Shu; Hoang Nguyen; Van den Veyver, Ignatia B.			Deletion of Porcn in Mice Leads to Multiple Developmental Defects and Models Human Focal Dermal Hypoplasia (Goltz Syndrome)	PLOS ONE			English	Article							POLARITY GENE PORCUPINE; MID/HINDBRAIN ORGANIZER; MOUSE EMBRYOS; X-CHROMOSOME; BETA-CATENIN; STEM-CELLS; MUTATIONS; SPECIFICATION; REGULATOR; SECRETION	Background: Focal Dermal Hypoplasia (FDH) is a genetic disorder characterized by developmental defects in skin, skeleton and ectodermal appendages. FDH is caused by dominant loss-of-function mutations in X-linked PORCN. PORCN orthologues in Drosophila and mice encode endoplasmic reticulum proteins required for secretion and function of Wnt proteins. Wnt proteins play important roles in embryo development, tissue homeostasis and stem cell maintenance. Since features of FDH overlap with those seen in mouse Wnt pathway mutants, FDH likely results from defective Wnt signaling but molecular mechanisms by which inactivation of PORCN affects Wnt signaling and manifestations of FDH remain to be elucidated. Results: We introduced intronic loxP sites and a neomycin gene in the mouse Porcn locus for conditional inactivation. Porcn-ex3-7flox mice have no apparent developmental defects, but chimeric mice retaining the neomycin gene (Porcn-ex3-7Neo-flox) have limb, skin, and urogenital abnormalities. Conditional Porcn inactivation by EIIa-driven or Hprt-driven Cre recombinase results in increased early embryonic lethality. Mesenchyme-specific Prx-Cre-driven inactivation of Porcn produces FDH-like limb defects, while ectodermal Krt14-Cre-driven inactivation produces thin skin, alopecia, and abnormal dentition. Furthermore, cell-based assays confirm that human PORCN mutations reduce WNT3A secretion. Conclusions: These data indicate that Porcn inactivation in the mouse produces a model for human FDH and that phenotypic features result from defective WNT signaling in ectodermal-and mesenchymal-derived structures.	[Liu, Wei; Wang, Xiaoling; Wen, Shu; Van den Veyver, Ignatia B.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Balasa, Alfred] ARS, USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Shaver, Timothy M.; Hoang Nguyen] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Ljungberg, M. Cecilia; Van den Veyver, Ignatia B.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine	Liu, W (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	iveyver@bcm.edu	Van den Veyver, Ignatia B/AAF-4510-2021	Van den Veyver, Ignatia B/0000-0002-0651-5924; Shaver, Timothy/0000-0002-3210-3691	March of Dimes Birth Defects Foundation [6-FY08-268]; National Foundation for Ectodermal Dysplasias [27568]; National Institutes of Health [R01-AR059122]; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center from Eunice Kennedy Shriver National Institute of Child Health and Human Development [P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059122] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); National Foundation for Ectodermal Dysplasias; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine Intellectual and Developmental Disabilities Research Center from Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this work was provided by The March of Dimes Birth Defects Foundation (6-FY08-268), the National Foundation for Ectodermal Dysplasias (Research Grant 27568), and the National Institutes of Health (R01-AR059122). This project was also supported by the administrative, neuropathology, and mouse embryonic stem cell cores of the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center, award number P30HD024064 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Clements SE, 2009, BRIT J DERMATOL, V160, P1103, DOI 10.1111/j.1365-2133.2009.09048.x; Clements SE, 2008, J DERMATOL SCI, V49, P39, DOI 10.1016/j.jdermsci.2007.09.004; Clements Suzanne E, 2009, Am J Med Genet A, V149A, P2050, DOI 10.1002/ajmg.a.32887; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; Doubravska L, 2008, APOPTOSIS, V13, P573, DOI 10.1007/s10495-008-0191-z; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fernandes PH, 2010, GENET TEST MOL BIOMA, V14, P709, DOI 10.1089/gtmb.2010.0089; Froyen G, 2009, CLIN GENET, V76, P535, DOI 10.1111/j.1399-0004.2009.01248.x; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; GOLTZ RW, 1962, ARCH DERMATOL, V86, P708, DOI 10.1001/archderm.1962.01590120006002; GOLTZ RW, 1992, ARCH DERMATOL, V128, P1108, DOI DOI 10.1001/ARCHDERM.128.8.1108.PUBMED:1497368; GORSKI JL, 1991, AM J MED GENET, V40, P332, DOI 10.1002/ajmg.1320400317; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; HALL EH, 1983, J AM ACAD DERMATOL, V9, P443, DOI 10.1016/S0190-9622(83)70157-X; Hancock S, 2002, AM J MED GENET, V110, P370, DOI 10.1002/ajmg.10456; Hierholzer A, 2010, DEV DYNAM, V239, P191, DOI 10.1002/dvdy.22075; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; HOWELL JB, 1989, J CUTAN PATHOL, V16, P237, DOI 10.1111/j.1600-0560.1989.tb00048.x; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lasocki AL, 2011, AUSTRALAS J DERMATOL, V52, P48, DOI 10.1111/j.1440-0960.2010.00662.x; Leoyklang P, 2008, CLIN GENET, V73, P373, DOI 10.1111/j.1399-0004.2008.00975.x; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lombardi MP, 2011, HUM MUTAT, V32, P723, DOI 10.1002/humu.21505; Luu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020940; Maas SM, 2009, J MED GENET, V46, P716, DOI 10.1136/jmg.2009.068403; Ohtola J, 2008, DEVELOPMENT, V135, P2321, DOI 10.1242/dev.021170; Patel JS, 1997, CLIN DYSMORPHOL, V6, P267, DOI 10.1097/00019605-199707000-00012; Prakash SK, 2002, HUM MOL GENET, V11, P3237, DOI 10.1093/hmg/11.25.3237; Sirous M, 2011, J RES MED SCI, V16, P836; Smigiel R, 2011, AM J MED GENET A, V155A, P1102, DOI 10.1002/ajmg.a.33895; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Sutton V.R., 2008, GENEREVIEWS; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	49	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32331	10.1371/journal.pone.0032331	http://dx.doi.org/10.1371/journal.pone.0032331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412863	gold, Green Submitted, Green Published			2022-12-25	WOS:000303021100014
J	Cantrup, R; Dixit, R; Palmesino, E; Bonfield, S; Shaker, T; Tachibana, N; Zinyk, D; Dalesman, S; Yamakawa, K; Stell, WK; Wong, RO; Reese, BE; Kania, A; Sauve, Y; Schuurmans, C				Cantrup, Robert; Dixit, Rajiv; Palmesino, Elena; Bonfield, Stephan; Shaker, Tarek; Tachibana, Nobuhiko; Zinyk, Dawn; Dalesman, Sarah; Yamakawa, Kazuhiro; Stell, William K.; Wong, Rachel O.; Reese, Benjamin E.; Kania, Artur; Sauve, Yves; Schuurmans, Carol			Cell-Type Specific Roles for PTEN in Establishing a Functional Retinal Architecture	PLOS ONE			English	Article							DARK-ADAPTED ELECTRORETINOGRAM; AMACRINE CELLS; NEGATIVE REGULATION; AXON REGENERATION; SELF-AVOIDANCE; N-CADHERIN; SOMA SIZE; DSCAM; MORPHOLOGY; DELETION	Background: The retina has a unique three-dimensional architecture, the precise organization of which allows for complete sampling of the visual field. Along the radial or apicobasal axis, retinal neurons and their dendritic and axonal arbors are segregated into layers, while perpendicular to this axis, in the tangential plane, four of the six neuronal types form patterned cellular arrays, or mosaics. Currently, the molecular cues that control retinal cell positioning are not well-understood, especially those that operate in the tangential plane. Here we investigated the role of the PTEN phosphatase in establishing a functional retinal architecture. Methodology/Principal Findings: In the developing retina, PTEN was localized preferentially to ganglion, amacrine and horizontal cells, whose somata are distributed in mosaic patterns in the tangential plane. Generation of a retina-specific Pten knock-out resulted in retinal ganglion, amacrine and horizontal cell hypertrophy, and expansion of the inner plexiform layer. The spacing of Pten mutant mosaic populations was also aberrant, as were the arborization and fasciculation patterns of their processes, displaying cell type-specific defects in the radial and tangential dimensions. Irregular oscillatory potentials were also observed in Pten mutant electroretinograms, indicative of asynchronous amacrine cell firing. Furthermore, while Pten mutant RGC axons targeted appropriate brain regions, optokinetic spatial acuity was reduced in Pten mutant animals. Finally, while some features of the Pten mutant retina appeared similar to those reported in Dscam-mutant mice, PTEN expression and activity were normal in the absence of Dscam. Conclusions/Significance: We conclude that Pten regulates somal positioning and neurite arborization patterns of a subset of retinal cells that form mosaics, likely functioning independently of Dscam, at least during the embryonic period. Our findings thus reveal an unexpected level of cellular specificity for the multi-purpose phosphatase, and identify Pten as an integral component of a novel cell positioning pathway in the retina.	[Cantrup, Robert; Dixit, Rajiv; Shaker, Tarek; Tachibana, Nobuhiko; Zinyk, Dawn; Schuurmans, Carol] Univ Calgary, Dept Biochem & Mol Biol, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Dixit, Rajiv; Kania, Artur] Univ Montreal, Dept Med, IRCM, Montreal, PQ H3C 3J7, Canada; [Bonfield, Stephan; Stell, William K.] Univ Calgary, Dept Cell Biol & Anat, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Reese, Benjamin E.] Univ Calif Santa Barbara, Neurosci Res Inst, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Dalesman, Sarah] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Yamakawa, Kazuhiro] RIKEN Brain Sci Inst, Neurogenet Lab, Wako, Saitama, Japan; [Wong, Rachel O.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Sauve, Yves] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada	University of Calgary; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Calgary; University of California System; University of California Santa Barbara; University of Calgary; RIKEN; University of Washington; University of Washington Seattle; University of Alberta	Cantrup, R (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.	cschuurm@ucalgary.ca	Yamakawa, Kazuhiro/N-5050-2015; Shaker, Tarek/N-7981-2019	Yamakawa, Kazuhiro/0000-0002-1478-4390; Shaker, Tarek/0000-0001-8329-4101; Schuurmans, Carol/0000-0003-3567-0058; Kania, Artur/0000-0002-5209-2520; Dalesman, Sarah/0000-0001-8548-3096	March of Dimes [1-FY08-356]; Canadian Institutes of Health Research (CIHR) [MOP-89994, 97758]; CIHR/Foundation Fighting Blindness (FFB) New Emerging Team [00933-000]; Natural Sciences and Engineering Research Council (NSERC); NIH [EY01730]; FFB; CIHR Canada HOPE; NATIONAL EYE INSTITUTE [P30EY001730, R01EY019968] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/Foundation Fighting Blindness (FFB) New Emerging Team(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FFB; CIHR Canada HOPE(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by operating grants to CS from the March of Dimes (1-FY08-356), Canadian Institutes of Health Research (CIHR) (MOP-89994), and a CIHR/Foundation Fighting Blindness (FFB) New Emerging Team grant (00933-000); a CIHR operating grant to AK (97758); a Discovery Grant and an Equipment Grant to WKS from the Natural Sciences and Engineering Research Council (NSERC); and a Core Grant for Vision Research (NIH EY01730) to ROW. CS and YS are Alberta Heritage Foundation for Medical Research (AHFMR) Senior Scholars. RC is supported by an FFB studentship and was supported by a CIHR Training Grant. RD was supported by a CIHR Canada HOPE Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula JD, 2007, INVEST OPHTH VIS SCI, V48, P5788, DOI 10.1167/iovs.07-0881; Alam S, 2005, DEV DYNAM, V234, P772, DOI 10.1002/dvdy.20577; Amano K, 2009, J NEUROSCI, V29, P2984, DOI 10.1523/JNEUROSCI.3624-08.2009; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Comer FI, 2007, CELL, V128, P239, DOI 10.1016/j.cell.2007.01.010; Deans MR, 2011, NEURON, V71, P820, DOI 10.1016/j.neuron.2011.06.026; Erdmann B, 2003, DEV DYNAM, V226, P570, DOI 10.1002/dvdy.10266; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Forte JD, 2008, J NEUROSCI METH, V169, P191, DOI 10.1016/j.jneumeth.2007.12.007; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2010, GENESIS, V48, P578, DOI 10.1002/dvg.20662; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Fuerst PG, 2009, CURR OPIN NEUROBIOL, V19, P389, DOI 10.1016/j.conb.2009.07.013; Galli-Resta L, 2008, PROG RETIN EYE RES, V27, P260, DOI 10.1016/j.preteyeres.2008.02.001; GalliResta L, 1997, J NEUROSCI, V17, P7831; Godinho L, 2005, DEVELOPMENT, V132, P5069, DOI 10.1242/dev.02075; Godinho L, 2007, NEURON, V56, P597, DOI 10.1016/j.neuron.2007.09.036; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Halfter W, 2001, DEV BIOL, V238, P79, DOI 10.1006/dbio.2001.0396; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Huckfeldt RM, 2009, NAT NEUROSCI, V12, P35, DOI 10.1038/nn.2236; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Keeley PW, 2010, J COMP NEUROL, V518, P1220, DOI 10.1002/cne.22270; Keeley PW, 2011, J COMP NEUROL, DOI [10.1002/cne.23027, DOI 10.1002/CNE.23027]; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Kim JW, 2008, GENE DEV, V22, P3147, DOI 10.1101/gad.1700108; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Lukasiewicz PD, 2005, PROG BRAIN RES, V147, P205, DOI 10.1016/S0079-6123(04)47016-2; Ma L, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-11; Marino S, 2002, DEVELOPMENT, V129, P3513; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; Oinuma I, 2010, J BIOL CHEM, V285, P28200, DOI 10.1074/jbc.M110.147546; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pimentel B, 2002, DEV BIOL, V247, P295, DOI 10.1006/dbio.2002.0703; Pinilla I, 2004, VISION RES, V44, P2467, DOI 10.1016/j.visres.2004.05.020; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Raven MA, 2003, J COMP NEUROL, V461, P123, DOI 10.1002/cne.10693; Reese B.E., 2008, EYE RETINA VISUAL SY, P147; Reese B.E., 2008, SENSES COMPREHENSIVE, V1, P439; Reese BE, 2002, PROG RETIN EYE RES, V21, P153, DOI 10.1016/S1350-9462(01)00024-6; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; Sakagami K, 2012, MOL CELL NEUROSCI, V49, P171, DOI 10.1016/j.mcn.2011.11.007; Sauve Y, 2006, VISION RES, V46, P1459, DOI 10.1016/j.visres.2005.11.009; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Sperow M, 2011, J PHYSL; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Yue Q, 2005, DEVELOPMENT, V132, P3281, DOI 10.1242/dev.01891; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	69	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32795	10.1371/journal.pone.0032795	http://dx.doi.org/10.1371/journal.pone.0032795			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403711	gold, Green Published			2022-12-25	WOS:000303017700108
J	Carrero, JA; Vivanco-Cid, H; Unanue, ER				Carrero, Javier A.; Vivanco-Cid, Hector; Unanue, Emil R.			Listeriolysin O Is Strongly Immunogenic Independently of Its Cytotoxic Activity	PLOS ONE			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSINS; PEST-LIKE SEQUENCE; T-CELL EPITOPES; LYMPHOCYTE APOPTOSIS; BACTERIAL TOXINS; DENDRITIC CELLS; MONOCYTOGENES; INFECTION; HEMOLYSIN; RECEPTOR	The presentation of microbial protein antigens by Major Histocompatibility Complex (MHC) molecules is essential for the development of acquired immunity to infections. However, most biochemical studies of antigen processing and presentation deal with a few relatively inert non-microbial model antigens. The bacterial pore-forming toxin listeriolysin O (LLO) is paradoxical in that it is cytotoxic at nanomolar concentrations as well as being the source of dominant CD4 and CD8 T cell epitopes following infection with Listeria monocytogenes. Here, we examined the relationship of LLO toxicity to its antigenicity and immunogenicity. LLO offered to antigen presenting cells (APC) as a soluble protein, was presented to CD4 T cells at picomolar to femtomolar concentrations-doses 3000-7000-fold lower than free peptide. This presentation required a dose of LLO below the cytotoxic level. Mutations of two key tryptophan residues reduced LLO toxicity by 10-100-fold but had no effect on its presentation to CD4 T cells. Thus there was a clear dissociation between the cytotoxic properties of LLO and its very high antigenicity. Presentation of LLO to CD8 T cells was not as robust as that seen in CD4 T cells, but still occurred in the nanomolar range. APC rapidly bound and internalized LLO, then disrupted endosomal compartments within 4 hours of treatment, allowing endosomal contents to access the cytosol. LLO was also immunogenic after in vivo administration into mice. Our results demonstrate the strength of LLO as an immunogen to both CD4 and CD8 T cells.	[Carrero, Javier A.; Unanue, Emil R.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA; [Vivanco-Cid, Hector] Univ Veracruzana, Inst Invest Med Biol, Cordoba, Veracruz, Mexico	Washington University (WUSTL); Universidad Veracruzana	Carrero, JA (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.	jacarrer@wustl.edu			National Institutes of Health (NIH) [AI062832]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062832] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grant AI062832 (E.R.U.) from the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barsig J, 1997, INFECT IMMUN, V65, P4075, DOI 10.1128/IAI.65.10.4075-4081.1997; BEATTIE IA, 1990, INFECT IMMUN, V58, P2792, DOI 10.1128/IAI.58.9.2792-2803.1990; BERCHE P, 1987, J IMMUNOL, V139, P3813; Browne KA, 1999, MOL CELL BIOL, V19, P8604; BRUNT LM, 1990, J IMMUNOL, V145, P3540; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; Carrero JA, 2004, J IMMUNOL, V172, P4866, DOI 10.4049/jimmunol.172.8.4866; Carrero JA, 2008, J IMMUNOL, V181, P1365, DOI 10.4049/jimmunol.181.2.1365; Carrero JA, 2007, IMMUNOL RES, V38, P333, DOI 10.1007/s12026-007-0017-z; Carrero JA, 2006, TRENDS IMMUNOL, V27, P497, DOI 10.1016/j.it.2006.09.005; Carrero JA, 2009, INFECT IMMUN, V77, P4371, DOI 10.1128/IAI.00419-09; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Darji A, 1997, IMMUNOL LETT, V57, P33, DOI 10.1016/S0165-2478(97)00071-0; Darji A, 1997, EUR J IMMUNOL, V27, P1696, DOI 10.1002/eji.1830270716; Decatur AL, 2000, SCIENCE, V290, P992, DOI 10.1126/science.290.5493.992; Edelson BT, 1999, J IMMUNOL, V163, P4087; Edelson BT, 2001, IMMUNITY, V14, P503, DOI 10.1016/S1074-7613(01)00139-X; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; GAILLARD JL, 1986, INFECT IMMUN, V52, P50, DOI 10.1128/IAI.52.1.50-55.1986; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Gekara NO, 2010, J INFECT DIS, V202, P1698, DOI 10.1086/657145; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Gilbert RJC, 2010, ADV EXP MED BIOL, V677, P56; Glomski IJ, 2003, INFECT IMMUN, V71, P6754, DOI 10.1128/IAI.71.12.6754-6765.2003; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Guzman CA, 1996, MOL MICROBIOL, V20, P119, DOI 10.1111/j.1365-2958.1996.tb02494.x; Hackam DJ, 1998, J EXP MED, V188, P351, DOI 10.1084/jem.188.2.351; Hamilton SE, 2006, J IMMUNOL, V177, P4012, DOI 10.4049/jimmunol.177.6.4012; Heuck AP, 2010, SUBCELL BIOCHEM, V51, P551, DOI 10.1007/978-90-481-8622-8_20; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; MICHEL E, 1990, MOL MICROBIOL, V4, P2167, DOI 10.1111/j.1365-2958.1990.tb00578.x; Neeson P, 2008, CANCER IMMUNOL IMMUN, V57, P493, DOI 10.1007/s00262-007-0388-y; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Paterson Y, 2010, SEMIN IMMUNOL, V22, P183, DOI 10.1016/j.smim.2010.02.002; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Pu Z, 2002, P NATL ACAD SCI USA, V99, P8844, DOI 10.1073/pnas.092260499; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; SAFLEY SA, 1991, J IMMUNOL, V146, P3604; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schnupf P, 2006, CELL MICROBIOL, V8, P353, DOI 10.1111/j.1462-5822.2005.00631.x; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Sewell DA, 2004, CANCER RES, V64, P8821, DOI 10.1158/0008-5472.CAN-04-1958; Singh R, 2005, J IMMUNOL, V175, P3663, DOI 10.4049/jimmunol.175.6.3663; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Velazquez C, 2002, J BIOL CHEM, V277, P42514, DOI 10.1074/jbc.M202316200; WADE WF, 1989, P NATL ACAD SCI USA, V86, P6297, DOI 10.1073/pnas.86.16.6297	52	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32310	10.1371/journal.pone.0032310	http://dx.doi.org/10.1371/journal.pone.0032310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403645	Green Submitted, gold, Green Published			2022-12-25	WOS:000303017700042
J	Chong, HH; Yao, X; Zhang, C; Cai, LF; Cui, S; Wang, YC; He, YX				Chong, Huihui; Yao, Xue; Zhang, Chao; Cai, Lifeng; Cui, Sheng; Wang, Youchun; He, Yuxian			Biophysical Property and Broad Anti-HIV Activity of Albuvirtide, a 3-Maleimimidopropionic Acid-Modified Peptide Fusion Inhibitor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN SERUM ALBUMINS; GP41 CORE STRUCTURE; IN-VITRO; ATOMIC-STRUCTURE; POTENT; ENFUVIRTIDE; RESISTANCE; ENTRY; REPLICATION	Albuvirtide (ABT) is a 3-maleimimidopropionic acid (MPA)-modified peptide HIV fusion inhibitor that can irreversibly conjugate to serum albumin. Previous studies demonstrated its in vivo long half-life and potent anti-HIV activity. Here, we focused to characterize its biophysical properties and evaluate its antiviral spectrum. In contrast to T20 (Enfuvirtide, Fuzeon), ABT was able to form a stable a-helical conformation with the target sequence and block the fusion-active six-helix bundle (6-HB) formation in a dominant-negative manner. It efficiently inhibited HIV-1 Env-mediated cell membrane fusion and virus entry. A large panel of 42 HIV-1 pseudoviruses with different genotypes were constructed and used for the antiviral evaluation. The results showed that ABT had potent inhibitory activity against the subtypes A, B and C that predominate the worldwide AIDS epidemics, and subtype B', CRF07_BC and CRF01_AE recombinants that are currently circulating in China. Furthermore, ABT was also highly effective against HIV-1 variants resistant to T20. Taken together, our data indicate that the chemically modified peptide ABT can serve as an ideal HIV-1 fusion inhibitor.	[Chong, Huihui; Yao, Xue; Zhang, Chao; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Chong, Huihui; Yao, Xue; Zhang, Chao; Cui, Sheng; He, Yuxian] Peking Union Med Coll, Beijing 100021, Peoples R China; [Cai, Lifeng] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China; [Wang, Youchun] Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China; National Institute of Food & Drug Control - China	Chong, HH (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China.	yhe@ipb.pumc.edu.cn	Cui, Sheng/AAQ-1721-2020; Sheng, CUI/M-6405-2013	Sheng, CUI/0000-0001-6329-3582; chong, huihui/0000-0001-6965-2742	Natural Science Foundation of China [30870123, 81025009]; National 973 program of China [2010CB530100]; National Science and Technology Major Project [2009ZX10004-303]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 program of China(National Basic Research Program of China); National Science and Technology Major Project	This work was supported by grants from Natural Science Foundation of China (30870123), and National Outstanding Youth Award of NSFC (81025009), and National 973 program of China (2010CB530100), and National Science and Technology Major Project (2009ZX10004-303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Ajaj K, 2009, CANCER CHEMOTH PHARM, V64, P413, DOI 10.1007/s00280-009-0942-8; Balan V, 2006, ANTIVIR THER, V11, P35; Berkhout B, 2011, ANTIVIR RES, V92, P7, DOI 10.1016/j.antiviral.2011.04.002; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chinnadurai R, 2005, AIDS, V19, P1401, DOI 10.1097/01.aids.0000180785.25800.de; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Chong HH, 2009, J CLIN VIROL, V45, P255, DOI 10.1016/j.jcv.2009.05.001; Cruz LJ, 2001, J PEPT SCI, V7, P511, DOI 10.1002/psc.336; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Esmaeili F, 2009, J PHARM SCI-US, V98, P2718, DOI 10.1002/jps.21599; Groenink M, 1997, AIDS RES HUM RETROV, V13, P179, DOI 10.1089/aid.1997.13.179; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; Hartung G, 1999, CLIN CANCER RES, V5, P753; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P11129, DOI 10.1128/JVI.01060-08; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Jacobs A, 2007, J BIOL CHEM, V282, P32406, DOI 10.1074/jbc.M705577200; JANSEN RW, 1993, MOL PHARMACOL, V44, P1003; Jette L, 2005, ENDOCRINOLOGY, V146, P3052, DOI 10.1210/en.2004-1286; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Loemba H, 2002, ANTIMICROB AGENTS CH, V46, P2087, DOI 10.1128/AAC.46.7.2087-2094.2002; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; McCutchan FE, 2000, AIDS, V14, pS31; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; Palmer S, 1998, AIDS RES HUM RETROV, V14, P157, DOI 10.1089/aid.1998.14.157; Patel IH, 2005, CLIN PHARMACOKINET, V44, P175, DOI 10.2165/00003088-200544020-00003; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Stoddart CA, 2008, J BIOL CHEM, V283, P34045, DOI 10.1074/jbc.M805536200; Swart PJ, 1996, J DRUG TARGET, V4, P109, DOI 10.3109/10611869609046269; TAKAMI M, 1992, BIOCHIM BIOPHYS ACTA, V1180, P180, DOI 10.1016/0925-4439(92)90066-V; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wexler-Cohen Y, 2007, FASEB J, V21, P3677, DOI 10.1096/fj.07-8582com; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xie D, 2010, ANTIMICROB AGENTS CH, V54, P191, DOI 10.1128/AAC.00976-09; Yao X, 2012, J BIOL CHEM	58	51	53	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32599	10.1371/journal.pone.0032599	http://dx.doi.org/10.1371/journal.pone.0032599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403678	Green Submitted, gold, Green Published			2022-12-25	WOS:000303017700075
J	Ke, L; Tong, ZH; Ni, HB; Ding, WW; Sun, JK; Li, WQ; Li, N; Li, JS				Ke, Lu; Tong, Zhi-hui; Ni, Hai-bin; Ding, Wei-wei; Sun, Jia-kui; Li, Wei-qin; Li, Ning; Li, Jie-shou			The Effect of Intra-Abdominal Hypertension Incorporating Severe Acute Pancreatitis in a Porcine Model	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; INTERNATIONAL-CONFERENCE; LUNG INJURY; HEMOFILTRATION; LAPAROSCOPY; ISCHEMIA; THERAPY; EXPERTS	Introduction: Abdominal compartment syndrome (ACS) and intra abdominal hypertension(IAH) are common clinical findings in patients with severe acute pancreatitis(SAP). It is thought that an increased intra abdominal pressure(IAP) is associated with poor prognosis in SAP patients. But the detailed effect of IAH/ACS on different organ system is not clear. The aim of this study was to assess the effect of SAP combined with IAH on hemodynamics, systemic oxygenation, and organ damage in a 12 h lasting porcine model. Measurements and Methods: Following baseline registrations, a total of 30 animals were divided into 5 groups (6 animals in each group): SAP+IAP30 group, SAP+IAP20 group, SAP group, IAP30 group(sham-operated but without SAP) and sham-operated group. We used a N-2 pneumoperitoneum to induce different levels of IAH and retrograde intra-ductal infusion of sodium taurocholate to induce SAP. The investigation period was 12 h. Hemodynamic parameters (CO, HR, MAP, CVP), urine output, oxygenation parameters(e. g., SvO2, PO2, PaCO2), peak inspiratory pressure, as well as serum parameters (e. g., ALT, amylase, lactate, creatinine) were recorded. Histological examination of liver, intestine, pancreas, and lung was performed. Main Results: Cardiac output significantly decreased in the SAP+IAH animals compared with other groups. Furthermore, AST, creatinine, SUN and lactate showed similar increasing tendency paralleled with profoundly decrease in SvO2. The histopathological analyses also revealed higher grade injury of liver, intestine, pancreas and lung in the SAP+IAH groups. However, few differences were found between the two SAP+IAH groups with different levels of IAP. Conclusions: Our newly developed porcine SAP+IAH model demonstrated that there were remarkable effects on global hemodynamics, oxygenation and organ function in response to sustained IAH of 12 h combined with SAP. Moreover, our model should be helpful to study the mechanisms of IAH/ACS-induced exacerbation and to optimize the treatment strategies for counteracting the development of organ dysfunction.	[Ke, Lu; Tong, Zhi-hui; Ni, Hai-bin; Ding, Wei-wei; Sun, Jia-kui; Li, Wei-qin; Li, Ning; Li, Jie-shou] Nanjing Univ, Dept Gen Surg, Jinling Hosp, Sch Med, Nanjing 210008, Peoples R China	Nanjing University	Ke, L (corresponding author), Nanjing Univ, Dept Gen Surg, Jinling Hosp, Sch Med, Nanjing 210008, Peoples R China.	kkb9832@gmail.com	D, W/AAV-4475-2021; Ke, Lu/ABD-2608-2022; Ding, Weiwei/L-8807-2019; Li, jie/GXG-4583-2022	D, W/0000-0002-5026-689X; Ke, Lu/0000-0001-8093-5073; Ding, Weiwei/0000-0002-5026-689X; 	social development funding of Jiangsu province	social development funding of Jiangsu province	This study was supported in part by the social development funding of Jiangsu province. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahrani AZ, 2008, PANCREAS, V36, P39, DOI 10.1097/mpa.0b013e318149f5bf; CAIN SM, 1977, J APPL PHYSIOL, V42, P228, DOI 10.1152/jappl.1977.42.2.228; Cheatham ML, 2007, INTENS CARE MED, V33, P951, DOI 10.1007/s00134-007-0592-4; Cheatham ML, 2009, CURR OPIN CRIT CARE, V15, P154, DOI 10.1097/MCC.0b013e3283297934; Cicalese L, 2001, DIGEST DIS SCI, V46, P1127, DOI 10.1023/A:1010786701289; de Laet I E, 2007, Med Intensiva, V31, P88; De Waele JJ, 2005, CRIT CARE, V9, pR452, DOI 10.1186/cc3754; Gallagher JJ, 2010, AACN ADV CRIT CARE, V21, P205, DOI 10.1097/NCI.0b013e3181d94fd5; Gecelter G, 2002, DIGEST SURG, V19, P402, DOI 10.1159/000065820; Gong GW, 2009, J INVEST SURG, V22, P362, DOI 10.1080/08941930903214719; Gong GW, 2009, FREE RADICAL RES, V43, P470, DOI 10.1080/10715760902846157; Rosas JMH, 2007, SURGERY, V141, P173, DOI 10.1016/j.surg.2006.04.016; HO HS, 1995, J SURG RES, V59, P497, DOI 10.1006/jsre.1995.1198; Hunter JD, 2004, ANAESTHESIA, V59, P899, DOI 10.1111/j.1365-2044.2004.03712.x; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jansen TC, 2009, CRIT CARE MED, V37, P2369, DOI 10.1097/CCM.0b013e3181a0f919; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Liu HY, 2008, PANCREAS, V36, P192, DOI 10.1097/MPA.0b013e31815a399f; Malbrain MLNG, 2006, INTENS CARE MED, V32, P1722, DOI 10.1007/s00134-006-0349-5; Malbrain MLNG, 2009, CRIT CARE MED, V37, P365, DOI 10.1097/CCM.0b013e3181935001; Menes T, 2000, SURG ENDOSC, V14, P1050, DOI 10.1007/s004640000216; Mentula P, 2010, ARCH SURG-CHICAGO, V145, P764, DOI 10.1001/archsurg.2010.132; Moore-Olufemi SD, 2005, SHOCK, V23, P571, DOI 10.1097/01.shk.0000161388.61935.e6; MUTOH T, 1991, J APPL PHYSIOL, V70, P2611, DOI 10.1152/jappl.1991.70.6.2611; Olofsson PH, 2009, CRIT CARE MED, V37, P230, DOI 10.1097/CCM.0b013e318192ff51; Otto J, 2010, SHOCK, V33, P639, DOI 10.1097/SHK.0b013e3181cb8be0; PARK PO, 1990, SURGERY, V107, P574; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; RYAN CM, 1993, GASTROENTEROLOGY, V104, P890, DOI 10.1016/0016-5085(93)91027-F; Schachtrupp A, 2005, SHOCK, V24, P153, DOI 10.1097/01.shk.0000172094.73918.c2; Schachtrupp A, 2003, J TRAUMA, V55, P734, DOI 10.1097/01.TA.0000042020.09010.D7; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Toens C, 2002, SHOCK, V18, P316, DOI 10.1097/00024382-200210000-00005; Vidal MG, 2008, CRIT CARE MED, V36, P1823, DOI 10.1097/CCM.0b013e31817c7a4d; Yan XW, 2006, INT J ARTIF ORGANS, V29, P293, DOI 10.1177/039139880602900307; Yekebas EF, 2002, KIDNEY INT, V62, P1806, DOI 10.1046/j.1523-1755.2002.00607.x; Zhou MT, 2010, WORLD J GASTROENTERO, V16, P2094, DOI 10.3748/wjg.v16.i17.2094	37	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e33125	10.1371/journal.pone.0033125	http://dx.doi.org/10.1371/journal.pone.0033125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403734	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700132
J	Ye, Q; He, K; Wu, SY; Wan, QH				Ye, Qing; He, Ke; Wu, Shao-Ying; Wan, Qiu-Hong			Isolation of a 97-kb Minimal Essential MHC B Locus from a New Reverse-4D BAC Library of the Golden Pheasant	PLOS ONE			English	Article							C-TYPE LECTIN; GENE MAP; CHICKEN; SEQUENCE; COMPLEX; CONSTRUCTION; POLYMORPHISM; GENOMICS; CONTIG; REGION	The bacterial artificial chromosome (BAC) system is widely used in isolation of large genomic fragments of interest. Construction of a routine BAC library requires several months for picking clones and arraying BACs into superpools in order to employ 4D-PCR to screen positive BACs, which might be time-consuming and laborious. The major histocompatibility complex (MHC) is a cluster of genes involved in the vertebrate immune system, and the classical avian MHC-B locus is a minimal essential one, occupying a 100-kb genomic region. In this study, we constructed a more effective reverse-4D BAC library for the golden pheasant, which first creates sub-libraries and then only picks clones of positive sub-libraries, and identified several MHC clones within thirty days. The full sequencing of a 97-kb reverse-4D BAC demonstrated that the golden pheasant MHC-B locus contained 20 genes and showed good synteny with that of the chicken. The notable differences between these two species were the numbers of class II B loci and NK genes and the inversions of the TAPBP gene and the TAP1-TAP2 region. Furthermore, the inverse TAP2-TAP1 was unique in the golden pheasant in comparison with that of chicken, turkey, and quail. The newly defined genomic structure of the golden pheasant MHC will give an insight into the evolutionary history of the avian MHC.	[Ye, Qing] Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, State Conservat Ctr Gene Resources Endangered Wil, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ye, Q (corresponding author), Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	qiuhongwan@zju.edu.cn			National Natural Science Foundation of China [31070334]; National Basic Research Program of the People's Republic of China (973 Program) [2007CB411600]; Fundamental Research Funds for the Central Universities of the People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of the People's Republic of China (973 Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities of the People's Republic of China	This work was supported by a grant from the National Natural Science Foundation of China (No. 31070334), by a grant from the National Basic Research Program of the People's Republic of China (973 Program; No. 2007CB411600), and by the Fundamental Research Funds for the Central Universities of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elsalam Kamel A., 2003, African Journal of Biotechnology, V2, P91; Alcaide M, 2008, MOL ECOL, V17, P2652, DOI 10.1111/j.1365-294X.2008.03791.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ando A, 2006, ANIM SCI J, V77, P127, DOI 10.1111/j.1740-0929.2006.00331.x; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; BRILES WE, 1993, IMMUNOGENETICS, V37, P408, DOI 10.1007/BF00222464; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burri R, 2008, IMMUNOGENETICS, V60, P543, DOI 10.1007/s00251-008-0308-0; Chaves LD, 2009, J IMMUNOL, V183, P6530, DOI 10.4049/jimmunol.0901310; Childers CP, 2006, ANIM GENET, V37, P121, DOI 10.1111/j.1365-2052.2005.01395.x; Clarke LCJ, 1976, CELL BIOCHEM FUNCT, P91; Debenham SL, 2005, GENOMICS, V85, P48, DOI 10.1016/j.ygeno.2004.09.009; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fu HH, 2000, GENOME RES, V10, P866, DOI 10.1101/gr.10.6.866; FUMIHITO A, 1995, P NATL ACAD SCI USA, V92, P11053, DOI 10.1073/pnas.92.24.11053; Gao JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-466; He K, 2009, CONSERV GENET, V10, P511, DOI 10.1007/s10592-008-9552-y; Hosomichi K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-322; Huang Y, 2004, BIOINFORMATICS, V20, P460, DOI 10.1093/bioinformatics/btg429; Hughes CR, 2008, IMMUNOGENETICS, V60, P219, DOI 10.1007/s00251-008-0287-1; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; KLEIN J, 1986, NATURAL HIST MAJOR H; Ma ZY, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.24.e106; Miyake T, 2004, COMP BIOCHEM PHYS C, V138, P233, DOI 10.1016/j.cca.2004.07.001; Montgomery SB, 2004, GENOME RES, V14, P956, DOI 10.1101/gr.1890304; NEI M, 1986, MOL BIOL EVOL, V3, P418; Osoegawa K, 2001, CURR PROTOC HUM GENE; Paterson A, 1996, DNA REVOLUTION, P7; Rogers SL, 2005, J IMMUNOL, V174, P3475, DOI 10.4049/jimmunol.174.6.3475; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 2001, MOL CLONING LAB MANU; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shen YY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-132; Shiina T, 2004, J IMMUNOL, V172, P6751, DOI 10.4049/jimmunol.172.11.6751; Shiina T, 2007, J IMMUNOL, V178, P7162, DOI 10.4049/jimmunol.178.11.7162; Simkova H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/302543; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Strackx M, 2011, IEEE I C ULTRA-WIDEB, P1, DOI 10.1109/ICUWB.2011.6058826; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsuda TT, 2001, IMMUNOGENETICS, V53, P712, DOI 10.1007/s002510100369; Wan QH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004147; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Westerdahl H, 2007, J ORNITHOL, V148, pS469, DOI 10.1007/s10336-007-0230-5; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Zeng CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-315; Zheng G., 1996, CHINA SPECIES RED LI	52	45	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32154	10.1371/journal.pone.0032154	http://dx.doi.org/10.1371/journal.pone.0032154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403630	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700027
J	Khan, Z; Ahmad, S; Joseph, L; Chandy, R				Khan, Ziauddin; Ahmad, Suhail; Joseph, Leena; Chandy, Rachel			Candida dubliniensis: An Appraisal of Its Clinical Significance as a Bloodstream Pathogen	PLOS ONE			English	Article							VIRUS-INFECTED PATIENTS; INTENSIVE-CARE-UNIT; ANTIFUNGAL SUSCEPTIBILITY; CANCER-PATIENTS; C-DUBLINIENSIS; SAUDI-ARABIA; IN-VITRO; ALBICANS; FUNGEMIA; IDENTIFICATION	A nine-year prospective study (2002-2010) on the prevalence of Candida dubliniensis among Candida bloodstream isolates is presented. The germ tube positive isolates were provisionally identified as C. dubliniensis by presence of fringed and rough colonies on sunflower seed agar. Subsequently, their identity was confirmed by Vitek2 Yeast identification system and/or by amplification and sequencing of the ITS region of rDNA. In all, 368 isolates were identified as C. dubliniensis; 67.1% came from respiratory specimens, 11.7% from oral swabs, 9.2% from urine, 3.8% from blood, 2.7% from vaginal swabs and 5.4% from other sources. All C. dubliniensis isolates tested by Etest were susceptible to voriconazole and amphotericin B. Resistance to fluconazole (>= 8 mg/ml) was observed in 2.5% of C. dubliniensis isolates, 7 of which occurred between 2008-2010. Of note was the diagnosis of C. dubliniensis candidemia in 14 patients, 11 of them occurring between 2008-2010. None of the bloodstream isolate was resistant to fluconazole, while a solitary isolate showed increased MIC to 5-flucytosine (>32 mu g/ml) and belonged to genotype 4. A review of literature since 1999 revealed 28 additional cases of C. dubliniensis candidemia, and 167 isolates identified from blood cultures since 1982. In conclusion, this study highlights a greater role of C. dubliniensis in bloodstream infections than hitherto recognized.	[Khan, Ziauddin; Ahmad, Suhail; Joseph, Leena; Chandy, Rachel] Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait	Kuwait University	Khan, Z (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait.	zkhan@hsc.edu.kw	Ahmad, Suhail/AAJ-5456-2021		KURA (Kuwait University Research Administration) [MI01/08]	KURA (Kuwait University Research Administration)	Financial support received from KURA (Kuwait University Research Administration), grant no. MI01/08, is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122, DOI 10.1086/513663; Ahmad S, 2004, J MED MICROBIOL, V53, P633, DOI 10.1099/jmm.0.05315-0; Ahmad S, 2012, MED MYCOL, V50, P244, DOI 10.3109/13693786.2011.597446; Al-Hedaithy SSA, 2003, MYCOSES, V46, P293, DOI 10.1046/j.1439-0507.2003.00893.x; Al-Sweih N, 2005, MYCOSES, V48, P347, DOI 10.1111/j.1439-0507.2005.01143.x; Asmundsdottir LR, 2008, CLIN INFECT DIS, V47, pE17, DOI 10.1086/589298; Baradkar VP, 2008, INDIAN J MED MICROBI, V26, P382, DOI 10.4103/0255-0857.43574; Boyle BM, 2002, INT J STD AIDS, V13, P55, DOI 10.1258/0956462021924497; Brandt ME, 2000, EMERG INFECT DIS, V6, P46, DOI 10.3201/eid0601.000108; Carr MJ, 2005, J CLIN MICROBIOL, V43, P3023, DOI 10.1128/JCM.43.6.3023-3026.2005; Chan-Tack KM, 2005, CLIN INFECT DIS, V40, P1209, DOI 10.1086/428846; Chen SCA, 2009, CLIN MICROBIOL INFEC, V15, P662, DOI 10.1111/j.1469-0691.2009.02821.x; Chen S, 2006, EMERG INFECT DIS, V12, P1508, DOI 10.3201/eid1210.060389; Cimolai N, 2002, J PEDIAT HEMATOL ONC, V24, P237, DOI 10.1097/00043426-200203000-00017; Coleman DC, 2010, FUTURE MICROBIOL, V5, P935, DOI [10.2217/fmb.10.51, 10.2217/FMB.10.51]; Dimopoulos G, 2008, ANESTH ANALG, V106, P523, DOI 10.1213/ane.0b013e3181607262; Bosco-Borgeat ME, 2011, MYCOPATHOLOGIA, V172, P407, DOI 10.1007/s11046-011-9450-6; Fanci R, 2009, J CHEMOTHERAPY, V21, P105, DOI 10.1179/joc.2009.21.1.105; Fotedar R, 2003, J CLIN MICROBIOL, V41, P1907, DOI 10.1128/JCM.41.5.1907-1911.2003; Gee SF, 2002, J CLIN MICROBIOL, V40, P556, DOI 10.1128/JCM.40.2.556-574.2002; Gottlieb GS, 2001, MED MYCOL, V39, P483, DOI 10.1080/mmy.39.6.483.485; Gutierrez J, 2002, J BASIC MICROB, V42, P207, DOI 10.1002/1521-4028(200206)42:3&lt;207::AID-JOBM207&gt;3.0.CO;2-C; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Jabra-Rizk MA, 2005, CLIN INFECT DIS, V41, P1064, DOI 10.1086/432943; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Khan ZU, 2008, ANTON LEEUW INT J G, V94, P343, DOI 10.1007/s10482-008-9251-1; Khan ZU, 2010, ANTON LEEUW INT J G, V97, P253, DOI 10.1007/s10482-009-9406-8; Khan ZU, 2004, CLIN MICROBIOL INFEC, V10, P590, DOI 10.1111/j.1469-0691.2004.00923.x; Kibbler CC, 2003, J HOSP INFECT, V54, P18, DOI 10.1016/S0195-6701(03)00085-9; Kim JO, 2003, J CLIN MICROBIOL, V41, P3354, DOI 10.1128/JCM.41.7.3354-3357.2003; Loreto ES, 2010, MYCOPATHOLOGIA, V169, P431, DOI 10.1007/s11046-010-9286-5; Marriott D, 2001, EMERG INFECT DIS, V7, P479, DOI 10.3201/eid0703.017326; Martinez M, 2002, J CLIN MICROBIOL, V40, P3135, DOI 10.1128/JCM.40.9.3135-3139.2002; McManus BA, 2008, J CLIN MICROBIOL, V46, P652, DOI 10.1128/JCM.01574-07; McManus BA, 2009, ANTIMICROB AGENTS CH, V53, P4678, DOI 10.1128/AAC.00607-09; McManus BA, 2009, EMERG INFECT DIS, V15, P1467, DOI 10.3201/eid1509.081660; McMullan R, 2002, EUR J CLIN MICROBIOL, V21, P635, DOI 10.1007/s10096-002-0786-1; Meis JFGM, 1999, EMERG INFECT DIS, V5, P150, DOI 10.3201/eid0501.990119; Metwally L, 2007, J INFECTION, V55, P174, DOI 10.1016/j.jinf.2007.04.003; Mokaddas E, 2011, MYCOSES, V54, pE29, DOI 10.1111/j.1439-0507.2009.01822.x; Moran GP, 2011, INT J MICROBIOL, DOI 10.115/2012/:205921; Mubareka S, 2005, TRANSPL INFECT DIS, V7, P146, DOI 10.1111/j.1399-3062.2005.00107.x; Nunn MA, 2007, EMERG INFECT DIS, V13, P747, DOI 10.3201/eid1305.061179; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Oxman DA, 2010, J ANTIMICROB CHEMOTH, V65, P1460, DOI 10.1093/jac/dkq136; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, DRUG RESIST UPDATE, V13, P180, DOI 10.1016/j.drup.2010.09.002; Sancak B, 2003, J CLIN MICROBIOL, V41, P489, DOI 10.1128/JCM.41.1.489-491.2003; Sebti A, 2001, CLIN INFECT DIS, V32, P1034, DOI 10.1086/319599; Silva Victor, 2003, Revista Iberoamericana de Micologia, V20, P46; Slavin MA, 2010, J ANTIMICROB CHEMOTH, V65, P1042, DOI 10.1093/jac/dkq053; Stokes C, 2007, FUNGAL GENET BIOL, V44, P920, DOI 10.1016/j.fgb.2006.11.014; Sullivan Derek, 1997, Current Topics in Medical Mycology, V8, P15; Sullivan DJ, 2011, VIRULENCE, V2, P77, DOI 10.4161/viru.2.1.15002; SULLIVAN DJ, 1995, MICROBIOL-UK, V141, P1507, DOI 10.1099/13500872-141-7-1507; Tan AL, 2002, EMERG INFECT DIS, V8, P445, DOI 10.3201/eid0804.010423; Tay ST, 2005, MYCOPATHOLOGIA, V159, P325, DOI 10.1007/s11046-004-6269-4; Tekeli A, 2006, MYCOSES, V49, P60, DOI 10.1111/j.1439-0507.2005.01181.x; Tortorano AM, 2004, J HOSP INFECT, V57, P8, DOI 10.1016/j.jhin.2004.01.017; van Hal SJ, 2009, TRANSPL INFECT DIS, V11, P122, DOI 10.1111/j.1399-3062.2009.00371.x; van Hal SJ, 2008, EMERG INFECT DIS, V14, P327, DOI 10.3201/eid1402.070985; Zepelin MB, 2002, AIDS, V16, P1237	62	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32952	10.1371/journal.pone.0032952	http://dx.doi.org/10.1371/journal.pone.0032952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396802	Green Published, Green Submitted, gold			2022-12-25	WOS:000303006500038
J	Podyma-Inoue, KA; Hara-Yokoyama, M; Shinomura, T; Kimura, T; Yanagishita, M				Podyma-Inoue, Katarzyna A.; Hara-Yokoyama, Miki; Shinomura, Tamayuki; Kimura, Tomoko; Yanagishita, Masaki			Syndecans Reside in Sphingomyelin-Enriched Low-Density Fractions of the Plasma Membrane Isolated from a Parathyroid Cell Line	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; LIPID RAFTS; DOMAINS; RECEPTOR; SURFACE; CHOLESTEROL; EXPRESSION; DYNAMICS; PROTEIN; IDENTIFICATION	Background: Heparan sulfate proteoglycans (HSPGs) are one of the basic constituents of plasma membranes. Specific molecular interactions between HSPGs and a number of extracellular ligands have been reported. Mechanisms involved in controlling the localization and abundance of HSPG on specific domains on the cell surface, such as membrane rafts, could play important regulatory roles in signal transduction. Methodology/Principal Findings: Using metabolic radiolabeling and sucrose-density gradient ultracentrifugation techniques, we identified [S-35] sulfate-labeled macromolecules associated with detergent-resistant membranes (DRMs) isolated from a rat parathyroid cell line. DRM fractions showed high specific radioactivity ([S-35] sulfate/mg protein), implying the specific recruitment of HSPGs to the membrane rafts. Identity of DRM-associated [S-35] sulfate-labeled molecules as HSPGs was confirmed by Western blotting with antibodies that recognize heparan sulfate (HS)-derived epitope. Analyses of core proteins by SDS-PAGE revealed bands with an apparent MW of syndecan-4 (30-33 kDa) and syndecan-1 (70 kDa) suggesting the presence of rafts with various HSPG species. DRM fractions enriched with HSPGs were characterized by high sphingomyelin content and found to only partially overlap with the fractions enriched in ganglioside GM1. HSPGs could be also detected in DRMs even after prior treatment of cells with heparitinase. Conclusions/Significance: Both syndecan-1 and syndecan-4 have been found to specifically associate with membrane rafts and their association seemed independent of intact HS chains. Membrane rafts in which HSPGs reside were also enriched with sphingomyelin, suggesting their possible involvement in FGF signaling. Further studies, involving proteomic characterization of membrane domains containing HSPGs might improve our knowledge on the nature of HSPG-ligand interactions and their role in different signaling platforms.	[Podyma-Inoue, Katarzyna A.; Hara-Yokoyama, Miki; Kimura, Tomoko; Yanagishita, Masaki] Tokyo Med & Dent Univ, Biochem Sect, Grad Sch Med & Dent Sci, Tokyo, Japan; [Shinomura, Tamayuki] Tokyo Med & Dent Univ, Sect Hard Tissue Engn, Dept Hard Tissue Engn, Grad Sch Med & Dent Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Podyma-Inoue, KA (corresponding author), Tokyo Med & Dent Univ, Biochem Sect, Grad Sch Med & Dent Sci, Tokyo, Japan.	kapobch@tmd.ac.jp	Inoue, Katarzyna A./ABD-9622-2020		Japanese Government	Japanese Government	This work was supported by the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Couchman JR, 1996, J CELL BIOCHEM, V61, P578, DOI 10.1002/(SICI)1097-4644(19960616)61:4<578::AID-JCB11>3.0.CO;2-C; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; HaraYokoyama M, 1996, J BIOL CHEM, V271, P12951, DOI 10.1074/jbc.271.22.12951; HASCALL VC, 1994, METHOD ENZYMOL, V230, P390; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Hullin-Matsuda F, 2007, CELL MOL LIFE SCI, V64, P2492, DOI 10.1007/s00018-007-7281-x; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kusano Y, 2004, J BIOCHEM, V135, P129, DOI 10.1093/jb/mvh015; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Mishra S, 2007, J NEUROCHEM, V103, P135, DOI 10.1111/j.1471-4159.2007.04720.x; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; Podyma-Inoue KA, 2002, J BIOL CHEM, V277, P32459, DOI 10.1074/jbc.M203282200; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Rodrigueza WV, 1997, ARTERIOSCL THROM VAS, V17, P383, DOI 10.1161/01.ATV.17.2.383; SAKAGUCHI K, 1991, J BIOL CHEM, V266, P7270; SAKAGUCHI K, 1987, P NATL ACAD SCI USA, V84, P3269, DOI 10.1073/pnas.84.10.3269; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Shinomura T, 2008, J BIOL CHEM, V283, P33658, DOI 10.1074/jbc.M800719200; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; TAKAGI Y, 1994, J BIOL CHEM, V269, P23743; TAKEUCHI Y, 1990, BIOCHEM SOC T, V18, P816, DOI 10.1042/bst0180816; TAKEUCHI Y, 1992, ARCH BIOCHEM BIOPHYS, V298, P371, DOI 10.1016/0003-9861(92)90424-U; TAKEUCHI Y, 1992, J BIOL CHEM, V267, P14677; TAKEUCHI Y, 1992, J BIOL CHEM, V267, P14685; TAKEUCHI Y, 1990, J BIOL CHEM, V265, P13661; Taylor RD, 2009, PLOS PATHOG, V5, P1; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YANAGISHITA M, 1989, J BIOL CHEM, V264, P15714; Yang Y, 2003, J BIOL CHEM, V278, P12888, DOI 10.1074/jbc.M209440200; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32351	10.1371/journal.pone.0032351	http://dx.doi.org/10.1371/journal.pone.0032351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396758	Green Published, Green Submitted, gold			2022-12-25	WOS:000303005000021
J	Stryer, L				Stryer, Lubert			Exploring Light and Life Undergraduate, Medical School, and Postdoctoral Years	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP; ENERGY-TRANSFER; RETINAL RODS; PHOSPHODIESTERASE; FLUORESCENCE; RHODOPSIN; KINETICS; VISION; ACTIVATION; MOLECULES		Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Stryer, L (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	stryer@stanford.edu						Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; BLOUT ER, 1959, P NATL ACAD SCI USA, V45, P1591, DOI 10.1073/pnas.45.11.1591; BROWN PK, 1964, SCIENCE, V144, P45, DOI 10.1126/science.144.3614.45; Cario G, 1923, Z PHYS, V17, P202, DOI 10.1007/BF01328679; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1983, BIOPHYS J, V43, P383, DOI 10.1016/S0006-3495(83)84361-6; GLAZER AN, 1984, TRENDS BIOCHEM SCI, V9, P423, DOI 10.1016/0968-0004(84)90146-4; GRIFFITHS M, 1955, NATURE, V176, P1211, DOI 10.1038/1761211a0; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HAUGLAND RP, 1969, P NATL ACAD SCI USA, V63, P23, DOI 10.1073/pnas.63.1.23; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; HUBBARD R, 1958, P NATL ACAD SCI USA, V44, P130, DOI 10.1073/pnas.44.2.130; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Jacobs GH, 2009, SCI AM, V300, P56, DOI 10.1038/scientificamerican0409-56; KARPEN JW, 1988, COLD SPRING HARB SYM, V53, P325, DOI 10.1101/SQB.1988.053.01.039; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; Komatsuzaki T., 2011, ADV CHEM PHYS, V146, P23; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; MACNICHOL EF, 1964, SCI AM, V211, P48, DOI 10.1038/scientificamerican1264-48; MATHIES R, 1976, P NATL ACAD SCI USA, V73, P2169, DOI 10.1073/pnas.73.7.2169; MATHIES R, 1976, P NATL ACAD SCI USA, V73, P1, DOI 10.1073/pnas.73.1.1; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NICOL GD, 1978, P NATL ACAD SCI USA, V75, P5217, DOI 10.1073/pnas.75.10.5217; OI VT, 1982, J CELL BIOL, V93, P981, DOI 10.1083/jcb.93.3.981; Pober J S, 1979, Adv Cyclic Nucleotide Res, V11, P265; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; STRYER L, 1987, CHEM SCRIPTA, V27B, P161; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; STRYER L, 1959, BIOCHIM BIOPHYS ACTA, V35, P242, DOI 10.1016/0006-3002(59)90355-5; STRYER L, 1964, J MOL BIOL, V8, P96, DOI 10.1016/S0022-2836(64)80152-2; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; STRYER LUBERT, 1960, RADIATION RES SUPPL, V2, P432, DOI 10.2307/3583609; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; TOMITA T, 1970, Quarterly Reviews of Biophysics, V3, P179; Tsien RY, 2009, ANGEW CHEM INT EDIT, V48, P5612, DOI 10.1002/anie.200901916; WEBER G, 1954, BIOCHEM J, V56, pR31; WHEELER GL, 1977, P NATL ACAD SCI USA, V74, P4238, DOI 10.1073/pnas.74.10.4238; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WU C, 1972, P NATL ACAD SCI USA, V69, P1104, DOI 10.1073/pnas.69.5.1104; YEE R, 1978, J BIOL CHEM, V253, P8902; Young T., 1802, PHILOS T ROY SOC LON, V92, P12, DOI DOI 10.1098/RSTL.1802.0004; ZIMMERMAN AL, 1985, P NATL ACAD SCI USA, V82, P8813, DOI 10.1073/pnas.82.24.8813; Zimmermann B, 2006, BBA-BIOENERGETICS, V1757, P311, DOI 10.1016/j.bbabio.2006.03.020	56	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15164	15173		10.1074/jbc.X112.361436	http://dx.doi.org/10.1074/jbc.X112.361436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411992	Green Published, hybrid			2022-12-25	WOS:000304006300002
J	Wang, K; Gu, SM; Yin, XY; Weintraub, ST; Hua, ZC; Jiang, JX				Wang, Ke; Gu, Sumin; Yin, Xinye; Weintraub, Susan T.; Hua, Zichun; Jiang, Jean X.			Developmental Truncations of Connexin 50 by Caspases Adaptively Regulate Gap Junctions/Hemichannels and Protect Lens Cells against Ultraviolet Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; FUNCTIONAL-CHARACTERIZATION; JUNCTIONS; DEGRADATION; MECHANISM; MICROPHTHALMIA; HEMICHANNEL; PROPAGATION; CLEAVAGE; DOMAIN	The gap junction-forming connexin (Cx) 50 is truncated gradually during lens development. Premature cleavage of lens connexins is thought to be associated with cataract formation. We have shown previously that Cx50 is likely to be cleaved by caspase-3 like protease during chick lens development. Here, using HPLC-electrospray tandem mass spectrometry, we mapped two cleavage sites at the C terminus of Cx50 after Glu-368 and Asp-379 and identified caspase-3 and caspase-1 as the responsible proteases, respectively. The activity of caspase-1, like caspase-3, was detected in the outer cortex increased during lens development, which coincided with the accumulation of the truncated fragments of Cx50 in the core region of the lens. The truncated Cx50 fragments present in older lenses were reproduced in the younger lens after treatment with UV radiation; this cleavage could be partially blocked by caspase-1/3-specific inhibitors. Interestingly, as compared with full-length Cx50, caspase-truncated Cx50 showed a dramatic decrease in gap junction coupling and a loss of hemichannel function. Furthermore, expression of caspase-truncated Cx50 fragments increased cell viability against UV radiation as compared with full-length Cx50. Together, these results suggest that both caspase-1 and -3 are responsible for the cleavage at the C terminus of Cx50 during lens development. The reduction of gap junction coupling and closure of hemichannels formed by truncated Cx50 are likely to adaptively protect cells against elevated oxidative stress associated with lens aging.	[Wang, Ke; Gu, Sumin; Yin, Xinye; Weintraub, Susan T.; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Wang, Ke; Hua, Zichun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Coll Life Sci, Nanjing 210093, Jiangsu, Peoples R China	University of Texas System; University of Texas Health San Antonio; Nanjing University	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu		Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY012085]; Welch Foundation [AQ-1507]; State Key Laboratory of Pharmaceutical Biotechnology [KFGW-200802]; NATIONAL EYE INSTITUTE [R29EY012085, R01EY012085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); State Key Laboratory of Pharmaceutical Biotechnology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY012085. This work was also supported by Welch Foundation Grant AQ-1507 (to J. X. J) and the Open Fund from the State Key Laboratory of Pharmaceutical Biotechnology (KFGW-200802) (to Z. H.).	Ayala MN, 2000, EXP EYE RES, V70, P451, DOI 10.1006/exer.1999.0801; Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Beebe DC, 2010, OPHTHALMIC RES, V44, P155, DOI 10.1159/000316481; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Chai ZF, 2011, MOL BIOL CELL, V22, P4503, DOI 10.1091/mbc.E11-05-0438; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Cooper K., 1991, BIOPHYSICS GAP JUNCT, P57; Cusato K, 2003, J NEUROSCI, V23, P6413; DeRosa AM, 2006, INVEST OPHTH VIS SCI, V47, P4474, DOI 10.1167/iovs.05-1582; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Gu SM, 2003, INVEST OPHTH VIS SCI, V44, P2103, DOI 10.1167/iovs.02-1045; Jiang JX, 2010, CURR MOL MED, V10, P851; Jiang J. X., 2000, CONNEXIN METHODS PRO, P159; JIANG JX, 1994, MOL BIOL CELL, V5, P363, DOI 10.1091/mbc.5.3.363; KISTLER J, 1987, INVEST OPHTH VIS SCI, V28, P1687; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Lin DB, 2006, J EXP BIOL, V209, P4371, DOI 10.1242/jeb.02524; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Lin JS, 1997, EUR J CELL BIOL, V73, P141; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Munoz B, 1999, ANN EPIDEMIOL, V9, P53, DOI 10.1016/S1047-2797(98)00026-X; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Rong P, 2002, DEVELOPMENT, V129, P167; Sellitto C, 2004, INVEST OPHTH VIS SCI, V45, P3196, DOI 10.1167/iovs.04-0194; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Wang Z, 2009, EXP EYE RES, V89, P898, DOI 10.1016/j.exer.2009.07.015; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; Xu X, 2002, J MEMBRANE BIOL, V186, P101, DOI 10.1007/s00232-001-0139-5; Yin XY, 2001, J BIOL CHEM, V276, P34567, DOI 10.1074/jbc.M106073200; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; ZIGMAN S, 1979, INVEST OPHTH VIS SCI, V18, P462	39	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15786	15797		10.1074/jbc.M111.313171	http://dx.doi.org/10.1074/jbc.M111.313171			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418432	Green Published, hybrid			2022-12-25	WOS:000304006300056
J	Komoriya, Y; Ariga, T; Iino, R; Imamura, H; Okuno, D; Noji, H				Komoriya, Yoshihito; Ariga, Takayuki; Iino, Ryota; Imamura, Hiromi; Okuno, Daichi; Noji, Hiroyuki			Principal Role of the Arginine Finger in Rotary Catalysis of F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ATP SYNTHASE; YEAST F-1 ATPASE; ESCHERICHIA-COLI; SINGLE-MOLECULE; ALPHA-SUBUNIT; CRYSTAL-STRUCTURE; ROTATION; MECHANISM; SITE; F1-ATPASE	F-1-ATPase (F-1) is an ATP-driven rotary motor wherein the gamma subunit rotates against the surrounding alpha(3)beta(3) stator ring. The 3 catalytic sites of F-1 reside on the interface of the alpha and beta subunits of the alpha(3)beta(3) ring. While the catalytic residues predominantly reside on the beta subunit, the alpha subunit has 1 catalytically critical arginine, termed the arginine finger, with stereogeometric similarities with the arginine finger of G-protein-activating proteins. However, the principal role of the arginine finger of F1 remains controversial. We studied the role of the arginine finger by analyzing the rotation of a mutant F-1 with a lysine substitution of the arginine finger. The mutant showed a 350-fold longer catalytic pause than the wild-type; this pause was further lengthened by the slowly hydrolyzed ATP analog ATP gamma S. On the other hand, the mutant F1 showed highly unidirectional rotation with a coupling ratio of 3 ATPs/turn, the same as wild-type, suggesting that cooperative torque generation by the 3 beta subunits was not impaired. The hybrid F-1 carrying a single copy of the alpha mutant revealed that the reaction step slowed by the mutation occurs at + 200 degrees from the binding angle of the mutant subunit. Thus, the principal role of the arginine finger is not to mediate cooperativity among the catalytic sites, but to enhance the rate of the ATP cleavage by stabilizing the transition state of ATP hydrolysis. Lysine substitution also caused frequent pauses because of severe ADP inhibition, and a slight decrease in ATP binding rate.	[Iino, Ryota; Noji, Hiroyuki] Univ Tokyo, Dept Appl Chem, Sch Engn, Tokyo 1138656, Japan; [Komoriya, Yoshihito; Imamura, Hiromi; Okuno, Daichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Ariga, Takayuki] Univ Tokyo, Dept Appl Phys, Sch Engn, Tokyo 1138656, Japan	University of Tokyo; Osaka University; University of Tokyo	Noji, H (corresponding author), Univ Tokyo, Dept Appl Chem, Sch Engn, Tokyo 1138656, Japan.	hnoji@appchem.t.u-tokyo.ac.jp	Ariga, Takayuki/ACM-3092-2022; Imamura, Hiromi/AAD-5109-2019; Iino, Ryota/B-7746-2011	Imamura, Hiromi/0000-0002-1896-0443; Iino, Ryota/0000-0003-0110-5704; Ariga, Takayuki/0000-0002-2045-5761	MEXT [18074005]; Ministry of Education, Culture, Sports, Science, and Technology, Japan	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research from MEXT (Project ID 18074005) (to H. N.), and by special education and research expenses grant (to H. N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ahmad Z, 2005, J BIOENERG BIOMEMBR, V37, P437, DOI 10.1007/s10863-005-9486-8; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Digel JG, 1996, J BIOL CHEM, V271, P19976, DOI 10.1074/jbc.271.33.19976; Dittrich M, 2003, BIOPHYS J, V85, P2253, DOI 10.1016/S0006-3495(03)74650-5; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Enoki S, 2009, J BIOL CHEM, V284, P23169, DOI 10.1074/jbc.M109.026401; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Iko Y, 2009, FEBS LETT, V583, P3187, DOI 10.1016/j.febslet.2009.08.042; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kinosita K Jr, 2000, Essays Biochem, V35, P3; Le NP, 2000, BIOCHEMISTRY-US, V39, P2778, DOI 10.1021/bi992530h; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shimo-Kon R, 2010, BIOPHYS J, V98, P1227, DOI 10.1016/j.bpj.2009.11.050; Sielaff H, 2008, BIOPHYS J, V95, P4979, DOI 10.1529/biophysj.108.139782; SOGA S, 1989, ARCH BIOCHEM BIOPHYS, V268, P643, DOI 10.1016/0003-9861(89)90332-9; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Toyabe S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.198103; TURINA P, 1993, J BIOL CHEM, V268, P6978; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Watanabe R, 2012, NAT CHEM BIOL, V8, P86, DOI 10.1038/nchembio.715; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Weber J, 2010, NAT CHEM BIOL, V6, P794, DOI 10.1038/nchembio.458; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	44	28	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15134	15142		10.1074/jbc.M111.328153	http://dx.doi.org/10.1074/jbc.M111.328153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403407	Green Published, hybrid			2022-12-25	WOS:000304003200074
J	Minashima, T; Small, W; Moss, SE; Kirsch, T				Minashima, Takeshi; Small, William; Moss, Stephen E.; Kirsch, Thorsten			Intracellular Modulation of Signaling Pathways by Annexin A6 Regulates Terminal Differentiation of Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GROWTH-PLATE CARTILAGE; HYPERTROPHIC CHONDROCYTES; X COLLAGEN; ALKALINE-PHOSPHATASE; SKELETAL DEVELOPMENT; MATRIX VESICLES; MINERALIZATION; EXPRESSION; APOPTOSIS	Annexin A6 (AnxA6) is highly expressed in hypertrophic and terminally differentiated growth plate chondrocytes. Rib chondrocytes isolated from newborn AnxA6-/- mice showed delayed terminal differentiation as indicated by reduced terminal differentiation markers, including alkaline phosphatase, matrix metalloproteases-13, osteocalcin, and runx2, and reduced mineralization. Lack of AnxA6 in chondrocytes led to a decreased intracellular Ca2+ concentration and protein kinase C alpha (PKC alpha) activity, ultimately resulting in reduced extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK) activities. The 45 C-terminal amino acids of AnxA6 (AnxA6(1-627)) were responsible for the direct binding of AnxA6 to PKC alpha. Consequently, transfection of AnxA6-/- chondrocytes with full-length AnxA6 rescued the reduced expression of terminal differentiation markers, whereas transfection of AnxA6-/- chondrocytes with AnxA6(1-627) did not or only partially rescued the decreased mRNA levels of terminal differentiation markers. In addition, lack of AnxA6 in matrix vesicles, which initiate the mineralization process in growth plate cartilage, resulted in reduced alkaline phosphatase activity and Ca2+ and inorganic phosphate (Pi) content and the inability to form hydroxyapatite-like crystals in vitro. Histological analysis of femoral, tibial, and rib growth plates from newborn mice revealed that the hypertrophic zone of growth plates from newborn AnxA6-/- mice was reduced in size. In addition, reduced mineralization was evident in the hypertrophic zone of AnxA6-/- growth plate cartilage, although apoptosis was not altered compared with wild type growth plates. In conclusion, AnxA6 via its stimulatory actions on PKC alpha and its role in mediating Ca2+ flux across membranes regulates terminal differentiation and mineralization events of chondrocytes.	[Minashima, Takeshi; Small, William; Kirsch, Thorsten] NYU, Hosp Joint Dis, Dept Orthopaed Surg, Musculoskeletal Res Ctr, New York, NY 10003 USA; [Moss, Stephen E.] UCL, UCL Inst Ophthalmol, Div Cell Biol, London EC1V 9EL, England	New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; University of London; University College London	Kirsch, T (corresponding author), NYU, Hosp Joint Dis, Dept Orthopaed Surg, Musculoskeletal Res Ctr, Suite 1500,301 E 17th St, New York, NY 10003 USA.	thorsten.kirsch@nyumc.org	Kirsch, Thorsten/GQP-1157-2022		National Institutes of Health from the NIAMS [R01AR046245, R01AR049074]; United Kingdom Medical Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046245, R01AR049074] Funding Source: NIH RePORTER	National Institutes of Health from the NIAMS; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR046245 and R01AR049074 from the NIAMS (to T. K.). This work was also supported by the United Kingdom Medical Research Council (to S. E. M.).	Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Belluoccio D, 2010, J BONE MINER RES, V25, P141, DOI 10.1359/jbmr.090710; Bist P, 2011, ONCOGENE, V30, P3174, DOI 10.1038/onc.2011.28; Boyan BD, 2004, STEROIDS, V69, P591, DOI 10.1016/j.steroids.2004.05.008; Brachvogel B, 2003, MOL CELL BIOL, V23, P2907, DOI 10.1128/MCB.23.8.2907-2913.2003; Cardo-Vila M, 2003, MOL CELL, V11, P1151, DOI 10.1016/S1097-2765(03)00138-2; Caunt CJ, 2012, BIOCHEM SOC T, V40, P224, DOI 10.1042/BST20110662; Dubois T, 1996, BBA-MOL CELL RES, V1313, P290, DOI 10.1016/0167-4889(96)00102-4; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Geisow MJ, 1988, MOL MECH SECRETION, P598; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; KIRSCH T, 1992, DIFFERENTIATION, V52, P89, DOI 10.1111/j.1432-0436.1992.tb00503.x; KIRSCH T, 1994, J BIOL CHEM, V269, P11462; Kirsch T, 2000, OSTEOARTHR CARTILAGE, V8, P294, DOI 10.1053/joca.1999.0304; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; LEBOY PS, 1989, J BIOL CHEM, V264, P17281; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Miedlich SU, 2010, J BIOL CHEM, V285, P18270, DOI 10.1074/jbc.M109.098616; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Namdari S, 2008, ARTHRITIS RHEUM, V58, P3520, DOI 10.1002/art.23999; Pfander D, 2001, AM J PATHOL, V159, P1777, DOI 10.1016/S0002-9440(10)63024-6; Rentero C, 2006, CELL SIGNAL, V18, P1006, DOI 10.1016/j.cellsig.2005.08.008; SCHLAEPFER DD, 1992, BIOCHEMISTRY-US, V31, P1886, DOI 10.1021/bi00121a043; Schmitz-Peiffer C, 1998, BIOCHEM J, V330, P675, DOI 10.1042/bj3300675; Shimo T, 2005, J BONE MINER RES, V20, P867, DOI 10.1359/JBMR.041235; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Wang W, 2003, J BIOL CHEM, V278, P3762, DOI 10.1074/jbc.M208868200; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Wang W, 2006, J BIOL CHEM, V281, P30848, DOI 10.1074/jbc.M605937200; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Young SW, 1996, FEBS LETT, V384, P181, DOI 10.1016/0014-5793(96)00287-6; Zhen XC, 2001, J BIOL CHEM, V276, P4879, DOI 10.1074/jbc.M004990200	42	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14803	14815		10.1074/jbc.M111.297861	http://dx.doi.org/10.1074/jbc.M111.297861			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399299	hybrid, Green Published			2022-12-25	WOS:000304003200045
J	Fang, Q; Huang, SQ				Fang, Qiang; Huang, Shuang-Quan			Relative Stability of Core Groups in Pollination Networks in a Biodiversity Hotspot over Four Years	PLOS ONE			English	Article							SPECIALIZATION; PATTERNS; NESTEDNESS; SELECTION; ECOLOGY; SYSTEMS; SIZE	Plants and their pollinators form pollination networks integral to the evolution and persistence of species in communities. Previous studies suggest that pollination network structure remains nested while network composition is highly dynamic. However, little is known about temporal variation in the structure and function of plant-pollinator networks, especially in species-rich communities where the strength of pollinator competition is predicted to be high. Here we quantify temporal variation of pollination networks over four consecutive years in an alpine meadow in the Hengduan Mountains biodiversity hotspot in China. We found that ranked positions and idiosyncratic temperatures of both plants and pollinators were more conservative between consecutive years than in non-consecutive years. Although network compositions exhibited high turnover, generalized core groups - decomposed by a k-core algorithm - were much more stable than peripheral groups. Given the high rate of turnover observed, we suggest that identical plants and pollinators that persist for at least two successive years sustain pollination services at the community level. Our data do not support theoretical predictions of a high proportion of specialized links within species-rich communities. Plants were relatively specialized, exhibiting less variability in pollinator composition at pollinator functional group level than at the species level. Both specialized and generalized plants experienced narrow variation in functional pollinator groups. The dynamic nature of pollination networks in the alpine meadow demonstrates the potential for networks to mitigate the effects of fluctuations in species composition in a high biodiversity area.	[Fang, Qiang; Huang, Shuang-Quan] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Fang, Q (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	sqhuang@whu.edu.cn		Fang, Qiang/0000-0001-5250-6992	National Science Foundation of China [31030016, 30825005]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grants from National Science Foundation of China (31030016 and 30825005) to SQH supported this work (http://www.nsfc.gov.cn/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Albrecht M, 2010, OIKOS, V119, P1610, DOI 10.1111/j.1600-0706.2010.18376.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Armbruster WS, 2000, NORSKE VIDENSKAPSAKA, V39, P139; ARROYO MTK, 1982, AM J BOT, V69, P82, DOI 10.2307/2442833; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Basilio AM, 2006, AUSTRAL ECOL, V31, P975, DOI 10.1111/j.1442-9993.2006.01666.x; Batagelj V, 2002, GEN CORES; Borgatti SP, 2002, UCINET 6 WINDOWS SOF; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Burkle L, 2009, OIKOS, V118, P1816, DOI 10.1111/j.1600-0706.2009.17740.x; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Dalsgaard B, 2008, OIKOS, V117, P789, DOI 10.1111/j.0030-1299.2008.16537.x; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Elberling H, 1999, ECOGRAPHY, V22, P314, DOI 10.1111/j.1600-0587.1999.tb00507.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Frund J, 2010, OIKOS, V119, P1581, DOI 10.1111/j.1600-0706.2010.18450.x; Gong YB, 2011, OECOLOGIA, V166, P671, DOI 10.1007/s00442-011-1910-7; Gong YB, 2009, P ROY SOC B-BIOL SCI, V276, P4013, DOI 10.1098/rspb.2009.1254; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; HERRERA CM, 1988, BIOL J LINN SOC, V35, P95, DOI 10.1111/j.1095-8312.1988.tb00461.x; Huang SQ, 2007, INT J PLANT SCI, V168, P325, DOI 10.1086/510209; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P173; Mayer C., 2011, Journal of Pollination Ecology, V3, P8; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026455; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; PARRISH JAD, 1979, ECOLOGY, V60, P597, DOI 10.2307/1936080; Petanidou T., 1993, Biodiversity Letters, V1, P9, DOI 10.2307/2999643; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Petanidou T, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P220; PETTERSSON MW, 1991, J ECOL, V79, P591, DOI 10.2307/2260655; Price MV, 2005, ECOLOGY, V86, P2106, DOI 10.1890/04-1274; SCHEMSKE DW, 1989, EVOLUTION, V43, P461, DOI 10.1111/j.1558-5646.1989.tb04240.x; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Vazquez DP, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P200; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Williams NM, 2001, CONSERV ECOL, V5; Wuchty S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-24	49	38	44	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32663	10.1371/journal.pone.0032663	http://dx.doi.org/10.1371/journal.pone.0032663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412902	gold, Green Submitted, Green Published			2022-12-25	WOS:000303062000014
J	Saito, Y; Kojima, T; Takahashi, N				Saito, Yohei; Kojima, Takuya; Takahashi, Naoki			Mab21l2 Is Essential for Embryonic Heart and Liver Development	PLOS ONE			English	Article							N-MYC GENE; CARDIAC DEVELOPMENT; VENTRAL MORPHOGENESIS; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; MOUSE EMBRYOGENESIS; NEUREGULIN RECEPTOR; NEURAL DEVELOPMENT; MAMMALIAN HEART; TUBE FORMATION	During mouse embryogenesis, proper formation of the heart and liver is especially important and is crucial for embryonic viability. In this study, we showed that Mab21l2 was expressed in the trabecular and compact myocardium, and that deletion of Mab21l2 resulted in a reduction of the trabecular myocardium and thinning of the compact myocardium. Mab21l2-deficient embryonic hearts had decreased expression of genes that regulate cell proliferation and apoptosis of cardiomyocytes. These results show that Mab21l2 functions during heart development by regulating the expression of such genes. Mab21l2 was also expressed in the septum transversum mesenchyme (STM). Epicardial progenitor cells are localized to the anterior surface of the STM (proepicardium), and proepicardial cells migrate onto the surface of the heart and form the epicardium, which plays an important role in heart development. The rest of the STM is essential for the growth and survival of hepatoblasts, which are bipotential progenitors for hepatocytes and cholangiocytes. Proepicardial cells in Mab21l2-deficient embryos had defects in cell proliferation, which led to a small proepicardium, in which alpha 4 integrin expression, which is essential for the migration of proepicardial cells, was down-regulated, suggesting that defects occurred in its migration. In Mab21l2-deficient embryos, epicardial formation was defective, suggesting that Mab21l2 plays important roles in epicardial formation through the regulation of the cell proliferation of proepicardial cells and the migratory process of proepicardial cells. Mab21l2-deficient embryos also exhibited hypoplasia of the STM surrounding hepatoblasts and decreased hepatoblast proliferation with a resultant loss of defective morphogenesis of the liver. These findings demonstrate that Mab21l2 plays a crucial role in both heart and liver development through STM formation.	[Saito, Yohei; Kojima, Takuya; Takahashi, Naoki] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Saito, Y (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	antkhs@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; JSPS; Grants-in-Aid for Scientific Research [10J04278] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology to N.T. and a Predoctoral Fellowship for Y.S. from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD SE, 1991, DEVELOPMENT, V113, P515; Baldwin HS, 1996, CARDIOVASC RES, V31, pE34; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Combs MD, 2011, DEVELOPMENT, V138, P1747, DOI 10.1242/dev.060996; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fishman MC, 1997, DEVELOPMENT, V124, P2099; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; Ho SH, 2001, DEV DYNAM, V221, P422, DOI 10.1002/dvdy.1161; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kochilas LK, 1999, PEDIATR RES, V45, P635, DOI 10.1203/00006450-199905010-00004; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; KWEE L, 1995, DEVELOPMENT, V121, P489; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2002, CANCER RES, V62, P301; Lau GTC, 2001, BIOCHEM BIOPH RES CO, V280, P1378, DOI 10.1006/bbrc.2001.4290; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lough J, 2000, DEV DYNAM, V217, P327, DOI 10.1002/(SICI)1097-0177(200004)217:4<327::AID-DVDY1>3.3.CO;2-B; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Mariani M, 1998, MECH DEVELOP, V79, P131, DOI 10.1016/S0925-4773(98)00180-4; Mariani M, 1999, HUM MOL GENET, V8, P2397, DOI 10.1093/hmg/8.13.2397; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; MOENS CB, 1993, DEVELOPMENT, V119, P485; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Moore AW, 1999, DEVELOPMENT, V126, P1845; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; RUSTGI AK, 1991, NATURE, V352, P541, DOI 10.1038/352541a0; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SAWAI S, 1993, DEVELOPMENT, V117, P1445; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Sengbusch JK, 2002, J CELL BIOL, V157, P873, DOI 10.1083/jcb.200203075; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Stuckmann I, 2003, DEV BIOL, V255, P334, DOI 10.1016/S0012-1606(02)00078-7; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Wartiovaara K, 2002, J NEUROSCI, V22, P815, DOI 10.1523/JNEUROSCI.22-03-00815.2002; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wolf LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004159; Wong RLY, 1999, MECH DEVELOP, V87, P185, DOI 10.1016/S0925-4773(99)00127-6; Wong YM, 2002, MECH DEVELOP, V113, P149, DOI 10.1016/S0925-4773(02)00012-6; Yamada R, 2004, DEV BIOL, V274, P295, DOI 10.1016/j.ydbio.2004.07.016; Yamada R, 2003, DEVELOPMENT, V130, P1759, DOI 10.1242/dev.00399; YANG JT, 1995, DEVELOPMENT, V121, P549; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	63	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32991	10.1371/journal.pone.0032991	http://dx.doi.org/10.1371/journal.pone.0032991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412967	gold, Green Submitted, Green Published			2022-12-25	WOS:000303062000025
J	Tiengwe, C; Marcello, L; Farr, H; Gadelha, C; Burchmore, R; Barry, JD; Bell, SD; McCulloch, R				Tiengwe, Calvin; Marcello, Lucio; Farr, Helen; Gadelha, Catarina; Burchmore, Richard; Barry, J. David; Bell, Stephen D.; McCulloch, Richard			Identification of ORC1/CDC6-Interacting Factors in Trypanosoma brucei Reveals Critical Features of Origin Recognition Complex Architecture	PLOS ONE			English	Article							DNA-REPLICATION; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; PLASMODIUM-FALCIPARUM; GENOME SEQUENCE; RNA INTERFERENCE; GENE-EXPRESSION; ATP-HYDROLYSIS; MCM COMPLEX	DNA Replication initiates by formation of a pre-replication complex on sequences termed origins. In eukaryotes, the prereplication complex is composed of the Origin Recognition Complex (ORC), Cdc6 and the MCM replicative helicase in conjunction with Cdt1. Eukaryotic ORC is considered to be composed of six subunits, named Orc1-6, and monomeric Cdc6 is closely related in sequence to Orc1. However, ORC has been little explored in protists, and only a single ORC protein, related to both Orc1 and Cdc6, has been shown to act in DNA replication in Trypanosoma brucei. Here we identify three highly diverged putative T. brucei ORC components that interact with ORC1/CDC6 and contribute to cell division. Two of these factors are so diverged that we cannot determine if they are eukaryotic ORC subunit orthologues, or are parasite-specific replication factors. The other we show to be a highly diverged Orc4 orthologue, demonstrating that this is one of the most widely conserved ORC subunits in protists and revealing it to be a key element of eukaryotic ORC architecture. Additionally, we have examined interactions amongst the T. brucei MCM subunits and show that this has the conventional eukaryotic heterohexameric structure, suggesting that divergence in the T. brucei replication machinery is limited to the earliest steps in origin licensing.	[Tiengwe, Calvin; Marcello, Lucio; Barry, J. David; McCulloch, Richard] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Farr, Helen; Gadelha, Catarina; Bell, Stephen D.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Burchmore, Richard] Univ Glasgow, Sir Henry Wellcome Funct Genom Facil, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Glasgow; University of Oxford; University of Glasgow	Tiengwe, C (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	richard.mcculloch@glasgow.ac.uk	Tiengwe, Calvin/AAH-6658-2020; Gadelha, Catarina/ABD-5623-2021; Burchmore, Richard/A-1896-2011	Tiengwe, Calvin/0000-0002-3742-6502; Gadelha, Catarina/0000-0001-5016-3682; Burchmore, Richard/0000-0003-1663-9004; MARCELLO, LUCIO/0000-0003-2252-1870; Bell, Stephen/0000-0002-8474-6592	Wellcome Trust [083485]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (http://www.wellcome.ac.uk/), grant number 083485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Brewster AS, 2010, CRIT REV BIOCHEM MOL, V45, P243, DOI 10.3109/10409238.2010.484836; BRUN R, 1979, ACTA TROP, V36, P289; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chen ZQ, 2008, P NATL ACAD SCI USA, V105, P10326, DOI 10.1073/pnas.0803829105; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Clarey MG, 2008, J STRUCT BIOL, V164, P241, DOI 10.1016/j.jsb.2008.08.006; Dang HQ, 2011, J BIOL CHEM, V286, P32424, DOI 10.1074/jbc.M111.240143; Daniels JP, 2010, MICROBIOL MOL BIOL R, V74, P552, DOI 10.1128/MMBR.00024-10; De Felice M, 2003, J BIOL CHEM, V278, P46424, DOI 10.1074/jbc.M306075200; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Dhar SK, 2000, J BIOL CHEM, V275, P34983, DOI 10.1074/jbc.M006069200; Donti TR, 2009, EMBO J; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Gibson DG, 2006, GENES CELLS, V11, P557, DOI 10.1111/j.1365-2443.2006.00967.x; Gill EE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-24; Gupta A, 2008, MOL MICROBIOL, V69, P646, DOI 10.1111/j.1365-2958.2008.06316.x; Gupta A, 2006, FEMS MICROBIOL LETT, V261, P12, DOI 10.1111/j.1574-6968.2006.00324.x; Gupta A, 2009, EUKARYOT CELL, V8, P1341, DOI 10.1128/EC.00170-09; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; HARTWELL LH, 1976, J MOL BIOL, V104, P803, DOI 10.1016/0022-2836(76)90183-2; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Houchens CR, 2008, J BIOL CHEM, V283, P30216, DOI 10.1074/jbc.M802649200; Kasiviswanathan R, 2005, NUCLEIC ACIDS RES, V33, P4940, DOI 10.1093/nar/gki807; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kato H, 2008, CELL CYCLE, V7, P1085; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Kumar D, 2008, BIOCHEM BIOPH RES CO, V375, P74, DOI 10.1016/j.bbrc.2008.07.125; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-60; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Mohammad MM, 2007, EMBO J, V26, P5048, DOI 10.1038/sj.emboj.7601919; Moon KY, 1999, P NATL ACAD SCI USA, V96, P12367, DOI 10.1073/pnas.96.22.12367; Moreno-del Alamo M, 2010, J MOL BIOL, V403, P24, DOI 10.1016/j.jmb.2010.08.022; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Neuwald AF, 1999, GENOME RES, V9, P27; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Ploubidou A, 1999, J CELL SCI, V112, P4641; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Robinson NP, 2007, P NATL ACAD SCI USA, V104, P5806, DOI 10.1073/pnas.0700206104; Robinson NP, 2005, FEBS J, V272, P3757, DOI 10.1111/j.1742-4658.2005.04768.x; Sasaki T, 2007, CURR OPIN CELL BIOL, V19, P337, DOI 10.1016/j.ceb.2007.04.007; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Tada S, 2007, FRONT BIOSCI-LANDMRK, V12, P1629, DOI 10.2741/2175; Takahashi N, 2004, J BIOL CHEM, V279, P8469, DOI 10.1074/jbc.M305531200; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Ueda J, 2005, AM J PHYSIOL-GASTR L, V288, pG842, DOI 10.1152/ajpgi.00463.2004; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wigley DB, 2009, CURR OPIN STRUC BIOL, V19, P72, DOI 10.1016/j.sbi.2008.12.010; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/j.jmb.2004.05.024	77	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32674	10.1371/journal.pone.0032674	http://dx.doi.org/10.1371/journal.pone.0032674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412905	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000303062000015
J	Keller, N; Bhatia, S; Braden, JN; Gildengorin, G; Johnson, J; Yedlin, R; Tseng, T; Knapp, J; Glaser, N; Jossan, P; Teran, S; Rhodes, ET; Noble, JA				Keller, Nancy; Bhatia, Suruchi; Braden, Jeanah N.; Gildengorin, Ginny; Johnson, Jameel; Yedlin, Rachel; Tseng, Teresa; Knapp, Jacquelyn; Glaser, Nicole; Jossan, Paula; Teran, Shawn; Rhodes, Erinn T.; Noble, Janelle A.			Distinguishing Type 2 Diabetes from Type 1 Diabetes in African American and Hispanic American Pediatric Patients	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; YOUTH PREVALENCE; CHILDREN; ADOLESCENTS; OBESITY; ONSET; SEARCH; AGE; PERIOD; RISK	Objective: To test the hypothesis that clinical observations made at patient presentation can distinguish type 2 diabetes (T2D) from type 1 diabetes (T1D) in pediatric patients aged 2 to 18. Subjects and Methods: Medical records of 227 African American and 112 Hispanic American pediatric patients diagnosed as T1D or T2D were examined to compare parameters in the two diseases. Age at presentation, BMI z-score, and gender were the variables used in logistic regression analysis to create models for T2D prediction. Results: The regression-based model created from African American data had a sensitivity of 92% and a specificity of 89%; testing of a replication cohort showed 91% sensitivity and 93% specificity. A model based on the Hispanic American data showed 92% sensitivity and 90% specificity. Similarities between African American and Hispanic American patients include: (1) age at onset for both T1D and T2D decreased from the 1980s to the 2000s; (2) risk of T2D increased markedly with obesity. Racial/ethnic-specific observations included: (1) in African American patients, the proportion of females was significantly higher than that of males for T2D compared to T1D (p<0.0001); (2) in Hispanic Americans, the level of glycated hemoglobin (HbA1c) was significantly higher in T1D than in T2D (p<0.002) at presentation; (3) the strongest contributor to T2D risk was female gender in African Americans, while the strongest contributor to T2D risk was BMI z-score in Hispanic Americans. Conclusions: Distinction of T2D from T1D at patient presentation was possible with good sensitivity and specificity using only three easily-assessed variables: age, gender, and BMI z-score. In African American pediatric diabetes patients, gender was the strongest predictor of T2D, while in Hispanic patients, BMI z-score was the strongest predictor. This suggests that race/ethnic specific models may be useful to optimize distinction of T1D from T2D at presentation.	[Keller, Nancy; Braden, Jeanah N.; Gildengorin, Ginny; Yedlin, Rachel; Knapp, Jacquelyn; Jossan, Paula; Teran, Shawn; Noble, Janelle A.] Childrens Hosp, Oakland, CA 94609 USA; [Keller, Nancy; Braden, Jeanah N.; Gildengorin, Ginny; Yedlin, Rachel; Knapp, Jacquelyn; Jossan, Paula; Teran, Shawn; Noble, Janelle A.] Res Ctr Oakland, Oakland, CA USA; [Bhatia, Suruchi] Sutter Pacific Med Ctr, Div Endocrinol & Diabet, San Francisco, CA USA; [Johnson, Jameel] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Tseng, Teresa] Univ Texas SW, Childrens Med Ctr, Dallas, TX 75390 USA; [Glaser, Nicole] UC Davis, Med Ctr, Dept Pediat, Sacramento, CA USA; [Rhodes, Erinn T.] Childrens Hosp Boston, Div Endocrinol, Boston, MA USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; California Pacific Medical Center; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Davis; Harvard University; Boston Children's Hospital	Keller, N (corresponding author), Childrens Hosp, Oakland, CA 94609 USA.	nkeller@chori.org			National Institutes of Health (U.S.) [DK61722, UL1 RR024131]; Centers for Disease Control and Prevention [K01DP000089]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [K01DP000089] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061722, R56DK061722] Funding Source: NIH RePORTER	National Institutes of Health (U.S.)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health (U.S.) grant DK61722 (JAN) with minority supplements to JNB and JJ. This work was also supported in part by National Institutes of Health (U.S.) CTSA grant UL1 RR024131 (GG) and Centers for Disease Control and Prevention grant K01DP000089 (ETR). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2009, ARCH PEDIAT ADOL MED, V163, P344, DOI 10.1001/archpediatrics.2009.18; Arslanian S, 2002, HORM RES, V57, P19, DOI 10.1159/000053308; Bruno G, 2001, DIABETOLOGIA, V44, P22, DOI 10.1007/s001250051575; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Feltbower RG, 2003, DIABETIC MED, V20, P437, DOI 10.1046/j.1464-5491.2003.00960.x; Gill-Carey O, 2007, PEDIATR DIABETES, V8, P42, DOI 10.1111/j.1399-5448.2007.00331.x; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Hannon TS, 2008, DIABETES CARE, V31, P1445, DOI 10.2337/dc08-0116; Jones KL, 2008, PEDIATRICS, V121, P361, DOI 10.1542/peds.2007-1234; Karvonen M, 1999, DIABETES CARE, V22, P1066, DOI 10.2337/diacare.22.7.1066; Kaufman FR, 2007, PEDIATR DIABETES, V8, P4, DOI 10.1111/j.1399-5448.2007.00327.x; Lawrence JM, 2009, DIABETES CARE, V32, pS123, DOI 10.2337/dc09-S204; Lipton R, 2002, DIABETES-METAB RES, V18, P135, DOI 10.1002/dmrr.265; Lipton RB, 2005, PEDIATRICS, V115, pE553, DOI 10.1542/peds.2004-1448; Liu LL, 2009, DIABETES CARE, V32, pS133, DOI 10.2337/dc09-S205; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; Mayer-Davis EJ, 2009, DIABETES CARE, V32, pS112, DOI 10.2337/dc09-S203; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; PinhasHamiel O, 1997, DIABETES CARE, V20, P484, DOI 10.2337/diacare.20.4.484; Saravanabhavan RC, 1999, J NATL MED ASSOC, V91, P265; Trevino RP, 2008, J AM DIET ASSOC, V108, P1846, DOI 10.1016/j.jada.2008.08.009; Walker SE, 2010, NUTR METAB CARDIOVAS; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Zdravkovic V, 2004, DIABETIC MED, V21, P1144, DOI 10.1111/j.1464-5491.2004.01297.x	24	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32773	10.1371/journal.pone.0032773	http://dx.doi.org/10.1371/journal.pone.0032773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412923	Green Published, gold			2022-12-25	WOS:000303060800050
J	van den Worm, SHE; Eriksson, KK; Zevenhoven, JC; Weber, F; Zust, R; Kuri, T; Dijkman, R; Chang, GH; Siddell, SG; Snijder, EJ; Thiel, V; Davidson, AD				van den Worm, Sjoerd H. E.; Eriksson, Klara Kristin; Zevenhoven, Jessika C.; Weber, Friedemann; Zuest, Roland; Kuri, Thomas; Dijkman, Ronald; Chang, Guohui; Siddell, Stuart G.; Snijder, Eric J.; Thiel, Volker; Davidson, Andrew D.			Reverse Genetics of SARS-Related Coronavirus Using Vaccinia Virus-Based Recombination	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; IN-VITRO; CELL-LINES; GENOME; RNA; REPLICATION; INTERFERON; RESPONSES; CLONING; MANIPULATION	Severe acute respiratory syndrome (SARS) is a zoonotic disease caused by SARS-related coronavirus (SARS-CoV) that emerged in 2002 to become a global health concern. Although the original outbreak was controlled by classical public health measures, there is a real risk that another SARS-CoV could re-emerge from its natural reservoir, either in its original form or as a more virulent or pathogenic strain; in which case, the virus would be difficult to control in the absence of any effective antiviral drugs or vaccines. Using the well-studied SARS-CoV isolate HKU-39849, we developed a vaccinia virus-based SARS-CoV reverse genetic system that is both robust and biosafe. The SARS-CoV genome was cloned in separate vaccinia virus vectors, (vSARS-CoV-5prime and vSARS-CoV-3prime) as two cDNAs that were subsequently ligated to create a genome-length SARS-CoV cDNA template for in vitro transcription of SARS-CoV infectious RNA transcripts. Transfection of the RNA transcripts into permissive cells led to the recovery of infectious virus (recSARS-CoV). Characterization of the plaques produced by recSARS-CoV showed that they were similar in size to the parental SARS-CoV isolate HKU-39849 but smaller than the SARS-CoV isolate Frankfurt-1. Comparative analysis of replication kinetics showed that the kinetics of recSARS-CoV replication are similar to those of SARS-CoV Frankfurt-1, although the titers of virus released into the culture supernatant are approximately 10-fold less. The reverse genetic system was finally used to generate a recSARS-CoV reporter virus expressing Renilla luciferase in order to facilitate the analysis of SARS-CoV gene expression in human dendritic cells (hDCs). In parallel, a Renilla luciferase gene was also inserted into the genome of human coronavirus 229E (HCoV-229E). Using this approach, we demonstrate that, in contrast to HCoV-229E, SARS-CoV is not able to mediate efficient heterologous gene expression in hDCs.	[van den Worm, Sjoerd H. E.; Zevenhoven, Jessika C.; Snijder, Eric J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Mol Virol Lab, Leiden, Netherlands; [Eriksson, Klara Kristin; Zuest, Roland; Dijkman, Ronald; Thiel, Volker] Kantonal Hosp St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Weber, Friedemann; Kuri, Thomas] Univ Freiburg, Dept Virol, D-79106 Freiburg, Germany; [Chang, Guohui; Siddell, Stuart G.; Davidson, Andrew D.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Thiel, Volker] Univ Zurich, Vetsuisse Fac, Zurich, Switzerland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Kantonsspital St. Gallen; University of Freiburg; University of Bristol; University of Zurich	van den Worm, SHE (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Mol Virol Lab, Leiden, Netherlands.	andrew.davidson@bristol.ac.uk	Weber, Friedemann/AAB-3425-2019; Thiel, Volker/AAI-2391-2019; Snijder, Eric J./E-6073-2018	Snijder, Eric J./0000-0003-3297-2309; Weber, Friedemann/0000-0001-9737-337X; Siddell, Stuart/0000-0002-8702-7868; Thiel, Volker/0000-0002-5783-0887; Dijkman, Ronald/0000-0003-0320-2743	Euro-Asian SARS-DTV Network from the European Commission on Specific Research and Technological Development; Swiss National Science Foundation; Bundesministerium fur Bildung und Forschung, Germany [01 KI 0705]	Euro-Asian SARS-DTV Network from the European Commission on Specific Research and Technological Development; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bundesministerium fur Bildung und Forschung, Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by the Euro-Asian SARS-DTV Network (SP22-CT-2004-511064) from the European Commission on Specific Research and Technological Development Program Integrating and Strengthening the European Research Area, the Swiss National Science Foundation (VT) and the Bundesministerium fur Bildung und Forschung, Germany (grant 01 KI 0705; FW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516; Almazan Fernando, 2008, V454, P275, DOI 10.1007/978-1-59745-181-9_20; Baric RS, 2005, CURR TOP MICROBIOL, V287, P229, DOI 10.1007/3-540-26765-4_8; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Cervantes-Barragan L, 2010, MBIO, V1, DOI 10.1128/mBio.00171-10; Chang Guo-hui, 2010, Virologica Sinica, V25, P361, DOI 10.1007/s12250-010-3124-2; Coley SE, 2005, J VIROL, V79, P3097, DOI 10.1128/JVI.79.5.3097-3106.2005; de Haan Cornelis A. M., 2008, V454, P229, DOI 10.1007/978-1-59745-181-9_17; Donaldson Eric F., 2008, V454, P293, DOI 10.1007/978-1-59745-181-9_21; Eriksson Klara Kristin, 2008, V454, P237, DOI 10.1007/978-1-59745-181-9_18; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001; Hertzig T, 2004, J GEN VIROL, V85, P1717, DOI 10.1099/vir.0.80044-0; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Law HKW, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-35; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; MERCHLINSKY M, 1992, VIROLOGY, V190, P522, DOI 10.1016/0042-6822(92)91246-Q; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Pfefferle S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-131; Roberts A, 2008, VIRUS RES, V133, P20, DOI 10.1016/j.virusres.2007.03.025; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Sperry SM, 2005, J VIROL, V79, P3391, DOI 10.1128/JVI.79.6.3391-3400.2005; Spiegel M, 2006, J GEN VIROL, V87, P1953, DOI 10.1099/vir.0.81624-0; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Thiel V, 2003, J VIROL, V77, P9790, DOI 10.1128/JVI.77.18.9790-9798.2003; Thiel V, 2001, J GEN VIROL, V82, P1273, DOI 10.1099/0022-1317-82-6-1273; Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001; van der Hoek L, 2007, ANTIVIR THER, V12, P651; van der Meer Y, 1998, J VIROL, V72, P6689, DOI 10.1128/JVI.72.8.6689-6698.1998; van Marle G, 1999, J VIROL, V73, P5274, DOI 10.1128/JVI.73.7.5274-5281.1999; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WEISSMAN B, 1980, CYTOGENET CELL GENET, V28, P227, DOI 10.1159/000131536; Yip CW, 2009, INFECT GENET EVOL, V9, P1185, DOI 10.1016/j.meegid.2009.09.015; Yount B, 2000, J VIROL, V74, P10600, DOI 10.1128/JVI.74.22.10600-10611.2000; Zeng FY, 2003, EXP BIOL MED, V228, P866, DOI 10.1177/15353702-0322807-13; Zhong NS, 2004, PHILOS T R SOC B, V359, P1115, DOI 10.1098/rstb.2004.1491	39	42	44	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32857	10.1371/journal.pone.0032857	http://dx.doi.org/10.1371/journal.pone.0032857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412934	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800055
J	von Rohr, CR; Koski, SE; Burkart, JM; Caws, C; Fraser, ON; Ziltener, A; van Schaik, CP				von Rohr, Claudia Rudolf; Koski, Sonja E.; Burkart, Judith M.; Caws, Clare; Fraser, Orlaith N.; Ziltener, Angela; van Schaik, Carel P.			Impartial Third-Party Interventions in Captive Chimpanzees: A Reflection of Community Concern	PLOS ONE			English	Article							MOUNTAIN GORILLAS; DOMINANCE; BEHAVIOR; EVOLUTION; CONFLICTS; PRIMATES; STRESS; CONSOLATION; COMPETITION; INTRAGROUP	Because conflicts among social group members are inevitable, their management is crucial for group stability. The rarest and most interesting form of conflict management is policing, i.e., impartial interventions by bystanders, which is of considerable interest due to its potentially moral nature. Here, we provide descriptive and quantitative data on policing in captive chimpanzees. First, we report on a high rate of policing in one captive group characterized by recently introduced females and a rank reversal between two males. We explored the influence of various factors on the occurrence of policing. The results show that only the alpha and beta males acted as arbitrators using manifold tactics to control conflicts, and that their interventions strongly depended on conflict complexity. Secondly, we compared the policing patterns in three other captive chimpanzee groups. We found that although rare, policing was more prevalent at times of increased social instability, both high-ranking males and females performed policing, and conflicts of all sex-dyad combinations were policed. These results suggest that the primary function of policing is to increase group stability. It may thus reflect prosocial behaviour based upon "community concern." However, policing remains a rare behaviour and more data are needed to test the generality of this hypothesis.	[von Rohr, Claudia Rudolf; Koski, Sonja E.; Burkart, Judith M.; Ziltener, Angela; van Schaik, Carel P.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [von Rohr, Claudia Rudolf] Univ Zurich, Univ Res Prior Program Eth, Zurich, Switzerland; [Caws, Clare] John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Fraser, Orlaith N.] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Zurich; University of Zurich; Liverpool John Moores University; University of Vienna	von Rohr, CR (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.	claudiarvr@aim.uzh.ch	Burkart, Judith M./P-6357-2014	Burkart, Judith M./0000-0002-6229-525X	University of Zurich; A. H. Schultz-Foundation of the Anthropological Institute and Museum at the University of Zurich; Liverpool John Moore University in UK; Chester Zoo in UK; Lucie Burgers Foundation in Netherlands	University of Zurich; A. H. Schultz-Foundation of the Anthropological Institute and Museum at the University of Zurich; Liverpool John Moore University in UK; Chester Zoo in UK; Lucie Burgers Foundation in Netherlands	This study was funded by the University Priority Research Program in Ethics at the University of Zurich and the A. H. Schultz-Foundation of the Anthropological Institute and Museum at the University of Zurich as well as the Liverpool John Moore University and the Chester Zoo, both in the UK. Furthermore, the authors thank the Lucie Burgers Foundation in the Netherlands for funding data collection in Arnhem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; Alexander R. D., 1979, DARWINISM HUMAN AFFA; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Aureli F., 2000, NATURAL CONFLICT RES; Bates D.M., 2010, LME4 MIXED EFFECTS M; Boehm Christopher, 1994, P211; Boehm Christopher, 1992, P137; Boesch C, 2000, CHIMPANZEES TAI FORE; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Castles DL, 1998, ETHOLOGY, V104, P148; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Cirulli F, 2009, NEUROSCI BIOBEHAV R, V33, P573, DOI 10.1016/j.neubiorev.2008.09.001; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; de Waal F., 1996, GOOD NATURED ORIGINS; de Waal F.B.M., 1989, Special Publication of the British Ecological Society, P243; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; de Waal FBM, 2010, PHILOS T R SOC B, V365, P2711, DOI 10.1098/rstb.2010.0119; DEWAAL F, 1982, CHIMPANZEE POLITICS; DEWAAL FBM, 1984, ETHOL SOCIOBIOL, V5, P239, DOI 10.1016/0162-3095(84)90004-9; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, AM NAT, V165, pE126, DOI 10.1086/429277; Frank SA, 2003, EVOLUTION, V57, P693; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Frank SA, 1996, ANIM BEHAV, V52, P1163, DOI 10.1006/anbe.1996.0263; Fraser ON, 2008, ETHOLOGY, V114, P834, DOI 10.1111/j.1439-0310.2008.01527.x; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser Orlaith N, 2009, Commun Integr Biol, V2, P285; Gilby IC, 2008, ANIM BEHAV, V75, P351, DOI 10.1016/j.anbehav.2007.06.008; Goodall J., 1986, CHIMPANZEES GOMBE PA; Jaeggi AV, 2010, PHILOS T R SOC B, V365, P2723, DOI 10.1098/rstb.2010.0118; Jennings DJ, 2011, ANIM BEHAV, V81, P1217, DOI 10.1016/j.anbehav.2011.03.007; Jennings DJ, 2009, ANIM BEHAV, V77, P343, DOI 10.1016/j.anbehav.2008.10.006; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KAPLAN JR, 1978, AM J PHYS ANTHROPOL, V49, P241, DOI 10.1002/ajpa.1330490212; Killen M, 2000, NATURAL CONFLICT RES, P352; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; Kummer H, 1967, SOCIAL COMMUNICATION; Kurland JA, 1977, KIN SELECTION JAPANE; Langergraber KE, 2007, PNAS EARLY EDITION, V104, P1; Lee P.M., 1997, BAYESIAN STAT INTRO; Lindburg D. G., 1971, PRIMATE BEHAV, V2, P2; Marlowe FW, 2009, NO HUM NAT, P417; Massen JJM, 2010, BEHAVIOUR, V147, P1379, DOI 10.1163/000579510X528224; Mitani JC, 2009, ANIM BEHAV, V77, P633, DOI 10.1016/j.anbehav.2008.11.021; Muller MN, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P112, DOI 10.1017/CBO9780511606397.012; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Nishida T., 1989, P68; Nishida Toshisada, 1996, P114, DOI 10.1017/CBO9780511752414.011; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; Petit O, 2000, NATURAL CONFLICT RES, P267; Preuschoft Signe, 2000, P77; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; PUSEY AE, 1990, BEHAVIOUR, V115, P203, DOI 10.1163/156853990X00581; R.D.C. Team, 2010, R LANGUAGE ENV STAT; REN RM, 1991, PRIMATES, V32, P321, DOI 10.1007/BF02382673; Romero T, 2010, J COMP PSYCHOL, V124, P278, DOI 10.1037/a0019144; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sicotte P, 1995, FOLIA PRIMATOL, V65, P14, DOI 10.1159/000156871; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Tajima T, 2010, PRIMATES, V51, P179, DOI 10.1007/s10329-009-0180-z; Townsend SW, 2007, CURR BIOL, V17, pR355, DOI 10.1016/j.cub.2007.03.020; van Hooff JARAM, 1973, SOCIAL COMMUNICATION, P75; Vervaecke H, 2000, PRIMATES, V41, P249, DOI 10.1007/BF02557595; von Rohr CR, 2011, BIOL PHILOS, V26, P1, DOI 10.1007/s10539-010-9240-4; Watts DP, 1997, BEHAVIOUR, V134, P23, DOI 10.1163/156853997X00269; WATTS DP, 1991, ETHOLOGY, V89, P135; Watts DP, 2000, NATURAL CONFLICT RES; Wittig RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013995; YAMAGIWA J, 1987, PRIMATES, V28, P1, DOI 10.1007/BF02382180; ZUCKER EL, 1987, ZOO BIOL, V6, P219, DOI 10.1002/zoo.1430060304	75	60	60	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32494	10.1371/journal.pone.0032494	http://dx.doi.org/10.1371/journal.pone.0032494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412879	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000303060800024
J	Brooks, A; Briet, OJT; Hardy, D; Steketee, R; Smith, TA				Brooks, Alan; Briet, Olivier J. T.; Hardy, Diggory; Steketee, Richard; Smith, Thomas A.			Simulated Impact of RTS,S/AS01 Vaccination Programs in the Context of Changing Malaria Transmission	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SCALE-UP; EPIDEMIOLOGIC MODEL; EXPANDED PROGRAM; MORBIDITY; MORTALITY; IMMUNIZATION; VACCINES; TRIAL	Introduction: The RTS, S/AS01 pre-erythrocytic malaria vaccine is in phase III clinical trials. It is critical to anticipate where and how it should be implemented if trials are successful. Such planning may be complicated by changing levels of malaria transmission. Methods/results: Computer simulations were used to examine RTS, S/AS01 impact, using a vaccine profile based on phase II trial results, and assuming that protection decays only slowly. Settings were simulated in which baseline transmission (in the absence of vaccine) was fixed or varied between 2 and 20 infectious mosquito bites per person per annum (ibpa) over ten years. Four delivery strategies were studied: routine infant immunization (EPI), EPI plus infant catch-up, EPI plus school-based campaigns, and EPI plus mass campaigns. Impacts in changing transmission settings were similar to those in fixed settings. Assuming a persistent effect of vaccination, at 2 ibpa, the vaccine averted approximately 5-7 deaths per 1000 doses of vaccine when delivered via mass campaigns, but the benefit was less at higher transmission levels. EPI, catch-up and school-based strategies averted 2-3 deaths per 1000 doses in settings with 2 ibpa. In settings where transmission was decreasing or increasing, EPI, catch-up and school-based strategies averted approximately 3-4 deaths per 1000 doses. Discussion: Where transmission is changing, it appears to be sufficient to consider simulations of pre-erythrocytic vaccine impact at a range of initial transmission levels. At 2 ibpa, mass campaigns averted the most deaths and reduced transmission, but this requires further study. If delivered via EPI, RTS, S/AS01 could avert approximately 6-11 deaths per 1000 vaccinees in all examined settings, similar to estimates for pneumococcal conjugate vaccine in African infants. These results support RTS, S/AS01 implementation via EPI, for example alongside vector control interventions, providing that the phase III trials provide support for our assumptions about efficacy.	[Brooks, Alan; Briet, Olivier J. T.; Hardy, Diggory; Smith, Thomas A.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Brooks, Alan; Briet, Olivier J. T.; Hardy, Diggory; Smith, Thomas A.] Univ Basel, Basel, Switzerland; [Steketee, Richard] PATH, Seattle, WA USA	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Brooks, A (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	Alan.Brooks@unibas.ch	Smith, Thomas/B-5569-2015; Briët, Olivier/K-1917-2015	Smith, Thomas/0000-0002-3650-9381; Briët, Olivier/0000-0003-1186-2688	PATH Malaria Vaccine Initiative	PATH Malaria Vaccine Initiative	This work was supported by a grant from the PATH Malaria Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Biellik R, 2009, VACCINE, V27, P6203, DOI 10.1016/j.vaccine.2009.08.003; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; da Silva Alfred, 2003, Sante, V13, P215; GAVI Alliance, 2011, GUID COUNTR PROP; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Levine OS, 2010, CURR OPIN INFECT DIS, V23, P236, DOI 10.1097/QCO.0b013e328338c135; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Maire N, 2006, AM J TROP MED HYG, V75, P104, DOI 10.4269/ajtmh.2006.75.104; Maire N, 2011, VALUE HEALTH, V14, P1028, DOI 10.1016/j.jval.2011.06.004; McNeil D. G., 2011, NY TIMES; Milstien J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-182; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Owusu-Agyei S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007302; Penny MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003193; Proietti C, 2011, AM J TROP MED HYG, V84, P830, DOI 10.4269/ajtmh.2011.10-0498; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Roll Back Malaria Partnership, 2010, PROGR IMP SER FOC ZA; Roll Back Malaria Partnership, 2010, PROGR IMP SER FOC SE; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; Smith T, 2001, T ROY SOC TROP MED H, V95, P1, DOI 10.1016/S0035-9203(01)90314-1; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Smith T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001157; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; UNICEF, 2011, STAT WORLD CHILDR; Vekemans J, 2009, VACCINE, V27, pG67, DOI 10.1016/j.vaccine.2009.10.013; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32587	10.1371/journal.pone.0032587	http://dx.doi.org/10.1371/journal.pone.0032587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412892	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000303021100020
J	Tan, MH; Mackay, DS; Cowing, J; Tran, HV; Smith, AJ; Wright, GA; Dev-Borman, A; Henderson, RH; Moradi, P; Russell-Eggitt, I; MacLaren, RE; Robson, AG; Cheetham, ME; Thompson, DA; Webster, AR; Michaelides, M; Ali, RR; Moore, AT				Tan, Mei Hong; Mackay, Donna S.; Cowing, Jill; Hoai Viet Tran; Smith, Alexander J.; Wright, Genevieve A.; Dev-Borman, Arundhati; Henderson, Robert H.; Moradi, Phillip; Russell-Eggitt, Isabelle; MacLaren, Robert E.; Robson, Anthony G.; Cheetham, Michael E.; Thompson, Dorothy A.; Webster, Andrew R.; Michaelides, Michel; Ali, Robin R.; Moore, Anthony T.			Leber Congenital Amaurosis Associated with AIPL1: Challenges in Ascribing Disease Causation, Clinical Findings, and Implications for Gene Therapy	PLOS ONE			English	Article							RETINAL DYSTROPHY; ISCEV STANDARD; MUTATIONS; PROTEIN; RPE65; ROD; ELECTRORETINOGRAPHY; UPDATE; MODEL; NUB1	Leber Congenital Amaurosis (LCA) and Early Childhood Onset Severe Retinal Dystrophy are clinically and genetically heterogeneous retinal disorders characterised by visual impairment and nystagmus from birth or early infancy. We investigated the prevalence of sequence variants in AIPL1 in a large cohort of such patients (n = 392) and probed the likelihood of disease-causation of the identified variants, subsequently undertaking a detailed assessment of the phenotype of patients with disease-causing mutations. Genomic DNA samples were screened for known variants in the AIPL1 gene using a microarray LCA chip, with 153 of these cases then being directly sequenced. The assessment of disease-causation of identified AIPL1 variants included segregation testing, assessing evolutionary conservation and in silico predictions of pathogenicity. The chip identified AIPL1 variants in 12 patients. Sequencing of AIPL1 in 153 patients and 96 controls found a total of 46 variants, with 29 being novel. In silico analysis suggested that only 6 of these variants are likely to be disease-causing, indicating a previously unrecognized high degree of polymorphism. Seven patients were identified with biallelic changes in AIPL1 likely to be disease-causing. In the youngest subject, electroretinography revealed reduced cone photoreceptor function, but rod responses were within normal limits, with no measurable ERG in other patients. An increasing degree and extent of peripheral retinal pigmentation and degree of maculopathy was noted with increasing age in our series. AIPL1 is significantly polymorphic in both controls and patients, thereby complicating the establishment of disease-causation of identified variants. Despite the associated phenotype being characterised by early-onset severe visual loss in our patient series, there was some evidence of a degree of retinal structural and functional preservation, which was most marked in the youngest patient in our cohort. This data suggests that there are patients who have a reasonable window of opportunity for gene therapy in childhood.	[Tan, Mei Hong; Mackay, Donna S.; Cowing, Jill; Hoai Viet Tran; Smith, Alexander J.; Dev-Borman, Arundhati; Henderson, Robert H.; Moradi, Phillip; Robson, Anthony G.; Cheetham, Michael E.; Webster, Andrew R.; Michaelides, Michel; Ali, Robin R.; Moore, Anthony T.] UCL, Inst Ophthalmol, Dept Genet, London, England; [Tan, Mei Hong; Hoai Viet Tran; Wright, Genevieve A.; Dev-Borman, Arundhati; Henderson, Robert H.; Moradi, Phillip; MacLaren, Robert E.; Robson, Anthony G.; Webster, Andrew R.; Michaelides, Michel; Moore, Anthony T.] Moorfields Eye Hosp, London, England; [Russell-Eggitt, Isabelle; Thompson, Dorothy A.] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [MacLaren, Robert E.] Oxford Univ Hosp NHS Trust, London, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust	Tan, MH (corresponding author), UCL, Inst Ophthalmol, Dept Genet, London, England.	michel.michaelides@ucl.ac.uk; tony.moore@ucl.ac.uk	Smith, Alexander/A-5142-2009; Henderson, Robert/AAA-2660-2020	Henderson, Robert/0000-0002-5250-6404; Cheetham, Michael/0000-0001-6429-654X; Ali, Robin/0000-0003-3126-6517; Mackay, Donna/0000-0002-2499-1203; Robson, Anthony/0000-0002-8391-6123; Thompson, Dorothy/0000-0001-5491-3911; MacLaren, Robert/0000-0002-3096-4682	Foundation Fighting Blindness (FFB, Owings Mills, MD, USA); Moorfields Special Trustees; Fight for Sight; European Union (AAVEYE); National Institute for Health Research UK; Medical Research Council; FFB; National Institute for Health Research [NF-SI-0508-10130] Funding Source: researchfish	Foundation Fighting Blindness (FFB, Owings Mills, MD, USA); Moorfields Special Trustees; Fight for Sight; European Union (AAVEYE)(European Commission); National Institute for Health Research UK(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FFB; National Institute for Health Research(National Institute for Health Research (NIHR))	The work was supported by grants from the Foundation Fighting Blindness (FFB, Owings Mills, MD, USA), Moorfields Special Trustees, Fight for Sight, European Union (AAVEYE) and the National Institute for Health Research UK to the Biomedical Research Centre for Ophthalmology based at Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology (London, UK). MHT was supported by a Medical Research Council Clinical Training Fellowship. MM is supported by an FFB Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dhamaraj S, 2004, ARCH OPHTHALMOL-CHIC, V122, P1029, DOI 10.1001/archopht.122.7.1029; Dyer MA, 2004, MOL BRAIN RES, V132, P208, DOI 10.1016/j.molbrainres.2004.10.011; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Flitcroft DI, 2005, BRIT J OPHTHALMOL, V89, P484, DOI 10.1136/bjo.2004.045328; Henderson RH, 2007, INVEST OPHTH VIS SCI, V48, P5684, DOI 10.1167/iovs.07-0207; Henderson RH, 2011, BRIT J OPHTHALMOL, V95, P811, DOI 10.1136/bjo.2010.186882; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; Holder GE, 2007, DOC OPHTHALMOL, V114, P111, DOI 10.1007/s10633-007-9053-1; Jacobson SG, 2011, INVEST OPHTH VIS SCI, V52, P70, DOI 10.1167/iovs.10-6127; Kanaya K, 2004, BIOCHEM BIOPH RES CO, V317, P768, DOI 10.1016/j.bbrc.2004.03.108; Kirschman LT, 2010, HUM MOL GENET, V19, P1076, DOI 10.1093/hmg/ddp571; KRISS A, 1994, INT J PSYCHOPHYSIOL, V16, P137, DOI 10.1016/0167-8760(89)90040-8; Mackay DS, 2011, MOL VIS, V17, P2706; Mackay DS, 2011, INVEST OPHTH VIS SCI, V52, P3032, DOI 10.1167/iovs.10-7025; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pasadhika S, 2010, INVEST OPHTH VIS SCI, V51, P2608, DOI 10.1167/iovs.09-3734; Pennesi ME, 2011, INVEST OPHTH VIS SCI, V52, P8166, DOI 10.1167/iovs.11-8298; Ramamurthy V, 2003, P NATL ACAD SCI USA, V100, P12630, DOI 10.1073/pnas.2134194100; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Sun X, 2010, GENE THER, V17, P117, DOI 10.1038/gt.2009.104; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Testa F, 2011, INVEST OPHTHALMOL VI; Thompson DA, 2004, PAEDIAT OPHTHALMOLOG, P87; van der Spuy J, 2004, J BIOL CHEM, V279, P48038, DOI 10.1074/jbc.M407871200; van der Spuy J, 2003, INVEST OPHTH VIS SCI, V44, P5396, DOI 10.1167/iovs.03-0686; Walia S, 2010, OPHTHALMOLOGY, V117, P1190, DOI 10.1016/j.ophtha.2009.09.056; Weleber RG, 2010, GENEREVIEWS; Weleber RG, 2011, INVEST OPHTH VIS SCI, V52, P292, DOI 10.1167/iovs.10-6106; Zernant J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/iovs.05-0111	37	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32330	10.1371/journal.pone.0032330	http://dx.doi.org/10.1371/journal.pone.0032330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412862	Green Submitted, Green Published, gold			2022-12-25	WOS:000303021100013
J	Guerrot, D; Dussaule, JC; Mael-Ainin, M; Xu-Dubois, YC; Rondeau, E; Chatziantoniou, C; Placier, S				Guerrot, Dominique; Dussaule, Jean-Claude; Mael-Ainin, Mouna; Xu-Dubois, Yi-Chun; Rondeau, Eric; Chatziantoniou, Christos; Placier, Sandrine			Identification of Periostin as a Critical Marker of Progression/Reversal of Hypertensive Nephropathy	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHESIS; L-NAME HYPERTENSION; ANGIOTENSIN-II; RECEPTOR ANTAGONISM; TRANSGENIC MICE; INHIBITION; FIBROSIS; EXPRESSION; SYNTHASE; KIDNEY	Progression of chronic kidney disease (CKD) is a major health issue due to persistent accumulation of extracellular matrix in the injured kidney. However, our current understanding of fibrosis is limited, therapeutic options are lacking, and progressive degradation of renal function prevails in CKD patients. Uncovering novel therapeutic targets is therefore necessary. We have previously demonstrated reversal of renal fibrosis with losartan in experimental hypertensive nephropathy. Reversal was achieved provided that the drug was administered before late stages of nephropathy, thereby determining a non-return point of CKD progression. In the present study, to identify factors critically involved in the progression of renal fibrosis, we introduced losartan at the non-return point in L-NAME treated Sprague Dawley rats. Our results showed either reversal or progression of renal disease with losartan, defining 2 groups according to the opposite evolution of renal function. We took advantage of these experimental conditions to perform a transcriptomic screening to identify novel factors potentially implicated in the mechanisms of CKD progression. A secondary analysis of selected markers was thereafter performed. Among the targets identified, periostin, an extracellular matrix protein, presented a significant 3.3-fold higher mRNA expression in progression compared to reversal group. Furthermore, independent of blood pressure, periostin was strongly correlated with plasma creatinine, proteinuria and renal blood flow, hallmarks of hypertensive renal disease severity. Periostin staining was predominant in the injured regions, both in experimental hypertensive and human nephropathy. These results identify periostin as a previously unrecognized marker associated with disease progression and regression in hypertensive nephropathy and suggest measuring periostin may be a sensitive tool to evaluate severity, progression and response to therapy in human kidney disease associated to hypertension.	[Guerrot, Dominique; Dussaule, Jean-Claude; Mael-Ainin, Mouna; Xu-Dubois, Yi-Chun; Rondeau, Eric; Chatziantoniou, Christos; Placier, Sandrine] Hop Tenon, INSERM, UMRS 702, F-75970 Paris, France; [Guerrot, Dominique; Dussaule, Jean-Claude; Mael-Ainin, Mouna; Rondeau, Eric; Chatziantoniou, Christos; Placier, Sandrine] Univ Paris 06, Paris, France; [Guerrot, Dominique] Ctr Hosp Univ Hop Rouen, Serv Nephrol, Rouen, France; [Dussaule, Jean-Claude] Hop St Antoine, AP HP, Serv Physiol, F-75571 Paris, France; [Xu-Dubois, Yi-Chun; Rondeau, Eric] Hop Tenon, AP HP, F-75970 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Guerrot, D (corresponding author), Hop Tenon, INSERM, UMRS 702, F-75970 Paris, France.	jean-claude.dussaule@sat.aphp.fr	Chatziantoniou, Christos/L-2501-2016; Guerrot, Dominique/N-7769-2019	Guerrot, Dominique/0000-0002-5953-5785; Guerrot, Dominique/0000-0001-9562-530X	University UPMC; INSERM	University UPMC; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	No current external funding sources for this study. Internal Funders of our lab are University UPMC (www.upmc.fr) and INSERM (www.inserm.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2004, J AM SOC NEPHROL, V15, P3063, DOI 10.1097/01.ASN.0000146121.72699.86; Boffa JJ, 1999, CIRCULATION, V100, P1901, DOI 10.1161/01.CIR.100.18.1901; Boffa JJ, 2003, J AM SOC NEPHROL, V14, P1132, DOI 10.1097/01.ASN.0000060574.38107.3B; Boffa JJ, 2001, HYPERTENSION, V37, P490, DOI 10.1161/01.HYP.37.2.490; Campbell DJ, 2006, J HYPERTENS, V24, P33, DOI 10.1097/01.hjh.0000198042.24257.bf; Chatziantoniou C, 2008, CURR OPIN NEPHROL HY, V17, P76, DOI 10.1097/MNH.0b013e3282f1bb69; Dussaule JC, 2011, INT J EXP PATHOL, V92, P151, DOI 10.1111/j.1365-2613.2011.00760.x; Guerrot D, 2011, AM J PATHOL, V179, P83, DOI 10.1016/j.ajpath.2011.03.023; Helle F, 2009, AM J PHYSIOL-RENAL, V297, pF191, DOI 10.1152/ajprenal.00015.2009; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Iekushi K, 2007, HYPERTENSION, V49, P1409, DOI 10.1161/HYPERTENSIONAHA.106.080994; Inserra F, 1996, J AM SOC NEPHROL, V7, P676; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; JOHNSON RJ, 1992, HYPERTENSION, V19, P464, DOI 10.1161/01.HYP.19.5.464; Kang YS, 2010, KIDNEY INT, V78, P363, DOI 10.1038/ki.2010.137; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Li GH, 2006, ATHEROSCLEROSIS, V188, P292, DOI 10.1016/j.atherosclerosis.2005.11.002; Li L, 2011, CARDIOVASC RES; Luvara G, 1998, ARTERIOSCL THROM VAS, V18, P1408, DOI 10.1161/01.ATV.18.9.1408; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Pechanova O, 2004, J HYPERTENS, V22, P167, DOI 10.1097/01.hjh.0000098155.70956.f3; Placier S, 2006, NEPHROL DIAL TRANSPL, V21, P881, DOI 10.1093/ndt/gfk004; Pohjolainen V, 2011, NEPHROL DIAL TRANSPL; Satirapoj B, 2011, NEPHROL DIAL TRANSPL, DOI [10.1093/ndt/gfr670.28, DOI 10.1093/NDT/GFR670.28]; Sen K, 2011, AM J PATHOL, V179, P1756, DOI 10.1016/j.ajpath.2011.06.002; Sorocos K, 2011, J UROLOGY, V186, P1537, DOI 10.1016/j.juro.2011.05.042; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Tharaux PL, 2000, HYPERTENSION, V36, P330, DOI 10.1161/01.HYP.36.3.330; Tharaux PL, 1999, CIRCULATION, V99, P2185, DOI 10.1161/01.CIR.99.16.2185; Wallace DP, 2008, AM J PHYSIOL-RENAL, V295, pF1463, DOI 10.1152/ajprenal.90266.2008	30	47	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31974	10.1371/journal.pone.0031974	http://dx.doi.org/10.1371/journal.pone.0031974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403621	Green Submitted, gold, Green Published			2022-12-25	WOS:000303017700018
J	Hay, CW; McEwan, IJ				Hay, Colin W.; McEwan, Iain J.			The Impact of Point Mutations in the Human Androgen Receptor: Classification of Mutations on the Basis of Transcriptional Activity	PLOS ONE			English	Article							REFRACTORY PROSTATE-CANCER; LIGAND-BINDING DOMAIN; GENE-MUTATIONS; DNA-BINDING; COACTIVATOR INTERACTIONS; MOLECULAR-MECHANISMS; RESPONSE ELEMENT; LNCAP CELLS; ACTIVATION; CASTRATION	Androgen receptor mediated signaling drives prostate cancer cell growth and survival. Mutations within the receptor occur infrequently in prostate cancer prior to hormonal therapy but become prevalent in incurable androgen independent and metastatic tumors. Despite the determining role played by the androgen receptor in all stages of prostate cancer progression, there is a conspicuous dearth of comparable data on the consequences of mutations. In order to remedy this omission, we have combined an expansive study of forty five mutations which are predominantly associated with high Gleason scores and metastatic tumors, and span the entire length of the receptor, with a literature review of the mutations under investigation. We report the discovery of a novel prevalent class of androgen receptor mutation that possesses loss of function at low levels of androgen yet transforms to a gain of function at physiological levels. Importantly, mutations introducing constitutive gain of function are uncommon, with the majority of mutations leading to either loss of function or no significant change from wild-type activity. Therefore, the widely accepted supposition that androgen receptor mutations in prostate cancer result in gain of function is appealing, but mistaken. In addition, the transcriptional outcome of some mutations is dependent upon the androgen receptor responsive element. We discuss the consequences of these findings and the role of androgen receptor mutations for prostate cancer progression and current treatment options.	[Hay, Colin W.; McEwan, Iain J.] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland	University of Aberdeen	Hay, CW (corresponding author), Univ Aberdeen, Sch Med Sci, Foresterhill, Aberdeen, Scotland.	iain.mcewan@abdn.ac.uk			Tenovus Scotland [GO6/11]; Chief Scientist Office, Government of Scotland [CZB/4/477]; Chief Scientist Office [CZB/4/477] Funding Source: researchfish	Tenovus Scotland; Chief Scientist Office, Government of Scotland; Chief Scientist Office	This work was supported in part by Tenovus Scotland (GO6/11) and funding from the Chief Scientist Office, Government of Scotland (Grant No. CZB/4/477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens-Fath I, 2005, FEBS J, V272, P74, DOI 10.1111/j.1432-1033.2004.04395.x; American Cancer Society, 2010, CANC FACTS FIG 2010; Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Baker ME, 1997, MOL CELL ENDOCRINOL, V135, P101, DOI 10.1016/S0303-7207(97)00207-4; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Berrevoets CA, 1998, MOL ENDOCRINOL, V12, P1172, DOI 10.1210/me.12.8.1172; Betney R, 2003, J MOL ENDOCRINOL, V31, P427, DOI 10.1677/jme.0.0310427; BLOK LJ, 1992, MOL CELL ENDOCRINOL, V88, P153, DOI 10.1016/0303-7207(92)90020-7; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; Brodie J, 2005, J MOL ENDOCRINOL, V34, P603, DOI 10.1677/jme.1.01723; Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955; Bruggenwirth HT, 1998, ENDOCRINOLOGY, V139, P103, DOI 10.1210/en.139.1.103; Buchanan G, 2001, MOL ENDOCRINOL, V15, P46, DOI 10.1210/me.15.1.46; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chen GC, 2005, PROSTATE, V63, P395, DOI 10.1002/pros.20191; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; DERUITER PE, 1995, MOL CELL ENDOCRINOL, V110, pR1, DOI 10.1016/0303-7207(95)03534-E; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; Duff J, 2005, MOL ENDOCRINOL, V19, P2943, DOI 10.1210/me.2005-0231; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI 10.2217/FON.09.117; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Evans BAJ, 1996, PROSTATE, V28, P162, DOI 10.1002/(SICI)1097-0045(199603)28:3<162::AID-PROS3>3.0.CO;2-H; Evaul K, 2010, ENDOCRINOLOGY, V151, P3514, DOI 10.1210/en.2010-0138; Faus H, 2008, J CELL BIOCHEM, V104, P511, DOI 10.1002/jcb.21640; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; GELLER J, 1985, SEMIN ONCOL, V12, P28; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Godoy A, 2011, PROSTATE, V71, P1033, DOI 10.1002/pros.21318; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haapala K, 2001, LAB INVEST, V81, P1647, DOI 10.1038/labinvest.3780378; Haelens A, 2007, CANCER RES, V67, P4514, DOI 10.1158/0008-5472.CAN-06-1701; Haile S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024197; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Hyytinen ER, 2002, LAB INVEST, V82, P1591, DOI 10.1097/01.LAB.0000038924.67707.75; Jagla M, 2007, ENDOCRINOLOGY, V148, P4334, DOI 10.1210/en.2007-0446; Kesler CT, 2007, MOL ENDOCRINOL, V21, P2071, DOI 10.1210/me.2007-0240; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Koochekpour S, 2010, ASIAN J ANDROL, V12, P639, DOI 10.1038/aja.2010.89; Lakshman KM, 2010, J CLIN ENDOCR METAB, V95, P3955, DOI 10.1210/jc.2010-0102; Lamb DJ, 2003, J ANDROL, V24, P215; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Li WH, 2005, MOL ENDOCRINOL, V19, P2273, DOI 10.1210/me.2005-0134; Li YD, 2008, CLIN EXP PHARMACOL P, V35, P1252, DOI 10.1111/j.1440-1681.2008.04999.x; Linja MJ, 2001, CANCER RES, V61, P3550; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Marcelli M, 2000, CANCER RES, V60, P944; McEwan IJ, 2004, ENDOCR-RELAT CANCER, V11, P281, DOI 10.1677/erc.0.0110281; Monge A, 2006, CELL MOL LIFE SCI, V63, P487, DOI 10.1007/s00018-005-5471-y; Mononen N, 2000, CANCER RES, V60, P6479; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; O'Mahony OA, 2008, MOL CANCER RES, V6, P1691, DOI 10.1158/1541-7786.MCR-08-0273; Ogino Y, 2009, ENDOCRINOLOGY, V150, P5415, DOI 10.1210/en.2009-0523; Page ST, 2006, J CLIN ENDOCR METAB, V91, P3850, DOI 10.1210/jc.2006-0968; Powell SM, 2004, ENDOCR-RELAT CANCER, V11, P117, DOI 10.1677/erc.0.0110117; Reddy GPV, 2006, J CELL BIOCHEM, V98, P1408, DOI 10.1002/jcb.20927; Reid J, 2002, J BIOL CHEM, V277, P41247, DOI 10.1074/jbc.M205220200; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; TAKAHASHI H, 1995, CANCER RES, V55, P1621; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Taneja SS, 2004, J BIOL CHEM, V279, P13944, DOI 10.1074/jbc.M306576200; Tanner TM, 2010, CELL MOL LIFE SCI, V67, P1919, DOI 10.1007/s00018-010-0302-1; Taplin ME, 1999, CANCER RES, V59, P2511; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Taplin ME, 2001, J CLIN ENDOCR METAB, V86, P3467, DOI 10.1210/jc.86.8.3467; Tiwary BK, 2009, MOL BIOL EVOL, V26, P123, DOI 10.1093/molbev/msn233; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Verrijdt G, 2000, J BIOL CHEM, V275, P12298, DOI 10.1074/jbc.275.16.12298; Vis AN, 2009, BJU INT, V104, P1191, DOI 10.1111/j.1464-410X.2009.08743.x; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Welsh M, 2011, ENDOCRINOLOGY, V152, P3541, DOI 10.1210/en.2011-0282; *WHO, 2008, CANC FACT SHEET; Wilson JD, 1996, PROSTATE, P88; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104	95	40	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32514	10.1371/journal.pone.0032514	http://dx.doi.org/10.1371/journal.pone.0032514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403669	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700066
J	Karlin, D; Belshaw, R				Karlin, David; Belshaw, Robert			Detecting Remote Sequence Homology in Disordered Proteins: Discovery of Conserved Motifs in the N-Termini of Mononegavirales phosphoproteins	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; NUCLEOCAPSID-BINDING DOMAIN; V-PROTEIN; WEB SERVER; P-PROTEIN; CRYSTAL-STRUCTURE; STRUCTURE PREDICTION; STRUCTURAL DISORDER; POLYMERASE COFACTOR; LINEAR MOTIFS	Paramyxovirinae are a large group of viruses that includes measles virus and parainfluenza viruses. The viral Phosphoprotein (P) plays a central role in viral replication. It is composed of a highly variable, disordered N-terminus and a conserved C-terminus. A second viral protein alternatively expressed, the V protein, also contains the N-terminus of P, fused to a zinc finger. We suspected that, despite their high variability, the N-termini of P/V might all be homologous; however, using standard approaches, we could previously identify sequence conservation only in some Paramyxovirinae. We now compared the N-termini using sensitive sequence similarity search programs, able to detect residual similarities unnoticeable by conventional approaches. We discovered that all Paramyxovirinae share a short sequence motif in their first 40 amino acids, which we called soyuz1. Despite its short length (11-16aa), several arguments allow us to conclude that soyuz1 probably evolved by homologous descent, unlike linear motifs. Conservation across such evolutionary distances suggests that soyuz1 plays a crucial role and experimental data suggest that it binds the viral nucleoprotein to prevent its illegitimate self-assembly. In some Paramyxovirinae, the N-terminus of P/V contains a second motif, soyuz2, which might play a role in blocking interferon signaling. Finally, we discovered that the P of related Mononegavirales contain similarly overlooked motifs in their N-termini, and that their C-termini share a previously unnoticed structural similarity suggesting a common origin. Our results suggest several testable hypotheses regarding the replication of Mononegavirales and suggest that disordered regions with little overall sequence similarity, common in viral and eukaryotic proteins, might contain currently overlooked motifs (intermediate in length between linear motifs and disordered domains) that could be detected simply by comparing orthologous proteins.	[Karlin, David; Belshaw, Robert] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Karlin, D (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	david.karlin@zoo.ox.ac.uk			Wellcome Trust [090005]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust grant number 090005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Assenberg R, 2010, J VIROL, V84, P1089, DOI 10.1128/JVI.01520-09; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baker KS, 2012, J GEN VIROL IN PRESS; Barr J, 1995, VIRUS RES, V39, P221, DOI 10.1016/0168-1702(95)00090-9; Batts WN, 2008, J AQUAT ANIM HEALTH, V20, P215, DOI 10.1577/H07-050.1; Bernhart Stephan H., 2009, Briefings in Functional Genomics & Proteomics, V8, P461, DOI 10.1093/bfgp/elp043; Bhella D, 2002, J GEN VIROL, V83, P1831, DOI 10.1099/0022-1317-83-8-1831; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Blanchard L, 2004, VIROLOGY, V319, P201, DOI 10.1016/j.virol.2003.10.029; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Castel G, 2009, J VIROL, V83, P10808, DOI 10.1128/JVI.00977-09; Chatziandreou N, 2002, VIROLOGY, V293, P234, DOI 10.1006/viro.2001.1302; Chen MZ, 2007, J VIROL, V81, P13478, DOI 10.1128/JVI.01244-07; Chenik M, 1998, J VIROL, V72, P1925, DOI 10.1128/JVI.72.3.1925-1930.1998; CHINCHAR VG, 1981, VIROLOGY, V109, P59, DOI 10.1016/0042-6822(81)90471-2; CHINCHAR VG, 1981, VIROLOGY, V115, P192, DOI 10.1016/0042-6822(81)90101-X; Ciancanelli MJ, 2009, J VIROL, V83, P7828, DOI 10.1128/JVI.02610-08; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Davey NE, 2010, NUCLEIC ACIDS RES, V38, pW534, DOI 10.1093/nar/gkq440; De BP, 2000, J VIROL, V74, P5886, DOI 10.1128/JVI.74.13.5886-5895.2000; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Ding HT, 2006, J VIROL, V80, P2808, DOI 10.1128/JVI.80.6.2808-2814.2006; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dortmans JCFM, 2011, J GEN VIROL, V92, P336, DOI 10.1099/vir.0.026344-0; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Dunbrack RL, 2006, CURR OPIN STRUC BIOL, V16, P374, DOI 10.1016/j.sbi.2006.05.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RJ, 2012, MOL BIOSYST, V8, P282, DOI 10.1039/c1mb05212h; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x; Gerard FCA, 2009, J MOL BIOL, V388, P978, DOI 10.1016/j.jmb.2009.03.061; Goncearenco A, 2010, BIOINFORMATICS, V26, pi497, DOI 10.1093/bioinformatics/btq374; Green TJ, 2011, J VIROL, V85, P2714, DOI 10.1128/JVI.01927-10; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Guenzel CA, 2009, THESIS U WUERZBURG; Habchi J, 2012, MOL BIOSYST, V8, P69, DOI 10.1039/c1mb05204g; Habchi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011684; HARTY RN, 1995, J GEN VIROL, V76, P2863, DOI 10.1099/0022-1317-76-11-2863; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hock M, 2010, VIROLOGY, V397, P64, DOI 10.1016/j.virol.2009.11.016; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Ivanov I, 2010, J VIROL, V84, P3707, DOI 10.1128/JVI.02557-09; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Karlin D, 2003, J GEN VIROL, V84, P3239, DOI 10.1099/vir.0.19451-0; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kimberlin CR, 2010, P NATL ACAD SCI USA, V107, P314, DOI 10.1073/pnas.0910547107; Kingston RL, 2008, J MOL BIOL, V379, P719, DOI 10.1016/j.jmb.2007.12.080; Kolesnikova L, 2000, J VIROL, V74, P3899, DOI 10.1128/JVI.74.8.3899-3904.2000; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Leung DW, 2009, P NATL ACAD SCI USA, V106, P411, DOI 10.1073/pnas.0807854106; Leyrat C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002248; Leyrat C, 2010, PROTEIN PEPTIDE LETT, V17, P979, DOI 10.2174/092986610791498939; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Llorente MT, 2006, J GEN VIROL, V87, P159, DOI 10.1099/vir.0.81430-0; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mavrakis M, 2004, J MOL BIOL, V343, P819, DOI 10.1016/j.jmb.2004.08.071; Mavrakis M, 2006, VIROLOGY, V349, P422, DOI 10.1016/j.virol.2006.01.030; McCarthy AJ, 2010, INFECT GENET EVOL, V10, P97, DOI 10.1016/j.meegid.2009.11.002; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Mihindukulasuriya KA, 2009, J VIROL, V83, P5109, DOI 10.1128/JVI.02667-08; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Moretti S, 2006, NUCLEIC ACIDS RES, V34, pW600, DOI 10.1093/nar/gkl170; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Nishio M, 1996, J GEN VIROL, V77, P2457, DOI 10.1099/0022-1317-77-10-2457; Nishio M, 2005, J VIROL, V79, P14756, DOI 10.1128/JVI.79.23.14756-14768.2005; Noda T, 2010, J GEN VIROL, V91, P1478, DOI 10.1099/vir.0.019794-0; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Peeters B, 2004, J GEN VIROL, V85, P2375, DOI 10.1099/vir.0.80160-0; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Pentony MM, 2010, PROTEINS, V78, P212, DOI 10.1002/prot.22504; PRECIOUS B, 1995, J VIROL, V69, P8001, DOI 10.1128/JVI.69.12.8001-8010.1995; Prins KC, 2010, J VIROL, V84, P10581, DOI 10.1128/JVI.00925-10; Procter JB, 2010, NAT METHODS, V7, pS16, DOI [10.1038/NMETH.1434, 10.1038/nmeth.1434]; Randall RE, 1996, VIROLOGY, V224, P121, DOI 10.1006/viro.1996.0513; Ribeiro EA, 2008, J MOL BIOL, V382, P525, DOI 10.1016/j.jmb.2008.07.028; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Schneider G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-164; Schneider U, 2005, VIRUS RES, V111, P148, DOI 10.1016/j.virusres.2005.04.006; Schneider U, 2004, J BIOL CHEM, V279, P55290, DOI 10.1074/jbc.M408913200; Schwemmle M, 1998, J BIOL CHEM, V273, P9007, DOI 10.1074/jbc.273.15.9007; Shaji D, 1999, VIROLOGY, V258, P415, DOI 10.1006/viro.1999.9740; Slack MS, 1998, VIRUS RES, V55, P167, DOI 10.1016/S0168-1702(98)00042-2; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Tober C, 1998, J VIROL, V72, P8124, DOI 10.1128/JVI.72.10.8124-8132.1998; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Torarinsson E, 2008, NUCLEIC ACIDS RES, V36, pW79, DOI 10.1093/nar/gkn275; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vidalain PO, 2010, MICROBES INFECT, V12, P1134, DOI 10.1016/j.micinf.2010.09.001; Watanabe N, 1996, MED MICROBIOL IMMUN, V185, P89, DOI 10.1007/s004300050019; Watanabe N, 1996, J GEN VIROL, V77, P327, DOI 10.1099/0022-1317-77-2-327; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61; WINTON J R, 1985, Fish Pathology, V20, P373; Witko SE, 2006, VIROLOGY, V348, P107, DOI 10.1016/j.virol.2005.12.019; Woo PCY, 2011, J VIROL, V85, P13473, DOI 10.1128/JVI.06356-11; Wunderlich K, 2011, ANTIMICROB AGENTS CH, V55, P696, DOI 10.1128/AAC.01419-10; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430	115	50	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31719	10.1371/journal.pone.0031719	http://dx.doi.org/10.1371/journal.pone.0031719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403617	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700014
J	Lankheet, MJM; Klink, PC; Borghuis, BG; Noest, AJ				Lankheet, Martin J. M.; Klink, P. Christiaan; Borghuis, Bart G.; Noest, Andre J.			Spike-Interval Triggered Averaging Reveals a Quasi-Periodic Spiking Alternative for Stochastic Resonance in Catfish Electroreceptors	PLOS ONE			English	Article							WHITE-NOISE ANALYSIS; NEURON; RESPONSES; INPUT; CELL; IDENTIFICATION; AMPULLARY; SYSTEMS; SIGNAL; MODEL	Catfish detect and identify invisible prey by sensing their ultra-weak electric fields with electroreceptors. Any neuron that deals with small-amplitude input has to overcome sensitivity limitations arising from inherent threshold non-linearities in spike-generation mechanisms. Many sensory cells solve this issue with stochastic resonance, in which a moderate amount of intrinsic noise causes irregular spontaneous spiking activity with a probability that is modulated by the input signal. Here we show that catfish electroreceptors have adopted a fundamentally different strategy. Using a reverse correlation technique in which we take spike interval durations into account, we show that the electroreceptors generate a supra-threshold bias current that results in quasi-periodically produced spikes. In this regime stimuli modulate the interval between successive spikes rather than the instantaneous probability for a spike. This alternative for stochastic resonance combines threshold-free sensitivity for weak stimuli with similar sensitivity for excitations and inhibitions based on single interspike intervals.	[Lankheet, Martin J. M.] Wageningen Univ, Wageningen, Netherlands; [Klink, P. Christiaan] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Klink, P. Christiaan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; Howard Hughes Med Inst, Ashburn, VA USA	Wageningen University & Research; Utrecht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Howard Hughes Medical Institute	Lankheet, MJM (corresponding author), Wageningen Univ, Wageningen, Netherlands.	martin.lankheet@wur.nl	Klink, Chris/P-5074-2019	Klink, Chris/0000-0002-6784-7842	Wageningen University; Utrecht University	Wageningen University(European Commission); Utrecht University	This work was supported by Wageningen University and Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIANOV GN, 1994, NEUROREPORT, V5, P1056, DOI 10.1097/00001756-199405000-00010; Arcas BAY, 2003, NEURAL COMPUT, V15, P1789, DOI 10.1162/08997660360675044; Avila-Akerberg O, 2011, EXP BRAIN RES, V210, P353, DOI [10.1007/s00221-011-2553-y, 10.1007/s00221-011-2639-6]; Bennett M V, 1979, Soc Gen Physiol Ser, V33, P91; Binder MD, 1999, J PHYSIOLOGY-PARIS, V93, P71, DOI 10.1016/S0928-4257(99)80137-5; Binder MD, 1999, J PHYSIOLOGY-PARIS, V93, P29, DOI 10.1016/S0928-4257(99)80134-X; Borghuis BG, 2003, J NEUROSCI METH, V123, P153, DOI 10.1016/S0165-0270(02)00347-3; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; BRAUN HA, 1994, NATURE, V367, P270, DOI 10.1038/367270a0; BRETSCHNEIDER F, 1985, COMP BIOCHEM PHYS A, V80, P191, DOI 10.1016/0300-9629(85)90540-7; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Chacron MJ, 2000, PHYS REV LETT, V85, P1576, DOI 10.1103/PhysRevLett.85.1576; CHANDLER JP, 1969, BEHAV SCI, V14, P81; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Kim YJ, 2006, VISION RES, V46, P392, DOI 10.1016/j.visres.2005.08.009; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; Lundstrom BN, 2006, J NEUROSCI, V26, P9030, DOI 10.1523/JNEUROSCI.0225-06.2006; MARMARELIS PZ, 1972, SCIENCE, V175, P1276, DOI 10.1126/science.175.4027.1276; MARMARELIS PZ, 1973, J NEUROPHYSIOL, V36, P605, DOI 10.1152/jn.1973.36.4.605; MARMARELIS PZ, 1973, KYBERNETIK, V12, P74, DOI 10.1007/BF00272463; MARMARELIS VZ, 1986, BIOL CYBERN, V54, P115, DOI 10.1007/BF00320482; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Neiman AB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061915; Neiman AB, 2004, J NEUROPHYSIOL, V92, P492, DOI 10.1152/jn.00742.2003; NOEST AJ, 1995, NATURE, V378, P341, DOI 10.1038/378341b0; Oswald AMM, 2004, J NEUROSCI, V24, P4351, DOI 10.1523/JNEUROSCI.0459-04.2004; Oswald AMM, 2007, J NEUROPHYSIOL, V97, P2731, DOI 10.1152/jn.00987.2006; Paninski L, 2006, NEURAL COMPUT, V18, P2592, DOI 10.1162/neco.2006.18.11.2592; Peters RC, 1997, NEUROSCIENCE, V81, P297, DOI 10.1016/S0306-4522(97)00190-5; Peters RC, 2007, BIOSYSTEMS, V89, P92, DOI 10.1016/j.biosystems.2006.05.014; Peters RC, 2007, BIOL REV, V82, P361, DOI 10.1111/j.1469-185X.2007.00015.x; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2006, J VISION, V6, P414, DOI 10.1167/6.4.9; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Pillow JW, 2003, NEUROCOMPUTING, V52-4, P109, DOI 10.1016/S0925-2312(02)00822-6; Powers RK, 2005, J PHYSIOL-LONDON, V562, P707, DOI 10.1113/jphysiol.2004.069039; Rieke F., 1997, SPIKES EXPLORING NEU; Sadeghi SG, 2007, J NEUROSCI, V27, P771, DOI 10.1523/JNEUROSCI.4690-06.2007; SCHAFER K, 1995, PFLUG ARCH EUR J PHY, V429, P378, DOI 10.1007/BF00374153; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Slee SJ, 2005, J NEUROSCI, V25, P9978, DOI 10.1523/JNEUROSCI.2666-05.2005; STEIN RB, 1965, BIOPHYS J, V5, P173, DOI 10.1016/S0006-3495(65)86709-1; TEUNIS PFM, 1991, NEUROSCIENCE, V41, P809, DOI 10.1016/0306-4522(91)90371-T; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; Vajda I, 2006, VISUAL NEUROSCI, V23, P233, DOI 10.1017/S0952523806232085; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; Vilela RD, 2009, J THEOR BIOL, V257, P90, DOI 10.1016/j.jtbi.2008.11.004; Zhang XJ, 2009, NEURAL COMPUT, V21, P3079, DOI 10.1162/neco.2009.06-08-807	53	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32786	10.1371/journal.pone.0032786	http://dx.doi.org/10.1371/journal.pone.0032786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403709	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700106
J	Merbs, SL; Khan, MA; Hackler, L; Oliver, VF; Wan, J; Qian, J; Zack, DJ				Merbs, Shannath L.; Khan, Miriam A.; Hackler, Laszlo, Jr.; Oliver, Verity F.; Wan, Jun; Qian, Jiang; Zack, Donald J.			Cell-Specific DNA Methylation Patterns of Retina-Specific Genes	PLOS ONE			English	Article							BINDING PROTEIN IRBP; CPG ISLANDS; REGIONS TDMS; EXPRESSION; MOUSE; HYPOMETHYLATION; OLIGONUCLEOTIDE; IDENTIFICATION; PROMOTER; METHYLTRANSFERASES	Many studies have demonstrated that epigenetic mechanisms are important in the regulation of gene expression during embryogenesis, gametogenesis, and other forms of tissue-specific gene regulation. We sought to explore the possible role of epigenetics, specifically DNA methylation, in the establishment and maintenance of cell type-restricted gene expression in the retina. To assess the relationship between DNA methylation status and expression level of retinal genes, bisulfite sequence analysis of the 1000 bp region around the transcription start sites (TSS) of representative rod and cone photoreceptor-specific genes and gene expression analysis were performed in the WERI and Y79 human retinoblastoma cell lines. Next, the homologous genes in mouse were bisulfite sequenced in the retina and in non-expressing tissues. Finally, bisulfite sequencing was performed on isolated photoreceptor and non-photoreceptor retinal cells isolated by laser capture microdissection. Differential methylation of rhodopsin (RHO), retinal binding protein 3 (RBP3, IRBP) cone opsin, short-wave-sensitive (OPN1SW), cone opsin, middle-wave-sensitive (OPN1MW), and cone opsin, long-wave-sensitive (OPN1LW) was found in the retinoblastoma cell lines that inversely correlated with gene expression levels. Similarly, we found tissue-specific hypomethylation of the promoter region of Rho and Rbp3 in mouse retina as compared to non-expressing tissues, and also observed hypomethylation of retinal-expressed microRNAs. The Rho and Rbp3 promoter regions were unmethylated in expressing photoreceptor cells and methylated in non-expressing, non-photoreceptor cells from the inner nuclear layer. A third regional hypomethylation pattern of photoreceptor-specific genes was seen in a subpopulation of non-expressing photoreceptors (Rho in cones from the Nrl -/- mouse and Opn1sw in rods). These results demonstrate that a number of photoreceptor-specific genes have cell-specific differential DNA methylation that correlates inversely with their expression level. Furthermore, these cell-specific patterns suggest that DNA methylation may play an important role in modulating photoreceptor gene expression in the developing mammalian retina.	[Merbs, Shannath L.; Khan, Miriam A.; Hackler, Laszlo, Jr.; Oliver, Verity F.; Wan, Jun; Qian, Jiang; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Zack, Donald J.] Univ Paris 06, Inst Vis, Paris, France	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; UDICE-French Research Universities; Sorbonne Universite	Merbs, SL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.	smerbs@jhmi.edu	Wan, Jun/A-2177-2014; Todd, Verity/K-7336-2012; Wan, Jun/H-7132-2013; Wan, Jun/AAN-1337-2020	Wan, Jun/0000-0001-9286-6562; Todd, Verity/0000-0003-4786-8272; Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562; Zack, Don/0000-0002-7966-1973	National Eye Institute [5R01EY009769, R21EY018703, 5P30EY001765]; Foundation Fighting Blindness; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY009769, P30EY001765, R21EY018703] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by grants from the National Eye Institute (5R01EY009769, SLM and DJZ; R21EY018703, SLM; and 5P30EY001765, DJZ), the Foundation Fighting Blindness, unrestricted funds from Research to Prevent Blindness, and generous gifts from Agnes Nixon, the Guerrieri Family Foundation, and Robert and Clarice Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1990, NUCLEIC ACIDS RES, V18, P5181, DOI 10.1093/nar/18.17.5181; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Arakawa T, 2011, ANAL BIOCHEM, V416, P211, DOI 10.1016/j.ab.2011.05.017; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Boatright JH, 2000, BRAIN RES, V887, P211, DOI 10.1016/S0006-8993(00)02990-5; Borst DE, 2001, CURR EYE RES, V23, P20, DOI 10.1076/ceyr.23.1.20.5419; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Deeb SS, 2010, OPHTHAL PHYSL OPT, V30, P446, DOI 10.1111/j.1475-1313.2010.00735.x; DIPOLO A, 1995, P NATL ACAD SCI USA, V92, P4016, DOI 10.1073/pnas.92.9.4016; El-Remessy AEB, 2000, MOL VIS, V6, P243; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; Han L, 2007, CANCER BIOL THER, V6, P1284; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ishii T, 2004, CANCER LETT, V212, P211, DOI 10.1016/j.canlet.2004.03.001; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kitamura E, 2007, GENOMICS, V89, P326, DOI 10.1016/j.ygeno.2006.11.006; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; KYRITSIS AP, 1985, J CELL PHYSIOL, V124, P233, DOI 10.1002/jcp.1041240210; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LIOU GI, 1994, DEV BIOL, V161, P345, DOI 10.1006/dbio.1994.1036; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Nagae G, 2011, HUM MOL GENET, V20, P2710, DOI 10.1093/hmg/ddr170; Nasonkin IO, 2011, J COMP NEUROL, V519, P1914, DOI 10.1002/cne.22613; Peng GH, 2011, P NATL ACAD SCI USA, V108, P17821, DOI 10.1073/pnas.1109209108; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Shaaban SA, 1998, INVEST OPHTH VIS SCI, V39, P885; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Smith AE, 2007, NUCLEIC ACIDS RES, V35, P740, DOI 10.1093/nar/gkl1053; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Suzuki M, 2007, GENES CELLS, V12, P1305, DOI 10.1111/j.1365-2443.2007.01136.x; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tittle RK, 2011, DEV BIOL, V350, P50, DOI 10.1016/j.ydbio.2010.11.009; van der Gun BTF, 2010, BIOCONJUGATE CHEM, V21, P1239, DOI 10.1021/bc1000388; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yao XM, 2003, J CLIN INVEST, V111, P265, DOI 10.1172/JCI200315109	46	40	40	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32602	10.1371/journal.pone.0032602	http://dx.doi.org/10.1371/journal.pone.0032602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403679	Green Submitted, gold, Green Published			2022-12-25	WOS:000303017700076
J	Xu, QH; Chou, B; Fitzsimmons, B; Miyanohara, A; Shubayev, V; Santucci, C; Hefferan, M; Marsala, M; Hua, XY				Xu, Qinghao; Chou, Beverly; Fitzsimmons, Bethany; Miyanohara, Atsushi; Shubayev, Veronica; Santucci, Camila; Hefferan, Michael; Marsala, Martin; Hua, Xiao-Ying			In Vivo Gene Knockdown in Rat Dorsal Root Ganglia Mediated by Self-Complementary Adeno-Associated Virus Serotype 5 Following Intrathecal Delivery	PLOS ONE			English	Article							SPINAL NERVE LIGATION; UP-REGULATION; EFFICIENT TRANSDUCTION; INTERFERING RNAS; EXPRESSION; NEURONS; VECTORS; CORD; SUBUNIT; INJURY	We report here in adult rat viral vector mediate-gene knockdown in the primary sensory neurons and the associated cellular and behavior consequences. Self-complementary adeno-associated virus serotype 5 (AAV5) was constructed to express green fluorescent protein (GFP) and a small interfering RNA (siRNA) targeting mammalian target of rapamycin (mTOR). The AAV vectors were injected via an intrathecal catheter. We observed profound GFP expression in lumbar DRG neurons beginning at 2-week post-injection. Of those neurons, over 85% were large to medium-diameter and co-labeled with NF200, a marker for myelinated fibers. Western blotting of mTOR revealed an 80% reduction in the lumbar DRGs (L4-L6) of rats treated with the active siRNA vectors compared to the control siRNA vector. Gene knockdown became apparent as early as 7-day post-injection and lasted for at least 5 weeks. Importantly, mTOR knockdown occurred in large (NF200) and small-diameter neurons (nociceptors). The viral administration induced an increase of Iba1 immunoreactivity in the DRGs, which was likely attributed to the expression of GFP but not siRNA. Rats with mTOR knockdown in DRG neurons showed normal general behavior and unaltered responses to noxious stimuli. In conclusion, intrathecal AAV5 is a highly efficient vehicle to deliver siRNA and generate gene knockdown in DRG neurons. This will be valuable for both basic research and clinic intervention of diseases involving primary sensory neurons.	[Xu, Qinghao; Chou, Beverly; Fitzsimmons, Bethany; Shubayev, Veronica; Santucci, Camila; Hefferan, Michael; Marsala, Martin; Hua, Xiao-Ying] Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA; [Miyanohara, Atsushi] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia	University of California System; University of California San Diego; University of California System; University of California San Diego; Slovak Academy of Sciences	Xu, QH (corresponding author), Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA.	q1xu@ucsd.edu			Department of Anesthesiology, University of California, San Diego; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066941] Funding Source: NIH RePORTER	Department of Anesthesiology, University of California, San Diego; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was funded by unrestricted funds from the Department of Anesthesiology, University of California, San Diego. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante CO, 2010, J PAIN, V11, P1356, DOI 10.1016/j.jpain.2010.03.013; Bernards Christopher M, 2004, Curr Opin Anaesthesiol, V17, P441, DOI 10.1097/00001503-200410000-00015; Birder LA, 1999, J PHYSIOL-LONDON, V515, P533, DOI 10.1111/j.1469-7793.1999.533ac.x; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Butler M, 2005, NEUROSCIENCE, V131, P705, DOI 10.1016/j.neuroscience.2004.11.038; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dirig DM, 1997, J NEUROSCI METH, V76, P183, DOI 10.1016/S0165-0270(97)00097-6; Ehlert EM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-20; Federici T, 2011, GENE THER; Foust KD, 2008, HUM GENE THER, V19, P61, DOI 10.1089/hum.2007.093; Garraway SM, 2007, J PHARMACOL EXP THER, V322, P982, DOI 10.1124/jpet.107.123125; Geranton SM, 2009, J NEUROSCI, V29, P15017, DOI 10.1523/JNEUROSCI.3451-09.2009; Gold MS, 2003, J NEUROSCI, V23, P158; Gregory EN, 2010, NEUROSCIENCE, V169, P1392, DOI 10.1016/j.neuroscience.2010.05.067; Hains BC, 2004, J NEUROSCI, V24, P4832, DOI 10.1523/JNEUROSCI.0300-04.2004; Iwamoto N, 2009, J GENE MED, V11, P498, DOI 10.1002/jgm.1325; Jimenez-Diaz L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001961; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kong FS, 2010, EXP EYE RES, V90, P546, DOI 10.1016/j.exer.2010.01.011; Krekoski CA, 1996, J NEUROSCI RES, V43, P1, DOI 10.1002/jnr.490430102; Krupp JL, 2004, ANESTHESIOLOGY, V100, P315, DOI 10.1097/00000542-200402000-00021; Lee YJ, 2002, MOL CELL NEUROSCI, V19, P186, DOI 10.1006/mcne.2001.1073; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Malkmus SA, 2004, METH MOLEC MED, P109; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; Schafers M, 2003, NEUROSCI LETT, V347, P179, DOI 10.1016/S0304-3940(03)00695-5; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Snyder BR, 2011, HUM GENE THER, V22, P1129, DOI 10.1089/hum.2011.008; Storek B, 2008, P NATL ACAD SCI USA, V105, P1055, DOI 10.1073/pnas.0708003105; Svensson CI, 2005, J NEUROCHEM, V92, P1508, DOI 10.1111/j.1471-4159.2004.02996.x; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Vulchanova L, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-31; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Xu JT, 2010, BRAIN RES, V1336, P46, DOI 10.1016/j.brainres.2010.04.010; Xu QH, 2011, J NEUROSCI, V31, P2113, DOI 10.1523/JNEUROSCI.2139-10.2011; Xu QH, 2008, J NEUROSCI, V28, P14087, DOI 10.1523/JNEUROSCI.2406-08.2008; Yaksh TL, 2001, J APPL PHYSIOL, V90, P2386, DOI 10.1152/jappl.2001.90.6.2386; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yaksh TL, 2004, ANESTH ANALG, V98, P1536, DOI 10.1213/01.ANE.0000122638.41130.BF; Yaksh TL, 2004, ANESTH ANALG, V98, P1509, DOI 10.1213/01.ANE.0000121768.79904.7F; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zheng H, 2010, HUM GENE THER, V21, P87, DOI 10.1089/hum.2009.131; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	48	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32581	10.1371/journal.pone.0032581	http://dx.doi.org/10.1371/journal.pone.0032581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403675	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700072
J	Wang, Z; Yuan, H; Roth, M; Stark, JM; Bhatia, R; Chen, WY				Wang, Z.; Yuan, H.; Roth, M.; Stark, J. M.; Bhatia, R.; Chen, W. Y.			SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells	ONCOGENE			English	Article						chronic myelogenous leukemia; BCR-ABL; SIRT1; DNA damage repair; mutation; acquired resistance	CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; DOUBLE-STRAND BREAKS; DNA-DAMAGE; CLINICAL RESISTANCE; STRESS-RESPONSE; ERROR-PRONE; C-ABL; IMATINIB; REPAIR	BCR-ABL transforms bone marrow progenitor cells and promotes genome instability, leading to development of chronic myelogenous leukemia (CML). The tyrosine kinase inhibitor imatinib effectively treats CML, but acquired resistance can develop because of BCR-ABL mutations. Mechanisms for acquisition of BCR-ABL mutations are not fully understood. Using a novel culture model of CML acquired resistance, we show that inhibition of SIRT1 deacetylase by small molecule inhibitors or gene knockdown blocks acquisition of BCR-ABL mutations and relapse of CML cells on tyrosine kinase inhibitors. SIRT1 knockdown also suppresses de novo genetic mutations of hypoxanthine phosphoribosyl transferase gene in CML and non-CML cells upon treatment with DNA damaging agent cannptothecin. Although SIRT1 can enhance cellular DNA damage response, it alters functions of DNA repair machineries in CML cells and stimulates activity of error-prone DNA damage repair, in association with acquisition of genetic mutations. These results reveal a previously unrecognized role of SIRT1 for promoting mutation acquisition in cancer, and have implication for targeting SIRT1 to overcome CML drug resistance. Oncogene (2013) 32, 589-598; doi:10.1038/onc.2012.83; published online 12 March 2012	[Wang, Z.; Yuan, H.; Roth, M.; Stark, J. M.; Chen, W. Y.] City Hope Natl Med Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA 91010 USA; [Bhatia, R.] City Hope Natl Med Ctr, Div Hematopoiet Stem Cell & Leukemia Res, Beckman Res Inst, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Chen, WY (corresponding author), City Hope Natl Med Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA 91010 USA.	wechen@coh.org	Chen, WenYong/D-6748-2012	Chen, WenYong/0000-0001-6913-5729; Bhatia, Ravi/0000-0001-5740-2316	US Department of Defense [W81XWH-06-1-0268]; STOPCANCER Foundation; V-Foundation; National Cancer Institute, NIH [R01 CA143421];  [R01 CA95684];  [R01 CA120954]; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA095684, R01CA120954, R01CA143421] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); STOPCANCER Foundation; V-Foundation; National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the following Grants: W81XWH-06-1-0268 from the US Department of Defense, a career development award from the STOPCANCER Foundation, a translational research grant from the V-Foundation and R01 CA143421 from the National Cancer Institute, NIH to WYC. RB was supported by R01 CA95684, and JMS was supported by R01 CA120954. The core facilities used in this study were supported by NCI P30 CA033572.	Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Brady N, 2003, CANCER RES, V63, P1798; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Fiskus W, 2006, CLIN CANCER RES, V12, P5869, DOI 10.1158/1078-0432.CCR-06-0980; Gaymes TJ, 2006, MOL CANCER RES, V4, P563, DOI 10.1158/1541-7786.MCR-06-0111; Gaymes TJ, 2002, CANCER RES, V62, P2791; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Issa JPJ, 1997, CANCER RES, V57, P1678; Jin SF, 1997, J BIOL CHEM, V272, P24763, DOI 10.1074/jbc.272.40.24763; Jung-Hynes B, 2009, J BIOL CHEM, V284, P3823, DOI 10.1074/jbc.M807869200; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; Koschmieder S, 2011, MYELOID LEUKEMIA BAS, P69; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nowicki MO, 2004, BLOOD, V104, P3746, DOI 10.1182/blood-2004-05-1941; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Quintas-Cardama A, 2011, LEUKEMIA, V25, P226, DOI 10.1038/leu.2010.276; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Slupianek A, 2006, DNA REPAIR, V5, P243, DOI 10.1016/j.dnarep.2005.10.005; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; von Bubnoff N, 2006, BLOOD, V108, P1328, DOI 10.1182/blood-2005-12-010132; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yu CR, 2003, CANCER RES, V63, P2118; Yuan HF, 2012, BLOOD, V119, P1904, DOI 10.1182/blood-2011-06-361691; Yuan HF, 2010, J BIOL CHEM, V285, P5085, DOI 10.1074/jbc.M109.039206; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhang B, 2010, CANCER CELL, V17, P427, DOI 10.1016/j.ccr.2010.03.011	58	73	76	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2013	32	5					589	598		10.1038/onc.2012.83	http://dx.doi.org/10.1038/onc.2012.83			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22410779	Green Accepted			2022-12-25	WOS:000316164700006
J	Yasaei, H; Gilham, E; Pickles, JC; Roberts, TP; O'Donovan, M; Newbold, RF				Yasaei, H.; Gilham, E.; Pickles, J. C.; Roberts, T. P.; O'Donovan, M.; Newbold, R. F.			Carcinogen-specific mutational and epigenetic alterations in INK4A, INK4B and p53 tumour-suppressor genes drive induced senescence bypass in normal diploid mammalian cells	ONCOGENE			English	Article						oncogene/stress-induced senescence; chemical carcinogen; ionizing radiation; Syrian hamster dermal cells; cell transformation assay	CELLULAR SENESCENCE; HUMAN CANCER; CHEEK-POUCH; P16(INK4A)/CDKN2A ALTERATIONS; DIOL EPOXIDE; LUNG-TUMORS; HAMSTER P16; RAS; IMMORTALIZATION; METHYLATION	Immortalization (senescence bypass) is a critical rate-limiting step in the malignant transformation of mammalian somatic cells. Human cells must breach at least two distinct senescence barriers to permit unfettered clonal evolution during cancer development: (1) stress- or oncogene-induced premature senescence (SIPS/OIS), mediated via the p16-Rb and/or ARF-p53-p21 tumour-suppressive pathways, and (2) replicative senescence triggered by telomere shortening. In contrast, because their telomerase is constitutively active, cells from small rodents possess only the SIPS/OIS barrier, and are therefore useful for studying SIPS/OIS bypass in isolation. Dermal fibroblasts from the Syrian hamster (SHD cells) are exceptionally resistant to spontaneous SIPS bypass, but it can be readily induced following exposure to a wide range of chemical and physical carcinogens. Here we show that a spectrum of carcinogen-specific mutational and epigenetic alterations involving the INK4A (p16), p53 and INK4B (p15) genes are associated with induced SIPS bypass. With ionizing radiation, immortalization is invariably accompanied by efficient biallelic deletion of the complete INK4/CDKN2 locus. In comparison, SHD cells immortalized by the powerful polycyclic hydrocarbon carcinogen benzo(a)pyrene display transversion point mutations in the DNA-binding domain of p53 coupled with INK4 alterations such as loss of expression of p15. Epimutational silencing of p16 is the primary event associated with immortalization by nickel, a human non-genotoxic carcinogen. As SIPS/OIS bypass is a prerequisite for the immortalization of normal diploid human epithelial cells, our results with the SHD model will provide a basis for delineating combinations of key molecular changes underpinning this important event in human carcinogenesis. Oncogene (2013) 32, 171-179; doi:10.1038/onc.2012.45; published online 12 March 2012	[Yasaei, H.; Gilham, E.; Pickles, J. C.; Roberts, T. P.; Newbold, R. F.] Brunel Univ, Sch Hlth Sci & Social Care, Inst Canc Genet & Pharmacogen, Div Biosci, Uxbridge UB8 3PH, Middx, England; [O'Donovan, M.] AstraZeneca R&D, Safety Assessment Grp, Macclesfield, Cheshire, England	Brunel University; AstraZeneca	Newbold, RF (corresponding author), Brunel Univ, Sch Hlth Sci & Social Care, Inst Canc Genet & Pharmacogen, Div Biosci, Kingston Lane, Uxbridge UB8 3PH, Middx, England.	robert.newbold@brunel.ac.uk	Roberts, Terry/A-8211-2014; Yasaei, Hemad/A-6351-2014	Pickles, Jessica/0000-0001-7888-1723	(UK) National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [G0800697/1]; UK BBSRC-CASE Studentship; Unilever Plc.; AstraZeneca; National Centre for the Replacement [NC/K500045/1, G0800697/1] Funding Source: researchfish	(UK) National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs); UK BBSRC-CASE Studentship; Unilever Plc.; AstraZeneca(AstraZeneca); National Centre for the Replacement	This work was fully funded by triennial Project Grant to RFN and MUD (ID G0800697/1) from the (UK) National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs). JCP is funded by a UK BBSRC-CASE Studentship award with Unilever Plc. EG was funded by a grant from AstraZeneca. We acknowledge Mrs Alison Marriott and Dr Rana Hasan for their expert technical assistance. We dedicate this article to colleagues Professor Philip D Lawley (1927-2011) who pioneered research into the reaction of alkylating carcinogens with DNA; and to Steven Pash (1955-2011) who assisted expertly with the generation of hamster cell cultures.	Arita A, 2009, METALLOMICS, V1, P222, DOI 10.1039/b903049b; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Camacho CV, 2010, CARCINOGENESIS, V31, P1889, DOI 10.1093/carcin/bgq153; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Chang KW, 2000, CARCINOGENESIS, V21, P1441, DOI 10.1093/carcin/21.7.1441; Chang KW, 1996, CARCINOGENESIS, V17, P595, DOI 10.1093/carcin/17.3.595; CHANG KW, 1994, CANCER RES, V54, P3878; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Creton S, 2012, MUTAGENESIS, V27, P93, DOI 10.1093/mutage/ger053; Csepregi A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-317; Florl AR, 2003, GENE CHROMOSOME CANC, V37, P141, DOI 10.1002/gcc.10192; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; GimenezConti IB, 1996, MOL CARCINOGEN, V16, P197, DOI 10.1002/(SICI)1098-2744(199608)16:4<197::AID-MC3>3.0.CO;2-D; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Grafstrom E, 2005, CLIN CANCER RES, V11, P2991, DOI 10.1158/1078-0432.CCR-04-1731; Haga K, 2007, CANCER SCI, V98, P147, DOI 10.1111/j.1349-7006.2006.00373.x; Hanaoka M, 2005, BIOCHEM BIOPH RES CO, V333, P1249, DOI 10.1016/j.bbrc.2005.06.034; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; LACONI S, 1995, CANCER RES, V55, P2560; Lam TK, 2009, ANN EPIDEMIOL, V19, P546, DOI 10.1016/j.annepidem.2009.03.003; LEGROS Y, 1992, GENE, V112, P247, DOI 10.1016/0378-1119(92)90384-2; Li JN, 2004, CARCINOGENESIS, V25, P263, DOI 10.1093/carcin/bgh007; Li JN, 2003, BIOCHEM BIOPH RES CO, V304, P241, DOI 10.1016/S0006-291X(03)00577-1; Li J, 2008, MOL CARCINOGEN, V47, P733, DOI 10.1002/mc.20424; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Liu ZP, 2005, CANCER RES, V65, P2583, DOI 10.1158/0008-5472.CAN-04-3675; Muscarella P, 2001, GENE, V278, P235, DOI 10.1016/S0378-1119(01)00728-4; NEWBOLD RF, 1977, MUTAT RES, V43, P101, DOI 10.1016/0027-5107(77)90136-1; NEWBOLD RF, 1976, NATURE, V261, P52, DOI 10.1038/261052a0; NEWBOLD RF, 1982, NATURE, V299, P633, DOI 10.1038/299633a0; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; NEWBOLD RF, 1980, NATURE, V283, P596, DOI 10.1038/283596a0; Newbold RF, 2005, INTRO CELLULAR MOL B, P170; Odell A, 2010, AGING-US, V2, P160, DOI 10.18632/aging.100129; OREFFO VIC, 1993, CARCINOGENESIS, V14, P451, DOI 10.1093/carcin/14.3.451; Peters G, 2008, NAT STRUCT MOL BIOL, V15, P1133, DOI 10.1038/nsmb1108-1133; POPESCU NC, 1995, CYTOGENET CELL GENET, V68, P71, DOI 10.1159/000133893; Raschke S, 2005, GENE CHROMOSOME CANC, V42, P58, DOI 10.1002/gcc.20119; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Russo I, 1998, ONCOGENE, V17, P3417, DOI 10.1038/sj.onc.1202261; Seluanov A, 2008, AGING CELL, V7, P813, DOI 10.1111/j.1474-9726.2008.00431.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; TROTT DA, 1995, CARCINOGENESIS, V16, P193, DOI 10.1093/carcin/16.2.193; Whibley C, 2010, J BIOL CHEM, V285, P11326, DOI 10.1074/jbc.M109.064444; Windhofer F, 2008, MUTAT RES-FUND MOL M, V638, P56, DOI 10.1016/j.mrfmmm.2007.08.016; Yaswen P, 2002, INT J BIOCHEM CELL B, V34, P1382, DOI 10.1016/S1357-2725(02)00047-X	50	40	42	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2013	32	2					171	179		10.1038/onc.2012.45	http://dx.doi.org/10.1038/onc.2012.45			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22410783	Bronze			2022-12-25	WOS:000314075500005
J	Alonso-del-Rivero, M; Trejo, SA; Reytor, ML; Rodriguez-de-la-Vega, M; Delfin, J; Diaz, J; Gonzalez-Gonzalez, Y; Canals, F; Chavez, MA; Aviles, FX				Alonso-del-Rivero, Maday; Trejo, Sebastian A.; Reytor, Mey L.; Rodriguez-de-la-Vega, Monica; Delfin, Julieta; Diaz, Joaquin; Gonzalez-Gonzalez, Yamile; Canals, Francesc; Angeles Chavez, Maria; Aviles, Francesc X.			Tri-domain Bifunctional Inhibitor of Metallocarboxypeptidases A and Serine Proteases Isolated from Marine Annelid Sabellastarte magnifica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; ENDOGENOUS PROTEIN INHIBITOR; AMINO-ACID-SEQUENCE; CARBOXYPEPTIDASE INHIBITOR; SEA-ANEMONE; 3-DIMENSIONAL STRUCTURE; ELASTASE INHIBITORS; CRYSTAL-STRUCTURE; ACTINIA-EQUINA; CDNA CLONING	This study describes a novel bifunctional metallocarboxypeptidase and serine protease inhibitor (SmCI) isolated from the tentacle crown of the annelid Sabellastarte magnifica. SmCI is a 165-residue glycoprotein with a molecular mass of 19.69 kDa (mass spectrometry) and 18 cysteine residues forming nine disulfide bonds. Its cDNA was cloned and sequenced by RT-PCR and nested PCR using degenerated oligonucleotides. Employing this information along with data derived from automatic Edman degradation of peptide fragments, the SmCI sequence was fully characterized, indicating the presence of three bovine pancreatic trypsin inhibitor/Kunitz domains and its high homology with other Kunitz serine protease inhibitors. Enzyme kinetics and structural analyses revealed SmCI to be an inhibitor of human and bovine pancreatic metallocarboxypeptidases of the A-type (but not B-type), with nanomolar K-i values. SmCI is also capable of inhibiting bovine pancreatic trypsin, chymotrypsin, and porcine pancreatic elastase in varying measures. When the inhibitor and its nonglycosylated form (SmCI N23A mutant) were overproduced recombinantly in a Pichia pastoris system, they displayed the dual inhibitory properties of the natural form. Similarly, two bi-domain forms of the inhibitor (recombinant rSmCI D1-D2 and rSmCI D2-D3) as well as its C-terminal domain (rSmCI-D3) were also overproduced. Of these fragments, only the rSmCI D1-D2 bi-domain retained inhibition of metallocarboxypeptidase A but only partially, indicating that the whole tri-domain structure is required for such capability in full. SmCI is the first proteinaceous inhibitor of metallocarboxypeptidases able to act as well on another mechanistic class of proteases (serine-type) and is the first of this kind identified in nature.	[Alonso-del-Rivero, Maday; Reytor, Mey L.; Delfin, Julieta; Diaz, Joaquin; Gonzalez-Gonzalez, Yamile; Angeles Chavez, Maria] Univ La Habana, Fac Biol, Ctr Estudio Prot, Havana 10400, Cuba; [Canals, Francesc] Hosp Valle De Hebron, Inst Recerca, E-08193 Barcelona, Spain; [Trejo, Sebastian A.; Rodriguez-de-la-Vega, Monica; Aviles, Francesc X.] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Trejo, Sebastian A.; Rodriguez-de-la-Vega, Monica; Aviles, Francesc X.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Universidad de la Habana; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Autonomous University of Barcelona	Chavez, MA (corresponding author), Univ La Habana, Fac Biol, Ctr Estudio Prot, Havana 10400, Cuba.	mchavez@infomed.sld.cu; FrancescXavier.Aviles@uab.es	Rodriguez de la Vega Otazo, Monica Margarita/H-7008-2015; Avilés, Francesc Xavier/A-2664-2015; Aviles, Francesc Xavier/F-3482-2019	Rodriguez de la Vega Otazo, Monica Margarita/0000-0002-1061-3471; Avilés, Francesc Xavier/0000-0002-1399-6789; Aviles, Francesc Xavier/0000-0002-1399-6789; Alonso del Rivero Antigua, Maday/0000-0003-1988-6852; Reytor Gonzalez, Mey Ling/0000-0002-0903-8772; Trejo, Sebastian/0000-0003-2866-5613	International Science Foundation, Sweden [F3342-1, F3342-2, F3276-1]; Ministerio de Ciencia e Innovacion, Spain [BIO2010-22321]; Xarxa de Referencia de Biotecnologia (Generalitat de Catalunya); Ministerio de Educacion y Ciencia of Spain; Agency for the Management of Grants from University and Research of Catalonia (Generalitat de Catalunya)	International Science Foundation, Sweden; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xarxa de Referencia de Biotecnologia (Generalitat de Catalunya); Ministerio de Educacion y Ciencia of Spain(Spanish Government); Agency for the Management of Grants from University and Research of Catalonia (Generalitat de Catalunya)	This work was supported in part by Grants F3342-1, F3342-2, and F3276-1 from the International Science Foundation, Sweden, Grant BIO2010-22321 from Ministerio de Ciencia e Innovacion, Spain, and by Xarxa de Referencia de Biotecnologia (Generalitat de Catalunya).; Recipient of a visiting fellowship from Ministerio de Educacion y Ciencia of Spain.; Recipient of a visitor grant from Agency for the Management of Grants from University and Research of Catalonia (Generalitat de Catalunya). To whom correspondence may be addressed. Tel.: 53-7832-4830; E-mail: mchavez@infomed.sld.cu.	Alonso del Rivero M., 2003, REV BIOL, V17, P80; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arolas JL, 2005, J MOL BIOL, V350, P489, DOI 10.1016/j.jmb.2005.05.015; Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Arolas JL, 2004, BIOCHEMISTRY-US, V43, P7973, DOI 10.1021/bi049596j; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Azzolini SS, 2003, ARCH BIOCHEM BIOPHYS, V417, P176, DOI 10.1016/S0003-9861(03)00344-8; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P561; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BERGER A, 1970, PHILOS T R SOC B, V257, P249, DOI 10.1098/rstb.1970.0024; Bergmeyer H. U., 1974, METHOD ENZYMAT AN, V1, P436; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chand HS, 2004, J BIOL CHEM, V279, P17500, DOI 10.1074/jbc.M400802200; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chavez M., 1998, Toxicon, V36, P1275; Czapinska H, 2000, J MOL BIOL, V295, P1237, DOI 10.1006/jmbi.1999.3445; Delfin J, 1994, Arch Med Res, V25, P199; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Franco OL, 2002, PROTEINS, V49, P335, DOI 10.1002/prot.10228; FRITZ H, 1983, ARZNEIMITTELFORSCH, V33-1, P479; FRITZ H, 1972, H-S Z PHYSIOL CHEM, V353, P19, DOI 10.1515/bchm2.1972.353.1.19; Gong HY, 2007, J INSECT PHYSIOL, V53, P1079, DOI 10.1016/j.jinsphys.2007.06.008; Gonzalez Y, 2004, TOXICON, V43, P219, DOI 10.1016/j.toxicon.2003.11.016; Gonzalez Y, 2007, BIOL CHEM, V388, P1183, DOI 10.1515/BC.2007.129; Gonzalez Y, 2007, COMP BIOCHEM PHYS A, V146, P506, DOI 10.1016/j.cbpa.2006.01.022; Grzesiak A, 2000, J MOL BIOL, V301, P205, DOI 10.1006/jmbi.2000.3935; GUASCH A, 1992, J MOL BIOL, V224, P141, DOI 10.1016/0022-2836(92)90581-4; HASS GM, 1981, BIOCHEMISTRY-US, V20, P2256, DOI 10.1021/bi00511a029; Hiraga K, 2000, J BIOL CHEM, V275, P25173, DOI 10.1074/jbc.M002623200; HOCHSTRASSER K, 1983, H-S Z PHYSIOL CHEM, V364, P1689, DOI 10.1515/bchm2.1983.364.2.1689; HOMANDBERG GA, 1989, ARCH BIOCHEM BIOPHYS, V270, P153, DOI 10.1016/0003-9861(89)90017-9; Huerta V., 1988, BIOTECNOLOGIA APLICA, V15, P108; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Kajan L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-304; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KOLKENBROCK H, 1987, BIOL CHEM H-S, V368, P93, DOI 10.1515/bchm3.1987.368.1.93; Krowarsch D, 1999, J MOL BIOL, V289, P175, DOI 10.1006/jmbi.1999.2757; Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski Jr. M., 2000, PROTEIN PROTEIN RECO, P228; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lenarcic B, 1997, J BIOL CHEM, V272, P13899; Liu Q, 2000, MOL BIOL REP, V27, P241, DOI 10.1023/A:1010971219806; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; MARTIN P, 1980, BIOCHIM BIOPHYS ACTA, V612, P410, DOI 10.1016/0005-2744(80)90124-2; Mateo C, 2007, BIOCHEM SOC T, V35, P1593, DOI 10.1042/BST0351593; McBride JD, 1999, EUR J BIOCHEM, V266, P403, DOI 10.1046/j.1432-1327.1999.00867.x; MEBS D, 1980, TOXICON, V18, P97, DOI 10.1016/0041-0101(80)90035-5; Milstone AM, 2000, J BIOL CHEM, V275, P29391, DOI 10.1074/jbc.M002715200; Minagawa S, 1997, COMP BIOCHEM PHYS B, V118, P381, DOI 10.1016/S0305-0491(97)00174-0; Mitteilung Z, 1976, J Clin Chem Clin Biochem, V14, P245; Mock WL, 1996, ANAL BIOCHEM, V239, P218, DOI 10.1006/abio.1996.0318; Mock WL, 1999, BIOORG MED CHEM LETT, V9, P187, DOI 10.1016/S0960-894X(98)00715-X; Nagle GT, 2001, EUR J BIOCHEM, V268, P1213, DOI 10.1046/j.1432-1327.2001.01972.x; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; Normant E, 1995, P NATL ACAD SCI USA, V92, P12225, DOI 10.1073/pnas.92.26.12225; Otlewski J, 1999, ACTA BIOCHIM POL, V46, P531, DOI 10.18388/abp.1999_4128; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; Pascual I, 2004, INT J BIOCHEM CELL B, V36, P138, DOI 10.1016/S1357-2725(03)00175-4; REES DC, 1980, P NATL ACAD SCI-BIOL, V77, P4633, DOI 10.1073/pnas.77.8.4633; Reverter D, 1998, J BIOL CHEM, V273, P32927, DOI 10.1074/jbc.273.49.32927; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Strukelj B, 2000, BIOCHEM BIOPH RES CO, V269, P732, DOI 10.1006/bbrc.2000.2356; Tanaka AS, 1999, IMMUNOPHARMACOLOGY, V45, P171, DOI 10.1016/S0162-3109(99)00074-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSCHESCHE H, 1987, BIOL CHEM H-S, V368, P1297, DOI 10.1515/bchm3.1987.368.2.1297; Vallee F, 1998, STRUCTURE, V6, P649, DOI 10.1016/S0969-2126(98)00066-5; Vendrell J., 2006, HDB METALLOPROTEINS, V3, P176; Ventura S, 1999, J BIOL CHEM, V274, P19925, DOI 10.1074/jbc.274.28.19925; Villanueva J, 1998, FEBS LETT, V440, P175, DOI 10.1016/S0014-5793(98)01447-1; Williams J W, 1979, Methods Enzymol, V63, P437; Xu YB, 1998, J MOL BIOL, V276, P955, DOI 10.1006/jmbi.1997.1582; ZEMKE KJ, 1991, FEBS LETT, V279, P240, DOI 10.1016/0014-5793(91)80158-Y; ZYKOVA TA, 1985, BIOORG KHIM+, V11, P293; Zykova TA, 1998, BIOORG KHIM+, V24, P509	79	20	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15427	15438		10.1074/jbc.M111.337261	http://dx.doi.org/10.1074/jbc.M111.337261			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411994	Green Published, hybrid			2022-12-25	WOS:000304006300024
J	Carroll, SH; Wigner, NA; Kulkarni, N; Johnston-Cox, H; Gerstenfeld, LC; Ravid, K				Carroll, Shannon H.; Wigner, Nathan A.; Kulkarni, Nitin; Johnston-Cox, Hillary; Gerstenfeld, Louis C.; Ravid, Katya			A2B Adenosine Receptor Promotes Mesenchymal Stem Cell Differentiation to Osteoblasts and Bone Formation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARROW STROMAL CELLS; SMOOTH-MUSCLE-CELLS; OSTEOGENIC DIFFERENTIATION; FRACTURE REPAIR; EXPRESSION; ACTIVATION; RELEASE; PROTEIN; VITRO; GENE	The differentiation of osteoblasts from their precursors, mesenchymal stem cells, is an important component of bone homeostasis as well as fracture healing. The A2B adenosine receptor (A2BAR) is a G alpha(s)/alpha(q)-protein-coupled receptor that signals via cAMP. cAMP-mediated signaling has been demonstrated to regulate the differentiation of mesenchymal stem cells (MSCs) into various skeletal tissue lineages. Here, we studied the role of this receptor in the differentiation of MSCs to osteoblasts. In vitro differentiation of bone marrow-derived MSCs from A2BAR KO mice resulted in lower expression of osteoblast differentiation transcription factors and the development of fewer mineralized nodules, as compared with WT mice. The mechanism of effect involves, at least partially, cAMP as indicated by experiments involving activation of the A2BAR or addition of a cAMP analog during differentiation. Intriguingly, in vivo, microcomputed tomography analysis of adult femurs showed lower bone density in A2BAR KO mice as compared with WT. Furthermore, A2BAR KO mice display a delay in normal fracture physiology with lower expression of osteoblast differentiation genes. Thus, our study identified the A2BAR as a new regulator of osteoblast differentiation, bone formation, and fracture repair.	[Ravid, Katya] Boston Univ, Sch Med, CVI, Dept Biochem, Boston, MA 02118 USA; [Wigner, Nathan A.; Kulkarni, Nitin; Gerstenfeld, Louis C.] Boston Univ, Sch Med, Dept Orthoped Surg, Boston, MA 02118 USA; [Johnston-Cox, Hillary; Ravid, Katya] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Ravid, K (corresponding author), Boston Univ, Sch Med, CVI, Dept Biochem, W-601,700 Albany St, Boston, MA 02118 USA.	kravid@bu.edu		Ravid, Katya/0000-0002-9918-3024; /0000-0002-0477-1211	National Institutes of Health [HL93149, AR046121]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007501, R01HL093149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL93149 (to K. R.). This work was also supported in part by National Institutes of Health Grant AR046121.	Costa MA, 2011, J CELL PHYSIOL, V226, P1353, DOI 10.1002/jcp.22458; Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016; Aspenberg P, 2010, ACTA ORTHOP, V81, P236, DOI 10.3109/17453671003761946; Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Borjesson AE, 2010, J BONE MINER RES, V25, P2414, DOI 10.1002/jbmr.156; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Evans BAJ, 2006, J BONE MINER RES, V21, P228, DOI 10.1359/JBMR.051021; Evans K, 2006, PERCEPT MOTOR SKILL, V103, P619, DOI 10.2466/PMS.103.2.619-628; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gharibi B, 2011, J BONE MINER RES, V26, P2112, DOI 10.1002/jbmr.424; Ghayor C, 2009, BIOCHEM BIOPH RES CO, V381, P247, DOI 10.1016/j.bbrc.2009.02.032; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Hilaire CS, 2008, BIOCHEM BIOPH RES CO, V375, P292, DOI 10.1016/j.bbrc.2008.07.059; Hoebertz A, 2003, TRENDS PHARMACOL SCI, V24, P290, DOI 10.1016/S0165-6147(03)00123-8; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Jepsen KJ, 2008, J BONE MINER RES, V23, P1204, DOI 10.1359/JBMR.080317; Jorgensen Niklas R, 2011, Curr Osteoporos Rep, V9, P149, DOI 10.1007/s11914-011-0065-0; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Koolpe M, 1999, ARTHRITIS RHEUM, V42, P258, DOI 10.1002/1529-0131(199902)42:2<258::AID-ANR7>3.0.CO;2-O; Lanske B, 1999, J CLIN INVEST, V104, P399, DOI 10.1172/JCI6629; Lo KWH, 2012, J TISSUE ENG REGEN M, V6, P40, DOI 10.1002/term.395; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787; Nagata A, 2009, J CELL PHYSIOL, V221, P75, DOI 10.1002/jcp.21831; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0; Ravid K, 1999, J CELL BIOCHEM, V75, P177, DOI 10.1002/(SICI)1097-4644(19991001)75:1<177::AID-JCB18>3.3.CO;2-N; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Siddappa R, 2009, TISSUE ENG PT A, V15, P2135, DOI 10.1089/ten.tea.2008.0512; Sugama R, 2006, BONE, V38, P206, DOI 10.1016/j.bone.2005.08.006; Tai GP, 2004, TISSUE ENG, V10, P1456, DOI 10.1089/1076327042500300; Takedachi M, 2012, J CELL PHYSIOL, V227, P2622, DOI 10.1002/jcp.23001; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; TURKSEN K, 1990, J CELL PHYSIOL, V142, P61, DOI 10.1002/jcp.1041420109; Wigner NA, 2010, J BONE MINER RES, V25, P724, DOI 10.1359/jbmr.091021; Xu Y, 2008, J BIOL CHEM, V283, P14213, DOI 10.1074/jbc.M708657200; Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Zhao ZR, 2005, MOL THER, V12, P247, DOI 10.1016/j.ymthe.2005.03.009	52	121	125	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15718	15727		10.1074/jbc.M112.344994	http://dx.doi.org/10.1074/jbc.M112.344994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403399	Green Published, hybrid			2022-12-25	WOS:000304006300050
J	Martinez, FP; Tang, QY				Martinez, Francisco Puerta; Tang, Qiyi			Leucine Zipper Domain Is Required for Kaposi Sarcoma-associated Herpesvirus (KSHV) K-bZIP Protein to Interact with Histone Deacetylase and Is Important for KSHV Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; PRIMARY EFFUSION LYMPHOMA; MULTICENTRIC CASTLEMANS-DISEASE; CREB-BINDING PROTEIN; CELL-CYCLE ARREST; GENE-EXPRESSION; HUMAN CYTOMEGALOVIRUS; DNA-REPLICATION; LYTIC REPLICATION; SPINDLE CELLS	The Kaposi sarcoma-associated herpesvirus (KSHV; or human herpesvirus-8)-encoded protein called K-bZIP (also named K8) was found to be multifunctional. In this study, we discovered that K-bZIP interacts with histone deacetylase (HDAC) 1/2 in 12-O-tetradecanoylphorbol-13-acetate-stimulated BCBL-1 lymphocyte cells. K-bZIP appears to repress HDAC activity through this interaction, which we determined to be independent of K-bZIP SUMOylation. We dissected the domains of K-bZIP and found that the leucine zipper (LZ) domain is essential for the interaction of K-bZIP and HDAC. In addition, we constructed a KSHV bacterial artificial chromosome (BAC) with LZ domain-deleted K-bZIP (KSHVdLZ) and transfected this mutated KSHV BAC DNA into HEK 293T cells. As a result, it was consistently found that K-bZIP without its LZ domain failed to interact with HDAC2. We also showed that the interaction between K-bZIP and HDAC is necessary for the inhibition of the lytic gene promoters (ORF50 and OriLyt) of KSHV by K-bZIP. Furthermore, we found that the LZ domain is also important for the interaction of K-bZIP with the promoters of ORF50 and OriLyt. Most interestingly, although it was found to have suppressive effects on the promoters of ORF50 and OriLyt, KSHVdLZ replicates at a significantly lower level than its BAC-derived revertant (KSHVdLZRev) or KSHVWT (BAC36) in HEK 293T cells. The defectiveness of KSHVdLZ replication can be partially rescued by siRNA against HDAC2. Our results suggest that the function of K-bZIP interaction with HDAC is two-layered. 1) K-bZIP inhibits HDAC activity generally so that KSHVdLZ replicates at a lower level than does KSHVWT. 2) K-bZIP can recruit HDAC to the promoters of OriLyt and ORF50 through interaction with HDAC for K-bZIP to have a temporary repressive effect on the two promoters.	[Martinez, Francisco Puerta; Tang, Qiyi] Ponce Sch Med, Res Ctr Minor Inst RCMI Program, Ponce, PR 00716 USA		Tang, QY (corresponding author), Ponce Sch Med, Res Ctr Minor Inst RCMI Program, Ponce, PR 00716 USA.	qtang@psm.edu			National Institutes of Health [U54RR022762]; National Center for Research Resources; RCMI Program Pilot [2G12RR003050-24]; American Cancer Society [RSG-090289-01-MPC]; American Cancer Society Institutional Research [IRG-92-032-13, Subaward 60-14599-01-01-S6]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050, U54RR022762] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); RCMI Program Pilot; American Cancer Society(American Cancer Society); American Cancer Society Institutional Research(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant U54RR022762 from the National Center for Research Resources (to Q. T.). This work was also supported by RCMI Program Pilot Grant 2G12RR003050-24 (to Q. T.), American Cancer Society Grant RSG-090289-01-MPC (to Q. T), and American Cancer Society Institutional Research Grant IRG-92-032-13, Subaward 60-14599-01-01-S6 (to Q. T.).	Al Mehairi S, 2005, J VIROL, V79, P7905, DOI 10.1128/JVI.79.12.7905-7910.2005; AMBROZIAK JA, 1995, SCIENCE, V268, P582, DOI 10.1126/science.7725108; Biberfeld P, 1998, CURR OPIN INFECT DIS, V11, P97, DOI 10.1097/00001432-199804000-00002; Blasig C, 1997, J VIROL, V71, P7963, DOI 10.1128/JVI.71.10.7963-7968.1997; BOSHOFF C, 1995, NAT MED, V1, P1274, DOI 10.1038/nm1295-1274; Boshoff C, 2001, ANNU REV MED, V52, P453, DOI 10.1146/annurev.med.52.1.453; Byun H, 2002, MOL CELLS, V14, P185; Carroll KD, 2006, J VIROL, V80, P9697, DOI 10.1128/JVI.00746-06; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chang PC, 2010, J BIOL CHEM, V285, P5266, DOI 10.1074/jbc.M109.088088; Chang PJ, 2011, VIROLOGY, V413, P194, DOI 10.1016/j.virol.2011.02.013; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Diamond C, 1998, J VIROL, V72, P6223, DOI 10.1128/JVI.72.7.6223-6227.1998; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Ellison TJ, 2009, VIROLOGY, V387, P76, DOI 10.1016/j.virol.2009.02.016; Ferenczy MW, 2009, J VIROL, V83, P8514, DOI 10.1128/JVI.00785-09; Gradoville L, 2000, J VIROL, V74, P6207, DOI 10.1128/JVI.74.13.6207-6212.2000; Gruffat H, 1999, J GEN VIROL, V80, P557, DOI 10.1099/0022-1317-80-3-557; Huang LM, 2001, J BIOL CHEM, V276, P13427, DOI 10.1074/jbc.M011314200; Hwang S, 2003, J GEN VIROL, V84, P665, DOI 10.1099/vir.0.18699-0; Hwang S, 2001, J VIROL, V75, P9509, DOI 10.1128/JVI.75.19.9509-9516.2001; Izumiya Y, 2005, J VIROL, V79, P9912, DOI 10.1128/JVI.79.15.9912-9925.2005; Izumiya Y, 2003, J VIROL, V77, P9652, DOI 10.1128/JVI.77.17.9652-9661.2003; Izumiya Y, 2003, J VIROL, V77, P1441, DOI 10.1128/JVI.77.2.1441-1451.2003; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kalejta RF, 2008, CURR TOP MICROBIOL, V325, P101; Katano H, 2001, VIROLOGY, V286, P446, DOI 10.1006/viro.2001.1005; Kato-Noah T, 2007, J VIROL, V81, P13519, DOI 10.1128/JVI.00832-07; Lefort S, 2007, J VIROL, V81, P10950, DOI 10.1128/JVI.00183-07; Lefort S, 2009, J VIROL, V83, P5869, DOI 10.1128/JVI.01821-08; Liao W, 2003, J VIROL, V77, P3809, DOI 10.1128/JVI.77.6.3809-3815.2003; Lin Cui Li, 2003, Journal of Virology, V77, P5578, DOI 10.1128/JVI.77.10.5578-5588.2003; Lin SF, 1999, J VIROL, V73, P1909, DOI 10.1128/JVI.73.3.1909-1917.1999; Lindsay CR, 2008, FRONT BIOSCI-LANDMRK, V13, P7132, DOI 10.2741/3216; Lu F, 2006, J VIROL, V80, P5273, DOI 10.1128/JVI.02541-05; Maul GG, 2008, CURR TOP MICROBIOL, V325, P117; Michaelis M, 2005, INVEST OPHTH VIS SCI, V46, P3451, DOI 10.1167/iovs.05-0369; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nevels M, 2004, P NATL ACAD SCI USA, V101, P17234, DOI 10.1073/pnas.0407933101; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Park J, 2000, J VIROL, V74, P11977, DOI 10.1128/JVI.74.24.11977-11982.2000; Park JJ, 2007, J GEN VIROL, V88, P3214, DOI 10.1099/vir.0.83171-0; Portes-Sentis S, 2001, J GEN VIROL, V82, P507, DOI 10.1099/0022-1317-82-3-507; Reinke AW, 2010, BIOCHEMISTRY-US, V49, P1985, DOI 10.1021/bi902065k; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Seaman WT, 1999, VIROLOGY, V263, P436, DOI 10.1006/viro.1999.9963; Seaman WT, 2003, VIROLOGY, V310, P72, DOI 10.1016/S0042-6822(03)00095-3; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Staskus KA, 1997, J VIROL, V71, P715, DOI 10.1128/JVI.71.1.715-719.1997; Sturzl M, 1997, INT J CANCER, V72, P68, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;68::AID-IJC10&gt;3.0.CO;2-6; Tang QY, 2006, J VIROL, V80, P7510, DOI 10.1128/JVI.00684-06; Tang QY, 2000, J VIROL, V74, P9694, DOI 10.1128/JVI.74.20.9694-9700.2000; Tang QY, 2003, J VIROL, V77, P1357, DOI 10.1128/JVI.77.2.1357-1367.2003; Tang S, 2002, J BIOL CHEM, V277, P14547, DOI 10.1074/jbc.M111308200; Tomita M, 2004, ONCOGENE, V23, P8272, DOI 10.1038/sj.onc.1208059; Viejo-Borbolla Abel, 2003, AIDS Rev, V5, P222; Wang SZE, 2004, J VIROL, V78, P4248, DOI 10.1128/JVI.78.8.4248-4267.2004; Wang Y, 2004, VIROLOGY, V325, P149, DOI 10.1016/j.virol.2004.04.030; Wang Y, 2008, J VIROL, V82, P2867, DOI 10.1128/JVI.01319-07; Wang Y, 2011, J VIROL, V85, P1943, DOI 10.1128/JVI.02060-10; Warden C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/124595; Wu FY, 2003, J VIROL, V77, P8893, DOI 10.1128/JVI.77.16.8893-8914.2003; Wu FY, 2002, P NATL ACAD SCI USA, V99, P10683, DOI 10.1073/pnas.162352299; Wu FY, 2001, J VIROL, V75, P1487, DOI 10.1128/JVI.75.3.1487-1506.2001; Yamanegi K, 2005, J VIROL, V79, P14207, DOI 10.1128/JVI.79.22.14207-14221.2005; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Ye JJ, 2007, J VIROL, V81, P9279, DOI 10.1128/JVI.00982-07; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002	70	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15622	15634		10.1074/jbc.M111.315861	http://dx.doi.org/10.1074/jbc.M111.315861			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416134	Green Published, hybrid			2022-12-25	WOS:000304006300042
J	Osborne, SE; Tuinema, BR; Mok, MCY; Lau, PS; Bui, NK; Tomljenovic-Berube, AM; Vollmer, W; Zhang, K; Junop, M; Coombes, BK				Osborne, Suzanne E.; Tuinema, Brian R.; Mok, Mac C. Y.; Lau, Pui Sai; Bui, Nhat Khai; Tomljenovic-Berube, Ana M.; Vollmer, Waldemar; Zhang, Kun; Junop, Murray; Coombes, Brian K.			Characterization of DalS, an ATP-binding Cassette Transporter for D-Alanine, and Its Role in Pathogenesis in Salmonella enterica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENICITY ISLAND-2; PEPTIDOGLYCAN STRUCTURE; SECRETION SYSTEM; VIRULENCE GENES; EXPRESSION; PROTEIN; IDENTIFICATION; TYPHIMURIUM; SURVIVAL	Expansion into new host niches requires bacterial pathogens to adapt to changes in nutrient availability and to evade an arsenal of host defenses. Horizontal acquisition of Salmonella Pathogenicity Island (SPI)-2 permitted the expansion of Salmonella enterica serovar Typhimurium into the intracellular environment of host cells by allowing it to deliver bacterial effector proteins across the phagosome membrane. This is facilitated by the SsrA-SsrB two-component regulatory system and a type III secretion system encoded within SPI-2. SPI-2 acquisition was followed by evolution of existing regulatory DNA, creating an expanded SsrB regulon involved in intracellular fitness and host infection. Here, we identified an SsrB-regulated operon comprising an ABC transporter in Salmonella. Biochemical and structural studies determined that the periplasmic solute-binding component, STM1633/DalS, transports D-alanine and that DalS is required for intracellular survival of the bacteria and for fitness in an animal host. This work exemplifies the role of nutrient exchange at the host-pathogen interface as a critical determinant of disease outcome.	[Osborne, Suzanne E.; Tuinema, Brian R.; Tomljenovic-Berube, Ana M.; Junop, Murray; Coombes, Brian K.] Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Osborne, Suzanne E.; Tuinema, Brian R.; Mok, Mac C. Y.; Lau, Pui Sai; Tomljenovic-Berube, Ana M.; Zhang, Kun; Junop, Murray; Coombes, Brian K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Bui, Nhat Khai; Vollmer, Waldemar] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	McMaster University; McMaster University; Newcastle University - UK	Coombes, BK (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	coombes@mcmaster.ca	Junop, Murray S/E-4160-2015	Junop, Murray S/0000-0001-6676-5717; Tomljenovic-Berube, Ana/0000-0003-4733-7164; Coombes, Brian/0000-0001-9883-1010	Canadian Institutes of Health [MOP-82704]; Canada Research Chairs Program; Infrastructure Investment from the Canada Foundation for Innovation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Infrastructure Investment from the Canada Foundation for Innovation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by Canadian Institutes of Health Research Grant MOP-82704 (to B. K. C.), the Canada Research Chairs Program (to B. K. C.), and Infrastructure Investment from the Canada Foundation for Innovation (to B. K. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Folkesson A, 2005, CELL MICROBIOL, V7, P147, DOI 10.1111/j.1462-5822.2004.00443.x; Giuliani SE, 2008, BIOCHEMISTRY-US, V47, P13974, DOI 10.1021/bi801648r; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GOODELL EW, 1987, J BACTERIOL, V169, P3861, DOI 10.1128/jb.169.8.3861-3865.1987; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; OH BH, 1993, J BIOL CHEM, V268, P11348; Osborne SE, 2009, P NATL ACAD SCI USA, V106, P3982, DOI 10.1073/pnas.0811669106; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Quintela JC, 1997, MOL MICROBIOL, V23, P693, DOI 10.1046/j.1365-2958.1997.2561621.x; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Tomljenovic-Berube AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000875; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; YAO NH, 1994, BIOCHEMISTRY-US, V33, P4769, DOI 10.1021/bi00182a004; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306	28	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15242	15250		10.1074/jbc.M112.348227	http://dx.doi.org/10.1074/jbc.M112.348227			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418438	Green Published, hybrid			2022-12-25	WOS:000304006300008
J	Tan, SH; Shui, GH; Zhou, J; Li, JJ; Bay, BH; Wenk, MR; Shen, HM				Tan, Shi Hao; Shui, Guanghou; Zhou, Jing; Li, Jasmine Jia'En; Bay, Boon-Huat; Wenk, Markus R.; Shen, Han-Ming			Induction of Autophagy by Palmitic Acid via Protein Kinase C-mediated Signaling Pathway Independent of mTOR (Mammalian Target of Rapamycin)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE INSULIN-RESISTANCE; FATTY-ACIDS; CELL-DEATH; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; LIPID-METABOLISM; SELF-DIGESTION; DUAL ROLE; LIPOTOXICITY	Lipotoxicity refers to the cytotoxic effects of excess fat accumulation in cells and has been implicated as one of the contributing factors to diseases like obesity, diabetes, and non-alcoholic fatty liver. In this study we sought to examine effects of palmitic acid (PA) and oleic acid, two of the common dietary fatty acids on the autophagic process. We found that PA, but not oleic acid, was able to cause an increase in autophagic flux, evidenced by LC3-II accumulation and formation of GFP-LC3 puncta. Notably, PA-induced autophagy was found to be independent of mTOR regulation. Next, in search of the mechanism mediating PA-induced autophagy, we found increased levels of diacylglycerol species and protein kinase C (PKC) activation in PA-treated cells. More importantly, inhibition of classical PKC isoforms (PKC-alpha) was able to effectively suppress PA-induced autophagy. Finally, we showed that inhibition of autophagy sensitized the cells to PA-induced apoptosis, suggesting the pro-survival function of autophagy induced by PA. Taken together, results from this study reveal a novel mechanism underlying free fatty acid-mediated autophagy. Furthermore, the pro-survival function of autophagy suggests modulation of autophagy as a potential therapeutic strategy in protection of cells against lipotoxicity and lipid-related metabolic diseases.	[Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Li, Jasmine Jia'En; Bay, Boon-Huat] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Tan, Shi Hao; Zhou, Jing; Shen, Han-Ming] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Tan, Shi Hao; Wenk, Markus R.; Shen, Han-Ming] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Wenk, MR (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore.	markus_wenk@nuhs.edu.sg; han-ming_shen@nuhs.edu.sg	SHEN, Han-Ming/B-5942-2011; Wenk, Markus Rene/D-1441-2014	SHEN, Han-Ming/0000-0001-7369-5227; ZHOU, JING/0000-0002-2475-7783; Shui, Guanghou/0000-0002-1621-9643	Singapore National Medical Research Council [NMRC/1260/2010]; Singapore Biomedical Research Council [BMRC/08/1/21/19/554]; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore(National University of Singapore)	This work was supported in part by research grants from the Singapore National Medical Research Council (NMRC/1260/2010) and the Singapore Biomedical Research Council (BMRC/08/1/21/19/554) (to H.-M. S.).; Supported by a research scholarship from NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore.	Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Chen JL, 2009, AUTOPHAGY, V5, P244, DOI 10.4161/auto.5.2.7549; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; COLEMAN R, 1976, J BIOL CHEM, V251, P4537; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; GSCHWENDT M, 1991, TRENDS BIOCHEM SCI, V16, P167, DOI 10.1016/0968-0004(91)90064-3; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Hosokawa N, 2007, FEBS LETT, V581, P2623, DOI 10.1016/j.febslet.2006.04.008; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Piro S, 2002, METABOLISM, V51, P1340, DOI 10.1053/meta.2002.35200; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shui GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019731; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Wang X, 2010, EXP CLIN ENDOCR DIAB, V118, P657, DOI 10.1055/s-0030-1252069; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	50	124	128	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14364	14376		10.1074/jbc.M111.294157	http://dx.doi.org/10.1074/jbc.M111.294157			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22408252	hybrid, Green Published			2022-12-25	WOS:000304003200005
J	Yang, Y; Yu, Y; Cheng, J; Liu, Y; Liu, DS; Wang, J; Zhu, MX; Wang, R; Xu, TL				Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Wang, Jin; Zhu, Michael X.; Wang, Rui; Xu, Tian-Le			Highly Conserved Salt Bridge Stabilizes Rigid Signal Patch at Extracellular Loop Critical for Surface Expression of Acid-sensing Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CURRENT; K+ CHANNEL; DOMAIN; PROTEIN; ASIC1A; CONTRIBUTES; MECHANISMS; ISCHEMIA; NEURONS; BINDING	Acid-sensing ion channels (ASICs) are non-selective cation channels activated by extracellular acidosis associated with many physiological and pathological conditions. A detailed understanding of the mechanisms that govern cell surface expression of ASICs, therefore, is critical for better understanding of the cell signaling under acidosis conditions. In this study, we examined the role of a highly conserved salt bridge residing at the extracellular loop of rat ASIC3 (Asp(107)-Arg(153)) and human ASIC1a (Asp(107)-Arg(160)) channels. Comprehensive mutagenesis and electrophysiological recordings revealed that the salt bridge is essential for functional expression of ASICs in a pH sensing-independent manner. Surface biotinylation and immunolabeling of an extracellular epitope indicated that mutations, including even minor alterations, at the salt bridge impaired cell surface expression of ASICs. Molecular dynamics simulations, normal mode analysis, and further mutagenesis studies suggested a high stability and structural constrain of the salt bridge, which serves to separate an adjacent structurally rigid signal patch, important for surface expression, from a flexible gating domain. Thus, we provide the first evidence of structural requirement that involves a stabilizing salt bridge and an exposed rigid signal patch at the destined extracellular loop for normal surface expression of ASICs. These findings will allow evaluation of new strategies aimed at preventing excessive excitability and neuronal injury associated with tissue acidosis and ASIC activation.	[Yang, Yang; Wang, Rui] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Xu, Tian-Le] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Xu, Tian-Le] Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhu, Michael X.] Chinese Acad Sci, Shanghai Inst Mat Med, Int Scientist Workstn Neuropharmacol, Shanghai 201203, Peoples R China; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Wang, Jin; Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Physiol, Shanghai 200025, Peoples R China; [Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Wang, Jin; Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Biochem, Shanghai 200025, Peoples R China; [Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Wang, Jin; Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Mol Cell Biol, Shanghai 200025, Peoples R China	Lanzhou University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Texas System; University of Texas Health Science Center Houston; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, R (corresponding author), 222 Tian Shui S Rd, Lanzhou 730000, Peoples R China.	wangrui@lzu.edu.cn; xu-happiness@shsmu.edu.cn			National Basic Research Program of China [2011CBA00408]; National Natural Science Foundation of China [91132303, 30830035, 31170787, 20932003]; Key National S&T Program "Major New Drug Development" [2012ZX09504001-003]; State Key Laboratory of Neuroscience	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National S&T Program "Major New Drug Development"; State Key Laboratory of Neuroscience	This work was supported National Basic Research Program of China Grant 2011CBA00408; National Natural Science Foundation of China Grants 91132303, 30830035, 31170787, and 20932003; Key National S&T Program "Major New Drug Development" Grant 2012ZX09504001-003; and the State Key Laboratory of Neuroscience.	Anzai N, 2002, J BIOL CHEM, V277, P16655, DOI 10.1074/jbc.M201087200; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Bargeton B, 2010, J BIOL CHEM, V285, P13816, DOI 10.1074/jbc.M109.086843; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Deval E, 2006, J BIOL CHEM, V281, P1796, DOI 10.1074/jbc.M509669200; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hoersch D, 2007, BIOPHYS J, V93, P1687, DOI 10.1529/biophysj.107.106633; Hruska-Hageman AM, 2004, J BIOL CHEM, V279, P46962, DOI 10.1074/jbc.M405874200; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang RT, 2010, J BIOL CHEM, V285, P15805, DOI 10.1074/jbc.M110.101980; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Jin WY, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-39; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; Laha KT, 2011, MOL PHARMACOL, V79, P662, DOI 10.1124/mol.110.068619; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li YF, 2003, J PHYSIOL-LONDON, V552, P73, DOI 10.1113/jphysiol.2003.047324; Mammen AL, 1997, J NEUROSCI, V17, P7351; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Nakajo K, 2008, J PHYSIOL-LONDON, V586, P2827, DOI 10.1113/jphysiol.2007.148601; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Sackin H, 2009, BIOPHYS J, V97, P1058, DOI 10.1016/j.bpj.2009.05.056; Sanchez R, 2000, METH MOL B, V143, P97; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Vergo S, 2011, BRAIN, V134, P571, DOI 10.1093/brain/awq337; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	50	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14443	14455		10.1074/jbc.M111.334250	http://dx.doi.org/10.1074/jbc.M111.334250			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399291	Green Published, hybrid			2022-12-25	WOS:000304003200012
J	Balint, M; Malnas, K; Nowak, C; Geismar, J; Vancsa, E; Polyak, L; Lengyel, S; Haase, P				Balint, Miklos; Malnas, Kristof; Nowak, Carsten; Geismar, Jutta; Vancsa, Eva; Polyak, Laszlo; Lengyel, Szabolcs; Haase, Peter			Species History Masks the Effects of Human-Induced Range Loss - Unexpected Genetic Diversity in the Endangered Giant Mayfly Palingenia longicauda	PLOS ONE			English	Article							POPULATION-STRUCTURE; RHYACOPHILA-PUBESCENS; PHYLOGEOGRAPHY; EPHEMEROPTERA; TRICHOPTERA; PATTERNS; COLONIZATION; BIODIVERSITY; INSIGHTS; MODEL	Freshwater biodiversity has declined dramatically in Europe in recent decades. Because of massive habitat pollution and morphological degradation of water bodies, many once widespread species persist in small fractions of their original range. These range contractions are generally believed to be accompanied by loss of intraspecific genetic diversity, due to the reduction of effective population sizes and the extinction of regional genetic lineages. We aimed to assess the loss of genetic diversity and its significance for future potential reintroduction of the long-tailed mayfly Palingenia longicauda (Olivier), which experienced approximately 98% range loss during the past century. Analysis of 936 bp of mitochondrial DNA of 245 extant specimens across the current range revealed a surprisingly large number of haplotypes (87), and a high level of haplotype diversity (Hd = 0.875). In contrast, historic specimens (6) from the lost range (Rhine catchment) were not differentiated from the extant Raba population (F-ST = 0.02, p = 0.61), despite considerable geographic distance separating the two rivers. These observations can be explained by an overlap of the current with the historic (Pleistocene) refugia of the species. Most likely, the massive recent range loss mainly affected the range which was occupied by rapid post-glacial dispersal. We conclude that massive range losses do not necessarily coincide with genetic impoverishment and that a species' history must be considered when estimating loss of genetic diversity. The assessment of spatial genetic structures and prior phylogeographic information seems essential to conserve once widespread species.	[Balint, Miklos; Nowak, Carsten; Geismar, Jutta; Haase, Peter] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Balint, Miklos] Univ Babes Bolyai, Ctr Mol Biol, Cluj Napoca, Romania; [Malnas, Kristof] BioAqua Pro Kft, Debrecen, Hungary; [Malnas, Kristof; Polyak, Laszlo; Lengyel, Szabolcs] Univ Debrecen, Dept Ecol, Debrecen, Hungary; [Nowak, Carsten; Geismar, Jutta; Haase, Peter] Senckenberg Res Inst, Dept River Ecol & Conservat, Frankfurt, Germany; [Nowak, Carsten; Geismar, Jutta; Haase, Peter] Nat Hist Museum, Frankfurt, Germany; [Vancsa, Eva] Univ Babes Bolyai, Dept Taxon & Ecol, Cluj Napoca, Romania	Babes Bolyai University from Cluj; University of Debrecen; Senckenberg Gesellschaft fur Naturforschung (SGN); Babes Bolyai University from Cluj	Balint, M (corresponding author), Biodivers & Climate Res Ctr, Frankfurt, Germany.	miklos.balint@senckenberg.de	Haase, Peter/A-5644-2011; Lengyel, Szabolcs/A-3483-2011; Nowak, Carsten/A-4466-2014	Lengyel, Szabolcs/0000-0002-7049-0100; Nowak, Carsten/0000-0002-3139-1951; Malnas, Kristof/0000-0003-3743-4921	Hesse's Ministry of Higher Education, Research, and the Arts; BioFresh EU; Hungarian Academy of Sciences; OTKA-Norway Financing Mechanism [78887, 85562]	Hesse's Ministry of Higher Education, Research, and the Arts; BioFresh EU; Hungarian Academy of Sciences(Hungarian Academy of Sciences); OTKA-Norway Financing Mechanism	Funding for this study comes from the research funding program Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of Hesse's Ministry of Higher Education, Research, and the Arts, and from the BioFresh EU FP7 research programme (http://www.freshwaterbiodiversity.eu). SL was supported by a Bolyai Research Fellowship from the Hungarian Academy of Sciences and by two OTKA-Norway Financing Mechanism grants (78887, 85562) during manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrikovics S, 2001, TISZA KLUB FUZETEK, V10, P1; Babik W, 2005, MOL ECOL, V14, P2475, DOI 10.1111/j.1365-294X.2005.02605.x; Balint M, 2008, J ZOOL SYST EVOL RES, V46, P340, DOI 10.1111/j.1439-0469.2008.00480.x; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Balint Miklos, 2011, P189; Balint M, 2011, ZOOSYMPOSIA, V5, P11, DOI 10.11646/zoosymposia.5.1.1; Balint M, 2009, ZOOTAXA, P39, DOI 10.11646/zootaxa.2148.1.3; Banarescu P., 1991, DISTRIBUTION DISPERS, VII; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barber-James HM, 2008, HYDROBIOLOGIA, V595, P339, DOI 10.1007/s10750-007-9028-y; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Behrmann-Godel J, 2004, MOL ECOL, V13, P491, DOI 10.1046/j.1365-294X.2003.02082.x; Brinson MM, 2002, ENVIRON CONSERV, V29, P115, DOI 10.1017/S0376892902000085; C?lix M., 2018, EUROPEAN RED LIST SA; Campos PF, 2010, MOL ECOL, V19, P4863, DOI 10.1111/j.1365-294X.2010.04826.x; Council of Europe, 2010, CONV CONS EUR WILDL; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Engelhardt CHM, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-10; Engelhardt CHM, 2008, FUND APPL LIMNOL, V173, P165, DOI 10.1127/1863-9135/2008/0173-0165; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Kotlik P, 2001, MOL ECOL, V10, P2177, DOI 10.1046/j.0962-1083.2001.01344.x; Kovacs Tibor, 2001, Folia Historico Naturalia Musei Matraensis, V25, P145; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Lehrian S, 2010, J N AM BENTHOL SOC, V29, P1100, DOI 10.1899/09-100.1; Lengyel S., 2004, TERMESZETVEDELMI KOZ, V11, P233; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Malnas K, 2011, J INSECT CONSERV, V15, P823, DOI 10.1007/s10841-011-9380-0; Menot G, 2006, SCIENCE, V313, P1623, DOI 10.1126/science.1130511; Merila J, 1997, EVOLUTION, V51, P946, DOI 10.1111/j.1558-5646.1997.tb03675.x; Monaghan MT, 2007, MOL PHYLOGENET EVOL, V45, P674, DOI 10.1016/j.ympev.2007.06.009; Pauls SU, 2008, MOL PHYLOGENET EVOL, V46, P776, DOI 10.1016/j.ympev.2007.11.003; Pauls SU, 2006, MOL ECOL, V15, P2153, DOI 10.1111/j.1365-294X.2006.02916.x; Pauls SU, 2009, J N AM BENTHOL SOC, V28, P517, DOI 10.1899/08-100.1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Previsic A, 2009, MOL ECOL, V18, P634, DOI 10.1111/j.1365-294X.2008.04046.x; Quantum GIS Development Team, 2011, QUANT GIS GEOGR INF; Rambaut A, 2009, TRACER V1 5; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RUSSEV B K, 1987, Tijdschrift voor Entomologie, V130, P109; Sartori M, 1998, 9815 TPVS COUNC EUR, P15; Sartori M, CURRENT DIRECTIONS R, P263; Sediva A, 2008, MOL ECOL, V17, P1277, DOI 10.1111/j.1365-294X.2007.03656.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Soldan T, 1791, 21 SIEEC U S BOH, P81; Theissinger K, 2011, FRESHWATER BIOL, V56, P2554, DOI 10.1111/j.1365-2427.2011.02681.x; Tittizer Thomas, 2008, Lauterbornia, V63, P57; Ujvarosi L, 2010, J N AM BENTHOL SOC, V29, P1075, DOI 10.1899/09-099.1; Volckaert FAM, 2002, J EVOLUTION BIOL, V15, P930, DOI 10.1046/j.1420-9101.2002.00469.x; Weiss S, 2002, MOL ECOL, V11, P1393, DOI 10.1046/j.1365-294X.2002.01544.x; Williams HC, 2006, MOL PHYLOGENET EVOL, V40, P370, DOI 10.1016/j.ympev.2006.03.004; Wintle BA, 2010, ECOL LETT, V13, P1325, DOI 10.1111/j.1461-0248.2010.01514.x; World Wildlife Fund, 2008, LIV PLAN REP; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1	63	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e31872	10.1371/journal.pone.0031872	http://dx.doi.org/10.1371/journal.pone.0031872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412844	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000002
J	Chen, XN; Margolis, KJ; Gershon, MD; Schwartz, GJ; Sze, JY				Chen, Xiaoning; Margolis, Kara J.; Gershon, Michael D.; Schwartz, Gary J.; Sze, Ji Y.			Reduced Serotonin Reuptake Transporter (SERT) Function Causes Insulin Resistance and Hepatic Steatosis Independent of Food Intake	PLOS ONE			English	Article							DIABETES-MELLITUS; MICE LACKING; FLUOXETINE; INSIGHTS; ANXIETY; HYPERPHAGIA; DEPRESSION; WEIGHT; 5-HYDROXYTRYPTAMINE; POLYMORPHISM	Serotonin reuptake transporter (SERT) is a key regulator of serotonin neurotransmission and a major target of antidepressants. Antidepressants, such as selectively serotonin reuptake inhibitors (SSRIs), that block SERT function are known to affect food intake and body weight. Here, we provide genetic evidence that food intake and metabolism are regulated by separable mechanisms of SERT function. SERT-deficient mice ate less during both normal diet and high fat diet feeding. The reduced food intake was accompanied with markedly elevated plasma leptin levels. Despite reduced food intake, SERT-deficient mice exhibited glucose intolerance and insulin resistance, and progressively developed obesity and hepatic steatosis. Several lines of evidence indicate that the metabolic deficits of SERT-deficient mice are attributable to reduced insulin-sensitivity in peripheral tissues. First, SERT-deficient mice exhibited beta-cell hyperplasia and islet-mass expansion. Second, biochemical analyses revealed constitutively elevated JNK activity and diminished insulin-induced AKT activation in the liver of SERT-deficient mice. SERT-deficient mice exhibited hyper-JNK activity and hyperinsulinemia prior to the development of obesity. Third, enhancing AKT signaling by PTEN deficiency corrected glucose tolerance in SERT-deficient mice. These findings have potential implications for designing selective SERT drugs for weight control and the treatment of metabolic syndromes.	[Chen, Xiaoning; Sze, Ji Y.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med & Neurosci, Bronx, NY 10467 USA; [Margolis, Kara J.; Gershon, Michael D.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University	Chen, XN (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	jiying.sze@einstein.yu.edu			National Institutes of Health [MH083982]; NIH [DK 020541 DK 026687]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, P60DK020541, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (MH083982)(JS), NIH DK 020541 DK 026687(GJS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; BREISCH ST, 1976, SCIENCE, V192, P382, DOI 10.1126/science.130678; Briscoe VJ, 2008, DIABETES, V57, P2453, DOI 10.2337/db08-0236; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cassidy F, 1999, AM J PSYCHIAT, V156, P1417; Chang AS, 1996, MOL BRAIN RES, V43, P185, DOI 10.1016/S0169-328X(96)00172-6; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Elwing JE, 2006, PSYCHOSOM MED, V68, P563, DOI 10.1097/01.psy.0000221276.17823.df; Fava M, 2000, J CLIN PSYCHIAT, V61, P863, DOI 10.4088/JCP.v61n1109; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; FLETCHER PJ, 1989, PHARMACOL BIOCHEM BE, V32, P907, DOI 10.1016/0091-3057(89)90057-9; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; GRAY DS, 1992, INT J OBESITY, V16, P193; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Homberg JR, 2010, OBESITY, V18, P137, DOI 10.1038/oby.2009.139; Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Lam Daniel D., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000245; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Liu Zhenqi, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P38; Lustman Patrick J, 2008, Curr Psychiatry Rep, V10, P495, DOI 10.1007/s11892-007-0020-8; Mathews TA, 2004, J NEUROSCI METH, V140, P169, DOI 10.1016/j.jneumeth.2004.05.017; Miller K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007739; Muller JM, 2011, GENES BRAIN BEHAV, V10, P166, DOI 10.1111/j.1601-183X.2010.00652.x; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Norris SL, 2004, ARCH INTERN MED, V164, P1395, DOI 10.1001/archinte.164.13.1395; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Raeder MB, 2006, J CLIN PSYCHIAT, V67, P1974, DOI 10.4088/JCP.v67n1219; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Roberge C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1465, DOI 10.1152/ajpendo.00516.2007; Ruddell RG, 2006, AM J PATHOL, V169, P861, DOI 10.2353/ajpath.2006.050767; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; SALLER CF, 1976, SCIENCE, V192, P385, DOI 10.1126/science.1257774; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Storgaard H, 2001, DIABETES, V50, P2770, DOI 10.2337/diabetes.50.12.2770; Stunes AK, 2011, DIABETES OBES METAB, V13, P551, DOI 10.1111/j.1463-1326.2011.01378.x; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Tjurmina OA, 2002, ENDOCRINOLOGY, V143, P4520, DOI 10.1210/en.2002-220416; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Yamada J, 1999, EUR J PHARMACOL, V382, P211, DOI 10.1016/S0014-2999(99)00593-2	53	52	55	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32511	10.1371/journal.pone.0032511	http://dx.doi.org/10.1371/journal.pone.0032511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412882	Green Submitted, Green Published, gold			2022-12-25	WOS:000303062000011
J	Gonzalez-Velez, V; Dupont, G; Gil, A; Gonzalez, A; Quesada, I				Gonzalez-Velez, Virginia; Dupont, Genevieve; Gil, Amparo; Gonzalez, Alejandro; Quesada, Ivan			Model for Glucagon Secretion by Pancreatic alpha-Cells	PLOS ONE			English	Article							CA2+ OSCILLATIONS; CALCIUM OSCILLATIONS; IDENTIFIED ALPHA; HUMAN ISLETS; BETA-CELLS; GLUCOSE; INSULIN; RELEASE; MECHANISMS; EXOCYTOSIS	Glucagon hormone is synthesized and released by pancreatic alpha-cells, one of the islet-cell types. This hormone, along with insulin, maintains blood glucose levels within the physiological range. Glucose stimulates glucagon release at low concentrations (hypoglycemia). However, the mechanisms involved in this secretion are still not completely clear. Here, using experimental calcium time series obtained in mouse pancreatic islets at low and high glucose conditions, we propose a glucagon secretion model for alpha-cells. Our model takes into account that the resupply of releasable granules is not only controlled by cytoplasmic Ca2+, as in other neuroendocrine and endocrine cells, but also by the level of extracellular glucose. We found that, although calcium oscillations are highly variable, the average secretion rates predicted by the model fall into the range of values reported in the literature, for both stimulated and non-stimulated conditions. For low glucose levels, the model predicts that there would be a well-controlled number of releasable granules refilled slowly from a large reserve pool, probably to ensure a secretion rate that could last for several minutes. Studying the alpha-cell response to the addition of insulin at low glucose, we observe that the presence of insulin reduces glucagon release by decreasing the islet Ca2+ level. This observation is in line with previous work reporting that Ca2+ dynamics, mainly frequency, is altered by insulin [1]. Thus, the present results emphasize the main role played by Ca2+ and glucose in the control of glucagon secretion by alpha-cells. Our modeling approach also shows that calcium oscillations potentiate glucagon secretion as compared to constant levels of this cellular messenger. Altogether, the model sheds new light on the subcellular mechanisms involved in alpha-cell exocytosis, and provides a quantitative predictive tool for studying glucagon secretion modulators in physiological and pathological conditions.	[Gonzalez-Velez, Virginia] Univ Autonoma Metropolitana Azcapotzalco, Dept Ciencias Basicas, Mexico City 13, DF, Mexico; [Gil, Amparo] Univ Cantabria, Dept Matemat Aplicada & Ciencias Computac, E-39005 Santander, Cantabria, Spain; [Dupont, Genevieve] Univ Libre Bruxelles, Unite Chronobiol, Brussels, Belgium; [Gonzalez, Alejandro; Quesada, Ivan] Univ Miguel Hernandez, CIBERDEM, Inst Bioingn, Elche, Spain	Universidad Autonoma Metropolitana - Mexico; Universidad de Cantabria; Universite Libre de Bruxelles; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universidad Miguel Hernandez de Elche	Gonzalez-Velez, V (corresponding author), Univ Autonoma Metropolitana Azcapotzalco, Dept Ciencias Basicas, Mexico City 13, DF, Mexico.	amparo.gil@unican.es	Gonzalez, Alejandro/AAG-4444-2020; Gonzalez-Velez, Virginia/A-3430-2012; Gil, Amparo/H-7594-2014; GONZALEZ-VELEZ, VIRGINIA/AAC-6673-2019; Ivan, Quesada/P-6541-2014	Gonzalez, Alejandro/0000-0001-7513-2516; Ivan, Quesada/0000-0002-9808-514X; Gil, Amparo/0000-0002-7449-4205	i-MATH Future Platform [C3-0136]; Ministerio de Ciencia e Innovacion, Spanish Government [BFU2010-21773]; CONACyT-Mexico [67287]; ESF FUNCDYN [EX/2337, EX/3617]; Fonds National de la Recherche Medicale [3.4636.04]	i-MATH Future Platform; Ministerio de Ciencia e Innovacion, Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ESF FUNCDYN; Fonds National de la Recherche Medicale(Fonds de la Recherche Scientifique - FNRS)	This work was supported by i-MATH Future Platform, Project Number C3-0136 (www.i-math.org), Ministerio de Ciencia e Innovacion, Spanish Government, Project BFU2010-21773 (www.micinn.es), CONACyT-Mexico, PhD scholarship number 67287 (www.conacyt.mx), ESF FUNCDYN Programme, Exchange Grants EX/2337 and EX/3617 (www.esf.org), and Fonds National de la Recherche Medicale, grant 3.4636.04 (www2.frs.fnrs.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SA, 2011, PFLUG ARCH EUR J PHY, V462, P443, DOI 10.1007/s00424-011-0979-5; Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; Barg S, 2003, PHARMACOL TOXICOL, V92, P3, DOI 10.1034/j.1600-0773.2003.920102.x; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Berts A, 1996, BBA-MOL CELL RES, V1310, P212, DOI 10.1016/0167-4889(95)00173-5; Bertuzzi A, 2007, AM J PHYSIOL-ENDOC M, V293, pE396, DOI 10.1152/ajpendo.00647.2006; Bode HP, 1999, PFLUG ARCH EUR J PHY, V437, P324, DOI 10.1007/s004240050786; BODE HP, 1994, BIOCHEM BIOPH RES CO, V205, P435, DOI 10.1006/bbrc.1994.2684; Chen YD, 2008, BIOPHYS J, V95, P2226, DOI 10.1529/biophysj.107.124990; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dupont G, 2003, CELL CALCIUM, V34, P485, DOI 10.1016/S0143-4160(03)00152-0; Gall D, 2000, J THEOR BIOL, V207, P445, DOI 10.1006/jtbi.2000.2139; Gonzalez-Velez V, 2004, COMPUT BIOL MED, V34, P279, DOI 10.1016/S0010-4825(03)00071-4; Gonzalez-Velez V, 2010, MATH BIOSCI ENG, V7, P793, DOI 10.3934/mbe.2010.7.793; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gromada J, 1997, J GEN PHYSIOL, V110, P217, DOI 10.1085/jgp.110.3.217; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Kits KS, 2000, BRAIN RES REV, V33, P78, DOI 10.1016/S0165-0173(00)00023-0; MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Olsen HL, 2005, ENDOCRINOLOGY, V146, P4861, DOI 10.1210/en.2005-0800; Pedersen M, 2009, PNAS, V106, P18; Pertusa JAG, 1999, J PHYSIOL-LONDON, V520, P473, DOI 10.1111/j.1469-7793.1999.00473.x; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; Quoix N, 2009, DIABETES, V58, P412, DOI 10.2337/db07-1298; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Tuduri E, 2008, AM J PHYSIOL-ENDOC M, V294, pE952, DOI 10.1152/ajpendo.00641.2007; Tuduri E, 2009, DIABETES, V58, P1616, DOI 10.2337/db08-1787; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Walker JN, 2011, DIABETES OBES METAB, V13, P95, DOI 10.1111/j.1463-1326.2011.01450.x	36	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32282	10.1371/journal.pone.0032282	http://dx.doi.org/10.1371/journal.pone.0032282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412861	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800013
J	Liongue, C; O'Sullivan, LA; Trengove, MC; Ward, AC				Liongue, Clifford; O'Sullivan, Lynda A.; Trengove, Monique C.; Ward, Alister C.			Evolution of JAK-STAT Pathway Components: Mechanisms and Role in Immune System Development	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SIGNALING PATHWAYS; JAK/STAT PATHWAY; GENOME DUPLICATION; CYTOKINE RECEPTORS; INTERLEUKIN-2 IL-2; ADAPTIVE IMMUNITY; GENE-ACTIVATION; SOCS PROTEINS; PIAS PROTEINS	Background: Lying downstream of a myriad of cytokine receptors, the Janus kinase (JAK) - Signal transducer and activator of transcription (STAT) pathway is pivotal for the development and function of the immune system, with additional important roles in other biological systems. To gain further insight into immune system evolution, we have performed a comprehensive bioinformatic analysis of the JAK-STAT pathway components, including the key negative regulators of this pathway, the SH2-domain containing tyrosine phosphatase (SHP), Protein inhibitors against Stats (PIAS), and Suppressor of cytokine signaling (SOCS) proteins across a diverse range of organisms. Results: Our analysis has demonstrated significant expansion of JAK-STAT pathway components co-incident with the emergence of adaptive immunity, with whole genome duplication being the principal mechanism for generating this additional diversity. In contrast, expansion of upstream cytokine receptors appears to be a pivotal driver for the differential diversification of specific pathway components. Conclusion: Diversification of JAK-STAT pathway components during early vertebrate development occurred concurrently with a major expansion of upstream cytokine receptors and two rounds of whole genome duplications. This produced an intricate cell-cell communication system that has made a significant contribution to the evolution of the immune system, particularly the emergence of adaptive immunity.	[Liongue, Clifford; Trengove, Monique C.; Ward, Alister C.] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Liongue, Clifford; Trengove, Monique C.; Ward, Alister C.] Deakin Univ, Strateg Res Ctr Mol & Med Res, Geelong, Vic 3217, Australia; [O'Sullivan, Lynda A.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3217, Australia	Deakin University; Deakin University; Deakin University	Liongue, C (corresponding author), Deakin Univ, Sch Med, Geelong, Vic 3217, Australia.	award@deakin.edu.au		Ward, Alister/0000-0001-7945-7975	Deakin University; Molecular and Medical Research Strategic Research Centre; Australian Research Council; Australian Postgraduate Awards	Deakin University; Molecular and Medical Research Strategic Research Centre; Australian Research Council(Australian Research Council); Australian Postgraduate Awards(Australian Government)	CL was supported by a Deakin University Postgraduate Research Award and a Molecular and Medical Research Strategic Research Centre Postdoctoral Fellowship, while both LAOS and MCT received Australian Postgraduate Awards. Australian Research Council Linkage-Equipment Infrastructure Fund supported FishWorks: Collaborative Infrastructure for Zebrafish Research, and ACW was funded by an Australian Research Council Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Conway G, 1997, P NATL ACAD SCI USA, V94, P3082, DOI 10.1073/pnas.94.7.3082; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Gorissen M, 2011, J ENDOCRINOL, V209, P175, DOI 10.1530/JOE-11-0033; Goto A, 2010, J BIOL CHEM, V285, P15731, DOI 10.1074/jbc.M109.082115; Haan C, 2002, BIOCHEM J, V361, P105, DOI 10.1042/0264-6021:3610105; Hino K, 2003, DEV GENES EVOL, V213, P264, DOI 10.1007/s00427-003-0318-8; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Johnson AN, 2011, DEVELOPMENT, V138, P4627, DOI 10.1242/dev.071464; Karsten P, 2002, MECH DEVELOP, V117, P343, DOI 10.1016/S0925-4773(02)00216-2; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levine RL, 2008, BLOOD, V111, P3913, DOI 10.1182/blood-2008-01-133322; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lewis RS, 2006, EXP HEMATOL, V34, P179, DOI 10.1016/j.exphem.2005.11.003; Lewis RS, 2004, GENE, V338, P65, DOI 10.1016/j.gene.2004.05.012; Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200; Liongue C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-120; Liongue C, 2011, CRIT REV IMMUNOL, V31, P61, DOI 10.1615/CritRevImmunol.v31.i1.60; Liongue C, 2009, INT J BIOCHEM CELL B, V41, P2372, DOI 10.1016/j.biocel.2009.08.011; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu MY, 2005, NUCLEIC ACIDS RES, V33, P95, DOI 10.1093/nar/gki152; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; Liu W, 2010, J CELL BIOCHEM, V109, P992, DOI 10.1002/jcb.22482; Lutfalla G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-29; Ma ACH, 2007, BLOOD, V110, P1824, DOI 10.1182/blood-2007-03-078287; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; O'Sullivan LA, 2007, MOL IMMUNOL, V44, P2497, DOI 10.1016/j.molimm.2006.11.025; Oates AC, 1999, BLOOD, V94, P2622, DOI 10.1182/blood.V94.8.2622.420k39_2622_2636; Oates AC, 1999, DEV DYNAM, V215, P352, DOI 10.1002/(SICI)1097-0177(199908)215:4<352::AID-AJA7>3.0.CO;2-J; Okada K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-218; Onnebo SMN, 2005, EXP HEMATOL, V33, P182, DOI 10.1016/j.exphem.2004.10.019; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Rawlings JS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-38; Schluter SF, 1999, DEV COMP IMMUNOL, V23, P107; Schmidt EE, 2007, BIOESSAYS, V29, P262, DOI 10.1002/bies.20546; Seo JH, 2010, CANCER LETT, V288, P50, DOI 10.1016/j.canlet.2009.06.023; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Seyfert HM, 2000, J MOL EVOL, V50, P550, DOI 10.1007/s002390010058; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Stofanko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014051; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VOSS SD, 1994, BLOOD, V83, P626; Wang Jing-Huan, 2010, World J Biol Chem, V1, P151, DOI 10.4331/wjbc.v1.i5.151; Wang W, 2011, BIOCHEM BIOPH RES CO, V410, P714, DOI 10.1016/j.bbrc.2011.05.119; Ward AC, 2000, BLOOD, V95, P19; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yoon WH, 2011, NAT CELL BIOL, V13, P1062, DOI 10.1038/ncb2316; Yoshimura A, 2005, ARTHRITIS RES THER, V7, P100, DOI 10.1186/ar1741; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P42, DOI 10.1016/j.dci.2009.08.001	81	85	89	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32777	10.1371/journal.pone.0032777	http://dx.doi.org/10.1371/journal.pone.0032777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412924	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800051
J	Vazquez-Mena, O; Medina-Martinez, I; Juarez-Torres, E; Barron, V; Espinosa, A; Villegas-Sepulveda, N; Gomez-Laguna, L; Nieto-Martinez, K; Orozco, L; Roman-Basaure, E; Cortez, SM; Ibanez, MB; Venegas-Vega, C; Guardado-Estrada, M; Rangel-Lopez, A; Kofman, S; Berumen, J				Vazquez-Mena, Oscar; Medina-Martinez, Ingrid; Juarez-Torres, Eligia; Barron, Valeria; Espinosa, Ana; Villegas-Sepulveda, Nicolas; Gomez-laguna, Laura; Nieto-Martinez, Karem; Orozco, Lorena; Roman-Basaure, Edgar; Munoz Cortez, Sergio; Borges Ibanez, Manuel; Venegas-Vega, Carlos; Guardado-Estrada, Mariano; Rangel-Lopez, Angelica; Kofman, Susana; Berumen, Jaime			Amplified Genes May Be Overexpressed, Unchanged, or Downregulated in Cervical Cancer Cell Lines	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; MOLECULAR CYTOGENETIC CHARACTERIZATION; CHROMOSOMAL-ABERRATIONS; RECURRENT PATTERN; COPY NUMBERS; IN-SITU; EXPRESSION; FREQUENT; GAIN; CARCINOMA	Several copy number-altered regions (CNAs) have been identified in the genome of cervical cancer, notably, amplifications of 3q and 5p. However, the contribution of copy-number alterations to cervical carcinogenesis is unresolved because genome-wide there exists a lack of correlation between copy-number alterations and gene expression. In this study, we investigated whether CNAs in the cell lines CaLo, CaSki, HeLa, and SiHa were associated with changes in gene expression. On average, 19.2% of the cell-line genomes had CNAs. However, only 2.4% comprised minimal recurrent regions (MRRs) common to all the cell lines. Whereas 3q had limited common gains (13%), 5p was entirely duplicated recurrently. Genome-wide, only 15.6% of genes located in CNAs changed gene expression; in contrast, the rate in MRRs was up to 3 times this. Chr 5p was confirmed entirely amplified by FISH; however, maximum 33.5% of the explored genes in 5p were deregulated. In 3q, this rate was 13.4%. Even in 3q26, which had 5 MRRs and 38.7% recurrently gained SNPs, the rate was only 15.1%. Interestingly, up to 19% of deregulated genes in 5p and 73% in 3q26 were downregulated, suggesting additional factors were involved in gene repression. The deregulated genes in 3q and 5p occurred in clusters, suggesting local chromatin factors may also influence gene expression. In regions amplified discontinuously, downregulated genes increased steadily as the number of amplified SNPs increased (p<0.01, Spearman's correlation). Therefore, partial gene amplification may function in silencing gene expression. Additional genes in 1q, 3q and 5p could be involved in cervical carcinogenesis, specifically in apoptosis. These include PARP1 in 1q, TNFSF10 and ECT2 in 3q and CLPTM1L, AHRR, PDCD6, and DAP in 5p. Overall, gene expression and copy-number profiles reveal factors other than gene dosage, like epigenetic or chromatin domains, may influence gene expression within the entirely amplified genome segments.	[Vazquez-Mena, Oscar; Medina-Martinez, Ingrid; Juarez-Torres, Eligia; Barron, Valeria; Espinosa, Ana; Guardado-Estrada, Mariano; Berumen, Jaime] Univ Nacl Autonoma Mexico, Fac Med, Hosp Gen Mexico, Unidad Med Genom, Mexico City 04510, DF, Mexico; [Villegas-Sepulveda, Nicolas] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [Gomez-laguna, Laura; Nieto-Martinez, Karem; Venegas-Vega, Carlos; Kofman, Susana] Univ Nacl Autonoma Mexico, Dept Genet, Fac Med, Hosp Gen Mexico, Mexico City 04510, DF, Mexico; [Orozco, Lorena] Inst Nacl Med Genom, Lab Genom Enfermedades Complejas, Mexico City, DF, Mexico; [Roman-Basaure, Edgar] Hosp Gen Mexico City, Serv Oncol, Mexico City, DF, Mexico; [Munoz Cortez, Sergio; Borges Ibanez, Manuel] Hosp Gen Mexico City, Serv Ginecol, Mexico City, DF, Mexico; [Rangel-Lopez, Angelica] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Unidad Invest Med Enfermedades Nefrol, Mexico City, DF, Mexico; [Berumen, Jaime] Univ Nacl Autonoma Mexico, Dept Expt Med, Fac Med, Mexico City 04510, DF, Mexico	Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Hospital General de Mexico; Hospital General de Mexico; Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico	Vazquez-Mena, O (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Hosp Gen Mexico, Unidad Med Genom, Mexico City 04510, DF, Mexico.	jaimeberumen@hotmail.com	Berumen, Jaime/AAL-5577-2020; Vazquez, Oscar/AAW-4057-2020; Rangel, Angelica/AAJ-2438-2020; Berumen, Jaime/F-7914-2018	Berumen, Jaime/0000-0001-6707-3317; Berumen, Jaime/0000-0001-6707-3317; Villegas-Sepulveda, Nicolas/0000-0001-9489-2545; Orozco, Lorena/0000-0002-5801-9180; VENEGAS-VEGA, CARLOS ALBERTO/0000-0001-5609-418X; ESPINOSA GARCIA, ANA MARIA/0000-0003-3255-4051	National Council of Science and Technology (CONACYT) [8135/A1, 24341, 80680]; National University of Mexico (UNAM) [SDI.PTID.05.2]	National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National University of Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	This work was supported by the National Council of Science and Technology (CONACYT), grant numbers 8135/A1, 24341 (to JB) and 80680 (to SK), and the National University of Mexico (UNAM), grant number SDI.PTID.05.2 (to JB). OVM, AE, IMM, and VB were recipients of a scholarship from CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz M, 2006, GENE CHROMOSOME CANC, V45, P829, DOI 10.1002/gcc.20343; Alameda F, 2009, HUM PATHOL, V40, P1474, DOI 10.1016/j.humpath.2009.03.013; Allen DG, 2000, BRIT J CANCER, V83, P1659, DOI 10.1054/bjoc.2000.1509; Andersson S, 2006, BRIT J CANCER, V95, P331, DOI 10.1038/sj.bjc.6603253; Arechaga-Ocampo E, 2008, GYNECOL ONCOL, V108, P10, DOI 10.1016/j.ygyno.2007.08.070; Atkin NB, 2000, CYTOGENET CELL GENET, V91, P44, DOI 10.1159/000056816; Barch MJ, 1997, AGT CYTOGENETICS LAB; Belloni E, 2011, ONCOGENE, V30, P1117, DOI 10.1038/onc.2010.478; Bertelsen BI, 2006, INT J CANCER, V118, P1877, DOI 10.1002/ijc.21461; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Caceres-Cortes JR, 2001, CANCER RES, V61, P6281; de Wit E, 2009, CHROMOSOMA, V118, P25, DOI 10.1007/s00412-008-0186-0; Dellas A, 1999, CANCER RES, V59, P3475; Dowen SE, 2003, ONCOGENE, V22, P2531, DOI 10.1038/sj.onc.1206296; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Heselmeyer K, 1997, GENE CHROMOSOME CANC, V19, P233, DOI 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Hidalgo A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang FY, 2006, GYNECOL ONCOL, V103, P219, DOI 10.1016/j.ygyno.2006.02.028; Huang FY, 2005, CANCER GENET CYTOGEN, V157, P42, DOI 10.1016/j.cancergencyto.2004.06.002; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kirchhoff M, 1999, GENE CHROMOSOME CANC, V24, P144, DOI 10.1002/(SICI)1098-2264(199902)24:2<144::AID-GCC7>3.0.CO;2-9; Kloth JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-53; Lyng H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-268; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Macville M, 1999, CANCER RES, V59, P141; Matthews CP, 2000, P SOC EXP BIOL MED, V223, P316, DOI 10.1046/j.1525-1373.2000.22345.x; MITRA AB, 1995, J NATL CANCER I, V87, P742, DOI 10.1093/jnci/87.10.742; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Oshimori N, 2009, EMBO J, V28, P2066, DOI 10.1038/emboj.2009.161; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peralta-Leal A, 2008, CLIN TRANSL ONCOL, V10, P318, DOI 10.1007/s12094-008-0207-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao PH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-5; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Scotto L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-58; Snijders PJF, 1998, CANCER RES, V58, P3812; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Srougi MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017108; Sugita M, 2000, CANCER GENET CYTOGEN, V117, P9, DOI 10.1016/S0165-4608(99)00135-1; Thein A, 2000, CANCER GENET CYTOGEN, V116, P59, DOI 10.1016/S0165-4608(99)00108-9; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umayahara K, 2002, GENE CHROMOSOME CANC, V33, P98, DOI 10.1002/gcc.1215; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Wang Huixia, 2006, BMC Genomics, V7, P166; Wilting S, 2006, J PATHOL, V209, P220, DOI 10.1002/path.1966; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yugawa T, 2009, REV MED VIROL, V19, P97, DOI 10.1002/rmv.605; Zheng M, 2004, AM J PATHOL, V165, P63, DOI 10.1016/S0002-9440(10)63275-0	59	37	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32667	10.1371/journal.pone.0032667	http://dx.doi.org/10.1371/journal.pone.0032667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412903	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800039
J	Whitehead, RD; Re, D; Xiao, DK; Ozakinci, G; Perrett, DI				Whitehead, Ross D.; Re, Daniel; Xiao, Dengke; Ozakinci, Gozde; Perrett, David I.			You Are What You Eat: Within-Subject Increases in Fruit and Vegetable Consumption Confer Beneficial Skin-Color Changes	PLOS ONE			English	Article							BETA-CAROTENE SUPPLEMENTATION; OXIDATIVE STRESS; RESPIRATORY BURST; DIETARY; ANTIOXIDANT; AGE; METABOLISM; FACES	Background: Fruit and vegetable consumption and ingestion of carotenoids have been found to be associated with human skin-color (yellowness) in a recent cross-sectional study. This carotenoid-based coloration contributes beneficially to the appearance of health in humans and is held to be a sexually selected cue of condition in other species. Methodology and Principal Findings: Here we investigate the effects of fruit and vegetable consumption on skin-color longitudinally to determine the magnitude and duration of diet change required to change skin-color perceptibly. Diet and skin-color were recorded at baseline and after three and six weeks, in a group of 35 individuals who were without makeup, self-tanning agents and/or recent intensive UV exposure. Six-week changes in fruit and vegetable consumption were significantly correlated with changes in skin redness and yellowness over this period, and diet-linked skin reflectance changes were significantly associated with the spectral absorption of carotenoids and not melanin. We also used psychophysical methods to investigate the minimum color change required to confer perceptibly healthier and more attractive skin-coloration. Modest dietary changes are required to enhance apparent health (2.91 portions per day) and attractiveness (3.30 portions). Conclusions: Increased fruit and vegetable consumption confers measurable and perceptibly beneficial effects on Caucasian skin appearance within six weeks. This effect could potentially be used as a motivational tool in dietary intervention.	[Whitehead, Ross D.; Re, Daniel; Xiao, Dengke; Perrett, David I.] Univ St Andrews, Percept Lab, Sch Psychol, St Andrews, Fife, Scotland; [Ozakinci, Gozde] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland	University of St Andrews; University of St Andrews	Whitehead, RD (corresponding author), Univ St Andrews, Percept Lab, Sch Psychol, St Andrews, Fife, Scotland.	rw394@st-andrews.ac.uk; dp@st-andrews.ac.uk	Whitehead, Ross D/G-8569-2014; Ozakinci, Gozde/B-7897-2012	Ozakinci, Gozde/0000-0001-5869-3274; Perrett, David/0000-0002-6025-0939	Economic and Social Research Council; corporation Unilever Research and Development USA	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); corporation Unilever Research and Development USA(Unilever)	This research was supported by the Economic and Social Research Council (www.esrc.ac.uk) and by the corporation Unilever Research and Development USA (http://www.unileverusa.com/innovation/innovationinunilever/research-dev/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaluf S, 2002, J NUTR, V132, P399, DOI 10.1093/jn/132.3.399; ALEXANDER M, 1985, IMMUNOL LETT, V9, P221, DOI 10.1016/0165-2478(85)90036-7; BENDICH A, 1991, P NUTR SOC, V50, P263, DOI 10.1079/PNS19910036; Bouilly-Gauthier D, 2010, BRIT J DERMATOL, V163, P536, DOI 10.1111/j.1365-2133.2010.09888.x; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Cesarone MR, 2008, ANGIOLOGY, V59, P408, DOI 10.1177/0003319708321801; Clarkson PM, 2000, AM J CLIN NUTR, V72, p637S, DOI 10.1093/ajcn/72.2.637S; Commission internationale de l'eclairage, 1976, CIE COL 4; Cowen JA, 2001, ANAL SCI, V17, pS353; Cross CE, 1998, ENVIRON HEALTH PERSP, V106, P1241, DOI 10.2307/3433992; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Darvin ME, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2952076; Dierckx N, 2003, EUR J CLIN NUTR, V57, P999, DOI 10.1038/sj.ejcn.1601635; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Dragsted LO, 2006, P NUTR SOC, V65, P61, DOI 10.1079/PNS2005480; Edwards EA, 1939, SCIENCE, V90, P235, DOI 10.1126/science.90.2332.235; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Fisher RA, 1915, EUGEN REV, V7, P184; Frisard M, 2006, ENDOCRINE, V29, P27, DOI 10.1385/ENDO:29:1:27; FULLER CJ, 1992, AM J CLIN NUTR, V56, P684, DOI 10.1093/ajcn/56.4.684; Ghosh D, 2009, MOL NUTR FOOD RES, V53, P322, DOI 10.1002/mnfr.200800182; Guenther PM, 2006, J AM DIET ASSOC, V106, P1371, DOI 10.1016/j.jada.2006.06.002; Hata TR, 2000, J INVEST DERMATOL, V115, P441, DOI 10.1046/j.1523-1747.2000.00060.x; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Hughes DA, 1997, J LAB CLIN MED, V129, P309, DOI 10.1016/S0022-2143(97)90179-7; Jones BC, 2005, HORM BEHAV, V48, P283, DOI 10.1016/j.yhbeh.2005.03.010; Kinnear PR, 2002, BRIT J OPHTHALMOL, V86, P1408, DOI 10.1136/bjo.86.12.1408; Krinsky NI, 1998, ANN NY ACAD SCI, V854, P443, DOI 10.1111/j.1749-6632.1998.tb09923.x; Lademann J, 2011, EXP DERMATOL, V20, P377, DOI 10.1111/j.1600-0625.2010.01189.x; LEE R, 1975, J INVEST DERMATOL, V64, P175, DOI 10.1111/1523-1747.ep12533341; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; MARGETTS BM, 1989, INT J EPIDEMIOL, V18, P868, DOI 10.1093/ije/18.4.868; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; McDonough KH, 2003, TOXICOLOGY, V189, P89, DOI 10.1016/S0300-483X(03)00155-0; Meinke MC, 2010, EUR J PHARM BIOPHARM, V76, P269, DOI 10.1016/j.ejpb.2010.06.004; Miller E S, 1937, Plant Physiol, V12, P667, DOI 10.1104/pp.12.3.667; National Health Service, 2007, HLTH SURV BRIT; OHNO H, 1988, EUR J APPL PHYSIOL O, V57, P173, DOI 10.1007/BF00640658; PARKER RS, 1988, AM J CLIN NUTR, V47, P33, DOI 10.1093/ajcn/47.1.33; Pike TW, 2007, P ROY SOC B-BIOL SCI, V274, P1591, DOI 10.1098/rspb.2007.0317; Polidori MC, 2003, BRIT J NUTR, V90, P147, DOI 10.1079/BJN2003890; Re DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017859; Richelle M, 2006, BRIT J NUTR, V96, P227, DOI 10.1079/BJN20061817; Rizwan M, 2011, BRIT J DERMATOL, V164, P154, DOI 10.1111/j.1365-2133.2010.10057.x; Sarna S, 1988, PIGMENTARY SYSTEM, P311; Sies H, 2005, J NUTR, V135, P969, DOI 10.1093/jn/135.5.969; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Stamatas GN, 2004, PIGM CELL RES, V17, P618, DOI 10.1111/j.1600-0749.2004.00204.x; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Thompson HJ, 1999, CARCINOGENESIS, V20, P2261, DOI 10.1093/carcin/20.12.2261; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Trivers R, 1972, PARENTAL INVESTMENT; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vassalle C, 2009, CLIN BIOCHEM, V42, P739, DOI 10.1016/j.clinbiochem.2008.11.017; Vinkler M, 2010, NATURWISSENSCHAFTEN, V97, P19, DOI 10.1007/s00114-009-0595-9; Walrand S, 2005, EUR J NUTR, V44, P114, DOI 10.1007/s00394-004-0501-3	59	78	78	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32988	10.1371/journal.pone.0032988	http://dx.doi.org/10.1371/journal.pone.0032988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412966	Green Published, gold			2022-12-25	WOS:000303060800069
J	Yuan, M; Coupe, M; Bai, YQ; Gauquelin-Koch, G; Jiang, SZ; Aubry, P; Wan, YM; Custaud, MA; Li, YH; Arbeille, P				Yuan, Ming; Coupe, Mickael; Bai, Yanqiang; Gauquelin-Koch, Guillemette; Jiang, Shizhong; Aubry, Patrick; Wan, Yumin; Custaud, Marc-Antoine; Li, Yinghui; Arbeille, Philippe			Peripheral Arterial and Venous Response to Tilt Test after a 60-Day Bedrest with and without Countermeasures (ES-IBREP)	PLOS ONE			English	Article							90-DAY BED-REST; EXERCISE COUNTERMEASURE; VIBRATION EXERCISE; FLOW; VOLUME; HEAD; VEIN; SKIN	We quantified the impact of 60-day head-down bed rest (HDBR) with countermeasures on arterial and venous response to tilt. Methods: Twenty-one males: 7 control (Con), 7 resistive vibration exercise (RVE) and 7 Chinese herb (Herb) were assessed. Subjects were identified as finisher (F) or non-finishers (NF) at the post-HDBR 20-min tilt test. The cerebral (MCA), femoral (FEM) arterial flow velocity and leg vascular resistance (FRI), the portal vein section (PV), the flow redistribution ratios (MCA/FEM; MCA/PV), the tibial (Tib), gastrocnemius (Gast), and saphenous (Saph) vein sections were measured by echography and Doppler ultrasonography. Arterial and venous parameters were measured at 3-min pre-tilt in the supine position, and at 1 min before the end of the tilt. Results: At post-HDBR tilt, MCA decreased more compared with pre-HDBR tilt in the Con, RVE, and Herb groups, the MCA/FEM tended to decrease in the Con and Herb groups (not significant) but remained stable in the RVE gr. FRI dropped in the Con gr, but remained stable in the Herb gr and increased in the RVE gr. PV decreased less in the Con and Herb groups but remained unchanged in the RVE gr. MCA/PV decreased in the Con and Herb groups, but increased to a similar extent in the RVE gr. Gast section significantly increased more in the Con gr only, whereas Tib section increased more in the Con and Herb groups but not in the RVE gr. The percent change in Saph section was similar at pre- and post-HDBR tilt. Conclusion: In the Con gr, vasoconstriction was reduced in leg and splanchnic areas. RVE and Herb contributed to prevent the loss of vasoconstriction in both areas, but the effect of RVE was higher. RVE and Herb contributed to limit Gast distension whereas only RVE had a protective effect on the Tib.	[Yuan, Ming; Bai, Yanqiang; Jiang, Shizhong; Wan, Yumin; Li, Yinghui] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Coupe, Mickael; Custaud, Marc-Antoine] Fac Med Angers, Ctr Natl Rech Sci, Inst Natl Sante & Rech Med, Unite Mixte Rech, Angers, France; [Gauquelin-Koch, Guillemette; Aubry, Patrick] Ctr Natl Etud Spatiales, Paris, France; [Arbeille, Philippe] Univ Hop Trousseau, UMPS CERCOM Med Physiol Spatiale, Tours, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; CHU Tours	Yuan, M (corresponding author), China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China.	yinghuidd@vip.sina.com; arbeille@med.univ-tours.fr	Custaud, Marc-Antoine/K-1376-2015		Centre National d'Etudes Spatiales; State Key Laboratory of Space Medicine Fundamentals and Application; China Astronaut Research and Training Center [NO:SMFA09A02, SMFA11A01]; China Advanced Space Medico-engineering Research Project [NO:SJ200801, 2011SY5406018]; China Manned Space Flight Project Foundation; Major State Basic Research Development Program of China (973 Program) [NO:2011CB707704]	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); State Key Laboratory of Space Medicine Fundamentals and Application; China Astronaut Research and Training Center; China Advanced Space Medico-engineering Research Project; China Manned Space Flight Project Foundation; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	The work was supported by Centre National d'Etudes Spatiales, the State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, grant NO:SMFA09A02, SMFA11A01, China Advanced Space Medico-engineering Research Project, NO:SJ200801, 2011SY5406018, the China Manned Space Flight Project Foundation and Major State Basic Research Development Program of China (973 Program, NO:2011CB707704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeille P, 2008, AM J PHYSIOL-HEART C, V295, pH1846, DOI 10.1152/ajpheart.509.2008; Arbeille P, 2008, J APPL PHYSIOL, V104, P938, DOI 10.1152/japplphysiol.01021.2007; Arbeille P, 2012, EUR J APPL PHYSIOL, V112, P277, DOI 10.1007/s00421-011-1935-y; Arbeille P, 1997, ULTRASOUND MED BIOL, V23, P415, DOI 10.1016/S0301-5629(96)00225-6; Arbeille P, 2008, J GRAVIT PHYSL, V15, P49; Arbeille PP, 2005, J APPL PHYSIOL, V99, P1853, DOI 10.1152/japplphysiol.00331.2005; Armbrecht G, 2010, OSTEOPOROSIS INT, V21, P597, DOI 10.1007/s00198-009-0985-z; Bleeker MWP, 2005, J APPL PHYSIOL, V99, P1293, DOI 10.1152/japplphysiol.00118.2005; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; Bull B S, 2003, Lab Hematol, V9, P1; Cardinale M, 2003, EXERC SPORT SCI REV, V31, P3, DOI 10.1097/00003677-200301000-00002; de Chantemele EB, 2004, J PHYSIOL-LONDON, V561, P611, DOI 10.1113/jphysiol.2004.069468; Herault S, 2002, EUR J APPL PHYSIOL, V87, P296, DOI 10.1007/s00421-002-0619-z; Johansen LB, 1997, CLIN PHYSIOL, V17, P203, DOI 10.1046/j.1365-2281.1997.02626.x; Lee WS, 2005, CLIN EXP PHARMACOL P, V32, P845, DOI 10.1111/j.1440-1681.2005.04275.x; LIU SF, 1990, EUR J PHARMACOL, V191, P345, DOI 10.1016/0014-2999(90)94167-V; MAGRINI F, 1989, CARDIOVASC RES, V23, P460, DOI 10.1093/cvr/23.5.460; Meng LQ, 2007, VASC PHARMACOL, V47, P174, DOI 10.1016/j.vph.2007.06.002; [米涛 MI Tao], 2008, [航天医学与医学工程, Space Medicine & Medical Engineering], V21, P22; Miller LG, 1998, ARCH INTERN MED, V158, P2200, DOI 10.1001/archinte.158.20.2200; Moriggi M, 2010, PROTEOMICS, V10, P3756, DOI 10.1002/pmic.200900817; OKADA A, 1991, EUR J APPL PHYSIOL O, V62, P324, DOI 10.1007/BF00634967; Park JY, 2009, J ETHNOPHARMACOL, V121, P69, DOI 10.1016/j.jep.2008.09.031; Qi Cun-fang, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P771; Ren HJ, 2009, CHIN HEART J, V21, P537; SAKAKIBARA H, 1990, INT ARCH OCC ENV HEA, V62, P455, DOI 10.1007/BF00379063; SAKAKIBARA H, 1991, INT ARCH OCC ENV HEA, V63, P145, DOI 10.1007/BF00379079; Tang YP, 2009, FREE RADICAL BIO MED, V47, P835, DOI 10.1016/j.freeradbiomed.2009.06.024; van Duijnhoven NTL, 2008, EUR J APPL PHYSIOL, V104, P991, DOI 10.1007/s00421-008-0854-z; van Duijnhoven NTL, 2010, HYPERTENSION, V56, P240, DOI 10.1161/HYPERTENSIONAHA.110.152868; van Duijnhoven NTL, 2010, J APPL PHYSIOL, V108, P28, DOI 10.1152/japplphysiol.00760.2009; Wu B, 2007, STROKE, V38, P1973, DOI 10.1161/STROKEAHA.106.473165; Young LR, 2007, J GRAVIT PHYSL, V14, pP31	33	12	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32854	10.1371/journal.pone.0032854	http://dx.doi.org/10.1371/journal.pone.0032854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412933	Green Published, gold			2022-12-25	WOS:000303060800054
J	Cho, YM; Kim, JH; Kim, M; Park, SJ; Koh, SH; Ahn, HS; Kang, GH; Lee, JB; Park, KS; Lee, HK				Cho, Young Min; Kim, Ju Han; Kim, Mingoo; Park, Su Jin; Koh, Sang Hyeok; Ahn, Hyo Seop; Kang, Gyeong Hoon; Lee, Jung-Bin; Park, Kyong Soo; Lee, Hong Kyu			Mesenchymal Stem Cells Transfer Mitochondria to the Cells with Virtually No Mitochondrial Function but Not with Pathogenic mtDNA Mutations	PLOS ONE			English	Article							EXPRESSION DATA; RHODAMINE 6G; FUSION; COMPLEMENTATION; CARDIOMYOCYTES; FRAMEWORK; RESCUE; SYSTEM; LINES	It has been reported that human mesenchymal stem cells (MSCs) can transfer mitochondria to the cells with severely compromised mitochondrial function. We tested whether the reported intercellular mitochondrial transfer could be replicated in different types of cells or under different experimental conditions, and tried to elucidate possible mechanism. Using biochemical selection methods, we found exponentially growing cells in restrictive media (uridine(-) and bromodeoxyuridine [BrdU](+)) during the coculture of MSCs (uridine-independent and BrdU-sensitive) and 143B-derived cells with severe mitochondrial dysfunction induced by either long-term ethidium bromide treatment or short-term rhodamine 6G (R6G) treatment (uridine-dependent but BrdU-resistant). The exponentially growing cells had nuclear DNA fingerprint patterns identical to 143B, and a sequence of mitochondrial DNA (mtDNA) identical to the MSCs. Since R6G causes rapid and irreversible damage to mitochondria without the removal of mtDNA, the mitochondrial function appears to be restored through a direct transfer of mitochondria rather than mtDNA alone. Conditioned media, which were prepared by treating mtDNA-less 143B rho(0) cells under uridine-free condition, induced increased chemotaxis in MSC, which was also supported by transcriptome analysis. Cytochalasin B, an inhibitor of chemotaxis and cytoskeletal assembly, blocked mitochondrial transfer phenomenon in the above condition. However, we could not find any evidence of mitochondrial transfer to the cells harboring human pathogenic mtDNA mutations (A3243G mutation or 4,977 bp deletion). Thus, the mitochondrial transfer is limited to the condition of a near total absence of mitochondrial function. Elucidation of the mechanism of mitochondrial transfer will help us create a potential cell therapy-based mitochondrial restoration or mitochondrial gene therapy for human diseases caused by mitochondrial dysfunction.	[Cho, Young Min; Park, Su Jin; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Ju Han; Kim, Mingoo] Seoul Natl Univ Biomed Informat SNUBI, Dept Biomed Informat, Seoul, South Korea; [Kim, Ju Han; Kim, Mingoo] Interdisciplinary Program Med Informat, Seoul, South Korea; [Koh, Sang Hyeok; Ahn, Hyo Seop] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul 151, South Korea; [Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Lee, Jung-Bin] Seoul Natl Univ, Coll Med, Dept Forens Med, Seoul 151, South Korea; [Lee, Hong Kyu] Eulji Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Eulji University	Cho, YM (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	ymchomd@snu.ac.kr	Park, Kyong Soo/C-2265-2008; Cho, Young Min/J-5669-2012; Kang, Gyeong Hoon/F-1051-2010; Kim, Ju Han/E-5983-2012	Park, Kyong Soo/0000-0003-3597-342X; Kang, Gyeong Hoon/0000-0003-2380-6675; 	Stem Cell Research Center [SC2020]; National Research Foundation of Korea (NRF) [2010-0028631]; Ministry of Education, Science and Technology	Stem Cell Research Center; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Stem Cell Research Center of the 21st Century Frontier Research Program (No. SC2020) and Basic Science Research Program through the National Research Foundation of Korea (NRF) (2010-0028631), which were funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquistapace A, 2011, STEM CELLS, V29, P812, DOI 10.1002/stem.632; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bini C, 2003, FORENSIC SCI INT, V135, P48, DOI 10.1016/S0379-0738(03)00167-1; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Chomyn A, 1996, Methods Enzymol, V264, P334, DOI 10.1016/S0076-6879(96)64031-2; DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598; GEAR ARL, 1974, J BIOL CHEM, V249, P3628; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishikawa F, 2006, FASEB J, V20, P950, DOI 10.1096/fj.05-4863fje; Kim J, 2008, J BIOMED INFORM, V41, P232, DOI 10.1016/j.jbi.2007.10.003; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Oh SK, 2005, STEM CELLS, V23, P211, DOI 10.1634/stemcells.2004-0122; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; TATUM EL, 1947, J BACTERIOL, V53, P673, DOI 10.1128/JB.53.6.673-684.1947; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Trounce I, 1996, SOMAT CELL MOLEC GEN, V22, P81, DOI 10.1007/BF02374379; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Williams AJ, 1999, HUM MOL GENET, V8, P1691, DOI 10.1093/hmg/8.9.1691; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; ZIEGLER ML, 1981, SOMAT CELL GENET, V7, P73, DOI 10.1007/BF01544749	27	115	122	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32778	10.1371/journal.pone.0032778	http://dx.doi.org/10.1371/journal.pone.0032778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412925	Green Published, Green Submitted, gold			2022-12-25	WOS:000303021100030
J	Chyou, S; Tian, S; Ekland, EH; Lu, TT				Chyou, Susan; Tian, Sha; Ekland, Eric H.; Lu, Theresa T.			Normalization of the Lymph Node T Cell Stromal Microenvironment in lpr/lpr Mice Is Associated with SU5416-Induced Reduction in Autoantibodies	PLOS ONE			English	Article							FIBROBLASTIC RETICULAR CELLS; TYROSINE KINASE; DENDRITIC CELLS; B-CELLS; PROTEIN-KINASE; LUPUS; GROWTH; ANTIGEN; DISEASE; SU5416	The vascular-stromal elements of lymph nodes can play important roles in regulating the activities of the lymphocytes within. During model immune responses, the vascular-stromal compartment has been shown to undergo proliferative expansion and functional alterations. The state of the vascular-stromal compartment and the potential importance of this compartment in a spontaneous, chronic model of autoimmunity have not been well studied. Here, we characterize the vascular expansion in MRL-lpr/lpr lymph nodes and attempt to ask whether inhibiting this expansion can interfere with autoantibody generation. We show that characteristics of vascular expansion in enlarging MRL-lpr/lpr lymph nodes resemble that of the VEGF-dependent expansion that occurs in wild-type mice after model immunization. Surprisingly, treatment with SU5416, an inhibitor of VEGF and other receptor tyrosine kinases, did not have sustained effects in inhibiting vascular growth, but attenuated the anti-dsDNA response and altered the phenotype of the double negative T cells that are expanded in these mice. In examining for anatomic correlates of these immunologic changes, we found that the double negative T cells are localized within ectopic follicles around a central B cell patch and that these T cell-rich areas lack the T zone stromal protein ER-TR7 as well as other elements of a normal T zone microenvironment. SU5416 treatment disrupted these follicles and normalized the association between T zone microenvironmental elements and T cell-rich areas. Recent studies have shown a regulatory role for T zone stromal elements. Thus, our findings of the association of anti-dsDNA responses, double negative T cell phenotype, and altered lymphocyte microenvironment suggest the possibility that lymphocyte localization in ectopic follicles protects them from regulation by T zone stromal elements and functions to maintain autoimmune responses. Potentially, altering the lymphocyte microenvironment that is set up by the vascular-stromal compartment can be a means by which to control undesired autoimmune responses.	[Chyou, Susan; Tian, Sha; Ekland, Eric H.; Lu, Theresa T.] Hosp Special Surg, Autoimmun & Inflammat Program, New York, NY 10021 USA; [Lu, Theresa T.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA	Cornell University	Chyou, S (corresponding author), Hosp Special Surg, Autoimmun & Inflammat Program, 535 E 70th St, New York, NY 10021 USA.	lut@hss.edu		Lu, Theresa/0000-0002-5707-8744	Lupus Research Institute;  [R01-AI069800];  [R01-AI079178]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079178] Funding Source: NIH RePORTER	Lupus Research Institute; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by R01-AI069800, R01-AI079178, and a Lupus Research Institute Novel Research Grant (http://www.lupusresearchinstitute.org) (to TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Buettner M, 2010, TRENDS IMMUNOL, V31, P80, DOI 10.1016/j.it.2009.11.003; Chowdhury S, 2011, HEMATOL ONCOL CLIN N, V25, P853, DOI 10.1016/j.hoc.2011.05.003; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Cohen PL, 2003, ANIMAL MODELS SLE CU, P152011; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Fields ML, 2005, IMMUNOL REV, V204, P165, DOI 10.1111/j.0105-2896.2005.00238.x; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Fong TAT, 1999, CANCER RES, V59, P99; Fox RA, 1943, AM J PATHOL, V19, P73; GINDHART TD, 1980, AM J PATHOL, V99, P805; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; INGHIRAMI G, 1988, CLIN EXP RHEUMATOL, V6, P269; Itokawa T, 2002, MOL CANCER THER, V1, P295; JACOBSON BA, 1995, IMMUNITY, V3, P509, DOI 10.1016/1074-7613(95)90179-5; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Khan O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026138; Kojima M, 2001, PATHOL RES PRACT, V197, P237, DOI 10.1078/0344-0338-00041; Kumamoto Y, 2011, P NATL ACAD SCI USA, V108, P8749, DOI 10.1073/pnas.1100567108; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; LIEBERUM B, 1988, CLIN IMMUNOL IMMUNOP, V46, P421, DOI 10.1016/0090-1229(88)90061-X; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; Manley PW, 2004, BBA-PROTEINS PROTEOM, V1697, P17, DOI 10.1016/j.bbapap.2003.11.010; Mologni L, 2006, J MOL ENDOCRINOL, V37, P199, DOI 10.1677/jme.1.01999; MORSE HC, 1982, J IMMUNOL, V129, P2612; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Mueller SN, 2007, P NATL ACAD SCI US; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; RAJAGOPALAN S, 1990, P NATL ACAD SCI USA, V87, P7020, DOI 10.1073/pnas.87.18.7020; Randall TD, 2011, IMMUNOL CELL BIOL; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Roskoski R, 2007, BIOCHEM BIOPH RES CO, V356, P323, DOI 10.1016/j.bbrc.2007.02.156; Sadanaga A, 2005, ARTHRITIS RHEUM-US, V52, P3987, DOI 10.1002/art.21424; Seagal J, 2003, INT IMMUNOL, V15, P1045, DOI 10.1093/intimm/dxg107; SHIVAKUMAR S, 1989, J IMMUNOL, V143, P103; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Smolich BD, 2001, BLOOD, V97, P1413, DOI 10.1182/blood.V97.5.1413; Spiekermann K, 2003, BLOOD, V101, P1494, DOI 10.1182/blood-2002-04-1045; Strawn LM, 1996, CANCER RES, V56, P3540; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; Tzeng TC, 2010, J IMMUNOL, V184, P4247, DOI 10.4049/jimmunol.0902914; VANVLIET E, 1986, J HISTOCHEM CYTOCHEM, V34, P883, DOI 10.1177/34.7.3519751; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Watanabe H, 2005, CLIN CANCER RES, V11, P407; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Yee KWH, 2002, BLOOD, V100, P2941, DOI 10.1182/blood-2002-02-0531; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385	64	40	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32828	10.1371/journal.pone.0032828	http://dx.doi.org/10.1371/journal.pone.0032828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412930	gold, Green Submitted, Green Published			2022-12-25	WOS:000303021100033
J	Jakubowska, A; Korona, R				Jakubowska, Agata; Korona, Ryszard			Epistasis for Growth Rate and Total Metabolic Flux in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DELETERIOUS MUTATIONS; EVOLUTION; RECOMBINATION; NETWORKS; FITNESS; TRANSCRIPTION; CELLS; SEX	Studies of interactions between gene deletions repeatedly show that the effect of epistasis on the growth of yeast cells is roughly null or barely positive. These observations relate generally to the pace of growth, its costs in terms of required metabolites and energy are unknown. We measured the maximum rate at which yeast cultures grow and amounts of glucose they consume per synthesized biomass for strains with none, single, or double gene deletions. Because all strains were maintained under a fermentative mode of growth and thus shared a common pattern of metabolic processes, we used the rate of glucose uptake as a proxy for the total flux of metabolites and energy. In the tested sample, the double deletions showed null or slightly positive epistasis both for the mean growth and mean flux. This concordance is explained by the fact that average efficiency of converting glucose into biomass was nearly constant, that is, it did not change with the strength of growth effect. Individual changes in the efficiency caused by gene deletions did have a genetic basis as they were consistent over several environments and transmitted between single and double deletion strains indicating that the efficiency of growth, although independent of its rate, was appreciably heritable. Together, our results suggest that data on the rate of growth can be used as a proxy for the rate of total metabolism when the goal is to find strong individual interactions or estimate the mean epistatic effect. However, it may be necessary to assay both growth and flux in order to detect smaller individual effects of epistasis.	[Jakubowska, Agata; Korona, Ryszard] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Jagiellonian University	Jakubowska, A (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	ryszard.korona@uj.edu.pl	Korona, Ryszard/J-7154-2015	Korona, Ryszard/0000-0002-4329-5908	Foundation for Polish Science; Ministry of Science and Higher Education of Poland [3970/B/P01/2009/36, DS/INoS/762/10]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the Foundation for Polish Science (The "Mistrz" Program) and the Ministry of Science and Higher Education of Poland grants 3970/B/P01/2009/36 and DS/INoS/762/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2010, TRENDS ECOL EVOL, V25, P450, DOI 10.1016/j.tree.2010.05.003; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Bell G, 2010, P ROY SOC B-BIOL SCI, V277, P1459, DOI 10.1098/rspb.2009.2099; CLIFTON D, 1993, J BACTERIOL, V175, P3289, DOI 10.1128/jb.175.11.3289-3294.1993; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; CROW JF, 1979, P NATL ACAD SCI USA, V76, P396, DOI 10.1073/pnas.76.1.396; Daae EB, 1999, METAB ENG, V1, P153, DOI 10.1006/mben.1998.0112; de Visser JAGM, 2007, NAT REV GENET, V8, P139, DOI 10.1038/nrg1985; de Visser JAGM, 2011, P ROY SOC B-BIOL SCI, V278, P3617, DOI 10.1098/rspb.2011.1537; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Jasnos L, 2008, GENETICS, V178, P2105, DOI 10.1534/genetics.107.084533; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; LAGUNAS R, 1986, YEAST, V2, P221, DOI 10.1002/yea.320020403; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Otto SP, 1997, NATURE, V390, P343, DOI 10.1038/36996; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; von der Haar T, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-87; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Wenger JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002202; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	38	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e33132	10.1371/journal.pone.0033132	http://dx.doi.org/10.1371/journal.pone.0033132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412994	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100051
J	Lutzner, N; Arce, JD; Rosl, F				Luetzner, Nicolas; Arce, Johanna De-Castro; Roesl, Frank			Gene Expression of the Tumour Suppressor LKB1 Is Mediated by Sp1, NF-Y and FOXO Transcription Factors	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR AFX; FORKHEAD; IDENTIFICATION; INACTIVATION; METABOLISM; MUTATIONS; SEQUENCES; APOPTOSIS; SURVIVAL	The serine/threonine kinase LKB1 is a tumour suppressor that regulates multiple biological pathways, including cell cycle control, cell polarity and energy metabolism by direct phosphorylation of 14 different AMP-activated protein kinase (AMPK) family members. Although many downstream targets have been described, the regulation of LKB1 gene expression is still poorly understood. In this study, we performed a functional analysis of the human LKB1 upstream regulatory region. We used 200 base pair deletion constructs of the 5'-flanking region fused to a luciferase reporter to identify the core promoter. It encompasses nucleotides -345 to + 52 relative to the transcription start site and coincides with a DNase I hypersensitive site. Based on extensive deletion and substitution mutant analysis of the LKB1 promoter, we identified four cis-acting elements which are critical for transcriptional activation. Using electrophoretic mobility shift assays as well as chromatin immunoprecipitations, we demonstrate that the transcription factors Sp1, NF-Y and two forkhead box O (FOXO) family members FOXO3 and FOXO4 bind to these elements. Overexpression of these factors significantly increased the LKB1 promoter activity. Conversely, small interfering RNAs directed against NF-Y alpha and the two FOXO proteins greatly reduced endogenous LKB1 expression and phosphorylation of LKB1's main substrate AMPK in three different cell lines. Taken together, these results demonstrate that Sp1, NF-Y and FOXO transcription factors are involved in the regulation of LKB1 transcription.	[Luetzner, Nicolas; Arce, Johanna De-Castro; Roesl, Frank] German Canc Res Ctr, Res Program Infect & Canc, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Lutzner, N (corresponding author), German Canc Res Ctr, Res Program Infect & Canc, Heidelberg, Germany.	n.luetzner@dkfz.de			Deutsches Krebsforschungszentrum (DKFZ); Israel's Ministry of Science and Technology (MOST)	Deutsches Krebsforschungszentrum (DKFZ)(Helmholtz Association); Israel's Ministry of Science and Technology (MOST)	This work was supported by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and Israel's Ministry of Science and Technology (MOST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Arce JDC, 2007, J BIOL CHEM, V282, P28520, DOI 10.1074/jbc.M702870200; Aretz S, 2005, HUM MUTAT, V26, P513, DOI 10.1002/humu.20253; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; CORDEN J, 1980, SCIENCE, V209, P1406, DOI 10.1126/science.6251548; Daniel S, 1996, J BIOL CHEM, V271, P1385, DOI 10.1074/jbc.271.3.1385; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Esteller M, 2000, ONCOGENE, V19, P164, DOI 10.1038/sj.onc.1203227; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; JEGHERS H, 1949, NEW ENGL J MED, V241, P1031, DOI 10.1056/NEJM194912292412601; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kabe Y, 2005, MOL CELL BIOL, V25, P512, DOI 10.1128/MCB.25.1.512-522.2005; Kang HT, 2003, J BIOL CHEM, V278, P51223, DOI 10.1074/jbc.M307332200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lee JH, 2009, HUM MOL GENET, V18, P835, DOI 10.1093/hmg/ddn409; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nafz J, 2007, BIOCHEM J, V403, P501, DOI 10.1042/BJ20061053; Nakau M, 2002, CANCER RES, V62, P4549; Pandey AK, 2009, FEBS J, V276, P4181, DOI 10.1111/j.1742-4658.2009.07091.x; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Perez-Sanchez C, 2000, J BIOL CHEM, V275, P12909, DOI 10.1074/jbc.275.17.12909; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Reichert M, 2007, CANCER RES, V67, P4149, DOI 10.1158/0008-5472.CAN-06-4484; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; STANBRIDGE EJ, 1982, SCIENCE, V215, P252, DOI 10.1126/science.7053574; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; THIESEN HJ, 1990, NUCLEIC ACIDS RES, V18, P3203, DOI 10.1093/nar/18.11.3203; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van Riggelen J, 2005, J BIOL CHEM, V280, P3286, DOI 10.1074/jbc.M409915200; Volikos E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039875; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; WRIGHT KL, 1995, J BIOL CHEM, V270, P20978, DOI 10.1074/jbc.270.36.20978; Wu W, 2006, MOL ENDOCRINOL, V20, P2304, DOI 10.1210/me.2006-0131	51	26	31	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32590	10.1371/journal.pone.0032590	http://dx.doi.org/10.1371/journal.pone.0032590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412893	gold, Green Published, Green Submitted			2022-12-25	WOS:000303021100021
J	Mervic, L				Mervic, Liljana			Time Course and Pattern of Metastasis of Cutaneous Melanoma Differ between Men and Women	PLOS ONE			English	Article							MALIGNANT-MELANOMA; GENDER-DIFFERENCES; LYMPH-NODE; SURVIVAL; PROGRESSION; GERMANY; RECURRENCE; BENEFIT; TRENDS; AGE	Background: This study identified sex differences in progression of cutaneous melanoma. Methodology/Principal Findings: Of 7,338 patients who were diagnosed as an invasive primary CM without clinically detectable metastases from 1976 to 2008 at the University of Tuebingen in Germany, 1,078 developed subsequent metastases during follow up. The metastatic pathways were defined in these patients and analyzed using the Kaplan-Meier method. Multivariate survival analysis was performed using Cox modeling. In 18.7% of men and 29.2% of women (P < 0.001) the first metastasis following diagnosis of primary tumor was locoregional as satellite/in-transit metastasis. The majority of men (54.0%) and women (47.6%, P = 0.035) exhibited direct regional lymph node metastasis. Direct distant metastasis from the stage of the primary tumor was observed in 27.3% of men and 23.2% of women (P = 0.13). Site of first metastasis was the most important prognostic factor of survival after recurrence in multivariate analysis (HR:1.3; 95% CI:1.0-1.6 for metastasis to the regional lymph nodes vs. satellite/in-transit recurrence, and HR:5.5; 95% CI: 4.2-7.1 for distant metastasis vs. satellite/in-transit recurrence, P < 0.001). Median time to distant metastasis was 40.5 months (IQR, 58.75) in women and 33 months (IQR, 44.25) in men (P = 0.002). Five-year survival after distant recurrence probability was 5.2% (95% CI:1.4-2.5) for men compared with 15.3% (95% CI:11.1-19.5; P = 0.008) for women. Conclusions/Significance: Both, the pattern of metastatic spread with more locoregional metastasis in women, and the time course with retracted metastasis in women contributed to the more favorable outcome of women. Furthermore, the total rate of metastasis is increased in men. Interestingly, there is also a much more favorable long term survival of women after development of distant metastasis. It remains a matter of debate and of future research, whether hormonal or immunologic factors may be responsible for these sex differences.	[Mervic, Liljana] Univ Tubingen, Ctr Dermatooncol, Dept Dermatol, Tubingen, Germany; [Mervic, Liljana] Univ Med Ctr Ljubljana, Dept Dermatovenereol, Ljubljana, Slovenia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University Medical Centre Ljubljana	Mervic, L (corresponding author), Univ Tubingen, Ctr Dermatooncol, Dept Dermatol, Tubingen, Germany.	liljana.mervic@kclj.si			Deutsche Krebshilfe, Bonn, Germany	Deutsche Krebshilfe, Bonn, Germany(Deutsche Krebshilfe)	Parts of this work were funded by Deutsche Krebshilfe, Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; BERNENGO MG, 1992, MELANOMA RES, V2, P157, DOI 10.1097/00008390-199209000-00003; Dong XD, 2000, CANCER-AM CANCER SOC, V88, P1063, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1063::AID-CNCR17>3.0.CO;2-E; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FUSI S, 1993, PLAST RECONSTR SURG, V91, P94, DOI 10.1097/00006534-199301000-00014; Garbe C, 2000, CANCER-AM CANCER SOC, V89, P1269, DOI 10.1002/1097-0142(20000915)89:6<1269::AID-CNCR11>3.0.CO;2-C; GARBE C, 1995, CANCER-AM CANCER SOC, V75, P2492, DOI 10.1002/1097-0142(19950515)75:10<2492::AID-CNCR2820751015>3.0.CO;2-W; HOLMAN CDJ, 1984, BRIT J CANCER, V50, P673, DOI 10.1038/bjc.1984.235; Joosse A, 2010, PIGM CELL MELANOMA R, V23, P352, DOI 10.1111/j.1755-148X.2010.00694.x; Kolmel KF, 2002, EUR J CANCER, V38, P1388, DOI 10.1016/S0959-8049(02)00104-1; Lasithiotakis K, 2008, CANCER, V112, P1795, DOI 10.1002/cncr.23359; Lasithiotakis KG, 2007, CANCER-AM CANCER SOC, V109, P1174, DOI 10.1002/cncr.22511; Lasithiotakis KG, 2006, CANCER-AM CANCER SOC, V107, P1331, DOI 10.1002/cncr.22126; Lee ML, 2000, MELANOMA RES, V10, P81; Leiter U, 2004, J SURG ONCOL, V86, P172, DOI 10.1002/jso.20079; Leong SPL, 2004, ANN SURG ONCOL, V11, p192S, DOI 10.1245/ASO.2004.12.922; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Medalie N, 2004, BRIT J DERMATOL, V151, P298, DOI 10.1111/j.1365-2133.2004.06132.x; Meier F, 2002, BRIT J DERMATOL, V147, P62, DOI 10.1046/j.1365-2133.2002.04867.x; Mervic L, 2011, MELANOMA RES, V21, P244, DOI 10.1097/CMR.0b013e32834577c8; MEYSKENS FL, 1988, CANCER-AM CANCER SOC, V62, P1207, DOI 10.1002/1097-0142(19880915)62:6<1207::AID-CNCR2820620628>3.0.CO;2-A; Miller JG, 1997, MELANOMA RES, V7, P197, DOI 10.1097/00008390-199706000-00003; Miller JG, 1997, BRIT J DERMATOL, V136, P657, DOI 10.1046/j.1365-2133.1997.6521618.x; Paharkova-Vatchkova V, 2004, J IMMUNOL, V172, P1426, DOI 10.4049/jimmunol.172.3.1426; Richardson B, 1999, BRIT J CANCER, V80, P2025, DOI 10.1038/sj.bjc.6690637; Scoggins CR, 2006, ANN SURG, V243, P693, DOI 10.1097/01.sla.0000216771.81362.6b; Tejera-Vaquerizo A, 2007, ACTAS DERMO-SIFILOGR, V98, P531, DOI 10.1016/S0001-7310(07)70128-X	28	56	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32955	10.1371/journal.pone.0032955	http://dx.doi.org/10.1371/journal.pone.0032955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412958	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100044
J	Blomgran, R; Brodin, VP; Verma, D; Bergstrom, I; Soderkvist, P; Sjowall, C; Eriksson, P; Lerm, M; Stendahl, O; Sarndahl, E				Blomgran, Robert; Brodin, Veronika Patcha; Verma, Deepti; Bergstrom, Ida; Soderkvist, Peter; Sjowall, Christopher; Eriksson, Per; Lerm, Maria; Stendahl, Olle; Sarndahl, Eva			Common Genetic Variations in the NALP3 Inflammasome Are Associated with Delayed Apoptosis of Human Neutrophils	PLOS ONE			English	Article							FAMILIAL MEDITERRANEAN FEVER; CELL-DEATH; RHEUMATOID-ARTHRITIS; MCL-1 EXPRESSION; ACTIVATION; DISEASE; RESOLUTION; TRANSMIGRATION; SUSCEPTIBILITY; POLYMORPHISMS	Background: Neutrophils are key-players in the innate host defense and their programmed cell death and removal are essential for efficient resolution of inflammation. These cells recognize a variety of pathogens, and the NOD-like receptors (NLRs) have been suggested as intracellular sensors of microbial components and cell injury/stress. Some NLR will upon activation form multi-protein complexes termed inflammasomes that result in IL-1 beta production. NLR mutations are associated with auto-inflammatory syndromes, and our previous data propose NLRP3 (Q705K)/CARD-8 (C10X) polymorphisms to contribute to increased risk and severity of inflammatory disease by acting as genetic susceptibility factors. These gene products are components of the NALP3 inflammasome, and approximately 6.5% of the Swedish population are heterozygote carriers of these combined gene variants. Since patients carrying the Q705K/C10X polymorphisms display leukocytosis, the aim of the present study was to find out whether the inflammatory phenotype was related to dysfunctional apoptosis and impaired clearance of neutrophils by macrophages. Methods and Findings: Patients carrying the Q705K/C10X polymorphisms displayed significantly delayed spontaneous as well as microbe-induced apoptosis compared to matched controls. Western blotting revealed increased levels and phosphorylation of Akt and Mcl-1 in the patients' neutrophils. In contrast to macrophages from healthy controls, macrophages from the patients produced lower amounts of TNF; suggesting impaired macrophage clearance response. Conclusions: The Q705K/C10X polymorphisms are associated with delayed apoptosis of neutrophils. These findings are explained by altered involvement of different regulators of apoptosis, resulting in an anti-apoptotic profile. Moreover, the macrophage response to ingestion of microbe-induced apoptotic neutrophils is altered in the patients. Taken together, the patients display impaired turnover and clearance of apoptotic neutrophils, pointing towards a dysregulated innate immune response that influences the resolution of inflammation. The future challenge is to understand how microbes affect the activation of inflammasomes, and why this interaction will develop into severe inflammatory disease in certain individuals.	[Blomgran, Robert; Brodin, Veronika Patcha; Lerm, Maria; Stendahl, Olle] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Med Microbiol, Linkoping, Sweden; [Verma, Deepti; Soderkvist, Peter] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden; [Sjowall, Christopher; Eriksson, Per] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Rheumatol, Linkoping, Sweden; [Bergstrom, Ida] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Sarndahl, Eva] Univ Orebro, Sch Hlth & Med Sci, Dept Clin Med, Orebro, Sweden; [Lerm, Maria] Karolinska Inst Huddinge, Ctr Infect Med, Stockholm, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Orebro University; Karolinska Institutet	Blomgran, R (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Med Microbiol, Linkoping, Sweden.	eva.sarndahl@oru.se	Sjöwall, Christopher/C-9678-2009; Lerm, Maria/AAA-1780-2020; Lerm, Maria/AAM-8705-2020; Verma, Deepti/AAI-9039-2020	Sjöwall, Christopher/0000-0003-0900-2048; Lerm, Maria/0000-0002-5092-9892; Blomgran, Robert/0000-0002-2767-8175	Swedish Research Council; Heart-Lung Foundation; King Gustaf V Memorial Foundation; County Council of Ostergotland; Soderberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart-Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf V Memorial Foundation; County Council of Ostergotland; Soderberg Foundation	This work was supported by grants from the Swedish Research Council (www.vr.se), Heart-Lung Foundation (www.hjart-lungfonden.se), the King Gustaf V Memorial Foundation, the County Council of Ostergotland, and R. Soderberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Arruda MA, 2009, FRONT BIOSCI-LANDMRK, V14, P4546, DOI 10.2741/3547; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Blomgran R, 2004, INFECT IMMUN, V72, P4570, DOI 10.1128/IAI.72.8.4570-4578.2004; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; CURNUTTE J T, 1992, Immunodeficiency Reviews, V3, P149; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Edwards SW, 2004, BIOCHEM SOC T, V32, P489, DOI 10.1042/BST0320489; Fadeel B, 2010, BIOCHEM BIOPH RES CO, V396, P7, DOI 10.1016/j.bbrc.2010.02.106; Filep JG, 2009, J CELL BIOCHEM, V108, P1039, DOI 10.1002/jcb.22351; Forsberg M, 2003, J LEUKOCYTE BIOL, V74, P620, DOI 10.1189/jlb.1202586; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Liu HT, 2006, ARTHRITIS RHEUM-US, V54, P3174, DOI 10.1002/art.22132; Liu HT, 2005, J IMMUNOL, V175, P8337, DOI 10.4049/jimmunol.175.12.8337; Maianski NA, 2004, J IMMUNOL, V172, P7024, DOI 10.4049/jimmunol.172.11.7024; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Matsuda T, 2001, SURGERY, V129, P76, DOI 10.1067/msy.2001.109060; Melley DD, 2005, CLIN SCI, V108, P413, DOI 10.1042/CS20040228; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Neven B, 2008, NAT CLIN PRACT RHEUM, V4, P481, DOI 10.1038/ncprheum0874; O'Neill S, 2000, J LEUKOCYTE BIOL, V68, P15; Ozen S, 2009, ANN RHEUM DIS, V68, P246, DOI 10.1136/ard.2008.092031; Patcha V, 2004, EXP CELL RES, V300, P308, DOI 10.1016/j.yexcr.2004.07.015; Persson YAZ, 2008, MICROBES INFECT, V10, P233, DOI 10.1016/j.micinf.2007.11.007; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; Roberts RL, 2011, ATHEROSCLEROSIS; Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201; Sarndahl E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001056; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seely AJE, 1998, ARCH SURG-CHICAGO, V133, P1305, DOI 10.1001/archsurg.133.12.1305; SENGELOV H, 1993, J CLIN INVEST, V92, P1467, DOI 10.1172/JCI116724; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Touitou I, 2007, ARTHRITIS RHEUM, V56, P1706, DOI 10.1002/art.22507; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Watson RWG, 1997, J IMMUNOL, V158, P945; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Zhang B, 2003, J BIOL CHEM, V278, P28443, DOI 10.1074/jbc.M210727200; Zhao M, 2003, EUR J BIOCHEM, V270, P3778, DOI 10.1046/j.1432-1033.2003.03765.x; Zheng LM, 2004, J IMMUNOL, V173, P6319, DOI 10.4049/jimmunol.173.10.6319	61	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31326	10.1371/journal.pone.0031326	http://dx.doi.org/10.1371/journal.pone.0031326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403613	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700010
J	Meurs, I; Calpe-Berdiel, L; Habets, KLL; Zhao, Y; Korporaal, SJA; Mommaas, AM; Josselin, E; Hildebrand, RB; Ye, D; Out, R; Kuiper, J; Van Berkel, TJC; Chimini, G; Van Eck, M				Meurs, Illiana; Calpe-Berdiel, Laura; Habets, Kim L. L.; Zhao, Ying; Korporaal, Suzanne J. A.; Mommaas, A. Mieke; Josselin, Emmanuelle; Hildebrand, Reeni B.; Ye, Dan; Out, Ruud; Kuiper, Johan; Van Berkel, Theo J. C.; Chimini, Giovanna; Van Eck, Miranda			Effects of Deletion of Macrophage ABCA7 on Lipid Metabolism and the Development of Atherosclerosis in the Presence and Absence of ABCA1	PLOS ONE			English	Article							CASSETTE TRANSPORTER A1; CHOLESTEROL EFFLUX; CELLULAR CHOLESTEROL; TANGIER-DISEASE; GENOMIC ORGANIZATION; APOPTOTIC CELLS; MICE; GENE; OVEREXPRESSION; MUTATIONS	ABCA7, a close relative of ABCA1 which facilitates cholesterol efflux to lipid-poor apoproteins, has been implicated in macrophage lipid efflux and clearance of apoptotic cells in in vitro studies. In the current study, we investigated the in vivo effects of macrophage ABCA7 deficiency on lipid metabolism and atherosclerosis. Chimeras with dysfunctional ABCA7 in macrophages and other blood cells were generated by transplantation of bone marrow from ABCA7 knockout (KO) mice into irradiated low-density lipoprotein receptor (LDLr) KO mice. Unexpectedly, macrophage ABCA7 deficiency did not significantly affect atherosclerosis susceptibility of LDLr KO mice after 10 weeks Western-type diet feeding. However, ABCA7 deficiency was associated with 2-fold (p<0.05) higher macrophage ABCA1 mRNA expression levels. Combined disruption of ABCA1 and ABCA7 in bone-marrow-derived cells increased atherosclerotic lesion development (1.5-fold (p>0.05) as compared to wild type transplanted mice. However, single deletion of ABCA1 had a similar effect (1.8-fold, p<0.05). Macrophage foam cell accumulation in the peritoneal cavity was reduced in ABCA1/ABCA7 dKO transplanted animals as compared to single ABCA1 KO transplanted mice, which was associated with increased ABCG1 expression. Interestingly, spleens of ABCA1/ABCA7 double KO transplanted mice were significantly larger as compared to the other 3 groups and showed massive macrophage lipid accumulation, a reduction in CD3+ T-cells, and increased expression of key regulators of erythropoiesis. In conclusion, deletion of ABCA7 in bone marrow-derived cells does not affect atherogenesis in the arterial wall neither in the absence or presence of ABCA1. Interestingly, combined deletion of bone marrow ABCA1 and ABCA7 causes severe splenomegaly associated with cellular lipid accumulation, a reduction in splenic CD3+ T cells, and induced markers of erythropoeisis. Our data indicate that ABCA7 may play a role in T cell proliferation and erythropoeisis in spleen.	[Meurs, Illiana; Calpe-Berdiel, Laura; Habets, Kim L. L.; Zhao, Ying; Korporaal, Suzanne J. A.; Hildebrand, Reeni B.; Ye, Dan; Out, Ruud; Kuiper, Johan; Van Berkel, Theo J. C.; Van Eck, Miranda] Leiden Univ, Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands; [Meurs, Illiana] Leiden Univ Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Mommaas, A. Mieke] Leiden Univ Med Ctr, Dept Mol Cell Biol, Electron Microscopy Sect, Leiden, Netherlands; [Josselin, Emmanuelle; Chimini, Giovanna] Univ Mediterranee, INSERM, Ctr Immunol Marseille Luminy, Marseille, France	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Meurs, I (corresponding author), Leiden Univ, Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, POB 9502, NL-2300 RA Leiden, Netherlands.	m.eck@lacdr.leidenuniv.nl	Zhao, Ying/C-3916-2011; Zhao, Ying/AAS-7970-2021; Van Berkel, Theo/ABD-7677-2021	van Eck, Miranda/0000-0003-3936-3194	Netherlands Organization for Scientific Research [917.66.301]; Agency for Management of University and Research (Beatriu de Pinos); Netherlands Heart Foundation [2006B107, 2007T056]; Top Institute Pharma (TIPharma) [T2-110]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Agency for Management of University and Research (Beatriu de Pinos); Netherlands Heart Foundation(Netherlands Heart Foundation); Top Institute Pharma (TIPharma)	This research was supported by The Netherlands Organization for Scientific Research (Grant 917.66.301 (I. M. and M. V. E.)), by the Agency for Management of University and Research Grants (Beatriu de Pinos Postdoctoral Grant (LC-B)), by the Netherlands Heart Foundation (Grant 2006B107) (S.J.A.K.), and by Top Institute Pharma (TIPharma project T2-110; R.O.). M.V.E. is an Established Investigator of the Netherlands Heart Foundation (Grant 2007T056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Broccardo C, 2001, CYTOGENET CELL GENET, V92, P264, DOI 10.1159/000056914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; GLOMSET JA, 1968, J LIPID RES, V9, P155; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092-JLR200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Ikeda Y, 2003, BIOCHEM BIOPH RES CO, V311, P313, DOI 10.1016/j.bbrc.2003.10.002; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; Kam HY, 1999, J APPL PHYSIOL, V87, P1901, DOI 10.1152/jappl.1999.87.5.1901; Kaminski WE, 2000, BIOCHEM BIOPH RES CO, V278, P782, DOI 10.1006/bbrc.2000.3880; Kaminski WE, 2000, BIOCHEM BIOPH RES CO, V273, P532, DOI 10.1006/bbrc.2000.2954; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kockx MM, 1998, ARTERIOSCL THROM VAS, V18, P1519, DOI 10.1161/01.ATV.18.10.1519; Kockx MM, 1998, CIRCULATION, V97, P2307, DOI 10.1161/01.CIR.97.23.2307; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Linsel-Nitschke P, 2005, J LIPID RES, V46, P86, DOI 10.1194/jlr.M400247-JLR200; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Schmitz G, 2000, CURR OPIN LIPIDOL, V11, P493, DOI 10.1097/00041433-200010000-00007; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Van Eck M, 2005, CURR OPIN LIPIDOL, V16, P307; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wellington CL, 2003, J LIPID RES, V44, P1470, DOI 10.1194/jlr.M300110-JLR200; Ye D, 2010, BIOCHEM BIOPH RES CO, V395, P387, DOI 10.1016/j.bbrc.2010.04.027; Young SG, 1999, NAT GENET, V22, P316, DOI 10.1038/11878	41	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e30984	10.1371/journal.pone.0030984	http://dx.doi.org/10.1371/journal.pone.0030984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403608	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700005
J	Procino, G; Mastrofrancesco, L; Tamma, G; Lasorsa, DR; Ranieri, M; Stringini, G; Emma, F; Svelto, M; Valenti, G				Procino, Giuseppe; Mastrofrancesco, Lisa; Tamma, Grazia; Lasorsa, Domenica Rita; Ranieri, Marianna; Stringini, Gilda; Emma, Francesco; Svelto, Maria; Valenti, Giovanna			Calcium-Sensing Receptor and Aquaporin 2 Interplay in Hypercalciuria-Associated Renal Concentrating Defect in Humans. An In Vivo and In Vitro Study	PLOS ONE			English	Article							VASOPRESSIN-ELICITED WATER; COLLECTING DUCT; MEMBRANE; PATHOPHYSIOLOGY; TRANSLOCATION; EXPRESSION; PHYSIOLOGY; EXCRETION; RISK; INHIBITION	One mechanism proposed for reducing the risk of calcium renal stones is activation of the calcium-sensing receptor (CaR) on the apical membranes of collecting duct principal cells by high luminal calcium. This would reduce the abundance of aquaporin-2 (AQP2) and in turn the rate of water reabsorption. While evidence in cells and in hypercalciuric animal models supports this hypothesis, the relevance of the interplay between the CaR and AQP2 in humans is not clear. This paper reports for the first time a detailed correlation between urinary AQP2 excretion under acute vasopressin action (DDAVP treatment) in hypercalciuric subjects and in parallel analyzes AQP2-CaR crosstalk in a mouse collecting duct cell line (MCD4) expressing endogenous and functional CaR. In normocalciurics, DDAVP administration resulted in a significant increase in AQP2 excretion paralleled by an increase in urinary osmolality indicating a physiological response to DDAVP. In contrast, in hypercalciurics, baseline AQP2 excretion was high and did not significantly increase after DDAVP. Moreover DDAVP treatment was accompanied by a less pronounced increase in urinary osmolality. These data indicate reduced urinary concentrating ability in response to vasopressin in hypercalciurics. Consistent with these results, biotinylation experiments in MCD4 cells revealed that membrane AQP2 expression in unstimulated cells exposed to CaR agonists was higher than in control cells and did not increase significantly in response to short term exposure to forskolin (FK). Interestingly, we found that CaR activation by specific agonists reduced the increase in cAMP and prevented any reduction in Rho activity in response to FK, two crucial pathways for AQP2 translocation. These data support the hypothesis that CaR-AQP2 interplay represents an internal renal defense to mitigate the effects of hypercalciuria on the risk of calcium precipitation during antidiuresis. This mechanism and possibly reduced medulla tonicity may explain the lower concentrating ability observed in hypercalciuric patients.	[Procino, Giuseppe; Mastrofrancesco, Lisa; Tamma, Grazia; Lasorsa, Domenica Rita; Ranieri, Marianna; Svelto, Maria; Valenti, Giovanna] Univ Bari, Dept Biosci Biotechnol & Pharmacol Sci, Bari, Italy; [Procino, Giuseppe; Mastrofrancesco, Lisa; Tamma, Grazia; Lasorsa, Domenica Rita; Ranieri, Marianna; Svelto, Maria; Valenti, Giovanna] Univ Bari, Ctr Excellence Comparat Genom, Bari, Italy; [Stringini, Gilda; Emma, Francesco] Bambino Gesu Pediat Hosp, Rome, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; IRCCS Bambino Gesu	Valenti, G (corresponding author), Univ Bari, Dept Biosci Biotechnol & Pharmacol Sci, Bari, Italy.	g.valenti@biologia.uniba.it	Emma, Francesco/H-2116-2012; Svelto, Maria/P-6186-2014; Centeno, Patricia Pacios/O-8368-2016; Ranieri, Marianna/J-9421-2018; Tamma, Grazia/F-8823-2016	Emma, Francesco/0000-0002-0383-3468; Ranieri, Marianna/0000-0003-3118-5813; Tamma, Grazia/0000-0002-8890-0278; Procino, Giuseppe/0000-0002-0043-7523; Svelto, Maria/0000-0002-5584-9541; VALENTI, GIOVANNA/0000-0003-0233-0778	Italian Ministry of University and Research [RBIN04PHZ7, PE 058, CIP PS_144]; Italian Telethon [GGP04202]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Telethon(Fondazione Telethon)	The research was supported by Fondo per gli Investimenti della Ricerca di Base from Italian Ministry of University and Research (grant code RBIN04PHZ7 to MS); by Italian Telethon (grant code GGP04202 to GV) and by the Regional Explorative and Strategic grants from Italian Ministry of University and Research (grant code PE 058 to GV and CIP PS_144 to GV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsland KJ, 2009, AM J PHYSIOL-RENAL, V297, pF1017, DOI 10.1152/ajprenal.00223.2009; Brown EM, 1999, AM J MED, V106, P238, DOI 10.1016/S0002-9343(98)00418-5; Brown EM, 1998, ANNU REV MED, V49, P15, DOI 10.1146/annurev.med.49.1.15; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; COE FL, 1979, NEW ENGL J MED, V300, P337, DOI 10.1056/NEJM197902153000703; Earm JH, 1998, J AM SOC NEPHROL, V9, P2181; Hammerland LG, 1998, MOL PHARMACOL, V53, P1083; Hasler U, 2009, AM J PHYSIOL-RENAL, V297, pF10, DOI 10.1152/ajprenal.00053.2009; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Iacobelli S, 2006, NEPHRON PHYSIOL, V104, P121, DOI 10.1159/000094968; Iacobelli S, 2010, ACTA PHYSIOL, V200, P339, DOI 10.1111/j.1748-1716.2010.02164.x; Iolascon A, 2007, NEPHRON PHYSIOL, V105, P33, DOI 10.1159/000098136; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Madore F, 1998, AM J HYPERTENS, V11, P46, DOI 10.1016/S0895-7061(97)00371-3; Mandel N, 2003, J UROLOGY, V169, P2026, DOI 10.1097/01.ju.0000065592.55499.4e; Meschi T, 2004, UROL INT, V72, P29, DOI 10.1159/000076588; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Porowski T, 2010, J UROLOGY, V184, P2103, DOI 10.1016/j.juro.2010.06.134; Procino G, 2008, SEMIN NEPHROL, V28, P297, DOI 10.1016/j.semnephrol.2008.03.007; Procino G, 2004, KIDNEY INT, V66, P2245, DOI 10.1111/j.1523-1755.2004.66036.x; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Ritter M, 2003, J BIOL CHEM, V278, P50163, DOI 10.1074/jbc.M300374200; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; Sands JM, 1997, J CLIN INVEST, V99, P1399, DOI 10.1172/JCI119299; Sands JM, 1998, AM J PHYSIOL-RENAL, V274, pF978, DOI 10.1152/ajprenal.1998.274.5.F978; Stechman MJ, 2009, PEDIATR NEPHROL, V24, P2321, DOI 10.1007/s00467-008-0807-0; Tamma G, 2003, J CELL SCI, V116, P1519, DOI 10.1242/jcs.00355; Tamma G, 2001, AM J PHYSIOL-RENAL, V281, pF1092, DOI 10.1152/ajprenal.0091.2001; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Thomas J, 2001, J MEMBRANE BIOL, V183, P115, DOI 10.1007/s00232-001-0059-4; Umenishi F, 2002, KIDNEY INT, V62, P2288, DOI 10.1046/j.1523-1755.2002.00686.x; Valenti G, 2000, J AM SOC NEPHROL, V11, P1873, DOI 10.1681/ASN.V11101873; Valenti G, 2005, ENDOCRINOLOGY, V146, P5063, DOI 10.1210/en.2005-0868; Valenti G, 2002, AM J PHYSIOL-RENAL, V283, pF895, DOI 10.1152/ajprenal.00354.2001; Valenti G, CELL PHYSL BIOCH, V26, P901; Vezzoli G, 2010, EUR J ENDOCRINOL; Worcester EM, 2008, SEMIN NEPHROL, V28, P120, DOI 10.1016/j.semnephrol.2008.01.005; Worcester EM, 2010, NEW ENGL J MED, V363, P954, DOI 10.1056/NEJMcp1001011; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	43	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e33145	10.1371/journal.pone.0033145	http://dx.doi.org/10.1371/journal.pone.0033145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403735	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700133
J	Zou, DH; He, JC; Zhang, K; Dai, JW; Zhang, WJ; Wang, SY; Zhou, J; Huang, YL; Zhang, ZY; Jiang, XQ				Zou, Duohong; He, Jiacai; Zhang, Kai; Dai, JieWen; Zhang, Wenjie; Wang, Shaoyi; Zhou, Jian; Huang, Yuanliang; Zhang, Zhiyuan; Jiang, Xinquan			The Bone-Forming Effects of HIF-1 alpha-Transduced BMSCs Promote Osseointegration with Dental Implant in Canine Mandible	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CRITICAL LIMB ISCHEMIA; CALVARIAL DEFECTS; GENE-THERAPY; IN-VITRO; CELLS; REGENERATION; SCAFFOLD	The presence of insufficient bone volume remains a major clinical problem for dental implant placement to restore the oral function. Gene-transduced stem cells provide a promising approach for inducing bone regeneration and enhancing osseointegration in dental implants with tissue engineering technology. Our previous studies have demonstrated that the hypoxia-inducible factor-1 alpha (HIF-1 alpha) promotes osteogenesis in rat bone mesenchymal stem cells (BMSCs). In this study, the function of HIF-1 alpha was validated for the first time in a preclinical large animal canine model in term of its ability to promote new bone formation in defects around implants as well as the osseointegration between tissue-engineered bone and dental implants. A lentiviral vector was constructed with the constitutively active form of HIF-1 alpha (cHIF). The ectopic bone formation was evaluated in nude mice. The therapeutic potential of HIF-1 alpha-overexpressing canine BMSCs in bone repair was evaluated in mesi-implant defects of immediate post-extraction implants in the canine mandible. HIF-1 alpha mediated canine BMSCs significantly promoted new bone formation both subcutaneously and in mesi-implant defects, including increased bone volume, bone mineral density, trabecular thickness, and trabecular bone volume fraction. Furthermore, osseointegration was significantly enhanced by HIF-1 alpha-overexpressing canine BMSCs. This study provides an important experimental evidence in a preclinical large animal model concerning to the potential applications of HIF-1 alpha in promoting new bone formation as well as the osseointegration of immediate implantation for oral function restoration.	[Zou, Duohong; Dai, JieWen; Zhang, Wenjie; Wang, Shaoyi; Zhang, Zhiyuan; Jiang, Xinquan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Zou, Duohong; He, Jiacai; Zhou, Jian] Anhui Med Univ, Stomatol Hosp, Sch Stomatol, Dept Oral & Maxillofacial Surg, Hefei, Peoples R China; [Zhang, Kai; Zhou, Jian] Bengbu Med Coll, Affiliated Hosp 1, Dept Stomatol, Bengbu, Anhui, Peoples R China; [Huang, Yuanliang] Tongji Univ, Shanghai E Hosp, Dept Stomatol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Anhui Medical University; Bengbu Medical College; Tongji University	Zou, DH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Peoples Hosp 9, Shanghai 200030, Peoples R China.	zhzhy@omschina.org.cn; xinquanj@yahoo.cn	zhang, zhiyuan/GRS-2141-2022; Zhang, Wenjie/O-5336-2014		National Natural Science Foundation of China [81100788, 81070864]; Science and Technology Commission of Shanghai Municipality [0952nm04000, 10430710900, 10dz2211600]; Science and Technology Commission of Anhui Municipality [11040606M173]; BSKY from Anhui Medical University [XJ201109, XJ201034]; National Basic Research Program of China (973 Program) [11XJ21024, 2012CB933600-4];  [NCET-08-0353]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Commission of Anhui Municipality; BSKY from Anhui Medical University; National Basic Research Program of China (973 Program)(National Basic Research Program of China); 	This work was supported by the National Natural Science Foundation of China (81100788, 81070864), NCET-08-0353, Science and Technology Commission of Shanghai Municipality (0952nm04000, 10430710900, 10dz2211600), Science and Technology Commission of Anhui Municipality (11040606M173), Grants for Scientific Research of BSKY(XJ201109, XJ201034) from Anhui Medical University, and 11XJ21024, National Basic Research Program of China (973 Program, 2012CB933600-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boix D, 2004, J PERIODONTOL, V75, P663, DOI 10.1902/jop.2004.75.5.663; Bosch-Marce M, 2007, CIRC RES, V101, P1310, DOI 10.1161/CIRCRESAHA.107.153346; Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7; Fierro FA, 2011, STEM CELLS, V29, P1727, DOI 10.1002/stem.720; Joshi A, 2004, BRIT DENT J, V196, P215, DOI 10.1038/sj.bdj.4810987; Kaigler D, 2011, EXPERT OPIN BIOL TH, V11, P375, DOI 10.1517/14712598.2011.554814; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maynard MA, 2005, FASEB J, V19, P1396, DOI 10.1096/fj.05-3788com; Ooms EM, 2003, BIOMATERIALS, V24, P749, DOI 10.1016/S0142-9612(02)00408-8; Pautke C, 2005, BONE, V37, P441, DOI 10.1016/j.bone.2005.05.008; Qu D, 2011, J BIOMED MAT RES A; Rajagopalan S, 2007, CIRCULATION, V115, P1234, DOI 10.1161/CIRCULATIONAHA.106.607994; Rey S, 2009, P NATL ACAD SCI USA, V106, P20399, DOI 10.1073/pnas.0911921106; Salinas CN, 2009, J DENT RES, V88, P681, DOI 10.1177/0022034509341553; Sarkar K, 2009, P NATL ACAD SCI USA, V106, P18769, DOI 10.1073/pnas.0910561106; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sjostrom M, 2007, CLIN IMPLANT DENT R, V9, P46, DOI 10.1111/j.1708-8208.2007.00034.x; Trisi P, 2002, INT J PERIODONT REST, V22, P535; Wang SY, 2011, BIOMATERIALS, V32, P3739, DOI 10.1016/j.biomaterials.2011.01.020; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Xiao CW, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015013; Yamada Y, 2004, CLIN ORAL IMPLAN RES, V15, P589, DOI 10.1111/j.1600-0501.2004.01038.x; Zhang C, 2010, ACTA PHARMACOL SIN, V31, P821, DOI 10.1038/aps.2010.67; Zhang YF, 2007, BIOMATERIALS, V28, P4635, DOI 10.1016/j.biomaterials.2007.07.009; Zou DH, 2011, BIOMATERIALS, V32, P9707, DOI 10.1016/j.biomaterials.2011.09.005; Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693	26	21	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32355	10.1371/journal.pone.0032355	http://dx.doi.org/10.1371/journal.pone.0032355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403648	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700045
J	Sidhapuriwala, JN; Hegde, A; Ang, AD; Zhu, YZ; Bhatia, M				Sidhapuriwala, Jenab N.; Hegde, Akhil; Ang, Abel D.; Zhu, Yi Zhun; Bhatia, Madhav			Effects of S-Propargyl-Cysteine (SPRC) in Caerulein-Induced Acute Pancreatitis in Mice	PLOS ONE			English	Article							INDUCED HINDPAW EDEMA; HYDROGEN-SULFIDE; OXIDATIVE STRESS; RAT MODEL; INJURY; DICLOFENAC; MEDIATOR; INTERLEUKIN-10; INFLAMMATION; PROTECTS	Hydrogen sulfide (H2S), a novel gaseous messenger, is synthesized endogenously from L-cysteine by two pyridoxal-5'-phosphate-dependent enzymes, cystathionine beta-synthase (CBS) and cystathionine c-lyase (CSE). S-propargyl-cysteine (SPRC) is a slow H2S releasing drug that provides cysteine, a substrate of CSE. The present study was aimed to investigate the effects of SPRC in an in vivo model of acute pancreatitis (AP) in mice. AP was induced in mice by hourly caerulein injections (50 mu g/kg) for 10 hours. Mice were treated with SPRC (10 mg/kg) or vehicle (distilled water). SPRC was administered either 12 h before or 3 h before the induction of pancreatitis. Mice were sacrificed 1 h after the last caerulein injection. Blood, pancreas and lung tissues were collected and processed to measure the plasma amylase, plasma H2S, myeloperoxidase (MPO) activities and cytokine levels in pancreas and lung. The results revealed that significant reduction of inflammation, both in pancreas and lung was associated with SPRC given 3 h prior to the induction of AP. Furthermore, the beneficial effects of SPRC were associated with reduction of pancreatic and pulmonary pro-inflammatory cytokines and increase of anti-inflammatory cytokine. SPRC administered 12 h before AP induction did not cause significant improvement in pancreatic and lung inflammation. Plasma H2S concentration showed significant difference in H2S levels between control, vehicle and SPRC (administered 3 h before AP) treatment groups. In conclusion, these data provide evidence for protective effects of SPRC in AP possibly by virtue of its slow release of endogenous H2S.	[Sidhapuriwala, Jenab N.; Zhu, Yi Zhun] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Hegde, Akhil; Ang, Abel D.; Bhatia, Madhav] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Zhu, Yi Zhun] Fudan Univ, Dept Pharmacol, Shanghai 200433, Peoples R China	National University of Singapore; University of Otago; Fudan University	Sidhapuriwala, JN (corresponding author), Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore.	madhav.bhatia@otago.ac.nz	Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	University of Otago PBRF; Lottery Health Research Grant; Cardiovascular Biology Research Programme	University of Otago PBRF; Lottery Health Research Grant; Cardiovascular Biology Research Programme	This work was supported, in part, by University of Otago PBRF Research Output Publishing Grant, Lottery Health Research Grant, and Cardiovascular Biology Research Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amagase H, 2006, J NUTR, V136, p716S, DOI 10.1093/jn/136.3.716S; Bang UC, 2008, WORLD J GASTROENTERO, V14, P2968, DOI 10.3748/wjg.14.2968; Bhatia M, 2000, J PATHOL, V190, P117; Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; Bhatia M, 2005, PANCREATOLOGY, V5, P132, DOI 10.1159/000085265; Bhatia M, 2008, SHOCK, V29, P84, DOI 10.1097/shk.0b013e31806ec26; Bos EM, 2009, J AM SOC NEPHROL, V20, P1901, DOI 10.1681/ASN.2008121269; Chooklin S, 2009, HEPATOB PANCREAT DIS, V8, P627; Chuah SC, 2007, AM J PHYSIOL-HEART C, V293, pH2693, DOI 10.1152/ajpheart.00853.2007; Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367; Deviere J, 2001, GASTROENTEROLOGY, V120, P498, DOI 10.1053/gast.2001.21172; Escobar J, 2009, CURR PHARM DESIGN, V15, P3027, DOI 10.2174/138161209789058075; Esechie A, 2008, CLIN SCI, V115, P91, DOI 10.1042/CS20080021; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Frossard JL, 2002, AM J PHYSIOL-LUNG C, V283, pL541, DOI 10.1152/ajplung.00413.2001; Kodai S, 2007, FREE RADICAL RES, V41, P489, DOI 10.1080/10715760601118361; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Lowicka E, 2007, PHARMACOL REP, V59, P4; Minter RM, 2001, J IMMUNOL, V167, P1053, DOI 10.4049/jimmunol.167.2.1053; Mizuguchi S, 2006, BIOFACTORS, V26, P81, DOI 10.1002/biof.5520260108; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Shanmugam Muthu Kumaraswamy, 2010, Inflammation & Allergy Drug Targets, V9, P20; Sherman S, 2009, PANCREAS, V38, P267, DOI 10.1097/MPA.0b013e31819777d5; Sidhapuriwala J, 2007, EUR J PHARMACOL, V569, P149, DOI 10.1016/j.ejphar.2007.05.003; Sidhapuriwala JN, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-35; Sivarajah A, 2009, SHOCK, V31, P267, DOI 10.1097/SHK.0b013e318180ff89; Sodha NR, 2009, J THORAC CARDIOV SUR, V138, P977, DOI 10.1016/j.jtcvs.2008.08.074; Spiller F, 2010, AM J RESP CRIT CARE, V182, P360, DOI 10.1164/rccm.200907-1145OC; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tonsi AF, 2009, WORLD J GASTROENTERO, V15, P2945, DOI 10.3748/wjg.15.2945; Wang Q, 2010, ANTIOXID REDOX SIGN, V12, P1155, DOI 10.1089/ars.2009.2947; Wang Q, 2009, J CARDIOVASC PHARM, V54, P139, DOI 10.1097/FJC.0b013e3181ac8e12; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005	37	31	31	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32574	10.1371/journal.pone.0032574	http://dx.doi.org/10.1371/journal.pone.0032574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396778	Green Published, Green Submitted, gold			2022-12-25	WOS:000303005000031
J	Krug, S; Kastenmuller, G; Stuckler, F; Rist, MJ; Skurk, T; Sailer, M; Raffler, J; Romisch-Margl, W; Adamski, J; Prehn, C; Frank, T; Engel, KH; Hofmann, T; Luy, B; Zimmermann, R; Moritz, F; Schmitt-Kopplin, P; Krumsiek, J; Kremer, W; Huber, F; Oeh, U; Theis, FJ; Szymczak, W; Hauner, H; Suhre, K; Daniel, H				Krug, Susanne; Kastenmueller, Gabi; Stueckler, Ferdinand; Rist, Manuela J.; Skurk, Thomas; Sailer, Manuela; Raffler, Johannes; Roemisch-Margl, Werner; Adamski, Jerzy; Prehn, Cornelia; Frank, Thomas; Engel, Karl-Heinz; Hofmann, Thomas; Luy, Burkhard; Zimmermann, Ralf; Moritz, Franco; Schmitt-Kopplin, Philippe; Krumsiek, Jan; Kremer, Werner; Huber, Fritz; Oeh, Uwe; Theis, Fabian J.; Szymczak, Wilfried; Hauner, Hans; Suhre, Karsten; Daniel, Hannelore			The dynamic range of the human metabolome revealed by challenges	FASEB JOURNAL			English	Article						clinical study; human physiology; nutrition; systems biology; time-resolved fingerprinting	MASS-SPECTROMETRY; INDIVIDUALITY; BIOMARKERS; URINE; MICE	Metabolic challenge protocols, such as the oral glucose tolerance test, can uncover early alterations in metabolism preceding chronic diseases. Nevertheless, most metabolomics data accessible today reflect the fasting state. To analyze the dynamics of the human metabolome in response to environmental stimuli, we submitted 15 young healthy male volunteers to a highly controlled 4 d challenge protocol, including 36 h fasting, oral glucose and lipid tests, liquid test meals, physical exercise, and cold stress. Blood, urine, exhaled air, and breath condensate samples were analyzed on up to 56 time points by MS-and NMR-based methods, yielding 275 metabolic traits with a focus on lipids and amino acids. Here, we show that physiological challenges increased interindividual variation even in phenotypically similar volunteers, revealing metabotypes not observable in baseline metabolite profiles; volunteer-specific metabolite concentrations were consistently reflected in various biofluids; and readouts from a systematic model of beta-oxidation (e. g., acetylcarnitine/palmitylcarnitine ratio) showed significant and stronger associations with physiological parameters (e. g., fat mass) than absolute metabolite concentrations, indicating that systematic models may aid in understanding individual challenge responses. Due to the multitude of analytical methods, challenges and sample types, our freely available metabolomics data set provides a unique reference for future metabolomics studies and for verification of systems biology models.-Krug, S., Kastenmuller, G., Stuckler, F., Rist, M. J., Skurk, T., Sailer, M., Raffler, J., Romisch-Margl, W., Adamski, J., Prehn, C., Frank, T., Engel, K.-H., Hofmann, T., Luy, B., Zimmermann, R., Moritz, F., Schmitt-Kopplin, P., Krumsiek, J., Kremer, W., Huber, F., Oeh, U., Theis, F. J., Szymczak, W., Hauner, H., Suhre, K., Daniel, H. The dynamic range of the human metabolome revealed by challenges. FASEB J. 26, 2607-2619 (2012). www.fasebj.org	[Krug, Susanne; Skurk, Thomas] Tech Univ Munich, Dept Med Nutr, Res Ctr Nutr & Food Sci, D-85350 Freising Weihenstephan, Germany; [Rist, Manuela J.; Sailer, Manuela; Daniel, Hannelore] Tech Univ Munich, Mol Nutr Unit, D-85350 Freising Weihenstephan, Germany; [Frank, Thomas; Engel, Karl-Heinz] Tech Univ Munich, Dept Gen Food Technol, D-85350 Freising Weihenstephan, Germany; [Hofmann, Thomas] Tech Univ Munich, Dept Food Chem & Mol Sensory Sci, D-85350 Freising Weihenstephan, Germany; [Kastenmueller, Gabi; Stueckler, Ferdinand; Raffler, Johannes; Roemisch-Margl, Werner; Krumsiek, Jan; Theis, Fabian J.; Suhre, Karsten] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Adamski, Jerzy; Prehn, Cornelia] Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany; [Zimmermann, Ralf] Helmholtz Zentrum Munchen, Comprehens Mol Analyt Cooperat Grp, Joint Mass Spectrometry Ctr, Neuherberg, Germany; [Moritz, Franco; Schmitt-Kopplin, Philippe] Helmholtz Zentrum Munchen, Analyt Biogeochem Res Unit, Neuherberg, Germany; [Oeh, Uwe; Szymczak, Wilfried] Helmholtz Zentrum Munchen, Med Radiat Phys & Diagnost Res Unit, Neuherberg, Germany; [Skurk, Thomas; Hauner, Hans] Tech Univ Munich, Klinikum Rechts Isar, D-8000 Munich, Germany; [Theis, Fabian J.] Tech Univ Munich, Dept Math, Munich, Germany; [Suhre, Karsten] Univ Munich, Fac Biol, Planegg Martinsried, Germany; [Luy, Burkhard] Karlsruhe Inst Technol, Inst Organ Chem, Karlsruhe, Germany; [Luy, Burkhard] Karlsruhe Inst Technol, Inst Biol Interfaces 2, Karlsruhe, Germany; [Zimmermann, Ralf] Univ Rostock, Dept Analyt Chem, Rostock, Germany; [Kremer, Werner] LipoFIT Analyt GmbH, Regensburg, Germany; [Kremer, Werner] Univ Regensburg, Inst Biophys & Phys Biochem, D-8400 Regensburg, Germany; [Kremer, Werner] Univ Regensburg, Ctr Magnet Resonance Chem & Biomed, Regensburg, Germany; [Suhre, Karsten] Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Rostock; University of Regensburg; University of Regensburg; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Skurk, T (corresponding author), Tech Univ Munich, Else Kroner Fresenius Ctr Nutr Med, Gregor Mendel Str 2, D-85350 Freising Weihenstephan, Germany.	skurk@tum.de	Kastenmüller, Gabi/ABF-5987-2020; Theis, Fabian J/ABD-5212-2021; Daniel, Hannelore/B-8982-2009; Schmitt-Kopplin, Philippe/H-6271-2011; Luy, Burkhard/I-1918-2013; Suhre, Karsten/AAF-1778-2020; Oeh, Uwe/B-8942-2015	Theis, Fabian J/0000-0002-2419-1943; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Luy, Burkhard/0000-0001-9580-6397; Suhre, Karsten/0000-0001-9638-3912; Adamski, Jerzy/0000-0001-9259-0199; Prehn, Cornelia/0000-0002-1274-4715; Skurk, Thomas/0000-0002-6875-1658; Raffler, Johannes/0000-0003-2495-4020; Kastenmuller, Gabi/0000-0002-2368-7322	Else Kroner-Fresenius-Foundation (Bad Homburg, Germany); Helmholtz Association within Helmholtz Alliance on Systems Biology; German Federal Ministry of Education and Research (BMBF) [0315494A, 03IS2061B]; Studienstiftung des Deutschen Volkes; Deutsche Forschungsgemeinschaft [Graduiertenkolleg 1563]	Else Kroner-Fresenius-Foundation (Bad Homburg, Germany); Helmholtz Association within Helmholtz Alliance on Systems Biology; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Studienstiftung des Deutschen Volkes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The comprehensiveness of this study became possible by the collaborating work of a consortium of scientists (the Munich Functional Metabolomics Initiative, http://www.mufumet.de). The authors are grateful to Prof. Martin Halle and Dr. Otto Zelger (Center for Prevention and Sports Medicine, Technische Universitat Munchen) for measuring the individual anaerobic threshold. The study was partially funded by the Else Kroner-Fresenius-Foundation (Bad Homburg, Germany), by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (project CoReNe), by a grant from the German Federal Ministry of Education and Research (BMBF) for the German Center Diabetes Research (DZD eV), by the BMBF-funded Medizinische Systembiologie-MedSys initiative (subproject SysMBo, project label 0315494A) and BMBF grant 03IS2061B (project Gani_Med). J. K. and F. S. are supported by Ph.D. student fellowships from the Studienstiftung des Deutschen Volkes and J. R. by the Deutsche Forschungsgemeinschaft Graduiertenkolleg 1563. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. Finally, the authors express their appreciation to all volunteers for their participation. Conflicts of interest: W. K. is employed by the University of Regensburg and is cofounder of LipoFIT Analytic GmbH; F. H. is cofounder and chief executive officer of LipoFIT Analytic GmbH. This private company provides fee-for-service NMR measurements. Direct financial benefits did not result from this work. The involvement of LipoFIT Analytic GmbH and the affiliation of F. H. and W. K. to LipoFIT Analytic GmbH do not alter the authors' adherence to all The FASEB Journal policies on sharing data and materials.	Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Begriche K, 2008, OBESITY, V16, P2053, DOI 10.1038/oby.2008.337; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Garrod Archibald E., 2002, Yale Journal of Biology and Medicine, V75, P221; Gowda GAN, 2008, EXPERT REV MOL DIAGN, V8, P617, DOI 10.1586/14737159.8.5.617; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Levy PA, 2010, J DEV BEHAV PEDIATR, V31, P622, DOI 10.1097/DBP.0b013e3181eedf01; Lindinger W, 1998, INT J MASS SPECTROM, V173, P191, DOI 10.1016/S0168-1176(97)00281-4; Lucio M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013317; Maher AD, 2007, ANAL CHEM, V79, P5204, DOI 10.1021/ac070212f; Martins A M, 1999, Sao Paulo Med J, V117, P251; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Ramsay RR, 2000, BIOCHEM SOC T, V28, P182, DOI 10.1042/bst0280182; Rashed MS, 2001, J CHROMATOGR B, V758, P27, DOI 10.1016/S0378-4347(01)00100-1; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Rubio-Aliaga I, 2011, METABOLOMICS, V7, P375, DOI 10.1007/s11306-010-0255-2; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1	28	231	235	1	83	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2607	2619		10.1096/fj.11-198093	http://dx.doi.org/10.1096/fj.11-198093			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22426117				2022-12-25	WOS:000305017200036
J	Ho, CJ; Zhao, J; Malinowski, S; Chahine, M; O'Leary, ME				Ho, Cojen; Zhao, Juan; Malinowski, Steven; Chahine, Mohamed; O'Leary, Michael E.			Differential Expression of Sodium Channel beta Subunits in Dorsal Root Ganglion Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTION-POTENTIAL INITIATION; AUXILIARY SUBUNIT; ALPHA-SUBUNIT; FUNCTIONAL EXPRESSION; EXTRACELLULAR DOMAIN; RAT-BRAIN; MODULATION; NA(V)1.7; ROLES; BETA-1-SUBUNIT	The small-diameter (<25 mu m) and large-diameter (>30 mu m) sensory neurons of the dorsal root ganglion (DRG) express distinct combinations of tetrodotoxin sensitive and tetrodotoxin-resistant Na+ channels that underlie the unique electrical properties of these neurons. In vivo, these Na+ channels are formed as complexes of pore-forming alpha and auxiliary beta subunits. The goal of this study was to investigate the expression of beta subunits in DRG sensory neurons. Quantitative single-cell RTPCR revealed that beta subunit mRNA is differentially expressed in small (beta(2) and beta(3)) and large (beta(1) and beta(2)) DRG neurons. This raises the possibility that beta subunit availability and Na+ channel composition and functional regulation may differ in these subpopulations of sensory neurons. To further explore these possibilities, we quantitatively compared the mRNA expression of the beta subunit with that of Na(v)1.7, a TTX-sensitive Na+ channel widely expressed in both small and large DRG neurons. Na(v)1.7 and beta subunit mRNAs were significantly correlated in small (beta(2) and beta(3)) and large (beta(1) and beta(2)) DRG neurons, indicating that these subunits are coexpressed in the same populations. Co-immunoprecipitation and immunocytochemistry indicated that Na(v)1.7 formed stable complexes with the beta(1)-beta(3) subunits in vivo and that Na(v)1.7 and beta(3) co-localized within the plasma membranes of small DRG neurons. Heterologous expression studies showed that beta(3) induced a hyperpolarizing shift in Na(v)1.7 activation, whereas beta(1) produced a depolarizing shift in inactivation and faster recovery. The data indicate that beta(3) and beta(1) subunits are preferentially expressed in small and large DRG neurons, respectively, and that these auxiliary subunits differentially regulate the gating properties of Na(v)1.7 channels.	[Ho, Cojen; Malinowski, Steven; O'Leary, Michael E.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Zhao, Juan; Chahine, Mohamed] Univ Laval, Ctr Rech Univ Laval Robert Giffard, Quebec City, PQ G1J 2G3, Canada	Jefferson University; Laval University	O'Leary, ME (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,JAH 473, Philadelphia, PA 19107 USA.	michael.oleary@jefferson.edu			National Institutes of Health from NIGMS [R01 GM078244]; Heart and Stroke Foundation of Quebec (HSFQ); Canadian Institutes of Health Research (CIHR) [INO-77909]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078244] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Heart and Stroke Foundation of Quebec (HSFQ); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM078244 from NIGMS (to M. E. O'L.). This work was also supported by the Heart and Stroke Foundation of Quebec (HSFQ) and Canadian Institutes of Health Research (CIHR) Grant INO-77909 (to M. C.).	Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; ATTWELL D, 1979, PFLUG ARCH EUR J PHY, V379, P137, DOI 10.1007/BF00586939; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen CF, 1995, PFLUG ARCH EUR J PHY, V431, P186, DOI 10.1007/BF00410190; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; Coward K, 2001, NEUROREPORT, V12, P483, DOI 10.1097/00001756-200103050-00012; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2009, BRAIN RES REV, V60, P65, DOI 10.1016/j.brainresrev.2008.12.005; Fischer TZ, 2010, ANN NY ACAD SCI, V1184, P196, DOI 10.1111/j.1749-6632.2009.05110.x; Harty TP, 2006, J NEUROSCI, V26, P12566, DOI 10.1523/JNEUROSCI.3424-06.2006; Henze DA, 2001, NEUROSCIENCE, V105, P121, DOI 10.1016/S0306-4522(01)00167-1; Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Isom LL, 2002, FRONT BIOSCI, V7, P12; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Lopez-Santiago LF, 2011, J BIOL CHEM, V286, P22913, DOI 10.1074/jbc.M111.242370; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; Meadows LS, 2002, NEUROSCIENCE, V114, P745, DOI 10.1016/S0306-4522(02)00242-7; MESSNER DJ, 1985, J BIOL CHEM, V260, P597; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; OH YS, 1995, MOL BRAIN RES, V30, P357, DOI 10.1016/0169-328X(95)00052-T; Platkiewicz J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000850; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Qu YS, 1999, J BIOL CHEM, V274, P32647, DOI 10.1074/jbc.274.46.32647; ROBERTS RH, 1987, J BIOL CHEM, V262, P2298; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Shah BS, 2000, EUR J NEUROSCI, V12, P3985, DOI 10.1046/j.1460-9568.2000.00294.x; SUTKOWSKI EM, 1990, J BIOL CHEM, V265, P12393; Takahashi N, 2003, NEUROSCIENCE, V121, P441, DOI 10.1016/S0306-4522(03)00432-9; Vijayaragavan K, 2004, BIOCHEM BIOPH RES CO, V319, P531, DOI 10.1016/j.bbrc.2004.05.026; Vijayaragavan K, 2001, J NEUROSCI, V21, P7909, DOI 10.1523/JNEUROSCI.21-20-07909.2001; Yu FH, 2003, J NEUROSCI, V23, P7577; Zhao J, 2007, J NEUROPHYSIOL, V98, P467, DOI 10.1152/jn.00117.2007; Zhao J, 2011, J NEUROPHYSIOL, V106, P608, DOI 10.1152/jn.00107.2011; Zimmer T, 2002, J GEN PHYSIOL, V120, P887, DOI 10.1085/jgp.20028703	47	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15044	15053		10.1074/jbc.M111.333740	http://dx.doi.org/10.1074/jbc.M111.333740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22408255	hybrid, Green Published			2022-12-25	WOS:000304003200066
J	Koch, S; Fritsch, MJ; Buchanan, G; Palmer, T				Koch, Sabrina; Fritsch, Maximilian J.; Buchanan, Grant; Palmer, Tracy			Escherichia coli TatA and TatB Proteins Have N-out, C-in Topology in Intact Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCASE; SEC-INDEPENDENT PROTEIN; CYSTEINE-SCANNING MUTAGENESIS; TRANSPORT SYSTEM; SIGNAL PEPTIDE; RHOMBOID PROTEASE; CLONING VECTORS; COMPONENT; EXPORT; COMPLEX	The twin arginine protein transport (Tat) system translocates folded proteins across the cytoplasmic membrane of pro-karyotes and the thylakoid membrane of chloroplasts. In Escherichia coli, TatA, TatB, and TatC are essential components of the machinery. Acomplex of TatB and TatC acts as the substrate receptor, whereas TatA is proposed to form the Tat transport channel. TatA and TatB are related proteins that comprise an N-terminal transmembrane helix and an adjacent amphipathic helix. Previous studies addressing the topological organization of TatA have given conflicting results. In this study, we have addressed the topological arrangement of TatA and TatB in intact cells by labeling of engineered cysteine residues with the membrane-impermeable thiol reagent methoxypolyethylene glycol maleimide. Our results show that TatA and TatB share an N-out, C-in topology, with no evidence that the amphipathic helices of either protein are exposed at the periplasmic side of the membrane. We further show that the N-out, C-in topology of TatA is fixed and is not affected by the absence of other Tat components or by the overproduction of a Tat substrate. These data indicate that topological reorganization of TatA is unlikely to accompany Tat-dependent protein transport.	[Koch, Sabrina; Fritsch, Maximilian J.; Buchanan, Grant; Palmer, Tracy] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Palmer, T (corresponding author), Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland.	t.palmer@dundee.ac.uk		Palmer, Tracy/0000-0001-9043-2592	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D011140/2, BB/D011140/1] Funding Source: researchfish; BBSRC [BB/D011140/2, BB/D011140/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council through a PhD studentship (to M. F.).	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Bauer J, 2011, BIOCHEMISTRY-US, V50, P5925, DOI 10.1021/bi1019995; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, ENZYMES, V25, P463, DOI 10.1016/S1874-6047(07)25018-8; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hashimoto-Gotoh T, 2000, GENE, V241, P185, DOI 10.1016/S0378-1119(99)00434-5; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; LEIVE L, 1968, J BIOL CHEM, V243, P2373; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; Maldonado B, 2011, FEBS LETT, V585, P478, DOI 10.1016/j.febslet.2011.01.016; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Palmer T. N., 2010, ECMWF SEM P DIAGN FO, P1; Palmer T, 2010, METHODS MOL BIOL, V619, P191, DOI 10.1007/978-1-60327-412-8_12; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Sambrook J, 2001, MOL CLONING LAB MANU; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; SILVESTRO A, 1988, BIOCHIM BIOPHYS ACTA, V954, P1, DOI 10.1016/0167-4838(88)90049-0; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Tarry M, 2009, J MOL BIOL, V386, P504, DOI 10.1016/j.jmb.2008.12.043; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	59	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14420	14431		10.1074/jbc.M112.354555	http://dx.doi.org/10.1074/jbc.M112.354555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399293	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000304003200010
J	Laricchiuta, D; Rossi, S; Musella, A; De Chiara, V; Cutuli, D; Centonze, D; Petrosini, L				Laricchiuta, Daniela; Rossi, Silvia; Musella, Alessandra; De Chiara, Valentina; Cutuli, Debora; Centonze, Diego; Petrosini, Laura			Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; ENDOCANNABINOID SYSTEM; INDIVIDUAL-DIFFERENCES; BEHAVIORAL-INHIBITION; MEDIATED CONTROL; FOOD-INTAKE; RAT-BRAIN; REWARD; CB1; ADOLESCENT	Approach or avoidance behaviors are accompanied by perceptual vigilance for, affective reactivity to and behavioral predisposition towards rewarding or punitive stimuli, respectively. We detected three subpopulations of C57BL/6J mice that responded with avoiding, balancing or approaching behaviors not induced by any experimental manipulation but spontaneously displayed in an approach/avoidance conflict task. Although the detailed neuronal mechanisms underlying the balancing between approach and avoidance are not fully clarified, there is growing evidence that endocannabinoid system (ECS) plays a critical role in the control of these balancing actions. The sensitivity of dorsal striatal synapses to the activation of cannabinoid CB1 receptors was investigated in the subpopulations of spontaneously avoiding, balancing or approaching mice. Avoiding animals displayed decreased control of CB1 receptors on GABAergic striatal transmission and in parallel increase of behavioral inhibition. Conversely, approaching animals exhibited increased control of CB1 receptors and in parallel increase of explorative behavior. Balancing animals reacted with balanced responses between approach and avoidance patterns. Treating avoiding animals with URB597 (fatty acid amide hydrolase inhibitor) or approaching animals with AM251 (CB1 receptor inverse agonist) reverted their respective behavioral and electrophysiological patterns. Therefore, enhanced or reduced CB1-mediated control on dorsal striatal transmission represents the synaptic hallmark of the approach or avoidance behavior, respectively. Thus, the opposite spontaneous responses to conflicting stimuli are modulated by a different involvement of endocannabinoid signaling of dorsal striatal neurons in the range of temperamental traits related to individual differences.	[Laricchiuta, Daniela; Rossi, Silvia; Musella, Alessandra; De Chiara, Valentina; Cutuli, Debora; Centonze, Diego; Petrosini, Laura] Fdn Santa Lucia, CERC, Rome, Italy; [Laricchiuta, Daniela; Cutuli, Debora; Petrosini, Laura] Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; [Rossi, Silvia; Musella, Alessandra; De Chiara, Valentina; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Neurosci, Neurol Clin, Rome, Italy	IRCCS Santa Lucia; Sapienza University Rome; University of Rome Tor Vergata	Laricchiuta, D (corresponding author), Fdn Santa Lucia, CERC, Rome, Italy.	daniela.laricchiuta@uniroma1.it	Laricchiuta, Daniela/K-1080-2016; Centonze, Diego/J-7767-2016; Cutuli, Debora/K-1081-2016; musella, alessandra/K-6372-2016	Laricchiuta, Daniela/0000-0003-2237-2086; Centonze, Diego/0000-0002-8390-8545; musella, alessandra/0000-0001-7889-9253; CUTULI, Debora/0000-0003-4788-2461; Rossi, Silvia/0000-0003-3257-8248	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This investigation was supported by MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) grants to LP and DC (www.miur.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2008, NEUROPSYCHOPHARMACOL, V33, P2217, DOI 10.1038/sj.npp.1301620; Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Al-Hayani A, 2000, BRIT J PHARMACOL, V131, P663, DOI 10.1038/sj.bjp.0703642; Arnett JJ, 1999, AM PSYCHOL, V54, P317, DOI 10.1037/0003-066X.54.5.317; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; Bjork JM, 2008, NEUROIMAGE, V42, P1609, DOI 10.1016/j.neuroimage.2008.06.035; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Centonze D, 2007, MOL CELL NEUROSCI, V35, P302, DOI 10.1016/j.mcn.2007.03.005; Centonze D, 2007, EUR J NEUROSCI, V25, P1631, DOI 10.1111/j.1460-9568.2007.05433.x; Chambers R Andrew, 2003, J Gambl Stud, V19, P53, DOI 10.1023/A:1021275130071; Cohen MX, 2005, COGNITIVE BRAIN RES, V25, P851, DOI 10.1016/j.cogbrainres.2005.09.018; Cota D, 2003, INT J OBESITY, V27, P289, DOI 10.1038/sj.ijo.0802250; De Chiara V, 2010, NEUROPSYCHOPHARMACOL, V35, P374, DOI 10.1038/npp.2009.141; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dubreucq S, 2010, EXP NEUROL, V224, P106, DOI 10.1016/j.expneurol.2010.01.017; Elliot AJ, 2002, J PERS SOC PSYCHOL, V82, P804, DOI 10.1037/0022-3514.82.5.804; Elliot AJ, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P3; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Good RL, 2011, PHARMACOL BIOCHEM BE, V98, P101, DOI 10.1016/j.pbb.2010.12.004; Hariri AR, 2009, ANNU REV NEUROSCI, V32, P225, DOI 10.1146/annurev.neuro.051508.135335; Hefner K, 2007, BEHAV BRAIN RES, V176, P210, DOI 10.1016/j.bbr.2006.10.001; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Higgs S, 2003, PSYCHOPHARMACOLOGY, V165, P370, DOI 10.1007/s00213-002-1263-3; Ito R, 2002, J NEUROSCI, V22, P6247; Jarrett MM, 2005, PHYSIOL BEHAV, V86, P475, DOI 10.1016/j.physbeh.2005.08.033; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kasch KL, 2002, J ABNORM PSYCHOL, V111, P589, DOI 10.1037//0021-843X.111.4.589; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 1999, J NEUROSCI, V19, P4544; Kliethermes CL, 2006, P NATL ACAD SCI USA, V103, P5018, DOI 10.1073/pnas.0509724103; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lafenetre P, 2009, NEUROPHARMACOLOGY, V57, P715, DOI 10.1016/j.neuropharm.2009.07.014; Maccarrone M, 2002, VITAM HORM, V65, P225, DOI 10.1016/S0083-6729(02)65066-6; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maccarrone M, 2009, J NEUROCHEM, V109, P371, DOI 10.1111/j.1471-4159.2009.05948.x; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2006, J Endocrinol Invest, V29, P27; Martin LE, 2004, NEUROREPORT, V15, P1519, DOI 10.1097/01.wnr.0000132920.12990.b9; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; McDonald J, 2003, NEUROPSYCHOPHARMACOL, V28, P1356, DOI 10.1038/sj.npp.1300176; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; Meyer B, 1999, J PSYCHOPATHOL BEHAV, V21, P275, DOI 10.1023/A:1022119414440; Mitchell JT, 2006, PERS INDIV DIFFER, V40, P749, DOI 10.1016/j.paid.2005.08.011; Mizuno K, 2008, NEUROIMAGE, V42, P369, DOI 10.1016/j.neuroimage.2008.04.253; Moesgaard B, 2000, J LIPID RES, V41, P985; Moreno M, 2010, NEUROPSYCHOPHARMACOL, V35, P1198, DOI 10.1038/npp.2009.224; Muris P, 2001, BEHAV RES THER, V39, P1051, DOI 10.1016/S0005-7967(00)00081-4; Musella A, 2010, NEUROSCIENCE, V167, P864, DOI 10.1016/j.neuroscience.2010.02.058; O'Gorman RL, 2006, NEUROIMAGE, V31, P489, DOI 10.1016/j.neuroimage.2005.12.048; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Pattij T, 2007, PSYCHOPHARMACOLOGY, V193, P85, DOI 10.1007/s00213-007-0773-4; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Pickering A.D., 2001, ADV INDIVIDUAL DIFFE, P113; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Quinn HR, 2008, NEUROPSYCHOPHARMACOL, V33, P1113, DOI 10.1038/sj.npp.1301475; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Rossi S, 2008, J NEUROSCI, V28, P7284, DOI 10.1523/JNEUROSCI.5346-07.2008; Rossi S, 2010, MOL PHARMACOL, V78, P260, DOI 10.1124/mol.110.064196; Simon JJ, 2010, NEUROIMAGE, V49, P1868, DOI 10.1016/j.neuroimage.2009.09.016; Slawecki CJ, 2005, BEHAV NEUROSCI, V119, P1477, DOI 10.1037/0735-7044.119.6.1477; Spear LP, 2002, J STUD ALCOHOL, P71, DOI 10.15288/jsas.2002.s14.71; Steele JD, 2007, BRAIN, V130, P2367, DOI 10.1093/brain/awm150; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; TOOBY J, 1990, ETHOL SOCIOBIOL, V11, P375, DOI 10.1016/0162-3095(90)90017-Z; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; Van Laere K, 2009, ARCH GEN PSYCHIAT, V66, P196, DOI 10.1001/archgenpsychiatry.2008.530; Wallace JM, 2003, ADDICTION, V98, P225, DOI 10.1046/j.1360-0443.2003.00282.x; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107; Zajonc R.B., 1998, HDB SOCIAL PSYCHOL, P591	85	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33260	10.1371/journal.pone.0033260	http://dx.doi.org/10.1371/journal.pone.0033260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413007	Green Submitted, Green Published, gold			2022-12-25	WOS:000303062000039
J	Qian, HF; Hu, BL; Yu, SQ; Pan, XJ; Wu, T; Fu, ZW				Qian, Haifeng; Hu, Baolan; Yu, Shuqiong; Pan, Xiangjie; Wu, Tao; Fu, Zhengwei			The Effects of Hydrogen Peroxide on the Circadian Rhythms of Microcystis aeruginosa	PLOS ONE			English	Article							AMINO-ACID-UPTAKE; GENE-EXPRESSION; LIGHT; CLOCK; CYANOBACTERIA; COOPERATE; KAIABC; WATER; TIME	Background: The cyanobacterium Microcystis aeruginosa is one of the principal bloom-forming cyanobacteria present in a wide range of freshwater ecosystems. M. aeruginosa produces cyanotoxins, which can harm human and animal health. Many metabolic pathways in M. aeruginosa, including photosynthesis and microcystin synthesis, are controlled by its circadian rhythms. However, whether xenobiotics affect the cyanobacterial circadian system and change its growth, physiology and biochemistry is unknown. We used real-time PCR to study the effect of hydrogen peroxide (H2O2) on the expression of clock genes and some circadian genes in M. aeruginosa during the light/dark (LD) cycle. Results: The results revealed that H2O2 changes the expression patterns of clock genes (kaiA, kaiB, kaiC and sasA) and significantly decreases the transcript levels of kaiB, kaiC and sasA. H2O2 treatment also decreased the transcription of circadian genes, such as photosynthesis-related genes (psaB, psbD1 and rbcL) and microcystin-related genes (mcyA, mcyD and mcyH), and changed their circadian expression patterns. Moreover, the physiological functions of M. aeruginosa, including its growth and microcystin synthesis, were greatly influenced by H2O2 treatment during LD. These results indicate that changes in the cyanobacterial circadian system can affect its physiological and metabolic pathways. Conclusion: Our findings show that a xenobiotic can change the circadian expression patterns of its clock genes to influence clock-controlled gene regulation, and these influences are evident at the level of cellular physiology.	[Qian, Haifeng; Yu, Shuqiong; Pan, Xiangjie; Wu, Tao; Fu, Zhengwei] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China; [Hu, Baolan] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University of Technology; Zhejiang University	Qian, HF (corresponding author), Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China.	azwfu2003@yahoo.com.cn	Fu, Zhengwei/G-3162-2011; Qian, Haifeng/A-7791-2012; Hu, baolan/E-1667-2012; Hu, baolan/K-8163-2012; qian, haifeng/H-4828-2012	Fu, Zhengwei/0000-0003-3351-3075; Qian, Haifeng/0000-0003-0807-9991; 	National Basic Research Program of China [2010CB126100]; Natural Science Foundation of China [21077093]; technology office in Zhejiang province [2010R10033]; Science Foundation of Chinese University	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); technology office in Zhejiang province; Science Foundation of Chinese University(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (No. 2010CB126100), the Natural Science Foundation of China (21077093), Qianjiang talents project of the technology office in Zhejiang province (2010R10033), and the Science Foundation of Chinese University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 1999, BIOCHEM BIOPH RES CO, V255, P47, DOI 10.1006/bbrc.1998.9996; Barrington DJ, 2008, ENVIRON SCI TECHNOL, V42, P8916, DOI 10.1021/es801717y; Bittencourt-Oliveira MD, 2005, BIOCHEM BIOPH RES CO, V326, P687, DOI 10.1016/j.bbrc.2004.11.091; Carmichael WW, 1996, TOXIC MICROCYSTIS, P1; CHEN TH, 1991, PLANT PHYSIOL, V97, P55, DOI 10.1104/pp.97.1.55; Codd GA, 2005, AQUAT ECOL SER, V3, P1; COOPER WJ, 1983, SCIENCE, V220, P711, DOI 10.1126/science.220.4598.711; Ditty JL, 2003, ANNU REV GENET, V37, P513, DOI 10.1146/annurev.genet.37.110801.142716; Dodd A, 2004, NEW PHYTOL, V162, P956; Drabkova M, 2007, ENVIRON SCI TECHNOL, V41, P309, DOI 10.1021/es060746i; Falconer Ian R., 1996, Phycologia, V35, P74, DOI 10.2216/i0031-8884-35-6S-74.1; Feng XG, 2006, BIOMED ENVIRON SCI, V19, P225; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Haydon MJ, 2011, J EXP BOT, V62, P2333, DOI 10.1093/jxb/err040; HUANG TC, 1994, PLANTA, V193, P131; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Kondo T, 2000, BIOESSAYS, V22, P10, DOI 10.1002/(SICI)1521-1878(200001)22:1<10::AID-BIES4>3.0.CO;2-A; Kotchoni SO, 2009, PLANT PHYSIOL, V149, P803, DOI 10.1104/pp.108.132324; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; LIU Y, 1995, J BACTERIOL, V177, P2080, DOI 10.1128/jb.177.8.2080-2086.1995; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Mary I, 2008, ENVIRON MICROBIOL, V10, P2124, DOI 10.1111/j.1462-2920.2008.01633.x; Metcalf JS, 2000, FEMS MICROBIOL LETT, V184, P241, DOI 10.1111/j.1574-6968.2000.tb09021.x; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Paerl H, 2008, ADV EXP MED BIOL, V619, P217, DOI 10.1007/978-0-387-75865-7_10; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Qian HF, 2010, AQUAT TOXICOL, V99, P405, DOI 10.1016/j.aquatox.2010.05.018; Schrader KK, 2003, APPL ENVIRON MICROB, V69, P5319, DOI 10.1128/AEM.69.9.5319-5327.2003; Skurlatov YI, 1998, ACTA HYDROCH HYDROB, V26, P5, DOI 10.1002/(SICI)1521-401X(199801)26:1<5::AID-AHEH5>3.0.CO;2-2; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Straub C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016208; Taniguchi Y, 2010, P NATL ACAD SCI USA, V107, P3263, DOI 10.1073/pnas.0909924107; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Wiedner C, 2003, APPL ENVIRON MICROB, V69, P1475, DOI 10.1128/AEM.69.3.1475-1481.2003; Wu T, 2008, J NEUROSCI RES, V86, P3246, DOI 10.1002/jnr.21769; Wu T, 2010, CHRONOBIOL INT, V27, P1, DOI 10.3109/07420520903398625; Wu T, 2010, AM J PHYSIOL-REG I, V298, pR635, DOI 10.1152/ajpregu.00578.2009; Xu Y, 2000, EMBO J, V19, P3349, DOI 10.1093/emboj/19.13.3349; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	42	13	17	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33347	10.1371/journal.pone.0033347	http://dx.doi.org/10.1371/journal.pone.0033347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22413018	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800094
J	Rose, WA; McGowin, CL; Spagnuolo, RA; Eaves-Pyles, TD; Popov, VL; Pyles, RB				Rose, William A., II; McGowin, Chris L.; Spagnuolo, Rae Ann; Eaves-Pyles, Tonyia D.; Popov, Vsevolod L.; Pyles, Richard B.			Commensal Bacteria Modulate Innate Immune Responses of Vaginal Epithelial Cell Multilayer Cultures	PLOS ONE			English	Article							GENITAL HERPES INFECTION; NEISSERIA-GONORRHOEAE; IN-VITRO; BENZALKONIUM CHLORIDE; MODEL; TRACT; HIV; QUANTIFICATION; MICROBICIDES; INFLAMMATION	The human vaginal microbiome plays a critical but poorly defined role in reproductive health. Vaginal microbiome alterations are associated with increased susceptibility to sexually-transmitted infections (STI) possibly due to related changes in innate defense responses from epithelial cells. Study of the impact of commensal bacteria on the vaginal mucosal surface has been hindered by current vaginal epithelial cell (VEC) culture systems that lack an appropriate interface between the apical surface of stratified squamous epithelium and the air-filled vaginal lumen. Therefore we developed a reproducible multilayer VEC culture system with an apical (luminal) air-interface that supported colonization with selected commensal bacteria. Multilayer VEC developed tight-junctions and other hallmarks of the vaginal mucosa including predictable proinflammatory cytokine secretion following TLR stimulation. Colonization of multilayers by common vaginal commensals including Lactobacillus crispatus, L. jensenii, and L. rhamnosus led to intimate associations with the VEC exclusively on the apical surface. Vaginal commensals did not trigger cytokine secretion but Staphylococcus epidermidis, a skin commensal, was inflammatory. Lactobacilli reduced cytokine secretion in an isolate-specific fashion following TLR stimulation. This tempering of inflammation offers a potential explanation for increased susceptibility to STI in the absence of common commensals and has implications for testing of potential STI preventatives.	[Rose, William A., II; Eaves-Pyles, Tonyia D.; Pyles, Richard B.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [McGowin, Chris L.; Popov, Vsevolod L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Spagnuolo, Rae Ann; Pyles, Richard B.] Univ Texas Med Branch, Dept Pediat, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rose, WA (corresponding author), Louisiana State Univ, Infect Dis Sect, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA.	rbpyles@utmb.edu			Gulf South STI/Topical Microbicides Cooperative Research Center [NIAID U19 AI61972]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI061972] Funding Source: NIH RePORTER	Gulf South STI/Topical Microbicides Cooperative Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WAR, CLM and RBP were supported by the Gulf South STI/Topical Microbicides Cooperative Research Center (NIAID U19 AI61972). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Anton G, 2008, INFECTION, V36, P147, DOI 10.1007/s15010-007-7152-2; Ashkar AA, 2004, J INFECT DIS, V190, P1841, DOI 10.1086/425079; Ayehunie S, 2006, TOXICOL IN VITRO, V20, P689, DOI 10.1016/j.tiv.2005.10.002; Baeten J, 2009, SEX TRANSM INFECT; BARBERINI F, 1991, ARCH HISTOL CYTOL, V54, P365, DOI 10.1679/aohc.54.365; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Brandtzaeg P, 2010, BENEF MICROBES, V1, P211, DOI 10.3920/BM2010.0009; Catalone BJ, 2004, ANTIMICROB AGENTS CH, V48, P1837, DOI 10.1128/AAC.48.5.1837-1847.2004; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; Coolen MJL, 2005, APPL ENVIRON MICROB, V71, P8729, DOI 10.1128/AEM.71.12.8729-8737.2005; D'Cruz OJ, 2005, TOXICOL PATHOL, V33, P465, DOI 10.1080/01926230590959866; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; ECKSTEIN P, 1969, J REPROD FERTIL, V20, P85; Eschenbach DA, 2000, CLIN INFECT DIS, V30, P901, DOI 10.1086/313818; Fan SR, 2008, INT J GYNECOL OBSTET, V103, P50, DOI 10.1016/j.ijgo.2008.05.020; Farage Miranda, 2006, Archives of Gynecology and Obstetrics, V273, P195, DOI 10.1007/s00404-005-0079-x; Farage MA, 2011, CURR PROBL DERMATOL, V40, P9, DOI 10.1159/000321042; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Ferris MJ, 2007, J CLIN MICROBIOL, V45, P1016, DOI 10.1128/JCM.02085-06; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Gillan DC, 1998, APPL ENVIRON MICROB, V64, P3464; Haggerty CL, 2008, SEX TRANSM INFECT; Hemmerling A, 2010, SEX TRANSM DIS, V37, P745, DOI 10.1097/OLQ.0b013e3181e50026; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; Herbst-Kralovetz MM, 2006, J VIROL, V80, P9988, DOI 10.1128/JVI.01099-06; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; Hjelm BE, 2010, BIOL REPROD, V82, P617, DOI 10.1095/biolreprod.109.080408; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Iavazzo C, 2008, MED SCI MONITOR, V14, pCR228; Jerse AE, 2002, INFECT IMMUN, V70, P2549, DOI 10.1128/IAI.70.5.2549-2558.2002; Langbein L, 2002, EUR J CELL BIOL, V81, P419, DOI 10.1078/0171-9335-00270; Libby EK, 2008, MICROBES INFECT, V10, P439, DOI 10.1016/j.micinf.2008.01.004; Liu XW, 2006, ANTIMICROB AGENTS CH, V50, P3250, DOI 10.1128/AAC.00493-06; Losikoff Phyllis, 2007, Infect Dis Obstet Gynecol, V2007, P92307, DOI 10.1155/2007/92307; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Mitchell CM, 2008, AIDS RES HUM RETROV, V24, P667, DOI [10.1089/aid.2007.0268, 10.1089/aid.2008.0268]; Muench DF, 2009, J INFECT DIS, V199, P1369, DOI 10.1086/597390; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Patton DL, 2004, J MED PRIMATOL, V33, P105, DOI 10.1111/j.1600-0684.2004.00059.x; Pyles RB, 2002, J VIROL, V76, P11387, DOI 10.1128/JVI.76.22.11387-11396.2002; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rivera AJ, 2011, AM J PRIMATOL, V73, P119, DOI 10.1002/ajp.20851; Santos Rocha C, INFLAMM BOWEL DIS; Siddique SA., 2003, J PELVIC SURG, V9, P263, DOI DOI 10.1097/01.SPV.0000094481.95144.3D; Sobel JD, 1996, J CLIN MICROBIOL, V34, P2497, DOI 10.1128/JCM.34.10.2497-2499.1996; Spencer SE, 2004, J INFECT DIS, V189, P410, DOI 10.1086/381125; Spurbeck RR, 2008, INFECT IMMUN, V76, P3124, DOI 10.1128/IAI.00101-08; Spurbeck RR, 2011, FUTURE MICROBIOL, V6, P567, DOI [10.2217/FMB.11.36, 10.2217/fmb.11.36]; Squier CA, 2008, J PHARM SCI-US, V97, P9, DOI 10.1002/jps.21077; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Vincent KL, 2008, SEX TRANSM DIS, V35, P269, DOI 10.1097/OLQ.0b013e31815abad8; Vincent KL, 2010, SEX TRANSM DIS, V37, P579, DOI 10.1097/OLQ.0b013e3181dac410; Vincent KL, 2009, SEX TRANSM DIS, V36, P312, DOI 10.1097/OLQ.0b013e31819496e4; Zarate Gabriela, 2009, Infect Dis Obstet Gynecol, V2009, P48358; Zenhom M, IMMUNOBIOLOGY; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	57	88	92	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32728	10.1371/journal.pone.0032728	http://dx.doi.org/10.1371/journal.pone.0032728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412914	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800046
J	Swindell, WR; Johnston, A; Sun, L; Xing, XY; Fisher, GJ; Bulyk, ML; Elder, JT; Gudjonsson, JE				Swindell, William R.; Johnston, Andrew; Sun, Liou; Xing, Xianying; Fisher, Gary J.; Bulyk, Martha L.; Elder, James T.; Gudjonsson, Johann E.			Meta-Profiles of Gene Expression during Aging: Limited Similarities between Mouse and Human and an Unexpectedly Decreased Inflammatory Signature	PLOS ONE			English	Article							INTERVENTIONS TESTING PROGRAM; PROTEIN-DNA INTERACTIONS; BINDING MICROARRAY DATA; AGED HUMAN SKIN; TRANSCRIPTION FACTOR; ALZHEIMER-DISEASE; PROMOTER ACTIVITY; ONLINE DATABASE; SKELETAL-MUSCLE; ELASTIC FIBERS	Background: Skin aging is associated with intrinsic processes that compromise the structure of the extracellular matrix while promoting loss of functional and regenerative capacity. These processes are accompanied by a large-scale shift in gene expression, but underlying mechanisms are not understood and conservation of these mechanisms between humans and mice is uncertain. Results: We used genome-wide expression profiling to investigate the aging skin transcriptome. In humans, age-related shifts in gene expression were sex-specific. In females, aging increased expression of transcripts associated with T-cells, B-cells and dendritic cells, and decreased expression of genes in regions with elevated Zeb1, AP-2 and YY1 motif density. In males, however, these effects were contrasting or absent. When age-associated gene expression patterns in human skin were compared to those in tail skin from CB6F1 mice, overall human-mouse correspondence was weak. Moreover, inflammatory gene expression patterns were not induced with aging of mouse tail skin, and well-known aging biomarkers were in fact decreased (e.g., Clec7a, Lyz1 and Lyz2). These unexpected patterns and weak human-mouse correspondence may be due to decreased abundance of antigen presenting cells in mouse tail skin with age. Conclusions: Aging is generally associated with a pro-inflammatory state, but we have identified an exception to this pattern with aging of CB6F1 mouse tail skin. Aging therefore does not uniformly heighten inflammatory status across all mouse tissues. Furthermore, we identified both intercellular and intracellular mechanisms of transcriptome aging, including those that are sex-and species-specific.	[Swindell, William R.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Johnston, Andrew; Xing, Xianying; Fisher, Gary J.; Elder, James T.; Gudjonsson, Johann E.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; [Sun, Liou] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA USA	Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Swindell, WR (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA.	wswindell@genetics.med.harvard.edu	Johnston, Andrew/I-7904-2014	Johnston, Andrew/0000-0002-1313-9402	University of Michigan Nathan Shock Center Functional Activity Core (NIH) [AG013283]; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	University of Michigan Nathan Shock Center Functional Activity Core (NIH); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the University of Michigan Nathan Shock Center Functional Activity Core (NIH AG013283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2008, CELL CYCLE, V7, P556, DOI 10.4161/cc.7.5.5490; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; [Anonymous], 2006, BIOL AGING OBSERVATI; Bandyopadhyay D, 2000, ANN NY ACAD SCI, V908, P71; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Bertram L, 2010, NAT REV NEUROL, V6, P11, DOI 10.1038/nrneurol.2009.213; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Braham C, 2002, DERMATOLOGY, V204, P325, DOI 10.1159/000063377; Brink TC, 2009, BIOGERONTOLOGY, V10, P721, DOI 10.1007/s10522-009-9219-1; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chung JH, 2002, ARCH DERMATOL, V138, P1437, DOI 10.1001/archderm.138.11.1437; CONTOREGGI CS, 1990, J ANDROL, V11, P460; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Dillner NB, 2004, DNA CELL BIOL, V23, P25, DOI 10.1089/104454904322745907; Doessing S, 2010, EUR J ENDOCRINOL, V163, P853, DOI 10.1530/EJE-10-0818; Doessing S, 2010, J PHYSIOL-LONDON, V588, P341, DOI 10.1113/jphysiol.2009.179325; Estep PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005242; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Gogly B, 1998, GERONTOLOGY, V44, P318, DOI 10.1159/000022035; Goukassian DA, 2004, REJUV RES, V7, P175, DOI 10.1089/rej.2004.7.175; Gudjonsson JE, 2007, J INVEST DERMATOL, V127, P1292, DOI 10.1038/sj.jid.5700807; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Hadshiew I M, 2000, Am J Contact Dermat, V11, P19, DOI 10.1016/S1046-199X(00)90028-9; Harper JM, 2006, J GERONTOL A-BIOL, V61, P1019, DOI 10.1093/gerona/61.10.1019; Helms SA, 2010, INT J BIOL SCI, V6, P475; Hornberger TA, 2005, J APPL PHYSIOL, V98, P1562, DOI 10.1152/japplphysiol.00870.2004; Hurt EM, 2008, MOL CELL BIOCHEM, V318, P89, DOI 10.1007/s11010-008-9860-z; Janig E, 2007, AM J PATHOL, V171, P1474, DOI 10.2353/ajpath.2007.061064; Jenkins G, 2002, MECH AGEING DEV, V123, P801, DOI 10.1016/S0047-6374(01)00425-0; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karim R, 2010, MENOPAUSE, V17, P785, DOI 10.1097/gme.0b013e3181cc50b2; Kavak E, 2010, NUCLEIC ACIDS RES, V38, P7008, DOI 10.1093/nar/gkq574; KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q; Laimer M, 2010, EXP DERMATOL, V19, P912, DOI 10.1111/j.1600-0625.2010.01144.x; Lelu K, 2010, EUR J IMMUNOL, V40, P3489, DOI 10.1002/eji.201040678; Lener T, 2006, EXP GERONTOL, V41, P387, DOI 10.1016/j.exger.2006.01.012; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Lustig A, 2007, CELL IMMUNOL, V245, P42, DOI 10.1016/j.cellimm.2007.03.008; Lustig A, 2009, INT J MED SCI, V6, P51; Mah N, 2004, PHYSIOL GENOMICS, V16, P361, DOI 10.1152/physiolgenomics.00080.2003; Makrantonaki E, 2010, EXP GERONTOL, V45, P801, DOI 10.1016/j.exger.2010.08.005; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB117, DOI 10.1093/gerona/55.3.B117; Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x; Murray D, 2000, J BIOL CHEM, V275, P3610, DOI 10.1074/jbc.275.5.3610; Nadon NL, 2008, AGE, V30, P187, DOI 10.1007/s11357-008-9048-1; Neter J., 1996, APPL LINEAR REGRESSI; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x; Philippakis AA, 2006, PLOS COMPUT BIOL, V2, P439, DOI 10.1371/journal.pcbi.0020053; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Rogojina A, 2003, MOL VIS, V9, P482; Sachs DL, 2011, CLIN PHARMACOL THER, V89, P34, DOI 10.1038/clpt.2010.259; Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stice JP, 2009, FUTUR CARDIOL, V5, P93, DOI 10.2217/14796678.5.1.93; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Susic Dinko, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P97, DOI 10.2174/1568006043481347; Swindell WR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011861; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Tanaka K, 2002, MOL CELL BIOL, V22, P4256, DOI 10.1128/MCB.22.12.4256-4267.2002; Tanriverdi F, 2006, CLIN ENDOCRINOL, V65, P579, DOI 10.1111/j.1365-2265.2006.02631.x; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Terraz C, 2001, J BIOL CHEM, V276, P37011, DOI 10.1074/jbc.M104185200; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wennmalm K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r109; Woo Yong, 2004, J Biomol Tech, V15, P276; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	82	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33204	10.1371/journal.pone.0033204	http://dx.doi.org/10.1371/journal.pone.0033204			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22413003	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800085
J	Albano, L; Rak, JM; Azzouz, DF; Cassuto-Viguier, E; Gugenheim, J; Lambert, NC				Albano, Laetitia; Rak, Justyna M.; Azzouz, Doua F.; Cassuto-Viguier, Elisabeth; Gugenheim, Jean; Lambert, Nathalie C.			Male Microchimerism at High Levels in Peripheral Blood Mononuclear Cells from Women with End Stage Renal Disease before Kidney Transplantation	PLOS ONE			English	Article							FETAL MICROCHIMERISM; HEALTHY WOMEN; CHIMERISM OCCURS; LUPUS NEPHRITIS; PREGNANCY; DNA; LONG; SCLERODERMA; FAILURE; MOTHER	Patients with end stage renal diseases (ESRD) are generally tested for donor chimerism after kidney transplantation for tolerance mechanism purposes. But, to our knowledge, no data are available on natural and/or iatrogenic microchimerism (Mc), deriving from pregnancy and/or blood transfusion, acquired prior to transplantation. In this context, we tested the prevalence of male Mc using a real time PCR assay for DYS14, a Y-chromosome specific sequence, in peripheral blood mononuclear cells (PBMC) from 55 women with ESRD, prior to their first kidney transplantation, and compared them with results from 82 healthy women. Male Mc was also quantified in 5 native kidney biopsies obtained two to four years prior to blood testing and in PBMC from 8 women collected after female kidney transplantation, several years after the initial blood testing. Women with ESRD showed statistically higher frequencies (62%) and quantities (98 genome equivalent cells per million of host cells, gEq/M) of male Mc in their PBMC than healthy women (16% and 0.3 gEq/M, p<0.00001 and p = 0.0005 respectively). Male Mc was increased in women with ESRD whether they had or not a history of male pregnancy and/or of blood transfusion. Three out of five renal biopsies obtained a few years prior to the blood test also contained Mc, but no correlation could be established between earlier Mc in a kidney and later presence in PBMC. Finally, several years after female kidney transplantation, male Mc was totally cleared from PBMC in all women tested but one. This intriguing and striking initial result of natural and iatrogenic male Mc persistence in peripheral blood from women with ESRD raises several hypotheses for the possible role of these cells in renal diseases. Further studies are needed to elucidate mechanisms of recruitment and persistence of Mc in women with ESRD.	[Albano, Laetitia; Cassuto-Viguier, Elisabeth] Ctr Hosp Univ Nice, Hop Pasteur, UMC Transplantat Renale, Nice, France; [Rak, Justyna M.; Azzouz, Doua F.; Lambert, Nathalie C.] INSERM, UMR1097, F-13258 Marseille, France; [Gugenheim, Jean] Hop Archet 2, Serv Chirurg & Transplantat Hepat, Nice, France; [Gugenheim, Jean] Univ Nice Sophia Antipolis, Fac Med, INSERM, IFR 50,U526, Nice, France	CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Albano, L (corresponding author), Ctr Hosp Univ Nice, Hop Pasteur, UMC Transplantat Renale, Nice, France.	nathalie.lambert@inserm.fr	Lambert, Nathalie C/P-6816-2016	Lambert, Nathalie C/0000-0001-5817-8686; GUGENHEIM, Jean/0000-0002-2624-3014				Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; de Bellefon Laurent Meric, 2010, Chimerism, V1, P56, DOI 10.4161/chim.1.2.14294; Dubernard G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1860; Dubey RK, 2001, AM J PHYSIOL-RENAL, V280, pF365, DOI 10.1152/ajprenal.2001.280.3.F365; DUNSFORD I, 1953, BRIT MED J, V2, P81, DOI 10.1136/bmj.2.4827.81; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Gadi VK, 2007, CANCER RES, V67, P9035, DOI 10.1158/0008-5472.CAN-06-4209; Hovinga ICLK, 2008, LUPUS, V17, P541, DOI 10.1177/0961203308089324; Hovinga ICLK, 2006, ARTHRITIS RHEUM-US, V54, P2944, DOI 10.1002/art.22038; Ji H, 2005, AM J PHYSIOL-HEART C, V288, pH43, DOI 10.1152/ajpheart.00630.2004; KASHIWAGI N, 1969, Surgical Forum (Chicago), V20, P374; Klintschar M, 2001, J CLIN ENDOCR METAB, V86, P2494, DOI 10.1210/jc.86.6.2494; Koopmans M, 2005, AM J TRANSPLANT, V5, P1495, DOI 10.1111/j.1600-6143.2005.00858.x; Koopmans M, 2008, J REPROD IMMUNOL, V78, P68, DOI 10.1016/j.jri.2008.01.002; Lambert NC, 2010, REV MED INTERNE, V31, P522, DOI 10.1016/j.revmed.2009.07.017; Lambert NC, 2005, ANN RHEUM DIS, V64, P845, DOI 10.1136/ard.2004.029314; Lambert NC, 2002, BLOOD, V100, P2845, DOI 10.1182/blood-2002-01-0295; Lee ESM, 2010, MOL HUM REPROD, V16, P869, DOI 10.1093/molehr/gaq067; Lee TH, 1999, BLOOD, V93, P3127; Lo YMD, 1996, BLOOD, V88, P4390; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mosca M, 2003, ANN RHEUM DIS, V62, P651, DOI 10.1136/ard.62.7.651; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; Nelson JL, 1998, SCAND J RHEUMATOL, P10; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; Rak JM, 2008, ARTHRITIS RHEUMATISM; Rak JM, 2009, RHEUMATOLOGY, V48, P363, DOI 10.1093/rheumatology/ken505; Reed AM, 2000, LANCET, V356, P2156, DOI 10.1016/S0140-6736(00)03500-5; Rinkevich Baruch, 2011, Chimerism, V2, P1, DOI 10.4161/chim.2.1.14725; ROBINSON HP, 1977, BRIT J OBSTET GYNAEC, V84, P22, DOI 10.1111/j.1471-0528.1977.tb12460.x; Starzl TE, 2004, P NATL ACAD SCI USA, V101, P14607, DOI 10.1073/pnas.0404829101; Stenvinkel P, 2002, NEPHROL DIAL TRANSPL, V17, P33, DOI 10.1093/ndt/17.suppl_8.33; Umansky SR, 2006, EXPERT REV MOL DIAGN, V6, P153, DOI 10.1586/14737159.6.2.153; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; Wang MJ, 2004, CLIN CHEM, V50, P211, DOI 10.1373/clinchem.2003.026914; Wang Y, 2004, BIOCHEM BIOPH RES CO, V325, P961, DOI 10.1016/j.bbrc.2004.10.105; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037	41	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32248	10.1371/journal.pone.0032248	http://dx.doi.org/10.1371/journal.pone.0032248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403639	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700036
J	Flatters, IJ; Otten, L; Witvliet, A; Henson, B; Holt, RJ; Culmer, P; Bingham, GP; Wilkie, RM; Mon-Williams, M				Flatters, Ian John; Otten, Loanne; Witvliet, Anna; Henson, Brian; Holt, Raymond John; Culmer, Pete; Bingham, Geoffrey Parker; Wilkie, Richard McGilchrist; Mon-Williams, Mark			Predicting the Effect of Surface Texture on the Qualitative Form of Prehension	PLOS ONE			English	Article							PRECISION GRIP; OBJECT TEXTURE; MOVEMENT TIME; SYSTEM	Reach-to-grasp movements change quantitatively in a lawful (i.e. predictable) manner with changes in object properties. We explored whether altering object texture would produce qualitative changes in the form of the precontact movement patterns. Twelve participants reached to lift objects from a tabletop. Nine objects were produced, each with one of three grip surface textures (high-friction, medium-friction and low-friction) and one of three widths (50 mm, 70 mm and 90 mm). Each object was placed at three distances (100 mm, 300 mm and 500 mm), representing a total of 27 trial conditions. We observed two distinct movement patterns across all trials-participants either: (i) brought their arm to a stop, secured the object and lifted it from the tabletop; or (ii) grasped the object 'on-the-fly', so it was secured in the hand while the arm was moving. A majority of grasps were on-the-fly when the texture was high-friction and none when the object was low-friction, with medium-friction producing an intermediate proportion. Previous research has shown that the probability of on-the-fly behaviour is a function of grasp surface accuracy constraints. A finger friction rig was used to calculate the coefficients of friction for the objects and these calculations showed that the area available for a stable grasp (the 'functional grasp surface size') increased with surface friction coefficient. Thus, knowledge of functional grasp surface size is required to predict the probability of observing a given qualitative form of grasping in human prehensile behaviour.	[Flatters, Ian John; Wilkie, Richard McGilchrist; Mon-Williams, Mark] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Flatters, Ian John; Henson, Brian; Holt, Raymond John; Culmer, Pete] Univ Leeds, Sch Mech Engn, Leeds, W Yorkshire, England; [Otten, Loanne; Witvliet, Anna] Radboud Univ Nijmegen, Nijmegen, Netherlands; [Bingham, Geoffrey Parker] Indiana Univ, Dept Brain & Psychol Sci, Bloomington, IN USA	University of Leeds; University of Leeds; Radboud University Nijmegen; Indiana University System; Indiana University Bloomington	Flatters, IJ (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	m.mon-williams@leeds.ac.uk	Wilkie, Richard M./G-5977-2012	Wilkie, Richard M./0000-0003-4299-7171; Flatters, Ian John/0000-0002-3789-0487; Culmer, Pete/0000-0003-2867-0420; Holt, Raymond/0000-0002-1614-5795; Mon-Williams, Mark/0000-0001-7595-8545	Engineering and Physical Sciences Research Council; EPSRC [EP/I500286/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I500286/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	IF was funded by an Engineering and Physical Sciences Research Council Collaboration Fund obtained by BH, RW, PC, and MMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cuijpers RH, 2004, J NEUROPHYSIOL, V91, P2598, DOI 10.1152/jn.00644.2003; FEARING RS, 1986, IEEE T ROBOTIC AUTOM, V2, P188, DOI 10.1109/JRA.1986.1087063; FIKES TG, 1994, J MOTOR BEHAV, V26, P325, DOI 10.1080/00222895.1994.9941688; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FORSSBERG H, 1995, EXP BRAIN RES, V104, P323; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Kleinholdermann U, 2007, EXP BRAIN RES, V180, P415, DOI 10.1007/s00221-007-0867-6; Mon-Williams M, 2011, EXP BRAIN RES, V211, P145, DOI 10.1007/s00221-011-2659-2; Munro H, 2007, EXP BRAIN RES, V183, P249, DOI 10.1007/s00221-007-1040-y; Shao F, 2010, P I MECH ENG H, V224, P97, DOI 10.1243/09544119JEIM658; van Bergen E, 2007, EXP BRAIN RES, V178, P180, DOI 10.1007/s00221-006-0722-1; WEIR PL, 1991, J MOTOR BEHAV, V23, P205, DOI 10.1080/00222895.1991.10118363; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	14	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32770	10.1371/journal.pone.0032770	http://dx.doi.org/10.1371/journal.pone.0032770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403706	Green Accepted, Green Published, gold			2022-12-25	WOS:000303017700103
J	Wouters, K; Cudejko, C; Gijbels, MJJ; Fuentes, L; Bantubungi, K; Vanhoutte, J; Dievart, R; Paquet, C; Bouchaert, E; Hannou, SA; Gizard, F; Tailleux, A; de Winther, MPJ; Staels, B; Paumelle, R				Wouters, Kristiaan; Cudejko, Celine; Gijbels, Marion J. J.; Fuentes, Lucia; Bantubungi, Kadiombo; Vanhoutte, Jonathan; Dievart, Rebecca; Paquet, Charlotte; Bouchaert, Emmanuel; Hannou, Sarah Anissa; Gizard, Florence; Tailleux, Anne; de Winther, Menno P. J.; Staels, Bart; Paumelle, Rejane			Bone Marrow p16(INK4a)-Deficiency Does Not Modulate Obesity, Glucose Homeostasis or Atherosclerosis Development	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; NONCODING RNA; MACROPHAGE; PROLIFERATION; INHIBITION; ACTIVATION; DISEASE; LOCUS; CELLS; POLARIZATION	Objective: A genomic region near the CDKN2A locus, encoding p16(INK4a), has been associated to type 2 diabetes and atherosclerotic vascular disease, conditions in which inflammation plays an important role. Recently, we found that deficiency of p16(INK4a) results in decreased inflammatory signaling in murine macrophages and that p16(INK4a) influences the phenotype of human adipose tissue macrophages. Therefore, we investigated the influence of immune cell p16(INK4a) on glucose tolerance and atherosclerosis in mice. Methods and Results: Bone marrow p16(INK4a)-deficiency in C57Bl6 mice did not influence high fat diet-induced obesity nor plasma glucose and lipid levels. Glucose tolerance tests showed no alterations in high fat diet-induced glucose intolerance. While bone marrow p16(INK4a)-deficiency did not affect the gene expression profile of adipose tissue, hepatic expression of the alternative markers Chi3l3, Mgl2 and IL10 was increased and the induction of pro-inflammatory Nos2 was restrained on the high fat diet. Bone marrow p16(INK4a)-deficiency in low density lipoprotein receptor-deficient mice did not affect western diet-induced atherosclerotic plaque size or morphology. In line, plasma lipid levels remained unaffected and p16w(INK4a)-deficient macrophages displayed equal cholesterol uptake and efflux compared to wild type macrophages. Conclusion: Bone marrow p16(INK4a)-deficiency does not affect plasma lipids, obesity, glucose tolerance or atherosclerosis in mice.	[Wouters, Kristiaan; Cudejko, Celine; Fuentes, Lucia; Bantubungi, Kadiombo; Vanhoutte, Jonathan; Dievart, Rebecca; Bouchaert, Emmanuel; Hannou, Sarah Anissa; Gizard, Florence; Tailleux, Anne; Staels, Bart; Paumelle, Rejane] Univ Lille Nord France, Lille, France; [Wouters, Kristiaan; Cudejko, Celine; Fuentes, Lucia; Bantubungi, Kadiombo; Vanhoutte, Jonathan; Dievart, Rebecca; Paquet, Charlotte; Bouchaert, Emmanuel; Hannou, Sarah Anissa; Gizard, Florence; Tailleux, Anne; Staels, Bart; Paumelle, Rejane] INSERM, U1011, F-59045 Lille, France; [Wouters, Kristiaan; Cudejko, Celine; Fuentes, Lucia; Bantubungi, Kadiombo; Vanhoutte, Jonathan; Dievart, Rebecca; Paquet, Charlotte; Bouchaert, Emmanuel; Hannou, Sarah Anissa; Gizard, Florence; Tailleux, Anne; Staels, Bart; Paumelle, Rejane] Univ Lille 2, Lille, France; [Wouters, Kristiaan; Cudejko, Celine; Fuentes, Lucia; Bantubungi, Kadiombo; Vanhoutte, Jonathan; Dievart, Rebecca; Paquet, Charlotte; Bouchaert, Emmanuel; Hannou, Sarah Anissa; Gizard, Florence; Tailleux, Anne; Staels, Bart; Paumelle, Rejane] Inst Pasteur, F-59019 Lille, France; [Gijbels, Marion J. J.] Maastricht Univ, Dept Mol Genet, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Gijbels, Marion J. J.] Maastricht Univ, Dept Pathol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [de Winther, Menno P. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	Wouters, K (corresponding author), Univ Lille Nord France, Lille, France.	bart.staels@pasteur-lille.fr	de Winther, Menno/E-8721-2012; hannou, sarah/AAT-2902-2020; Paumelle, Réjane/R-6675-2018; BOUCHAERT, Emmanuel/AFU-7112-2022; Fuentes, Lucia/R-6445-2016; Wouters, Kristiaan/A-8536-2013; TAILLEUX, Anne/R-5530-2018; Staels, Bart/N-9497-2016	hannou, sarah/0000-0003-4780-5773; Paumelle, Réjane/0000-0002-4489-0717; BOUCHAERT, Emmanuel/0000-0003-2558-9862; Wouters, Kristiaan/0000-0001-7127-6950; TAILLEUX, Anne/0000-0003-1430-2627; Staels, Bart/0000-0002-3784-1503; de Winther, Menno/0000-0002-4038-6636; bantubungi, kadiombo/0000-0002-6152-5623	Fondation pour la Recherche Medicale [DCV20070409276]; EFSD/GlaxoSmithKline; Cost Action [BM0602]; Conseil regional Nord Pas-de-Calais; FEDER; European FP7 Marie Curie [PIEF-GA-2009-235221]; European Atherosclerosis Society; Nouvelle Societe Francaise d'Atherosclerose/Schering-Plough/MSD; GlaxoSmithKline	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); EFSD/GlaxoSmithKline(GlaxoSmithKline); Cost Action(European Cooperation in Science and Technology (COST)); Conseil regional Nord Pas-de-Calais(Region Hauts-de-France); FEDER(European Commission); European FP7 Marie Curie; European Atherosclerosis Society; Nouvelle Societe Francaise d'Atherosclerose/Schering-Plough/MSD(Merck & CompanySchering Plough Corporation); GlaxoSmithKline(GlaxoSmithKline)	This work was supported by the Fondation pour la Recherche Medicale (www.frm.org)(DCV20070409276, B.S.), an EFSD/GlaxoSmithKline Research Grant (http://www.europeandiabetesfoundation.org/GSK/EFSD-GSK-RFA10.html)(B.S. and K.W.), the Cost Action (BM0602), and the Conseil regional Nord Pas-de-Calais and FEDER. K.W. was supported by a European FP7 Marie Curie grant (http://cordis.europa.eu/mariecurie-actions/) (PIEF-GA-2009-235221) and a European Atherosclerosis Society grant. C.C. was supported by a doctoral fellowship from the Nouvelle Societe Francaise d'Atherosclerose/Schering-Plough/MSD (www.nsfa.asso.fr). M.W. is an established investigator of the Netherlands Heart Foundation (2007T067)(www.hartstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Part of the funding was received from a commercial source (GlaxoSmithKline). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915; Bianchi T, 2006, ONCOGENE, V25, P4110, DOI 10.1038/sj.onc.1209437; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; Cardenas JC, 2011, ARTERIOSCL THROM VAS, V31, P827, DOI 10.1161/ATVBAHA.110.221721; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Cudejko C, 2011, BLOOD, V118, P2556, DOI 10.1182/blood-2010-10-313106; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Desvergne B, 2008, CELL METAB, V7, P467, DOI 10.1016/j.cmet.2008.05.002; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Fuentes L, 2011, DIABETOLOGIA, V54, P3150, DOI 10.1007/s00125-011-2324-0; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; Gonzalez-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026; Hausman GJ, 2006, J CLIN INVEST, V116, P3103, DOI 10.1172/JCI30666; HEINECKE JW, 1991, ARTERIOSCLER THROMB, V11, P1643, DOI 10.1161/01.ATV.11.6.1643; Holdt LM, 2011, ATHEROSCLEROSIS, V214, P264, DOI 10.1016/j.atherosclerosis.2010.06.029; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kim JA, 2007, CELL IMMUNOL, V245, P16, DOI 10.1016/j.cellimm.2007.03.003; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Koga M, 2007, CIRC RES, V101, P348, DOI 10.1161/CIRCRESAHA.106.147256; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kuo CL, 2011, ARTERIOSCL THROM VAS, V31, P2483, DOI 10.1161/ATVBAHA.111.234492; Linsel-Nitschke P, 2011, ATHEROSCLEROSIS, V214, P257, DOI 10.1016/j.atherosclerosis.2010.08.059; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; McPherson R, 2010, NEW ENGL J MED, V362, P1736, DOI 10.1056/NEJMcibr1002359; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Panousis CG, 2000, J LIPID RES, V41, P75; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pechlivanis S, 2010, ARTERIOSCL THROM VAS, V30, P1867, DOI 10.1161/ATVBAHA.110.208496; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021	40	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32440	10.1371/journal.pone.0032440	http://dx.doi.org/10.1371/journal.pone.0032440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403661	Green Submitted, gold, Green Published			2022-12-25	WOS:000303017700058
J	Yao, LG; Wang, SS; Su, SO; Yao, N; He, J; Peng, L; Sun, JC				Yao, Lunguang; Wang, Shanshan; Su, Shuo; Yao, Ning; He, Jian; Peng, Li; Sun, Jingchen			Construction of a Baculovirus-Silkworm Multigene Expression System and Its Application on Producing Virus-Like Particles	PLOS ONE			English	Article							ESCHERICHIA-COLI; EFFICIENT METHOD; GENE; NUCLEOPOLYHEDROVIRUS; INSECT	A new baculovirus-silkworm multigene expression system named Bombyx mori MultiBac is developed and described here, by which multiple expression cassettes can be introduced into the Bombyx mori nuclear polyhedrosis virus (BmNPV) genome efficiently. The system consists of three donor vectors (pCTdual, pRADM and pUCDMIG) and an invasive diaminopimelate (DAP) auxotrophic recipient E. coli containing BmNPV-Bacmid (BmBacmid) with a homologous recombination region, an attTn7 site and a loxp site. Two genes carried by pCTdual are firstly inserted into BmBacmid by homologous recombination, while the other eight genes in pRADM and pUCDMIG are introduced into BmBacmid through Tn7 transposition and cre-loxp recombination. Then the invasive and DAP auxotrophic E. coli carrying recombinant BmBacmid is directly injected into silkworm for expressing heterologous genes in larvae or pupae. Three structural genes of rotavirus and three fluorescent genes have been simultaneously expressed in silkworm larvae using our new system, resulting in the formation of virus-like particles (VLPs) of rotavirus and the color change of larvae. The VLPs were purified from hemolymph by ultracentrifugation using CsCl gradients, with a yield of 12.7 mu g per larva. For the great capacity of foreign genes and the low cost of feeding silkworm, this high efficient BmMultiBac expression system provides a suitable platform to produce VLPs or protein complexes.	[Yao, Lunguang; Wang, Shanshan; Yao, Ning; Peng, Li; Sun, Jingchen] Nanyang Normal Univ, Henan Prov Key Lab Funiu Mt Insect Biol, Rothamsted Res Joint Lab Insect Biol, China United Kingdom Nanyang Normal Univ, Nanyang, Peoples R China; [Wang, Shanshan; Su, Shuo; Peng, Li; Sun, Jingchen] S China Agr Univ, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Yao, Ning] SW Jiaotong Univ, Sch Life Sci & Engn, Chengdu, Peoples R China; [He, Jian] Sun Yat Sen Univ, Guangzhou E Campus Lab Ctr, Guangzhou 510275, Guangdong, Peoples R China	Nanyang Normal College; South China Agricultural University; Southwest Jiaotong University; Sun Yat Sen University	Yao, LG (corresponding author), Nanyang Normal Univ, Henan Prov Key Lab Funiu Mt Insect Biol, Rothamsted Res Joint Lab Insect Biol, China United Kingdom Nanyang Normal Univ, Nanyang, Peoples R China.	lunguangyao@163.com; cyfz@scau.edu.cn			National Natural Science Foundation of China [81072494, 30700750, 30871828]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant number 81072494, 30700750 and 30871828] (http://isis.nsfc.gov.cn/portal/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Cao CP, 2006, CURR SCI INDIA, V91, P1692; Chen YJ, 2005, BIOCHEM BIOPH RES CO, V335, P616, DOI 10.1016/j.bbrc.2005.07.116; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Dojima T, 2009, J BIOTECHNOL, V143, P27, DOI 10.1016/j.jbiotec.2009.06.013; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; HAZIZA C, 1982, EMBO J, V1, P379, DOI 10.1002/j.1460-2075.1982.tb01178.x; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Kost TA, 2010, CURR GENE THER, V10, P168; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Long Hu, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1491; Motohashi T, 2005, BIOCHEM BIOPH RES CO, V326, P564, DOI 10.1016/j.bbrc.2004.11.060; Noad RJ, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-87; Park EY, 2008, BIOTECHNOL APPL BIOC, V49, P135, DOI 10.1042/BA20070098; Sambrook J, 2001, MOL CLONING LAB MANU; Sun JC, 2009, BIOTECHNOL PROGR, V25, P524, DOI 10.1002/btpr.125; Sun JC, 2010, BIOTECHNOL APPL BIOC, V57, P117, DOI 10.1042/BA20100148; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yao LG, 2007, BIOTECHNOL APPL BIOC, V48, P45, DOI 10.1042/BA20070017; Yao LG, 2010, J BIOTECHNOL, V145, P23, DOI 10.1016/j.jbiotec.2009.10.003; Yao Ning, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P572, DOI 10.1016/S1872-2075(06)60046-0	21	32	36	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32510	10.1371/journal.pone.0032510	http://dx.doi.org/10.1371/journal.pone.0032510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403668	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700065
J	Mihara, M; Miyai, I; Hattori, N; Hatakenaka, M; Yagura, H; Kawano, T; Okibayashi, M; Danjo, N; Ishikawa, A; Inoue, Y; Kubota, K				Mihara, Masahito; Miyai, Ichiro; Hattori, Noriaki; Hatakenaka, Megumi; Yagura, Hajime; Kawano, Teiji; Okibayashi, Masaki; Danjo, Nobuyoshi; Ishikawa, Akihiro; Inoue, Yoshihiro; Kubota, Kisou			Neurofeedback Using Real-Time Near-Infrared Spectroscopy Enhances Motor Imagery Related Cortical Activation	PLOS ONE			English	Article							BRAIN ACTIVATION; MENTAL PRACTICE; NEUROLOGICAL REHABILITATION; PHYSICAL THERAPY; FUNCTIONAL BRAIN; CONTROLLED-TRIAL; HAND MOVEMENTS; STROKE; MODEL; NIRS	Accumulating evidence indicates that motor imagery and motor execution share common neural networks. Accordingly, mental practices in the form of motor imagery have been implemented in rehabilitation regimes of stroke patients with favorable results. Because direct monitoring of motor imagery is difficult, feedback of cortical activities related to motor imagery (neurofeedback) could help to enhance efficacy of mental practice with motor imagery. To determine the feasibility and efficacy of a real-time neurofeedback system mediated by near-infrared spectroscopy (NIRS), two separate experiments were performed. Experiment 1 was used in five subjects to evaluate whether real-time cortical oxygenated hemoglobin signal feedback during a motor execution task correlated with reference hemoglobin signals computed off-line. Results demonstrated that the NIRS-mediated neurofeedback system reliably detected oxygenated hemoglobin signal changes in real-time. In Experiment 2, 21 subjects performed motor imagery of finger movements with feedback from relevant cortical signals and irrelevant sham signals. Real neurofeedback induced significantly greater activation of the contralateral premotor cortex and greater self-assessment scores for kinesthetic motor imagery compared with sham feedback. These findings suggested the feasibility and potential effectiveness of a NIRS-mediated real-time neurofeedback system on performance of kinesthetic motor imagery. However, these results warrant further clinical trials to determine whether this system could enhance the effects of mental practice in stroke patients.	[Mihara, Masahito; Miyai, Ichiro; Hattori, Noriaki; Hatakenaka, Megumi; Yagura, Hajime; Kawano, Teiji; Okibayashi, Masaki; Kubota, Kisou] Morinomiya Hosp, Neurorehabil Res Inst, Osaka, Japan; [Hattori, Noriaki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan; [Okibayashi, Masaki; Danjo, Nobuyoshi] Morinomiya Hosp, Dept Rehabil, Osaka, Japan; [Ishikawa, Akihiro; Inoue, Yoshihiro] Shimadzu Co Ltd, Med Syst Div, R&D Dept, Kyoto, Japan	Japan Science & Technology Agency (JST); Shimadzu Corporation	Mihara, M (corresponding author), Morinomiya Hosp, Neurorehabil Res Inst, Osaka, Japan.	m-mihara@omichikai.or.jp		Hattori, Noriaki/0000-0003-0114-5327; Mihara, Masahito/0000-0001-5103-7784; Miyai, Ichiro/0000-0002-7218-7551	Japan Society for the Promotion of Science (JSPS) [23700500]; Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [23700500] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was granted by a Grant-in-Aid for Young Scientists (B) (23700500) from Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp), and a Grant-in-Aid for the "Research Committee for Ataxic Diseases" for Research on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan (http://www.mhlw.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagarinao E, 2003, NEUROIMAGE, V19, P422, DOI 10.1016/S1053-8119(03)00081-8; Berman BD, 2011, NEUROIMAGE; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cannestra AF, 2003, NEUROREPORT, V14, P1961, DOI 10.1097/00001756-200310270-00016; Cirstea CM, 2006, STROKE, V37, P1237, DOI 10.1161/01.STR.0000217417.89347.63; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cope M, 1988, Adv Exp Med Biol, V222, P183; COX RW, 1995, MAGNET RESON MED, V33, P230, DOI 10.1002/mrm.1910330213; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Dobkin BH, 2007, J PHYSIOL-LONDON, V579, P637, DOI 10.1113/jphysiol.2006.123067; Egner T, 2004, CLIN NEUROPHYSIOL, V115, P131, DOI 10.1016/S1388-2457(03)00353-5; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Fuchs T, 2003, APPL PSYCHOPHYS BIOF, V28, P1, DOI 10.1023/A:1022353731579; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Guillot A, 2009, HUM BRAIN MAPP, V30, P2157, DOI 10.1002/hbm.20658; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Holper L, 2010, NEUROIMAGE, V50, P190, DOI 10.1016/j.neuroimage.2009.12.055; HOSHI Y, 1993, NEUROSCI LETT, V150, P5, DOI 10.1016/0304-3940(93)90094-2; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Hugdahl K, 1996, CURR OPIN NEUROBIOL, V6, P252, DOI 10.1016/S0959-4388(96)80080-8; Ietswaart M, 2011, BRAIN, V134, P1373, DOI 10.1093/brain/awr077; Jackson PL, 2003, NEUROIMAGE, V20, P1171, DOI 10.1016/S1053-8119(03)00369-0; Jasdzewski G, 2003, NEUROIMAGE, V20, P479, DOI 10.1016/S1053-8119(03)00311-2; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Johnson SH, 2002, J COGNITIVE NEUROSCI, V14, P841, DOI 10.1162/089892902760191072; Johnson SH, 2000, NEUROREPORT, V11, P729, DOI 10.1097/00001756-200003200-00015; Kohno S, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2814249; Kotchoubey B, 2001, EPILEPSIA, V42, P406, DOI 10.1046/j.1528-1157.2001.22200.x; Lotze M, 2006, NEUROPSYCHOLOGIA, V44, P1787, DOI 10.1016/j.neuropsychologia.2006.03.016; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Malouin F, 2008, NEUROREHAB NEURAL RE, V22, P330, DOI 10.1177/1545968307313499; Malouin Francine, 2007, J Neurol Phys Ther, V31, P20; Malouin F, 2008, ARCH PHYS MED REHAB, V89, P311, DOI 10.1016/j.apmr.2007.11.006; Mansouri C, 2010, LASER MED SCI, V25, P431, DOI 10.1007/s10103-010-0754-4; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Munroe KJ, 2000, SPORT PSYCHOL, V14, P119, DOI 10.1123/tsp.14.2.119; Okamoto M, 2005, NEUROIMAGE, V26, P18, DOI 10.1016/j.neuroimage.2005.01.018; Okamoto M, 2006, APPETITE, V47, P220, DOI 10.1016/j.appet.2006.04.003; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; Penny W, 2003, HUMAN BRAIN FUNCTION, P843, DOI DOI 10.1016/B978-012264841-0/50044-5; Plichta MM, 2007, HUM BRAIN MAPP, V28, P733, DOI 10.1002/hbm.20303; Plichta MM, 2007, NEUROIMAGE, V35, P625, DOI 10.1016/j.neuroimage.2006.11.028; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Roure R, 1999, PHYSIOL BEHAV, V66, P63, DOI 10.1016/S0031-9384(99)00026-8; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Sadato N, 1996, J NEUROSCI, V16, P2693; Sato H, 2004, NEUROIMAGE, V21, P1554, DOI 10.1016/j.neuroimage.2003.12.017; Sharma N, 2008, NEUROIMAGE, V41, P92, DOI 10.1016/j.neuroimage.2008.02.009; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Takeuchi M, 2009, BRAIN TOPOGR, V22, P197, DOI 10.1007/s10548-009-0109-2; Tomasino B, 2003, BRAIN COGNITION, V51, P368, DOI 10.1016/S0278-2626(02)00570-5; Toronov VY, 2007, NEUROIMAGE, V34, P1136, DOI 10.1016/j.neuroimage.2006.08.048; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uludag K, 2004, NEUROIMAGE, V22, P583, DOI 10.1016/j.neuroimage.2004.02.023; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; WARNER L, 1988, PHYS THER, V68, P516, DOI 10.1093/ptj/68.4.516; WINSTEIN CJ, 1991, PHYS THER, V71, P140, DOI 10.1093/ptj/71.2.140; Yamada T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275469; Yoo SS, 2008, INT J IMAG SYST TECH, V18, P69, DOI 10.1002/ima.20139; Zhang Q, 2009, NEUROIMAGE, V45, P788, DOI 10.1016/j.neuroimage.2008.12.048	73	184	191	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32234	10.1371/journal.pone.0032234	http://dx.doi.org/10.1371/journal.pone.0032234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396753	Green Published, gold, Green Submitted			2022-12-25	WOS:000303006500013
J	Chiu, CF; Ho, MY; Peng, JM; Hung, SW; Lee, WH; Liang, CM; Liang, SM				Chiu, C-F; Ho, M-Y; Peng, J-M; Hung, S-W; Lee, W-H; Liang, C-M; Liang, S-M			Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane	ONCOGENE			English	Article						prohibitin; Akt; Raf-1; metastasis; invasion	CANCER-CELLS; ROLES; REPRESSION; TISSUE	Prohibitin (PHB) is indispensable for Ras-induced Raf-1 activation, cell migration and growth; however, the exact role of PHB in the molecular pathogenesis of cancer metastasis remains largely unexamined. Here, we found a positive correlation between plasma membrane-associated PHB and the clinical stages of cancer. The level of PHB phosphorylated at threonine 258 (T258) and tyrosine 259 (Y259) in human cancer-cell membranes correlated with the invasiveness of cancer cells. Overexpression of phosphorylated PHB (phospho-PHB) in the lipid-raft domain of the cell membrane enhanced cell migration/invasion through PI3K/Akt and Raf-1/ERK activation. It also enhanced epithelial-mesenchynnal transition, matrix metalloproteinase-2 activity and invasiveness of cancer cells in vitro. Immunoprecipitation analysis demonstrated that phospho-PHB associated with Raf-1, Akt and Ras in the membrane and was essential for the activation of Raf-1 signaling by Ras. Mice implanted with cancer cells stably overexpressing PHB in the plasma membrane showed enlarged cervical tumors, enhanced metastasis and shorter survival time compared with mice implanted with cancer cells without PHB overexpression. Dephosphorylation of PHB at T258 by site-directed mutagenesis diminished the in vitro and in vivo effects of PHB. These results suggest that increase in phospho-PHB T258 in the raft domain of the plasma membrane has a role in the Ras-driven activation of PI3K/Akt and Raf-1/ERK-signaling cascades and results in the promotion of cancer metastasis. Oncogene (2013) 32, 777-787; doi:10.1038/onc.2012.86; published online 12 March 2012	[Chiu, C-F; Liang, S-M] Natl Cheng Kung Univ, Inst Biotechnol, Coll Biosci & Biotechnol, Tainan 70101, Taiwan; [Chiu, C-F; Hung, S-W; Liang, S-M] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 11529, Taiwan; [Ho, M-Y; Peng, J-M; Liang, C-M; Liang, S-M] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Lee, W-H] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, Taipei, Taiwan; [Liang, C-M] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Medical University; Shuang Ho Hospital; Academia Sinica - Taiwan	Liang, SM (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	cmliang@gate.sinica.edu.tw; smyang@gate.sinica.edu.tw		Liang, Shu-Mei/0000-0001-8926-4747; Chiu, Ching-Feng/0000-0001-5591-0288	National Science Council, Taiwan [NSC 96-2313-B-001-005-MY3, NSC 99-2313-B-001-004-MY3]; Academia Sinica	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by the National Science Council, Taiwan (grants NSC 96-2313-B-001-005-MY3 and NSC 99-2313-B-001-004-MY3 to Shu-Mei Liang), and Academia Sinica (to Shu-Mei Liang and Chi-Ming Liang). We thank Chi-Ying Huang of National Yang Ming University, Taiwan for designing phosphorylated peptides to make antibodies against phospho-PHB. We also thank Shu-Chen Shen and Tzu-Wen Tai of the Scientific Instrument Center, Academia Sinica for their assistance with confocal microscopy analyses and flow cytometric analysis.	Ande SR, 2009, BBA-MOL CELL RES, V1793, P1372, DOI 10.1016/j.bbamcr.2009.05.008; Ande SR, 2010, BIOCHEM CELL BIOL, V88, P553, DOI [10.1139/O09-177, 10.1139/o09-177]; Broustas CG, 2002, J BIOL CHEM, V277, P3053, DOI 10.1074/jbc.M106343200; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; Dart DA, 2009, ENDOCR-RELAT CANCER, V16, P1157, DOI 10.1677/ERC-09-0028; DELLORCO RT, 1997, BREAST J, V3, P85; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Han EKH, 2008, ANTICANCER RES, V28, P957; Huang Q, 2006, CANCER RES, V66, P5807, DOI 10.1158/0008-5472.CAN-06-0077; Kang XD, 2008, J GASTROENTEROL, V43, P618, DOI 10.1007/s00535-008-2208-3; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; LIOTTA LA, 1991, CANCER RES, V51, pS5054; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nock NL, 2010, ENERG BALANCE CANCER, V1, P129, DOI 10.1007/978-1-4419-5515-9_5; Patel N, 2010, P NATL ACAD SCI USA, V107, P2503, DOI 10.1073/pnas.0910649107; Peng XJ, 2006, CANCER RES, V66, P7361, DOI 10.1158/0008-5472.CAN-06-1004; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; SATOH T, 1992, J BIOL CHEM, V267, P24149; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Ummanni R, 2008, CANCER LETT, V266, P171, DOI 10.1016/j.canlet.2008.02.047; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wu TF, 2007, ANTICANCER RES, V27, P895; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	29	55	61	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 7	2013	32	6					777	787		10.1038/onc.2012.86	http://dx.doi.org/10.1038/onc.2012.86			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	101AF	22410782				2022-12-25	WOS:000315746700011
J	Schallreuter, KU; Salem, MAEL; Gibbons, NCJ; Martinez, A; Slominski, R; Ludemann, J; Rokos, H				Schallreuter, Karin U.; Salem, Mohamed A. E. L.; Gibbons, Nick C. J.; Martinez, Aurora; Slominski, Radomir; Luedemann, Juergen; Rokos, Hartmut			Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 1: epidermal H2O2/ONOO--mediated stress abrogates tryptophan hydroxylase and dopa decarboxylase activities, leading to low serotonin and melatonin levels	FASEB JOURNAL			English	Article						MITF; calcium channel; hydrogen peroxide; peroxynitrite	HYDROGEN-PEROXIDE H2O2; SUPPORTS OXIDATIVE STRESS; CATALASE GENE; DNA-DAMAGE; COMPUTER-SIMULATION; ANTIOXIDANT ENZYMES; AUTOIMMUNE-DISEASE; CALCIUM IMBALANCE; VITAMIN-C; IN-VIVO	Vitiligo is characterized by a progressive loss of inherited skin color. The cause of the disease is still unknown. To date, there is accumulating in vivo and in vitro evidence for massive oxidative stress via hydrogen peroxide (H2O2) and peroxynitrite (ONOO-) in the skin of affected individuals. Autoimmune etiology is the favored theory. Since depletion of the essential amino acid L-tryptophan (Trp) affects immune response mechanisms, we here looked at epidermal Trp metabolism via tryptophan hydroxylase (TPH) with its downstream cascade, including serotonin and melatonin. Our in situ immunofluorescence and Western blot data reveal significantly lower TPH1 expression in patients with vitiligo. Expression is also low in melanocytes and keratinocytes under in vitro conditions. Although in vivo Fourier transform-Raman spectroscopy proves the presence of 5-hydroxytryptophan, epidermal TPH activity is completely absent. Regulation of TPH via microphthalmia-associated transcription factor and L-type calcium channels is severely affected. Moreover, dopa decarboxylase (DDC) expression is significantly lower, in association with decreased serotonin and melatonin levels. Computer simulation supports H2O2/ONOO--mediated oxidation/nitration of TPH1 and DDC, affecting, in turn, enzyme functionality. Taken together, our data point to depletion of epidermal Trp by Fenton chemistry and exclude melatonin as a relevant contributor to epidermal redox balance and immune response in vitiligo.-Schallreuter, K. U., Salem, M. A. E. L., Gibbons, N. C. J., Martinez, A., Slominski, R., Ludemann, J., Rokos, H. Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 1: epidermal H2O2/ONOO--mediated stress abrogates tryptophan hydroxylase and dopa decarboxylase activities, leading to low serotonin and melatonin levels. FASEB J. 26, 2457-2470 (2012). www.fasebj.org	[Schallreuter, Karin U.; Salem, Mohamed A. E. L.; Gibbons, Nick C. J.; Slominski, Radomir] Univ Bradford, Ctr Skin Sci, Dept Clin & Expt Dermatol, Bradford BD7 1DP, W Yorkshire, England; [Schallreuter, Karin U.; Salem, Mohamed A. E. L.; Gibbons, Nick C. J.; Rokos, Hartmut] Ernst Moritz Arndt Univ Greifswald, Inst Pigmentary Disorders, Greifswald, Germany; [Luedemann, Juergen] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Martinez, Aurora] Univ Bergen, Dept Biochem, Bergen, Norway	University of Bradford; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Bergen	Schallreuter, KU (corresponding author), Univ Bradford, Ctr Skin Sci, Dept Clin & Expt Dermatol, Bradford BD7 1DP, W Yorkshire, England.	k.schallreuter@bradford.ac.uk	Martinez, Aurora/M-3088-2019	Martinez, Aurora/0000-0003-1643-6506	Deutsche Vitiligo Verein eV (Hamburg, Germany)	Deutsche Vitiligo Verein eV (Hamburg, Germany)	The authors thank the participating patients for their patience during this long-lasting international collaborative investigation. The work has been supported by private donations to K.U.S. and by the Deutsche Vitiligo Verein eV (Hamburg, Germany).	Allegra M, 2003, J PINEAL RES, V34, P1, DOI 10.1034/j.1600-079X.2003.02112.x; Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165; ARONOFF S, 1965, SCIENCE, V150, P72, DOI 10.1126/science.150.3692.72; Barbosa R, 2008, LIFE SCI, V82, P529, DOI 10.1016/j.lfs.2007.12.011; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; CALANCHINIPOSTIZZI E, 1987, DERMATOLOGICA, V174, P266, DOI 10.1159/000249197; Casp CB, 2002, PIGM CELL RES, V15, P62, DOI 10.1034/j.1600-0749.2002.00057.x; CASSONE VM, 1990, TRENDS NEUROSCI, V13, P457, DOI 10.1016/0166-2236(90)90099-V; DELGOBBO V, 1989, INT J IMMUNOPHARMACO, V11, P567, DOI 10.1016/0192-0561(89)90187-2; Dell'Anna M. L., 2006, J INVEST DERMATOL S3, V126, P403; Dell'Anna ML, 2003, PIGM CELL RES, V16, P553, DOI 10.1034/j.1600-0749.2003.00087.x; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; Fischer TW, 2008, EXP DERMATOL, V17, P713, DOI 10.1111/j.1600-0625.2008.00767.x; Fischer TW, 2006, FASEB J, V20, P1564, DOI 10.1096/fj.05-5227fje; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; FLATMARK T, 1980, ANAL BIOCHEM, V107, P71, DOI 10.1016/0003-2697(80)90494-7; Gavalas NG, 2006, BIOCHEM BIOPH RES CO, V345, P1586, DOI 10.1016/j.bbrc.2006.05.063; Gibbons NQ, 2006, J INVEST DERMATOL, V126, P2576, DOI 10.1038/sj.jid.5700612; GIORDANO M, 1991, J PINEAL RES, V10, P117, DOI 10.1111/j.1600-079X.1991.tb00827.x; Gitto E, 2001, J PHARM PHARMACOL, V53, P1393, DOI 10.1211/0022357011777747; Gomez M, 2005, FREE RADICAL BIO MED, V38, P104, DOI 10.1016/j.freeradbiomed.2004.10.009; Hasse S, 2004, J INVEST DERMATOL, V122, P307, DOI 10.1046/j.0022-202X.2004.22230.x; Ishii S, 1996, J BIOCHEM, V120, P369; Jin Y, 2010, NAT GENET, V42, P576, DOI 10.1038/ng.602; KIISTALA U, 1968, J INVEST DERMATOL, V50, P129, DOI 10.1038/jid.1968.15; Kitamura R, 2004, J PATHOL, V202, P463, DOI 10.1002/path.1538; Konakchieva R, 1995, J NEUROIMMUNOL, V63, P125, DOI 10.1016/0165-5728(95)00135-2; LISSONI P, 1993, CANCER-AM CANCER SOC, V71, P2076, DOI 10.1002/1097-0142(19930315)71:6<2076::AID-CNCR2820710624>3.0.CO;2-I; Lopez-Burillo S, 2003, J PINEAL RES, V34, P269, DOI 10.1034/j.1600-079X.2003.00041.x; LOPEZGONZALEZ MA, 1992, NEUROSCI LETT, V136, P150, DOI 10.1016/0304-3940(92)90036-7; Maresca V, 1997, J INVEST DERMATOL, V109, P310, DOI 10.1111/1523-1747.ep12335801; Marles LK, 2003, EXP DERMATOL, V12, P61, DOI 10.1034/j.1600-0625.2003.120108.x; McKinney J, 2001, BIOCHEMISTRY-US, V40, P15591, DOI 10.1021/bi015722x; Morii E, 2001, BLOOD, V97, P2038, DOI 10.1182/blood.V97.7.2038; MORREY KM, 1994, J IMMUNOL, V153, P2671; ORECCHIA G, 1994, DERMATOLOGY, V189, P350, DOI 10.1159/000246877; Park HH, 2006, EXP DERMATOL, V15, P377, DOI 10.1111/j.0906-6705.2006.00423.x; Pey AL, 2006, FASEB J, V20, P2130, DOI 10.1096/fj.06-5835fje; PIOLI C, 1993, INT J IMMUNOPHARMACO, V15, P463, DOI 10.1016/0192-0561(93)90060-C; Poon Angela M. S., 1994, Biological Signals, V3, P107; Reiter RJ, 2003, ACTA BIOCHIM POL, V50, P1129; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rokos H, 2002, BIOCHEM BIOPH RES CO, V292, P805, DOI 10.1006/bbrc.2002.6727; Rokos H, 2008, J RAMAN SPECTROSC, V39, P1214, DOI 10.1002/jrs.1968; Salem MMAEL, 2009, FASEB J, V23, P3790, DOI 10.1096/fj.09-132621; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Schallreuter KU, 2007, BIOCHEM BIOPH RES CO, V360, P70, DOI 10.1016/j.bbrc.2007.05.218; Schallreuter KU, 2008, INT J DERMATOL, V47, P743, DOI 10.1111/j.1365-4632.2008.03660.x; Schallreuter KU, 2008, J INVEST DERMATOL, V128, P808, DOI 10.1038/sj.jid.5701100; Schallreuter KU, 2006, J INVEST DERMATOL, V126, P1036, DOI 10.1038/sj.jid.5700257; Schallreuter KU, 2012, FASEB J, V26, P2471, DOI 10.1096/fj.11-201897; Schallreuter KU, 1996, ARCH DERMATOL RES, V288, P14, DOI 10.1007/BF02505037; SCHALLREUTER KU, 1991, J INVEST DERMATOL, V97, P1081, DOI 10.1111/1523-1747.ep12492612; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; SCHALLREUTER KU, 1994, BBA-MOL BASIS DIS, V1226, P181, DOI 10.1016/0925-4439(94)90027-2; SCHALLREUTER KU, 1994, SCIENCE, V263, P1444, DOI 10.1126/science.8128228; Schallreuter KU, 2002, DERMATOLOGY, V204, P194, DOI 10.1159/000057881; Shalbaf M, 2008, EXP DERMATOL, V17, P761, DOI 10.1111/j.1600-0625.2008.00697.x; Slominski A, 2002, FASEB J, V16, P896, DOI 10.1096/fj.01-0952fje; SLOMINSKI A, 1989, J ROY SOC MED, V82, P539, DOI 10.1177/014107688908200911; Slominski A, 2005, ENDOCRINE, V27, P137, DOI 10.1385/ENDO:27:2:137; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2003, BBA-MOL BASIS DIS, V1639, P80, DOI 10.1016/S0925-4439(03)00124-8; Slominski A, 2003, J CELL PHYSIOL, V196, P144, DOI 10.1002/jcp.10287; Slominski A, 2002, FEBS LETT, V511, P102, DOI 10.1016/S0014-5793(01)03319-1; Slominski A, 2008, TRENDS ENDOCRIN MET, V19, P17, DOI 10.1016/j.tem.2007.10.007; Slominski A, 2008, EXP DERMATOL, V17, P148, DOI 10.1111/j.1600-0625.2007.00666_5.x; Spencer JD, 2007, J INVEST DERMATOL, V127, P411, DOI 10.1038/sj.jid.5700538; Spritz RA, 2012, J INVEST DERMATOL, V132, P268, DOI 10.1038/jid.2011.321; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; TAN DX, 1993, CANCER LETT, V70, P65, DOI 10.1016/0304-3835(93)90076-L; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Wajs E, 1995, EUR J ENDOCRINOL, V133, P754, DOI 10.1530/eje.0.1330754; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; Winiarska K, 2006, J PINEAL RES, V40, P168, DOI 10.1111/j.1600-079X.2005.00295.x; Wood JM, 2009, FASEB J, V23, P2065, DOI 10.1096/fj.08-125435; Wood JM, 2008, EXP DERMATOL, V17, P366, DOI 10.1111/j.1600-0625.2008.00699.x; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Zmijewski MA, 2009, MOL CELL ENDOCRINOL, V307, P211, DOI 10.1016/j.mce.2009.04.010	80	34	35	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2457	2470		10.1096/fj.11-197137	http://dx.doi.org/10.1096/fj.11-197137			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415302				2022-12-25	WOS:000305017200023
J	Schallreuter, KU; Salem, MAEL; Gibbons, NCJ; Maitland, DJ; Marsch, E; Elwary, SMA; Healey, AR				Schallreuter, Karin U.; Salem, Mohamed A. E. L.; Gibbons, Nick C. J.; Maitland, Derek J.; Marsch, Elke; Elwary, Souna M. A.; Healey, Andrew R.			Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 2: epidermal H2O2/ONOO--mediated stress in vitiligo hampers indoleamine 2,3-dioxygenase and aryl hydrocarbon receptor-mediated immune response signaling	FASEB JOURNAL			English	Article						peroxynitrite; Treg; IDO; hydrogen peroxide	SUPPORTS OXIDATIVE STRESS; REGULATORY T-CELLS; H2O2 ACCUMULATION; NITRIC-OXIDE; IN-VIVO; SKIN; IDENTIFICATION; PATHOGENESIS; EXPRESSION; TOLERANCE	Vitiligo is characterized by a mostly progressive loss of the inherited skin color. The cause of the disease is still unknown, despite accumulating in vivo and in vitro evidence of massive oxidative stress via hydrogen peroxide (H2O2) and peroxynitrite (ONOO-) in the skin of affected individuals. The most favored hypothesis is based on autoimmune mechanisms. Since depletion of the essential amino acid L-tryptophan (Trp) severely affects various immune responses, we here looked at Trp metabolism and signaling in these patients. Our in vivo and in vitro data revealed total absence of epidermal Trp hydroxylase activities and the presence of H2O2/ONOO- deactivated indoleamine 2,3-dioxygenase. Aryl hydrocarbon receptor signaling is severely impaired despite the ligand (Trp dimer) being formed, as shown by mass spectrometry. Loss of this signal is supported by the absence of downstream signals (COX-2 and CYP1A1) as well as regulatory T-lymphocytes and by computer modeling. In vivo Fourier transform Raman spectroscopy confirmed the presence of Trp metabolites together with H2O2 supporting deprivation of the epidermal Trp pool by Fenton chemistry. Taken together, our data support a long-expressed role for in loco redox balance and a distinct immune response. These insights could open novel treatment strategies for this disease.-Schallreuter, K. U., Salem, M. A. E. L., Gibbons, N.C.J., Maitland, D. J., Marsch, E., Elwary, S., Healey, A. R. Blunted epidermal L-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 2: epidermal H2O2/ONOO--mediated stress in vitiligo hampers indoleamine 2,3-dioxygenase and aryl hydrocarbon receptor-mediated immune response signaling. FASEB J. 26, 2471-2485 (2012). www.fasebj.org	[Schallreuter, Karin U.; Salem, Mohamed A. E. L.; Gibbons, Nick C. J.; Elwary, Souna M. A.] Univ Bradford, Ctr Skin Sci, Dept Clin & Expt Dermatol, Bradford BD7 1DP, W Yorkshire, England; [Schallreuter, Karin U.; Salem, Mohamed A. E. L.; Gibbons, Nick C. J.; Marsch, Elke; Elwary, Souna M. A.] Univ Greifswald, Inst Pigmentary Disorders, Greifswald, Germany; [Maitland, Derek J.] Univ Bradford, Dept Chem & Forens Sci, Bradford BD7 1DP, W Yorkshire, England; [Healey, Andrew R.] Univ Bradford, Analyt Ctr, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; Ernst Moritz Arndt Universitat Greifswald; University of Bradford; University of Bradford	Schallreuter, KU (corresponding author), Univ Bradford, Ctr Skin Sci, Dept Clin & Expt Dermatol, Bradford BD7 1DP, W Yorkshire, England.	k.schallreuter@bradford.ac.uk			Deutsche Vitiligo Verein eV (Hamburg, Germany)	Deutsche Vitiligo Verein eV (Hamburg, Germany)	This research was kindly supported by the Deutsche Vitiligo Verein eV (Hamburg, Germany) and by a grant to K. U. S. and by private donations. The authors are grateful for excellent technical support by Ms. M. A. T. el Sayed.	Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Basak PY, 2009, J AM ACAD DERMATOL, V60, P256, DOI 10.1016/j.jaad.2008.09.048; CALANCHINIPOSTIZZI E, 1987, DERMATOLOGICA, V174, P266, DOI 10.1159/000249197; Dyer JM, 2006, PHOTOCH PHOTOBIO SCI, V5, P698, DOI 10.1039/b603030k; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Fujigaki H, 2006, J IMMUNOL, V176, P372, DOI 10.4049/jimmunol.176.1.372; GRIMES PE, 1986, J AM ACAD DERMATOL, V14, P196, DOI 10.1016/S0190-9622(86)70021-2; Hasse S, 2004, J INVEST DERMATOL, V122, P307, DOI 10.1046/j.0022-202X.2004.22230.x; Jux B, 2011, J INVEST DERMATOL, V131, P203, DOI 10.1038/jid.2010.269; KIISTALA U, 1968, J INVEST DERMATOL, V50, P129, DOI 10.1038/jid.1968.15; King NJC, 2007, INT J BIOCHEM CELL B, V39, P2167, DOI 10.1016/j.biocel.2007.01.004; Klarquist J, 2010, PIGM CELL MELANOMA R, V23, P276, DOI 10.1111/j.1755-148X.2010.00688.x; Marles LK, 2003, EXP DERMATOL, V12, P61, DOI 10.1034/j.1600-0625.2003.120108.x; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Parrish J. A., 1979, DERMATOLOGY GENERAL, P942; Pey AL, 2006, FASEB J, V20, P2130, DOI 10.1096/fj.06-5835fje; Pingle Shubhangi K, 2008, Indian J Occup Environ Med, V12, P107, DOI 10.4103/0019-5278.44690; Poljak A, 2006, ARCH BIOCHEM BIOPHYS, V450, P9, DOI 10.1016/j.abb.2006.03.003; Rannug U, 1995, CHEM BIOL, V2, P841, DOI 10.1016/1074-5521(95)90090-X; Rokos H, 2008, J RAMAN SPECTROSC, V39, P1214, DOI 10.1002/jrs.1968; Salem MMAEL, 2009, FASEB J, V23, P3790, DOI 10.1096/fj.09-132621; Samelson-Jones BJ, 2006, BIOCHEMISTRY-US, V45, P8527, DOI 10.1021/bi060143j; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Schallreuter KU, 2008, INT J DERMATOL, V47, P743, DOI 10.1111/j.1365-4632.2008.03660.x; Schallreuter KU, 2007, LIFE SCI, V80, P2221, DOI 10.1016/j.lfs.2007.01.028; Schallreuter KU, 2012, FASEB J, V26, P2457, DOI 10.1096/fj.11-197137; Schallreuter KU, 1996, ARCH DERMATOL RES, V288, P14, DOI 10.1007/BF02505037; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; SCHALLREUTER KU, 1994, SCIENCE, V263, P1444, DOI 10.1126/science.8128228; Schallreuter KU, 2002, DERMATOLOGY, V204, P194, DOI 10.1159/000057881; Schallreuter KU, 2001, J INVEST DERMATOL, V116, P167, DOI 10.1046/j.1523-1747.2001.00220.x; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schroecksnadel K, 2006, CLIN RHEUMATOL, V25, P334, DOI 10.1007/s10067-005-0056-6; Shalbaf M, 2008, EXP DERMATOL, V17, P761, DOI 10.1111/j.1600-0625.2008.00697.x; Slominski A, 2002, FASEB J, V16, P896, DOI 10.1096/fj.01-0952fje; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2003, BBA-MOL BASIS DIS, V1639, P80, DOI 10.1016/S0925-4439(03)00124-8; Slominski A, 2008, TRENDS ENDOCRIN MET, V19, P17, DOI 10.1016/j.tem.2007.10.007; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; THOMAS SR, 1994, J BIOL CHEM, V269, P14457; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Wood JM, 2009, FASEB J, V23, P2065, DOI 10.1096/fj.08-125435	51	48	52	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2471	2485		10.1096/fj.11-201897	http://dx.doi.org/10.1096/fj.11-201897			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415306				2022-12-25	WOS:000305017200024
J	Wang, WY; Jiang, QY; Argentini, M; Cornu, D; Gigant, B; Knossow, M; Wang, CG				Wang, Weiyi; Jiang, Qiyang; Argentini, Manuela; Cornu, David; Gigant, Benoit; Knossow, Marcel; Wang, Chunguang			Kif2C Minimal Functional Domain Has Unusual Nucleotide Binding Properties That Are Adapted to Microtubule Depolymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROMERE-ASSOCIATED KINESIN; PROTEIN-LIGAND INTERACTIONS; HAND-OVER-HAND; ATP HYDROLYSIS; BETA-TUBULIN; PLUS ENDS; 8-NM STEP; MCAK; MECHANISM; DEPOLYMERASE	The kinesin-13 Kif2C hydrolyzes ATP and uses the energy released to disassemble microtubules. The mechanism by which this is achieved remains elusive. Here we show that Kif2C( sN+M), a monomeric construct consisting of the motor domain with the proximal part of the N-terminal Neck extension but devoid of its more distal, unstructured, and highly basic part, has a robust depolymerase activity. When detached from microtubules, the Kif2C-(sN+M) nucleotide-binding site is occupied by ATP at physiological concentrations of adenine nucleotides. As a consequence, Kif2C-(sN+M) starts its interaction with microtubules in that state, which differentiates kinesin-13s from motile kinesins. Moreover, in this ATP-bound conformational state, Kif2C-(sN+M) has a higher affinity for soluble tubulin compared with microtubules. We propose a mechanism in which, in the first step, the specificity of ATP-bound Kif2C for soluble tubulin causes it to stabilize a curved conformation of tubulin heterodimers at the ends of microtubules. Data from an ATPase-deficient Kif2C mutant suggest that, then, ATP hydrolysis precedes and is required for tubulin release to take place. Finally, comparison with Kif2C-Motor indicates that the binding specificity for curved tubulin and, accordingly, the microtubule depolymerase activity are conferred to the motor domain by its N-terminal Neck extension.	[Gigant, Benoit; Knossow, Marcel] CNRS, Lab Enzymol & Biochim Struct, Ctr Rech Gif, F-91198 Gif Sur Yvette, France; [Wang, Weiyi; Jiang, Qiyang; Wang, Chunguang] Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China; [Argentini, Manuela; Cornu, David] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Tongji University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Knossow, M (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Ctr Rech Gif, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	knossow@lebs.cnrs-gif.fr; chunguangwang@tongji.edu.cn	Wang, Weiyi/GZN-0408-2022	Gigant, Benoit/0000-0002-5946-6759	Natural Science Foundation of China [30700125]; Chinese Ministry of Education [NCET-10-0604]; Science and Technology Commission of Shanghai Municipality [07pj14086, 074307039, 11JC1413100]; CNRS [PICS 4889]; Agence Nationale pour la Recherche [ANR-05-BLAN-0292, ANR-09-BLAN-0071]; Fondation pour la Recherche Medicale [DEQ20081213979]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work is supported by Natural Science Foundation of China Grant 30700125, Chinese Ministry of Education Grant NCET-10-0604, Science and Technology Commission of Shanghai Municipality Grants 07pj14086, 074307039, and 11JC1413100, CNRS through a Projet International de Cooperation Scientifique grant (PICS 4889), Agence Nationale pour la Recherche Grants ANR-05-BLAN-0292 and ANR-09-BLAN-0071, and Fondation pour la Recherche Medicale Grant DEQ20081213979.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; BEST D, 1981, ANAL BIOCHEM, V114, P281, DOI 10.1016/0003-2697(81)90481-4; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Clement MJ, 2005, BIOCHEMISTRY-US, V44, P14616, DOI 10.1021/bi0512492; Cooper JR, 2010, NAT STRUCT MOL BIOL, V17, P77, DOI 10.1038/nsmb.1728; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Friel CT, 2011, EMBO J, V30, P3928, DOI 10.1038/emboj.2011.290; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hertzer KM, 2006, MOL BIOL CELL, V17, P700, DOI 10.1091/mbc.E05-08-0821; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Jameson David M., 2005, V305, P301; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Moore A, 2004, TRENDS CELL BIOL, V14, P537, DOI 10.1016/j.tcb.2004.09.001; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Press W. H., 1992, NUMERICAL RECIPES C, P178; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; ROMBERG L, 1993, NATURE, V361, P168, DOI 10.1038/361168a0; SADHU A, 1992, J BIOL CHEM, V267, P11352; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Smyczynski C, 2000, J MOL BIOL, V295, P325, DOI 10.1006/jmbi.1999.3356; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Tan DY, 2008, STRUCTURE, V16, P1732, DOI 10.1016/j.str.2008.08.017; Tan DY, 2006, J CELL BIOL, V175, P25, DOI 10.1083/jcb.200605194; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wagenbach M, 2008, J CELL BIOL, V183, P617, DOI 10.1083/jcb.200805145; Wang CG, 2007, BIOCHEMISTRY-US, V46, P10595, DOI 10.1021/bi701147f; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	51	27	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15143	15153		10.1074/jbc.M111.317859	http://dx.doi.org/10.1074/jbc.M111.317859			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403406	Green Published, hybrid			2022-12-25	WOS:000304003200075
J	Zoghbi, ME; Krishnan, S; Altenberg, GA				Zoghbi, Maria E.; Krishnan, Srinivasan; Altenberg, Guillermo A.			Dissociation of ATP-binding Cassette Nucleotide-binding Domain Dimers into Monomers during the Hydrolysis Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CATALYTIC CYCLE; ABC TRANSPORTER; P-GLYCOPROTEIN; MOVEMENT; CLASSIFICATION; SPECTROSCOPY; MECHANISMS	ATP-binding cassette (ABC) proteins have two nucleotide-binding domains (NBDs) that work as dimers to bind and hydrolyze ATP, but the molecular mechanism of nucleotide hydrolysis is controversial. In particular, it is still unresolved whether hydrolysis leads to dissociation of the ATP-induced dimers or opening of the dimers, with the NBDs remaining in contact during the hydrolysis cycle. We studied a prototypical ABC NBD, the Methanococcus jannaschii MJ0796, using spectroscopic techniques. We show that fluorescence from a tryptophan positioned at the dimer interface and luminescence resonance energy transfer between probes reacted with single-cysteine mutants can be used to follow NBD association/dissociation in real time. The intermonomer distances calculated from luminescence resonance energy transfer data indicate that the NBDs separate completely following ATP hydrolysis, instead of opening. The results support ABC protein NBD association/dissociation, as opposed to constant-contact models.	[Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center	Altenberg, GA (corresponding author), Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu	Krishnan, Srinivasan/M-1354-2019	Altenberg, Guillermo/0000-0002-8932-740X	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; Cancer Prevention and Research Institute of Texas [RP101073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM79629 and 3R01GM079629-03S1 (to G. A. A.). This work was also supported by Cancer Prevention and Research Institute of Texas Grant RP101073.	Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen JY, 1999, BIOCONJUGATE CHEM, V10, P311, DOI 10.1021/bc980113w; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Knauf PA, 2004, BLOOD CELL MOL DIS, V32, P360, DOI 10.1016/j.bcmd.2004.01.007; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378	26	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14994	15000		10.1074/jbc.M112.340281	http://dx.doi.org/10.1074/jbc.M112.340281			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403405	Green Published, hybrid			2022-12-25	WOS:000304003200061
J	Zhao, JC; Carmody, LA; Kalikin, LM; Li, J; Petrosino, JF; Schloss, PD; Young, VB; LiPuma, JJ				Zhao, Jiangchao; Carmody, Lisa A.; Kalikin, Linda M.; Li, Jun; Petrosino, Joseph F.; Schloss, Patrick D.; Young, Vincent B.; LiPuma, John J.			Impact of Enhanced Staphylococcus DNA Extraction on Microbial Community Measures in Cystic Fibrosis Sputum	PLOS ONE			English	Article							AUREUS; BACTERIA	Staphylococcus aureus is a common constituent of the bacterial community inhabiting the airways of persons with cystic fibrosis (CF). Culture-independent studies have shown that this species is often present in relatively high abundance and would therefore be expected to exert a pronounced effect on measures of CF airway bacterial community structure. We investigated the impact of DNA extraction method on pyrosequencing-based measures of Staphylococcus abundance and bacterial community structure in 17 sputum samples from five CF patients. Staphylococcus was detected in fewer samples when DNA was extracted using a standard bacterial lysis method compared to when DNA was extracted using a lysis buffer amended with lysostaphin and lysozyme. The standard lysis method resulted in significantly lower measures of Staphylococcus relative abundance and higher levels of community diversity, richness, and evenness compared to the lysostaphin-lysozyme modified method. Measures of community dynamics in serial sputum samples from the same individual were nevertheless highly concordant between the two DNA extraction methods. These results illustrate the impact of DNA preparation method on measures of Staphylococcus abundance and bacterial community structures in studies of the airways microbiota in CF.	[Zhao, Jiangchao; Carmody, Lisa A.; Kalikin, Linda M.; LiPuma, John J.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Zhao, Jiangchao; Carmody, Lisa A.; Kalikin, Linda M.; LiPuma, John J.] Univ Michigan, Dept Communicable Dis, Ann Arbor, MI 48109 USA; [Li, Jun] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagenom & Microbiome Res, Houston, TX 77030 USA; [Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Schloss, Patrick D.; Young, Vincent B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Young, Vincent B.] Univ Michigan, Internal Med Infect Dis Div, Ann Arbor, MI 48109 USA; [LiPuma, John J.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor College of Medicine; Baylor College of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zhao, JC (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	jlipuma@umich.edu	Young, Vincent Bensan/M-9916-2019; Young, Vincent B/B-3179-2009; Zhao, Jiangchao/J-4627-2014; Petrosino, Joseph F./AAF-1621-2019	Young, Vincent Bensan/0000-0003-3687-2364; Young, Vincent B/0000-0003-3687-2364; Zhao, Jiangchao/0000-0002-2992-8967; Li, Jun/0000-0001-6727-0812; Schloss, Patrick/0000-0002-6935-4275	NHLBI [1RC1HL100809-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100809] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI grant 1RC1HL100809-01 (http://www.nhlbi.nih.gov/funding/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besier S, 2007, J CLIN MICROBIOL, V45, P168, DOI 10.1128/JCM.01510-06; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Heijerman Harry, 2005, J Cyst Fibros, V4 Suppl 2, P3, DOI 10.1016/j.jcf.2005.05.005; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stressmann FA, 2011, J CLIN MICROBIOL, V49, P281, DOI 10.1128/JCM.01650-10; VANBELKUM A, 1993, J CLIN MICROBIOL, V31, P798, DOI 10.1128/JCM.31.4.798-803.1993; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101	16	42	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33127	10.1371/journal.pone.0033127	http://dx.doi.org/10.1371/journal.pone.0033127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412992	Green Submitted, Green Published, gold			2022-12-25	WOS:000303062000033
J	Ford, AH; Garrido, GJ; Beer, C; Lautenschlager, NT; Arnolda, L; Flicker, L; Almeida, OP				Ford, Andrew H.; Garrido, Griselda J.; Beer, Christopher; Lautenschlager, Nicola T.; Arnolda, Leonard; Flicker, Leon; Almeida, Osvaldo P.			Homocysteine, Grey Matter and Cognitive Function in Adults with Cardiovascular Disease	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE; ALZHEIMERS-DISEASE; RISK-FACTOR; HEART-FAILURE; BRAIN ATROPHY; B-VITAMINS; MYOCARDIAL-INFARCTION; FOLIC-ACID; METAANALYSIS; HIPPOCAMPUS	Background: Elevated total plasma homocysteine (tHcy) has been associated with cognitive impairment, vascular disease and brain atrophy. Methods: We investigated 150 volunteers to determine if the association between high tHcy and cerebral grey matter volume and cognitive function is independent of cardiovascular disease. Results: Participants with high tHcy (>= 15 mu mol/L) showed a widespread relative loss of grey matter compared with people with normal tHcy, although differences between the groups were minimal once the analyses were adjusted for age, gender, diabetes, hypertension, smoking and prevalent cardiovascular disease. Individuals with high tHcy had worse cognitive scores across a range of domains and less total grey matter volume, although these differences were not significant in the adjusted models. Conclusions: Our results suggest that the association between high tHcy and loss of cerebral grey matter volume and decline in cognitive function is largely explained by increasing age and cardiovascular diseases and indicate that the relationship is not causal.	[Ford, Andrew H.; Garrido, Griselda J.; Beer, Christopher; Lautenschlager, Nicola T.; Flicker, Leon; Almeida, Osvaldo P.] Univ Western Australia, Western Australian Ctr Hlth & Ageing, Med Res Ctr, Perth, WA 6009, Australia; [Ford, Andrew H.; Lautenschlager, Nicola T.; Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Ford, Andrew H.; Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia; [Beer, Christopher; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Lautenschlager, Nicola T.] Univ Melbourne, Acad Unit Psychiat Old Age, Dept Psychiat, St Georges Hosp, Melbourne, Vic, Australia; [Arnolda, Leonard] Australian Natl Univ, Acad Unit Internal Med, Sch Med, Canberra, ACT, Australia	University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; St George Hospital; University of Melbourne; Australian National University	Ford, AH (corresponding author), Univ Western Australia, Western Australian Ctr Hlth & Ageing, Med Res Ctr, Perth, WA 6009, Australia.	andrew.ford@uwa.edu.au	Arnolda, Leonard/Z-1174-2019; Etherton-Beer, Christopher/B-2714-2014; Flicker, Leon/AAE-1530-2022; Arnolda, Leonard F/B-7711-2013; Almeida, Osvaldo P./A-4925-2008	Arnolda, Leonard/0000-0001-8173-3318; Etherton-Beer, Christopher/0000-0001-5148-0188; Flicker, Leon/0000-0002-3650-0475; Arnolda, Leonard F/0000-0001-8173-3318; Almeida, Osvaldo P./0000-0002-8689-6199; Lautenschlager, Nicola/0000-0003-4850-7794	National Health and Medical Research Council of Australia (NHMRC) [403996]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by a competitive project grant from the National Health and Medical Research Council of Australia (NHMRC grant number: 403996). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Almeida OP, 2012, INT PSYCHOGERIATR, V24, P38, DOI 10.1017/S1041610211001657; Castel A, 2010, EUROPACE, V12, P1136, DOI 10.1093/europace/euq163; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Blom HJ, 2011, J INHERIT METAB DIS, V34, P75, DOI 10.1007/s10545-010-9177-4; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Clarke R, 2001, J CARDIOVASC RISK, V8, P363, DOI 10.1097/00043798-200112000-00005; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Clarke R, 2011, J INHERIT METAB DIS, V34, P83, DOI 10.1007/s10545-010-9235-y; de Jager CA, 2011, INT J GERIATR PSYCHI; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; den Heijer T, 2003, BRAIN, V126, P170, DOI 10.1093/brain/awg006; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Egger G, 2001, AUST NZ J PUBL HEAL, V25, P561, DOI 10.1111/j.1467-842X.2001.tb00326.x; Firbank MJ, 2010, INT PSYCHOGERIATR, V22, P804, DOI 10.1017/S1041610210000499; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford AH, 2011, MOL PSYCHIAT; Foundas AL, 1997, NEUROPSY NEUROPSY BE, V10, P81; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; Herrmann M, 2006, EUR J HEART FAIL, V8, P571, DOI 10.1016/j.ejheart.2005.11.016; Howard MA, 2003, BRAIN RES PROTOC, V10, P125, DOI 10.1016/S1385-299X(02)00202-7; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Lazarewicz JW, 2003, NEUROCHEM RES, V28, P259, DOI 10.1023/A:1022329317218; Lazzerini PE, 2010, AUTOIMMUN REV, V9, P181, DOI 10.1016/j.autrev.2009.08.004; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Sachdev PS, 2005, PROG NEURO-PSYCHOPH, V29, P1152, DOI 10.1016/j.pnpbp.2005.06.026; Sachdev PS, 2002, NEUROLOGY, V58, P1539, DOI 10.1212/WNL.58.10.1539; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shiraki M, 2011, J BONE MINER METAB, V29, P62, DOI 10.1007/s00774-010-0191-2; SKOOG I, 1994, DEMENTIA, V5, P137, DOI 10.1159/000106711; Smith AD, 2008, FOOD NUTR BULL, V29, pS143, DOI 10.1177/15648265080292S119; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; The Criteria Committee of the New York Heart Association, NOM CRIT DIAGN DIS H; Vafai SB, 2002, FEBS LETT, V518, P1, DOI 10.1016/S0014-5793(02)02702-3; Vasan RS, 2003, JAMA-J AM MED ASSOC, V289, P1251, DOI 10.1001/jama.289.10.1251; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Wald DS, 2010, AM J MED, V123, P522, DOI 10.1016/j.amjmed.2010.01.017; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Williams JG, 2003, INT J GERIATR PSYCH, V18, P631, DOI 10.1002/gps.886; Xu D, 2000, FEBS LETT, V470, P20, DOI 10.1016/S0014-5793(00)01278-3; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33345	10.1371/journal.pone.0033345	http://dx.doi.org/10.1371/journal.pone.0033345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22413017	Green Published, gold			2022-12-25	WOS:000303060800093
J	Zhou, MG; Zhang, Q; Zhao, JP; Jin, ML				Zhou, Mingguang; Zhang, Qiang; Zhao, Jianping; Jin, Meilin			Haemophilus parasuis Encodes Two Functional Cytolethal Distending Toxins: CdtC Contains an Atypical Cholesterol Recognition/Interaction Region	PLOS ONE			English	Article							HUMAN T-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; G(2) ARREST; CHOLERA-TOXIN; CYCLE ARREST; IN-VIVO; GENES; EXPRESSION; PROTEIN; INTERNALIZATION	Haemophilus parasuis is the causative agent of Glasser's disease of pigs, a disease associated with fibrinous polyserositis, polyarthritis and meningitis. We report here H. parasuis encodes two copies of cytolethal distending toxins (Cdts), which these two Cdts showed the uniform toxin activity in vitro. We demonstrate that three Cdt peptides can form an active tripartite holotoxin that exhibits maximum cellular toxicity, and CdtA and CdtB form a more active toxin than CdtB and CdtC. Moreover, the cellular toxicity is associated with the binding of Cdt subunits to cells. Further analysis indicates that CdtC subunit contains an atypical cholesterol recognition/interaction amino acid consensus (CRAC) region. The mutation of CRAC site resulted in decreased cell toxicity. Finally, western blot analysis show all the 15 H. parasuis reference strains and 109 clinical isolates expressed CdtB subunit, indicating that Cdt is a conservative putative virulence factor for H. parasuis. This is the first report of the molecular and cellular basis of Cdt host interactions in H. parasuis.	[Zhou, Mingguang; Zhang, Qiang; Zhao, Jianping; Jin, Meilin] Huazhong Agr Univ, Coll Vet Med, Natl Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Zhou, MG (corresponding author), Huazhong Agr Univ, Coll Vet Med, Natl Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	jml8328@126.com			973 program [2006CB504404]; 863 program [2006AA10A206]; National Key Technology RD Program [2006BAD06A11]; State Key Laboratory of Agriculture Microbiology	973 program(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); National Key Technology RD Program(National Key Technology R&D Program); State Key Laboratory of Agriculture Microbiology	The work was supported by 973 program (2006CB504404), 863 program (2006AA10A206), National Key Technology R&D Program (2006BAD06A11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the State Key Laboratory of Agriculture Microbiology for their support of these studies. We would also thank Yanxiu Liu for her careful revision of the language of this manuscript.	Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Bouchet B, 2009, MICROB PATHOGENESIS, V46, P108, DOI 10.1016/j.micpath.2008.10.008; Cai XW, 2005, VET MICROBIOL, V111, P231, DOI 10.1016/j.vetmic.2005.07.007; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Cortes-Bratti X, 2000, INFECT IMMUN, V68, P6903, DOI 10.1128/IAI.68.12.6903-6911.2000; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Falnes PO, 2000, INT J MED MICROBIOL, V290, P471; Gelfanova V, 1999, INFECT IMMUN, V67, P6394; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; Hickey TE, 2000, INFECT IMMUN, V68, P6535, DOI 10.1128/IAI.68.12.6535-6541.2000; Hill CE, 2003, VET MICROBIOL, V96, P189, DOI 10.1016/S0378-1135(03)00212-8; Jin H, 2008, ENVIRON MICROBIOL, V10, P3326, DOI 10.1111/j.1462-2920.2008.01729.x; Lara-Tejero M, 2002, TRENDS MICROBIOL, V10, P147, DOI 10.1016/S0966-842X(02)02316-8; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; Li JX, 2009, PREV VET MED, V91, P274, DOI 10.1016/j.prevetmed.2009.06.004; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; Mayer MPA, 1999, INFECT IMMUN, V67, P1227, DOI 10.1128/IAI.67.3.1227-1237.1999; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; Melnikow E, 2005, VET MICROBIOL, V110, P255, DOI 10.1016/j.vetmic.2005.08.007; Metcalf DS, 2007, CAN J VET RES, V71, P181; Nishikubo S, 2003, J BIOL CHEM, V278, P50671, DOI 10.1074/jbc.M305062200; Okuda J, 1997, INFECT IMMUN, V65, P428, DOI 10.1128/IAI.65.2.428-433.1997; Oliveira S, 2004, CAN J VET RES, V68, P71; Oliveira S, 2003, AM J VET RES, V64, P435, DOI 10.2460/ajvr.2003.64.435; Olvera A, 2010, VET RES, V41, DOI 10.1051/vetres/2009074; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; RAPPGABRIELSON VJ, 1992, AM J VET RES, V53, P659; Ruiz A, 2001, J CLIN MICROBIOL, V39, P1757, DOI 10.1128/JCM.39.5.1757-1762.2001; Schraw W, 2002, J BIOL CHEM, V277, P34642, DOI 10.1074/jbc.M203466200; SCOTT DA, 1994, INFECT IMMUN, V62, P244, DOI 10.1128/IAI.62.1.244-251.1994; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Stevens MK, 1999, INFECT IMMUN, V67, P3900, DOI 10.1128/IAI.67.8.3900-3908.1999; Wolf AA, 1998, J CELL BIOL, V141, P917, DOI 10.1083/jcb.141.4.917; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007	39	23	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32580	10.1371/journal.pone.0032580	http://dx.doi.org/10.1371/journal.pone.0032580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412890	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800031
J	Knieke, K; Lingel, H; Chamaon, K; Brunner-Weinzierl, MC				Knieke, Karin; Lingel, Holger; Chamaon, Kathrin; Brunner-Weinzierl, Monika C.			Migration of Th1 Lymphocytes Is Regulated by CD152 (CTLA-4)-Mediated Signaling via PI3 Kinase-Dependent Akt Activation	PLOS ONE			English	Article							T-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-KINASE; IN-VIVO; CTLA-4 DETERMINES; UP-REGULATION; 2 GRK2; CHEMOKINE; CHEMOTAXIS; EXPRESSION	Efficient adaptive immune responses require the localization of T lymphocytes in secondary lymphoid organs and inflamed tissues. To achieve correct localization of T lymphocytes, the migration of these cells is initiated and directed by adhesion molecules and chemokines. It has recently been shown that the inhibitory surface molecule CD152 (CTLA-4) initiates Th cell migration, but the molecular mechanism underlying this effect remains to be elucidated. Using CD4 T lymphocytes derived from OVA-specific TCR transgenic CD152-deficient and CD152-competent mice, we demonstrate that chemokine-triggered signal transduction is differentially regulated by CD152 via phosphoinositide 3-kinase (PI3K)-dependent activation of protein kinase B (PKB/Akt). In the presence of CD152 signaling, the chemoattractant CCL4 selectively induces the full activation of Akt via phosphorylation at threonine 308 and serine 473 in pro-inflammatory Th lymphocytes expressing the cognate chemokine receptor CCR5. Akt signals lead to cytoskeleton rearrangements, which are indispensable for migration. Therefore, this novel Akt-modulating function of CD152 signals affecting T cell migration demonstrates that boosting CD152 or its down-stream signal transduction could aid therapies aimed at sensitizing T lymphocytes for optimal migration, thus contributing to a precise and effective immune response.	[Knieke, Karin; Lingel, Holger; Chamaon, Kathrin; Brunner-Weinzierl, Monika C.] Otto von Guericke Univ, Univ Hosp Magdeburg, Dept Expt Pediat, Magdeburg, Germany	Otto von Guericke University; University Hospital Magdeburg	Knieke, K (corresponding author), Otto von Guericke Univ, Univ Hosp Magdeburg, Dept Expt Pediat, Magdeburg, Germany.	Monika.Brunner-Weinzierl@med.ovgu.de	Brunner-Weinzierl, Monika/AAB-8813-2019	Brunner-Weinzierl, Monika/0000-0002-6838-3568	Deutsche Forschungsgemeinschaft [Br1860/6, SFB 854]; medical department of the Otto-von-Guericke University of Magdeburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); medical department of the Otto-von-Guericke University of Magdeburg	The study was supported by the Dr.-Robert Pfleger Stiftung, Deutsche Forschungsgemeinschaft Br1860/6, and SFB 854. KK was supported by a grant of the medical department of the Otto-von-Guericke University of Magdeburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Brunner MC, 1999, J IMMUNOL, V162, P5813; Cronshaw DG, 2004, J IMMUNOL, V172, P7761, DOI 10.4049/jimmunol.172.12.7761; Debes GF, 2002, J IMMUNOL, V168, P5441, DOI 10.4049/jimmunol.168.11.5441; DEBLASI A, 1995, J CLIN INVEST, V95, P203, DOI 10.1172/JCI117641; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; HOFF H, 2006, SIGNAL TRANSDUCT, V6, P260; Hoff H, 2009, J IMMUNOL, V182, P5342, DOI 10.4049/jimmunol.0801624; Honczarenko M, 1999, BLOOD, V94, P2990, DOI 10.1182/blood.V94.9.2990.421k36_2990_2998; JONES SA, 1995, FEBS LETT, V364, P211, DOI 10.1016/0014-5793(95)00397-R; Knieke K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005702; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Mirenda V, 2007, BLOOD, V109, P2968, DOI 10.1182/blood-2006-10-050724; Morley SC, 2010, J IMMUNOL, V184, P3628, DOI 10.4049/jimmunol.0903851; Olsson C, 1999, J BIOL CHEM, V274, P14400, DOI 10.1074/jbc.274.20.14400; Pandiyan P, 2004, J EXP MED, V199, P831, DOI 10.1084/jem.20031058; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Penela P, 2009, CELL ADHES MIGR, V3, P19, DOI 10.4161/cam.3.1.7149; Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rudolph M, 2011, J IMMUNOL, V186, P5580, DOI 10.4049/jimmunol.1003381; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Shahabi NA, 2008, J LEUKOCYTE BIOL, V83, P663, DOI 10.1189/jlb.0607420; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Smit MJ, 2003, BLOOD, V102, P1959, DOI 10.1182/blood-2002-12-3945; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P901, DOI 10.1189/jlb.0403136; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Ward SG, 2009, BIOCHEM J, V418, P13, DOI 10.1042/BJ20081969; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Weninger W, 2003, SEMIN IMMUNOL, V15, P257, DOI 10.1016/j.smim.2003.08.007; Zell T, 1996, J IMMUNOL, V156, P883; Zola H., 2004, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0603s30, DOI 10.1002/0471142956.CY0603S30]	50	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e31391	10.1371/journal.pone.0031391	http://dx.doi.org/10.1371/journal.pone.0031391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412835	Green Submitted, Green Published, gold			2022-12-25	WOS:000303021100006
J	Wang, SL; Zhang, H; Wiltshire, T; Sealock, R; Faber, JE				Wang, Shiliang; Zhang, Hua; Wiltshire, Tim; Sealock, Robert; Faber, James E.			Genetic Dissection of the Canq1 Locus Governing Variation in Extent of the Collateral Circulation	PLOS ONE			English	Article							NONCODING RNAS; IDENTIFICATION; COMPLEX; TRANSCRIPTION; MAINTENANCE; DETERMINANT; RAREFACTION; ACTIVATION; EXPRESSION; SEVERITY	Background.: Native (pre-existing) collaterals are arteriole-to-arteriole anastomoses that interconnect adjacent arterial trees and serve as endogenous bypass vessels that limit tissue injury in ischemic stroke, myocardial infarction, coronary and peripheral artery disease. Their extent (number and diameter) varies widely among mouse strains and healthy humans. We previously identified a major quantitative trait locus on chromosome 7 (Canq1, LOD = 29) responsible for 37% of the heritable variation in collateral extent between C57BL/6 and BALB/c mice. We sought to identify candidate genes in Canq1 responsible for collateral variation in the cerebral pial circulation, a tissue whose strain-dependent variation is shared by similar variation in other tissues. Methods and Findings: Collateral extent was intermediate in a recombinant inbred line that splits Canq1 between the C57BL/6 and BALB/c strains. Phenotyping and SNP-mapping of an expanded panel of twenty-one informative inbred strains narrowed the Canq1 locus, and genome-wide linkage analysis of a SWRxSJL-F2 cross confirmed its haplotype structure. Collateral extent, infarct volume after cerebral artery occlusion, bleeding time, and re-bleeding time did not differ in knockout mice for two vascular-related genes located in Canq1, IL4ra and Itgal. Transcript abundance of 6 out of 116 genes within the 95% confidence interval of Canq1 were differentially expressed >2-fold (p-value < 0.05 divided by 150) in the cortical pia mater from C57BL/6 and BALB/c embryos at E14.5, E16.5 and E18.5 time-points that span the period of collateral formation. Conclusions: These findings refine the Canq1 locus and identify several genes as high-priority candidates important in specifying native collateral formation and its wide variation.	[Wang, Shiliang; Zhang, Hua; Sealock, Robert; Faber, James E.] Univ N Carolina, Dept Physiol, Chapel Hill, NC 27515 USA; [Wiltshire, Tim] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Wang, Shiliang; Zhang, Hua; Sealock, Robert; Faber, James E.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wang, SL (corresponding author), Univ N Carolina, Dept Physiol, Chapel Hill, NC 27515 USA.	jefaber@med.unc.edu			National Institutes of Health, Heart Lung and Blood Institute [HL062584, HL090655]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111070, R01HL062584, R01HL090655] Funding Source: NIH RePORTER	National Institutes of Health, Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding support for this work was received from the National Institutes of Health, Heart Lung and Blood Institute, grants HL062584 and HL090655 (to JEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam TV, 2004, AM J PHYSIOL-HEART C, V287, pH2555, DOI 10.1152/ajpheart.00588.2004; Ayotunde OD, 2008, CIRCULATION, V117, P1207; Brozici M, 2003, STROKE, V34, P2750, DOI 10.1161/01.STR.0000095791.85737.65; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Chalothorn D, 2010, PHYSIOL GENOMICS, V42, P469, DOI 10.1152/physiolgenomics.00070.2010; Chalothorn D, 2010, J MOL CELL CARDIOL, V49, P251, DOI 10.1016/j.yjmcc.2010.03.014; Chalothorn D, 2009, CIRC RES, V105, P89, DOI 10.1161/CIRCRESAHA.109.197145; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Chuai M, 2009, CURR OPIN GENET DEV, V19, P343, DOI 10.1016/j.gde.2009.06.007; Clayton JA, 2008, CIRC RES, V103, P1027, DOI 10.1161/CIRCRESAHA.108.181115; Dai XM, 2010, CIRC RES, V106, P1870, DOI 10.1161/CIRCRESAHA.109.212746; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; de Marchi SF, 2011, CARDIOLOGY, V118, P198, DOI 10.1159/000328648; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Faber JE, 2011, ARTERIOSCL THROM VAS, V31, P1748, DOI 10.1161/ATVBAHA.111.227314; Faber JE, 2011, ARTERIOGENESIS MOL R, P1; Faffe DS, 2006, AM J RESP CELL MOL, V34, P213, DOI 10.1165/rcmb.2005-0147OC; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Fujioka Y, 2002, J BIOL CHEM, V277, P21585, DOI 10.1074/jbc.M201523200; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ghogomu SM, 2006, J BIOL CHEM, V281, P1755, DOI 10.1074/jbc.M505869200; Hoover-Plow Jane, 2006, BMC Blood Disord, V6, P6, DOI 10.1186/1471-2326-6-6; Hsia DA, 2010, P NATL ACAD SCI USA, V107, P9671, DOI 10.1073/pnas.1000401107; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Keum S, 2009, CIRC-CARDIOVASC GENE, V2, DOI 10.1161/CIRCGENETICS.109.883231; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lucitti JL, 2012, CIRC RES IN PRESS; Lynch M, 1999, GENETICS, V152, P1753; Mace EM, 2009, J IMMUNOL, V182, P948, DOI 10.4049/jimmunol.182.2.948; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Manichaikul A, 2009, GENETICS, V181, P1077, DOI 10.1534/genetics.108.094565; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; Menon BK, 2011, AM J NEURORADIOL, V32, P1640, DOI 10.3174/ajnr.A2564; Mohr J.P, 2004, STROKE PATHOPHYSIOLO; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Noel JF, 2011, DNA REPAIR, V10, P271, DOI 10.1016/j.dnarep.2010.11.010; Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Toyo-oka K, 2008, J CELL BIOL, V180, P1133, DOI 10.1083/jcb.200705148; Wang SL, 2010, CIRC RES, V107, P558, DOI 10.1161/CIRCRESAHA.110.224634; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; Wentzel P, 2009, BRAIN RES, V1305, pS50, DOI 10.1016/j.brainres.2009.08.057; Yamaji-Kegan K, 2009, J IMMUNOL, V182, P5469, DOI 10.4049/jimmunol.0713347; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10	62	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e31910	10.1371/journal.pone.0031910	http://dx.doi.org/10.1371/journal.pone.0031910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412848	Green Submitted, Green Published, gold			2022-12-25	WOS:000303021100009
J	Kozarewa, I; Rosa-Rosa, JM; Wardell, CP; Walker, BA; Fenwick, K; Assiotis, I; Mitsopoulos, C; Zvelebil, M; Morgan, GJ; Ashworth, A; Lord, CJ				Kozarewa, Iwanka; Rosa-Rosa, Juan Manuel; Wardell, Christopher P.; Walker, Brian A.; Fenwick, Kerry; Assiotis, Ioannis; Mitsopoulos, Costas; Zvelebil, Marketa; Morgan, Gareth J.; Ashworth, Alan; Lord, Christopher J.			A Modified Method for Whole Exome Resequencing from Minimal Amounts of Starting DNA	PLOS ONE			English	Article							SEQUENCING DATA; CANCER GENOME; FRAMEWORK	Next generation DNA sequencing (NGS) technologies have revolutionized the pace at which whole genome and exome sequences can be generated. However, despite these advances, many of the methods for targeted resequencing, such as the generation of high-depth exome sequences, are somewhat limited by the relatively large amounts of starting DNA that are normally required. In the case of tumour analysis this is particularly pertinent as many tumour biopsies often return submicrogram quantities of DNA, especially when tumours are microdissected prior to analysis. Here, we present a method for exome capture and resequencing using as little as 50 ng of starting DNA. The sequencing libraries generated by this minimal starting amount (MSA-Cap) method generate datasets that are comparable to standard amount (SA) whole exome libraries that use three micrograms of starting DNA. This method, which can be performed in most laboratories using commonly available reagents, has the potential to enhance large scale profiling efforts such as the resequencing of tumour exomes.	[Kozarewa, Iwanka; Rosa-Rosa, Juan Manuel; Fenwick, Kerry; Assiotis, Ioannis; Mitsopoulos, Costas; Zvelebil, Marketa; Ashworth, Alan; Lord, Christopher J.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Wardell, Christopher P.; Walker, Brian A.; Morgan, Gareth J.] Inst Canc Res, Haematooncol Res Unit, Sutton, Surrey, England; [Ashworth, Alan] Inst Canc Res, Gene Funct Grp, Canc Res UK, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Kozarewa, I (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	Chris.Lord@icr.ac.uk	Lord, Christopher/AAX-7130-2021; Wardell, Christopher/B-5053-2018; Lord, Christopher J/B-3295-2012	Wardell, Christopher/0000-0002-9416-7818; Lord, Christopher J/0000-0002-3226-0515; morgan, gareth/0000-0002-4271-6360; Zvelebil, Marketa/0000-0001-8018-5591; Mitsopoulos, Costas/0000-0002-9116-5921; Walker, Brian/0000-0002-8615-6254	Institute of Cancer Research, Breakthrough Breast Cancer; Cancer Research UK [BBC054X]	Institute of Cancer Research, Breakthrough Breast Cancer; Cancer Research UK(Cancer Research UK)	This work was supported by The Institute of Cancer Research, Breakthrough Breast Cancer and Cancer Research UK, under the grant BBC054X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; [Anonymous], 2003, NATURE, V426, P789; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Barber LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021639; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Kozarewa I, 2011, METHODS MOL BIOL, V733, P257, DOI 10.1007/978-1-61779-089-8_18; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rosa M, 2010, DIAGN CYTOPATHOL; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596	15	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32617	10.1371/journal.pone.0032617	http://dx.doi.org/10.1371/journal.pone.0032617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403682	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700079
J	Nakagawa, T; Pellegrino, M; Sato, K; Vosshall, LB; Touhara, K				Nakagawa, Tatsuro; Pellegrino, Maurizio; Sato, Koji; Vosshall, Leslie B.; Touhara, Kazushige			Amino Acid Residues Contributing to Function of the Heteromeric Insect Olfactory Receptor Complex	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; PHEROMONE RECEPTOR; GENE; EXPRESSION; PROTEINS; IDENTIFICATION; ACCESSIBILITY; EVOLUTION; TOPOLOGY; NEURONS	Olfactory receptors (Ors) convert chemical signals-the binding of odors and pheromones-to electrical signals through the depolarization of olfactory sensory neurons. Vertebrates Ors are G-protein-coupled receptors, stimulated by odors to produce intracellular second messengers that gate ion channels. Insect Ors are a heteromultimeric complex of unknown stoichiometry of two seven transmembrane domain proteins with no sequence similarity to and the opposite membrane topology of G-protein-coupled receptors. The functional insect Or comprises an odor-or pheromone-specific Or subunit and the Orco co-receptor, which is highly conserved in all insect species. The insect Or-Orco complex has been proposed to function as a novel type of ligand-gated nonselective cation channel possibly modulated by G-proteins. However, the Or-Orco proteins lack homology to any known family of ion channel and lack known functional domains. Therefore, the mechanisms by which odors activate the Or-Orco complex and how ions permeate this complex remain unknown. To begin to address the relationship between Or-Orco structure and function, we performed site-directed mutagenesis of all 83 conserved Glu, Asp, or Tyr residues in the silkmoth BmOr-1-Orco pheromone receptor complex and measured functional properties of mutant channels expressed in Xenopus oocytes. 13 of 83 mutations in BmOr-1 and BmOrco altered the reversal potential and rectification index of the BmOr-1-Orco complex. Three of the 13 amino acids (D299 and E356 in BmOr-1 and Y464 in BmOrco) altered both current-voltage relationships and K+ selectivity. We introduced the homologous Orco Y464 residue into Drosophila Orco in vivo, and observed variable effects on spontaneous and evoked action potentials in olfactory neurons that depended on the particular Or-Orco complex examined. Our results provide evidence that a subset of conserved Glu, Asp and Tyr residues in both subunits are essential for channel activity of the heteromeric insect Or-Orco complex.	[Nakagawa, Tatsuro; Sato, Koji; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Pellegrino, Maurizio; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA; [Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	University of Tokyo; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Nakagawa, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.	ktouhara@mail.ecc.u-tokyo.ac.jp		Vosshall, Leslie/0000-0002-6060-8099; xing zhi, zuo teng/0000-0001-6198-6406	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); National Institutes of Health (NIH) [RO1 DC008600]; NIH US-Japan BRCP; JSPS Japan; JSPS	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH US-Japan BRCP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to KT (Grants-in-Aid for Scientific Research on Priority Areas) and KS (Grants-in-Aid for Scientific Research Young Scientist A), a grant to LBV from the National Institutes of Health (NIH) (RO1 DC008600), and NIH US-Japan BRCP and JSPS Japan-U.S. Cooperative Science Program funding to KT and LBV. TN was supported by a Grant-in-Aid for JSPS Fellows. LBV is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Becchetti A, 1999, J GEN PHYSIOL, V114, P377, DOI 10.1085/jgp.114.3.377; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Miura N, 2009, INT J BIOL SCI, V5, P319; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Patch HM, 2009, CHEM SENSES, V34, P305, DOI 10.1093/chemse/bjp002; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; ROST B, 1995, PROTEIN SCI, V4, P521; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010	48	95	102	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32372	10.1371/journal.pone.0032372	http://dx.doi.org/10.1371/journal.pone.0032372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403649	Green Published, gold			2022-12-25	WOS:000303017700046
J	O'Sullivan, DM; Nicoara, SC; Mutetwa, R; Mungofa, S; Lee, OYC; Minnikin, DE; Bardwell, MW; Corbett, EL; McNerney, R; Morgan, GH				O'Sullivan, Denise M.; Nicoara, Simona C.; Mutetwa, Reggie; Mungofa, Stanley; Lee, Oona Y-C.; Minnikin, David E.; Bardwell, Max W.; Corbett, Elizabeth L.; McNerney, Ruth; Morgan, Geraint H.			Detection of Mycobacterium tuberculosis in Sputum by Gas Chromatography-Mass Spectrometry of Methyl Mycocerosates Released by Thermochemolysis	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; DIAGNOSTIC-ACCURACY; TUBERCLE-BACILLI; IDENTIFICATION; ACIDS	Tuberculosis requires rapid diagnosis to prevent further transmission and allow prompt administration of treatment. Current methods for diagnosing pulmonary tuberculosis lack sensitivity are expensive or are extremely slow. The identification of lipids using gas chromatography-electron impact mass spectrometry (GC-EI/MS) could provide an alternative solution. We have studied mycocerosic acid components of the phthiocerol dimycocerosate (PDIM) family of lipids using thermochemolysis GC-EI/MS. To facilitate use of the technology in a routine diagnostic laboratory a simple extraction procedure was employed where PDIMs were extracted from sputum using petroleum ether, a solvent of low polarity. We also investigated a method using methanolic tetramethylammonium hydroxide, which facilitates direct transesterification of acidic components to methyl esters in the inlet of the GC-MS system. This eliminates conventional chemical manipulations allowing rapid and convenient analysis of samples. When applied to an initial set of 40 sputum samples, interpretable results were obtained for 35 samples with a sensitivity relative to culture of 94% (95% CI: 69.2,100) and a specificity of 100% (95% CI: 78.1,100). However, blinded testing of a larger set of 395 sputum samples found the assay to have a sensitivity of 61.3% (95% CI: 54.9,67.3) and a specificity of 70.6% (95% CI: 62.3,77.8) when compared to culture. Using the results obtained we developed an improved set of classification criteria, which when applied in a blinded re-analysis increased the sensitivity and specificity of the assay to 64.9% (95% CI: 58.6,70.8) and 76.2% (95% CI: 68.2,82.8) respectively. Highly variable levels of background signal were observed from individual sputum samples that inhibited interpretation of the data. The diagnostic potential of using thermochemolytic GC-EI/MS of PDIM biomarkers for diagnosis of tuberculosis in sputum has been established; however, further refinements in sample processing are required to enhance the sensitivity and robustness of the test.	[O'Sullivan, Denise M.; Corbett, Elizabeth L.; McNerney, Ruth] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Nicoara, Simona C.; Bardwell, Max W.; Morgan, Geraint H.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Mutetwa, Reggie; Mungofa, Stanley; Corbett, Elizabeth L.] Biomed Res & Training Inst, Harare, Zimbabwe; [Lee, Oona Y-C.; Minnikin, David E.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of London; London School of Hygiene & Tropical Medicine; Open University - UK; Biomedical Research Training Institute; University of Birmingham	O'Sullivan, DM (corresponding author), LGC, Teddington, Middx, England.	Ruth.Mcnerney@lshtm.ac.uk		Corbett, Elizabeth/0000-0002-3552-3181; MCNERNEY, Ruth/0000-0002-1957-443X	Wellcome Trust [083597]; Leverhulme Trust [F/00 094/BL]; Department for International Development, UK	Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Department for International Development, UK	This work was supported by the Wellcome Trust project grant 083597 and The Leverhulme Trust through an Emeritus Fellowship to D. E. M. and Project Grant F/00 094/BL (D. E. M., O.Y-C.L.). RM received salary support from the Department for International Development, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alugupalli S, 1998, J MICROBIOL METH, V31, P143, DOI 10.1016/S0167-7012(97)00100-0; Balabanova Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007129; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; DAFFE M, 1988, J GEN MICROBIOL, V134, P2049; Dobson G., 1985, CHEM METHODS BACTERI, P237; DWORZANSKI JP, 1990, APPL ENVIRON MICROB, V56, P1717, DOI 10.1128/AEM.56.6.1717-1724.1990; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; HOBBY GL, 1973, ANTIMICROB AGENTS CH, V4, P94, DOI 10.1128/AAC.4.2.94; Kaal E, 2009, J CHROMATOGR A, V1216, P6319, DOI 10.1016/j.chroma.2009.06.078; MALLET AI, 1984, BIOMED MASS SPECTROM, V11, P79, DOI 10.1002/bms.1200110207; McNerney R, 2011, NAT REV MICROBIOL, V9, P204, DOI 10.1038/nrmicro2521; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; MINNIKIN DE, 1985, J GEN MICROBIOL, V131, P1375; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; MINNIKIN DE, 1993, ANN SOC BELG MED TR, V73, P13; MINNIKIN DE, 1993, ANN SOC BELG MED TR, V73, P25; Mutetwa R, 2009, INT J TUBERC LUNG D, V13, P1253; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Redman JE, 2009, TUBERCULOSIS, V89, P267, DOI 10.1016/j.tube.2009.04.001; World Health Organization, 2010, GLOB TUB CONTR WHO R; World Health Organization, 2011, RAP IMPL XPERT MTB R; YEAGER H, 1967, AM REV RESPIR DIS, V95, P998	22	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32836	10.1371/journal.pone.0032836	http://dx.doi.org/10.1371/journal.pone.0032836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403716	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700113
J	Yang, WW; Miao, AJ; Yang, LY				Yang, Wei-Wan; Miao, Ai-Jun; Yang, Liu-Yan			Cd2+ Toxicity to a Green Alga Chlamydomonas reinhardtii as Influenced by Its Adsorption on TiO2 Engineered Nanoparticles	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; BIOAVAILABILITY; CADMIUM; CU; BIOACCUMULATION; CARBON; SIZE; PHYTOPLANKTON; ECOTOXICITY; ENVIRONMENT	In the present study, Cd2+ adsorption on polyacrylate-coated TiO2 engineered nanoparticles (TiO2-ENs) and its effect on the bioavailability as well as toxicity of Cd2+ to a green alga Chlamydomonas reinhardtii were investigated. TiO2-ENs could be well dispersed in the experimental medium and their pH(pzc) is approximately 2. There was a quick adsorption of Cd2+ on TiO2-ENs and a steady state was reached within 30 min. A pseudo-first order kinetics was found for the time-related changes in the amount of Cd2+ complexed with TiO2-ENs. At equilibrium, Cd2+ adsorption followed the Langmuir isotherm with the maximum binding capacity 31.9, 177.1, and 242.2 mg/g when the TiO2-EN concentration was 1, 10, and 100 mg/l, respectively. On the other hand, Cd2+ toxicity was alleviated in the presence of TiO2-ENs. Algal growth was less suppressed in treatments with comparable total Cd2+ concentration but more TiO2-ENs. However, such toxicity difference disappeared and all the data points could be fitted to a single Logistic dose-response curve when cell growth inhibition was plotted against the free Cd2+ concentration. No detectable amount of TiO2-ENs was found to be associated with the algal cells. Therefore, TiO2-ENs could reduce the free Cd2+ concentration in the toxicity media, which further lowered its bioavailability and toxicity to C. reinhardtii.	[Yang, Wei-Wan; Miao, Ai-Jun; Yang, Liu-Yan] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Yang, WW (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China.	miaoaj@nju.edu.cn	yang, liu/GVU-8760-2022; liu, yang/HHY-8583-2022		National Natural Science Foundation of China [41001338]; Natural Science Foundation of Jiangsu Province [BK2010371]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The financial support offered by the National Natural Science Foundation of China (41001338) and the Natural Science Foundation of Jiangsu Province (BK2010371) to AJM have made this work possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, METAL SPECIATION BIO; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Azizian S, 2004, J COLLOID INTERF SCI, V276, P47, DOI 10.1016/j.jcis.2004.03.048; Baun A, 2008, AQUAT TOXICOL, V86, P379, DOI 10.1016/j.aquatox.2007.11.019; Chen M, 2001, LIMNOL OCEANOGR, V46, P1956, DOI 10.4319/lo.2001.46.8.1956; de Jonge LW, 2004, VADOSE ZONE J, V3, P321, DOI 10.2113/3.2.321; Debnath S, 2011, DESALINATION, V273, P330, DOI 10.1016/j.desal.2011.01.043; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Engates KE, 2011, ENVIRON SCI POLLUT R, V18, P386, DOI 10.1007/s11356-010-0382-3; Fan WH, 2011, ENVIRON POLLUT, V159, P729, DOI 10.1016/j.envpol.2010.11.030; Future Markets Inc, 2011, WORLD MARK NAN TIT D; Gao Y, 2004, LANGMUIR, V20, P9585, DOI 10.1021/la049334i; Guillard R.R., 1975, CULTURE MARINE INVER, P29, DOI 10.1007/978-1-4615-8714-9_3.; Hao YM, 2010, J HAZARD MATER, V184, P392, DOI 10.1016/j.jhazmat.2010.08.048; Hartmann NB, 2010, TOXICOLOGY, V269, P190, DOI 10.1016/j.tox.2009.08.008; Honeyman BD, 1999, NATURE, V397, P23, DOI 10.1038/16150; Huang C.P., 2005, R831721 EPA; Kim KT, 2010, ENVIRON TOXICOL CHEM, V29, P122, DOI 10.1002/etc.8; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Lavoie M, 2009, AQUAT TOXICOL, V92, P65, DOI 10.1016/j.aquatox.2008.12.007; Liufu SC, 2005, J COLLOID INTERF SCI, V281, P155, DOI 10.1016/j.jcis.2004.08.075; Menard A, 2011, ENVIRON POLLUT, V159, P677, DOI 10.1016/j.envpol.2010.11.027; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Miao AJ, 2005, ENVIRON TOXICOL CHEM, V24, P2603, DOI 10.1897/05-009R.1; Miyajima T, 1996, J COLLOID INTERF SCI, V184, P279, DOI 10.1006/jcis.1996.0621; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Pan JF, 2004, ENVIRON POLLUT, V129, P467, DOI 10.1016/j.envpol.2003.11.015; Park JW, 2010, CHEMOSPHERE, V81, P1227, DOI 10.1016/j.chemosphere.2010.09.036; Sadiq IM, 2011, ECOTOX ENVIRON SAFE, V74, P1180, DOI 10.1016/j.ecoenv.2011.03.006; Schwab F, 2011, ENVIRON SCI TECHNOL, V45, P6136, DOI 10.1021/es200506b; Sun HW, 2007, WATER AIR SOIL POLL, V178, P245, DOI 10.1007/s11270-006-9194-y; Sun HW, 2009, ENVIRON POLLUT, V157, P1165, DOI 10.1016/j.envpol.2008.08.022; Wang DM, 2011, SCI TOTAL ENVIRON, V409, P1351, DOI 10.1016/j.scitotenv.2010.12.024; Wang NX, 2012, WATER RES, V46, P369, DOI 10.1016/j.watres.2011.10.035; Wang WX, 2006, ENVIRON POLLUT, V142, P303, DOI 10.1016/j.envpol.2005.10.005; Zhang XZ, 2007, CHEMOSPHERE, V67, P160, DOI 10.1016/j.chemosphere.2006.09.003; Zhu XS, 2011, ENVIRON SCI TECHNOL, V45, P3753, DOI 10.1021/es103779h	39	56	68	5	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32300	10.1371/journal.pone.0032300	http://dx.doi.org/10.1371/journal.pone.0032300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403644	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700041
J	Yamamura, S; Yatsushiro, S; Yamaguchi, Y; Abe, K; Shinohara, Y; Tamiya, E; Baba, Y; Kataoka, M				Yamamura, Shohei; Yatsushiro, Shouki; Yamaguchi, Yuka; Abe, Kaori; Shinohara, Yasuo; Tamiya, Eiichi; Baba, Yoshinobu; Kataoka, Masatoshi			Accurate Detection of Carcinoma Cells by Use of a Cell Microarray Chip	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; ANTIBODIES	Background: Accurate detection and analysis of circulating tumor cells plays an important role in the diagnosis and treatment of metastatic cancer treatment. Methods and Findings: A cell microarray chip was used to detect spiked carcinoma cells among leukocytes. The chip, with 20,944 microchambers (105 mm width and 50 mm depth), was made from polystyrene; and the formation of monolayers of leukocytes in the microchambers was observed. Cultured human T lymphoblastoid leukemia (CCRF-CEM) cells were used to examine the potential of the cell microarray chip for the detection of spiked carcinoma cells. A T lymphoblastoid leukemia suspension was dispersed on the chip surface, followed by 15 min standing to allow the leukocytes to settle down into the microchambers. Approximately 29 leukocytes were found in each microchamber when about 600,000 leukocytes in total were dispersed onto a cell microarray chip. Similarly, when leukocytes isolated from human whole blood were used, approximately 89 leukocytes entered each microchamber when about 1,800,000 leukocytes in total were placed onto the cell microarray chip. After washing the chip surface, PE-labeled anti-cytokeratin monoclonal antibody and APC-labeled anti-CD326 (EpCAM) monoclonal antibody solution were dispersed onto the chip surface and allowed to react for 15 min; and then a microarray scanner was employed to detect any fluorescence-positive cells within 20 min. In the experiments using spiked carcinoma cells (NCI-H1650, 0.01 to 0.0001%), accurate detection of carcinoma cells was achieved with PE-labeled anti-cytokeratin monoclonal antibody. Furthermore, verification of carcinoma cells in the microchambers was performed by double staining with the above monoclonal antibodies. Conclusion: The potential application of the cell microarray chip for the detection of CTCs was shown, thus demonstrating accurate detection by double staining for cytokeratin and EpCAM at the single carcinoma cell level.	[Yamamura, Shohei; Yatsushiro, Shouki; Yamaguchi, Yuka; Abe, Kaori; Baba, Yoshinobu; Kataoka, Masatoshi] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa, Japan; [Shinohara, Yasuo] Univ Tokushima, Div Prot Express, Inst Genome Res, Tokushima 770, Japan; [Tamiya, Eiichi] Osaka Univ, Dept Appl Phys, Grad Sch Engn, Suita, Osaka 565, Japan; [Baba, Yoshinobu] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 46401, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokushima University; Osaka University; Nagoya University	Yamamura, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa, Japan.	m-kataoka@aist.go.jp	YATSUSHIRO, shouki/M-8155-2018; Tamiya, Eiichi/M-6111-2018; Kataoka, Masatoshi/M-6925-2018; yamamura, shohei/M-8071-2018	YATSUSHIRO, shouki/0000-0002-6123-1561; Tamiya, Eiichi/0000-0002-7646-4827; Kataoka, Masatoshi/0000-0001-9779-8319; yamamura, shohei/0000-0002-4971-4560	Japan Society for the Promotion of Science (JSPS) [23310093, 22710124, 23590165]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", and by grants-in-aid (23310093, 22710124, and 23590165) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunni-Fabbroni M, 2010, METHODS, V50, P289, DOI 10.1016/j.ymeth.2010.01.027; den Toonder J, 2011, LAB CHIP, V11, P375, DOI 10.1039/c0lc90100h; Deng G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2131; Di Carlo D, 2006, ANAL CHEM, V78, P7918; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Masuda K, 2011, CLIN CANCER RES, V17, P1; Mocellin S, 2006, TRENDS MOL MED, V12, P130, DOI 10.1016/j.molmed.2006.01.006; Mostert B, 2011, BREAST CANCER RES TR, V127, P33, DOI 10.1007/s10549-010-0879-y; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Park Y, 2011, WORLD J CLIN ONCOL, V2, P303, DOI 10.5306/wjco.v2.i8.303; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Sieuwerts AM, 2009, J NATL CANCER I, V101, P61, DOI 10.1093/jnci/djn419; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Yamamura S, 2005, ANAL CHEM, V77, P8050, DOI 10.1021/ac0515632; Yatsushiro S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013179	17	18	18	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32370	10.1371/journal.pone.0032370	http://dx.doi.org/10.1371/journal.pone.0032370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396762	Green Published, gold, Green Submitted			2022-12-25	WOS:000303005000024
J	Zirbes, L; Brostaux, Y; Mescher, M; Jason, M; Haubruge, E; Deneubourg, JL				Zirbes, Lara; Brostaux, Yves; Mescher, Mark; Jason, Maxime; Haubruge, Eric; Deneubourg, Jean-Louis			Self-Assemblage and Quorum in the Earthworm Eisenia fetida (Oligochaete, Lumbricidae)	PLOS ONE			English	Article							DECISION-MAKING; BEHAVIOR; AGGREGATION; INSECT; SOIL; COCKROACHES; MECHANISMS; DYNAMICS; PATTERNS	Despite their ubiquity and ecological significance in temperate ecosystems, the behavioural ecology of earthworms is not well described. This study examines the mechanisms that govern aggregation behaviour specially the tendency of individuals to leave or join groups in the compost earthworm Eisenia fetida, a species with considerable economic importance, especially in waste management applications. Through behavioural assays combined with mathematical modelling, we provide the first evidence of self-assembled social structures in earthworms and describe key mechanisms involved in cluster formation. We found that the probability of an individual joining a group increased with group size, while the probability of leaving decreased. Moreover, attraction to groups located at a distance was observed, suggesting a role for volatile cues in cluster formation. The size of earthworm clusters appears to be a key factor determining the stability of the group. These findings enhance our understanding of intra-specific interactions in earthworms and have potential implications for extraction and collection of earthworms in vermicomposting processes.	[Zirbes, Lara; Brostaux, Yves; Jason, Maxime; Haubruge, Eric] Univ Liege, Gembloux, Belgium; [Mescher, Mark] Penn State Univ, Ctr Chem Ecol, Dept Entomol, State Coll, PA USA; [Deneubourg, Jean-Louis] Free Univ Brussels, Unit Social Ecol, Brussels, Belgium	University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Zirbes, L (corresponding author), Univ Liege, Gembloux, Belgium.	Lara.Zirbes@ulg.ac.be		Brostaux, Yves/0000-0001-6172-7869; Haubruge, Eric/0000-0002-8138-0476	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (FRIA), Belgium	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (FRIA), Belgium(Fonds de la Recherche Scientifique - FNRS)	Lara Zirbes was financially supported by a PhD grant from the Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (FRIA), Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W., 1949, PRINCIPLES ANIMAL EC; Allee W. C., 1931, ANIMAL AGGREGATION S; Almohamad R, 2009, BIOTECHNOL AGRON SOC, V13, P467; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; Anderson C, 2002, INSECT SOC, V49, P99, DOI 10.1007/s00040-002-8286-y; Ben-Jacob E, 2008, EUR PHYS J B, V65, P315, DOI 10.1140/epjb/e2008-00222-x; Bertram B.C.R., 1978, P64; BOAG B, 1994, PEDOBIOLOGIA, V38, P303; Bouche MB, 1977, ECOL B STOCKHOLM, V25, P122, DOI DOI 10.2307/20112572; Bruhn H, 2006, DEV COMP IMMUNOL, V30, P597, DOI 10.1016/j.dci.2005.09.002; Butt Kevin R., 2005, Biologist (London), V52, P218; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Costa J., 2006, OTHER INSECT SOC; Cully SM, 2004, INSECT SOC, V51, P317, DOI 10.1007/s00040-004-0743-3; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dambach M, 1999, J INSECT PHYSIOL, V45, P423, DOI 10.1016/S0022-1910(98)00141-3; Darwin C., 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Depickere S, 2004, J INSECT BEHAV, V17, P81, DOI 10.1023/B:JOIR.0000025134.06111.be; Doeksen J, 1967, MEDED I BIOL SCHEIK, V353, P199; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO, V3rd; Fiore C, 2004, BEHAV PROCESS, V67, P327, DOI 10.1016/j.beproc.2004.06.001; Fraenkel GS, 1961, ORIENTATION ANIMALS; Fragoso C., 1999, EARTHWORM MANAGEMENT; Glass EV, 1998, EXP APPL ACAROL, V22, P31, DOI 10.1023/A:1006081323887; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Huang KM, 2008, J NEUROSCI METH, V171, P153, DOI 10.1016/j.jneumeth.2008.01.027; Jeanson R, 2004, BEHAV ECOL SOCIOBIOL, V55, P388, DOI 10.1007/s00265-003-0716-y; Jimenez JJ, 2001, APPL SOIL ECOL, V17, P267, DOI 10.1016/S0929-1393(01)00133-0; Kalinnikova TB, 2003, RUSS J ECOL+, V34, P198, DOI 10.1023/A:1023687503809; Krause J, 2002, LIVING GROUPS; Laothawornkitkul J, 2009, NEW PHYTOL, V183, P27, DOI 10.1111/j.1469-8137.2009.02859.x; Lavelle P., 1983, P449; Lee K. E, 1985, EARTHWORMS THEIR ECO; Nuutinen V, 1997, J ZOOL, V242, P783, DOI 10.1111/j.1469-7998.1997.tb05826.x; Okubo A., 1980, DIFFUSION ECOLOGICAL; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pillot MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014487; Pulliam HR, 1984, BEHAV ECOLOGY EVOLUT, P122; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; REINECKE AJ, 1990, REV ECOL BIOL SOL, V27, P221; Rombke J, 2005, ECOTOX ENVIRON SAFE, V62, P249, DOI 10.1016/j.ecoenv.2005.03.027; Sempo G, 2009, ETHOLOGY, V115, P1150, DOI 10.1111/j.1439-0310.2009.01699.x; Sinha MP, 1998, RECENT ADV ECOBIOLOG, P257; Stocker S, 1999, MATH BIOSCI, V156, P167, DOI 10.1016/S0025-5564(98)10065-2; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; TREHERNE JE, 1980, ANIM BEHAV, V28, P1119, DOI 10.1016/S0003-3472(80)80100-X; Uvarov AV, 2009, PEDOBIOLOGIA, V53, P1, DOI 10.1016/j.pedobi.2009.05.001; Vasquez RA, 2000, P ROY SOC B-BIOL SCI, V267, P157, DOI 10.1098/rspb.2000.0981; Wenke K, 2010, PLANTA, V231, P499, DOI 10.1007/s00425-009-1076-2; Wertheim B, 2005, ANNU REV ENTOMOL, V50, P321, DOI 10.1146/annurev.ento.49.061802.123329; Zirbes L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021927; Zirbes L, 2010, ETHOLOGY, V116, P546, DOI 10.1111/j.1439-0310.2010.01768.x	56	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32564	10.1371/journal.pone.0032564	http://dx.doi.org/10.1371/journal.pone.0032564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396774	Green Published, gold, Green Submitted			2022-12-25	WOS:000303005000028
J	Karmouty-Quintana, H; Zhong, HY; Acero, L; Weng, TT; Melicoff, E; West, JD; Hemnes, A; Grenz, A; Eltzschig, HK; Blackwell, TS; Xia, Y; Johnston, RA; Zeng, DW; Belardinelli, L; Blackburn, MR				Karmouty-Quintana, Harry; Zhong, Hongyan; Acero, Luis; Weng, Tingting; Melicoff, Ernestina; West, James D.; Hemnes, Anna; Grenz, Almut; Eltzschig, Holger K.; Blackwell, Timothy S.; Xia, Yang; Johnston, Richard A.; Zeng, Dewan; Belardinelli, Luiz; Blackburn, Michael R.			The A(2B) adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease	FASEB JOURNAL			English	Article						vascular remodeling; fibrosis; G-protein coupled receptors; purinergic signaling; smooth muscle; interleukin-6	ARTERIAL-HYPERTENSION; INCREASED ENDOTHELIN-1; GENE-TRANSFER; FIBROSIS; INFLAMMATION; SMOOTH; MICE; GROWTH; HYPERRESPONSIVENESS; INTERLEUKIN-6	Development of pulmonary hypertension is a common and deadly complication of interstitial lung disease. Little is known regarding the cellular and molecular mechanisms that lead to pulmonary hypertension in patients with interstitial lung disease, and effective treatment options are lacking. The purpose of this study was to examine the adenosine 2B receptor (A(2B)R) as a regulator of vascular remodeling and pulmonary hypertension secondary to pulmonary fibrosis. To accomplish this, cellular and molecular changes in vascular remodeling were monitored in mice exposed to bleomycin in conjunction with genetic removal of the A(2B)R or treatment with the A(2B)R antagonist GS-6201. Results demonstrated that GS-6201 treatment or genetic removal of the A(2B)R attenuated vascular remodeling and hypertension in our model. Furthermore, direct A(2B)R activation on vascular cells promoted interleukin-6 and endothelin-1 release. These studies identify a novel mechanism of disease progression to pulmonary hypertension and support the development of A(2B)R antagonists for the treatment of pulmonary hypertension secondary to interstitial lung disease.-Karmouty-Quintana, H., Zhong, H., Acero, L., Weng, T., Melicoff, E., West, J. D., Hemnes, A., Grenz, A., Eltzschig, H. K., Blackwell, T. S., Xia, Y., Johnston, R. A., Zeng, D., Belardinelli, L., Blackburn, M. R. The A(2B) adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease. FASEB J. 26, 2546-2557 (2012). www.fasebj.org	[Karmouty-Quintana, Harry; Acero, Luis; Weng, Tingting; Melicoff, Ernestina; Xia, Yang; Blackburn, Michael R.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Johnston, Richard A.] Univ Texas Med Sch Houston, Dept Pediat, Houston, TX 77030 USA; [Zhong, Hongyan; Zeng, Dewan; Belardinelli, Luiz] Gilead Sci Inc, Palo Alto, CA USA; [Melicoff, Ernestina] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [West, James D.; Hemnes, Anna; Blackwell, Timothy S.] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN USA; [Grenz, Almut; Eltzschig, Holger K.] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Gilead Sciences; Baylor College of Medicine; Vanderbilt University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Blackburn, MR (corresponding author), Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, 6431 Fannin, Houston, TX 77030 USA.	michael.r.blackburn@uth.tmc.edu	West, James/E-2960-2010; Karmouty-Quintana, Harry/ABC-9144-2020	West, James/0000-0002-6004-0202; Karmouty-Quintana, Harry/0000-0003-4753-9823; Blackburn, Michael/0000-0002-1394-9966; Melicoff, Ernestina/0000-0001-5696-7112; Johnston, Richard/0000-0003-0686-5139	Gilead Sciences Inc.; American Heart Association [11POST7580121]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098294, R01HL085317, R01HL070952] Funding Source: NIH RePORTER	Gilead Sciences Inc.(Gilead Sciences); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a research contract from Gilead Sciences Inc. (to M. R. B.). In addition, H. K.-Q. was supported in part by an American Heart Association South-West Affiliate postdoctoral fellowship (11POST7580121).	Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Ask K, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-16; Behr J, 2008, EUR RESPIR J, V31, P1357, DOI 10.1183/09031936.00171307; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Cacoub P, 1997, CARDIOVASC RES, V33, P196, DOI 10.1016/S0008-6363(96)00189-7; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; Chunn JL, 2001, J IMMUNOL, V167, P4676, DOI 10.4049/jimmunol.167.8.4676; Clozel M, 2005, ANN MED, V37, P2, DOI 10.1080/07853890410018925; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Grobe AC, 2006, AM J PHYSIOL-LUNG C, V290, pL1069, DOI 10.1152/ajplung.00408.2005; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Hemnes AR, 2008, AM J PHYSIOL-LUNG C, V294, pL24, DOI 10.1152/ajplung.00245.2007; Hopkins N, 2002, J ANAT, V201, P335, DOI 10.1046/j.1469-7580.2002.00096.x; Johnston RA, 2008, J APPL PHYSIOL, V104, P1727, DOI 10.1152/japplphysiol.00075.2008; Kalla RV, 2009, PURINERG SIGNAL, V5, P21, DOI 10.1007/s11302-008-9119-x; Kamezaki F, 2008, AM J RESP CRIT CARE, V177, P219, DOI 10.1164/rccm.200702-264OC; Kelland NF, 2010, J VASC RES, V47, P16, DOI 10.1159/000231717; Knight DA, 2003, PHARMACOL THERAPEUT, V99, P327, DOI 10.1016/S0163-7258(03)00095-0; Koupenova M, 2012, CIRCULATION, V125, P354, DOI 10.1161/CIRCULATIONAHA.111.057596; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Leuchte HH, 2006, AM J RESP CRIT CARE, V173, P744, DOI 10.1164/rccm.200510-1545OC; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Nadrous HF, 2005, CHEST, V128, P2393, DOI 10.1378/chest.128.4.2393; Nathan SD, 2007, AM J RESP CRIT CARE, V175, P875, DOI 10.1164/rccm.200608-1153CC; Ortiz LA, 2002, AM J PHYSIOL-LUNG C, V282, pL1209, DOI 10.1152/ajplung.00144.2001; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Park SH, 1997, AM J RESP CRIT CARE, V156, P600, DOI 10.1164/ajrccm.156.2.9607123; Rubens C, 2001, CHEST, V120, P1562, DOI 10.1378/chest.120.5.1562; Ryu JH, 2002, MAYO CLIN PROC, V77, P1221, DOI 10.4065/77.11.1221; Schroll S, 2010, RESP PHYSIOL NEUROBI, V170, P32, DOI 10.1016/j.resp.2009.11.005; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Shahar I, 1999, INT J IMMUNOPHARMACO, V21, P759, DOI 10.1016/S0192-0561(99)00056-9; Shalaby KH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-82; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Shetty Nagalakshmi, 2011, Inflammation & Allergy Drug Targets, V10, P19; Shorr AF, 2003, CHEST, V124, P922, DOI 10.1378/chest.124.3.922; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; SOFIA M, 1995, SARCOIDOSIS, V12, P118; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; STELZNER TJ, 1992, AM J PHYSIOL, V262, pL614, DOI 10.1152/ajplung.1992.262.5.L614; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Terashita K, 2006, RESPIROLOGY, V11, P145, DOI 10.1111/j.1440-1843.2006.00826.x; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Tofovic SP, 2009, VASC PHARMACOL, V51, P190, DOI 10.1016/j.vph.2009.06.002; Van Rheen Z, 2011, AM J RESP CELL MOL, V44, P500, DOI 10.1165/rcmb.2010-0065OC; Weitzenblum E, 2009, SEMIN RESP CRIT CARE, V30, P458, DOI 10.1055/s-0029-1233315; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008; Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105; Yang ZH, 1999, CIRCULATION, V100, P5, DOI 10.1161/01.CIR.100.1.5; Zaynagetdinov R, 2010, AM J RESP CELL MOL, V42, P564, DOI 10.1165/rcmb.2008-0391OC; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224; Zhou Y, 2009, PHARMACOL THERAPEUT, V123, P105, DOI 10.1016/j.pharmthera.2009.04.003	65	71	74	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2546	2557		10.1096/fj.11-200907	http://dx.doi.org/10.1096/fj.11-200907			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415303	Green Published			2022-12-25	WOS:000305017200031
J	Nusca, TD; Kim, Y; Maltseva, N; Lee, JY; Eschenfeldt, W; Stols, L; Schofield, MM; Scaglione, JB; Dixon, SD; Oves-Costales, D; Challis, GL; Hanna, PC; Pfleger, BF; Joachimiak, A; Sherman, DH				Nusca, Tyler D.; Kim, Youngchang; Maltseva, Natalia; Lee, Jung Yeop; Eschenfeldt, William; Stols, Lucy; Schofield, Michael M.; Scaglione, Jamie B.; Dixon, Shandee D.; Oves-Costales, Daniel; Challis, Gregory L.; Hanna, Philip C.; Pfleger, Brian F.; Joachimiak, Andrzej; Sherman, David H.			Functional and Structural Analysis of the Siderophore Synthetase AsbB through Reconstitution of the Petrobactin Biosynthetic Pathway from Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED IRON ACQUISITION; PATHOGENIC BACTERIA; PROTEIN-STRUCTURE; DATA-COLLECTION; IMMUNE-SYSTEM; CITRIC-ACID; I-TASSER; ENZYME; ACHROMOBACTIN; TRANSPORT	Petrobactin, a mixed catechol-carboxylate siderophore, is required for full virulence of Bacillus anthracis, the causative agent of anthrax. The asbABCDEF operon encodes the biosynthetic machinery for this secondary metabolite. Here, we show that the function of five gene products encoded by the asb operon is necessary and sufficient for conversion of endogenous precursors to petrobactin using an in vitro system. In this pathway, the siderophore synthetase AsbB catalyzes formation of amide bonds crucial for petrobactin assembly through use of biosynthetic intermediates, as opposed to primary metabolites, as carboxylate donors. In solving the crystal structure of the B. anthracis siderophore biosynthesis protein B (AsbB), we disclose a three-dimensional model of a nonribosomal peptide synthetase-independent siderophore (NIS) synthetase. Structural characteristics provide new insight into how this bifunctional condensing enzyme can bind and adenylate multiple citrate-containing substrates followed by incorporation of both natural and unnatural polyamine nucleophiles. This activity enables formation of multiple end-stage products leading to final assembly of petrobactin. Subsequent enzymatic assays with the nonribosomal peptide synthetase-like AsbC, AsbD, and AsbE polypeptides show that the alternative products of AsbB are further converted to petrobactin, verifying previously proposed convergent routes to formation of this siderophore. These studies identify potential therapeutic targets to halt deadly infections caused by B. anthracis and other pathogenic bacteria and suggest new avenues for the chemoenzymatic synthesis of novel compounds.	[Kim, Youngchang; Maltseva, Natalia; Eschenfeldt, William; Stols, Lucy; Joachimiak, Andrzej] Argonne Natl Lab, Midw Ctr Struct Genom, Argonne, IL 60439 USA; [Kim, Youngchang; Maltseva, Natalia; Eschenfeldt, William; Stols, Lucy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Nusca, Tyler D.; Lee, Jung Yeop; Schofield, Michael M.; Scaglione, Jamie B.; Pfleger, Brian F.; Sherman, David H.] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA; [Nusca, Tyler D.; Dixon, Shandee D.; Hanna, Philip C.; Sherman, David H.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Oves-Costales, Daniel; Challis, Gregory L.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Pfleger, Brian F.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Joachimiak, Andrzej] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Warwick; University of Wisconsin System; University of Wisconsin Madison; University of Chicago; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Joachimiak, A (corresponding author), Argonne Natl Lab, Midw Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov; davidhs@umich.edu	Oves-Costales, Daniel/I-1543-2015; Pfleger, Brian Frederick/AAA-2559-2022	Oves-Costales, Daniel/0000-0001-9986-4623; Pfleger, Brian Frederick/0000-0002-9232-9959; Challis, Gregory/0000-0001-5976-3545; Joachimiak, Andrzej/0000-0003-2535-6209	National Institutes of Health [GM074942]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Biotechnology and Biological Sciences Research Council [BB/F013760/1]; Great Lakes Regional Center for Excellence (GLRCE) in Biodefense and Emerging Infectious Disease [U54-AI-057153]; H. W. Vahlteich Professorship; BBSRC [BB/F013760/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942, U54GM094585, T32GM008353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Great Lakes Regional Center for Excellence (GLRCE) in Biodefense and Emerging Infectious Disease; H. W. Vahlteich Professorship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942 (to A. J.). This work was also supported by the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357 (to A. J.), by the Biotechnology and Biological Sciences Research Council through Grant BB/F013760/1 (to G. L. C.), and by Great Lakes Regional Center for Excellence (GLRCE) in Biodefense and Emerging Infectious Disease Grant U54-AI-057153 and the H. W. Vahlteich Professorship (to D. H. S.).	Abergel RJ, 2008, J AM CHEM SOC, V130, P2124, DOI 10.1021/ja077202g; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnow LE, 1937, J BIOL CHEM, V118, P531; Barbeau K, 2002, J AM CHEM SOC, V124, P378, DOI 10.1021/ja0119088; Barry SM, 2009, CURR OPIN CHEM BIOL, V13, P205, DOI 10.1016/j.cbpa.2009.03.008; Berti AD, 2009, J BACTERIOL, V191, P4594, DOI 10.1128/JB.00457-09; Bouzianas DG, 2009, TRENDS MICROBIOL, V17, P522, DOI 10.1016/j.tim.2009.08.006; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Carlson PE, 2010, MOL MICROBIOL, V75, P900, DOI 10.1111/j.1365-2958.2009.07025.x; Casadevall A, 2010, NAT REV MICROBIOL, V8, P149, DOI 10.1038/nrmicro2299; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Drake EJ, 2010, BIOCHEMISTRY-US, V49, P9292, DOI 10.1021/bi101226n; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2010, Journal of Structural and Functional Genomics, V11, P31, DOI 10.1007/s10969-010-9082-y; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Fox DT, 2008, BIOCHEMISTRY-US, V47, P12251, DOI 10.1021/bi801876q; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Gupte A, 2008, J MED CHEM, V51, P7495, DOI 10.1021/jm8008037; Hanson RM, 2010, J APPL CRYSTALLOGR, V43, P1250, DOI 10.1107/S0021889810030256; Holinsworth B, 2009, BIOMETALS, V22, P625, DOI 10.1007/s10534-009-9239-y; Hotta K, 2010, MICROBIOL-SGM, V156, P1918, DOI 10.1099/mic.0.039404-0; Kadi N, 2009, METHOD ENZYMOL, V458, P431, DOI 10.1016/S0076-6879(09)04817-4; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Koppisch AT, 2008, BIOMETALS, V21, P581, DOI 10.1007/s10534-008-9144-9; Koppisch AT, 2008, J ORG CHEM, V73, P5759, DOI 10.1021/jo800427f; Koppisch AT, 2005, BIOMETALS, V18, P577, DOI 10.1007/s10534-005-1782-6; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2005, J MOL BIOL, V351, P614, DOI 10.1016/j.jmb.2005.05.067; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020777; Lindley PF, 1996, REP PROG PHYS, V59, P867, DOI 10.1088/0034-4885/59/7/002; Liu HC, 2007, J AM SOC MASS SPECTR, V18, P842, DOI 10.1016/j.jasms.2007.01.005; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; McMahon SA, 2008, ACTA CRYSTALLOGR F, V64, P1052, DOI 10.1107/S1744309108032132; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mollmann U, 2009, BIOMETALS, V22, P615, DOI 10.1007/s10534-009-9219-2; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Navas E, 2002, CLIN MICROBIOL INFEC, V8, P534, DOI 10.1046/j.1469-0691.2002.00495.x; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Oves-Costales D, 2008, CHEM COMMUN, P4034, DOI 10.1039/b809353a; Oves-Costales D, 2007, J AM CHEM SOC, V129, P8416, DOI 10.1021/ja072391o; Oves-Costales D, 2009, CHEM COMMUN, P6530, DOI 10.1039/b913092f; Oves-Costales D, 2009, CHEM COMMUN, P1389, DOI 10.1039/b823147h; Pereira LS, 2007, BIOCHEM BIOPH RES CO, V352, P953, DOI 10.1016/j.bbrc.2006.11.128; Pfleger BF, 2008, P NATL ACAD SCI USA, V105, P17133, DOI 10.1073/pnas.0808118105; Pfleger BF, 2007, BIOCHEMISTRY-US, V46, P4147, DOI 10.1021/bi6023995; Pradines B, 1996, ANTIMICROB AGENTS CH, V40, P2094, DOI 10.1128/AAC.40.9.2094; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmelz S, 2011, J MOL BIOL, V412, P495, DOI 10.1016/j.jmb.2011.07.059; Schmelz S, 2009, NAT CHEM BIOL, V5, P174, DOI 10.1038/nchembio.145; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; TAIT GH, 1975, BIOCHEM J, V146, P191, DOI 10.1042/bj1460191; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Upson RH, 1996, ANAL BIOCHEM, V243, P41, DOI 10.1006/abio.1996.0479; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1726, DOI 10.1107/S0907444999008392; Wilson DJ, 2010, ANAL BIOCHEM, V404, P56, DOI 10.1016/j.ab.2010.04.033; Wilson MK, 2006, BIOCHEM BIOPH RES CO, V348, P320, DOI 10.1016/j.bbrc.2006.07.055; Wilson MK, 2010, BIOMETALS, V23, P129, DOI 10.1007/s10534-009-9272-x; Zawadzka AM, 2009, BIOCHEMISTRY-US, V48, P3645, DOI 10.1021/bi8018674; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	70	26	30	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16058	16072		10.1074/jbc.M112.359349	http://dx.doi.org/10.1074/jbc.M112.359349			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22408253	Green Published, hybrid			2022-12-25	WOS:000304006300083
J	Hayashi, H; Naoi, S; Nakagawa, T; Nishikawa, T; Fukuda, H; Imajoh-Ohmi, S; Kondo, A; Kubo, K; Yabuki, T; Hattori, A; Hirouchi, M; Sugiyama, Y				Hayashi, Hisamitsu; Naoi, Sotaro; Nakagawa, Takayuki; Nishikawa, Toru; Fukuda, Hiroyuki; Imajoh-Ohmi, Shinobu; Kondo, Ayano; Kubo, Kiyotaka; Yabuki, Takashi; Hattori, Asami; Hirouchi, Masakazu; Sugiyama, Yuichi			Sorting Nexin 27 Interacts with Multidrug Resistance-associated Protein 4 (MRP4) and Mediates Internalization of MRP4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ DOMAIN INTERACTION; REGULATES TRAFFICKING; ANTIVIRAL DRUGS; TRANSPORT; ENDOCYTOSIS; EXPRESSION; CELLS; DEGRADATION; INVOLVEMENT; MEMBRANE	Multidrug resistance-associated protein 4 (MRP4/ABCC4) makes a vital contribution to the bodily distribution of drugs and endogenous compounds because of its cellular efflux abilities. However, little is known about the mechanism regulating its cell surface expression. MRP4 has a PDZ-binding motif, which is a potential sequence that modulates the membrane expression of MRP4 via interaction with PDZ adaptor proteins. To investigate this possible relationship, we performed GST pull-down assays and subsequent analysis with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. This method identified sorting nexin 27 (SNX27) as the interacting PDZ adaptor protein with a PDZ-binding motif of MRP4. Its interaction was confirmed by a coimmunoprecipitation study using HEK293 cells. Knockdown of SNX27 by siRNA in HEK293 cells raised MRP4 expression on the plasma membrane, increased the extrusion of 6-[C-14] mercaptopurine, an MRP4 substrate, and conferred resistance against 6-[C-14] mercaptopurine. Cell surface biotinylation studies indicated that the inhibition of MRP4 internalization was responsible for these results. Immunocytochemistry and cell surface biotinylation studies using COS-1 cells showed that SNX27 localized to both the early endosome and the plasma membrane. These data suggest that SNX27 interacts with MRP4 near the plasma membrane and promotes endocytosis of MRP4 and thereby negatively regulates its cell surface expression and transport function.	[Hayashi, Hisamitsu; Naoi, Sotaro; Nakagawa, Takayuki; Kondo, Ayano; Kubo, Kiyotaka; Yabuki, Takashi; Hattori, Asami; Hirouchi, Masakazu; Sugiyama, Yuichi] Univ Tokyo, Lab Mol Pharmacokinet, Dept Med Pharmaceut, Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan; [Nishikawa, Toru] Tokyo Med & Dent Univ, Dept Psychiat & Behav Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Fukuda, Hiroyuki; Imajoh-Ohmi, Shinobu] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); University of Tokyo	Hayashi, H (corresponding author), Univ Tokyo, Lab Mol Pharmacokinet, Dept Med Pharmaceut, Grad Sch Pharmaceut Sci,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hayapi@mol.f.u-tokyo.ac.jp; sugiyama@mol.f.u-tokyo.ac.jp		Hayashi, Hisamitsu/0000-0002-5247-895X	National Institute of Biomedical Innovation [23790175]	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and Grant-in-Aid for Young Scientists (B) 23790175.	Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Cai L, 2011, MOL CELL BIOL, V31, P1734, DOI 10.1128/MCB.01044-10; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Done SC, 2002, J BIOL CHEM, V277, P17108, DOI 10.1074/jbc.M201326200; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Hayashi H, 2005, BBA-MOL CELL BIOL L, V1738, P54, DOI 10.1016/j.bbalip.2005.10.006; Hayashi H, 2005, HEPATOLOGY, V41, P916, DOI 10.1002/hep.20627; Hayashi H, 2007, HEPATOLOGY, V45, P1506, DOI 10.1002/hep.21630; Hayashi H, 2012, HEPATOLOGY, V55, P1889, DOI 10.1002/hep.25591; Hayashi H, 2009, MOL PHARMACOL, V75, P143, DOI 10.1124/mol.108.049288; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; Hori N, 2011, ATHEROSCLEROSIS, V215, P383, DOI 10.1016/j.atherosclerosis.2010.12.033; Imaoka T, 2007, MOL PHARMACOL, V71, P619, DOI 10.1124/mol.106.028233; Joubert L, 2004, J CELL SCI, V117, P5367, DOI 10.1242/jcs.01379; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Kool M, 1997, CANCER RES, V57, P3537; Krishnamurthy P, 2008, CANCER RES, V68, P4983, DOI 10.1158/0008-5472.CAN-07-6790; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Misaki R, 2007, BIOCHEM BIOPH RES CO, V360, P580, DOI 10.1016/j.bbrc.2007.06.101; Miyagawa M, 2009, J PHARMACOL EXP THER, V329, P551, DOI 10.1124/jpet.108.148411; Mizuno T, 2011, HEPATOLOGY, V54, P631, DOI 10.1002/hep.24387; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Rincon E, 2011, J CELL SCI, V124, P776, DOI 10.1242/jcs.072447; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Sugiura T, 2011, J PHARM SCI-US, V100, P3620, DOI 10.1002/jps.22575; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Valdes JL, 2011, J BIOL CHEM, V286, P39403, DOI 10.1074/jbc.M111.260802; Wielinga PR, 2002, MOL PHARMACOL, V62, P1321, DOI 10.1124/mol.62.6.1321; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974	38	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15054	15065		10.1074/jbc.M111.337931	http://dx.doi.org/10.1074/jbc.M111.337931			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22411990	Green Published, hybrid			2022-12-25	WOS:000304003200067
J	Qi, XM; Zhi, HY; Lepp, A; Wang, P; Huang, J; Basir, Z; Chitambar, CR; Myers, CR; Chen, G				Qi, Xiaomei; Zhi, Huiying; Lepp, Adrienne; Wang, Phillip; Huang, Jian; Basir, Zainab; Chitambar, Christopher R.; Myers, Charles R.; Chen, Guan			p38 gamma Mitogen-activated Protein Kinase (MAPK) Confers Breast Cancer Hormone Sensitivity by Switching Estrogen Receptor (ER) Signaling from Classical to Nonclassical Pathway via Stimulating ER Phosphorylation and c-Jun Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; RAS TRANSFORMATION; DOWN-REGULATION; ALPHA; RESISTANCE; SERINE-118; EXPRESSION; TUMORS; INHIBITION; P38-ALPHA	Estrogen receptor (ER) alpha promotes breast cancer growth by regulating gene expression through classical estrogen response element (ERE) binding and nonclassical (interaction with c-Jun at AP-1 sites) pathways. ER is the target for anti-estrogens such as tamoxifen (TAM). However, the potential for classical versus nonclassical ER signaling to influence hormone sensitivity is not known. Moreover, anti-estrogens frequently activate several signaling cascades besides the target ER, and the implications of these "off-target" signaling events have not been explored. Here, we report that p38 gamma MAPK is selectively activated by treatment with TAM. This results in both phosphorylation of ER at Ser-118 and stimulation of c-Jun transcription, thus switching ER signaling from the classical to the nonclassical pathway leading to increased hormone sensitivity. Unexpectedly, phosphorylation at Ser-118 is required for ER to bind both p38 gamma and c-Jun, thereby promoting ER relocation from ERE to AP-1 promoter sites. Thus, ER/Ser-118 phosphorylation serves as a central mechanism by which p38 gamma regulates signaling transduction of ER with its inhibitor TAM.	[Qi, Xiaomei; Zhi, Huiying; Lepp, Adrienne; Wang, Phillip; Myers, Charles R.; Chen, Guan] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Huang, Jian; Basir, Zainab] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Chitambar, Christopher R.] Med Coll Wisconsin, Div Hematol & Oncol, Milwaukee, WI 53226 USA; [Chen, Guan] Zablocki Vet Affairs Med Ctr, Res Serv, Milwaukee, WI 53295 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Chen, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	gchen@mcw.edu		Myers, Charles/0000-0001-7956-3217	National Institutes of Health [R01 91576]; Veterans Affairs Merit Review; Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House)	This work was supported, whole or in part, by National Institutes of Health Grant R01 91576. This work was also supported by grants from a Veterans Affairs Merit Review and the Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House).	Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bedard PL, 2008, BREAST CANCER RES TR, V108, P307, DOI 10.1007/s10549-007-9606-8; Chen DS, 2002, ONCOGENE, V21, P4921, DOI 10.1038/sj.onc.1205420; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; CHEN GA, 1995, BIOCHEM PHARMACOL, V49, P1691, DOI 10.1016/0006-2952(95)00079-F; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Glidewell-Kenney C, 2005, MOL CELL ENDOCRINOL, V245, P53, DOI 10.1016/j.mce.2005.10.003; Gross EA, 2002, J BIOL CHEM, V277, P13873, DOI 10.1074/jbc.M111994200; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Henrich LM, 2003, MOL CELL BIOL, V23, P5979, DOI 10.1128/MCB.23.17.5979-5988.2003; Hou S., 2010, UCSD NATURE MOL PAGE, DOI [10.1038/mp.a001720.01, DOI 10.1038/MP.A001720.01]; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Ishii Y, 2008, CANCER RES, V68, P852, DOI 10.1158/0008-5472.CAN-07-2879; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; Kok M, 2009, JNCI-J NATL CANCER I, V101, P1725, DOI 10.1093/jnci/djp412; Kronblad A, 2005, ONCOGENE, V24, P6835, DOI 10.1038/sj.onc.1208830; Kukkonen-Macchi A, 2011, J CELL SCI, V124, P216, DOI 10.1242/jcs.068254; Lassar AB, 2009, J CELL BIOL, V187, P941, DOI 10.1083/jcb.200911123; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Linderholm BK, 2011, BREAST CANCER RES TR, V125, P457, DOI 10.1007/s10549-010-1252-x; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Madeo A, 2010, ONCOGENE, V29, P978, DOI 10.1038/onc.2009.400; Mandlekar S, 2000, CANCER RES, V60, P5995; Meng FY, 2011, NEOPLASIA, V13, P472, DOI 10.1593/neo.101748; Moran N, 2011, NAT BIOTECHNOL, V29, P301, DOI 10.1038/nbt0411-301; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Osborne C. K., 2008, U. S. Patent, Patent No. [7,402,402, B2, 7402402]; Oyama M, 2011, J BIOL CHEM, V286, P818, DOI 10.1074/jbc.M110.156877; Ozes O, 2008, United States Patent-US, P1, Patent No. [7,407,973, 7407973, US7407973B2]; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2011, J BIOL CHEM, V286, P35883, DOI 10.1074/jbc.M111.229260; Qi XM, 2004, J BIOL CHEM, V279, P6769, DOI 10.1074/jbc.M311492200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Rosenthal DT, 2011, CANCER RES, V71, P6338, DOI 10.1158/0008-5472.CAN-11-1291; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Walters MR, 2002, J BIOL CHEM, V277, P1669, DOI 10.1074/jbc.M109320200; Weitsman GE, 2006, CANCER RES, V66, P10162, DOI 10.1158/0008-5472.CAN-05-4111; Wu CC, 2010, PROTEIN CELL, V1, P573, DOI 10.1007/s13238-010-0075-1; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456; Zhi HY, 2011, ONCOGENE, V30, P1706, DOI 10.1038/onc.2010.543	57	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14681	14691		10.1074/jbc.M112.349357	http://dx.doi.org/10.1074/jbc.M112.349357			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399296	Green Published, hybrid			2022-12-25	WOS:000304003200034
J	Byrgazov, K; Manoharadas, S; Kaberdina, AC; Vesper, O; Moll, I				Byrgazov, Konstantin; Manoharadas, Salim; Kaberdina, Anna C.; Vesper, Oliver; Moll, Isabella			Direct Interaction of the N-Terminal Domain of Ribosomal Protein S1 with Protein S2 in Escherichia coli	PLOS ONE			English	Article							MESSENGER-RNA; TRANSLATION INITIATION; SECONDARY STRUCTURE; BINDING DOMAIN; 30-S SUBUNIT; RIBOSOMAL-PROTEIN-S1; LEADERLESS; VISUALIZATION; LOCALIZATION; RECOGNITION	Despite of the high resolution structure available for the E. coli ribosome, hitherto the structure and localization of the essential ribosomal protein S1 on the 30 S subunit still remains to be elucidated. It was previously reported that protein S1 binds to the ribosome via protein-protein interaction at the two N-terminal domains. Moreover, protein S2 was shown to be required for binding of protein S1 to the ribosome. Here, we present evidence that the N-terminal domain of S1 (amino acids 1-106; S1(106)) is necessary and sufficient for the interaction with protein S2 as well as for ribosome binding. We show that over production of protein S1(106) affects E. coli growth by displacing native protein S1 from its binding pocket on the ribosome. In addition, our data reveal that the coiled-coil domain of protein S2 (S2 alpha(2)) is sufficient to allow protein S1 to bind to the ribosome. Taken together, these data uncover the crucial elements required for the S1/S2 interaction, which is pivotal for translation initiation on canonical mRNAs in Gram-negative bacteria. The results are discussed in terms of a model wherein the S1/S2 interaction surface could represent a possible target to modulate the selectivity of the translational machinery and thereby alter the translational program under distinct conditions.	[Byrgazov, Konstantin; Manoharadas, Salim; Kaberdina, Anna C.; Vesper, Oliver; Moll, Isabella] Univ Vienna, Ctr Mol Biol, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Byrgazov, K (corresponding author), Univ Vienna, Ctr Mol Biol, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Vienna, Austria.	Isabella.Moll@univie.ac.at	MANOHARADAS, SALIM/ABC-6986-2020; Moll, Isabella/E-8665-2012; Byrgazov, Konstantin/G-9358-2016	MANOHARADAS, SALIM/0000-0002-1875-5976; Byrgazov, Konstantin/0000-0002-8924-9536; Moll, Isabella/0000-0002-3210-4336	Austrian Science Fund (FWF) [P20112-B3, P22249-B20]; Austrian Science Fund (FWF) [P 22249] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The research was funded to IM by the Austrian Science Fund (FWF): P20112-B3 and P22249-B20; http://www.fwf.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprandi P, 2008, J BIOL CHEM, V283, P13289, DOI 10.1074/jbc.M707111200; Aseev LV, 2008, RNA, V14, P1882, DOI 10.1261/rna.1099108; BEAR DG, 1976, P NATL ACAD SCI USA, V73, P1824, DOI 10.1073/pnas.73.6.1824; BOILEAU G, 1981, J BIOL CHEM, V256, P8222; BOLLEN A, 1979, J MOL BIOL, V132, P219, DOI 10.1016/0022-2836(79)90392-9; BONI IV, 1982, EUR J BIOCHEM, V121, P371, DOI 10.1111/j.1432-1033.1982.tb05796.x; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; Boni IV, 2001, EMBO J, V20, P4222, DOI 10.1093/emboj/20.15.4222; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; DeLano MC, PYMOL MOL SYSTEM; Delvillani F, 2011, NUCLEIC ACIDS RES, V39, P7702, DOI 10.1093/nar/gkr417; DESMIT MH, 1994, J MOL BIOL, V244, P144, DOI 10.1006/jmbi.1994.1714; Ederth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn992; Grill S, 2000, EMBO J, V19, P4101, DOI 10.1093/emboj/19.15.4101; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; GUERRIERTAKADA C, 1983, J BIOL CHEM, V258, P3649; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAUGHREA M, 1978, J MOL BIOL, V122, P109, DOI 10.1016/0022-2836(78)90111-0; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; McGinness KE, 2004, P NATL ACAD SCI USA, V101, P13454, DOI 10.1073/pnas.0405521101; Moll I, 2002, MOL MICROBIOL, V44, P1387, DOI 10.1046/j.1365-2958.2002.02971.x; Okada T, 2004, BIOSCI BIOTECH BIOCH, V68, P2319, DOI 10.1271/bbb.68.2319; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; POTAPOV AP, 1992, BIOCHEM INT, V27, P745; Qi H, 2007, J MOL BIOL, V368, P845, DOI 10.1016/j.jmb.2007.02.068; Saguy M, 2007, NUCLEIC ACIDS RES, V35, P2368, DOI 10.1093/nar/gkm100; Salah P, 2009, NUCLEIC ACIDS RES, V37, P5578, DOI 10.1093/nar/gkp547; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; SILLERS IY, 1981, J MOL BIOL, V153, P761, DOI 10.1016/0022-2836(81)90417-4; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; SUBRAMANIAN AR, 1983, PROG NUCLEIC ACID RE, V28, P101, DOI 10.1016/S0079-6603(08)60085-9; SUBRAMANIAN AR, 1981, EUR J BIOCHEM, V119, P245, DOI 10.1111/j.1432-1033.1981.tb05600.x; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; SURYANARAYANA T, 1983, BIOCHEMISTRY-US, V22, P2715, DOI 10.1021/bi00280a020; SZER W, 1975, P NATL ACAD SCI USA, V72, P2325, DOI 10.1073/pnas.72.6.2325; Tedin K, 1997, MOL MICROBIOL, V25, P189, DOI 10.1046/j.1365-2958.1997.4421810.x; THOMAS JO, 1978, J MOL BIOL, V123, P163, DOI 10.1016/0022-2836(78)90319-4; VANDIEIJEN G, 1978, EUR J BIOCHEM, V90, P571; VANDIEIJEN G, 1976, EUR J BIOCHEM, V64, P511; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; WALLECZEK J, 1990, J BIOL CHEM, V265, P11338; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281	48	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32702	10.1371/journal.pone.0032702	http://dx.doi.org/10.1371/journal.pone.0032702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412910	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800044
J	Xue, GG; Aida, Y; Onodera, T; Sakudo, A				Xue, Guangai; Aida, Yoko; Onodera, Takashi; Sakudo, Akikazu			The 5 ' Flanking Region and Intron1 of the Bovine Prion Protein Gene (PRNP) Are Responsible for Negative Feedback Regulation of the Prion Protein	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; PROMOTER ACTIVITY; KNOCKOUT MICE; BINDING-SITE; EXPRESSION; PRP; POLYMORPHISMS; SUSCEPTIBILITY; PROLIFERATION; SEQUENCE	Transcription factors regulate gene expression by controlling the transcription rate. Some genes can repress their own expression to prevent over production of the corresponding protein, although the mechanism and significance of this negative feedback regulation remains unclear. In the present study, we describe negative feedback regulation of the bovine prion protein (PrP) gene PRNP in Japanese Black cattle. The PrP-expressing plasmid pEF-boPrP and luciferase-expressing plasmids containing the partial promoter fragment of PRNP incorporating naturally occurring single-nucleotide or insertion/deletion polymorphisms were transfected into N2a cells. Transfection of pEF-boPrP induced PrP overexpression and decreased the promoter activity of PRNP in the wild-type haplotype (23-bp Del, 12-bp Del, and -47C). Reporter gene assays further demonstrated that the 12- and 23-bp Ins/Del polymorphisms, which are thought to be associated with Sp1 (Specific protein 1) and RP58 (Repressor Protein with a predicted molecular mass of 58 kDa), in intron1 and the upstream region, respectively, and an additional polymorphism (-47C -> A) in the Sp1-binding site responded differently to PrP overexpression. With the -47C SNP, the presence of the Del in either the 23-bp Ins/Del or the 12-bp Ins/Del allele was essential for the negative feedback caused by PrP overexpression. Furthermore, deletion mutants derived from the wildtype haplotype showed that nucleotides -315 to +2526, which include the 5 '-flanking region and exon1, were essential for the response. These results indicate that certain negative feedback response elements are located in these sequences, suggesting that regulation by transcription factors such as Sp1 and RP58 may contribute to the negative feedback mechanism of PRNP.	[Xue, Guangai; Onodera, Takashi] Univ Tokyo, Sch Agr & Life Sci, Dept Mol Immunol, Bunkyo Ku, Tokyo, Japan; [Xue, Guangai; Aida, Yoko] RIKEN, Viral Infect Dis Res Unit, Wako, Saitama, Japan; [Sakudo, Akikazu] Univ Ryukyus, Fac Med, Sch Hlth Sci, Lab Biometabol Chem, Nishihara, Okinawa 90301, Japan	University of Tokyo; RIKEN; University of the Ryukyus	Xue, GG (corresponding author), Univ Tokyo, Sch Agr & Life Sci, Dept Mol Immunol, Bunkyo Ku, Tokyo, Japan.	sakudo@med.u-ryukyu.ac.jp	Sakudo, Akikazu/B-1368-2014		Ministry of Health, Labour and Welfare of Japan [H23-013]; Ministry of Education, Science, Culture and Technology of Japan [23780299]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aids from the Ministry of Health, Labour and Welfare of Japan (H23-013) and Grant-in-Aids for Scientific Research (23780299) from the Ministry of Education, Science, Culture and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Desaint Stephane, 2004, Lipids Health Dis, V3, P4, DOI 10.1186/1476-511X-3-4; El Wakil A, 2006, DEVELOPMENT, V133, P2155, DOI 10.1242/dev.02377; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Haigh CL, 2007, J MOL BIOL, V368, P915, DOI 10.1016/j.jmb.2007.02.086; Hosokawa T, 2008, BIOCHEM BIOPH RES CO, V366, P657, DOI 10.1016/j.bbrc.2007.11.163; Inoue S, 1997, J VET MED SCI, V59, P175, DOI 10.1292/jvms.59.175; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Kim Y, 2008, TRANSBOUND EMERG DIS, V55, P105, DOI 10.1111/j.1865-1682.2007.00997.x; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Miller J.N., 2010, STAT CHEMOMETRICS AN, Vsixth; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Msalya G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018787; Nakamura I, 2007, INTERVIROLOGY, V50, P190, DOI 10.1159/000099217; Premzl M, 2005, GENE, V349, P121, DOI 10.1016/j.gene.2004.11.049; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sakudo A, 2006, MINI-REV MED CHEM, V6, P589, DOI 10.2174/138955706776876159; Sakudo A, 2010, CURR PROTEIN PEPT SC, V11, P166, DOI 10.2174/138920310790848386; Sakudo A, 2009, PROTEIN PEPTIDE LETT, V16, P217, DOI 10.2174/092986609787601732; Sakudo A, 2009, CURR MED CHEM, V16, P380, DOI 10.2174/092986709787002673; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Windl O, 1999, J GEN VIROL, V80, P15, DOI 10.1099/0022-1317-80-1-15; Xue GA, 2008, BIOCHEM BIOPH RES CO, V372, P530, DOI 10.1016/j.bbrc.2008.05.085	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32870	10.1371/journal.pone.0032870	http://dx.doi.org/10.1371/journal.pone.0032870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412936	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800056
J	Ji, ZG; Ito, S; Honjoh, T; Ohta, H; Ishizuka, T; Fukazawa, Y; Yawo, H				Ji, Zhi-Gang; Ito, Shin; Honjoh, Tatsuya; Ohta, Hiroyuki; Ishizuka, Toru; Fukazawa, Yugo; Yawo, Hiromu			Light-evoked Somatosensory Perception of Transgenic Rats That Express Channelrhodopsin-2 in Dorsal Root Ganglion Cells	PLOS ONE			English	Article							SENSORY NEURONS; GREEN-ALGAE; IMMUNOCYTOCHEMICAL LOCALIZATION; NEUROFILAMENT IMMUNOREACTIVITY; CONDUCTION-VELOCITY; PRIMARY AFFERENTS; NERVOUS-SYSTEM; GATED CHANNELS; SPINAL-CORD; PROTEIN	In vertebrate somatosensory systems, each mode of touch-pressure, temperature or pain is sensed by sensory endings of different dorsal root ganglion (DRG) neurons, which conducted to the specific cortical loci as nerve impulses. Therefore, direct electrical stimulation of the peripheral nerve endings causes an erroneous sensation to be conducted by the nerve. We have recently generated several transgenic lines of rat in which channelrhodopsin-2 (ChR2) transgene is driven by the Thy-1.2 promoter. In one of them, W-TChR2V4, some neurons were endowed with photosensitivity by the introduction of the ChR2 gene, coding an algal photoreceptor molecule. The DRG neurons expressing ChR2 were immunohistochemically identified using specific antibodies to the markers of mechanoreceptive or nociceptive neurons. Their peripheral nerve endings in the plantar skin as well as the central endings in the spinal cord were also examined. We identified that ChR2 is expressed in a certain population of large neurons in the DRG of W-TChR2V4. On the basis of their morphology and molecular markers, these neurons were classified as mechanoreceptive but not nociceptive. ChR2 was also distributed in their peripheral sensory nerve endings, some of which were closely associated with CK20-positive cells to form Merkel cell-neurite complexes or with S-100-positive cells to form structures like Meissner's corpuscles. These nerve endings are thus suggested to be involved in the sensing of touch. Each W-TChR2V4 rat showed a sensory-evoked behavior in response to blue LED flashes on the plantar skin. It is thus suggested that each rat acquired an unusual sensory modality of sensing blue light through the skin as touch-pressure. This light-evoked somatosensory perception should facilitate study of how the complex tactile sense emerges in the brain.	[Ji, Zhi-Gang; Ito, Shin; Honjoh, Tatsuya; Ohta, Hiroyuki; Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Ji, Zhi-Gang; Ito, Shin; Honjoh, Tatsuya; Ohta, Hiroyuki; Ishizuka, Toru; Yawo, Hiromu] JST, CREST, Sendai, Miyagi, Japan; [Ji, Zhi-Gang; Ito, Shin; Honjoh, Tatsuya; Yawo, Hiromu] Tohoku Univ, Basic & Translat Res Ctr Global Brain Sci, Sendai, Miyagi 980, Japan; [Ohta, Hiroyuki] Natl Def Med Coll, Dept Physiol, Tokorozawa, Saitama 359, Japan; [Fukazawa, Yugo] Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan; [Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Ctr Neurosci, Sendai, Miyagi 980, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; National Defense Medical College - Japan; Nagoya University; Tohoku University	Ji, ZG (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan.	yawo-hiromu@m.tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Yawo, Hiromu/I-4871-2015; Fukazawa, Yugo/H-9899-2012	Ishizuka, Toru/0000-0003-4405-8792; Yawo, Hiromu/0000-0002-4299-3288; Fukazawa, Yugo/0000-0001-7436-8797; Ohta, Hiroyuki/0000-0002-1816-7912	National Institute of Biomedical Innovation (NIBIO), Japan; Global COE, MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan; MEXT, Japan	National Institute of Biomedical Innovation (NIBIO), Japan(National Institute of Biomedical Innovation); Global COE, MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan; Global COE Program (Basic & Translational Research Centre for Global Brain Science), MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan; and Strategic Research Program for Brain Sciences (SRPBS), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Basbaum AI, 2000, PRINCIPLES NEURAL SC, P430; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Campagnola L, 2008, J NEUROSCI METH, V169, P27, DOI 10.1016/j.jneumeth.2007.11.012; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Dawson LF, 2011, NEUROSCIENCE, V175, P300, DOI 10.1016/j.neuroscience.2010.11.064; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Ha SO, 2000, MOL BRAIN RES, V81, P181, DOI 10.1016/S0169-328X(00)00144-3; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; Hu J, 2010, EMBO J, V29, P855, DOI 10.1038/emboj.2009.398; Hu ZH, 1997, J PHYSIOL-LONDON, V501, P67, DOI 10.1111/j.1469-7793.1997.067bo.x; ICHIKAWA H, 1994, BRAIN RES, V655, P241, DOI 10.1016/0006-8993(94)91620-9; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KINNMAN E, 1992, EXP BRAIN RES, V91, P61; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lu SG, 2008, NEUROSCIENCE, V153, P279, DOI 10.1016/j.neuroscience.2008.02.006; MCLEAN MJ, 1988, MOL CELL BIOCHEM, V80, P95; Moll I, 2005, EUR J CELL BIOL, V84, P259, DOI 10.1016/j.ejcb.2004.12.023; Morris R, 2004, BRAIN RES REV, V46, P173, DOI 10.1016/j.brainresrev.2004.07.002; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Novakovic SD, 1999, PAIN, V80, P273, DOI 10.1016/S0304-3959(98)00225-5; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PERRY MJ, 1991, J NEUROCYTOL, V20, P746, DOI 10.1007/BF01187848; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Provitera V, 2007, MUSCLE NERVE, V35, P767, DOI 10.1002/mus.20771; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; Tan ZY, 2006, J NEUROPHYSIOL, V95, P1115, DOI 10.1152/jn.00830.2005; Todd AJ, 2002, EXP PHYSIOL, V87, P245, DOI 10.1113/eph8702351; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Torsney C, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-17; Villiere V, 1996, J NEUROPHYSIOL, V76, P1924, DOI 10.1152/jn.1996.76.3.1924; Vulchanova L, 1998, EUR J NEUROSCI, V10, P3470, DOI 10.1046/j.1460-9568.1998.00355.x; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Xu Z, 2006, CURR OPIN NEUROBIOL, V16, P460, DOI 10.1016/j.conb.2006.06.002	49	52	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32699	10.1371/journal.pone.0032699	http://dx.doi.org/10.1371/journal.pone.0032699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412908	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100023
J	Shenoi, SV; Brooks, RP; Barbour, R; Altice, FL; Zelterman, D; Moll, AP; Master, I; van der Merwe, TL; Friedland, GH				Shenoi, Sheela V.; Brooks, Ralph P.; Barbour, Russell; Altice, Frederick L.; Zelterman, Daniel; Moll, Anthony P.; Master, Iqbal; van der Merwe, Theo L.; Friedland, Gerald H.			Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; TREATMENT OUTCOMES; INTEGRATION	Background: Drug-resistant tuberculosis (TB) is a major threat to global public health. Patients with extensively drug-resistant TB (XDR-TB), particularly those with HIV-coinfection, experience high and accelerated mortality with limited available interventions. To determine modifiable factors associated with survival, we evaluated XDR-TB patients from a community-based hospital in rural South Africa where a large number of XDR-TB cases were first detected. Methodology/Principal Findings: A retrospective case control study was conducted of XDR-TB patients diagnosed from 2005-2008. Survivors, those alive at 180 days from diagnostic sputum collection date, were compared with controls who died within 180 days. Clinical, laboratory and microbiological correlates of survival were assessed in 69 survivors (median survival 565 days [IQR 384-774] and 73 non-survivors (median survival 34 days [IQR 18-90]). Among 129 HIV+ patients, multivariate analyses of modifiable factors demonstrated that negative AFB smear (AOR 8.4, CI 1.84-38.21), a lower laboratory index of routine laboratory findings (AOR 0.48, CI 0.22-1.02), CD4>200 cells/mm(3) (AOR 11.53, 1.1-119.32), and receipt of antiretroviral therapy (AOR 20.9, CI 1.16-376.83) were independently associated with survival from XDR-TB. Conclusions/Significance: Survival from XDR-TB with HIV-coinfection is associated with less advanced stages of both diseases at time of diagnosis, absence of laboratory markers indicative of multiorgan dysfunction, and provision of antiretroviral therapy. Survival can be increased by addressing these modifiable risk factors through policy changes and improved clinical management. Health planners and clinicians should develop programmes focusing on earlier case finding and integration of HIV and drug-resistant TB diagnostic, therapeutic, and preventive activities.	[Shenoi, Sheela V.; Altice, Frederick L.; Friedland, Gerald H.] Yale Univ, Sch Med New Haven, Infect Dis Sect, Dept Med,AIDS Program, New Haven, CT 06520 USA; [Brooks, Ralph P.] Philanjalo Care Ctr, Tugela Ferry, South Africa; [Barbour, Russell; Zelterman, Daniel] Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA; [Zelterman, Daniel] Yale Univ, Sch Publ Hlth, Div Biostat, New Haven, CT 06520 USA; [Moll, Anthony P.; van der Merwe, Theo L.] Church Scotland Hosp, Tugela Ferry, South Africa; [Master, Iqbal] King George V Mem Hosp, Durban, South Africa	Yale University; Yale University; Yale University	Shenoi, SV (corresponding author), Yale Univ, Sch Med New Haven, Infect Dis Sect, Dept Med,AIDS Program, New Haven, CT 06520 USA.	sheela.shenoi@yale.edu	Shenoi, Sheela/Z-2641-2019; Shenoi, Sheela/GRY-6103-2022	Shenoi, Sheela/0000-0001-7654-4344; Zelterman, Daniel/0000-0003-0711-8688	Fogarty International Clinical Research Fellowship [R24TW007988]; Fulbright Program; Gilead Foundation; PEPFAR (President's Emergency Plan for AIDS Relief); Irene Diamond Fund; National Institute on Drug Abuse [K24 DA017072]; Center for Interdisciplinary Research on AIDS, NIH [5P30MH062294-07]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072] Funding Source: NIH RePORTER	Fogarty International Clinical Research Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fulbright Program; Gilead Foundation(Gilead Sciences); PEPFAR (President's Emergency Plan for AIDS Relief); Irene Diamond Fund; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Center for Interdisciplinary Research on AIDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	SVS received funding from Fogarty International Clinical Research Fellowship (R24TW007988), Fulbright Program, Gilead Foundation, and PEPFAR (the President's Emergency Plan for AIDS Relief). GHF receives funding from the Irene Diamond Fund, Gilead Foundation and PEPFAR. FLA receives funding from the National Institute on Drug Abuse (K24 DA017072). RB is supported by the Center for Interdisciplinary Research on AIDS, NIH 5P30MH062294-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], AIDS PROGR SECT INF; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Balabanova Y, 2011, BMJ OPEN, V1, DOI [10.1136/bmjopen-2011-0003511, 10.1136/bmjopen-2011-000351]; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; Buthelezi S, 2008, 2 M GLOB XDR TB TASK; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Dobson AJ, INTRO GEN LINEAR MOD; Friedland G, 2004, CLIN INFECT DIS, V38, pS421, DOI 10.1086/421407; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Gandhi NR, 2009, JAIDS-J ACQ IMM DEF, V50, P37, DOI 10.1097/QAI.0b013e31818ce6c4; Jack C, 2004, JAIDS-J ACQ IMM DEF, V36, P929, DOI 10.1097/00126334-200408010-00006; Jeon DS, 2009, INT J TUBERC LUNG D, V13, P594; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2005, CLIN INFECT DIS, V41, P1783, DOI 10.1086/498308; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Little R. J. A., 1987, STAT ANAL MISSING DA; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Republic of South Africa Department of Health, 2004, S AFR NAT TUB CONTR; Republic of South Africa Department of Health, 2008, UMZ DISTR HLTH PROF; Republic of South Africa Department of Health, 2008, NAT HIV SYPH PREV SU; Republic of South Africa Department of Health, 2010, S AFR ANT TREATM GUI; Republic of South Africa Department of Health, 2004, NAT ANT TREATM GUID; Shah NS, 2011, AM J RESP CRIT CARE, V183, P1427, DOI 10.1164/rccm.201009-1449OC; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020; Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496; Sylla L, 2007, INT J DRUG POLICY, V18, P306, DOI 10.1016/j.drugpo.2007.03.001; THERNEAU T., 2011, SURVIVAL ANAL INCLUD; WHO, 2008, EPI SEM 2008; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization, 2009, RAP ADV ANT THER HIV	40	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e31786	10.1371/journal.pone.0031786	http://dx.doi.org/10.1371/journal.pone.0031786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412840	gold, Green Submitted, Green Published			2022-12-25	WOS:000303021100008
J	Cheng, SH; Zhao, SL; Nelson, B; Kesavan, C; Qin, XZ; Wergedal, J; Mohan, S; Xing, WR				Cheng, Shaohong; Zhao, Shien Lucy; Nelson, Brittany; Kesavan, Chandrasekhar; Qin, Xuezhong; Wergedal, Jon; Mohan, Subburaman; Xing, Weirong			Targeted Disruption of Ephrin B1 in Cells of Myeloid Lineage Increases Osteoclast Differentiation and Bone Resorption in Mice	PLOS ONE			English	Article							ACTIN CYTOSKELETON; EZRIN/RADIXIN/MOESIN PROTEINS; OSTERIX EXPRESSION; EPHB RECEPTORS; FACTOR-I; LIGANDS; PHOSPHATE; MEMBRANE; PHOSPHORYLATION; PROLIFERATION	Disruption of ephrin B1 in collagen I producing cells in mice results in severe skull defects and reduced bone formation. Because ephrin B1 is also expressed during osteoclast differentiation and because little is known on the role of ephrin B1 reverse signaling in bone resorption, we examined the bone phenotypes in ephrin B1 conditional knockout mice, and studied the function of ephrin B1 reverse signaling on osteoclast differentiation and resorptive activity. Targeted deletion of ephrin B1 gene in myeloid lineage cells resulted in reduced trabecular bone volume, trabecular number and trabecular thickness caused by increased TRAP positive osteoclasts and bone resorption. Histomorphometric analyses found bone formation parameters were not changed in ephrin B1 knockout mice. Treatment of wild-type precursors with clustered soluble EphB2-Fc inhibited RANKL induced formation of multinucleated osteoclasts, and bone resorption pits. The same treatment of ephrin B1 deficient precursors had little effect on osteoclast differentiation and pit formation. Similarly, activation of ephrin B1 reverse signaling by EphB2-Fc treatment led to inhibition of TRAP, cathepsin K and NFATc1 mRNA expression in osteoclasts derived from wild-type mice but not conditional knockout mice. Immunoprecipitation with NHERF1 antibody revealed ephrin B1 interacted with NHERF1 in differentiated osteoclasts. Treatment of osteoclasts with exogenous EphB2-Fc resulted in reduced phosphorylation of ezrin/radixin/moesin. We conclude that myeloid lineage produced ephrin B1 is a negative regulator of bone resorption in vivo, and that activation of ephrin B1 reverse signaling inhibits osteoclast differentiation in vitro in part via a mechanism that involves inhibition of NFATc1 expression and modulation of phosphorylation status of ezrin/radixin/moesin.	[Cheng, Shaohong; Zhao, Shien Lucy; Kesavan, Chandrasekhar; Qin, Xuezhong; Wergedal, Jon; Mohan, Subburaman; Xing, Weirong] Jerry L Pettis VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA; [Kesavan, Chandrasekhar; Qin, Xuezhong; Wergedal, Jon; Mohan, Subburaman; Xing, Weirong] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA; [Wergedal, Jon; Mohan, Subburaman] Loma Linda Univ, Dept Biochem, Loma Linda, CA 92350 USA; [Nelson, Brittany; Mohan, Subburaman] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA	Loma Linda University; Loma Linda University; Loma Linda University	Cheng, SH (corresponding author), Jerry L Pettis VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA.	Weirong.Xing@va.gov			National Institutes of Health [R21AR056833]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant R21AR056833. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Arthur A, 2011, BONE, V48, P533, DOI 10.1016/j.bone.2010.10.180; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; BECKMANN MP, 1994, EMBO J, V13, P3757, DOI 10.1002/j.1460-2075.1994.tb06685.x; Bong YS, 2007, P NATL ACAD SCI USA, V104, P17305, DOI 10.1073/pnas.0702337104; Bong YS, 2004, BIOCHEM J, V377, P499, DOI 10.1042/BJ20031449; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bush JO, 2010, GENE DEV, V24, P2068, DOI 10.1101/gad.1963210; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Edderkaoui B, 2007, GENOME RES, V17, P577, DOI 10.1101/gr.6009507; Edwards Claire M, 2008, Int J Med Sci, V5, P263; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; James MF, 2004, J CELL SCI, V117, P2951, DOI 10.1242/jcs.01156; Janckila AJ, 2001, J BONE MINER RES, V16, P788, DOI 10.1359/jbmr.2001.16.4.788; Jensen PL, 2000, STEM CELLS, V18, P63, DOI 10.1634/stemcells.18-1-63; Khadeer MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1633, DOI 10.1152/ajpcell.00580.2002; Lee HS, 2008, NAT CELL BIOL, V10, P979, DOI 10.1038/ncb1758; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; North HA, 2009, DEVELOPMENT, V136, P2467, DOI 10.1242/dev.034405; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Qin XZ, 2006, ENDOCRINOLOGY, V147, P5653, DOI 10.1210/en.2006-1055; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Thelin WR, 2005, J BIOL CHEM, V280, P41512, DOI 10.1074/jbc.M507308200; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167; Xing WR, 2007, J BIOL CHEM, V282, P22052, DOI 10.1074/jbc.M702614200; Xing WR, 2011, PHYSIOL GENOMICS, V43, P749, DOI 10.1152/physiolgenomics.00229.2010; Xing WR, 2010, MOL CELL BIOL, V30, P711, DOI 10.1128/MCB.00610-09; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	46	36	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32887	10.1371/journal.pone.0032887	http://dx.doi.org/10.1371/journal.pone.0032887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403721	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700118
J	Paschaki, M; Lin, SC; Wong, RLY; Finnell, RH; Dolle, P; Niederreither, K				Paschaki, Marie; Lin, Song-Chang; Wong, Rebecca Lee Yean; Finnell, Richard H.; Dolle, Pascal; Niederreither, Karen			Retinoic Acid-Dependent Signaling Pathways and Lineage Events in the Developing Mouse Spinal Cord	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; VERTEBRATE NEURAL-TUBE; DORSAL-ROOT GANGLIA; NERVE GROWTH-FACTOR; NEURITE OUTGROWTH; SONIC HEDGEHOG; MOTOR-NEURONS; PROGENITOR CELLS; RETINALDEHYDE DEHYDROGENASE-2; NEUROGENIN2 EXPRESSION	Studies in avian models have demonstrated an involvement of retinoid signaling in early neural tube patterning. The roles of this signaling pathway at later stages of spinal cord development are only partly characterized. Here we use Raldh2-null mouse mutants rescued from early embryonic lethality to study the consequences of lack of endogenous retinoic acid (RA) in the differentiating spinal cord. Mid-gestation RA deficiency produces prominent structural and molecular deficiencies in dorsal regions of the spinal cord. While targets of Wnt signaling in the dorsal neuronal lineage are unaltered, reductions in Fibroblast Growth Factor (FGF) and Notch signaling are clearly observed. We further provide evidence that endogenous RA is capable of driving stem cell differentiation. Raldh2 deficiency results in a decreased number of spinal cord derived neurospheres, which exhibit a reduced differentiation potential. Raldh2-null neurospheres have a decreased number of cells expressing the neuronal marker beta-III-tubulin, while the nestin-positive cell population is increased. Hence, in vivo retinoid deficiency impaired neural stem cell growth. We propose that RA has separable functions in the developing spinal cord to (i) maintain high levels of FGF and Notch signaling and (ii) drive stem cell differentiation, thus restricting both the numbers and the pluripotent character of neural stem cells.	[Paschaki, Marie; Dolle, Pascal] Univ Strasbourg, Inst Natl Sante & Rech Med U 964, Ctr Natl Rech Sci UMR 7104, Dev & Stem Cells Dept,Inst Genet & Biol Mol & Cel, Illkirch Graffenstaden, France; [Lin, Song-Chang] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Wong, Rebecca Lee Yean] Texas A&M Univ Syst Hlth Sci Ctr, Inst Biosci & Technol, Ctr Environm & Genet Med, Houston, TX USA; [Finnell, Richard H.; Niederreither, Karen] Univ Texas Austin, Dept Nutr Sci, Dell Pediat Res Inst, Austin, TX 78712 USA; [Lin, Song-Chang] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin; Baylor College of Medicine	Paschaki, M (corresponding author), Univ Strasbourg, Inst Natl Sante & Rech Med U 964, Ctr Natl Rech Sci UMR 7104, Dev & Stem Cells Dept,Inst Genet & Biol Mol & Cel, Illkirch Graffenstaden, France.	karenn@austin.utexas.edu	Dolle, Pascal/A-8037-2010; Finnell, Richard/D-8174-2018	Dolle, Pascal/0000-0002-9294-9090; Finnell, Richard/0000-0002-5962-8754; Paschaki, Marie/0000-0002-9490-8997	National Institute of Health [R01 HL070733]; Agence Nationale de la Recherche (ANR Neurosciences); Fondation pour la Recherche Medicale; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070733] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche (ANR Neurosciences)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health (R01 HL070733), Agence Nationale de la Recherche (ANR Neurosciences), and Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2010, BIRTH DEFECTS RES A, V88, P895, DOI 10.1002/bdra.20721; Agudo M, 2010, NEUROBIOL DIS, V37, P147, DOI 10.1016/j.nbd.2009.09.018; Akai J, 2005, GENE DEV, V19, P2877, DOI 10.1101/gad.357705; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Bertrand N, 2000, DEVELOPMENT, V127, P4837; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; Castillo HA, 2010, DEVELOPMENT, V137, P507, DOI 10.1242/dev.043257; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Chen F, 2007, DEVELOPMENT IN PRESS; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Chotteau-Lelievre Anne, 2006, Methods Mol Biol, V326, P61; Chudley AE, 2005, CAN MED ASSOC J, V172, pS1, DOI 10.1503/cmaj.1040302; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; Corcoran J, 1999, NAT NEUROSCI, V2, P307, DOI 10.1038/7214; Corcoran J, 2002, J CELL SCI, V115, P4735, DOI 10.1242/jcs.00169; Corcoran J, 2002, J CELL SCI, V115, P3779, DOI 10.1242/jcs.00046; Corcoran J, 2000, J CELL SCI, V113, P2567; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gaspard N, 2010, CURR OPIN NEUROBIOL, V20, P37, DOI 10.1016/j.conb.2009.12.001; Genethliou N, 2009, BIOCHEM BIOPH RES CO, V390, P1114, DOI 10.1016/j.bbrc.2009.08.154; Goez HR, 2011, J CHILD NEUROL, V26, P231, DOI 10.1177/0883073810380458; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goodman AB, 2003, P NATL ACAD SCI USA, V100, P2901, DOI 10.1073/pnas.0437937100; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Haskell GT, 2005, J NEUROSCI, V25, P7636, DOI 10.1523/JNEUROSCI.0485-05.2005; Hatakeyama J, 2006, DEV NEUROSCI-BASEL, V28, P92, DOI 10.1159/000090756; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Jarvis CI, 2010, EUR J NEUROSCI, V32, P1246, DOI 10.1111/j.1460-9568.2010.07426.x; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Ji SJ, 2006, DEV BIOL, V297, P249, DOI 10.1016/j.ydbio.2006.05.015; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Leung C, 2012, STEM CELLS DEV; Lewis J, 1998, NATURE, V393, P304, DOI 10.1038/30597; Li P, 2010, DEV CELL, V18, P480, DOI 10.1016/j.devcel.2009.12.019; Lillien L, 2000, DEVELOPMENT, V127, P4993; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Maden M, 1997, DEVELOPMENT, V124, P2799; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Maden M, 2006, J NEUROBIOL, V66, P726, DOI 10.1002/neu.20248; Martinez-Morales PL, 2011, J CELL BIOL, V194, P489, DOI 10.1083/jcb.201011077; Mey J, 2006, J NEUROBIOL, V66, P757, DOI 10.1002/neu.20238; Mic FA, 2002, DEVELOPMENT, V129, P2271; Molotkova N, 2005, MECH DEVELOP, V122, P145, DOI 10.1016/j.mod.2004.10.008; Muley PD, 2008, DEV NEUROBIOL, V68, P1441, DOI 10.1002/dneu.20670; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Namba T, 2009, GLIA, V57, P1082, DOI 10.1002/glia.20831; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2002, P NATL ACAD SCI USA, V99, P16111, DOI 10.1073/pnas.252626599; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Peljto M, 2011, CURR OPIN NEUROBIOL, V21, P43, DOI 10.1016/j.conb.2010.09.012; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Plachta N, 2004, DEVELOPMENT, V131, P5449, DOI 10.1242/dev.01420; Plum LA, 2001, EXP BIOL MED, V226, P766, DOI 10.1177/153537020222600809; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Rabadan MA, 2011, CELL DEATH DIFFER; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204; Ribes V, 2008, DEV BIOL, V321, P470, DOI 10.1016/j.ydbio.2008.06.003; Ribes V, 2009, DEVELOPMENT, V136, P665, DOI 10.1242/dev.016204; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Rubert G, 2006, J NEUROSCI RES, V84, P483, DOI 10.1002/jnr.20963; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Scuteri A, 2010, NEUROSCI LETT, V486, P141, DOI 10.1016/j.neulet.2010.09.028; Shimojo H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00078; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Simmons AD, 2001, DEV BIOL, V229, P327, DOI 10.1006/dbio.2000.9984; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Skaggs K, 2011, DEVELOPMENT, V138, P3199, DOI 10.1242/dev.057281; So PL, 2006, DEV BIOL, V298, P167, DOI 10.1016/j.ydbio.2006.06.027; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; TOSNEY KW, 1995, BIOESSAYS, V17, P379, DOI 10.1002/bies.950170503; Ulloa F, 2010, DEV DYNAM, V239, P69, DOI 10.1002/dvdy.22058; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, DEVELOPMENT, V132, P1611, DOI 10.1242/dev.01718; White FA, 1996, J NEUROSCI, V16, P4662; Wilson L, 2004, DEV BIOL, V269, P433, DOI 10.1016/j.ydbio.2004.01.034; Wong LF, 2006, NAT NEUROSCI, V9, P243, DOI 10.1038/nn1622; Yelin R, 2005, DEV BIOL, V279, P193, DOI 10.1016/j.ydbio.2004.12.014; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	110	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32447	10.1371/journal.pone.0032447	http://dx.doi.org/10.1371/journal.pone.0032447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396766	Green Published, gold, Green Submitted			2022-12-25	WOS:000303006500018
J	Murfuni, I; Nicolai, S; Baldari, S; Crescenzi, M; Bignami, M; Franchitto, A; Pichierri, P				Murfuni, I.; Nicolai, S.; Baldari, S.; Crescenzi, M.; Bignami, M.; Franchitto, A.; Pichierri, P.			The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation	ONCOGENE			English	Article						RecQ helicases; replication fork arrest; genome instability; Werner syndrome	DNA-DAMAGE RESPONSE; WERNERS-SYNDROME PROTEIN; REPLICATION FORK; S-PHASE; HOMOLOGOUS RECOMBINATION; SYNTHETIC LETHALITY; CANCER DEVELOPMENT; HELICASE ACTIVITY; DEPENDENT MANNER; DOWN-REGULATION	Oncogene-induced replication stress is recognized as the primary cause of accumulation of DNA damage and genome instability in precancerous cells. Although the molecular mechanisms responding to such type of replication perturbation are not fully characterized, it has been speculated that their dysfunction may enhance genonne instability and accelerate tumor progression. Here, we show that the WRN protein, a member of the human RecQ helicases, is necessary to sustain replication fork progression in response to oncogene-induced replication stress. Loss of WRN affects cell cycle progression and results in enhanced accumulation of double-strand breaks and instability at common fragile sites in cells experiencing oncogene-induced replication stress. Moreover, we demonstrate that double-strand breaks, observed upon oncogene over-expression, depend on the MUS81 endonuclease, which represents a parallel pathway collaborating with WRN to prevent cell death. Overall, our findings give insights into the mechanisms protecting replication forks in cells experiencing oncogene-induced replication stress, and identify factor\s that, when mutated or dysfunctional, may enhance genome instability in precancerous cells. In addition, because concomitant depletion of WRN and MUS81 causes synthetic sickness in cells growing under oncogene-induced replication stress, our results support the possibility of targeting cancer cells with an impaired replication fork recovery pathway by a specific inactivation of the other parallel pathway. Oncogene (2013) 32, 610-620; doi:10.1038/onc.2012.80; published online 12 March 2012	[Murfuni, I.; Nicolai, S.; Bignami, M.; Pichierri, P.] Ist Super Sanita, Sect Expt & Computat Carcinogenesis, I-00161 Rome, Italy; [Baldari, S.; Franchitto, A.] Ist Super Sanita, Sect Mol Epidemiol, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Crescenzi, M.] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Franchitto, A (corresponding author), Ist Super Sanita, Dept Primary Prevent, Sect Expt Carcinogenesis, Viale Regina Elena 299, I-00161 Rome, Italy.	annapaola.franchitto@iss.it; pietro.pichierri@iss.it	Pichierri, Pietro/AAA-5476-2021; Crescenzi, Marco/J-3603-2018; Baldari, Silvia/AAA-5959-2021; Franchitto, Annapaola/K-7564-2016	Pichierri, Pietro/0000-0002-2702-3523; Crescenzi, Marco/0000-0003-0156-1494; Baldari, Silvia/0000-0001-7982-9468; Franchitto, Annapaola/0000-0003-4232-4727	Association for International Cancer Research [07-497]; Associazione ltaliana per la Ricerca sul Cancro (AIRC) [IG 9294, IG 4400]	Association for International Cancer Research; Associazione ltaliana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	We are grateful to Dr Pavel Janscak for providing the siRNAs and antibody against RECQ5. We also thank Drs D Toniolo and M Rocchi for providing bacterial artificial chromosomes for FISH analysis. This work was supported by a grant from the Association for International Cancer Research (Grant 07-497) to PP. and by grants from Associazione ltaliana per la Ricerca sul Cancro (AIRC) to PP. (IG 9294) and A.F. (IG 4400).	Aggarwal M, 2011, P NATL ACAD SCI USA, V108, P1525, DOI 10.1073/pnas.1006423108; Agrelo R, 2006, P NATL ACAD SCI USA, V103, P8822, DOI 10.1073/pnas.0600645103; Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 1997, EXP CELL RES, V237, P1, DOI 10.1006/excr.1997.3776; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Duker NJ, 2002, AM J MED GENET, V115, P125, DOI 10.1002/ajmg.10688; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Franchitto A, 2002, HUM MOL GENET, V11, P2447, DOI 10.1093/hmg/11.20.2447; Franchitto A, 2003, CANCER RES, V63, P3289; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Froget B, 2008, MOL BIOL CELL, V19, P445, DOI 10.1091/mbc.E07-07-0728; Gilad O, 2010, CANCER RES, V70, P9693, DOI 10.1158/0008-5472.CAN-10-2286; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Latella L, 2001, MOL CELL BIOL, V21, P5631, DOI 10.1128/MCB.21.16.5631-5643.2001; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Lopez-Contreras AJ, 2010, DNA REPAIR, V9, P1249, DOI 10.1016/j.dnarep.2010.09.012; Mao FJ, 2010, CANCER RES, V70, P6548, DOI 10.1158/0008-5472.CAN-10-0475; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; OLIVE PL, 1991, CANCER RES, V51, P4671; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; Pichierri P, 2011, AGING-US, V3, P311, DOI 10.18632/aging.100293; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Schwendener S, 2010, J BIOL CHEM, V285, P15739, DOI 10.1074/jbc.M110.110478; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Trowbridge K, 2007, GENETICS, V176, P1993, DOI 10.1534/genetics.106.070060; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wu F, 2011, CANCER SCI, V102, P472, DOI 10.1111/j.1349-7006.2010.01790.x; Wu F, 2010, ANTICANCER RES, V30, P5011; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yuan SSF, 2003, MUTAT RES-FUND MOL M, V525, P85, DOI 10.1016/S0027-5107(03)00009-5	54	35	37	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2013	32	5					610	620		10.1038/onc.2012.80	http://dx.doi.org/10.1038/onc.2012.80			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22410776				2022-12-25	WOS:000316164700008
J	Meijnen, JP; de Winde, JH; Ruijssenaars, HJ				Meijnen, Jean-Paul; de Winde, Johannes H.; Ruijssenaars, Harald J.			Metabolic and Regulatory Rearrangements Underlying Efficient D-Xylose Utilization in Engineered Pseudomonas putida S12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; L-ARABINOSE; CORYNEBACTERIUM-GLUTAMICUM; CATABOLITE REPRESSION; GLUCOSE-METABOLISM; ZYMOMONAS-MOBILIS; ESCHERICHIA-COLI; PATHWAY; FERMENTATION; BACTERIOPHAGE-P1	Previously, an efficient D-xylose utilizing Pseudomonas putida S12 strain was obtained by introducing the D-xylose isomerase pathway from Escherichia coli, followed by evolutionary selection. In the present study, systemic changes associated with the evolved phenotype were identified by transcriptomics, enzyme activity analysis, and inverse engineering. A key element in improving the initially poor D-xylose utilization was the redistribution of 6-phospho-D-gluconate (6-PG) between the Entner-Doudoroff pathway and the oxidative pentose phosphate (PP) pathway. This redistribution increased the availability of 6-PG for oxidative decarboxylation to D-ribose-5-phosphate, which is essential for the utilization of D-xylose via the nonoxidative PP pathway. The metabolic redistribution of 6-PG was procured by modified HexR regulation, which in addition appeared to control periplasmic sugar oxidation. Because the absence of periplasmic D-xylonate formation was previously demonstrated to be essential for achieving a high biomass yield on D-xylose, the aberrant HexR control appeared to underlie both the improved growth rate and biomass yield of the evolved D-xylose utilizing P. putida strain. The increased oxidative PP pathway activity furthermore resulted in an elevated NADH/NAD(+) ratio that caused the metabolic flux to be redirected from the TCA cycle to the glyoxylate shunt, which was also activated transcriptionally. Clearly, these findings may serve as an important case in point to engineer and improve the utilization of non-natural carbon sources in a wide range of industrial microorganisms.	[Meijnen, Jean-Paul; de Winde, Johannes H.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Meijnen, Jean-Paul; de Winde, Johannes H.; Ruijssenaars, Harald J.] Biobased Sustainable Ind Chem B Basic, NL-2628 BC Delft, Netherlands; [Meijnen, Jean-Paul; de Winde, Johannes H.; Ruijssenaars, Harald J.] Kluyver Ctr Genom Ind Fermentat, NL-2600 GA Delft, Netherlands; [Ruijssenaars, Harald J.] BIRD Engn BV, NL-3115 HG Schiedam, Netherlands	Delft University of Technology	de Winde, JH (corresponding author), Delft Univ Technol, Dept Biotechnol, Julianalaan 67, NL-2628 BC Delft, Netherlands.	J.H.DeWinde@tudelft.nl	Meijnen, Jean-Paul/AAC-5553-2020; de Winde, J.H./AAC-5520-2021	de Winde, J.H./0000-0002-7999-9317	Netherlands Ministry of Economic Affairs; B-Basic	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic	This work was supported by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations through B-Basic, a public-private NWO-Advanced Chemical Technologies for Sustainability program.	[Anonymous], 1982, MOL CLONING LAB MANU; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Daddaoua A, 2009, J BIOL CHEM, V284, P21360, DOI 10.1074/jbc.M109.014555; Deanda K, 1996, APPL ENVIRON MICROB, V62, P4465, DOI 10.1128/AEM.62.12.4465-4470.1996; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Gonzalez R, 2002, BIOTECHNOL PROGR, V18, P6, DOI 10.1021/bp010121i; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; HARTMANS S, 1989, APPL ENVIRON MICROB, V55, P2850, DOI 10.1128/AEM.55.11.2850-2855.1989; Kawaguchi H, 2008, APPL MICROBIOL BIOT, V77, P1053, DOI 10.1007/s00253-007-1244-x; Kawaguchi H, 2006, APPL ENVIRON MICROB, V72, P3418, DOI 10.1128/AEM.72.5.3418-3428.2006; Kim J, 2008, MICROBIOL-SGM, V154, P3905, DOI 10.1099/mic.0.2008/020362-0; Koopman F, 2010, P NATL ACAD SCI USA, V107, P4919, DOI 10.1073/pnas.0913039107; Kuyper M, 2005, FEMS YEAST RES, V5, P925, DOI 10.1016/j.femsyr.2005.04.004; Lange JP, 2007, BIOFUEL BIOPROD BIOR, V1, P39, DOI 10.1002/bbb.7; Lee JW, 2011, TRENDS BIOTECHNOL, V29, P370, DOI 10.1016/j.tibtech.2011.04.001; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; MATSUSHITA K, 1995, BIOSCI BIOTECH BIOCH, V59, P1548, DOI 10.1271/bbb.59.1548; Meijnen JP, 2008, APPL ENVIRON MICROB, V74, P5031, DOI 10.1128/AEM.00924-08; Meijnen JP, 2011, INT SUGAR J, V113, P24; Meijnen JP, 2009, APPL ENVIRON MICROB, V75, P2784, DOI 10.1128/AEM.02713-08; Milanesio P, 2011, ENVIRON MICROBIOL, V13, P324, DOI 10.1111/j.1462-2920.2010.02331.x; Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07; Nijkamp K, 2005, APPL MICROBIOL BIOT, V69, P170, DOI 10.1007/s00253-005-1973-7; Nijkamp K, 2007, APPL MICROBIOL BIOT, V74, P617, DOI 10.1007/s00253-006-0703-0; Octave S, 2009, BIOCHIMIE, V91, P659, DOI 10.1016/j.biochi.2009.03.015; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; TRIAS J, 1988, BIOCHIM BIOPHYS ACTA, V938, P493, DOI 10.1016/0005-2736(88)90148-4; van Maris AJA, 2007, ADV BIOCHEM ENG BIOT, V108, P179, DOI 10.1007/10_2007_057; Van Vleet JH, 2009, CURR OPIN BIOTECH, V20, P300, DOI 10.1016/j.copbio.2009.06.001; Verhoef S, 2007, J BIOTECHNOL, V132, P49, DOI 10.1016/j.jbiotec.2007.08.031; Verhoef S, 2009, APPL ENVIRON MICROB, V75, P931, DOI 10.1128/AEM.02186-08; Wierckx NJP, 2008, J BACTERIOL, V190, P2822, DOI 10.1128/JB.01379-07; Wierckx NJP, 2005, APPL ENVIRON MICROB, V71, P8221, DOI 10.1128/AEM.71.12.8221-8227.2005; Wisselink HW, 2007, APPL ENVIRON MICROB, V73, P4881, DOI 10.1128/AEM.00177-07; Wisselink HW, 2009, APPL ENVIRON MICROB, V75, P907, DOI 10.1128/AEM.02268-08; Yanase H, 2007, APPL ENVIRON MICROB, V73, P2592, DOI 10.1128/AEM.02302-06; ZHANG M, 1995, SCIENCE, V267, P240, DOI 10.1126/science.267.5195.240	43	14	14	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14606	14614		10.1074/jbc.M111.337501	http://dx.doi.org/10.1074/jbc.M111.337501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22416130	Green Published, hybrid			2022-12-25	WOS:000304003200027
J	Mohib, K; AlKhamees, B; Zein, HS; Allan, D; Wang, LS				Mohib, Kanishka; AlKhamees, Bodour; Zein, Haggag S.; Allan, David; Wang, Lisheng			Embryonic Stem Cell-Derived Factors Inhibit T Effector Activation and Induce T Regulatory Cells by Suppressing PKC-theta Activation	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; DIFFERENTIATED DERIVATIVES; IMMUNE PRIVILEGE; MOUSE STO; EXPRESSION; PREIMPLANTATION; TRANSPLANTATION; RECRUITMENT; GROWTH; NFAT	Embryonic stem cells (ESCs) possess immune privileged properties and have the capacity to modulate immune activation. However, the mechanisms by which ESCs inhibit immune activation remain mostly unknown. We have previously shown that ESC-derived factors block dendritic cell maturation, thereby indirectly affecting T cell activation. Here, we show that ESC-derived factors also directly affect T cell activation. We provide the first demonstration that ESC-derived factors significantly down-regulated the expressions of IL-2 and IFN-gamma, while markedly up-regulating the expression of IL-10, TGF-beta, and Treg transcription factor Foxp3 in CD4+ CD25+ T cells. Furthermore, ESC-derived factors robustly suppressed T cell proliferation in response to the protein kinase C-h (PKC-theta) activator phorbol 12-myristate 13-acetate (PMA). Western blot analysis indicated that ESC-derived factors prevented PKC-theta phosphorylation without influencing total PKC-theta levels. Moreover, I kappa B-alpha degradation was abrogated, confirming absence of PKC-theta activity. The impact of ESC-derived factors on PKC-theta activation appeared to be specific since other upstream T cell signaling components were not affected. In conclusion, ESCs appear to directly impact T cell activation and polarization by negatively regulating the PKC-theta pathway.	[Mohib, Kanishka; AlKhamees, Bodour; Zein, Haggag S.; Allan, David; Wang, Lisheng] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Allan, David; Wang, Lisheng] Univ Ottawa, Ottawa Hlth Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Wang, Lisheng] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Mohib, K (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	lwang@uottawa.ca	Mohib, Kanishka/H-2528-2017	Mohib, Kanishka/0000-0002-7332-5530; Zein, Sharif/0000-0002-8863-1450; Allan, David/0000-0003-3261-8289	Canadian Institutes of Health Research (CIHR) [MOP-220632, MSH-166732]; Ontario Government; Department of Medicine, University of Ottawa; Canadian Blood Services (CBS); King Saud Bin Abdulaziz University for Health Sciences	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Government; Department of Medicine, University of Ottawa; Canadian Blood Services (CBS); King Saud Bin Abdulaziz University for Health Sciences	This work was supported by operating grants from the Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca/e/193.html MOP-220632) to LW, CIHR New Investigator Awards to LW (MSH-166732) and to DA (MSH-196457), an Early Research Award from the Ontario Government (http://www.mri.gov.on.ca/english/programs/era/program.asp) to LW and a Research Award from the Department of Medicine, University of Ottawa to DA. KM is supported by the Canadian Blood Services (CBS http://www.bloodservices.ca/) Graduate Fellowship Scholarship program, BA by King Saud Bin Abdulaziz University for Health Sciences Scholarship program (also an employee of King Saud Bin Abdulaziz University for Health Sciences, College of Medicine) and DA is an Adjunct Scientist with CBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; BERNSTINE EG, 1973, P NATL ACAD SCI USA, V70, P3899, DOI 10.1073/pnas.70.12.3899; BONNARD GD, 1979, J IMMUNOL, V123, P2704; BUDD RC, 1987, J IMMUNOL, V138, P3120; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; ISAKOV N, 1987, J IMMUNOL, V138, P3100; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Koch CA, 2008, STEM CELLS, V26, P89, DOI 10.1634/stemcells.2007-0151; Koch KS, 2006, IMMUNOLOGY, V119, P98, DOI 10.1111/j.1365-2567.2006.02412.x; Kriegel MA, 2009, P NATL ACAD SCI USA, V106, P16770, DOI 10.1073/pnas.0908957106; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Magliocca JF, 2006, STEM CELLS DEV, V15, P707, DOI 10.1089/scd.2006.15.707; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mohib K, 2010, STEM CELL REV REP, V6, P611, DOI 10.1007/s12015-010-9185-7; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Passalacqua M, 2009, ARCH BIOCHEM BIOPHYS, V481, P202, DOI 10.1016/j.abb.2008.11.013; Rambhatla L, 2003, CELL TRANSPLANT, V12, P1, DOI 10.3727/000000003783985179; Reddy RC, 2005, PROTEIN SCI, V14, P929, DOI 10.1110/ps.041085005; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; SOLTER D, 1970, NATURE, V227, P503, DOI 10.1038/227503a0; Soto-Nieves N, 2009, J EXP MED, V206, P867, DOI 10.1084/jem.20082731; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; TESTI R, 1989, J IMMUNOL, V143, P1123; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TOURAINE JL, 1977, J EXP MED, V145, P460, DOI 10.1084/jem.145.2.460; Valenzuela JO, 2009, J CLIN INVEST, V119, P3774, DOI 10.1172/JCI39692; Verloes A, 2011, J IMMUNOL, V186, P2663, DOI 10.4049/jimmunol.1001081; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Weiss A, 1991, Semin Immunol, V3, P313; Wu DC, 2008, STEM CELLS, V26, P1939, DOI 10.1634/stemcells.2008-0078; Yachimovich-Cohen N, 2010, J IMMUNOL, V184, P1300, DOI 10.4049/jimmunol.0804261; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhang MJ, 2005, STEM CELLS, V23, P186, DOI 10.1634/stemcells.2004-0129	49	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32420	10.1371/journal.pone.0032420	http://dx.doi.org/10.1371/journal.pone.0032420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412871	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800018
J	Roderburg, C; Mollnow, T; Bongaerts, B; Elfimova, N; Cardenas, DV; Berger, K; Zimmermann, H; Koch, A; Vucur, M; Luedde, M; Hellerbrand, C; Odenthal, M; Trautwein, C; Tacke, F; Luedde, T				Roderburg, Christoph; Mollnow, Tobias; Bongaerts, Brenda; Elfimova, Natalia; Cardenas, David Vargas; Berger, Katharina; Zimmermann, Henning; Koch, Alexander; Vucur, Mihael; Luedde, Mark; Hellerbrand, Claus; Odenthal, Margarete; Trautwein, Christian; Tacke, Frank; Luedde, Tom			Micro-RNA Profiling in Human Serum Reveals Compartment-Specific Roles of miR-571 and miR-652 in Liver Cirrhosis	PLOS ONE			English	Article							STELLATE CELL ACTIVATION; CIRCULATING MICRORNAS; EXPRESSION; BIOMARKERS; FIBROSIS; CANCER; TISSUE; IDENTIFICATION; MIR-29	Background and Aims: Micro-RNAs (miRNAs) have recently emerged as crucial modulators of molecular processes involved in chronic liver diseases. The few miRNAs with previously proposed roles in liver cirrhosis were identified in screening approaches on liver parenchyma, mostly in rodent models. Therefore, in the present study we performed a systematic screening approach in order to identify miRNAs with altered levels in the serum of patients with chronic liver disease and liver cirrhosis. Methods: We performed a systematic, array-based miRNA expression analysis on serum samples from patients with liver cirrhosis. In functional experiments we evaluated the relationship between alterations of miRNA serum levels and their role in distinct cellular compartments involved in hepatic cirrhosis. Results: The array analysis and the subsequent confirmation by qPCR in a larger patient cohort identified significant alterations in serum levels of miR-513-3p, miR-571 and miR-652, three previously uncharacterized miRNAs, in patients with alcoholic or hepatitis C induced liver cirrhosis. Of these, miR-571 serum levels closely correlated with disease stages, thus revealing potential as a novel biomarker for hepatic cirrhosis. Further analysis revealed that up-regulation of miR-571 in serum reflected a concordant regulation in cirrhotic liver tissue. In isolated primary human liver cells, miR-571 was up-regulated in human hepatocytes and hepatic stellate cells in response to the pro-fibrogenic cytokine TGF-beta. In contrast, alterations in serum levels of miR-652 were stage-independent, reflecting a concordant down-regulation of this miRNA in circulating monocytes of patients with liver cirrhosis, which was inducible by proinflammatory stimuli like bacterial lipopolysaccharide. Conclusion: Alterations of miR571 and miR-652 serum levels in patients with chronic liver disease reflect their putative roles in the mediation of fibrogenic and inflammatory processes in distinct cellular compartments involved in the pathogenesis of liver cirrhosis.	[Roderburg, Christoph; Mollnow, Tobias; Cardenas, David Vargas; Berger, Katharina; Zimmermann, Henning; Koch, Alexander; Vucur, Mihael; Trautwein, Christian; Tacke, Frank; Luedde, Tom] Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany; [Bongaerts, Brenda] Maastricht Univ Med Ctr, Dept Pathol, Maastricht, Netherlands; [Elfimova, Natalia; Odenthal, Margarete] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Luedde, Mark] Univ Kiel, Dept Cardiol & Angiol, Kiel, Germany; [Hellerbrand, Claus] Univ Regensburg, Dept Internal Med 1, Regensburg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Maastricht University; Maastricht University Medical Centre (MUMC); University of Cologne; University of Kiel; University of Regensburg	Roderburg, C (corresponding author), Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany.	tluedde@ukaachen.de	Roderburg, Christoph/AHC-8101-2022; Tacke, Frank/ABF-2212-2020; Roderburg, Christoph/AAR-3051-2021; Luedde, Tom/AAE-9135-2022	Roderburg, Christoph/0000-0002-1409-7697; Luedde, Tom/0000-0002-6288-8821; Janssen, Katharina/0000-0002-7589-9722	German Research Foundation [SFB-TRR57 P06, P09, Ta434/2-1]; European Research Council [ERC-2007-Stg/208237-Luedde-Med3-Aachen]; Interdisciplinary Centre for Clinical Research (IZKF) "BIOMAT''; medical faculty Aachen	German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Interdisciplinary Centre for Clinical Research (IZKF) "BIOMAT''; medical faculty Aachen	This work was supported by the German Research Foundation (SFB-TRR57 P06 and P09, Ta434/2-1), a starting grant of the European Research Council within the FP 7 (ERC-2007-Stg/208237-Luedde-Med3-Aachen), the Interdisciplinary Centre for Clinical Research (IZKF) "BIOMAT'' and a grant from the START-program of the medical faculty Aachen to C.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2011, J INFECT DIS, V203, P1753, DOI 10.1093/infdis/jir186; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bihrer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026971; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Gieling RG, 2008, CLIN LIVER DIS, V12, P915, DOI 10.1016/j.cld.2008.07.001; Gressner OA, 2008, J HEPATOL, V49, P758, DOI 10.1016/j.jhep.2008.03.029; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Li YP, 2011, P NATL ACAD SCI USA, V108, P4991, DOI 10.1073/pnas.1016606108; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Mendrick DL, 2011, PHARMACOGENOMICS, V12, P235, DOI 10.2217/PGS.10.184; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Sekiya Y, 2011, BIOCHEM BIOPH RES CO, V412, P74, DOI 10.1016/j.bbrc.2011.07.041; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wanninger J, 2011, FEBS LETT, V585, P1338, DOI 10.1016/j.febslet.2011.04.003; Wu XL, 2008, WORLD J GASTROENTERO, V14, P2100, DOI 10.3748/wjg.14.2100; Xie T, 2011, PHYSIOL GENOMICS, V43, P479, DOI 10.1152/physiolgenomics.00222.2010; Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	39	82	84	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32999	10.1371/journal.pone.0032999	http://dx.doi.org/10.1371/journal.pone.0032999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412969	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800071
J	Biesbroek, G; Sanders, EAM; Roeselers, G; Wang, XH; Caspers, MPM; Trzcinski, K; Bogaert, D; Keijser, BJF				Biesbroek, Giske; Sanders, Elisabeth A. M.; Roeselers, Guus; Wang, Xinhui; Caspers, Martien P. M.; Trzcinski, Krzysztof; Bogaert, Debby; Keijser, Bart J. F.			Deep Sequencing Analyses of Low Density Microbial Communities: Working at the Boundary of Accurate Microbiota Detection	PLOS ONE			English	Article							HUMAN GASTROINTESTINAL-TRACT; CYCLE NUMBER; BACTERIAL; PCR; DNA; TIME; PROJECT; SAMPLES	Introduction: Accurate analyses of microbiota composition of low-density communities (10(3) - 10(4) bacteria/sample) can be challenging. Background DNA from chemicals and consumables, extraction biases as well as differences in PCR efficiency can significantly interfere with microbiota assessment. This study was aiming to establish protocols for accurate microbiota analysis at low microbial density. Methods: To examine possible effects of bacterial density on microbiota analyses we compared microbiota profiles of serial diluted saliva and low (nares, nasopharynx) and high-density (oropharynx) upper airway communities in four healthy individuals. DNA was extracted with four different extraction methods (Epicentre Masterpure, Qiagen DNeasy, Mobio Powersoil and a phenol bead-beating protocol combined with Agowa-Mag-mini). Bacterial DNA recovery was analysed by 16S qPCR and microbiota profiles through GS-FLX-Titanium-Sequencing of 16S rRNA gene amplicons spanning the V5-V7 regions. Results: Lower template concentrations significantly impacted microbiota profiling results. With higher dilutions, low abundant species were overrepresented. In samples of < 10(5) bacteria per ml, e.g. DNA < 1 pg/mu l, microbiota profiling deviated from the original sample and other dilutions showing a significant increase in the taxa Proteobacteria and decrease in Bacteroidetes. In similar low density samples, DNA extraction method determined if DNA levels were below or above 1 pg/mu l and, together with lysis preferences per method, had profound impact on microbiota analyses in both relative abundance as well as representation of species. Conclusion: This study aimed to interpret microbiota analyses of low-density communities. Bacterial density seemed to interfere with microbiota analyses at < than 10(6) bacteria per ml or DNA < 1 pg/mu l. We therefore recommend this threshold for working with low density materials. This study underlines that bias reduction is crucial for adequate profiling of especially low-density bacterial communities.	[Biesbroek, Giske; Sanders, Elisabeth A. M.; Wang, Xinhui; Trzcinski, Krzysztof; Bogaert, Debby] Dept Pediat Infect Dis & Immun UMC Utrecht, Utrecht, Netherlands; [Roeselers, Guus; Caspers, Martien P. M.; Keijser, Bart J. F.] TNO Earth Environm & Life Sci, Res Grp Microbiol & Syst Biol, Zeist, Netherlands	Netherlands Organization Applied Science Research	Biesbroek, G (corresponding author), Dept Pediat Infect Dis & Immun UMC Utrecht, Utrecht, Netherlands.	dbogaert@umcutrecht.nl	Trzcinski, Krzysztof/I-8840-2019; Roeselers, Guus/J-2971-2012; Keijser, Bart J f/C-5402-2012	Trzcinski, Krzysztof/0000-0002-5433-8846; Roeselers, Guus/0000-0002-4725-6105; Bogaert, Debby/0000-0003-2651-7000	Netherlands Organisation for Scientific Research through NWO-VENI [91610121]; Netherlands Organisation for Scientific Research through ZonMw [91209010]; EU [Antiresdev 241446]	Netherlands Organisation for Scientific Research through NWO-VENI; Netherlands Organisation for Scientific Research through ZonMw; EU(European Commission)	This work was supported by grants from The Netherlands Organisation for Scientific Research through NWO-VENI grant 91610121 (DB) and ZonMw grant 91209010 (XW and GB) and EU FP7 grant Antiresdev 241446 (BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hayward AL, 1998, NUCLEIC ACIDS RES, V26, P2511, DOI 10.1093/nar/26.11.2511; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Klaschik S, 2002, MOL BIOTECHNOL, V22, P231, DOI 10.1385/MB:22:3:231; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Muhl H, 2010, DIAGN MICR INFEC DIS, V66, P41, DOI 10.1016/j.diagmicrobio.2008.07.011; Parker CT, 2009, CELL MICROBIOL, V11, P363, DOI 10.1111/j.1462-5822.2008.01272.x; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Tanner MA, 1998, APPL ENVIRON MICROB, V64, P3110; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Zoetendal EG, 2001, SYST APPL MICROBIOL, V24, P405, DOI 10.1078/0723-2020-00060; Zoetendal EG, 2006, NAT PROTOC, V1, P870, DOI 10.1038/nprot.2006.142	31	131	136	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32942	10.1371/journal.pone.0032942	http://dx.doi.org/10.1371/journal.pone.0032942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412957	Green Submitted, Green Published, gold			2022-12-25	WOS:000303021100043
J	Devi, L; Alldred, MJ; Ginsberg, SD; Ohno, M				Devi, Latha; Alldred, Melissa J.; Ginsberg, Stephen D.; Ohno, Masuo			Mechanisms Underlying Insulin Deficiency-Induced Acceleration of beta-Amyloidosis in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; A-BETA; DIABETES-MELLITUS; SIGNALING PATHWAY; MEMORY DEFICITS; BRAIN INSULIN; NEURON LOSS; SECRETASE; PROTEIN; IMPAIRMENT	Although evidence is accumulating that diabetes mellitus is an important risk factor for sporadic Alzheimer's disease (AD), the mechanisms by which defects in insulin signaling may lead to the acceleration of AD progression remain unclear. In this study, we applied streptozotocin (STZ) to induce experimental diabetes in AD transgenic mice (5XFAD model) and investigated how insulin deficiency affects the beta-amyloidogenic processing of amyloid precursor protein (APP). Two and half months after 5XFAD mice were treated with STZ (90 mg/kg, i.p., once daily for two consecutive days), they showed significant reductions in brain insulin levels without changes in insulin receptor expression. Concentrations of cerebral amyloid-beta peptides (A beta 40 and A beta 42) were significantly increased in STZ-treated 5XFAD mice as compared with vehicle-treated 5XFAD controls. Importantly, STZ-induced insulin deficiency upregulated levels of both beta-site APP cleaving enzyme 1 (BACE1) and full-length APP in 5XFAD mouse brains, which was accompanied by dramatic elevations in the beta-cleaved C-terminal fragment (C99). Interestingly, BACE1 mRNA levels were not affected, whereas phosphorylation of the translation initiation factor eIF2 alpha, a mechanism proposed to mediate the post-transcriptional upregulation of BACE1, was significantly elevated in STZ-treated 5XFAD mice. Meanwhile, levels of GGA3, an adapter protein responsible for sorting BACE1 to lysosomal degradation, are indistinguishable between STZ- and vehicle-treated 5XFAD mice. Moreover, STZ treatments did not affect levels of A beta-degrading enzymes such as neprilysin and insulin-degrading enzyme (IDE) in 5XFAD brains. Taken together, our findings provide a mechanistic foundation for a link between diabetes and AD by demonstrating that insulin deficiency may change APP processing to favor beta-amyloidogenesis via the translational upregulation of BACE1 in combination with elevations in its substrate, APP.	[Devi, Latha; Alldred, Melissa J.; Ginsberg, Stephen D.; Ohno, Masuo] Ctr Dementia Res, Nathan Kline Inst, Orangeburg, NY USA; [Alldred, Melissa J.; Ginsberg, Stephen D.; Ohno, Masuo] NYU, Langone Med Ctr, Dept Psychiat, New York, NY USA; [Ginsberg, Stephen D.] NYU, Langone Med Ctr, Dept Physiol & Neurosci, New York, NY USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Devi, L (corresponding author), Ctr Dementia Res, Nathan Kline Inst, Orangeburg, NY USA.	mohno@nki.rfmh.org	, SDG/AAB-3329-2022	Ginsberg, Stephen/0000-0002-1797-4288	Alzheimer's Association [IIRG-08-91231]; American Health Assistance Foundation [A2011311]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014449, P01AG017617, R01AG043375] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Alzheimer's Association (IIRG-08-91231) and American Health Assistance Foundation (A2011311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; Alldred MJ, 2008, INT J MOL SCI, V9, P2091, DOI 10.3390/ijms9112091; Beeri MS, 2008, NEUROLOGY, V71, P750, DOI 10.1212/01.wnl.0000324925.95210.6d; Borghi R, 2007, NEUROBIOL AGING, V28, P1009, DOI 10.1016/j.neurobiolaging.2006.05.004; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Cotel MC, 2012, NEUROBIOL AGING, V33, P96, DOI 10.1016/j.neurobiolaging.2010.02.012; Coulson DTR, 2010, J ALZHEIMERS DIS, V22, P1111, DOI 10.3233/JAD-2010-101254; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; Devi L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-34; Devi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012974; Devi L, 2010, EUR J NEUROSCI, V31, P110, DOI 10.1111/j.1460-9568.2009.07031.x; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gengler S, 2012, NEUROBIOL AGING, V33, P265, DOI 10.1016/j.neurobiolaging.2010.02.014; Ginsberg Stephen D., 2008, V439, P147, DOI 10.1007/978-1-59745-188-8_10; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holscher C, 2011, BIOCHEM SOC T, V39, P891, DOI 10.1042/BST0390891; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hu C, 2011, N-S ARCH PHARMACOL, V383, P309, DOI 10.1007/s00210-010-0593-7; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jolivalt CG, 2010, EXP NEUROL, V223, P422, DOI 10.1016/j.expneurol.2009.11.005; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; Menon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018660; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Ohno M, 2009, NEUROBIOL LEARN MEM, V92, P455, DOI 10.1016/j.nlm.2009.05.001; Park SA, 2011, J CLIN NEUROL, V7, P10, DOI 10.3988/jcn.2011.7.1.10; Plaschke K, 2010, J ALZHEIMERS DIS, V19, P691, DOI 10.3233/JAD-2010-1270; Plastino M, 2010, J NEUROL SCI, V288, P112, DOI 10.1016/j.jns.2009.09.022; Preece P, 2003, MOL BRAIN RES, V116, P155, DOI 10.1016/S0169-328X(03)00233-X; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Santosa C, 2011, NEUROBIOL DIS, V43, P176, DOI 10.1016/j.nbd.2011.03.009; Sarajarvi T, 2009, J BIOL CHEM, V284, P34433, DOI 10.1074/jbc.M109.036202; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sullivan JM, 1999, J CEREBR BLOOD F MET, V19, P1010, DOI 10.1097/00004647-199909000-00009; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Wang X, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-46; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	55	120	124	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32792	10.1371/journal.pone.0032792	http://dx.doi.org/10.1371/journal.pone.0032792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403710	gold, Green Submitted, Green Published			2022-12-25	WOS:000303017700107
J	Fu, ZD; Csanaky, IL; Klaassen, CD				Fu, Zidong Donna; Csanaky, Ivan L.; Klaassen, Curtis D.			Gender-Divergent Profile of Bile Acid Homeostasis during Aging of Mice	PLOS ONE			English	Article							AGE-RELATED-CHANGES; LIFE-SPAN; CHOLESTEROL; LIVER; METABOLISM; RECEPTOR; TRANSPORTERS; EXPRESSION; CLONING; SERUM	Aging is a physiological process with a progressive decline of adaptation and functional capacity of the body. Bile acids (BAs) have been recognized as signaling molecules regulating the homeostasis of glucose, lipid, and energy. The current study characterizes the age-related changes of individual BA concentrations by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) in serum and liver of male and female C57BL/6 mice from 3 to 27 months of age. Total BA concentrations in serum increased 340% from 3 to 27 months in female mice, whereas they remained relatively constant with age in male mice. During aging, male and female mice shared the following changes: (1) BA concentrations in liver remained relatively constant; (2) the proportions of beta-muricholic acid (beta MCA) increased and deoxycholic acid (DCA) decreased between 3 and 27 months in serum and liver; and (3) total BAs in serum and liver became more hydrophilic between 3 and 27 months. In female mice, (1) the mRNAs of hepatic BA uptake transporters, the Na+/taurocholate cotransporting polypeptide (Ntcp) and the organic anion transporting polypeptide 1b2 (Oatp1b2), decreased after 12 months, and similar trends were observed for their proteins; (2) the mRNA of the rate-limiting enzyme for BA synthesis, cholesterol 7 alpha-hydroxylase (Cyp7a1), increased from 3 to 9 months and remained high thereafter. However, in male mice, Ntcp, Oatp1b2, and Cyp7a1 mRNAs remained relatively constant with age. In summary, the current study shows gender-divergent profiles of BA concentrations and composition in serum and liver of mice during aging, which is likely due to the gender-divergent expression of BA transporters Ntcp and Oatp1b2 as well as the synthetic enzyme Cyp7a1.	[Fu, Zidong Donna; Csanaky, Ivan L.; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Fu, ZD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	cklaasse@kumc.edu	Fu, Zidong/A-2703-2017		National Institutes of Health [ES-009649, ES-019487, DK-081461]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009649, R01ES019487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health grants ES-009649, ES-019487, and DK-081461. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akare S, 2006, INT J CANCER, V119, P2958, DOI 10.1002/ijc.22231; Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x; Anwer MS, 2004, HEPATOLOGY, V39, P581, DOI 10.1002/hep.20090; Ballatori N, 2008, AM J PHYSIOL-GASTR L, V295, pG179, DOI 10.1152/ajpgi.90319.2008; Bertolotti M, 2007, EUR J CLIN INVEST, V37, P501, DOI 10.1111/j.1365-2362.2007.01808.x; BERTOLOTTI M, 1993, J LIPID RES, V34, P1001; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Cheng X, 2007, BIOCHEM PHARMACOL, V74, P1665, DOI 10.1016/j.bcp.2007.08.014; Chiang JYL, 2003, AM J PHYSIOL-GASTR L, V284, pG349, DOI 10.1152/ajpgi.00417.2002; CHIANG JYL, 1998, FRONT BIOSCI, V3, P176; Csanaky IL, 2011, HEPATOLOGY, V53, P272, DOI 10.1002/hep.23984; Csanaky IL, 2009, AM J PHYSIOL-GASTR L, V297, pG419, DOI 10.1152/ajpgi.90728.2008; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; Falany CN, 1997, J LIPID RES, V38, P1139; Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; GOODRICK CL, 1975, J GERONTOL, V30, P257, DOI 10.1093/geronj/30.3.257; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; HEUMAN DM, 1989, J LIPID RES, V30, P719; Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Li TG, 2012, J LIPIDS, V2012, DOI 10.1155/2012/754067; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; SALEMANS JMJI, 1993, EUR J CLIN INVEST, V23, P192, DOI 10.1111/j.1365-2362.1993.tb00761.x; SHNEIDER BL, 1995, J CLIN INVEST, V95, P745, DOI 10.1172/JCI117722; Simon FR, 1999, AM J PHYSIOL-GASTR L, V276, pG556, DOI 10.1152/ajpgi.1999.276.2.G556; Song PZ, 2011, TOXICOL SCI, V123, P359, DOI 10.1093/toxsci/kfr177; UCHIDA K, 1990, ARCH GERONTOL GERIAT, V10, P37, DOI 10.1016/0167-4943(90)90042-5; UCHIDA K, 1978, J LIPID RES, V19, P544; Vina Jose, 2005, Sci Aging Knowledge Environ, V2005, ppe17, DOI 10.1126/sageke.2005.23.pe17; Wang DQH, 2003, AM J PHYSIOL-GASTR L, V285, pG494, DOI 10.1152/ajpgi.00156.2003; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641; Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683	37	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32551	10.1371/journal.pone.0032551	http://dx.doi.org/10.1371/journal.pone.0032551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403674	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700071
J	Lan, YM; Wang, Q; Cole, JR; Rosen, GL				Lan, Yemin; Wang, Qiong; Cole, James R.; Rosen, Gail L.			Using the RDP Classifier to Predict Taxonomic Novelty and Reduce the Search Space for Finding Novel Organisms	PLOS ONE			English	Article							DIVERSITY; SEQUENCES	Background: Currently, the naive Bayesian classifier provided by the Ribosomal Database Project (RDP) is one of the most widely used tools to classify 16S rRNA sequences, mainly collected from environmental samples. We show that RDP has 97+% assignment accuracy and is fast for 250 bp and longer reads when the read originates from a taxon known to the database. Because most environmental samples will contain organisms from taxa whose 16S rRNA genes have not been previously sequenced, we aim to benchmark how well the RDP classifier and other competing methods can discriminate these novel taxa from known taxa. Principal Findings: Because each fragment is assigned a score (containing likelihood or confidence information such as the boostrap score in the RDP classifier), we "train" a threshold to discriminate between novel and known organisms and observe its performance on a test set. The threshold that we determine tends to be conservative (low sensitivity but high specificity) for naive Bayesian methods. Nonetheless, our method performs better with the RDP classifier than the other methods tested, measured by the f-measure and the area-under-the-curve on the receiver operating characteristic of the test set. By constraining the database to well-represented genera, sensitivity improves 3-15%. Finally, we show that the detector is a good predictor to determine novel abundant taxa (especially for finer levels of taxonomy where novelty is more likely to be present). Conclusions: We conclude that selecting a read-length appropriate RDP bootstrap score can significantly reduce the search space for identifying novel genera and higher levels in taxonomy. In addition, having a well-represented database significantly improves performance while having genera that are "highly" similar does not make a significant improvement. On a real dataset from an Amazon Terra Preta soil sample, we show that the detector can predict (or correlates to) whether novel sequences will be assigned to new taxa when the RDP database "doubles" in the future.	[Lan, Yemin; Cole, James R.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Wang, Qiong] Michigan State Univ, Ribosomal Database Project, E Lansing, MI 48824 USA; [Rosen, Gail L.] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA	Drexel University; Michigan State University; Drexel University	Lan, YM (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	gailr@ece.drexel.edu	Wang, Qiong/ABG-2681-2020	Rosen, Gail/0000-0003-1763-5750	National Science Foundation (NSF) CAREER [0845827]; Department of Energy (DOE), Office of Science (BER) [DE-SC0004335]; DOE BER [DE-FG02-99ER62848]; NSF [1120622]	National Science Foundation (NSF) CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Department of Energy (DOE), Office of Science (BER)(United States Department of Energy (DOE)); DOE BER(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	This work was supported in part by the National Science Foundation (NSF) CAREER award #0845827, NSF award #1120622, Department of Energy (DOE), Office of Science (BER) award DE-SC0004335, and DOE BER No. DE-FG02-99ER62848. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li L, 2010, J DENT RES, V89, P980, DOI 10.1177/0022034510370026; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; Navarrete A. A., 2010, Diversity, V2, P787; PACE B, 1984, J BIOL CHEM, V259, P1454; Peplies J, 2008, SYST APPL MICROBIOL, V31, P251, DOI 10.1016/j.syapm.2008.08.003; Rosen Gail, 2008, Advances in Bioinformatics, V2008, P205969, DOI 10.1155/2008/205969; Rosen GL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/495849; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Ulrich A, 2006, FEMS MICROBIOL ECOL, V56, P430, DOI 10.1111/j.1574-6941.2006.00085.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	26	99	111	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32491	10.1371/journal.pone.0032491	http://dx.doi.org/10.1371/journal.pone.0032491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403664	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700061
J	Xie, H; Wang, JM; Dhaunchak, AS; Shang, J; Kou, LP; Guo, MM; Wu, Y; Gu, Q; Colman, D; Wu, XR; Jiang, YW				Xie, Han; Wang, Jingmin; Dhaunchak, Ajit Singh; Shang, Jing; Kou, Liping; Guo, Mangmang; Wu, Ye; Gu, Qiang; Colman, David; Wu, Xiru; Jiang, Yuwu			Functional Studies of MLC1 Mutations in Chinese Patients with Megalencephalic Leukoencephalopathy with Subcortical Cysts	PLOS ONE			English	Article							DER-KNAAP-DISEASE; DYSTROPHIN-GLYCOPROTEIN COMPLEX; GENETIC-HETEROGENEITY; CELL MODEL; PROTEIN; SCHIZOPHRENIA; ASTROCYTES; CAVEOLINS; SYSTEMS	Megalencephalic leukoencephalopathy with subcortical cysts (MLC, MIM# 604004) is an autosomal recessive inherited disease mostly resulting from MLC1 mutations. In this study, we finished the functional analysis of MLC1 mutations identified recently in Chinese patients, including five newly described missense mutations (R22Q, A32V, G73E, A275T, Y278H), one known nonsense mutation (Y198X), and two known missense mutations (S69L, T118M). We found MLC1(wt) was localized to the cell periphery, whereas mutant R22Q, A32V, G73E, S69L and T118M were trapped in the lumen of endoplasmic reticulum (ER) when we transfected the wild-type and mutant MLC1 in U373MG cells. Compared to wild type, the mutant G73E, T118M, Y198X and A275T transcript decreased and all mutants except R22Q had lower protein expression in transfected U373MG cells. Therefore, we propose that all these eight MLC1 mutations had functional effect either on their protein/mRNA expression, or on their intracellular protein localization, or both.	[Xie, Han; Wang, Jingmin; Shang, Jing; Kou, Liping; Guo, Mangmang; Wu, Ye; Gu, Qiang; Wu, Xiru; Jiang, Yuwu] Peking Univ, Dept Pediat, Hosp 1, Beijing 100871, Peoples R China; [Dhaunchak, Ajit Singh; Colman, David] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Shang, Jing; Kou, Liping] Shanxi Med Univ, Taiyuan, Shanxi, Peoples R China	Peking University; McGill University; Shanxi Medical University	Xie, H (corresponding author), Peking Univ, Dept Pediat, Hosp 1, Beijing 100871, Peoples R China.	wxrwwn@gmail.com; jiangyw@263.net	jiang, yu/HGU-0029-2022		National Key Research Project "11-5'' [2006BAI05A07]; Science and Technology Ministry of China [2007CB5119004]; National Natural Science Foundation of China [30973227]	National Key Research Project "11-5''; Science and Technology Ministry of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research Project "11-5'' (No: 2006BAI05A07) (http://program.most.gov.cn/), "973'' Project of the Science and Technology Ministry of China (No. 2007CB5119004) (http://program.most.gov.cn/), the National Natural Science Foundation of China (30973227)(http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini E, 2008, MOL CELL NEUROSCI, V37, P480, DOI 10.1016/j.mcn.2007.11.003; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Angelika S, 2003, GLIA, V44, P283; Anna D, 2008, HUM MOL GENET, V17, P3728; Ben-Zeev B, 2002, HUM GENET, V111, P214, DOI 10.1007/s00439-002-0770-y; Blattner R, 2003, NEUROPEDIATRICS, V34, P215; Boor I, 2007, ACTA NEUROPATHOL, V114, P403, DOI 10.1007/s00401-007-0247-0; Boor PKI, 2006, HUM MUTAT, V27, P505, DOI 10.1002/humu.20332; Boor PKI, 2005, J NEUROPATH EXP NEUR, V64, P412; Duarri A, 2011, NEUROBIOL DIS, V43, P228, DOI 10.1016/j.nbd.2011.03.015; Gorospe JR, 2004, NEUROLOGY, V62, P878, DOI 10.1212/01.WNL.0000115106.88813.5B; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Koussa S, 2005, REV NEUROL-FRANCE, V161, P183, DOI 10.1016/S0035-3787(05)85021-0; Lanciotti A, 2010, NEUROBIOL DIS, V37, P581, DOI 10.1016/j.nbd.2009.11.008; Leegwater PAJ, 2002, HUM GENET, V110, P279, DOI 10.1007/s00439-002-0682-x; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Lopez-Hernandez T, 2011, AM J HUM GENET, V88, P422, DOI 10.1016/j.ajhg.2011.02.009; Meyer J, 2001, MOL PSYCHIATR, V6, P302, DOI 10.1038/sj.mp.4000869; Montagna Giorgia, 2006, Hum Mutat, V27, P292, DOI 10.1002/humu.9407; Morita H, 2006, BRAIN DEV-JPN, V28, P466, DOI 10.1016/j.braindev.2005.12.006; Patrono C, 2003, NEUROLOGY, V61, P534, DOI 10.1212/01.WNL.0000076184.21183.CA; Ridder MC, 2011, BRAIN, V134, P3342, DOI 10.1093/brain/awr255; Rubie C, 2003, HUM MUTAT, V21, P45, DOI 10.1002/humu.10145; Saijo H, 2003, BRAIN DEV-JPN, V25, P362, DOI 10.1016/S0387-7604(03)00006-8; Silva WI, 2007, J NEUROCHEM, V103, P101, DOI 10.1111/j.1471-4159.2007.04712.x; Tania LH, 2011, HUM MOL GENET, V20, P3266; Teijido O, 2004, HUM MOL GENET, V13, P2581, DOI 10.1093/hmg/ddh291; Teijido O, 2007, NEUROBIOL DIS, V26, P532, DOI 10.1016/j.nbd.2007.01.016; Tsujino S, 2003, J HUM GENET, V48, P605, DOI 10.1007/s10038-003-0085-4; VANDERKNAAP MS, 1995, ANN NEUROL, V37, P324, DOI 10.1002/ana.410370308; Wang JM, 2011, J HUM GENET, V56, P138, DOI 10.1038/jhg.2010.146	32	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e33087	10.1371/journal.pone.0033087	http://dx.doi.org/10.1371/journal.pone.0033087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22416245	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700130
J	Sharma, L; Kaur, J; Shukla, G				Sharma, Lalita; Kaur, Jagdeep; Shukla, Geeta			Role of Oxidative Stress and Apoptosis in the Placental Pathology of Plasmodium berghei Infected Mice	PLOS ONE			English	Article							FALCIPARUM-MALARIA; MURINE MALARIA; BIRTH-WEIGHT; PREGNANCY; GENERATION; MITOCHONDRIA; PATHOGENESIS; MECHANISMS; BURDEN; DEATH	Placental malaria is a common clinical complication during pregnancy and is associated with abortion, premature delivery, intrauterine growth retardation and low birth weight. The present study was designed to delineate the underlying mechanism of placental pathology during malarial infection with special reference to oxidative stress and apoptosis. Experimentally, pregnant BALB/c mice were infected with Plasmodium berghei infected red blood cells on gestation day 10. The presence of malarial infection in placenta was confirmed by histopathological studies. It was observation that infected placenta had plugged placental sinusoids with parasitized red blood cells and malarial pigments. Interestingly, we found significant increase in the level of malondialdehyde, the index of oxidative stress and decreased activity of catalase, the antioxidant in infected placenta. Furthermore, in infected placenta the oxidative stress mediated apoptosis was determined by DNA fragmentation assay, ethidium bromide/acridine orange staining and caspase activity. It was observed that oxidative stress begin after second day of malarial infection. Interestingly, it was observed that there was down regulation of anti-apoptotic protein Bcl-2 and up regulation of pro-apoptotic protein Bax in infected placenta, suggesting the involvement of mitochondrial pathway of apoptosis which was further confirmed by activation of caspase 9. However, no change in the expression of Fas gene and caspase 8 activity, indicated the absence of death receptor pathway. Thus, it can be concluded that the placental pathology during malarial infection is mediated by mitochondrial pathway of apoptosis occurring due to augmented lipid peroxidation which may in turn jeopardise the materno-fetal relationship.	[Sharma, Lalita; Shukla, Geeta] Panjab Univ, Dept Microbiol, Chandigarh 160014, India; [Kaur, Jagdeep] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India	Panjab University; Panjab University	Sharma, L (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	geeta_shukla@pu.ac.in		Sharma, Lalita/0000-0002-0017-3636; Kaur, Jagdeep/0000-0002-2252-2489	University Grant Commission (UGC) New Delhi, India [33-207/2007-SR]	University Grant Commission (UGC) New Delhi, India(University Grants Commission, India)	The financial assistance provided by University Grant Commission (UGC) New Delhi, India (UGC Reference No 33-207/2007-SR), to carry out the present work is highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Chen HW, 2002, BRIT J PHARMACOL, V137, P771, DOI 10.1038/sj.bjp.0704908; CLARK IA, 1986, ADV PARASIT, V25, P1, DOI 10.1016/S0065-308X(08)60341-3; CLARK IA, 1983, INFECT IMMUN, V39, P1; Crocker IP, 2004, PLACENTA, V25, P273, DOI 10.1016/j.placenta.2003.09.010; CURFS JHAJ, 1989, CLIN EXP IMMUNOL, V75, P136; Czaja MJ, 2002, ANTIOXID REDOX SIGN, V4, P759, DOI 10.1089/152308602760598909; Das BS, 1999, T ROY SOC TROP MED H, V93, P58, DOI 10.1016/S0035-9203(99)90180-3; Davison BB, 2000, AM J TROP MED HYG, V63, P158, DOI 10.4269/ajtmh.2000.63.158; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gulbins E, 2003, EXP PHYSIOL, V88, P85, DOI 10.1113/eph8802503; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; JAYSHREE RS, 1993, APMIS, V101, P762, DOI 10.1111/j.1699-0463.1993.tb00177.x; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; KHARAZMI A, 1987, SCAND J IMMUNOL, V25, P335, DOI 10.1111/j.1365-3083.1987.tb02198.x; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Kulkarni A G, 2003, Indian J Clin Biochem, V18, P136, DOI 10.1007/BF02867380; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luck H., 1965, METHOD ENZYMATIC ANA, P885, DOI DOI 10.1016/B978-0-12-395630-9.50158-4; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Ndam NT, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/43785; Neres R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001608; OCKENHOUSE CF, 1984, J IMMUNOL, V132, P424; Pabon A, 2003, CLIN BIOCHEM, V36, P71, DOI 10.1016/S0009-9120(02)00423-X; Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006; PORTA J, 1993, CLIN NEUROPATHOL, V12, P142; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Samak AC, 2004, M J M, V8, P61; Sharma JB, 2006, INT J GYNECOL OBSTET, V94, P23, DOI 10.1016/j.ijgo.2006.03.025; Shukla G., 2007, SAJOSPS, V7, P81; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Strauss WM., 1987, CURRENT PROTOCOLS MO, P221; Uneke Chigozie J, 2008, Yale J Biol Med, V81, P1; VINAYAK VK, 1986, AUST J EXP BIOL MED, V64, P223, DOI 10.1038/icb.1986.24; WATKINSON M, 1983, BMJ-BRIT MED J, V287, P251, DOI 10.1136/bmj.287.6387.251; *WHO, 2008, WHOHTMGMP20081; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; WOZENCRAFT AO, 1984, INFECT IMMUN, V43, P664, DOI 10.1128/IAI.43.2.664-669.1984; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	45	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32694	10.1371/journal.pone.0032694	http://dx.doi.org/10.1371/journal.pone.0032694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396790	gold, Green Published, Green Submitted			2022-12-25	WOS:000303005000035
J	Rice, WL; Zhang, Y; Chen, Y; Matsuzaki, T; Brown, D; Lu, HAJ				Rice, William L.; Zhang, Yan; Chen, Ying; Matsuzaki, Toshiyuki; Brown, Dennis; Lu, Hua A. Jenny			Differential, Phosphorylation Dependent Trafficking of AQP2 in LLC-PK1 Cells	PLOS ONE			English	Article							WATER CHANNEL AQUAPORIN-2; RENAL EPITHELIAL-CELLS; NEPHROGENIC DIABETES-INSIPIDUS; COLLECTING DUCT CELLS; PLASMA-MEMBRANE; PRINCIPAL CELLS; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; APICAL MEMBRANE; IN-VIVO	The kidney maintains water homeostasis by modulating aquaporin 2 (AQP2) on the plasma membrane of collecting duct principal cells in response to vasopressin (VP). VP mediated phosphorylation of AQP2 at serine 256 is critical for this effect. However, the role of phosphorylation of other serine residues in the AQP2 C-terminus is less well understood. Here, we examined the effect of phosphorylation of S256, S261 and S269 on AQP2 trafficking and association with recycling pathway markers. We used LLC-PK1 cells expressing AQP2(S-D) or (S-A) phospho mutants and a 20 degrees C cold block, which allows endocytosis to continue, but prevents protein exit from the trans Golgi network (TGN), inducing formation of a perinuclear AQP2 patch. AQP2-S256D persists on the plasma membrane during cold block, while wild type AQP2, AQP2-S256A, S261A, S269A and S269D are internalized and accumulate in the patch. Development of this patch, a measure of AQP2 internalization, was most rapid with AQP2-S256A, and slowest with S261A and S269D. AQP2-S269D exhibited a biphasic internalization profile with a significant amount not internalized until 150 minutes of cold block. After rewarming to 37 degrees C, wt AQP2, AQP2-S261A and AQP2-S269D rapidly redistributed throughout the cytoplasm within 20 minutes, whereas AQP2-S256A dissipated more slowly. Colocalization of AQP2 mutants with several key vesicular markers including clathrin, HSP70/HSC70, EEA, GM130 and Rab11 revealed no major differences. Overall, our data provide evidence supporting the role of S256 and S269 in the maintenance of AQP2 at the cell surface and reveal the dynamics of internalization and recycling of differentially phosphorylated AQP2 in cell culture.	[Rice, William L.] Massachusetts Gen Hosp, Dept Med, Program Membrane Biol, Ctr Syst Biol,Div Nephrol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rice, WL (corresponding author), Massachusetts Gen Hosp, Dept Med, Program Membrane Biol, Ctr Syst Biol,Div Nephrol, Boston, MA 02114 USA.	Halu@partners.org			National Institutes of Health (NIH) [DK075940, DK38452, 5T32 DK007540-24]; American Society of Nephrology (ASN); Boston Area Diabetes and Endocrinology Research Center (NIH) [DK-57521]; Center for the Study of Inflammatory Bowel Disease (NIH) [DK-43351]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351, K08DK075940, P01DK038452, T32DK007540] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology (ASN); Boston Area Diabetes and Endocrinology Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for the Study of Inflammatory Bowel Disease (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the National Institutes of Health (NIH), www.nih.gov. H. J. Lu is supported by an NIH KO8 grant DK075940 and a Gottschalk research grant from the American Society of Nephrology (ASN http://www.asn-online.org/grants_and_funding/career-development-details.aspx). Additional support was from NIH grant DK38452 (D. Brown). W. Rice is supported by an NIH training grant (NIH 5T32 DK007540-24). The Microscopy Core Facility of the Program in Membrane Biology receives additional support from the Boston Area Diabetes and Endocrinology Research Center (NIH DK-57521) and from the Center for the Study of Inflammatory Bowel Disease (NIH DK-43351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bouley R, 2000, J CLIN INVEST, V106, P1115, DOI 10.1172/JCI9594; Bouley R, 2005, AM J PHYSIOL-RENAL, V288, pF1103, DOI 10.1152/ajprenal.00337.2004; Bouley R, 2005, AM J PHYSIOL-CELL PH, V288, pC1390, DOI 10.1152/ajpcell.00353.2004; Bouley R, 2008, SEMIN NEPHROL, V28, P266, DOI 10.1016/j.semnephrol.2008.03.010; Bouley R, 2011, J AM SOC NEPHROL, V22, P59, DOI 10.1681/ASN.2009121267; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Gustafson CE, 2000, AM J PHYSIOL-RENAL, V278, pF317, DOI 10.1152/ajprenal.2000.278.2.F317; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hendriks G, 2004, J BIOL CHEM, V279, P2975, DOI 10.1074/jbc.M310767200; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Katsura T, 1996, AM J PHYSIOL-RENAL, V270, pF548, DOI 10.1152/ajprenal.1996.270.3.F548; Klussmann E, 2001, J BIOL CHEM, V276, P20451, DOI 10.1074/jbc.M010270200; KNEPPER MA, 1993, AM J PHYSIOL, V265, pF214, DOI 10.1152/ajprenal.1993.265.2.F214; Li W, 2011, AM J PHYSIOL-RENAL, V301, pF309, DOI 10.1152/ajprenal.00001.2011; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Lu HJ, 2008, AM J PHYSIOL-RENAL, V295, pF290, DOI 10.1152/ajprenal.00072.2008; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Moeller HB, 2011, AM J PHYSL RENAL PHY; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Noda Y, 2005, BIOL CELL, V97, P885; Nunes P, 2008, AM J PHYSIOL-CELL PH, V295, pC1476, DOI 10.1152/ajpcell.00344.2008; Olesen ETB, 2011, P NATL ACAD SCI USA, V108, P12949, DOI 10.1073/pnas.1104691108; Procino G, 2003, FASEB J, V17, P1886, DOI 10.1096/fj.02-0870fje; Procino G, 2011, PFLUG ARCH EUR J PHY, V462, P753, DOI 10.1007/s00424-011-1007-5; Russo LM, 2006, AM J PHYSIOL-RENAL, V291, pF246, DOI 10.1152/ajprenal.00437.2005; SIPE DM, 1991, J BIOL CHEM, V266, P3469; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Tamma G, 2003, J CELL SCI, V116, P1519, DOI 10.1242/jcs.00355; Tamma G, 2001, AM J PHYSIOL-RENAL, V281, pF1092, DOI 10.1152/ajprenal.0091.2001; Tamma G, 2011, AM J PHYSIOL-CELL PH, V300, pC636, DOI 10.1152/ajpcell.00433.2009; Valenti G, 2000, J CELL SCI, V113, P1985; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; Wade JB, 2011, AM J PHYSIOL-RENAL, V301, pF308, DOI 10.1152/ajprenal.00248.2011	42	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32843	10.1371/journal.pone.0032843	http://dx.doi.org/10.1371/journal.pone.0032843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22403603	Green Submitted, Green Published, gold			2022-12-25	WOS:000302999600065
J	Yu, YH; Chen, HA; Chen, PS; Cheng, YJ; Hsu, WH; Chang, YW; Chen, YH; Jan, Y; Hsiao, M; Chang, TY; Liu, YH; Jeng, YM; Wu, CH; Huang, MT; Su, YH; Hung, MC; Chien, MH; Chen, CY; Kuo, ML; Su, JL				Yu, Y-H; Chen, H-A; Chen, P-S; Cheng, Y-J; Hsu, W-H; Chang, Y-W; Chen, Y-H; Jan, Y.; Hsiao, M.; Chang, T-Y; Liu, Y-H; Jeng, Y-M; Wu, C-H; Huang, M-T; Su, Y-H; Hung, M-C; Chien, M-H; Chen, C-Y; Kuo, M-L; Su, J-L			MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol	ONCOGENE			English	Article						FOXC2; miR-520h; resveratrol; metastasis	PROTEIN PHOSPHATASE 2A; EPITHELIAL-MESENCHYMAL TRANSITION; KAPPA-B KINASE; TRANSCRIPTION FACTORS; COLORECTAL-CANCER; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; EXPRESSION; CELL; METASTASIS	Resveratrol, a phytochemical found in various plants and Chinese herbs, is associated with multiple tumor-suppressing activities, has been tested in clinical trials. However, the molecular mechanisms involved in resveratrol-mediated tumor suppressing activities are not yet completely defined. Here, we showed that treatment with resveratrol inhibited cell mobility through induction of the mesenchymal-epithelial transition (MET) in lung cancer cells. We. also found that downregulation of FOXC2 (forkhead box C2) is critical for resveratrol-mediated suppression of tumor metastasis in an in vitro and in vivo models. We also identified a signal cascade, namely, resveratrol-vertical bar miRNA-520h-vertical bar PP2A/C-vertical bar Akt -> NF-kappa B -> FOXC2, in which resveratrol inhibited the expression of FOXC2 through regulation of miRNA-520h-mediated signal cascade. This study identified a new miRNA-520h-related signal cascade involved in resveratrol-mediated tumor suppression activity and provide the clinical significances of miR-520h, PP2A/C and FOXC2 in lung cancer patients. Our results indicated a functional link between resveratrol-mediated miRNA-520h regulation and tumor suppressing ability, and provide a new insight into the role of resveratrol-induced molecular and epigenetic regulations in tumor suppression. Oncogene (2013) 32, 431-443; doi:10.1038/onc.2012.74; published online 12 March 2012	[Yu, Y-H; Hsu, W-H] China Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taichung, Taiwan; [Yu, Y-H; Hsu, W-H] China Med Univ Hosp, Div Crit Care Med, Taichung, Taiwan; [Yu, Y-H] China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan; [Chen, H-A; Wu, C-H; Huang, M-T; Su, Y-H; Chien, M-H] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chen, H-A; Wu, C-H; Huang, M-T; Su, Y-H] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Chen, P-S; Kuo, M-L] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan; [Chen, P-S; Kuo, M-L] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 10764, Taiwan; [Chen, P-S; Kuo, M-L] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Cheng, Y-J; Chang, T-Y; Hung, M-C; Su, J-L] China Med Univ, Coll Med, Grad Inst Canc Biol, Taichung 40402, Taiwan; [Chang, Y-W] Natl Yang Ming Univ, Grad Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chen, Y-H; Liu, Y-H; Hung, M-C; Su, J-L] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Jan, Y.; Hsiao, M.] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Jeng, Y-M] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Chien, M-H] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Chen, C-Y] China Med Univ Hosp, Ctr Canc, Taichung, Taiwan; [Su, J-L] China Med Univ, Canc Biol & Drug Discovery PhD Degree Program, Taichung 40402, Taiwan; [Su, J-L] Asia Univ, Dept Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Su, JL (corresponding author), China Med Univ, Coll Med, Grad Inst Canc Biol, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.	mhchien1976@gmail.com; jlsu@mail.cmu.edu.tw	Hsiao, Michael/U-6238-2019; Chen, Pai-Sheng/G-2130-2012; Hung, Mien-Chie/ABD-5911-2021	Hsiao, Michael/0000-0001-8529-9213; Chen, Pai-Sheng/0000-0003-0513-1467; Hung, Mien-Chie/0000-0003-4317-4740; Su, Yen-Hao/0000-0001-8288-3772; JENG, YUNG-MING/0000-0002-3878-4491; KUO, MIN-LIANG/0000-0002-7139-0144	National Science Council [NSC-2632-B-001-MY3, NSC 96-2320-B-004-MY2, NSC 97-2320-B-039-039-MY3, NSC 98-2815-C-039-082-B]; National Health Research Institutes Grant from Taiwan [NHRI-EX98-9712BC, NHRI-EX99-9712BC, NHRI-EX100-9712BC]; Department of Health, Executive Yuan Grant from Taiwan [DOH99-TD-G111-011]; China Medical University [CMU96-220, CMU97-077, CMU97-277, CMU-99-NTU-08, CMU100-TS-06, DMR-101-014]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes Grant from Taiwan; Department of Health, Executive Yuan Grant from Taiwan; China Medical University(China Medical University)	This work was partially supported by the National Science Council Grant (NSC-2632-B-001-MY3, NSC 96-2320-B-004-MY2, NSC 97-2320-B-039-039-MY3 and NSC 98-2815-C-039-082-B to J-LS); National Health Research Institutes Grant from Taiwan (NHRI-EX98-9712BC, NHRI-EX99-9712BC and NHRI-EX100-9712BC to J-LS); Department of Health, Executive Yuan Grant from Taiwan (DOH99-TD-G111-011 to J-LS); Grants from China Medical University (CMU96-220, CMU97-077 and CMU97-277 to J-LS; CMU-99-NTU-08, CMU100-TS-06 and DMR-101-014 to Y-HY).	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Browne G, 2010, CELL CYCLE, V9, P886, DOI 10.4161/cc.9.5.10839; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Choi HK, 2006, CANCER LETT, V242, P198, DOI 10.1016/j.canlet.2005.11.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gronning LM, 2002, MOL ENDOCRINOL, V16, P873, DOI 10.1210/me.16.4.873; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Hamamori Y, 1997, MOL CELL BIOL, V17, P6563, DOI 10.1128/MCB.17.11.6563; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Holmes-McNary M, 2000, CANCER RES, V60, P3477; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kuhn H, 2002, EUR RESPIR J, V20, P703, DOI 10.1183/09031936.02.00294502; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li Q, 2009, AM J PHYSIOL-ENDOC M, V4, P965; Liao Y, 2004, CANCER RES, V64, P5938, DOI 10.1158/0008-5472.CAN-04-1533; Lu YB, 2005, J LEUKOCYTE BIOL, V78, P259, DOI 10.1189/jlb.0904498; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Ngan CY, 2007, BRIT J CANCER, V96, P986, DOI 10.1038/sj.bjc.6603651; Nishida N, 2011, ANN SURG ONCOL, V18, P535, DOI 10.1245/s10434-010-1274-y; PAGET S, 1989, CANCER METAST REV, V8, P98; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Saiko P, 2008, MUTAT RES-REV MUTAT, V658, P68, DOI 10.1016/j.mrrev.2007.08.004; Sano H, 2010, BIOCHEM BIOPH RES CO, V392, P201, DOI 10.1016/j.bbrc.2010.01.015; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Stewart JR, 1999, BIOCHEMISTRY-US, V38, P13244, DOI 10.1021/bi990875u; Stewart JR, 2000, BIOCHEM PHARMACOL, V60, P1355, DOI 10.1016/S0006-2952(00)00450-0; Su JL, 2010, CANCER RES, V70, P5096, DOI 10.1158/0008-5472.CAN-09-4148; Sun HZ, 2010, J ENDOCRINOL, V204, P311, DOI 10.1677/JOE-09-0270; Tili E, 2010, BIOCHEM PHARMACOL, V80, P2057, DOI 10.1016/j.bcp.2010.07.003; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Topczewska JM, 2001, GENE DEV, V15, P2483, DOI 10.1101/gad.907401; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	54	101	110	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2013	32	4					431	443		10.1038/onc.2012.74	http://dx.doi.org/10.1038/onc.2012.74			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22410781				2022-12-25	WOS:000315551300004
J	Jules, J; Zhang, P; Ashley, JW; Wei, S; Shi, ZQ; Liu, JZ; Michalek, SM; Feng, X				Jules, Joel; Zhang, Ping; Ashley, Jason W.; Wei, Shi; Shi, Zhenqi; Liu, Jianzhong; Michalek, Suzanne M.; Feng, Xu			Molecular Basis of Requirement of Receptor Activator of Nuclear Factor kappa B Signaling for Interleukin 1-mediated Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; RANK CYTOPLASMIC MOTIF; BONE-RESORPTION; RHEUMATOID-ARTHRITIS; TNF-ALPHA; FAMILY-MEMBERS; DIFFERENTIATION; CELLS; LIGAND; STIMULATION	IL-1, a proinflammatory cytokine, is implicated in bone loss in various pathological conditions by promoting osteoclast formation, survival, and function. Although IL-1 alone can sufficiently prolong osteoclast survival and activate osteoclast function, IL-1-mediated osteoclastogenesis requires the receptor activator of NF-kappa B (RANK) ligand (RANKL). However, the molecular basis of the dependence of IL-1-mediated osteoclastogenesis on RANKL is not fully understood. Here we show that although IL-1 cannot activate the expression of the osteoclast genes encoding matrix metalloproteinase 9, cathepsin K, tartrate-resistant acid phosphatase, and carbonic anhydrase II in bone marrow macrophages (BMMs), RANKL renders these osteoclast genes responsive to IL-1. We further demonstrate that IL-1 alone fails to induce the expression of nuclear factor of activated T cell cytoplasmic 1 (NFATc1), a master transcriptional regulator of osteoclastogenesis), in BMMs but can up-regulate its expression in the presence of permissive levels of RANKL or with RANKL pretreatment. The RANK IVVY motif, which has been previously shown to commit BMMs to the osteoclast lineage in RANKL- and TNF alpha-mediated osteoclastogenesis, also plays a crucial role in IL-1-mediated osteoclastogenesis by changing the four osteoclast marker and NFATc1 genes to an IL-1-inducible state. Finally, we show that MyD88, a known critical component of the IL-1 receptor I signaling pathway, plays a crucial role in IL-1-mediated osteoclastogenesis from RANKL-primed BMMs by up-regulating the expression of the osteoclast marker and NFATc1 genes. This study reveals a novel mechanism of IL-1-mediated osteoclastogenesis and supports the promising potential of the IVVY motif to serve as a therapeutic target for inflammatory bone loss.	[Jules, Joel; Ashley, Jason W.; Wei, Shi; Shi, Zhenqi; Liu, Jianzhong; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Zhang, Ping; Michalek, Suzanne M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Feng, X (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1670 Univ Blvd,Volker Hall,G046B, Birmingham, AL 35294 USA.	xufeng@uab.edu	Ashley, Jason Waid/S-9142-2019	Ashley, Jason/0000-0003-1064-542X; Zhang, Ping/0000-0002-4585-9893	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health [AR47830, 5P30 AR046031]; NIAMS, National Institutes of Health Graduate Research Supplement [AR47830]; Research and Education Foundation of American College of Rheumatology; University of Alabama at Birmingham Center for Metabolic Bone Disease [T32 AR047512]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047830, P30AR046031, P30AR048311, T32AR047512] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS, National Institutes of Health Graduate Research Supplement; Research and Education Foundation of American College of Rheumatology; University of Alabama at Birmingham Center for Metabolic Bone Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported, in whole or in part, by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health grant AR47830 (to X. F.) NIAMS, National Institutes of Health Graduate Research Supplement to AR47830 (to J. J.), and NIAMS, National Institutes of Health Grant 5P30 AR046031 (to the University of Alabama at Birminghan Core Center for Basic Skeletal Research (CCBSR)). This work was also supported by a Within Our Reach innovative basic research grant from the Research and Education Foundation of American College of Rheumatology (to X. F.) and training fellowship T32 AR047512 from the University of Alabama at Birmingham Center for Metabolic Bone Disease (to J. W. A.).	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Beyaert R, 1998, CYTOKINES, P335, DOI 10.1016/B978-012498340-3/50025-7; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Furst DE, 2004, CLIN THER, V26, P1960, DOI 10.1016/j.clinthera.2004.12.019; GOWEN M, 1985, J CLIN INVEST, V75, P1223, DOI 10.1172/JCI111819; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Hara Y, 1998, CALCIFIED TISSUE INT, V63, P63, DOI 10.1007/s002239900490; HEATH JK, 1985, CALCIFIED TISSUE INT, V37, P95; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Jimi E, 1998, J BIOL CHEM, V273, P8799, DOI 10.1074/jbc.273.15.8799; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kim H, 2009, J CLIN INVEST, V119, P813, DOI 10.1172/JCI36809; Kim JH, 2009, J IMMUNOL, V183, P1862, DOI 10.4049/jimmunol.0803007; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li P, 2004, J BONE MINER RES, V19, P207, DOI 10.1359/JBMR.0301233; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Liu W, 2005, J BIOL CHEM, V280, P43064, DOI 10.1074/jbc.M509006200; Liu W, 2004, J BIOL CHEM, V279, P54759, DOI 10.1074/jbc.M404687200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Ma T, 2004, CYTOKINE, V26, P138, DOI 10.1016/j.cyto.2004.02.001; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Nakamura I, 2006, VITAM HORM, V74, P357, DOI 10.1016/S0083-6729(06)74015-8; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pacifici R, 1998, ENDOCRINOLOGY, V139, P2659, DOI 10.1210/en.139.6.2659; PACIFICI R, 1987, P NATL ACAD SCI USA, V84, P4616, DOI 10.1073/pnas.84.13.4616; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; Strand V, 2004, RHEUMATOLOGY, V43, P10, DOI 10.1093/rheumatology/keh202; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Xu DR, 2004, BIOCHEM J, V383, P219, DOI 10.1042/BJ20040961	45	55	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15728	15738		10.1074/jbc.M111.296228	http://dx.doi.org/10.1074/jbc.M111.296228			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416138	Green Published, hybrid			2022-12-25	WOS:000304006300051
J	Yoo, JO; Lim, YC; Kim, YM; Ha, KS				Yoo, Je-Ok; Lim, Young-Cheol; Kim, Young-Myeong; Ha, Kwon-Soo			Transglutaminase 2 Promotes Both Caspase-dependent and Caspase-independent Apoptotic Cell Death via the Calpain/Bax Protein Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PHOTODYNAMIC THERAPY; EPIDERMAL-GROWTH-FACTOR; TISSUE TRANSGLUTAMINASE; CANCER CELLS; ENDOPLASMIC-RETICULUM; INTRACELLULAR CA2+; ACTIVATION; STRESS; MECHANISMS; INDUCTION	Transglutaminase 2(TG2) is a versatile protein that is implicated in significant biological processes, including cell death and degenerative diseases. A possible role of TG2 in the apoptotic death of cancer cells induced by photodynamic therapy (PDT) was suggested recently; however, the mechanism by which TG2 regulates apoptotic responses to PDT remains to be elucidated. In this study, we investigated the key signaling pathways stimulated during apoptotic cell death following PDT and whether inhibition of TG2 activation using pharmacological approaches and siRNAs affects the signaling pathways. PDT caused the release of both cytochrome c and apoptosis-inducing factor (AIF) by damaging mitochondria, which resulted in caspase-dependent and caspase-independent apoptotic cell death, respectively. Released AIF translocated to the nucleus and, synergistically with the caspase-dependent pathway, led to apoptotic cell death. Both the caspase cascade and the activation of AIF following PDT were mediated by TG2 activation. In addition, PDT-activated calpain was responsible for the sequential events of Bax translocation, the collapse of Delta Psi(m), caspase-3 activation, and AIF translocation, all of which were provoked by TG2 activation. Together, these results demonstrate that PDT with a chlorin-based photosensitizer targets TG2 by activating calpain-linduced Bax translocation, which induces apoptotic cell death through both caspase-dependent and AIF-mediated pathways. Moreover, these results indicate that TG2 may be a possible therapeutic target for PDT treatment of cancer.	[Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 200701, Kangwon Do, South Korea; Kangwon Natl Univ, Sch Med, Inst Med Sci, Chunchon 200701, Kangwon Do, South Korea	Kangwon National University; Kangwon National University	Ha, KS (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwondaehak Gil 1, Chunchon 200701, Kangwon Do, South Korea.	ksha@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	Korea Research Foundation [2008-05943]; Ministry of Health and Welfare [1020420]; Korean Ministry of Education, Science, and Technology (Medical & Bio-Materials Research Center)	Korea Research Foundation(National Research Foundation of Korea); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Korean Ministry of Education, Science, and Technology (Medical & Bio-Materials Research Center)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by Basic Research Program Grant 2008-05943 from the Korea Research Foundation, National R&D Program for Cancer Control Grant 1020420 from the Ministry of Health and Welfare, and the Korean Ministry of Education, Science, and Technology (Regional Core Research Program/Medical & Bio-Materials Research Center).	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Almeida RD, 2004, BBA-REV CANCER, V1704, P59, DOI 10.1016/j.bbcan.2004.05.003; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Caccamo D, 2010, AMINO ACIDS, V38, P653, DOI 10.1007/s00726-009-0428-3; Chung PS, 2009, CANCER BIOL THER, V8, P1343, DOI 10.4161/cbt.8.14.8693; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Filiano AJ, 2010, NEUROBIOL DIS, V39, P334, DOI 10.1016/j.nbd.2010.04.018; Fok JY, 2007, APOPTOSIS, V12, P1455, DOI 10.1007/s10495-007-0079-3; Furre IE, 2005, CANCER RES, V65, P11051, DOI 10.1158/0008-5472.CAN-05-0510; Furre IE, 2006, APOPTOSIS, V11, P2031, DOI 10.1007/s10495-006-0190-x; Haggie PM, 2002, J BIOL CHEM, V277, P40782, DOI 10.1074/jbc.M207456200; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Isaeva EV, 2005, J PHYSIOL-LONDON, V565, P855, DOI 10.1113/jphysiol.2005.086280; Kao SH, 2010, J CELL BIOCHEM, V110, P660, DOI 10.1002/jcb.22577; Lee MJ, 2009, TOXICOLOGY, V264, P205, DOI 10.1016/j.tox.2009.08.012; Lee ZW, 2003, BIOCHEM BIOPH RES CO, V305, P633, DOI 10.1016/S0006-291X(03)00835-0; Lee ZW, 2000, CELL SIGNAL, V12, P91, DOI 10.1016/S0898-6568(99)00069-8; Lindfors K, 2010, AUTOIMMUN REV, V9, P744, DOI 10.1016/j.autrev.2010.06.003; Lorenzo HK, 2007, DRUG RESIST UPDATE, V10, P235, DOI 10.1016/j.drup.2007.11.001; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Nadalutti C, 2011, CELL PROLIFERAT, V44, P49, DOI 10.1111/j.1365-2184.2010.00716.x; Ortel B, 2009, FRONT BIOSCI-LANDMRK, V14, P4157, DOI 10.2741/3520; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Robertson CA, 2009, J PHOTOCH PHOTOBIO B, V96, P1, DOI 10.1016/j.jphotobiol.2009.04.001; Robitaille K, 2008, CELL DEATH DIFFER, V15, P1522, DOI 10.1038/cdd.2008.77; Ruan QM, 2007, J NEUROCHEM, V102, P25, DOI 10.1111/j.1471-4159.2007.04491.x; Sanges D, 2006, APOPTOSIS, V11, P1629, DOI 10.1007/s10495-006-9006-2; Sarang Z, 2007, CELL DEATH DIFFER, V14, P1842, DOI 10.1038/sj.cdd.4402193; Shin DM, 2008, FASEB J, V22, P2498, DOI 10.1096/fj.07-095455; Song H, 2011, J RECEPT SIG TRANSD, V31, P66, DOI 10.3109/10799893.2010.529577; Sanchez-Gomez MV, 2011, J NEUROSCI, V31, P2996, DOI 10.1523/JNEUROSCI.5578-10.2011; Vittar NBR, 2010, INT J BIOCHEM CELL B, V42, P1123, DOI 10.1016/j.biocel.2010.03.019; Yi SJ, 2004, BIOCHEM BIOPH RES CO, V325, P819, DOI 10.1016/j.bbrc.2004.10.122; Yoo JO, 2011, J CELL BIOCHEM, V112, P3061, DOI 10.1002/jcb.23231; Yoo JO, 2005, BIOCHEM BIOPH RES CO, V337, P655, DOI 10.1016/j.bbrc.2005.09.108; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	38	31	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14377	14388		10.1074/jbc.M111.326074	http://dx.doi.org/10.1074/jbc.M111.326074			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22418443	Green Published, hybrid			2022-12-25	WOS:000304003200006
J	Wu, B; Dong, BJ; Xu, YJ; Zhang, Q; Shen, JF; Chen, HF; Xue, W				Wu, Bin; Dong, Baijun; Xu, Yuejuan; Zhang, Qiang; Shen, Jinfang; Chen, Huafeng; Xue, Wei			Economic Evaluation of First-Line Treatments for Metastatic Renal Cell Carcinoma: A Cost-Effectiveness Analysis in A Health Resource-Limited Setting	PLOS ONE			English	Article							INTERFERON-ALPHA; SUNITINIB; BEVACIZUMAB; TEMSIROLIMUS; GUIDELINES; MANAGEMENT; SYSTEM	Background: To estimate, from the perspective of the Chinese healthcare system, the economic outcomes of five different first-line strategies among patients with metastatic renal cell carcinoma (mRCC). Methods and Findings: A decision-analytic model was developed to simulate the lifetime disease course associated with renal cell carcinoma. The health and economic outcomes of five first-line strategies (interferon-alfa, interleukin-2, interleukin-2 plus interferon-alfa, sunitinib and bevacizumab plus interferon-alfa) were estimated and assessed by indirect comparison. The clinical and utility data were taken from published studies. The cost data were estimated from local charge data and current Chinese practices. Sensitivity analyses were used to explore the impact of uncertainty regarding the results. The impact of the sunitinib patient assistant program (SPAP) was evaluated via scenario analysis. The base-case analysis showed that the sunitinib strategy yielded the maximum health benefits: 2.71 life years and 1.40 quality-adjusted life-years (QALY). The marginal cost-effectiveness (cost per additional QALY) gained via the sunitinib strategy compared with the conventional strategy was $220,384 (without SPAP, interleukin-2 plus interferon-alfa and bevacizumab plus interferon-alfa were dominated) and $16,993 (with SPAP, interferon-alfa, interleukin-2 plus interferon-alfa and bevacizumab plus interferon-alfa were dominated). In general, the results were sensitive to the hazard ratio of progression-free survival. The probabilistic sensitivity analysis demonstrated that the sunitinib strategy with SPAP was the most cost-effective approach when the willingness-to-pay threshold was over $16,000. Conclusions: Our analysis suggests that traditional cytokine therapy is the cost-effective option in the Chinese healthcare setting. In some relatively developed regions, sunitinib with SPAP may be a favorable cost-effective alternative for mRCC.	[Wu, Bin; Shen, Jinfang; Chen, Huafeng] Shanghai Jiao Tong Univ, Clin Outcomes & Econ Grp, Dept Pharm, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China; [Dong, Baijun; Xue, Wei] Shanghai Jiao Tong Univ, Dept Urol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Xu, Yuejuan] South E Univ, Dept Oncol, Hosp Nanjing 2, Sch Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Qiang] Shanghai Univ Tradit Chinese Med, Dept Oncol, Shanghai Putuo Hosp, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine	Wu, B (corresponding author), Shanghai Jiao Tong Univ, Clin Outcomes & Econ Grp, Dept Pharm, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China.	xwurosjtu@yeah.net			Shanghai government [08411951500]	Shanghai government	This work was supported by a grant from Shanghai government (no. 08411951500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; Benedict A, 2011, BJU INT; Chabot I, 2010, VALUE HEALTH, V13, P837, DOI 10.1111/j.1524-4733.2010.00738.x; Coon JT, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14020; COON JT, 2010, HEALTH TECHNOL ASSES, V14, pR3; Coppin C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001425.pub2; Curti BD, 2004, JAMA-J AM MED ASSOC, V292, P97, DOI 10.1001/jama.292.1.97; de Reijke TM, 2009, EUR J CANCER, V45, P765, DOI 10.1016/j.ejca.2008.12.010; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Gore ME, 2008, BJU INT, V101, P1063, DOI 10.1111/j.1464-410X.2008.07435.x; Gore ME, 2010, LANCET, V375, P641, DOI 10.1016/S0140-6736(09)61921-8; Hougaard JL, 2011, APPL HEALTH ECON HEA, V9, P1, DOI 10.2165/11531800-000000000-00000; Hoyle M, 2010, VALUE HEALTH, V13, P61, DOI 10.1111/j.1524-4733.2009.00617.x; Hutson Thomas E, 2005, Clin Genitourin Cancer, V4, P181, DOI 10.3816/CGC.2005.n.030; Kielhorn A, 2008, CURR MED RES OPIN, V24, P2639, DOI [10.1185/03007990802321683, 10.1185/03007990802321683 ]; Lam JS, 2008, NAT CLIN PRACT UROL, V5, P308, DOI 10.1038/ncpuro1121; Mickisch G, 2010, BRIT J CANCER, V102, P80, DOI 10.1038/sj.bjc.6605417; Molina AM, 2011, ONCOLOGIST, V16, P45, DOI 10.1634/theoncologist.2011-S2-45; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Ravasio R, 2011, CLIN DRUG INVEST, V31, P507, DOI 10.2165/11590230-000000000-00000; Remak E, 2008, J CLIN ONCOL, V26, P3995, DOI 10.1200/JCO.2007.13.2662; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sengupta S, 2005, UROLOGY, V66, P36, DOI 10.1016/j.urology.2005.06.004; Sun M, 2010, NAT REV UROL, V7, P327, DOI 10.1038/nrurol.2010.57; Vickers MM, 2010, UROLOGY, V76, P430, DOI 10.1016/j.urology.2009.12.031; Wagstaff A, 2009, HEALTH ECON, V18, pS7, DOI 10.1002/hec.1518; Wu B, 2011, CLIN THER, V33, P1446, DOI 10.1016/j.clinthera.2011.09.016	32	57	62	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32530	10.1371/journal.pone.0032530	http://dx.doi.org/10.1371/journal.pone.0032530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412884	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062000013
J	Chaika, NV; Yu, F; Purohit, V; Mehla, K; Lazenby, AJ; DiMaio, D; Anderson, JM; Yeh, JJ; Johnson, KR; Hollingsworth, MA; Singh, PK				Chaika, Nina V.; Yu, Fang; Purohit, Vinee; Mehla, Kamiya; Lazenby, Audrey J.; DiMaio, Dominick; Anderson, Judy M.; Yeh, Jen Jen; Johnson, Keith R.; Hollingsworth, Michael A.; Singh, Pankaj K.			Differential Expression of Metabolic Genes in Tumor and Stromal Components of Primary and Metastatic Loci in Pancreatic Adenocarcinoma	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER-1 EXPRESSION; GLUCOSE-METABOLISM; CELL-METABOLISM; CANCER; REVEALS	Background: Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States with a five-year survival rate of 6%. It is characterized by extremely aggressive tumor growth rate and high incidence of metastasis. One of the most common and profound biochemical phenotypes of animal and human cancer cells is their ability to metabolize glucose at high rates, even under aerobic conditions. However, the contribution of metabolic interrelationships between tumor cells and cells of the surrounding microenvironment to the progression of cancer is not well understood. We evaluated differential expression of metabolic genes and, hence, metabolic pathways in primary tumor and metastases of patients with pancreatic adenocarcinoma. Methods and Findings: We analyzed the metabolic gene (those involved in glycolysis, tri-carboxylic acid pathway, pentose-phosphate pathway and fatty acid metabolism) expression profiles of primary and metastatic lesions from pancreatic cancer patients by gene expression arrays. We observed two principal results: genes that were upregulated in primary and most of the metastatic lesions; and genes that were upregulated only in specific metastatic lesions in a site-specific manner. Immunohistochemical (IHC) analyses of several metabolic gene products confirmed the gene expression patterns at the protein level. The IHC analyses also revealed differential tumor and stromal expression patterns of metabolic enzymes that were correlated with the metastasis sites. Conclusions: Here, we present the first comprehensive studies that establish differential metabolic status of tumor and stromal components and elevation of aerobic glycolysis gene expression in pancreatic cancer.	[Chaika, Nina V.; Purohit, Vinee; Mehla, Kamiya; Anderson, Judy M.; Johnson, Keith R.; Hollingsworth, Michael A.; Singh, Pankaj K.] Univ Nebraska Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE 68198 USA; [Yu, Fang] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA; [Purohit, Vinee; Lazenby, Audrey J.; DiMaio, Dominick; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Yeh, Jen Jen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Surg & Pharmacol, Chapel Hill, NC 27599 USA; [Johnson, Keith R.; Hollingsworth, Michael A.; Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Johnson, Keith R.; Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Johnson, Keith R.] Univ Nebraska Med Ctr, Coll Dent Oral Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Chaika, NV (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE 68198 USA.	pankaj.singh@unmc.edu	Purohit, Vinee/GSO-0751-2022; Yu, Fang/B-9874-2013; Purohit, Vinee/F-4302-2014; Purohit, Vinee/AAA-3991-2019	Purohit, Vinee/0000-0001-8093-5540; Purohit, Vinee/0000-0001-8093-5540; Singh, Pankaj/0000-0001-8903-0131	NCI [P50 CA127297, U01 CA111294, R21 CA137401]; NATIONAL CANCER INSTITUTE [P50CA127297, U01CA111294, R21CA137401] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Specialized Programs for Research Excellence (SPORE) grant in GI/pancreatic cancer (P50 CA127297, NCI) to MAH and KRJ, a SPORE (P50 CA127297, NCI) Career Development Award to PKS, an Early Diagnosis of Pancreatic Cancer grant (U01 CA111294, NCI) to MAH, and R21 (R21 CA137401, NCI) to KRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Cavalieri D, 2007, ONCOL RES, V16, P535, DOI 10.3727/096504007783438376; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dong X, 2010, CANCER; Dong XQ, 2011, CANCER-AM CANCER SOC, V117, P480, DOI 10.1002/cncr.25612; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Godoy A, 2006, J CELL PHYSIOL, V207, P614, DOI 10.1002/jcp.20606; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Higashi T, 2002, J NUCL MED, V43, P173; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kogure K, 1996, J BIOL CHEM, V271, P15230, DOI 10.1074/jbc.271.25.15230; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Maher JC, 2005, PANCREAS, V30, pE34, DOI 10.1097/01.mpa.0000153327.46945.26; Miederer M, 2010, GASTROENTEROL CLIN N, V39, P923, DOI 10.1016/j.gtc.2010.08.031; Nelson D. L., 2005, LEHNINGER PRINCIPLES, P521; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Pizzi S, 2009, HISTOL HISTOPATHOL, V24, P175, DOI 10.14670/HH-24.175; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tanimoto K, 2010, NUCL MED COMMUN, V31, P604, DOI 10.1097/MNM.0b013e328339350c; Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107	27	74	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32996	10.1371/journal.pone.0032996	http://dx.doi.org/10.1371/journal.pone.0032996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412968	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800070
J	Gauthier, MG; Norio, P; Bechhoefer, J				Gauthier, Michel G.; Norio, Paolo; Bechhoefer, John			Modeling Inhomogeneous DNA Replication Kinetics	PLOS ONE			English	Article							XENOPUS EGG EXTRACTS; MAMMALIAN-CELLS; DORMANT ORIGINS; FISSION YEAST; PHASE-CHANGE; GENOME; INITIATION; TRANSCRIPTION; ORGANIZATION; CHECKPOINT	In eukaryotic organisms, DNA replication is initiated at a series of chromosomal locations called origins, where replication forks are assembled proceeding bidirectionally to replicate the genome. The distribution and firing rate of these origins, in conjunction with the velocity at which forks progress, dictate the program of the replication process. Previous attempts at modeling DNA replication in eukaryotes have focused on cases where the firing rate and the velocity of replication forks are homogeneous, or uniform, across the genome. However, it is now known that there are large variations in origin activity along the genome and variations in fork velocities can also take place. Here, we generalize previous approaches to modeling replication, to allow for arbitrary spatial variation of initiation rates and fork velocities. We derive rate equations for left-and right-moving forks and for replication probability over time that can be solved numerically to obtain the mean-field replication program. This method accurately reproduces the results of DNA replication simulation. We also successfully adapted our approach to the inverse problem of fitting measurements of DNA replication performed on single DNA molecules. Since such measurements are performed on specified portion of the genome, the examined DNA molecules may be replicated by forks that originate either within the studied molecule or outside of it. This problem was solved by using an effective flux of incoming replication forks at the model boundaries to represent the origin activity outside the studied region. Using this approach, we show that reliable inferences can be made about the replication of specific portions of the genome even if the amount of data that can be obtained from single-molecule experiments is generally limited.	[Gauthier, Michel G.; Bechhoefer, John] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Norio, Paolo] Montefiore Med Ctr, Dept Oncol, Moses Div, Bronx, NY 10467 USA; [Norio, Paolo] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Simon Fraser University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gauthier, MG (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	johnb@sfu.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; Human Frontier Science Program (HFSP); National Institutes of Health [R01GM080606]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080606] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Michel G. Gauthier and John Bechhoefer were supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada and by the Human Frontier Science Program (HFSP). Paolo Norio was supported by National Institutes of Health grant R01GM080606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; Avrami M., 1940, J CHEM PHYS, V8, P212, DOI [DOI 10.1063/1.1750631, 10.1063/1.1750631]; Bechhoefer J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.098105; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; Blow JJ, 2009, EMBO REP, V10, P406, DOI 10.1038/embor.2009.5; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; de Moura APS, 2010, NUCLEIC ACIDS RES, V38, P5623, DOI 10.1093/nar/gkq343; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; FRANK FC, 1974, J CRYST GROWTH, V22, P233, DOI 10.1016/0022-0248(74)90100-6; Gauthier MG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218104; Gauthier MG, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.158104; Goldar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002919; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; Herrick J, 1999, CHROMOSOME RES, V7, P409, DOI 10.1023/A:1009276210892; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Herrick J, 2008, CHROMOSOMA, V117, P243, DOI 10.1007/s00412-007-0145-1; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Johnson WA, 1939, T AM I MIN MET ENG, V135, P416; Jun S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011908; Jun S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011909; Katsuno Y, 2009, P NATL ACAD SCI USA, V106, P3184, DOI 10.1073/pnas.0809350106; Kaufmann WK, 2010, CARCINOGENESIS, V31, P751, DOI 10.1093/carcin/bgp230; Kolmogorov, 1937, B ACAD SCI USSR PHYS, V3, P335; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Lygeros J, 2008, P NATL ACAD SCI USA, V105, P12295, DOI 10.1073/pnas.0805549105; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; Nieduszynski CA, 2005, NUCLEIC ACIDS RES, V33, P2410, DOI 10.1093/nar/gki539; Norio P, 2004, PLOS BIOL, V2, P816, DOI 10.1371/journal.pbio.0020152; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Spiesser TW, 2009, MOL GENET GENOMICS, V282, P25, DOI 10.1007/s00438-009-0443-9; TELLINGHUISEN J, 1994, J MOL SPECTROSC, V165, P255, DOI 10.1006/jmsp.1994.1127; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yang SCH, DNA REPLICATION METH, P555; Yang SCH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.61; Yang SCH, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041917; Zhang HY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051903	46	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32053	10.1371/journal.pone.0032053	http://dx.doi.org/10.1371/journal.pone.0032053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412853	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800010
J	Kwasa, J; Cettomai, D; Lwanya, E; Osiemo, D; Oyaro, P; Birbeck, GL; Price, RW; Bukusi, EA; Cohen, CR; Meyer, ACL				Kwasa, Judith; Cettomai, Deanna; Lwanya, Edwin; Osiemo, Dennis; Oyaro, Patrick; Birbeck, Gretchen L.; Price, Richard W.; Bukusi, Elizabeth A.; Cohen, Craig R.; Meyer, Ana-Claire L.			Lessons Learned Developing a Diagnostic Tool for HIV-Associated Dementia Feasible to Implement in Resource-Limited Settings: Pilot Testing in Kenya	PLOS ONE			English	Article							VIRUS-ASSOCIATED DEMENTIA; ANTIRETROVIRAL THERAPY; CRYPTOCOCCAL ANTIGENEMIA; NEUROPSYCHIATRIC AIDS; INFECTED ADULTS; RISK-FACTORS; IMPAIRMENT; DISEASE; SCALE; PERFORMANCE	Objective: To conduct a preliminary evaluation of the utility and reliability of a diagnostic tool for HIV-associated dementia (HAD) for use by primary health care workers (HCW) which would be feasible to implement in resource-limited settings. Background: In resource-limited settings, HAD is an indication for anti-retroviral therapy regardless of CD4 T-cell count. Anti-retroviral therapy, the treatment for HAD, is now increasingly available in resource-limited settings. Nonetheless, HAD remains under-diagnosed likely because of limited clinical expertise and availability of diagnostic tests. Thus, a simple diagnostic tool which is practical to implement in resource-limited settings is an urgent need. Methods: A convenience sample of 30 HIV-infected outpatients was enrolled in Western Kenya. We assessed the sensitivity and specificity of a diagnostic tool for HAD as administered by a primary HCW. This was compared to an expert clinical assessment which included examination by a physician, neuropsychological testing, and in selected cases, brain imaging. Agreement between HCW and an expert examiner on certain tool components was measured using Kappa statistic. Results: The sample was 57% male, mean age was 38.6 years, mean CD4 T-cell count was 323 cells/mu L, and 54% had less than a secondary school education. Six (20%) of the subjects were diagnosed with HAD by expert clinical assessment. The diagnostic tool was 63% sensitive and 67% specific for HAD. Agreement between HCW and expert examiners was poor for many individual items of the diagnostic tool (K = .03-.65). This diagnostic tool had moderate sensitivity and specificity for HAD. However, reliability was poor, suggesting that substantial training and formal evaluations of training adequacy will be critical to enable HCW to reliably administer a brief diagnostic tool for HAD.	[Kwasa, Judith; Cettomai, Deanna; Lwanya, Edwin; Osiemo, Dennis; Oyaro, Patrick; Bukusi, Elizabeth A.; Meyer, Ana-Claire L.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Cettomai, Deanna; Price, Richard W.; Meyer, Ana-Claire L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Birbeck, Gretchen L.] Michigan State Univ, E Lansing, MI 48824 USA; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	Kenya Medical Research Institute; University of California System; University of California San Francisco; Michigan State University; University of California System; University of California San Francisco	Kwasa, J (corresponding author), Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya.	meyerac@sfgh.ucsf.edu		Meyer, Ana-Claire/0000-0002-4906-3059; Saylor, Deanna/0000-0002-9297-0244	Fulbright African Regional Research Program; American Academy of Neurology Foundation; Doris Duke International Clinical Research Fellowship; National Institutes of Health [5 R24 TW00798, 3 R24 TW00798-02S1]; Fogarty International Center through Vanderbilt University; National Cancer Institute; National Institute on Drug Abuse, Office of the Director, National Institutes of Health; National Institute of Mental Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	Fulbright African Regional Research Program; American Academy of Neurology Foundation; Doris Duke International Clinical Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center through Vanderbilt University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse, Office of the Director, National Institutes of Health; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Fulbright African Regional Research Program, American Academy of Neurology Foundation Practice Research Training Fellowship, and Doris Duke International Clinical Research Fellowship. In addition this study was supported by the Fogarty International Clinical Research Fellowship (5 R24 TW00798; 3 R24 TW00798-02S1) from the National Institutes of Health, Fogarty International Center through Vanderbilt University, the National Cancer Institute, the National Institute on Drug Abuse, Office of the Director, National Institutes of Health and the National Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Benedict RHB, 1997, BRIEF VISUAL MEMORY; Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Birbeck GL, 2009, AM J TROP MED HYG, V80, P669, DOI 10.4269/ajtmh.2009.80.669; Castaneda AE, 2008, J AFFECT DISORDERS, V110, P36, DOI 10.1016/j.jad.2007.12.239; Chelune G. J., 1986, ADV CLIN NEUROPSYCHO, V3, P15, DOI DOI 10.1007/978-1-4613-2211-5_4; Clifford DB, 2007, J NEUROVIROL, V13, P67, DOI 10.1080/13550280601169837; Dunbar N, 1997, J NeuroAIDS, V1, P73, DOI 10.1300/J128v01n03_05; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; HOWLETT WP, 1989, AIDS, V3, P289, DOI 10.1097/00002030-198905000-00007; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Jowi J O, 2007, East Afr Med J, V84, P97; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kvalsund MP, 2009, AM J TROP MED HYG, V80, P1054, DOI 10.4269/ajtmh.2009.80.1054; Lafayette I, 2003, GROOVED PEGBOARD USE; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P422; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P51; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P39; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; Meyer A, 2009, PREVALENCE HIV UNPUB; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Monforte AD, 2004, ANN NEUROL, V55, P320, DOI 10.1002/ana.10827; MONSCH AU, 1992, ARCH NEUROL-CHICAGO, V49, P1253, DOI 10.1001/archneur.1992.00530360051017; Njamnshi AK, 2008, JAIDS-J ACQ IMM DEF, V49, P393, DOI 10.1097/QAI.0b013e318183a9df; PAR, 1992, FING TAPP US GUID; PERRIENS JH, 1992, J ACQ IMMUN DEF SYND, V5, P333; PORTEGIES P, 1989, BRIT MED J, V299, P819, DOI 10.1136/bmj.299.6703.819; POWER C, 1995, J ACQ IMMUN DEF SYND, V8, P273, DOI 10.1097/00042560-199503010-00008; Robertson KR, 2006, J CLIN EXP NEUROPSYC, V28, P1053, DOI 10.1080/13803390500205684; Robertson KR, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-8; Sacktor N, 2006, NEUROLOGY, V67, P311, DOI 10.1212/01.wnl.0000225183.74521.72; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Sacktor N, 2002, J NEUROVIROL, V8, P115, DOI 10.1080/13550280290101094; Sacktor NC, 2005, AIDS, V19, P1367; Sacktor NC, 2000, J NEUROVIROL, V6, P84, DOI 10.3109/13550280009006385; Sacktor NC, 1999, NEUROLOGY, V52, P1640, DOI 10.1212/WNL.52.8.1640; SAYKIN AJ, 1991, J NEUROPSYCH CLIN N, V3, P286; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Singh Dinesh, 2010, BMC Res Notes, V3, P28, DOI 10.1186/1756-0500-3-28; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tozzi V, 2005, J NEUROVIROL, V11, P265, DOI 10.1080/13550280590952790; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wong MH, 2007, NEUROLOGY, V68, P350, DOI 10.1212/01.wnl.0000252811.48891.6d; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2006, WORLD HLTH REP WORK; World Health Organization, 2008, TASK SHIFT RAT RED T; World Health Organization World Federation of Neurology, 2004, ATL COUNTR RES NEUR, P1	51	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32898	10.1371/journal.pone.0032898	http://dx.doi.org/10.1371/journal.pone.0032898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412945	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800061
J	McCall, BD; Pennings, SC				McCall, Brittany D.; Pennings, Steven C.			Disturbance and Recovery of Salt Marsh Arthropod Communities following BP Deepwater Horizon Oil Spill	PLOS ONE			English	Article							BOTTOM-UP FORCES; TOP-DOWN; RESIDUAL PETROLEUM; RELATIVE STRENGTH; FOOD-WEB; VEGETATION; IMPACT; CONSEQUENCES; SOILS; COAST	Oil spills represent a major environmental threat to coastal wetlands, which provide a variety of critical ecosystem services to humanity. The U.S. Gulf of Mexico is a hub of oil and gas exploration activities that historically have impacted intertidal habitats such as salt marsh. Following the BP Deepwater Horizon oil spill, we sampled the terrestrial arthropod community and marine invertebrates found in stands of Spartina alterniflora, the most abundant plant in coastal salt marshes. Sampling occurred in 2010 as oil was washing ashore and a year later in 2011. In 2010, intertidal crabs and terrestrial arthropods (insects and spiders) were suppressed by oil exposure even in seemingly unaffected stands of plants; however, Littoraria snails were unaffected. One year later, crab and arthropods had largely recovered. Our work is the first attempt that we know of assessing vulnerability of the salt marsh arthropod community to oil exposure, and it suggests that arthropods are both quite vulnerable to oil exposure and quite resilient, able to recover from exposure within a year if host plants remain healthy.	[McCall, Brittany D.; Pennings, Steven C.] Univ Houston, Dept Biol & Biochem, Houston, TX 77030 USA	University of Houston System; University of Houston	McCall, BD (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77030 USA.	spennings@uh.edu	Pennings, Steven C/A-8326-2013	Pennings, Steven C/0000-0003-4757-7125	National Science Foundation [OCE10-45221, OCE06-20959]; Division Of Ocean Sciences [1045221] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the National Science Foundation (OCE10-45221, OCE06-20959) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade ML, 2004, J ENVIRON QUAL, V33, P2103, DOI 10.2134/jeq2004.2103; Barth DHJ, 2007, AQUAT ECOSYST HEALTH, V10, P327, DOI 10.1080/14634980701512624; Bertness MD, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P39; Bogran C.E., 2006, TEXAS FARMER COLLECT; Brook AJ, 2008, J APPL ECOL, V45, P1357, DOI 10.1111/j.1365-2664.2008.01530.x; Carman KR, 1997, LIMNOL OCEANOGR, V42, P561, DOI 10.4319/lo.1997.42.3.0561; CLARKE PJ, 1994, J EXP MAR BIOL ECOL, V175, P43, DOI 10.1016/0022-0981(94)90175-9; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; Culbertson JB, 2008, ENVIRON POLLUT, V154, P312, DOI 10.1016/j.envpol.2007.10.008; Culbertson JB, 2007, MAR POLLUT BULL, V54, P955, DOI 10.1016/j.marpolbul.2007.02.015; DeLaune RD, 2003, AQUAT ECOL, V37, P351, DOI 10.1023/B:AECO.0000007047.42636.96; Denno RF, 1996, ECOL MONOGR, V66, P389, DOI 10.2307/2963487; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Denno RF, 2005, ANN ZOOL FENN, V42, P295; Denno RF, 2003, ECOLOGY, V84, P1032, DOI 10.1890/0012-9658(2003)084[1032:PRARSO]2.0.CO;2; Denno RF, 2000, ECOLOGY, V81, P1814, DOI 10.1890/0012-9658(2000)081[1814:FICIPQ]2.0.CO;2; DOI US, 2011, GULF OCS REG ACT; Fischer JM, 2000, ESTUARIES, V23, P565, DOI 10.2307/1353146; Gilfillan ES, 1995, MAR POLLUT BULL, V30, P780, DOI 10.1016/0025-326X(95)00069-Y; Gratton C, 2003, OECOLOGIA, V134, P487, DOI 10.1007/s00442-002-1137-8; Hester MW, 2000, MAR ENVIRON RES, V49, P233, DOI 10.1016/S0141-1136(99)00071-9; KNEIB RT, 1984, ESTUARIES, V7, P392, DOI 10.2307/1351621; Lindau CW, 1999, MAR POLLUT BULL, V38, P1216, DOI 10.1016/S0025-326X(99)00165-4; McFarlin CR, 2008, ESTUAR COAST, V31, P313, DOI 10.1007/s12237-008-9036-9; Melville F, 2009, MAR POLLUT BULL, V58, P263, DOI 10.1016/j.marpolbul.2008.09.022; Mitsch W. J., 1993, WETLANDS; ODUM WE, 1988, ANNU REV ECOL SYST, V19, P147, DOI 10.1146/annurev.es.19.110188.001051; Oil Spill Commission, 2011, DEEP WAT GULF OIL DI; Peacock EE, 2005, ENVIRON FORENSICS, V6, P273, DOI 10.1080/15275920500194480; Pennings SC, 2001, MARINE COMMUNITY ECOLOGY, P289; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; Pfeiffer W.J., 1981, ECOLOGY SALT MARSH, P87, DOI DOI 10.1007/978-1-4612-5893-3_5; Roth AMF, 2009, ESTUAR COAST, V32, P565, DOI 10.1007/s12237-009-9135-2; Silliman BR, HUMAN IMPACTS SALT M; Stadler T, 2009, B INSECTOL, V62, P169; TEAL JM, 1984, ENVIRON MANAGE, V8, P27, DOI 10.1007/BF01867871; Vega FA, 2009, J HAZARD MATER, V166, P1020, DOI 10.1016/j.jhazmat.2008.11.113; Wimp GM, 2010, ECOLOGY, V91, P3303, DOI 10.1890/09-1291.1	39	74	75	0	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32735	10.1371/journal.pone.0032735	http://dx.doi.org/10.1371/journal.pone.0032735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412916	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800047
J	Yadav, R; Gupta, SC; Hillman, BG; Bhatt, JM; Stairs, DJ; Dravid, SM				Yadav, Roopali; Gupta, Subhash C.; Hillman, Brandon G.; Bhatt, Jay M.; Stairs, Dustin J.; Dravid, Shashank M.			Deletion of Glutamate Delta-1 Receptor in Mouse Leads to Aberrant Emotional and Social Behaviors	PLOS ONE			English	Article							SCHIZOPHRENIA-SUSCEPTIBILITY GENE; SCAFFOLDING PROTEIN SHANK3; AUTISM SPECTRUM DISORDERS; ASHKENAZI JEWISH FAMILIES; CASE-CONTROL ASSOCIATION; MEDIAL TEMPORAL-LOBE; D-CYCLOSERINE; PREFRONTAL CORTEX; MAJOR DEPRESSION; BIPOLAR DISORDER	The delta family of ionotropic glutamate receptors consists of glutamate d1 (GluD1) and glutamate delta 2 (GluD2) receptors. While the role of GluD2 in the regulation of cerebellar physiology is well understood, the function of GluD1 in the central nervous system remains elusive. We demonstrate for the first time that deletion of GluD1 leads to abnormal emotional and social behaviors. We found that GluD1 knockout mice (GluD1 KO) were hyperactive, manifested lower anxiety-like behavior, depression-like behavior in a forced swim test and robust aggression in the resident-intruder test. Chronic lithium rescued the depression-like behavior in GluD1 KO. GluD1 KO mice also manifested deficits in social interaction. In the sociability test, GluD1 KO mice spent more time interacting with an inanimate object compared to a conspecific mouse. D-Cycloserine (DCS) administration was able to rescue social interaction deficits observed in GluD1 KO mice. At a molecular level synaptoneurosome preparations revealed lower GluA1 and GluA2 subunit expression in the prefrontal cortex and higher GluA1, GluK2 and PSD95 expression in the amygdala of GluD1 KO. Moreover, DCS normalized the lower GluA1 expression in prefrontal cortex of GluD1 KO. We propose that deletion of GluD1 leads to aberrant circuitry in prefrontal cortex and amygdala owing to its potential role in presynaptic differentiation and synapse formation. Furthermore, these findings are in agreement with the human genetic studies suggesting a strong association of GRID1 gene with several neuropsychiatric disorders including schizophrenia, bipolar disorder, autism spectrum disorders and major depressive disorder.	[Yadav, Roopali; Gupta, Subhash C.; Hillman, Brandon G.; Bhatt, Jay M.; Dravid, Shashank M.] Creighton Univ, Dept Pharmacol, Omaha, NE 68178 USA; [Stairs, Dustin J.] Creighton Univ, Dept Psychol, Omaha, NE 68178 USA	Creighton University; Creighton University	Yadav, R (corresponding author), Creighton Univ, Dept Pharmacol, Omaha, NE 68178 USA.	ShashankDravid@creighton.edu			Health Future Foundation; National Alliance for Research on Schizophrenia and Depression; National Center for Research Resources [G20RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER	Health Future Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Health Future Foundation (SMD) and the National Alliance for Research on Schizophrenia and Depression (SMD). The project was also supported by G20RR024001 from National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Balciuniene J, 2007, AM J HUM GENET, V80, P938, DOI 10.1086/513607; Baldessarini RJ, 2000, ARCH GEN PSYCHIAT, V57, P187, DOI 10.1001/archpsyc.57.2.187; Baumann N, 2010, NEUROCHEM RES, V35, P1875, DOI 10.1007/s11064-010-0298-9; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; Carter CS, 2007, BIOL PSYCHIAT, V62, P709, DOI 10.1016/j.biopsych.2007.07.012; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Deutsch SI, 2011, BRAIN RES BULL, V84, P8, DOI 10.1016/j.brainresbull.2010.10.006; Dravid SM, 2010, J NEUROSCI, V30, P2741, DOI 10.1523/JNEUROSCI.5390-09.2010; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Du J, 2003, ANN NY ACAD SCI, V1003, P378, DOI 10.1196/annals.1300.031; Du J, 2008, J NEUROSCI, V28, P68, DOI 10.1523/JNEUROSCI.3080-07.2008; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; EASTWOOD SL, 1995, MOL BRAIN RES, V29, P211, DOI 10.1016/0169-328X(94)00247-C; Eastwood SL, 1997, MOL BRAIN RES, V44, P92, DOI 10.1016/S0169-328X(96)00195-7; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Feyissa AM, 2010, PROG NEURO-PSYCHOPH, V34, P279, DOI 10.1016/j.pnpbp.2009.11.018; FRANZEN EA, 1973, NEUROPSYCHOLOGIA, V11, P141, DOI 10.1016/0028-3932(73)90002-X; Gao JG, 2007, MOL CELL BIOL, V27, P4500, DOI 10.1128/MCB.02051-06; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Greenwood TA, 2011, AM J PSYCHIAT, V168, P930, DOI 10.1176/appi.ajp.2011.10050723; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P544, DOI 10.1016/j.biopsych.2007.11.011; Guo Hui, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P703, DOI 10.3969/j.issn.1672-7347.2011.08.001; Guo SZ, 2007, SCHIZOPHR RES, V93, P385, DOI 10.1016/j.schres.2007.03.007; Hall FS, 2002, PHARMACOL BIOCHEM BE, V73, P185, DOI 10.1016/S0091-3057(02)00796-7; HARRISON PJ, 1991, LANCET, V337, P450, DOI 10.1016/0140-6736(91)93392-M; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Hermes G, 2011, PHYSIOL BEHAV, V104, P354, DOI 10.1016/j.physbeh.2010.12.019; Hillman BG, 2011, NEUROBIOL LEARN MEM, V95, P404, DOI 10.1016/j.nlm.2011.01.008; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Hofmann SG, 2006, ARCH GEN PSYCHIAT, V63, P298, DOI 10.1001/archpsyc.63.3.298; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kakegawa W, 2005, P NATL ACAD SCI USA, V102, P17846, DOI 10.1073/pnas.0508910102; Kakegawa W, 2009, J NEUROSCI, V29, P5738, DOI 10.1523/JNEUROSCI.6013-08.2009; Karolewicz B, 2009, INT J NEUROPSYCHOPH, V12, P143, DOI 10.1017/S1461145708008985; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kim S, 2010, MOL PSYCHIATR, V15, P326, DOI 10.1038/mp.2008.99; Klimek V, 2002, BIOL PSYCHIAT, V52, P740, DOI 10.1016/S0006-3223(02)01383-5; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Kohda K, 2003, MOL BRAIN RES, V110, P27, DOI 10.1016/S0169-328X(02)00561-2; Kuroyanagi T, 2009, P NATL ACAD SCI USA, V106, P4912, DOI 10.1073/pnas.0900892106; Lachman HM, 2006, NEUROPSYCHOBIOLOGY, V53, P57, DOI 10.1159/000091720; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liu GX, 2007, NEUROPSYCHOPHARMACOL, V32, P1531, DOI 10.1038/sj.npp.1301281; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; Manji HK, 2001, BRIT J PSYCHIAT, V178, pS107, DOI 10.1192/bjp.178.41.s107; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; MAYAT E, 1995, J NEUROSCI, V15, P2533, DOI 10.1523/JNEUROSCI.15-03-02533.1995; MCALLISTER KH, 1994, PSYCHOPHARMACOLOGY, V116, P317, DOI 10.1007/BF02245335; Modi ME, 2011, BIOL PSYCHIAT, V70, P298, DOI 10.1016/j.biopsych.2011.01.026; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Muhleisen TW, 2011, SCHIZOPHR RES, V127, P35, DOI 10.1016/j.schres.2011.01.001; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Ng WXD, 2009, NEUROSCI BIOBEHAV R, V33, P336, DOI 10.1016/j.neubiorev.2008.10.001; Orsetti M, 2008, EUR J NEUROSCI, V27, P2156, DOI 10.1111/j.1460-9568.2008.06155.x; Orsetti M, 2009, PHARMACOGENET GENOM, V19, P600, DOI 10.1097/FPC.0b013e32832ee573; Padberg F, 2009, EXP NEUROL, V219, P2, DOI 10.1016/j.expneurol.2009.04.020; Porter RHP, 1997, BRAIN RES, V751, P217, DOI 10.1016/S0006-8993(96)01404-7; Posey DJ, 2004, AM J PSYCHIAT, V161, P2115, DOI 10.1176/appi.ajp.161.11.2115; Prather MD, 2001, NEUROSCIENCE, V106, P653, DOI 10.1016/S0306-4522(01)00445-6; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Safieddine S, 1997, J NEUROSCI, V17, P7523; Sanacora G, 2006, BIOL PSYCHIAT, V59, P284, DOI 10.1016/j.biopsych.2005.07.015; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Scarr E, 2003, BIPOLAR DISORD, V5, P257, DOI 10.1034/j.1399-5618.2003.00024.x; Schmitt A., 2011, EUR ARCH PSYCHIAT CL; Shah AK, 2010, NEUROSCI LETT, V475, P80, DOI 10.1016/j.neulet.2010.03.047; Shaltiel G, 2008, MOL PSYCHIATR, V13, P858, DOI 10.1038/mp.2008.20; Sheinin A, 2001, NEUROPHARMACOLOGY, V41, P151, DOI 10.1016/S0028-3908(01)00073-9; Sheinkopf SJ, 2005, MED HLTH RI, V88, P157; Sheinkopf Stephen J, 2005, Med Health R I, V88, P152; Sheline YI, 1998, NEUROREPORT, V9, P2023, DOI 10.1097/00001756-199806220-00021; Smith M, 2009, ANN NY ACAD SCI, V1151, P102, DOI 10.1111/j.1749-6632.2008.03571.x; Stevens KE, 1997, PHARMACOL BIOCHEM BE, V58, P1031, DOI 10.1016/S0091-3057(97)00306-7; Stilo Simona A, 2010, Dialogues Clin Neurosci, V12, P305; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takayama C, 1996, DEV BRAIN RES, V92, P147, DOI 10.1016/0165-3806(95)00212-X; Taylor MJ, 2011, INT J NEUROPSYCHOPH, V14, P255, DOI 10.1017/S1461145710001094; Treutlein J, 2009, SCHIZOPHR RES, V111, P123, DOI 10.1016/j.schres.2009.03.011; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Uemura T, 2008, BIOCHEM BIOPH RES CO, V377, P1315, DOI 10.1016/j.bbrc.2008.10.170; van Bon BWM, 2011, EUR J HUM GENET, V19, P400, DOI 10.1038/ejhg.2010.211; Venken T, 2008, MOL PSYCHIATR, V13, P442, DOI 10.1038/sj.mp.4002039; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wood Jacqueline N, 2003, Behav Cogn Neurosci Rev, V2, P97; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yue WH, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-7; Zhao HM, 1997, J NEUROCHEM, V68, P1041; Zhu YL, 2009, SCHIZOPHR RES, V109, P86, DOI 10.1016/j.schres.2009.01.022	109	74	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32969	10.1371/journal.pone.0032969	http://dx.doi.org/10.1371/journal.pone.0032969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412961	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800066
J	Ivanovic, T; Rozendaal, R; Floyd, DL; Popovic, M; van Oijen, AM; Harrison, SC				Ivanovic, Tijana; Rozendaal, Rutger; Floyd, Daniel L.; Popovic, Milos; van Oijen, Antoine M.; Harrison, Stephen C.			Kinetics of Proton Transport into Influenza Virions by the Viral M2 Channel	PLOS ONE			English	Article							VIRUS RIBONUCLEOPROTEINS; MEMBRANE-FUSION; ION-CHANNEL; A VIRUSES; PROTEIN; CONDUCTION; MECHANISM; SUGGEST	M2 protein of influenza A viruses is a tetrameric transmembrane proton channel, which has essential functions both early and late in the virus infectious cycle. Previous studies of proton transport by M2 have been limited to measurements outside the context of the virus particle. We have developed an in vitro fluorescence-based assay to monitor internal acidification of individual virions triggered to undergo membrane fusion. We show that rimantadine, an inhibitor of M2 proton conductance, blocks the acidification-dependent dissipation of fluorescence from a pH-sensitive virus-content probe. Fusion-pore formation usually follows internal acidification but does not require it. The rate of internal virion acidification increases with external proton concentration and saturates with a pK(m) of similar to 4.7. The rate of proton transport through a single, fully protonated M2 channel is approximately 100 to 400 protons per second. The saturating proton-concentration dependence and the low rate of internal virion acidification derived from authentic virions support a transporter model for the mechanism of proton transfer.	[Ivanovic, Tijana; Rozendaal, Rutger; Floyd, Daniel L.; van Oijen, Antoine M.; Harrison, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ivanovic, Tijana] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Popovic, Milos] Univ Colorado, Dept Elect Engn, Boulder, CO 80309 USA; [Harrison, Stephen C.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Ivanovic, T (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Popović, Miloš A./AAC-6940-2020; van Oijen, Antoine/I-3167-2014	Popović, Miloš A./0000-0002-8048-0678; van Oijen, Antoine/0000-0002-1794-5161	National Institutes of Health (NIH) [U54AI057159, R21AI72346]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R21AI072346] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health (NIH) Grants U54AI057159 to SCH (the SCH project of the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases, D. Kasper, PI) and R21AI72346 to AMvO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BRON R, 1993, VIROLOGY, V195, P808, DOI 10.1006/viro.1993.1435; Chen HN, 2007, BIOPHYS J, V93, P3470, DOI 10.1529/biophysj.107.105742; DESSELBERGER U, 1975, ARCH VIROL, V49, P365, DOI 10.1007/BF01318246; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Khurana E, 2009, P NATL ACAD SCI USA, V106, P1069, DOI 10.1073/pnas.0811720106; Killian Mary Lea, 2008, V436, P47, DOI 10.1007/978-1-59745-279-3_7; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Pielak RM, 2010, J AM CHEM SOC, V132, P17695, DOI 10.1021/ja108458u; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; SKEHEL JJ, 1971, VIROLOGY, V44, P396, DOI 10.1016/0042-6822(71)90270-4; SUGRUE RJ, 1990, EMBO J, V9, P3469, DOI 10.1002/j.1460-2075.1990.tb07555.x; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; WANG C, 1995, BIOPHYS J, V69, P1363, DOI 10.1016/S0006-3495(95)80003-2; WHARTON SA, 1994, J GEN VIROL, V75, P945, DOI 10.1099/0022-1317-75-4-945; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988	22	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e31566	10.1371/journal.pone.0031566	http://dx.doi.org/10.1371/journal.pone.0031566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412838	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100007
J	Tsai, PSJ; Brewis, IA; van Maaren, J; Gadella, BM				Tsai, Pei-Shiue J.; Brewis, Ian A.; van Maaren, Jillis; Gadella, Bart M.			Involvement of Complexin 2 in Docking, Locking and Unlocking of Different SNARE Complexes during Sperm Capacitation and Induced Acrosomal Exocytosis	PLOS ONE			English	Article							PLASMA-MEMBRANE; ZONA-PELLUCIDA; LIPID RAFTS; CHOLESTEROL DEPLETION; BOAR SPERMATOZOA; ARYLSULFATASE-A; CELLS; PROGESTERONE; SECRETION; PROTEINS	Acrosomal exocytosis (AE) is an intracellular multipoint fusion reaction of the sperm plasma membrane (PM) with the outer acrosomal membrane (OAM). This unique exocytotic event enables the penetration of the sperm through the zona pellucida of the oocyte. We previously observed a stable docking of OAM to the PM brought about by the formation of the trans-SNARE complex (syntaxin 1B, SNAP 23 and VAMP 3). By using electron microscopy, immunochemistry and immunofluorescence techniques in combination with functional studies and proteomic approaches, we here demonstrate that calcium ionophore-induced AE results in the formation of unilamellar hybrid membrane vesicles containing a mixture of components originating from the two fused membranes. These mixed vesicles (MV) do not contain the earlier reported trimeric SNARE complex but instead possess a novel trimeric SNARE complex that contained syntaxin 3, SNAP 23 and VAMP 2, with an additional SNARE interacting protein, complexin 2. Our data indicate that the earlier reported raft and capacitation-dependent docking phenomenon between the PM and OAM allows a specific rearrangement of molecules between the two docked membranes and is involved in (1) recruiting SNAREs and complexin 2 in the newly formed lipid-ordered microdomains, (2) the assembly of a fusion-driving SNARE complex which executes Ca2+-dependent AE, (3) the disassembly of the earlier reported docking SNARE complex, (4) the recruitment of secondary zona binding proteins at the zona interacting sperm surface. The possibility to study separate and dynamic interactions between SNARE proteins, complexin and Ca2+ which are all involved in AE make sperm an ideal model for studying exocytosis.	[Tsai, Pei-Shiue J.; van Maaren, Jillis; Gadella, Bart M.] Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Farm Anim Hlth, Utrecht, Netherlands; [Tsai, Pei-Shiue J.; Gadella, Bart M.] Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Biochem & Cell Biol, Utrecht, Netherlands; [Brewis, Ian A.] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales	Utrecht University; Utrecht University; Cardiff University	Tsai, PSJ (corresponding author), Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Farm Anim Hlth, Utrecht, Netherlands.	b.m.gadella@uu.nl	Gadella, B.M./S-8667-2019	TSAI, PEI-SHIUE/0000-0001-8217-6285; van Maaren, Jillis/0000-0003-4047-6049	Utrecht University	Utrecht University	This research was paid for by Utrecht University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann F, 2008, J CELL PHYSIOL, V214, P757, DOI 10.1002/jcp.21272; Ackermann F, 2009, J CELL SCI, V122, P4547, DOI 10.1242/jcs.058263; Bos E S, 1981, J Immunoassay, V2, P187, DOI 10.1080/15321818108056977; Bou-haila A, 2009, ARCH BIOCHEM BIOPHYS, V485, P72; Breden TG, 1996, J ANDROL, V17, P443; Brennan P, 2009, PROTEOM CLIN APPL, V3, P359, DOI 10.1002/prca.200800137; Cai HJ, 2008, P NATL ACAD SCI USA, V105, P19538, DOI 10.1073/pnas.0810232105; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; DUDKIEWICZ AB, 1984, BIOL REPROD, V30, P1005, DOI 10.1095/biolreprod30.4.1005; Flesch FM, 1999, BIOCHEM BIOPH RES CO, V262, P787, DOI 10.1006/bbrc.1999.1300; Flesch FM, 1998, BIOL REPROD, V59, P1530, DOI 10.1095/biolreprod59.6.1530; Flesch FM, 2001, J CELL SCI, V114, P3543; Florman HM, 2008, INT J DEV BIOL, V52, P503, DOI 10.1387/ijdb.082696hf; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Gadella BM, 2011, ADV EXP MED BIOL, V713, P65, DOI 10.1007/978-94-007-0763-4_5; Krishnakumar SS, 2011, NAT STRUCT MOL BIOL, V18, P934, DOI 10.1038/nsmb.2103; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Martin JA, 2011, CURR BIOL, V21, P97, DOI 10.1016/j.cub.2010.12.014; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; O'Flaherty C, 2005, BBA-GEN SUBJECTS, V1726, P96, DOI 10.1016/j.bbagen.2005.07.012; Rodriguez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021925; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Shadan S, 2004, BIOL REPROD, V71, P253, DOI 10.1095/biolreprod.103.026435; SOUCEK DA, 1984, BIOL REPROD, V31, P687, DOI 10.1095/biolreprod31.4.687; Stein A, 2009, NEURON, V64, P295, DOI 10.1016/j.neuron.2009.10.026; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Tantibhedhyangkul J, 2002, BIOL REPROD, V67, P212, DOI 10.1095/biolreprod67.1.212; Therien I, 2003, BIOL REPROD, V69, P1408, DOI 10.1095/biolreprod.103.017855; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Tsai PS, 2007, MOL MEMBR BIOL, V24, P313, DOI 10.1080/09687860701228692; Tsai PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011204; Ucar O, 2003, ACTA VET HUNG, V51, P103, DOI 10.1556/AVet.51.2003.1.10; van Gestel RA, 2005, MOL HUM REPROD, V11, P583, DOI 10.1093/molehr/gah200; van Gestel RA, 2007, MOL HUM REPROD, V13, P445, DOI 10.1093/molehr/gam030; Verhage M, 2009, P NATL ACAD SCI USA, V106, P19745, DOI 10.1073/pnas.0911425106; Wit H, 2010, BIOCHEM SOC T, V38, P192; Yang XF, 2010, NEURON, V68, P907, DOI 10.1016/j.neuron.2010.11.001; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304; Zhao L, 2007, DEV BIOL, V309, P236, DOI 10.1016/j.ydbio.2007.07.009	42	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32603	10.1371/journal.pone.0032603	http://dx.doi.org/10.1371/journal.pone.0032603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412896	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000303021100022
J	Brachi, B; Aime, C; Glorieux, C; Cuguen, J; Roux, F				Brachi, Benjamin; Aime, Carla; Glorieux, Cedric; Cuguen, Joel; Roux, Fabrice			Adaptive Value of Phenological Traits in Stressful Environments: Predictions Based on Seed Production and Laboratory Natural Selection	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; ARABIDOPSIS-THALIANA; FLOWERING TIME; GENETIC-VARIATION; EVOLUTIONARY ECOLOGY; ALLELIC VARIATION; LOCAL ADAPTATION; POPULATION-SIZE; PLANT SIZE; GERMINATION	Phenological traits often show variation within and among natural populations of annual plants. Nevertheless, the adaptive value of post-anthesis traits is seldom tested. In this study, we estimated the adaptive values of pre- and post-anthesis traits in two stressful environments (water stress and interspecific competition), using the selfing annual species Arabidopsis thaliana. By estimating seed production and by performing laboratory natural selection (LNS), we assessed the strength and nature (directional, disruptive and stabilizing) of selection acting on phenological traits in A. thaliana under the two tested stress conditions, each with four intensities. Both the type of stress and its intensity affected the strength and nature of selection, as did genetic constraints among phenological traits. Under water stress, both experimental approaches demonstrated directional selection for a shorter life cycle, although bolting time imposes a genetic constraint on the length of the interval between bolting and anthesis. Under interspecific competition, results from the two experimental approaches showed discrepancies. Estimation of seed production predicted directional selection toward early pre-anthesis traits and long post-anthesis periods. In contrast, the LNS approach suggested neutrality for all phenological traits. This study opens questions on adaptation in complex natural environment where many selective pressures act simultaneously.	[Brachi, Benjamin; Aime, Carla; Glorieux, Cedric; Cuguen, Joel; Roux, Fabrice] Univ Sci & Technol Lille Lille 1, CNRS, UMR 8198, Lab Genet & Evolut Populat Vegetales, Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Lille - ISITE; Universite de Lille	Roux, F (corresponding author), Univ Sci & Technol Lille Lille 1, CNRS, UMR 8198, Lab Genet & Evolut Populat Vegetales, Villeneuve Dascq, France.	fabrice.roux@univ-lille1.fr	Cuguen, Joël/A-1708-2009	Cuguen, Joël/0000-0002-6448-920X; Fabrice, Roux/0000-0001-8059-5638; Brachi, Benjamin/0000-0001-5988-7150; Aime, Carla/0000-0002-9579-3861	French Ministry of Higher Education and Research	French Ministry of Higher Education and Research	This study was supported by a Ph.D. fellowship from the French Ministry of Higher Education and Research to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Andalo C, 1998, ANN BOT-LONDON, V81, P405, DOI 10.1006/anbo.1997.0574; Andalo C, 1999, NEW PHYTOL, V142, P173, DOI 10.1046/j.1469-8137.1999.00396.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; BERNIER G, 1988, ANNU REV PLANT PHYS, V39, P175, DOI 10.1146/annurev.arplant.39.1.175; Bischoff A, 2006, J ECOLOGY, V94; Bischoff A, 2010, OIKOS, V119, P445, DOI 10.1111/j.1600-0706.2009.17776.x; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Byers DL, 2005, GENETICA, V123, P107, DOI 10.1007/s10709-003-2721-5; Callahan HS, 2002, ECOLOGY, V83, P1965, DOI 10.1890/0012-9658(2002)083[1965:SIPAIE]2.0.CO;2; Clauss MJ, 2000, AM NAT, V155, P168, DOI 10.1086/303314; Clerkx EJM, 2004, PLANT PHYSIOL, V135, P432, DOI 10.1104/pp.103.036814; COHEN D, 1976, AM NAT, V110, P801, DOI 10.1086/283103; COHEN D, 1971, J THEOR BIOL, V33, P299, DOI 10.1016/0022-5193(71)90068-3; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 2005, SEED SCI RES, V15, P175, DOI 10.1079/SSR2005208; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; DORN LA, 1991, EVOLUTION, V45, P371, DOI 10.1111/j.1558-5646.1991.tb04411.x; Dorn LA, 2000, EVOLUTION, V54, P1982, DOI 10.1111/j.0014-3820.2000.tb01242.x; Earley EJ, 2009, AM J BOT, V96, P786, DOI 10.3732/ajb.0800149; Egli DB, 2004, ADV AGRON, V83, P243, DOI 10.1016/S0065-2113(04)83005-0; EISEN EJ, 1975, GENETICS, V79, P305; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Engelmann K, 2006, ADV BOT RES, V44, P507, DOI 10.1016/S0065-2296(06)44013-1; Fuller RC, 2005, INTEGR COMP BIOL, V45, P391, DOI 10.1093/icb/45.3.391; Goss EM, 2007, OECOLOGIA, V152, P71, DOI 10.1007/s00442-006-0631-9; Griffith TM, 2005, J EVOLUTION BIOL, V18, P1601, DOI 10.1111/j.1420-9101.2005.01021.x; HANRAHAN JP, 1973, GENETICS, V73, P513; Heschel MS, 2005, AM J BOT, V92, P37, DOI 10.3732/ajb.92.1.37; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Kamaluddin, 2007, J PLANT BIOL, V50, P504, DOI 10.1007/BF03030690; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lacey EP, 2003, ECOLOGY, V84, P2462, DOI 10.1890/02-0101; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Le Corre V, 2005, MOL ECOL, V14, P4181, DOI 10.1111/j.1365-294X.2005.02722.x; Lennartsson T, 1997, AM NAT, V149, P1147, DOI 10.1086/286043; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Lynch M., 1998, GENETICS ANAL QUANTI; Marquis R. J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P301; McKay JK, 2003, MOL ECOL, V12, P1137, DOI 10.1046/j.1365-294X.2003.01833.x; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI 10.1111/j.1558-5646.1987.tb02457.x; Mullen LM, 2009, P ROY SOC B-BIOL SCI, V276, P3809, DOI 10.1098/rspb.2009.1146; Mutic JJ, 2007, MOL ECOL, V16, P2371, DOI 10.1111/j.1365-294X.2007.03259.x; O'Neil P, 1999, ECOLOGY, V80, P806, DOI 10.2307/177019; ONeil P, 1997, EVOLUTION, V51, P267, DOI [10.1111/j.1558-5646.1997.tb02408.x, 10.2307/2410980]; Pilson D, 2000, OECOLOGIA, V122, P72, DOI 10.1007/PL00008838; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Pouteau S, 2009, J EXP BOT, V60, P3367, DOI 10.1093/jxb/erp173; R Development Core Team, 2009, R FDN STAT COMP; Raabova J, 2007, BIOL CONSERV, V139, P348, DOI 10.1016/j.biocon.2007.07.007; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.2307/2409632; Roff DA, 2007, NAT REV GENET, V8, P116, DOI 10.1038/nrg2040; Roux F, 2005, EVOLUTION, V59, P2264, DOI 10.1111/j.0014-3820.2005.tb00934.x; Roux F, 2004, GENETICS, V166, P449, DOI 10.1534/genetics.166.1.449; Roux F, 2010, GENETICS, V185, P283, DOI 10.1534/genetics.109.112383; Scarcelli N, 2007, P NATL ACAD SCI USA, V104, P16986, DOI 10.1073/pnas.0708209104; SCHMITT J, 1983, OECOLOGIA, V59, P135, DOI 10.1007/BF00388084; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Stinchcombe JR, 2008, EVOLUTION, V62, P2435, DOI 10.1111/j.1558-5646.2008.00449.x; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Tabien RE, 2009, J CEREAL SCI, V49, P122, DOI 10.1016/j.jcs.2008.07.015; VanDijk H, 1997, ACTA OECOL, V18, P47, DOI 10.1016/S1146-609X(97)80080-X; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Weinig C, 2007, EVOLUTION, V61, P58, DOI 10.1111/j.1558-5646.2007.00005.x; Weis AE, 2004, AM J BOT, V91, P825, DOI 10.3732/ajb.91.6.825; Wender NJ, 2005, AM J BOT, V92, P960, DOI 10.3732/ajb.92.6.960; Wielgolaski FE, 2001, INT J BIOMETEOROL, V45, P196, DOI 10.1007/s004840100100; Yang W, 2008, FIELD CROP RES, V105, P221, DOI 10.1016/j.fcr.2007.10.006	74	39	39	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32069	10.1371/journal.pone.0032069	http://dx.doi.org/10.1371/journal.pone.0032069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403624	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700021
J	Golomb, BA; Evans, MA; White, HL; Dimsdale, JE				Golomb, Beatrice A.; Evans, Marcella A.; White, Halbert L.; Dimsdale, Joel E.			Trans Fat Consumption and Aggression	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ACID-COMPOSITION; SYSTEMIC INFLAMMATION; DIETARY-INTAKE; HEART-DISEASE; PLASMA; OMEGA-3-FATTY-ACIDS; INSULIN; ALTER; N-3	Background: Dietary trans fatty acids (dTFA) are primarily synthetic compounds that have been introduced only recently; little is known about their behavioral effects. dTFA inhibit production of omega-3 fatty acids, which experimentally have been shown to reduce aggression. Potential behavioral effects of dTFA merit investigation. We sought to determine whether dTFA are associated with aggression/irritability. Methodolgy/Prinicpal Findings: We capitalized on baseline dietary and behavioral assessments in an existing clinical trial to analyze the relationship of dTFA to aggression. Of 1,018 broadly sampled baseline subjects, the 945 adult men and women who brought a completed dietary survey to their baseline visit are the target of this analysis. Subjects (seen 1999-2004) were not on lipid medications, and were without LDL-cholesterol extremes, diabetes, HIV, cancer or heart disease. Outcomes assessed adverse behaviors with impact on others: Overt Aggression Scale Modified-aggression subscale (primary behavioral endpoint); Life History of Aggression; Conflict Tactics Scale; and self-rated impatience and irritability. The association of dTFA to aggression was analyzed via regression and ordinal logit, unadjusted and adjusted for potential confounders (sex, age, education, alcohol, and smoking). Additional analyses stratified on sex, age, and ethnicity, and examined the prospective association. Greater dTFA were strongly significantly associated with greater aggression, with dTFA more consistently predictive than other assessed aggression predictors. The relationship was upheld with adjustment for confounders, was preserved across sex, age, and ethnicity strata, and held cross-sectionally and prospectively. Conclusions/Significance: This study provides the first evidence linking dTFA with behavioral irritability and aggression. While confounding is always a concern in observational studies, factors including strength and consistency of association, biological gradient, temporality, and biological plausibility add weight to the prospect of a causal connection. Our results may have relevance to public policy determinations regarding dietary trans fats.	[Golomb, Beatrice A.; Evans, Marcella A.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Golomb, Beatrice A.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [White, Halbert L.] Univ Calif San Diego, Dept Econ, San Diego, CA 92103 USA; [Dimsdale, Joel E.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Golomb, BA (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	bgolomb@ucsd.edu			National Institutes of Health [NHLBI RO1 HL63055-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant from the National Institutes of Health (NHLBI RO1 HL63055-05). The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albuquerque KT, 2006, NUTRITION, V22, P820, DOI 10.1016/j.nut.2006.04.009; ASCHERIO A, 1995, J INTERN MED, V238, P93, DOI 10.1111/j.1365-2796.1995.tb00906.x; Cassagno N, 2005, BRIT J NUTR, V94, P346, DOI 10.1079/BJN20051512; Chukwujekwu D C, 2008, Niger J Med, V17, P153; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; Conklin SM, 2007, PSYCHIAT RES, V152, P1, DOI 10.1016/j.psychres.2006.10.006; Corcoran MP, 2007, AM J CLIN NUTR, V85, P662; DESCHRIJVER R, 1982, LIPIDS, V17, P27, DOI 10.1007/BF02535118; Dyerberg J, 2006, ATHEROSCLEROSIS SUPP, V7, P33, DOI 10.1016/j.atherosclerosissup.2006.04.017; Elias SL, 2002, J AM DIET ASSOC, V102, P46, DOI 10.1016/S0002-8223(02)90015-5; Endicott J, 2002, PSYCHIAT RES, V112, P153, DOI 10.1016/S0165-1781(02)00185-3; Engblom D, 2002, J MOL MED, V80, P5, DOI 10.1007/s00109-001-0289-z; Fontani G, 2005, EUR J CLIN INVEST, V35, P691, DOI 10.1111/j.1365-2362.2005.01570.x; Golomb BA, 2004, CONTROL CLIN TRIALS, V25, P178, DOI 10.1016/j.cct.2003.08.014; Golomb BA, 2000, J PSYCHIATR RES, V34, P301, DOI 10.1016/S0022-3956(00)00024-8; Harnack L, 2003, J AM DIET ASSOC, V103, P1160, DOI 10.1016/S0002-8223(03)00976-3; Hibbeln JR, 2006, INT REV PSYCHIATR, V18, P107, DOI 10.1080/09540260600582967; HILL EG, 1979, J NUTR, V109, P1759, DOI 10.1093/jn/109.10.1759; Ibrahim A, 2005, METABOLISM, V54, P240, DOI 10.1016/j.metabol.2004.08.019; Innis SM, 1999, AM J CLIN NUTR, V70, P383; Iribarren C, 2004, EUR J CLIN NUTR, V58, P24, DOI 10.1038/sj.ejcn.1601739; Kawachi I, 1996, CIRCULATION, V94, P2090, DOI 10.1161/01.CIR.94.9.2090; KNAPP HR, 1989, NUTR REV, V47, P301; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; KURATA N, 1980, LIPIDS, V15, P1029, DOI 10.1007/BF02534319; Larque E, 2000, PEDIATR RES, V47, P278, DOI 10.1203/00006450-200002000-00021; Larque E, 2001, EARLY HUM DEV, V65, pS31, DOI 10.1016/S0378-3782(01)00201-8; Lemaitre RN, 2002, CIRCULATION, V105, P697, DOI 10.1161/hc0602.103583; Lemaitre RN, 2006, ATHEROSCLEROSIS SUPP, V7, P13, DOI 10.1016/j.atherosclerosissup.2006.04.003; Lemaitre RN, 2006, CIRCULATION, V114, P209, DOI 10.1161/CIRCULATIONAHA.106.620336; Liu JH, 2004, AM J PSYCHIAT, V161, P2005, DOI 10.1176/appi.ajp.161.11.2005; Margari F, 2005, INT J METH PSYCH RES, V14, P109, DOI 10.1002/mpr.22; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; MENSINK RP, 1993, PROG LIPID RES, V32, P111, DOI 10.1016/0163-7827(93)90007-J; Mensink RP, 2005, CURR OPIN LIPIDOL, V16, P27, DOI 10.1097/00041433-200502000-00006; MENSINK RP, 1994, ANN MED, V26, P461, DOI 10.3109/07853899409148369; MENSINK RP, 1989, NEW ENGL J MED, V321, P436, DOI 10.1056/NEJM198908173210705; Morse B J, 1995, Violence Vict, V10, P251; Mozaffarian D, 2004, AM J CLIN NUTR, V80, P1521, DOI 10.1093/ajcn/80.6.1521; Mozaffarian D, 2004, AM J CLIN NUTR, V79, P606, DOI 10.1093/ajcn/79.4.606; Natarajan S, 2005, BRIT J NUTR, V93, P829, DOI 10.1079/BJN20051442; Ribeiro L, 1990, Arq Bras Cardiol, V54, P279; Sanchez-Villegas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016268; Schafer J, 1998, AM J PUBLIC HEALTH, V88, P1702, DOI 10.2105/AJPH.88.11.1702; Schakel Sally F., 1997, Journal of Food Composition and Analysis, V10, P102, DOI 10.1006/jfca.1997.0527; Silver J M, 1991, J Neuropsychiatry Clin Neurosci, V3, pS22; Sorgi P, 1991, J NEUROPSYCHIAT, V3, P52; STENDER S, 1995, CLIN SCI, V88, P375, DOI 10.1042/cs0880375; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Sundram K, 1997, J NUTR, V127, pS514, DOI 10.1093/jn/127.3.514S; Sundram K, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-3; US Food and Drug Administration, 2003, FDA ACTS PROV BETT I; VARTIAINEN E, 1994, BRIT MED J, V309, P445, DOI 10.1136/bmj.309.6952.445; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	54	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32175	10.1371/journal.pone.0032175	http://dx.doi.org/10.1371/journal.pone.0032175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403632	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700029
J	Imchen, T				Imchen, Temjensangba			Recruitment Potential of a Green Alga Ulva flexuosa Wulfen Dark Preserved Zoospore and Its Development	PLOS ONE			English	Article							ENTEROMORPHA-INTESTINALIS CHLOROPHYTA; LABORATORY CULTURE; GERMLING GROWTH; SALINITY; IRRADIANCE; NUTRIENTS; TEMPERATURE; PROPAGULES; SETTLEMENT; SPORES	The recruitment potential and the ability of Ulva flexuosa Wulfen zoospores to survive darkness were tested under different conditions in the present study. The dark preserved zoospore was cultured under a two-factor experimental design to test the effect of salinity and nitrate, effect of salinity and phosphate, effect of light and salinity, and effect of light and phosphate. The recruitment (germination and growth) of zoospores was significantly affected by light and salinity. The nitrate concentration of 20 mu mol.l(-1) was found to initiate the process of germination and its subsequent growth and, its effect appeared greatest under 25 psu condition. While nitrate enhances the growth of biomass more than phosphate, both show a positive interactive effect on biomass increase when crossed with salinity. The combined effect of 25 psu salinity and 8 mu mol.l(-1) phosphate exhibited higher biomass growth. There was a significant effect of light and salinity on the biomass of zoospore, though there was no significant interaction between the two factors. There was an increase in biomass of growing zoospores to increase in light intensity and 80 mu mol.m(-2).s(-1) of light intensity was considered optimal. Similarly, high light intensity condition favored higher biomass growth and there was significant interaction between light (80 mu mol. m(-2).s(-1)) and phosphate (4 mu mol. l(-1)) in high salinity (35 psu) condition. The result of this study showed that dark preserved zoospores of U. flexuosa have the potential for recruitment and it gives us an understanding how different factors play a role in the process of recruitment.	CSIR, Natl Inst Oceanog, Goa, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Imchen, T (corresponding author), CSIR, Natl Inst Oceanog, Goa, India.	timchen@nio.org		Imchen, Temjensangba/0000-0003-0330-3173	National Institute of Oceanography, Goa, India	National Institute of Oceanography, Goa, India	Thanks to Dr. SR Shetye, Director, National Institute of Oceanography, Goa, India for his support and encouragement. I am grateful to Dr. AC Anil for his invaluable advice and encouragement. I also thank Dr. SS Sawant, Dr. MP Tapaswi and Mr. Venkat for their support. I am also grateful to the unknown reviewers for their suggestions on improving this manuscript. This is a NIO contribution No. 5124.	Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Brown D, 1994, MODELS BIOL MATH STA; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; Cie DK, 2008, J PHYCOL, V44, P495, DOI 10.1111/j.1529-8817.2008.00464.x; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Hoffmann AJ, 1991, MARINE ECOLOGY PROGR, V78, P71; JONES W E, 1968, British Phycological Bulletin, V3, P525; Kamer K, 2001, MAR ECOL PROG SER, V218, P87, DOI 10.3354/meps218087; Kim KY, 1996, PHYCOLOGIA, V35, P327, DOI 10.2216/i0031-8884-35-4-327.1; Kolwalkar JP, 2007, AQUAT BOT, V86, P86, DOI 10.1016/j.aquabot.2006.09.014; LEUKART P, 1994, EUR J PHYCOL, V29, P103, DOI 10.1080/09670269400650551; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Lotze HK, 2000, OIKOS, V89, P46, DOI 10.1034/j.1600-0706.2000.890106.x; Lotze HK, 2002, LIMNOL OCEANOGR, V47, P1734, DOI 10.4319/lo.2002.47.6.1734; Martins I, 1999, ACTA OECOL, V20, P259, DOI 10.1016/S1146-609X(99)00140-X; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; Santelices B, 2002, REV CHIL HIST NAT, V75, P547; Schories D., 1995, NETH J AQUAT ECOL, V29, P341; Schramm W, 1999, J APPL PHYCOL, V11, P69, DOI 10.1023/A:1008076026792; Shin HW, 2008, J ENVIRON BIOL, V29, P613; Sokal R. R, 1981, BIOMETRY; Sousa AI, 2007, J EXP MAR BIOL ECOL, V341, P142, DOI 10.1016/j.jembe.2006.09.020; Sturtevant R, ENTEROMORPHA FLEXUOS; Sudhir P, 2004, PHOTOSYNTHETICA, V42, P481, DOI 10.1007/S11099-005-0001-6; Taylor R, 2001, BOT MAR, V44, P327, DOI 10.1515/BOT.2001.042; van Katwijk MM, 1999, MAR ECOL PROG SER, V190, P155, DOI 10.3354/meps190155; West JA, 1999, HYDROBIOLOGIA, V399, P101; Worm B, 1999, MAR ECOL PROG SER, V185, P309, DOI 10.3354/meps185309	28	16	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32651	10.1371/journal.pone.0032651	http://dx.doi.org/10.1371/journal.pone.0032651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403690	Green Published, gold			2022-12-25	WOS:000303017700087
J	Lages, NF; Cordeiro, C; Silva, MS; Freire, AP; Ferreira, AEN				Lages, Nuno F.; Cordeiro, Carlos; Silva, Marta Sousa; Freire, Ana Ponces; Ferreira, Antonio E. N.			Optimization of Time-Course Experiments for Kinetic Model Discrimination	PLOS ONE			English	Article							GLYOXALASE-I; GLOBAL OPTIMIZATION; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; PARAMETER-ESTIMATION; METHYLGLYOXAL; MECHANISM; GLYCATION; PATHWAY; SYSTEM	Systems biology relies heavily on the construction of quantitative models of biochemical networks. These models must have predictive power to help unveiling the underlying molecular mechanisms of cellular physiology, but it is also paramount that they are consistent with the data resulting from key experiments. Often, it is possible to find several models that describe the data equally well, but provide significantly different quantitative predictions regarding particular variables of the network. In those cases, one is faced with a problem of model discrimination, the procedure of rejecting inappropriate models from a set of candidates in order to elect one as the best model to use for prediction. In this work, a method is proposed to optimize the design of enzyme kinetic assays with the goal of selecting a model among a set of candidates. We focus on models with systems of ordinary differential equations as the underlying mathematical description. The method provides a design where an extension of the Kullback-Leibler distance, computed over the time courses predicted by the models, is maximized. Given the asymmetric nature this measure, a generalized differential evolution algorithm for multiobjective optimization problems was used. The kinetics of yeast glyoxalase I (EC 4.4.1.5) was chosen as a difficult test case to evaluate the method. Although a single-substrate kinetic model is usually considered, a two-substrate mechanism has also been proposed for this enzyme. We designed an experiment capable of discriminating between the two models by optimizing the initial substrate concentrations of glyoxalase I, in the presence of the subsequent pathway enzyme, glyoxalase II (EC 3.1.2.6). This discriminatory experiment was conducted in the laboratory and the results indicate a two-substrate mechanism for the kinetics of yeast glyoxalase I.	[Lages, Nuno F.; Cordeiro, Carlos; Silva, Marta Sousa; Freire, Ana Ponces; Ferreira, Antonio E. N.] Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, Ctr Quim & Bioquim, Lisbon, Portugal; [Lages, Nuno F.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Green Ctr Syst Biol, Dallas, TX 75390 USA	Universidade de Lisboa; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lages, NF (corresponding author), Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, Ctr Quim & Bioquim, Lisbon, Portugal.	aeferreira@fc.ul.pt	FT-ICR-MS, Lisboa/T-5273-2018; Ferreira, Antonio/GXH-7620-2022; Ferreira, António EN/E-6488-2012; Silva, Marta Sousa/N-2084-2019	Ferreira, Antonio/0000-0001-5239-8020; Ferreira, António EN/0000-0002-9625-8115; Silva, Marta Sousa/0000-0002-3080-9682; Cordeiro, Carlos/0000-0001-6327-8606; Ponces-Freire, Ana/0000-0003-2280-8193	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/21947/2005, PPCDT/QUI/62027/2004]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Work supported by a doctoral fellowship SFRH/BD/21947/2005 and grant PPCDT/QUI/62027/2004 from Fundacao para a Ciencia e Tecnologia, Portugal (www.fct.mctes.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A., 2005, EVOLUTIONARY MULTIOB; Amisaki T, 1995, J PHARMACOKINET BIOP, V23, P479, DOI 10.1007/BF02353470; Ashlock D, 2006, EVOLUTIONARY COMPUTA; Bardsley WG, 1996, COMPUT CHEM, V20, P145, DOI 10.1016/0097-8485(95)00074-7; BARTFAI T, 1973, BIOCHEMISTRY-US, V12, P387, DOI 10.1021/bi00727a004; Bito A, 1999, PROTEIN EXPRES PURIF, V17, P456, DOI 10.1006/prep.1999.1151; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; Bucala R, 1992, Adv Pharmacol, V23, P1; Burnham K. P., 1998, MODEL SELECTION INFE; Castellani R, 1996, BRAIN RES, V737, P195, DOI 10.1016/0006-8993(96)00729-9; Chen F, 2004, P NATL ACAD SCI USA, V101, P7687, DOI 10.1073/pnas.0402338101; CLIFFE EE, 1961, BIOCHEM J, V79, P475, DOI 10.1042/bj0790475; Cornish-Bowden A, 2004, INITIAL RATE MEASURE; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; da Costa G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024850; Edgeworth F. Y., 1881, MATH PHYS; Fang HB, 2008, EVOL COMPUT, V16, P355, DOI 10.1162/evco.2008.16.3.355; Freire AP, 2003, BIOCHEM SOC T, V31, P1409; Gomes R, 2005, BIOCHEM J, V385, P339, DOI 10.1042/BJ20040833; Gomes RA, 2005, FEBS J, V272, P4521, DOI 10.1111/j.1742-4658.2005.04872.x; GUHA MK, 1988, BIOCHEMISTRY-US, V27, P8818, DOI 10.1021/bi00424a020; Gutenkunst RN, 2007, PLOS COMPUTATIONAL B, V3; Hindmarsh AC, 1983, SCI COMPUT, V1, P55; KELLUM MW, 1978, ANAL BIOCHEM, V85, P586, DOI 10.1016/0003-2697(78)90258-0; KERMACK WO, 1957, BIOCHEM J, V65, P48, DOI 10.1042/bj0650048; Kremling A, 2004, GENOME RES, V14, P1773, DOI 10.1101/gr.1226004; Kukkonen S, 2005, IEEE C EVOL COMPUTAT, P443; Kukkonen S, 2007, IEEE C EVOL COMPUTAT, P3593; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; MANNERVIK B, 1973, EUR J BIOCHEM, V37, P270, DOI 10.1111/j.1432-1033.1973.tb02985.x; MARMSTAL E, 1979, BIOCHEM J, V183, P23, DOI 10.1042/bj1830023; Martins AM, 2001, EUR J BIOCHEM, V268, P3930, DOI 10.1046/j.1432-1327.2001.02304.x; Martins AM, 1999, ARCH BIOCHEM BIOPHYS, V366, P15, DOI 10.1006/abbi.1999.1173; Melykuti B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-38; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Nagaraj RH, 2003, BIOCHEMISTRY-US, V42, P10746, DOI 10.1021/bi034541n; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pareto V, 1896, COURS EC POLITIQUE; PETZOLD L, 1983, SIAM J SCI STAT COMP, V4, P136, DOI 10.1137/0904010; Polisetty PK, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-4; Price K. V., 1999, NEW IDEAS OPTIMIZATI, P79; RACKER E, 1951, J BIOL CHEM, V190, P685; Ridderstrom M, 1996, J BIOL CHEM, V271, P319, DOI 10.1074/jbc.271.1.319; Rodriguez-Fernandez M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-483; SELLIN S, 1983, J BIOL CHEM, V258, P8872; Silva MS, 2005, FEBS J, V272, P2388, DOI 10.1111/j.1742-4658.2005.04632.x; Skanda D, 2010, BIOINFORMATICS, V26, P939, DOI 10.1093/bioinformatics/btq074; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; TALESA V, 1990, BIOCHEM INT, V20, P53; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; Varma A., 1999, PARAMETRIC SENSITIVI; Voit E, 2006, P NATL ACAD SCI USA, V103, P9452, DOI 10.1073/pnas.0603337103	54	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32749	10.1371/journal.pone.0032749	http://dx.doi.org/10.1371/journal.pone.0032749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403703	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700100
J	Partty, A; Kalliomaki, M; Endo, A; Salminen, S; Isolauri, E				Partty, Anna; Kalliomaaki, Marko; Endo, Akihito; Salminen, Seppo; Isolauri, Erika			Compositional Development of Bifidobacterium and Lactobacillus Microbiota Is Linked with Crying and Fussing in Early Infancy	PLOS ONE			English	Article							INTESTINAL MICROFLORA; GUT MICROBIOTA; COLICKY; CYTOKINES; PATTERNS	Objectives: Our aim was to establish whether there is an interconnection between the compositional development of the gut microbiota and the amount of fussing and crying in early infancy. Methods: Behavioral patterns of 89 infants during the 7th and 12th week of life were recorded in parental diaries. Total distress was defined as the sum of daily amounts of crying and fussing. Infants' gut microbiota profiles were investigated by several molecular assays during the first six months of life. Results: The median (range) duration of total distress among the infants was 106 (0-478) minutes a day during the 7th and 58 (0-448) minutes a day during the 12th week. The proportion of Bifidobacterium counts to total bacterial counts was inversely associated with the amount of crying and fussing during the first 3 months of life (p = 0.03), although the number of Bifidobacterium breve was positively associated with total distress (p = 0.02). The frequency of Lactobacillus spp. at the age of 3 weeks was inversely associated with total infant distress during the 7th week of life (p = 0.02). Conclusions: Bifidobacterium and Lactobacillus appear to protect against crying and fussing. Identification of specific strains with optimal protective properties would benefit at-risk infants.	[Partty, Anna; Kalliomaaki, Marko; Isolauri, Erika] Univ Turku, Dept Pediat, Turku Univ Hosp, Turku, Finland; [Endo, Akihito; Salminen, Seppo] Univ Turku, Dept Biochem & Food Chem, Turku, Finland	University of Turku; University of Turku	Partty, A (corresponding author), Univ Turku, Dept Pediat, Turku Univ Hosp, Turku, Finland.	aklein@utu.fi		Kalliomaki, Marko/0000-0002-9438-7052	Paivikki and Sakari Sohlberg Foundation; Foundation for Pediatric Research; Turku University Hospital	Paivikki and Sakari Sohlberg Foundation; Foundation for Pediatric Research; Turku University Hospital	None of the authors has any financial relationship relevant to this article. The study was funded by the Paivikki and Sakari Sohlberg Foundation, the Foundation for Pediatric Research, and an EVO grant from Turku University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 1996, ACTA PAEDIATR, V85, P463, DOI 10.1111/j.1651-2227.1996.tb14062.x; BARR RG, 1992, PEDIATRICS, V90, P14; BARR RG, 1988, ARCH DIS CHILD, V63, P380, DOI 10.1136/adc.63.4.380; BARR RG, 1989, CHALLENGES TO DEVELOPMENTAL PARADIGMS : IMPLICATIONS FOR THEORY, ASSESSMENT AND TREATMENT, P43; BRAZELTON TB, 1962, PEDIATRICS, V29, P579; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; Endo A, 2005, J BIOSCI BIOENG, V99, P216, DOI 10.1263/jbb.99.216; Endo A, 2010, ANAEROBE, V16, P590, DOI 10.1016/j.anaerobe.2010.10.005; Gueimonde M, 2007, NEONATOLOGY, V92, P64, DOI 10.1159/000100088; He F, 2002, MICROBIOL IMMUNOL, V46, P781, DOI 10.1111/j.1348-0421.2002.tb02765.x; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Kalliomaki M, 2001, ARCH DIS CHILD, V84, P349, DOI 10.1136/adc.84.4.349; LEHTONEN L, 1994, J PEDIATR GASTR NUTR, V19, P310, DOI 10.1097/00005176-199410000-00009; Lucassen PLBJ, 2000, PEDIATRICS, V106, P1349, DOI 10.1542/peds.106.6.1349; Marques TM, 2010, CURR OPIN BIOTECH, V21, P149, DOI 10.1016/j.copbio.2010.03.020; Menard O, 2008, APPL ENVIRON MICROB, V74, P660, DOI 10.1128/AEM.01261-07; MILLER AR, 1993, PEDIATRICS, V92, P551; Nylund L, 2010, J MICROBIOL METH, V83, P231, DOI 10.1016/j.mimet.2010.09.003; Ouwehand AC, 2001, J ALLERGY CLIN IMMUN, V108, P144, DOI 10.1067/mai.2001.115754; Rhoads JM, 2009, J PEDIATR-US, V155, P823, DOI 10.1016/j.jpeds.2009.05.012; Savino F, 2005, PEDIAT ALLERG IMM-UK, V16, P72, DOI 10.1111/j.1399-3038.2005.00207.x; Savino F, 2004, ACTA PAEDIATR, V93, P825, DOI [10.1080/08035250410027625, 10.1111/j.1651-2227.2004.tb03025.x]; Savino F, 2009, ACTA PAEDIATR, V98, P1582, DOI 10.1111/j.1651-2227.2009.01419.x; Savino F, 2007, PEDIATRICS, V119, pE124, DOI 10.1542/peds.2006-1222; Savino F, 2010, PEDIATRICS, V126, pE526, DOI 10.1542/peds.2010-0433; Scalabrin DM, 2011, J PEDIAT GASTRO 0921; Stifter CA, 1998, CHILD CARE HLTH DEV, V24, P339, DOI 10.1046/j.1365-2214.2002.00088.x; WESSEL MA, 1954, PEDIATRICS, V14, P421; Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004	30	70	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32495	10.1371/journal.pone.0032495	http://dx.doi.org/10.1371/journal.pone.0032495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403665	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700062
J	Zhou, FF; Ma, Q; Li, GJ; Xu, Y				Zhou, Fengfeng; Ma, Qin; Li, Guojun; Xu, Ying			QServer: A Biclustering Server for Prediction and Assessment of Co-Expressed Gene Clusters	PLOS ONE			English	Article							EXPRESSION; MICROARRAYS; ALGORITHM	Background: Biclustering is a powerful technique for identification of co-expressed gene groups under any (unspecified) substantial subset of given experimental conditions, which can be used for elucidation of transcriptionally co-regulated genes. Results: We have previously developed a biclustering algorithm, QUBIC, which can solve more general biclustering problems than previous biclustering algorithms. To fully utilize the analysis power the algorithm provides, we have developed a web server, QServer, for prediction, computational validation and analyses of co-expressed gene clusters. Specifically, the QServer has the following capabilities in addition to biclustering by QUBIC: (i) prediction and assessment of conserved cis regulatory motifs in promoter sequences of the predicted co-expressed genes; (ii) functional enrichment analyses of the predicted co-expressed gene clusters using Gene Ontology (GO) terms, and (iii) visualization capabilities in support of interactive biclustering analyses. QServer supports the biclustering and functional analysis for a wide range of organisms, including human, mouse, Arabidopsis, bacteria and archaea, whose underlying genome database will be continuously updated. Conclusion: We believe that QServer provides an easy-to-use and highly effective platform useful for hypothesis formulation and testing related to transcription co-regulation.	[Zhou, Fengfeng] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Res Ctr Biomed Informat Technol, Shenzhen, Peoples R China; [Zhou, Fengfeng; Ma, Qin; Li, Guojun; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, BioEnergy Sci Ctr BESC,Inst Bioinformat, Athens, GA 30602 USA; [Li, Guojun] Shandong Univ, Sch Math, Jinan 250100, Peoples R China; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); University System of Georgia; University of Georgia; Shandong University; Jilin University	Zhou, FF (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Res Ctr Biomed Informat Technol, Shenzhen, Peoples R China.	xyn@bmb.uga.edu	Zhou, Fengfeng/A-8932-2008; Ma, Qin/V-7920-2019; Ma, Qin/O-1525-2013	Zhou, Fengfeng/0000-0002-8108-6007; Ma, Qin/0000-0002-3264-8392; Ma, Qin/0000-0002-3264-8392	National Science Foundation [DBI0542119, DEB0830024, MCB0958172]; USG; Office of Biological and Environmental Research in the DOE Office of Science; National Science Foundation of China (NSFC) [60673059, 10631070, 60373025]; Taishan Scholar Fund from Shandong Province, China	National Science Foundation(National Science Foundation (NSF)); USG; Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Taishan Scholar Fund from Shandong Province, China	This work was supported by the National Science Foundation (DBI0542119, DEB0830024, MCB0958172), the USG Inter-Institutional Collaborative Grant (Development of an Integrated Modeling Pipeline for Systems Biological Studies for Microbial Organisms) and the grant for the BioEnergy Science Center, which is a U.S. Department of Energy BioEnergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. This work was also supported by the National Science Foundation of China (NSFC Grants 60673059, 10631070 and 60373025 to Dr. Li, partially); and Taishan Scholar Fund from Shandong Province, China (to Dr. Li). Funding for open access charge: National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Goncalves Joana P, 2009, BMC Res Notes, V2, P124, DOI 10.1186/1756-0500-2-124; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Huttenhower C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-250; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kersey P, 2005, NUCLEIC ACIDS RES, V33, pD297, DOI 10.1093/nar/gri039; Li GJ, 2011, NUCLEIC ACIDS RES, V39, pE42, DOI 10.1093/nar/gkq948; Li GJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp491; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Madeira SC, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-8; Mejia-Roa E, 2008, NUCLEIC ACIDS RES, V36, pW523, DOI 10.1093/nar/gkn335; MORGAN JN, 1963, J AM STAT ASSOC, V58, P415, DOI 10.2307/2283276; Poole Rebecca L., 2007, V406, P179; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Pruess Manuela, 2005, In Silico Biology, V5, P179; Seo J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-395; The UniProt Consortium, 2009, NUCL ACIDS RES; Waltman P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r96; Werner T, 2001, PHARMACOGENOMICS, V2, P25, DOI 10.1517/14622416.2.1.25; Wu CJ, 2005, NUCLEIC ACIDS RES, V33, pW596, DOI 10.1093/nar/gki469; Zhou FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-36; Zhou FF, 2005, FEBS LETT, V579, P3369, DOI 10.1016/j.febslet.2005.04.076	28	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32660	10.1371/journal.pone.0032660	http://dx.doi.org/10.1371/journal.pone.0032660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403692	Green Published, gold			2022-12-25	WOS:000303017700089
J	Harley, CA; Jesus, CSH; Carvalho, R; Brito, RMM; Morais-Cabral, JH				Harley, Carol A.; Jesus, Catarina S. H.; Carvalho, Ricardo; Brito, Rui M. M.; Morais-Cabral, Joao H.			Changes in Channel Trafficking and Protein Stability Caused by LQT2 Mutations in the PAS Domain of the HERG Channel	PLOS ONE			English	Article							LONG-QT-SYNDROME; HUMAN INWARD RECTIFIER; ARNT-SIM DOMAIN; POTASSIUM CHANNEL; PHARMACOLOGICAL RESCUE; MOLECULAR DETERMINANTS; CARDIAC-ARRHYTHMIA; MUTANT CHANNELS; ION-CHANNEL; N-TERMINUS	Inherited human long-QT2 syndrome (LQTS) results from mutations in the gene encoding the HERG channel. Several LQT2-associated mutations have been mapped to the amino terminal cytoplasmic Per-Arnt-Sim (PAS) domain of the HERG1a channel subunit. Here we have characterized the trafficking properties of some LQT2-associated PAS domain mutants and analyzed rescue of the trafficking mutants by low temperature (27 degrees C) or by the pore blocker drug E4031. We show that the LQT2-associated mutations in the PAS domain of the HERG channel display molecular properties that are distinct from the properties of LQT2-associated mutations in the trans-membrane region. Unlike the latter, many of the tested PAS domain LQT2-associated mutations do not result in trafficking deficiency of the channel. Moreover, the majority of the PAS domain mutations that cause trafficking deficiencies are not rescued by a pore blocking drug. We have also explored the in vitro folding stability properties of isolated mutant PAS domain proteins using a thermal unfolding fluorescence assay and a chemical unfolding assay.	[Harley, Carol A.; Carvalho, Ricardo; Morais-Cabral, Joao H.] Univ Porto, Inst Biol Mol & Celular, IBMC, P-4100 Oporto, Portugal; [Jesus, Catarina S. H.; Brito, Rui M. M.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Brito, Rui M. M.] Univ Coimbra, Fac Sci & Technol, Dept Chem, Coimbra, Portugal	Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra	Harley, CA (corresponding author), Univ Porto, Inst Biol Mol & Celular, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	harleyca@ibmc.up.pt	Morais-Cabral, Joao H/J-4914-2013; Jesus, Catarina/K-6557-2019; Harley, Carol/J-5375-2013	Morais-Cabral, Joao H/0000-0002-4461-9716; Jesus, Catarina/0000-0003-1812-1663; Harley, Carol/0000-0003-3610-0604; Brito, Rui/0000-0001-9128-2557; Carvalho, Ricardo/0000-0002-5994-0094	European Molecular Biology Organization, EMBO; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/43896/2008]	European Molecular Biology Organization, EMBO(European Molecular Biology Organization (EMBO)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by the European Molecular Biology Organization, EMBO (Installation Grant to JHMC) and Fundacao para a Ciencia e a Tecnologia (PhD fellowship SFRH/BD/43896/2008 to CSHJ and Ciencia 2008 fellowship to CAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Hayashi K, 2004, CLIN SCI, V107, P175, DOI 10.1042/CS20030351; Jongbloed R, 2002, HUM MUTAT, V20, P382, DOI 10.1002/humu.10131; Kamiya K, 2006, MOL PHARMACOL, V69, P1709, DOI 10.1124/mol.105.020990; Larsen LA, 2001, CLIN CHEM, V47, P1390; LeesMiller JP, 1997, CIRC RES, V81, P719; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; London B, 1997, CIRC RES, V81, P870; Lupoglazoff JM, 2001, CIRCULATION, V103, P1095, DOI 10.1161/01.CIR.103.8.1095; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; Paulussen A, 2002, J BIOL CHEM, V277, P48610, DOI 10.1074/jbc.M206569200; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Robertson GA, 2006, HANDB EXP PHARMACOL, V171, P349; RODEN DM, 1993, CLIN CARDIOL, V16, P683, DOI 10.1002/clc.4960160910; Rossenbacker T, 2005, CIRCULATION, V111, P961, DOI 10.1161/01.CIR.0000156327.35255.D8; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANTORO MG, 1981, J GEN VIROL, V53, P75, DOI 10.1099/0022-1317-53-1-75; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Van Langen IM, 2003, J MED GENET, V40, P141, DOI 10.1136/jmg.40.2.141; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438	33	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32654	10.1371/journal.pone.0032654	http://dx.doi.org/10.1371/journal.pone.0032654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396785	Green Published, Green Submitted, gold			2022-12-25	WOS:000303006500030
J	Zhou, JJ; Pashmforoush, M; Sucov, HM				Zhou, Jingjing; Pashmforoush, Mohammad; Sucov, Henry M.			Endothelial Neuropilin Disruption in Mice Causes DiGeorge Syndrome-Like Malformations via Mechanisms Distinct to Those Caused by Loss of Tbx1	PLOS ONE			English	Article							CARDIAC NEURAL CREST; 22Q11 DELETION SYNDROME; ARCH ARTERY DEVELOPMENT; PHARYNGEAL ARCH; OUTFLOW TRACT; CARDIOVASCULAR DEVELOPMENT; SYNDROME PHENOTYPE; GENETIC PATHWAYS; FACIAL SYNDROME; SYNDROME REGION	The spectrum of human congenital malformations known as DiGeorge syndrome (DGS) is replicated in mice by mutation of Tbx1. Vegfa has been proposed as a modifier of DGS, based in part on the occurrence of comparable phenotypes in Tbx1 and Vegfa mutant mice. Many additional genes have been shown to cause DGS-like phenotypes in mice when mutated; these generally intersect in some manner with Tbx1, and therefore impact the same developmental processes in which Tbx1 itself is involved. In this study, using Tie2Cre, we show that endothelial-specific mutation of the gene encoding the VEGFA coreceptor neuropilin-1 (Nrp1) also replicates the most prominent terminal phenotypes that typify DGS. However, the developmental etiologies of these defects are fundamentally different from those caused by absence of TBX1. In Tie2Cre/Nrp1 mutants, initial pharyngeal organization is normal but subsequent pharyngeal organ growth is impaired, second heart field differentiation is normal but cardiac outflow tract cushion organization is distorted, neural crest cell migration is normal, and palatal mesenchyme proliferation is impaired with no change in apoptosis. Our results demonstrate that impairment of VEGF-dependent endothelial pathways leads to a spectrum of DiGeorge syndrome-type malformations, through processes that are distinguishable from those controlled by Tbx1.	[Zhou, Jingjing; Pashmforoush, Mohammad; Sucov, Henry M.] Univ So Calif, Keck Sch Med, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90033 USA	University of Southern California	Zhou, JJ (corresponding author), Univ So Calif, Keck Sch Med, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90033 USA.	sucov@usc.edu		Sucov, Henry/0000-0002-3792-3795	National Institutes of Health [HL078891]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL078891 to H.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal VS, 2008, DEV DISABIL RES REV, V14, P19, DOI 10.1002/ddrr.4; AMIN N, 1994, CLEFT PALATE-CRAN J, V31, P332, DOI 10.1597/1545-1569(1994)031<0332:AIVPOT>2.3.CO;2; Arnold JS, 2006, DEVELOPMENT, V133, P977, DOI 10.1242/dev.02264; Calmont A, 2009, DEVELOPMENT, V136, P3173, DOI 10.1242/dev.028902; Cariboni A, 2011, DEVELOPMENT, V138, P3723, DOI 10.1242/dev.063362; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Chen L, 2010, J CELL BIOL, V189, P417, DOI 10.1083/jcb.200912037; Chen L, 2009, CIRC RES, V105, P842, DOI 10.1161/CIRCRESAHA.109.200295; Choi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000395; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Clouthier DE, 2003, DEV BIOL, V261, P506, DOI 10.1016/S0012-1606(03)00128-3; Daw SCM, 1996, NAT GENET, V13, P458, DOI 10.1038/ng0896-458; Dyer LA, 2009, DEV BIOL, V330, P305, DOI 10.1016/j.ydbio.2009.03.028; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Frank DU, 2002, DEVELOPMENT, V129, P4591; Garg V, 2001, DEV BIOL, V235, P62, DOI 10.1006/dbio.2001.0283; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gottlieb S, 1998, AM J HUM GENET, V62, P495, DOI 10.1086/301718; Goudy S, 2010, MECH DEVELOP, V127, P292, DOI 10.1016/j.mod.2010.03.001; Gregg J M, 1971, Cleft Palate J, V8, P101; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Guo C, 2011, J CLIN INVEST; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Huh SH, 2010, DEVELOPMENT, V137, P1137, DOI 10.1242/dev.045534; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; Kisanuki YY, 2010, HYPERTENSION, V56, P121, DOI 10.1161/HYPERTENSIONAHA.109.138701; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kochilas L, 2002, DEV BIOL, V251, P157, DOI 10.1006/dbio.2002.0819; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; KURIHARA Y, 1995, J CARDIOVASC PHARM, V26, pS13, DOI 10.1097/00005344-199506263-00005; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lindsay EA, 2001, HUM MOL GENET, V10, P997, DOI 10.1093/hmg/10.9.997; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Mori K, 2010, CELL IMMUNOL, V260, P66, DOI 10.1016/j.cellimm.2009.09.007; Morishima M, 2003, DEV DYNAM, V228, P95, DOI 10.1002/dvdy.10358; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Roberts C, 2005, DEV DYNAM, V232, P928, DOI 10.1002/dvdy.20268; Roberts C, 2006, HUM MOL GENET, V15, P3394, DOI 10.1093/hmg/ddl416; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Scambler PJ, 2010, PEDIATR CARDIOL, V31, P378, DOI 10.1007/s00246-009-9613-0; Shprintzen RJ, 2005, CURR OPIN PEDIATR, V17, P725, DOI 10.1097/01.mop.0000184465.73833.0b; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Stalmans I, 2005, Verh K Acad Geneeskd Belg, V67, P229; SULIK KK, 1988, DEVELOPMENT, V103, P213; Theveniau-Ruissy M, 2008, CIRC RES, V103, P142, DOI 10.1161/CIRCRESAHA.108.172189; van Bueren KL, 2010, DEV BIOL, V340, P369, DOI 10.1016/j.ydbio.2010.01.020; van den Akker NMS, 2007, CIRC RES, V100, P842, DOI 10.1161/01.RES.0000261656.04773.39; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Waldo KL, 1996, DEV DYNAM, V205, P281, DOI 10.1002/(SICI)1097-0177(199603)205:3<281::AID-AJA8>3.0.CO;2-E; Webb S, 2003, J ANAT, V202, P327, DOI 10.1046/j.1469-7580.2003.00168.x; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yamazaki H, 2005, INT IMMUNOL, V17, P549, DOI 10.1093/intimm/dxh237; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; Zhang Y, 2009, DEV BIOL, V325, P82, DOI 10.1016/j.ydbio.2008.09.031; Zhang Z, 2005, DEVELOPMENT, V132, P5307, DOI 10.1242/dev.02086; Zhang Z, 2006, DEVELOPMENT, V133, P3587, DOI 10.1242/dev.02539	73	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32429	10.1371/journal.pone.0032429	http://dx.doi.org/10.1371/journal.pone.0032429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396765	Green Published, gold, Green Submitted			2022-12-25	WOS:000303006500017
J	Mishra, S; Sgaier, SK; Thompson, LH; Moses, S; Ramesh, BM; Alary, M; Wilson, D; Blanchard, JF				Mishra, Sharmistha; Sgaier, Sema K.; Thompson, Laura H.; Moses, Stephen; Ramesh, B. M.; Alary, Michel; Wilson, David; Blanchard, James F.			HIV Epidemic Appraisals for Assisting in the Design of Effective Prevention Programmes: Shifting the Paradigm Back to Basics	PLOS ONE			English	Article							INJECTION-DRUG USE; SEX; TRANSMISSION; HIV/AIDS; DYNAMICS; IMPACT; PREVALENCE; MIGRATION; RISK	Background: To design HIV prevention programmes, it is critical to understand the temporal and geographic aspects of the local epidemic and to address the key behaviours that drive HIV transmission. Two methods have been developed to appraise HIV epidemics and guide prevention strategies. The numerical proxy method classifies epidemics based on current HIV prevalence thresholds. The Modes of Transmission (MOT) model estimates the distribution of incidence over one year among risk-groups. Both methods focus on the current state of an epidemic and provide short-term metrics which may not capture the epidemiologic drivers. Through a detailed analysis of country and sub-national data, we explore the limitations of the two traditional methods and propose an alternative approach. Methods and Findings: We compared outputs of the traditional methods in five countries for which results were published, and applied the numeric and MOT model to India and six districts within India. We discovered three limitations of the current methods for epidemic appraisal: (1) their results failed to identify the key behaviours that drive the epidemic; (2) they were difficult to apply to local epidemics with heterogeneity across district-level administrative units; and (3) the MOT model was highly sensitive to input parameters, many of which required extraction from non-regional sources. We developed an alternative decision-tree framework for HIV epidemic appraisals, based on a qualitative understanding of epidemiologic drivers, and demonstrated its applicability in India. The alternative framework offered a logical algorithm to characterize epidemics; it required minimal but key data. Conclusions: Traditional appraisals that utilize the distribution of prevalent and incident HIV infections in the short-term could misguide prevention priorities and potentially impede efforts to halt the trajectory of the HIV epidemic. An approach that characterizes local transmission dynamics provides a potentially more effective tool with which policy makers can design intervention programmes.	[Mishra, Sharmistha] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Mishra, Sharmistha] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Sgaier, Sema K.] Bill & Melinda Gates Fdn, Global Hlth Program, New Delhi, India; [Thompson, Laura H.; Moses, Stephen; Blanchard, James F.] Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada; [Ramesh, B. M.] Karnataka Hlth Promot Trust, Bangalore, Karnataka, India; [Alary, Michel] Univ Laval, Ctr Rech FRSQ, CHA Univ Quebec, URESP, Quebec City, PQ, Canada; [Wilson, David] World Bank, Global HIV AIDS Program, Washington, DC 20433 USA	Imperial College London; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Manitoba; Laval University; The World Bank	Mishra, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	james_blanchard@umanitoba.ca	Thompson, Laura Hilary/Y-1832-2019	Blanchard, James/0000-0002-4701-590X; Thompson, Laura Hilary/0000-0003-3792-9772; Mishra, Sharmistha/0000-0001-8492-5470	World Bank	World Bank(The World Bank India)	This study was funded in part by the World Bank for the co-ordination of aggregate data retrieval in districts Varanasi and Ganjam, and for a planning meeting with co-authors. No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper are those of the authors and do not necessarily reflect the official policy or position of the funding source.	Alarcon Villaverde JO, 2009, MODOS TRANSMISION VI; Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; ANDERSON R M, 1991; Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; Behrman J, 2011, SEXUAL TRANSMISSION; Blanchard JF, 2002, SEX TRANSM INFECT, V78, pI183, DOI 10.1136/sti.78.suppl_1.i183; Boily MC, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000343773.59776.5b; Coffee M, 2007, AIDS, V21, P343, DOI 10.1097/QAD.0b013e328011dac9; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; Deering KN, 2008, AIDS, V22, pS165, DOI 10.1097/01.aids.0000343774.59776.95; Emmanuel F, 2010, AIDS, V24, pS77, DOI 10.1097/01.aids.0000386737.25296.c4; Gelmon L, 2006, SEXUAL NETWORKING ST; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Government of Uganda, 2010, BUDG MON REP; Gray RT, 2009, CURR HIV RES, V7, P656, DOI 10.2174/157016209789973637; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Jia YJ, 2008, INT J EPIDEMIOL, V37, P1287, DOI 10.1093/ije/dyn196; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2007, MOD EXP SHORT TERM D; Kenya National Aids Control Council, 2009, KEN HIV PREV RESP MO; Lesotho National AIDS Commission, 2009, LES HIV PREV RESP MO; Lowndes C, 2011, AIDS BEHAV; Lyerla R, 2006, SEX TRANSM INFECT, V82, pIII41, DOI 10.1136/sti.2006.020198; Maleta K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-243; Medhi GK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-64; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Moses SA, 2006, AIDS S ASIA UNDERSTA; National Agency for the Control of AIDS, 2010, UNGASS COUNTR PROGR; National AIDS Control Council, 2010, UNGASS COUNTR REP KE; National AIDS Control Organization, 2009, ANN REPORT 2008 2009; National AIDS Control Organization, 2010, UNAIDS COUNTR PROGR; National AIDS Prevention and Alleviation Committee, 2010, UNGASS COUNTR PROGR; Nnorom J, 2008, W AFRICA HIV AIDS EP; Obengo T.J., 2020, UTILITARIAN ASSESSME; Pisani E, 2003, BRIT MED J, V326, P1384, DOI 10.1136/bmj.326.7403.1384; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stigum H, 1997, AM J EPIDEMIOL, V145, P644, DOI 10.1093/oxfordjournals.aje.a009162; Tempalski B, 2009, INT J DRUG POLICY, V20, P4, DOI 10.1016/j.drugpo.2008.02.002; Uganda National AIDS Commission, 2009, UG HIV MOD TRANSM PR; *UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS, 2009, HIV EP UPD; UNAIDS/GAMET, 2009, AN HIV PREV RESP MOD; UNAIDS/WHO/UNICEF, 2011, GLOB HIV AIDS RESP E; UNAIDS/WHO working group on global HIV/AIDS and STI surveillance, 2000, GUID SEC GEN HIV SUR; United Nations Development Programme, 2007, NAT PLAN STRAT INT H; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; Wylie JL, 2007, HEALTH PLACE, V13, P617, DOI 10.1016/j.healthplace.2006.09.002; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003	49	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32324	10.1371/journal.pone.0032324	http://dx.doi.org/10.1371/journal.pone.0032324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396756	Green Published, gold, Green Submitted			2022-12-25	WOS:000303005000019
J	Pan, YY; Wang, SM; Huang, KJ; Chiang, CC; Wang, CT				Pan, Yen-Yu; Wang, Shiu-Mei; Huang, Kuo-Jung; Chiang, Chien-Cheng; Wang, Chin-Tien			Placement of Leucine Zipper Motifs at the Carboxyl Terminus of HIV-1 Protease Significantly Reduces Virion Production	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MAJOR HOMOLOGY REGION; GAG-POL POLYPROTEIN; REVERSE-TRANSCRIPTASE; VIRAL INFECTIVITY; PARTICLE MATURATION; NUCLEOCAPSID DOMAIN; SEQUENCES UPSTREAM; PRECURSOR; REPLICATION	Natural HIV-1 protease (PR) is homodimeric. Some researchers believe that interactions between HIV-1 Gag-Pol molecules trigger the activation of embedded PR (which mediates Gag and Gag-Pol cleavage), and that Gag-Pol assembly domains outside of PR may contribute to PR activation by influencing PR dimer interaction in a Gag-Pol context. To determine if the enhancement of PR dimer interaction facilitates PR activation, we placed single or tandem repeat leucine zippers (LZ) at the PR C-terminus, and looked for a correlation between enhanced Gag processing efficiency and increased Gag-PR-LZ multimerization capacity. We found significant reductions in virus-like particles (VLPs) produced by HIV-1 mutants, with LZ fused to the end of PR as a result of enhanced Gag cleavage efficiency. Since VLP production can be restored to wt levels following PR activity inhibition, this assembly defect is considered PR activity-dependent. We also found a correlation between the LZ enhancement effect on Gag cleavage and enhanced Gag-PR multimerization. The results suggest that PR dimer interactions facilitated by forced Gag-PR multimerization lead to premature Gag cleavage, likely a result of premature PR activation. Our conclusion is that placement of a heterologous dimerization domain downstream of PR enhances PR-mediated Gag cleavage efficiency, implying that structural conformation, rather than the primary sequence outside of PR, is a major determinant of HIV-1 PR activation.	[Pan, Yen-Yu; Huang, Kuo-Jung; Wang, Chin-Tien] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Pan, Yen-Yu; Wang, Shiu-Mei; Chiang, Chien-Cheng; Wang, Chin-Tien] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Pan, YY (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	chintien@ym.edu.tw			Taipei Veterans General Hospital [V98C1-021, V99C1-013]; National Science Council, Taiwan [NSC 97-2320-B-010-002-MY3]; Ministry of Education	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education	This work was supported by Grants V98C1-021 and V99C1-013 from Taipei Veterans General Hospital, by Grant NSC 97-2320-B-010-002-MY3 from the National Science Council, Taiwan, and by a grant from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGO SJ, 1995, J VIROL, V69, P5988, DOI 10.1128/JVI.69.10.5988-5994.1995; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; Chang YF, 2007, J MOL BIOL, V370, P585, DOI 10.1016/j.jmb.2007.05.020; Chen AI, 2006, VIROLOGY, V348, P84, DOI 10.1016/j.virol.2005.12.009; Chen SW, 2004, VIROLOGY, V318, P534, DOI 10.1016/j.virol.2003.08.043; Chiang CC, 2010, J VIROL, V84, P976, DOI 10.1128/JVI.01532-09; Chiang CC, 2009, VIROLOGY, V383, P261, DOI 10.1016/j.virol.2008.10.027; Chiu HC, 2002, J VIROL, V76, P3221, DOI 10.1128/JVI.76.7.3221-3231.2002; Chiu HC, 2006, J GEN VIROL, V87, P2041, DOI 10.1099/vir.0.81601-0; CO E, 1994, BIOCHEMISTRY-US, V33, P1248, DOI 10.1021/bi00171a027; Figueiredo A, 2006, PLOS PATHOG, V2, P1051, DOI 10.1371/journal.ppat.0020119; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Halwani R, 2003, J VIROL, V77, P3973, DOI 10.1128/JVI.77.7.3973-3984.2003; Hill MK, 2001, J VIROL, V75, P6835, DOI 10.1128/JVI.75.15.6835-6840.2001; Huang MJ, 1997, J VIROL, V71, P4472, DOI 10.1128/JVI.71.6.4472-4478.1997; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; KRAUSSLICH HG, 1991, P NATL ACAD SCI USA, V88, P3213, DOI 10.1073/pnas.88.8.3213; Leiherer A, 2009, J VIROL, V83, P7210, DOI 10.1128/JVI.02603-08; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Liao WH, 2007, J VIROL, V81, P5155, DOI 10.1128/JVI.01796-06; Liao WH, 2004, VIROLOGY, V329, P180, DOI 10.1016/j.virol.2004.08.010; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; LORIAUX MM, 1993, P NATL ACAD SCI USA, V90, P9046, DOI 10.1073/pnas.90.19.9046; LOUIS JM, 1994, P NATL ACAD SCI USA, V91, P7970, DOI 10.1073/pnas.91.17.7970; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Louis JM, 1999, J BIOL CHEM, V274, P23437, DOI 10.1074/jbc.274.33.23437; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; PARK J, 1992, J VIROL, V66, P6304, DOI 10.1128/JVI.66.11.6304-6313.1992; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; PARTIN K, 1991, P NATL ACAD SCI USA, V88, P4776, DOI 10.1073/pnas.88.11.4776; Paulus C, 2004, VIROLOGY, V330, P271, DOI 10.1016/j.virol.2004.09.013; PENG C, 1989, J VIROL, V63, P2550, DOI 10.1128/JVI.63.6.2550-2556.1989; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Pettit SC, 2003, J VIROL, V77, P366, DOI 10.1128/JVI.77.1.366-374.2003; Quillent C, 1996, VIROLOGY, V219, P29, DOI 10.1006/viro.1996.0219; ROSE JR, 1995, J VIROL, V69, P2751; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; SRINIVASAKUMAR N, 1995, J VIROL, V69, P6106, DOI 10.1128/JVI.69.10.6106-6114.1995; Swanstrom R., 1997, P263; Tachedjian G, 2005, FEBS LETT, V579, P379, DOI 10.1016/j.febslet.2004.11.099; Tachedjian G, 2003, J MOL BIOL, V326, P381, DOI 10.1016/S0022-2836(02)01433-X; Tachedjian G, 2001, P NATL ACAD SCI USA, V98, P7188, DOI 10.1073/pnas.121055998; Tang C, 2008, NATURE, V455, P693, DOI 10.1038/nature07342; Tessmer U, 1998, J VIROL, V72, P3459, DOI 10.1128/JVI.72.4.3459-3463.1998; Venezia CF, 2006, BIOCHEMISTRY-US, V45, P2779, DOI 10.1021/bi051915z; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; Wang CT, 2000, J VIROL, V74, P3418, DOI 10.1128/JVI.74.7.3418-3422.2000; Wang SM, 2008, J BIOMED SCI, V15, P719, DOI 10.1007/s11373-008-9265-8; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998; ZYBARTH G, 1995, J VIROL, V69, P3878, DOI 10.1128/JVI.69.6.3878-3884.1995	58	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32845	10.1371/journal.pone.0032845	http://dx.doi.org/10.1371/journal.pone.0032845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396796	Green Published, gold, Green Submitted			2022-12-25	WOS:000303005000039
J	Byun, EH; Kim, WS; Kim, JS; Jung, ID; Park, YM; Kim, HJ; Cho, SN; Shin, SJ				Byun, Eui-Hong; Kim, Woo Sik; Kim, Jong-Seok; Jung, In Duk; Park, Yeong-Min; Kim, Hwa-Jung; Cho, Sang-Nae; Shin, Sung Jae			Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, induces maturation of dendritic cells and drives Th1 immune response	FASEB JOURNAL			English	Article						Toll-like receptor; tuberculosis; surface molecules; proinflammatory cytokines; memory T cell	ANTIGEN ESAT-6; T-CELLS; PROTEIN; MEMORY; EXPRESSION; INFECTION; CFP32; IDENTIFICATION; RECEPTORS; INDUCTION	Tuberculosis (TB) caused by Mycobacterium tuberculosis constitutes an ongoing threat to global health. An antigen that can induce dendritic cell (DC) maturation and lead to enhanced cellular immunity is crucial to the development of an effective TB vaccine. Here, we investigated the functional roles and the related signaling mechanism of the Rv0577 protein, a M. tuberculosis complex-restricted secreted protein involved in the methylglyoxal detoxification pathway. Rv0577 recognizes Toll-like receptor 2 (TLR2) and functionally induces DC maturation by augmenting the expression of cell surface molecules (CD80, CD86, and MHC class I and II) and proinflammatory cytokine production (TNF-alpha, IL-1 beta, IL-6, and IL-12p70) in DCs on MyD88-dependent signaling, mitogen-activated protein kinases, and nuclear factor kappa B signaling pathways. In addition, Rv0577-treated DCs activated naive T cells, effectively polarized CD4(+) and CD8(+) T cells to secrete IFN-gamma and IL-2, and induced T-cell proliferation, indicating that this protein possibly contributes to Th1-polarization of the immune response. More important, unlike LPS, Rv0577-treated DCs specifically induced the proliferation of memory CD4(+)/CD8(+) CD44(high) CD62L(low) T cells in the spleen of M. tuberculosis-infected mice in a TLR2-dependent manner. Taken together, these findings suggest that Rv0577 may regulate innate and adaptive immunity by interacting with TLR2, a finding that could be helpful in the design of new TB vaccines.-Byun, E.-H., Kim, W. S., Kim, J.-S., Jung, I. D., Park, Y.-M., Kim, H.-J., Cho, S.-N., Shin, S. J. Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, induces maturation of dendritic cells and drives Th1 immune response. FASEB J. 26, 2695-2711 ( 2012). www.fasebj.org	[Byun, Eui-Hong; Kim, Woo Sik; Kim, Jong-Seok; Kim, Hwa-Jung; Shin, Sung Jae] Chungnam Natl Univ, Dept Microbiol, Coll Med, Taejon 301747, South Korea; [Byun, Eui-Hong; Kim, Woo Sik; Kim, Jong-Seok; Kim, Hwa-Jung; Shin, Sung Jae] Chungnam Natl Univ, Res Inst Med Sci, Coll Med, Taejon 301747, South Korea; [Jung, In Duk; Park, Yeong-Min] Pusan Natl Univ, Dept Microbiol & Immunol, Sch Med, Yangsan, South Korea; [Cho, Sang-Nae] Yonsei Univ, Coll Med, Dept Microbiol, Inst Immunol & Immunol Dis, Seoul, South Korea	Chungnam National University; Chungnam National University; Pusan National University; Pusan National University Hospital; Yonsei University; Yonsei University Health System	Shin, SJ (corresponding author), Chungnam Natl Univ, Dept Microbiol, Coll Med, Taejon 301747, South Korea.	sjshin@cnu.ac.kr		Kim, Hwa-Jung/0000-0002-1127-0909	National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0017906]; Ministry for Health and Welfare, Republic of Korea [11203901_26555]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST; 2011-0017906) and by a grant from the National Research and Development Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (11203901_26555).	AbouZeid C, 1997, INFECT IMMUN, V65, P1856, DOI 10.1128/IAI.65.5.1856-1862.1997; ANDERSEN P, 1994, INFECT IMMUN, V62, P2536, DOI 10.1128/IAI.62.6.2536-2544.1994; Andreu N, 2004, FEMS MICROBIOL LETT, V231, P283, DOI 10.1016/S0378-1097(04)00008-4; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Benabdesselem C, 2007, MOL BIOTECHNOL, V35, P41, DOI 10.1385/MB:35:1:41; Benabdesselem C, 2006, J CLIN MICROBIOL, V44, P3086, DOI 10.1128/JCM.02672-05; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Byun EH, 2012, J MOL MED, V90, P285, DOI 10.1007/s00109-011-0819-2; Cardoso FLL, 2002, INFECT IMMUN, V70, P6707, DOI 10.1128/IAI.70.12.6707-6714.2002; Cho DH, 2006, PROTEOMICS, V6, P5785, DOI 10.1002/pmic.200600207; COOPER AM, 1995, CURR OPIN IMMUNOL, V7, P512, DOI 10.1016/0952-7915(95)80096-4; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Drage MG, 2010, NAT STRUCT MOL BIOL, V17, P1088, DOI 10.1038/nsmb.1869; Druszczynska M, 2011, POSTEP HIG MED DOSW, V65, P28, DOI 10.5604/17322693.931545; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Gerberick GF, 1997, TOXICOL APPL PHARM, V146, P1, DOI 10.1006/taap.1997.8218; Giri PK, 2010, PROTEOMICS, V10, P3190, DOI 10.1002/pmic.200900840; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Gruppo V, 2002, MICROBIOL-SGM, V148, P2959, DOI 10.1099/00221287-148-10-2959; Hogevold HE, 1997, PERFUSION-UK, V12, P9, DOI 10.1177/026765919701200103; Huard RC, 2003, INFECT IMMUN, V71, P6871, DOI 10.1128/IAI.71.12.6871-6883.2003; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Khan N, 2008, CELL MICROBIOL, V10, P1711, DOI 10.1111/j.1462-5822.2008.01161.x; Lee JS, 2009, INFECT IMMUN, V77, P2979, DOI 10.1128/IAI.01411-08; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Narayana Y, 2007, CLIN VACCINE IMMUNOL, V14, P1334, DOI 10.1128/CVI.00181-07; ORME IM, 1993, J INFECT DIS, V167, P1481, DOI 10.1093/infdis/167.6.1481; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sousa CRE, 2001, IMMUNITY, V14, P495; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Steinman RM, 1999, J LEUKOCYTE BIOL, V66, P205, DOI 10.1002/jlb.66.2.205; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P841, DOI 10.1111/j.1348-0421.2003.tb03450.x; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wang BL, 2007, CLIN VACCINE IMMUNOL, V14, P902, DOI 10.1128/CDLI.00077-07	51	66	75	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2695	2711		10.1096/fj.11-199588	http://dx.doi.org/10.1096/fj.11-199588			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415304				2022-12-25	WOS:000305017200045
J	Crosby, HA; Pelletier, DA; Hurst, GB; Escalante-Semerena, JC				Crosby, Heidi A.; Pelletier, Dale A.; Hurst, Gregory B.; Escalante-Semerena, Jorge C.			System-wide Studies of N-Lysine Acetylation in Rhodopseudomonas palustris Reveal Substrate Specificity of Protein Acetyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA SYNTHETASE; CLONING VECTORS; IDENTIFICATION; COENZYME; STRATEGIES; LIGASE; ENZYME; SIR2; PROPIONYLATION; DEACETYLATION	N-Lysine acetylation is a posttranslational modification that has been well studied in eukaryotes and is likely widespread in prokaryotes as well. The central metabolic enzyme acetyl-CoA synthetase is regulated in both bacteria and eukaryotes by acetylation of a conserved lysine residue in the active site. In the purple photosynthetic alpha-proteobacterium Rhodopseudomonas palustris, two protein acetyltransferases (RpPat and the newly identified RpKatA) and two deacetylases (RpLdaA and RpSrtN) regulate the activities of AMP-forming acyl-CoA synthetases. In this work, we used LC/MS/MS to identify other proteins regulated by the N-lysine acetylation/deacetylation system of this bacterium. Of the 24 putative acetylated proteins identified, 14 were identified more often in a strain lacking both deacetylases. Nine of these proteins were members of the AMP-forming acyl-CoA synthetase family. RpPat acetylated all nine of the acyl-CoA synthetases identified by this work, and RpLdaA deacetylated eight of them. In all cases, acetylation occurred at the conserved lysine residue in the active site, and acetylation decreased activity of the enzymes by >70%. Our results show that many different AMP-forming acyl-CoA synthetases are regulated by N-lysine acetylation. Five non-acyl-CoA synthetases were identified as possibly acetylated, including glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Rpa1177, a putative 4-oxalocrotonate tautomerase. Neither RpPat nor RpKatA acetylated either of these proteins in vitro. It has been reported that Salmonella enterica Pat (SePat) can acetylate a number of metabolic enzymes, including GAPDH, but we were unable to confirm this claim, suggesting that the substrate range of SePat is not as broad as suggested previously.	[Crosby, Heidi A.; Escalante-Semerena, Jorge C.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Pelletier, Dale A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Hurst, Gregory B.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Escalante-Semerena, JC (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	escalante@bact.wisc.edu		Pelletier, Dale/0000-0002-4321-7918; Hurst, Gregory/0000-0002-7650-8009; Crosby, Heidi/0000-0002-0360-0779	National Institutes of Health [R01 GM62203]; USPHS from the NIGMS [T32 GM08349]; USPHS biotechnology training; Office of Biological and Environmental Research, United States Department of Energy [DE-AC05-00OR22725]; Oak Ridge National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062203, T32GM008349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS from the NIGMS; USPHS biotechnology training; Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); Oak Ridge National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM62203, a USPHS grant from the NIGMS (to J.C. E.-S.), and T32 GM08349, a USPHS biotechnology training grant (to H.A.C.). This work was also supported by the Genomic Science Program, Office of Biological and Environmental Research, United States Department of Energy under Contract DE-AC05-00OR22725 with Oak Ridge National Laboratory, managed and operated by UT-Battelle, LLC (for G. B. H. and D. A. P.).	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bloch K. D., 1995, CURRENT PROTOCOLS MO, P311; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Chan CH, 2011, MOL MICROBIOL, V80, P168, DOI 10.1111/j.1365-2958.2011.07566.x; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; EGLAND PG, 1995, J BACTERIOL, V177, P6545, DOI 10.1128/jb.177.22.6545-6551.1995; Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hervey WJ, 2009, J PROTEOME RES, V8, P3675, DOI 10.1021/pr801088f; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; Koetsier MJ, 2009, BIOCHEM J, V417, P467, DOI 10.1042/BJ20081257; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang WX, 2012, RNA, V18, P37, DOI 10.1261/rna.030213.111; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Lima BP, 2011, MOL MICROBIOL, V81, P1190, DOI 10.1111/j.1365-2958.2011.07742.x; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Meades G, 2010, NUCLEIC ACIDS RES, V38, P1217, DOI 10.1093/nar/gkp1079; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Schaefer AL, 2008, NATURE, V454, P595, DOI 10.1038/nature07088; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Searle BC, 2008, J PROTEOME RES, V7, P245, DOI 10.1021/pr070540w; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2003, GENETICS, V163, P545; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Strader MB, 2004, J PROTEOME RES, V3, P965, DOI 10.1021/pr049940z; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Thao S, 2011, CURR OPIN MICROBIOL, V14, P200, DOI 10.1016/j.mib.2010.12.013; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P536, DOI 10.1107/S1744309109014729	59	68	68	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15590	15601		10.1074/jbc.M112.352104	http://dx.doi.org/10.1074/jbc.M112.352104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416131	Green Published, hybrid			2022-12-25	WOS:000304006300039
J	Kim, T; Ravilious, GE; Sept, D; Cooper, JA				Kim, Taekyung; Ravilious, Geoffrey E.; Sept, David; Cooper, John A.			Mechanism for CARMIL Protein Inhibition of Heterodimeric Actin-capping Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARBED END; CELL MORPHOLOGY; FILAMENT; DOMAIN; BINDING; IDENTIFICATION; NUCLEATION; DYNAMICS; CKIP-1; MOTIF	Capping protein (CP) controls the polymerization of actin filaments by capping their barbed ends. In lamellipodia, CP dissociates from the actin cytoskeleton rapidly, suggesting the possible existence of an uncapping factor, for which the protein CARMIL (capping protein, Arp2/3 and myosin-I linker) is a candidate. CARMIL binds to CP via two motifs. One, the CP interaction (CPI) motif, is found in a number of unrelated proteins; the other motif is unique to CARMILs, the CARMIL-specific interaction motif. A 115-aa CARMIL fragment of CARMIL with both motifs, termed the CP-binding region (CBR), binds to CP with high affinity, inhibits capping, and causes uncapping. We wanted to understand the structural basis for this function. We used a collection of mutants affecting the actin-binding surface of CP to test the possibility of a steric-blocking model, which remained open because a region of CBR was not resolved in the CBR/CP co-crystal structure. The CP actin-binding mutants bound CBR normally. In addition, a CBR mutant with all residues of the unresolved region changed showed nearly normal binding to CP. Having ruled out a steric-blocking model, we tested an allosteric model with molecular dynamics. We found that CBR binding induces changes in the conformation of the actin-binding surface of CP. In addition, similar to 30-aa truncations on the actin-binding surface of CP decreased the affinity of CBR for CP. Thus, CARMIL promotes uncapping by binding to a freely accessible site on CP bound to a filament barbed end and inducing a change in the conformation of the actin-binding surface of CP.	[Kim, Taekyung; Cooper, John A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Ravilious, Geoffrey E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Sept, David] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Sept, David] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cooper, JA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	jcooper@wustl.edu	Cooper, John/E-9389-2012; Cooper, John/D-4448-2014	Cooper, John/0000-0002-0933-4571; Sept, David/0000-0003-3719-2483	National Institutes of Health [R01GM38542, R01GM67246]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095509, R01GM067246, R01GM038542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM38542 (to J. A. C.) and R01GM67246 (to D. S.).	BEARER EL, 1991, J CELL BIOL, V115, P1629, DOI 10.1083/jcb.115.6.1629; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Canton DA, 2006, J BIOL CHEM, V281, P36347, DOI 10.1074/jbc.M607595200; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; COOPER JA, 1984, J CELL BIOL, V99, P217, DOI 10.1083/jcb.99.1.217; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hernandez-Valladares M, 2010, NAT STRUCT MOL BIOL, V17, P497, DOI 10.1038/nsmb.1792; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kim T, 2010, J MOL BIOL, V404, P794, DOI 10.1016/j.jmb.2010.10.017; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P370; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liang Y, 2009, MOL BIOL CELL, V20, P5290, DOI 10.1091/mbc.E08-10-1071; Makhina EN, 2001, METHOD PHARMACOL TOX, P261; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Remmert K, 2004, J BIOL CHEM, V279, P3068, DOI 10.1074/jbc.M308829200; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Takeda S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035005; Takeda S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000416; Uruno T, 2006, J BIOL CHEM, V281, P10635, DOI 10.1074/jbc.M513186200; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; Zwolak A, 2010, J BIOL CHEM, V285, P29014, DOI 10.1074/jbc.M110.134221	36	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15251	15262		10.1074/jbc.M112.345447	http://dx.doi.org/10.1074/jbc.M112.345447			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411988	Green Published, hybrid			2022-12-25	WOS:000304006300009
J	Fielhaber, JA; Tan, J; Joung, KB; Attias, O; Huegel, S; Bader, M; Roux, PP; Kristof, AS				Fielhaber, Jill A.; Tan, Jason; Joung, Kwang-Bo; Attias, Ortal; Huegel, Stefanie; Bader, Michael; Roux, Philippe P.; Kristof, Arnold S.			Regulation of Karyopherin alpha 1 and Nuclear Import by Mammalian Target of Rapamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; UNPHOSPHORYLATED STAT1; INTERFERON-GAMMA; BINDING PARTNER; GENE-EXPRESSION; PHOSPHATASE 2A; MTOR; TRANSCRIPTION; PHOSPHORYLATION; COMPLEX	Under conditions of reduced mitogen or nutritional substrate levels, the serine/threonine kinase target of rapamycin can augment the nuclear content of distinct transcription factors and promote the induction of stress response genes. In its latent (i.e., unphosphorylated) form, the transcription factor STAT1 regulates a subset of genes involved in immune modulation and apoptosis. Based on previous work indicating a functional relationship between mammalian target of rapamycin (mTOR) and the nuclear content of latent STAT1, we investigated the mechanism by which mTOR controls STAT1 nuclear import. By fluorescence confocal microscopy, inactivation of mTOR with rapamycin promoted the nuclear translocation of unphosphorylated STAT1, but not that of a STAT1 mutant incapable of binding its nuclear import adaptor karyopherin-alpha 1 (KPNA1). By immunoprecipitation, KPNA1 was physically associated with mTOR and STAT1 in a complex that translocated to the nucleus in response to rapamycin. Although mTOR is not a kinase for KPNA1, the mTOR-associated phosphatase protein phosphatase 2A catalytic interacted directly with KPNA1 and regulated nuclear import of the mTOR-KPNA1 complex. KPNA1, or its interaction with STAT1, was required for the nuclear import of latent STAT1, transcriptional induction of the STAT1 gene, and caspase-3 activation under conditions of reduced mTOR activity (i.e. rapamycin, glucose starvation, serum withdrawal). Therefore, at low mitogen or nutrient levels, mTOR and protein phosphatase 2A catalytically control the constitutive nuclear import of latent STAT1 by KPNA1, which are key modulators of STAT1 expression and apoptosis.	[Fielhaber, Jill A.; Tan, Jason; Joung, Kwang-Bo; Attias, Ortal; Kristof, Arnold S.] McGill Univ, Fac Med, Crit Care Div, Montreal, PQ H3A 1A1, Canada; [Fielhaber, Jill A.; Tan, Jason; Joung, Kwang-Bo; Attias, Ortal; Kristof, Arnold S.] McGill Univ, Fac Med, Div Resp, Montreal, PQ H3A 1A1, Canada; [Fielhaber, Jill A.; Tan, Jason; Joung, Kwang-Bo; Attias, Ortal; Kristof, Arnold S.] McGill Univ, Fac Med, Meakins Christie Labs, Montreal, PQ H3A 1A1, Canada; [Huegel, Stefanie; Bader, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Roux, Philippe P.] Univ Montreal, Stn Ctr Ville, Fac Med, Inst Res Immunol & Canc, Quebec City, PQ H3C 2J7, Canada	McGill University; McGill University; McGill University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Laval University; Universite de Montreal	Kristof, AS (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, 687 Pine Ave W,L3-05, Montreal, PQ H3A 1A1, Canada.	arnold.kristof@mcgill.ca	Bader, Michael/K-2124-2013; Roux, Philippe P./J-3996-2012	Roux, Philippe P./0000-0002-5962-0250; Bader, Michael/0000-0003-4780-4164	National Institutes of Health [R01-CA125436]; Canadian Cancer Society Research Institute [018311]; Canada Research Chair grant; Human Frontier Science Program Organization; Tuberous Sclerosis Alliance; Deutsche Forschungsgemeinschaft [BA1374/21-1]; NATIONAL CANCER INSTITUTE [R01CA125436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canada Research Chair grant(Canada Research Chairs); Human Frontier Science Program Organization(Human Frontier Science Program); Tuberous Sclerosis Alliance; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA125436 (to A. S. K.). This work was also supported by Canadian Cancer Society Research Institute Grant 018311, a Canada Research Chair grant, and funds from the Human Frontier Science Program Organization (to P. P. R.); funds from Tuberous Sclerosis Alliance and a Canada Research Chair grant (to A. S. K.); and Deutsche Forschungsgemeinschaft Grant BA1374/21-1 (M. B.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Faustino RS, 2007, CLIN PHARMACOL THER, V81, P880, DOI 10.1038/sj.clpt.6100141; Fielhaber JA, 2009, J BIOL CHEM, V284, P24341, DOI 10.1074/jbc.M109.033530; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kristof AS, 2006, J BIOL CHEM, V281, P23958, DOI 10.1074/jbc.M513918200; Kristof AS, 2010, LYMPHAT RES BIOL, V8, P33, DOI 10.1089/lrb.2009.0019; Kristof AS, 2003, J BIOL CHEM, V278, P33637, DOI 10.1074/jbc.M301053200; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Liu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010578; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shmidt T, 2007, NAT CELL BIOL, V9, P1337, DOI 10.1038/ncb1207-1337; Stephanou A, 2003, INT J EXP PATHOL, V84, P239, DOI 10.1111/j.0959-9673.2003.00363.x; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Wong LH, 2002, J BIOL CHEM, V277, P19408, DOI 10.1074/jbc.M111302200; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14325	14335		10.1074/jbc.M111.246785	http://dx.doi.org/10.1074/jbc.M111.246785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399302	Green Published, hybrid			2022-12-25	WOS:000304003200002
J	Fraga, AG; Martins, TG; Torrado, E; Huygen, K; Portaels, F; Silva, MT; Castro, AG; Pedrosa, J				Fraga, Alexandra G.; Martins, Teresa G.; Torrado, Egidio; Huygen, Kris; Portaels, Francoise; Silva, Manuel T.; Castro, Antonio G.; Pedrosa, Jorge			Cellular Immunity Confers Transient Protection in Experimental Buruli Ulcer following BCG or Mycolactone-Negative Mycobacterium ulcerans Vaccination	PLOS ONE			English	Article							BOVIS BCG; INFECTION; DISEASE; TOXIN; MACROPHAGES; OSTEOMYELITIS; HETEROGENEITY; TUBERCULOSIS; IMMUNOLOGY; RESPONSES	Background: Buruli ulcer (BU) is an emerging infectious disease caused by Mycobacterium ulcerans that can result in extensive necrotizing cutaneous lesions due to the cytotoxic exotoxin mycolactone. There is no specific vaccine against BU but reports show some degree of cross-reactive protection conferred by M. bovis BCG immunization. Alternatively, an M. ulcerans-specific immunization could be a better preventive strategy. Methodology/Principal Findings: In this study, we used the mouse model to characterize the histological and cytokine profiles triggered by vaccination with either BCG or mycolactone-negative M. ulcerans, followed by footpad infection with virulent M. ulcerans. We observed that BCG vaccination significantly delayed the onset of M. ulcerans growth and footpad swelling through the induction of an earlier and sustained IFN-gamma T cell response in the draining lymph node (DLN). BCG vaccination also resulted in cell-mediated immunity (CMI) in M. ulcerans-infected footpads, given the predominance of a chronic mononuclear infiltrate positive for iNOS, as well as increased and sustained levels of IFN-gamma and TNF. No significant IL-4, IL-17 or IL-10 responses were detected in the footpad or the DLN, in either infected or vaccinated mice. Despite this protective Th1 response, BCG vaccination did not avoid the later progression of M. ulcerans infection, regardless of challenge dose. Immunization with mycolactone-deficient M. ulcerans also significantly delayed the progression of footpad infection, swelling and ulceration, but ultimately M. ulcerans pathogenic mechanisms prevailed. Conclusions/Significance: The delay in the emergence of pathology observed in vaccinated mice emphasizes the relevance of protective Th1 recall responses against M. ulcerans. In future studies it will be important to determine how the transient CMI induced by vaccination is compromised.	[Fraga, Alexandra G.; Martins, Teresa G.; Torrado, Egidio; Castro, Antonio G.; Pedrosa, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Fraga, Alexandra G.; Martins, Teresa G.; Castro, Antonio G.; Pedrosa, Jorge] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Huygen, Kris] Sci Inst Publ Hlth WIV ISP, Sci Serv Immunol, Brussels, Belgium; [Portaels, Francoise] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Silva, Manuel T.] Inst Mol & Cell Biol, Oporto, Portugal	Universidade do Minho; Institute of Tropical Medicine (ITM); Universidade do Porto	Fraga, AG (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	jpedrosa@ecsaude.uminho.pt	Pedrosa, Jorge/H-4877-2011; Fraga, Alexandra G./T-5174-2018; Torrado, Egídio/T-5156-2018; Castro, Gil/T-7584-2018	Pedrosa, Jorge/0000-0002-8204-4888; Fraga, Alexandra G./0000-0003-2029-1629; Torrado, Egídio/0000-0002-7462-8234; Castro, Gil/0000-0002-4684-4183; Huygen, Kris/0000-0001-7808-0512	European Community [241500]; Health Services of Fundacao Calouste Gulbenkian; Portuguese Science and Technology Foundation (FCT) [SFRH/BPD/68547/2010, SFRH/BD/41598/2007]	European Community(European Commission); Health Services of Fundacao Calouste Gulbenkian; Portuguese Science and Technology Foundation (FCT)(Portuguese Foundation for Science and Technology)	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement N degrees 241500 (BuruliVac). This work was additionally supported by a Grant from the Health Services of Fundacao Calouste Gulbenkian, and by the Portuguese Science and Technology Foundation (FCT) fellowships SFRH/BPD/68547/2010, SFRH/BD/41598/2007 to A. G. Fraga and T. G. Martins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; [Anonymous], 1969, LANCET, V1, P111; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Behr MA, 1997, NATURE, V389, P133, DOI 10.1038/38151; Burke GS, 2005, EMERG INFECT DIS, V11, P36; Converse PJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000985; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; Diaz D, 2006, CLIN VACCINE IMMUNOL, V13, P1314, DOI 10.1128/CVI.00254-06; DING AH, 1988, J IMMUNOL, V141, P2407; Dobos KM, 2000, EMERG INFECT DIS, V6, P158, DOI 10.3201/eid0602.000208; Einarsdottir T, 2011, HUM VACCINES, V7, P1198, DOI 10.4161/hv.7.11.17751; FENNER F, 1957, AM REV TUBERC PULM, V76, P76; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fraga AG, 2011, INFECT IMMUN, V79, P421, DOI 10.1128/IAI.00820-10; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Gooding TM, 2002, INFECT IMMUN, V70, P5562, DOI 10.1128/IAI.70.10.5562-5567.2002; Gooding TM, 2001, INFECT IMMUN, V69, P1704, DOI 10.1128/IAI.69.3.1704-1707.2001; Herbinger KH, 2009, INFECTION, V37, P20, DOI 10.1007/s15010-008-8073-4; Hong H, 2005, CHEMBIOCHEM, V6, P643, DOI 10.1002/cbic.200400339; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Huygen K, 2009, MED MICROBIOL IMMUN, V198, P69, DOI 10.1007/s00430-009-0109-6; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Lagarrigue V, 2000, Med Trop (Mars), V60, P262; Marsollier L, 2007, PLOS MED, V4, P288, DOI 10.1371/journal.pmed.0040064; Mve-Obiang A, 2003, INFECT IMMUN, V71, P774, DOI 10.1128/IAI.71.2.774-783.2003; Oliveira MS, 2005, INFECT IMMUN, V73, P6299, DOI 10.1128/IAI.73.10.6299-6310.2005; Phanzu DM, 2006, AM J TROP MED HYG, V75, P311, DOI 10.4269/ajtmh.2006.75.311; Phillips R, 2004, ANTIMICROB AGENTS CH, V48, P3130, DOI 10.1128/AAC.48.8.3130-3132.2004; Portaels F, 2004, INFECT IMMUN, V72, P62, DOI 10.1128/IAI.72.1.62-65.2004; Portaels F, 2002, CLIN DIAGN LAB IMMUN, V9, P1389, DOI 10.1128/CDLI.9.6.1389-1391.2002; Portaels F, 2003, B SEANC ACAD R SCI O, V49, P30; Rodrigues LC, 2007, VACCINE, V25, P6842, DOI 10.1016/j.vaccine.2007.07.032; Rondini S, 2006, J PATHOL, V208, P119, DOI 10.1002/path.1864; Rondini S, 2006, J CLIN MICROBIOL, V44, P4273, DOI 10.1128/JCM.00970-06; Silva MT, 2007, PLOS MED, V4, P229, DOI 10.1371/journal.pmed.0040063; Silva MT, 2009, LANCET INFECT DIS, V9, P699, DOI 10.1016/S1473-3099(09)70234-8; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; SMITH PG, 1976, T ROY SOC TROP MED H, V70, P449, DOI 10.1016/0035-9203(76)90128-0; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Stinear TP, 2005, J BACTERIOL, V187, P1668, DOI 10.1128/JB.187.5.1668-1676.2005; Tanghe A, 2001, INFECT IMMUN, V69, P5403, DOI 10.1128/IAI.69.9.5403-5411.2001; Tanghe A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000199; Tanghe A, 2007, INFECT IMMUN, V75, P2642, DOI 10.1128/IAI.01622-06; Torrado E, 2007, INFECT IMMUN, V75, P3979, DOI 10.1128/IAI.00290-07; Torrado E, 2007, INFECT IMMUN, V75, P977, DOI 10.1128/IAI.00889-06; Torrado E, 2010, J IMMUNOL, V184, P947, DOI 10.4049/jimmunol.0902717; World Health Organization. Global Buruli Ulcer Initiative, 2004, WHOCDSCPEGBUI200410	50	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33406	10.1371/journal.pone.0033406	http://dx.doi.org/10.1371/journal.pone.0033406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413022	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000045
J	Schwarz, MA; Thornton, J; Xu, HM; Awasthi, N; Schwarz, RE				Schwarz, Margaret A.; Thornton, Janet; Xu, Haiming; Awasthi, Niranjan; Schwarz, Roderich E.			Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II	PLOS ONE			English	Article							TUMOR-DERIVED CYTOKINE; EMAP-II; ANTIANGIOGENIC PROTEINS; COMBINATION THERAPY; PANCREATIC-CANCER; POTENTIAL ROLE; LUNG; NEOVASCULARIZATION; APOPTOSIS; P43	Background: Endothelial-Monocyte Activating Polypeptide ( EMAP II) is a secreted protein with well-established anti-angiogenic activities. Intracellular EMAP II expression is increased during fetal development at epithelial/mesenchymal boundaries and in pathophysiologic fibroproliferative cells of bronchopulmonary dysplasia, emphysema, and scar fibroblast tissue following myocardial ischemia. Precise function and regulation of intracellular EMAP II, however, has not been explored to date. Methodology/Principal Findings: Here we show that high intracellular EMAP II suppresses cellular proliferation by slowing progression through the G2M cell cycle transition in epithelium and fibroblast. Furthermore, EMAP II binds to and is phosphorylated by Cdk1, and exhibits nuclear/cytoplasmic partitioning, with only nuclear EMAP II being phosphorylated. We observed that extracellular secreted EMAP II induces endothelial cell apoptosis, where as excess intracellular EMAP II facilitates epithelial and fibroblast cells migration. Conclusions/Significance: Our findings suggest that EMAP II has specific intracellular effects, and that this intracellular function appears to antagonize its extracellular anti-angiogenic effects during fetal development and pulmonary disease progression.	[Schwarz, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Schwarz, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	margaret.schwarz@utsouthwestern.edu		Thornton, Janet/0000-0003-0824-4096	National Institutes of Health (NIH) [HL60061, HL75764]; Children's Clinical Research Advisory Committee; UT Southwestern Simmons Comprehensive Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075764, R29HL060061, R01HL060061] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Clinical Research Advisory Committee; UT Southwestern Simmons Comprehensive Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research was supported in part by National Institutes of Health (NIH) grants HL60061 (MAS), HL75764 (MAS), the Children's Clinical Research Advisory Committee, and the UT Southwestern Simmons Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi N, 2009, LAB INVEST, V89, P38, DOI 10.1038/labinvest.2008.106; Berger AC, 2000, J IMMUNOTHER, V23, P519, DOI 10.1097/00002371-200009000-00002; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Chen Y, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-1; Clauss M, 2011, J CLIN INVEST, V121, P2470, DOI 10.1172/JCI43881; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Furukawa Y, 2000, J BIOL CHEM, V275, P21661, DOI 10.1074/jbc.M906893199; KAO J, 1992, J BIOL CHEM, V267, P20239; KAO J, 1994, J BIOL CHEM, V269, P25106; Kao J, 1993, Behring Inst Mitt, P92; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Kuo CJ, 2001, J CELL BIOL, V152, P1233, DOI 10.1083/jcb.152.6.1233; Liu J, 2006, EXP CELL RES, V312, P2231, DOI 10.1016/j.yexcr.2006.03.024; Murray JC, 2004, J LEUKOCYTE BIOL, V75, P772, DOI 10.1189/jlb.1003487; Park SG, 2005, AM J PATHOL, V166, P387, DOI 10.1016/S0002-9440(10)62262-6; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Quintos-Alagheband ML, 2004, ANTIOXID REDOX SIGN, V6, P137, DOI 10.1089/152308604771978444; Schwarz M, 1999, AM J PHYSIOL-LUNG C, V276, pL365, DOI 10.1152/ajplung.1999.276.2.L365; Schwarz MA, 1999, J EXP MED, V190, P341, DOI 10.1084/jem.190.3.341; Schwarz MA, 2005, EXP CELL RES, V311, P229, DOI 10.1016/j.yexcr.2005.09.008; Schwarz MA, 2004, AM J RESP CELL MOL, V30, P784, DOI 10.1165/rcmb.2003-0145OC; Schwarz MA, 2000, MECH DEVELOP, V95, P123, DOI 10.1016/S0925-4773(00)00361-0; Schwarz MA, 2011, AM J RESP CELL MOL, V44, P682, DOI 10.1165/rcmb.2009-0309OC; Schwarz RE, 2004, J SURG RES, V120, P64, DOI 10.1016/j.jss.2003.10.005; Schwarz RE, 2010, CANC BIOL THER, V9; Schwarz RE, 2010, ANN SURG ONCOL, V17, P1442, DOI 10.1245/s10434-009-0879-5; Schwarz RE, 2009, SURGERY, V146, P241, DOI 10.1016/j.surg.2009.04.015; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Thompson JL, 2004, J SURG RES, V116, P156, DOI 10.1016/j.jss.2003.06.001; Youssef MMS, 2006, BRIT J CANCER, V95, P735, DOI 10.1038/sj.bjc.6603299; Zhang FR, 2002, AM J PHYSIOL-LUNG C, V282, pL1239, DOI 10.1152/ajplung.00141.2001; Zhang FR, 2000, DEV DYNAM, V218, P490, DOI 10.1002/1097-0177(200007)218:3<490::AID-DVDY1005>3.0.CO;2-C	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33101	10.1371/journal.pone.0033101	http://dx.doi.org/10.1371/journal.pone.0033101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412987	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062000031
J	Roberts, DJ; Celi, AC; Riley, LE; Onderdonk, AB; Boyd, TK; Johnson, LC; Lieberman, E				Roberts, Drucilla J.; Celi, Ann C.; Riley, Laura E.; Onderdonk, Andrew B.; Boyd, Theonia K.; Johnson, Lise Carolyn; Lieberman, Ellice			Acute Histologic Chorioamnionitis at Term: Nearly Always Noninfectious	PLOS ONE			English	Article							ACUTE PLACENTAL INFLAMMATION; RECEPTOR ANTAGONIST; EPIDURAL ANALGESIA; INFECTION; LABOR; PATTERNS; DELIVERY; FEVER; BIRTH; CYTOKINES	Background: The link between histologic acute chorioamnionitis and infection is well established in preterm deliveries, but less well-studied in term pregnancies, where infection is much less common. Methodology/Principal Findings: We conducted a secondary analysis among 195 low-risk women with term pregnancies enrolled in a randomized trial. Histologic and microbiologic evaluation of placentas included anaerobic and aerobic cultures (including mycoplasma/ureaplasma species) as well as PCR. Infection was defined as >= 1,000 cfu of a single known pathogen or a >= 2 log difference in counts for a known pathogen versus other organisms in a mixed culture. Placental membranes were scored and categorized as: no chorioamnionitis, Grade 1 (subchorionitis and patchy acute chorioamnionitis), or Grade 2 (severe, confluent chorioamnionitis). Grade 1 or grade 2 histologic chorioamnionitis was present in 34% of placentas (67/195), but infection was present in only 4% (8/195). Histologic chorioamnionitis was strongly associated with intrapartum fever >38 degrees C [69% (25/36) fever, 26% (42/159) afebrile, P<.0001]. Fever occurred in 18% (n = 36) of women. Most febrile women [92% (33/36)] had received epidural for pain relief, though the association with fever was present with and without epidural. The association remained significant in a logistic regression controlling for potential confounders (OR = 5.8, 95% CI = 2.2, 15.0). Histologic chorioamnionitis was also associated with elevated serum levels of interleukin-8 (median = 1.3 pg/mL no histologic chorioamnionitis, 1.5 pg/mL Grade 1, 2.1 pg/mL Grade 2, P = 0.05) and interleukin-6 (median levels = 2.2 pg/mL no chorioamnionitis, 5.3 pg/mL Grade 1, 24.5 pg/mL Grade 2, P = 0.02) at admission for delivery as well as higher admission WBC counts (mean = 12,000cells/mm(3) no chorioamnionitis, 13,400cells/mm(3) Grade 1, 15,700cells/mm(3) Grade 2, P = 0.0005). Conclusion/Significance: Our results suggest histologic chorioamnionitis at term most often results from a noninfectious inflammatory process. It was strongly associated with fever, most of which was related to epidural used for pain relief. A more 'activated' maternal immune system at admission was also associated with histologic chorioamnionitis.	[Roberts, Drucilla J.] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Celi, Ann C.] Harvard Univ, Brigham & Womens Hosp, Div Gen Med, Sch Med, Boston, MA 02115 USA; [Riley, Laura E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA USA; [Onderdonk, Andrew B.] Harvard Univ, Brigham & Womens Hosp, Clin Microbiol Lab, Sch Med, Boston, MA 02115 USA; [Boyd, Theonia K.] Harvard Univ, Childrens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA; [Lieberman, Ellice] Harvard Univ, Brigham & Womens Hosp, Dept Obstet & Gynecol, Sch Med, Boston, MA 02115 USA; [Lieberman, Ellice] Harvard Univ, Brigham & Womens Hosp, Dept Newborn Med, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Roberts, DJ (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA.	elieberman@partners.org	Roberts, Drucilla/AAB-6379-2022		Maternal Child Health Bureau, Health Resources and Services Administration [R40 MC00248]; National Heart, Lung, and Blood Institute [RO1HL081663]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081663] Funding Source: NIH RePORTER	Maternal Child Health Bureau, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the Maternal Child Health Bureau, Health Resources and Services Administration (R40 MC00248). ACC's work on the current manuscript was in part supported by National Heart, Lung, and Blood Institute reentry award RO1HL081663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen R, 2005, OBSTET GYNECOL, V106, P802, DOI 10.1097/01.AOG.0000178750.84837.ed; BAERGEN R, 1994, ARCH PATHOL LAB MED, V118, P52; Bytautiene E, 2004, AM J OBSTET GYNECOL, V191, P1356, DOI 10.1016/j.ajog.2004.06.092; DeJongh RF, 1997, ACTA ANAESTH SCAND, V41, P853, DOI 10.1111/j.1399-6576.1997.tb04800.x; Dollner H, 2002, BJOG-INT J OBSTET GY, V109, P534, DOI 10.1111/j.1471-0528.2002.01028.x; Elenkov IJ, 1999, BEST PRACT RES CL EN, V13, P583, DOI 10.1053/beem.1999.0045; Elenkov IJ, 2008, NEUROCHEM INT, V52, P40, DOI 10.1016/j.neuint.2007.06.037; Fox H, 2007, PATHOLOGY PLACENTA, V3rd; Goetzl L, 2002, AM J OBSTET GYNECOL, V187, P834, DOI 10.1067/mob.2002.127135; Goldenberg RL, 2006, AM J OBSTET GYNECOL, V195, P1533, DOI 10.1016/j.ajog.2006.05.023; Green HP, 2007, INFECT CONT HOSP EP, V28, P886, DOI 10.1086/518843; Hecht JL, 2008, PEDIATR DEVEL PATHOL, V11, P15, DOI 10.2350/07-06-0285.1; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Kohl BA, 2006, CURR OPIN CRIT CARE, V12, P325, DOI 10.1097/01.ccx.0000235210.85073.fc; Leuschner F, 2009, J AUTOIMMUN, V33, P282, DOI 10.1016/j.jaut.2009.07.009; Lieberman E, 1997, PEDIATRICS, V99, P415, DOI 10.1542/peds.99.3.415; Liu SL, 2001, AM J OBSTET GYNECOL, V184, P90, DOI 10.1067/mob.2001.108073; Miralles R, 2005, PEDIATR RES, V57, P570, DOI 10.1203/01.PDR.0000155944.48195.97; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.068; Redline RW, 2007, PEDIATR DEVEL PATHOL, V10, P282, DOI 10.2350/06-12-0203.1; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Redline RW, 2004, SEMIN NEONATOL, V9, P65; Riley LE, 2011, OBSTET GYNECOL, V117, P588, DOI 10.1097/AOG.0b013e31820b0503; Robertson A, 2006, INFECT PREGNANCY CHO; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1382, DOI 10.1016/0002-9378(92)91609-E; Romero R, 2011, J MATERN-FETAL NEO M, V24, P1444, DOI 10.3109/14767058.2011.591460; Romero R, 2010, J MATERN-FETAL NEO M, V23, P351, DOI 10.3109/14767050903177193; Salafia CM, 1997, AM J PERINAT, V14, P419, DOI 10.1055/s-2007-994172; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Sharma SK, 2002, ANESTHESIOLOGY, V96, P546, DOI 10.1097/00000542-200203000-00007; Yektaei-Karin E, 2007, PEDIAT ALLERG IMM-UK, V18, P643, DOI 10.1111/j.1399-3038.2007.00578.x; YUE D, 1987, OBSTET GYNECOL, V70, P175; Zaaijman T, 1982, J OBSTET GYNAECOL, V2, P155; Zanardo V, 2008, PEDIATR DEVEL PATHOL, V11, P350, DOI 10.2350/07-08-0324.1; ZHANG J, 1985, INT J GYNECOL PATHOL, V4, P1, DOI 10.1097/00004347-198501000-00001	35	93	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e31819	10.1371/journal.pone.0031819	http://dx.doi.org/10.1371/journal.pone.0031819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412842	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800005
J	Galiano, M; Johnson, BF; Myers, R; Ellis, J; Daniels, R; Zambon, M				Galiano, Monica; Johnson, Benjamin F.; Myers, Richard; Ellis, Joanna; Daniels, Rod; Zambon, Maria			Fatal Cases of Influenza A(H3N2) in Children: Insights from Whole Genome Sequence Analysis	PLOS ONE			English	Article							A VIRUS; RECEPTOR SPECIFICITY; CELL TROPISM; HEMAGGLUTININ; EVOLUTION; EPIDEMIC; RESIDUES; REVEALS; PASSAGE; SITES	During the Northern Hemisphere winter of 2003-2004 the emergence of a novel influenza antigenic variant, A/Fujian/411/2002-like(H3N2), was associated with an unusually high number of fatalities in children. Seventeen fatal cases in the UK were laboratory confirmed for Fujian/411-like viruses. To look for phylogenetic patterns and genetic markers that might be associated with increased virulence, sequencing and phylogenetic analysis of the whole genomes of 63 viruses isolated from fatal cases and non fatal "control" cases was undertaken. The analysis revealed the circulation of two main genetic groups, I and II, both of which contained viruses from fatal cases. No associated amino acid substitutions could be linked with an exclusive or higher occurrence in fatal cases. The Fujian/411-like viruses in genetic groups I and II completely displaced other A(H3N2) viruses, but they disappeared after 2004. This study shows that two A(H3N2) virus genotypes circulated exclusively during the winter of 2003-2004 in the UK and caused an unusually high number of deaths in children. Host factors related to immune state and differences in genetic background between patients may also play important roles in determining the outcome of an influenza infection.	[Galiano, Monica; Myers, Richard; Ellis, Joanna; Zambon, Maria] Hlth Protect Agcy, Microbiol Serv, London, England; [Johnson, Benjamin F.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Virol Sect, London, England; [Daniels, Rod] MRC Natl Inst Med Res, Div Virol, London, England	Health Protection Agency; Imperial College London; MRC National Institute for Medical Research	Galiano, M (corresponding author), Hlth Protect Agcy, Microbiol Serv, London, England.	Monica.Galiano@hpa.org.uk		Johnson, Benjamin/0000-0001-5991-7612	Wellcome Trust [GR081346MA]; MRC [MC_U117512723] Funding Source: UKRI; Medical Research Council [MC_U117512723] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MG's work was supported with funding from Wellcome Trust, grant No GR081346MA (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barr IG, 2005, J MED VIROL, V76, P391, DOI 10.1002/jmv.20374; Berkhoff EGM, 2007, J GEN VIROL, V88, P530, DOI 10.1099/vir.0.82120-0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Bush RM, 2000, P NATL ACAD SCI USA, V97, P6974, DOI 10.1073/pnas.97.13.6974; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; COOKE MK, 2005, COMMUN DIS REP CDR S, V15, P1; DIBRINO M, 1994, J BIOL CHEM, V269, P32426; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fleming D M, 2000, Commun Dis Public Health, V3, P32; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Gupta R, 2004, PREDICTION N GLYCOSY; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hiromoto Y, 2000, VIROLOGY, V272, P429, DOI 10.1006/viro.2000.0371; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; Johnson BF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007671; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Kim JH, 2010, J GEN VIROL, V91, P1284, DOI 10.1099/vir.0.018143-0; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Mubareka S, 2008, J INFECT DIS, V197, P1, DOI 10.1086/524067; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Pebody RG, 2010, EUROSURVEILLANCE, V15; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Sachedina N, 2010, LANCET, V376, P1846, DOI 10.1016/S0140-6736(10)61195-6; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; World Health Organization, 2005, Wkly Epidemiol Rec, V80, P65	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e33166	10.1371/journal.pone.0033166	http://dx.doi.org/10.1371/journal.pone.0033166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412998	gold, Green Submitted, Green Published			2022-12-25	WOS:000303021100053
J	Aladin, F; Einerhand, AWC; Bouma, J; Bezemer, S; Hermans, P; Wolvers, D; Bellamy, K; Frenken, LGJ; Gray, J; Iturriza-Gomara, M				Aladin, Farah; Einerhand, Alexandra W. C.; Bouma, Janneke; Bezemer, Sandra; Hermans, Pim; Wolvers, Danielle; Bellamy, Kate; Frenken, Leon G. J.; Gray, Jim; Iturriza-Gomara, Miren			In Vitro Neutralisation of Rotavirus Infection by Two Broadly Specific Recombinant Monovalent Llama-Derived Antibody Fragments	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PEDIATRIC POPULATION; CONFER PROTECTION; BOVINE COLOSTRUM; INDUCED DIARRHEA; CHILDREN; IMMUNOGLOBULIN; PROTEIN; GASTROENTERITIS; PATHOGENESIS	Rotavirus is the main cause of viral gastroenteritis in young children. Therefore, the development of inexpensive antiviral products for the prevention and/or treatment of rotavirus disease remains a priority. Previously we have shown that a recombinant monovalent antibody fragment (referred to as Anti-Rotavirus Proteins or ARP1) derived from a heavy chain antibody of a llama immunised with rotavirus was able to neutralise rotavirus infection in a mouse model system. In the present work we investigated the specificity and neutralising activity of two llama antibody fragments, ARP1 and ARP3, against 13 cell culture adapted rotavirus strains of diverse genotypes. In addition, immunocapture electron microscopy (IEM) was performed to determine binding of ARP1 to clinical isolates and cell culture adapted strains. ARP1 and ARP3 were able to neutralise a broad variety of rotavirus serotypes/genotypes in vitro, and in addition, IEM showed specific binding to a variety of cell adapted strains as well as strains from clinical specimens. These results indicated that these molecules could potentially be used as immunoprophylactic and/or immunotherapeutic products for the prevention and/ or treatment of infection of a broad range of clinically relevant rotavirus strains.	[Aladin, Farah; Gray, Jim; Iturriza-Gomara, Miren] Hlth Protect Agcy, Ctr Infect, Enter Virus Unit, London, England; [Einerhand, Alexandra W. C.; Bouma, Janneke] Erasmus MC Sophia, Pediat Lab, Rotterdam, Netherlands; [Bezemer, Sandra; Hermans, Pim] BAC BV, Naarden, Netherlands; [Wolvers, Danielle; Frenken, Leon G. J.] Unilever Res & Dev Vlaardingen BV, Vlaardingen, Netherlands; [Bellamy, Kate] Unilever Res & Dev Colworth House, Sharnbrook, Beds, England	Health Protection Agency; Erasmus University Rotterdam; Erasmus MC; Unilever; Unilever	Aladin, F (corresponding author), Hlth Protect Agcy, Ctr Infect, Enter Virus Unit, London, England.	miren.iturriza@hpa.org.uk	Gomara, Miren Iturriza/B-4351-2013	Gomara, Miren Iturriza/0000-0001-5816-6423; Einerhand, Alexandra/0000-0003-0934-1920	European seventh framework programme [HEALTHF52008202162]	European seventh framework programme(European Commission)	This work was funded in part by a grant from the European seventh framework programme HEALTHF52008202162) (LACTOBODY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2007, FIELDS VIROLOGY; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; DAVIDSON GP, 1989, LANCET, V2, P709, DOI 10.1016/S0140-6736(89)90771-X; Estes M, VIRAL GASTROENTERITI, P207; Frenken LGJ, 2000, J BIOTECHNOL, V78, P11, DOI 10.1016/S0168-1656(99)00228-X; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; GREENBERG H, 1983, INFECT IMMUN, V39, P91, DOI 10.1128/IAI.39.1.91-99.1983; Gualtero DF, 2007, ARCH VIROL, V152, P2183, DOI 10.1007/s00705-007-1055-5; Guandalini S, 2000, J PEDIATR GASTR NUTR, V30, P54, DOI 10.1097/00005176-200001000-00018; HOLMSTROM K, 1993, ANAL BIOCHEM, V209, P278, DOI 10.1006/abio.1993.1120; ITURRIZAGOMARA M, 2003, VIRAL GASTROENTERITI, P317; Khoury H, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-9; Ledeboer AM, 2002, J DAIRY SCI, V85, P1376, DOI 10.3168/jds.S0022-0302(02)74204-5; Linhares AC, 2011, REV MED VIROL; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Ogilvie I, 2011, HUM VACCINES, V7, P523, DOI 10.4161/hv.7.5.14819; Pant N, 2006, J INFECT DIS, V194, P1580, DOI 10.1086/508747; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Pesavento JB, 2003, J VIROL, V77, P3291, DOI 10.1128/JVI.77.5.3291-3296.2003; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Salazar-Lindo E, 2000, NEW ENGL J MED, V343, P463, DOI 10.1056/NEJM200008173430703; SALIM AFM, 1990, BAILLIERE CLIN GASTR, V4, P593, DOI 10.1016/0950-3528(90)90051-H; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Sarker SA, 1998, PEDIATR INFECT DIS J, V17, P1149, DOI 10.1097/00006454-199812000-00010; Sarker SA, 2001, J PEDIATR GASTR NUTR, V32, P19, DOI 10.1097/00005176-200101000-00009; Schumann T, 2009, VIROLOGY, V386, P334, DOI 10.1016/j.virol.2009.01.040; Schwartz-Cornil I, 2002, J VIROL, V76, P8110, DOI 10.1128/JVI.76.16.8110-8117.2002; Servin AL, 2003, PERSP MED V, V9, P237; Tate JE, 2011, LANCET INFECT DIS; Taylor J. A., 2003, VIRAL GASTROENTERITI; Ursu K, 2009, ARCH VIROL, V154, P1365, DOI 10.1007/s00705-009-0439-0; van der Linden RHJ, 2000, J BIOTECHNOL, V80, P261, DOI 10.1016/S0168-1656(00)00274-1; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045	37	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32949	10.1371/journal.pone.0032949	http://dx.doi.org/10.1371/journal.pone.0032949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403728	Green Published, gold			2022-12-25	WOS:000303017700125
J	Hoffman, JI; Clarke, A; Clark, MS; Fretwell, P; Peck, LS				Hoffman, Joseph I.; Clarke, Andy; Clark, Melody S.; Fretwell, Peter; Peck, Lloyd S.			Unexpected Fine-Scale Population Structure in a Broadcast-Spawning Antarctic Marine Mollusc	PLOS ONE			English	Article							LIMPET NACELLA-CONCINNA; GENETIC-STRUCTURE; GENOTYPING ERRORS; ADELAIDE ISLAND; LIFE-HISTORY; AFLP; CONNECTIVITY; DISPERSAL; DIFFERENTIATION; PHYLOGEOGRAPHY	Several recent empirical studies have challenged the prevailing dogma that broadcast-spawning species exhibit little or no population genetic structure by documenting genetic discontinuities associated with large-scale oceanographic features. However, relatively few studies have explored patterns of genetic differentiation over fine spatial scales. Consequently, we used a hierarchical sampling design to investigate the basis of a weak but significant genetic difference previously reported between Antarctic limpets (Nacella concinna) sampled from Adelaide and Galindez Islands near the base of the Antarctic Peninsula. Three sites within Ryder Bay, Adelaide Island (Rothera Point, Leonie and Anchorage Islands) were each sub-sampled three times, yielding a total of 405 samples that were genotyped at 155 informative Amplified Fragment Length Polymorphisms (AFLPs). Contrary to our initial expectations, limpets from Anchorage Island were found to be subtly, but significantly distinct from those sampled from the other sites. This suggests that local processes may play an important role in generating fine-scale population structure even in species with excellent dispersal capabilities, and highlights the importance of sampling at multiple spatial scales in population genetic surveys.	[Hoffman, Joseph I.] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany; [Clarke, Andy; Clark, Melody S.; Fretwell, Peter; Peck, Lloyd S.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	University of Bielefeld; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hoffman, JI (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	joseph.hoffman@uni-bielefeld.de	Clark, Melody S/D-7371-2014; Hoffman, Joseph i/K-7725-2012	Clark, Melody S/0000-0002-3442-3824; Hoffman, Joseph i/0000-0001-5895-8949	Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance; Deutsche Forschungsgemeinschaft; Bielefeld University; NERC [dml011000, bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025, dml011000] Funding Source: researchfish	Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance Fellowship to J. I. Hoffman. The authors also acknowledge support for the publication fee from the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 1997, MAR BIOL, V129, P97, DOI 10.1007/s002270050150; Ayre DJ, 2000, EVOLUTION, V54, P1590; Bay LK, 2006, MAR BIOL, V149, P1247, DOI 10.1007/s00227-006-0276-6; BEAUMONT AR, 1991, J MOLLUS STUD, V57, P443, DOI 10.1093/mollus/57.4.443; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bowden DA, 2005, MAR BIOL, V146, P1235, DOI 10.1007/s00227-004-1526-0; Bowden DA, 2006, MAR ECOL PROG SER, V316, P1, DOI 10.3354/meps316001; Bowden DA, 2009, MAR BIOL, V156, P2033, DOI 10.1007/s00227-009-1235-9; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Chwedorzewska KJ, 2010, POL POLAR RES, V31, P195, DOI 10.4202/ppres.2010.11; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Dasmahapatra KK, 2009, HEREDITY, V103, P168, DOI 10.1038/hdy.2009.25; de Aranzamendi MC, 2008, MAR BIOL, V154, P875, DOI 10.1007/s00227-008-0980-5; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Golledge NR, 2010, GEOGR ANN A, V92A, P111, DOI 10.1111/j.1468-0459.2010.00381.x; HEDGECOCK D, 1994, CAL COOP OCEAN FISH, V35, P73; Hoffman JI, 2011, MAR BIOL, V158, P287, DOI 10.1007/s00227-010-1558-6; Hoffman JI, 2010, MAR BIOL, V157, P765, DOI 10.1007/s00227-009-1360-5; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hoffman JI, 2011, J HERED, V102, P55, DOI 10.1093/jhered/esq094; Hofmann E.E., 1996, FDN ECOLOGICAL RES W, P61; JOHNSON MS, 1982, MAR BIOL, V70, P157, DOI 10.1007/BF00397680; Maughan PJ, 1996, THEOR APPL GENET, V93, P392, DOI 10.1007/BF00223181; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Morley SA, 2010, J EXP MAR BIOL ECOL, V390, P1, DOI 10.1016/j.jembe.2010.04.040; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Palumbi SR, 2003, ECOL APPL, V13, pS146; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peck LS, 2010, GLOBAL CHANGE BIOL, V16, P2614, DOI 10.1111/j.1365-2486.2009.02071.x; POWELL A. W. B., 1951, DISC REP, V26, P49; Richards VP, 2007, MOL ECOL, V16, P139, DOI 10.1111/j.1365-294X.2006.03145.x; Savidge DK, 2009, DEEP-SEA RES PT I, V56, P1633, DOI 10.1016/j.dsr.2009.05.011; Sherman CDH, 2008, BIOL J LINN SOC, V95, P106, DOI 10.1111/j.1095-8312.2008.01044.x; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Stanwell-Smith D, 1998, J MOLLUS STUD, V64, P123, DOI 10.1093/mollus/64.1.123; Stanwell-Smith D, 1998, BIOL BULL-US, V194, P44, DOI 10.2307/1542512; Temby N, 2007, MAR FRESHWATER RES, V58, P733, DOI 10.1071/MF07015; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walker A. J. M., 1972, BRIT ANTARCTIC SURVE, V28, P49; Watts PC, 2006, MAR BIOL, V149, P1093, DOI 10.1007/s00227-006-0288-2; Weihe E, 2008, AQUAT BIOL, V4, P155, DOI 10.3354/ab00103	48	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32415	10.1371/journal.pone.0032415	http://dx.doi.org/10.1371/journal.pone.0032415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403655	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000303017700052
J	Sogaard, OS; Lohse, N; Ostergaard, L; Kronborg, G; Roge, B; Gerstoft, J; Sorensen, HT; Obel, N				Sogaard, Ole S.; Lohse, Nicolai; Ostergaard, Lars; Kronborg, Gitte; Roge, Birgit; Gerstoft, Jan; Sorensen, Henrik T.; Obel, Niels			Morbidity and Risk of Subsequent Diagnosis of HIV: A Population Based Case Control Study Identifying Indicator Diseases for HIV Infection	PLOS ONE			English	Article							INJECTING DRUG-USERS; ANTIRETROVIRAL THERAPY; UNITED-STATES; CARE; HEALTH; TRANSMISSION; VIRUS; RECOMMENDATIONS; PREVENTION; PNEUMONIA	Background: Early identification of persons with undiagnosed HIV infection is an important health care issue. We examined associations between diseases diagnosed in hospitals and risk of subsequent HIV diagnosis. Methods: In this population-based case control study, cases were persons with incident HIV infection diagnosed in Denmark between 1 January 1995 and 1 June 2008. Risk-set sampling was used to identify 19 age- and gender-matched population controls for each HIV case, using the HIV diagnosis date as the index date for both cases and controls. Prior hospital diagnoses obtained from Danish medical databases were first categorized into 22 major disease categories (excluding AIDS-defining diseases except tuberculosis) and then subdivided into 161 subcategories, allowing us to examine specific diseases as potential HIV indicators by conditional logistic regression. Results: The study included 2,036 HIV cases and 35,718 controls. Persons with the following disease categories had a high risk of HIV diagnosis during the subsequent 5-year period: sexually transmitted infections and viral hepatitis (adjusted odds ratio [aOR] = 12.3, 95% CI: 9.60-15.7), hematological diseases (aOR = 4.28, 3.13-5.85), lower respiratory tract infections (aOR = 3.98, 3.14-5.04)), CNS infections (aOR = 3.44, 1.74-6.80), skin infections (aOR = 3.05, 2.47-3.75), other infections (aOR = 4.64, 3.89-5.54), and substance abuse (aOR = 2.60, 2.06-3.29). Several specific diseases were associated with aORs>20 including syphilis, hepatitis A, non "A" viral hepatitis, herpes zoster, candida infection, endocarditis, thrombocytopenia, and opioid abuse. Conclusions: Targeted testing for HIV in patients diagnosed with diseases associated with HIV may lead to earlier treatment and thereby reduced morbidity, mortality and HIV transmission.	[Sogaard, Ole S.; Ostergaard, Lars] Aarhus Univ Hosp, Dept Infect Dis, Skejby, Denmark; [Lohse, Nicolai; Sorensen, Henrik T.] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Kronborg, Gitte] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Roge, Birgit] Kolding Cty Hosp, Dept Infect Dis, Kolding, Denmark; [Gerstoft, Jan; Obel, Niels] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Sorensen, Henrik T.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Aarhus University; Aarhus University; University of Copenhagen; Kolding Hospital; Rigshospitalet; University of Copenhagen; Boston University	Sogaard, OS (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, Skejby, Denmark.	olesoega@rm.dk	Sorensen, Henrik Toft/Z-6181-2019; Ostergaard, Lars/AAA-3020-2020; Søgaard, Ole S/P-6058-2016; Lohse, Nicolai/ABE-5884-2020; Søgaard, Ole Schmeltz/AEP-7968-2022	Sorensen, Henrik Toft/0000-0003-4299-7040; Ostergaard, Lars/0000-0003-2459-0511; Søgaard, Ole Schmeltz/0000-0001-9107-2023; Obel, Niels/0000-0002-5031-0045; Ostergaard, Lars/0000-0002-7619-605X; Lohse, Nicolai/0000-0001-8403-8759	Institute of Clinical Medicine at Aarhus; Copenhagen University	Institute of Clinical Medicine at Aarhus; Copenhagen University	This study was supported by the Institute of Clinical Medicine at Aarhus and Copenhagen University. The funders had roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis. The corresponding author had the final responsibility to submit for publication.	[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Bini EJ, 2006, J CLIN GASTROENTEROL, V40, P732, DOI 10.1097/00004836-200609000-00014; Bottieau E, 2006, J TRAVEL MED, V13, P191, DOI 10.1111/j.1708-8305.2006.00049.x; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chiao EY, 2010, JAMA-J AM MED ASSOC, V304, P334, DOI 10.1001/jama.2010.752; Coenen T, 2008, HIV MED, V9, P1, DOI 10.1111/j.1468-1293.2008.00583.x; de la Fuente L, 2009, AIDS PATIENT CARE ST, V23, P625, DOI 10.1089/apc.2009.0019; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Gazzard B, 2008, HIV MED, V9, P34, DOI 10.1111/j.1468-1293.2008.00592.x; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Haukoos JS, 2008, ANN EMERG MED, V51, P303, DOI 10.1016/j.annemergmed.2007.10.028; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Kendrick SR, 2004, AIDS, V18, P2208, DOI 10.1097/00002030-200411050-00017; KITAHATA MM, 2009, N ENGL J MED; Klein D, 2003, JAIDS-J ACQ IMM DEF, V32, P143, DOI 10.1097/00126334-200302010-00005; Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mazick A, 2005, Euro Surveill, V10, P111; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mounier-Jack S, 2008, HIV MED, V9, P13, DOI 10.1111/j.1468-1293.2008.00585.x; Nickelsen T N, 2001, Ugeskr Laeger, V164, P33; Noskin GA, 1996, CLIN CHEST MED, V17, P713, DOI 10.1016/S0272-5231(05)70341-5; Obel N, 2008, INT J EPIDEMIOL; Olsen JH, 1997, APMIS, V105, P141; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pedersen CB, 2006, DAN MED BULL, V53, P441; Prevention ECfDCa, 2010, HIV TEST INCR UPT EF; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Richardson DB, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2004.014472; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sogaard OS, 2008, CLIN INFECT DIS, V47, P1345, DOI 10.1086/592692; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32538	10.1371/journal.pone.0032538	http://dx.doi.org/10.1371/journal.pone.0032538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403672	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700069
J	Tilghman, SL; Bratton, MR; Segar, HC; Martin, EC; Rhodes, LV; Li, M; McLachlan, JA; Wiese, TE; Nephew, KP; Burow, ME				Tilghman, Syreeta L.; Bratton, Melyssa R.; Segar, H. Chris; Martin, Elizabeth C.; Rhodes, Lyndsay V.; Li, Meng; McLachlan, John A.; Wiese, Thomas E.; Nephew, Kenneth P.; Burow, Matthew E.			Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER CELLS; MIR-21 EXPRESSION; OVARIAN-STEROIDS; DNA METHYLATION; LEYDIG-CELLS; NUCLEIC-ACID; TUMOR; RECEPTOR; MECHANISMS	Background: Several environmental agents termed "endocrine disrupting compounds" or EDCs have been reported to bind and activate the estrogen receptor-alpha (ER). The EDCs DDT and BPA are ubiquitously present in the environment, and DDT and BPA levels in human blood and adipose tissue are detectable in most if not all women and men. ER-mediated biological responses can be regulated at numerous levels, including expression of coding RNAs (mRNAs) and more recently noncoding RNAs (ncRNAs). Of the ncRNAs, microRNAs have emerged as a target of estrogen signaling. Given the important implications of EDC-regulated ER function, we sought to define the effects of BPA and DDT on microRNA regulation and expression levels in estrogen-responsive human breast cancer cells. Methodology/Principal Findings: To investigate the cellular effects of DDT and BPA, we used the human MCF-7 breast cancer cell line, which is ER (+) and hormone sensitive. Our results show that DDT and BPA potentiate ER transcriptional activity, resulting in an increased expression of receptor target genes, including progesterone receptor, bcl-2, and trefoil factor 1. Interestingly, a differential increase in expression of Jun and Fas by BPA but not DDT or estrogen was observed. In addition to ER responsive mRNAs, we investigated the ability of DDT and BPA to alter the miRNA profiles in MCF-7 cells. While the EDCs and estrogen similarly altered the expression of multiple microRNAs in MCF-7 cells, including miR-21, differential patterns of microRNA expression were induced by DDT and BPA compared to estrogen. Conclusions/Significance: We have shown, for the first time, that BPA and DDT, two well known EDCs, alter the expression profiles of microRNA in MCF-7 breast cancer cells. A better understanding of the molecular mechanisms of these compounds could provide important insight into the role of EDCs in human disease, including breast cancer.	[Tilghman, Syreeta L.; Wiese, Thomas E.] Xavier Univ Louisiana, Coll Pharm, Div Basic Pharmaceut Sci, New Orleans, LA USA; [Tilghman, Syreeta L.; Bratton, Melyssa R.; McLachlan, John A.; Wiese, Thomas E.; Burow, Matthew E.] Tulane Univ, Ctr Bioenvironm Res, New Orleans, LA 70118 USA; [Bratton, Melyssa R.; McLachlan, John A.] Tulane Univ, Dept Pharmacol, New Orleans, LA 70118 USA; [Segar, H. Chris; Martin, Elizabeth C.; Rhodes, Lyndsay V.; Burow, Matthew E.] Tulane Univ, Dept Med, Sect Hematol & Med Oncol, New Orleans, LA 70118 USA; [Li, Meng; Nephew, Kenneth P.] Indiana Univ, Sch Med, Dept Med Sci, Bloomington, IN USA	Xavier University of Louisiana; Tulane University; Tulane University; Tulane University; Indiana University System; Indiana University Bloomington	Tilghman, SL (corresponding author), Xavier Univ Louisiana, Coll Pharm, Div Basic Pharmaceut Sci, New Orleans, LA USA.	mburow@tulane.edu	Burow, Matthew/D-6351-2013; Rhodes, Lyndsay/AAC-4989-2020; Tilghman, Syreeta/GXH-9699-2022; Bratton, Melyssa/G-9431-2019	Burow, Matthew/0000-0002-0642-6630; Rhodes, Lyndsay/0000-0001-7672-2059; Tilghman, Syreeta/0000-0003-3215-1252; Bratton, Melyssa/0000-0001-9063-2025	National Cancer Institute [NCI ICBP U54CA113001]; Office of Naval Research [09-10 N00014-10-1-0270]; NATIONAL CANCER INSTITUTE [U54CA113001] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Naval Research(Office of Naval Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by National Cancer Institute grant NCI ICBP U54CA113001 (to K.E.N.) and Office of Naval Research grant 09-10 N00014-10-1-0270 (to M. E. B. and J. A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Bagchi G, 2009, TOXICOL APPL PHARM, V238, P101, DOI 10.1016/j.taap.2008.03.015; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boue SM, 2009, ENDOCRINOLOGY, V150, P2446, DOI 10.1210/en.2008-1235; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Burow ME, 1999, CARCINOGENESIS, V20, P2057, DOI 10.1093/carcin/20.11.2057; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cohen A, 2008, ENDOCRINOLOGY, V149, P1687, DOI 10.1210/en.2007-0969; Cuellar TL, 2005, J ENDOCRINOL, V187, P327, DOI 10.1677/joe.1.06426; Du J, 2009, CELL RES, V19, P487, DOI 10.1038/cr.2009.34; Eskenazi B, 2009, ENVIRON HEALTH PERSP, V117, P1359, DOI 10.1289/ehp.11748; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Frigo DE, 2004, CARCINOGENESIS, V25, P249, DOI 10.1093/carcin/bgh009; Frigo DE, 2002, ENVIRON HEALTH PERSP, V110, P1239, DOI 10.1289/ehp.021101239; Hancock KD, 2009, TOXICOL LETT, V184, P169, DOI 10.1016/j.toxlet.2008.11.005; Hengstler JG, CRIT REV TOXICOL, V41, P263; Hsu PY, 2009, CANCER RES, V69, P5936, DOI 10.1158/0008-5472.CAN-08-4914; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Klotz DM, 1996, ENVIRON HEALTH PERSP, V104, P1084, DOI 10.2307/3433121; Kovalchuk O, 2007, CELL CYCLE, V6, P2010, DOI 10.4161/cc.6.16.4549; Krol J, NAT REV GENET, V11, P597; La Sala G, 2010, INT J DEV BIOL, V54, P717, DOI 10.1387/ijdb.092883gs; Lockett J, 2006, J CELL BIOCHEM, V97, P651, DOI 10.1002/jcb.20721; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Moffat ID, 2007, TOXICOL SCI, V99, P470, DOI 10.1093/toxsci/kfm189; Nana-Sinkam SP, TRANSL RES, V157, P216; Nothnick WB, 2010, REPROD SCI, V17, P987, DOI 10.1177/1933719110377472; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Rossi M, 2007, J PHARMACOL EXP THER, V320, P465, DOI 10.1124/jpet.106.113613; Roy JR, 2009, MED SCI MONITOR, V15, pRA137; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tessel MA, CURR OPIN ONCOL, V22, P592; Tilghman SL, 2010, STEROIDS, V75, P520, DOI 10.1016/j.steroids.2010.05.004; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Zhao YC, 2011, BREAST CANCER RES TR, V127, P69, DOI 10.1007/s10549-010-0972-2; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	55	110	114	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32754	10.1371/journal.pone.0032754	http://dx.doi.org/10.1371/journal.pone.0032754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403704	gold, Green Submitted, Green Published			2022-12-25	WOS:000303017700101
J	Campa, D; Sainz, J; Pardini, B; Vodickova, L; Naccarati, A; Rudolph, A; Novotny, J; Forsti, A; Buch, S; von Schonfels, W; Schafmayer, C; Volzke, H; Hoffmeister, M; Frank, B; Barale, R; Hemminki, K; Hampe, J; Chang-Claude, J; Brenner, H; Vodicka, P; Canzian, F				Campa, Daniele; Sainz, Juan; Pardini, Barbara; Vodickova, Ludmila; Naccarati, Alessio; Rudolph, Anja; Novotny, Jan; Forsti, Asta; Buch, Stephan; von Schoenfels, Witigo; Schafmayer, Clemens; Voelzke, Henry; Hoffmeister, Michael; Frank, Bernd; Barale, Roberto; Hemminki, Kari; Hampe, Jochen; Chang-Claude, Jenny; Brenner, Hermann; Vodicka, Pavel; Canzian, Federico			A Comprehensive Investigation on Common Polymorphisms in the MDR1/ABCB1 Transporter Gene and Susceptibility to Colorectal Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; RESISTANCE 1 MDR1; P-GLYCOPROTEIN; ABCB1 GENE; RISK; DISEASE; EXPRESSION; RECEPTOR; SURVIVAL	ATP Binding Cassette B1 (ABCB1) is a transporter with a broad substrate specificity involved in the elimination of several carcinogens from the gut. Several polymorphic variants within the ABCB1 gene have been reported as modulators of ABCB1-mediated transport. We investigated the impact of ABCB1 genetic variants on colorectal cancer (CRC) risk. A hybrid tagging/functional approach was performed to select 28 single nucleotide polymorphisms (SNPs) that were genotyped in 1,321 Czech subjects, 699 CRC cases and 622 controls. In addition, six potentially functional SNPs were genotyped in 3,662 German subjects, 1,809 cases and 1,853 controls from the DACHS study. We found that three functional SNPs (rs1202168, rs1045642 and rs868755) were associated with CRC risk in the German population. Carriers of the rs1202168_T and rs868755_T alleles had an increased risk for CRC (P-trend = 0.016 and 0.029, respectively), while individuals bearing the rs1045642_C allele showed a decreased risk of CRC (P-trend = 0.022). We sought to replicate the most significant results in an independent case-control study of 3,803 subjects, 2,169 cases and 1,634 controls carried out in the North of Germany. None of the SNPs tested were significantly associated with CRC risk in the replication study. In conclusion, in this study of about 8,800 individuals we show that ABCB1 gene polymorphisms play at best a minor role in the susceptibility to CRC.	[Campa, Daniele; Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Campa, Daniele; Barale, Roberto] Univ Pisa, Dept Biol, Pisa, Italy; [Sainz, Juan; Forsti, Asta; Hemminki, Kari] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Pardini, Barbara; Vodickova, Ludmila; Naccarati, Alessio; Vodicka, Pavel] Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic; [Rudolph, Anja; Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Novotny, Jan] Charles Univ Prague, Dept Oncol, Fac Med 1, Prague, Czech Republic; [Forsti, Asta; Hemminki, Kari] SUS Malmo, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden; [Buch, Stephan; Hampe, Jochen] Univ Hosp Schleswig Holstein, Dept Gen Internal Med, Kiel, Germany; [Buch, Stephan; Schafmayer, Clemens] Univ Hosp Schleswig Holstein, POPGEN Biobank Project, Kiel, Germany; [von Schoenfels, Witigo; Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, Kiel, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Univ Hosp, Greifswald, Germany; [Hoffmeister, Michael; Frank, Bernd; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic	Helmholtz Association; German Cancer Research Center (DKFZ); University of Pisa; Helmholtz Association; German Cancer Research Center (DKFZ); Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Helmholtz Association; German Cancer Research Center (DKFZ); Charles University Prague; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; German Cancer Research Center (DKFZ); Charles University Prague	Campa, D (corresponding author), German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany.	f.canzian@dkfz.de	Hampe, Jochen/A-2555-2010; Hoffmeister, Michael/B-5745-2012; Campa, Daniele/K-1617-2016; Pardini, Barbara/ABI-2295-2020; Hoffmeister, Michael/AAB-2321-2022; Vodickova, Ludmila/H-3083-2014; Pardini, Barbara/K-9451-2016; Brenner, Hermann/ABE-6383-2020; Hoffmeister, Michael/T-7187-2019; Canzian, Federico/I-2804-2014; Vodicka, Pavel/H-3370-2014; Buch, Stephan/AAV-5028-2021; Juan, Sainz/Y-6473-2019; Brenner, Hermann/B-4627-2017	Hampe, Jochen/0000-0002-2421-6127; Hoffmeister, Michael/0000-0002-8307-3197; Campa, Daniele/0000-0003-3220-9944; Pardini, Barbara/0000-0001-9571-4257; Hoffmeister, Michael/0000-0002-8307-3197; Pardini, Barbara/0000-0001-9571-4257; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Juan, Sainz/0000-0002-9355-2423; Brenner, Hermann/0000-0002-6129-1572; Canzian, Federico/0000-0002-4261-4583; BARALE, Roberto/0000-0003-4161-2241; Vodicka, Pavel/0000-0003-2376-1243; Rudolph, Anja/0000-0001-7520-2035; Naccarati, Alessio/0000-0001-5774-0905	Grant Agency of the Czech Republic [CZ GACR GA 310/07/1430, GA P304/10/1286]; German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; Federal State of Mecklenburg-Vorpommern	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Federal State of Mecklenburg-Vorpommern	This work was partially supported by the following grants: CZ GACR GA 310/07/1430 and GA P304/10/1286 from the Grant Agency of the Czech Republic. The DACHS study was supported by grants from the German Research Council (Deutsche Forschungsgemeinschaft, grant numbers BR 1704/6-1, BR 1704/6-3, BR 1704/6-4 and CH 117/1-1), and the German Federal Ministry of Education and Research (grant numbers 01KH0404 and 01ER0814). SHIP is conducted by the Research Network of Community Medicine at the University of Greifswald, which is funded by the German Federal Ministry of Education and Research and the Federal State of Mecklenburg-Vorpommern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Andersen V, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-18; Atalay C, 2008, J CHEMOTHERAPY, V20, P734, DOI 10.1179/joc.2008.20.6.734; Bae SY, 2006, CANCER SCI, V97, P774, DOI 10.1111/j.1349-7006.2006.00241.x; Balcerczak E, 2010, INT J COLORECTAL DIS, V25, P1167, DOI 10.1007/s00384-010-0961-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Buda G, 2010, ANN HEMATOL, V89, P1133, DOI 10.1007/s00277-010-0992-3; Campa D, 2008, CLIN PHARMACOL THER, V83, P559, DOI 10.1038/sj.clpt.6100385; Campa D, 2008, MUTAT RES-FUND MOL M, V645, P56, DOI 10.1016/j.mrfmmm.2008.08.001; Campa D, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-112; Campa D, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-88; Campa D, 2009, BREAST CANCER RES TR, V118, P565, DOI 10.1007/s10549-009-0347-8; Capron A, 2010, PHARMACOGENOMICS, V11, P703, DOI [10.2217/pgs.10.43, 10.2217/PGS.10.43]; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carrai M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020464; Chen Bowang, 2009, BMC Res Notes, V2, P214, DOI 10.1186/1756-0500-2-214; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De Iudicibus S, 2008, ANTICANCER RES, V28, P3921; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Dietrich CG, 2003, GUT, V52, P1788, DOI 10.1136/gut.52.12.1788; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ferlay J, 2010, INT J CANC; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; Gurney H, 2007, CLIN PHARMACOL THER, V82, P33, DOI 10.1038/sj.clpt.6100201; Ho GT, 2005, GASTROENTEROLOGY, V128, P288, DOI 10.1053/j.gastro.2004.11.019; Hughes D, 2010, COLORECTAL DIS; Hughes DJ, 2010, J GASTROINTEST CANC; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Ichihara S, 2008, GENOMICS, V91, P512, DOI 10.1016/j.ygeno.2008.03.004; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jamroziak K, 2004, EUR J HAEMATOL, V72, P314, DOI 10.1111/j.1600-0609.2004.00228.x; Johnatty SE, 2008, CLIN CANCER RES, V14, P5594, DOI 10.1158/1078-0432.CCR-08-0606; Khedri A, 2011, MOL BIOL REP, V38, P2939, DOI 10.1007/s11033-010-9957-9; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kurzawski M, 2005, EUR J CLIN PHARMACOL, V61, P389, DOI 10.1007/s00228-005-0926-5; Landi D, 2010, MUTAT RES; Lascorz J, 2010, CARCINOGENESIS, V31, P1612, DOI 10.1093/carcin/bgq146; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lu PH, 2010, BREAST CANC RES TREA; Mickley LA, 1998, BLOOD, V91, P1749, DOI 10.1182/blood.V91.5.1749.1749_1749_1756; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Osswald E, 2007, EUR J CLIN PHARMACOL, V63, P9, DOI 10.1007/s00228-006-0225-9; Panczyk M, 2009, INT J COLORECTAL DIS, V24, P895, DOI 10.1007/s00384-009-0724-0; PENNY JI, 1994, BBA-MOL BASIS DIS, V1226, P232, DOI 10.1016/0925-4439(94)90034-5; Petrova DT, 2008, J CANCER RES CLIN, V134, P317, DOI 10.1007/s00432-007-0279-9; PHANG JM, 1993, CANCER RES, V53, P5977; Potocnik U, 2004, GENES IMMUN, V5, P530, DOI 10.1038/sj.gene.6364123; Sainz J, 2011, ENDOCR-RELAT CANCER, V18, P265, DOI 10.1530/ERC-10-0264; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Schafmayer C, 2009, INT J CANCER, V124, P75, DOI 10.1002/ijc.23872; Shitara K, 2010, ASIAN PAC J CANCER P, V11, P447; Sissung TM, 2008, CLIN CANCER RES, V14, P4543, DOI 10.1158/1078-0432.CCR-07-4230; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IP, BR J CANC, V102, P447; van Herwaarden AE, 2003, CANCER RES, V63, P6447; Vineis P, 2008, MUTAGENESIS, V23, P439, DOI 10.1093/mutage/gen042; Walle UK, 1999, CARCINOGENESIS, V20, P2153, DOI 10.1093/carcin/20.11.2153	66	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32784	10.1371/journal.pone.0032784	http://dx.doi.org/10.1371/journal.pone.0032784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396794	Green Published, Green Submitted, gold			2022-12-25	WOS:000303006500034
J	Prlic, M; Sacks, JA; Bevan, MJ				Prlic, Martin; Sacks, Jilian A.; Bevan, Michael J.			Dissociating Markers of Senescence and Protective Ability in Memory T Cells	PLOS ONE			English	Article							CLONAL EXPANSION; VIRAL-INFECTION; EFFECTOR; EXPRESSION; DIFFERENTIATION; SIGNALS; PROLIFERATION; VACCINATION; ACTIVATION; GENERATION	No unique transcription factor or biomarker has been identified to reliably distinguish effector from memory T cells. Instead a set of surface markers including IL-7Ra and KLRG1 is commonly used to predict the potential of CD8 effector T cells to differentiate into memory cells. Similarly, these surface markers together with the tumor necrosis factor family member CD27 are frequently used to predict a memory T cell's ability to mount a recall response. Expression of these markers changes every time a memory cell is stimulated and repeated stimulation can lead to T cell senescence and loss of memory T cell responsiveness. This is a concern for prime-boost vaccine strategies which repeatedly stimulate T cells with the aim of increasing memory T cell frequency. The molecular cues that cause senescence are still unknown, but cell division history is likely to play a major role. We sought to dissect the roles of inflammation and cell division history in developing T cell senescence and their impact on the expression pattern of commonly used markers of senescence. We developed a system that allows priming of CD8 T cells with minimal inflammation and without acquisition of maximal effector function, such as granzyme expression, but a cell division history similar to priming with systemic inflammation. Memory cells derived from minimal effector T cells are fully functional upon rechallenge, have full access to non-lymphoid tissue and appear to be less senescent by phenotype upon rechallenge. However, we report here that these currently used biomarkers to measure senescence do not predict proliferative potential or protective ability, but merely reflect initial priming conditions.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Prlic, M (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	mprlic@fhcrc.org; mbevan@u.washington.edu		Prlic, Martin/0000-0002-0685-9321	National Institutes of Health [AI 019335, AI 079159]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019335, R01AI019335, K99AI079159, R00AI079159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI 019335 (to MJB) and AI 079159 (to MP) and the Howard Hughes Medical Institute (to MJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam A, 2009, BLOOD, V114, P2121, DOI 10.1182/blood-2009-05-220087; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Baars PA, 2005, EUR J IMMUNOL, V35, P3131, DOI 10.1002/eji.200425770; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Daniels MA, 2010, CELL MOL LIFE SCI, V67, P2863, DOI 10.1007/s00018-010-0362-2; Duttagupta PA, 2009, CRIT REV IMMUNOL, V29, P469, DOI 10.1615/CritRevImmunol.v29.i6.20; Effros RB, 1997, IMMUNOL TODAY, V18, P450, DOI 10.1016/S0167-5699(97)01079-7; Grundemann C, 2010, EUR J IMMUNOL, V40, P1303, DOI 10.1002/eji.200939771; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Keppler SJ, 2009, EUR J IMMUNOL, V39, P1774, DOI 10.1002/eji.200839093; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Moffat JM, 2009, EUR J IMMUNOL, V39, P1203, DOI 10.1002/eji.200839183; Mueller SN, 2010, J IMMUNOL, V185, P2182, DOI 10.4049/jimmunol.1001142; Ochsenbein AF, 2004, J EXP MED, V200, P1407, DOI 10.1084/jem.20040717; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Prlic M, 2005, J IMMUNOL, V175, P2152, DOI 10.4049/jimmunol.175.4.2152; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Sun JC, 2006, J IMMUNOL, V177, P4458, DOI 10.4049/jimmunol.177.7.4458; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Teague RM, 2004, J IMMUNOL, V173, P3131, DOI 10.4049/jimmunol.173.5.3131; Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; van Gisbergen KPJM, 2011, IMMUNITY, V35, P97, DOI 10.1016/j.immuni.2011.04.020; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014	40	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32576	10.1371/journal.pone.0032576	http://dx.doi.org/10.1371/journal.pone.0032576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396780	gold, Green Published, Green Submitted			2022-12-25	WOS:000303006500026
J	Shi, SJ; Blobner, BM; Kashlan, OB; Kleyman, TR				Shi, Shujie; Blobner, Brandon M.; Kashlan, Ossama B.; Kleyman, Thomas R.			Extracellular Finger Domain Modulates the Response of the Epithelial Sodium Channel to Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ SELF-INHIBITION; GAMMA-SUBUNIT; ALPHA-SUBUNIT; ENAC; PEPTIDE; FURIN; ACTIVATION; MECHANISM; PROTEASES; FLOW	The epithelial sodium channel (ENaC) is regulated by multiple extracellular stimuli, including shear stress. Previous studies suggest that the extracellular finger domains of ENaC alpha and gamma subunits contain allosteric regulatory modules. However, the role of the finger domain in the shear stress response is unknown. We examined whether mutations of specific residues in the finger domain of the alpha subunit altered the response of channels to shear stress. We observed that Trp substitutions at multiple sites within the tract alpha Lys-250-alpha Leu-290 altered the magnitude or kinetics of channel activation by shear stress. Consistent with these findings, deletion of two predicted peripheral beta strands (alpha Ile-251-alpha Tyr-268) led to slower channel activation by shear stress, suggesting that these structures participate in the shear stress response. The effects of mutations on the shear stress response did not correlate with their effects on allosteric Na+ inhibition (i.e. Na+ self-inhibition), indicating a divergence within the finger domain regarding mechanisms by which the channel responds to these two external stimuli. This result contrasts with well correlated effects we previously observed at sites near the extracellular mouth of the pore, suggesting mechanistic convergence in proximity to the pore. Our results suggest that the finger domain has an important role in the modulation of channel activity in response to shear stress.	[Shi, Shujie; Blobner, Brandon M.; Kashlan, Ossama B.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Renal Elect Div, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Dept Med, Renal Elect Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Shi, Shujie/D-4999-2012		National Institutes of Health [R37 DK051391, K01 DK078734, P30 DK079307]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078734, R37DK051391, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 DK051391, K01 DK078734, and P30 DK079307.; Supported by a postdoctoral fellowship from the American Heart Association.	Abi-Antoun T, 2011, AM J PHYSIOL-RENAL, V300, pF1089, DOI 10.1152/ajprenal.00610.2010; Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Drummond HA, 2008, PHYSIOLOGY, V23, P23, DOI 10.1152/physiol.00034.2007; Guan ZR, 2009, HYPERTENSION, V54, P1062, DOI 10.1161/HYPERTENSIONAHA.109.137992; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kim KJ, 2011, BRIT J NUTR, V106, P1836, DOI 10.1017/S0007114511002534; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963	25	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15439	15444		10.1074/jbc.M112.346551	http://dx.doi.org/10.1074/jbc.M112.346551			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22408250	Green Published, hybrid			2022-12-25	WOS:000304006300025
J	Saito, A; Ariki, S; Sohma, H; Nishitani, C; Inoue, K; Ebata, N; Takahashi, M; Hasegawa, Y; Kuronuma, K; Takahashi, H; Kuroki, Y				Saito, Atsushi; Ariki, Shigeru; Sohma, Hitoshi; Nishitani, Chiaki; Inoue, Kanako; Ebata, Nobutaka; Takahashi, Motoko; Hasegawa, Yoshihiro; Kuronuma, Koji; Takahashi, Hiroki; Kuroki, Yoshio			Pulmonary Surfactant Protein A Protects Lung Epithelium from Cytotoxicity of Human beta-Defensin 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; NEUTROPHIL DEFENSINS; LEGIONELLA-PNEUMOPHILA; HUMAN BETA-DEFENSIN-2; CYTOKINE PRODUCTION; ALPHA-DEFENSINS; INNATE IMMUNITY; CELLS; EXPRESSION; MECHANISMS	Defensins are important molecules in the innate immune system that eliminate infectious microbes. They also exhibit cytotoxicity against host cells in higher concentrations. The mechanisms by which hosts protect their own cells from cytotoxicity of defensins have been poorly understood. We found that the cytotoxicity of human beta-defensin 3 (hBD3) against lung epithelial cells was dose-dependently attenuated by pulmonary surfactant protein A (SP-A), a collectin implicated in host defense and regulation of inflammatory responses in the lung. The direct interaction between SP-A and hBD3 may be an important factor in decreasing this cytotoxicity because preincubation of epithelial cells with SP-A did not affect the cytotoxicity. Consistent with in vitro analysis, intratracheal administration of hBD3 to SP-A(-/-) mice resulted in more severe tissue damage compared with that in WT mice. These data indicate that SP-A protects lung epithelium from tissue injury caused by hBD3. Furthermore, we found that the functional region of SP-A lies within Tyr(161)-Lys(201). Synthetic peptide corresponding to this region, tentatively called SP-A Y161-G200, also inhibited cytotoxicity of hBD3 in a dose-dependent manner. The SP-A Y161-G200 is a candidate as a therapeutic reagent that prevents tissue injury during inflammation.	[Ariki, Shigeru] Sapporo Med Univ, Dept Biochem, Sch Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Saito, Atsushi; Hasegawa, Yoshihiro; Kuronuma, Koji; Takahashi, Hiroki] Sapporo Med Univ, Dept Internal Med 3, Sch Med, Sapporo, Hokkaido 0608556, Japan; [Sohma, Hitoshi] Sapporo Med Univ, Dept Educ Dev, Ctr Med Educ, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Ariki, S (corresponding author), Sapporo Med Univ, Dept Biochem, Sch Med, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	sarikscb@sapmed.ac.jp	Ariki, Shigeru/E-3861-2014; Saito, Atsushi/M-7382-2018; Takahashi, Motoko/I-3154-2013	Ariki, Shigeru/0000-0001-5838-499X; Saito, Atsushi/0000-0003-3430-884X; Takahashi, Motoko/0000-0002-2112-6142	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22790764] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aarbiou J, 2004, AM J RESP CELL MOL, V30, P193, DOI 10.1165/rcmb.2002-0267OC; Aarbiou J, 2006, INFLAMM RES, V55, P119, DOI 10.1007/s00011-005-0062-9; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chino N, 2006, INT J PEPT RES THER, V12, P203, DOI 10.1007/s10989-006-9018-3; Dathe M, 2002, BBA-BIOMEMBRANES, V1558, P171, DOI 10.1016/S0005-2736(01)00429-1; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia-Verdugo I, 2003, BIOCHEMISTRY-US, V42, P9532, DOI 10.1021/bi0347196; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Ishimoto H, 2006, EUR RESPIR J, V27, P253, DOI 10.1183/09031936.06.00105904; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Kustanovich I, 2002, J BIOL CHEM, V277, P16941, DOI 10.1074/jbc.M111071200; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; LICHTENSTEIN AK, 1988, J IMMUNOL, V140, P2686; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; Ozaki A, 2005, FEBS J, V272, P3863, DOI 10.1111/j.1742-4658.2005.04800.x; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Sakamoto N, 2005, AM J PHYSIOL-LUNG C, V288, pL508, DOI 10.1152/ajplung.00076.2004; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Scharf S, 2010, AM J PHYSIOL-LUNG C, V298, pL687, DOI 10.1152/ajplung.00365.2009; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Tecle T, 2010, INNATE IMMUN-LONDON, V16, P151, DOI 10.1177/1753425910365734; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; VANDEGRAAF EA, 1992, J LAB CLIN MED, V120, P252; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zelezetsky I, 2005, PEPTIDES, V26, P2368, DOI 10.1016/j.peptides.2005.05.002; Zhang H, 2001, AM J PHYSIOL-LUNG C, V280, pL947, DOI 10.1152/ajplung.2001.280.5.L947; Zhou L, 2011, AMINO ACIDS, V40, P123, DOI 10.1007/s00726-010-0565-8	41	8	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15034	15043		10.1074/jbc.M111.308056	http://dx.doi.org/10.1074/jbc.M111.308056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22418431	Green Published, hybrid			2022-12-25	WOS:000304003200065
J	Tian, LJ; McClafferty, H; Knaus, HG; Ruth, P; Shipston, MJ				Tian, Lijun; McClafferty, Heather; Knaus, Hans-Guenther; Ruth, Peter; Shipston, Michael J.			Distinct Acyl Protein Transferases and Thioesterases Control Surface Expression of Calcium-activated Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT REGULATION; CRYSTAL-STRUCTURE; PALMITOYLATION; IDENTIFICATION; LOCALIZATION; TRAFFICKING; STABILITY; MEMBRANE; SUBUNITS; REVEALS	Protein palmitoylation is rapidly emerging as an important determinant in the regulation of ion channels, including large conductance calcium-activated potassium (BK) channels. However, the enzymes that control channel palmitoylation are largely unknown. Indeed, although palmitoylation is the only reversible lipid modification of proteins, acyl thioesterases that control ion channel depalmitoylation have not been identified. Here, we demonstrate that palmitoylation of the intracellular S0-S1 loop of BK channels is controlled by two of the 23 mammalian palmitoyl-transferases, zDHHC22 and zDHHC23. Palmitoylation by these acyl transferases is essential for efficient cell surface expression of BK channels. In contrast, depalmitoylation is controlled by the cytosolic thioesterase APT1 (LYPLA1), but not APT2 (LYPLA2). In addition, we identify a splice variant of LYPLAL1, a homolog with similar to 30% identity to APT1, that also controls BK channel depalmitoylation. Thus, both palmitoyl acyltransferases and acyl thioesterases display discrete substrate specificity for BK channels. Because depalmitoylated BK channels are retarded in the trans-Golgi network, reversible protein palmitoylation provides a critical checkpoint to regulate exit from the trans-Golgi network and thus control BK channel cell surface expression.	[Tian, Lijun; McClafferty, Heather; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Knaus, Hans-Guenther] Med Univ Innsbruck, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; [Ruth, Peter] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany	University of Edinburgh; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust program grant (to M. J. S., H. K., and P. R.).	Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Burger M, 2012, J LIPID RES, V53, P43, DOI 10.1194/jlr.M019851; Chen L, 2010, J BIOL CHEM, V285, P23263, DOI 10.1074/jbc.M110.139758; Chen ML, 2008, J MOL HISTOL, V39, P125, DOI 10.1007/s10735-007-9144-z; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Devedjiev Y, 2000, STRUCTURE, V8, P1137, DOI 10.1016/S0969-2126(00)00529-3; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hirano T, 2009, BBA-MOL CELL BIOL L, V1791, P797, DOI 10.1016/j.bbalip.2009.05.001; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saitoh F, 2004, J BIOL CHEM, V279, P29461, DOI 10.1074/jbc.M401471200; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Steinberg GR, 2007, AM J PHYSIOL-ENDOC M, V293, pE958, DOI 10.1152/ajpendo.00235.2007; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329	34	80	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14718	14725		10.1074/jbc.M111.335547	http://dx.doi.org/10.1074/jbc.M111.335547			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399288	hybrid, Green Published			2022-12-25	WOS:000304003200037
J	Fan, YF; Fan, YB; Li, ZY; Lv, CS; Zhang, B				Fan, Yifang; Fan, Yubo; Li, Zhiyu; Lv, Changsheng; Zhang, Bo			Bone Surface Mapping Method	PLOS ONE			English	Article							SUPERRESOLUTION; RECOGNITION; MECHANISMS; STRESS	Bone shape is an important factor to determine the bone's structural function. For the asymmetrically shaped and anisotropically distributed bone in vivo, a surface mapping method is proposed on the bases of its geometric transformation invariance and its uniqueness of the principal axes of inertia. Using spiral CT scanning, we can make precise measurements to bone in vivo. The coordinate transformations lead to the principal axes of inertia, with which the prime meridian and the contour can be set. Methods such as tomographic reconstruction and boundary development are employed so that the surface of bone in vivo can be mapped. Experimental results show that the surface mapping method can reflect the shape features and help study the surface changes of bone in vivo. This method can be applied to research into the surface characteristics and changes of organ, tissue or cell whenever its digitalized surface is obtained.	[Fan, Yifang; Lv, Changsheng; Zhang, Bo] Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China; [Fan, Yifang] Beihang Univ, Key Lab Biomech & Mechanobiol, Minist Educ, Sch Biol Sci & Med Engn, Beijing, Peoples R China; [Li, Zhiyu] Jinan Univ, Coll Foreign Studies, Guangzhou, Guangdong, Peoples R China	Guangzhou Sport University; Beihang University; Jinan University	Fan, YF (corresponding author), Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China.	tfyf@gipe.edu.cn; yubofan@buaa.edu.cn	Fan, Yifang/V-6281-2019	Fan, Yifang/0000-0001-5338-9847	National Natural Science Foundation of China [10772053, 10925208, 10972061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by National Natural Science Foundation of China (http://www.nsfc.gov.cn) under the grant numbers 10772053, 10925208 and 10972061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batalin IA, 2008, J MATH PHYS, V49, DOI 10.1063/1.2835485; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Beer F.P., 2007, VECTOR MECH ENG STAT, V8th ed; BESL PJ, 1986, COMPUT VISION GRAPH, V33, P33, DOI 10.1016/0734-189X(86)90220-3; BIEWENER AA, 1983, J ZOOL, V201, P67, DOI 10.1111/j.1469-7998.1983.tb04261.x; Bouxsein Mary L, 2006, Curr Osteoporos Rep, V4, P49, DOI 10.1007/s11914-006-0002-9; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Coburn JC, 2007, J BIOMECH, V40, P203, DOI 10.1016/j.jbiomech.2005.11.015; Cuntz H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000251; DeSilva JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014432; Fan YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028868; Haker S, 2000, IEEE T VIS COMPUT GR, V6, P181, DOI 10.1109/2945.856998; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hugate R, 2004, J BONE JOINT SURG AM, V86A, P794, DOI 10.2106/00004623-200404000-00019; Kelber A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021892; Ketcham RA, 2004, J MICROSC-OXFORD, V213, P158, DOI 10.1111/j.1365-2818.2004.01277.x; KEYAK JH, 1990, J BIOMED ENG, V12, P389, DOI 10.1016/0141-5425(90)90022-F; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Kuchment A, 2011, SCI AM, V305, P72, DOI 10.1038/scientificamerican1011-72; Licker MD, 2003, DICT MATH; Marieb EN, 2007, HUMAN ANATOMY PHYSL; Matthews F, 2009, J DIGIT IMAGING, V22, P473, DOI 10.1007/s10278-008-9078-8; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Morris C, DICT SCI TECHNOLOGY; Nguyen N, 2000, CIRC SYST SIGNAL PR, V19, P321, DOI 10.1007/BF01200891; Nikravesh P, 2005, MULTIBODY SYST DYN, V13, P211, DOI 10.1007/s11044-005-2514-y; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Peterlik H, 2006, NAT MATER, V5, P52, DOI 10.1038/nmat1545; Rochefort G, 2006, IEEE T IMAGE PROCESS, V15, P3325, DOI 10.1109/TIP.2006.881996; Seeman E, 2008, J BONE MINER METAB, V26, P1, DOI 10.1007/s00774-007-0793-5; Suri JS, 2002, PATTERN ANAL APPL, V5, P46, DOI 10.1007/s100440200005; Thornton ST, 2004, CLASSICAL DYNAMICS P, P415; Tsui J, 2000, FUNDAMENTALS GLOBAL; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; Ward CV, 2011, SCIENCE, V331, P750, DOI 10.1126/science.1201463	35	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32926	10.1371/journal.pone.0032926	http://dx.doi.org/10.1371/journal.pone.0032926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412952	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000021
J	Burbano, HA; Green, RE; Maricic, T; Lalueza-Fox, C; de la Rasilla, M; Rosas, A; Kelso, J; Pollard, KS; Lachmann, M; Paabo, S				Burbano, Hernan A.; Green, Richard E.; Maricic, Tomislav; Lalueza-Fox, Carles; de la Rasilla, Marco; Rosas, Antonio; Kelso, Janet; Pollard, Katherine S.; Lachmann, Michael; Paeaebo, Svante			Analysis of Human Accelerated DNA Regions Using Archaic Hominin Genomes	PLOS ONE			English	Article							BIASED GENE CONVERSION; NONCODING SEQUENCES; EL-SIDRON; NEANDERTHAL; EVOLUTION; PATTERNS; ASTURIAS; CAVE	Several previous comparisons of the human genome with other primate and vertebrate genomes identified genomic regions that are highly conserved in vertebrate evolution but fast-evolving on the human lineage. These human accelerated regions (HARs) may be regions of past adaptive evolution in humans. Alternatively, they may be the result of non-adaptive processes, such as biased gene conversion. We captured and sequenced DNA from a collection of previously published HARs using DNA from an Iberian Neandertal. Combining these new data with shotgun sequence from the Neandertal and Denisova draft genomes, we determine at least one archaic hominin allele for 84% of all positions within HARs. We find that 8% of HAR substitutions are not observed in the archaic hominins and are thus recent in the sense that the derived allele had not come to fixation in the common ancestor of modern humans and archaic hominins. Further, we find that recent substitutions in HARs tend to have come to fixation faster than substitutions elsewhere in the genome and that substitutions in HARs tend to cluster in time, consistent with an episodic rather than a clock-like process underlying HAR evolution. Our catalog of sequence changes in HARs will help prioritize them for functional studies of genomic elements potentially responsible for modern human adaptations.	[Burbano, Hernan A.; Maricic, Tomislav; Kelso, Janet; Lachmann, Michael; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Lalueza-Fox, Carles] Univ Pompeu Fabra, Inst Evolutionary Biol, Consejo Super Invest Cient, Barcelona, Spain; [de la Rasilla, Marco] Univ Oviedo, Dept Hist, Area Prehist, Oviedo, Spain; [Rosas, Antonio] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Max Planck Society; University of California System; University of California Santa Cruz; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Burbano, HA (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	hernan.a.burbano@googlemail.com	Rosas, Antonio/D-9742-2016; LALUEZA-FOX, CARLES/AAG-5341-2020; Kelso, Janet/N-1812-2019	Rosas, Antonio/0000-0002-5829-9952; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Kelso, Janet/0000-0002-3618-322X; de la RASILLA, Marco/0000-0002-5505-0625; Green, Richard/0000-0003-0516-5827; Burbano, Hernan A./0000-0003-3433-719X; Maricic, Tomislav/0000-0003-3267-0474	Presidential Innovation Found of the Max Planck Society; Searle Scholars Program; Ministerio de Ciencia e Innovacion of Spain [BFU2009-06974]; Principado de Asturias-Universidad de Oviedo; National Institute of General Medical Sciences [GM082901]; Gladstone Institutes; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082901] Funding Source: NIH RePORTER	Presidential Innovation Found of the Max Planck Society; Searle Scholars Program; Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Principado de Asturias-Universidad de Oviedo; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the Presidential Innovation Found of the Max Planck Society. REG was supported by the Searle Scholars Program. CL-F was supported by a grant BFU2009-06974 from the Ministerio de Ciencia e Innovacion of Spain. Research at El Sidron was supported by several grants from Principado de Asturias-Universidad de Oviedo. KSP was supported by the National Institute of General Medical Sciences (grant #GM082901) and funding from the Gladstone Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird CP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r118; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Bush EC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-17; De Torres T, 2009, ARCHAEOMETRY; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Fortea J, 2008, J HUM EVOL, V55, P353, DOI 10.1016/j.jhevol.2008.03.005; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; LANDER E S, 1988, Genomics, V2, P231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	32	34	38	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32877	10.1371/journal.pone.0032877	http://dx.doi.org/10.1371/journal.pone.0032877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412940	Green Published, gold			2022-12-25	WOS:000303060800058
J	Unzu, C; Sampedro, A; Sardh, E; Mauleon, I; de Salamanca, RE; Prieto, J; Salido, E; Harper, P; Fontanellas, A				Unzu, Carmen; Sampedro, Ana; Sardh, Eliane; Mauleon, Itsaso; Enriquez de Salamanca, Rafael; Prieto, Jesus; Salido, Eduardo; Harper, Pauline; Fontanellas, Antonio			Renal Failure Affects the Enzymatic Activities of the Three First Steps in Hepatic Heme Biosynthesis in the Acute Intermittent Porphyria Mouse	PLOS ONE			English	Article							DELTA-AMINOLEVULINIC-ACID; PORPHOBILINOGEN DEAMINASE; HEPATOCELLULAR-CARCINOMA; HEREDITARY TYROSINEMIA; LIVER; TRANSPLANTATION; DEHYDRATASE; NEUROPATHY; DISEASE; SWEDEN	Chronic kidney disease is a long-term complication in acute intermittent porphyria (AIP). The pathophysiological significance of hepatic overproduction of the porphyrin precursors aminolevulinate acid (ALA) and porphobilinogen (PBG) in chronic kidney disease is unclear. We have investigated the effect of repetitive acute attacks on renal function and the effect of total or five-sixth nephrectomy causing renal insufficiency on hepatic heme synthesis in the porphobilinogen deaminase (PBGD)-deficient (AIP) mouse. Phenobarbital challenge in the AIP-mice increased urinary porphyrin precursor excretion. Successive attacks throughout 14 weeks led to minor renal lesions with no impact on renal function. In the liver of wild type and AIP mice, 5/6 nephrectomy enhanced transcription of the first and rate-limiting ALA synthase. As a consequence, urinary PBG excretion increased in AIP mice. The PBG/ALA ratio increased from 1 in sham operated AIP animals to over 5 (males) and over 13 (females) in the 5/6 nephrectomized mice. Total nephrectomy caused a rapid decrease in PBGD activity without changes in enzyme protein level in the AIP mice but not in the wild type animals. In conclusion, high concentration of porphyrin precursors had little impact on renal function. However, progressive renal insufficiency aggravates porphyria attacks and increases the PBG/ALA ratio, which should be considered a warning sign for potentially life-threatening impairment in AIP patients with signs of renal failure.	[Unzu, Carmen; Sampedro, Ana; Mauleon, Itsaso; Prieto, Jesus; Fontanellas, Antonio] Univ Navarra, Gene Therapy & Hepatol Area, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Sardh, Eliane] Stockholm Soder Hosp, Karolinska Inst, Dept Internal Med, Stockholm, Sweden; [Sardh, Eliane; Harper, Pauline] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Porphyria Ctr Sweden, Stockholm, Sweden; [Enriquez de Salamanca, Rafael] Univ Complutense, Hosp Univ Octubre 12, Res Ctr, E-28040 Madrid, Spain; [Salido, Eduardo] Univ La Laguna, Univ Hosp Canarias, Ctr Biomed Res Rare Dis CIBERER, E-38207 San Cristobal la Laguna, Spain	University of Navarra; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Complutense University of Madrid; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de la Laguna	Unzu, C (corresponding author), Univ Navarra, Gene Therapy & Hepatol Area, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain.	afontanellas@unav.es	Fontanellas, Antonio/AAD-8073-2022; Unzu, Carmen/M-1026-2019; Salido, Eduardo C/I-2232-2015; Sardh, Eliane/AFV-2232-2022; Unzu, Carmen/ABC-2904-2021	Fontanellas, Antonio/0000-0001-9279-7990; Salido, Eduardo C/0000-0001-9599-9854; Sardh, Eliane/0000-0002-2366-2213; Unzu, Carmen/0000-0002-1582-7196; Prieto, Jesus/0000-0002-1091-9593	UTE of Centro de Investigacion Medica Aplicada, University of Navarra; Spanish Fondo de Investigacion Sanitaria [PI061475, PS09/02639]; Spanish Fundacion Mutua Madrilena de Investigacion Medica; European Project AIPGENE [FP7Health-2010-261506]	UTE of Centro de Investigacion Medica Aplicada, University of Navarra; Spanish Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Spanish Fundacion Mutua Madrilena de Investigacion Medica; European Project AIPGENE	This work was supported in part by grants from UTE project of Centro de Investigacion Medica Aplicada, University of Navarra, Spanish Fondo de Investigacion Sanitaria (PI061475 & PS09/02639), Spanish Fundacion Mutua Madrilena de Investigacion Medica and from the European Project AIPGENE (FP7Health-2010-261506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andant C, 2000, J HEPATOL, V32, P933, DOI 10.1016/S0168-8278(00)80097-5; Anderson KE, 2005, ANN INTERN MED, V142, P439, DOI 10.7326/0003-4819-142-6-200503150-00010; Andersson C, 2000, J INTERN MED, V248, P319, DOI 10.1046/j.1365-2796.2000.00743.x; Asselbergs FW, 2009, AM J CRIT CARE, V18, P180, DOI 10.4037/ajcc2009196; BERLIN A, 1974, Z KLIN CHEM KLIN BIO, V12, P389; DHAR GJ, 1978, ACTA MED SCAND, V203, P437; FONTANELLAS A, 1995, AM J KIDNEY DIS, V25, P30, DOI 10.1016/0272-6386(95)90621-5; Gill R, 2009, BIOCHEM J, V420, P17, DOI 10.1042/BJ20082077; GORCHEIN A, 1987, CLIN SCI, V72, P103, DOI 10.1042/cs0720103; Innala E, 2011, J INTERN MED, V269, P538, DOI 10.1111/j.1365-2796.2010.02335.x; Karbownik M, 2000, CANCER LETT, V161, P1, DOI 10.1016/S0304-3835(00)00568-1; KAUPPINEN R, 1992, MEDICINE, V71, P1; LAIWAH AACY, 1983, Q J MED, V52, P92; Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; Linet MS, 1999, AM J EPIDEMIOL, V149, P1010; Marsden JT, 2008, CLIN NEPHROL, V69, P339; MAUZERALL D, 1960, J AM CHEM SOC, V82, P2605, DOI 10.1021/ja01495a053; MIYAGI K, 1971, J LAB CLIN MED, V78, P683; NUNEZ D J, 1987, Nephrology Dialysis Transplantation, V2, P271; Onozato ML, 2001, CLIN NEPHROL, V55, P171; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Sardh E, 2009, CELL MOL BIOL, V55, P66, DOI 10.1170/T840; SASSA S, 1990, PEDIATRICS, V86, P84; Schneider-Yin X, 2009, SWISS MED WKLY, V139, P198, DOI smw-12496; Shoolingin-Jordan P.M.L., 2003, PHYSIOL RES, V52, p24S; SITA D, 1984, ITAL J NEUROL SCI, V5, P299, DOI 10.1007/BF02043962; Song S, 2009, NEPHROL DIAL TRANSPL, V24, P1157, DOI 10.1093/ndt/gfn626; THUNELL S, 1995, EUR J CLIN CHEM CLIN, V33, P179; Thunell S, 2007, BRIT J CLIN PHARMACO, V64, P668, DOI 10.1111/j.0306-5251.2007.02955.x; Tracz MJ, 2007, J AM SOC NEPHROL, V18, P414, DOI 10.1681/ASN.2006080894; Unzu C, 2011, MOL THER, V19, P243, DOI 10.1038/mt.2010.210; Wahlin S, 2010, TRANSPL INT, V23, pe18, DOI 10.1111/j.1432-2277.2009.01035.x; Warholm C, 2003, J CLIN PHARMACOL, V43, P1158, DOI 10.1177/0091270003257223; WESTERLUND J, 1988, CLIN CHEM, V34, P345	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32978	10.1371/journal.pone.0032978	http://dx.doi.org/10.1371/journal.pone.0032978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412963	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100045
J	Froguel, P; Ndiaye, NC; Bonnefond, A; Bouatia-Naji, N; Dechaume, A; Siest, G; Herbeth, B; Falchi, M; Bottolo, L; Gueant-Rodriguez, RM; Lecoeur, C; Langlois, MR; Labrune, Y; Ruokonen, A; El Shamieh, S; Stathopoulou, MG; Morandi, A; Maffeis, C; Meyre, D; Delanghe, JR; Jacobson, P; Sjostrom, L; Carlsson, LMS; Walley, A; Elliott, P; Jarvelin, MR; Dedoussis, GV; Visvikis-Siest, S				Froguel, Philippe; Ndiaye, Ndeye Coumba; Bonnefond, Amelie; Bouatia-Naji, Nabila; Dechaume, Aurelie; Siest, Gerard; Herbeth, Bernard; Falchi, Mario; Bottolo, Leonardo; Gueant-Rodriguez, Rosa-Maria; Lecoeur, Cecile; Langlois, Michel R.; Labrune, Yann; Ruokonen, Aimo; El Shamieh, Said; Stathopoulou, Maria G.; Morandi, Anita; Maffeis, Claudio; Meyre, David; Delanghe, Joris R.; Jacobson, Peter; Sjostrom, Lars; Carlsson, Lena M. S.; Walley, Andrew; Elliott, Paul; Jarvelin, Marjo-Riita; Dedoussis, George V.; Visvikis-Siest, Sophie			A Genome-Wide Association Study Identifies rs2000999 as a Strong Genetic Determinant of Circulating Haptoglobin Levels	PLOS ONE			English	Article							PEDIGREE ANALYSIS; RISK-FACTORS; POLYMORPHISM; HEMOGLOBIN; PHENOTYPE; PLASMA; CHOLESTEROL; BIOMARKERS; CHILDHOOD; PROTEINS	Haptoglobin is an acute phase inflammatory marker. Its main function is to bind hemoglobin released from erythrocytes to aid its elimination, and thereby haptoglobin prevents the generation of reactive oxygen species in the blood. Haptoglobin levels have been repeatedly associated with a variety of inflammation-linked infectious and non-infectious diseases, including malaria, tuberculosis, human immunodeficiency virus, hepatitis C, diabetes, carotid atherosclerosis, and acute myocardial infarction. However, a comprehensive genetic assessment of the inter-individual variability of circulating haptoglobin levels has not been conducted so far. We used a genome-wide association study initially conducted in 631 French children followed by a replication in three additional European sample sets and we identified a common single nucleotide polymorphism (SNP), rs2000999 located in the Haptoglobin gene (HP) as a strong genetic predictor of circulating Haptoglobin levels (P-overall = 8.1 x 10(-59)), explaining 45.4% of its genetic variability (11.8% of Hp global variance). The functional relevance of rs2000999 was further demonstrated by its specific association with HP mRNA levels (beta = 0.23 +/- 0.08, P = 0.007). Finally, SNP rs2000999 was associated with decreased total and low-density lipoprotein cholesterol in 8,789 European children (P-total cholesterol = 0.002 and P-LDL = 0.0008). Given the central position of haptoglobin in many inflammation-related metabolic pathways, the relevance of rs2000999 genotyping when evaluating haptoglobin concentration should be further investigated in order to improve its diagnostic/therapeutic and/or prevention impact.	[Froguel, Philippe; Bonnefond, Amelie; Bouatia-Naji, Nabila; Dechaume, Aurelie; Lecoeur, Cecile; Labrune, Yann; Morandi, Anita; Meyre, David] Univ Lille 2, Inst Pasteur, Inst Biol, Ctr Natl Rech Sci CNRS 8199, Lille, France; [Froguel, Philippe; Falchi, Mario; Bottolo, Leonardo; Walley, Andrew] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Ndiaye, Ndeye Coumba; Bonnefond, Amelie; Siest, Gerard; Herbeth, Bernard; El Shamieh, Said; Stathopoulou, Maria G.; Dedoussis, George V.; Visvikis-Siest, Sophie] Univ Lorraine, Cardiovasc Genet Res Unit, EA4373, Nancy, France; [Gueant-Rodriguez, Rosa-Maria] Nancy Univ, Fac Med, Inst Natl Sante & Rech Med INSERM, U954, Nancy, France; [Langlois, Michel R.; Delanghe, Joris R.] Ghent Univ Hosp, Dept Clin Chem, Ghent, Belgium; [Langlois, Michel R.] Univ Ghent, Fac Med & Hlth Sci, Dept Cardiovasc Dis, B-9000 Ghent, Belgium; [Ruokonen, Aimo] Univ Oulu, Inst Clin Med Biochem, Oulu, Finland; [Morandi, Anita; Maffeis, Claudio] Reg Ctr Juvenile Diabet Obes & Clin Nutr, Verona, Italy; [Jacobson, Peter; Sjostrom, Lars; Carlsson, Lena M. S.; Elliott, Paul] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Jarvelin, Marjo-Riita] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Ctr Environm & Hlth, Dept Epidemiol & Biostat,MRC Hlth Protect Agcy HP, London, England; [Jarvelin, Marjo-Riita] Univ Oulu, Bioctr Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riita] Natl Inst Hlth & Welf Oulu, Dept Children Young People & Families, Oulu, Finland; [Dedoussis, George V.] Harokopio Univ, Dept Nutr Dietet, Athens, Greece; [Visvikis-Siest, Sophie] Ctr Hosp Univ Nancy, Dept Internal Med & Geriatr, Nancy, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Ghent University; Ghent University Hospital; Ghent University; University of Oulu; University of Gothenburg; Imperial College London; University of Oulu; Harokopio University Athens; CHU de Nancy	Froguel, P (corresponding author), Univ Lille 2, Inst Pasteur, Inst Biol, Ctr Natl Rech Sci CNRS 8199, Lille, France.	p.froguel@imperial.ac.uk; Sophie.Visvikis-Siest@inserm.fr	Shamieh, Said El/J-6343-2019; Carlsson, Lena/F-7570-2018; Bouatia-Naji, Nabila/AGF-1400-2022; Morandi, Anita/AAC-4067-2022; Walley, Andrew J/D-2573-2009; Falchi, Mario/F-5956-2013; Dedoussis, George/AAN-7252-2021; Visvikis-Siest, Sophie/H-2324-2014; Stathopoulou, Maria/H-7324-2016; Bonnefond, Amélie/O-2784-2017; Maffeis, Claudio/AAG-5347-2020; BOUATIA-NAJI, NABILA/D-5863-2013; FROGUEL, Philippe/O-6799-2017	Shamieh, Said El/0000-0002-8522-0445; Carlsson, Lena/0000-0003-4145-6242; Bouatia-Naji, Nabila/0000-0001-5424-2134; Walley, Andrew J/0000-0001-7707-7549; Dedoussis, George/0000-0002-7798-6221; Visvikis-Siest, Sophie/0000-0001-8104-8425; Stathopoulou, Maria/0000-0003-4376-2083; Bonnefond, Amélie/0000-0001-9976-3005; FROGUEL, Philippe/0000-0003-2972-0784; Elliott, Paul/0000-0002-7511-5684; MORANDI, Anita/0000-0002-2631-9330; SIEST, Gerard/0000-0002-3001-760X; Falchi, Mario/0000-0002-5646-1004; Bottolo, Leonardo/0000-0002-6381-2327; Jacobson, Peter/0000-0002-1769-1827; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	"Caisse Nationale d'Assurance Maladies des Travailleurs Salaries'' (CNAM); "Institut National de la Sante et de la Recherche Medicale''(INSERM); Region Lorraine; Communaute Urbaine du Grand Nancy; Henri Poincare University of Nancy 1; "BioIntelligence'' project; Contrat Plan Etat Region; Fond Europeen pour le Developpement Regional; Academy of Finland (Center of Excellence in Complex Disease Genetics and SALVE) [104781, 120315, 129269, 1114194]; University Hospital Oulu, Biocenter; University of Oulu, Finland; European Commission (EURO-BLCS) [QLG1-CT-2000-01643]; National Heart, Lung, and Blood Institute [5R01HL087679-02, 1RL1MH083268-01]; National Institutes of Health/National Institute of Mental Health [5R01MH63706:02]; ENGAGE [HEALTH-F4-2007-201413]; Medical Research Council [G0500539, G0600705]; Biocentrum Helsinki; Coca-Cola Hellas; Swedish Research Council [K2010-55X-11285-13]; Swedish Foundation for Strategic Research; Swedish federal government under the LUA/ALF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER; Medical Research Council [G0801056B, G0801056] Funding Source: researchfish; MRC [G0600705, G0801056] Funding Source: UKRI	"Caisse Nationale d'Assurance Maladies des Travailleurs Salaries'' (CNAM); "Institut National de la Sante et de la Recherche Medicale''(INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Lorraine(Region Grand-Est); Communaute Urbaine du Grand Nancy(Region Grand-Est); Henri Poincare University of Nancy 1; "BioIntelligence'' project; Contrat Plan Etat Region; Fond Europeen pour le Developpement Regional; Academy of Finland (Center of Excellence in Complex Disease Genetics and SALVE); University Hospital Oulu, Biocenter; University of Oulu, Finland; European Commission (EURO-BLCS)(European CommissionEuropean Commission Joint Research Centre); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biocentrum Helsinki; Coca-Cola Hellas; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish federal government under the LUA/ALF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The STANISLAS Family Study was supported by the "Caisse Nationale d'Assurance Maladies des Travailleurs Salaries'' (CNAM), the "Institut National de la Sante et de la Recherche Medicale''(INSERM), the "Region Lorraine'', the "Communaute Urbaine du Grand Nancy'', the Henri Poincare University of Nancy 1, and the "BioIntelligence'' project; the Verona and French Obese children cohorts were supported by funding from "Contrat Plan Etat Region'' entitled "Genetic dissection of polygenic obesity using GWA approach'' and the "Fond Europeen pour le Developpement Regional''; the NFBC1986 has received financial support from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland, the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), the National Heart, Lung, and Blood Institute grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), National Institutes of Health/National Institute of Mental Health (5R01MH63706:02), ENGAGE project and grant agreement HEALTH-F4-2007-201413, and the Medical Research Council (G0500539, G0600705, PrevMetSyn/SALVE). The DNA extractions, sample quality controls, biobank up-keeping and aliquotting was performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki; The GENDAI cohort was funded by a research grant from Coca-Cola Hellas; The Sib Pair cohort was supported by the Swedish Research Council (K2010-55X-11285-13), the Swedish Foundation for Strategic Research to Sahlgrenska Centre for Cardiovascular and Metabolic Research and the Swedish federal government under the LUA/ALF agreement. The haptoglobin measurements of replication populations were supported by SIEMENS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asleh R, 2005, CIRC RES, V96, P435, DOI 10.1161/01.RES.0000156653.05853.b9; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; BACQ Y, 1993, GASTROEN CLIN BIOL, V17, P364; Balestrieri M, 2001, MOL REPROD DEV, V59, P186, DOI 10.1002/mrd.1021; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Braeckman L, 1999, ATHEROSCLEROSIS, V143, P383, DOI 10.1016/S0021-9150(98)00330-X; Calderoni DR, 2006, ANN TROP MED PARASIT, V100, P213, DOI 10.1179/136485906X86356; Carlsson LMS, 2009, BIOCHEM BIOPH RES CO, V382, P309, DOI 10.1016/j.bbrc.2009.03.014; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; Delanghe J, 1998, CLIN CHEM LAB MED, V36, P691, DOI 10.1515/CCLM.1998.122; Delanghe JR, 1998, AIDS, V12, P1027, DOI 10.1097/00002030-199809000-00009; DONNER A, 1981, AM J EPIDEMIOL, V114, P149, DOI 10.1093/oxfordjournals.aje.a113162; Eisaev B A, 1995, Probl Tuberk, P20; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friis T, 2003, JAIDS-J ACQ IMM DEF, V33, P74, DOI 10.1097/00126334-200305010-00011; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Holme I, 2010, ATHEROSCLEROSIS, V213, P299, DOI 10.1016/j.atherosclerosis.2010.08.049; Holme I, 2009, ANN MED, V41, P522, DOI 10.1080/07853890903089453; Igl W, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000798; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Kasvosve I, 2010, ADV CLIN CHEM, V50, P23, DOI 10.1016/S0065-2423(10)50002-7; Koch W, 2002, CLIN CHEM, V48, P1377; Koda Y, 1998, AM J HUM GENET, V62, P245, DOI 10.1086/301701; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Langlois MR, 1996, CLIN CHEM, V42, P1589; Levy AP, 2000, NEW ENGL J MED, V343, P969, DOI 10.1056/NEJM200009283431313; Louagie HK, 1996, J HEPATOL, V25, P10, DOI 10.1016/S0168-8278(96)80321-7; MAEDA N, 1985, J BIOL CHEM, V260, P6698; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Marcovina SM, 2007, J INTERN MED, V261, P214, DOI 10.1111/j.1365-2796.2006.01734.x; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Mohapatra M K, 1999, J Assoc Physicians India, V47, P874; Okazaki T, 1997, CLIN CHIM ACTA, V258, P137, DOI 10.1016/S0009-8981(96)06468-6; Papoutsakis C, 2007, CLIN CHEM LAB MED, V45, P309, DOI 10.1515/CCLM.2007.080; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Ritchie RF, 2000, J CLIN LAB ANAL, V14, P284, DOI 10.1002/1098-2825(20001212)14:6<284::AID-JCLA7>3.0.CO;2-U; Rohde KH, 2004, INFECT IMMUN, V72, P2494, DOI 10.1128/IAI.72.5.2494-2506.2004; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Ryndel M, 2010, CLIN CHIM ACTA, V411, P500, DOI 10.1016/j.cca.2009.12.025; Salvatore A, 2009, J NEUROCHEM, V110, P255, DOI 10.1111/j.1471-4159.2009.06121.x; Speeckaert R, 2009, CLIN CHEM LAB MED, V47, P826, DOI 10.1515/CCLM.2009.193; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Turner SJ, 2008, AM HEART J, V155, P806, DOI 10.1016/j.ahj.2007.11.037; Van Vlierberghe H, 2001, EUR J GASTROEN HEPAT, V13, P1077, DOI 10.1097/00042737-200109000-00014; Visvikis-Siest S, 2008, CLIN CHEM LAB MED, V46, P733, DOI 10.1515/CCLM.2008.178; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	53	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32327	10.1371/journal.pone.0032327	http://dx.doi.org/10.1371/journal.pone.0032327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403646	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700043
J	Merlin, JC; Rajasekaran, S; Mi, T; Schiller, MR				Merlin, Jerlin C.; Rajasekaran, Sanguthevar; Mi, Tian; Schiller, Martin R.			Reducing False-Positive Prediction of Minimotifs with a Genetic Interaction Filter	PLOS ONE			English	Article							INTERACTION NETWORKS; MOTIFS; CONSERVATION; MINER; YEAST; TOOL; ELM	Background: Minimotifs are short contiguous peptide sequences in proteins that have known functions. At its simplest level, the minimotif sequence is present in a source protein and has an activity relationship with a target, most of which are proteins. While many scientists routinely investigate new minimotif functions in proteins, the major web-based discovery tools have a high rate of false-positive prediction. Any new approach that reduces false-positives will be of great help to biologists. Methods and Findings: We have built three filters that use genetic interactions to reduce false-positive minimotif predictions. The basic filter identifies those minimotifs where the source/target protein pairs have a known genetic interaction. The HomoloGene genetic interaction filter extends these predictions to predicted genetic interactions of orthologous proteins and the node-based filter identifies those minimotifs where proteins that have a genetic interaction with the source or target have a genetic interaction. Each filter was evaluated with a test data set containing thousands of true and false-positives. Based on sensitivity and selectivity performance metrics, the basic filter had the best discrimination for true positives, whereas the node-based filter had the highest sensitivity. We have implemented these genetic interaction filters on the Minimotif Miner 2.3 website. The genetic interaction filter is particularly useful for improving predictions of posttranslational modifications such as phosphorylation and proteolytic cleavage sites. Conclusions: Genetic interaction data sets can be used to reduce false-positive minimotif predictions. Minimotif prediction in known genetic interactions can help to refine the mechanisms behind the functional connection between genes revealed by genetic experimentation and screens.	[Merlin, Jerlin C.; Rajasekaran, Sanguthevar; Mi, Tian] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA; [Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	University of Connecticut; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Merlin, JC (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA.	rajasek@engr.uconn.edu; martin.schiller@unlv.edu		Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [GM079689, LM 010101]; National Science Foundation [NSF 0829916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079689] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010101] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [0829916] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work has been supported in part by the National Institutes of Health (through grants GM079689 and LM 010101) and the National Science Foundation (through grant NSF 0829916). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Chica C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006052; Davey NE, 2011, NUCLEIC ACIDS RES, V39, pW56, DOI 10.1093/nar/gkr402; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; R Development Core Team, 2006, R LANG ENV STAT COMP; Rajasekaran S, 2011, PROTEINS, V79, P153, DOI 10.1002/prot.22868; Rajasekaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012276; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Ren SY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-452; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Via A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-351; Vyas J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-360; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Xiang Y, 2007, PLOS BIOL, V5, P2831, DOI 10.1371/journal.pbio.0050323; Ye P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-270	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32630	10.1371/journal.pone.0032630	http://dx.doi.org/10.1371/journal.pone.0032630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403687	Green Published, gold			2022-12-25	WOS:000303017700084
J	Obiol-Pardo, C; Alcarraz-Vizan, G; Cascante, M; Rubio-Martinez, J				Obiol-Pardo, Cristian; Alcarraz-Vizan, Gema; Cascante, Marta; Rubio-Martinez, Jaime			Diphenyl Urea Derivatives as Inhibitors of Transketolase: A Structure-Based Virtual Screening	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; THIAMINE ANALOGS; COMPLEX; ENZYME; DIPHOSPHATE	Transketolase is an enzyme involved in a critical step of the non-oxidative branch of the pentose phosphate pathway whose inhibition could lead to new anticancer drugs. Here, we report new human transketolase inhibitors, based on the phenyl urea scaffold, found by applying structure-based virtual screening. These inhibitors are designed to cover a hot spot in the dimerization interface of the homodimer of the enzyme, providing for the first time compounds with a suggested novel binding mode not based on mimicking the thiamine pyrophosphate cofactor.	[Obiol-Pardo, Cristian; Rubio-Martinez, Jaime] Univ Barcelona, Fac Quim, Dept Quim Fis, E-08028 Barcelona, Spain; [Alcarraz-Vizan, Gema; Cascante, Marta] Inst Recerca Quim Teor & Comp IQTCUB, Barcelona, Spain	University of Barcelona	Obiol-Pardo, C (corresponding author), Intelligent Pharma SL, Barcelona Sci Pk PCB, Barcelona, Spain.	martacascante@ub.edu; jaime.rubio@ub.edu	Martinez, Jaime Rubio/F-9672-2011; CASCANTE, MARTA/AAG-4355-2022; Rubio Martinez, Jaime/GRY-6502-2022; CASCANTE, MARTA/AFK-5991-2022; Martinez, Jaime Rubio/AAC-9626-2021	Martinez, Jaime Rubio/0000-0002-5529-2325; CASCANTE, MARTA/0000-0002-2062-4633; Rubio Martinez, Jaime/0000-0002-5529-2325; CASCANTE, MARTA/0000-0002-2062-4633; Alcarraz-Vizan, Gema/0000-0002-2429-0597	Spanish Ministry of Science and Innovation [SAF2008-00164, CTQ2006-06588/BQU]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06/0020/0046]; Instituto de Salud Carlos III (ISCIII); European Regional Development Fund (ERDF) "Una manera de hacer Europa''; European Union; AGAUR-Generalitat de Catalunya [2009SGR1308]; ICREA Academia''; ICREA Foundation-Generalitat de Catalunya	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF) "Una manera de hacer Europa''(European Commission); European Union(European Commission); AGAUR-Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); ICREA Academia''(ICREA); ICREA Foundation-Generalitat de Catalunya(ICREA)	This study was supported by projects SAF2008-00164 and CTQ2006-06588/BQU from the Spanish Ministry of Science and Innovation, (RD06/0020/0046) from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation & European Regional Development Fund (ERDF) "Una manera de hacer Europa'' and the European Union FEDER funds (http://ec.europa.eu/regional_policy/funds/feder/index_es.htm). It has also received financial support from the "AGAUR-Generalitat de Catalunya'' (grant 2009SGR1308). MC acknowledges the support received through the prize "ICREA Academia'' for excellence in research, funded by the ICREA Foundation-Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asztalos P, 2007, BIOCHEMISTRY-US, V46, P12037, DOI 10.1021/bi700844m; Case D.A., 2006, AMBER, V9; Comin-Anduix B, 2001, EUR J BIOCHEM, V268, P4177, DOI 10.1046/j.1432-1327.2001.02329.x; Gerhardt S, 2003, PLANT PHYSIOL, V132, P1941, DOI 10.1104/pp.103.020982; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Le Huerou Y, 2008, BIOORG MED CHEM LETT, V18, P505, DOI 10.1016/j.bmcl.2007.11.100; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; Mitschke L, 2010, J BIOL CHEM, V285, P31559, DOI 10.1074/jbc.M110.149955; NIKKOLA M, 1994, J MOL BIOL, V238, P387, DOI 10.1006/jmbi.1994.1299; NILSSON U, 1993, FEBS LETT, V326, P145, DOI 10.1016/0014-5793(93)81779-Y; Obiol-Pardo C, 2008, J MOL RECOGNIT, V21, P190, DOI 10.1002/jmr.887; Obiol-Pardo C, 2009, J MOL GRAPH MODEL, V27, P723, DOI 10.1016/j.jmgm.2008.11.005; Rais B, 1999, FEBS LETT, V456, P113, DOI 10.1016/S0014-5793(99)00924-2; SMEETS EHJ, 1971, CLIN CHIM ACTA, V33, P379, DOI 10.1016/0009-8981(71)90496-7; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P2206, DOI 10.1016/j.bmcl.2007.11.101; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P509, DOI 10.1016/j.bmcl.2007.11.098; Vizan P, 2008, METABOLOMICS, V4, P1, DOI 10.1007/s11306-007-0101-3; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wikner C, 1997, BIOCHEMISTRY-US, V36, P15643, DOI 10.1021/bi971606b	21	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32276	10.1371/journal.pone.0032276	http://dx.doi.org/10.1371/journal.pone.0032276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403640	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700037
J	Yang, XH; Feng, ZE; Yan, M; Hanada, S; Zuo, H; Yang, CZ; Han, ZG; Guo, W; Chen, WT; Zhang, P				Yang, Xi-Hu; Feng, Zhi-En; Yan, Ming; Hanada, Sayaka; Zuo, Hui; Yang, Cheng-Zhe; Han, Ze-Guan; Guo, Wei; Chen, Wan-Tao; Zhang, Ping			XIAP Is a Predictor of Cisplatin-Based Chemotherapy Response and Prognosis for Patients with Advanced Head and Neck Cancer	PLOS ONE			English	Article							X-LINKED INHIBITOR; APOPTOSIS PROTEIN; EXPRESSION; IAPS; CELLS	Background: Approximately 60-80% of patients with advanced head and neck squamous cell carcinoma (HNSCC) die within five years after diagnosis. Cisplatin-based chemotherapy is the most commonly used palliative treatment for these patients. To evaluate the prognostic value of X-linked inhibitor of apoptosis (XIAP) level as a potential biomarker in these patients, we investigated the relationship between XIAP expression and cisplatin response of these patients and their prognosis. Methodology/Principal Findings: Sixty patients with advanced HNSCC were recruited in this study. Expression of XIAP was examined both before and after chemotherapy and was correlated with chemotherapy response, clinicopathology parameters and clinical outcomes of the patients. We found that XIAP was expressed in 17 (20.83%) of the 60 advanced HNSCC samples and the expression was significantly associated with cisplatin resistance (P = 0.036) and poor clinical outcome (P = 0.025). Cisplatin-based chemotherapy induced XIAP expression in those post-chemotherapy samples (P = 0.011), was further associated with poorer clinical outcome (P = 0.029). Multivariate analysis demonstrated that only alcohol consumption, lymph node metastasis and XIAP level were independently associated with the prognosis of advanced HNSCC patients. Inhibiting XIAP expression with siRNA in XIAP overexpressed HNSCC cells remarkably increased their sensitivity to cisplatin treatment to nearly a 3 fold difference. Conclusions/Significance: Our results demonstrate that XIAP overexpression plays an important role in the disease course and cisplatin-resistance of advanced HNSCC. XIAP is a valuable predictor of cisplatin-response and prognosis for patients with advanced head and neck cancer. Down-regulation of XIAP might be a promising adjuvant therapy for those patients of advanced HNSCC.	[Yang, Xi-Hu; Feng, Zhi-En; Yan, Ming; Yang, Cheng-Zhe; Han, Ze-Guan; Guo, Wei; Chen, Wan-Tao; Zhang, Ping] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200030, Peoples R China; [Yang, Xi-Hu; Feng, Zhi-En; Yan, Ming; Yang, Cheng-Zhe; Han, Ze-Guan; Chen, Wan-Tao] Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Hanada, Sayaka; Zuo, Hui] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA	Shanghai Jiao Tong University; University System of Maryland; University of Maryland Baltimore	Yang, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200030, Peoples R China.	pingzhang73@hotmail.com	Feng, Zhien/O-2982-2018	Feng, Zhien/0000-0003-1952-6734	National Natural Science Foundation of China [30772433]; Science and Technology Commission of Shanghai Municipality [07QA14038]; Shanghai Leading Academic Discipline Project [S30206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This study was supported by Project of National Natural Science Foundation of China (Grant No. 30772433), Project of Science and Technology Commission of Shanghai Municipality (Grant No. 07QA14038), and Shanghai Leading Academic Discipline Project (Project No. S30206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantana A, 2004, MOL CANCER THER, V3, P699; Cao W, 2011, CANC PREV RES PHILA; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Choe KS, 2011, CANCER; Cillessen SAGM, 2008, BLOOD, V111, P369, DOI 10.1182/blood-2007-04-085480; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; DEVERAUX QL, 1998, EMBO J, V17, P2215, DOI DOI 10.1093/EMBOJ/17.8.2215; Devi GR, 2004, DRUG NEWS PERSPECT, V17, P127, DOI 10.1358/dnp.2004.17.2.829046; Gourin CG, 2006, LARYNGOSCOPE, V116, P1093, DOI 10.1097/01.mlg.0000224939.61503.83; Hauswald H, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-70; Hitt R, 2005, EUR J CANCER, V41, P453, DOI 10.1016/j.ejca.2004.10.014; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Hu YP, 2003, CLIN CANCER RES, V9, P2826; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kelsen DP, 2007, J CLIN ONCOL, V25, P3719, DOI 10.1200/JCO.2006.10.4760; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Li YX, 2006, PANCREAS, V32, P288, DOI 10.1097/01.mpa.0000218314.67111.fb; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizutani Y, 2007, INT J ONCOL, V30, P919; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Petak I, 2010, NAT REV DRUG DISCOV, V9, P523, DOI 10.1038/nrd3135; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Xiang GA, 2009, J SURG ONCOL, V100, P708, DOI 10.1002/jso.21408	26	48	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31601	10.1371/journal.pone.0031601	http://dx.doi.org/10.1371/journal.pone.0031601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403616	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700013
J	Dalerum, F; Perbro, A; Magnusdottir, R; Hersteinsson, P; Angerbjorn, A				Dalerum, Fredrik; Perbro, Anna; Magnusdottir, Rannveig; Hersteinsson, Pall; Angerbjorn, Anders			The Influence of Coastal Access on Isotope Variation in Icelandic Arctic Foxes	PLOS ONE			English	Article							STABLE-ISOTOPES; ALOPEX-LAGOPUS; DISCRIMINATION FACTORS; NICHE WIDTH; DIET; DELTA-C-13; SPECIALIZATION; DELTA-N-15; DYNAMICS; ECOLOGY	To quantify the ecological effects of predator populations, it is important to evaluate how population-level specializations are dictated by intra-versus inter-individual dietary variation. Coastal habitats contain prey from the terrestrial biome, the marine biome and prey confined to the coastal region. Such habitats have therefore been suggested to better support predator populations compared to habitats without coastal access. We used stable isotope data on a small generalist predator, the arctic fox, to infer dietary strategies between adult and juvenile individuals with and without coastal access on Iceland. Our results suggest that foxes in coastal habitats exhibited a broader isotope niche breadth compared to foxes in inland habitats. This broader niche was related to a greater diversity of individual strategies rather than to a uniform increase in individual niche breadth or by individuals retaining their specialization but increasing their niche differentiation. Juveniles in coastal habitats exhibited a narrower isotope niche breadth compared to both adults and juveniles in inland habitats, and juveniles in inland habitats inhabited a lower proportion of their total isotope niche compared to adults and juveniles from coastal habitats. Juveniles in both habitats exhibited lower intra-individual variation compared to adults. Based on these results, we suggest that foxes in both habitats were highly selective with respect to the resources they used to feed offspring, but that foxes in coastal habitats preferentially utilized marine resources for this purpose. We stress that coastal habitats should be regarded as high priority areas for conservation of generalist predators as they appear to offer a wide variety of dietary options that allow for greater flexibility in dietary strategies.	[Dalerum, Fredrik] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa; [Dalerum, Fredrik] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Perbro, Anna; Angerbjorn, Anders] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Magnusdottir, Rannveig; Hersteinsson, Pall] Univ Iceland, Fac Life & Environm Sci, Reykjavik, Iceland	University of Pretoria; University of Pretoria; Stockholm University; University of Iceland	Dalerum, F (corresponding author), Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa.	fredrik.dalerum@zoology.up.ac.za	Angerbjörn, Anders/AAX-3670-2021; Dalerum, Fredrik/M-6068-2017; Angerbjorn, Anders/A-5982-2013	Dalerum, Fredrik/0000-0001-9737-8242; Angerbjorn, Anders/0000-0001-5535-9086	Icelandic Science Research Fund; Icelandic Ministry of the Environment; EU-Life foundation; University of Pretoria	Icelandic Science Research Fund; Icelandic Ministry of the Environment; EU-Life foundation; University of Pretoria	This study was financially supported by the Icelandic Science Research Fund, The Icelandic Ministry of the Environment, EU-Life foundation to the extended Swedish-Finnish Alopex project (SEFALO+), and a research fellowship from the University of Pretoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Angerbjorn A, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P163; Angerbjorn A, 1999, J ANIM ECOL, V68, P34, DOI 10.1046/j.1365-2656.1999.00258.x; ANGERBJORN A, 1995, ANN ZOOL FENN, V32, P55; ANGERBJORN A, 1994, OECOLOGIA, V99, P226, DOI 10.1007/BF00627734; Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.2307/3072028; Braestrup F. W., 1941, Meddelelser om Gronland, V131, P1; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; CHISHOLM BS, 1982, SCIENCE, V216, P1131, DOI 10.1126/science.216.4550.1131; Dalerum F, 2000, ARCTIC, V53, P1; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Dalerum Fredrik, 2009, Current Zoology, V55, P188; del Rio CM, 2009, OECOLOGIA, V161, P149, DOI 10.1007/s00442-009-1357-2; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Dennis CA, 2010, RAPID COMMUN MASS SP, V24, P3515, DOI 10.1002/rcm.4807; Edwards MA, 2011, OECOLOGIA, V165, P877, DOI 10.1007/s00442-010-1869-9; Elmhagen B, 2000, J ZOOL, V251, P139, DOI 10.1111/j.1469-7998.2000.tb00599.x; FAY FH, 1989, CAN J ZOOL, V67, P1986, DOI 10.1139/z89-283; Frafjord Karl, 1993, Norwegian Journal of Agricultural Sciences, V7, P301; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hersteinsson P, 1996, J ZOOL, V240, P457, DOI 10.1111/j.1469-7998.1996.tb05298.x; HERSTEINSSON P, 1984, THESIS U OXFORD; HERSTEINSSON P, 1999, ARCTIC FOXES HORNSTR; Krebs CJ, 2003, CAN J ZOOL, V81, P827, DOI [10.1139/z03-061, 10.1139/Z03-061]; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LIDEN K, 1995, J ARCHAEOL SCI, V22, P321, DOI 10.1006/jasc.1995.0034; LINDSTROM ER, 1994, ECOGRAPHY, V17, P17, DOI 10.1111/j.1600-0587.1994.tb00073.x; Macpherson A. H., 1969, Canadian Wildlife Service Report Series, VNo. 8, P1; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Oksanen J, 2011, R PACKAGE VERSION 1; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; POND CM, 1995, J ZOOL, V236, P611, DOI 10.1111/j.1469-7998.1995.tb02735.x; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Tannerfeldt M, 1998, OIKOS, V83, P545, DOI 10.2307/3546681; Taylor R.J., 1984, PREDATION; Tesseraud S, 2000, POULTRY SCI, V79, P1465, DOI 10.1093/ps/79.10.1465; Urton EJM, 2005, OECOLOGIA, V145, P317, DOI 10.1007/s00442-005-0124-2; Welle S., 1999, HUMAN PROTEIN METABO, DOI 10.1007/978-1-4612-1458-8; Wheeless CR, 2011, WHEELESS TXB ORTHOPA	55	16	16	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32071	10.1371/journal.pone.0032071	http://dx.doi.org/10.1371/journal.pone.0032071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396749	Green Published, Green Submitted, gold			2022-12-25	WOS:000303005000015
J	Marchant, J; Cowper, B; Liu, Y; Lai, L; Pinzan, C; Marq, JB; Friedrich, N; Sawmynaden, K; Liew, L; Chai, WG; Childs, RA; Saouros, S; Simpson, P; Barreira, MCR; Feizi, T; Soldati-Favre, D; Matthews, S				Marchant, Jan; Cowper, Ben; Liu, Yan; Lai, Livia; Pinzan, Camila; Marq, Jean Baptiste; Friedrich, Nikolas; Sawmynaden, Kovilen; Liew, Lloyd; Chai, Wengang; Childs, Robert A.; Saouros, Savvas; Simpson, Peter; Roque Barreira, Maria Cristina; Feizi, Ten; Soldati-Favre, Dominique; Matthews, Stephen			Galactose Recognition by the Apicomplexan Parasite Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELL INVASION; NEOSPORA-CANINUM; MICRONEMAL PROTEINS; CRYSTAL-STRUCTURES; PLASMA-MEMBRANE; GM1 GANGLIOSIDE; BINDING LECTIN; APPLE DOMAINS; IDENTIFICATION; OLIGOSACCHARIDE	Toxosplasma gondii is the model parasite of the phylum Apicomplexa, which contains numerous obligate intracellular parasites of medical and veterinary importance, including Eimeria, Sarcocystis, Cryptosporidium, Cyclospora, and Plasmodium species. Members of this phylum actively enter host cells by a multistep process with the help of microneme protein (MIC) complexes that play important roles in motility, host cell attachment, moving junction formation, and invasion. T. gondii (Tg)MIC1-4-6 complex is the most extensively investigated microneme complex, which contributes to host cell recognition and attachment via the action of TgMIC1, a sialic acid-binding adhesin. Here, we report the structure of TgMIC4 and reveal its carbohydrate-binding specificity to a variety of galactose-containing carbohydrate ligands. The lectin is composed of six apple domains in which the fifth domain displays a potent galactose-binding activity, and which is cleaved from the complex during parasite invasion. We propose that galactose recognition by TgMIC4 may compromise host protection from galectin-mediated activation of the host immune system.	[Marchant, Jan; Cowper, Ben; Lai, Livia; Liew, Lloyd; Saouros, Savvas; Simpson, Peter; Matthews, Stephen] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Liu, Yan; Chai, Wengang; Childs, Robert A.; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 0NN, England; [Pinzan, Camila; Roque Barreira, Maria Cristina] Univ Sao Paulo, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Sao Paulo, Brazil; [Marq, Jean Baptiste; Friedrich, Nikolas; Soldati-Favre, Dominique] Univ Geneva CMU, Fac Med, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland; [Sawmynaden, Kovilen] Natl Inst Med Res, London NW7 1AA, England	Imperial College London; Imperial College London; Universidade de Sao Paulo; University of Geneva; MRC National Institute for Medical Research	Matthews, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, S Kensington Campus, London SW7 2AZ, England.	s.j.matthews@imperial.ac.uk	Pinzan, Camila Figueiredo/C-2470-2015; Liu, Yan/D-9117-2013; Roque-Barreira, Maria-Cristina/A-4552-2008	Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Matthews, Steve/0000-0003-0676-0927; Simpson, Pete/0000-0002-2679-9303; Liu, Yan/0000-0002-2566-6867; Feizi, Ten/0000-0001-6495-0329; Friedrich, Nikolas/0000-0003-0694-657X	Medical Research Council [G0800038, G9601454]; Swiss National Foundation UK Research Councils' Basic Technology Initiative; EPSRC [GRS/79268, EP/G037604/1]; European Union; MRC [G9601454, G0800038] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/S79268/02, EP/G037604/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Foundation UK Research Councils' Basic Technology Initiative; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Medical Research Council Grants G0800038 (to S. J. M.) and G9601454 (to T. F.), Swiss National Foundation UK Research Councils' Basic Technology Initiative "Glycoarrays," and EPSRC Translational Grants GRS/79268 and EP/G037604/1(to T. F.).; Supported by European Union FP6 program BioMalPar.	Bhat N, 2007, J BIOL CHEM, V282, P34877, DOI 10.1074/jbc.M706950200; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brown Philip J., 2003, Journal of Structural and Functional Genomics, V4, P227, DOI 10.1023/B:JSFG.0000016118.87333.03; Campanero-Rhodes MA, 2007, J VIROL, V81, P12846, DOI 10.1128/JVI.01311-07; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Cerede O, 2005, J EXP MED, V201, P453, DOI 10.1084/jem.20041672; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; Coley AM, 2007, PLOS PATHOG, V3, P1827; Debierre-Grockiego F, 2010, J BIOL CHEM, V285, P32744, DOI 10.1074/jbc.M110.137588; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eswar N., 2001, CURRENT PROTOCOLS PR, P1; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; Ferguson DJP, 2000, INT J PARASITOL, V30, P1203, DOI 10.1016/S0020-7519(00)00096-5; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Frederick JR, 2005, GLYCOBIOLOGY, V15, p53R, DOI 10.1093/glycob/cwj007; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; Garnett JA, 2009, PROTEIN SCI, V18, P1935, DOI 10.1002/pro.204; Gronwald W, 2008, J MOL BIOL, V381, P913, DOI 10.1016/j.jmb.2008.06.034; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Holmner A, 2011, J MOL BIOL, V406, P387, DOI 10.1016/j.jmb.2010.11.060; Keller N, 2004, INFECT IMMUN, V72, P4791, DOI 10.1128/IAI.72.8.4791-4800.2004; Keller N, 2002, INFECT IMMUN, V70, P3187, DOI 10.1128/IAI.70.6.3187-3198.2002; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; Lourenco EV, 2001, GLYCOBIOLOGY, V11, P541, DOI 10.1093/glycob/11.7.541; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Matta-Camacho E, 2009, J MOL BIOL, V386, P569, DOI 10.1016/j.jmb.2008.09.086; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Muller JJ, 2001, ACTA CRYSTALLOGR D, V57, P1042, DOI 10.1107/S0907444901007284; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Nudelman I, 2010, BIOCHEMISTRY-US, V49, P5117, DOI 10.1021/bi100041f; Palma AS, 2011, BIOCHEM BIOPH RES CO, V408, P548, DOI 10.1016/j.bbrc.2011.04.055; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Periz J, 2007, J BIOL CHEM, V282, P16891, DOI 10.1074/jbc.M702407200; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; RICHARDS FO, 1995, CLIN INFECT DIS, V21, pS49, DOI 10.1093/clinids/21.Supplement_1.S49; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rothova Aniki, 2003, Curr Opin Ophthalmol, V14, P384, DOI 10.1097/00055735-200312000-00011; Saouros S, 2007, PROTEIN PEPTIDE LETT, V14, P411, DOI 10.2174/092986607780782876; Saouros S, 2005, J BIOL CHEM, V280, P38583, DOI 10.1074/jbc.C500365200; Sawmynaden K, 2008, EMBO REP, V9, P1149, DOI 10.1038/embor.2008.179; Sell M, 2005, CLIN NEUROPATHOL, V24, P106; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Silber AM, 2002, EXP PARASITOL, V100, P217, DOI 10.1016/S0014-4894(02)00013-9; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Srinivasan S, 2007, J PARASITOL, V93, P1046, DOI 10.1645/GE-1181R1.1; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Vaillant V, 2005, FOODBORNE PATHOG DIS, V2, P221, DOI 10.1089/fpd.2005.2.221; Yoshida H, 2010, J BIOL CHEM, V285, P36969, DOI 10.1074/jbc.M110.163402; Young AR, 2002, GLYCOCONJUGATE J, V19, P601, DOI 10.1023/B:GLYC.0000014091.00844.0a	61	39	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16720	16733		10.1074/jbc.M111.325928	http://dx.doi.org/10.1074/jbc.M111.325928			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22399295	hybrid, Green Published			2022-12-25	WOS:000304030900060
J	Saito, M; Mylvaganum, M; Tam, P; Novak, A; Binnington, B; Lingwood, C				Saito, Mitsumasa; Mylvaganum, Murugespillai; Tam, Patty; Novak, Anton; Binnington, Beth; Lingwood, Clifford			Structure-dependent Pseudoreceptor Intracellular Traffic of Adamantyl Globotriaosyl Ceramide Mimics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; SHIGA-LIKE TOXIN; CHOLERA-TOXIN; RECEPTOR FUNCTION; RETROGRADE TRANSPORT; GLYCOLIPID RECEPTOR; B-SUBUNIT; VEROTOXIN BINDING; GOLGI-APPARATUS; LIPID RAFTS	The verotoxin (VT) (Shiga toxin) receptor globotriaosyl ceramide (Gb(3)), mediates VT1/VT2 retrograde transport to the endoplasmic reticulum (ER) for cytosolic A subunit access to inhibit protein synthesis. Adamantyl Gb(3) is an amphipathic competitive inhibitor of VT1/VT2 Gb(3) binding. However, Gb(3)-negative VT-resistant CHO/Jurkat cells incorporate adaGb(3) to become VT1/VT2 sensitive. CarboxyadaGb(3), urea-adaGb(3), and hydroxyethyl adaGb(3), preferentially bound by VT2, also mediate VT1/VT2 cytotoxicity. VT1/VT2 internalize to early endosomes but not to Golgi/ER. AdabisGb(3) (two deacyl Gb(3)s linked to adamantane) protects against VT1/VT2 more effectively than adaGb(3) without incorporating into Gb(3)-negative cells. AdaGb(3) (but not hydroxyethyl adaGb(3)) incorporation into Gb(3)-positive Vero cells rendered punctate cell surface VT1/VT2 binding uniform and subverted subsequent Gb(3)-dependent retrograde transport to Golgi/ER to render cytotoxicity (reduced for VT1 but not VT2) brefeldin A-resistant. VT2-induced vacuolation was maintained in adaGb(3)-treated Vero cells, but vacuolar membrane VT2 was lost. AdaGb(3) destabilized membrane cholesterol and reduced Gb(3) cholesterol stabilization in phospholipid liposomes. Cholera toxin GM1-mediated Golgi/ER targeting was unaffected by adaGb(3). We demonstrate the novel, lipid-dependent, pseudoreceptor function of Gb(3) mimics and their structure-dependent modulation of endogenous intracellular Gb(3) vesicular traffic.	[Saito, Mitsumasa; Mylvaganum, Murugespillai; Novak, Anton; Binnington, Beth; Lingwood, Clifford] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Tam, Patty; Lingwood, Clifford] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada; [Tam, Patty; Lingwood, Clifford] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Lingwood, C (corresponding author), Hosp Sick Children, Res Inst, Clifford Lingwood Mol Struct & Funct Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	msaito@bact.med.kyushu-u.ac.jp; cling@sickkids.on.ca			Canadian Institutes of Health Research [MT 13747]; Ontario HIV Treatment Network; Canfar	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Canfar	This work was supported by Canadian Institutes of Health Research Grant MT 13747 and grants from Ontario HIV Treatment Network and Canfar.	Amessou M, 2008, BIOCONJUGATE CHEM, V19, P532, DOI 10.1021/bc7003999; Arab S, 1999, ONCOL RES, V11, P33; Arab S, 1996, GLYCOCONJUGATE J, V13, P159, DOI 10.1007/BF00731490; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Badizadegan K, 2004, AM J PHYSIOL-CELL PH, V287, pC1453, DOI 10.1152/ajpcell.00189.2004; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; BOYD B, 1994, EUR J BIOCHEM, V223, P873, DOI 10.1111/j.1432-1033.1994.tb19064.x; CALANDER N, 1988, BIOCHIMIE, V70, P1673, DOI 10.1016/0300-9084(88)90302-1; Chark D, 2004, EUR J BIOCHEM, V271, P405, DOI 10.1046/j.1432-1033.2003.03941.x; Devenica D, 2011, MED ONCOL, V28, pS675, DOI 10.1007/s12032-010-9732-8; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Falguieres T, 2008, MOL CANCER THER, V7, P2498, DOI 10.1158/1535-7163.MCT-08-0430; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fritz VMR, 1997, BBA-GENE STRUCT EXPR, V1354, P153, DOI 10.1016/S0167-4781(97)00117-6; Goldwater PN, 2007, EXPERT REV ANTI-INFE, V5, P653, DOI 10.1586/14787210.5.4.653; Hall A, 2010, J PHYS CHEM B, V114, P7797, DOI 10.1021/jp912175d; Halling KK, 2008, BIOPHYS J, V95, P3861, DOI 10.1529/biophysj.108.133744; Heath-Engel Hannah M., 2003, Angiogenesis, V6, P129, DOI 10.1023/B:AGEN.0000011799.47529.fd; Hoey DEE, 2003, CELL MICROBIOL, V5, P85, DOI 10.1046/j.1462-5822.2003.00254.x; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Johannes L, 2003, TRAFFIC, V4, P323, DOI 10.1034/j.1600-0854.2003.00089.x; Johansson D., 2009, BMC CANCER, V9, P67; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kamani M, 2011, J BIOL CHEM, V286, P21413, DOI 10.1074/jbc.M110.207670; Karch H, 2006, SEMIN THROMB HEMOST, V32, P105, DOI 10.1055/s-2006-939766; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Kawano K, 2008, EUR J CLIN MICROBIOL, V27, P227, DOI 10.1007/s10096-007-0420-3; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; Khine AA, 2004, GLYCOBIOLOGY, V14, P701, DOI 10.1093/glycob/cwh085; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kitov PI, 2008, P NATL ACAD SCI USA, V105, P16837, DOI 10.1073/pnas.0804919105; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; LaCasse EC, 1999, BLOOD, V94, P2901; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lingwood CA, 2010, FEBS LETT, V584, P1879, DOI 10.1016/j.febslet.2009.11.089; Lingwood CA, 1996, GLYCOCONJUGATE J, V13, P495, DOI 10.1007/BF00731435; Lingwood Clifford, 2006, V347, P305; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lund N, 2009, BLOOD, V113, P4980, DOI 10.1182/blood-2008-03-143396; Mahfoud R, 2002, J LIPID RES, V43, P1670, DOI 10.1194/jlr.M200165-JLR200; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; Mahfoud R, 2009, J LIPID RES, V50, P1744, DOI 10.1194/jlr.M800385-JLR200; Majoul I, 2002, J CELL SCI, V115, P817; MANGENEY M, 1991, EUR J IMMUNOL, V21, P1131, DOI 10.1002/eji.1830210507; McKenzie J, 2009, FEBS J, V276, P1581, DOI 10.1111/j.1742-4658.2009.06890.x; Muthing J, 2009, THROMB HAEMOSTASIS, V101, P252, DOI 10.1160/TH08-05-0317; Mylvaganam M, 1999, BIOCHEM BIOPH RES CO, V257, P391, DOI 10.1006/bbrc.1999.0474; Mylvaganam M., 2003, CARBOHYDRATE BASED D, P761; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nishikawa K, 2005, J INFECT DIS, V191, P2097, DOI 10.1086/430388; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; NYHOLM PG, 1993, BIOCHEMISTRY-US, V32, P1225, DOI 10.1021/bi00056a005; Nyholm PG, 1996, CHEM BIOL, V3, P263, DOI 10.1016/S1074-5521(96)90106-4; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Pagano RE, 2000, METHOD ENZYMOL, V312, P523; Pagano RE, 2000, TRAFFIC, V1, P807, DOI 10.1034/j.1600-0854.2000.011101.x; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; PETRIC M, 1987, FEMS MICROBIOL LETT, V41, P63; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rutjes NWP, 2002, KIDNEY INT, V62, P832, DOI 10.1046/j.1523-1755.2002.00502.x; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Salhia B, 2002, NEOPLASIA, V4, P304, DOI 10.1038/sj.neo.7900243; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; SANDVIG K, 1994, FEBS LETT, V346, P99, DOI 10.1016/0014-5793(94)00281-9; Sandvig K, 2010, TOXICON, V56, P1181, DOI 10.1016/j.toxicon.2009.11.021; Schapiro FB, 1998, AM J PHYSIOL-CELL PH, V274, pC319, DOI 10.1152/ajpcell.1998.274.2.C319; Schwarzmann G, 2001, SEMIN CELL DEV BIOL, V12, P163, DOI 10.1006/scdb.2000.0233; Sillence DJ, 2002, J LIPID RES, V43, P1837, DOI 10.1194/jlr.M200232-JLR200; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; Soltyk AM, 2002, J BIOL CHEM, V277, P5351, DOI 10.1074/jbc.M107472200; Spillsberg B, 2003, TRAFFIC, V4, P544, DOI 10.1034/j.1600-0854.2003.00111.x; SPITALNIK PF, 1995, TRANSFUS MED REV, V9, P110, DOI 10.1016/S0887-7963(05)80050-1; STHILAIRE PM, 1994, BIOCHEMISTRY-US, V33, P14452, DOI 10.1021/bi00252a011; Tam PJ, 2007, MICROBIOL-SGM, V153, P2700, DOI 10.1099/mic.0.2007/006858-0; Tam P, 2008, J CELL PHYSIOL, V216, P750, DOI 10.1002/jcp.21456; Veiga MP, 2001, BIOCHEMISTRY-US, V40, P2614, DOI 10.1021/bi0019803; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Wolf AA, 2008, INFECT IMMUN, V76, P1476, DOI 10.1128/IAI.01286-07; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328	89	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16073	16087		10.1074/jbc.M111.318196	http://dx.doi.org/10.1074/jbc.M111.318196			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22418442	hybrid, Green Published			2022-12-25	WOS:000304030900001
J	Cross, AS; Hyun, SW; Miranda-Ribera, A; Feng, CG; Liu, AG; Nguyen, C; Zhang, L; Luzina, IG; Atamas, SP; Twaddell, WS; Guang, W; Lillehoj, EP; Puche, AC; Huang, W; Wang, LX; Passaniti, A; Goldblum, SE				Cross, Alan S.; Hyun, Sang Won; Miranda-Ribera, Alba; Feng, Chiguang; Liu, Anguo; Chinh Nguyen; Zhang, Lei; Luzina, Irina G.; Atamas, Sergei P.; Twaddell, William S.; Guang, Wei; Lillehoj, Erik P.; Puche, Adam C.; Huang, Wei; Wang, Lai-Xi; Passaniti, Antonino; Goldblum, Simeon E.			NEU1 and NEU3 Sialidase Activity Expressed in Human Lung Microvascular Endothelia NEU1 RESTRAINS ENDOTHELIAL CELL MIGRATION, WHEREAS NEU3 DOES NOT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B16 MELANOMA-CELLS; LYSOSOMAL SIALIDASE; PLASMA-MEMBRANE; GROWTH-FACTOR; ADHESION MOLECULES; HUMAN NEUTROPHILS; TUMOR-CELLS; SIALYL-LEX; SURFACE; RECEPTOR	The microvascular endothelial surface expresses multiple molecules whose sialylation state regulates multiple aspects of endothelial function. To better regulate these sialoproteins, we asked whether endothelial cells (ECs) might express one or more catalytically active sialidases. Human lung microvascular EC lysates contained heat-labile sialidase activity for a fluorogenic substrate, 2'-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid (4-MU-NANA), that was dose-dependently inhibited by the competitive sialidase inhibitor, 2,3-dehydro-2-deoxy-N-acetylneuraminic acid but not its negative control. The EC lysates also contained sialidase activity for a ganglioside mixture. Using real time RT-PCR to detect mRNAs for the four known mammalian sialidases, NEU1, -2, -3, and -4, NEU1 mRNA was expressed at levels 2700-fold higher that those found for NEU2, -3, or -4. Western analyses indicated NEU1 and -3 protein expression. Using confocal microscopy and flow cytometry, NEU1 was immunolocalized to both the plasma membrane and the perinuclear region. NEU3 was detected both in the cytosol and nucleus. Prior siRNA-mediated knockdown of NEU1 and NEU3 each decreased EC sialidase activity for 4-MU-NANA by >65 and >17%, respectively, and for the ganglioside mixture by 0 and 40%, respectively. NEU1 overexpression in ECs reduced their migration into a wound by >40%, whereas NEU3 overexpression did not. Immunohistochemical studies of normal human tissues immunolocalized NEU1 and NEU3 proteins to both pulmonary and extrapulmonary vascular endothelia. These combined data indicate that human lung microvascular ECs as well as other endothelia express catalytically active NEU1 and NEU3. NEU1 restrains EC migration, whereas NEU3 does not.	[Hyun, Sang Won; Miranda-Ribera, Alba; Liu, Anguo; Chinh Nguyen; Guang, Wei; Lillehoj, Erik P.; Passaniti, Antonino; Goldblum, Simeon E.] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Cross, Alan S.; Feng, Chiguang; Zhang, Lei] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Chinh Nguyen] Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA; [Cross, Alan S.; Luzina, Irina G.; Atamas, Sergei P.; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Twaddell, William S.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Guang, Wei; Lillehoj, Erik P.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Puche, Adam C.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Huang, Wei; Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Inst Human Virol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, Mucosal Biol Res Ctr, 20 Penn St,Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu	Wang, Lai-Xi/E-8790-2019; wang, xl/Y-8251-2019; Wang, Lai-Xi/E-8755-2019; Wang, Xin/AAN-8435-2021; Huang, Wei/P-9631-2017	Wang, Lai-Xi/0000-0003-4293-5819; Wang, Xin/0000-0002-4457-7376; Huang, Wei/0000-0001-6432-1848; , Erik/0000-0003-0910-6074; Lillehoj, Erik/0000-0002-2710-1704	National Institutes of Health [HL086933, HL084223]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084223, R01HL086933] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL086933 (to A. S. C.) and HL084223 (to S. E. G.).	Achyuthan KE, 2001, COMP BIOCHEM PHYS B, V129, P29, DOI 10.1016/S1096-4959(01)00372-4; Arabkhari M, 2010, GLYCOBIOLOGY, V20, P603, DOI 10.1093/glycob/cwq010; AUGUSTINVOSS HG, 1992, J CELL BIOL, V119, P483, DOI 10.1083/jcb.119.2.483; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2000, J BIOL CHEM, V275, P37657, DOI 10.1074/jbc.M007380200; BORN GVR, 1985, BRIT J EXP PATHOL, V66, P543; BROQUET P, 1991, INT J BIOCHEM, V23, P385, DOI 10.1016/0020-711X(91)90164-I; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; CROSS AS, 1991, J CLIN INVEST, V88, P2067, DOI 10.1172/JCI115536; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; Cuniberti LA, 2005, ATHEROSCLEROSIS, V181, P225, DOI 10.1016/j.atherosclerosis.2005.01.021; D'Souza DR, 2009, J BIOL CHEM, V284, P17947, DOI 10.1074/jbc.M109.002378; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Geyer H, 1999, GLYCOBIOLOGY, V9, P915, DOI 10.1093/glycob/9.9.915; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; HANASAKI K, 1994, J BIOL CHEM, V269, P10637; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; Hyun SW, 2011, EXP LUNG RES, V37, P327, DOI 10.3109/01902148.2011.566673; IRIE S, 1988, J CLIN INVEST, V82, P508, DOI 10.1172/JCI113625; Jayanth P, 2010, CELL SIGNAL, V22, P1193, DOI 10.1016/j.cellsig.2010.03.011; Kato T, 2001, INT J CANCER, V92, P797, DOI 10.1002/ijc.1268; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; Liu YH, 2006, CANCER RES, V66, P10408, DOI 10.1158/0008-5472.CAN-06-1572; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Monti E, 1999, GLYCOBIOLOGY, V9, P1313, DOI 10.1093/glycob/9.12.1313; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Monti E, 1999, GENOMICS, V57, P137, DOI 10.1006/geno.1999.5749; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Mukhejee P, 2008, J LIPID RES, V49, P929, DOI 10.1194/jlr.R800006-JLR200; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; Qian J, 2009, ACTA PHARMACOL SIN, V30, P1039, DOI 10.1038/aps.2009.84; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Rifat S, 2008, J LEUKOCYTE BIOL, V84, P1075, DOI 10.1189/jlb.0706462; Rusnati M, 1999, MOL BIOL CELL, V10, P313, DOI 10.1091/mbc.10.2.313; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Sawada M, 2002, INT J CANCER, V97, P180, DOI 10.1002/ijc.1598; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Smith CW, 2008, J ALLERGY CLIN IMMUN, V121, pS375, DOI 10.1016/j.jaci.2007.07.030; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Tokuyama S, 1997, INT J CANCER, V73, P410, DOI 10.1002/(SICI)1097-0215(19971104)73:3<410::AID-IJC16>3.0.CO;2-G; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; WALZ G, 1990, SCIENCE, V250, P1132, DOI 10.1126/science.1701275; Wang JF, 2009, J NEUROCHEM, V111, P547, DOI 10.1111/j.1471-4159.2009.06339.x; Weber KSC, 2004, INFLAMMATION, V28, P177, DOI 10.1023/B:IFLA.0000049042.73926.eb; YANG CL, 1995, CANCER RES, V55, P4210	65	43	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15966	15980		10.1074/jbc.M112.346817	http://dx.doi.org/10.1074/jbc.M112.346817			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403397	Green Published, hybrid			2022-12-25	WOS:000304006300075
J	Jong, A; Wu, CH; Gonzales-Gomez, I; Kwon-Chung, KJ; Chang, YC; Tseng, HK; Cho, WL; Huang, SH				Jong, Ambrose; Wu, Chun-Hua; Gonzales-Gomez, Ignacio; Kwon-Chung, Kyung J.; Chang, Yun C.; Tseng, Hsiang-Kuang; Cho, Wen-Long; Huang, Sheng-He			Hyaluronic Acid Receptor CD44 Deficiency Is Associated with Decreased Cryptococcus neoformans Brain Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; BINDING-SITE; LIPID RAFTS; SIMVASTATIN; INVOLVEMENT; MICE; PATHOGENESIS; RECRUITMENT; ACTIVATION	Cryptococcus neoformans is a pathogenic yeast that can invade the brain and cause meningoencephalitis. Our previous in vitro studies suggested that the interaction between C. neoformans hyaluronic acid and human brain endothelial CD44 could be the initial step of brain invasion. In this report, we used a CD44 knock-out (KO or CD44(-/-)) mouse model to explore the importance of CD44 in C. neoformans brain invasion. Our results showed that C. neoformans-infected CD44 KO mice survived longer than the infected wild-type mice. Consistent with our in vitro results, the brain and cerebrospinal fluid fungal burden was reduced in CD44-deficient mice. Histopathological studies showed smaller and fewer cystic lesions in the brains of CD44 KO mice. Interestingly, the cystic lesions contained C. neoformans cells embedded within their polysaccharide capsule and were surrounded by host glial cells. We also found that a secondary hyaluronic acid receptor, RHAMM (receptor of hyaluronan-mediated motility), was present in the CD44 KO mice. Importantly, our studies demonstrated an in vivo blocking effect of simvastatin. These results suggest that the CD44 and RHAMM receptors function on membrane lipid rafts during invasion and that simvastatin may have a potential therapeutic role in C. neoformans infections of the brain.	[Jong, Ambrose; Wu, Chun-Hua] Childrens Hosp Los Angeles, Div Hematol Oncol, Saban Res Inst, Los Angeles, CA 90027 USA; [Huang, Sheng-He] Childrens Hosp Los Angeles, Div Infect Dis, Saban Res Inst, Los Angeles, CA 90027 USA; [Gonzales-Gomez, Ignacio] Univ S Florida, All Childrens Hosp, Dept Pathol & Lab Med, St Petersburg, FL 33701 USA; [Kwon-Chung, Kyung J.; Chang, Yun C.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Tseng, Hsiang-Kuang; Cho, Wen-Long] Mackay Mem Hosp, Dept Internal Med, New Taipei 252, Taiwan; [Tseng, Hsiang-Kuang; Cho, Wen-Long] MacKay Med Coll, New Taipei 252, Taiwan	Children's Hospital Los Angeles; Children's Hospital Los Angeles; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mackay Memorial Hospital; Mackay Medical College	Jong, A (corresponding author), Childrens Hosp Los Angeles, Div Hematol Oncol, Saban Res Inst, Mailstop 57,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	ajong@chla.usc.edu			National Institutes of Health [R01-NS047599, R56-AI40635]; National Institutes of Health NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000057, R56AI040635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS047599 (to A. J.) and R56-AI40635 (to S. H. H.).; Supported by the National Institutes of Health NIAID intramural research program.	Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Casadevall A, 2009, TRENDS MICROBIOL, V17, P158, DOI 10.1016/j.tim.2008.12.005; Chang YC, 2006, INFECT IMMUN, V74, P3930, DOI 10.1128/IAI.00089-06; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chretien F, 2002, J INFECT DIS, V186, P522, DOI 10.1086/341564; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Jong A, 2007, EUKARYOT CELL, V6, P1486, DOI 10.1128/EC.00120-07; Lee JD, 2006, ACTA TROP, V97, P204, DOI 10.1016/j.actatropica.2005.11.003; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; McFadden D, 2006, TRENDS MICROBIOL, V14, P497, DOI 10.1016/j.tim.2006.09.003; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Miida Takashi, 2004, J Atheroscler Thromb, V11, P253; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Rouschop KMA, 2006, J IMMUNOL, V177, P7225, DOI 10.4049/jimmunol.177.10.7225; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Wang B, 1999, J BIOL CHEM, V274, P8291, DOI 10.1074/jbc.274.12.8291; Yauch LE, 2006, PLOS PATHOG, V2, P1060, DOI 10.1371/journal.ppat.0020120; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	30	59	64	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15298	15306		10.1074/jbc.M112.353375	http://dx.doi.org/10.1074/jbc.M112.353375			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418440	Green Published, hybrid			2022-12-25	WOS:000304006300013
J	Kjenseth, A; Fykerud, TA; Sirnes, S; Bruun, J; Yohannes, Z; Kolberg, M; Omori, Y; Rivedal, E; Leithe, E				Kjenseth, Ane; Fykerud, Tone A.; Sirnes, Solveig; Bruun, Jarle; Yohannes, Zeremariam; Kolberg, Matthias; Omori, Yasufumi; Rivedal, Edgar; Leithe, Edward			The Gap Junction Channel Protein Connexin 43 Is Covalently Modified and Regulated by SUMOylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR COMMUNICATION; INTRACELLULAR-TRANSPORT; PROTEASOMAL DEGRADATION; GROWTH-CONTROL; LIFE-CYCLE; UBIQUITIN; SUMO; DISEASE; CELLS; INTERNALIZATION	SUMOylation is a posttranslational modification in which a member of the small ubiquitin-like modifier (SUMO) family of proteins is conjugated to lysine residues in specific target proteins. Most known SUMOylation target proteins are located in the nucleus, but there is increasing evidence that SUMO may also be a key determinant of many extranuclear processes. Gap junctions consist of arrays of intercellular channels that provide direct transfer of ions and small molecules between adjacent cells. Gap junction channels are formed by integral membrane proteins called connexins, of which the best-studied isoform is connexin 43 (Cx43). Here we show that Cx43 is posttranslationally modified by SUMOylation. The data suggest that the SUMO system regulates the Cx43 protein level and the level of functional Cx43 gap junctions at the plasma membrane. Cx43 was found to be modified by SUMO- 1, -2, and -3. Evidence is provided that the membrane-proximal lysines at positions 144 and 237, located in the Cx43 intracellular loop and C-terminal tail, respectively, act as SUMO conjugation sites. Mutations of lysine 144 or lysine 237 resulted in reduced Cx43 SUMOylation and reduced Cx43 protein and gap junction levels. Altogether, these data identify Cx43 as a SUMOylation target protein and represent the first evidence that gap junctions are regulated by the SUMO system.	[Kjenseth, Ane; Fykerud, Tone A.; Sirnes, Solveig; Bruun, Jarle; Yohannes, Zeremariam; Kolberg, Matthias; Rivedal, Edgar; Leithe, Edward] Univ Oslo, Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, N-0310 Oslo, Norway; [Kjenseth, Ane; Fykerud, Tone A.; Sirnes, Solveig; Bruun, Jarle; Yohannes, Zeremariam; Kolberg, Matthias; Rivedal, Edgar; Leithe, Edward] Univ Oslo, Ctr Canc Biomed, Fac Med, N-0310 Oslo, Norway; [Omori, Yasufumi] Akita Univ, Dept Mol & Tumour Pathol, Sch Med, Hondo, Akita 0108543, Japan	University of Oslo; University of Oslo; Akita University	Leithe, E (corresponding author), Univ Oslo, Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, N-0310 Oslo, Norway.	eleithe@rr-research.no	Kolberg, Matthias/G-2784-2011; Kolberg, Matthias/AAY-3478-2021	Kolberg, Matthias/0000-0001-8288-5364; 	Norwegian Cancer Society; Norwegian Research Council	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Cancer Society and the Norwegian Research Council.	Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Herve JC, 2007, J MEMBRANE BIOL, V217, P21, DOI 10.1007/s00232-007-9054-8; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Jordan K, 2001, J CELL SCI, V114, P763; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; Kim JH, 2009, BBA-MOL BASIS DIS, V1792, P155, DOI 10.1016/j.bbadis.2008.12.008; King TJ, 2000, CARCINOGENESIS, V21, P311; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; Koval M, 2006, TRENDS CELL BIOL, V16, P159, DOI 10.1016/j.tcb.2006.01.006; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LARSEN WJ, 1978, TISSUE CELL, V10, P585, DOI 10.1016/S0040-8166(16)30351-2; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Leithe E, 2006, BIOCHEM J, V393, P59, DOI 10.1042/BJ20050674; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2003, CARCINOGENESIS, V24, P1239, DOI 10.1093/carcin/bgg066; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Lichtenstein A, 2011, J CELL SCI, V124, P910, DOI 10.1242/jcs.073072; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Opsahl H, 2000, CELL ADHES COMMUN, V7, P367, DOI 10.3109/15419060009109019; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rivedal E, 1996, CARCINOGENESIS, V17, P2321, DOI 10.1093/carcin/17.11.2321; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Severs NJ, 2004, CARDIOVASC RES, V62, P368, DOI 10.1016/j.cardiores.2003.12.007; Sirnes S, 2008, BIOCHEM BIOPH RES CO, V373, P597, DOI 10.1016/j.bbrc.2008.06.095; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199	56	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15851	15861		10.1074/jbc.M111.281832	http://dx.doi.org/10.1074/jbc.M111.281832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411987	Green Published, hybrid			2022-12-25	WOS:000304006300064
J	Tamura, Y; Onguka, O; Hobbs, AEA; Jensen, RE; Iijima, M; Claypool, SM; Sesaki, H				Tamura, Yasushi; Onguka, Ouma; Hobbs, Alyson E. Aiken; Jensen, Robert E.; Iijima, Miho; Claypool, Steven M.; Sesaki, Hiromi			Role for Two Conserved Intermembrane Space Proteins, Ups1p and Up2p, in Intra-mitochondrial Phospholipid Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; CARDIOLIPIN BIOSYNTHESIS; PRESEQUENCE TRANSLOCASE; YEAST MITOCHONDRIA; CONTACT SITES; MAINTENANCE; COMPLEX; IMPORT	Mitochondrial membranes maintain a specific phospholipid composition. Most phospholipids are synthesized in the endoplasmic reticulum (ER) and transported to mitochondria, but cardiolipin and phosphatidylethanolamine are produced in mitochondria. In the yeast Saccharomyces cerevisiae, phospholipid exchange between the ER and mitochondria relies on the ER-mitochondria encounter structure (ERMES) complex, which physically connects the ER and mitochondrial outer membrane. However, the proteins and mechanisms involved in phospholipid transport within mitochondria remain elusive. Here, we investigated the role of the conserved intermembrane space proteins, Ups1p and Ups2p, and an inner membrane protein, Mdm31p, in phospholipid metabolism. Our data show that loss of the ERMES complex, Ups1p, and Mdm31p causes similar defects in mitochondrial phospholipid metabolism, mitochondrial morphology, and cell growth. Defects in cells lacking the ERMES complex or Ups1p are suppressed by Mdm31p overexpression as well as additional loss of Ups2p, which antagonizes Ups1p. Combined loss of the ERMES complex and Ups1p exacerbates phospholipid defects. Finally, pulse-chase experiments using [C-14] serine revealed that Ups1p and Ups2p antagonistically regulate conversion of phosphatidylethanolamine to phosphatidylcholine. Our results suggest that Ups proteins and Mdm31p play important roles in phospholipid biosynthesis in mitochondria. Ups proteins may function in phospholipid trafficking between the outer and inner mitochondrial membranes.	[Tamura, Yasushi; Hobbs, Alyson E. Aiken; Jensen, Robert E.; Iijima, Miho; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Onguka, Ouma; Claypool, Steven M.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Tamura, Y (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	ytamura1@jhmi.edu; sclaypo1@jhmi.edu; hsesaki@jhmi.edu	Tamura, Yasushi/A-9997-2013; Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/H-8270-2017	Tamura, Yasushi/0000-0002-8462-0607; Claypool, Steven/0000-0001-5316-1623	National Institutes of Health [GM084015, GM089853]; Japan Society for the Promotion of Science	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in whole or in part, by National Institutes of Health Grants GM084015 (to M. I.) and GM089853 (to H. S.). This work was also supported by a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science (to Y. T.).	Adams A, 1997, METHODS YEAST GENETI; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Brachmann CB, 1998, YEAST, V14, P115; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dimmer KS, 2005, J CELL BIOL, V168, P103, DOI 10.1083/jcb.200410030; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Fujimoto M, 2011, INT REV CEL MOL BIO, V292, P73, DOI 10.1016/B978-0-12-386033-0.00002-5; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Harada Y, 2010, BIOCHEM BIOPH RES CO, V392, P228, DOI 10.1016/j.bbrc.2010.01.024; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; JENSEN RE, 1992, MOL CELL BIOL, V12, P4677, DOI 10.1128/MCB.12.10.4677; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B, 2011, P NATL ACAD SCI USA, V108, P14151, DOI 10.1073/pnas.1111314108; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; PON L, 1989, J CELL BIOL, V109, P2603, DOI 10.1083/jcb.109.6.2603; Rujiviphat J, 2009, J BIOL CHEM, V284, P28682, DOI 10.1074/jbc.M109.044933; Sani MA, 2009, BBA-BIOMEMBRANES, V1788, P623, DOI 10.1016/j.bbamem.2008.12.014; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; SIMBENI R, 1993, BIOCHIM BIOPHYS ACTA, V1145, P1, DOI 10.1016/0005-2736(93)90374-9; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Stroud DA, 2011, J MOL BIOL, V413, P743, DOI 10.1016/j.jmb.2011.09.012; Tamura Y, 2010, EMBO J, V29, P2875, DOI 10.1038/emboj.2010.149; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; VOELKER DR, 1989, J BIOL CHEM, V264, P8019; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057	55	75	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15205	15218		10.1074/jbc.M111.338665	http://dx.doi.org/10.1074/jbc.M111.338665			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403410	hybrid, Green Published			2022-12-25	WOS:000304006300005
J	Law, IKM; Murphy, JE; Bakirtzi, K; Bunnett, NW; Pothoulakis, C				Law, Ivy Ka Man; Murphy, Jane E.; Bakirtzi, Kyriaki; Bunnett, Nigel W.; Pothoulakis, Charalabos			Neurotensin-induced Proinflammatory Signaling in Human Colonocytes Is Regulated by beta-Arrestins and Endothelin-converting Enzyme-1-dependent Endocytosis and Resensitization of Neurotensin Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; COLONIC EPITHELIAL-CELLS; MAP KINASE ACTIVATION; KAPPA-B PATHWAYS; INTERLEUKIN-8 EXPRESSION; INTESTINAL INFLAMMATION; NEUROKININ-1 RECEPTOR; EGF RECEPTOR; TRAFFICKING; ENZYME-1	The neuropeptide/hormone neurotensin (NT) mediates intestinal inflammation and cell proliferation by binding of its high affinity receptor, neurotensin receptor-1 (NTR1). NT stimulates IL-8 expression in NCM460 human colonic epithelial cells by both MAP kinase-and NF-kappa B-dependent pathways. Although the mechanism of NTR1 endocytosis has been studied, the relationship between NTR1 intracellular trafficking and inflammatory signaling remains to be elucidated. In the present study, we show that in NCM460 cells exposed to NT, beta-arrestin-1 (beta ARR1), and beta-arrestin-2 (beta ARR2) translocate to early endosomes together with NTR1. Endothelin-converting enzyme-1 (ECE-1) degrades NT in acidic conditions, and its activity is crucial for NTR1 recycling. Pretreatment of NCM460 cells with the ECE-1 inhibitor SM19712 or gene silencing of beta ARR1 or beta ARR2 inhibits NT-stimulated ERK1/2 and JNK phosphorylation, NF-kappa B p65 nuclear translocation and phosphorylation, and IL-8 secretion. Furthermore, NT-induced cell proliferation, but not IL-8 transcription, is attenuated by the JNK inhibitor, JNK(AII). Thus, NTR1 internalization and recycling in human colonic epithelial cells involves beta ARRs and ECE-1, respectively. Our results also indicate that beta ARRs and ECE-1-dependent recycling regulate MAP kinase and NF-kappa B signaling as well as cell proliferation in human colonocytes in response to NT.	[Law, Ivy Ka Man; Bakirtzi, Kyriaki; Pothoulakis, Charalabos] Univ Calif Los Angeles, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA; [Murphy, Jane E.; Bunnett, Nigel W.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Murphy, Jane E.; Bunnett, Nigel W.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Melbourne, Vic 3052, Australia	University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pothoulakis, C (corresponding author), Univ Calif Los Angeles, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA.	cpothoulakis@mednet.ucla.edu	Law, Ka Man (Ivy)/AAF-7097-2020	Law, Ka Man (Ivy)/0000-0002-7430-1215; Bunnett, Nigel W./0000-0003-3367-0644	National Institutes of Health [DK60729, P50 DK 64539, DK43207, DK39957, JCCC/P30 CA016042, CURE/P30 DK041301]; National Health and Medical Research Council Australia [633033]; Blinder Research Foundation for Crohn's Disease; Eli and Edythe Broad Chair; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK060729, R37DK039957, R01DK039957, P50DK064539, R01DK043207, R56DK043207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Blinder Research Foundation for Crohn's Disease; Eli and Edythe Broad Chair; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60729, P50 DK 64539 (to C. P.), DK43207, and DK39957 (to N. W. B.). This work was also supported by National Health and Medical Research Council Australia Fellowship 633033 (to N. W. B.), and the Blinder Research Foundation for Crohn's Disease and the Eli and Edythe Broad Chair (to C. P.). This work was also supported in part by National Institutes of Health Grants JCCC/P30 CA016042 and CURE/P30 DK041301.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Auyeung KKW, 2009, INT J MOL MED, V23, P189, DOI 10.3892/ijmm_00000116; Azarani A, 1998, BIOCHEM J, V333, P439, DOI 10.1042/bj3330439; Bakirtzi K, 2011, GASTROENTEROLOGY, V141, P1749, DOI 10.1053/j.gastro.2011.07.038; Bohm SK, 1997, BIOCHEM J, V322, P1; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Botto JM, 1998, BIOCHEM BIOPH RES CO, V243, P585, DOI 10.1006/bbrc.1997.8071; Brun P, 2005, AM J PHYSIOL-GASTR L, V288, pG621, DOI 10.1152/ajpgi.00140.2004; Castagliuolo I, 1999, J CLIN INVEST, V103, P843, DOI 10.1172/JCI4217; Cattaruzza F, 2009, BRIT J PHARMACOL, V156, P730, DOI 10.1111/j.1476-5381.2008.00039.x; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; Chao C, 2005, J SURG RES, V129, P313, DOI 10.1016/j.jss.2005.04.038; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Conner DA, 1997, CIRC RES, V81, P1021; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Ehlers RA, 2000, BIOCHEM BIOPH RES CO, V269, P704, DOI 10.1006/bbrc.2000.2335; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Garland AM, 1996, MOL PHARMACOL, V49, P438; Gomez PF, 2005, J IMMUNOL, V175, P6924, DOI 10.4049/jimmunol.175.10.6924; Gui XY, 2008, PEPTIDES, V29, P1609, DOI 10.1016/j.peptides.2008.04.014; Hassan S, 2006, REGUL PEPTIDES, V133, P105, DOI 10.1016/j.regpep.2005.09.031; Hermans E, 1997, BRIT J PHARMACOL, V121, P1817, DOI 10.1038/sj.bjp.0701334; Hermans E, 1998, PHARMACOL THERAPEUT, V79, P89, DOI 10.1016/S0163-7258(98)00009-6; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Johnson GD, 1999, J BIOL CHEM, V274, P4053, DOI 10.1074/jbc.274.7.4053; Kisfalvi K, 2010, J CELL PHYSIOL, V223, P309, DOI 10.1002/jcp.22036; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Muller L, 2003, J BIOL CHEM, V278, P545, DOI 10.1074/jbc.M208949200; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; POLAK JM, 1977, NATURE, V270, P183, DOI 10.1038/270183a0; Roosterman D, 2004, J BIOL CHEM, V279, P30670, DOI 10.1074/jbc.M402479200; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Roosterman D, 2008, ENDOCRINOLOGY, V149, P2200, DOI 10.1210/en.2007-1628; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; SAKODA T, 1992, ONCOGENE, V7, P1705; Sakoda T, 1999, J MOL CELL CARDIOL, V31, P2037, DOI 10.1006/jmcc.1999.1035; Savdie C, 2006, CELL TISSUE RES, V324, P69, DOI 10.1007/s00441-005-0102-3; Schmidlin F, 2001, J BIOL CHEM, V276, P25427, DOI 10.1074/jbc.M101688200; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Toy-Miou-Leong M, 2004, J BIOL CHEM, V279, P12636, DOI 10.1074/jbc.M303384200; Vandenbulcke F, 2000, J CELL SCI, V113, P2963; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhao DZ, 2007, INT J CANCER, V120, P1652, DOI 10.1002/ijc.22407; Zhao DZ, 2006, PEPTIDES, V27, P2434, DOI 10.1016/j.peptides.2005.12.016; Zhao DZ, 2011, J BIOL CHEM, V286, P6092, DOI 10.1074/jbc.M110.192534; Zhao DZ, 2005, MOL PHARMACOL, V67, P2025, DOI 10.1124/mol.104.010801; Zhao DZ, 2004, J BIOL CHEM, V279, P43547, DOI 10.1074/jbc.M401453200; Zhao DZ, 2003, AM J PHYSIOL-CELL PH, V284, pC1397, DOI 10.1152/ajpcell.00328.2002; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200	71	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15066	15075		10.1074/jbc.M111.327262	http://dx.doi.org/10.1074/jbc.M111.327262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22416137	Green Published, hybrid			2022-12-25	WOS:000304003200068
J	Alexander, KA; Blackburn, JK; Vandewalle, ME; Pesapane, R; Baipoledi, EK; Elzer, PH				Alexander, Kathleen Anne; Blackburn, Jason Kenna; Vandewalle, Mark Eric; Pesapane, Risa; Baipoledi, Eddie Kekgonne; Elzer, Phil H.			Buffalo, Bush Meat, and the Zoonotic Threat of Brucellosis in Botswana	PLOS ONE			English	Article							FLUORESCENCE-POLARIZATION ASSAY; AFRICAN BUFFALO; SYNCERUS-CAFFER; WOOD BISON; TUBERCULOSIS; DIAGNOSIS; ZOONOSES; DYNAMICS; DISEASE	Background: Brucellosis is a zoonotic disease of global importance infecting humans, domestic animals, and wildlife. Little is known about the epidemiology and persistence of brucellosis in wildlife in Southern Africa, particularly in Botswana. Methods: Archived wildlife samples from Botswana (1995-2000) were screened with the Rose Bengal Test (RBT) and fluorescence polarization assay (FPA) and included the African buffalo (247), bushbuck (1), eland (5), elephant (25), gemsbok (1), giraffe (9), hartebeest (12), impala (171), kudu (27), red lechwe (10), reedbuck (1), rhino (2), springbok (5), steenbok (2), warthog (24), waterbuck (1), wildebeest (33), honey badger (1), lion (43), and zebra (21). Human case data were extracted from government annual health reports (1974-2006). Findings: Only buffalo (6%, 95% CI 3.04%-8.96%) and giraffe (11%, 95% CI 0-38.43%) were confirmed seropositive on both tests. Seropositive buffalo were widely distributed across the buffalo range where cattle density was low. Human infections were reported in low numbers with most infections (46%) occurring in children (<14 years old) and no cases were reported among people working in the agricultural sector. Conclusions: Low seroprevalence of brucellosis in Botswana buffalo in a previous study in 1974 and again in this survey suggests an endemic status of the disease in this species. Buffalo, a preferred source of bush meat, is utilized both legally and illegally in Botswana. Household meat processing practices can provide widespread pathogen exposure risk to family members and the community, identifying an important source of zoonotic pathogen transmission potential. Although brucellosis may be controlled in livestock populations, public health officials need to be alert to the possibility of human infections arising from the use of bush meat. This study illustrates the need for a unified approach in infectious disease research that includes consideration of both domestic and wildlife sources of infection in determining public health risks from zoonotic disease invasions.	[Alexander, Kathleen Anne; Pesapane, Risa] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Alexander, Kathleen Anne; Vandewalle, Mark Eric] CARACAL Ctr Conservat African Resources Anim Comm, Kasane, Botswana; [Blackburn, Jason Kenna] Univ Florida, Dept Geog, Spatial Epidemiol & Ecol Res Lab, Gainesville, FL 32611 USA; [Blackburn, Jason Kenna] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Baipoledi, Eddie Kekgonne] Botswana Dept Vet Serv, Gaborone, Botswana; [Elzer, Phil H.] Louisiana State Univ Agr Ctr, Dept Vet Sci, Baton Rouge, LA USA	Virginia Polytechnic Institute & State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Louisiana State University System; Louisiana State University	Alexander, KA (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	kathyalx@vt.edu	Alexander, Kathleen A/A-9765-2010; Pesapane, Risa/AAG-2407-2020; Blackburn, Jason/AAV-9445-2020	Alexander, Kathleen A/0000-0001-7338-5341; Pesapane, Risa/0000-0001-9318-9911; Blackburn, Jason/0000-0003-0928-4831	Virginia Tech; WildiZe Foundation; Emerging Pathogens Institute at the University of Florida; Louisiana State University Agricultural Center Experiment Station; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	Virginia Tech; WildiZe Foundation; Emerging Pathogens Institute at the University of Florida; Louisiana State University Agricultural Center Experiment Station; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Financial support was provided by Virginia Tech, the WildiZe Foundation, the Emerging Pathogens Institute at the University of Florida, and the Louisiana State University Agricultural Center Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Shaalan Mohammed, 2002, International Journal of Infectious Diseases, V6, P182, DOI 10.1016/S1201-9712(02)90108-6; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; CHAPARRO F, 1990, J S AFR VET ASSOC, V61, P110; Cooper A C, 1974, Bull Epizoot Dis Afr, V22, P119; Cross PC, 2010, ECOL APPL, V20, P278, DOI 10.1890/08-2062.1; Dajer A, 1999, PREV VET MED, V40, P67, DOI 10.1016/S0167-5877(99)00004-5; Davis D. S., 1990, Animal brucellosis., P321; Dobson A, 1996, ECOLOGY, V77, P1026, DOI 10.2307/2265573; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; El-Metwally Mohamed Tolba, 2011, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V41, P35; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Gomo C, 2011, TROP ANIM HLTH PROD, P1; Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; HERR S, 1981, ONDERSTEPOORT J VET, V48, P133; Hitchcock R.K., 1996, BOTSWANA NOTES RECOR, V28, P55; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; John K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-162; Joly DO, 2005, J ANIM ECOL, V74, P543, DOI 10.1111/j.1365-2656.2005.00953.x; Kgathi D.L., 2005, BOTSWANA NOTES RECOR, V37, P61; Lundervold M, 2001, THESIS IMPERIAL COLL; MacMillan A., 1990, Animal brucellosis., P153; Madsen M, 1995, J ZOO WILDLIFE MED, V26, P240; Maquart M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-145; Marriott FHC, 1985, SAMPLING PROCEDURES; Mbaiwa JE, 2009, TOURISM DEV RURAL LI; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086; Mfunda Iddi M., 2010, International Journal of Biodiversity and Conservation, V2, P263; Mooketsi C., 2001, PULA BOTSWANA J AFRI, V15, P108; Muller Z., 2008, QUANTIFYING GIRAFFE; Munoz PM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-46; Ndibalema VG, 2008, AFR J ECOL, V46, P311, DOI 10.1111/j.1365-2028.2007.00836.x; Nielsen K, 1996, J IMMUNOL METHODS, V195, P161, DOI 10.1016/0022-1759(96)00116-0; Nielsen K, 2002, J IMMUNOASS IMMUNOCH, V23, P307, DOI 10.1081/IAS-120013030; OIE, 2004, BOV BRUC, P409; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; PAUL J, 1995, T ROY SOC TROP MED H, V89, P228, DOI 10.1016/0035-9203(95)90508-1; Robinson Timothy P, 2007, Vet Ital, V43, P745; Roy S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001259; Serrano E, 2011, EPIDEMIOLOGY INFECT, V1, P1; SINCLAIR A R E, 1974, East African Wildlife Journal, V12, P169; TESSARO SV, 1993, CAN J VET RES, V57, P231; Thebe PC, CULTURE CUSTOMS BOTS; USAID, 2007, AFR REG HIV AIDS COU; VanderPost C, COMMUNITY NATURAL RE; WAGHELA S, 1986, J WILDLIFE DIS, V22, P189, DOI 10.7589/0090-3558-22.2.189; Yoo HS, 2010, J REPROD DEVELOP, V56, pS53, DOI 10.1262/jrd.1056S53; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283	50	43	44	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32842	10.1371/journal.pone.0032842	http://dx.doi.org/10.1371/journal.pone.0032842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412932	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000017
J	Kriesel, JD; Hobbs, MR; Jones, BB; Milash, B; Nagra, RM; Fischer, KF				Kriesel, John D.; Hobbs, Maurine R.; Jones, Brandt B.; Milash, Brett; Nagra, Rashed M.; Fischer, Kael F.			Deep Sequencing for the Detection of Virus-Like Sequences in the Brains of Patients with Multiple Sclerosis: Detection of GBV-C in Human Brain	PLOS ONE			English	Article							HEPATITIS-G-VIRUS; C/HEPATITIS-G VIRUS; NON-A; MOLECULAR-CLONING; INFECTION; PREVALENCE; DISEASE; TRANSMISSION; THERAPY; CLUSTER	Multiple sclerosis (MS) is a demyelinating disease of unknown origin that affects the central nervous system of an estimated 400,000 Americans. GBV-C or hepatitis G is a flavivirus that is found in the serum of 1-2% of blood donors. It was originally associated with hepatitis, but is now believed to be a relatively non-pathogenic lymphotropic virus. Fifty frozen specimens from the brains of deceased persons affected by MS were obtained along with 15 normal control brain specimens. RNA was extracted and ribosomal RNAs were depleted before sequencing on the Illumina GAII. These 36 bp reads were compared with a non-redundant database derived from the 600,000+ viral sequences in GenBank organized into 4080 taxa. An individual read successfully aligned to the viral database was considered to be a "hit''. Normalized MS specimen hit rates for each viral taxon were compared to the distribution of hits in the normal controls. Seventeen MS and 11 control brain extracts were sequenced, yielding 4-10 million sequences ("reads'') each. Over-representation of sequence from at least one of 12 viral taxa was observed in 7 of the 17 MS samples. Sequences resembling other viruses previously implicated in the pathogenesis of MS were not significantly enriched in any of the diseased brain specimens. Sequences from GB virus C (GBV-C), a flavivirus not previously isolated from brain, were enriched in one of the MS samples. GBV-C in this brain specimen was confirmed by specific amplification in this single MS brain specimen, but not in the 30 other MS brain samples available. The entire 9.4 kb sequence of this GBV-C isolate is reported here. This study shows the feasibility of deep sequencing for the detection of occult viral infections in the brains of deceased persons with MS. The first isolation of GBV-C from human brain is reported here.	[Kriesel, John D.; Hobbs, Maurine R.; Jones, Brandt B.] Univ Utah, Dept Internal Med, Div Infect Dis, Salt Lake City, UT 84112 USA; [Milash, Brett] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Nagra, Rashed M.] W Los Angeles VA Med Ctr, Human Brain & Spinal Fluid Resource Ctr, Los Angeles, CA USA; [Fischer, Kael F.] ARUP Labs, Salt Lake City, UT USA; [Fischer, Kael F.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Kriesel, JD (corresponding author), Univ Utah, Dept Internal Med, Div Infect Dis, Salt Lake City, UT 84112 USA.	John.Kriesel@hsc.utah.edu	Fischer, Kael/F-7756-2015	Fischer, Kael/0000-0002-7547-330X	National Multiple Sclerosis Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077023] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was supported by grants from the National Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Atkins GJ, 2000, REV MED VIROL, V10, P291, DOI 10.1002/1099-1654(200009/10)10:5&lt;291::AID-RMV278&gt;3.0.CO;2-U; Bjorkman P, 2001, VOX SANG, V81, P148, DOI 10.1046/j.1423-0410.2001.00098.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Clevenberg P., 1998, Clin Microbiol Infect, V4, P644, DOI 10.1111/j.1469-0691.1998.tb00347.x; De Renzo A, 2002, HAEMATOLOGICA, V87, P714; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Epstein JH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000972; Erker JC, 1996, J GEN VIROL, V77, P2713, DOI 10.1099/0022-1317-77-11-2713; Esper F, 2005, J INFECT DIS, V191, P492, DOI 10.1086/428138; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Giannoulis E, 2004, ACTA HAEMATOL-BASEL, V112, P189, DOI 10.1159/000081270; Giulivi A, 2000, VOX SANG, V79, P201, DOI 10.1159/000056731; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Hoftberger R, 2007, MULT SCLER, V13, P1100, DOI 10.1177/1352458507078684; Hyland CA, 1998, TRANSFUSION, V38, P821, DOI 10.1046/j.1537-2995.1998.38998409001.x; Kahn JS, 2007, PEDIATR INFECT DIS J, V26, P745, DOI 10.1097/INF.0b013e3181376428; Kao JH, 1997, J MED VIROL, V53, P348, DOI 10.1002/(SICI)1096-9071(199712)53:4&lt;348::AID-JMV6&gt;3.0.CO;2-7; Krajden M, 2010, INT J CANCER, V126, P2885, DOI 10.1002/ijc.25035; Kurtzke JF, 2000, J NEUROVIROL, V6, pS134; Kurtzke John F, 2005, Phys Med Rehabil Clin N Am, V16, P327, DOI 10.1016/j.pmr.2005.01.013; Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;60::AID-JMV10&gt;3.0.CO;2-A; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; McLinden JH, 2011, 2011 M INF DIS SOC A; Meinl E, 1999, CURR OPIN NEUROL, V12, P303, DOI 10.1097/00019052-199906000-00009; Mohr EL, 2010, J GEN VIROL; Mohr EL, 2010, J IMMUNOL, V185, P4496, DOI 10.4049/jimmunol.1001980; Murray J, 2002, BMJ-BRIT MED J, V325, P1128, DOI 10.1136/bmj.325.7373.1128; Oleszak EL, 2004, CLIN MICROBIOL REV, V17, P174, DOI 10.1128/CMR.17.1.174-207.2004; Osorio Y, 2005, EXP NEUROL, V193, P1, DOI 10.1016/j.expneurol.2004.12.004; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Radkowski M, 1998, SCAND J INFECT DIS, V30, P539, DOI 10.1080/00365549850161647; Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548; Reshetnyak VI, 2008, WORLD J GASTROENTERO, V14, P4725, DOI 10.3748/wjg.14.4725; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Souza IE, 2006, J CLIN MICROBIOL, V44, P3105, DOI 10.1128/JCM.02663-05; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Tsunoda I, 1996, J NEUROPATH EXP NEUR, V55, P673, DOI 10.1097/00005072-199606000-00001; Tucker T J, 2001, Clin Lab, V47, P239; Tucker TJ, 2000, J MED VIROL, V61, P52, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;52::AID-JMV8&gt;3.0.CO;2-L; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10; Zandian M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016820; Zandian M, 2009, INVEST OPHTH VIS SCI, V50, P3275, DOI 10.1167/iovs.08-3211	47	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e31886	10.1371/journal.pone.0031886	http://dx.doi.org/10.1371/journal.pone.0031886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412845	Green Published, gold			2022-12-25	WOS:000303062000003
J	Minakawa, N; Dida, GO; Sonye, GO; Futami, K; Njenga, SM				Minakawa, Noboru; Dida, Gabriel O.; Sonye, George O.; Futami, Kyoko; Njenga, Sammy M.			Malaria Vectors in Lake Victoria and Adjacent Habitats in Western Kenya	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; ANOPHELES-FUNESTUS DIPTERA; GAMBIAE COMPLEX; WATER HYACINTH; AQUATIC STAGES; CULICIDAE; MOSQUITOS; ABUNDANCE; FALL; IDENTIFICATION	The prevalence of malaria among the residents of the Lake Victoria basin remains high. The environment associated with the lake may maintain a high number of malaria vectors. Lake habitats including water hyacinths have been suspected to be the source of vectors. This study investigated whether malaria vectors breed in the lake habitats and adjacent backwater pools. Anopheline larvae were collected within the littoral zone of the lake and adjacent pools located along approximately 24.3 km of the lakeshore in western Kenya, and their breeding sites characterized. Three primary vector species, Anopheles arabiensis, Anopheles gambiae s.s. and Anopheles funestus s.s., and three potential vectors, were found in the lake habitats. Unexpectedly, An. arabiensis was the most dominant vector species in the lake sampling sites. Its habitats were uncovered or covered with short grass. A potential secondary malaria vector, Anopheles rivulorum, dominated the water hyacinths in the lake. Most breeding sites in the lake were limited to areas that were surrounded by tall emergent plants, including trees, and those not exposed to waves. Nearly half of adjacent habitats were lagoons that were separated from the lake by sand bars. Lagoons contained a variety of microhabitats. Anopheles arabiensis dominated open habitats, whereas An. funestus s.s. was found mainly in vegetated habitats in lagoons. The current study confirmed that several breeding sites are associated with Lake Victoria. Given that Lake Victoria is the second largest lake in the world, the lake related habitats must be extensive; therefore, making targeted vector control difficult. Further exploration is necessary to estimate the effects of lake associated habitats on malaria transmission so as to inform a rational decision-making process for vector control.	[Minakawa, Noboru; Futami, Kyoko] Nagasaki Univ, Dept Vector Ecol & Environm, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Minakawa, Noboru; Futami, Kyoko] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Dida, Gabriel O.] Maseno Univ, Sch Publ Hlth, Maseno, Kenya; [Sonye, George O.] Springs Hope, Mbita, Kenya; [Njenga, Sammy M.] Kenya Govt Med Res Ctr, Eastern & So Africa Ctr Int Parasite Control, Nairobi, Kenya	Nagasaki University; Nagasaki University; Maseno University; Kenya Medical Research Institute	Minakawa, N (corresponding author), Nagasaki Univ, Dept Vector Ecol & Environm, Inst Trop Med NEKKEN, Nagasaki 852, Japan.	Minakawa@nagasaki-u.ac.jp		O Dida, Gabriel/0000-0003-2442-0352; , Noboru/0000-0003-3664-9605; Njenga, Sammy/0000-0001-6309-476X	Global COE at Nagasaki University, Japan	Global COE at Nagasaki University, Japan	The work described here was supported by the Global COE Program at Nagasaki University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TP, 2004, J AQUAT PLANT MANAGE, V42, P73; Andrianaivolambo L, 2010, ACTA TROP, V116, P240, DOI 10.1016/j.actatropica.2010.08.017; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; [Anonymous], 1999, DAMS DIS ECOLOGICAL; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; CARRARA GC, 1990, MED VET ENTOMOL, V4, P421, DOI 10.1111/j.1365-2915.1990.tb00460.x; Cohuet A, 2004, J MED ENTOMOL, V41, P901, DOI 10.1603/0022-2585-41.5.901; Dia I, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-61; Evans AM, 1937, NATURE, V31, P187; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; GILLIES MT, 1968, PUBLICATION S AFRICA, V54; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Gurmu S, 1996, J BUS ECON STAT, V14, P469, DOI 10.2307/1392255; Hancock GLR, 1934, J ANIM ECOL, V3, P202; HOPKINS G. H. E., 1940, EAST AFRICAN MED JOUR, V17, P189; Imbahale SS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-81; Imbahale SS, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-130; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; Lautze J, 2007, TROP MED INT HEALTH, V12, P982, DOI 10.1111/j.1365-3156.2007.01878.x; Leeson H.S., 1937, B ENTOMOL RSE, V28, P587; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; MBOGO CNM, 1993, AM J TROP MED HYG, V49, P245, DOI 10.4269/ajtmh.1993.49.245; Minakawa N, 2005, J MED ENTOMOL, V42, P295, DOI 10.1603/0022-2585(2005)042[0295:RBOOAG]2.0.CO;2; Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Minakawa N, 1999, J FRESHWATER ECOL, V14, P249, DOI 10.1080/02705060.1999.9663676; Minakawa N, 2001, J MED ENTOMOL, V38, P388, DOI 10.1603/0022-2585-38.3.388; Minakawa N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-119; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Navarro LA., 2000, WATER HYACINTH AFRIC; Ndenga BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019473; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Ofulla A. V. O., 2010, Lakes & Reservoirs Research and Management, V15, P255, DOI 10.1111/j.1440-1770.2010.00434.x; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Root G P, 1999, Int J Popul Geogr, V5, P117, DOI 10.1002/(SICI)1099-1220(199903/04)5:2<117::AID-IJPG127>3.0.CO;2-I; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; STEPHENSON TD, 1990, J GREAT LAKES RES, V16, P71, DOI 10.1016/S0380-1330(90)71399-8; Temu EA, 2007, ACTA TROP, V102, P119, DOI 10.1016/j.actatropica.2007.04.009; WHO, 2004, WHOCDSCPEPVC200410; Wilkes TJ, 1996, MED VET ENTOMOL, V10, P108, DOI 10.1111/j.1365-2915.1996.tb00092.x; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21	45	53	53	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32725	10.1371/journal.pone.0032725	http://dx.doi.org/10.1371/journal.pone.0032725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412913	gold, Green Submitted, Green Published			2022-12-25	WOS:000303062000016
J	Li, MJ; Feng, FJ; Cheng, LL				Li, Mingjun; Feng, Fengjuan; Cheng, Lailiang			Expression Patterns of Genes Involved in Sugar Metabolism and Accumulation during Apple Fruit Development	PLOS ONE			English	Article							SUCROSE-PHOSPHATE SYNTHASE; SORBITOL-DEHYDROGENASE; PHENOLIC-COMPOUNDS; ORGANIC-ACIDS; ARABIDOPSIS; INVERTASE; TRANSPORTER; ROLES; COMPARTMENTATION; PHOTOSYNTHESIS	Both sorbitol and sucrose are imported into apple fruit from leaves. The metabolism of sorbitol and sucrose fuels fruit growth and development, and accumulation of sugars in fruit is central to the edible quality of apple. However, our understanding of the mechanisms controlling sugar metabolism and accumulation in apple remains quite limited. We identified members of various gene families encoding key enzymes or transporters involved in sugar metabolism and accumulation in apple fruit using homology searches and comparison of their expression patterns in different tissues, and analyzed the relationship of their transcripts with enzyme activities and sugar accumulation during fruit development. At the early stage of fruit development, the transcript levels of sorbitol dehydrogenase, cell wall invertase, neutral invertase, sucrose synthase, fructokinase and hexokinase are high, and the resulting high enzyme activities are responsible for the rapid utilization of the imported sorbitol and sucrose for fruit growth, with low levels of sugar accumulation. As the fruit continues to grow due to cell expansion, the transcript levels and activities of these enzymes are down-regulated, with concomitant accumulation of fructose and elevated transcript levels of tonoplast monosaccharide transporters (TMTs), MdTMT1 and MdTMT2; the excess carbon is converted into starch. At the late stage of fruit development, sucrose accumulation is enhanced, consistent with the elevated expression of sucrose-phosphate synthase (SPS), MdSPS5 and MdSPS6, and an increase in its total activity. Our data indicate that sugar metabolism and accumulation in apple fruit is developmentally regulated. This represents a comprehensive analysis of the genes involved in sugar metabolism and accumulation in apple, which will serve as a platform for further studies on the functions of these genes and subsequent manipulation of sugar metabolism and fruit quality traits related to carbohydrates.	[Li, Mingjun; Feng, Fengjuan] NW A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Li, Mingjun; Feng, Fengjuan; Cheng, Lailiang] Cornell Univ, Dept Hort, Ithaca, NY 14853 USA	Northwest A&F University - China; Cornell University	Li, MJ (corresponding author), NW A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	LC89@Cornell.edu		Li, Mingjun/0000-0001-5508-895X	Cornell University Agricultural Experiment Station	Cornell University Agricultural Experiment Station	This study was supported by Cornell University Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afoufa-Bastien D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-245; Aluri S, 2007, P NATL ACAD SCI USA, V104, P2537, DOI 10.1073/pnas.0610278104; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; BERUTER J, 1985, J PLANT PHYSIOL, V121, P331, DOI 10.1016/S0176-1617(85)80026-2; Bieniawska Z, 2007, PLANT J, V49, P810, DOI 10.1111/j.1365-313X.2006.03011.x; Braun DM, 2009, PLANT PHYSIOL, V149, P71, DOI 10.1104/pp.108.129049; Chen LS, 2002, J EXP BOT, V53, P341, DOI 10.1093/jexbot/53.367.341; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cho JI, 2009, PLANT PHYSIOL, V149, P745, DOI 10.1104/pp.108.131227; Cho YH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001263; Claeyssen E, 2007, PHYTOCHEMISTRY, V68, P709, DOI 10.1016/j.phytochem.2006.12.001; Dai N, 2011, PLANT MOL BIOL, V76, P1, DOI 10.1007/s11103-011-9757-1; DANCER J, 1990, PLANTA, V182, P223, DOI 10.1007/BF00197115; De Coninck B, 2005, PLANT CELL ENVIRON, V28, P432, DOI 10.1111/j.1365-3040.2004.01281.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fan RC, 2009, PLANT PHYSIOL, V150, P1880, DOI 10.1104/pp.109.141374; Gao ZF, 2005, J AM SOC HORTIC SCI, V130, P261, DOI 10.21273/JASHS.130.2.261; Gao ZF, 2003, PLANT PHYSIOL, V131, P1566, DOI 10.1104/pp.102.016725; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Granot D, 2007, FUNCT PLANT BIOL, V34, P564, DOI 10.1071/FP06207; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; HUBBARD NL, 1991, PHYSIOL PLANTARUM, V82, P191, DOI [10.1111/j.1399-3054.1991.tb00080.x, 10.1034/j.1399-3054.1991.820208.x]; Huber SC, 1996, ANNU REV PLANT PHYS, V47, P431, DOI 10.1146/annurev.arplant.47.1.431; Janssen BJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-16; Karve A, 2008, PLANTA, V228, P411, DOI 10.1007/s00425-008-0746-9; Karve A, 2009, J EXP BOT, V60, P4137, DOI 10.1093/jxb/erp252; Li P, 2011, P NATL ACAD SCI USA, V108, P3436, DOI 10.1073/pnas.1018665108; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lutfiyya LL, 2007, J PLANT PHYSIOL, V164, P923, DOI 10.1016/j.jplph.2006.04.014; Mishra BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004502; Moscatello S, 2011, SCI HORTIC-AMSTERDAM, V128, P197, DOI 10.1016/j.scienta.2011.01.013; Nguyen-Quoc B, 2001, J EXP BOT, V52, P881, DOI 10.1093/jexbot/52.358.881; Nonis A, 2008, PLANTA, V229, P129, DOI 10.1007/s00425-008-0815-0; Nosarszewski M, 2004, PHYSIOL PLANTARUM, V121, P391, DOI 10.1111/j.1399-3054.2004.00344.x; Nosarzewski M, 2007, J EXP BOT, V58, P1863, DOI 10.1093/jxb/erm048; Park SW, 2002, PLANT SCI, V162, P513, DOI 10.1016/S0168-9452(01)00599-4; Patrick JW, 1997, ANNU REV PLANT PHYS, V48, P191, DOI 10.1146/annurev.arplant.48.1.191; RENZ A, 1993, PLANTA, V190, P166; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Schulz A, 2011, PLANT J, V68, P129, DOI 10.1111/j.1365-313X.2011.04672.x; STITT M, 1988, PLANTA, V174, P217, DOI 10.1007/BF00394774; Sturm A, 1999, PLANT PHYSIOL, V121, P1, DOI 10.1104/pp.121.1.1; Sun JD, 2011, PLANT CELL ENVIRON, V34, P592, DOI 10.1111/j.1365-3040.2010.02265.x; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang HC, 2010, PLANTA, V232, P511, DOI 10.1007/s00425-010-1194-x; Wang L, 2010, PLANT PHYSIOL, V154, P744, DOI 10.1104/pp.110.162487; Wormit A, 2006, PLANT CELL, V18, P3476, DOI 10.1105/tpc.106.047290; Yamaki S, 1995, ACTA HORTIC, P109, DOI 10.17660/ActaHortic.1995.398.11; YAMAKI S, 1992, J AM SOC HORTIC SCI, V117, P951, DOI 10.21273/JASHS.117.6.951; YAMAKI S, 1984, PLANT CELL PHYSIOL, V25, P151; Zhang LY, 2004, PLANT PHYSIOL, V135, P574, DOI 10.1104/pp.103.036632; Zhang YZ, 2010, FOOD CHEM, V123, P1013, DOI 10.1016/j.foodchem.2010.05.053; Zhou R, 2006, J EXP BOT, V57, P3647, DOI 10.1093/jxb/erl112; ZRENNER R, 1995, PLANT J, V7, P97, DOI 10.1046/j.1365-313X.1995.07010097.x	60	230	251	17	216	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33055	10.1371/journal.pone.0033055	http://dx.doi.org/10.1371/journal.pone.0033055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412983	Green Submitted, gold, Green Published			2022-12-25	WOS:000303060800080
J	Rogers, HH; Griffiths-Jones, S				Rogers, Hubert H.; Griffiths-Jones, Sam			Mitochondrial Pseudogenes in the Nuclear Genomes Drosophila	PLOS ONE			English	Article							TRANSFER-RNA GENES; DNA LOSS; EVOLUTION; SEQUENCE; INSERTIONS; NUMTS; DUPLICATIONS; SUBSTITUTION; MELANOGASTER; PROGRAM	Mitochondrial pseudogenes in nuclear chromosomes (numts) have been detected in the genomes of a diverse range of eukaryotic species. However, the numt content of different genomes and their properties is not uniform, and study of these differences provides insight into the mechanisms and dynamics of genome evolution in different organisms. In the genus Drosophila, numts have previously only been identified on a genome-wide scale in the melanogaster subgroup. The present study extends the identification to 11 species of the Drosophila genus. We identify a total of 302 numts and show that the numt complement is highly variable in Drosophilids, ranging from just 4 in D. melanogaster to 67 in D. willistoni, broadly correlating with genome size. Many numts have undergone large-scale rearrangements in the nucleus, including interruptions, inversions, deletions and duplications of sequence of variable size. Estimating the age of the numts in the nucleus by phylogenetic tree reconstruction reveals the vast majority of numts to be recent gains, 90% having arisen on terminal branches of the species tree. By identifying paralogs and counting duplications among the extant numts we estimate that 23% of extant numts arose through post-insertion duplications. We estimate genus average rates of insertion of 0.75 per million years, and a duplication rate of 0.010 duplications per numt per million years.	[Rogers, Hubert H.; Griffiths-Jones, Sam] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Rogers, HH (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	sam.griffiths-jones@manchester.ac.uk	Griffiths-Jones, Sam/H-2998-2014	Griffiths-Jones, Sam/0000-0001-6043-807X	Biotechnology and Biological Sciences Research Council; University of Manchester	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester	This work was supported by a Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) studentship to H.H.R. and by a University of Manchester Fellowship to S.G.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behura SK, 2007, MOL BIOL EVOL, V24, P1492, DOI 10.1093/molbev/msm068; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bensasson D, 2003, J MOL EVOL, V57, P343, DOI 10.1007/s00239-003-2485-7; Bensasson D, 2001, MOL BIOL EVOL, V18, P246, DOI 10.1093/oxfordjournals.molbev.a003798; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Chen JM, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/56182; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Conery J S, 2001, Pac Symp Biocomput, P167; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gish W, 1996, WUBLAST 2 0MP; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hazkani-Covo E, 2003, J MOL EVOL, V56, P169, DOI 10.1007/s00239-002-2390-5; Hazkani-Covo E, 2007, MOL BIOL EVOL, V24, P13, DOI 10.1093/molbev/msl149; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Leister D, 2005, TRENDS GENET, V21, P655, DOI 10.1016/j.tig.2005.09.004; LEWIS DL, 1994, MOL BIOL EVOL, V11, P523; Li RQ, 2005, PLOS COMPUT BIOL, V1, P313, DOI 10.1371/journal.pcbi.0010043; Li W. H, 1997, MOL EVOLUTION; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mishmar D, 2004, HUM MUTAT, V23, P125, DOI 10.1002/humu.10304; Montooth KL, 2009, J MOL EVOL, V69, P94, DOI 10.1007/s00239-009-9255-0; Moriyama EN, 1997, J MOL EVOL, V45, P378, DOI 10.1007/PL00006243; Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971; Nergadze SG, 2010, ANIM GENET, V41, P176, DOI 10.1111/j.1365-2052.2010.02130.x; Nielsen KK, 2001, MOL PHYLOGENET EVOL, V18, P362, DOI 10.1006/mpev.2000.0885; Noutsos C, 2007, TRENDS GENET, V23, P597, DOI 10.1016/j.tig.2007.08.016; Pamilo P, 2007, MOL BIOL EVOL, V24, P1340, DOI 10.1093/molbev/msm055; Petrov DA, 1998, MOL BIOL EVOL, V15, P293, DOI 10.1093/oxfordjournals.molbev.a025926; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rogers HH, 2010, GENOME BIOL EVOL, V2, P467, DOI 10.1093/gbe/evq034; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Sawamura K, 2008, MOL PHYLOGENET EVOL, V48, P1087, DOI 10.1016/j.ympev.2008.06.007; SHARP PM, 1989, J MOL EVOL, V28, P398, DOI 10.1007/BF02603075; Sheppard AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000323; Singh ND, 2004, MOL BIOL EVOL, V21, P670, DOI 10.1093/molbev/msh060; Smit A, 1996, REPEATMASKER OPEN 30; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	48	33	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32593	10.1371/journal.pone.0032593	http://dx.doi.org/10.1371/journal.pone.0032593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412894	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800032
J	Hainaut, M; Sagnier, T; Berenger, H; Pradel, J; Graba, Y; Miotto, B				Hainaut, Matthieu; Sagnier, Thierry; Berenger, Helene; Pradel, Jacques; Graba, Yacine; Miotto, Benoit			The MYST-Containing Protein Chameau Is Required for Proper Sensory Organ Specification during Drosophila Thorax Morphogenesis	PLOS ONE			English	Article							ACHAETE-SCUTE COMPLEX; ZINC-FINGER PROTEIN; LOOP-HELIX PROTEINS; HISTONE ACETYLTRANSFERASE; TRANSCRIPTIONAL ACTIVITY; LATERAL INHIBITION; DNA-BINDING; NEGATIVE REGULATOR; NEURAL DEVELOPMENT; BRISTLE PATTERNS	The adult thorax of Drosophila melanogaster is covered by a stereotyped pattern of mechanosensory bristles called macrochaetes. Here, we report that the MYST containing protein Chameau (Chm) contributes to the establishment of this pattern in the most dorsal part of the thorax. Chm mutant pupae present extra-dorsocentral (DC) and scutellar (SC) macrochaetes, but a normal number of the other macrochaetes. We provide evidences that chm restricts the singling out of sensory organ precursors from proneural clusters and genetically interacts with transcriptional regulators involved in the regulation of achaete and scute in the DC and SC proneural cluster. This function of chm likely relies on chromatin structure regulation since a protein with a mutation in the conserved catalytic site fails to rescue the formation of supernumerary DC and SC bristles in chm mutant flies. This is further supported by the finding that mutations in genes encoding chromatin modifiers and remodeling factors, including Polycomb group (PcG) and Trithorax group (TrxG) members, dominantly modulate the penetrance of chm extra bristle phenotype. These data support a critical role for chromatin structure modulation in the establishment of the stereotyped sensory bristle pattern in the fly thorax.	[Hainaut, Matthieu; Sagnier, Thierry; Berenger, Helene; Pradel, Jacques; Graba, Yacine; Miotto, Benoit] Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, CNRS, UMR6216, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Hainaut, M (corresponding author), Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, CNRS, UMR6216, Marseille, France.	graba@ibdml.univmed.fr; benoit.miotto@univ-paris-diderot.fr	Miotto, Benoit/CAF-2937-2022; Miotto, Benoit/I-6040-2018; Graba, Yacine/AAC-9010-2019	Miotto, Benoit/0000-0003-2857-2126; Miotto, Benoit/0000-0003-2857-2126; 	Centre National de la Recherche Scientifique (CNRS); Association pour la Recherche contre le Cancer (ARC); CEntre Franco-Indien pour la Promotion de la Recherche Avancee (CEFIPRA); Agence Nationale de la Recherche (ANR); Ministere de l'enseignement superieur et de la Recherche (MRT); l'Association pour la Recherche contre le cancer (ARC)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); CEntre Franco-Indien pour la Promotion de la Recherche Avancee (CEFIPRA); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere de l'enseignement superieur et de la Recherche (MRT); l'Association pour la Recherche contre le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), grants from Association pour la Recherche contre le Cancer (ARC), CEntre Franco-Indien pour la Promotion de la Recherche Avancee (CEFIPRA) and Agence Nationale de la Recherche (ANR), and fellowships from Ministere de l'enseignement superieur et de la Recherche (MRT) and l'Association pour la Recherche contre le cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Asmar J, 2008, DEV BIOL, V316, P487, DOI 10.1016/j.ydbio.2008.01.040; Axelrod JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145pe38; Ayyar S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001178; Badenhorst P, 2002, MECH DEVELOP, V117, P87, DOI 10.1016/S0925-4773(02)00183-1; Bejarano F, 2008, GENETICS, V178, P307, DOI 10.1534/genetics.107.081869; Bhattacharya A, 2011, CELL, V147, P881, DOI 10.1016/j.cell.2011.08.055; Biryukova I, 2005, DEV BIOL, V288, P559, DOI 10.1016/j.ydbio.2005.09.033; Biryukova I, 2008, DEV BIOL, V323, P64, DOI 10.1016/j.ydbio.2008.08.014; BOULIANNE GL, 1991, EMBO J, V10, P2975, DOI 10.1002/j.1460-2075.1991.tb07848.x; CABRERA CV, 1994, DEVELOPMENT, V120, P3595; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; CAMPUZANO S, 1985, CELL, V40, P327, DOI 10.1016/0092-8674(85)90147-3; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Contzler R, 2006, BIOCHEM BIOPH RES CO, V350, P208, DOI 10.1016/j.bbrc.2006.09.030; Cubadda Y, 1997, GENE DEV, V11, P3083, DOI 10.1101/gad.11.22.3083; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Furman DR, 2009, COMPUT BIOL CHEM, V33, P231, DOI 10.1016/j.compbiolchem.2009.04.001; Garcia-Bellido A, 2009, GENETICS, V182, P631, DOI 10.1534/genetics.109.104083; Garcia-Garcia MJ, 1999, DEVELOPMENT, V126, P3523; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; Gho M, 1999, DEVELOPMENT, V126, P3573; Gomez-Skarmeta J, 2003, NAT REV NEUROSCI, V4, P587, DOI 10.1038/nrn1142; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Haenlin M, 1997, GENE DEV, V11, P3096, DOI 10.1101/gad.11.22.3096; Heitzler P, 2003, GENE DEV, V17, P591, DOI 10.1101/gad.255703; Heitzler P, 1996, GENETICS, V143, P1271; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Koto A, 2011, CURR BIOL, V21, P278, DOI 10.1016/j.cub.2011.01.015; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; MARTINEZ C, 1993, MOL CELL BIOL, V13, P3514, DOI 10.1128/MCB.13.6.3514; Miotto B, 2006, GENE DEV, V20, P101, DOI 10.1101/gad.359506; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2006, MOL CELL BIOL, V26, P5969, DOI 10.1128/MCB.00696-06; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; Modolell J, 1998, INT J DEV BIOL, V42, P275; Mourikis P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-107; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Pena-Rangel MT, 2002, GENETICS, V160, P1035; Phillips RG, 1999, DEV BIOL, V207, P150, DOI 10.1006/dbio.1998.9149; Ramain P, 2000, MOL CELL, V6, P781, DOI 10.1016/S1097-2765(05)00079-1; RAMAIN P, 1993, DEVELOPMENT, V119, P1277; Reeves N, 2005, DEV CELL, V8, P413, DOI 10.1016/j.devcel.2005.01.020; Renaud O, 2001, DEV BIOL, V240, P361, DOI 10.1006/dbio.2001.0482; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Sambandan D, 2006, GENETICS, V174, P1349, DOI 10.1534/genetics.106.060574; Sato M, 2000, MECH DEVELOP, V93, P127, DOI 10.1016/S0925-4773(00)00282-3; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Simpson P, 1999, DEVELOPMENT, V126, P1349; Simpson P, 2007, TRENDS GENET, V23, P350, DOI 10.1016/j.tig.2007.04.006; SINGSON A, 1994, GENE DEV, V8, P2058, DOI 10.1101/gad.8.17.2058; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Srinivasan S, 2005, DEVELOPMENT, V132, P1623, DOI 10.1242/dev.01713; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; VANDOREN M, 1991, DEVELOPMENT, V113, P245; VANDOREN M, 1994, GENE DEV, V8, P2729, DOI 10.1101/gad.8.22.2729; Vanolst L, 2005, DEVELOPMENT, V132, P4327, DOI 10.1242/dev.02014; Yamasaki Y, 2006, DEV GROWTH DIFFER, V48, P411, DOI 10.1111/j.1440-169x.2006.00880.x; Yang MY, 2012, DEVELOPMENT, V139, P325, DOI 10.1242/dev.074260; Zenvirt S, 2008, GENETICS, V179, P1989, DOI 10.1534/genetics.108.090076	75	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32882	10.1371/journal.pone.0032882	http://dx.doi.org/10.1371/journal.pone.0032882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412942	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100038
J	Kaltenpoth, M; Corneli, PS; Dunn, DM; Weiss, RB; Strohm, E; Seger, J				Kaltenpoth, Martin; Corneli, Patrice Showers; Dunn, Diane M.; Weiss, Robert B.; Strohm, Erhard; Seger, Jon			Accelerated Evolution of Mitochondrial but Not Nuclear Genomes of Hymenoptera: New Evidence from Crabronid Wasps	PLOS ONE			English	Article							HOLOMETABOLOUS INSECT ORDERS; TRANSFER-RNA GENES; CONTROL REGION; PHYLOGENETIC UTILITY; MOLECULAR EVOLUTION; NUCLEOTIDE-SEQUENCE; APIS-MELLIFERA; ORGANIZATION; DNA; ORTHOPTERA	Mitochondrial genes in animals are especially useful as molecular markers for the reconstruction of phylogenies among closely related taxa, due to the generally high substitution rates. Several insect orders, notably Hymenoptera and Phthiraptera, show exceptionally high rates of mitochondrial molecular evolution, which has been attributed to the parasitic lifestyle of current or ancestral members of these taxa. Parasitism has been hypothesized to entail frequent population bottlenecks that increase rates of molecular evolution by reducing the efficiency of purifying selection. This effect should result in elevated substitution rates of both nuclear and mitochondrial genes, but to date no extensive comparative study has tested this hypothesis in insects. Here we report the mitochondrial genome of a crabronid wasp, the European beewolf (Philanthus triangulum, Hymenoptera, Crabronidae), and we use it to compare evolutionary rates among the four largest holometabolous insect orders (Coleoptera, Diptera, Hymenoptera, Lepidoptera) based on phylogenies reconstructed with whole mitochondrial genomes as well as four single-copy nuclear genes (18S rRNA, arginine kinase, wingless, phosphoenolpyruvate carboxykinase). The mt-genome of P. triangulum is 16,029 bp in size with a mean A+T content of 83.6%, and it encodes the 37 genes typically found in arthropod mt genomes (13 protein-coding, 22 tRNA, and two rRNA genes). Five translocations of tRNA genes were discovered relative to the putative ancestral genome arrangement in insects, and the unusual start codon TTG was predicted for cox2. Phylogenetic analyses revealed significantly longer branches leading to the apocritan Hymenoptera as well as the Orussoidea, to a lesser extent the Cephoidea, and, possibly, the Tenthredinoidea than any of the other holometabolous insect orders for all mitochondrial but none of the four nuclear genes tested. Thus, our results suggest that the ancestral parasitic lifestyle of Apocrita is unlikely to be the major cause for the elevated substitution rates observed in hymenopteran mitochondrial genomes.	[Kaltenpoth, Martin] Max Planck Inst Chem Ecol, Res Grp Insect Symbiosis, Jena, Germany; [Kaltenpoth, Martin; Dunn, Diane M.; Weiss, Robert B.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Kaltenpoth, Martin; Strohm, Erhard] Univ Regensburg, Inst Zool, D-8400 Regensburg, Germany; [Corneli, Patrice Showers; Seger, Jon] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Max Planck Society; Utah System of Higher Education; University of Utah; University of Regensburg; Utah System of Higher Education; University of Utah	Kaltenpoth, M (corresponding author), Max Planck Inst Chem Ecol, Res Grp Insect Symbiosis, Jena, Germany.	mkaltenpoth@ice.mpg.de	Kaltenpoth, Martin/M-8475-2014	Kaltenpoth, Martin/0000-0001-9450-0345; Showers Corneli, Patrice/0000-0003-0136-1775	Volkswagen foundation [I/82682]; Max Planck Society; German Science Foundation (DFG) [STR-532/2-2]	Volkswagen foundation(Volkswagen); Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation (DFG)(German Research Foundation (DFG))	We gratefully acknowledge financial support from the Volkswagen foundation through a postdoctoral fellowship to MK (I/82682) and from the Max Planck Society (MK). This study was partly supported by the German Science Foundation (DFG STR-532/2-2 to ES and MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Beckenbach AT, 2009, GENOME BIOL EVOL, V1, P278, DOI 10.1093/gbe/evp027; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Cameron SL, 2008, GENOME, V51, P800, DOI 10.1139/G08-066; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Castro LR, 2002, MOL BIOL EVOL, V19, P1100, DOI 10.1093/oxfordjournals.molbev.a004168; Castro LR, 2005, MOL PHYLOGENET EVOL, V34, P469, DOI 10.1016/j.ympev.2004.11.005; Castro LR, 2007, SYST ENTOMOL, V32, P60, DOI 10.1111/j.1365-3113.2006.00356.x; Castro LR, 2006, GENOME, V49, P752, DOI 10.1139/G06-030; Cha SY, 2007, GENE, V392, P206, DOI 10.1016/j.gene.2006.12.031; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CLARY DO, 1987, J MOL EVOL, V25, P116, DOI 10.1007/BF02101753; CROZIER RH, 1989, MOL BIOL EVOL, V6, P399; CROZIER RH, 1993, GENETICS, V133, P97; Dowton M, 2001, BIOL J LINN SOC, V74, P87, DOI 10.1006/bijl.2001.0577; Dowton M, 2003, J MOL EVOL, V56, P517, DOI 10.1007/s00239-002-2420-3; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Dowton M, 1997, MOL BIOL EVOL, V14, P109, DOI 10.1093/oxfordjournals.molbev.a025696; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; Dowton M, 2009, MOL PHYLOGENET EVOL, V52, P512, DOI 10.1016/j.ympev.2009.04.001; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Fenn JD, 2007, INSECT MOL BIOL, V16, P239, DOI 10.1111/j.1365-2583.2006.00721.x; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Goettler W, 2007, ARTHROPOD STRUCT DEV, V36, P1, DOI 10.1016/j.asd.2006.08.003; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Hu M, 2002, MOL CELL PROBE, V16, P261, DOI 10.1006/mcpr.2002.0422; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Johnson KP, 2003, MOL PHYLOGENET EVOL, V26, P231, DOI 10.1016/S1055-7903(02)00342-1; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, 2006, INT J SYST EVOL MICR, V56, P1403, DOI 10.1099/ijs.0.64117-0; Kaltenpoth M, 2010, EVOL ECOL, V24, P463, DOI 10.1007/s10682-009-9319-z; Kawakita A, 2003, MOL BIOL EVOL, V20, P87, DOI 10.1093/molbev/msg007; Kimura M., 1983, NEUTRAL THEORY MOL E, DOI [10.1017/CBO9780511623486, DOI 10.1017/CBO9780511623486]; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessinger AC, 2000, MED VET ENTOMOL, V14, P71, DOI 10.1046/j.1365-2915.2000.00209.x; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MADDISON DR, 2005, MACCLADE 4 08 ANAL P; Michener CD, 2007, BEES WORLD; Mindell DP, 1996, ANNU REV ECOL SYST, V27, P279, DOI 10.1146/annurev.ecolsys.27.1.279; Moretti S, 2008, NUCLEIC ACIDS RES, V36, pW10, DOI 10.1093/nar/gkn278; Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; ONeill K. M, 1988, NATURAL HIST BEHAV N; Page RDM, 1998, MOL PHYLOGENET EVOL, V9, P276, DOI 10.1006/mpev.1997.0458; Peters RS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-55; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; Sheffield NC, 2008, MOL BIOL EVOL, V25, P2499, DOI 10.1093/molbev/msn198; Sheffield NC, 2010, MITOCHONDR DNA, V21, P87, DOI 10.3109/19401736.2010.500812; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Silvestre D, 2008, GENET MOL BIOL, V31, P451, DOI 10.1590/S1415-47572008000300010; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Strohm E, 1995, ALLOKATION ELTERLICH; Swofford DL, 2001, PAUP 4 10B PHYLOGENE; Tinbergen N., 1932, Zeitschrift fuer Vergleichende Physiologie Berlin, V16, P305; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; Whitfield JB, 2003, ADV PARASIT, V54, P69, DOI 10.1016/S0065-308X(03)54002-7; Whiting MF, 2002, ZOOL SCR, V31, P3, DOI 10.1046/j.0300-3256.2001.00093.x; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7	88	47	47	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32826	10.1371/journal.pone.0032826	http://dx.doi.org/10.1371/journal.pone.0032826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412929	Green Published, Green Submitted, gold			2022-12-25	WOS:000303021100032
J	Kosacka, J; Nowicki, M; Kloting, N; Kern, M; Stumvoll, M; Bechmann, I; Serke, H; Bluher, M				Kosacka, Joanna; Nowicki, Marcin; Kloeting, Nora; Kern, Matthias; Stumvoll, Michael; Bechmann, Ingo; Serke, Heike; Blueher, Matthias			COMP-Angiopoietin-1 Recovers Molecular Biomarkers of Neuropathy and Improves Vascularisation in Sciatic Nerve of ob/ob Mice	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; DIABETIC-NEUROPATHY; PERIPHERAL NEUROPATHY; TNF-ALPHA; AXONAL REGENERATION; INSULIN-RESISTANCE; NEURITE OUTGROWTH; GENE-EXPRESSION; GROWTH-FACTOR; BLOOD-FLOW	Background: Leptin-deficient ob/ob mice are a model of type 2 diabetes induced peripheral neuropathy. Ob/ob mice exhibit obesity, insulin resistance, hyperglycaemia, and alterations of peripheral nerve fibres and endoneural microvessels. Here we test the hypothesis that cartilage oligomeric matrix protein (COMP)-Ang-1, a soluble and stabile form of Ang-1 which promotes angiogenesis and nerve growth, improves regeneration of nerve fibres and endoneural microvessels in ob/ob mice. Methods and Findings: COMP-Ang-1 (100 ng/ml) or NaCl were intraperitoneally (i.p.) injected into male (N = 184), 3-month old, ob/ob or ob/+ mice for 7 and 21 days. We measured expression of Nf68, GAP43, Cx32, Cx26, Cx43, and TNF alpha in sciatic nerves using Western blot analysis. To investigate the inflammation in sciatic nerves, numbers of macrophages and T-cells were counted after immunofluorescence staining. In ultrathin section, number of myelinated/non-mylinated nerve fibers, g-ratio, the thickness of Schwann cell basal lamina and microvessel endothelium were investigated. Endoneural microvessels were reconstructed with intracardial FITC injection. Treatment with COMP-Ang-1 over 21 days significantly reduced fasting blood glucose and plasma cholesterol concentrations compared to saline treated ob/ob mice. In addition, COMP-Ang-1 treatment: 1) up-regulated expression of Nf68 and GAP43; 2) improved expression of gap junction proteins including connexin 32 and 26; 3) suppressed the expression of TNF alpha and Cx43 and 4) led to decreased macrophage and T-cell infiltration in sciatic nerve of ob/ob mice. The significant changes of sciatic nerve ultrastructure were not observed after 21-day long COMP-Ang-1 treatment. COMP-Ang-1 treated ob/ob mice displayed regeneration of small-diameter endoneural microvessels. Effects of COMP-Ang-1 corresponded to increased phosphorylation of Akt and p38 MAPK upon Tie-2 receptor. Conclusions: COMP-Ang-1 recovers molecular biomarkers of neuropathy, promotes angiogenesis and suppresses inflammation in sciatic nerves of ob/ob mice suggesting COMP-Ang-1 as novel treatment option to improve morphologic and protein expression changes associated with diabetic neuropathy.	[Kosacka, Joanna; Kloeting, Nora; Kern, Matthias; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Nowicki, Marcin; Bechmann, Ingo; Serke, Heike] Univ Leipzig, Inst Anat, Leipzig, Germany; [Kloeting, Nora] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Kosacka, J (corresponding author), Univ Leipzig, Dept Med, Leipzig, Germany.	Joanna.Kosacka@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240	Junior Research Programme formel.1 [934000-913]; Faculty of Medicine, University of Leipzig, Germany	Junior Research Programme formel.1; Faculty of Medicine, University of Leipzig, Germany	This work was supported by research grant from the Junior Research Programme formel.1 (934000-913), Faculty of Medicine, University of Leipzig, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandross KJ, 1998, GLIA, V24, P21, DOI 10.1002/(SICI)1098-1136(199809)24:1<21::AID-GLIA3>3.0.CO;2-3; Chen JX, 2008, ARTERIOSCL THROM VAS, V28, P1606, DOI 10.1161/ATVBAHA.108.169235; Chen XY, 2009, NEUROSCI RES, V64, P348, DOI 10.1016/j.neures.2009.04.007; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Coppey LJ, 2002, DIABETES-METAB RES, V18, P49, DOI 10.1002/dmrr.257; Drel VR, 2006, DIABETES, V55, P3335, DOI 10.2337/db06-0885; Empl M, 2001, NEUROLOGY, V56, P1371, DOI 10.1212/WNL.56.10.1371; GIANNINI C, 1995, ANN NEUROL, V37, P498, DOI 10.1002/ana.410370412; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219; Hobson MI, 2002, ANN ROY COLL SURG, V84, P47; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Joussen AM, 2002, AM J PATHOL, V160, P1683, DOI 10.1016/S0002-9440(10)61115-7; Jung YJ, 2009, AM J PHYSIOL-RENAL, V297, pF952, DOI 10.1152/ajprenal.00064.2009; Kim HC, 2009, DIABETIC MED, V26, P1228, DOI 10.1111/j.1464-5491.2009.02856.x; King RHM, 2001, J CLIN PATHOL-MOL PA, V54, P400; Kosacka J, 2005, CELL TISSUE RES, V320, P11, DOI 10.1007/s00441-004-1068-2; Lee KN, 2010, PHARMACOLOGY, V86, P327, DOI 10.1159/000321885; Lee S, 2007, NEPHROL DIAL TRANSPL, V22, P396, DOI 10.1093/ndt/gfl598; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; McLean WG, 1997, NEUROCHEM RES, V22, P951, DOI 10.1023/A:1022466624223; Murashov AK, 2001, MOL BRAIN RES, V93, P199, DOI 10.1016/S0169-328X(01)00212-1; Nagaoka T, 1999, J HISTOCHEM CYTOCHEM, V47, P937, DOI 10.1177/002215549904700711; Namikawa K, 2000, J NEUROSCI, V20, P2875; Nowicki M, 2012, J NEUROSCI RES, V90, P122, DOI 10.1002/jnr.22728; NUKADA H, 1988, BRAIN RES, V449, P89, DOI 10.1016/0006-8993(88)91027-X; Park BH, 2011, BONE; Patel JI, 2005, BRIT J OPHTHALMOL, V89, P480, DOI 10.1136/bjo.2004.049940; Pitre DA, 2001, NEUROSCI LETT, V303, P67, DOI 10.1016/S0304-3940(01)01696-2; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Sacerdote P, 2008, NEUROSCI LETT, V436, P210, DOI 10.1016/j.neulet.2008.03.023; Said G, 2003, BRAIN, V126, P376, DOI 10.1093/brain/awg029; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Scott JN, 1999, BRAIN, V122, P2109, DOI 10.1093/brain/122.11.2109; Shimizu F, 2011, DIABETOLOGIA, V54, P1517, DOI 10.1007/s00125-011-2107-7; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Sung HK, 2009, AM J PHYSIOL-ENDOC M, V297, pE402, DOI 10.1152/ajpendo.00122.2009; Tahrani AA, 2010, EXPERT OPIN EMERG DR, V15, P661, DOI 10.1517/14728214.2010.512610; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Ward NL, 2005, J COMP NEUROL, V482, P244, DOI 10.1002/cne.20422; Ward NL, 2002, SEMIN CELL DEV BIOL, V13, P19, DOI 10.1006/scdb.2001.0288; Weerasuriya A, 2011, METHODS MOL BIOL, V686, P149, DOI 10.1007/978-1-60761-938-3_6; Yamazaki T, 2009, J PERIPHER NERV SYST, V14, P165, DOI 10.1111/j.1529-8027.2009.00228.x; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; YASUDA H, 1987, NEUROLOGY, V37, P20, DOI 10.1212/WNL.37.1.20; Zochodne DW, 2001, BRAIN, V124, P2319, DOI 10.1093/brain/124.11.2319	50	26	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32881	10.1371/journal.pone.0032881	http://dx.doi.org/10.1371/journal.pone.0032881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412941	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100037
J	Jaenicke, E; Pairet, B; Hartmann, H; Decker, H				Jaenicke, Elmar; Pairet, Bruno; Hartmann, Hermann; Decker, Heinz			Crystallization and Preliminary Analysis of Crystals of the 24-Meric Hemocyanin of the Emperor Scorpion (Pandinus imperator)	PLOS ONE			English	Article							CRYO-EM STRUCTURE; EURYPELMA-CALIFORNICUM; TARANTULA HEMOCYANIN; LIMULUS-POLYPHEMUS; MOLECULAR-MODEL; PHENOLOXIDASE ACTIVITY; OXYGEN; INTERFACES; RESOLUTION; REVEALS	Hemocyanins are giant oxygen transport proteins found in the hemolymph of several invertebrate phyla. They constitute giant multimeric molecules whose size range up to that of cell organelles such as ribosomes or even small viruses. Oxygen is reversibly bound by hemocyanins at binuclear copper centers. Subunit interactions within the multisubunit hemocyanin complex lead to diverse allosteric effects such as the highest cooperativity for oxygen binding found in nature. Crystal structures of a native hemocyanin oligomer larger than a hexameric substructure have not been published until now. We report for the first time growth and preliminary analysis of crystals of the 24-meric hemocyanin (M-W = 1.8 MDa) of emperor scorpion (Pandinus imperator), which diffract to a resolution of 6.5 angstrom. The crystals are monoclinc with space group C 1 2 1 and cell dimensions a = 311.61 angstrom, b = 246.58 angstrom and c = 251.10 angstrom (alpha = 90.00 degrees, beta = 90.02 degrees, gamma = 90.00 degrees). The asymmetric unit contains one molecule of the 24-meric hemocyanin and the solvent content of the crystals is 56%. A preliminary analysis of the hemocyanin structure reveals that emperor scorpion hemocyanin crystallizes in the same oxygenated conformation, which is also present in solution as previously shown by cryo-EM reconstruction and small angle x-ray scattering experiments.	[Jaenicke, Elmar; Pairet, Bruno; Hartmann, Hermann; Decker, Heinz] Johannes Gutenberg Univ Mainz, Inst Mol Biophys, Mainz, Germany	Johannes Gutenberg University of Mainz	Jaenicke, E (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mol Biophys, Mainz, Germany.	elmar.jaenicke@uni-mainz.de			"International Graduate School of Immunotherapy" (DFG) [GK 1043]; "Research Center Immunology" of the Johannes Gutenberg University	"International Graduate School of Immunotherapy" (DFG)(German Research Foundation (DFG)); "Research Center Immunology" of the Johannes Gutenberg University	Funding was provided by "GK 1043 - International Graduate School of Immunotherapy" (DFG) and "Research Center Immunology" of the Johannes Gutenberg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baird S, 2007, BBA-PROTEINS PROTEOM, V1774, P1380, DOI 10.1016/j.bbapap.2007.08.019; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Burmester T, 2001, MOL BIOL EVOL, V18, P184, DOI 10.1093/oxfordjournals.molbev.a003792; Cong Y, 2009, STRUCTURE, V17, P749, DOI 10.1016/j.str.2009.03.005; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Decker H, 1998, J BIOL CHEM, V273, P25889, DOI 10.1074/jbc.273.40.25889; Decker H, 2004, DEV COMP IMMUNOL, V28, P673, DOI 10.1016/j.dci.2003.11.007; Decker H, 1996, FEBS LETT, V393, P226, DOI 10.1016/0014-5793(96)00887-3; DECKER H, 1990, BIOPHYS CHEM, V37, P257, DOI 10.1016/0301-4622(90)88025-N; DECKER H, 1990, NATURWISSENSCHAFTEN, V77, P561, DOI 10.1007/BF01133724; DECKER H, 1988, BIOCHEMISTRY-US, V27, P6901, DOI 10.1021/bi00418a036; Decker H, 2001, J BIOL CHEM, V276, P17796, DOI 10.1074/jbc.M010436200; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gatsogiannis C, 2007, J MOL BIOL, V374, P465, DOI 10.1016/j.jmb.2007.09.036; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; GAYKEMA WPJ, 1986, J MOL BIOL, V187, P255, DOI 10.1016/0022-2836(86)90233-0; Hartmann H, 2004, J BIOL CHEM, V279, P2841, DOI 10.1074/jbc.M308959200; Hartmann H, 2002, BBA-PROTEINS PROTEOM, V1601, P132, DOI 10.1016/S1570-9639(02)00459-4; Hartmann H, 2001, J BIOL CHEM, V276, P19954, DOI 10.1074/jbc.M010435200; HAZES B, 1993, PROTEIN SCI, V2, P597; Jaenicke E, 1999, J BIOL CHEM, V274, P34267, DOI 10.1074/jbc.274.48.34267; Jaenicke E, 2010, BIOCHEM J, V426, P373, DOI 10.1042/BJ20091501; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lieb B, 2001, P NATL ACAD SCI USA, V98, P4546, DOI 10.1073/pnas.071049998; LOEWE R, 1978, J COMP PHYSIOL, V128, P161, DOI 10.1007/BF00689480; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; Markl J, 2009, J MOL BIOL, V392, P362, DOI 10.1016/j.jmb.2009.06.082; Martin AG, 2007, J MOL BIOL, V366, P1332, DOI 10.1016/j.jmb.2006.11.075; Menze MA, 2005, BIOCHEMISTRY-US, V44, P10328, DOI 10.1021/bi050507s; Nillius D, 2008, FEBS LETT, V582, P749, DOI 10.1016/j.febslet.2008.01.056; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROBERT CH, 1987, P NATL ACAD SCI USA, V84, P1891, DOI 10.1073/pnas.84.7.1891; Rolff M, 2011, CHEM SOC REV, V40, P4077, DOI 10.1039/c0cs00202j; Royer WE, 2006, STRUCTURE, V14, P1167, DOI 10.1016/j.str.2006.05.011; Salvato B, 1998, BIOCHEMISTRY-US, V37, P14065, DOI 10.1021/bi980879j; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; SOLOMON EI, 1994, CHEM REV, V94, P827, DOI 10.1021/cr00027a013; TSAO J, 1991, SCIENCE, V251, P1456, DOI 10.1126/science.2006420; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Voit R, 2000, J BIOL CHEM, V275, P39339, DOI 10.1074/jbc.M005442200; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; Zleteva T, 1996, FEBS LETT, P384	47	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32548	10.1371/journal.pone.0032548	http://dx.doi.org/10.1371/journal.pone.0032548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403673	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700070
J	Kjaer, L; Westman, M; Riley, CH; Hogdall, E; Bjerrum, OW; Hasselbalch, H				Kjaer, Lasse; Westman, Maj; Riley, Caroline Hasselbalch; Hogdall, Estrid; Bjerrum, Ole Weis; Hasselbalch, Hans			A Highly Sensitive Quantitative Real-Time PCR Assay for Determination of Mutant JAK2 Exon 12 Allele Burden	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; POLYCYTHEMIA-VERA PATIENTS; TYROSINE KINASE JAK2; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; MUTATIONS; INHIBITOR; MYELOFIBROSIS; JAK2V617F; IDENTIFICATION	Mutations in the Janus kinase 2 (JAK2) gene have become an important identifier for the Philadelphia-chromosome negative chronic myeloproliferative neoplasms. In contrast to the JAK2V617F mutation, the large number of JAK2 exon 12 mutations has challenged the development of quantitative assays. We present a highly sensitive real-time quantitative PCR assay for determination of the mutant allele burden of JAK2 exon 12 mutations. In combination with high resolution melting analysis and sequencing the assay identified six patients carrying previously described JAK2 exon 12 mutations and one novel mutation. Two patients were homozygous with a high mutant allele burden, whereas one of the heterozygous patients had a very low mutant allele burden. The allele burden in the peripheral blood resembled that of the bone marrow, except for the patient with low allele burden. Myeloid and lymphoid cell populations were isolated by cell sorting and quantitative PCR revealed similar mutant allele burdens in CD16+ granulocytes and peripheral blood. The mutations were also detected in B-lymphocytes in half of the patients at a low allele burden. In conclusion, our highly sensitive assay provides an important tool for quantitative monitoring of the mutant allele burden and accordingly also for determining the impact of treatment with interferon-alpha-2, shown to induce molecular remission in JAK2V617F-positive patients, which may be a future treatment option for JAK2 exon 12-positive patients as well.	[Kjaer, Lasse; Riley, Caroline Hasselbalch] Herlev Hosp, Dept Hematol, DK-2730 Herlev, Denmark; [Westman, Maj] Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Hogdall, Estrid] Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Bjerrum, Ole Weis] Rigshosp, Dept Hematol, DK-2100 Copenhagen, Denmark; [Hasselbalch, Hans] Roskilde Hosp, Dept Hematol, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Kjaer, L (corresponding author), Herlev Hosp, Dept Hematol, DK-2730 Herlev, Denmark.	Laskja01@heh.regionh.dk	Bjerrum, Ole Weis/AAF-9999-2019; Hasselbalch, Hans/H-2217-2017	Kjaer, Lasse/0000-0001-6767-0226; Hogdall, Estrid/0000-0003-4689-5658; Hasselbalch, Hans/0000-0003-3936-8032				Barosi G, 2011, EXPERT OPIN PHARMACO, V12, P1597, DOI 10.1517/14656566.2011.568939; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Carillo S, 2011, J MOL DIAGN, V13, P263, DOI 10.1016/j.jmoldx.2010.12.002; Carobbio A, 2011, BLOOD, V117, P5857, DOI 10.1182/blood-2011-02-339002; Dawson MA, 2010, BRIT J HAEMATOL, V150, P46, DOI 10.1111/j.1365-2141.2010.08175.x; Hasselbalch HC, 2011, CURR DRUG TARGETS, V12, P392; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2008, HAEMATOL-HEMATOL J, V93, P1560, DOI 10.3324/haematol.12883; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Larsen TS, 2008, LEUKEMIA, V22, P194, DOI 10.1038/sj.leu.2404861; Larsen TS, 2007, BRIT J HAEMATOL, V136, P745, DOI 10.1111/j.1365-2141.2007.06497.x; Lasho TL, 2008, LEUKEMIA, V22, P1790, DOI 10.1038/leu.2008.56; Laughlin TS, 2010, J MOL DIAGN, V12, P278, DOI 10.2353/jmoldx.2010.090177; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li S, 2008, BLOOD, V111, P3863, DOI 10.1182/blood-2007-09-111971; Lippert E, 2009, HAEMATOL-HEMATOL J, V94, P38, DOI 10.3324/haematol.13486; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Pardanani A, 2011, LEUKEMIA, V25, P218, DOI 10.1038/leu.2010.269; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Passamonti F, 2010, LEUKEMIA, V24, P1574, DOI 10.1038/leu.2010.148; Passamonti F, 2011, BLOOD, V117, P2813, DOI 10.1182/blood-2010-11-316810; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Rapado I, 2009, J MOL DIAGN, V11, P155, DOI 10.2353/jmoldx.2009.080110; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Schnittger S, 2009, HAEMATOL-HEMATOL J, V94, P414, DOI 10.3324/haematol.13223; Scott LM, 2011, AM J HEMATOL, V86, P668, DOI 10.1002/ajh.22063; Tefferi A, 2006, CANCER-AM CANCER SOC, V106, P631, DOI 10.1002/cncr.21645; Theocharides A, 2008, HAEMATOL-HEMATOL J, V93, P1890, DOI 10.3324/haematol.13074; Vannucchi AM, 2007, LEUKEMIA, V21, P1952, DOI 10.1038/sj.leu.2404854; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e33100	10.1371/journal.pone.0033100	http://dx.doi.org/10.1371/journal.pone.0033100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403733	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700131
J	Re, DE; O'Connor, JJM; Bennett, PJ; Feinberg, DR				Re, Daniel E.; O'Connor, Jillian J. M.; Bennett, Patrick J.; Feinberg, David R.			Preferences for Very Low and Very High Voice Pitch in Humans	PLOS ONE			English	Article							SPEAKING FUNDAMENTAL-FREQUENCY; VOCAL-TRACT LENGTH; GLOTTAL-PULSE RATE; FORMANT FREQUENCIES; WOMENS PREFERENCES; BODY-SIZE; MENS VOICES; ATTRACTIVENESS; SEX; DISCRIMINATION	Manipulations of voice pitch have been shown to alter attractiveness ratings, but whether preferences extend to very low or very high voice pitch is unknown. Here, we manipulated voice pitch in averaged men's and women's voices by 2 Hz intervals to create a range of male and female voices speaking monopthong vowel sounds and spanning a range of frequencies from normal to very low and very high pitch. With these voices, we used the method of constant stimuli to measure preferences for voice. Nineteen university students (ages: 20-25) participated in three experiments. On average, men preferred high-pitched women's voices to low-pitched women's voices across all frequencies tested. On average, women preferred men's voices lowered in pitch, but did not prefer very low men's voices. The results of this study may reflect selection pressures for men's and women's voices, and shed light on a perceptual link between voice pitch and vocal attractiveness.	[Re, Daniel E.; O'Connor, Jillian J. M.; Bennett, Patrick J.; Feinberg, David R.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University	Re, DE (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	feinberg@mcmaster.ca	Feinberg, David/C-1249-2009; O'Connor, Jillian/G-8469-2012; O'Connor, Jillian/F-5686-2011	Feinberg, David/0000-0003-4179-1446; O'Connor, Jillian/0000-0002-4539-1020	DRF from the Social Sciences and Humanities Research Council of Canada; Canada Foundation for Innovation; Ontario's Ministry of Research and Innovation	DRF from the Social Sciences and Humanities Research Council of Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario's Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was funded by grants to DRF from the Social Sciences and Humanities Research Council of Canada, Canada Foundation for Innovation, and Ontario's Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol J, 1999, J VOICE, V13, P424, DOI 10.1016/S0892-1997(99)80048-4; Andersson Malte, 1994; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Aronson AE, 1990, CLIN DISORDERS VOICE; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BENJAMIN BJ, 1981, J GERONTOL, V36, P722, DOI 10.1093/geronj/36.6.722; Boersma P., 2021, PRAAT DOING PHONETIC; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Bruckert L, 2006, P ROY SOC B-BIOL SCI, V273, P83, DOI 10.1098/rspb.2005.3265; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; BURKHARDT D, 1988, J COMP PHYSIOL A, V162, P649, DOI 10.1007/BF01342640; Charpentier F., 1989, P EUROSPEECH 89, V2, P13; COHEN RM, 1992, EXP BRAIN RES, V92, P165; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Damrose EJ, 2009, AURIS NASUS LARYNX, V36, P110, DOI 10.1016/j.anl.2008.03.002; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Farrell ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018533; Feinberg DR, 2011, BEHAV ECOL, V22, P1320, DOI 10.1093/beheco/arr134; Feinberg DR, 2008, EVOL HUM BEHAV, V29, P233, DOI 10.1016/j.evolhumbehav.2007.12.008; Feinberg DR, 2008, PERCEPTION, V37, P615, DOI 10.1068/p5514; Feinberg DR, 2008, EVOL ANTHROPOL, V17, P112, DOI 10.1002/evan.20166; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Flanagan JL, 1957, J ACOUST SOC AM, V30, P7; Fraccaro P.J., 2011, J EVOLUTIONARY PSYCH, V9, P57, DOI [10.1556/JEP.9.2011.33.1, DOI 10.1556/JEP.9.2011.33.1]; Fraccaro PJ, 2010, EVOL PSYCHOL-US, V8, P447, DOI 10.1177/147470491000800311; Geary DC, 2004, J SEX RES, V41, P27, DOI 10.1080/00224490409552211; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; GILBERT HR, 1974, J PSYCHOLINGUIST RES, V3, P225, DOI 10.1007/BF01069239; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; HARI R, 1984, NEUROSCI LETT, V50, P127, DOI 10.1016/0304-3940(84)90474-9; Hodges-Simeon CR, 2010, HUM NATURE-INT BIOS, V21, P406, DOI 10.1007/s12110-010-9101-5; Jenkins JS, 1998, LANCET, V351, P1877, DOI 10.1016/S0140-6736(97)10198-2; Jones BC, 2008, BIOL LETTERS, V4, P192, DOI 10.1098/rsbl.2007.0626; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Kawahara H, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL I, PROCEEDINGS, P256; KLATT DH, 1973, J ACOUST SOC AM, V53, P8, DOI 10.1121/1.1913333; Klinge A, 2009, J ACOUST SOC AM, V125, P304, DOI 10.1121/1.3021315; KUNZEL HJ, 1989, PHONETICA, V46, P117; LASS NJ, 1978, J ACOUST SOC AM, V63, P1218, DOI 10.1121/1.381808; Little AC, 2010, PSYCHONEUROENDOCRINO, V35, P912, DOI 10.1016/j.psyneuen.2009.12.006; Liu C, 2004, ACOUST RES LETT ONL, V5, P31, DOI 10.1121/1.1635431; LUCE RD, 1978, PERCEPT PSYCHOPHYS, V23, P363, DOI 10.3758/BF03204138; Magnus D. B. E., 1958, Proceedings 10th International Congress of Entomology Montreal 1956, V2, P405; Moore B. C. J., 1995, HEARING; MOORE BCJ, 1992, J ACOUST SOC AM, V91, P2881, DOI 10.1121/1.402925; Motulskey H, 2004, FITTING MODELS BIOL; Newman SR, 2000, J VOICE, V14, P72, DOI 10.1016/S0892-1997(00)80096-X; Nishio M, 2008, FOLIA PHONIATR LOGO, V60, P120, DOI 10.1159/000118510; O'Connor JJM, 2011, EVOL PSYCHOL-US, V9, P64, DOI 10.1177/147470491100900109; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Pisanski K, 2011, J ACOUST SOC AM, V129, P2201, DOI 10.1121/1.3552866; Puts DA, 2011, PERS INDIV DIFFER, V50, P111, DOI 10.1016/j.paid.2010.09.011; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; ROWLAND WJ, 1989, BEHAV ECOL SOCIOBIOL, V24, P433, DOI 10.1007/BF00293272; RUSSELL A, 1995, J SPEECH HEAR RES, V38, P101, DOI 10.1044/jshr.3801.101; Saxton TK, 2006, ETHOLOGY, V112, P1179, DOI 10.1111/j.1439-0310.2006.01278.x; Smith DRR, 2007, J ACOUST SOC AM, V122, P3628, DOI 10.1121/1.2799507; Smith DRR, 2005, J ACOUST SOC AM, V118, P3177, DOI 10.1121/1.2047107; Smith DRR, 2005, J ACOUST SOC AM, V117, P305, DOI 10.1121/1.1828637; SORENSEN D, 1982, J COMMUN DISORD, V15, P135, DOI 10.1016/0021-9924(82)90027-2; Stevens S., HDB EXPT PSYCHOL; Titze IR, 1994, PRINCIPLES VOCAL PRO; Vukovic J, 2008, PERS INDIV DIFFER, V45, P451, DOI 10.1016/j.paid.2008.05.013; Vukovic J, 2010, BEHAV ECOL, V21, P767, DOI 10.1093/beheco/arq051	72	44	46	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32719	10.1371/journal.pone.0032719	http://dx.doi.org/10.1371/journal.pone.0032719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928WA	22403701	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700098
J	Schottner, S; Wild, C; Hoffmann, F; Boetius, A; Ramette, A				Schoettner, Sandra; Wild, Christian; Hoffmann, Friederike; Boetius, Antje; Ramette, Alban			Spatial Scales of Bacterial Diversity in Cold-Water Coral Reef Ecosystems	PLOS ONE			English	Article							LOPHELIA-PERTUSA SCLERACTINIA; INTERGENIC SPACER ANALYSIS; COMMUNITY STRUCTURE; NORTHEAST ATLANTIC; DEEP; MUCUS; BIODIVERSITY; HABITAT; TEMPERATURE; POPULATIONS	Background: Cold-water coral reef ecosystems are recognized as biodiversity hotspots in the deep sea, but insights into their associated bacterial communities are still limited. Deciphering principle patterns of bacterial community variation over multiple spatial scales may however prove critical for a better understanding of factors contributing to cold-water coral reef stability and functioning. Methodology/Principal Findings: Bacterial community structure, as determined by Automated Ribosomal Intergenic Spacer Analysis (ARISA), was investigated with respect to (i) microbial habitat type and (ii) coral species and color, as well as the three spatial components (iii) geomorphologic reef zoning, (iv) reef boundary, and (v) reef location. Communities revealed fundamental differences between coral-generated (branch surface, mucus) and ambient microbial habitats (seawater, sediments). This habitat specificity appeared pivotal for determining bacterial community shifts over all other study levels investigated. Coral-derived surfaces showed species-specific patterns, differing significantly between Lophelia pertusa and Madrepora oculata, but not between L. pertusa color types. Within the reef center, no community distinction corresponded to geomorphologic reef zoning for both coral-generated and ambient microbial habitats. Beyond the reef center, however, bacterial communities varied considerably from local to regional scales, with marked shifts toward the reef periphery as well as between different in-and offshore reef sites, suggesting significant biogeographic imprinting but weak microbe-host specificity. Conclusions/Significance: This study presents the first multi-scale survey of bacterial diversity in cold-water coral reefs, spanning a total of five observational levels including three spatial scales. It demonstrates that bacterial communities in cold-water coral reefs are structured by multiple factors acting at different spatial scales, which has fundamental implications for the monitoring of microbial diversity and function in those ecosystems.	[Schoettner, Sandra; Boetius, Antje; Ramette, Alban] Max Planck Inst Marine Microbiol, HGF MPG Joint Res Grp Deep Sea Ecol & Technol, Bremen, Germany; [Wild, Christian] Leibniz Ctr Trop Marine Ecol, Coral Reef Ecol Grp, Bremen, Germany; [Hoffmann, Friederike] Univ Bergen, Ctr Geobiol, Bergen, Norway; [Hoffmann, Friederike] Uni Res AS, Uni Environm, Bergen, Norway	Max Planck Society; Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bergen; University of Bergen	Schottner, S (corresponding author), Univ Bergen, Marine Microbiol Grp, Bergen, Norway.	aramette@mpi-bremen.de	Boetius, Antje/D-5459-2013; Ramette, Alban/E-9197-2016	Boetius, Antje/0000-0003-2117-4176; Ramette, Alban/0000-0002-3437-4639	German Research Foundation (DFG) [Wi 2677/3-1]; EU [226354]; Max Planck Society; Helmholtz Association	German Research Foundation (DFG)(German Research Foundation (DFG)); EU(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Association(Helmholtz Association)	This work was funded by the German Research Foundation (DFG) (grant Wi 2677/3-1) to CW within the EuroDIVERSITY project MiCROSYSTEMS, by the German Research Foundation to FH, and by the EU 6th FP HERMES and the EU 7th FP HERMIONE (grant agreement no 226354) to AB. Further support was received from the Max Planck Society and the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Berke SK, 2010, INTEGR COMP BIOL, V50, P147, DOI 10.1093/icb/icq077; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Bongiorni L, 2010, BIOL CONSERV, V143, P1687, DOI 10.1016/j.biocon.2010.04.009; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Brooke S, 2009, MAR ECOL PROG SER, V397, P153, DOI 10.3354/meps08344; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; Brown MV, 2005, AQUAT MICROB ECOL, V41, P15, DOI 10.3354/ame041015; Bruck TB, 2007, MAR BIOTECHNOL, V9, P561, DOI 10.1007/s10126-007-9009-1; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Dodds LA, 2007, J EXP MAR BIOL ECOL, V349, P205, DOI 10.1016/j.jembe.2007.05.013; Dodds LA, 2009, MAR ECOL PROG SER, V397, P113, DOI 10.3354/meps08143; Drollet JH, 1997, MAR FRESHWATER RES, V48, P329, DOI 10.1071/MF96087; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Forsterra F, 2008, MAR ECOL PROG SER, V370, P121, DOI 10.3354/meps07630; Freiwald A, 1997, SOC SEDIMENT GEOL SP, P141; Freiwald A, 2002, FACIES, V47, P179, DOI 10.1007/BF02667712; Freiwald A., 2002, OCEAN MARGIN SYSTEMS, DOI DOI 10.1007/978-3-662-05127-6_23; Freiwald A., 2004, COLD WATER CORAL REE; Freiwald Andre, 1998, Historical Biology, V13, P37; Gray MA, 2011, FEMS MICROBIOL ECOL, V76, P109, DOI 10.1111/j.1574-6941.2010.01033.x; Grosskurth AK, 2007, THESIS C VONOSSIETZK; Hall-Spencer JM, 2007, DIS AQUAT ORGAN, V76, P87, DOI 10.3354/dao076087; Hansson L, 2009, MAR ECOL PROG SER, V397, P89, DOI 10.3354/meps08429; Henry LA, 2007, DEEP-SEA RES PT I, V54, P654, DOI 10.1016/j.dsr.2007.01.005; Henry LA, 2010, CORAL REEFS, V29, P427, DOI 10.1007/s00338-009-0577-6; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hewson I, 2006, MAR ECOL PROG SER, V306, P79, DOI 10.3354/meps306079; Hovland Martin, 2008, P1; JENSEN A, 1992, SARSIA, V77, P53, DOI 10.1080/00364827.1992.10413492; Jensen S, 2008, DEEP-SEA RES PT I, V55, P1554, DOI 10.1016/j.dsr.2008.06.008; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kellogg CA, 2009, APPL ENVIRON MICROB, V75, P2294, DOI 10.1128/AEM.02357-08; Kiriakoulakis K, 2005, ERLANGEN EARTH C SER, P715, DOI 10.1007/3-540-27673-4_37; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Le Goff-Vitry MC, 2004, MOL ECOL, V13, P537, DOI 10.1046/j.1365-294X.2004.2079.x; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Maier C, 2009, BIOGEOSCIENCES, V6, P1671, DOI 10.5194/bg-6-1671-2009; Mancini I, 1999, HELV CHIM ACTA, V82, P677, DOI 10.1002/(SICI)1522-2675(19990505)82:5<677::AID-HLCA677>3.0.CO;2-0; MEIKLE P, 1988, MAR BIOL, V99, P187, DOI 10.1007/BF00391980; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mortensen PB, 2001, J MAR BIOL ASSOC UK, V81, P581, DOI 10.1017/S002531540100426X; Neulinger SC, 2008, APPL ENVIRON MICROB, V74, P7272, DOI 10.1128/AEM.01777-08; Neulinger SC, 2009, APPL ENVIRON MICROB, V75, P1437, DOI 10.1128/AEM.01781-08; Penn K, 2006, APPL ENVIRON MICROB, V72, P1680, DOI 10.1128/AEM.72.2.1680-1683.2006; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts M, 2009, COLD WATER CORALS BI; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; Rohwer F, 2004, CORAL HEALTH AND DISEASE, P265; Rosenberg E, 2007, OCEANOGRAPHY, V20, P146, DOI 10.5670/oceanog.2007.60; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Schottner S, 2011, ENVIRON MICROBIOL, V13, P1815, DOI 10.1111/j.1462-2920.2011.02494.x; Schottner S, 2009, ISME J, V3, P756, DOI 10.1038/ismej.2009.15; Spalding M.D., 2001, UNEP WCMC WORLD ATLA; Sweet MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021195; Webster NS, 2007, FEMS MICROBIOL ECOL, V59, P81, DOI 10.1111/j.1574-6941.2006.00195.x; Wild C, 2010, AQUAT BIOL, V10, P131; WILSON JB, 1979, J MAR BIOL ASSOC UK, V59, P165, DOI 10.1017/S0025315400046257; Yakimov MM, 2006, DEEP-SEA RES PT I, V53, P62, DOI 10.1016/j.dsr.2005.07.005	70	29	29	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32093	10.1371/journal.pone.0032093	http://dx.doi.org/10.1371/journal.pone.0032093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403625	Green Accepted, Green Published, gold			2022-12-25	WOS:000303017700022
J	Sugahara, J; Fujishima, K; Nunoura, T; Takaki, Y; Takami, H; Takai, K; Tomita, M; Kanai, A				Sugahara, Junichi; Fujishima, Kosuke; Nunoura, Takuro; Takaki, Yoshihiro; Takami, Hideto; Takai, Ken; Tomita, Masaru; Kanai, Akio			Genomic Heterogeneity in a Natural Archaeal Population Suggests a Model of tRNA Gene Disruption	PLOS ONE			English	Article							ORDER THERMOPROTEALES; SPLICING MOTIFS; SULFOLOBUS; SEQUENCE; DNA; INTRONS; INTEGRATION; EVOLUTION; PLASMID; VIRUSES	Understanding the mechanistic basis of the disruption of tRNA genes, as manifested in the intron-containing and split tRNAs found in Archaea, will provide considerable insight into the evolution of the tRNA molecule. However, the evolutionary processes underlying these disruptions have not yet been identified. Previously, a composite genome of the deep-branching archaeon Caldiarchaeum subterraneum was reconstructed from a community genomic library prepared from a C. subterraneum-dominated microbial mat. Here, exploration of tRNA genes from the library reveals that there are at least three types of heterogeneity at the tRNA(Thr) (GGU) gene locus in the Caldiarchaeum population. All three involve intronic gain and splitting of the tRNA gene. Of two fosmid clones found that encode tRNA(Thr) (GGU), one (tRNA(Thr-I)) contains a single intron, whereas another (tRNA(Thr-II)) contains two introns. Notably, in the clone possessing tRNA(Thr-II), a 5' fragment of the tRNA(Thr-I) (tRNA(Thr-F)) gene was observed 1.8-kb upstream of tRNA(Thr-II). The composite genome contains both tRNA(Thr-II) and tRNA(Thr-F), although the loci are >500 kb apart. Given that the 1.8-kb sequence flanked by tRNA(Thr-F) and tRNA(Thr-II) is predicted to encode a DNA recombinase and occurs in six regions of the composite genome, it may be a transposable element. Furthermore, its dinucleotide composition is most similar to that of the pNOB8-type plasmid, which is known to integrate into archaeal tRNA genes. Based on these results, we propose that the gain of the tRNA intron and the scattering of the tRNA fragment occurred within a short time frame via the integration and recombination of a mobile genetic element.	[Sugahara, Junichi; Fujishima, Kosuke; Tomita, Masaru; Kanai, Akio] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Sugahara, Junichi; Tomita, Masaru; Kanai, Akio] Keio Univ, Syst Biol Program, Grad Sch Media & Governance, Fujisawa, Kanagawa, Japan; [Nunoura, Takuro] Japan Agcy Marine Earth Sci & Technol, Subsurface Geobiol & Adv Res Project, Extremobiosphere Res Program, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Takaki, Yoshihiro; Takami, Hideto] Japan Agcy Marine Earth Sci & Technol, Microbial Genome Res Grp, Extremobiosphere Res Program, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan	Keio University; Keio University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Sugahara, J (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	akio@sfc.keio.ac.jp	Kanai, Akio/C-4921-2014; Nunoura, Takuro/AAL-6266-2020; Takami, Hideto/D-4200-2012	Kanai, Akio/0000-0002-6362-2419; Nunoura, Takuro/0000-0003-2323-0880; Takami, Hideto/0000-0003-3433-7018; Fujishima, Kosuke/0000-0002-8844-812X	Ministry of Education, Culture, Sports, Science and Technology of Japan [22370066, 18681030, 20310124]; Institute for Fermentation, Osaka, Japan; Yamagata Prefectural Government and Tsuruoka City, Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Fermentation, Osaka, Japan(Institute for Fermentation (IFO)); Yamagata Prefectural Government and Tsuruoka City, Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by a Grant-in-Aid for Scientific Research (B) (no. 22370066) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to AK); a research fund of the Institute for Fermentation, Osaka, Japan (to AK); research funds from the Yamagata Prefectural Government and Tsuruoka City, Japan (to MT); the Japan Society for the Promotion of Science (to JS); and a Grant-in-Aid for Young Scientists (A) (no. 18681030; to TN) and part of a Grant-in-Aid for Scientific Research (B) (no. 20310124; to HT) from the Ministry of Education, Culture, Sports, Science & Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Campbell A, 1999, P NATL ACAD SCI USA, V96, P9184, DOI 10.1073/pnas.96.16.9184; Chan PP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r38; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DEVEREUX R, 1990, J BACTERIOL, V172, P3609, DOI 10.1128/jb.172.7.3609-3619.1990; Erauso G, 2006, MICROBIOL-SGM, V152, P1951, DOI 10.1099/mic.0.28861-0; Fujishima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001622; Fujishima K, 2010, MOL BIOL EVOL, V27, P2233, DOI 10.1093/molbev/msq111; Fujishima K, 2009, P NATL ACAD SCI USA, V106, P2683, DOI 10.1073/pnas.0808246106; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; KAINE BP, 1983, P NATL ACAD SCI-BIOL, V80, P3309, DOI 10.1073/pnas.80.11.3309; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marck C, 2003, RNA, V9, P1516, DOI 10.1261/rna.5132503; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Nunoura T, 2005, ENVIRON MICROBIOL, V7, P1967, DOI 10.1111/j.1462-2920.2005.00881.x; Nunoura T, 2011, EXTREMOPHILES HDB, P1099; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Randau L, 2005, P NATL ACAD SCI USA, V102, P17934, DOI 10.1073/pnas.0509197102; Randau L, 2005, NATURE, V433, P537, DOI 10.1038/nature03233; Randau L, 2008, EMBO REP, V9, P623, DOI 10.1038/embor.2008.101; REITER WD, 1989, NUCLEIC ACIDS RES, V17, P1907, DOI 10.1093/nar/17.5.1907; Rice G, 2001, P NATL ACAD SCI USA, V98, P13341, DOI 10.1073/pnas.231170198; SCHLEPER C, 1995, J BACTERIOL, V177, P4417, DOI 10.1128/jb.177.15.4417-4426.1995; SCHLEPER C, 1992, P NATL ACAD SCI USA, V89, P7645, DOI 10.1073/pnas.89.16.7645; She Q, 2004, BIOCHEM SOC T, V32, P222, DOI 10.1042/BST0320222; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Sugahara J, 2008, MOL BIOL EVOL, V25, P2709, DOI 10.1093/molbev/msn216; Sugahara J, 2007, RNA, V13, P671, DOI 10.1261/rna.309507; Sugahara J, 2009, J MOL EVOL, V69, P497, DOI 10.1007/s00239-009-9294-6; Suzuki Haruo, 2008, Nucleic Acids Res, V36, pe147, DOI 10.1093/nar/gkn753; Tocchini-Valentini GD, 2005, P NATL ACAD SCI USA, V102, P15418, DOI 10.1073/pnas.0506750102; VALENZUELA P, 1978, P NATL ACAD SCI USA, V75, P190, DOI 10.1073/pnas.75.1.190; Wang Y, 2007, VIROLOGY, V363, P124, DOI 10.1016/j.virol.2007.01.035; Wiedenheft B, 2004, J VIROL, V78, P1954, DOI 10.1128/JVI.78.4.1954-1961.2004	35	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32504	10.1371/journal.pone.0032504	http://dx.doi.org/10.1371/journal.pone.0032504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403667	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700064
J	Tollenaere, C; Ivanova, S; Duplantier, JM; Loiseau, A; Rahalison, L; Rahelinirina, S; Brouat, C				Tollenaere, Charlotte; Ivanova, Svilena; Duplantier, Jean-Marc; Loiseau, Anne; Rahalison, Lila; Rahelinirina, Soanandrasana; Brouat, Carine			Contrasted Patterns of Selection on MHC-Linked Microsatellites in Natural Populations of the Malagasy Plague Reservoir	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; YERSINIA-PESTIS; GENETIC-STRUCTURE; RATTUS-RATTUS; CLASS-I; POSITIVE SELECTION; GAMMA-INTERFERON; BROWN TROUT; LOCI; EXPRESSION	Plague (Yersinia pestis infection) is a highly virulent rodent disease that persists in many natural ecosystems. The black rat (Rattus rattus) is the main host involved in the plague focus of the central highlands of Madagascar. Black rat populations from this area are highly resistant to plague, whereas those from areas in which the disease is absent (low altitude zones of Madagascar) are susceptible. Various lines of evidence suggest a role for the Major Histocompatibility Complex (MHC) in plague resistance. We therefore used the MHC region as a candidate for detecting signatures of plague-mediated selection in Malagasy black rats, by comparing population genetic structures for five MHC-linked microsatellites and neutral markers in two sampling designs. We first compared four pairs of populations, each pair including one population from the plague focus and one from the disease-free zone. Plague-mediated selection was expected to result in greater genetic differentiation between the two zones than expected under neutrality and this was observed for one MHC-class I-linked locus (D20Img2). For this marker as well as for four other MHC-linked loci, a geographic pattern of genetic structure was found at local scale within the plague focus. This pattern would be expected if plague selection pressures were spatially variable. Finally, another MHC-class I-linked locus (D20Rat21) showed evidences of balancing selection, but it seems more likely that this selection would be related to unknown pathogens more widely distributed in Madagascar than plague.	[Tollenaere, Charlotte; Ivanova, Svilena; Duplantier, Jean-Marc; Brouat, Carine] UMR CBGP INRA IRD Cirad Montpellier SupAgro, Inst Rech Dev, Montferrier Sur Lez, France; [Loiseau, Anne] UMR CBGP INRA IRD Cirad Montpellier SupAgro, Inst Natl Rech Agron, Montferrier Sur Lez, France; [Rahalison, Lila; Rahelinirina, Soanandrasana] Inst Pasteur Madagascar, Unite Peste, Antananarivo, Madagascar	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Tollenaere, C (corresponding author), UMR CBGP INRA IRD Cirad Montpellier SupAgro, Inst Rech Dev, Montferrier Sur Lez, France.	carine.brouat@ird.fr	Brouat, carine/G-8533-2013; Tollenaere, Charlotte/ABB-6175-2020	Brouat, carine/0000-0001-6167-308X; Tollenaere, Charlotte/0000-0003-2045-2824; Ivanova, Svilena/0000-0002-9288-9606	Institut de Recherche pour le Developpement; Institut Pasteur de Madagascar; Agence Nationale pour la Recherche	Institut de Recherche pour le Developpement; Institut Pasteur de Madagascar; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was funded by the Institut de Recherche pour le Developpement, the Institut Pasteur de Madagascar and an Agence Nationale pour la Recherche, Sante-Environnement et Sante-Travail program on plague diffusion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2006, MOL ECOL, V15, P923, DOI 10.1111/j.1365-294X.2006.02843.x; Ao L, 2008, TOXICOL IN VITRO, V22, P116, DOI 10.1016/j.tiv.2007.08.013; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Babik W, 2008, MOL ECOL, V17, P2339, DOI 10.1111/j.1365-294X.2008.03757.x; Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BRYGOO E. R., 1966, Arch. Inst. Pasteur Madagascar, V35, P9; Bryja J, 2007, MOL ECOL, V16, P5084, DOI 10.1111/j.1365-294X.2007.03584.x; Bryja J, 2005, MOL ECOL NOTES, V5, P173, DOI 10.1111/j.1471-8286.2004.00855.x; Cavagna P, 2002, MAMM GENOME, V13, P157, DOI [10.1007/BF02684021, 10.1007/s0033501-1020-7]; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charbonnel N, 2005, HEREDITY, V95, P377, DOI 10.1038/sj.hdy.6800735; Cizkova D, 2011, HEREDITY, V106, P727, DOI 10.1038/hdy.2010.112; Dennis D, PLAGUE MANUAL EPIDEM; Dionne M, 2007, EVOLUTION, V61, P2154, DOI 10.1111/j.1558-5646.2007.00178.x; Doxiadis GGM, 2007, P NATL ACAD SCI USA, V104, P8907, DOI 10.1073/pnas.0702964104; Duplantier J.-M., 2003, P158; Ekblom R, 2007, MOL ECOL, V16, P1439, DOI 10.1111/j.1365-294X.2007.03281.x; Evans ML, 2010, HEREDITY, V104, P449, DOI 10.1038/hdy.2009.121; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Gilabert A, 2007, CAN J ZOOL, V85, P965, DOI 10.1139/Z07-083; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guryev V, 2006, PLOS GENET, V2, P1111, DOI 10.1371/journal.pgen.0020121; Hansen MM, 2007, MOL ECOL, V16, P1413, DOI 10.1111/j.1365-294X.2007.03255.x; Hurt P, 2004, GENOME RES, V14, P631, DOI 10.1101/gr.1987704; Ioannidu S, 2001, J IMMUNOL, V166, P3957, DOI 10.4049/jimmunol.166.6.3957; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jensen LF, 2008, HEREDITY, V100, P79, DOI 10.1038/sj.hdy.6801067; Jiggins FM, 2007, J EVOLUTION BIOL, V20, P965, DOI 10.1111/j.1420-9101.2007.01305.x; Lambert ND, 2009, J IMMUNOL, V182; Lambracht-Washington D, 2008, IMMUNOGENETICS, V60, P131, DOI 10.1007/s00251-008-0282-6; Loiseau A, 2008, MOL ECOL RESOUR, V8, P916, DOI 10.1111/j.1755-0998.2008.02115.x; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Luikart G, 2008, BIOL LETTERS, V4, P228, DOI 10.1098/rsbl.2007.0633; Migliani R, 2006, TROP MED INT HEALTH, V11, P1228, DOI 10.1111/j.1365-3156.2006.01677.x; MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Neff BD, 2010, MOL ECOL RESOUR, V10, P546, DOI 10.1111/j.1755-0998.2009.02786.x; Oetjen K, 2010, MAR BIOL, V157, P81, DOI 10.1007/s00227-009-1297-8; Parent MA, 2006, INFECT IMMUN, V74, P3381, DOI 10.1128/IAI.00185-06; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Rahalison L, 2003, SUSCEPTIBILITY PLAGU; Rahelinirina S, 2009, THESIS ANTANANARIVO; Robins JH, 2008, MOL PHYLOGENET EVOL, V49, P460, DOI 10.1016/j.ympev.2008.08.001; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saikh KU, 2006, J INFECT DIS, V194, P1753, DOI 10.1086/509507; Santucci F, 2007, HEREDITY, V99, P340, DOI 10.1038/sj.hdy.6801006; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; SHEPHERD AJ, 1986, J HYG-CAMBRIDGE, V96, P171, DOI 10.1017/S0022172400065943; Shim HK, 2006, IMMUNOLOGY, V119, P385, DOI 10.1111/j.1365-2567.2006.02447.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Teacher AGF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004616; THOMAS RE, 1988, J WILDLIFE DIS, V24, P327, DOI 10.7589/0090-3558-24.2.327; Tollenaere C, 2010, ECOHEALTH, V7, P242, DOI 10.1007/s10393-010-0312-3; Tollenaere C, 2010, J BIOGEOGR, V37, P398, DOI 10.1111/j.1365-2699.2009.02228.x; Turner JK, 2008, INFECT IMMUN, V76, P4092, DOI 10.1128/IAI.00488-08; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vitalis R, 2001, GENETICS, V158, P1811; Vitalis R, 2011, POPULATION GENOMICS; Vogler AJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001319; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; World Health Organization, 2010, Weekly Epidemiological Record, V85, P40	69	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32814	10.1371/journal.pone.0032814	http://dx.doi.org/10.1371/journal.pone.0032814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403713	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700110
J	van Vliet-Ostaptchouk, JV; van Haeften, TW; Landman, GWD; Reiling, E; Kleefstra, N; Bilo, HJG; Klungel, OH; de Boer, A; van Diemen, CC; Wijmenga, C; Boezen, HM; Dekker, JM; van 't Riet, E; Nijpels, G; Welschen, LMC; Zavrelova, H; Bruin, EJ; Elbers, CC; Bauer, F; Onland-Moret, NC; van der Schouw, YT; Grobbee, DE; Spijkerman, AMW; van der A, DL; Simonis-Bik, AM; Eekhoff, EMW; Diamant, M; Kramer, MHH; Boomsma, DI; de Geus, EJ; Willemsen, G; Slagboom, PE; Hofker, MH; 't Hart, LM				van Vliet-Ostaptchouk, Jana V.; van Haeften, Timon W.; Landman, Gijs W. D.; Reiling, Erwin; Kleefstra, Nanne; Bilo, Henk J. G.; Klungel, Olaf H.; de Boer, Anthonius; van Diemen, Cleo C.; Wijmenga, Cisca; Boezen, H. Marike; Dekker, Jacqueline M.; van 't Riet, Esther; Nijpels, Giel; Welschen, Laura M. C.; Zavrelova, Hata; Bruin, Elinda J.; Elbers, Clara C.; Bauer, Florianne; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Grobbee, Diederick E.; Spijkerman, Annemieke M. W.; van der A, Daphne L.; Simonis-Bik, Annemarie M.; Eekhoff, Elisabeth M. W.; Diamant, Michaela; Kramer, Mark H. H.; Boomsma, Dorret I.; de Geus, Eco J.; Willemsen, Gonneke; Slagboom, P. Eline; Hofker, Marten H.; 't Hart, Leen M.			Common Variants in the Type 2 Diabetes KCNQ1 Gene Are Associated with Impairments in Insulin Secretion During Hyperglycaemic Glucose Clamp	PLOS ONE			English	Article							BETA-CELL FUNCTION; SUSCEPTIBILITY LOCI; FASTING GLUCOSE; POLYMORPHISMS; RELEASE; DESIGN	Background: Genome-wide association studies in Japanese populations recently identified common variants in the KCNQ1 gene to be associated with type 2 diabetes. We examined the association of these variants within KCNQ1 with type 2 diabetes in a Dutch population, investigated their effects on insulin secretion and metabolic traits and on the risk of developing complications in type 2 diabetes patients. Methodology: The KCNQ1 variants rs151290, rs2237892, and rs2237895 were genotyped in a total of 4620 type 2 diabetes patients and 5285 healthy controls from the Netherlands. Data on macrovascular complications, nephropathy and retinopathy were available in a subset of diabetic patients. Association between genotype and insulin secretion/action was assessed in the additional sample of 335 individuals who underwent a hyperglycaemic clamp. Principal Findings: We found that all the genotyped KCNQ1 variants were significantly associated with type 2 diabetes in our Dutch population, and the association of rs151290 was the strongest (OR 1.20, 95% CI 1.07-1.35, p = 0.002). The risk C-allele of rs151290 was nominally associated with reduced first-phase glucose-stimulated insulin secretion, while the non-risk T-allele of rs2237892 was significantly correlated with increased second-phase glucose-stimulated insulin secretion (p = 0.025 and 0.0016, respectively). In addition, the risk C-allele of rs2237892 was associated with higher LDL and total cholesterol levels (p = 0.015 and 0.003, respectively). We found no evidence for an association of KCNQ1 with diabetic complications. Conclusions: Common variants in the KCNQ1 gene are associated with type 2 diabetes in a Dutch population, which can be explained at least in part by an effect on insulin secretion. Furthermore, our data suggest that KCNQ1 is also associated with lipid metabolism.	[van Vliet-Ostaptchouk, Jana V.; Bruin, Elinda J.; Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.] Univ Groningen, Dept Endocrinol, Univ Med Ctr Groningen, Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.; Boezen, H. Marike] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, Groningen, Netherlands; [van Haeften, Timon W.] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands; [Landman, Gijs W. D.; Kleefstra, Nanne; Bilo, Henk J. G.; 't Hart, Leen M.] Isala Clin, Ctr Diabet, Zwolle, Netherlands; [Reiling, Erwin] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands; [Kleefstra, Nanne; Bilo, Henk J. G.] Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Kleefstra, Nanne] Med Res Grp, Langerhans, Zwolle, Netherlands; [Klungel, Olaf H.; de Boer, Anthonius] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [van Diemen, Cleo C.; Wijmenga, Cisca] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, Groningen, Netherlands; [Dekker, Jacqueline M.; van 't Riet, Esther; Nijpels, Giel; Welschen, Laura M. C.; Zavrelova, Hata; Boomsma, Dorret I.; de Geus, Eco J.; Willemsen, Gonneke] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Dekker, Jacqueline M.; van 't Riet, Esther] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Nijpels, Giel; Welschen, Laura M. C.] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Zavrelova, Hata] Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Elbers, Clara C.; Bauer, Florianne; Onland-Moret, N. Charlotte] Univ Med Ctr Utrecht, Dept Med Genet DBG, Utrecht, Netherlands; [Elbers, Clara C.; Bauer, Florianne; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Spijkerman, Annemieke M. W.; van der A, Daphne L.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Simonis-Bik, Annemarie M.; Eekhoff, Elisabeth M. W.; Diamant, Michaela; Kramer, Mark H. H.] Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, Amsterdam, Netherlands; [Boomsma, Dorret I.; de Geus, Eco J.; Willemsen, Gonneke] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Slagboom, P. Eline; 't Hart, Leen M.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands	University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Isala Clinics; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Langerhans Medical Research Group; Utrecht University; University of Groningen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Vliet-Ostaptchouk, JV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	j.v.van.vliet@umcg.nl	Grobbee, Diederick/C-7651-2014; Kramer, Mark/GWQ-3502-2022; 't Hart, Leen/ABG-3185-2021; van der Schouw, Yvonne T./F-8327-2014; Slagboom, P. Eline/R-4790-2016; Wijmenga, Cisca/AAE-7719-2019; Landman, Gijs/AAJ-5540-2021; Wijmenga, Cisca/D-2173-2009; de Geus, Eco J.C./M-9318-2015; Boomsma, Dorret I/AAX-4470-2020; Onland-Moret, N. Charlotte/G-9185-2011	Grobbee, Diederick/0000-0003-4472-4468; 't Hart, Leen/0000-0003-4401-2938; van der Schouw, Yvonne T./0000-0002-4605-435X; Slagboom, P. Eline/0000-0002-2875-4723; Wijmenga, Cisca/0000-0002-5635-1614; Landman, Gijs/0000-0002-6852-6450; de Geus, Eco J.C./0000-0001-6022-2666; Onland-Moret, N. Charlotte/0000-0002-2360-913X; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Kleefstra, Nanne/0000-0003-1473-8519; Willemsen, Gonneke/0000-0003-3755-0236; Eekhoff, Elisabeth/0000-0001-5399-676X	SenterNovem (an IOP Genomics from Agentschap NL) [IGE05012]; Dutch Diabetes Research Foundation [2006.00.060]; Novo Nordisk BV (Alphen aan de Rijn, the Netherlands); Scientific Institute of Dutch Pharmacists (WINAp, The Hague, the Netherlands); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF) (The Netherlands)	SenterNovem (an IOP Genomics from Agentschap NL); Dutch Diabetes Research Foundation; Novo Nordisk BV (Alphen aan de Rijn, the Netherlands)(Netherlands Government); Scientific Institute of Dutch Pharmacists (WINAp, The Hague, the Netherlands); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF) (The Netherlands)(Netherlands GovernmentWorld Cancer Research Fund International (WCRF))	This study was funded by SenterNovem (an IOP Genomics IGE05012 from Agentschap NL), and by the Dutch Diabetes Research Foundation (2006.00.060). In addition, the UDES study was supported by an unrestricted research grant from Novo Nordisk BV (Alphen aan de Rijn, the Netherlands), and the Scientific Institute of Dutch Pharmacists (WINAp, The Hague, the Netherlands). The EPIC-NL study was funded by the Dutch Ministry of Public Health, Welfare and Sports (VWS), the Netherlands Cancer Registry (NKR), the LK Research Funds, the Dutch Prevention Funds, the Dutch ZON (Zorg Onderzoek Nederland), and the World Cancer Research Fund (WCRF) (The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Been LF, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-18; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Boini KM, 2009, AM J PHYSL REGUL INT; Chen Z, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-35; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Grallert H, 2010, HORM METAB RES, V42, P149, DOI 10.1055/s-0029-1241170; Granier C, 2008, NEPHROL DIAL TRANSPL, V23, P792, DOI 10.1093/ndt/gfm834; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Holmkvist J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005872; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Jonsson A, 2009, DIABETES, V58, P2409, DOI 10.2337/db09-0246; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; McCarthy MI, 2011, DIABETIC MED, V28, P132, DOI 10.1111/j.1464-5491.2010.03194.x; Mussig K, 2009, DIABETES, V58, P1715, DOI 10.2337/db08-1589; Ohshige T, 2010, DIABETES CARE, V33, P842, DOI 10.2337/dc09-1933; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Simonis-Bik AM, 2010, DIABETES, V59, P293, DOI 10.2337/db09-1048; Sluijs I, 2010, NETH J MED, V68, P333; Stancakova A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Szoke E, 2008, DIABETES CARE, V31, P539, DOI 10.2337/dc07-1443; 't Hart LM, 2010, DIABETES, V59, P287, DOI 10.2337/db09-0736; 't Hart LM, 2002, DIABETES, V51, P884, DOI 10.2337/diabetes.51.3.884; Tan JT, 2009, DIABETES, V58, P1445, DOI 10.2337/db08-1138; Ubink-Veltmaat LJ, 2003, EUR J EPIDEMIOL, V18, P793, DOI 10.1023/A:1025369623365; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; van Vliet-Ostaptchouk JV, 2007, DIABETOLOGIA, V50, P59, DOI 10.1007/s00125-006-0477-z; van 't Riet E, 2010, DIABETES CARE, V33, P61, DOI 10.2337/dc09-0677; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Welschen LMC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-74; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zavrelova H, 2011, DIABETES CARE, V34, P867, DOI 10.2337/dc10-1741	36	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32148	10.1371/journal.pone.0032148	http://dx.doi.org/10.1371/journal.pone.0032148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403629	gold, Green Published			2022-12-25	WOS:000303017700026
J	Vlachos, A; Becker, D; Jedlicka, P; Winkels, R; Roeper, J; Deller, T				Vlachos, Andreas; Becker, Denise; Jedlicka, Peter; Winkels, Raphael; Roeper, Jochen; Deller, Thomas			Entorhinal Denervation Induces Homeostatic Synaptic Scaling of Excitatory Postsynapses of Dentate Granule Cells in Mouse Organotypic Slice Cultures	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FASCIA-DENTATA; AMPA RECEPTOR; CORTEX LESION; DEPENDENT PLASTICITY; ADULT-RATS; GYRUS; HIPPOCAMPUS; REINNERVATION; EXPRESSION	Denervation-induced changes in excitatory synaptic strength were studied following entorhinal deafferentation of hippocampal granule cells in mature (>= 3 weeks old) mouse organotypic entorhino-hippocampal slice cultures. Whole-cell patch-clamp recordings revealed an increase in excitatory synaptic strength in response to denervation during the first week after denervation. By the end of the second week synaptic strength had returned to baseline. Because these adaptations occurred in response to the loss of excitatory afferents, they appeared to be in line with a homeostatic adjustment of excitatory synaptic strength. To test whether denervation-induced changes in synaptic strength exploit similar mechanisms as homeostatic synaptic scaling following pharmacological activity blockade, we treated denervated cultures at 2 days post lesion for 2 days with tetrodotoxin. In these cultures, the effects of denervation and activity blockade were not additive, suggesting that similar mechanisms are involved. Finally, we investigated whether entorhinal denervation, which removes afferents from the distal dendrites of granule cells while leaving the associational afferents to the proximal dendrites of granule cells intact, results in a global or a local up-scaling of granule cell synapses. By using computational modeling and local electrical stimulations in Strontium (Sr2+)- containing bath solution, we found evidence for a lamina-specific increase in excitatory synaptic strength in the denervated outer molecular layer at 3-4 days post lesion. Taken together, our data show that entorhinal denervation results in homeostatic functional changes of excitatory postsynapses of denervated dentate granule cells in vitro.	[Vlachos, Andreas; Becker, Denise; Jedlicka, Peter; Winkels, Raphael; Deller, Thomas] Goethe Univ Frankfurt, Ctr Neurosci, Inst Clin Neuroanat, Frankfurt, Germany; [Roeper, Jochen] Goethe Univ Frankfurt, Ctr Neurosci, Inst Neurophysiol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Vlachos, A (corresponding author), Goethe Univ Frankfurt, Ctr Neurosci, Inst Clin Neuroanat, Frankfurt, Germany.	a.vlachos@med.uni-frankfurt.de	Jedlicka, Peter/B-6094-2012; Jedlicka, Peter/AAW-4207-2020	Jedlicka, Peter/0000-0001-6571-5742; Jedlicka, Peter/0000-0001-6571-5742; Roeper, Jochen/0000-0003-2145-8742; Becker, Denise/0000-0003-0132-9986	Deutsche Forschungsgemeinschaft (DFG) [DE 551/10-1, DE 551/11-1]; LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); German-Israeli Foundation (GIF) [G-2239-2096.1/2009]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	This work was supported by Deutsche Forschungsgemeinschaft (DFG DE 551/10-1; DE 551/11-1 to TD), LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF to AV and TD) and German-Israeli Foundation (GIF G-2239-2096.1/2009 to AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral David G., 1995, P443; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; BlascoIbanez JM, 1997, HIPPOCAMPUS, V7, P307, DOI 10.1002/(SICI)1098-1063(1997)7:3<307::AID-HIPO6>3.0.CO;2-H; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Caceres A., 1983, J COMP NEUROL, V136, P287; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Deeg KE, 2011, NAT NEUROSCI, V14, P548, DOI 10.1038/nn.2772; Del Turco D, 2003, HIPPOCAMPUS, V13, P685, DOI 10.1002/hipo.10118; Del Turco Domenico, 2007, V399, P55, DOI 10.1007/978-1-59745-504-6_5; Deller T, 1997, PROG NEUROBIOL, V53, P687, DOI 10.1016/S0301-0082(97)00044-0; Deller T, 1999, EXP NEUROL, V156, P239, DOI 10.1006/exnr.1999.7020; Deller T, 2007, PROG BRAIN RES, V163, P501, DOI 10.1016/S0079-6123(07)63027-1; Diekmann S, 1996, BRAIN PATHOL, V6, P205, DOI 10.1111/j.1750-3639.1996.tb00846.x; Dinocourt C, 2011, EPILEPSIA, V52, P1656, DOI 10.1111/j.1528-1167.2011.03113.x; Echegoyen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000700; FAGAN AM, 1990, EXP NEUROL, V110, P105, DOI 10.1016/0014-4886(90)90055-W; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fenger C, 2006, GLIA, V54, P591, DOI 10.1002/glia.20405; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; GAGE FH, 1988, EXP NEUROL, V102, P2, DOI 10.1016/0014-4886(88)90073-8; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; GALL C, 1979, BRAIN RES, V175, P37, DOI 10.1016/0006-8993(79)90512-2; Goda Y, 1998, P NATL ACAD SCI USA, V95, P1283, DOI 10.1073/pnas.95.3.1283; Haas CA, 1999, J NEUROSCI, V19, P9953; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kim J, 2008, NEURON, V58, P925, DOI 10.1016/j.neuron.2008.05.009; Kluge A, 1998, HIPPOCAMPUS, V8, P57, DOI 10.1002/(SICI)1098-1063(1998)8:1<57::AID-HIPO6>3.3.CO;2-I; Krueppel R, 2011, NEURON, V71, P512, DOI 10.1016/j.neuron.2011.05.043; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; MATTHEWS DA, 1976, BRAIN RES, V115, P1, DOI 10.1016/0006-8993(76)90819-2; Mitra A, 2012, NAT NEUROSCI, V15, P250, DOI 10.1038/nn.3004; Muller CM, 2010, CELL CALCIUM, V47, P242, DOI 10.1016/j.ceca.2009.12.006; NADLER JV, 1978, BRAIN RES, V142, P174, DOI 10.1016/0006-8993(78)90188-9; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; PARNAVELAS JG, 1974, NATURE, V248, P71, DOI 10.1038/248071a0; Peng YR, 2009, NEURON, V61, P71, DOI 10.1016/j.neuron.2008.11.015; Phinney AL, 2004, EUR J NEUROSCI, V19, P1731, DOI 10.1111/j.1460-9568.2004.03280.x; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Prang P, 2003, BRAIN RES, V978, P205, DOI 10.1016/S0006-8993(03)02836-1; REEVES TM, 1988, EXP NEUROL, V102, P37, DOI 10.1016/0014-4886(88)90076-3; SAPER CB, 1987, NEUROSCIENCE, V23, P389, DOI 10.1016/0306-4522(87)90063-7; Savin C, 2009, J R SOC INTERFACE, V6, P655, DOI 10.1098/rsif.2008.0387; Schmidt-Hieber C, 2007, J NEUROSCI, V27, P8430, DOI 10.1523/JNEUROSCI.1787-07.2007; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Small DH, 2008, TRENDS MOL MED, V14, P103, DOI 10.1016/j.molmed.2007.12.006; Small DH, 2004, TRENDS NEUROSCI, V27, P245, DOI 10.1016/j.tins.2004.03.006; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; STEWARD O, 1993, EXP NEUROL, V124, P167, DOI 10.1006/exnr.1993.1187; Steward O, 1997, J COMP NEUROL, V380, P70, DOI 10.1002/(SICI)1096-9861(19970331)380:1<70::AID-CNE5>3.0.CO;2-Q; STEWARD O, 1983, J COMP NEUROL, V214, P370, DOI 10.1002/cne.902140403; Steward O, 1994, NEUROBIOLOGY CENTRAL, P266; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vitureira N, 2012, CURR OPIN NEUROBIOL, V22, P516, DOI 10.1016/j.conb.2011.09.006; Vlachos A, 2012, J COMP NEUROL, V520, P1891, DOI 10.1002/cne.23017; Vuksic M, 2008, HIPPOCAMPUS, V18, P364, DOI 10.1002/hipo.20398; Vuksic M, 2011, EXP NEUROL, V230, P176, DOI 10.1016/j.expneurol.2011.04.011; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137	75	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32883	10.1371/journal.pone.0032883	http://dx.doi.org/10.1371/journal.pone.0032883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403720	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700117
J	Vuylsteke, B; Semde, G; Sika, L; Crucitti, T; Traore, VE; Buve, A; Laga, M				Vuylsteke, Bea; Semde, Gisele; Sika, Lazare; Crucitti, Tania; Traore, Virginie Ettiegne; Buve, Anne; Laga, Marie			HIV and STI Prevalence among Female Sex Workers in Cote d'Ivoire: Why Targeted Prevention Programs Should Be Continued and Strengthened	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED DISEASES; TRICHOMONAS-VAGINALIS; DECLINE; PCR	Objective: To assess condom use and prevalence of STIs and HIV among female sex workers (FSWs), as part of a comprehensive monitoring and evaluation plan of a nationwide sex worker prevention project in Cote d'Ivoire. Design and Methods: Cross sectional surveys were conducted among FSWs attending five project clinics in Abidjan and San Pedro (2007), and in Yamoussoukro and Gagnoa (2009). A standardized questionnaire was administered in a face-to-face interview, which included questions on socio-demographic characteristics, sexual behaviour and condom use. After the interview, the participants were asked to provide samples for STI and HIV testing. Results: A total of 1110 FSWs participated in the surveys. There were large differences in socio-demographic and behavioural characteristics between FSW coming for the first time as compared to FSW coming on a routine visit. The prevalence of N. gonorrhoeae or C. trachomatis was 9.1%, 11.8% among first vs. 6.9% routine attendees (p = 0.004). The overall HIV prevalence was 26.6%, it was lower among first time attendees (17.5% as compared to 33.9% for routine attendees, p < 0.001). The HIV prevalence among first attendees was also lower than the proportion of HIV positive tests from routine testing and counselling services in the same clinics. Conclusions: The results show a relatively high STI and HIV prevalence among FSWs in different cities in Cote d'Ivoire. In the light of these results, prevention efforts should continue to focus on FSWs in the country.	[Vuylsteke, Bea; Buve, Anne; Laga, Marie] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Semde, Gisele] Global Program Management, Abidjan, Cote Ivoire; [Sika, Lazare] Natl Inst Stat & Appl Econ, Dept Populat Res & Dev, Abidjan, Cote Ivoire; [Crucitti, Tania] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Vuylsteke, B (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	bvuylsteke@itg.be	Crucitti, Tania/AAB-9967-2019; Crucitti, Tania/AAH-1902-2021; Crucitti, Tania/AEQ-9792-2022	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038	Belgian Directorate General for Cooperation; Institute of Tropical Medicine [FA3-I]	Belgian Directorate General for Cooperation; Institute of Tropical Medicine	The study was funded by the Belgian Directorate General for Cooperation: http://diplomatie.belgium.be/en/policy/development_cooperation/through the framework agreement program with the Institute of Tropical Medicine: FA3-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; Crucitti T, 2003, SEX TRANSM INFECT, V79, P393, DOI 10.1136/sti.79.5.393; Ghys PD, 2002, AIDS, V16, P251, DOI 10.1097/00002030-200201250-00015; http://www.who.int/hiv/pub/surveillance/en/cds_edc_2000_5.pdf, 2000, GUID 2 GEN HIV SURV; Institut National de la Statistique (INS) et Ministere de Lutte contre le Sida (Cote d'Ivoire) et ORC Macro, 2006, ENQ IND SID COT IV 2; KENGNE P, 1994, CELL MOL BIOL, V40, P819; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Shaio MF, 1997, J CLIN MICROBIOL, V35, P132, DOI 10.1128/JCM.35.1.132-138.1997; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001; UNAIDS Monitoring and Evaluation Fundamentals, 2010, INTR TRIANG; Vuylsteke B, 2008, PREVENTING HIV SEX W, P376; Wi T, 2006, SEX TRANSM INFECT, V82, P386, DOI 10.1136/sti.2005.018283	13	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32627	10.1371/journal.pone.0032627	http://dx.doi.org/10.1371/journal.pone.0032627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403685	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700082
J	Dallas, MR; Liu, GS; Chen, WC; Thomas, SN; Wirtz, D; Huso, DL; Konstantopoulos, K				Dallas, Matthew R.; Liu, Guosheng; Chen, Wei-Chiang; Thomas, Susan N.; Wirtz, Denis; Huso, David L.; Konstantopoulos, Konstantinos			Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis	FASEB JOURNAL			English	Article						CEA; cytoplasmic compliance; migration	COLORECTAL-CARCINOMA CELLS; VARIANT ISOFORMS; BREAST-CANCER; DECREASED EXPRESSION; HEPATIC METASTASIS; HOMOTYPIC ADHESION; IN-VITRO; INVASION; INHIBITION; PROGNOSIS	After separating from a primary tumor, metastasizing cells enter the circulatory system and interact with host cells before lodging in secondary organs. Previous studies have implicated the surface glycoproteins CD44 and carcinoembryonic antigen (CEA) in adhesion, migration, and invasion, suggesting that they may influence metastatic progression. To elucidate the role of these multifunctional molecules while avoiding the potential drawbacks of ectopic expression or monoclonal antibody treatments, we silenced the expression of CD44 and/or CEA in LS174T colon carcinoma cells and analyzed their ability to metastasize in 2 independent mouse models. Quantitative PCR revealed that CD44 knockdown increased lung and liver metastasis >10-fold, while metastasis was decreased by >50% following CEA knockdown. These findings were corroborated by in vitro experiments assessing the metastatic potential of LS174T cells. Cell migration was decreased as a result of silencing CEA but was enhanced in CD44-knockdown cells. In addition, CD44 silencing promoted homotypic aggregation of LS147T cells, a phenotype that was reversed by additional CEA knockdown. Finally, CD44-knockdown cells exhibited greater mechanical compliance than control cells, a property that correlates with increased metastatic potential. Collectively, these data indicate that CEA, but not CD44, is a viable target for therapeutics aimed at curbing colon carcinoma metastasis.-Dallas, M. R., Liu, G., Chen, W.-C., Thomas, S. N., Wirtz, D., Huso, D. L., Konstantopoulos, K. Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis. FASEB J. 26, 2648-2656 (2012). www.fasebj.org	[Dallas, Matthew R.; Chen, Wei-Chiang; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Dallas, Matthew R.; Chen, Wei-Chiang; Wirtz, Denis; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Dallas, Matthew R.; Chen, Wei-Chiang; Wirtz, Denis; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Ctr Canc Nanotechnol Excellence, Baltimore, MD 21218 USA; [Dallas, Matthew R.; Chen, Wei-Chiang; Wirtz, Denis; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Liu, Guosheng; Huso, David L.] Johns Hopkins Med Inst, Dept Mol & Comparat Pathol, Baltimore, MD 21205 USA; [Liu, Guosheng; Huso, David L.] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Thomas, Susan N.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Georgia; Georgia Institute of Technology	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	konstant@jhu.edu	Thomas, Susan/A-9947-2009; Thomas, Susan/B-4592-2016; Konstantopoulos, Konstantinos/A-7045-2011	Thomas, Susan/0000-0003-4651-232X; 	U.S. National Institutes of Health/National Cancer Institute [R01-CA-101135, U54-CA-143868]; NATIONAL CANCER INSTITUTE [R01CA101135, U54CA143868] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Institutes of Health/National Cancer Institute grants R01-CA-101135 and U54-CA-143868. The authors thank Philip Yang for critical input to this work.	Alves CS, 2009, J BIOL CHEM, V284, P1177, DOI 10.1074/jbc.M805144200; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Choi SH, 2000, INT J CANCER, V85, P523, DOI 10.1002/(SICI)1097-0215(20000215)85:4<523::AID-IJC13>3.0.CO;2-6; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; De Marzo AM, 1998, PROSTATE, V34, P162; Edmiston KH, 1997, CANCER RES, V57, P4432; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; Gangopadhyay A, 1998, CLIN EXP METASTAS, V16, P703, DOI 10.1023/A:1006576627429; Gangopadhyay A, 1996, CANCER RES, V56, P4805; Gao AC, 1997, CANCER RES, V57, P846; GOLDENBERG DM, 1976, J NATL CANCER I, V57, P11, DOI 10.1093/jnci/57.1.11; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada N, 2001, INT J CANCER, V91, P67, DOI 10.1002/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D; HASHINO J, 1994, CLIN EXP METASTAS, V12, P324, DOI 10.1007/BF01753839; Jadhav S, 2001, J IMMUNOL, V167, P5986, DOI 10.4049/jimmunol.167.10.5986; Jessup JM, 2004, CLIN EXP METASTAS, V21, P709, DOI 10.1007/s10585-004-7705-z; Jessup JM, 2004, INT J CANCER, V111, P332, DOI 10.1002/ijc.20264; Jothy S, 2003, CLIN EXP METASTAS, V20, P195, DOI 10.1023/A:1022931016285; KAUFMANN M, 1995, LANCET, V345, P615, DOI 10.1016/S0140-6736(95)90521-9; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; KITSUKI H, 1995, CANCER LETT, V88, P7, DOI 10.1016/0304-3835(94)03605-I; Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207; Li Y, 2010, CANCER RES, V70, P8159, DOI 10.1158/0008-5472.CAN-10-1073; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; McCarty OJT, 2000, BLOOD, V96, P1789, DOI 10.1182/blood.V96.5.1789.h8001789_1789_1797; Morrin M, 2002, INT J COLORECTAL DIS, V17, P30, DOI 10.1007/s003840100335; MULDER JWR, 1994, LANCET, V344, P1470, DOI 10.1016/S0140-6736(94)90290-9; Murray EW, 1998, J BIOL CHEM, V273, P25279, DOI 10.1074/jbc.273.39.25279; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Noordzij MA, 1999, INT J CANCER, V84, P478, DOI 10.1002/(SICI)1097-0215(19991022)84:5<478::AID-IJC5>3.0.CO;2-N; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; SHIVELY JE, 1985, CRC CR REV ONCOL-HEM, V2, P355, DOI 10.1016/S1040-8428(85)80008-1; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Terpe HJ, 1996, AM J PATHOL, V148, P453; Thomas SN, 2008, J BIOL CHEM, V283, P15647, DOI 10.1074/jbc.M800543200; UPDYKE TV, 1986, CLIN EXP METASTAS, V4, P273, DOI 10.1007/BF00133592; Weg-Remers S, 1998, EUR J CANCER, V34, P1607, DOI 10.1016/S0959-8049(98)00177-4; WIELENGA VJM, 1993, CANCER RES, V53, P4754; Wirth T, 2002, CLIN EXP METASTAS, V19, P155, DOI 10.1023/A:1014566127493; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Yoshioka T, 1998, JPN J CANCER RES, V89, P177, DOI 10.1111/j.1349-7006.1998.tb00546.x; Yuce I, 2011, AM J OTOLARYNG, V32, P141, DOI 10.1016/j.amjoto.2010.01.001; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940	51	36	39	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2648	2656		10.1096/fj.12-203786	http://dx.doi.org/10.1096/fj.12-203786			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415308	Green Published			2022-12-25	WOS:000305017200040
J	Erener, S; Mirsaidi, A; Hesse, M; Tiaden, AN; Ellingsgaard, H; Kostadinova, R; Donath, MY; Richards, PJ; Hottiger, MO				Erener, Sueheda; Mirsaidi, Ali; Hesse, Mareike; Tiaden, Andre N.; Ellingsgaard, Helga; Kostadinova, Radina; Donath, Marc Y.; Richards, Peter J.; Hottiger, Michael O.			ARTD1 deletion causes increased hepatic lipid accumulation in mice fed a high-fat diet and impairs adipocyte function and differentiation	FASEB JOURNAL			English	Article						adipogenesis; ADP-ribosylation; liver; PARP-1	POLY(ADP-RIBOSE) POLYMERASE; ADIPOSE-TISSUE; ADP-RIBOSYLATION; GENE-EXPRESSION; TELOMERE LENGTH; PPAR-GAMMA; LIVER; INFLAMMATION; OBESITY; CELLS	ADP-ribosyltransferase Diphtheria toxin-like 1 [ARTD1; formerly called poly-ADP-ribose polymerase 1 (PARP1)] is a chromatin-associated enzyme involved in regulating metabolic homeostasis. The liver is at the core of glucose and lipid metabolism and is significantly affected by obesity and the metabolic syndrome. Here, we show that when fed a high-fat diet (HFD), mice lacking ARTD1 developed exacerbated hepatic steatosis. ARTD1(-/-) mice had a 19% higher liver weight than wild-type (WT) animals and exhibited a significantly increased serum concentration of cholesterol (38%) and impaired glucose tolerance. In addition, adipocyte function and size were significantly reduced in ARTD1(-/-) mice fed an HFD (7794 mu m(2) for WT and 5579 mu m(2) for ARTD1(-/-) mice). The significantly reduced adipogenic differentiation of adipose-derived stromal cells (ASCs) isolated from ARTD1(-/-) mice (28 vs. 11% Oil red O-positive cells in WT and ARTD1(-/-) ASCs, respectively) suggested that impaired adipogenesis as the underlying cause for this adipose tissue malfunction. This function of ARTD1 was specific for adipogenesis, since osteogenic differentiation was not affected by the ARTD1 deletion. In summary, we show that ARTD1(-/-) mice fed an HFD display impaired adipogenesis and show exacerbated hepatic steatosis, which can have important implications for nonalcoholic fatty liver disease.-Erener, S., Mirsaidi, A., Hesse, M., Tiaden, A. N., Ellingsgaard, H., Kostadinova, R., Donath, M. Y., Richards, P. J., Hottiger, M. O. ARTD1 deletion causes increased hepatic lipid accumulation in mice fed a high-fat diet and impairs adipocyte function and differentiation. FASEB J. 26, 2631-2638 (2012). www.fasebj.org	[Erener, Sueheda; Hesse, Mareike; Kostadinova, Radina; Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Erener, Sueheda; Hesse, Mareike] Univ Zurich, Life Sci Zurich Grad Sch, Mol Life Sci Program, CH-8057 Zurich, Switzerland; [Mirsaidi, Ali; Tiaden, Andre N.; Richards, Peter J.] Univ Zurich, Competence Ctr Appl Biotechnol & Mol Med, Bone & Stem Cell Res Grp, CH-8057 Zurich, Switzerland; [Mirsaidi, Ali; Richards, Peter J.; Hottiger, Michael O.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Inst Physiol, CH-8057 Zurich, Switzerland; [Ellingsgaard, Helga; Donath, Marc Y.] Univ Basel Hosp, Clin Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland	University of Zurich; University of Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Basel	Hottiger, MO (corresponding author), Univ Zurich, Inst Vet Biochem & Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	hottiger@vetbio.uzh.ch	Lehmann, Mareike/S-8727-2019; Hottiger, Michael O./J-7747-2013; Ellingsgaard, Helga/AAD-5705-2022	Lehmann, Mareike/0000-0002-8601-8206; Hottiger, Michael O./0000-0002-7323-2270; Ellingsgaard, Helga/0000-0002-9105-5247	University of Zurich; Swiss National Science Foundation [31-122421, 310030B-138667]; Kanton of Zurich	University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton of Zurich	The authors thank I. Mittner and M. Wanner (University of Zurich) for FFA measurements. F. Freimoser (University of Zurich) provided editorial assistance and critical input during the writing. This work was supported in part by the University Research Priority Program, Integrative Human Physiology, at the University of Zurich; a Forschungskredit of the University of Zurich (to M. H.); Swiss National Science Foundation grants 31-122421 and 310030B-138667; and the Kanton of Zurich (to M. O. H.). The authors declare no conflicts of interest. Author contributions: S. E., A. M., M. H., P. J. R., R. K., M. Y. D., and M. O. H. designed the experiments; S. E., A. M., M. H., A. N. T., and H. E. performed the experiments; P. J. R. and M. O. H. supervised the study; M. O. H., S. E., and P. J. R. wrote and edited the manuscript.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Cortez-Pinto H, 1999, CLIN NUTR, V18, P353, DOI 10.1016/S0261-5614(99)80015-6; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Devalaraja-Narashimha K, 2010, J ENDOCRINOL, V205, P242, DOI 10.1677/JOE-09-0402; di Fagagna FD, 1999, NAT GENET, V23, P76; Erener S, 2012, MOL ENDOCRINOL, V26, P79, DOI 10.1210/me.2011-1163; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Messner S, 2011, TRENDS CELL BIOL, V21, P534, DOI 10.1016/j.tcb.2011.06.001; Mirsaidi A, 2012, J TISSUE ENG REGEN M, V6, P378, DOI 10.1002/term.440; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Samper E, 2001, J CELL BIOL, V154, P49, DOI 10.1083/jcb.200103049; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	32	39	39	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2631	2638		10.1096/fj.11-200212	http://dx.doi.org/10.1096/fj.11-200212			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22426118				2022-12-25	WOS:000305017200038
J	Lu, D; Soleymani, S; Madakshire, R; Insel, PA				Lu, David; Soleymani, Sahar; Madakshire, Rohit; Insel, Paul A.			ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y(2) receptors	FASEB JOURNAL			English	Article						cardiac fibrosis; purinergic signaling; extracellular matrix; alpha-smooth muscle actin; MAPK/ERK activation	PANNEXIN 1 CHANNELS; FIND-ME SIGNAL; EXTRACELLULAR ATP; TGF-BETA; NUCLEOTIDE RECEPTORS; GROWTH-FACTOR; HEART; EXPRESSION; INHIBITION; ASTROCYTES	Cardiac fibroblasts (CFs) play an essential role in remodeling of the cardiac extracellular matrix. Extracellular nucleotide signaling may provoke a profibrotic response in CFs. We tested the hypothesis that physical perturbations release ATP from CFs and that ATP participates in profibrotic signaling. ATP release was abolished by the channel inhibitor carbenoxolone and inhibited by knockdown of either connexin (Cx)43 or Cx45 (47 and 35%, respectively), implying that hypotonic stimulation induces ATP release via Cx43 and Cx45 hemichannels, although pannexin 1 may also play a role. ATP released by hypotonic stimulation rapidly (<10 min) increased phosphorylated ERK by 5-8 fold, an effect largely eliminated by P2Y(2) receptor knockdown or ATP hydrolysis with apyrase. ATP stimulation of P2Y(2) receptors increased alpha-smooth muscle actin (alpha-SMA) production, and in an ERK-dependent manner, ATP increased collagen accumulation by 60% and mRNA expression of profibrotic markers: plasminogen activator inhibitor-1 and monocyte chemotactic protein-1 by 4.5- and 4.0-fold, respectively. Apyrase treatment substantially reduced the basal profibrotic phenotype, decreasing collagen and alpha-SMA content and increasing matrix metalloproteinase expression. Thus, ATP release activates P2Y(2) receptors to mediate profibrotic responses in CFs, implying that nucleotide release under both basal and activated states is likely an important mechanism for fibroblast homeostasis.-Lu, D., Soleymani, S., Madakshire, R., Insel, P. A. ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y(2) receptors. FASEB J. 26, 2580-2591 (2012). www.fasebj.org	[Lu, David; Soleymani, Sahar; Madakshire, Rohit; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, BSB 3076,9500 Gilman Dr 0636, La Jolla, CA 92093 USA.	pinsel@ucsd.edu			U.S. National Institutes of Health (NIH); Ellison Medical Research Foundation; University of California-San Diego Academic Senate; NIH [1T32HL098062-01A1]; National Research Service [1F31AG039992-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG039992] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Research Foundation(Lawrence Ellison Foundation); University of California-San Diego Academic Senate; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Nakon Aroonsakool for assistance in the isolation of rat CFs and Eveline Sun Arnold for assistance with confocal microscopy. This work was supported by research grants from the U.S. National Institutes of Health (NIH) and the Ellison Medical Research Foundation and support from the University of California-San Diego Academic Senate (to P. A. I.). D. L. was supported by NIH training grant 1T32HL098062-01A1 and National Research Service Award 1F31AG039992-01. The authors declare no conflicts of interests.	Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Beyer EC, 2001, CELL COMMUN ADHES, V8, P199, DOI 10.3109/15419060109080723; Braun OO, 2010, J MOL CELL CARDIOL, V49, P362, DOI 10.1016/j.yjmcc.2010.05.001; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Communi D, 2000, CELL SIGNAL, V12, P351, DOI 10.1016/S0898-6568(00)00083-8; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Dranoff JA, 2004, AM J PHYSIOL-GASTR L, V287, pG417, DOI 10.1152/ajpgi.00294.2003; Dubyak GR, 2009, AM J PHYSIOL-CELL PH, V296, pC235, DOI 10.1152/ajpcell.00639.2008; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Espira L, 2009, CAN J PHYSIOL PHARM, V87, P996, DOI 10.1139/Y09-105; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Gunduz D, 2006, CARDIOVASC RES, V71, P764, DOI 10.1016/j.cardiores.2006.06.011; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Johansen D, 2011, CELL PHYSIOL BIOCHEM, V28, P103, DOI 10.1159/000331719; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; LaFramboise WA, 2007, AM J PHYSIOL-CELL PH, V292, pC1799, DOI 10.1152/ajpcell.00166.2006; Lal H, 2009, FRONT BIOSCI-LANDMRK, V14, P2307, DOI 10.2741/3381; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lugo-Garcia L, 2007, EUR J PHARMACOL, V568, P54, DOI 10.1016/j.ejphar.2007.04.012; Manso AM, 2009, J INVEST MED, V57, P856, DOI 10.2310/JIM.0b013e3181c5e61f; Martinez AD, 2002, CIRC RES, V90, P1100, DOI 10.1161/01.RES.0000019580.64013.31; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Missan S, 2011, CARDIOVASC RES, V91, P429, DOI 10.1093/cvr/cvr074; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratchford AM, 2010, J BIOL CHEM, V285, P7545, DOI 10.1074/jbc.M109.078170; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Schock SC, 2008, BIOCHEM BIOPH RES CO, V368, P138, DOI 10.1016/j.bbrc.2008.01.054; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sobel BE, 2006, LIFE SCI, V79, P1600, DOI 10.1016/j.lfs.2006.05.011; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Stenmark KR, 2002, CHEST, V122, p326S, DOI 10.1378/chest.122.6_suppl.326S; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; van der Vliet A, 2011, SUBCELL BIOCHEM, V55, P139, DOI 10.1007/978-94-007-1217-1_6; Vasquez C, 2010, CIRC RES, V107, P1011, DOI 10.1161/CIRCRESAHA.110.227421; Verma SK, 2011, CARDIOVASC RES, V90, P88, DOI 10.1093/cvr/cvq385; Wilden PA, 1998, AM J PHYSIOL-HEART C, V275, pH1209, DOI 10.1152/ajpheart.1998.275.4.H1209; Yamamoto K, 2011, J CELL SCI, V124, P3477, DOI 10.1242/jcs.087221; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Ye ZC, 2009, GLIA, V57, P258, DOI 10.1002/glia.20754; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910; Zhang Y, 2010, AM J PHYSIOL-HEART C, V298, pH477, DOI 10.1152/ajpheart.00806.2009	64	69	69	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2580	2591		10.1096/fj.12-204677	http://dx.doi.org/10.1096/fj.12-204677			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415310	Green Published			2022-12-25	WOS:000305017200034
J	Dogo-Isonagie, C; Lam, S; Gustchina, E; Acharya, P; Yang, YP; Shahzad-ul-Hussan, S; Clore, GM; Kwong, PD; Bewley, CA				Dogo-Isonagie, Cajetan; Lam, Son; Gustchina, Elena; Acharya, Priyamvada; Yang, Yongping; Shahzad-ul-Hussan, Syed; Clore, G. Marius; Kwong, Peter D.; Bewley, Carole A.			Peptides from Second Extracellular Loop of C-C Chemokine Receptor Type 5 (CCR5) Inhibit Diverse Strains of HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-COUPLED RECEPTOR; ENVELOPE GLYCOPROTEIN; CORECEPTOR ACTIVITY; GP120 BINDING; N-TERMINUS; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; ENTRY INHIBITORS; MEMBRANE-FUSION	To initiate HIV entry, the HIV envelope protein gp120 must engage its primary receptor CD4 and a coreceptor CCR5 or CXCR4. In the absence of a high resolution structure of a gp120-coreceptor complex, biochemical studies of CCR5 have revealed the importance of its N terminus and second extracellular loop (ECL2) in binding gp120 and mediating viral entry. Using a panel of synthetic CCR5 ECL2-derived peptides, we show that the C-terminal portion of ECL2 (2C, comprising amino acids Cys-178 to Lys-191) inhibit HIV-1 entry of both CCR5- and CXCR4-using isolates at low micromolar concentrations. In functional viral assays, these peptides inhibited HIV-1 entry in a CD4-independent manner. Neutralization assays designed to measure the effects of CCR5 ECL2 peptides when combined with either with the small molecule CD4 mimetic NBD-556, soluble CD4, or the CCR5 N terminus showed additive inhibition for each, indicating that ECL2 binds gp120 at a site distinct from that of N terminus and acts independently of CD4. Using saturation transfer difference NMR, we determined the region of CCR5 ECL2 used for binding gp120, showed that it can bind to gp120 from both R5 and X4 isolates, and demonstrated that the peptide interacts with a CD4-gp120 complex in a similar manner as to gp120 alone. As the CCR5 N terminus-gp120 interactions are dependent on CD4 activation, our data suggest that gp120 has separate binding sites for the CCR5 N terminus and ECL2, the ECL2 binding site is present prior to CD4 engagement, and it is conserved across CCR5-and CXCR4-using strains. These peptides may serve as a starting point for the design of inhibitors with broad spectrum anti-HIV activity.	[Dogo-Isonagie, Cajetan; Lam, Son; Shahzad-ul-Hussan, Syed; Bewley, Carole A.] NIDDK, Bioorgan Chem Lab, Bethesda, MD 20892 USA; [Gustchina, Elena; Clore, G. Marius] NIDDK, Chem Phys Lab, Bethesda, MD 20892 USA; [Acharya, Priyamvada; Yang, Yongping; Shahzad-ul-Hussan, Syed; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bewley, CA (corresponding author), NIDDK, Bioorgan Chem Lab, 8 Ctr Dr, Bethesda, MD 20892 USA.	caroleb@mail.nih.gov	Clore, G. Marius/A-3511-2008; Clore, G Marius/L-2546-2018	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; Acharya, Priyamvada/0000-0002-0089-277X; Bewley, Carole/0000-0003-2203-0852	National Institutes of Health (NIDDK and NIAID); Office of the Director, National Institutes of Health; Intramural AIDS Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023, ZIADK032103, ZIADK029038] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK and NIAID); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural AIDS Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program, National Institutes of Health (NIDDK and NIAID), and the Intramural AIDS Targeted Antiviral Program, Office of the Director, National Institutes of Health (to C. A. B. and G. M. C.).; Recipient of an Intramural AIDS Research Fellowship award.	Acharya P, 2011, ACS CHEM BIOL, V6, P1069, DOI 10.1021/cb200068b; Agrawal L, 2004, BLOOD, V103, P1211, DOI 10.1182/blood-2003-08-2669; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; Da LT, 2011, J CHEM INF MODEL, V51, P359, DOI 10.1021/ci1003448; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P40397, DOI 10.1074/jbc.M206784200; FISHER RA, 1988, NATURE, V331, P76, DOI 10.1038/331076a0; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gustchina E, 2008, J VIROL, V82, P10032, DOI 10.1128/JVI.01050-08; Gustchina E, 2007, J VIROL, V81, P12946, DOI 10.1128/JVI.01260-07; Gustchina E, 2006, J MOL BIOL, V364, P283, DOI 10.1016/j.jmb.2006.09.017; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Konishi K, 2000, CHEM PHARM BULL, V48, P308; Lam SN, 2008, BIOORGAN MED CHEM, V16, P10113, DOI 10.1016/j.bmc.2008.10.005; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Misumi S, 2001, J VIROL, V75, P11614, DOI 10.1128/JVI.75.23.11614-11620.2001; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Neuhaus D., 1989, NUCL OVERHAUSER EFFE; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pontow S, 2001, J VIROL, V75, P11503, DOI 10.1128/JVI.75.23.11503-11514.2001; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Ross TM, 1998, J VIROL, V72, P1918, DOI 10.1128/JVI.72.3.1918-1924.1998; Schnur E, 2011, J MOL BIOL, V410, P778, DOI 10.1016/j.jmb.2011.04.023; Schon A, 2006, BIOCHEMISTRY-US, V45, P10973, DOI 10.1021/bi061193r; Shahzad-ul-Hussan S, 2011, J BIOL CHEM, V286, P20788, DOI 10.1074/jbc.M111.232678; Tarasova NI, 1999, J BIOL CHEM, V274, P34911, DOI 10.1074/jbc.274.49.34911; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zhang YJ, 1999, J VIROL, V73, P3443, DOI 10.1128/JVI.73.4.3443-3448.1999; Zhao Q, 2005, VIROLOGY, V339, P213, DOI 10.1016/j.virol.2005.06.008; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	56	21	22	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15076	15086		10.1074/jbc.M111.332361	http://dx.doi.org/10.1074/jbc.M111.332361			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403408	Green Published, hybrid			2022-12-25	WOS:000304003200069
J	Peng, RQ; Wan, HY; Li, HF; Liu, M; Li, X; Tang, H				Peng, Rui-Qing; Wan, Hai-Ying; Li, Hai-Fang; Liu, Min; Li, Xin; Tang, Hua			MicroRNA-214 Suppresses Growth and Invasiveness of Cervical Cancer Cells by Targeting UDP-N-acetyl-alpha-D-galactosamine: Polypeptide N-Acetylgalactosaminyltransferase 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; LUNG-CANCER; EXPRESSION; INVASION; PROLIFERATION; REPRESSES; GLYCOSYLATION; ACCUMULATION; METASTASIS; CARCINOMA	MicroRNAs are a class of small noncoding RNAs that function as key regulators of gene expression at the post-transcriptional level. In this study, we demonstrate that miR-214 is frequently down-regulated in cervical cancer, and its expression reduces the proliferation, migration, and invasiveness of cervical cancer cells, whereas inhibiting its expression results in enhanced proliferation, migration, and invasion. miR-214 binds to the 3'-UTR of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7), thereby repressing GALNT7 expression. Furthermore, we are the first to show, using quantitative real-time PCR, that GALNT7 is frequently up-regulated in cervical cancer. The knockdown of GALNT7 markedly inhibits cervical cancer cell proliferation, migration, and invasion, whereas ectopic expression of GALNT7 significantly enhances these properties, indicating that GALNT7 might function as an oncogene in cervical cancer. The restoration of GALNT7 expression can counteract the effect of miR-214 on cell proliferation, migration, and invasiveness of cervical cancer cells. Together, these results indicate that miR-214 is a new regulator of GALNT7, and both miR-214 and GALNT7 play important roles in the pathogenesis of cervical cancer.	Tianjin Med Univ, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China; Tianjin Med Univ, Basic Med Sch, Tianjin 300070, Peoples R China	Tianjin Medical University; Tianjin Medical University	Tang, H (corresponding author), 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	htang2002@yahoo.com			National Natural Science Foundation of China [30873017, 91029714, 31071191]; Natural Science Foundation of Tianjin [08JCZDJC23300, 09JCZDJC17500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China (Grants 30873017 and 91029714, 31071191) and the Natural Science Foundation of Tianjin (Grants 08JCZDJC23300 and 09JCZDJC17500).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Casey RC, 2003, CLIN EXP METASTAS, V20, P143, DOI 10.1023/A:1022670501667; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ellenson LH, 2004, CANCER CELL, V5, P533, DOI 10.1016/j.ccr.2004.05.029; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Karlidag T, 2007, AM J OTOLARYNG, V28, P31, DOI 10.1016/j.amjoto.2006.06.008; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai KW, 2010, EUR J CANCER, V46, P1456, DOI 10.1016/j.ejca.2010.01.036; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Noordhuis MG, 2011, INT J RADIAT ONCOL, V79, P325, DOI 10.1016/j.ijrobp.2010.09.043; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Rao QX, 2012, MED ONCOL, V29, P1242, DOI 10.1007/s12032-011-9830-2; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STROUS GJAM, 1979, P NATL ACAD SCI USA, V76, P2694, DOI 10.1073/pnas.76.6.2694; Tang H, 2008, CLIN CHIM ACTA, V394, P81, DOI 10.1016/j.cca.2008.04.012; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Xiong X, 2011, PATHOL ONCOL RES, V17, P931, DOI 10.1007/s12253-011-9406-7; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yeung CLA, 2011, ONCOGENE, V30, P2401, DOI 10.1038/onc.2010.613; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	43	143	151	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14301	14309		10.1074/jbc.M111.337642	http://dx.doi.org/10.1074/jbc.M111.337642			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22399294	Green Published, hybrid			2022-12-25	WOS:000303996300081
J	Wolf, D; Jehle, F; Rodriguez, AO; Dufner, B; Hoppe, N; Colberg, C; Lozhkin, A; Bassler, N; Rupprecht, B; Wiedemann, A; Hilgendorf, I; Stachon, P; Willecke, F; Febbraio, M; Binder, CJ; Bode, C; Zirlik, A; Peter, K				Wolf, Dennis; Jehle, Felix; Rodriguez, Alexandra Ortiz; Dufner, Bianca; Hoppe, Natalie; Colberg, Christian; Lozhkin, Andrey; Bassler, Nicole; Rupprecht, Benjamin; Wiedemann, Ansgar; Hilgendorf, Ingo; Stachon, Peter; Willecke, Florian; Febbraio, Mark; Binder, Christoph J.; Bode, Christoph; Zirlik, Andreas; Peter, Karlheinz			CD40L Deficiency Attenuates Diet-Induced Adipose Tissue Inflammation by Impairing Immune Cell Accumulation and Production of Pathogenic IgG- Antibodies	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FREE FATTY-ACIDS; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HEPATIC STEATOSIS; SOLUBLE CD40L; VISCERAL FAT; T-CELLS; OBESITY	Background: Adipose tissue inflammation fuels the metabolic syndrome. We recently reported that CD40L - an established marker and mediator of cardiovascular disease - induces inflammatory cytokine production in adipose cells in vitro. Here, we tested the hypothesis that CD40L deficiency modulates adipose tissue inflammation in vivo. Methodology/Principal Findings: WT or CD40L(-/-) mice consumed a high fat diet (HFD) for 20 weeks. Inflammatory cell recruitment was impaired in mice lacking CD40L as shown by a decrease of adipose tissue macrophages, B-cells, and an increase in protective T-regulatory cells. Mechanistically, CD40L-deficient mice expressed significantly lower levels of the pro-inflammatory chemokine MCP-1 both, locally in adipose tissue and systemically in plasma. Moreover, levels of proinflammatory IgG-antibodies against oxidized lipids were reduced in CD40L(-/-) mice. Also, circulating low-density lipoproteins and insulin levels were lower in CD40L(-/-) mice. However, CD40L(-/-) mice consuming HFD were not protected from the onset of diet-induced obesity (DIO), insulin resistance, and hepatic steatosis, suggesting that CD40L selectively limits the inflammatory features of diet-induced obesity rather than its metabolic phenotype. Interestingly, CD40L(-/-) mice consuming a low fat diet (LFD) showed both, a favorable inflammatory and metabolic phenotype characterized by diminished weight gain, improved insulin tolerance, and attenuated plasma adipokine levels. Conclusion: We present the novel finding that CD40L deficiency limits adipose tissue inflammation in vivo. These findings identify CD40L as a potential mediator at the interface of cardiovascular and metabolic disease.	[Wolf, Dennis; Jehle, Felix; Rodriguez, Alexandra Ortiz; Dufner, Bianca; Hoppe, Natalie; Colberg, Christian; Lozhkin, Andrey; Rupprecht, Benjamin; Wiedemann, Ansgar; Hilgendorf, Ingo; Stachon, Peter; Willecke, Florian; Bode, Christoph; Zirlik, Andreas] Univ Freiburg, Dept Cardiol, Atherogenesis Res Grp, Freiburg, Germany; [Jehle, Felix; Bassler, Nicole; Febbraio, Mark; Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria	University of Freiburg; Baker Heart and Diabetes Institute; Medical University of Vienna; Austrian Academy of Sciences	Wolf, D (corresponding author), Univ Freiburg, Dept Cardiol, Atherogenesis Res Grp, Freiburg, Germany.	andreas.zirlik@uniklinik-freiburg.de	Wolf, Dennis/S-9217-2018; Wolf, Dennis/G-8299-2012; Febbraio, Mark/AAE-9632-2019; Peter, Karlheinz/E-8772-2010; /S-2765-2019; Hilgendorf, Ingo/AFM-6379-2022; Zirlik, Andreas/A-6400-2011	Wolf, Dennis/0000-0003-1525-4348; Peter, Karlheinz/0000-0002-8040-2258; /0000-0002-8040-2258; Hilgendorf, Ingo/0000-0002-0024-1643; Zirlik, Andreas/0000-0001-6290-3297; Binder, Christoph J./0000-0001-8313-7050	Deutsche Forschungsgemeinschaft (DFG) [ZI743/3-1, ZI743/3-2]; Fritz-Thyssen-Stiftung; National Health and Medical Research Council of Australia; Bayer Science and Education Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fritz-Thyssen-Stiftung; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Bayer Science and Education Foundation	This work was supported by research grants from the Deutsche Forschungsgemeinschaft (DFG ZI743/3-1 and 3-2) and from the Fritz-Thyssen-Stiftung to AZ and grants from the National Health and Medical Research Council of Australia to KP. KP is a Future Fellow of the Australian Research Council. DW was funded by a fellowship of the Bayer Science and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavendiek U, 2005, ARTERIOSCL THROM VAS, V25, P1244, DOI 10.1161/01.ATV.0000161420.55482.ef; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Cipollone F, 2003, CIRCULATION, V108, P2776, DOI 10.1161/01.CIR.0000103700.05109.0D; Cipollone F, 2002, CIRCULATION, V106, P399, DOI 10.1161/01.CIR.0000025419.95769.F0; den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.107.151621; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Klein S, 2004, J CLIN INVEST, V113, P1530, DOI 10.1172/JCI200422028; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Missiou A, CIRC RES, V107, P757; Missiou A, 2010, CIRCULATION, V121, P2033, DOI 10.1161/CIRCULATIONAHA.109.895037; Missiou A, 2010, THROMB HAEMOSTASIS, V103, P788, DOI 10.1160/TH09-07-0463; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Connell J, PLOS ONE, V5, pe9997; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Schonbeck U, 2000, INT J BIOCHEM CELL B, V32, P687, DOI 10.1016/S1357-2725(00)00016-9; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stachon P, PLOS ONE, V5; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Tilg H, HEPATOLOGY, V52, P1836; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Varo N, 2003, CIRCULATION, V107, P2664, DOI 10.1161/01.CIR.0000074043.46437.44; Villeneuve J, HEPATOLOGY, V52, P1968; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, NAT MED; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566	49	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33026	10.1371/journal.pone.0033026	http://dx.doi.org/10.1371/journal.pone.0033026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412980	Green Published, gold			2022-12-25	WOS:000303062000027
J	Adriaenssens, EM; Van Vaerenbergh, J; Vandenheuvel, D; Dunon, V; Ceyssens, PJ; De Proft, M; Kropinski, AM; Noben, JP; Maes, M; Lavigne, R				Adriaenssens, Evelien M.; Van Vaerenbergh, Johan; Vandenheuvel, Dieter; Dunon, Vincent; Ceyssens, Pieter-Jan; De Proft, Maurice; Kropinski, Andrew M.; Noben, Jean-Paul; Maes, Martine; Lavigne, Rob			T4-Related Bacteriophage LIMEstone Isolates for the Control of Soft Rot on Potato Caused by 'Dickeya solani'	PLOS ONE			English	Article							PLANT-DISEASE CONTROL; ERWINIA-CHRYSANTHEMI; HOMING ENDONUCLEASES; PHAGE THERAPY; CAROTOVORA; PREDICTION; NOMENCLATURE; DISCOVERY; SEQUENCES; ELEMENTS	The bacterium 'Dickeya solani', an aggressive biovar 3 variant of Dickeya dianthicola, causes rotting and blackleg in potato. To control this pathogen using bacteriophage therapy, we isolated and characterized two closely related and specific bacteriophages, vB_DsoM_LIMEstone1 and vB_DsoM_LIMEstone2. The LIMEstone phages have a T4-related genome organization and share DNA similarity with Salmonella phage Vil. Microbiological and molecular characterization of the phages deemed them suitable and promising for use in phage therapy. The phages reduced disease incidence and severity on potato tubers in laboratory assays. In addition, in a field trial of potato tubers, when infected with 'Dickeya solani', the experimental phage treatment resulted in a higher yield. These results form the basis for the development of a bacteriophage-based biocontrol of potato plants and tubers as an alternative for the use of antibiotics.	[Adriaenssens, Evelien M.; Vandenheuvel, Dieter; Dunon, Vincent; Ceyssens, Pieter-Jan; Lavigne, Rob] Katholieke Univ Leuven, Div Gene Technol, B-3001 Heverlee, Belgium; [Adriaenssens, Evelien M.; Van Vaerenbergh, Johan; Maes, Martine] Inst Agr & Fisheries Res, Unit Plant Crop Protect, Merelbeke, Belgium; [Adriaenssens, Evelien M.; De Proft, Maurice] Katholieke Univ Leuven, Div Crop Biotech, B-3001 Heverlee, Belgium; [Kropinski, Andrew M.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Noben, Jean-Paul] Hasselt Univ, Sch Life Sci, Biomed Res Inst, Diepenbeek, Belgium; [Noben, Jean-Paul] Hasselt Univ, Sch Life Sci, Transnat Univ Limburg, Diepenbeek, Belgium	KU Leuven; Institute For Agricultural & Fisheries Research; KU Leuven; Public Health Agency of Canada; University of Guelph; Hasselt University; Hasselt University	Adriaenssens, EM (corresponding author), Katholieke Univ Leuven, Div Gene Technol, B-3001 Heverlee, Belgium.	rob.lavigne@biw.kuleuven.be	Dunon, Vincent/O-7296-2019; Adriaenssens, Evelien/E-8004-2013; Kropinski, Andrew M/H-7130-2016; Noben, Jean-Paul/E-8066-2011	Dunon, Vincent/0000-0002-6009-2061; Adriaenssens, Evelien/0000-0003-4826-5406; Kropinski, Andrew M/0000-0002-6871-6799; Noben, Jean-Paul/0000-0003-3368-5686; Ceyssens, Pieter-Jan/0000-0001-7735-8316; Lavigne, Rob/0000-0001-7377-1314; Vandenheuvel, Dieter/0000-0002-4398-1916	Katholieke Universiteit Leuven; Institute for Agricultural and Fisheries Research Flanders (ILVO); Fonds voor Wetenschappelijk Onderzoek (FWO Flanders)	Katholieke Universiteit Leuven(KU Leuven); Institute for Agricultural and Fisheries Research Flanders (ILVO); Fonds voor Wetenschappelijk Onderzoek (FWO Flanders)(FWO)	EMA and the experimental work were funded through a PhD scholarship by the Katholieke Universiteit Leuven and the Institute for Agricultural and Fisheries Research Flanders (ILVO). PJC hold a post-doctoral fellowship of the Fonds voor Wetenschappelijk Onderzoek (FWO Flanders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Hans-W., 2009, V501, P113, DOI 10.1007/978-1-60327-164-6_12; Adams M.H., 1959, BACTERIOPHAGES, P14; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Anany H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-242; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balogh B, 2010, CURR PHARM BIOTECHNO, V11, P48, DOI 10.2174/138920110790725302; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; BELFORT M, 1990, ANNU REV GENET, V24, P363; Bleasby A, 2011, FUZZNUC; Ceyssens PJ, 2008, J BACTERIOL, V190, P1429, DOI 10.1128/JB.01441-07; Czajkowski R, 2011, PLANT PATHOL, V60, P999, DOI 10.1111/j.1365-3059.2011.02470.x; DARRASSE A, 1994, APPL ENVIRON MICROB, V60, P1437, DOI 10.1128/AEM.60.5.1437-1443.1994; Denou E, 2009, VIROLOGY, V388, P21, DOI 10.1016/j.virol.2009.03.009; EAYRE CG, 1995, PLANT DIS, V79, P801, DOI 10.1094/PD-79-0801; Edgell DR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-290; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gill JJ, 2003, APPL ENVIRON MICROB, V69, P2133, DOI 10.1128/AEM.69.4.2133-2138.2003; GILL JJ, 2003, BACTERIOPHAGE ECOLOG; Glasner JD, 2011, J BACTERIOL, V193, P2076, DOI 10.1128/JB.01513-10; GoodrichBlair H, 1996, CELL, V84, P211, DOI 10.1016/S0092-8674(00)80976-9; Gordon L, 2003, BIOINFORMATICS, V19, P1964, DOI 10.1093/bioinformatics/btg265; Jones JB, 2007, ANNU REV PHYTOPATHOL, V45, P245, DOI 10.1146/annurev.phyto.45.062806.094411; Kasman LM, 2002, J VIROL, V76, P5557, DOI 10.1128/JVI.76.11.5557-5564.2002; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Kutter E., 2005, BACTERIOPHAGES BIOL; Kutter EM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-430; Laurila J, 2010, EUR J PLANT PATHOL, V126, P249, DOI 10.1007/s10658-009-9537-9; Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McKenna F, 2001, PLANT PATHOL, V50, P666, DOI 10.1046/j.1365-3059.2001.00648.x; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Muller I, 2011, J BACTERIOL, V193, P795, DOI 10.1128/JB.01293-10; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; NASSAR A, 1994, APPL ENVIRON MICROB, V60, P3781, DOI 10.1128/AEM.60.10.3781-3789.1994; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P2388, DOI 10.1099/ijs.0.009258-0; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; Pickard D, 2010, J BACTERIOL, V192, P5746, DOI 10.1128/JB.00659-10; Ravensdale M, 2007, CAN J PLANT PATHOL, V29, P121, DOI 10.1080/07060660709507448; RESIBOIS A, 1984, VIROLOGY, V137, P102, DOI 10.1016/0042-6822(84)90013-8; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Sambrook J, 2001, MOL CLONING LAB MANU; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Sandegren L, 2005, NUCLEIC ACIDS RES, V33, P6203, DOI 10.1093/nar/gki932; SCHOONEJANS E, 1987, J BACTERIOL, V169, P4011, DOI 10.1128/jb.169.9.4011-4017.1987; Slawiak M, 2009, EUR J PLANT PATHOL, V125, P245, DOI 10.1007/s10658-009-9479-2; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Tatusov T, 2011, ORF FINDER; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	101	101	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33227	10.1371/journal.pone.0033227	http://dx.doi.org/10.1371/journal.pone.0033227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22413005	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800086
J	Li, S; Sun, F; Zhang, YB; Gui, JF; Zhang, QY				Li, Shun; Sun, Fan; Zhang, Yi-Bing; Gui, Jian-Fang; Zhang, Qi-Ya			Identification of DreI as an Antiviral Factor Regulated by RLR Signaling Pathway	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; TROUT ONCORHYNCHUS-MYKISS; DEPENDENT PROTEIN-KINASE; IFN-BETA PROMOTER; I-LIKE RECEPTORS; RIG-I; FUNCTIONAL-CHARACTERIZATION; PARALICHTHYS-OLIVACEUS; SPRING VIREMIA; CARP VIRUS	Background: Retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) had been demonstrated to prime interferon (IFN) response against viral infection via the conserved RLR signaling in fish, and a novel fish-specific gene, the grass carp reovirus (GCRV)-induced gene 2 (Gig2), had been suggested to play important role in host antiviral response. Methodology/Principal Findings: In this study, we cloned and characterized zebrafish Gig2 homolog (named Danio rerio Gig2-I, DreI), and revealed its antiviral role and expressional regulation signaling pathway. RT-PCR, Western blot and promoter activity assay indicate that DreI can be induced by poly I: C, spring viremia of carp virus (SVCV) and recombinant IFN (rIFN), showing that DreI is a typical ISG. Using the pivotal signaling molecules of RLR pathway, including RIG-I, MDA5 and IRF3 from crucian carp, it is found that DreI expression is regulated by RLR cascade and IRF3 plays an important role in this regulation. Furthermore, promoter mutation assay confirms that the IFN-stimulated regulatory elements (ISRE) in the 59 flanking region of DreI is essential for its induction. Finally, overexpression of DreI leads to establish a strong antiviral state against SVCV and Rana grylio virus (RGV) infection in EPC (Epithelioma papulosum cyprinid) cells. Conclusions/Significance: These data indicate that DreI is an antiviral protein, which is regulated by RLR signaling pathway.	[Li, Shun; Sun, Fan; Zhang, Yi-Bing; Gui, Jian-Fang; Zhang, Qi-Ya] Chinese Acad Sci, Grad Sch, State Key Lab Freshwater Ecol & Biotechnol, Wuhan Ctr Dev Biol,Inst Hydrobiol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Li, S (corresponding author), Chinese Acad Sci, Grad Sch, State Key Lab Freshwater Ecol & Biotechnol, Wuhan Ctr Dev Biol,Inst Hydrobiol, Wuhan, Peoples R China.	zhangqy@ihb.ac.cn	SUN, FAN/K-8683-2017; SUN, FAN/GWA-1524-2022	SUN, FAN/0000-0002-3538-9701	National Major Basic Research Program [2009CB118704, 2010CB126303]; Chinese Academy of Sciences [KSCX2-EW-Z-3]; National Natural Science Foundation of China [30871938, 31072239]; State Key Laboratory of Freshwater Ecology and Biotechnology (FEBL) [2008FBZ15, 2008FBZ16]	National Major Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Freshwater Ecology and Biotechnology (FEBL)	This work was supported by National Major Basic Research Program (2009CB118704, 2010CB126303), Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-3), National Natural Science Foundation of China (30871938, 31072239) and the State Key Laboratory of Freshwater Ecology and Biotechnology (FEBL) research grant (2008FBZ15,2008FBZ16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Biacchesi S, 2009, J VIROL, V83, P7815, DOI 10.1128/JVI.00404-09; Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Chen ZY, 2008, VET IMMUNOL IMMUNOP, V123, P266, DOI 10.1016/j.vetimm.2008.02.011; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Collet B, 2001, EUR J BIOCHEM, V268, P1577, DOI 10.1046/j.1432-1033.2001.02021.x; Huang YH, 2007, APOPTOSIS, V12, P1569, DOI 10.1007/s10495-007-0089-1; Jiang J, 2009, MOL IMMUNOL, V46, P3131, DOI 10.1016/j.molimm.2009.05.183; Jin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012883; Johnson CL, 2006, TRENDS IMMUNOL, V27, P1, DOI 10.1016/j.it.2005.11.004; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010308; Li G, 2009, MOL BIOL EVOL, V26, P1619, DOI 10.1093/molbev/msp074; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin CH, 2006, BIOCHEM BIOPH RES CO, V351, P534, DOI 10.1016/j.bbrc.2006.10.063; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Liu TK, 2011, J VIROL, V85, P12769, DOI 10.1128/JVI.05849-11; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Ohtani M, 2010, J IMMUNOL, V185, P7507, DOI 10.4049/jimmunol.1001850; Ooi EL, 2006, FISH SHELLFISH IMMUN, V21, P293, DOI 10.1016/j.fsi.2005.12.004; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Plant KP, 2008, FISH SHELLFISH IMMUN, V24, P575, DOI 10.1016/j.fsi.2008.01.006; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shivappa RB, 2008, J FISH DIS, V31, P249, DOI 10.1111/j.1365-2761.2007.00894.x; Simora RM, FISH SHELLFISH IMMUN, V29, P979; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; Sun F, 2011, J IMMUNOL, V187, P2531, DOI 10.4049/jimmunol.1100642; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Vitour Damien, 2007, Sci STKE, V2007, ppe20, DOI 10.1126/stke.3842007pe20; Wang L, 2006, J INTERF CYTOK RES, V26, P256, DOI 10.1089/jir.2006.26.256; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yap WH, 2003, IMMUNOGENETICS, V54, P705, DOI 10.1007/s00251-002-0525-x; Yasuike M, 2011, COMP IMMUNOL MICROB, V34, P83, DOI 10.1016/j.cimid.2010.02.005; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yu FF, 2010, MOL IMMUNOL, V47, P2330, DOI 10.1016/j.molimm.2010.05.282; Zhang QY, 2001, DIS AQUAT ORGAN, V48, P27, DOI 10.3354/dao048027; Zhang YB, 2004, DIS AQUAT ORGAN, V60, P1, DOI 10.3354/dao060001; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	44	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32427	10.1371/journal.pone.0032427	http://dx.doi.org/10.1371/journal.pone.0032427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412872	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800019
J	Ong, KW; Hsu, A; Tan, BKH				Ong, Khang Wei; Hsu, Annie; Tan, Benny Kwong Huat			Chlorogenic Acid Stimulates Glucose Transport in Skeletal Muscle via AMPK Activation: A Contributor to the Beneficial Effects of Coffee on Diabetes	PLOS ONE			English	Article							PROTEIN-KINASE; CAFFEINE INGESTION; TOLERANCE TEST; INSULIN ACTION; ENDOTHELIAL-CELLS; CONSUMPTION; RISK; MEN; MELLITUS; PHOSPHORYLATION	Chlorogenic acid (CGA) has been shown to delay intestinal glucose absorption and inhibit gluconeogenesis. Our aim was to investigate the role of CGA in the regulation of glucose transport in skeletal muscle isolated from db/db mice and L6 skeletal muscle cells. Oral glucose tolerance test was performed on db/db mice treated with CGA and soleus muscle was isolated for 2-deoxyglucose transport study. 2DG transport was also examined in L6 myotubes with or without inhibitors such as wortmannin or compound c. AMPK was knocked down with AMPKa1/2 siRNA to study its effect on CGA-stimulated glucose transport. GLUT 4 translocation, phosphorylation of AMPK and Akt, AMPK activity, and association of IRS-1 and PI3K were investigated in the presence of CGA. In db/db mice, a significant decrease in fasting blood sugar was observed 10 minutes after the intraperitoneal administration of 250 mg/kg CGA and the effect persisted for another 30 minutes after the glucose challenge. Besides, CGA stimulated and enhanced both basal and insulin-mediated 2DG transports in soleus muscle. In L6 myotubes, CGA caused a dose-and time-dependent increase in glucose transport. Compound c and AMPK alpha 1/2 siRNA abrogated the CGA-stimulated glucose transport. Consistent with these results, CGA was found to phosphorylate AMPK and ACC, consistent with the result of increased AMPK activities. CGA did not appear to enhance association of IRS-1 with p85. However, we observed activation of Akt by CGA. These parallel activations in turn increased translocation of GLUT 4 to plasma membrane. At 2 mmol/l, CGA did not cause any significant changes in viability or proliferation of L6 myotubes. Our data demonstrated for the first time that CGA stimulates glucose transport in skeletal muscle via the activation of AMPK. It appears that CGA may contribute to the beneficial effects of coffee on Type 2 diabetes mellitus.	[Ong, Khang Wei; Hsu, Annie; Tan, Benny Kwong Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	National University of Singapore	Ong, KW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore.	benny_tan@nuhs.edu.sg			National University of Singapore [R-184-000-148-112]; Department of Pharmacology, National University of Singapore	National University of Singapore(National University of Singapore); Department of Pharmacology, National University of Singapore(National University of Singapore)	This work was supported by research grant (R-184-000-148-112) from the National University of Singapore. KWO was supported by a research scholarship from the National University of Singapore. AH was supported by the Department of Pharmacology, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x; Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444; Battram DS, 2007, J PHYSIOL-LONDON, V583, P1069, DOI 10.1113/jphysiol.2007.130526; Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276; Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1033::AID-JSFA595&gt;3.0.CO;2-T, 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T]; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Valk HW, 1999, NETH J MED, V54, P139, DOI 10.1016/S0300-2977(99)00005-4; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; KLIP A, 1984, AM J PHYSIOL, V247, pE297, DOI 10.1152/ajpendo.1984.247.3.E297; Konrad D, 2005, DIABETOLOGIA, V48, P954, DOI 10.1007/s00125-005-1713-7; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566; Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x; Liu IM, 2000, BRIT J PHARMACOL, V129, P631, DOI 10.1038/sj.bjp.0703082; McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; OKADA T, 1994, J BIOL CHEM, V269, P3568; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311; Petrie HJ, 2004, AM J CLIN NUTR, V80, P22; Prabhakar PK, 2009, PHYTOMEDICINE, V16, P1119, DOI 10.1016/j.phymed.2009.05.021; Prakash NS, 2002, EUPHYTICA, V124, P265, DOI 10.1023/A:1015736220358; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Robinson LE, 2004, J NUTR, V134, P2528, DOI 10.1093/jn/134.10.2528; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529; Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583; Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213; van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120; van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3; van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1	46	164	175	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32718	10.1371/journal.pone.0032718	http://dx.doi.org/10.1371/journal.pone.0032718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412912	gold, Green Published			2022-12-25	WOS:000303060800045
J	Strnad, P; Kucukoglu, O; Lunova, M; Guldiken, N; Lienau, TC; Stickel, F; Omary, MB				Strnad, Pavel; Kucukoglu, Ozlem; Lunova, Mariia; Guldiken, Nurdan; Lienau, Tim C.; Stickel, Felix; Omary, M. Bishr			Non-Coding Keratin Variants Associate with Liver Fibrosis Progression in Patients with Hemochromatosis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HEREDITARY HEMOCHROMATOSIS; MOUSE-LIVER; DISEASE; MUTATIONS; POLYMORPHISM; DISORDERS; CIRRHOSIS; PREDISPOSES; MECHANISMS	Background: Keratins 8 and 18 (K8/K18) are intermediate filament proteins that protect the liver from various forms of injury. Exonic K8/K18 variants associate with adverse outcome in acute liver failure and with liver fibrosis progression in patients with chronic hepatitis C infection or primary biliary cirrhosis. Given the association of K8/K18 variants with end-stage liver disease and progression in several chronic liver disorders, we studied the importance of keratin variants in patients with hemochromatosis. Methods: The entire K8/K18 exonic regions were analyzed in 162 hemochromatosis patients carrying homozygous C282Y HFE (hemochromatosis gene) mutations. 234 liver-healthy subjects were used as controls. Exonic regions were PCR-amplified and analyzed using denaturing high-performance liquid chromatography and DNA sequencing. Previously-generated transgenic mice overexpressing K8 G62C were studied for their susceptibility to iron overload. Susceptibility to iron toxicity of primary hepatocytes that express K8 wild-type and G62C was also assessed. Results: We identified amino-acid-altering keratin heterozygous variants in 10 of 162 hemochromatosis patients (6.2%) and non-coding heterozygous variants in 6 additional patients (3.7%). Two novel K8 variants (Q169E/R275W) were found. K8 R341H was the most common amino-acid altering variant (4 patients), and exclusively associated with an intronic KRT8 IVS7+ 10delC deletion. Intronic, but not amino-acid-altering variants associated with the development of liver fibrosis. In mice, or ex vivo, the K8 G62C variant did not affect iron-accumulation in response to iron-rich diet or the extent of iron-induced hepatocellular injury. Conclusion: In patients with hemochromatosis, intronic but not exonic K8/K18 variants associate with liver fibrosis development.	[Strnad, Pavel; Kucukoglu, Ozlem; Lunova, Mariia; Guldiken, Nurdan] Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany; [Lienau, Tim C.] Univ Med Berlin, Charite, Med Klin Schwerpunkt Hepatol & Gastroenterol, Berlin, Germany; [Stickel, Felix] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany; [Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA	Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg; University of Michigan System; University of Michigan	Strnad, P (corresponding author), Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany.	pavel.strnad@uniklinik-ulm.de	Kucukoglu, Ozlem/J-4713-2019; Lunova, Mariia/G-8447-2014	Kucukoglu, Ozlem/0000-0002-4217-9075; Omary, Bishr/0000-0002-8624-2347; Lunova, Mariia/0000-0002-5795-7781	National Institutes of Health (NIH) [DK52951]; Department of Veterans; Emmy-Noether-Programme [STR 1095/2-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052951, R56DK052951] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans; Emmy-Noether-Programme(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grant DK52951 and the Department of Veterans Affairs (to MBO) and the Emmy-Noether-Programme funding STR 1095/2-1 (to PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2009, GENET MED, V11, P307, DOI 10.1097/GIM.0b013e31819d30f2; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; Di Bisceglie AM, 1992, GASTROENTEROLOGY, V102, P6; Hesse M, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012393; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kazemi-Shirazi L, 1999, GASTROENTEROLOGY, V116, P127, DOI 10.1016/S0016-5085(99)70236-2; Ku NO, 2007, HEPATOLOGY, V46, P1639, DOI 10.1002/hep.21976; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; Lee P, 2002, BLOOD CELL MOL DIS, V29, P471, DOI 10.1006/bcmd.2002.0586; MOREL I, 1990, BIOCHEM PHARMACOL, V39, P1647, DOI 10.1016/0006-2952(90)90107-V; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Osterreicher CH, 2005, J HEPATOL, V42, P914, DOI 10.1016/j.jhep.2005.01.023; Pietrangelo A, 2011, J HEPATOL, V54, P173, DOI 10.1016/j.jhep.2010.08.004; Ramm GA, 2005, SEMIN LIVER DIS, V25, P433, DOI 10.1055/s-2005-923315; Rochette J, 2010, HUM GENET, V128, P233, DOI 10.1007/s00439-010-0852-1; Stickel F, 2005, ARCH INTERN MED, V165, P1835, DOI 10.1001/archinte.165.16.1835; Strnad P, 2006, HUM MUTAT, V27, P444, DOI 10.1002/humu.20311; Strnad P, 2008, GASTROENTEROLOGY, V134, P1169, DOI 10.1053/j.gastro.2008.01.035; Strnad P, 2006, HEPATOLOGY, V43, P1354, DOI 10.1002/hep.21211; Strnad P, 2010, GASTROENTEROLOGY, V139, P828, DOI 10.1053/j.gastro.2010.06.007; Weiss G, 2010, NAT REV GASTRO HEPAT, V7, P50, DOI 10.1038/nrgastro.2009.201; WHITE GP, 1978, BIOCHIM BIOPHYS ACTA, V543, P217, DOI 10.1016/0304-4165(78)90066-1; Wood MJ, 2008, BLOOD, V111, P4456, DOI 10.1182/blood-2007-11-122374; Zhong BH, 2009, HEPATOLOGY, V50, P546, DOI 10.1002/hep.23041; Zhou Q, 2005, HEPATOLOGY, V41, P517, DOI 10.1002/hep.20578; Zimmer V, 2011, CURR OPIN GASTROEN, V27, P231, DOI 10.1097/MOG.0b013e3283444862	31	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32669	10.1371/journal.pone.0032669	http://dx.doi.org/10.1371/journal.pone.0032669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412904	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800040
J	Liang, X; Wang, JH; Yan, CG; Shu, N; Xu, K; Gong, GL; He, Y				Liang, Xia; Wang, Jinhui; Yan, Chaogan; Shu, Ni; Xu, Ke; Gong, Gaolang; He, Yong			Effects of Different Correlation Metrics and Preprocessing Factors on Small-World Brain Functional Networks: A Resting-State Functional MRI Study	PLOS ONE			English	Article							LOW-FREQUENCY; NEURONAL OSCILLATIONS; MODULAR ORGANIZATION; ANATOMICAL NETWORKS; CORTICAL NETWORKS; GLOBAL SIGNAL; DEFAULT MODE; CONNECTIVITY; FMRI; FLUCTUATIONS	Graph theoretical analysis of brain networks based on resting-state functional MRI (R-fMRI) has attracted a great deal of attention in recent years. These analyses often involve the selection of correlation metrics and specific preprocessing steps. However, the influence of these factors on the topological properties of functional brain networks has not been systematically examined. Here, we investigated the influences of correlation metric choice (Pearson's correlation versus partial correlation), global signal presence (regressed or not) and frequency band selection [slow-5 (0.01-0.027 Hz) versus slow-4 (0.027-0.073 Hz)] on the topological properties of both binary and weighted brain networks derived from them, and we employed test-retest (TRT) analyses for further guidance on how to choose the "best'' network modeling strategy from the reliability perspective. Our results show significant differences in global network metrics associated with both correlation metrics and global signals. Analysis of nodal degree revealed differing hub distributions for brain networks derived from Pearson's correlation versus partial correlation. TRT analysis revealed that the reliability of both global and local topological properties are modulated by correlation metrics and the global signal, with the highest reliability observed for Pearson's-correlation-based brain networks without global signal removal (WOGR-PEAR). The nodal reliability exhibited a spatially heterogeneous distribution wherein regions in association and limbic/paralimbic cortices showed moderate TRT reliability in Pearson's-correlation-based brain networks. Moreover, we found that there were significant frequency-related differences in topological properties of WOGR-PEAR networks, and brain networks derived in the 0.027-0.073 Hz band exhibited greater reliability than those in the 0.01-0.027 Hz band. Taken together, our results provide direct evidence regarding the influences of correlation metrics and specific preprocessing choices on both the global and nodal topological properties of functional brain networks. This study also has important implications for how to choose reliable analytical schemes in brain network studies.	[Liang, Xia; Wang, Jinhui; Yan, Chaogan; Shu, Ni; Gong, Gaolang; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Xu, Ke] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Peoples R China	Beijing Normal University; China Medical University	Liang, X (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	yong.he@bnu.edu.cn	Wang, jinhui/AAF-8668-2019; He, Yong/C-2161-2009; 夏, 梁/GZK-3584-2022; Yan, Chao-Gan/D-1713-2015; He, Yong/Q-5756-2018	夏, 梁/0000-0003-3747-0746; Yan, Chao-Gan/0000-0003-3413-5977; He, Yong/0000-0002-7039-2850	Natural Science Foundation of China [81030028, 30870667]; Beijing Natural Science Foundation [7102090]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the Natural Science Foundation of China (Grant Nos. 81030028 and 30870667), Beijing Natural Science Foundation (Grant No. 7102090) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry, YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fox MD, 2005, PNAS; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Jalili M, 2011, J INTEGR NEUROSCI, V10, P213, DOI 10.1142/S0219635211002725; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Park CH, 2008, PHYSICA A, V387, P5958, DOI 10.1016/j.physa.2008.06.048; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Sampat M P, 2006, Br J Radiol, V79 Spec No 2, pS134, DOI 10.1259/bjr/96723280; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Telesford Qawi K, 2010, Front Neuroinform, V4, P117, DOI 10.3389/fninf.2010.00117; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Wang J, 2009, HUM BRAIN MAPP; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Winer B.J., 1971, STATISTICAL PRINCIPL, P283; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	70	115	118	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32766	10.1371/journal.pone.0032766	http://dx.doi.org/10.1371/journal.pone.0032766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412922	Green Published, gold			2022-12-25	WOS:000303021100029
J	Singh, PK; Chittpurna; Ashish; Sharma, V; Patil, PB; Korpole, S				Singh, Pradip Kumar; Chittpurna; Ashish; Sharma, Vikas; Patil, Prabhu B.; Korpole, Suresh			Identification, Purification and Characterization of Laterosporulin, a Novel Bacteriocin Produced by Brevibacillus sp Strain GI-9	PLOS ONE			English	Article							CLASS-II BACTERIOCINS; GENETIC-CHARACTERIZATION; BACILLUS; FAMILY; SUBSTANCE; BACTIBASE; PEPTIDES; SEQUENCE; IMMUNITY; DATABASE	Background: Bacteriocins are antimicrobial peptides that are produced by bacteria as a defense mechanism in complex environments. Identification and characterization of novel bacteriocins in novel strains of bacteria is one of the important fields in bacteriology. Methodology/Findings: The strain GI-9 was identified as Brevibacillus sp. by 16 S rRNA gene sequence analysis. The bacteriocin produced by strain GI-9, namely, laterosporulin was purified from supernatant of the culture grown under optimal conditions using hydrophobic interaction chromatography and reverse-phase HPLC. The bacteriocin was active against a wide range of Gram-positive and Gram-negative bacteria. MALDI-TOF experiments determined the precise molecular mass of the peptide to be of 5.6 kDa and N-terminal sequencing of the thermo-stable peptide revealed low similarity with existing antimicrobial peptides. The putative open reading frame (ORF) encoding laterosporulin and its surrounding genomic region was fished out from the draft genome sequence of GI-9. Sequence analysis of the putative bacteriocin gene did not show significant similarity to any reported bacteriocin producing genes in database. Conclusions: We have identified a bacteriocin producing strain GI-9, belonging to the genus Brevibacillus sp. Biochemical and genomic characterization of laterosporulin suggests it as a novel bacteriocin with broad spectrum antibacterial activity.	[Singh, Pradip Kumar; Chittpurna; Ashish; Sharma, Vikas; Patil, Prabhu B.; Korpole, Suresh] Council Sci & Ind Res Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Singh, PK (corresponding author), Council Sci & Ind Res Inst Microbial Technol, Chandigarh, India.	pbpatil@imtech.res.in; suresh@imtech.res.in	Singh, Pradip_not in use../GLR-1752-2022; Sharma, Vikas/O-2937-2016; singh, pradip/ACF-9094-2022	Singh, Pradip_not in use../0000-0003-0551-6877; Patil, Prabhu/0000-0003-2720-1059	Council of Scientific and Industrial Research (CSIR); Department of Biotechnology, Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors thank Council of Scientific and Industrial Research (CSIR) and Department of Biotechnology, Government of India for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern M, 2003, FEMS MICROBIOL LETT, V220, P127, DOI 10.1016/S0378-1097(03)00086-7; Appleyard AN, 2009, CHEM BIOL, V16, P490, DOI 10.1016/j.chembiol.2009.03.011; Bizani D, 2002, J APPL MICROBIOL, V93, P512, DOI 10.1046/j.1365-2672.2002.01720.x; Chawawisit K, 2008, WORLD J MICROB BIOT, V24, P2199, DOI 10.1007/s11274-008-9730-6; Cherif A, 2001, LETT APPL MICROBIOL, V32, P243, DOI 10.1046/j.1472-765X.2001.00898.x; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; DAVID GFX, 1973, J ANAT, V115, P79; de Jong A, 2006, NUCLEIC ACIDS RES, V34, pW273, DOI 10.1093/nar/gkl237; Dimitrijevic R, 2009, J APPL MICROBIOL, V107, P2108, DOI 10.1111/j.1365-2672.2009.04539.x; Dischinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006788; Djukic M, 2011, J BACTERIOL, V193, P5535, DOI 10.1128/JB.05696-11; Drider D, 2006, MICROBIOL MOL BIOL R, V70, P564, DOI 10.1128/MMBR.00016-05; Faheem F, 2007, PAK J BOT, V39, P1293; Fimland G, 2005, J PEPT SCI, V11, P688, DOI 10.1002/psc.699; Fujita K, 2007, APPL ENVIRON MICROB, V73, P2871, DOI 10.1128/AEM.02286-06; Garneau S, 2002, BIOCHIMIE, V84, P577, DOI 10.1016/S0300-9084(02)01414-1; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; GROSS E, 1973, H-S Z PHYSIOL CHEM, V354, P810; Hammami R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-89; Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; James R, 1991, BACTERIOCINS MICROCI, V65, P519; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Kruszewska D, 2004, J ANTIMICROB CHEMOTH, V54, P648, DOI 10.1093/jac/dkh387; Kumarathasan P, 2005, ANAL BIOCHEM, V346, P85, DOI 10.1016/j.ab.2005.06.004; LANYI B, 1987, METHOD MICROBIOL, V19, P1; Le Marrec C, 2000, APPL ENVIRON MICROB, V66, P5213, DOI 10.1128/AEM.66.12.5213-5220.2000; Lechner S, 1998, INT J SYST BACTERIOL, V48, P1373, DOI 10.1099/00207713-48-4-1373; Mah JH, 2001, J MICROBIOL BIOTECHN, V11, P577; Maldonado A, 2003, APPL ENVIRON MICROB, V69, P383, DOI 10.1128/AEM.69.1.383-389.2003; MORTVEDT CI, 1991, APPL ENVIRON MICROB, V57, P1829; NACLERIO G, 1993, APPL ENVIRON MICROB, V59, P4313, DOI 10.1128/AEM.59.12.4313-4316.1993; Nissen-Meyer J, 2009, CURR PHARM BIOTECHNO, V10, P19, DOI 10.2174/138920109787048661; Oppegard C, 2007, J MOL MICROB BIOTECH, V13, P210, DOI 10.1159/000104750; Parente E, 1999, APPL MICROBIOL BIOT, V52, P628, DOI 10.1007/s002530051570; Pattnaik P, 2001, J APPL MICROBIOL, V91, P636, DOI 10.1046/j.1365-2672.2001.01429.x; Pokusaeva K, 2009, CENT EUR J BIOL, V4, P196, DOI 10.2478/s11535-009-0009-1; Ren Zhao-Zhen, 2007, Weishengwu Xuebao, V47, P997; Riley MA, 1998, ANNU REV GENET, V32, P255, DOI 10.1146/annurev.genet.32.1.255; Riley MA, 2003, J EVOLUTION BIOL, V16, P690, DOI 10.1046/j.1420-9101.2003.00575.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sebei S, 2007, J APPL MICROBIOL, V103, P1621, DOI 10.1111/j.1365-2672.2007.03395.x; Smibert RM, 1994, METHODS GEN MOL BACT; Suresh K, 2006, INT J SYST EVOL MICR, V56, P1703, DOI 10.1099/ijs.0.64144-0; Svetoch EA, 2005, NUCLEIC ACIDS RES, V28, P4317; TAGG JR, 1976, BACTERIOL REV, V40, P722, DOI 10.1128/MMBR.40.3.722-756.1976; Tiwari SK, 2008, FOOD BIOTECHNOL, V22, P64, DOI 10.1080/08905430701864009; van Belkum MJ, 2000, NAT PROD REP, V17, P323, DOI 10.1039/a801347k; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Yamazaki K, 2005, APPL ENVIRON MICROB, V71, P554, DOI 10.1128/AEM.71.1.554-557.2005	52	47	51	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31498	10.1371/journal.pone.0031498	http://dx.doi.org/10.1371/journal.pone.0031498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403615	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700012
J	Tsai, YJ; Lee, HI; Lin, A				Tsai, Yuan-Jhih; Lee, Hsing-I; Lin, Alan			Ribosome Distribution in HeLa Cells during the Cell Cycle	PLOS ONE			English	Article							HUMAN RIBOSOMAL-PROTEIN-L7; NUCLEAR ENTRY; BINDING; TRANSLOCATION; LOCALIZATION; BIOGENESIS; SUBUNIT; SURFACE	In this study, we employed a surface-specific antibody against the large ribosome subunit to investigate the distribution of ribosomes in cells during the cell cycle. The antibody, anti-L7n, was raised against an expansion segment (ES) peptide from the large subunit ribosomal protein L7, and its ribosome-surface specificity was evident from the positive immuno-reactivity of ribosome particles and the detection of 60 S immune-complex formation by an immuno-electron microscopy. Using immunofluorescent staining, we have microscopically revealed that ribosomes are dispersed in the cytoplasm of cells throughout all phases of the cell cycle, except at the G2 phase where ribosomes show a tendency to gather toward the nuclear envelope. The finding in G2 cells was confirmed by electron microscopy using a morphometric assay and paired t test. Furthermore, further observations have shown that ribosomes are not distributed immune-fluorescently with nuclear envelope markers including the nuclear pore complex, the integral membrane protein gp210, the inner membrane protein lamin B2, and the endoplasm reticulum membrane during cell division we propose that the mechanism associated with ribosome segregation into daughter cells could be independent of the processes of disassembly and reassembly of the nuclear envelope.	[Tsai, Yuan-Jhih; Lee, Hsing-I; Lin, Alan] Natl Yang Ming Univ, Sch Life Sci, Inst Genome Sci, Taipei 112, Taiwan; [Lin, Alan] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Tsai, YJ (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Genome Sci, Taipei 112, Taiwan.	alin@ym.edu.tw			National Science Council, Taiwan [NSC99-2311-B-010-003]; Ministry of Education, Taiwan, Aim for the Top University Plan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Aim for the Top University Plan	This study was supported in part by grants from National Science Council, Taiwan (NSC99-2311-B-010-003), and a Grant from the Ministry of Education, Taiwan, Aim for the Top University Plan. The funders had no role in study in design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benyamini P, 2009, MOL BIOL CELL, V20, P732, DOI 10.1091/mbc.E08-07-0682; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; BIRKY CW, 1983, INT REV CYTOL, P49; Chen IJ, 2008, BIOCHEM CELL BIOL, V86, P271, DOI [10.1139/O08-032, 10.1139/o08-032]; Cohen M, 2003, MOL BIOL CELL, V14, P4230, DOI 10.1091/mbc.E03-04-0260; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Errington RJ, 2010, CELL CYCLE, V9, P121, DOI 10.4161/cc.9.1.10246; HESKETH JE, 1991, CELL BIOL INT REP, V15, P141, DOI 10.1016/0309-1651(91)90105-R; JU QD, 1994, YEAST, V10, P151, DOI 10.1002/yea.320100203; Ko JR, 2006, FEBS LETT, V580, P3804, DOI 10.1016/j.febslet.2006.05.073; Larsen TH, 1998, J HISTOCHEM CYTOCHEM, V46, P963, DOI 10.1177/002215549804600810; LIN A, 1991, FEBS LETT, V287, P121, DOI 10.1016/0014-5793(91)80030-7; Lopez-Soler RI, 2001, J CELL BIOL, V154, P61, DOI 10.1083/jcb.200101025; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; MORI H, 1980, J CELL BIOL, V84, P340, DOI 10.1083/jcb.84.2.340; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Qian W, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3477179; SAVITZ AJ, 1993, J CELL BIOL, V120, P853, DOI 10.1083/jcb.120.4.853; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; STOFFLER G, 1984, J BIOL CHEM, V259, P4521; Summers HD, 2011, NAT NANOTECHNOL, V6, P170, DOI [10.1038/nnano.2010.277, 10.1038/NNANO.2010.277]; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; VEDELER A, 1990, CELL BIOL INT REP, V14, P211, DOI 10.1016/S0309-1651(05)80003-7; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989; Wu WC, 2007, FEBS LETT, V581, P651, DOI 10.1016/j.febslet.2007.01.023; Yokoyama T, 2008, NUCLEIC ACIDS RES, V36, P3539, DOI 10.1093/nar/gkn224	27	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32820	10.1371/journal.pone.0032820	http://dx.doi.org/10.1371/journal.pone.0032820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403714	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700111
J	Wang, L; Zhou, C; He, Z; Wang, ZG; Wang, JL; Wang, YF				Wang, Ling; Zhou, Chun; He, Zhen; Wang, Zheng-Guang; Wang, Jia-Lin; Wang, Yu-Feng			Wolbachia Infection Decreased the Resistance of Drosophila to Lead	PLOS ONE			English	Article							LIFE-SHORTENING WOLBACHIA; INDUCED OXIDATIVE STRESS; ALPHA-TOCOPHEROL; ANTIOXIDANT; INCOMPATIBILITY; INTOXICATION; SYMBIONT; SYSTEM; KIDNEY; CELLS	Background: The heavy metal lead has been shown to be associated with a genotoxic risk. Drosophila melanogaster is a model organism commonly utilized in genetic toxicology testing. The endosymbionts - Wolbachia are now very common in both wild populations and laboratory stocks of Drosophila. Wolbachia may induce resistance to pathogenic viruses, filarial nematodes and Plasmodium in fruit fly and mosquito hosts. However the effect of Wolbachia infection on the resistance of their hosts to heavy metal is unknown. Methodology/Principal Findings: Manipulating the lead content in the diet of Drosophila melanogaster, we found that lead consumption had no different effects on developmental time between Wolbachia-infected (Dmel wMel) and -uninfected (Dmel T) flies. While in Pb-contaminated medium, significantly reduced amount of pupae and adults of Dmel wMel were emerged, and Dmel wMel adults had significantly shorter longevity than that of Dmel T flies. Lead infusion in diet resulted in significantly decreased superoxide dismutase (SOD) activity in Dmel T flies (P<0.05), but not in Dmel wMel flies. Correspondingly, lead cultures induced a 10.8 fold increase in malonaldehyde (MDA) contents in Dmel T larvae (P<0.05). While in Dmel wMel larvae, it resulted in only a 1.3 fold increase. By quantitative RT-PCR, we showed that lead infused medium caused significantly increased expression level of relish and CecA2 genes in Dmel T flies (P<0.01). Lead cultures did not change dramatically the expression of these genes in Dmel wMel flies. Conclusions/Significance: These results suggest that Wolbachia infection decreased the resistance of Drosophila to lead likely by limiting the production of peroxides resulted from lead, thus being unable to activate the immunological pathway in the host to prevent them from lead damage. This represents a novel Wolbachia-host interaction and provides information that researchers working on Drosophila toxicology should take in consideration the presence of Wolbachia in the stocks they are analyzing.	[Wang, Ling; Zhou, Chun; He, Zhen; Wang, Zheng-Guang; Wang, Jia-Lin; Wang, Yu-Feng] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China	Central China Normal University	Wang, L (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	yfengw@mail.ccnu.edu.cn		Wang, Ling/0000-0002-0787-3352	National Natural Science Foundation of China [30970405]; Chinese Ministry of Education [109118]; Fund of National Innovation Project for Undergraduates [091051126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Fund of National Innovation Project for Undergraduates	This work was supported by the National Natural Science Foundation of China to YF Wang and JL Wang (http://www.nsfc.gov.cn/) (No. 30970405) and the Key Project of Chinese Ministry of Education to YF Wang (http://www.dost.moe.edu.cn/) (No. 109118), and the Fund of National Innovation Project for Undergraduates (http://jwc.ccnu.edu.cn/) (No. 091051126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Almeida M, 2010, MOL ENDOCRINOL, V24, P2030, DOI 10.1210/me.2010-0189; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Ashry KM, 2010, FOOD CHEM TOXICOL, V48, P236, DOI 10.1016/j.fct.2009.10.006; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Carmona ER, 2011, MUTAT RES-GEN TOX EN, V724, P35, DOI 10.1016/j.mrgentox.2011.05.008; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Fernandez-Cabezudo MJ, 2003, FREE RADICAL RES, V37, P437, DOI 10.1080/1071576031000076277; Govindarajan R, 1999, AM J HEMATOL, V62, P122, DOI 10.1002/(SICI)1096-8652(199910)62:2<122::AID-AJH14>3.0.CO;2-R; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1988, GENETICS, V119, P435; Hsu PC, 2002, TOXICOLOGY, V180, P33, DOI 10.1016/S0300-483X(02)00380-3; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kovacic P, 2008, J RECEPT SIG TRANSD, V28, P323, DOI [10.1080/10799890802305217, 10.1080/10799890802305217 ]; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Krocova Z, 2000, TOXICOL IN VITRO, V14, P33, DOI 10.1016/S0887-2333(99)00089-2; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moniuszko-Jakoniuk J, 2007, PHARMACOL REP, V59, P217; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Pande M, 2001, ENVIRON TOXICOL PHAR, V9, P173, DOI 10.1016/S1382-6689(01)00064-3; Patra R C, 2011, Vet Med Int, V2011, P457327, DOI 10.4061/2011/457327; Patra RC, 2001, TOXICOLOGY, V162, P81, DOI 10.1016/S0300-483X(01)00345-6; Peng Y, 2009, CHINESE SCI BULL, V54, P1369, DOI 10.1007/s11434-009-0183-6; Pistl J, 2008, HELMINTHOLOGIA, V45, P69, DOI 10.2478/s11687-008-0013-4; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; VOGEL E, 1976, BIOL ZBL, V95, P405; Vogel EW, 1999, IARC SCI PUBL, P427; Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Yamada R, 2007, GENETICS, V177, P801, DOI 10.1534/genetics.106.068486; Yang LH, 2010, J INSECT PHYSIOL, V56, P1871, DOI 10.1016/j.jinsphys.2010.08.006; Ye XB, 1999, J TOXICOL ENV HEAL A, V57, P161, DOI 10.1080/009841099157737	42	11	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32643	10.1371/journal.pone.0032643	http://dx.doi.org/10.1371/journal.pone.0032643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403688	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700085
J	Carricart-Ganivet, JP; Cabanillas-Teran, N; Cruz-Ortega, I; Blanchon, P				Carricart-Ganivet, Juan P.; Cabanillas-Teran, Nancy; Cruz-Ortega, Israel; Blanchon, Paul			Sensitivity of Calcification to Thermal Stress Varies among Genera of Massive Reef-Building Corals	PLOS ONE			English	Article							REGION-WIDE DECLINES; SKELETAL EXTENSION; CLIMATE-CHANGE; MONTASTRAEA-ANNULARIS; SURFACE-TEMPERATURE; PORITES-ASTREOIDES; GROWTH; DENSITY; VARIABILITY; LIGHT	Reductions in calcification in reef-building corals occur when thermal conditions are suboptimal, but it is unclear how they vary between genera in response to the same thermal stress event. Using densitometry techniques, we investigate reductions in the calcification rate of massive Porites spp. from the Great Barrier Reef (GBR), and P. astreoides, Montastraea faveolata, and M. franksi from the Mesoamerican Barrier Reef (MBR), and correlate them to thermal stress associated with ocean warming. Results show that Porites spp. are more sensitive to increasing temperature than Montastraea, with calcification rates decreasing by 0.40 g cm(-2) year(-1) in Porites spp. and 0.12 g cm(-2) year(-1) in Montastraea spp. for each 1 degrees C increase. Under similar warming trends, the predicted calcification rates at 2100 are close to zero in Porites spp. and reduced by 40% in Montastraea spp. However, these predictions do not account for ocean acidification. Although yearly mean aragonite saturation (Omega(ar)) at MBR sites has recently decreased, only P. astreoides at Chinchorro showed a reduction in calcification. In corals at the other sites calcification did not change, indicating there was no widespread effect of Omega(ar) changes on coral calcification rate in the MBR. Even in the absence of ocean acidification, differential reductions in calcification between Porites spp. and Montastraea spp. associated with warming might be expected to have significant ecological repercussions. For instance, Porites spp. invest increased calcification in extension, and under warming scenarios it may reduce their ability to compete for space. As a consequence, shifts in taxonomic composition would be expected in Indo-Pacific reefs with uncertain repercussions for biodiversity. By contrast, Montastraea spp. use their increased calcification resources to construct denser skeletons. Reductions in calcification would therefore make them more susceptible to both physical and biological breakdown, seriously affecting ecosystem function in Atlantic reefs.	[Carricart-Ganivet, Juan P.; Cruz-Ortega, Israel; Blanchon, Paul] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico; [Carricart-Ganivet, Juan P.; Cabanillas-Teran, Nancy] Colegio Frontera Sur, Unidad Chetumal, Chetmal, Quintana Roo, Mexico	Universidad Nacional Autonoma de Mexico; El Colegio de la Frontera Sur (ECOSUR)	Carricart-Ganivet, JP (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico.	carricart@cmarl.unam.mx	Terán, Nancy Cabanillas/O-4191-2019; Blanchon, Paul/B-7720-2009	Terán, Nancy Cabanillas/0000-0003-1268-5900; Blanchon, Paul/0000-0002-7792-5808	Consejo Nacional de Ciencia y Tecnologia (CONACyT); EU FORCE	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); EU FORCE	This project was funded by grants from the Consejo Nacional de Ciencia y Tecnologia (CONACyT; http://www.conacyt.gob.mx/) and EU FORCE project (http://force-project.eu/) to JPCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barnes D.J., 1990, P109; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carricart-Ganivet JP, 2007, MAR BIOL, V153, P1, DOI 10.1007/s00227-007-0780-3; Carricart-Ganivet JP, 2004, J EXP MAR BIOL ECOL, V302, P249, DOI 10.1016/j.jembe.2003.10.015; Carricart-Ganivet JP, 2001, B MAR SCI, V68, P133; Carricart-Ganivet JP, 2007, J EXP MAR BIOL ECOL, V351, P27, DOI 10.1016/j.jembe.2007.05.038; Carricart-Ganivet JP, 2007, J EXP MAR BIOL ECOL, V344, P67, DOI 10.1016/j.jembe.2006.12.018; Carricart-Ganivet JP, 2011, J EXP MAR BIOL ECOL, V405, P73, DOI 10.1016/j.jembe.2011.05.020; Ceccarelli DM, 2011, MAR FRESHWATER RES, V62, P1214, DOI 10.1071/MF11013; CHALKER BE, 1990, CORAL REEFS, V9, P11, DOI 10.1007/BF00686717; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Croquer A, 2009, DIS AQUAT ORGAN, V83, P209, DOI 10.3354/dao02012; Cruz-Pinon G, 2003, MAR BIOL, V143, P491, DOI 10.1007/s00227-003-1127-3; Davies P.J., 1983, Australian Institute of Marine Science Contribution, P69; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DODGE RE, 1984, B MAR SCI, V34, P288; Done Terry, 2011, P281; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Elizalde-Rendon EM, 2010, CORAL REEFS, V29, P607, DOI 10.1007/s00338-010-0604-7; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gledhill DK, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004629; Glynn PW, 1996, CORAL REEFS, V15, P71; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Helmle Kevin P., 2011, P958; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Lough JM, 2008, MAR ECOL PROG SER, V373, P257, DOI 10.3354/meps07398; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Lough JM, 1997, J EXP MAR BIOL ECOL, V211, P29, DOI 10.1016/S0022-0981(96)02710-4; LOUGH JM, 1992, J EXP MAR BIOL ECOL, V155, P1, DOI 10.1016/0022-0981(92)90024-5; Lough JM, 1999, 28 CRC REEF RES CTR; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Perry CT, 2008, CORAL REEFS, V27, P853, DOI 10.1007/s00338-008-0418-z; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; POTTS DC, 1985, MAR ECOL PROG SER, V23, P79, DOI 10.3354/meps023079; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; Saenger C, 2009, NAT GEOSCI, V2, P492, DOI 10.1038/ngeo552; SCOFFIN TP, 1972, SCIENCE, V178, P1280, DOI 10.1126/science.178.4067.1280; Smith S.V., 1983, Australian Institute of Marine Science Contribution, P240; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Veron J.E.N., 2000, CORALS WORLD, V1-3; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Worum FP, 2007, LIMNOL OCEANOGR, V52, P2317, DOI 10.4319/lo.2007.52.5.2317; Yakob L, 2011, P NATL ACAD SCI USA, V108, P1967, DOI 10.1073/pnas.1015443108; Yentsch CS, 2002, J EXP MAR BIOL ECOL, V268, P171, DOI 10.1016/S0022-0981(01)00379-3	66	71	74	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32859	10.1371/journal.pone.0032859	http://dx.doi.org/10.1371/journal.pone.0032859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396797	Green Submitted, Green Published, gold			2022-12-25	WOS:000303005000040
J	Desnos-Ollivier, M; Robert, V; Raoux-Barbot, D; Groenewald, M; Dromer, F				Desnos-Ollivier, Marie; Robert, Vincent; Raoux-Barbot, Dorothee; Groenewald, Marizeth; Dromer, Francoise			Antifungal Susceptibility Profiles of 1698 Yeast Reference Strains Revealing Potential Emerging Human Pathogens	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; PHYLOGENETIC-RELATIONSHIPS; AZOLE RESISTANCE; GLUCAN SYNTHASE; SEQUENCES; PROPOSAL; TROPICALIS; MICS; NOV.	New molecular identification techniques and the increased number of patients with various immune defects or underlying conditions lead to the emergence and/or the description of novel species of human and animal fungal opportunistic pathogens. Antifungal susceptibility provides important information for ecological, epidemiological and therapeutic issues. The aim of this study was to assess the potential risk of the various species based on their antifungal drug resistance, keeping in mind the methodological limitations. Antifungal susceptibility profiles to the five classes of antifungal drugs (polyens, azoles, echinocandins, allylamines and antimetabolites) were determined for 1698 yeast reference strains belonging to 992 species (634 Ascomycetes and 358 Basidiomycetes). Interestingly, geometric mean minimum inhibitory concentrations (MICs) of all antifungal drugs tested were significantly higher for Basidiomycetes compared to Ascomycetes (p < 0.001). Twenty four strains belonging to 23 species of which 19 were Basidiomycetes seem to be intrinsically "resistant" to all drugs. Comparison of the antifungal susceptibility profiles of the 4240 clinical isolates and the 315 reference strains belonging to 53 shared species showed similar results. Even in the absence of demonstrated in vitro/in vivo correlation, knowing the in vitro susceptibility to systemic antifungal agents and the putative intrinsic resistance of yeast species present in the environment is important because they could become opportunistic pathogens.	[Desnos-Ollivier, Marie; Raoux-Barbot, Dorothee; Dromer, Francoise] Inst Pasteur, Unite Mycol Mol, Ctr Natl Reference Mycol & Antifong, Paris, France; [Desnos-Ollivier, Marie; Raoux-Barbot, Dorothee; Dromer, Francoise] CNRS, URA3012, Paris, France; [Robert, Vincent; Groenewald, Marizeth] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Desnos-Ollivier, M (corresponding author), Inst Pasteur, Unite Mycol Mol, Ctr Natl Reference Mycol & Antifong, Paris, France.	dromer@pasteur.fr	Desnos-Ollivier, Marie/ADH-3485-2022; Groenewald, Marizeth/G-4976-2012	Desnos-Ollivier, Marie/0000-0002-9137-0466; Groenewald, Marizeth/0000-0003-0835-5925	Institut Pasteur	Institut Pasteur(European Commission)	This work was supported by the Institut Pasteur. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanio A, 2011, J ANTIMICROB CHEMOTH, V66, P371, DOI 10.1093/jac/dkq450; Baixench MT, 2007, J ANTIMICROB CHEMOTH, V59, P1076, DOI 10.1093/jac/dkm095; Dannaoui E, 2011, EMERG INFEC IN PRESS; de Hoog GS, 1998, MYCOSES, V41, P183, DOI 10.1111/j.1439-0507.1998.tb00321.x; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Desnos-Ollivier M, 2008, ANTIMICROB AGENTS CH, V52, P3092, DOI 10.1128/AAC.00088-08; Desnos-Ollivier M, 2008, J CLIN MICROBIOL, V46, P2389, DOI 10.1128/JCM.00053-08; Desnos-Ollivier M, 2008, EMERG INFECT DIS, V14, P557, DOI 10.3201/eid1404.071083; Donnelly SM, 1999, MICROBIOL-UK, V145, P1871, DOI 10.1099/13500872-145-8-1871; Ji HT, 2000, J MED CHEM, V43, P2493, DOI 10.1021/jm990589g; Kahn JN, 2007, ANTIMICROB AGENTS CH, V51, P1876, DOI 10.1128/AAC.00067-07; Knutsen AK, 2007, INT J SYST EVOL MICR, V57, P2426, DOI 10.1099/ijs.0.65200-0; Kurtzman C.P., 1998, YEASTS TAXONOMIC STU; Kurtzman CP, 2008, FEMS YEAST RES, V8, P939, DOI 10.1111/j.1567-1364.2008.00419.x; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; Kurtzman CP, 2005, ANTON LEEUW INT J G, V88, P121, DOI 10.1007/s10482-005-2495-0; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Lodder J, 1970, YEASTS TAXONOMIC STU; Lortholary O, 2011, ANTIMICROB AGENTS CH, V55, P532, DOI 10.1128/AAC.01128-10; MASCLAUX F, 1995, J MED VET MYCOL, V33, P327; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Reverberi M, 2004, APPL MICROBIOL BIOT, V66, P217, DOI 10.1007/s00253-004-1662-y; Robert VA, 2009, J INFECT DIS, V200, P1623, DOI 10.1086/644642; Rodriguez-Tudela JL, 2008, CLIN MICROBIOL INFEC, V14, P398, DOI 10.1111/j.1469-0691.2007.01935.x; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	29	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32278	10.1371/journal.pone.0032278	http://dx.doi.org/10.1371/journal.pone.0032278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396754	Green Submitted, Green Published, gold			2022-12-25	WOS:000303005000018
J	Hubert, N; Hanner, R; Holm, E; Mandrak, NE; Taylor, E; Burridge, M; Watkinson, D; Dumont, P; Curry, A; Bentzen, P; Zhang, JB; April, J; Bernatchez, L				Hubert, Nicolas; Hanner, Robert; Holm, Erling; Mandrak, Nicholas E.; Taylor, Eric; Burridge, Mary; Watkinson, Douglas; Dumont, Pierre; Curry, Allen; Bentzen, Paul; Zhang, Junbin; April, Julien; Bernatchez, Louis			Identifying Canadian Freshwater Fishes through DNA Barcodes	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; MITOCHONDRIAL-DNA; DIVERSITY; TAXONOMY; DIPTERA; PHYLOGEOGRAPHY; PROMISE; LARVAE; GENUS; REEF	Background: DNA barcoding aims to provide an efficient method for species-level identifications using an array of species specific molecular tags derived from the 59 region of the mitochondrial cytochrome c oxidase I (COI) gene. The efficiency of the method hinges on the degree of sequence divergence among species and species-level identifications are relatively straightforward when the average genetic distance among individuals within a species does not exceed the average genetic distance between sister species. Fishes constitute a highly diverse group of vertebrates that exhibit deep phenotypic changes during development. In this context, the identification of fish species is challenging and DNA barcoding provide new perspectives in ecology and systematics of fishes. Here we examined the degree to which DNA barcoding discriminate freshwater fish species from the well-known Canadian fauna, which currently encompasses nearly 200 species, some which are of high economic value like salmons and sturgeons. Methodology/Principal Findings: We bi-directionally sequenced the standard 652 bp "barcode'' region of COI for 1360 individuals belonging to 190 of the 203 Canadian freshwater fish species (95%). Most species were represented by multiple individuals (7.6 on average), the majority of which were retained as voucher specimens. The average genetic distance was 27 fold higher between species than within species, as K2P distance estimates averaged 8.3% among congeners and only 0.3% among concpecifics. However, shared polymorphism between sister-species was detected in 15 species (8% of the cases). The distribution of K2P distance between individuals and species overlapped and identifications were only possible to species group using DNA barcodes in these cases. Conversely, deep hidden genetic divergence was revealed within two species, suggesting the presence of cryptic species. Conclusions/Significance: The present study evidenced that freshwater fish species can be efficiently identified through the use of DNA barcoding, especially the species complex of small-sized species, and that the present COI library can be used for subsequent applications in ecology and systematics.	[Hubert, Nicolas; April, Julien; Bernatchez, Louis] Univ Laval, Dept Biol, Ste Foy, PQ G1K 7P4, Canada; [Hanner, Robert; Zhang, Junbin] Univ Guelph, Biodiversity Inst Ontario, Canadian Barcode Life Network, Guelph, ON, Canada; [Holm, Erling; Burridge, Mary] Royal Ontario Museum, Dept Nat Hist, Toronto, ON, Canada; [Mandrak, Nicholas E.] Great Lakes Lab Fisheries & Aquat Sci, Fisheries & Oceans Canada, Burlington, ON, Canada; [Taylor, Eric] Dept Zool, Vancouver, BC, Canada; [Watkinson, Douglas] Freshwater Inst, Fisheries & Oceans Canada, Cent & Arctic Region, Winnipeg, MB, Canada; [Dumont, Pierre] Minist Ressources Naturelles Quebec, Longueuil, Quebec, Canada; [Curry, Allen] Univ New Brunswick, Fish & Wildlife Res Unit, Fredericton, NB, Canada; [Bentzen, Paul] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Laval University; University of Guelph; Royal Ontario Museum; Fisheries & Oceans Canada; Fisheries & Oceans Canada; University of New Brunswick; Dalhousie University	Hubert, N (corresponding author), Univ Laval, Dept Biol, Pavillon Charles Eugene Marchand, Ste Foy, PQ G1K 7P4, Canada.	Louis.Bernatchez@bio.ulaval.ca	Curry, R. Allen/ABG-3515-2020; 赵, 鹏/B-8401-2009	Curry, R. Allen/0000-0002-7083-9878; Bernatchez, Louis/0000-0002-8085-9709; Hubert, Nicolas/0000-0001-9248-3377; Bentzen, Paul/0000-0003-4288-7730	Canadian Barcode of Life Network from NSERC, Genome Canada	Canadian Barcode of Life Network from NSERC, Genome Canada(Genome Canada)	This research was supported through funding to the Canadian Barcode of Life Network from NSERC, Genome Canada (through the Ontario Genomics Institute). Other sponsors listed at www.BOLNET.ca.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Barber P, 2006, P ROY SOC B-BIOL SCI, V273, P2053, DOI 10.1098/rspb.2006.3540; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; BIRKY CW, 1989, GENETICS, V121, P613; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Caterino MS, 2006, SYST ENTOMOL, V31, P405, DOI 10.1111/j.1365-3113.2006.00338.x; *CESCC, 2001, WILD SPEC 2000 GEN S; CLARE EB, 2006, MOL ECOL NOTES, V7, P184; Corin SE, 2007, DIVERS DISTRIB, V13, P510, DOI 10.1111/j.1472-4642.2007.00355.x; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; DAWNAY NR, 2007, FORENSIC SC IN PRESS; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hubert N, 2008, MOL PHYLOGENET EVOL, V46, P375, DOI 10.1016/j.ympev.2007.04.002; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Mandrak N. E., 1992, CHECKLIST ONTARIO FR; MCPHAIL JD, 1970, B FISHERIES RES BOAR, V173; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; NELSON JS, 1992, FISHES ALBERTA; Nelson LA, 2007, MED VET ENTOMOL, V21, P44, DOI 10.1111/j.1365-2915.2007.00664.x; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Pfenninger M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-100; Pfenninger M, 2007, MOL ECOL, V16, P1957, DOI 10.1111/j.1365-294X.2006.03136.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pons J, 2006, MOL ECOL NOTES, V6, P623, DOI 10.1111/j.1471-8286.2006.01353.x; Ratnasingham S, MOL ECOLOGY NOTES, V7, P355; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P991, DOI 10.1603/0013-8746(2006)99[991:MPOTVP]2.0.CO;2; Scott WB, 1998, FRESHWATER FISHES CA; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; *STAT GRAPH CORP, 1999, STAT PACK; STEWART KW, 2004, FRESHWATER FISHES MA; TAJIMA F, 1983, GENETICS, V105, P437; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	55	450	485	1	200	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2490	10.1371/journal.pone.0002490	http://dx.doi.org/10.1371/journal.pone.0002490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	22423312	Green Published, gold			2022-12-25	WOS:000263280700054
J	Westendorp, B; Major, JL; Nader, M; Salih, M; Leenen, FHH; Tuana, BS				Westendorp, Bart; Major, Jennifer L.; Nader, Moni; Salih, Maysoon; Leenen, Frans H. H.; Tuana, Balwant S.			The E2F6 repressor activates gene expression in myocardium resulting in dilated cardiomyopathy	FASEB JOURNAL			English	Article						connexin-43; micro-RNA; transcription factors; transgenic mice	CONNEXIN43 EXPRESSION; INDUCED APOPTOSIS; GAP-JUNCTIONS; MAP KINASE; PROTEIN; FAMILY; PROLIFERATION; INHIBITION; MUTATION; HEART	The E2F/Rb pathway regulates cardiac growth and development and holds great potential as a therapeutic target. The E2F6 repressor is a unique E2F member that acts independently of pocket proteins. Forced expression of E2F6 in mouse myocardium induced heart failure and mortality, with severity of symptoms correlating to E2F6 levels. Echocardiography demonstrated a 37% increase (P<0.05) in left ventricular end-diastolic diameter and reduced ejection fraction (<40%, P<0.05) in young transgenic (Tg) mice. Microarray and qPCR analysis revealed a paradoxical increase in E2F-responsive genes, which regulate the cell cycle, without changes in cardiomyocyte cell number or size in Tg mice. Young adult Tg mice displayed a 75% (P<0.01) decrease in gap junction protein connexin-43, resulting in abnormal electrocardiogram including a 24% (P<0.05) increase in PR interval. Further, mir-206, which targets connexin-43, was up-regulated 10-fold (P<0.05) in Tg myocardium. The mitogen-activated protein kinase pathway, which regulates the levels of miR-206 and connexin-43, was activated in Tg hearts. Thus, deregulated E2F6 levels evoked abnormal gene expression at transcriptional and post-transcriptional levels, leading to cardiac remodeling and dilated cardiomyopathy. The data highlight an unprecedented role for the strict regulation of the E2F pathway in normal postnatal cardiac function.-Westen-dorp, B., Major, J. L., Nader, M., Salih, M., Leenen, F. H. H., Tuana, B. S. The E2F6 repressor activates gene expression in myocardium resulting in dilated cardiomyopathy. FASEB J. 26, 2569-2579 (2012). www.fasebj.org	[Westendorp, Bart; Major, Jennifer L.; Nader, Moni; Salih, Maysoon; Leenen, Frans H. H.; Tuana, Balwant S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Westendorp, Bart; Nader, Moni; Leenen, Frans H. H.; Tuana, Balwant S.] Univ Ottawa, Hypertens Unit, Inst Heart, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Tuana, BS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	btuana@uottawa.ca	Major, Jennifer/K-7268-2019	Nader, Moni/0000-0003-2138-5213; Westendorp, Bart/0000-0003-1043-3638	Canadian Institutes of Health Research [57809]; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by an operating grant from the Canadian Institutes of Health Research (57809) to B. S. T. B. W. and M. N. were supported by postdoctoral research fellowships from the Heart and Stroke Foundation of Canada. F. H. H. L. holds the Pfizer Chair in Hypertension Research, an endowed chair supported by Pfizer Canada, the University of Ottawa Heart Institute Foundation, and the Canadian Institutes of Health Research. The authors declare no conflicts of interest.	Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Asp P, 2009, GENE DEV, V23, P37, DOI 10.1101/gad.1727309; Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Baudet S, 2000, CARDIOVASC RES, V46, P17, DOI 10.1016/S0008-6363(00)00015-8; Berman SD, 2009, P NATL ACAD SCI USA, V106, P14932, DOI 10.1073/pnas.0902408106; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Dahme T, 2002, EUR J BIOCHEM, V269, P5030, DOI 10.1046/j.1432-1033.2002.03210.x; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; Ebelt H, 2008, CARDIOVASC RES, V80, P219, DOI 10.1093/cvr/cvn194; Gard JJ, 2005, CARDIOVASC RES, V67, P539, DOI 10.1016/j.cardiores.2005.04.004; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Ivanova IA, 2009, ONCOGENE, V28, P52, DOI 10.1038/onc.2008.354; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kalma Y, 2004, ENDOCRINOLOGY, V145, P1617, DOI 10.1210/en.2003-1051; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; King JC, 2008, CELL CYCLE, V7, P3775, DOI 10.4161/cc.7.23.7240; Kitamura H, 2003, CIRC J, V67, P1017, DOI 10.1253/circj.67.1017; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Luk A, 2009, J CLIN PATHOL, V62, P219, DOI 10.1136/jcp.2008.060731; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Movassagh M, 2006, J PHARM PHARMACOL, V58, P73, DOI 10.1211/jpp.58.1.0009; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; Nader M., AM J PHYSL IN PRESS, V287, pH2468; Park JH, 2008, CELL PROLIFERAT, V41, P786, DOI 10.1111/j.1365-2184.2008.00552.x; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Sirnes S, 2009, BIOCHEM BIOPH RES CO, V382, P41, DOI 10.1016/j.bbrc.2009.02.141; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; Storre J, 2002, EMBO REP, V3, P695, DOI 10.1093/embo-reports/kvf141; Sun LP, 2010, CHINESE MED J-PEKING, V123, P1058, DOI 10.3760/cma.j.issn.0366-6999.2010.08.015; Sussman MA, 1998, J CLIN INVEST, V101, P51, DOI 10.1172/JCI1167; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; van Amerongen MJ, 2010, CARDIOVASC RES, V86, P92, DOI 10.1093/cvr/cvp383; Vanderheyden M, 2008, J AM COLL CARDIOL, V51, P129, DOI 10.1016/j.jacc.2007.07.087; Vara D, 2003, J BIOL CHEM, V278, P21388, DOI 10.1074/jbc.M212612200; WALSH MJ, 1995, J BIOL CHEM, V270, P5289, DOI 10.1074/jbc.270.10.5289; Wohlschlaeger J, 2010, J HEART LUNG TRANSPL, V29, P117, DOI 10.1016/j.healun.2009.09.017; Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yang WW, 2007, CELL DEATH DIFFER, V14, P807, DOI 10.1038/sj.cdd.4402062; Yang WW, 2008, MOL BIOL CELL, V19, P3691, DOI 10.1091/mbc.E08-02-0171	60	13	15	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2569	2579		10.1096/fj.11-203174	http://dx.doi.org/10.1096/fj.11-203174			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22403008				2022-12-25	WOS:000305017200033
J	Eroglu, A; Hruszkewycz, DP; dela Sena, C; Narayanasamy, S; Riedl, KM; Kopec, RE; Schwartz, SJ; Curley, RW; Harrison, EH				Eroglu, Abdulkerim; Hruszkewycz, Damian P.; dela Sena, Carlo; Narayanasamy, Sureshbabu; Riedl, Ken M.; Kopec, Rachel E.; Schwartz, Steven J.; Curley, Robert W., Jr.; Harrison, Earl H.			Naturally Occurring Eccentric Cleavage Products of Provitamin A beta-Carotene Function as Antagonists of Retinoic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; VITAMIN-A; IN-VIVO; LUNG-CANCER; CONVERSION; BETA-APO-13-CAROTENONE; EXPRESSION; FERRETS; ALPHA; CELLS	beta-Carotene is the major dietary source of provitamin A. Central cleavage of beta-carotene catalyzed by beta-carotene oxygenase 1 yields two molecules of retinaldehyde. Subsequent oxidation produces all-trans-retinoic acid (ATRA), which functions as a ligand for a family of nuclear transcription factors, the retinoic acid receptors (RARs). Eccentric cleavage of beta-carotene at non-central double bonds is catalyzed by other enzymes and can also occur non-enzymatically. The products of these reactions are beta-apocarotenals and beta-apocarotenones, whose biological functions in mammals are unknown. We used reporter gene assays to show that none of the beta-apocarotenoids significantly activated RARs. Importantly, however, beta-apo-14'-carotenal, beta-apo-14'-carotenoic acid, and beta-apo-13-carotenone antagonized ATRA-induced transactivation of RARs. Competitive radioligand binding assays demonstrated that these putative RAR antagonists compete directly with retinoic acid for high affinity binding to purified receptors. Molecular modeling studies confirmed that beta-apo-13-carotenone can interact directly with the ligand binding site of the retinoid receptors. beta-Apo-13-carotenone and the beta-apo-14'-carotenoids inhibited ATRA-induced expression of retinoid responsive genes in Hep G2 cells. Finally, we developed an LC/MS method and found 3-5 nM beta-apo-13-carotenone was present in human plasma. These findings suggest that beta-apocarotenoids function as naturally occurring retinoid antagonists. The antagonism of retinoid signaling by these metabolites may have implications for the activities of dietary beta-carotene as a provitamin A and as a modulator of risk for cardiovascular disease and cancer.	[Eroglu, Abdulkerim; dela Sena, Carlo; Narayanasamy, Sureshbabu; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [Eroglu, Abdulkerim; dela Sena, Carlo; Curley, Robert W., Jr.; Harrison, Earl H.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Hruszkewycz, Damian P.; Narayanasamy, Sureshbabu; Curley, Robert W., Jr.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Riedl, Ken M.; Kopec, Rachel E.; Schwartz, Steven J.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harrison, EH (corresponding author), 350 Campbell Hall,1787 Neil Ave, Columbus, OH 43210 USA.	Harrison.304@osu.edu	Harrison, Earl H/AAN-5378-2021; NARAYANASAMY, SURESHBABU/AAN-6604-2021; Kopec, Rachel E/A-1533-2017; Riedl, Ken/K-1881-2019; Eroglu, Abdulkerim/J-5862-2019; riedl, ken/G-8621-2014	Eroglu, Abdulkerim/0000-0001-5350-450X; riedl, ken/0000-0002-9020-3471; Kopec, Rachel/0000-0002-1368-6713; Narayanasamy, Sureshbabu/0000-0002-5846-3230; Schwartz, Steven/0000-0002-1427-5780	National Institutes of Health [R01-DK044498, R01-Hl049879]; Ohio Agricultural Research and Development Center; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Agricultural Research and Development Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK044498 and R01-Hl049879 (to E. H. H.). This work was also supported by a grant from the Ohio Agricultural Research and Development Center (to E. H. H., K. M. R., and R. W. C.).	COREY EJ, 1968, J AM CHEM SOC, V90, P5616, DOI 10.1021/ja01022a059; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025; Fleshman MK, 2011, J AGR FOOD CHEM, V59, P4448, DOI 10.1021/jf200416a; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Goodwin T. W., 1963, BIOSYNTHESIS VITAMIN, P270; Ho CC, 2007, AM J CLIN NUTR, V85, P770, DOI 10.1093/ajcn/85.3.770; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Karrer P, 1931, HELV CHIM ACTA, V14, P1431, DOI 10.1002/hlca.19310140622; Liu C, 2000, CARCINOGENESIS, V21, P2245, DOI 10.1093/carcin/21.12.2245; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Marsh RS, 2010, EXP BIOL MED, V235, P342, DOI 10.1258/ebm.2009.009202; Moore T, 1930, BIOCHEM J, V24, P692, DOI 10.1042/bj0240692; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Omenn GS, 1996, J NATL CANCER I, V88, P1550, DOI 10.1093/jnci/88.21.1550; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Prakash P, 2004, J NUTR, V134, P667, DOI 10.1093/jn/134.3.667; Rarey M, 1999, BIOINFORMATICS, V15, P243, DOI 10.1093/bioinformatics/15.3.243; REPA JJ, 1993, P NATL ACAD SCI USA, V90, P7293, DOI 10.1073/pnas.90.15.7293; Russell RM, 2004, J NUTR, V134, p262S, DOI 10.1093/jn/134.1.262S; Shmarakov I, 2010, ARCH BIOCHEM BIOPHYS, V504, P3, DOI 10.1016/j.abb.2010.05.010; TANG GW, 1991, BIOCHEMISTRY-US, V30, P9829, DOI 10.1021/bi00105a003; Tay S, 2010, MOL PHARMACOL, V77, P218, DOI 10.1124/mol.109.059071; WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	28	104	104	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15886	15895		10.1074/jbc.M111.325142	http://dx.doi.org/10.1074/jbc.M111.325142			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418437	hybrid, Green Published			2022-12-25	WOS:000304006300067
J	Lu, N; Ji, T; Zhang, JH; Sun, YH; Tao, Y				Lu, Nan; Ji, Ting; Zhang, Jia-Hua; Sun, Yue-Hua; Tao, Yi			Evolutionary Dynamics of Fearfulness and Boldness: A Stochastic Simulation Model	PLOS ONE			English	Article							REALIZED HERITABILITY; BEHAVIORAL SYNDROMES; LIFE-HISTORY; TRADE-OFFS; PERSONALITY; HYPOTHESIS; TRAITS	A stochastic simulation model is investigated for the evolution of anti-predator behavior in birds. The main goal is to reveal the effects of population size, predation threats, and energy lost per escape on the evolutionary dynamics of fearfulness and boldness. Two pure strategies, fearfulness and boldness, are assumed to have different responses for the predator attacks and nonlethal disturbance. On the other hand, the co-existence mechanism of fearfulness and boldness is also considered. For the effects of total population size, predation threats, and energy lost per escape, our main results show that: (i) the fearful (bold) individuals will be favored in a small (large) population, i. e. in a small (large) population, the fearfulness (boldness) can be considered to be an ESS; (ii) in a population with moderate size, fearfulness would be favored under moderate predator attacks; and (iii) although the total population size is the most important factor for the evolutionary dynamics of both fearful and bold individuals, the small energy lost per escape enables the fearful individuals to have the ability to win the advantage even in a relatively large population. Finally, we show also that the co-existence of fearful and bold individuals is possible when the competitive interactions between individuals are introduced.	[Lu, Nan; Ji, Ting; Zhang, Jia-Hua; Sun, Yue-Hua; Tao, Yi] Chinese Acad Sci, Inst Zool, Grp Theoret Biol, Grp Avian Ecol,Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Lu, Nan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lu, N (corresponding author), Chinese Acad Sci, Inst Zool, Grp Theoret Biol, Grp Avian Ecol,Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiting@ioz.ac.cn		Lyu, Nan/0000-0002-2544-6864; Tao, Yi/0000-0002-0749-6614	National Natural Sciences Foundation of China [30870305]; Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Basic Research Program (973) of the People's Republic of China [2007CB109107]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program (973) of the People's Republic of China(National Basic Research Program of China)	This work was supported by National Natural Sciences Foundation of China (30870305), Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences (KSCX2-EW-Z-4), and National Basic Research Program (973) (No. 2007CB109107) of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2006, ETHOLOGY, V112, P209, DOI 10.1111/j.1439-0310.2006.01209.x; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Bouchard TJ, 2001, BEHAV GENET, V31, P243; BUSS DM, 1991, ANNU REV PSYCHOL, V42, P459, DOI 10.1146/annurev.ps.42.020191.002331; CRESSMAN R, 1987, J THEOR BIOL, V126, P393, DOI 10.1016/S0022-5193(87)80147-9; Cresswell W, 2000, P ROY SOC B-BIOL SCI, V267, P733, DOI 10.1098/rspb.2000.1064; de Azevedo CS, 2006, REV BRAS ZOOL, V23, P202, DOI 10.1590/S0101-81752006000100012; DEHN MM, 1990, BEHAV ECOL SOCIOBIOL, V26, P337; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Ji T, 2009, J THEOR BIOL, V256, P637, DOI 10.1016/j.jtbi.2008.10.009; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Maynard Smith J., 1982, pi; Minderman J, 2009, BEHAV ECOL, V20, P830, DOI 10.1093/beheco/arp067; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sirot E, 2007, J EVOLUTION BIOL, V20, P1809, DOI 10.1111/j.1420-9101.2007.01385.x; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	28	0	0	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32258	10.1371/journal.pone.0032258	http://dx.doi.org/10.1371/journal.pone.0032258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412859	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000007
J	Talbot, E; Munseri, P; Teixeira, P; Matee, M; Bakari, M; Lahey, T; von Reyn, F				Talbot, Elizabeth; Munseri, Patricia; Teixeira, Pedro; Matee, Mecky; Bakari, Muhammad; Lahey, Timothy; von Reyn, Fordham			Test Characteristics of Urinary Lipoarabinomannan and Predictors of Mortality among Hospitalized HIV-Infected Tuberculosis Suspects in Tanzania	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; ENVELOPE	Background: Tuberculosis is the most common cause of death among patients with HIV infection living in tuberculosis endemic countries, but many cases are not diagnosed pre-mortem. We assessed the test characteristics of urinary lipoarabinomannan (LAM) and predictors of mortality among HIV-associated tuberculosis suspects in Tanzania. Methods: We prospectively enrolled hospitalized HIV-infected patients in Dar es Salaam, with >= 2 weeks of cough or fever, or weight loss. Subjects gave 2 mLs of urine to test for LAM using a commercially available ELISA, >= 2 sputum specimens for concentrated AFB smear and solid media culture, and 40 mLs of blood for culture. Results: Among 212 evaluable subjects, 143 (68%) were female; mean age was 36 years; and the median CD4 count 86 cells/mm 3.69 subjects (33%) had culture confirmation of tuberculosis and 65 (31%) were LAM positive. For 69 cases of sputum or blood culture-confirmed tuberculosis, LAM sensitivity was 65% and specificity 86% compared to 36% and 98% for sputum smear. LAM test characteristics were not different in patients with bacteremia but showed higher sensitivity and lower specificity with decreasing CD4 cell count. Two month mortality was 64 (53%) of 121 with outcomes available. In multivariate analysis there was significant association of mortality with absence of anti-retroviral therapy (p = 0.004) and a trend toward association with a positive urine LAM (p = 0.16). Among culture-negative patients mortality was 9 (75%) of 12 in LAM positive patients and 27 (38%) of 71 in LAM negative patients (p = 0.02). Conclusions: Urine LAM is more sensitive than sputum smear and has utility for the rapid diagnosis of culture-confirmed tuberculosis in this high-risk population. Mortality data raise the possibility that urine LAM may also be a marker for culture-negative tuberculosis.	[Talbot, Elizabeth; Teixeira, Pedro; Lahey, Timothy; von Reyn, Fordham] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; [Talbot, Elizabeth] Fdn Innovat New Diagnost, Geneva, Switzerland; [Munseri, Patricia; Matee, Mecky; Bakari, Muhammad] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Munseri, Patricia] Karolinska Inst, Stockholm, Sweden	Dartmouth College; Foundation For Innovative New Diagnostics; Muhimbili University of Health & Allied Sciences; Karolinska Institutet	Talbot, E (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA.	Elizabeth.talbot@dartmouth.edu		Teixeira, J. Pedro/0000-0002-2466-9644	National Institutes of Health [D43TW006807]; Dartmouth Hitchcock Medical Center Department of Medicine; Foundation for Innovative New Diagnostics, Geneva, Switzerland; FOGARTY INTERNATIONAL CENTER [D43TW006807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dartmouth Hitchcock Medical Center Department of Medicine; Foundation for Innovative New Diagnostics, Geneva, Switzerland; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Institutes of Health-Fogarty Training Grant D43TW006807 (PJM and FvR), the Dartmouth Hitchcock Medical Center Department of Medicine, and the Foundation for Innovative New Diagnostics, Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Eng J, 2006, ROC ANAL WEB BASED C; Gounder CR, 2011, JAIDS-J ACQ IMM DEF, V58, P219, DOI 10.1097/QAI.0b013e31822b75d4; KRASNOW I, 1969, APPL MICROBIOL, V18, P915, DOI 10.1128/AEM.18.5.915-917.1969; Lee RE, 1996, CURR TOP MICROBIOL, V215, P1; Lockman S, 2003, INT J TUBERC LUNG D, V7, P714; Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711; Munseri PJ, 2011, SCAND J INFECT DIS, V43, P696, DOI 10.3109/00365548.2011.577802; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; von Reyn CF, 2011, J INFECT DIS, V204, P817, DOI 10.1093/infdis/jir418; von Reyn CF, 1999, AIDS, V13, P2193, DOI 10.1097/00002030-199911120-00001; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; WHO, 1997, TREATM TUB GUID NAT, V2	17	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32876	10.1371/journal.pone.0032876	http://dx.doi.org/10.1371/journal.pone.0032876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412939	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062000018
J	Apostolopoulou, M; Ligon, L				Apostolopoulou, Maria; Ligon, Lee			Cadherin-23 Mediates Heterotypic Cell-Cell Adhesion between Breast Cancer Epithelial Cells and Fibroblasts	PLOS ONE			English	Article							PROMOTES MOTILITY; N-CADHERIN; HAIR-CELLS; EXPRESSION; SUPERFAMILY; CONTACT; FILAMENTS; INVASION; HEARING; FAMILY	In the early stages of breast cancer metastasis, epithelial cells penetrate the basement membrane and invade the surrounding stroma, where they encounter fibroblasts. Paracrine signaling between fibroblasts and epithelial tumor cells contributes to the metastatic cascade, but little is known about the role of adhesive contacts between these two cell types in metastasis. Here we show that MCF-7 breast cancer epithelial cells and normal breast fibroblasts form heterotypic adhesions when grown together in co-culture, as evidenced by adhesion assays. PCR and immunoblotting show that both cell types express multiple members of the cadherin superfamily, including the atypical cadherin, cadherin-23, when grown in isolation and in co-culture. Immunocytochemistry experiments show that cadherin-23 localizes to homotypic adhesions between MCF-7 cells and also to heterotypic adhesions between the epithelial cells and fibroblasts, and antibody inhibition and RNAi experiments show that cadherin-23 plays a role in mediating these adhesive interactions. Finally, we show that cadherin-23 is upregulated in breast cancer tissue samples, and we hypothesize that heterotypic adhesions mediated by this atypical cadherin may play a role in the early stages of metastasis.	[Apostolopoulou, Maria] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Apostolopoulou, M (corresponding author), Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA.	ligonl@rpi.edu		Ligon, Lee/0000-0002-5735-3654	American Cancer Society [RSG-10-245-01-CSM]	American Cancer Society(American Cancer Society)	Funding was provided by the American Cancer Society Research Scholar Grant RSG-10-245-01-CSM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Di Palma F, 2001, GENE, V281, P31, DOI 10.1016/S0378-1119(01)00761-2; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; Feltes CM, 2002, CANCER RES, V62, P6688; FRANKE WW, 1978, P NATL ACAD SCI USA, V75, P5034, DOI 10.1073/pnas.75.10.5034; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Hirano S, 2003, FRONT BIOSCI-LANDMRK, V8, pD306, DOI 10.2741/972; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masur K, 2001, MOL BIOL CELL, V12, P1973, DOI 10.1091/mbc.12.7.1973; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Okazaki N, 2002, CARCINOGENESIS, V23, P1139, DOI 10.1093/carcin/23.7.1139; Omelchenko T, 2001, P NATL ACAD SCI USA, V98, P8632, DOI 10.1073/pnas.151247698; Sakaguchi H, 2009, CURR OPIN OTOLARYNGO, V17, P388, DOI 10.1097/MOO.0b013e3283303472; Samoszuk M, 2005, BREAST CANCER RES, V7, pR274, DOI 10.1186/bcr995; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Taniuchi K, 2005, CANCER RES, V65, P3092, DOI 10.1158/0008.5472.CAN-04-3646; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; Wadlow RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006888; Yonezawa S, 2006, HUM MUTAT, V27, P88, DOI 10.1002/humu.20266	28	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33289	10.1371/journal.pone.0033289	http://dx.doi.org/10.1371/journal.pone.0033289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22413011	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800088
J	Vieira, PMD; Francisco, AF; Machado, EMD; Nogueira, NC; Fonseca, KD; Reis, AB; Teixeira-Carvalho, A; Martins, OA; Tafuri, WL; Carneiro, CM				de Abreu Vieira, Paula Melo; Francisco, Amanda Fortes; de Meneses Machado, Evandro Marques; Nogueira, Nivia Carolina; Fonseca, Katia da Silva; Reis, Alexandre Barbosa; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis; Tafuri, Washington Luiz; Carneiro, Claudia Martins			Different Infective Forms Trigger Distinct Immune Response in Experimental Chagas Disease	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; TNF-ALPHA; MACROPHAGE ACTIVATION; PHENOTYPIC FEATURES; ACUTE-PHASE; TRYPOMASTIGOTES; CARDIOMYOPATHY; MICE; INDETERMINATE; EXPRESSION	Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host interaction and/or target cell invasion, they differ in the molecules present on the surface. Thus, aspects related to the variability that the forms of T. cruzi interacts with host cells may lead to fundamental implications on the immune response against this parasite and, consequently, the clinical evolution of Chagas disease. We have shown that BT infected mice presented higher levels of parasitemia during all the acute phase of infection. Moreover, the infection with either MT or BT forms resulted in increased levels of total leukocytes, monocytes and lymphocytes, specifically later for MT and earlier for BT. The infection with BT forms presented earlier production of proinflammatory cytokine TNF-alpha and later of IFN-gamma by both T cells subpopulations. This event was accompanied by an early cardiac inflammation with an exacerbation of this process at the end of the acute phase. On the other hand, infection with MT forms result in an early production of IFN-gamma, with subsequent control in the production of this cytokine by IL-10, which provided to these animals an immunomodulatory profile in the end of the acute phase. These results are in agreement with what was found for cardiac inflammation where animals infected with MT forms showed intense cardiac inflammation later at infection, with a decrease in the same at the end of this phase. In summary, our findings emphasize the importance of taking into account the inoculums source of T. cruzi, since vectorial or transfusional routes of T. cruzi infection may trigger distinct parasite-host interactions during the acute phase that may influence relevant biological aspects of chronic Chagas disease.	[de Abreu Vieira, Paula Melo; Francisco, Amanda Fortes; Nogueira, Nivia Carolina; Fonseca, Katia da Silva; Reis, Alexandre Barbosa; Tafuri, Washington Luiz; Carneiro, Claudia Martins] Univ Fed Ouro Preto UFOP, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol NUPEB, Ouro Preto, MG, Brazil; [de Meneses Machado, Evandro Marques] Univ Fed Ouro Preto UFOP, Lab Doenca Chagas, Nucleo Pesquisas Ciencias Biol NUPEB, Ouro Preto, MG, Brazil; [Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil; [Reis, Alexandre Barbosa; Carneiro, Claudia Martins] Univ Fed Ouro Preto UFOP, Escola Farm, Dept Anal Clin, Ouro Preto, MG, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Fundacao Oswaldo Cruz; Universidade Federal de Ouro Preto	Vieira, PMD (corresponding author), Univ Fed Ouro Preto UFOP, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol NUPEB, Ouro Preto, MG, Brazil.	carneirocm@gmail.com	carneiro, claudia m/B-6205-2013; Martins-Filho, Olindo Assis/ABE-6278-2021; carneiro, Claudia Martins/AAP-4455-2020; Reis, Alexandre Barbosa/I-9945-2014; Vieira, Paula/G-9402-2012; Machado, Evandro/G-1184-2012	Martins-Filho, Olindo Assis/0000-0002-5494-4889; carneiro, Claudia Martins/0000-0002-6002-857X; Reis, Alexandre Barbosa/0000-0001-8123-4164; Machado, Evandro/0000-0003-2786-7117; Fortes Francisco, Amanda/0000-0002-3475-8130	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Universidade Federal de Ouro Preto (UFOP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523; Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249; Andrade SG, 2008, MEM I OSWALDO CRUZ, V103, P21, DOI 10.1590/S0074-02762008005000006; Bern C, 2008, CURR OPIN INFECT DIS, V21, P476, DOI 10.1097/QCO.0b013e32830ef5b6; Brener Z, 1997, INT ARCH ALLERGY IMM, V114, P103, DOI 10.1159/000237653; Camargo MM, 1997, J IMMUNOL, V158, P5890; Camargo MM, 1997, J IMMUNOL, V159, P6131; Carneiro CM, 2007, ACTA TROP, V101, P120, DOI 10.1016/j.actatropica.2006.12.009; Coura-Vital W, 2008, EXP PARASITOL, V120, P269, DOI 10.1016/j.exppara.2008.08.001; de Meis J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000417; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Kroll-Palhares K, 2008, MEM I OSWALDO CRUZ, V103, P375, DOI 10.1590/S0074-02762008000400011; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Lima ES, 2001, INT J EXP PATHOL, V82, P327, DOI 10.1046/j.1365-2613.2001.00203.x; NAKHLE MC, 1989, REV INST MED TROP SP, V31, P384, DOI 10.1590/S0036-46651989000600004; Nascentes GA, 2010, VECTOR-BORNE ZOONOT, V10, P1; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; RAMIREZ MI, 1993, INFECT IMMUN, V61, P3636, DOI 10.1128/IAI.61.9.3636-3641.1993; REED SG, 1988, J IMMUNOL, V140, P4342; Reis MM, 1997, CLIN IMMUNOL IMMUNOP, V83, P165, DOI 10.1006/clin.1997.4335; Ribeirao M, 2000, PARASITE IMMUNOL, V22, P49, DOI 10.1046/j.1365-3024.2000.00260.x; ROWLAND EC, 1984, J PARASITOL, V70, P819, DOI 10.2307/3281771; RUSSO M, 1989, PARASITE IMMUNOL, V11, P385, DOI 10.1111/j.1365-3024.1989.tb00675.x; Sathler-Avelar R, 2003, SCAND J IMMUNOL, V58, P655, DOI 10.1111/j.1365-3083.2003.01340.x; Sathler-Avelar R, 2008, MICROBES INFECT, V10, P103, DOI 10.1016/j.micinf.2007.10.009; Souza PEA, 2004, INFECT IMMUN, V72, P5283, DOI 10.1128/IAI.72.9.5283-5291.2004; STAROBINAS N, 1991, RES IMMUNOL, V142, P117, DOI 10.1016/0923-2494(91)90019-F; Talvani A, 2004, J INFECT DIS, V189, P214, DOI 10.1086/380803; TARLETON RL, 1988, CLIN EXP IMMUNOL, V73, P186; Truyens C, 1999, INFECT IMMUN, V67, P5579, DOI 10.1128/IAI.67.11.5579-5586.1999; Vitelli-Avelar DM, 2008, SCAND J IMMUNOL, V68, P516, DOI 10.1111/j.1365-3083.2008.02167.x; Zarnbrano-Villa S, 2002, TRENDS PARASITOL, V18, P272, DOI 10.1016/S1471-4922(02)02289-4	36	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32912	10.1371/journal.pone.0032912	http://dx.doi.org/10.1371/journal.pone.0032912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412949	Green Published, gold, Green Accepted			2022-12-25	WOS:000303060800062
J	Shen, CL; Ding, M; Ratner, D; Montelaro, RC; Chen, Y; Gupta, P				Shen, Chengli; Ding, Ming; Ratner, Deena; Montelaro, Ronald C.; Chen, Yue; Gupta, Phalguni			Evaluation of Cervical Mucosa in Transmission Bottleneck during Acute HIV-1 Infection Using a Cervical Tissue-Based Organ Culture	PLOS ONE			English	Article							RHESUS MACAQUES; CELL-FREE; TYPE-1; SEMEN; BLOOD; COMPARTMENTALIZATION; INOCULATION; PHYLOGENIES; PHENOTYPE; MODULATE	Background: Although there are different strains of HIV-1 in a chronically infected individual, only one or limited virus strains are successfully transmitted to a new individual. The reason for this "transmission bottleneck'' is as yet unknown. Methodology/Principal Findings: A human cervical explant model was used to measure HIV-1 transmission efficiency of viral strains from chronic infections, and transmitter/founder variants. We also evaluated the genetic characteristics of HIV-1 variants in the inoculums compared to those transmitted across the cervical mucosa. Eight different HIV-1 isolates were used in this study, six chronic isolates and two transmitter/founder viruses. The transmission efficiency of the chronic and transmitter/founder virus isolates and the viral diversity of chronic isolates before and after viral transmission were assessed. The results indicate that transmitter/founder viruses did not display higher transmission efficiency than chronic HIV-1 isolates. Furthermore, no evidence for a difference in diversity was found between the inoculums and transmitted virus strains. Phylogenetic analysis indicated that the sequences of variants in the inoculums and those present in transmitted virus intermingled irrespective of co-receptor usage. In addition, the inoculum and transmitted variants had a similar pairwise distance distribution. Conclusion: There was no selection of a single or limited number of viral variants during HIV-1 transmission across the cervical mucosa in the organ culture model, indicating that the cervical mucosa alone may not produce the transmission bottleneck of HIV-1 infection observed in vivo.	[Shen, Chengli; Ding, Ming; Ratner, Deena; Chen, Yue; Gupta, Phalguni] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Shen, Chengli] Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Montelaro, Ronald C.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Montelaro, Ronald C.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shen, CL (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	pgupta1@pitt.edu			National Institutes of Health [R01HD052436]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052436] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the National Institutes of Health (R01HD052436). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atula S, 1997, EXP CELL RES, V235, P180, DOI 10.1006/excr.1997.3676; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Fox-Canale AM, 2007, VIROLOGY, V369, P55, DOI 10.1016/j.virol.2007.07.008; Gilbert PB, 2005, BIOMETRICS, V61, P106, DOI 10.1111/j.0006-341X.2005.020719.x; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P15, DOI 10.1186/1477-3155-8-15; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; McElrath MJ, 2010, ANTIMICROB AGENTS CH, V54, P763, DOI 10.1128/AAC.00891-09; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; MILLER CJ, 1992, LAB INVEST, V67, P628; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rodriguez MA, 2009, VIROLOGY, V385, P416, DOI 10.1016/j.virol.2008.12.025; Saidi H, 2007, VIROLOGY, V358, P55, DOI 10.1016/j.virol.2006.07.029; Saidi H, 2009, AIDS RES HUM RETROV, V25, P497, DOI 10.1089/aid.2008.0156; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SCHUTTE B, 1995, CYTOMETRY, V21, P177, DOI 10.1002/cyto.990210210; Scurry J, 1998, HISTOPATHOLOGY, V32, P399; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; SLATKIN M, 1990, GENETICS, V126, P249; SLATKIN M, 1989, GENETICS, V123, P603; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	37	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32539	10.1371/journal.pone.0032539	http://dx.doi.org/10.1371/journal.pone.0032539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412886	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000303060800027
J	Vlahos, R; Wark, PAB; Anderson, GP; Bozinovski, S				Vlahos, Ross; Wark, Peter A. B.; Anderson, Gary P.; Bozinovski, Steven			Glucocorticosteroids Differentially Regulate MMP-9 and Neutrophil Elastase in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; IN-VIVO; TISSUE INHIBITOR; INNATE IMMUNITY; RELEASE; MATRIX-METALLOPROTEINASE-9; INFLAMMATION; GELATINASE; INTERLEUKIN-8	Background: Chronic Obstructive Pulmonary Disease (COPD) is currently the fifth leading cause of death worldwide. Neutrophilic inflammation is prominent, worsened during infective exacerbations and is refractory to glucocorticosteroids (GCs). Deregulated neutrophilic inflammation can cause excessive matrix degradation through proteinase release. Gelatinase and azurophilic granules within neutrophils are a major source of matrix metalloproteinase (MMP)-9 and neutrophil elastase (NE), respectively, which are elevated in COPD. Methods: Secreted MMP-9 and NE activity in BALF were stratified according to GOLD severity stages. The regulation of secreted NE and MMP-9 in isolated blood neutrophils was investigated using a pharmacological approach. In vivo release of MMP-9 and NE in mice exposed to cigarette smoke (CS) and/or the TLR agonist lipopolysaccharide (LPS) in the presence of dexamethasone (Dex) was investigated. Results: Neutrophil activation as assessed by NE release was increased in severe COPD (36-fold, GOLD II vs. IV). MMP-9 levels (8-fold) and activity (21-fold) were also elevated in severe COPD, and this activity was strongly associated with BALF neutrophils (r = 0.92, p < 0.001), but not macrophages (r = 0.48, p = 0.13). In vitro, release of NE and MMP-9 from fMLP stimulated blood neutrophils was insensitive to Dex and attenuated by the PI3K inhibitor, wortmannin. In vivo, GC resistant neutrophil activation (NE release) was only seen in mice exposed to CS and LPS. In addition, GC refractory MMP-9 expression was only associated with neutrophil activation. Conclusions: As neutrophils become activated with increasing COPD severity, they become an important source of NE and MMP-9 activity, which secrete proteinases independently of TIMPs. Furthermore, as NE and MMP-9 release was resistant to GC, targeting of the PI3K pathway may offer an alternative pathway to combating this proteinase imbalance in severe COPD.	[Vlahos, Ross; Anderson, Gary P.; Bozinovski, Steven] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia; [Wark, Peter A. B.] John Hunter Hosp, Resp Med HMRI, Newcastle, NSW, Australia	University of Melbourne; John Hunter Hospital	Vlahos, R (corresponding author), Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia.	bozis@unimelb.edu.au	Wark, Peter/G-7037-2013; Vlahos, Ross/AAM-3837-2020	Wark, Peter/0000-0001-5676-6126; Vlahos, Ross/0000-0001-8443-7071; Anderson, Gary/0000-0001-6580-3398; Bozinovski, Steven/0000-0001-6533-8641	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2004, LANCET, V363, P731, DOI 10.1016/S0140-6736(04)15650-X; Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bozinovski S, 2005, J PROTEOME RES, V4, P136, DOI 10.1021/pr049829t; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; Bozinovski S, 2008, AM J RESP CRIT CARE, V177, P269, DOI 10.1164/rccm.200705-678OC; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Culpitt SV, 2005, RESP MED, V99, P703, DOI 10.1016/j.rmed.2004.10.022; Culpitt SV, 1999, AM J RESP CRIT CARE, V160, P1635, DOI 10.1164/ajrccm.160.5.9811058; DAMIANO VV, 1986, J CLIN INVEST, V78, P482, DOI 10.1172/JCI112600; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Donaldson GC, 2003, EUR RESPIR J, V22, P931, DOI 10.1183/09031936.03.00038303; Ehrenfeld P, 2009, J LEUKOCYTE BIOL, V86, P1179, DOI 10.1189/jlb.0109012; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Ferry G, 1997, FEBS LETT, V402, P111, DOI 10.1016/S0014-5793(96)01508-6; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; Kuwahara I, 2006, AM J PHYSIOL-LUNG C, V291, pL407, DOI 10.1152/ajplung.00471.2005; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; Naylor EJ, 2007, AM J RESP CELL MOL, V37, P135, DOI 10.1165/rcmb.2006-0375OC; Opdenakker G, 1998, IMMUNOL TODAY, V19, P182, DOI 10.1016/S0167-5699(97)01243-7; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Owen Caroline A, 2008, Int J Chron Obstruct Pulmon Dis, V3, P253; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Pruijt JFM, 1999, P NATL ACAD SCI USA, V96, P10863, DOI 10.1073/pnas.96.19.10863; Pugin J, 1999, AM J RESP CELL MOL, V20, P458, DOI 10.1165/ajrcmb.20.3.3311; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; RYDER MI, 1994, EXP LUNG RES, V20, P283, DOI 10.3109/01902149409064388; Salaun C, 2004, BBA-MOL CELL RES, V1693, P81, DOI 10.1016/j.bbamcr.2004.05.008; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shao MXG, 2005, J IMMUNOL, V175, P4009, DOI 10.4049/jimmunol.175.6.4009; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781; Yan CH, 2004, FASEB J, V18, P540, DOI 10.1096/fj.03-0960fje	40	58	62	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33277	10.1371/journal.pone.0033277	http://dx.doi.org/10.1371/journal.pone.0033277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22413009	gold, Green Submitted, Green Published			2022-12-25	WOS:000303060800087
J	Ward, AJW; Krause, J; Sumpter, DJT				Ward, Ashley J. W.; Krause, Jens; Sumpter, David J. T.			Quorum Decision-Making in Foraging Fish Shoals	PLOS ONE			English	Article							INFORMATION-TRANSFER; PUBLIC INFORMATION; STRATEGIES; SCROUNGERS; PRODUCERS; ACCURACY; ANIMALS; SPEED; SIZE	Quorum responses provide a means for group-living animals to integrate and filter disparate social information to produce accurate and coherent group decisions. A quorum response may be defined as a steep increase in the probability of group members performing a given behaviour once a threshold minimum number of their group mates already performing that behaviour is exceeded. In a previous study we reported the use of a quorum response in group decision-making of threespine sticklebacks (Gasterosteus aculeatus) under a simulated predation threat. Here we examine the use of quorum responses by shoals of sticklebacks in first locating and then leaving a foraging patch. We show that a quorum rule explains movement decisions by threespine sticklebacks toward and then away from a food patch. Following both to and from a food patch occurred when a threshold number of initiators was exceeded, with the threshold being determined by the group size.	[Ward, Ashley J. W.] Univ Leicester, Dept Biol, Leicester, Leics, England; [Ward, Ashley J. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Krause, Jens] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Sumpter, David J. T.] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden	University of Leicester; University of Sydney; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Uppsala University	Ward, AJW (corresponding author), Univ Leicester, Dept Biol, Leicester, Leics, England.	ashleyjwward@gmail.com	Krause, Jens/J-4381-2013	Krause, Jens/0000-0002-1289-2857; Ward, Ashley/0000-0003-0842-533X	National Environmental Research Council of the UK [NE/C002393/1]; University of Sydney; NERC [NE/D011035/1] Funding Source: UKRI; Natural Environment Research Council [NE/D011035/1] Funding Source: researchfish	National Environmental Research Council of the UK; University of Sydney(University of Sydney); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the National Environmental Research Council of the UK (Grant No. NE/C002393/1) and by a Vice Chancellor's Grant provided to AW by the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; BARNARD CJ, 1981, ANIM BEHAV, V29, P543, DOI 10.1016/S0003-3472(81)80117-0; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; CLARK CW, 1984, AM NAT, V123, P626, DOI 10.1086/284228; Collins LM, 2007, J R SOC INTERFACE, V4, P65, DOI 10.1098/rsif.2006.0157; Conradt L, 2007, P ROY SOC B-BIOL SCI, V274, P2317, DOI 10.1098/rspb.2007.0186; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Coolen I, 2005, BEHAV ECOL, V16, P865, DOI 10.1093/beheco/ari064; Coolen I, 2003, P ROY SOC B-BIOL SCI, V270, P2413, DOI 10.1098/rspb.2003.2525; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Day RL, 2001, ANIM BEHAV, V62, P917, DOI 10.1006/anbe.2001.1820; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Fernandez-Juricic E, 2004, TRENDS ECOL EVOL, V19, P25, DOI 10.1016/j.tree.2003.10.003; Fernandez-Juricic E, 2005, ANIM BEHAV, V69, P73, DOI 10.1016/j.anbehav.2004.01.019; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Giraldeau L.A., 2000, MG BEH ECOL; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; GODIN JGJ, 1985, BEHAV ECOL SOCIOBIOL, V16, P105, DOI 10.1007/BF00295142; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Laland KN, 1998, BEHAV ECOL, V9, P493, DOI 10.1093/beheco/9.5.493; Meunier H, 2006, BEHAVIOUR, V143, P1511, DOI 10.1163/156853906779366982; Morrell LJ, 2004, BEHAV ECOL SOCIOBIOL, V56, P539, DOI 10.1007/s00265-004-0821-6; Passino KM, 2006, BEHAV ECOL SOCIOBIOL, V59, P427, DOI 10.1007/s00265-005-0067-y; Perez-Escudero A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002282; Pitcher T.J., 1983, British Freshwater Fisheries Conference Proceedings, V3, P220; Pitcher T.J., 1993, FISH FISHERIES SERIE, V7; PITCHER TJ, 1982, BEHAV ECOL SOCIOBIOL, V10, P149, DOI 10.1007/BF00300175; Pratt SC, 2005, BEHAV ECOL, V16, P488, DOI 10.1093/beheco/ari020; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Ruxton GD, 2005, BEHAV ECOL, V16, P856, DOI 10.1093/beheco/ari063; RYER CH, 1991, ENVIRON BIOL FISH, V30, P317, DOI 10.1007/BF02028847; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sumpter D, 2008, THEOR BIOSCI, V127, P177, DOI 10.1007/s12064-008-0040-1; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; VICKERY WL, 1991, AM NAT, V137, P847, DOI 10.1086/285197; Wagner RH, 2003, ANIM BEHAV, V65, P405, DOI 10.1006/anbe.2003.2037; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Webster MM, 2008, P ROY SOC B-BIOL SCI, V275, P2869, DOI 10.1098/rspb.2008.0817; Webster MM, 2010, BIOL REV	48	45	45	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32411	10.1371/journal.pone.0032411	http://dx.doi.org/10.1371/journal.pone.0032411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412869	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800016
J	Lanini, S; Garbuglia, AR; Puro, V; Solmone, M; Martini, L; Arcese, W; Costa, AN; Borgia, P; Piselli, P; Capobionchi, MR; Ippolito, G				Lanini, Simone; Garbuglia, Anna Rosa; Puro, Vincenzo; Solmone, Mariacarmela; Martini, Lorena; Arcese, William; Costa, Alessandro Nanni; Borgia, Piero; Piselli, Pierluca; Capobionchi, Maria Rosaria; Ippolito, Giuseppe			Hospital Cluster of HBV Infection: Molecular Evidence of Patient-to-Patient Transmission through Lancing Device	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; C VIRUS; REACTIVATION; OUTBREAKS; DISEASE	Introduction: In western countries the transmission of hepatitis B virus (HBV) transmission through multi-patients lancing devices has been inferred since early '90s, however no study has ever provided biological evidence which directly link these device with HBV cross-infection. Here we present results of an outbreak investigation which could associate, by molecular techniques, the use of lancing device on multiple patients with HBV transmission in an Italian oncohematology unit. Methods: The outbreak investigation was designed as a retrospective cohort study to identify all potential cases. All cases identified were eventually confirmed through molecular epidemiology techniques. Audit of personnel including extensive review of infection control measures and reviewing personnel's tests for HBV was done identify transmission route. Results: Between 4 May 2006 and 21 February 2007, six incident cases of HBV infection were reported among 162 patients admitted in the oncohematology. The subsequent molecular instigation proved that 3 out 6 incident cases and one prevalent cases (already infected with HBV at the admission) represented a monophyletic cluster of infection. The eventual environmental investigation found that an identical HBV viral strain was present on a multi-patients lancing device in use in the unit and the inferential analysis showed a statistically significant association between undergoing lancing procedures and the infection. Discussion: This investigation provide molecular evidence to link a HBV infection cluster to multi-patients lancing device and highlights that patients undergoing capillary blood sampling by non-disposable lancing device may face an unacceptable increased risk of HBV infection. Therefore we believe that multi-patients lancing devices should be banned from healthcare settings and replace with disposable safety lancets that permanently retract to prevent the use of the same device on multiple patients. The use of non-disposable lancing devices should be restricted to individual use at patients' home.	[Lanini, Simone; Garbuglia, Anna Rosa; Puro, Vincenzo; Solmone, Mariacarmela; Martini, Lorena; Piselli, Pierluca; Capobionchi, Maria Rosaria; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; [Arcese, William] Fdn Policlin Tor Vergata, Rome, Italy; [Costa, Alessandro Nanni] CNT ISS Ctr Nazl Trapianti, Rome, Italy; [Borgia, Piero] Agenzia Sanita Pubbl Lazio, Rome, Italy	IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS)	Lanini, S (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.	simone.lanini@inmi.it	Ippolito, Giuseppe/J-7207-2017; Piselli, Pierluca/K-5337-2016; GARBUGLIA, ANNA ROSA/AAC-6556-2022; Lanini, Simone/C-7523-2012	Piselli, Pierluca/0000-0002-7342-0263; GARBUGLIA, ANNA ROSA/0000-0002-2687-8642; Lanini, Simone/0000-0002-6743-4001; Ippolito, Giuseppe/0000-0002-1076-2979; puro, vincenzo/0000-0003-0291-4490; ARCESE, WILLIAM/0000-0001-5697-366X	Italian Ministry of Health ('Ricerca Corrente IRCCS Lazzaro Spallanzani'); Regional Reference Centre for Healthcare-related infections (Centro di Riferimento per le Infezioni associate alle Pratiche Assistenziali della Regione Lazio - CRIPA- Lazio)	Italian Ministry of Health ('Ricerca Corrente IRCCS Lazzaro Spallanzani')(Ministry of Health, Italy); Regional Reference Centre for Healthcare-related infections (Centro di Riferimento per le Infezioni associate alle Pratiche Assistenziali della Regione Lazio - CRIPA- Lazio)	This study was funded by grants from the Italian Ministry of Health ('Ricerca Corrente IRCCS Lazzaro Spallanzani') and the Regional Reference Centre for Healthcare-related infections (Centro di Riferimento per le Infezioni associate alle Pratiche Assistenziali della Regione Lazio - CRIPA- Lazio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOND WW, 1981, LANCET, V1, P550; Desenclos JC, 2001, INFECT CONT HOSP EP, V22, P701, DOI 10.1086/501849; Dreesman JM, 2006, EPIDEMIOL INFECT, V134, P1102, DOI 10.1017/S0950268806005942; Duffell EF, 2011, EPIDEMIOL INFECT, V139, P327, DOI 10.1017/S0950268810001007; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; Gotz HM, 2008, 2007 EURO SURVEILL, V13, P27; Hansen ME, 1998, SEMIN ULTRASOUND CT, V19, P209, DOI 10.1016/S0887-2171(98)90062-2; Iudicone P, 2009, VOX SANG, V96, P292, DOI 10.1111/j.1423-0410.2009.01171.x; Kadi Z, 2006, J HOSP INFECT, V63, P65, DOI 10.1016/j.jhin.2005.11.008; Karayiannis P, 1995, HEPATOLOGY, V22, P1628, DOI 10.1016/0270-9139(95)90183-3; Komiya Y, 2008, TRANSFUSION, V48, P286, DOI 10.1111/j.1537-2995.2007.01522.x; La Torre G, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-84; Lanini S, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-15; Louie RF, 2005, POINT CARE, V4, P158, DOI 10.1097/01.poc.0000189933.35225.77; Mindikoglu AL, 2006, CLIN GASTROENTEROL H, V4, P1076, DOI 10.1016/j.cgh.2006.05.027; Mirandola S, 2011, J VIRAL HEPATITIS, V18, pE212, DOI 10.1111/j.1365-2893.2011.01435.x; Moro ML, 2002, INFECT CONT HOSP EP, V23, P338, DOI 10.1086/502062; POLISH LB, 1992, NEW ENGL J MED, V326, P721, DOI 10.1056/NEJM199203123261101; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8; TEDDER RS, 1995, LANCET, V346, P137, DOI 10.1016/S0140-6736(95)91207-X; Thompson Nicola D, 2009, J Diabetes Sci Technol, V3, P283; Thompson ND, 2009, ANN INTERN MED, V150, P33, DOI 10.7326/0003-4819-150-1-200901060-00007; Vincenti D, 2009, J VIROL METHODS, V159, P53, DOI 10.1016/j.jviromet.2009.02.027; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e33122	10.1371/journal.pone.0033122	http://dx.doi.org/10.1371/journal.pone.0033122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412991	Green Submitted, gold, Green Published			2022-12-25	WOS:000303021100050
J	Douzinas, EE; Livaditi, O; Tasoulis, MK; Prigouris, P; Bakos, D; Goutas, N; Vlachodimitropoulos, D; Andrianakis, I; Betrosian, A; Tsoukalas, GD				Douzinas, Emmanuel E.; Livaditi, Olga; Tasoulis, Marios-Konstantinos; Prigouris, Panagiotis; Bakos, Dimitrios; Goutas, Nikolaos; Vlachodimitropoulos, Dimitrios; Andrianakis, Ilias; Betrosian, Alex; Tsoukalas, George D.			Nitrosative and Oxidative Stresses Contribute to Post-Ischemic Liver Injury Following Severe Hemorrhagic Shock: The Role of Hypoxemic Resuscitation	PLOS ONE			English	Article							HEPATIC ISCHEMIA-REPERFUSION; NITRIC-OXIDE SYNTHASE; INFLAMMATORY RESPONSE; MECHANISMS; RAT; NEUTROPHIL; EXPRESSION; INOS; ISCHEMIA/REPERFUSION; PATHOPHYSIOLOGY	Purpose: Hemorrhagic shock and resuscitation is frequently associated with liver ischemia-reperfusion injury. The aim of the study was to investigate whether hypoxemic resuscitation attenuates liver injury. Methods: Anesthetized, mechanically ventilated New Zealand white rabbits were exsanguinated to a mean arterial pressure of 30 mmHg for 60 minutes. Resuscitation under normoxemia (Normox-Res group, n = 16, PaO2 = 95-105 mmHg) or hypoxemia (Hypox-Res group, n = 15, PaO2 = 35-40 mmHg) followed, modifying the FiO(2). Animals not subjected to shock constituted the sham group (n = 11, PaO2 = 95-105 mmHg). Indices of the inflammatory, oxidative and nitrosative response were measured and histopathological and immunohistochemical studies of the liver were performed. Results: Normox-Res group animals exhibited increased serum alanine aminotransferase, tumor necrosis factor - alpha, interleukin (IL) -1 beta and IL-6 levels compared with Hypox-Res and sham groups. Reactive oxygen species generation, malondialdehyde formation and myeloperoxidase activity were all elevated in Normox-Res rabbits compared with Hypox-Res and sham groups. Similarly, endothelial NO synthase and inducible NO synthase mRNA expression was up-regulated and nitrotyrosine immunostaining increased in animals resuscitated normoxemically, indicating a more intense nitrosative stress. Hypox-Res animals demonstrated a less prominent histopathologic injury which was similar to sham animals. Conclusions: Hypoxemic resuscitation prevents liver reperfusion injury through attenuation of the inflammatory response and oxidative and nitrosative stresses.	[Douzinas, Emmanuel E.; Livaditi, Olga; Tasoulis, Marios-Konstantinos; Prigouris, Panagiotis; Bakos, Dimitrios; Andrianakis, Ilias; Betrosian, Alex] Univ Athens, Sch Med, Dept Crit Care Med 3, GR-11527 Athens, Greece; [Goutas, Nikolaos; Vlachodimitropoulos, Dimitrios] Univ Athens, Sch Med, Dept Forens Med & Toxicol, GR-11527 Athens, Greece; [Tsoukalas, George D.] Sotiria Resp Hosp, Pulm Clin 4, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens	Douzinas, EE (corresponding author), Univ Athens, Sch Med, Dept Crit Care Med 3, GR-11527 Athens, Greece.	edouzin@med.uoa.gr	Tasoulis, Marios Konstantinos/H-6764-2019	Tasoulis, Marios Konstantinos/0000-0001-9453-1547; Vlachodimitropoulos, Dimitris/0000-0002-8720-9960				Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; BIASI F, 1994, FREE RADICAL BIO MED, V17, P225, DOI 10.1016/0891-5849(94)90078-7; Casillas-Ramirez A, 2006, LIFE SCI, V79, P1881, DOI 10.1016/j.lfs.2006.06.024; Chen CF, 2007, TRANSPL P, V39, P858, DOI 10.1016/j.transproceed.2007.02.018; Chen T, 2003, CURR MOL MED, V3, P519, DOI 10.2174/1566524033479582; Collins JL, 2003, SHOCK, V19, P117, DOI 10.1097/00024382-200302000-00005; Cottart CH, 1999, HEPATOLOGY, V29, P809, DOI 10.1002/hep.510290317; Douzinas EE, 2004, CRIT CARE MED, V32, P2279, DOI 10.1097/01.CCM.0000145582.03345.C8; Douzinas EE, 1997, AM J RESP CRIT CARE, V155, P53, DOI 10.1164/ajrccm.155.1.9001289; Douzinas EE, 2003, CRIT CARE MED, V31, P2183, DOI 10.1097/01.CCM.0000080488.30157.D8; Douzinas EE, 2008, INTENS CARE MED, V34, P1133, DOI 10.1007/s00134-007-0940-4; Douzinas EE, 2011, FREE RADICAL BIO MED, V50, P245, DOI 10.1016/j.freeradbiomed.2010.10.712; Douzinas EE, 2009, CRIT CARE MED, V37, P869, DOI 10.1097/CCM.0b013e31819b81ec; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fondevilla C, 2003, EXP MOL PATHOL, V74, P86, DOI 10.1016/S0014-4800(03)00008-X; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Glantzounis GK, 2007, FREE RADICAL BIO MED, V42, P882, DOI 10.1016/j.freeradbiomed.2006.12.020; Glantzounis GK, 2005, LIVER TRANSPLANT, V11, P1031, DOI 10.1002/lt.20504; GONZALEZFLECHA B, 1993, J CLIN INVEST, V91, P456, DOI 10.1172/JCI116223; GRANGER DN, 1995, ANNU REV PHYSIOL, V57, P311, DOI 10.1146/annurev.ph.57.030195.001523; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; Hines IN, 2005, BIOMED PHARMACOTHER, V59, P183, DOI 10.1016/j.biopha.2005.03.011; Hines IN, 2002, MOL CELL BIOCHEM, V234, P229, DOI 10.1023/A:1015952926016; Hsu CM, 2002, SHOCK, V17, P280, DOI 10.1097/00024382-200204000-00007; Hur GM, 1999, BIOCHEM BIOPH RES CO, V261, P917, DOI 10.1006/bbrc.1999.1143; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; Jaeschke H, 1998, J Hepatobiliary Pancreat Surg, V5, P402; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jarrar D, 2000, J TRAUMA, V49, P879, DOI 10.1097/00005373-200011000-00015; Jarrar D, 1999, INT J MOL MED, V4, P575; Kan WH, 2008, J APPL PHYSIOL, V105, P1076, DOI 10.1152/japplphysiol.90495.2008; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Lee VG, 2001, SHOCK, V16, P355, DOI 10.1097/00024382-200116050-00006; Lichtman SN, 1999, SEMIN LIVER DIS, V19, P171, DOI 10.1055/s-2007-1007108; MCQUILLAN LP, 1994, AM J PHYSIOL-HEART C, V267, pH1921; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Portella AOV, 2004, TRANSPL P, V36, P846, DOI 10.1016/j.transproceed.2004.03.047; RAPPAPORT AM, 1976, BEITR PATHOL, V157, P215, DOI 10.1016/S0005-8165(76)80083-2; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; SHENKAR R, 1994, AM J RESP CELL MOL, V10, P290, DOI 10.1165/ajrcmb.10.3.8117448; Sobajima Satoshi, 2005, Spine J, V5, P14, DOI 10.1016/j.spinee.2004.05.251; Stephens B, 2008, MOL CANCER THER, V7, P202, DOI 10.1158/1535-7163.MCT-07-0542; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Szabo C, SHOCK; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tasoulis MK, 2009, TOHOKU J EXP MED, V219, P193, DOI 10.1620/tjem.219.193; Wang Y, 1998, SHOCK, V10, P20, DOI 10.1097/00024382-199807000-00004; Wanner GA, 1996, SHOCK, V5, P34, DOI 10.1097/00024382-199601000-00008; Zucker KE, 2006, CLIN EXP IMMUNOL, V143, P458, DOI 10.1111/j.1365-2249.2006.03011.x	51	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32968	10.1371/journal.pone.0032968	http://dx.doi.org/10.1371/journal.pone.0032968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403729	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700126
J	Sardu, C; Cocco, E; Mereu, A; Massa, R; Cuccu, A; Marrosu, MG; Contu, P				Sardu, Claudia; Cocco, Eleonora; Mereu, Alessandra; Massa, Roberta; Cuccu, Alessandro; Marrosu, Maria Giovanna; Contu, Paolo			Population Based Study of 12 Autoimmune Diseases in Sardinia, Italy: Prevalence and Comorbidity	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; MYASTHENIA-GRAVIS; CELIAC-DISEASE; PSORIATIC-ARTHRITIS; SYSTEMIC-SCLEROSIS; DIABETES-MELLITUS; PATIENT DATABASE; EPIDEMIOLOGY; FAMILIES; COUNTY	Background: The limited availability of prevalence data based on a representative sample of the general population, and the limited number of diseases considered in studies about co-morbidity are the critical factors in study of autoimmune diseases. This paper describes the prevalence of 12 autoimmune diseases in a representative sample of the general population in the South of Sardinia, Italy, and tests the hypothesis of an overall association among these diseases. Methods: Data were obtained from 21 GPs. The sample included 25,885 people. Prevalence data were expressed with 95% Poisson C.I. The hypothesis of an overall association between autoimmune diseases was tested by evaluating the co-occurrence within individuals. Results: Prevalence per 100,000 are: 552 rheumatoid arthritis, 124 ulcerative colitis, 15 Crohn's disease, 464 type 1 diabetes, 81 systemic lupus erythematosus, 124 celiac disease, 35 myasthenia gravis, 939 psoriasis/psoriatic arthritis, 35 systemic sclerosis, 224 multiple sclerosis, 31 Sjogren's syndrome, and 2,619 autoimmune thyroiditis. An overall association between autoimmune disorders was highlighted. Conclusions: The comparisons with prevalence reported in current literature do not show outlier values, except possibly for a few diseases like celiac disease and myasthenia gravis. People already affected by a first autoimmune disease have a higher probability of being affected by a second autoimmune disorder. In the present study, the sample size, together with the low overall prevalence of autoimmune diseases in the population, did not allow us to examine which diseases are most frequently associated with other autoimmune diseases. However, this paper makes available an adequate control population for future clinical studies aimed at exploring the co-morbidity of specific pairs of autoimmune diseases.	[Sardu, Claudia; Mereu, Alessandra; Massa, Roberta; Cuccu, Alessandro; Contu, Paolo] Univ Cagliari, Dipartimento Sanita Pubbl, Cagliari, Italy; [Cocco, Eleonora; Marrosu, Maria Giovanna] Univ Cagliari, Dipartimento Sci Cardiovasc & Neurol, Ctr Sclerosi Multipla, Cagliari, Italy	University of Cagliari; University of Cagliari	Sardu, C (corresponding author), Univ Cagliari, Dipartimento Sanita Pubbl, Cagliari, Italy.	cla.sardu@tiscali.it	Contu, Paolo/I-2409-2019; Cocco, Eleonora/G-5064-2012	Cocco, Eleonora/0000-0002-3878-8820; Marrosu, Maria Giovanna/0000-0003-2334-2081; Contu, Paolo/0000-0002-5511-0923; Mereu, Alessandra/0000-0001-7166-9666				Becher H, 2009, INT J CLIN PHARM TH, V47, P617; Chifflot H, 2008, SEMIN ARTHRITIS RHEU, V37, P223, DOI 10.1016/j.semarthrit.2007.05.003; Cocco E, 2011, MULT SCLER J, V17, P1282, DOI 10.1177/1352458511408754; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Dietlein G, 2002, INT J CLIN PHARM TH, V40, P130; Eaton WW, 2007, J AUTOIMMUN, V29, P1, DOI 10.1016/j.jaut.2007.05.002; Eaton WW, 2010, IMMUNOL RES, V47, P228, DOI 10.1007/s12026-009-8153-2; Feldkamp J, 2009, DEUT MED WOCHENSCHR, V134, P2504, DOI 10.1055/s-0029-1243053; Flynn RWV, 2004, J CLIN ENDOCR METAB, V89, P3879, DOI 10.1210/jc.2003-032089; Frongia O, 1997, ACTA DIABETOL, V34, P199, DOI 10.1007/s005920050074; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Kalb B, 2002, NEUROEPIDEMIOLOGY, V21, P221, DOI 10.1159/000065639; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Lakatos Laszlo, 2003, Orv Hetil, V144, P1819; Le Guern V, 2004, RHEUMATOLOGY, V43, P1129, DOI 10.1093/rheumatology/keh253; Marrie RA, 2007, LANCET NEUROL, V6, P575, DOI 10.1016/S1474-4422(07)70157-6; Marrosu MG, 2002, LANCET, V359, P1461, DOI 10.1016/S0140-6736(02)08431-3; Menardo G, 2006, SCAND J GASTROENTERO, V41, P1414, DOI 10.1080/00365520600815605; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Oopik M, 2003, J NEUROL NEUROSUR PS, V74, P1638, DOI 10.1136/jnnp.74.12.1638; Pavlovic-Calic N, 2008, INT J COLORECTAL DIS, V23, P957, DOI 10.1007/s00384-008-0493-1; Poulas K, 2001, J NEUROL NEUROSUR PS, V71, P352, DOI 10.1136/jnnp.71.3.352; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Roka V, 2007, EUR J GASTROEN HEPAT, V19, P982, DOI 10.1097/MEG.0b013e328209ff76; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Shbeeb M, 2000, J RHEUMATOL, V27, P1247; Somers EC, 2006, EPIDEMIOLOGY, V17, P202, DOI 10.1097/01.ede.0000193605.93416.df; Songini Marco, 2010, J Diabetes Sci Technol, V4, P1248; Trontzas PI, 2005, ANN RHEUM DIS, V64, P1240, DOI 10.1136/ard.2004.031021; Waterfield M, 2010, ANN NY ACAD SCI, V1214, P138, DOI 10.1111/j.1749-6632.2010.05818.x; Zivadinov R, 1998, NEUROEPIDEMIOLOGY, V17, P265, DOI 10.1159/000026179	31	111	116	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32487	10.1371/journal.pone.0032487	http://dx.doi.org/10.1371/journal.pone.0032487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396771	gold, Green Published, Green Submitted			2022-12-25	WOS:000303006500022
J	Carlson, SM; Hilborn, R; Hendry, AP; Quinn, TP				Carlson, Stephanie M.; Hilborn, Ray; Hendry, Andrew P.; Quinn, Thomas P.			Predation by Bears Drives Senescence in Natural Populations of Salmon	PLOS ONE			English	Article							REPRODUCTIVE LIFE-SPAN; ADULT SOCKEYE-SALMON; EVOLUTIONARY-THEORIES; ONCORHYNCHUS-NERKA; SEXUAL-DIMORPHISM; BROWN BEARS; MORTALITY; ENERGY; SIZE; SELECTION	Classic evolutionary theory predicts that populations experiencing higher rates of environmentally caused ("extrinsic'') mortality should senesce more rapidly, but this theory usually neglects plausible relationships between an individual's senescent condition and its susceptibility to extrinsic mortality. We tested for the evolutionary importance of this condition dependence by comparing senescence rates among natural populations of sockeye salmon (Oncorhynchus nerka) subject to varying degrees of predation by brown bears (Ursus arctos). We related senescence rates in six populations to (1) the overall rate of extrinsic mortality, and (2) the degree of condition dependence in this mortality. Senescence rates were determined by modeling the mortality of individually-tagged breeding salmon at each site. The overall rate of extrinsic mortality was estimated as the long-term average of the annual percentage of salmon killed by bears. The degree of condition dependence was estimated as the extent to which bears killed salmon that exhibited varying degrees of senescence. We found that the degree of condition dependence in extrinsic mortality was very important in driving senescence: populations where bears selectively killed fish showing advanced senescence were those that senesced least rapidly. The overall rate of extrinsic mortality also contributed to among-population variation in senescence-but to a lesser extent. Condition-dependent susceptibility to extrinsic mortality should be incorporated more often into theoretical models and should be explicitly tested in natural populations.	[Carlson, Stephanie M.; Hilborn, Ray; Quinn, Thomas P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Carlson, Stephanie M.; Hilborn, Ray; Quinn, Thomas P.] Univ Calif Santa Cruz, Fisheries Res Inst, Santa Cruz, CA 95064 USA; [Hendry, Andrew P.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Hendry, Andrew P.] McGill Univ, Dept Biol, Montreal, PQ H3A 2K6, Canada	University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; McGill University; McGill University	Carlson, SM (corresponding author), Univ Calif Santa Cruz, Dept Appl Math & Stat, Jack Baskin Sch Engn, Santa Cruz, CA 95064 USA.	scarlson@soe.ucsc.edu	Hilborn, Ray W/D-6332-2013; Hendry, Andrew/C-5765-2008	Hendry, Andrew/0000-0002-4807-6667; Carlson, Stephanie/0000-0003-3055-6483	National Science Foundation; Gordon and Betty Moore Foundation; Pacific Seafood Processors Association; National Marine Fisheries Service; School of Aquatic and Fishery Sciences; American Fisheries Society's J. Frances Allen Scholarship; H. Mason Keeler Endowment to the School of Aquatic and Fishery Sciences, University of Washington	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Seafood Processors Association; National Marine Fisheries Service; School of Aquatic and Fishery Sciences; American Fisheries Society's J. Frances Allen Scholarship; H. Mason Keeler Endowment to the School of Aquatic and Fishery Sciences, University of Washington(University of Washington)	This research was supported by the National Science Foundation, the Gordon and Betty Moore Foundation, the Pacific Seafood Processors Association, the National Marine Fisheries Service, and the School of Aquatic and Fishery Sciences. SMC received partial support from the American Fisheries Society's J. Frances Allen Scholarship and the H. Mason Keeler Endowment to the School of Aquatic and Fishery Sciences, University of Washington. Aside from providing funds for research, the above funding agencies were not involved with any aspect of this project ( from study design through manuscript preparation).	ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; ALLISON PD, 1995, SURVIVAL ANAL SAS SY; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Baudisch A, 2005, P NATL ACAD SCI USA, V102, P8263, DOI 10.1073/pnas.0502155102; Berg OK, 1995, CAN J ZOOL, V73, P1999, DOI 10.1139/z95-235; BLAIR GR, 1991, CAN J ZOOL, V69, P176, DOI 10.1139/z91-027; Bronikowski AM, 2005, TRENDS ECOL EVOL, V20, P271, DOI 10.1016/j.tree.2005.03.011; Bryant MJ, 2004, AM NAT, V163, P55, DOI 10.1086/380650; Burgner R. L., 1991, PACIFIC SALMON LIFE, P1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carlson SM, 2004, CAN J ZOOL, V82, P1878, DOI 10.1139/Z04-189; Carlson SM, 2007, ECOLOGY, V88, P2620, DOI 10.1890/06-1171.1; Crawley M. J, 2002, STAT COMPUTING INTRO; DRENT RH, 1980, ARDEA, V68, P225; Dudycha JL, 2001, ECOL LETT, V4, P102; Dudycha JL, 1999, EVOLUTION, V53, P1744, DOI 10.1111/j.1558-5646.1999.tb04559.x; Gende SM, 2004, J FRESHWATER ECOL, V19, P149, DOI 10.1080/02705060.2004.9664522; Gende SM, 2004, CAN J ZOOL, V82, P75, DOI 10.1139/Z03-226; Gende SM, 2004, OIKOS, V104, P518, DOI 10.1111/j.0030-1299.2004.12762.x; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hendry AP, 1999, CAN J ZOOL, V77, P1663, DOI 10.1139/cjz-77-11-1663; Hendry AP, 1999, OIKOS, V85, P499, DOI 10.2307/3546699; Hendry AP, 2004, P ROY SOC B-BIOL SCI, V271, P259, DOI 10.1098/rspb.2003.2600; Hilborn R., 1997, MONOGRAPHS POPULATIO, V28; Hodgson S, 2002, CAN J ZOOL, V80, P542, DOI 10.1139/Z02-030; LIN J, 2007, THESIS U WASHINGTON; McPhee MV, 1998, ENVIRON BIOL FISH, V51, P369, DOI 10.1023/A:1007432928783; Medawar P., 1952, UNSOLVED PROBLEM BIO; Morbey YE, 2005, AM NAT, V166, P556, DOI 10.1086/491720; Quinn TP, 1999, OECOLOGIA, V121, P273, DOI 10.1007/s004420050929; Quinn TP, 1998, J FISH BIOL, V52, P1295, DOI 10.1111/j.1095-8649.1998.tb00974.x; Quinn TP, 2001, T AM FISH SOC, V130, P995, DOI 10.1577/1548-8659(2001)130<0995:SASSMO>2.0.CO;2; Quinn TP, 2001, CAN J ZOOL, V79, P1782, DOI 10.1139/cjz-79-10-1782; Quinn TP, 2001, EVOL ECOL RES, V3, P917; Reimchen TE, 2000, CAN J ZOOL, V78, P448, DOI 10.1139/cjz-78-3-448; Reznick D, 2001, EXP GERONTOL, V36, P791, DOI 10.1016/S0531-5565(00)00241-2; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; Ricklefs RE, 2002, J GERONTOL A-BIOL, V57, pB69, DOI 10.1093/gerona/57.2.B69; Ricklefs RE, 2001, EXP GERONTOL, V36, P845, DOI 10.1016/S0531-5565(00)00245-X; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Tatar M, 1997, OECOLOGIA, V111, P357, DOI 10.1007/s004420050246; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2006, TRENDS ECOL EVOL, V21, P458, DOI 10.1016/j.tree.2006.05.008; Williams PD, 2003, EVOLUTION, V57, P1478	44	44	44	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1286	10.1371/journal.pone.0001286	http://dx.doi.org/10.1371/journal.pone.0001286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	22423309	gold, Green Published			2022-12-25	WOS:000207459500005
J	Palorini, R; De Rasmo, D; Gaviraghi, M; Danna, LS; Signorile, A; Cirulli, C; Chiaradonna, F; Alberghina, L; Papa, S				Palorini, R.; De Rasmo, D.; Gaviraghi, M.; Danna, L. Sala; Signorile, A.; Cirulli, C.; Chiaradonna, F.; Alberghina, L.; Papa, S.			Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration	ONCOGENE			English	Article						cancer cell metabolism; oncogenic K-ras; PKA; mitochondrial morphology; mitochondrial activity; glucose deprivation	DEPENDENT PROTEIN-KINASE; ADENYLATE-CYCLASE ACTIVITY; CYCLIC-AMP; COMPLEX-I; REGULATORY SUBUNITS; GENE-EXPRESSION; THYROID-CELLS; HUMAN CANCER; METABOLISM; PHOSPHORYLATION	The Warburg effect in cancer cells has been proposed to involve several mechanisms, including adaptation to hypoxia, oncogenes activation or loss of oncosuppressors and impaired mitochondria! function. In previous papers, it has been shown that K-ras transformed mouse cells are much more sensitive as compared with normal cells to glucose withdrawal (undergoing apoptosis) and present a high glycolytic rate and a strong reduction of mitochondrial complex I. Recent observations suggest that transformed cells have a derangement in the cyclic adenosine nnonophosphate/cAMP-dependent protein kinase (cAMP/PKA) pathway, which is known to regulate several mitochondrial functions. Herein, the derangement of the cAMP/PKA pathway and its impact on transformation-linked changes of mitochondrial functions is investigated. Exogenous stimulation of PKA activity, achieved by forskolin treatment protected K-ras-transformed cells from apoptosis induced by glucose deprivation, enhanced complex I activity, intracellular adenosine triphosphate (ATP) levels, mitochondrial fusion and decreased intracellular reactive oxygen species (ROS) levels. Several of these effects were almost completely prevented by inhibiting the PKA activity. Short-time treatment with compounds favoring mitochondrial fusion strongly decreased the cellular ROS levels especially in transformed cells. These findings support the notion that glucose shortage-induced apoptosis, specific of K-ras-transformed cells, is associated to a derangement of PKA signaling that leads to mitochondrial complex I decrease, reduction of ATP formation, prevalence of mitochondrial fission over fusion, and thereby opening new approaches for development of anticancer drugs. Oncogene (2013) 32, 352-362; doi:10.1038/onc.2012.50; published online 12 March 2012	[Palorini, R.; Gaviraghi, M.; Danna, L. Sala; Cirulli, C.; Chiaradonna, F.; Alberghina, L.] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, MI, Italy; [De Rasmo, D.; Signorile, A.; Papa, S.] Univ Bari, Dept Med Biochem Biol & Phys DIBIFIM, Bari, Italy; [De Rasmo, D.; Papa, S.] CNR, Inst Biomembranes & Bioenerget IBBE, I-70126 Bari, Italy	University of Milano-Bicocca; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR)	Chiaradonna, F (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Piazza Sci 2, I-20126 Milan, MI, Italy.	ferdinando.chiaradonna@unimib.it	Gaviraghi, Marco/AAB-1582-2020; De Rasmo, Domenico/AAC-4672-2020; CHIARADONNA, Ferdinando/K-4959-2016	Gaviraghi, Marco/0000-0003-2791-3638; De Rasmo, Domenico/0000-0002-3917-2411; CHIARADONNA, Ferdinando/0000-0001-8529-2732; Papa, Sergio/0000-0002-4417-1763; Signorile, Anna/0000-0001-9045-891X; Alberghina, Lilia/0000-0003-1694-931X	MIUR (FIRB-ITALBIONET); Italian Government (FAR); MIUR (Progetto FIRB Rete Nazionale per lo Studio della Proteomica Umana-Italian Human ProteomeNet); Progetto Strategico [Ric.002]; Cip [PS 101]; FOR [2000/06]	MIUR (FIRB-ITALBIONET)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Italian Government (FAR); MIUR (Progetto FIRB Rete Nazionale per lo Studio della Proteomica Umana-Italian Human ProteomeNet)(Ministry of Education, Universities and Research (MIUR)); Progetto Strategico; Cip; FOR	This work has been supported by a grant to LA from MIUR (FIRB-ITALBIONET), grants to FC from the Italian Government (FAR) and MIUR (Prin 2008), grant to DDR and CC from MIUR (Progetto FIRB futuro in ricerca, 2008), grants to SP from MIUR (Progetto FIRB Rete Nazionale per lo Studio della Proteomica Umana-Italian Human ProteomeNet, 2009) and Progetto Strategico Ric.002, Cip PS 101, FOR 2000/06.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Alchanati I, 2006, ONCOGENE, V25, P7138, DOI 10.1038/sj.onc.1209708; Balestrieri C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S1; Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006; Baratta MG, 2009, MOL ENDOCRINOL, V23, P838, DOI 10.1210/me.2008-0353; Bellis A, 2009, ARTERIOSCL THROM VAS, V29, P1207, DOI 10.1161/ATVBAHA.109.184135; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Borlikova G, 2009, MOL NEUROBIOL, V40, P73, DOI 10.1007/s12035-009-8072-1; BOS JL, 1989, CANCER RES, V49, P4682; Bossu P, 2000, ONCOGENE, V19, P2147, DOI 10.1038/sj.onc.1203539; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Capaldi RA, 2002, BBA-BIOENERGETICS, V1555, P192, DOI 10.1016/S0005-2728(02)00277-3; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Chiaradonna F, 2012, BIOTECHNOL ADV, V30, P30, DOI 10.1016/j.biotechadv.2011.07.006; Chiaradonna F, 2008, FRONT BIOSCI-LANDMRK, V13, P5257, DOI 10.2741/3079; Chiaradonna F, 2006, BBA-BIOENERGETICS, V1757, P1338, DOI 10.1016/j.bbabio.2006.08.001; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; De Rasmo D, 2011, EUR J PHARMACOL, V652, P15, DOI 10.1016/j.ejphar.2010.11.016; De Rasmo D, 2009, FEBS J, V276, P4325, DOI 10.1111/j.1742-4658.2009.07133.x; Depre C, 1998, J CLIN INVEST, V101, P390, DOI 10.1172/JCI1168; Feliciello A, 1996, J BIOL CHEM, V271, P25350, DOI 10.1074/jbc.271.41.25350; FRANKS DJ, 1987, J CELL BIOCHEM, V33, P87, DOI 10.1002/jcb.240330203; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gaglio D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004715; GALLO A, 1995, CELL GROWTH DIFFER, V6, P91; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Grandemange S, 2009, SEMIN CANCER BIOL, V19, P50, DOI 10.1016/j.semcancer.2008.12.001; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HIRAKI Y, 1989, MOL ENDOCRINOL, V3, P1470, DOI 10.1210/mend-3-9-1470; HOSAKA Y, 1992, ENDOCRINOLOGY, V131, P159, DOI 10.1210/en.131.1.159; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KONISHIIMAMURA L, 1988, BIOCHEM BIOPH RES CO, V153, P1214, DOI 10.1016/S0006-291X(88)81357-3; KONISHIIMAMURA L, 1987, BIOCHEM BIOPH RES CO, V146, P47, DOI 10.1016/0006-291X(87)90688-7; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674; Lenaz G, 2010, BBA-BIOENERGETICS, V1797, P633, DOI 10.1016/j.bbabio.2010.01.025; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Ma WZ, 2007, J BIOENERG BIOMEMBR, V39, P243, DOI 10.1007/s10863-007-9083-0; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; Mazurek S, 2003, ANTICANCER RES, V23, P1149; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; OSAWA H, 1995, DIABETES, V44, P1426, DOI 10.2337/diabetes.44.12.1426; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Papa S, 1996, EUR J BIOCHEM, V240, P461, DOI 10.1111/j.1432-1033.1996.0461h.x; Papa S, 2008, BBA-BIOENERGETICS, V1777, P719, DOI 10.1016/j.bbabio.2008.04.005; Papa S, 2006, IUBMB LIFE, V58, P173, DOI 10.1080/15216540500494516; Piccoli C, 2006, FEBS LETT, V580, P4539, DOI 10.1016/j.febslet.2006.06.085; Plecita-Hlavata L, 2008, BBA-BIOENERGETICS, V1777, P834, DOI 10.1016/j.bbabio.2008.04.002; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Rodenhuis S, 1992, Semin Cancer Biol, V3, P241; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sardanelli AM, 2006, FEBS LETT, V580, P5690, DOI 10.1016/j.febslet.2006.09.020; SCHWOCH G, 1990, BIOCHEM J, V270, P181, DOI 10.1042/bj2700181; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Signorile A, 2002, FEBS LETT, V512, P91, DOI 10.1016/S0014-5793(02)02226-3; Simonnet H, 2003, CARCINOGENESIS, V24, P1461, DOI 10.1093/carcin/bgg109; Tortora G, 2002, ANN NY ACAD SCI, V968, P139, DOI 10.1111/j.1749-6632.2002.tb04332.x; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; YAMAMOTO F, 1984, NUCLEIC ACIDS RES, V12, P8873, DOI 10.1093/nar/12.23.8873; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	72	43	44	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2013	32	3					352	362		10.1038/onc.2012.50	http://dx.doi.org/10.1038/onc.2012.50			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22410778				2022-12-25	WOS:000314736600009
J	Itagaki, K; Naito, T; Iwakiri, R; Haga, M; Miura, S; Saito, Y; Owaki, T; Kamiya, S; Iyoda, T; Yajima, H; Iwashita, S; Ejiri, SI; Fukai, F				Itagaki, Keisuke; Naito, Toshihiko; Iwakiri, Ryota; Haga, Makoto; Miura, Shougo; Saito, Yohei; Owaki, Toshiyuki; Kamiya, Sadahiro; Iyoda, Takuya; Yajima, Hirofumi; Iwashita, Shintaro; Ejiri, Shin-Ichiro; Fukai, Fumio			Eukaryotic Translation Elongation Factor 1A Induces Anoikis by Triggering Cell Detachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR TU; EXTRACELLULAR-MATRIX; ANTIADHESIVE SITE; PLASMA-MEMBRANE; FIBRONECTIN; IDENTIFICATION; PEPTIDE; PROTEINS; SURVIVAL; DEPRIVATION	Anoikis, apoptosis because of loss of cell anchorage, is crucial for tissue homeostasis. Fibronectin not only provides a scaffold for cell anchorage but also harbors a cryptic antiadhesive site capable of inducing beta 1-integrin inactivation. In this study, this cryptic antiadhesive site is implicated in spontaneous induction of anoikis. Nontransformed fibroblasts (NIH3T3) adhering to a fibronectin substratum underwent anoikis during serum starvation culture. This anoikis was caused by proteolytic exposure of the cryptic antiadhesive site in fibronectin by matrix metalloproteinase. Eukaryotic elongation factor 1A (eEF1A) was identified as a membrane receptor for the exposed antiadhesive site. Serum starvation raised the membrane residence of eEF1A, and siRNA-based disruption of this increase rendered cells anoikis-resistant. By contrast, cells became more susceptible to anoikis in parallel with increased membrane residence of eEF1A by enforced expression. These results demonstrate that eEF1A acts as a membrane receptor for the cryptic antiadhesive site of fibronectin, which contributes to cell regulation, including anoikis, through negative regulation of cell anchorage.	[Fukai, Fumio] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, Noda, Chiba 2788510, Japan; [Yajima, Hirofumi] Tokyo Univ Sci, Dept Appl Chem, Noda, Chiba 2788510, Japan; [Kamiya, Sadahiro] Josai Int Univ, Fac Pharmaceut Sci, Dept Drug Informat, Togane, Chiba 2838555, Japan; [Iwashita, Shintaro; Ejiri, Shin-Ichiro] Iwaki Meisei Univ, Fac Pharm, Iwaki, Fukushima 9708551, Japan	Tokyo University of Science; Tokyo University of Science; Iwaki Meisei University	Fukai, F (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	fukai@rs.noda.tus.ac.jp		Iwashita, Shintaro/0000-0001-8086-9192	Vehicle Racing Commemorative Foundation	Vehicle Racing Commemorative Foundation	This work was supported in part by the Vehicle Racing Commemorative Foundation.	Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Baqui M, 2003, J BIOL CHEM, V278, P1206, DOI 10.1074/jbc.M210266200; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bialik S, 1999, CIRC RES, V85, P403, DOI 10.1161/01.RES.85.5.403; Bonavita F, 2003, FEBS LETT, V536, P85, DOI 10.1016/S0014-5793(03)00029-2; BRANDS JHGM, 1986, EUR J BIOCHEM, V155, P167, DOI 10.1111/j.1432-1033.1986.tb09472.x; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chan JR, 2001, J EXP MED, V193, P1149, DOI 10.1084/jem.193.10.1149; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Erickson HP, 2002, J MUSCLE RES CELL M, V23, P575, DOI 10.1023/A:1023427026818; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fukai F, 1996, BIOCHEM BIOPH RES CO, V220, P394, DOI 10.1006/bbrc.1996.0416; Fukai F, 1997, J BIOCHEM-TOKYO, V121, P189; Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; JACOBSON GR, 1976, NATURE, V261, P23, DOI 10.1038/261023a0; Kamiya SL, 2002, BIOCHEMISTRY-US, V41, P3270, DOI 10.1021/bi015660a; Kato R, 2002, CLIN CANCER RES, V8, P2455; Kato R, 2001, EXP CELL RES, V265, P54, DOI 10.1006/excr.2001.5179; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kinzy TG, 2000, COLD SPRING HARBOR M, V39, P973; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4; Miura S, 2007, BIOL PHARM BULL, V30, P891, DOI 10.1248/bpb.30.891; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Peason J. P., 2005, COLONIZATION MUCOSAL, P3; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Sabarth N, 2002, J BIOL CHEM, V277, P27896, DOI 10.1074/jbc.M204473200; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Watanabe K, 2000, BIOCHEMISTRY-US, V39, P7138, DOI 10.1021/bi992670r; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	47	16	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16037	16046		10.1074/jbc.M111.308122	http://dx.doi.org/10.1074/jbc.M111.308122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22399298	hybrid, Green Published			2022-12-25	WOS:000304006300081
J	Matsui, H; Yokoyama, T; Sekiguchi, K; Iijima, D; Sunaga, H; Maniwa, M; Ueno, M; Iso, T; Arai, M; Kurabayashi, M				Matsui, Hiroki; Yokoyama, Tomoyuki; Sekiguchi, Kenichi; Iijima, Daisuke; Sunaga, Hiroaki; Maniwa, Moeno; Ueno, Manabu; Iso, Tatsuya; Arai, Masashi; Kurabayashi, Masahiko			Stearoyl-CoA Desaturase-1 (SCD1) Augments Saturated Fatty Acid-Induced Lipid Accumulation and Inhibits Apoptosis in Cardiac Myocytes	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; ANGIOTENSIN-II; MICE; EXPRESSION; DISRUPTION; OXIDATION; PROTECTS; GENE; DIET	Mismatch between the uptake and utilization of long-chain fatty acids in the myocardium leads to abnormally high intracellular fatty acid concentration, which ultimately induces myocardial dysfunction. Stearoyl-Coenzyme A desaturase-1 (SCD1) is a rate-limiting enzyme that converts saturated fatty acids (SFAs) to monounsaturated fatty acids. Previous studies have shown that SCD1-deficinent mice are protected from insulin resistance and diet-induced obesity; however, the role of SCD1 in the heart remains to be determined. We examined the expression of SCD1 in obese rat hearts induced by a sucrose-rich diet for 3 months. We also examined the effect of SCD1 on myocardial energy metabolism and apoptotic cell death in neonatal rat cardiac myocytes in the presence of SFAs. Here we showed that the expression of SCD1 increases 3.6-fold without measurable change in the expression of lipogenic genes in the heart of rats fed a high-sucrose diet. Forced SCD1 expression augmented palmitic acid-induced lipid accumulation, but attenuated excess fatty acid oxidation and restored reduced glucose oxidation. Of importance, SCD1 substantially inhibited SFA-induced caspase 3 activation, ceramide synthesis, diacylglycerol synthesis, apoptotic cell death, and mitochondrial reactive oxygen species (ROS) generation. Experiments using SCD1 siRNA confirmed these observations. Furthermore, we showed that exposure of cardiac myocytes to glucose and insulin induced SCD1 expression. Our results indicate that SCD1 is highly regulated by a metabolic syndrome component in the heart, and such induction of SCD1 serves to alleviate SFA-induced adverse fatty acid catabolism, and eventually to prevent SFAs-induced apoptosis.	[Matsui, Hiroki; Sekiguchi, Kenichi; Ueno, Manabu; Iso, Tatsuya; Arai, Masashi; Kurabayashi, Masahiko] Gunma Univ, Dept Med & Biol Sci, Grad Sch Med, Maebashi, Gunma 371, Japan; [Matsui, Hiroki; Yokoyama, Tomoyuki; Iijima, Daisuke; Sunaga, Hiroaki; Maniwa, Moeno] Gunma Univ, Dept Lab Sci, Grad Sch Hlth Sci, Maebashi, Gunma 371, Japan	Gunma University; Gunma University	Matsui, H (corresponding author), Gunma Univ, Dept Med & Biol Sci, Grad Sch Med, Showa Machi, Maebashi, Gunma 371, Japan.	tyokoyama@gunma-u.ac.jp	Matsui, Hiroki/P-4033-2019	Matsui, Hiroki/0000-0003-3243-333X; Iso, Tatsuya/0000-0001-5045-1676	Japan Society for the Promotion of Science; Japan Cardiovascular Foundation; Foundation for Ikiiki Health Promotion; Grants-in-Aid for Scientific Research [23590661] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Cardiovascular Foundation; Foundation for Ikiiki Health Promotion; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to HM, TY and MK), a grant from the Japan Cardiovascular Foundation (to MK), and a grant from the Foundation for Ikiiki Health Promotion (to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Dobrzyn P, 2008, AM J PHYSIOL-ENDOC M, V294, pE357, DOI 10.1152/ajpendo.00471.2007; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hellemans KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007266; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu XQ, 2010, ARTERIOSCL THROM VAS, V30, P31, DOI 10.1161/ATVBAHA.109.195636; Lopaschuk GD, 2007, CIRC RES, V101, P335, DOI 10.1161/CIRCRESAHA.107.150417; Lopaschuk Gary D, 2002, Heart Fail Rev, V7, P149; MacDonald MLE, 2009, ARTERIOSCL THROM VAS, V29, P341, DOI 10.1161/ATVBAHA.108.181099; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Miyazaki M, 2001, J LIPID RES, V42, P1018; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; RANDLE PJ, 1963, LANCET, V1, P785; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Sekiguchi K, 2007, AM J PHYSIOL-HEART C, V292, pH1443, DOI 10.1152/ajpheart.01056.2006; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Umeda M, 2003, HYPERTENS RES, V26, P485, DOI 10.1291/hypres.26.485; Yokoyama T, 1999, AM J PHYSIOL-HEART C, V276, pH1968, DOI 10.1152/ajpheart.1999.276.6.H1968	38	58	62	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33283	10.1371/journal.pone.0033283	http://dx.doi.org/10.1371/journal.pone.0033283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413010	Green Submitted, gold, Green Published			2022-12-25	WOS:000303062000041
J	Milnthorpe, AT; Soloviev, M				Milnthorpe, Andrew T.; Soloviev, Mikhail			The Use of EST Expression Matrixes for the Quality Control of Gene Expression Data	PLOS ONE			English	Article							NORMALIZED CDNA LIBRARY; TISSUE EXPRESSION; IDENTIFICATION; CANCER; SUBTRACTION; DISCOVERY; PROFILES; HYBRIDIZATION; CONSTRUCTION; SPECIFICITY	EST expression profiling provides an attractive tool for studying differential gene expression, but cDNA libraries' origins and EST data quality are not always known or reported. Libraries may originate from pooled or mixed tissues; EST clustering, EST counts, library annotations and analysis algorithms may contain errors. Traditional data analysis methods, including research into tissue-specific gene expression, assume EST counts to be correct and libraries to be correctly annotated, which is not always the case. Therefore, a method capable of assessing the quality of expression data based on that data alone would be invaluable for assessing the quality of EST data and determining their suitability for mRNA expression analysis. Here we report an approach to the selection of a small generic subset of 244 UniGene clusters suitable for identification of the tissue of origin for EST libraries and quality control of the expression data using EST expression information alone. We created a small expression matrix of UniGene IDs using two rounds of selection followed by two rounds of optimisation. Our selection procedures differ from traditional approaches to finding "tissue-specific'' genes and our matrix yields consistency high positive correlation values for libraries with confirmed tissues of origin and can be applied for tissue typing and quality control of libraries as small as just a few hundred total ESTs. Furthermore, we can pick up tissue correlations between related tissues e. g. brain and peripheral nervous tissue, heart and muscle tissues and identify tissue origins for a few libraries of uncharacterised tissue identity. It was possible to confirm tissue identity for some libraries which have been derived from cancer tissues or have been normalised. Tissue matching is affected strongly by cancer progression or library normalisation and our approach may potentially be applied for elucidating the stage of normalisation in normalised libraries or for cancer staging.	[Milnthorpe, Andrew T.; Soloviev, Mikhail] Royal Holloway Univ London, Sch Biol Sci, CBMS, Egham, Surrey, England	University of London; Royal Holloway University London	Milnthorpe, AT (corresponding author), Royal Holloway Univ London, Sch Biol Sci, CBMS, Egham, Surrey, England.	Mikhail.Soloviev@rhul.ac.uk		Soloviev, Mikhail/0000-0002-3235-1134				Allan L, 2010, PRENATAL DIAG, V30, P639, DOI 10.1002/pd.2540; Arhondakis S, 2006, FEBS LETT, V580, P5772, DOI 10.1016/j.febslet.2006.09.034; Baron D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-113; Bidon N, 2001, GENE, V274, P253, DOI 10.1016/S0378-1119(01)00598-4; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Brakus SM, 2010, EUR J ORAL SCI, V118, P537, DOI 10.1111/j.1600-0722.2010.00777.x; Brown AC, 2004, GENOMICS, V83, P528, DOI 10.1016/j.ygeno.2003.09.012; Clegg N, 2004, PROSTATE, V60, P227, DOI 10.1002/pros.20055; De Young MP, 2002, IN VIVO, V16, P239; Elfilali A, 2006, NUCLEIC ACIDS RES, V34, pD613, DOI 10.1093/nar/gkj022; Hu RM, 2000, P NATL ACAD SCI USA, V97, P9543, DOI 10.1073/pnas.160270997; Huang Zhi Gang, 2006, Chin J Dig Dis, V7, P97, DOI 10.1111/j.1443-9573.2006.00254.x; Huminiecki L, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-31; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Kawamoto S, 1996, GENE, V174, P151, DOI 10.1016/0378-1119(96)00512-4; Kogenaru S, 2010, THEOR CHEM ACC, V125, P651, DOI 10.1007/s00214-009-0670-5; Krief S, 1999, J BIOL CHEM, V274, P36592, DOI 10.1074/jbc.274.51.36592; Kuska B, 1996, J NATL CANCER I, V88, P1801, DOI 10.1093/jnci/88.24.1801; Leyritz J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-378; Li QA, 2011, MOL BIOL REP, V38, P2597, DOI 10.1007/s11033-010-0400-z; Liang S, 2006, PHYSIOL GENOMICS, V26, P158, DOI 10.1152/physiolgenomics.00313.2005; Liu DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-77; Marzioni D, 2004, DEV DYNAM, V231, P839, DOI 10.1002/dvdy.20178; Meng Ling-xin, 2007, Zhonghua Wei Chang Wai Ke Za Zhi, V10, P169; Milnthorpe AT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-97; Miner D, 2003, PRENATAL DIAG, V23, P410, DOI 10.1002/pd.608; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; Pao SY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-86; Park YR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S40; Ray A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-22; Russ J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-305; SASAKI YF, 1994, NUCLEIC ACIDS RES, V22, P987, DOI 10.1093/nar/22.6.987; Schlamp K, 2008, GENE, V427, P47, DOI 10.1016/j.gene.2008.08.026; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Skrabanek L, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.21.e102; Soares Marcelo Bento, 2009, V533, P109, DOI 10.1007/978-1-60327-136-3_6; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Song J, 2003, BIOTEACH J, V1, P99; Strausberg R. L., 2002, Pharmacogenomics Journal, V2, P156, DOI 10.1038/sj.tpj.6500103; Strausberg RL, 2001, TRENDS CELL BIOL, V11, pS66, DOI 10.1016/S0962-8924(01)82370-9; Susko E, 2004, BIOINFORMATICS, V20, P2279, DOI 10.1093/bioinformatics/bth239; TANAKA O, 1995, ANAT REC, V241, P417, DOI 10.1002/ar.1092410317; Vaes BLT, 2002, J BONE MINER RES, V17, P2106, DOI 10.1359/jbmr.2002.17.12.2106; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Yousef GM, 2004, BRIT J CANCER, V90, P167, DOI 10.1038/sj.bjc.6601451; Zhang Y, 2004, BIOINFORMATICS, V20, P2390, DOI 10.1093/bioinformatics/bth256	46	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32966	10.1371/journal.pone.0032966	http://dx.doi.org/10.1371/journal.pone.0032966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412959	Green Published, gold			2022-12-25	WOS:000303062000023
J	Castaneda, TR; Abplanalp, W; Um, SH; Pfluger, PT; Schrott, B; Brown, K; Grant, E; Carnevalli, L; Benoit, SC; Morgan, DA; Gilham, D; Hui, DY; Rahmouni, K; Thomas, G; Kozma, SC; Clegg, DJ; Tschop, MH				Castaneda, Tamara R.; Abplanalp, William; Um, Sung Hee; Pfluger, Paul T.; Schrott, Brigitte; Brown, Kimberly; Grant, Erin; Carnevalli, Larissa; Benoit, Stephen C.; Morgan, Donald A.; Gilham, Dean; Hui, David Y.; Rahmouni, Kamal; Thomas, George; Kozma, Sara C.; Clegg, Deborah J.; Tschoep, Matthias H.			Metabolic Control by S6 Kinases Depends on Dietary Lipids	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; INSULIN-RESISTANCE; SKELETAL-MUSCLE; MAMMALIAN TARGET; AMINO-ACID; RAPAMYCIN; MICE; ACTIVATION; PATHWAY; RAPTOR	Targeted deletion of S6 kinase (S6K) 1 in mice leads to higher energy expenditure and improved glucose metabolism. However, the molecular mechanisms controlling these effects remain to be fully elucidated. Here, we analyze the potential role of dietary lipids in regulating the mTORC1/S6K system. Analysis of S6K phosphorylation in vivo and in vitro showed that dietary lipids activate S6K, and this effect is not dependent upon amino acids. Comparison of male mice lacking S6K1 and 2 (S6K-dko) with wt controls showed that S6K-dko mice are protected against obesity and glucose intolerance induced by a high-fat diet. S6K-dko mice fed a high-fat diet had increased energy expenditure, improved glucose tolerance, lower fat mass gain, and changes in markers of lipid metabolism. Importantly, however, these metabolic phenotypes were dependent upon dietary lipids, with no such effects observed in S6K-dko mice fed a fat-free diet. These changes appear to be mediated via modulation of cellular metabolism in skeletal muscle, as shown by the expression of genes involved in energy metabolism. Taken together, our results suggest that the metabolic functions of S6K in vivo play a key role as a molecular interface connecting dietary lipids to the endogenous control of energy metabolism.	[Castaneda, Tamara R.] German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany; [Abplanalp, William; Schrott, Brigitte; Brown, Kimberly; Grant, Erin; Benoit, Stephen C.] Univ Cincinnati, Coll Med, Dept Med, Metab Dis Inst,Div Endocrinol, Cincinnati, OH USA; [Um, Sung Hee; Thomas, George; Kozma, Sara C.] Univ Cincinnati, Metab Dis Inst, Dept Mol Oncogenesis, Cincinnati, OH USA; [Um, Sung Hee] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Seoul, South Korea; [Pfluger, Paul T.; Tschoep, Matthias H.] Environm Hlth GmbH, German Res Ctr, HelmholtzZentrum Munchen, Neuherberg, Germany; [Carnevalli, Larissa] German Canc Res Ctr, Germany Div Stem Cells & Canc, Heidelberg Inst Stem Cell Technol & Expt Med HI S, Heidelberg, Germany; [Morgan, Donald A.; Rahmouni, Kamal] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Gilham, Dean] Resverlogix Corp TSX RVX, Nw Calgary, AB, Canada; [Hui, David Y.] Univ Cincinnati, Dept Pathol, Metab Dis Inst, Ctr Arteriosclerosis Studies, Cincinnati, OH USA; [Clegg, Deborah J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	Deutsches Diabetes-Zentrum (DDZ); University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Sungkyunkwan University (SKKU); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); University of Iowa; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas	Castaneda, TR (corresponding author), German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany.	matthias.tschoep@helmholtz-muenchen.de	Rahmouni, Kamal/Y-1788-2019; Morgan, Donald A/L-6907-2013; Tschoep, Matthias H/I-5443-2014; Pfluger, Paul T/A-3770-2019; Thomas, George/K-9235-2014	Morgan, Donald A/0000-0003-3167-1643; Pfluger, Paul T/0000-0002-8118-7588; Thomas, George/0000-0003-3518-8149; Rahmouni, Kamal/0000-0001-5136-6748; Tschoep, Matthias/0000-0002-4744-371X; Carnevalli, Larissa/0000-0001-7432-0195	National Institutes of Health [DK73802, DK078019, DK077975, DK056863]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078019, P01DK056863, R01DK073802, R01DK077975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK73802 and DK078019 to GT and DK077975 and DK056863 to MHT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Carnevalli LS, 2010, DEV CELL, V18, P763, DOI 10.1016/j.devcel.2010.02.018; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Ono H, 2008, J CLIN INVEST, V118, P2959, DOI 10.1172/JCI34277; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Villanueva EC, 2009, ENDOCRINOLOGY, V150, P4541, DOI 10.1210/en.2009-0642; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006	28	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32631	10.1371/journal.pone.0032631	http://dx.doi.org/10.1371/journal.pone.0032631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412899	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800036
J	Dudziec, E; Gogol-Doring, A; Cookson, V; Chen, W; Catto, J				Dudziec, Ewa; Gogol-Doering, Andreas; Cookson, Victoria; Chen, Wei; Catto, James			Integrated Epigenome Profiling of Repressive Histone Modifications, DNA Methylation and Gene Expression in Normal and Malignant Urothelial Cells	PLOS ONE			English	Article							PROMOTER HYPERMETHYLATION; BLADDER; PROGRESSION; PROLIFERATION; SUPPRESSOR; CANDIDATE; CARCINOMA; CHROMATIN; PATTERNS; CANCER	Epigenetic regulation of gene expression is commonly altered in human cancer. We have observed alterations of DNA methylation and microRNA expression that reflect the biology of bladder cancer. This common disease arises by distinct pathways with low and high-grade differentiation. We hypothesized that epigenetic gene regulation reflects an interaction between histone and DNA modifications, and differences between normal and malignant urothelial cells represent carcinogenic events within bladder cancer. To test this we profiled two repressive histone modifications (H3K9m3 and H3K27m3) using ChIP-Seq, cytosine methylation using MeDIP and mRNA expression in normal and malignant urothelial cell lines. In genes with low expression we identified H3K27m3 and DNA methylation each in 20-30% of genes and both marks in 5% of genes. H3K9m3 was detected in 5-10% of genes but was not associated with overall expression. DNA methylation was more closely related to gene expression in malignant than normal cells. H3K27m3 was the epigenetic mark most specifically correlated to gene silencing. Our data suggest that urothelial carcinogenesis is accompanied by a loss of control of both DNA methylation and H3k27 methylation. From our observations we identified a panel of genes with cancer specific-epigenetic mediated aberrant expression including those with reported carcinogenic functions and members potentially mediating a positive epigenetic feedback loop. Pathway enrichment analysis revealed genes marked by H3K9m3 were involved with cell homeostasis, those marked by H3K27m3 mediated pro-carcinogenic processes and those marked with cytosine methylation were mixed in function. In 150 normal and malignant urothelial samples, our gene panel correctly estimated expression in 65% of its members. Hierarchical clustering revealed that this gene panel stratified samples according to the presence and phenotype of bladder cancer.	[Dudziec, Ewa; Catto, James] Univ Sheffield, Inst Canc Studies, Sheffield, S Yorkshire, England; [Dudziec, Ewa; Catto, James] Univ Sheffield, Acad Urol Unit, Sheffield, S Yorkshire, England; [Gogol-Doering, Andreas; Chen, Wei] Max Delbruck Ctr Mol Med, Berlin, Germany	University of Sheffield; University of Sheffield; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Dudziec, E (corresponding author), Univ Sheffield, Inst Canc Studies, Sheffield, S Yorkshire, England.	j.catto@sheffield.ac.uk	Chen, Wei/C-1273-2011	Chen, Wei/0000-0003-3263-1627; catto, james/0000-0003-2787-8828	Yorkshire Cancer Research, Sheffield Hospitals Charitable Trust; European Union (European Community) [FP7/2007-2013, HEALTH-F2-2007-201438]	Yorkshire Cancer Research, Sheffield Hospitals Charitable Trust; European Union (European Community)(European Commission)	This work was supported by a GSK Clinician Scientist fellowship to JC and project grants to JC from Yorkshire Cancer Research, Sheffield Hospitals Charitable Trust and from the European Union (European Community's Seventh Framework Programme. Grant Numbers: FP7/2007-2013, HEALTH-F2-2007-201438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamidi C, 2011, GENOME RES, V21, P1193, DOI 10.1101/gr.113779.110; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Catto JWF, 2003, ONCOGENE, V22, P8699, DOI 10.1038/sj.onc.1206964; Catto JWF, 2005, J CLIN ONCOL, V23, P2903, DOI 10.1200/JCO.2005.03.163; Dhawan D, 2006, J PATHOL, V209, P336, DOI 10.1002/path.1991; Dudziec E, 2011, CLIN CANCER RES, V17, P1287, DOI 10.1158/1078-0432.CCR-10-2017; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Gould JJ, 2010, J UROLOGY, V183, P2395, DOI 10.1016/j.juro.2010.02.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ishii H, 1999, P NATL ACAD SCI USA, V96, P3928, DOI 10.1073/pnas.96.7.3928; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Knowles MA, 2005, CANCER LETT, V225, P121, DOI 10.1016/j.canlet.2004.10.047; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Rush M, 2009, EPIGENETICS-US, V4, P300; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; SOUTHGATE J, 1994, LAB INVEST, V71, P583; TANAKA M, 1995, CANCER RES, V55, P3228; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; van Oers JMM, 2009, EUR UROL, V55, P650, DOI 10.1016/j.eururo.2008.06.013; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yates DR, 2007, CLIN CANCER RES, V13, P2046, DOI 10.1158/1078-0432.CCR-06-2476	36	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32750	10.1371/journal.pone.0032750	http://dx.doi.org/10.1371/journal.pone.0032750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412920	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000303060800049
J	Ngamskulrungroj, P; Chang, Y; Hansen, B; Bugge, C; Fischer, E; Kwon-Chung, KJ				Ngamskulrungroj, Popchai; Chang, Yun; Hansen, Bryan; Bugge, Cliff; Fischer, Elizabeth; Kwon-Chung, Kyung J.			Characterization of the Chromosome 4 Genes That Affect Fluconazole-Induced Disomy Formation in Cryptococcus neoformans	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; AMINO-ACID SUBSTITUTIONS; AZOLE ANTIFUNGAL AGENTS; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; DRUG-RESISTANCE; RETROGRADE TRANSPORT; NUCLEAR-ENVELOPE; YEAST; IDENTIFICATION	Heteroresistance in Cryptococcus neoformans is an intrinsic adaptive resistance to azoles and the heteroresistant phenotype is associated with disomic chromosomes. Two chromosome 1 (Chr1) genes, ERG11, the fluconazole target, and AFR1, a drug transporter, were reported as major factors in the emergence of Chr1 disomy. In the present study, we show Chr4 to be the second most frequently formed disomy at high concentrations of fluconazole (FLC) and characterize the importance of resident genes contributing to disomy formation. We deleted nine Chr4 genes presumed to have functions in ergosterol biosynthesis, membrane composition/integrity or drug transportation that could influence Chr4 disomy under FLC stress. Of these nine, disruption of three genes homologous to Sey1 (a GTPase), Glo3 and Gcs2 (the ADP-ribosylation factor GTPase activating proteins) significantly reduced the frequency of Chr4 disomy in heteroresistant clones. Furthermore, FLC resistant clones derived from sey1 Delta glo3 Delta did not show disomy of either Chr4 or Chr1 but instead had increased the copy number of the genes proximal to ERG11 locus on Chr1. Since the three genes are critical for the integrity of endoplasmic reticulum (ER) in Saccharomyces cerevisiae, we used Sec61 beta-GFP fusion as a marker to study the ER in the mutants. The cytoplasmic ER was found to be elongated in sey1D but without any discernable alteration in gcs2 Delta and glo3 Delta under fluorescence microscopy. The aberrant ER morphology of all three mutant strains, however, was discernable by transmission electron microscopy. A 3D reconstruction using Focused Ion Beam Scanning Electron Microscopy (FIB-SEM) revealed considerably reduced reticulation in the ER of glo3 Delta and gcs2 Delta strains. In sey1 Delta, ER reticulation was barely detectable and cisternae were expanded extensively compared to the wild type strains. These data suggest that the genes required for maintenance of ER integrity are important for the formation of disomic chromosomes in C. neoformans under azole stress.	[Ngamskulrungroj, Popchai; Chang, Yun; Kwon-Chung, Kyung J.] NIAID, Mol Microbiol Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Ngamskulrungroj, Popchai] Mahidol Univ, Dept Microbiol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Hansen, Bryan; Fischer, Elizabeth] NIAID, Electron Microscopy Unit, Rocky Mt Labs, NIH, Hamilton, MT USA; [Bugge, Cliff] FEI Co, Hillsboro, OR USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Thermo Fisher Scientific; FEI Company	Ngamskulrungroj, P (corresponding author), NIAID, Mol Microbiol Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	june_kwon-chung@nih.gov	Ngamskulrungroj, Popchai/N-8545-2019; Ngamskulrungroj, Popchai/ABE-7699-2021	Ngamskulrungroj, Popchai/0000-0001-5162-5498; 	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001042, ZICAI001052] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was primarily supported by funds from the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; BARD M, 1993, LIPIDS, V28, P963, DOI 10.1007/BF02537115; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Brands A, 2002, PLANT PHYSIOL, V130, P1121, DOI 10.1104/pp.007716; Brion LP, 2007, J INFECTION, V54, P521, DOI 10.1016/j.jinf.2006.11.017; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Chen LM, 2010, J INT MED RES, V38, P536, DOI 10.1177/147323001003800216; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Favre B, 1999, MICROBIOL-SGM, V145, P2715, DOI 10.1099/00221287-145-10-2715; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Gonzalez Y, 2009, J CELL SCI, V122, P2464, DOI 10.1242/jcs.049999; Gupta V, 1998, CURR GENET, V34, P192, DOI 10.1007/s002940050385; Havel VE, 2011, EUKARYOT CELL, V10, P895, DOI 10.1128/EC.00006-11; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Hua ZL, 2003, MOL BIOL CELL, V14, P4971, DOI 10.1091/mbc.E03-07-0463; Kwon-Chung KJ, 2000, MED MYCOL, V38, P205, DOI 10.1080/mmy.38.s1.205.213; KWONCHUNG JK, 1992, MED MYCOL, P397; Lengeler KB, 2000, P NATL ACAD SCI USA, V97, P14455, DOI 10.1073/pnas.97.26.14455; Lettner T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011993; Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.e04-04-0316; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Martinez M, 2002, J ANTIMICROB CHEMOTH, V49, P515, DOI 10.1093/jac/49.3.515; Mondon P, 1999, ANTIMICROB AGENTS CH, V43, P1856, DOI 10.1128/AAC.43.8.1856; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Perea S, 2001, ANTIMICROB AGENTS CH, V45, P2676, DOI 10.1128/AAC.45.10.2676-2684.2001; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; PIDOUX AL, 1993, J CELL SCI, V105, P1115; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Posteraro B, 2003, MOL MICROBIOL, V47, P357, DOI 10.1046/j.1365-2958.2003.03281.x; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Rodero L, 2003, ANTIMICROB AGENTS CH, V47, P3653, DOI 10.1128/AAC.47.11.3653-3656.2003; Saidane S, 2006, MOL MICROBIOL, V60, P1546, DOI 10.1111/j.1365-2958.2006.05196.x; Sanglard D, 1997, MICROBIOL-UK, V143, P405, DOI 10.1099/00221287-143-2-405; Schindler C, 2009, TRAFFIC, V10, P1362, DOI 10.1111/j.1600-0854.2009.00952.x; Schmitt HD, 2010, TRENDS CELL BIOL, V20, P257, DOI 10.1016/j.tcb.2010.02.001; Schulz TA, 2007, BBA-MOL CELL BIOL L, V1771, P769, DOI 10.1016/j.bbalip.2007.03.003; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Sionov E, 2009, ANTIMICROB AGENTS CH, V53, P2804, DOI 10.1128/AAC.00295-09; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Varma A, 2010, ANTIMICROB AGENTS CH, V54, P2303, DOI 10.1128/AAC.00153-10; Wang H, 2005, MOL BIOL CELL, V16, P4202, DOI 10.1091/mbc.E05-05-0472; WASHTON H, 1989, DIAGN MICR INFEC DIS, V12, pS229; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701; Zhang S, 2011, J BIOL CHEM	62	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33022	10.1371/journal.pone.0033022	http://dx.doi.org/10.1371/journal.pone.0033022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412978	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800078
J	Vanhaecke, D; de Leaniz, CG; Gajardo, G; Young, K; Sanzana, J; Orellana, G; Fowler, D; Howes, P; Monzon-Arguello, C; Consuegra, S				Vanhaecke, Delphine; de Leaniz, Carlos Garcia; Gajardo, Gonzalo; Young, Kyle; Sanzana, Jose; Orellana, Gabriel; Fowler, Daniel; Howes, Paul; Monzon-Arguello, Catalina; Consuegra, Sofia			DNA Barcoding and Microsatellites Help Species Delimitation and Hybrid Identification in Endangered Galaxiid Fishes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; NATURAL HYBRIDIZATION; GENETIC-EVIDENCE; BROWN TROUT; POPULATION; DIVERSITY; SOUTH; INTROGRESSION; SALMONIDS; EVOLUTION	The conservation of data deficient species is often hampered by inaccurate species delimitation. The galaxiid fishes Aplochiton zebra and Aplochiton taeniatus are endemic to Patagonia (and for A. zebra the Falkland Islands), where they are threatened by invasive salmonids. Conservation of Aplochiton is complicated because species identification is hampered by the presence of resident as well as migratory ecotypes that may confound morphological discrimination. We used DNA barcoding (COI, cytochrome b) and a new developed set of microsatellite markers to investigate the relationships between A. zebra and A. taeniatus and to assess their distributions and relative abundances in Chilean Patagonia and the Falkland Islands. Results from both DNA markers were 100% congruent and revealed that phenotypic misidentification was widespread, size-dependent, and highly asymmetric. While all the genetically classified A. zebra were correctly identified as such, 74% of A. taeniatus were incorrectly identified as A. zebra, the former species being more widespread than previously thought. Our results reveal, for the first time, the presence in sympatry of both species, not only in Chilean Patagonia, but also in the Falkland Islands, where A. taeniatus had not been previously described. We also found evidence of asymmetric hybridisation between female A. taeniatus and male A. zebra in areas where invasive salmonids have become widespread. Given the potential consequences that species misidentification and hybridisation can have for the conservation of these endangered species, we advocate the use of molecular markers in order to reduce epistemic uncertainty.	[Vanhaecke, Delphine; Monzon-Arguello, Catalina; Consuegra, Sofia] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [de Leaniz, Carlos Garcia; Howes, Paul; Monzon-Arguello, Catalina] Swansea Univ, Coll Sci, Dept Biosci, Swansea, W Glam, Wales; [Gajardo, Gonzalo; Young, Kyle; Sanzana, Jose; Orellana, Gabriel] Univ Los Lagos, Lab Genet Acuicultura & Biodiversidad, Osorno, Chile	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Swansea University; Universidad de Los Lagos	Vanhaecke, D (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	skc@aber.ac.uk	Consuegra, Sofia/G-1788-2010; Vanhaecke, Delphine/AFK-2576-2022; G., Gonzalo Gajardo/H-6104-2019; Gajardo, Gonzalo/AAN-3507-2020; de Leaniz, Carlos Garcia/AAQ-4171-2020	Consuegra, Sofia/0000-0003-4403-2509; Gajardo, Gonzalo/0000-0001-8634-141X; de Leaniz, Carlos Garcia/0000-0003-1650-2729	DEFRA Darwin Initiative [162/15/020]; Darwin post-project award 'Protecting galaxiids from salmonid invasions in Chile and the Falklands' [EIDPO-041]; University of Los Lagos (Chile); Falkland Islands Development Corporation	DEFRA Darwin Initiative; Darwin post-project award 'Protecting galaxiids from salmonid invasions in Chile and the Falklands'; University of Los Lagos (Chile); Falkland Islands Development Corporation	Funding for this study was provided by a DEFRA Darwin Initiative (Grant No. 162/15/020) and a Darwin post-project award 'Protecting galaxiids from salmonid invasions in Chile and the Falklands' (Grant No. EIDPO-041; www.biodiversity.cl); with additional support from the University of Los Lagos (Chile) and Falkland Islands Development Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2011, MOL ECOL RESOUR, V11, P219, DOI 10.1111/j.1755-0998.2010.02944.x; Arnold ML, 2006, ZOOLOGY, V109, P261, DOI 10.1016/j.zool.2006.03.006; Arntzen JW, 2009, EVOLUTION, V63, P1191, DOI 10.1111/j.1558-5646.2009.00611.x; AVISE JC, 1984, GENETICS, V108, P237; Belkhir K., 2001, GENETIX 4 02 LOGICIE; Blackwell Brian G., 2000, Reviews in Fisheries Science, V8, P1, DOI 10.1080/10641260091129161; Brown RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020350; Brown V, 2010, B BRIT ECOLOGICAL SO, V41, P48; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; CAMPOS H, 1985, ARCH HYDROBIOL, V104, P169; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Consuegra S, 2007, EVOL ECOL, V21, P229, DOI 10.1007/s10682-006-9001-7; Consuegra S, 2011, EVOL APPL, V4, P660, DOI 10.1111/j.1752-4571.2011.00189.x; Cussac V, 2004, J BIOGEOGR, V31, P103, DOI 10.1046/j.0305-0270.2003.01000.x; DAUGHERTY CH, 1990, NATURE, V347, P177, DOI 10.1038/347177a0; De Leaniz CG, 2010, SYST BIODIVERS, V8, P447, DOI 10.1080/14772000.2010.537706; DELEANIZ CG, 1989, J FISH BIOL, V34, P41, DOI 10.1111/j.1095-8649.1989.tb02956.x; Dyer Brian S., 2000, Estudios Oceanologicos, V19, P77; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R, INTRO CONSERVATION G; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Habit E, 2010, GLOBAL ECOL BIOGEOGR, V19, P697, DOI 10.1111/j.1466-8238.2010.00541.x; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hendry AP, 2010, EVOLUTION, V64, P1517, DOI 10.1111/j.1558-5646.2010.00947.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; LAMB T, 1986, P NATL ACAD SCI USA, V83, P2526, DOI 10.1073/pnas.83.8.2526; Lattuca ME, 2008, ECOL FRESHW FISH, V17, P394, DOI 10.1111/j.1600-0633.2008.00292.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McDowall RM, 2006, REV FISH BIOL FISHER, V16, P233, DOI 10.1007/s11160-006-9017-7; MCDOWALL RM, 1971, J ROY SOC NEW ZEAL, V1, P31, DOI 10.1080/03036758.1971.10419354; MCDOWALL RM, 1971, ZOOL J LINN SOC-LOND, V50, P33, DOI 10.1111/j.1096-3642.1971.tb00751.x; McDowall RM, 1998, FRESHWATER BIOL, V40, P111; McDowall RM, 1999, MOL ECOL, V8, P527, DOI 10.1046/j.1365-294x.1999.00560.x; MCDOWALL RM, 1988, COPEIA, P233, DOI 10.2307/1445940; MCDOWALL RM, 1987, JPN J ICHTHYOL, V34, P377; McDowall RM, 2001, AQUAT CONSERV, V11, P473, DOI 10.1002/aqc.499; McDowall RM, 1997, REV FISH BIOL FISHER, V7, P443, DOI 10.1023/A:1018404331601; Milano D, 2006, BIOL J LINN SOC, V87, P69, DOI 10.1111/j.1095-8312.2006.00556.x; Miller MP, 1997, TOOLS POPULATION GEN; MILLER RR, 1989, FISHERIES, V14, P22, DOI 10.1577/1548-8446(1989)014<0022:EONAFD>2.0.CO;2; Milne DJ, 2009, WILDLIFE RES, V36, P496, DOI 10.1071/WR08165; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M, 1987, MOL EVOLUTIONARY GEN; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Oliveira R, 2010, CONSERV GENET, V11, P1023, DOI 10.1007/s10592-009-9947-4; Oliveira R, 2008, CONSERV GENET, V9, P1, DOI 10.1007/s10592-007-9297-z; Paabo S, 1990, AMPLIFYING ANCIENT D; Pascual MA, 2007, AQUAT ECOSYST HEALTH, V10, P212, DOI 10.1080/14634980701351361; Pastorini J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-32; Peter W, 1999, ANIM BEHAV, V58, P1; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Primmer CR, 2005, J AVIAN BIOL, V36, P348; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roberts DG, 2009, J EVOLUTION BIOL, V22, P27, DOI 10.1111/j.1420-9101.2008.01620.x; Salzburger W, 2002, MOL ECOL, V11, P619, DOI 10.1046/j.0962-1083.2001.01438.x; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schroder A, 2009, J ANIM ECOL, V78, P1152, DOI 10.1111/j.1365-2656.2009.01590.x; SCRIBNER KT, 1994, EVOLUTION, V48, P155, DOI [10.2307/2410011, 10.1111/j.1558-5646.1994.tb01302.x]; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Speziale K, 2010, NATURE, V467, P153, DOI 10.1038/467153c; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor EB, 1996, EVOLUTION, V50, P401, DOI [10.2307/2410810, 10.1111/j.1558-5646.1996.tb04502.x]; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waters JM, 1997, AUST J ZOOL, V45, P39, DOI 10.1071/ZO96049; Welch JJ, 2004, EVOLUTION, V58, P1145; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Young KA, 2010, ANIM CONSERV, V13, P399, DOI 10.1111/j.1469-1795.2010.00354.x; Young KA, 2009, BIOL INVASIONS, V11, P1955, DOI 10.1007/s10530-008-9372-5	79	28	29	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32939	10.1371/journal.pone.0032939	http://dx.doi.org/10.1371/journal.pone.0032939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412956	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100042
J	L'Abee-Lund, TM; Jorgensen, HJ; O'Sullivan, K; Bohlin, J; Ligard, G; Granum, PE; Lindback, T				L'Abee-Lund, Trine M.; Jorgensen, Hannah J.; O'Sullivan, Kristin; Bohlin, Jon; Ligard, Goro; Granum, Per Einar; Lindback, Toril			The Highly Virulent 2006 Norwegian EHEC O103:H25 Outbreak Strain Is Related to the 2011 German O104:H4 Outbreak Strain	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; HEMOLYTIC-UREMIC SYNDROME; IN-VIVO; TOXIN; O157-H7; INFECTION; EVOLUTION; SEQUENCE; GENOME; PHAGES	In 2006, a severe foodborne EHEC outbreak occured in Norway. Seventeen cases were recorded and the HUS frequency was 60%. The causative strain, Esherichia coli O103:H25, is considered to be particularly virulent. Sequencing of the outbreak strain revealed resemblance to the 2011 German outbreak strain E. coli O104:H4, both in genome and Shiga toxin 2-encoding (Stx2) phage sequence. The nucleotide identity between the Stx2 phages from the Norwegian and German outbreak strains was 90%. During the 2006 outbreak, stx2-positive O103: H25 E. coli was isolated from two patients. All the other outbreak associated isolates, including all food isolates, were stx-negative, and carried a different phage replacing the Stx2 phage. This phage was of similar size to the Stx2 phage, but had a distinctive early phage region and no stx gene. The sequence of the early region of this phage was not retrieved from the bacterial host genome, and the origin of the phage is unknown. The contaminated food most likely contained a mixture of E. coli O103: H25 cells with either one of the phages.	[L'Abee-Lund, Trine M.; Jorgensen, Hannah J.; O'Sullivan, Kristin; Bohlin, Jon; Ligard, Goro; Granum, Per Einar; Lindback, Toril] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway	Norwegian University of Life Sciences	L'Abee-Lund, TM (corresponding author), Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	toril.lindback@nvh.no	Lindbäck, Toril/AAZ-9278-2020	Bohlin, Jon/0000-0002-0992-1311; Lindback, Toril/0000-0002-5245-1087; Jorgensen, Hannah Joan/0000-0002-1788-9219	Research Council of Norway [178274/I10]	Research Council of Norway(Research Council of Norway)	This work was supported by The Research Council of Norway (project 178274/I10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Allison HE, 2007, FUTURE MICROBIOL, V2, P165, DOI 10.2217/17460913.2.2.165; Bielaszewska M, 2006, APPL ENVIRON MICROB, V72, P1900, DOI 10.1128/AEM.72.3.1900-1909.2006; Bielaszewska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001024; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Sablet T, 2008, MICROBIOL-SGM, V154, P176, DOI 10.1099/mic.0.2007/009704-0; de Sablet T, 2009, INFECT IMMUN, V77, P783, DOI 10.1128/IAI.01048-08; Feng P, 2001, CLIN DIAGN LAB IMMUN, V8, P711, DOI 10.1128/CDLI.8.4.711-717.2001; Fogg PCM, 2007, MICROBIOL-SGM, V153, P4098, DOI 10.1099/mic.0.2007/011205-0; Friedrich AW, 2007, CLIN INFECT DIS, V45, P39, DOI 10.1086/518573; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gamage SD, 2003, INFECT IMMUN, V71, P3107, DOI 10.1128/IAI.71.6.3107-3115.2003; Gamage SD, 2004, INFECT IMMUN, V72, P7131, DOI 10.1128/IAI.72.12.7131-7139.2004; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Johansen BK, 2001, MICROBIOL-SGM, V147, P1929, DOI 10.1099/00221287-147-7-1929; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Karama M, 2008, J CLIN MICROBIOL, V46, P3569, DOI 10.1128/JCM.01095-08; Karch H, 2009, BERL MUNCH TIERARZTL, V122, P417, DOI 10.2376/0005-9366-122-417; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Klapproth JA, 2000, INFECT IMMUN, V68, P2148, DOI 10.1128/IAI.68.4.2148-2155.2000; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; MacKenzie AMR, 1998, J CLIN MICROBIOL, V36, P1608, DOI 10.1128/JCM.36.6.1608-1611.1998; Makino K, 1999, GENES GENET SYST, V74, P227, DOI 10.1266/ggs.74.227; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Mellmann A, 2008, APPL ENVIRON MICROB, V74, P67, DOI 10.1128/AEM.01906-07; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Muniesa M, 1998, APPL ENVIRON MICROB, V64, P2443; Murase T, 1999, CURR MICROBIOL, V38, P48, DOI 10.1007/PL00006771; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paton AW, 2010, TOXINS, V2, P215, DOI 10.3390/toxins2020215; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Perry LL, 2009, FEMS MICROBIOL LETT, V292, P182, DOI 10.1111/j.1574-6968.2009.01511.x; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rivas M, 2006, FOODBORNE PATHOG DIS, V3, P88, DOI 10.1089/fpd.2006.3.88; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schimmer B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-41; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Schmidt H, 1996, MICROBIOL-UK, V142, P907, DOI 10.1099/00221287-142-4-907; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Sekse C, 2008, FOODBORNE PATHOG DIS, V5, P801, DOI 10.1089/fpd.2008.0130; Sekse C, 2009, INT J FOOD MICROBIOL, V133, P259, DOI 10.1016/j.ijfoodmicro.2009.05.026; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TARR PI, 1990, J INFECT DIS, V162, P553, DOI 10.1093/infdis/162.2.553; Toshima H, 2007, APPL ENVIRON MICROB, V73, P7582, DOI 10.1128/AEM.01326-07; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu CJ, 2011, J MICROBIOL IMMUNOL, V44, P390, DOI 10.1016/j.jmii.2011.07.001	57	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31413	10.1371/journal.pone.0031413	http://dx.doi.org/10.1371/journal.pone.0031413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403614	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700011
J	Pyrc, K; Stozek, K; Wojcik, K; Gawron, K; Zeglen, S; Karolak, W; Wojarski, J; Ochman, M; Hubalewska-Mazgaj, M; Bochenek, G; Sanak, M; Zembala, M; Szczeklik, A; Potempa, J				Pyrc, Krzysztof; Stozek, Karol; Wojcik, Krzysztof; Gawron, Katarzyna; Zeglen, Slawomir; Karolak, Wojciech; Wojarski, Jacek; Ochman, Marek; Hubalewska-Mazgaj, Magdalena; Bochenek, Grazyna; Sanak, Marek; Zembala, Marian; Szczeklik, Andrzej; Potempa, Jan			Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens	PLOS ONE			English	Article							HUMAN CORONAVIRUS NL63; YOUNG-CHILDREN; DIFFERENTIAL DISPLAY; TRACT INFECTIONS; CILIATED CELLS; MULTIPLEX PCR; VIRUSES; IDENTIFICATION; SURVEILLANCE; RHINOVIRUSES	Rapid and accurate detection and identification of viruses causing respiratory tract infections is important for patient care and disease control. Despite the fact that several assays are available, identification of an etiological agent is not possible in similar to 30% of patients suffering from respiratory tract diseases. Therefore, the aim of the current study was to develop a diagnostic set for the detection of respiratory viruses with sensitivity as low as 1-10 copies per reaction. Evaluation of the assay using a training clinical sample set showed that viral nucleic acids were identified in similar to 76% of cases. To improve assay performance and facilitate the identification of novel species or emerging strains, cultures of fully differentiated human airway epithelium were used to pre-amplify infectious viruses. This additional step resulted in the detection of pathogens in all samples tested. Based on these results it can be hypothesized that the lack of an etiological agent in some clinical samples, both reported previously and observed in the present study, may result not only from the presence of unknown viral species, but also from imperfections in the detection methods used.	[Pyrc, Krzysztof; Stozek, Karol; Gawron, Katarzyna; Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Wojcik, Krzysztof] Jagiellonian Univ, Div Cell Biophys, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Zeglen, Slawomir; Karolak, Wojciech; Wojarski, Jacek; Ochman, Marek; Zembala, Marian] Silesian Ctr Heart Dis, Dept Cardiac Surg & Transplantol, Zabrze, Poland; [Wojcik, Krzysztof; Hubalewska-Mazgaj, Magdalena; Bochenek, Grazyna; Sanak, Marek; Szczeklik, Andrzej] Jagiellonian Univ, Coll Med, Dept Med, Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Oral Hlth & System Dis Res Grp, Louisville, KY 40292 USA	Jagiellonian University; Jagiellonian University; Silesian Center for Heart Diseases; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Louisville	Pyrc, K (corresponding author), Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	k.a.pyrc@uj.edu.pl	Sanak, Marek/AAV-1628-2021; Potempa, Jan/AAA-6850-2021; Wójcik, Krzysztof/GQP-4829-2022	Sanak, Marek/0000-0001-7635-8103; Wojcik, Krzysztof/0000-0001-9786-2499; Pyrc, Krzysztof/0000-0002-3867-7688; Wojarski, Jacek/0000-0001-7724-8213; Potempa, Jan/0000-0002-3600-7461; Gawron, Katarzyna/0000-0003-3430-6270; Ochman, Marek/0000-0002-1410-5845	Ministry of Scientific Research, Poland [0095/B/P01/2009/37]; Ministry of Science and Higher Education, Poland [IP 2010 033870]; Foundation for Polish Science [HOM/2008/12]; European Union [POIG.02.01.00-12-064/08]	Ministry of Scientific Research, Poland; Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union(European Commission)	This work was supported by the grant from the Ministry of Scientific Research, Poland (0095/B/P01/2009/37) (KP), Iuventus Plus grant from the Ministry of Science and Higher Education, Poland (IP 2010 033870) (KP) and Foundation for Polish Science within the Homing Programme (HOM/2008/12) (KP). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08 - "Molecular biotechnology for health"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Banach BS, 2009, J VIROL METHODS, V156, P19, DOI 10.1016/j.jviromet.2008.10.022; Barenfanger J, 2000, J CLIN MICROBIOL, V38, P2824, DOI 10.1128/JCM.38.8.2824-2828.2000; de Vries M, 2008, J CLIN MICROBIOL, V46, P759, DOI 10.1128/JCM.02009-07; de Vries M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016118; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; FOX JP, 1985, AM J EPIDEMIOL, V122, P830, DOI 10.1093/oxfordjournals.aje.a114166; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gharabaghi F, 2011, CLIN MICROBIOL INFEC, V17, P1900, DOI 10.1111/j.1469-0691.2011.03529.x; Jokela P, 2010, CLIN MICROBIOL INFEC, V16, P1568, DOI 10.1111/j.1469-0691.2010.03191.x; Tan LV, 2011, J INFECT DEV COUNTR, V5, P142, DOI 10.3855/jidc.1087; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lu YF, 2004, J VIROL METHODS, V121, P107, DOI 10.1016/j.jviromet.2004.06.008; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; Mahony JB, 2010, EXPERT REV ANTI-INFE, V8, P1273, DOI [10.1586/eri.10.121, 10.1586/ERI.10.121]; Mahony JB, 2009, J CLIN VIROL, V45, P200, DOI 10.1016/j.jcv.2009.05.031; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Nuutila J, 2007, CURR OPIN INFECT DIS, V20, P304, DOI 10.1097/QCO.0b013e3280964db4; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Pyrc K, 2006, J MOL BIOL, V364, P964, DOI 10.1016/j.jmb.2006.09.074; Pyrc K, 2006, ANTIMICROB AGENTS CH, V50, P2000, DOI 10.1128/AAC.01598-05; Pyrc K, 2010, J VIROL, V84, P11255, DOI 10.1128/JVI.00947-10; Pyrc Krzysztof, 2008, V454, P73, DOI 10.1007/978-1-59745-181-9_7; REED L. J., 1938, AMER JOUR HYG, V27, P493; Regamey N, 2008, PEDIATR INFECT DIS J, V27, P100, DOI 10.1097/INF.0b013e31815922c8; REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9; Sadeghi CD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-41; Schildgen O, 2006, J VIROL METHODS, V138, P207, DOI 10.1016/j.jviromet.2006.07.023; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005; Thomazelli LM, 2007, J PEDIAT-BRAZIL, V83, P422, DOI 10.1590/S0021-75572007000600005; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; Tsuchiya LRRV, 2005, J INFECTION, V51, P401, DOI 10.1016/j.jinf.2004.12.002; van de Pol AC, 2006, CRIT CARE, V10, DOI 10.1186/cc4895; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2005, PLOS MED, V2, P764, DOI 10.1371/journal.pmed.0020240; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; WALD ER, 1991, PEDIATRICS, V87, P129; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; ZENG DL, 1988, CHINESE MED J-PEKING, V101, P787; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005	50	10	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32582	10.1371/journal.pone.0032582	http://dx.doi.org/10.1371/journal.pone.0032582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403676	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700073
J	Rak-Raszewska, A; Marcello, M; Kenny, S; Edgar, D; See, V; Murray, P				Rak-Raszewska, Aleksandra; Marcello, Marco; Kenny, Simon; Edgar, David; See, Violaine; Murray, Patricia			Quantum Dots Do Not Affect the Behaviour of Mouse Embryonic Stem Cells and Kidney Stem Cells and Are Suitable for Short-Term Tracking	PLOS ONE			English	Article							EXPRESSION; FUSION	Quantum dots (QDs) are small nanocrystals widely used for labelling cells in order to enable cell tracking in complex environments in vitro, ex vivo and in vivo. They present many advantages over traditional fluorescent markers as they are resistant to photobleaching and have narrow emission spectra. Although QDs have been used effectively in cell tracking applications, their suitability has been questioned by reports showing they can affect stem cell behaviour and can be transferred to neighbouring cells. Using a variety of cellular and molecular biology techniques, we have investigated the effect of QDs on the proliferation and differentiation potential of two stem cell types: mouse embryonic stem cells and tissue-specific stem cells derived from mouse kidney. We have also tested if QDs released from living or dead cells can be taken up by neighbouring cells, and we have determined if QDs affect the degree of cell-cell fusion; this information is critical in order to assess the suitability of QDs for stem cell tracking. We show here that QDs have no effect on the viability, proliferation or differentiation potential of the two stem cell types. Furthermore, we show that the extent of transfer of QDs to neighbouring cells is <4%, and that QDs do not increase the degree of cell-cell fusion. However, although the QDs have a high labelling efficiency (>85%), they are rapidly depleted from both stem cell populations. Taken together, our results suggest that QDs are effective cell labelling probes that are suitable for short-term stem cell tracking.	[Rak-Raszewska, Aleksandra; Kenny, Simon; Edgar, David; Murray, Patricia] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Marcello, Marco; See, Violaine] Univ Liverpool, Inst Integrat Biol, Ctr Cell Imaging, Liverpool L69 3BX, Merseyside, England; [Kenny, Simon] Alder Hey Childrens NHS Fdn Trust, Dept Paediat Surg Urol, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; Alder Hey Children's NHS Foundation Trust	Rak-Raszewska, A (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	a.rakraszewska@googlemail.com		Murray, Patricia/0000-0003-1316-148X; Kenny, Simon/0000-0002-5917-8554; Rak-Raszewska, Aleksandra/0000-0002-2399-4410	Alder Hey Children's Kidney Fund [10991]; MolFun European Union; KIDSTEM European Union 6 Research Training Network; KidRegen European Union; MRC [G0300296, G0802548] Funding Source: UKRI; Medical Research Council [G0300296, G0802548] Funding Source: researchfish	Alder Hey Children's Kidney Fund; MolFun European Union; KIDSTEM European Union 6 Research Training Network; KidRegen European Union; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding bodies: 1. Alder Hey Children's Kidney Fund 10991. 2. MolFun European Union Framework Programme 6 Early Stage Training Grant. 3. KIDSTEM European Union Framework Programme 6 Research Training Network Grant. 4. KidRegen European Union Framework Programme 7 Reintegration Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Avitabile D, 2011, AM J PHYSIOL-HEART C, V300, pH1875, DOI 10.1152/ajpheart.00523.2010; Cai KQ, 2008, DEV DYNAM, V237, P2820, DOI 10.1002/dvdy.21703; Clift MJD, 2011, NANOTOXICOLOGY, V5, P664, DOI 10.3109/17435390.2010.534196; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Hoshino A, 2004, NANO LETT, V4, P2163, DOI 10.1021/nl048715d; Hsieh SC, 2006, BIOMATERIALS, V27, P1656, DOI 10.1016/j.biomaterials.2005.09.004; Hsieh SC, 2006, J BIOMED MATER RES B, V79B, P95, DOI 10.1002/jbm.b.30517; Jin T, 2010, MOL BIOSYST, V6, P2325, DOI 10.1039/c0mb00056f; Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m; Lin S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-67; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012075; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mora CF, 2012, STEM CELLS DEV, V21, P296, DOI 10.1089/scd.2010.0470; Murray P, 2001, J CELL SCI, V114, P931; Parak W, 2009, NANOTECHNOLOGY, V16, pR9; Pi QM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-36; Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Ranjbarvaziri S, 2011, BIOMATERIALS, V32, P5195, DOI 10.1016/j.biomaterials.2011.04.004; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Rosen AB, 2007, STEM CELLS, V25, P2128, DOI 10.1634/stemcells.2006-0722; Solanki A, 2008, NANOMEDICINE-UK, V3, P567, DOI 10.2217/17435889.3.4.567; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Wang SH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425102; Yu WW, 2006, BIOCHEM BIOPH RES CO, V348, P781, DOI 10.1016/j.bbrc.2006.07.160; YU ZW, 1994, BIOSCIENCE REP, V14, P259, DOI 10.1007/BF01199051; Zhang LW, 2009, TOXICOL SCI, V110, P138, DOI 10.1093/toxsci/kfp087	30	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32650	10.1371/journal.pone.0032650	http://dx.doi.org/10.1371/journal.pone.0032650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403689	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700086
J	Ranganathan, S; Singh, PK; Singh, U; Singru, PS; Padinhateeri, R; Maji, SK				Ranganathan, Srivastav; Singh, Pradeep K.; Singh, Uday; Singru, Praful S.; Padinhateeri, Ranjith; Maji, Samir K.			Molecular Interpretation of ACTH-beta-Endorphin Coaggregation: Relevance to Secretory Granule Biogenesis	PLOS ONE			English	Article							PROTEIN; AGGREGATION; STORAGE; PEPTIDES; SIMULATIONS; AMYLOIDS; DYNAMICS; HORMONES	Peptide/protein hormones could be stored as non-toxic amyloid-like structures in pituitary secretory granules. ACTH and beta-endorphin are two of the important peptide hormones that get co-stored in the pituitary secretory granules. Here, we study molecular interactions between ACTH and beta-endorphin and their colocalization in the form of amyloid aggregates. Although ACTH is known to be a part of ACTH-beta-endorphin aggregate, ACTH alone cannot aggregate into amyloid under various plausible conditions. Using all atom molecular dynamics simulation we investigate the early molecular interaction events in the ACTH-beta-endorphin system, beta-endorphin-only system and ACTH-only system. We find that beta-endorphin and ACTH formed an interacting unit, whereas negligible interactions were observed between ACTH molecules in ACTH-only system. Our data suggest that ACTH is not only involved in interaction with beta-endorphin but also enhances the stability of mixed oligomers of the entire system.	[Ranganathan, Srivastav; Singh, Pradeep K.; Padinhateeri, Ranjith; Maji, Samir K.] Indian Inst Technol, Wadhwani Res Ctr Biosci & Bioengn, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Singh, Uday; Singru, Praful S.] NISER, Sch Biol Sci, Bhubaneswar, Orissa, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; National Institute of Science Education & Research (NISER)	Ranganathan, S (corresponding author), Indian Inst Technol, Wadhwani Res Ctr Biosci & Bioengn, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	ranjithp@iitb.ac.in; samirmaji@iitb.ac.in	Maji, Samir K. K./B-9640-2019	Maji, Samir K. K./0000-0002-9110-1565; Singh, Pradeep/0000-0002-4625-9873; Ranganathan, Srivastav/0000-0003-4364-0959; Singh, Uday/0000-0002-5747-8369	Council of Scientific and Industrial Research (Department of Science and Technology) [37(1404)/10/EMR-11, SR/FR/LS-032/2009]; Department of Biotechnology, Government of India; Division Of Behavioral and Cognitive Sci [0924181] Funding Source: National Science Foundation	Council of Scientific and Industrial Research (Department of Science and Technology); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by the Council of Scientific and Industrial Research (37(1404)/10/EMR-11, Department of Science and Technology (SR/FR/LS-032/2009) and Department of Biotechnology, Government of India for financial support. The Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cruz L, 2005, P NATL ACAD SCI USA, V102, P18258, DOI 10.1073/pnas.0509276102; Dannies PS, 2003, BIODRUGS, V17, P315, DOI 10.2165/00063030-200317050-00002; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Eipper B A, 1980, Endocr Rev, V1, P1; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GORR SU, 1995, BIOCHEM BIOPH RES CO, V215, P82, DOI 10.1006/bbrc.1995.2436; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacob R., 2010, PROTEIN AGGREGATION, P79; KELLY RB, 1987, NATURE, V326, P14, DOI 10.1038/326014a0; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Ma BY, 2000, J MOL BIOL, V296, P1091, DOI 10.1006/jmbi.2000.3518; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Maji S. K., 2010, FUNCTIONAL AMYLOID A, P135; Maji SK, 2009, FEBS LETT, V583, P2610, DOI 10.1016/j.febslet.2009.07.003; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; ODONOHUE TL, 1982, PEPTIDES, V3, P353, DOI 10.1016/0196-9781(82)90098-5; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Talbot NJ, 2003, CURR BIOL, V13, pR696, DOI 10.1016/j.cub.2003.08.040; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Venkatesh SG, 2004, AM J PHYSIOL-CELL PH, V286, pC365, DOI 10.1152/ajpcell.00338.2003; WEBER E, 1978, BRAIN RES, V157, P385, DOI 10.1016/0006-8993(78)90047-1	37	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31924	10.1371/journal.pone.0031924	http://dx.doi.org/10.1371/journal.pone.0031924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403619	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700016
J	Tkachenko, E; Tse, D; Sideleva, O; Deharvengt, SJ; Luciano, MR; Xu, Y; McGarry, CL; Chidlow, J; Pilch, PF; Sessa, WC; Toomre, DK; Stan, RV				Tkachenko, Eugene; Tse, Dan; Sideleva, Olga; Deharvengt, Sophie J.; Luciano, Marcus R.; Xu, Yan; McGarry, Caitlin L.; Chidlow, John; Pilch, Paul F.; Sessa, William C.; Toomre, Derek K.; Stan, Radu V.			Caveolae, Fenestrae and Transendothelial Channels Retain PV1 on the Surface of Endothelial Cells	PLOS ONE			English	Article							MICROVASCULAR PERMEABILITY; CAVEOLIN-1-DEFICIENT MICE; NULL MICE; PROTEIN; ENDOCYTOSIS; DYNAMIN; ANGIOGENESIS; DIAPHRAGMS; FORM; PV-1	PV1 protein is an essential component of stomatal and fenestral diaphragms, which are formed at the plasma membrane of endothelial cells (ECs), on structures such as caveolae, fenestrae and transendothelial channels. Knockout of PV1 in mice results in in utero and perinatal mortality. To be able to interpret the complex PV1 knockout phenotype, it is critical to determine whether the formation of diaphragms is the only cellular role of PV1. We addressed this question by measuring the effect of complete and partial removal of structures capable of forming diaphragms on PV1 protein level. Removal of caveolae in mice by knocking out caveolin-1 or cavin-1 resulted in a dramatic reduction of PV1 protein level in lungs but not kidneys. The magnitude of PV1 reduction correlated with the abundance of structures capable of forming diaphragms in the microvasculature of these organs. The absence of caveolae in the lung ECs did not affect the transcription or translation of PV1, but it caused a sharp increase in PV1 protein internalization rate via a clathrin-and dynamin-independent pathway followed by degradation in lysosomes. Thus, PV1 is retained on the cell surface of ECs by structures capable of forming diaphragms, but undergoes rapid internalization and degradation in the absence of these structures, suggesting that formation of diaphragms is the only role of PV1.	[Tkachenko, Eugene] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Tse, Dan; Sideleva, Olga; Deharvengt, Sophie J.; Luciano, Marcus R.; Xu, Yan; McGarry, Caitlin L.; Stan, Radu V.] Dartmouth Med Sch, Dept Pathol, Lebanon, NH USA; [Stan, Radu V.] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH USA; [Tse, Dan; McGarry, Caitlin L.; Stan, Radu V.] Dartmouth Med Sch, Heart & Vasc Res Ctr, Lebanon, NH USA; [Stan, Radu V.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH USA; [Chidlow, John; Sessa, William C.] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Toomre, Derek K.] Yale Univ, Dept Cell Biol, New Haven, CT USA; [Pilch, Paul F.] Boston Univ, Dept Biochem, Boston, MA 02215 USA	University of California System; University of California San Diego; Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Yale University; Yale University; Boston University	Tkachenko, E (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	Radu.V.Stan@Dartmouth.edu	Stan, Radu/AAE-7574-2021; Sessa, William C/B-6844-2011	Stan, Radu/0000-0003-2969-1725; Sessa, William C/0000-0001-5759-1938; Tkachenko, Eugene/0000-0002-7964-484X; Pilch, Paul/0000-0003-1997-0499	National Institutes of Health (NIH) [HL65418, HL83249, HL092085, RR16437, 1DP2OD002980, F32 HL094012-01]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL094012, R01HL092085, R01HL065418, R37HL061371, R01HL083249] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002980] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported from the National Institutes of Health (NIH) grants HL65418, HL83249, HL092085 and RR16437 (PI Green) to Dr. Stan, and 1DP2OD002980 to Dr. Toomre. Dr. Tkachenko is supported by NIH F32 HL094012-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DUIJVESTIJN AM, 1987, J IMMUNOL, V138, P713; Dvorak HF, 2010, CURR OPIN HEMATOL, V17, P225, DOI 10.1097/MOH.0b013e3283386638; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Gonnord P, 2011, SEMIN CELL DEV BIOL; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; GRINDE B, 1980, BIOCHIM BIOPHYS ACTA, V632, P73, DOI 10.1016/0304-4165(80)90250-0; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hnasko R, 2006, CELL CYCLE, V5, P2012, DOI 10.4161/cc.5.17.3216; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Ichimura K, 2008, J AM SOC NEPHROL, V19, P1463, DOI 10.1681/ASN.2007101138; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lin MI, 2007, CANCER RES, V67, P2849, DOI 10.1158/0008-5472.CAN-06-4082; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Madden SL, 2004, AM J PATHOL, V165, P601, DOI 10.1016/S0002-9440(10)63324-X; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; MILICI AJ, 1985, CIRC RES, V56, P709, DOI 10.1161/01.RES.56.5.709; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; NEUMANN R, 1994, ARCH DERMATOL, V130, P879, DOI 10.1001/archderm.130.7.879; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Razani B, 2001, J BIOL CHEM, V276, P38121; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; SIMIONESCU M, 1974, J CELL BIOL, V60, P128, DOI 10.1083/jcb.60.1.128; Simionescu M, 1980, Ciba Found Symp, V78, P11; Stan RV, 2007, J CELL MOL MED, V11, P621, DOI 10.1111/j.1582-4934.2007.00075.x; Stan RV, 1999, J CELL BIOL, V145, P1189, DOI 10.1083/jcb.145.6.1189; Stan RV, 2004, MOL BIOL CELL, V15, P3615, DOI 10.1091/mbc.E03-08-0593; Stan RV, 2004, AM J PHYSIOL-HEART C, V286, pH1347, DOI 10.1152/ajpheart.00909.2003; Stan RV, 2001, GENOMICS, V72, P304, DOI 10.1006/geno.2000.6489; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Strickland LA, 2005, J PATHOL, V206, P466, DOI 10.1002/path.1805; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Tse D, 2011, DIAPHRAGMS FEN UNPUB; Tse D, 2010, SEMIN THROMB HEMOST, V36, P236, DOI 10.1055/s-0030-1253447; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; WILCOX D, 1992, BIOCHEM J, V285, P495, DOI 10.1042/bj2850495; Yamamoto I, 2007, AM J TRANSPLANT, V7, P1954, DOI 10.1111/j.1600-6143.2007.01876.x; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	61	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32655	10.1371/journal.pone.0032655	http://dx.doi.org/10.1371/journal.pone.0032655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403691	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700088
J	Pan, ZY; Guo, YP; Qi, HP; Fan, K; Wang, S; Zhao, H; Fan, YH; Xie, J; Guo, F; Hou, YL; Wang, N; Huo, R; Zhang, Y; Liu, Y; Du, ZM				Pan, Zhenyu; Guo, Yueping; Qi, Hanping; Fan, Kai; Wang, Shu; Zhao, Hua; Fan, Yuhua; Xie, Jing; Guo, Feng; Hou, Yunlong; Wang, Ning; Huo, Rong; Zhang, Yong; Liu, Yan; Du, Zhimin			M-3 Subtype of Muscarinic Acetylcholine Receptor Promotes Cardioprotection via the Suppression of miR-376b-5p	PLOS ONE			English	Article							NF-KAPPA-B; SUDDEN CARDIAC DEATH; MYOCARDIAL-ISCHEMIA; GROWTH-FACTOR; NEUROTROPHIC FACTOR; ISCHEMIA/REPERFUSION INJURY; REPERFUSION INJURY; PROTEIN-KINASE; ACTIVATION; HEART	The M-3 subtype of muscarinic acetylcholine receptors (M-3-mAChR) plays a protective role in myocardial ischemia and microRNAs (miRNAs) participate in many cardiac pathophysiological processes, including ischemia-induced cardiac injury. However, the role of miRNAs in M-3-mAChR mediated cardioprotection remains unexplored. The present study was designed to identify miRNAs that are involved in cardioprotective effects of M-3-mAChR against myocardial ischemia and elucidate the underlying mechanisms. We established rat model of myocardial ischemia and performed miRNA microarray analysis to identify miRNAs involved in the cardioprotection of M-3-mAChR. In H9c2 cells, the viability, intracellular free Ca2+ concentration ([Ca2+]i), intracellular reactive oxygen species (ROS), miR-376b-5p expression level, brain derived neurophic factor (BDNF) and nuclear factor kappa-B (NF-kappa B) levels were measured. Our results demonstrated that M-3-mAChR protected myocardial ischemia injury. Microarray analysis and qRT-PCR revealed that miR-376b-5p was significantly up-regulated in ischemic heart tissue and the M-3-mAChRs agonist choline reversed its up-regulation. In vitro, miR-376b-5p promoted H2O2-induced H9c2 cell injuries measured by cells viability, [Ca2+]i and ROS. Western blot and luciferase assay identified BDNF as a direct target of miR-376b-5p. M-3-mAChR activated NF-kappa B and thereby inhibited miR-376b-5p expression. Our data show that a novel M-3-mAChR/NF-kappa B/miR-376b-5p/BDNF axis plays an important role in modulating cardioprotection. MiR-376b-5p promotes myocardial ischemia injury possibly by inhibiting BDNF expression and M-3-mAChR provides cardioprotection at least partially mediated by the downregulation of miR-376b-5p through NF-kappa B. These findings provide new insight into the potential mechanism by which M-3-mAChR provides cardioprotection against myocardial ischemia injury.	[Pan, Zhenyu; Qi, Hanping; Fan, Kai; Wang, Shu; Zhao, Hua; Xie, Jing; Guo, Feng; Hou, Yunlong; Wang, Ning; Huo, Rong; Zhang, Yong; Liu, Yan] Harbin Med Univ, Minist Educ, Key Lab Cardiovasc Res, Dept Pharmacol,State Prov Key Labs Biomed Pharmac, Harbin, Heilongjiang, Peoples R China; [Guo, Yueping] Harbin Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Harbin, Heilongjiang, Peoples R China; [Fan, Yuhua; Du, Zhimin] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Pan, ZY (corresponding author), Harbin Med Univ, Minist Educ, Key Lab Cardiovasc Res, Dept Pharmacol,State Prov Key Labs Biomed Pharmac, Harbin, Heilongjiang, Peoples R China.	liuyangy2000@yahoo.com.cn; dzm1956@126.com			National Natural Science Foundation of China [30973531, 81072639]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (no. 30973531 and 81072639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanji AO, 2007, SCAND J CLIN LAB INV, V67, P553, DOI 10.1080/00365510601173153; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; BOLLI R, 1984, J MOL CELL CARDIOL, V16, P1101, DOI 10.1016/S0022-2828(84)80037-1; Cain BS, 1999, J MOL CELL CARDIOL, V31, P931, DOI 10.1006/jmcc.1999.0924; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Chu CH, 2008, J ENDOCRINOL, V197, P381, DOI 10.1677/JOE-07-0619; Dana A, 2000, CIRCULATION, V101, P2841, DOI 10.1161/01.CIR.101.24.2841; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Downey JM, 2009, CIRC J, V73, P1171, DOI 10.1253/circj.CJ-09-0338; Fauconnier J, 2010, PROG BIOPHYS MOL BIO, V103, P71, DOI 10.1016/j.pbiomolbio.2010.01.002; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Ferreira M, 2010, BMC SPORTS SCI MED R, V2, DOI 10.1186/1758-2555-2-19; Fujino H, 2000, BIOL PHARM BULL, V23, P1198; Gumina RJ, 1997, BASIC RES CARDIOL, V92, P201, DOI 10.1007/BF00788515; Guo Zhu-ying, 2008, Chinese Journal of Pathology, V37, P760; Guo ZY, 2010, BIOMED PHARMACOTHER, V64, P184, DOI 10.1016/j.biopha.2009.09.015; Hiltunen JO, 2001, J PATHOL, V194, P247, DOI 10.1002/path.878; Katare RG, 2009, J MOL CELL CARDIOL, V46, P405, DOI 10.1016/j.yjmcc.2008.10.027; Kreusser MM, 2008, J MOL CELL CARDIOL, V44, P380, DOI 10.1016/j.yjmcc.2007.10.019; Kumarswamy R, 2010, CIRC RES, V106, pE8, DOI 10.1161/CIRCRESAHA.110.220616; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Liu Y, 2009, N-S ARCH PHARMACOL, V379, P511, DOI 10.1007/s00210-008-0376-6; Liu Y, 2008, CAN J PHYSIOL PHARM, V86, P860, DOI 10.1139/Y08-094; Lorgis L, 2009, ANN CARDIOL ANGEIOL, V58, P99, DOI 10.1016/j.ancard.2008.11.001; Luo ZY, 1997, ANN THORAC SURG, V64, P993, DOI 10.1016/S0003-4975(97)00715-7; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Maulik N, 1998, FEBS LETT, V429, P365, DOI 10.1016/S0014-5793(98)00632-2; Maulik N, 1999, FEBS LETT, V443, P331, DOI 10.1016/S0014-5793(98)01719-0; Morgan EN, 1999, ANN THORAC SURG, V68, P377, DOI 10.1016/S0003-4975(99)00646-3; MYERBURG RJ, 1993, ANN INTERN MED, V119, P1187, DOI 10.7326/0003-4819-119-12-199312150-00006; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Ono K, 1999, LAB INVEST, V79, P195; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Shi H, 1999, MOL PHARMACOL, V55, P497; Shimizu N, 1998, CARDIOVASC RES, V38, P116, DOI 10.1016/S0008-6363(97)00327-1; Siehler S, 2001, J BIOL CHEM, V276, P48733, DOI 10.1074/jbc.M011072200; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Todisco A, 1999, BIOCHEM BIOPH RES CO, V261, P877, DOI 10.1006/bbrc.1999.1141; Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Xuan YT, 1999, CIRC RES, V84, P1095, DOI 10.1161/01.RES.84.9.1095; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yang BF, 2005, CELL PHYSIOL BIOCHEM, V16, P163, DOI 10.1159/000089842; Yue P, 2006, CELL PHYSIOL BIOCHEM, V17, P129, DOI 10.1159/000092074; Zheng Hai, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P140	45	33	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32571	10.1371/journal.pone.0032571	http://dx.doi.org/10.1371/journal.pone.0032571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396777	Green Submitted, Green Published, gold			2022-12-25	WOS:000303006500024
J	Heinis, M; Soggia, A; Bechetoille, C; Simon, MT; Peyssonnaux, C; Rustin, P; Scharfmann, R; Duvillie, B				Heinis, Mylene; Soggia, Andrea; Bechetoille, Camille; Simon, Marie-Therese; Peyssonnaux, Carole; Rustin, Pierre; Scharfmann, Raphael; Duvillie, Bertrand			HIF1 alpha and pancreatic beta-cell development	FASEB JOURNAL			English	Article						oxygen tension; pVHL; pancreas; development	LINDAU TUMOR-SUPPRESSOR; OXYGEN-TENSION; EMBRYONIC-DEVELOPMENT; HYPOXIC RESPONSE; IN-VITRO; DIFFERENTIATION; MESENCHYME; ENDOCRINE; HIF-1-ALPHA; METABOLISM	During early embryogenesis, the pancreas shows a paucity of blood flow, and oxygen tension, the partial pressure of oxygen (pO(2)), is low. Later, the blood flow increases as beta-cell differentiation occurs. We have previously reported that pO(2) controls beta-cell development in rats. Here, we checked that hypoxia inducible factor 1 alpha (HIF1 alpha) is essential for this control. First, we demonstrated that the effect of pO(2) on beta-cell differentiation in vitro was independent of epitheliomesenchymal interactions and that neither oxidative nor energetic stress occurred. Second, the effect of pO(2) on pancreas development was shown to be conserved among species, since increasing pO(2) to 21 vs. 3% also induced beta-cell differentiation in mouse (7-fold, P<0.001) and human fetal pancreas. Third, the effect of hypoxia was mediated by HIF1 alpha, since the addition of an HIF1 alpha inhibitor at 3% O-2 increased the number of NGN3-expressing progenitors as compared to nontreated controls (9.2-fold, P<0.001). In contrast, when we stabilized HIF1 alpha by deleting ex vivo the gene encoding pVHL in E13.5 pancreas from Vhl floxed mice, Ngn3 expression and beta-cell development decreased in such Vhl-deleted pancreas compared to controls (2.5 fold, P<0.05, and 6.6-fold, P<0.001, respectively). Taken together, these data demonstrate that HIF1 alpha exerts a negative control over beta-cell differentiation.-Heinis, M., Soggia, A., Bechetoille, C., Simon, M.-T., Peyssonnaux, C., Rustin, P., Scharfmann, R., Duvillie, B. HIF1 alpha and pancreatic beta-cell development. FASEB J. 26, 2734-2742 (2012). www.fasebj.org	[Heinis, Mylene; Soggia, Andrea; Bechetoille, Camille; Simon, Marie-Therese; Scharfmann, Raphael; Duvillie, Bertrand] Univ Paris 05, INSERM, Fac Med, Res Ctr Growth & Signalling,U845, Paris, France; [Peyssonnaux, Carole] Univ Paris 05, Ctr Natl Rech Sci, Inst Cochin, Unite Mixte Rech UMR 8104, Paris, France; [Peyssonnaux, Carole] INSERM, U1016, F-75015 Paris, France; [Rustin, Pierre] INSERM, U676, F-75015 Paris, France; [Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Duvillie, B (corresponding author), INSERM, Fac Necker, U845, 156 Rue Vaugirard, F-75015 Paris, France.	bertrand.duvillie@inserm.fr	scharfmann, raphael/L-3296-2017; Peyssonnaux, Carole/GLU-5786-2022; Duvillie, Bertrand/N-4343-2018; Peyssonnaux, Carole/L-4057-2017	Peyssonnaux, Carole/0000-0002-1392-8225; Duvillie, Bertrand/0000-0003-0551-8100; Scharfmann, Raphael/0000-0001-7619-337X	French Ministry of Research and Technology; U.S. National Institutes of Health beta-Cell Biology Consortium; 6th European Union Framework Program beta-Cell Therapy Integrated Project; bilateral program Bundesministerium fur Bildung und Forschung L'Agence Nationale de la Recherche; European Foundation; Societe Francophone du Diabete/Association Francaise des Diabetiques	French Ministry of Research and Technology; U.S. National Institutes of Health beta-Cell Biology Consortium; 6th European Union Framework Program beta-Cell Therapy Integrated Project; bilateral program Bundesministerium fur Bildung und Forschung L'Agence Nationale de la Recherche(French National Research Agency (ANR)); European Foundation(European Science Foundation (ESF)); Societe Francophone du Diabete/Association Francaise des Diabetiques	The authors thank Genethon (Evry, France) for providing Ade-GFP-Cre ref.pG3.42155 and Dr. Sylvie Fabrega for the virus amplification. The authors thank Dr. Susan Saint-Just for correcting the English of the manuscript. M. H. and A. S. received support from the French Ministry of Research and Technology. This study received support from the U.S. National Institutes of Health beta-Cell Biology Consortium, the 6th European Union Framework Program beta-Cell Therapy Integrated Project, the bilateral program Bundesministerium fur Bildung und Forschung L'Agence Nationale de la Recherche, European Foundation for the Study of Diabetes/NovoNordisk/Juvenile Diabetes Research Foundation, and Societe Francophone du Diabete/Association Francaise des Diabetiques. Author contributions: M. H. performed research and analyzed data; A. S., C. B., and M.-T.S., performed research; C. P. provided the transgenic mice and proofread the manuscript; P. R. performed research and proofread the manuscript; R. S. designed research and corrected the manuscript; B. D. designed and performed research, analyzed data, and wrote the manuscript.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Attali M, 2007, DIABETES, V56, P1248, DOI 10.2337/db06-1307; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Biju MP, 2004, MOL CELL BIOL, V24, P9038, DOI 10.1128/MCB.24.20.9038-9047.2004; Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Cantley J., DIABETES OBES METAB, V12, P159; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Cejudo-Martin P, 2005, DEV CELL, V9, P575, DOI 10.1016/j.devcel.2005.10.001; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Duvillie B, 2006, DIABETES, V55, P582, DOI 10.2337/diabetes.55.03.06.db05-0839; Fraker CA, 2007, STEM CELLS, V25, P3155, DOI 10.1634/stemcells.2007-0445; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Guillemain G, 2007, J BIOL CHEM, V282, P15228, DOI 10.1074/jbc.M610986200; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Heinis M, 2010, HORM RES PAEDIAT, V74, P77, DOI 10.1159/000314894; Heinis M, 2010, DIABETES, V59, P662, DOI 10.2337/db09-0891; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lee K, 2007, J MED CHEM, V50, P1675, DOI 10.1021/jm0610292; Li C, 2011, J CELL PHYSIOL, V226, P2429, DOI 10.1002/jcp.22591; Lin Q, 2006, J BIOL CHEM, V281, P30678, DOI 10.1074/jbc.C600120200; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miralles F, 1999, DEV DYNAM, V214, P116, DOI 10.1002/(SICI)1097-0177(199902)214:2<116::AID-AJA2>3.0.CO;2-M; Miralles F, 1998, DEVELOPMENT, V125, P1017; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Scharfmann R, 2000, DIABETOLOGIA, V43, P1083, DOI 10.1007/s001250051498; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Shah SR, 2011, DEV BIOL, V349, P342, DOI 10.1016/j.ydbio.2010.10.033; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; YOCHIM JM, 1968, ENDOCRINOLOGY, V83, P706, DOI 10.1210/endo-83-4-706; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908	47	13	14	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2012	26	7					2734	2742		10.1096/fj.11-199224	http://dx.doi.org/10.1096/fj.11-199224			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	967MP	22426121	Green Published			2022-12-25	WOS:000305912500003
J	Schyr, RBH; Shabtai, Y; Shashikant, CS; Fainsod, A				Schyr, Rachel Ben-Haroush; Shabtai, Yehuda; Shashikant, Cooduvalli S.; Fainsod, Abraham			Cdx1 is essential for the initiation of HoxC8 expression during early embryogenesis	FASEB JOURNAL			English	Article						gene regulation; gastrulation; Xenopus; chromatin immunoprecipitation; mouse; colinearity	MOUSE EMBRYONIC-DEVELOPMENT; ANTERIOR-POSTERIOR AXIS; HOMEOBOX GENE; XENOPUS-LAEVIS; RETINOIC ACID; CAUDAL GENES; POSITIONAL INFORMATION; OVERLAPPING FUNCTIONS; TEMPORAL COLINEARITY; EARLY ENHANCER	The Hox genes pattern the anterior-posterior axis in developing embryos through tightly regulated, partially overlapping, temporal and spatial expression domains. Initial regulation of Hox expression is important to establish these overlapping transcription domains. The Cdx homeodomain factors have been proposed as Hox regulators, but their precise role and mechanism during this regulatory interaction remain unclear. In Xenopus embryos, HoxC8 transcripts begin to accumulate during mid/late gastrula. Cdx1 overexpression and knockdown lead to precocious or slower HoxC8 expression, respectively. The mouse HoxC8 early enhancer when introduced into Xenopus embryos recapitulates the endogenous XHoxC8 temporal expression pattern and shows the same responsiveness to Cdx1 regulation. Three pairs of conserved Cdx binding sites were identified within the HoxC8 early enhancer. We demonstrate that Cdx1 binds directly these responsive elements during embryogenesis, as part of the mechanism for the timely activation of HoxC8 expression. We define the function and mechanism of Cdx1 regulation on HoxC8 expression and suggest the possibility that the temporal changes in Cdx activity levels during gastrulation, combined with differential DNA binding affinity, might play a role in the establishment of Hox sequential activation.-Ben-Haroush Schyr, R., Shabtai, Y., Shashikant, C. S., Fainsod, A. Cdx1 is essential for the initiation of HoxC8 expression during early embryogenesis. FASEB J. 26, 2674-2684 (2012). www.fasebj.org	[Schyr, Rachel Ben-Haroush; Shabtai, Yehuda; Fainsod, Abraham] Hebrew Univ Jerusalem, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, Fac Med, IL-91120 Jerusalem, Israel; [Shashikant, Cooduvalli S.] Penn State Univ, Dept Dairy & Anim Sci, Coll Agr Sci, University Pk, PA 16802 USA	Hebrew University of Jerusalem; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Fainsod, A (corresponding author), Hebrew Univ Jerusalem, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, Fac Med, POB 12272, IL-91120 Jerusalem, Israel.	abrahamf@ekmd.huji.ac.il	Fainsod, Abraham/AAE-5633-2019	Shabtai, Yehuda/0000-0002-2415-4421; Schyr, Rachel/0000-0002-4894-7979	U.S.-Israel Binational Science Foundation; March of Dimes Birth Defects Foundation; Canadian Friends of Hebrew University; Wolfson Family Chair in Genetics	U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); March of Dimes Birth Defects Foundation(March of Dimes); Canadian Friends of Hebrew University; Wolfson Family Chair in Genetics	The authors thank Y. Dor, G. Pillemer, and Z. Paroush for critically reading this manuscript and F. H. Ruddle for fruitful discussions during the course of this research. This work was funded, in part, by grants from the U.S.-Israel Binational Science Foundation, the March of Dimes Birth Defects Foundation, the Canadian Friends of the Hebrew University, and the Wolfson Family Chair in Genetics to A. F.	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; ARCIONI L, 1992, EMBO J, V11, P265, DOI 10.1002/j.1460-2075.1992.tb05049.x; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Belting HG, 1998, J EXP ZOOL, V282, P196, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;196::AID-JEZ22&gt;3.0.CO;2-R; BLUMBERG B, 1991, SCIENCE, V253, P194, DOI 10.1126/science.1677215; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Charite J, 1998, DEVELOPMENT, V125, P4349; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Crawford M, 2003, J EXP ZOOL PART B, V295B, P1, DOI 10.1002/jez.b.00002; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; DEKKER EJ, 1993, MECH DEVELOP, V40, P3, DOI 10.1016/0925-4773(93)90083-A; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; DUBOULE D, 1994, DEVELOPMENT, P135; Epstein M, 1997, DEVELOPMENT, V124, P3805; Faas L, 2009, DEV DYNAM, V238, P835, DOI 10.1002/dvdy.21901; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; FRUMKIN A, 1993, DEVELOPMENT, V118, P553; GAMER LW, 1993, MECH DEVELOP, V43, P71, DOI 10.1016/0925-4773(93)90024-R; Gaunt SJ, 2004, INT J DEV BIOL, V48, P613, DOI 10.1387/ijdb.041829sg; GAUNT SJ, 1994, DEV DYNAM, V199, P229, DOI 10.1002/aja.1001990307; Gaunt SJ, 1996, DEV DYNAM, V207, P270, DOI 10.1002/(SICI)1097-0177(199611)207:3<270::AID-AJA4>3.0.CO;2-E; Gaunt SJ, 2008, DEVELOPMENT, V135, P2511, DOI 10.1242/dev.015909; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Isaacs HV, 1998, EMBO J, V17, P3413, DOI 10.1093/emboj/17.12.3413; Juan AH, 2003, DEVELOPMENT, V130, P4823, DOI 10.1242/dev.00672; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kobrossy L, 2006, J BIOL CHEM, V281, P25926, DOI 10.1074/jbc.M602555200; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Levy V, 2002, DEV BIOL, V248, P40, DOI 10.1006/dbio.2002.0705; Lohnes D, 2003, BIOESSAYS, V25, P971, DOI 10.1002/bies.10340; MARGALIT Y, 1993, NUCLEIC ACIDS RES, V21, P4915, DOI 10.1093/nar/21.21.4915; Marom K, 1997, MECH DEVELOP, V64, P41, DOI 10.1016/S0925-4773(97)00043-9; MEYER BI, 1993, DEVELOPMENT, V117, P191; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; NORTHROP JL, 1994, DEV BIOL, V161, P490, DOI 10.1006/dbio.1994.1047; Pillemer G, 1998, MECH DEVELOP, V71, P193, DOI 10.1016/S0925-4773(97)00193-7; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Pownall ME, 1996, DEVELOPMENT, V122, P3881; Rousso SZ, 2011, DEV DYNAM, V240, P796, DOI 10.1002/dvdy.22588; Shashikant CS, 1995, DEVELOPMENT, V121, P4339; Shashikant CS, 1996, P NATL ACAD SCI USA, V93, P12364, DOI 10.1073/pnas.93.22.12364; Shen WF, 1997, J BIOL CHEM, V272, P8198, DOI 10.1074/jbc.272.13.8198; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Taylor JK, 1997, NUCLEIC ACIDS RES, V25, P2293, DOI 10.1093/nar/25.12.2293; van den Akker E, 2002, DEVELOPMENT, V129, P2181; van Nes J, 2006, DEVELOPMENT, V133, P419, DOI 10.1242/dev.02216; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Wacker SA, 2004, DEV BIOL, V266, P123, DOI 10.1016/j.ydbio.2003.10.011; Wang WCH, 2004, J EXP ZOOL PART B, V302B, P436, DOI 10.1002/jez.b.21009; Young T, 2009, CURR TOP DEV BIOL, V88, P235, DOI 10.1016/S0070-2153(09)88008-3	57	8	8	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2674	2684		10.1096/fj.11-191403	http://dx.doi.org/10.1096/fj.11-191403			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22426122	Bronze			2022-12-25	WOS:000305017200043
J	Cihil, KM; Ellinger, P; Fellows, A; Stolz, DB; Madden, DR; Swiatecka-Urban, A				Cihil, Kristine M.; Ellinger, Philipp; Fellows, Abigail; Stolz, Donna Beer; Madden, Dean R.; Swiatecka-Urban, Agnieszka			Disabled-2 Protein Facilitates Assembly Polypeptide-2-independent Recruitment of Cystic Fibrosis Transmembrane Conductance Regulator to Endocytic Vesicles in Polarized Human Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN ADAPTERS; HALF-LIFE; CFTR; TRAFFICKING; GENE; AP-2; DELTA-F508-CFTR; IDENTIFICATION; DEGRADATION; ENDOSOMES	Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-activated Cl- channel expressed in the apical plasma membrane of fluid-transporting epithelia, where the plasma membrane abundance of CFTR is in part controlled by clathrin-mediated endocytosis. The protein networks that control CFTR endocytosis in epithelial cells have only been partially explored. The assembly polypeptide-2 complex (AP-2) is the prototypical endocytic adaptor critical for optimal clathrin coat formation. AP-2 is essential for recruitment of cargo proteins bearing the YXX Phi motif. Although AP-2 interacts directly with CFTR in vitro and facilitates CFTR endocytosis in some cell types, it remains unknown whether it is critical for CFTR uptake into clathrin-coated vesicles (CCVs). Disabled-2 (Dab2) is a clathrin-associated sorting protein (CLASP) that contributes to clathrin recruitment, vesicle formation, and cargo selection. In intestinal epithelial cells Dab2 was not found to play a direct role in CFTR endocytosis. By contrast, AP-2 and Dab2 were shown to facilitate CFTR endocytosis in human airway epithelial cells, although the specific mechanism remains unknown. Our data demonstrate that Dab2 mediates AP-2 independent recruitment of CFTR to CCVs in polarized human airway epithelial cells. As a result, it facilitates CFTR endocytosis and reduces CFTR abundance and stability in the plasma membrane. These effects are mediated by the DAB homology domain. Moreover, we show that in human airway epithelial cells AP-2 is not essential for CFTR recruitment to CCVs.	[Cihil, Kristine M.; Swiatecka-Urban, Agnieszka] Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15224 USA; [Ellinger, Philipp; Fellows, Abigail; Madden, Dean R.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Stolz, Donna Beer; Swiatecka-Urban, Agnieszka] Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Swiatecka-Urban, A (corresponding author), Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15224 USA.	asurban@pitt.edu	SWIATECKA-URBAN, AGNIESZKA/H-6494-2015; Swiatecka-Urban, Agnieszka/AAP-6041-2020	SWIATECKA-URBAN, AGNIESZKA/0000-0002-6575-0334; 	National Institutes of Health [R01HL090767, R01HL090767-02S1, R01DK075309]; Pennsylvania Department of Health; Hitchcock Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Hitchcock Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants R01HL090767 and R01HL090767-02S1 (to A. S.-U.) and Grant R01DK075309 (to D. R. M.). This work was also supported by the Pennsylvania Department of Health, Health Research Formula Fund to the Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System (to A. S.-U.) and a Hitchcock Foundation Program Project Grant (to D. R. M.).	Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Chang CW, 1997, J NEUROCHEM, V69, P859; Collaco A, 2010, J BIOL CHEM, V285, P17177, DOI 10.1074/jbc.M110.127613; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Girard Martine, 2005, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0313s26; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hentchel-Franks K, 2004, AM J RESP CELL MOL, V31, P140, DOI 10.1165/rcmb.2004-0012OC; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Hu W, 2001, BIOCHEM J, V354, P561, DOI 10.1042/0264-6021:3540561; Kues WA, 2000, BIOL REPROD, V62, P412, DOI 10.1095/biolreprod62.2.412; Lukacs GL, 1997, BIOCHEM J, V328, P353; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Okiyoneda T, 2007, BBA-MOL CELL RES, V1773, P476, DOI 10.1016/j.bbamcr.2007.01.004; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; WATTS C, 1988, EMBO J, V7, P1937, DOI 10.1002/j.1460-2075.1988.tb03031.x; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Weixel KM, 2000, J BIOL CHEM, V275, P3655, DOI 10.1074/jbc.275.5.3655; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200	37	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15087	15099		10.1074/jbc.M112.341875	http://dx.doi.org/10.1074/jbc.M112.341875			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399289	Green Published, hybrid			2022-12-25	WOS:000304003200070
J	Heath, S; McMahon, K; Nickels, L; Angwin, A; MacDonald, A; van Hees, S; Johnson, K; Copland, D				Heath, Shiree; McMahon, Katie; Nickels, Lyndsey; Angwin, Anthony; MacDonald, Anna; van Hees, Sophia; Johnson, Kori; Copland, David			Priming Picture Naming with a Semantic Task: An fMRI Investigation	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; FUNCTIONAL-ANATOMY; REPETITION SUPPRESSION; ALZHEIMERS-DISEASE; WORD PRODUCTION; LANGUAGE AREAS; MEMORY; BRAIN; LONG; MRI	Prior semantic processing can enhance subsequent picture naming performance, yet the neurocognitive mechanisms underlying this effect and its longevity are unknown. This functional magnetic resonance imaging study examined whether different neurological mechanisms underlie short-term (within minutes) and long-term (within days) facilitation effects from a semantic task in healthy older adults. Both short-and long-term facilitated items were named significantly faster than unfacilitated items, with short-term items significantly faster than long-term items. Region of interest results identified decreased activity for long-term facilitated items compared to unfacilitated and short-term facilitated items in the mid-portion of the middle temporal gyrus, indicating lexical-semantic priming. Additionally, in the whole brain results, increased activity for short-term facilitated items was identified in regions previously linked to episodic memory and object recognition, including the right lingual gyrus (extending to the precuneus region) and the left inferior occipital gyrus (extending to the left fusiform region). These findings suggest that distinct neurocognitive mechanisms underlie short-and long-term facilitation of picture naming by a semantic task, with long-term effects driven by lexical-semantic priming and short-term effects by episodic memory and visual object recognition mechanisms.	[Heath, Shiree; MacDonald, Anna; van Hees, Sophia; Copland, David] Univ Queensland, Clin Res Ctr, Language Neurosci Lab, Brisbane, Qld, Australia; [McMahon, Katie; Johnson, Kori] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia; [Nickels, Lyndsey] Macquarie Univ, ARC Ctr Excellence Cognit & its Disorders, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia; [Angwin, Anthony] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia	University of Queensland; University of Queensland; Macquarie University; University of Queensland	Heath, S (corresponding author), Univ Queensland, Clin Res Ctr, Language Neurosci Lab, Brisbane, Qld, Australia.	shiree.heath@uq.edu.au	MacDonald, Anna/G-2531-2010; Copland, David A/F-1409-2010; Angwin, Anthony/AAC-8524-2019; Angwin, Anthony J/F-7888-2010; McMahon, Katie L/C-6440-2009; Copland, David/AAE-5334-2020; Nickels, Lyndsey/O-7838-2019	Copland, David A/0000-0002-2257-4270; Angwin, Anthony/0000-0003-4547-9433; Angwin, Anthony J/0000-0003-4547-9433; McMahon, Katie L/0000-0002-6357-615X; Copland, David/0000-0002-2257-4270; Nickels, Lyndsey/0000-0002-0311-3524; Ramajoo, Kori/0000-0001-5218-6423; Heath, Shiree/0000-0001-8454-0570; Heath, Shiree/0000-0002-7602-0425	Australian Research Council [DP0880556]; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council Discovery grant (number DP0880556). DC was supported by a National Health and Medical Research Council Career Development Award - Clinical and Nickels by a National Health and Medical Research Council Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrahams S, 2003, HUM BRAIN MAPP, V20, P29, DOI 10.1002/hbm.10126; Baayen R. H, 1995, CELEX LEXICAL DATABA; Badgaiyan RD, 2000, HUM BRAIN MAPP, V10, P197, DOI 10.1002/1097-0193(200008)10:4<197::AID-HBM50>3.0.CO;2-B; Barch DM, 1999, NEUROIMAGE, V10, P642, DOI 10.1006/nimg.1999.0500; Becker S, 1997, J EXP PSYCHOL LEARN, V23, P1059, DOI 10.1037/0278-7393.23.5.1059; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Buchsbaum BR, 2001, COGNITIVE SCI, V25, P663, DOI 10.1207/s15516709cog2505_2; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cave CB, 1997, PSYCHOL SCI, V8, P322, DOI 10.1111/j.1467-9280.1997.tb00446.x; Chao LL, 1999, J COGNITIVE NEUROSCI, V11, P25, DOI 10.1162/089892999563229; Copland DA, 2003, NEUROIMAGE, V20, P302, DOI 10.1016/S1053-8119(03)00279-9; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Creem SH, 2001, ACTA PSYCHOL, V107, P43, DOI 10.1016/S0001-6918(01)00021-X; DAVIS HP, 1990, BEHAV NEUROSCI, V104, P288, DOI 10.1037/0735-7044.104.2.288; DEMB JB, 1995, J NEUROSCI, V15, P5870; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Eden GF, 1999, MAGN RESON MED, V41, P13, DOI 10.1002/(SICI)1522-2594(199901)41:1<13::AID-MRM4>3.0.CO;2-T; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fleischman DA, 1999, NEUROPSYCHOLOGY, V13, P22, DOI 10.1037/0894-4105.13.1.22; Fleischman DA, 2007, CORTEX, V43, P889, DOI 10.1016/S0010-9452(08)70688-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; Gaab N, 2007, HUM BRAIN MAPP, V28, P703, DOI 10.1002/hbm.20298; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; Garrard P, 2001, COGN NEUROPSYCHOL, V18, P125, DOI 10.1080/02643290125857; Gold BT, 2006, J NEUROSCI, V26, P6523, DOI 10.1523/JNEUROSCI.0808-06.2006; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Howard D, 2006, CORTEX, V42, P946, DOI 10.1016/S0010-9452(08)70439-8; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Joordens S, 1997, J EXP PSYCHOL LEARN, V23, P1083, DOI 10.1037/0278-7393.23.5.1083; Kan IP, 2003, COGN NEUROPSYCHOL, V20, P525, DOI 10.1080/02643290244000257; Kellenbach ML, 2005, CORTEX, V41, P121, DOI 10.1016/S0010-9452(08)70887-6; Kiss GR, 1973, COMPUTER LIT STUDIES, P153; Kohler S, 2000, ACTA PSYCHOL, V105, P159, DOI 10.1016/S0001-6918(00)00059-7; Laganaro M, 2006, NEUROPSYCHOL REHABIL, V16, P630, DOI 10.1080/09602010543000064; Levelt WJM, 1999, TRENDS COGN SCI, V3, P223, DOI 10.1016/S1364-6613(99)01319-4; LEVELT WJM, 1992, COGNITION, V42, P1, DOI 10.1016/0010-0277(92)90038-J; Maess B, 2002, J COGNITIVE NEUROSCI, V14, P455, DOI 10.1162/089892902317361967; MCNAMARA TP, 1992, J EXP PSYCHOL LEARN, V18, P1173, DOI 10.1037/0278-7393.18.6.1173; Meister IG, 2005, EUR J NEUROSCI, V21, P1101, DOI 10.1111/j.1460-9568.2005.03941.x; Meister IG, 2007, EXP BRAIN RES, V183, P371, DOI 10.1007/s00221-007-1051-8; MITCHELL DB, 1988, J EXP PSYCHOL LEARN, V14, P213, DOI 10.1037/0278-7393.14.2.213; Mitchell DB, 2003, PSYCHOL AGING, V18, P807, DOI 10.1037/0882-7974.18.4.807; Moore CJ, 1999, NEUROIMAGE, V10, P181, DOI 10.1006/nimg.1999.0450; Morrison CM, 1997, Q J EXP PSYCHOL-A, V50, P528, DOI 10.1080/027249897392017; MORTON J, 1969, PSYCHOL REV, V76, P165, DOI 10.1037/h0027366; Mummery CJ, 1999, NEUROIMAGE, V9, P516, DOI 10.1006/nimg.1999.0434; Nickels L, 2002, APHASIOLOGY, V16, P935, DOI 10.1080/02687030244000563; Nickels L, 2002, APHASIOLOGY, V16, P1047, DOI 10.1080/02687040143000618; Nickles L., 2001, HDB COGNITIVE NEUROP, P291; Nobre AC, 1997, CURR OPIN NEUROBIOL, V7, P262, DOI 10.1016/S0959-4388(97)80015-3; Papathanasiou I., 2000, ACQUIRED NEUROGENIC, P76; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Price CJ, 2005, HUM BRAIN MAPP, V25, P70, DOI 10.1002/hbm.20132; Raboyeau G, 2008, NEUROLOGY, V70, P290, DOI 10.1212/01.wnl.0000287115.85956.87; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Raposo A, 2006, NEUROPSYCHOLOGIA, V44, P2284, DOI 10.1016/j.neuropsychologia.2006.05.017; Rissman J, 2003, J COGNITIVE NEUROSCI, V15, P1160, DOI 10.1162/089892903322598120; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Spaan PEJ, 2010, AGING NEUROPSYCHOL C, V18, P86, DOI 10.1080/13825585.2010.511146; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; van Turennout M, 2003, CEREB CORTEX, V13, P381, DOI 10.1093/cercor/13.4.381; Vaughan JT, 2002, MAGNET RESON MED, V47, P990, DOI 10.1002/mrm.10141; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wagner AD, 1997, J COGNITIVE NEUROSCI, V9, P714, DOI 10.1162/jocn.1997.9.6.714; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; WHEELDON LR, 1994, J MEM LANG, V33, P332, DOI 10.1006/jmla.1994.1016; WHEELDON LR, 1992, Q J EXP PSYCHOL-A, V44, P723, DOI 10.1080/14640749208401307; Wig GS, 2009, J NEUROPHYSIOL, V101, P2632, DOI 10.1152/jn.91213.2008; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Zeng HR, 2002, MAGN RESON MED, V48, P137, DOI 10.1002/mrm.10200	87	17	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32809	10.1371/journal.pone.0032809	http://dx.doi.org/10.1371/journal.pone.0032809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412928	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800053
J	Stuss, DP; Boyd, JD; Levin, DB; Delaney, KR				Stuss, David P.; Boyd, Jamie D.; Levin, David B.; Delaney, Kerry R.			MeCP2 Mutation Results in Compartment-Specific Reductions in Dendritic Branching and Spine Density in Layer 5 Motor Cortical Neurons of YFP-H Mice	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME BRAIN; X-CHROMOSOME INACTIVATION; GENE-EXPRESSION; MOUSE MODELS; CEREBRAL-CORTEX; TRANSCRIPTIONAL REPRESSOR; SYNAPTIC PLASTICITY; DELAYED MATURATION; PYRAMIDAL NEURONS	Rett Syndrome (RTT) is a neurodevelopmental disorder predominantly caused by mutations in the X-linked gene MECP2. A primary feature of the syndrome is the impaired maturation and maintenance of excitatory synapses in the central nervous system (CNS). Different RTT mouse models have shown that particular Mecp2 mutations have highly variable effects on neuronal architecture. Distinguishing MeCP2 mutant cellular phenotypes therefore demands analysis of specific mutations in well-defined neuronal subpopulations. We examined a transgenically labeled subset of cortical neurons in YFP-H mice crossed with the Mecp2(tm1.1Jae) mutant line. YFP+ Layer 5 pyramidal neurons in the motor cortex of wildtype and hemizygous mutant male mice were examined for differences in dendrite morphology and spine density. Total basal dendritic length was decreased by 18.6% due to both shorter dendrites and reduced branching proximal to the soma. Tangential dendrite lengths in the apical tuft were reduced by up to 26.6%. Spine density was reduced by 47.4% in the apical tuft and 54.5% in secondary apical dendrites, but remained unaffected in primary apical and proximal basal dendrites. We also found that MeCP2 mutation reduced the number of YFP+ cells in YFP-H mice by up to 72% in various cortical regions without affecting the intensity of YFP expression in individual cells. Our results support the view that the effects of MeCP2 mutation are highly context-dependent and cannot be generalized across mutation types and cell populations.	[Stuss, David P.; Delaney, Kerry R.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Boyd, Jamie D.] Univ British Columbia, Fac Med, Dept Psychiat, Vancouver, BC, Canada; [Levin, David B.] Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada	University of Victoria; University of British Columbia; University of Manitoba	Stuss, DP (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	stussd@uvic.ca			IRSF; International Rett Syndrome Foundation; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research	IRSF; International Rett Syndrome Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by the Rett Syndrome Research Foundation (now the IRSF, below) (to Dr. Levin and Dr. Delaney; grant title "MeCP2 Replacement Therapy for Rett Syndrome: A mouse mode"l). The International Rett Syndrome Foundation (http://www.rettsyndrome.org/) (to Dr. Delaney; grant title "Cell autonomous versus environmental effects on neuronal morphology in brains of a Rett syndrome mouse model), and by graduate scholarships (to Dr. Stuss) from Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and the Michael Smith Foundation for Health Research (http://www.msfhr.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; Akemann W, 2004, J COMP NEUROL, V480, P72, DOI 10.1002/cne.20338; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Armstrong DD, 1998, J NEUROPATH EXP NEUR, V57, P1013, DOI 10.1097/00005072-199811000-00003; Armstrong DD, 2001, BRAIN DEV-JPN, V23, pS72, DOI 10.1016/S0387-7604(01)00332-1; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Balmer D, 2003, J MOL MED-JMM, V81, P61, DOI 10.1007/s00109-002-0396-5; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; BAUMAN ML, 1995, NEUROPEDIATRICS, V26, P105, DOI 10.1055/s-2007-979737; Beirowski B, 2004, J NEUROSCI METH, V134, P23, DOI 10.1016/j.jneumeth.2003.10.016; Belichenko NP, 2008, J COMP NEUROL, V508, P184, DOI 10.1002/cne.21673; Belichenko NP, 2009, NEUROBIOL DIS, V34, P71, DOI 10.1016/j.nbd.2008.12.016; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; Belichenko PV, 1997, ACTA NEUROPATHOL, V93, P50, DOI 10.1007/s004010050582; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Bittner T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015477; Braunschweig D, 2004, HUM MOL GENET, V13, P1275, DOI 10.1093/hmg/ddh142; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Carter JC, 2008, AM J NEURORADIOL, V29, P436, DOI 10.3174/ajnr.A0857; Cassel S, 2004, NEUROBIOL DIS, V15, P206, DOI 10.1016/j.nbd.2003.10.011; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001; Charman T, 2005, EUR J HUM GENET, V13, P1121, DOI 10.1038/sj.ejhg.5201471; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cohen DRS, 2003, MOL CELL NEUROSCI, V22, P417, DOI 10.1016/S1044-7431(03)00026-5; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Coy JF, 1999, HUM MOL GENET, V8, P1253, DOI 10.1093/hmg/8.7.1253; Degano AL, 2009, MOL CELL NEUROSCI, V42, P243, DOI 10.1016/j.mcn.2009.07.009; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Gibson JH, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-53; Graubert TA, 1998, NUCLEIC ACIDS RES, V26, P2849, DOI 10.1093/nar/26.12.2849; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hagberg B, 2002, MENT RETARD DEV D R, V8, P61, DOI 10.1002/mrdd.10020; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Jentarra GM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-19; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kishi N, 2010, EXP NEUROL, V222, P51, DOI 10.1016/j.expneurol.2009.12.007; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Landi S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00045; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Migliore M, 2005, NAT REV NEUROSCI, V6, P810, DOI 10.1038/nrn1769; Miller MN, 2008, J NEUROSCI, V28, P13716, DOI 10.1523/JNEUROSCI.2940-08.2008; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Mullaney BC, 2004, NEUROSCIENCE, V123, P939, DOI 10.1016/j.neuroscience.2003.11.025; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; OLEARY DDM, 1985, BRAIN RES, V336, P326, DOI 10.1016/0006-8993(85)90661-4; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peddada S, 2006, HUM MOL GENET, V15, P2003, DOI 10.1093/hmg/ddl124; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; PERCY AK, 1988, J CHILD NEUROL, V3, pS65, DOI 10.1177/0883073888003001S12; Reichwald K, 2000, MAMM GENOME, V11, P182, DOI 10.1007/s003350010035; Samaco RC, 2004, HUM MOL GENET, V13, P629, DOI 10.1093/hmg/ddh063; Schanen C, 2004, AM J MED GENET A, V126A, P129, DOI 10.1002/ajmg.a.20571; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; STANFIELD BB, 1985, J COMP NEUROL, V238, P236, DOI 10.1002/cne.902380210; Subramaniam B, 1997, NEUROLOGY, V48, P399, DOI 10.1212/WNL.48.2.399; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; THONG IG, 1987, NEUROSCI LETT, V80, P275, DOI 10.1016/0304-3940(87)90467-8; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Tsiola A, 2003, J COMP NEUROL, V461, P415, DOI 10.1002/cne.10628; Urdinguio RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003669; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Wu H, 2010, P NATL ACAD SCI US; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yu JN, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.006.2008; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	91	50	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e31896	10.1371/journal.pone.0031896	http://dx.doi.org/10.1371/journal.pone.0031896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412847	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800008
J	Hodaie, M; Chen, DQX; Quan, J; Laperriere, N				Hodaie, Mojgan; Chen, David Qixiang; Quan, Jessica; Laperriere, Normand			Tractography Delineates Microstructural Changes in the Trigeminal Nerve after Focal Radiosurgery for Trigeminal Neuralgia	PLOS ONE			English	Article							GAMMA-KNIFE SURGERY; VISUALIZATION; DEMYELINATION; DYSFUNCTION	Purpose: Focal radiosurgery is a common treatment modality for trigeminal neuralgia (TN), a neuropathic facial pain condition. Assessment of treatment effectiveness is primarily clinical, given the paucity of investigational tools to assess trigeminal nerve changes. Since diffusion tensor imaging (DTI) provides information on white matter microstructure, we explored the feasibility of trigeminal nerve tractography and assessment of DTI parameters to study microstructural changes after treatment. We hypothesized that trigeminal tractography provides more information than 2D-MR imaging, allowing detection of unique, focal changes in the target area after radiosurgery. Changes in specific diffusivities may provide insight into the mechanism of action of radiosurgery on the trigeminal nerve. Methods and Materials: Five TN patients (4 females, 1 male, average age 67 years) treated with Gamma Knife radiosurgery, 80 Gy/100% isodose line underwent 3Tesla MR trigeminal nerve tractography before and sequentially up to fourteen months after treatment. Fractional anisotropy (FA), radial (RD) and axial (AD) diffusivities were calculated for the radiosurgical target area defined as the region-of-interest. Areas outside target and the contralateral nerve served as controls. Results: Trigeminal tractography accurately detected the radiosurgical target. Radiosurgery resulted in 47% drop in FA values at the target with no significant change in FA outside the target, demonstrating highly focal changes after treatment. RD but not AD changed markedly, suggesting that radiosurgery primarily affects myelin. Tractography was more sensitive than conventional gadolinium-enhanced post-treatment MR, since FA changes were detected regardless of trigeminal nerve enhancement. In subjects with long term follow-up, recovery of FA/RD correlated with pain recurrence. Conclusions: DTI parameters accurately detect the effects of focal radiosurgery on the trigeminal nerve, serving as an in vivo imaging tool to study TN. This study is a proof of principle for further assessment of DTI parameters to understand the pathophysiology of TN and treatment effects.	[Hodaie, Mojgan] Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Hodaie, Mojgan; Chen, David Qixiang] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON M5S 1A1, Canada; [Quan, Jessica] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Laperriere, Normand] Princess Margaret Hosp, Radiat Med Program, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Hodaie, M (corresponding author), Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada.	mojgan.hodaie@uhn.on.ca		Laperriere, Normand/0000-0001-8930-9650; Chen, David Qixiang/0000-0001-6407-8024	Physicians' Services Incorporated Foundation (PSI Foundation)	Physicians' Services Incorporated Foundation (PSI Foundation)	This work was partially funded by the Physicians' Services Incorporated Foundation (PSI Foundation, www.psifoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alberico RA, 2001, AM J NEURORADIOL, V22, P1944; Boorman ED, 2007, CURR BIOL, V17, P1426, DOI 10.1016/j.cub.2007.07.040; Burchiel KJ, 2003, NEUROSURGERY, V53, P1164, DOI 10.1227/01.NEU.0000088806.11659.D8; Chen DQ, 2011, NEUROSURGERY, V68, P1077, DOI 10.1227/NEU.0b013e31820c6cbe; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Gronseth G, 2008, NEUROLOGY, V71, P1183, DOI 10.1212/01.wnl.0000326598.83183.04; HILTON DA, 1994, NEUROSURGERY, V35, P299, DOI 10.1227/00006123-199408000-00017; Hodaie M, 2010, NEUROSURGERY, V66, P788, DOI 10.1227/01.NEU.0000367613.09324.DA; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kihlstrom L, 1997, NEUROSURGERY, V41, P396, DOI 10.1097/00006123-199708000-00011; Kondziolka D, 2000, NEUROSURGERY, V46, P971, DOI 10.1097/00006123-200004000-00038; Kondziolka D, 1996, J NEUROSURG, V84, P940, DOI 10.3171/jns.1996.84.6.0940; Kondziolka D, 2009, J NEUROSURG; Linskey ME, 2008, J NEUROSURG, V109, P160, DOI 10.3171/JNS/2008/109/12/S25; Love S, 2001, BRAIN, V124, P2347, DOI 10.1093/brain/124.12.2347; Love S, 1998, BRAIN PATHOL, V8, P1; Massager N, 2007, INT J RADIAT ONCOL, V69, P1514, DOI 10.1016/j.ijrobp.2007.05.013; Massager N, 2007, NEUROSURGERY, V60, P681, DOI 10.1227/01.NEU.0000255393.77538.75; Matsuda S, 2010, J NEUROSURG, V113, P184, DOI 10.3171/2010.8.GKS10953; Mori S, 2008, ORAL SURG ORAL MED O, V106, P270, DOI 10.1016/j.tripleo.2008.03.015; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Pollock BE, 2006, J NEUROSURG, V105, P103, DOI 10.3171/sup.2006.105.7.103; Regis J, 2006, J NEUROSURG, V104, P913, DOI 10.3171/jns.2006.104.6.913; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Taoka T, 2006, J MAGN RESON IMAGING, V24, P1005, DOI 10.1002/jmri.20725	26	48	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32745	10.1371/journal.pone.0032745	http://dx.doi.org/10.1371/journal.pone.0032745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412918	Green Published, Green Submitted, gold			2022-12-25	WOS:000303021100026
J	Kazantsev, V; Tyukin, I				Kazantsev, Victor; Tyukin, Ivan			Adaptive and Phase Selective Spike Timing Dependent Plasticity in Synaptically Coupled Neuronal Oscillators	PLOS ONE			English	Article							CALCIUM; MODULATION; SYNAPSES; DYNAMICS; PATTERNS; SYSTEMS; STDP	We consider and analyze the influence of spike-timing dependent plasticity (STDP) on homeostatic states in synaptically coupled neuronal oscillators. In contrast to conventional models of STDP in which spike-timing affects weights of synaptic connections, we consider a model of STDP in which the time lags between pre-and/or post-synaptic spikes change internal state of pre-and/or post-synaptic neurons respectively. The analysis reveals that STDP processes of this type, modeled by a single ordinary differential equation, may ensure efficient, yet coarse, phase-locking of spikes in the system to a given reference phase. Precision of the phase locking, i.e. the amplitude of relative phase deviations from the reference, depends on the values of natural frequencies of oscillators and, additionally, on parameters of the STDP law. These deviations can be optimized by appropriate tuning of gains (i.e. sensitivity to spike-timing mismatches) of the STDP mechanism. However, as we demonstrate, such deviations can not be made arbitrarily small neither by mere tuning of STDP gains nor by adjusting synaptic weights. Thus if accurate phase-locking in the system is required then an additional tuning mechanism is generally needed. We found that adding a very simple adaptation dynamics in the form of slow fluctuations of the base line in the STDP mechanism enables accurate phase tuning in the system with arbitrary high precision. Adaptation operating at a slow time scale may be associated with extracellular matter such as matrix and glia. Thus the findings may suggest a possible role of the latter in regulating synaptic transmission in neuronal circuits.	[Kazantsev, Victor] RAS, Inst Appl Phys, Dept Nonlinear Dynam, Nizhnii Novgorod, Russia; [Kazantsev, Victor] Univ Nizhny Novgorod, Dept Neurodynam & Neurobiol, Nizhnii Novgorod, Russia; [Tyukin, Ivan] Univ Leicester, Dept Math, Leicester, Leics, England	Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; Lobachevsky State University of Nizhni Novgorod; University of Leicester	Kazantsev, V (corresponding author), RAS, Inst Appl Phys, Dept Nonlinear Dynam, Nizhnii Novgorod, Russia.	vkazan@neuron.appl.sci-nnov.ru	Tyukin, Ivan Yu/M-8466-2013; Tyukin, Ivan/Q-6747-2019; Kazantsev, Victor B/L-1424-2013	Tyukin, Ivan Yu/0000-0002-7359-7966; Tyukin, Ivan/0000-0002-7359-7966; Kazantsev, Viktor/0000-0002-2881-6648	Russian Academy of Sciences; Russian President grant [MD-5096.2011.2]; Royal Society; Russian Foundation for Basic Research [11-04-12144]; Federal Program "Scientific and Scientific-educational brainpower of innovative Russia'' [652 14.740.11.0075]	Russian Academy of Sciences(Russian Academy of Sciences); Russian President grant; Royal Society(Royal Society of London); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Program "Scientific and Scientific-educational brainpower of innovative Russia''	This work was supported by the Molecular and Cellular Biology Program of the Russian Academy of Sciences http://molbiol.edu.ru/data/(VK), Russian President grant MD-5096.2011.2, http://grants.extech.ru (VK), Royal Society Joint UK-Russia Project Grant http://royalsociety.org/grants/schemes/international-joint-projects/ (VK, IT), Russian Foundation for Basic Research Grant No. 11-04-12144, http://www.rfbr.ru (VK), Federal Program "Scientific and Scientific-educational brainpower of innovative Russia'' for 2009-2013 (Grant No. 652 14.740.11.0075) http://www.fcpk.ru (VK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Bem T, 2004, J NEUROPHYSIOL, V91, P693, DOI 10.1152/jn.00783.2003; Chik D, 2009, NEURAL NETWORKS, V22, P890, DOI 10.1016/j.neunet.2009.02.002; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Diana MA, 2005, CELL CALCIUM, V37, P497, DOI 10.1016/j.ceca.2005.01.020; Dityatev A, 2011, CURR OPIN NEUROBIOL, V21, P353, DOI 10.1016/j.conb.2010.12.006; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Graupner M, 2007, PLOS COMPUT BIOL, V3, P2299, DOI 10.1371/journal.pcbi.0030221; Guckenheimer J., 1986, NONLINEAR OSCILLATIO; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Izhikevich EM, 2003, NEURAL COMPUT, V15, P1511, DOI 10.1162/089976603321891783; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kazantsev VB, 2005, CHAOS, V15, DOI 10.1063/1.1883866; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Lanore F, 2009, J NEUROSCI, V29, P8299, DOI 10.1523/JNEUROSCI.1997-09.2009; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; Ohno-Shosaku T, 2005, CELL CALCIUM, V38, P369, DOI 10.1016/j.ceca.2005.06.014; Pikovsky A, 2001, SYNCHRONIZATION UNIF; Rolston JD, 2007, NEUROSCIENCE, V148, P294, DOI 10.1016/j.neuroscience.2007.05.025; ROWAT PF, 1993, J NEUROPHYSIOL, V70, P1030, DOI 10.1152/jn.1993.70.3.1030; Shilnikov LP, 2001, METHODS QUALITATIVE; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Szatmary B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000879; Tyukin I, 2011, ADAPTATION IN DYNAMICAL SYSTEMS, P1, DOI 10.1017/CBO9780511973437; Tyukin I, 2008, SIAM J CONTROL OPTIM, V47, P849, DOI 10.1137/060672546; Whitehead A, 2003, BIOL CYBERN, V88, P229, DOI 10.1007/s00422-002-0376-4	35	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e30411	10.1371/journal.pone.0030411	http://dx.doi.org/10.1371/journal.pone.0030411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412830	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100002
J	Walper, SA; Anderson, GP; Lee, PAB; Glaven, RH; Liu, JL; Bernstein, RD; Zabetakis, D; Johnson, L; Czarnecki, JM; Goldman, ER				Walper, Scott A.; Anderson, George P.; Lee, P. Audrey Brozozog; Glaven, Richard H.; Liu, Jinny L.; Bernstein, Rachel D.; Zabetakis, Dan; Johnson, Linwood; Czarnecki, Jill M.; Goldman, Ellen R.			Rugged Single Domain Antibody Detection Elements for Bacillus anthracis Spores and Vegetative Cells	PLOS ONE			English	Article							REAL-TIME PCR; S-LAYER; CEREUS GROUP; ANTIGEN RECEPTOR; PHAGE DISPLAY; LIGHT-CHAINS; PROTEINS; IDENTIFICATION; FRAGMENTS; SHARKS	Significant efforts to develop both laboratory and field-based detection assays for an array of potential biological threats started well before the anthrax attacks of 2001 and have continued with renewed urgency following. While numerous assays and methods have been explored that are suitable for laboratory utilization, detection in the field is often complicated by requirements for functionality in austere environments, where limited cold-chain facilities exist. In an effort to overcome these assay limitations for Bacillus anthracis, one of the most recognizable threats, a series of single domain antibodies (sdAbs) were isolated from a phage display library prepared from immunized llamas. Characterization of target specificity, affinity, and thermal stability was conducted for six sdAb families isolated from rounds of selection against the bacterial spore. The protein target for all six sdAb families was determined to be the S-layer protein EA1, which is present in both vegetative cells and bacterial spores. All of the sdAbs examined exhibited a high degree of specificity for the target bacterium and its spore, with affinities in the nanomolar range, and the ability to refold into functional antigen-binding molecules following several rounds of thermal denaturation and refolding. This research demonstrates the capabilities of these sdAbs and their potential for integration into current and developing assays and biosensors.	[Walper, Scott A.; Anderson, George P.; Liu, Jinny L.; Zabetakis, Dan; Goldman, Ellen R.] USN, Ctr Bio Mol Sci & Engn, Res Lab, Washington, DC 20375 USA; [Lee, P. Audrey Brozozog; Glaven, Richard H.; Bernstein, Rachel D.] Nova Res Inc, Alexandria, VA USA; [Johnson, Linwood; Czarnecki, Jill M.] USN, Biol Def Res Directorate, Med Res Ctr, Silver Spring, MD USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Nova Research, Inc.; United States Department of Defense; United States Navy	Walper, SA (corresponding author), USN, Ctr Bio Mol Sci & Engn, Res Lab, Washington, DC 20375 USA.	ellen.goldman@nrl.navy.mil	Walper, Scott/A-5110-2018; Anderson, George P/D-2461-2011	Walper, Scott/0000-0002-9436-3456; Anderson, George P/0000-0001-7545-9893; LEE, PAMELA/0000-0002-9341-0759	Defense Threat Reduction Agency [CBM.DIAGB.01.10.NRL.011]; Office of Naval Research NRL	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Office of Naval Research NRL(Office of Naval Research)	This work was supported by the Defense Threat Reduction Agency, project # CBM.DIAGB.01.10.NRL.011 and the Office of Naval Research NRL base funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Anderson GP, 2010, ANAL CHEM, V82, P7202, DOI 10.1021/ac100961x; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Castanha ER, 2006, J MICROBIOL METH, V67, P230, DOI 10.1016/j.mimet.2006.03.024; Conway JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008818; Couture-Tosi E, 2002, J BACTERIOL, V184, P6448, DOI 10.1128/JB.184.23.6448-6456.2002; Dooley H, 2003, MOL IMMUNOL, V40, P25, DOI 10.1016/S0161-5890(03)00084-1; Ellerbrok H, 2002, FEMS MICROBIOL LETT, V214, P51, DOI 10.1016/S0378-1097(02)00837-6; ETIENNETOUMELIN I, 1995, J BACTERIOL, V177, P614, DOI 10.1128/jb.177.3.614-620.1995; EZZELL JW, 1988, INFECT IMMUN, V56, P349, DOI 10.1128/IAI.56.2.349-356.1988; FARCHAUS JW, 1995, J BACTERIOL, V177, P2481, DOI 10.1128/jb.177.9.2481-2489.1995; Frenken LGJ, 1999, BIOCHIM BIOPHYS ACTA; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Goldman ER, 2008, ANAL CHEM, V80, P8583, DOI 10.1021/ac8014774; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; GRIFFITHS AD, 1993, EMBO J, V12, P725, DOI 10.1002/j.1460-2075.1993.tb05706.x; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; HARRELL LJ, 1995, J CLIN MICROBIOL, V33, P1847, DOI 10.1128/JCM.33.7.1847-1850.1995; Hart SJ, 2006, ANAL CHEM, V78, P3221, DOI 10.1021/ac052221z; Hayhurst A, 2003, J IMMUNOL METHODS, V276, P185, DOI 10.1016/S0022-1759(03)00100-5; HENDERSON I, 1994, INT J SYST BACTERIOL, V44, P99, DOI 10.1099/00207713-44-1-99; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jackson PJ, 1998, P NATL ACAD SCI USA, V95, P1224, DOI 10.1073/pnas.95.3.1224; Lane HC, 2001, NAT MED, V7, P1271, DOI 10.1038/nm1201-1271; Leski TA, 2009, APPL ENVIRON MICROB, V75, P7163, DOI 10.1128/AEM.01069-09; Love TE, 2008, J IMMUNOL METHODS, V334, P1, DOI 10.1016/j.jim.2007.12.022; Lowman H.B, 2004, PHAGE DISPLAY; Mesnage S, 1997, MOL MICROBIOL, V23, P1147, DOI 10.1046/j.1365-2958.1997.2941659.x; Mesnage S, 1998, J BACTERIOL, V180, P52, DOI 10.1128/JB.180.1.52-58.1998; Meyer W, 1999, LETT APPL MICROBIOL, V28, P98, DOI 10.1046/j.1365-2672.1999.00494.x; Mignot T, 2002, MOL MICROBIOL, V43, P1615, DOI 10.1046/j.1365-2958.2002.02852.x; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Nuttall SD, 2001, MOL IMMUNOL, V38, P313, DOI 10.1016/S0161-5890(01)00057-8; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Pribil PA, 2005, J MASS SPECTROM, V40, P464, DOI 10.1002/jms.816; Qi YA, 2001, APPL ENVIRON MICROB, V67, P3720, DOI 10.1128/AEM.67.8.3720-3727.2001; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; SEKI T, 1978, INT J SYST BACTERIOL, V28, P182, DOI 10.1099/00207713-28-2-182; SOMERVILLE HJ, 1972, J GEN MICROBIOL, V73, P257, DOI 10.1099/00221287-73-2-257; Swain MD, 2011, ANAL BIOCHEM, V417, P188, DOI 10.1016/j.ab.2011.06.012; TURNBULL PCB, 1992, J APPL BACTERIOL, V72, P21; Wang DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007810; WANG PZ, 1984, J BIOL CHEM, V259, P8619; Williams DD, 2004, J BACTERIOL, V186, P566, DOI 10.1128/JB.186.2.566-569.2004	48	34	35	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32801	10.1371/journal.pone.0032801	http://dx.doi.org/10.1371/journal.pone.0032801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412927	Green Submitted, Green Published, gold			2022-12-25	WOS:000303021100031
J	Wang, MY; Zhang, RX; He, J; Qiu, LX; Li, J; Wang, YO; Sun, MH; Yang, YJ; Wang, JC; Yang, JM; Qian, J; Jin, L; Ma, HX; Wei, QY; Zhou, XY				Wang, Mengyun; Zhang, Ruoxin; He, Jing; Qiu, Lixin; Li, Jin; Wang, Yanong; Sun, Menghong; Yang, Yajun; Wang, Jiucun; Yang, Jingmin; Qian, Ji; Jin, Li; Ma, Hongxia; Wei, Qingyi; Zhou, Xiaoyan			Potentially Functional Variants of PLCE1 Identified by GWASs Contribute to Gastric Adenocarcinoma Susceptibility in an Eastern Chinese Population	PLOS ONE			English	Article							PHOSPHOLIPASE-C-EPSILON; SQUAMOUS-CELL CARCINOMA; DNA-REPAIR; CANCER; POLYMORPHISMS; GENES; INFLAMMATION; ASSOCIATION; MUTATIONS; IL-1RN	Background: Recent genome-wide association studies (GWAS) have found a single nucleotide polymorphism (SNP, rs2274223 A>G) in PLCE1 to be associated with risk of gastric adenocarcinoma. In the present study, we validated this finding and also explored the risk associated with another unreported potentially functional SNP (rs11187870 G>C) of PLCE1 in a hospital-based case-control study of 1059 patients with pathologically confirmed gastric adenocarcinoma and 1240 frequency-matched healthy controls. Methodology/Principal Findings: We determined genotypes of these two SNPs by the Taqman assay and used logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (95% CI). We found that a significant higher gastric adenocarcinoma risk was associated with rs2274223 variant G allele (adjusted OR = 1.35, 95% CI = 1.14-1.60 for AG+GG vs. AA) and rs11187870 variant C allele (adjusted OR = 1.26, 95% CI = 1.05-1.50 for CG+CC vs. GG). We also found that the number of combined risk alleles (i.e., rs2274223G and rs11187870C) was associated with risk of gastric adenocarcinoma in an allele-dose effect manner (P-trend = 0.0002). Stratification analysis indicated that the combined effect of rs2274223G and rs11187870C variant alleles was more evident in subgroups of males, non-smokers, non-drinkers and patients with gastric cardia adenocarcinoma. Further real-time PCR results showed that expression levels of PLCE1 mRNA were significantly lower in tumors than in adjacent noncancerous tissues (0.019 +/- 0.002 vs. 0.008 +/- 0.001, P < 0.05). Conclusions/Significances: Our results further confirmed that genetic variations in PLCE1 may contribute to gastric adenocarcinoma risk in an eastern Chinese population.	[Wang, Mengyun; Zhang, Ruoxin; He, Jing; Wei, Qingyi; Zhou, Xiaoyan] Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China; [Qiu, Lixin; Li, Jin] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Wang, Yanong] Fudan Univ, Shanghai Canc Ctr, Dept Abdominal Surg, Shanghai 200433, Peoples R China; [Sun, Menghong; Zhou, Xiaoyan] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Yang, Yajun; Wang, Jiucun; Yang, Jingmin; Qian, Ji; Jin, Li] Fudan Univ, Sch Life Sci, Key Lab Contemporary Anthropol, Minist Educ,State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Yang, Yajun; Wang, Jiucun; Yang, Jingmin; Qian, Ji; Jin, Li] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China; [Ma, Hongxia] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Nanjing, Jiangsu, Peoples R China; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Sun, Menghong; Zhou, Xiaoyan] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Nanjing Medical University; University of Texas System; UTMD Anderson Cancer Center; Fudan University	Wang, MY (corresponding author), Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China.	weiqingyi@yahoo.com; xyzhou100@yahoo.com	Jin, Li/C-1468-2009; He, Jing/M-5774-2015; Wang, Jiucun/J-8744-2012; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; He, Jing/0000-0002-1954-2892; Wang, Jiucun/0000-0003-2765-0620; 	Fudan University; Ministry of Health [201002007]; Fundamental Research Funds for the Central Universities	Fudan University; Ministry of Health; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by funding from Chinese Recruitment Program of Global Experts at Fudan University and a grant from the Ministry of Health (grant number 201002007), and was sponsored by the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Barnes MR, 2007, EXPERT OPIN BIOL TH, V7, P1387, DOI 10.1517/14712598.7.9.1387; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Boccia S, 2006, MUTAGENESIS, V21, P115, DOI 10.1093/mutage/gel005; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Chang-Claude J, 2005, CLIN CANCER RES, V11, P4802, DOI 10.1158/1078-0432.CCR-04-2657; Garza-Gonzalez E, 2005, INT J CANCER, V114, P237, DOI 10.1002/ijc.20718; Gbadegesin R, 2008, NEPHROL DIAL TRANSPL, V23, P1291, DOI 10.1093/ndt/gfm759; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hu Zhibin, 2007, Gastrointest Cancer Res, V1, P12; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Ruzzo A, 2005, ANN ONCOL, V16, P887, DOI 10.1093/annonc/mdi184; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Sun L, 2008, EUR J CANCER PREV, V17, P446, DOI 10.1097/CEJ.0b013e328305a140; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang X., 2011, MED ONCOL; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; Wu MS, 2005, CANCER EPIDEM BIOMAR, V14, P1878, DOI 10.1158/1055-9965.EPI-04-0792; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yun S, 2008, J BIOL CHEM, V283, P341, DOI 10.1074/jbc.M704180200; Zhang HZ, 2011, CARCINOGENESIS, V32, P848, DOI 10.1093/carcin/bgr051	35	30	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e31932	10.1371/journal.pone.0031932	http://dx.doi.org/10.1371/journal.pone.0031932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412849	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100010
J	Bilgin, CC; Ray, S; Baydil, B; Daley, WP; Larsen, M; Yener, B				Bilgin, Cemal Cagatay; Ray, Shayoni; Baydil, Banu; Daley, William P.; Larsen, Melinda; Yener, Bulent			Multiscale Feature Analysis of Salivary Gland Branching Morphogenesis	PLOS ONE			English	Article							DYNAMICS; CELL	Pattern formation in developing tissues involves dynamic spatio-temporal changes in cellular organization and subsequent evolution of functional adult structures. Branching morphogenesis is a developmental mechanism by which patterns are generated in many developing organs, which is controlled by underlying molecular pathways. Understanding the relationship between molecular signaling, cellular behavior and resulting morphological change requires quantification and categorization of the cellular behavior. In this study, tissue-level and cellular changes in developing salivary gland in response to disruption of ROCK-mediated signaling by are modeled by building cell-graphs to compute mathematical features capturing structural properties at multiple scales. These features were used to generate multiscale cell-graph signatures of untreated and ROCK signaling disrupted salivary gland organ explants. From confocal images of mouse submandibular salivary gland organ explants in which epithelial and mesenchymal nuclei were marked, a multiscale feature set capturing global structural properties, local structural properties, spectral, and morphological properties of the tissues was derived. Six feature selection algorithms and multiway modeling of the data was performed to identify distinct subsets of cell graph features that can uniquely classify and differentiate between different cell populations. Multiscale cell-graph analysis was most effective in classification of the tissue state. Cellular and tissue organization, as defined by a multiscale subset of cell-graph features, are both quantitatively distinct in epithelial and mesenchymal cell types both in the presence and absence of ROCK inhibitors. Whereas tensor analysis demonstrate that epithelial tissue was affected the most by inhibition of ROCK signaling, significant multiscale changes in mesenchymal tissue organization were identified with this analysis that were not identified in previous biological studies. We here show how to define and calculate a multiscale feature set as an effective computational approach to identify and quantify changes at multiple biological scales and to distinguish between different states in developing tissues.	[Bilgin, Cemal Cagatay; Baydil, Banu; Yener, Bulent] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Ray, Shayoni; Daley, William P.; Larsen, Melinda] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Bilgin, CC (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Life Sci, Berkeley, CA 94720 USA.	yener@cs.rpi.edu		Larsen, Melinda/0000-0002-5026-2012	National Institutes of Health [R01 DE019244, RO1 EB008016]; Div Of Biological Infrastructure [0922830] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by the National Institutes of Health (R01 DE019244 to ML and BY and RO1 EB008016 to BY and George Plopper). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Barabasi A., 2007, NEW ENGLAND J MED; Bilgin C, 2007, 29 INT C IEEE ENG ME; Bilgin CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012783; Bilgin CC, 2010, I S BIOMED IMAGING, P1427, DOI 10.1109/ISBI.2010.5490267; Bilgin CC, 2010, DATA MIN KNOWL DISC, V20, P416, DOI 10.1007/s10618-009-0153-2; Bilke S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.036106; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chung F., 1997, SPECTRAL GRAPH THEOR; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Daley WP, 2012, DEVELOPMENT, V139, P411, DOI 10.1242/dev.075366; Daley WP, 2011, DEV DYNAM, V240, P2069, DOI 10.1002/dvdy.22714; Daley WP, 2009, DEV BIOL, V336, P169, DOI 10.1016/j.ydbio.2009.09.037; Feng YQ, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2085, DOI 10.1109/ICMLC.2003.1259848; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Gunduz C, 2004, BIOINFORMATICS, V20, P145, DOI 10.1093/bioinformatics/bth933; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hall M, 1999, THESIS CITESEER 19, P19; Hartmann D, 2007, MATH MED BIOL, V24, P209, DOI 10.1093/imammb/dql029; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Keenan SJ, 2000, J PATHOL, V192, P351, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH708>3.0.CO;2-I; KIRA K, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P129; Larsen M, 2003, DEV BIOL, V255, P178, DOI 10.1016/S0012-1606(02)00047-7; Larsen M, 2010, WILEY INTERDISCIPLIN; Larsen M, 2006, J CELL SCI, V119, P3376, DOI 10.1242/jcs.03079; Liu H., 1996, ICML, V96, P319; Lubkin SR, 2002, BIOMECH MODEL MECHAN, V1, P5, DOI 10.1007/s10237-002-0001-4; Lubkin SR, 2008, CURR TOP DEV BIOL, V81, P249, DOI 10.1016/S0070-2153(07)81008-8; Lund AW, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/928286; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Molina LC, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P306, DOI 10.1109/ICDM.2002.1183917; Otsu N, 1975, AUTOMATICA, V11, P285; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rawat A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S7; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Tucker L.R, 1964, CONTRIBUTIONS MATH P, P109; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei C, 2007, TISSUE ENG, V13, P721, DOI 10.1089/ten.2006.0123; Weyn B, 1999, CYTOMETRY, V35, P23, DOI 10.1002/(SICI)1097-0320(19990101)35:1<23::AID-CYTO4>3.0.CO;2-P; Wise B. M., 2006, CHEMOMETRICS TUTORIA	45	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32906	10.1371/journal.pone.0032906	http://dx.doi.org/10.1371/journal.pone.0032906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403724	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700121
J	Corley, SW; Piper, EK; Jonsson, NN				Corley, Sean W.; Piper, Emily K.; Jonsson, Nicholas N.			Generation of Full-Length cDNAs for Eight Putative GPCnR from the Cattle Tick, R. microplus Using a Targeted Degenerate PCR and Sequencing Strategy	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; FUNCTIONAL EXPRESSION; MUSCARINIC AGONISTS; MOLECULAR-BIOLOGY; GABA(B) RECEPTOR; LIGAND-BINDING; OCTOPAMINE; ACTIVATION; BEHAVIOR; CLONING	We describe here a rapid and efficient method for the targeted isolation of specific members of gene families without the need for cloning. Using this strategy we isolated full length cDNAs for eight putative G-protein coupled neurotransmitter receptors (GPCnR) from the cattle tick Rhipicephalus (Boophilus) microplus. Gene specific degenerate primers were designed using aligned amino acid sequences of similar receptor types from several insect and arachnid species. These primers were used to amplify and sequence a section of the target gene. Rapid amplification of cDNA ends (RACE) PCR was used to generate full length cDNA sequences. Phylogenetic analysis placed 7 of these sequences into Class A G-protein coupled receptors (GPCR) (Rm_alpha 2AOR, Rm_beta 2AOR, Rm_Dop1R, Rm_Dop2R, Rm_INDR, Rm_5-HT7R and Rm_mAchR), and one into Class C GPCR (Rm_GABA(B)R). Of the 7 Class A sequences, only Rm_mAchR is not a member of the biogenic amine receptor family. The isolation of these putative receptor sequences provides an opportunity to gain an understanding of acaricide resistance mechanisms such as amitraz resistance and might suggest possibilities for the development of new acaricides.	[Corley, Sean W.; Piper, Emily K.; Jonsson, Nicholas N.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Jonsson, Nicholas N.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Queensland; University of Glasgow	Corley, SW (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.	s.corley@uq.edu.au	Piper, Emily/A-7000-2012; JONSSON, Nicholas/K-6025-2019	JONSSON, Nicholas/0000-0003-3245-9783				[Anonymous], [No title captured]; Baxter GD, 1999, INSECT BIOCHEM MOLEC, V29, P461, DOI 10.1016/S0965-1748(99)00023-5; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BIGG DCH, 1976, NATURE, V262, P220, DOI 10.1038/262220a0; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Chen A, 2004, INSECT MOL BIOL, V13, P45, DOI 10.1111/j.1365-2583.2004.00457.x; CLAASSEN DE, 1986, J NEUROBIOL, V17, P1, DOI 10.1002/neu.480170102; Dick MR, 1997, PESTIC SCI, V49, P268, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;268::AID-PS527&gt;3.0.CO;2-C; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; EVANS PD, 1980, NATURE, V287, P60, DOI 10.1038/287060a0; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Grisi L., 2002, A Hora Veterinaria, V21, P8; Han KA, 1998, J NEUROSCI, V18, P3650; Heinrich R, 2001, P NATL ACAD SCI USA, V98, P9919, DOI 10.1073/pnas.151131998; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Larhammar D, 1996, REGUL PEPTIDES, V65, P165, DOI 10.1016/0167-0115(96)00110-3; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Menzel R., 1988, Modulation of synaptic transmission and plasticity in nervous sytems., P333; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Mustard JA, 2005, ARCH INSECT BIOCHEM, V59, P103, DOI 10.1002/arch.20065; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Robas N, 2003, CURR OPIN PHARMACOL, V3, P121, DOI 10.1016/S1471-4892(03)00010-9; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Schoneberg T, 1999, MOL CELL ENDOCRINOL, V151, P181, DOI 10.1016/S0303-7207(99)00017-9; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; STEWART NP, 1982, J PARASITOL, V68, P691, DOI 10.2307/3280930; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339	36	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32480	10.1371/journal.pone.0032480	http://dx.doi.org/10.1371/journal.pone.0032480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403662	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000303017700059
J	Goodman, J; Maschinski, J; Hughes, P; McAuliffe, J; Roncal, J; Powell, D; Sternberg, LO				Goodman, Joie; Maschinski, Joyce; Hughes, Phillip; McAuliffe, Joe; Roncal, Julissa; Powell, Devon; Sternberg, Leonel O'reilly			Differential Response to Soil Salinity in Endangered Key Tree Cactus: Implications for Survival in a Changing Climate	PLOS ONE			English	Article							SEA-LEVEL RISE; FOREST STRUCTURE; FLORIDA-KEYS; MIGRATION; IMPACTS; DEBATE; PLANTS; SHIFT	Understanding reasons for biodiversity loss is essential for developing conservation and management strategies and is becoming increasingly urgent with climate change. Growing at elevations <1.4 m in the Florida Keys, USA, the endangered Key tree cactus (Pilosocereus robinii) experienced 84 percent loss of total stems from 1994 to 2007. The most severe losses of 99 and 88 percent stems occurred in the largest populations in the Lower Keys, where nine storms with high wind velocities and storm surges, occurred during this period. In contrast, three populations had substantial stem proliferation. To evaluate possible mortality factors related to changes in climate or forest structure, we examined habitat variables: soil salinity, elevation, canopy cover, and habitat structure near 16 dying or dead and 18 living plants growing in the Lower Keys. Soil salinity and elevation were the preliminary factors that discriminated live and dead plants. Soil salinity was 1.5 times greater, but elevation was 12 cm higher near dead plants than near live plants. However, distribution-wide stem loss was not significantly related to salinity or elevation. Controlled salinity trials indicated that salt tolerance to levels above 40 mM NaCl was related to maternal origin. Salt sensitive plants from the Lower Keys had less stem growth, lower root: shoot ratios, lower potassium: sodium ratios and lower recovery rate, but higher delta C-13 than a salt tolerant lineage of unknown origin. Unraveling the genetic structure of salt tolerant and salt sensitive lineages in the Florida Keys will require further genetic tests. Worldwide rare species restricted to fragmented, low-elevation island habitats, with little or no connection to higher ground will face challenges from climate change-related factors. These great conservation challenges will require traditional conservation actions and possibly managed relocation that must be informed by studies such as these.	[Goodman, Joie; Maschinski, Joyce; Roncal, Julissa; Powell, Devon] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Coral Gables, FL USA; [Hughes, Phillip] US Fish & Wildlife Serv, Big Pine Key, FL USA; [McAuliffe, Joe] Desert Bot Garden, Phoenix, AZ USA; [Roncal, Julissa] Inst Rech Dev, UMR DIADE, Montpellier, France; [Sternberg, Leonel O'reilly] Univ Miami, Miami, FL USA	United States Department of the Interior; US Fish & Wildlife Service; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Miami	Goodman, J (corresponding author), Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Coral Gables, FL USA.	jmaschinski@fairchildgarden.org		Hughes, Phillip/0000-0002-2653-9851; Roncal, Julissa/0000-0001-8632-4206	U.S. Fish and Wildlife Service [40816G065, 4018176G065]; Florida Department of Agriculture and Consumer Services Division of Plant Industry [011299, 012863]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Florida Department of Agriculture and Consumer Services Division of Plant Industry	Funding for this research was provided by the U.S. Fish and Wildlife Service (Agreement 40816G065 and 4018176G065)http://www.fws. gov/grants/and the Florida Department of Agriculture and Consumer Services Division of Plant Industry(Contract #011299 and #012863)http://www.freshfromflorida.com/pi/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P, 1998, NEW PHYTOL, V138, P171, DOI 10.1046/j.1469-8137.1998.00111.x; [Anonymous], 2007, JMP 7; [Anonymous], 2001, CACTUS FAMILY; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; BROKAW NVL, 1991, BIOTROPICA, V23, P386, DOI 10.2307/2388256; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; De Boer AH, 2003, PLANT CELL ENVIRON, V26, P87, DOI 10.1046/j.1365-3040.2003.00930.x; de Gouvenain RC, 2003, BIOTROPICA, V35, P166, DOI 10.1111/j.1744-7429.2003.tb00276.x; Donoghue JF, 2011, CLIMATIC CHANGE, V107, P17, DOI 10.1007/s10584-011-0077-x; ESRI, 2010, ARCMAPT VERS 10 0; Falk D.A., 1996, RESTORING DIVERSITY; Farnsworth EJ, 2006, ECOL APPL, V16, P1327, DOI 10.1890/1051-0761(2006)016[1327:BADORP]2.0.CO;2; *FLOR NAT AR INV, 1990, GUID NAT COMM FLOR; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; Guiney J.L., 1999, PRELIMINARY REPORT H; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hunt D., 2006, NEW CACTUS LEXICON; Hunter ML, 2007, CONSERV BIOL, V21, P1356, DOI 10.1111/j.1523-1739.2007.00780.x; Karim MF, 2008, GLOBAL ENVIRON CHANG, V18, P490, DOI 10.1016/j.gloenvcha.2008.05.002; LaFever DH, 2007, ENVIRON MANAGE, V40, P430, DOI 10.1007/s00267-006-0204-z; Lidz BH, 2006, J COASTAL RES, V22, P750, DOI 10.2112/06-0634.1; Lima AN, 1996, BRADLEYA, V14, P57, DOI DOI 10.25223/BRAD.N14.1996.A7; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; MASCHINSKI J, 2009, ASSESSMENT POPULATIO; Maschinski J, 2011, CLIMATIC CHANGE, V107, P147, DOI 10.1007/s10584-011-0083-z; Maunder M., 2004, EX SITU PLANT CONSER; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Mitchell K., 2007, QUANTITATIVE ANAL PO; Mousavi ME, 2011, CLIMATIC CHANGE, V104, P575, DOI 10.1007/s10584-009-9790-0; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Myers RL, 1990, ECOSYSTEMS FLORIDA; National Hurricane Center, 2009, HIST HURR TRACKS; National Institute of Health, 2007, IM J SOFTW; National Oceanic and Atmospheric Administration (NOAA), 2011, FLOR KEYS CLIM; Overpeck JT, 2009, P NATL ACAD SCI USA, V106, P21461, DOI 10.1073/pnas.0912878107; Pasch R., 2006, TROPICAL CYCLONE REP; Rabinowitz D., 1986, CONSERVATION BIOL SC, P182; RHOADE JD, 1996, SSSA BOOK SER, V5, P427; Robertson W, 2007, BIG PINE KEY SURVEY; Rogers DA, 2008, ECOLOGY, V89, P2482, DOI 10.1890/07-1129.1; Root TL, 2006, CONSERV BIOL, V20, P706, DOI 10.1111/j.1523-1739.2006.00465.x; Ross MS, 2009, FRONT ECOL ENVIRON, V7, P471, DOI 10.1890/070221; ROSS MS, 1994, ECOL APPL, V4, P144, DOI 10.2307/1942124; ROSS MS, 1992, BIOTROPICA, V24, P488, DOI 10.2307/2389011; Saha AK, 2011, CLIMATIC CHANGE, V107, P81, DOI 10.1007/s10584-011-0082-0; Scalley TH, 2010, BIOTROPICA, V42, P455, DOI 10.1111/j.1744-7429.2009.00609.x; Stanton EA, 2007, FLORIDA CLIMATE CHAN; STERNBERG LO, 1984, PLANT PHYSIOL, V74, P104, DOI 10.1104/pp.74.1.104; Systat Software Inc, 2007, SYSTAT 12; TANNER EVJ, 1991, BIOTROPICA, V23, P513, DOI 10.2307/2388274; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; US Fish and Wildlife Service, 2010, 5 YEAR STAT REV KEY; US Fish and Wildlife Service, 1999, S FLOR MULT REC PLAN; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Vitt P, 2010, BIOL CONSERV, V143, P18, DOI 10.1016/j.biocon.2009.08.015; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walton TL, 2007, OCEAN ENG, V34, P1832, DOI 10.1016/j.oceaneng.2007.02.003; White P.S., 2004, ASSEMBLY RULES RESTO, P342; Zappi D.C., 1994, PILOSOCEREUS CACTACE	66	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32528	10.1371/journal.pone.0032528	http://dx.doi.org/10.1371/journal.pone.0032528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403670	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700067
J	Hernandez, LL; Grayson, BE; Yadav, E; Seeley, RJ; Horseman, ND				Hernandez, Laura L.; Grayson, Bernadette E.; Yadav, Ekta; Seeley, Randy J.; Horseman, Nelson D.			High Fat Diet Alters Lactation Outcomes: Possible Involvement of Inflammatory and Serotonergic Pathways	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; MATERNAL OBESITY; DELAYED-ONSET; WEIGHT-GAIN; PREGNANCY; MICE; LACTOGENESIS; ASSOCIATION; ACTIVATION; OVERWEIGHT	Delay in the onset of lactogenesis has been shown to occur in women who are obese, however the mechanism altered within the mammary gland causing the delay remains unknown. Consumption of high fat diets (HFD) has been previously determined to result decreased litters and litter numbers in rodent models due to a decrease in fertility. We examined the effects of feeding a HFD (60% kcal from fat) diet versus a low-fat diet (LFD; 10% kcal from fat) to female Wistar rats on lactation outcomes. Feeding of HFD diet resulted in increased pup weights compared to pups from LFD fed animals for 4 d post-partum. Lactation was delayed in mothers on HFD but they began to produce copious milk volumes beginning 2 d post-partum, and milk yield was similar to LFD by day 3. Mammary glands collected from lactating animals on HFD diet, displayed a disrupted morphologies, with very few and small alveoli. Consistently, there was a significant decrease in the mRNA expression of milk protein genes, glucose transporter 1 (GLUT1) and keratin 5 (K5), a luminobasal cell marker in the mammary glands of HFD lactating animals. Expression of tryptophan hydroxylase 1 (TPH1), the rate-limiting enzyme in serotonin (5-HT) biosynthesis, and the 5-HT7 receptor (HTR7), which regulates mammary gland involution, were significantly increased in mammary glands of HFD animals. Additionally, we saw elevation of the inflammatory markers interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha). These results indicate that consumption of HFD impairs mammary parenchymal tissue and impedes its ability to synthesize and secrete milk, possibly through an increase in 5-HT production within the mammary gland leading to an inflammatory process.	[Hernandez, Laura L.; Yadav, Ekta; Horseman, Nelson D.] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45221 USA; [Hernandez, Laura L.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Grayson, Bernadette E.; Seeley, Randy J.] Univ Cincinnati, Metab Dis Res Inst, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; University of Cincinnati	Hernandez, LL (corresponding author), Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45221 USA.	llhernandez@wisc.edu	Yadav, Ekta/ABC-7392-2020	Hernandez, Laura/0000-0001-7591-5203; Seeley, Randy/0000-0002-3721-5625	NIH/NCI [T32 CA059268]; National Research Initiative from United States Department of Agriculture-National Institute of Food and Agriculture [2007-35206-17898]; NATIONAL CANCER INSTITUTE [T32CA059268] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Initiative from United States Department of Agriculture-National Institute of Food and Agriculture; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this research was provided by NIH/NCI#T32 CA059268 and National Research Initiative Grant #2007-35206-17898 from United States Department of Agriculture-National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir Lisa H, 2007, BMC Pregnancy Childbirth, V7, P9, DOI 10.1186/1471-2393-7-9; Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Boecker W, 2003, CELL PROLIFERAT, V36, P73, DOI 10.1046/j.1365-2184.36.s.1.7.x; Chapman D J, 1999, J Hum Lact, V15, P107, DOI 10.1177/089033449901500207; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Couldrey C, 2002, DEV DYNAM, V223, P459, DOI 10.1002/dvdy.10065; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; de Assis S, 2006, J NUTR, V136, P998, DOI 10.1093/jn/136.4.998; De Assis S, 2006, ANN NY ACAD SCI, V1089, P14, DOI 10.1196/annals.1386.039; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flint DJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1179, DOI 10.1152/ajpendo.00433.2004; Freeman DJ, 2010, SEMIN FETAL NEONAT M, V15, P113, DOI 10.1016/j.siny.2009.09.001; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Haney PM, 2004, ADV EXP MED BIOL, V554, P253; Haughian JM, 2011, P NATL ACAD SCI 1003; Hernandez LL, 2008, J DAIRY SCI, V91, P1834, DOI 10.3168/jds.2007-0766; Hue-Beauvais C, 2011, DEV DYNAM, V240, P347, DOI 10.1002/dvdy.22536; Josefson J, 2011, J AM DIET ASSOC, V111, P50, DOI 10.1016/j.jada.2010.10.015; Kamikawa A, 2009, DEV DYNAM, V238, P1092, DOI 10.1002/dvdy.21947; Karalis KP, 2009, FEBS J, V276, P5747, DOI 10.1111/j.1742-4658.2009.07304.x; KARKALAS J, 1985, J SCI FOOD AGR, V36, P1019, DOI 10.1002/jsfa.2740361018; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; Leonard SA, 2011, AM J CLIN NUTR, V93, P556, DOI 10.3945/ajcn.110.002352; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu H, 2007, J INVEST DERMATOL, V127, P2781, DOI 10.1038/sj.jid.5700918; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Neville MC, 1999, CLIN PERINATOL, V26, P251, DOI 10.1016/S0095-5108(18)30053-8; Nommsen-Rivers LA, 2010, AM J CLIN NUTR, V92, P574, DOI 10.3945/ajcn.2010.29192; Oddy WH, 2006, J PEDIATR-US, V149, P185, DOI 10.1016/j.jpeds.2006.04.005; Olson LK, 2010, INT J OBESITY, V34, P1415, DOI 10.1038/ijo.2010.51; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Piantoni P, 2010, BIOINFORM BIOL INSIG, V4, P85; Rasmussen KM, 2007, ANNU REV NUTR, V27, P103, DOI 10.1146/annurev.nutr.27.061406.093738; Rasmussen KM, 2004, PEDIATRICS, V113, pE465, DOI 10.1542/peds.113.5.e465; Rasmussen KM, 1998, J NUTR, V128, p390S, DOI 10.1093/jn/128.2.390S; ROLLS BJ, 1982, PHYSIOL BEHAV, V28, P393, DOI 10.1016/0031-9384(82)90130-5; Sejrsen K, 2000, DOMEST ANIM ENDOCRIN, V19, P93, DOI 10.1016/S0739-7240(00)00070-9; Stein T, 2009, J MAMMARY GLAND BIOL, V14, P99, DOI 10.1007/s10911-009-9120-1; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Stunes AK, 2011, DIABETES OBES METAB, V13, P551, DOI 10.1111/j.1463-1326.2011.01378.x; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Thorn SR, 2010, ENDOCRINOLOGY, V151, P3985, DOI 10.1210/en.2010-0029; TRASK DK, 1990, P NATL ACAD SCI USA, V87, P2319, DOI 10.1073/pnas.87.6.2319; WELDON WC, 1991, J ANIM SCI, V69, P194	47	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32598	10.1371/journal.pone.0032598	http://dx.doi.org/10.1371/journal.pone.0032598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403677	Green Submitted, gold, Green Published			2022-12-25	WOS:000303017700074
J	Larson, S; Jameson, R; Etnier, M; Jones, T; Hall, R				Larson, Shawn; Jameson, Ron; Etnier, Michael; Jones, Terry; Hall, Roberta			Genetic Diversity and Population Parameters of Sea Otters, Enhydra lutris, before Fur Trade Extirpation from 1741-1911	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; MINK MUSTELA-VISON; REMNANT	All existing sea otter, Enhydra lutris, populations have suffered at least one historic population bottleneck stemming from the fur trade extirpations of the eighteenth and nineteenth centuries. We examined genetic variation, gene flow, and population structure at five microsatellite loci in samples from five pre-fur trade populations throughout the sea otter's historical range: California, Oregon, Washington, Alaska, and Russia. We then compared those values to genetic diversity and population structure found within five modern sea otter populations throughout their current range: California, Prince William Sound, Amchitka Island, Southeast Alaska and Washington. We found twice the genetic diversity in the pre-fur trade populations when compared to modern sea otters, a level of diversity that was similar to levels that are found in other mammal populations that have not experienced population bottlenecks. Even with the significant loss in genetic diversity modern sea otters have retained historical structure. There was greater gene flow before extirpation than that found among modern sea otter populations but the difference was not statistically significant. The most dramatic effect of pre fur trade population extirpation was the loss of genetic diversity. For long term conservation of these populations increasing gene flow and the maintenance of remnant genetic diversity should be encouraged.	[Larson, Shawn] Seattle Aquarium, Research Anim Hlth, Seattle, WA USA; [Jameson, Ron] US Geol Survey, Western Ecol Res Ctr, Philomath, OR USA; [Etnier, Michael] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Jones, Terry] Calif Polytech State Univ San Luis Obispo, Dept Social Sci, San Luis Obispo, CA 93407 USA; [Hall, Roberta] Oregon State Univ, Dept Anthropol, Corvallis, OR 97331 USA	United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; California State University System; California Polytechnic State University San Luis Obispo; Oregon State University	Larson, S (corresponding author), Seattle Aquarium, Research Anim Hlth, Seattle, WA USA.	s.larson@seattleaquarium.org			Seattle Aquarium's general operating fund; Foley Frischkorn Conservation Fund; Seattle Aquarium Society; California Sea Grant [R/CZ-187]	Seattle Aquarium's general operating fund; Foley Frischkorn Conservation Fund; Seattle Aquarium Society; California Sea Grant	This research was supported primarily by the Seattle Aquarium's general operating fund. Other supporting funds came from the Foley Frischkorn Conservation Fund and the Seattle Aquarium Society. Analysis of the otter remains from Diablo Canyon was funded by California Sea Grant R/CZ-187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2008, ANIM CONSERV, V11, P35, DOI 10.1111/j.1469-1795.2007.00144.x; Avise John C., 1994, pi; BERTA A, 1985, J PALEONTOL, V59, P809; Bodkin JL, 1999, CONSERV BIOL, V13, P1378, DOI 10.1046/j.1523-1739.1999.98124.x; Cheney LC, 1995, THESIS CALIFORNIA ST; Cornuet JM, 1996, GENETICS, V144, P2001; Cronin MA, 1996, J MAMMAL, V77, P546, DOI 10.2307/1382828; Dallas JF, 1998, MOL ECOL, V7, P1248; Daugherty RD, 1967, ARCHAEOLOGICAL GEOCH; ESTES JA, 1990, J ANIM ECOL, V59, P385, DOI 10.2307/4870; Fitzhugh B, 2007, REPORT ARCHAEO UNPUB; Fleming MA, 1999, MOL ECOL, V8, P1352, DOI 10.1046/j.1365-294X.1999.00701_2.x; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Greenwood RobertaS., 1972, SAN LUIS OBISPO COUN, V7; HAGELBERG E, 1991, P ROY SOC B-BIOL SCI, V244, P45, DOI 10.1098/rspb.1991.0049; Hall RL, 1995, PEOPLE COQUILLE ESTU; Hoelzel A.R., 1992, P159; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; JAMESON R J, 1982, Wildlife Society Bulletin, V10, P100; Jones TL, 2008, AM ANTIQUITY, V73, P289, DOI 10.2307/25470479; Kenyon K.W, 1969, SEA OTTER E PACIFIC; Langella O., 1999, POPULATIONS 1 2 32; Larson S, 2002, J MAMMAL, V83, P893, DOI 10.1644/1545-1542(2002)083<0893:MDAMDV>2.0.CO;2; Larson S, 2002, MOL ECOL, V11, P1899, DOI 10.1046/j.1365-294X.2002.01599.x; Lyman R. L., 1991, PREHISTORY OREGON CO; Murray MS, 2005, 4 U AL FAIRB LAK CLA; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; OConnell M, 1996, MOL ECOL, V5, P311, DOI 10.1111/j.1365-294X.1996.tb00320.x; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pritchard JK, 2000, GENETICS, V155, P945; Rathbun GB, 2000, SOUTHWEST NAT, V45, P322, DOI 10.2307/3672835; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riedman ML, 1990, BIOL REP, V90, P126; Rosenbaum HC, 1997, MOL ECOL, V6, P677, DOI 10.1046/j.1365-294X.1997.00230.x; Rotterman LM, 1992, THESIS U MINNESOTA M; Samuels SR, 1991, OZETTE ARCHAEOLOGICA, V1; Sanchez MS, 1992, THESIS U CALIFORNIA; Scheffer VB, 2000, LAST SEA OTTER HUNTE, P14; Turner CG, 1974, ARCTIC ANTHR S, V11; Valentine K, 2008, CONSERV GENET, V9, P933, DOI 10.1007/s10592-007-9422-z; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WILSON DE, 1991, J MAMMAL, V72, P22, DOI 10.2307/1381977	44	31	31	7	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32205	10.1371/journal.pone.0032205	http://dx.doi.org/10.1371/journal.pone.0032205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403635	Green Published, gold			2022-12-25	WOS:000303017700032
J	Tieri, P; Termanini, A; Bellavista, E; Salvioli, S; Capri, M; Franceschi, C				Tieri, Paolo; Termanini, Alberto; Bellavista, Elena; Salvioli, Stefano; Capri, Miriam; Franceschi, Claudio			Charting the NF-kappa B Pathway Interactome Map	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; REGULATORY ELEMENT DATABASE; CROSS-TALK; SIGNAL-TRANSDUCTION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; INNATE IMMUNITY; KINASE-BETA; P53 GENE; T-CELLS	Inflammation is part of a complex physiological response to harmful stimuli and pathogenic stress. The five components of the Nuclear Factor kappa B (NF-kappa B) family are prominent mediators of inflammation, acting as key transcriptional regulators of hundreds of genes. Several signaling pathways activated by diverse stimuli converge on NF-kappa B activation, resulting in a regulatory system characterized by high complexity. It is increasingly recognized that the number of components that impinges upon phenotypic outcomes of signal transduction pathways may be higher than those taken into consideration from canonical pathway representations. Scope of the present analysis is to provide a wider, systemic picture of the NF-kappa B signaling system. Data from different sources such as literature, functional enrichment web resources, protein-protein interaction and pathway databases have been gathered, curated, integrated and analyzed in order to reconstruct a single, comprehensive picture of the proteins that interact with, and participate to the NF-kappa B activation system. Such a reconstruction shows that the NF-kappa B interactome is substantially different in quantity and quality of components with respect to canonical representations. The analysis highlights that several neglected but topologically central proteins may play a role in the activation of NF-kappa B mediated responses. Moreover the interactome structure fits with the characteristics of a bow tie architecture. This interactome is intended as an open network resource available for further development, refinement and analysis.	[Tieri, Paolo; Termanini, Alberto; Bellavista, Elena; Salvioli, Stefano; Capri, Miriam; Franceschi, Claudio] Univ Bologna, CIG Luigi Galvani Interdept Ctr, Bologna, Italy; [Tieri, Paolo; Bellavista, Elena; Salvioli, Stefano; Capri, Miriam; Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Tieri, Paolo] CNR, IAC, Rome, Italy	University of Bologna; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR)	Tieri, P (corresponding author), Univ Bologna, CIG Luigi Galvani Interdept Ctr, Bologna, Italy.	p.tieri@iac.cnr.it	Tieri, Paolo/AAY-1042-2020; Capri, Miriam/K-4700-2016; Termanini, Alberto/AAB-9934-2019; Tieri, Paolo/B-8468-2008; Franceschi, Claudio/L-4484-2017; Salvioli, Stefano/K-6663-2016	Tieri, Paolo/0000-0002-3635-7664; Capri, Miriam/0000-0001-9077-0401; Termanini, Alberto/0000-0002-9697-906X; Tieri, Paolo/0000-0002-3635-7664; Franceschi, Claudio/0000-0001-9841-6386; Salvioli, Stefano/0000-0002-6191-1225	European Union [259679, 223576]; Roberto and Cornelia Pallotti Legacy for cancer research	European Union(European Commission); Roberto and Cornelia Pallotti Legacy for cancer research	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreements IDEAL (no 259679) and MYOAGE (no 223576) to CF, and Roberto and Cornelia Pallotti Legacy for cancer research to CF and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alberti S, 2006, MECH AGEING DEV, V127, P560, DOI 10.1016/j.mad.2006.01.014; Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; [Anonymous], 2011, NAT IMMUNOL, V12, P681; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Bell S, 1996, MOL CELL BIOL, V16, P6477; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bhalla US, 2003, PROG BIOPHYS MOL BIO, V81, P45, DOI 10.1016/S0079-6107(02)00046-9; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bhattacharya Sanjoy K, 2010, Syst Synth Biol, V4, P139, DOI 10.1007/s11693-009-9051-6; Bhattacharya SK, 2010, WILEY INTERDISCIPLIN, V9999; Bista P, 2010, J BIOL CHEM, V285, P12971, DOI 10.1074/jbc.M109.076091; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Campbell KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-101; Caron E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.108; Cevenini E, 2010, CURR PHARM DESIGN, V16, P802, DOI 10.2174/138161210790883660; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Cohen S, 2004, MOL CELL BIOL, V24, P475, DOI 10.1128/MCB.24.1.475-486.2004; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; DOBRZANSKI P, 1994, EMBO J, V13, P4608, DOI 10.1002/j.1460-2075.1994.tb06782.x; Donze O, 2004, EMBO J, V23, P564, DOI 10.1038/sj.emboj.7600078; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; Gilmore T, 2002, CANCER LETT, V181, P1, DOI 10.1016/S0304-3835(01)00795-9; Gilmore T., 2010, REL NF KAPPAB TRANSC; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden Matthew S, 2006, Cell, V127, P1286; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hedayat M, 2011, LANCET INFECT DIS, V11, P702, DOI 10.1016/S1473-3099(11)70099-8; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Ikeda A, 2000, BIOCHEM BIOPH RES CO, V272, P375, DOI 10.1006/bbrc.2000.2786; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Ivakhno S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-27; Jeong SJ, 2004, BLOOD, V104, P1490, DOI 10.1182/blood-2003-12-4174; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kitano H, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100039; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Lecca P, 2011, METHODS MOL BIOL, V719, P435, DOI 10.1007/978-1-61779-027-0_20; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Nourbakhsh M, 1999, EMBO J, V18, P6415, DOI 10.1093/emboj/18.22.6415; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ostan R, 2008, NEUROIMMUNOMODULAT, V15, P224, DOI 10.1159/000156466; Ottaviani E, 2008, BIOESSAYS, V30, P868, DOI 10.1002/bies.20801; Ottaviani E, 2011, CELL TISSUE RES, V344, P213, DOI 10.1007/s00441-011-1147-0; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pasparakis M, 2006, CELL DEATH DIFFER, V13, P861, DOI 10.1038/sj.cdd.4401870; Pei XH, 1999, J BIOL CHEM, V274, P35240, DOI 10.1074/jbc.274.49.35240; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pham LV, 2005, BLOOD, V106, P3940, DOI 10.1182/blood-2005-03-1167; Platzer A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-224; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Qin CH, 2002, MOL ENDOCRINOL, V16, P1793, DOI 10.1210/me.2002-0006; Ravi R, 1998, CANCER RES, V58, P4531; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simko GI, 2009, GENOME MED, V1, DOI 10.1186/gm90; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Taylor IW, 2008, CELL, V133, DOI 10.1016/j.cell.2008.04.007; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Tieri P, 2011, METHODS MOL BIOL, V719, P415, DOI 10.1007/978-1-61779-027-0_19; Tieri P, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-32; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Vescovini R, 2007, J IMMUNOL, V179, P4283, DOI 10.4049/jimmunol.179.6.4283; Vescovini R, 2010, J IMMUNOL, V184, P3242, DOI 10.4049/jimmunol.0902890; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wang YC, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-S2-S1, 10.1186/1752-0509-4-20]; Ward KR, 2004, ONCOGENE, V23, P1187, DOI 10.1038/sj.onc.1207226; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Weil R, 2006, CELL DEATH DIFFER, V13, P826, DOI 10.1038/sj.cdd.4401856; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003; Wong ET, 2009, CLIN SCI, V116, P451, DOI 10.1042/CS20080502; Wu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010137; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; WU HY, 1994, J BIOL CHEM, V269, P20067; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19; Yeung Natalie, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0813s23; Ying HQ, 2011, CANCER DISCOV, V1, P158, DOI 10.1158/2159-8290.CD-11-0031; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004	118	52	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32678	10.1371/journal.pone.0032678	http://dx.doi.org/10.1371/journal.pone.0032678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403694	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700091
J	Witkowski, B; Lelievre, J; Nicolau-Travers, ML; Iriart, X; Soh, PN; Bousejra-ElGarah, F; Meunier, B; Berry, A; Benoit-Vical, F				Witkowski, Benoit; Lelievre, Joel; Nicolau-Travers, Marie-Laure; Iriart, Xavier; Soh, Patrice Njomnang; Bousejra-ElGarah, Fatima; Meunier, Bernard; Berry, Antoine; Benoit-Vical, Francoise			Evidence for the Contribution of the Hemozoin Synthesis Pathway of the Murine Plasmodium yoelii to the Resistance to Artemisinin-Related Drugs	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; FALCIPARUM-MALARIA; MEFLOQUINE RESISTANCE; RODENT MALARIA; CHLOROQUINE RESISTANCE; HEMOGLOBIN CATABOLISM; POTENT INHIBITORS; PFMDR1 GENE; ANTIMALARIAL; HEME	Plasmodium falciparum malaria is a major global health problem, causing approximately 780,000 deaths each year. In response to the spreading of P. falciparum drug resistance, WHO recommended in 2001 to use artemisinin derivatives in combination with a partner drug (called ACT) as first-line treatment for uncomplicated falciparum malaria, and most malaria-endemic countries have since changed their treatment policies accordingly. Currently, ACT are often the last treatments that can effectively and rapidly cure P. falciparum infections permitting to significantly decrease the mortality and the morbidity due to malaria. However, alarming signs of emerging resistance to artemisinin derivatives along the Thai-Cambodian border are of major concern. Through long-term in vivo pressures, we have been able to select a murine malaria model resistant to artemisinins. We demonstrated that the resistance of Plasmodium to artemisinin-based compounds depends on alterations of heme metabolism and on a loss of hemozoin formation linked to the down-expression of the recently identified Heme Detoxification Protein (HDP). These artemisinins resistant strains could be able to detoxify the free heme by an alternative catabolism pathway involving glutathione (GSH)-mediation. Finally, we confirmed that artemisinins act also like quinolines against Plasmodium via hemozoin production inhibition. The work proposed here described the mechanism of action of this class of molecules and the resistance to artemisinins of this model. These results should help both to reinforce the artemisinins activity and avoid emergence and spread of endoperoxides resistance by focusing in adequate drug partners design. Such considerations appear crucial in the current context of early artemisinin resistance in Asia.	[Witkowski, Benoit; Lelievre, Joel; Nicolau-Travers, Marie-Laure; Soh, Patrice Njomnang; Bousejra-ElGarah, Fatima; Meunier, Bernard; Benoit-Vical, Francoise] CNRS, Chim Coordinat Lab, F-31077 Toulouse, France; [Witkowski, Benoit; Lelievre, Joel; Nicolau-Travers, Marie-Laure; Soh, Patrice Njomnang; Bousejra-ElGarah, Fatima; Meunier, Bernard; Benoit-Vical, Francoise] Univ Toulouse 3, UPS, INPT, LCC, F-31062 Toulouse, France; [Witkowski, Benoit; Lelievre, Joel; Nicolau-Travers, Marie-Laure; Iriart, Xavier; Soh, Patrice Njomnang; Berry, Antoine; Benoit-Vical, Francoise] Ctr Hosp Univ Toulouse, Serv Parasitol Mycol, Toulouse, France; [Witkowski, Benoit; Lelievre, Joel; Nicolau-Travers, Marie-Laure; Iriart, Xavier; Soh, Patrice Njomnang; Berry, Antoine; Benoit-Vical, Francoise] Univ Toulouse 3, Fac Med Rangueil, F-31062 Toulouse, France; [Iriart, Xavier; Berry, Antoine] Univ Toulouse 3, UMR 152, IRD UPS, F-31062 Toulouse, France; [Meunier, Bernard] Palumed, Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Witkowski, B (corresponding author), CNRS, Chim Coordinat Lab, 205 Route Narbonne, F-31077 Toulouse, France.	Francoise.Vical@inserm.fr	Benoit-Vical, Francoise/E-3938-2016; Berry, Antoine/J-9352-2014; Witkowski, Benoit/T-1118-2019; Hua, QX/HGE-3640-2022; MEUNIER, Bernard/J-4879-2013; IRIART, Xavier/J-3830-2014	Benoit-Vical, Francoise/0000-0002-9468-4823; MEUNIER, Bernard/0000-0003-2200-7142; Berry, Antoine/0000-0002-6626-7766; Bousejra-El Garah, Fatima/0000-0001-7217-5879; IRIART, Xavier/0000-0002-0998-8962	European Union (FSE); Region Midi-Pyrenees; Freanch National Research Agency ANR [ANR-06-RIB-020]	European Union (FSE)(European Social Fund (ESF)European Commission); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Freanch National Research Agency ANR(French National Research Agency (ANR))	J.L. is indebted to the European Union program (FSE grant) for a PhD fellowship and B. W. received a PhD grant from the Region Midi-Pyrenees. The Freanch National Research Agency ANR (ANR-06-RIB-020) is acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO GLOB MAL PROGR; ASAWAMAHASAKDA W, 1994, MOL BIOCHEM PARASIT, V67, P183, DOI 10.1016/0166-6851(94)00128-6; BASCO LK, 1992, ANTIMICROB AGENTS CH, V36, P209, DOI 10.1128/AAC.36.1.209; Benoit-Vical F, 2007, ANTIMICROB AGENTS CH, V51, P1463, DOI 10.1128/AAC.00967-06; Boissier J, 2009, ANTIMICROB AGENTS CH, V53, P4903, DOI 10.1128/AAC.00640-09; Soares JBRC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000477; Coulibaly B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005318; Dechy-Cabaret O, 2000, CHEMBIOCHEM, V1, P281, DOI 10.1002/1439-7633(20001117)1:4<281::AID-CBIC281>3.3.CO;2-N; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Ferrer-Rodriguez I, 2004, J PARASITOL, V90, P152, DOI 10.1645/GE-3225; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Friebolin W, 2008, J MED CHEM, V51, P1260, DOI 10.1021/jm7009292; Garah FBE, 2008, EUR J INORG CHEM, P2133, DOI 10.1002/ejic.200800129; Gervais GW, 1999, EXP PARASITOL, V91, P86, DOI 10.1006/expr.1999.4344; Ginsburg H, 1998, BIOCHEM PHARMACOL, V56, P1305, DOI 10.1016/S0006-2952(98)00184-1; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Haynes RK, 2003, ANTIMICROB AGENTS CH, V47, P1175, DOI 10.1128/AAC.47.3.1175.2003; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kannan R, 2002, CHEM BIOL, V9, P321, DOI 10.1016/S1074-5521(02)00117-5; Keiser J, 2007, J PARASITOL, V93, P1208, DOI 10.1645/GE-1143R.1; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loup C, 2007, ANTIMICROB AGENTS CH, V51, P3768, DOI 10.1128/AAC.00239-07; Marley SE, 1997, ANTIMICROB AGENTS CH, V41, P91, DOI 10.1128/AAC.41.1.91; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Meshnick SR, 2003, ANTIMICROB AGENTS CH, V47, P2712, DOI 10.1128/AAC.47.8.2712-2713.2003; Nagelschmitz J, 2008, ANTIMICROB AGENTS CH, V52, P3085, DOI 10.1128/AAC.01585-07; ODUOLA AMJ, 1993, T ROY SOC TROP MED H, V87, P81, DOI 10.1016/0035-9203(93)90434-R; Oliveira MF, 2004, J INFECT DIS, V190, P843, DOI 10.1086/422759; ORJIH AU, 1993, BIOCHIM BIOPHYS ACTA, V1157, P270, DOI 10.1016/0304-4165(93)90109-L; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Parapini S, 2004, FEBS LETT, V575, P91, DOI 10.1016/j.febslet.2004.08.039; PETERS W, 1991, ANN TROP MED PARASIT, V85, P5, DOI 10.1080/00034983.1991.11812525; PETERS W, 1977, ANN TROP MED PARASIT, V71, P419, DOI 10.1080/00034983.1977.11687207; Peters W, 1980, CHEMOTHERAPY MALARIA, P145; Platel DFN, 1999, MOL BIOCHEM PARASIT, V98, P215, DOI 10.1016/S0166-6851(98)00170-4; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Robert A, 2005, P NATL ACAD SCI USA, V102, P13676, DOI 10.1073/pnas.0500972102; Robert A, 2002, ACCOUNTS CHEM RES, V35, P167, DOI 10.1021/ar990164o; Singh N, 2000, ACTA TROP, V77, P185, DOI 10.1016/S0001-706X(00)00133-9; Sissoko MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006732; Walker DJ, 2000, ANTIMICROB AGENTS CH, V44, P344, DOI 10.1128/AAC.44.2.344-347.2000; Walliker D, 2005, ACTA TROP, V94, P251, DOI 10.1016/j.actatropica.2005.04.005; Wang J, 2010, PLOS ONE, V5, pA158, DOI 10.1371/journal.pone.0009582; Warhurst DC, 2001, NEW ENGL J MED, V344, P299, DOI 10.1056/NEJM200101253440411; Witkowski B, 2009, DRUG RESIST UPDATE, V12, P42, DOI 10.1016/j.drup.2009.01.001; WOOD PA, 1993, AM J TROP MED HYG, V48, P465, DOI 10.4269/ajtmh.1993.48.465; Zoungrana A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001630	51	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32620	10.1371/journal.pone.0032620	http://dx.doi.org/10.1371/journal.pone.0032620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403683	gold, Green Submitted, Green Published			2022-12-25	WOS:000303017700080
J	Oeckl, P; Steinacker, P; Lehnert, S; Jesse, S; Kretzschmar, HA; Ludolph, AC; Otto, M; Ferger, B				Oeckl, Patrick; Steinacker, Petra; Lehnert, Stefan; Jesse, Sarah; Kretzschmar, Hans A.; Ludolph, Albert C.; Otto, Markus; Ferger, Boris			CSF Concentrations of cAMP and cGMP Are Lower in Patients with Creutzfeldt-Jakob Disease but Not Parkinson's Disease and Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; CYCLIC-NUCLEOTIDES; L-DOPA; DIAGNOSIS; DEMENTIA; 14-3-3-PROTEIN; MONOPHOSPHATE; BIOMARKERS; PROTEIN	Background: The cyclic nucleotides cyclic adenosine-39,59-monophosphate (cAMP) and cyclic guanosine-39,59-monophosphate (cGMP) are important second messengers and are potential biomarkers for Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and Creutzfeldt-Jakob disease (CJD). Methodology/Principal Findings: Here, we investigated by liquid chromatography/tandem mass spectrometry (LC-MS/MS) the cerebrospinal fluid (CSF) concentrations of cAMP and cGMP of 82 patients and evaluated their diagnostic potency as biomarkers. For comparison with a well-accepted biomarker, we measured tau concentrations in CSF of CJD and control patients. CJD patients (n = 15) had lower cAMP (270%) and cGMP (255%) concentrations in CSF compared with controls (n = 11). There was no difference in PD, PD dementia (PDD) and ALS cases. Receiver operating characteristic (ROC) curve analyses confirmed cAMP and cGMP as valuable diagnostic markers for CJD indicated by the area under the curve (AUC) of 0.86 (cAMP) and 0.85 (cGMP). We calculated a sensitivity of 100% and specificity of 64% for cAMP and a sensitivity of 67% and specificity of 100% for cGMP. The combination of both nucleotides increased the sensitivity to 80% and specificity to 91% for the term cAMPxcGMP (AUC 0.92) and to 93% and 100% for the ratio tau/cAMP (AUC 0.99). Conclusions/Significance: We conclude that the CSF determination of cAMP and cGMP may easily be included in the diagnosis of CJD and could be helpful in monitoring disease progression as well as in therapy control.	[Oeckl, Patrick; Ferger, Boris] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Dis Res, Biberach, Germany; [Steinacker, Petra; Lehnert, Stefan; Jesse, Sarah; Ludolph, Albert C.; Otto, Markus] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol & Prion Res, Munich, Germany	Boehringer Ingelheim; Ulm University; University of Munich	Oeckl, P (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, CNS Dis Res, Biberach, Germany.	boris.ferger@boehringer-ingelheim.com	Otto, Markus/F-4304-2015	Otto, Markus/0000-0003-4273-4267; Oeckl, Patrick/0000-0002-7652-7023	Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	The authors PO and BF are employees of Boehringer Ingelheim Pharma GmbH & Co. KG. The company funded the study. The funder has approved submission of the manuscript. The funder did play a role in study design, data collection and analysis, decision to publish, and presentation of the manuscript.	Aguila MC, 1999, BRAIN RES, V816, P241, DOI 10.1016/S0006-8993(98)01186-X; Baltrons MA, 2008, NEUROCHEM RES, V33, P2427, DOI 10.1007/s11064-008-9681-1; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Baker SG, 2007, AM STAT, V61, P343, DOI 10.1198/000313007X247643; Baltrons MA, 2004, NEUROBIOL DIS, V17, P462, DOI 10.1016/j.nbd.2004.07.022; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BELMAKER RH, 1978, PSYCHOPHARMACOLOGY, V58, P307, DOI 10.1007/BF00427396; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Brettschneider J, 2007, NEUROSCI LETT, V416, P257, DOI 10.1016/j.neulet.2007.02.002; Cali C, 2010, J NEUROIMMUNOL, V224, P13, DOI 10.1016/j.jneuroim.2010.05.004; COVICKOVICSTERNIC N, 1987, EUR NEUROL, V27, P24; Cramer H, 1984, Adv Neurol, V40, P431; CRAMER H, 1973, ARCH NEUROL-CHICAGO, V29, P197, DOI 10.1001/archneur.1973.00490270079014; Dupiereux Ingrid, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P2; Geschwind MD, 2003, ARCH NEUROL-CHICAGO, V60, P813, DOI 10.1001/archneur.60.6.813; Giorgi M, 2008, EUR J NEUROSCI, V28, P941, DOI 10.1111/j.1460-9568.2008.06387.x; HARTLEY JPR, 1981, THORAX, V36, P823, DOI 10.1136/thx.36.11.823; HOSSAIN MA, 1993, J PHARMACOL EXP THER, V267, P1105; IKEDA M, 1995, J NEURAL TRANSM-GEN, V100, P263, DOI 10.1007/BF01276464; Ilzecka J, 2004, J NEURAL TRANSM, V111, P167, DOI 10.1007/s00702-003-0086-7; Jesse S, 2011, J NEUROL, V258, P1034, DOI 10.1007/s00415-010-5876-x; Jesse S, 2009, CNS NEUROSCI THER, V15, P157, DOI 10.1111/j.1755-5949.2008.00064.x; Kenney K, 2000, ANN NEUROL, V48, P395, DOI 10.1002/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO;2-A; MAIDA E, 1981, J NEUROL, V225, P145, DOI 10.1007/BF00313327; Martinez M, 1999, BRAIN RES, V846, P265, DOI 10.1016/S0006-8993(99)01981-2; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Navarro JA, 1998, J NEUROL SCI, V155, P92, DOI 10.1016/S0022-510X(97)00267-0; Nyhlen J, 2010, BIOMARK MED, V4, P671, DOI [10.2217/bmm.10.84, 10.2217/BMM.10.84]; Oeckl P, 2012, J NEUROSCI METH, V203, P338, DOI 10.1016/j.jneumeth.2011.09.032; Otto M, 2004, NEUROLOGY, V62, P714, DOI 10.1212/01.WNL.0000113764.35026.EF; Otto M, 2002, NEUROLOGY, V58, P192, DOI 10.1212/WNL.58.2.192; Otto M, 1997, J NEUROL, V244, P566, DOI 10.1007/s004150050145; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016804; Steinacker P, 2010, J ALZHEIMERS DIS, V22, P119, DOI 10.3233/JAD-2010-100030; Steinacker P, 2010, PROTEOMICS, V10, P81, DOI 10.1002/pmic.200900246; Torremans A, 2010, BRAIN RES BULL, V81, P549, DOI 10.1016/j.brainresbull.2009.12.004; TSANG D, 1976, J NEUROL NEUROSUR PS, V39, P1186, DOI 10.1136/jnnp.39.12.1186; TSUJI M, 1981, PSYCHONEUROENDOCRINO, V6, P171, DOI 10.1016/0306-4530(81)90009-3; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Venneti S, 2010, CLIN LAB MED, V30, P293, DOI 10.1016/j.cll.2009.11.002; VOLICER L, 1986, NEUROLOGY, V36, P89, DOI 10.1212/WNL.36.1.89; VOLICER L, 1985, J GERONTOL, V40, P708, DOI 10.1093/geronj/40.6.708; World Health Organization, 1998, CONS CRIT SPOR CJD; Zhang YH, 2009, J CHROMATOGR B, V877, P513, DOI 10.1016/j.jchromb.2008.12.063	47	19	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32664	10.1371/journal.pone.0032664	http://dx.doi.org/10.1371/journal.pone.0032664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396786	Green Published, Green Submitted, gold			2022-12-25	WOS:000303006500031
J	Di Camillo, B; Irving, BA; Schimke, J; Sanavia, T; Toffolo, G; Cobelli, C; Nair, KS				Di Camillo, Barbara; Irving, Brian A.; Schimke, Jill; Sanavia, Tiziana; Toffolo, Gianna; Cobelli, Claudio; Nair, K. Sreekumaran			Function-Based Discovery of Significant Transcriptional Temporal Patterns in Insulin Stimulated Muscle Cells	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; PROTEIN-SYNTHESIS; GENE-EXPRESSION; GLYCOGEN-SYNTHESIS; PHYSIOLOGICAL HYPERINSULINEMIA; PHOSPHATIDYLINOSITOL 3-KINASE; TSC1-TSC2 COMPLEX; AMINO-ACIDS; S6 KINASE; ACTIVATION	Background: Insulin action on protein synthesis (translation of transcripts) and post-translational modifications, especially of those involving the reversible modifications such as phosphorylation of various signaling proteins, are extensively studied but insulin effect on transcription of genes, especially of transcriptional temporal patterns remains to be fully defined. Methodology/Principal Findings: To identify significant transcriptional temporal patterns we utilized primary differentiated rat skeletal muscle myotubes which were treated with insulin and samples were collected every 20 min for 8 hours. Pooled samples at every hour were analyzed by gene array approach to measure transcript levels. The patterns of transcript levels were analyzed based on a novel method that integrates selection, clustering, and functional annotation to find the main temporal patterns associated to functional groups of differentially expressed genes. 326 genes were found to be differentially expressed in response to in vitro insulin administration in skeletal muscle myotubes. Approximately 20% of the genes that were differentially expressed were identified as belonging to the insulin signaling pathway. Characteristic transcriptional temporal patterns include: (a) a slow and gradual decrease in gene expression, (b) a gradual increase in gene expression reaching a peak at about 5 hours and then reaching a plateau or an initial decrease and other different variable pattern of increase in gene expression over time. Conclusion/Significance: The new method allows identifying characteristic dynamic responses to insulin stimulus, common to a number of genes and associated to the same functional group. The results demonstrate that insulin treatment elicited different clusters of gene transcript profile supporting a temporal regulation of gene expression by insulin in skeletal muscle cells.	[Di Camillo, Barbara; Sanavia, Tiziana; Toffolo, Gianna; Cobelli, Claudio] Univ Padua, Dept Informat Engn, Padua, Italy; [Irving, Brian A.; Schimke, Jill; Nair, K. Sreekumaran] Mayo Clin, Div Endocrinol Metab Nutr & Internal Med, Rochester, MN USA	University of Padua; Mayo Clinic	Di Camillo, B (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	Nair.sree@mayo.edu	Sanavia, Tiziana/F-9446-2015; Irving, Brian/B-9683-2016; Di Camillo, Barbara/L-3202-2013	Sanavia, Tiziana/0000-0003-3288-0631; Irving, Brian/0000-0002-4131-9523; Di Camillo, Barbara/0000-0001-8415-4688	CARIPARO [RO1 DK 41973, KL2 RR084151]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041973] Funding Source: NIH RePORTER	CARIPARO(Fondazione Cariparo); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by CARIPARO 2008/2010 "Systems biology approaches to infer gene regulation from gene and protein time series data"(RO1 DK 41973, KL2 RR084151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Chow LS, 2006, AM J PHYSIOL-ENDOC M, V291, pE729, DOI 10.1152/ajpendo.00003.2006; Coletta DK, 2008, AM J PHYSIOL-ENDOC M, V294, pE910, DOI 10.1152/ajpendo.00607.2007; Di Camillo B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S10; Dorrestijn J, 1996, DIABETOLOGIA, V39, P558, DOI 10.1007/s001250050478; Dotan-Cohen D, 2007, BIOINFORMATICS, V23, P3335, DOI 10.1093/bioinformatics/btm526; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; GELFAND RA, 1987, J CLIN INVEST, V80, P1, DOI 10.1172/JCI113033; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Hansen L, 2004, BIOCHEM BIOPH RES CO, V323, P685, DOI 10.1016/j.bbrc.2004.08.146; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KAHN CR, 1995, NATURE, V373, P384; KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; Karakelides H, 2007, DIABETES, V56, P2683, DOI 10.2337/db07-0378; Kimball SR, 1998, AM J PHYSIOL-CELL PH, V274, pC221, DOI 10.1152/ajpcell.1998.274.1.C221; MARETTE A, 1992, DIABETES, V41, P1562, DOI 10.2337/diabetes.41.12.1562; Meng J, 2009, BIOINFORMATICS, V25, P1521, DOI 10.1093/bioinformatics/btp235; Nygren J, 2003, DIABETES, V52, P1377, DOI 10.2337/diabetes.52.6.1377; Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Shen WH, 2005, J ENDOCRINOL, V185, P275, DOI 10.1677/joe.1.06080; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Somwar R, 1998, AM J PHYSIOL-ENDOC M, V275, pE618, DOI 10.1152/ajpendo.1998.275.4.E618; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Vignes M, 2009, IEEE ACM T COMPUT BI, V6, P260, DOI 10.1109/TCBB.2007.70248; Wang YN, 2008, J MOL CELL CARDIOL, V45, P812, DOI 10.1016/j.yjmcc.2008.07.016; Yang X, 2002, DIABETOLOGIA, V45, P1584, DOI 10.1007/s00125-002-0905-7	38	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32391	10.1371/journal.pone.0032391	http://dx.doi.org/10.1371/journal.pone.0032391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396763	Green Submitted, Green Published, gold			2022-12-25	WOS:000303005000025
J	Itokazu, T; Fujita, Y; Takahashi, R; Yamashita, T				Itokazu, Takahide; Fujita, Yuki; Takahashi, Ryosuke; Yamashita, Toshihide			Identification of the Neogenin-Binding Site on the Repulsive Guidance Molecule A	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; VISUAL-SYSTEM; DAP-KINASE; RGMA; EXPRESSION; GROWTH; GENE; DCC	Repulsive guidance molecule (RGM) is a membrane-bound protein that was originally identified as an axon guidance molecule in the chick retinotectal system. RGMa, one of the 3 isoforms found in mammals, is involved in laminar patterning, cephalic neural tube closure, axon guidance, and inhibition of axonal regeneration. In addition to its roles in the nervous system, RGMa plays a role in enhancing helper T-cell activation. Binding of RGM to its receptor, neogenin, is considered necessary to transduce these signals; however, information on the binding of RGM to neogenin is limited. Using co-immunoprecipitation studies, we have identified that the RGMa region required for binding to neogenin contains amino acids (aa) 259-295. Synthesized peptide consisting of aa 284-293 directly binds to the extracellular domain (ECD) of recombinant neogenin, and addition of this peptide inhibits RGMa-induced growth cone collapse in mouse cortical neurons. Thus, we propose that this peptide is a promising lead in finding reagents capable of inhibiting RGMa signaling.	[Itokazu, Takahide; Fujita, Yuki; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Itokazu, Takahide; Fujita, Yuki; Yamashita, Toshihide] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan; [Itokazu, Takahide; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto, Japan	Osaka University; Japan Science & Technology Agency (JST); Kyoto University	Itokazu, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018; Itokazu, Takahide/0000-0003-2977-7190	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology, Chiyoda-ku, Tokyo, Japan	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology, Chiyoda-ku, Tokyo, Japan	This work was supported by Japan Science and Technology Agency, Core Research for Evolutional Science and Technology, 5 Sanbancho, Chiyoda-ku, Tokyo 102-0075, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; Endo M, 2009, J NEUROSCI, V29, P6649, DOI 10.1523/JNEUROSCI.0927-09.2009; Fujita Y, 2008, CELL DEATH DIFFER, V15, P1593, DOI 10.1038/cdd.2008.92; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Mueller BK, 2006, PHILOS T R SOC B, V361, P1513, DOI 10.1098/rstb.2006.1888; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Schmidtmer J, 2004, GENE EXPR PATTERNS, V4, P105, DOI 10.1016/S1567-133X(03)00144-3; Schwab JM, 2005, ARCH NEUROL-CHICAGO, V62, P1561, DOI 10.1001/archneur.62.10.1561; Schwab JM, 2005, EUR J NEUROSCI, V21, P1569, DOI 10.1111/j.1460-9568.2005.03962.x; Severyn CJ, 2009, BIOCHEM J, V422, P393, DOI 10.1042/BJ20090978; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; Tassew NG, 2008, MOL CELL NEUROSCI, V37, P761, DOI 10.1016/j.mcn.2008.01.002; Yamashita T, 2007, CURR OPIN NEUROBIOL, V17, P29, DOI 10.1016/j.conb.2006.12.001	22	12	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32791	10.1371/journal.pone.0032791	http://dx.doi.org/10.1371/journal.pone.0032791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396795	Green Published, gold, Green Submitted			2022-12-25	WOS:000303005000038
J	Mao, WK; You, T; Ye, B; Li, X; Dong, HH; Hill, JA; Li, FQ; Xu, HD				Mao, Weike; You, Tao; Ye, Bo; Li, Xiang; Dong, Henry H.; Hill, Joseph A.; Li, Faqian; Xu, Haodong			Reactive Oxygen Species Suppress Cardiac Na(V)1.5 Expression through Foxo1	PLOS ONE			English	Article							INSULIN-RESPONSE SEQUENCE; TRANSCRIPTION FACTORS; ANDROGEN RECEPTOR; OXIDATIVE-STRESS; HEART; GROWTH; CELLS; MOUSE; PHOSPHORYLATION; ACTIVATION	Na(V)1.5 is a cardiac voltage-gated Na+ channel asubunit and is encoded by the SCN5a gene. The activity of this channel determines cardiac depolarization and electrical conduction. Channel defects, including mutations and decrease of channel protein levels, have been linked to the development of cardiac arrhythmias. The molecular mechanisms underlying the regulation of Na(V)1.5 expression are largely unknown. Forkhead box O (Foxo) proteins are transcriptional factors that bind the consensus DNA sequences in their target gene promoters and regulate the expression of these genes. Comparative analysis revealed conserved DNA sequences, 5'-CAAAACA-3' (insulin responsive element, IRE), in rat, mouse and human SCN5a promoters with the latter two containing two overlapping Foxo protein binding IREs, 5'-CAAAACAAAACA-3'. This finding led us to hypothesize that Foxo1 regulates Na(V)1.5 expression by directly binding the SCN5a promoter and affecting its transcriptional activity. In the present study, we determined whether Foxo1 regulates Na(V)1.5 expression at the transcriptional level and also defined the role of Foxo1 in hydrogen peroxide (H2O2)-mediated Na(V)1.5 suppression in HL-1 cardiomyocytes using chromatin immunoprecipitation (ChIP), constitutively nuclear Foxo1 expression, and RNAi Foxo1 knockdown as well as whole cell voltage-clamp recordings. ChIP with anti-Foxo1 antibody and follow-up semi-quantitative PCR with primers flanking Foxo1 binding sites in the proximal SCN5a promoter region clearly demonstrated enrichment of DNA, confirming Foxo1 recruitment to this consensus sequence. Foxo1 mutant (T24A/S319A-GFP, Foxo1-AA-GFP) was retained in nuclei, leading to a decrease of Na(V)1.5 expression and Na+ current, while silencing of Foxo1 expression by RNAi resulted in the augmentation of Na(V)1.5 expression. H2O2 significantly reduced NaV1.5 expression by promoting Foxo1 nuclear localization and this reduction was prevented by RNAi silencing Foxo1 expression. These studies indicate that Foxo1 negatively regulates Na(V)1.5 expression in cardiomyocytes and reactive oxygen species suppress Na(V)1.5 expression through Foxo1.	[Mao, Weike; You, Tao; Ye, Bo; Li, Xiang; Li, Faqian; Xu, Haodong] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Xu, Haodong] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [You, Tao] Soochow Univ, Affiliated Hosp 2, Div Cardiol, Suzhou, Jiangsu, Peoples R China; [Dong, Henry H.] UPMC, Childrens Hosp Pittsburgh, Rangoes Res Ctr, Div Immunogenet, Pittsburgh, PA USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA	University of Rochester; University of Rochester; Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mao, WK (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Anesthesiol, Wuhan 430074, Hubei, Peoples R China.	Haodong_Xu@URMC.Rochestser.edu	Ye, Bo/X-7115-2019; xu, hao/GWQ-7394-2022	Ye, Bo/0000-0002-1728-6506; Dong, H. Henry/0000-0003-0279-5241	National Institute of Health (NIH) [K08HL088127, HL-075173, HL-080144, HL-090842, DK066301, DK087764]; American Heart Association (AHA) [12GRNT9690003, 0640084N]; AHA-Jon Holden DeHaan Foundation [0970518N]; American Diabetes Association [7-08-MN-21]; Lawrence J. and Florence A. DeGeorge Charitable Trust [10GRNT4460014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL088127, R01HL111480, R01HL075173, R01HL090842, R01HL080144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087764, R01DK066301] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); AHA-Jon Holden DeHaan Foundation; American Diabetes Association(American Diabetes Association); Lawrence J. and Florence A. DeGeorge Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	HX is supported by grants from National Institute of Health (NIH) (K08HL088127) and American Heart Association (AHA) (12GRNT9690003); JAH is supported by grants from NIH (HL-075173, HL-080144 and HL-090842), AHA (0640084N), AHA-Jon Holden DeHaan Foundation (0970518N) and American Diabetes Association (7-08-MN-21); HHD is supported by grants from NIH (DK066301 and DK087764); FL is supported by grant from AHA and the Lawrence J. and Florence A. DeGeorge Charitable Trust (10GRNT4460014). The funders had no role in study design, data collect and analysis, decision to publish, or preparation of the manuscript.	Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Baba S, 2005, CIRCULATION, V112, P2386, DOI 10.1161/CIRCULATIONAHA.105.534784; BARRINGTON PL, 1988, J MOL CELL CARDIOL, V20, P1163, DOI 10.1016/0022-2828(88)90596-2; Briggs LE, 2008, CIRC RES, V103, P580, DOI 10.1161/CIRCRESAHA.108.171835; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Fukuda K, 2005, CIRC RES, V97, P1262, DOI 10.1161/01.RES.0000195844.31466.e9; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kaestner KH, 2000, GENE DEV, V14, P142; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lakatta Edward G, 2002, Mol Interv, V2, P431, DOI 10.1124/mi.2.7.431; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Liu P, 2008, CANCER RES, V68, P10290, DOI 10.1158/0008-5472.CAN-08-2038; Lu Z, 2008, CIRC RES, V103, P269, DOI 10.1161/CIRCRESAHA.107.166678; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakajima T, 2010, J MOL CELL CARDIOL, V48, P352, DOI 10.1016/j.yjmcc.2009.11.016; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Philip-Couderc P, 2008, CIRC RES, V102, pE20, DOI 10.1161/CIRCRESAHA.107.166744; Pu JL, 1997, CIRC RES, V81, P110, DOI 10.1161/01.RES.81.1.110; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Ronnebaum SM, ANN REV PHYSL, V72, P81; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Shang LL, 2008, AM J PHYSIOL-CELL PH, V294, pC372, DOI 10.1152/ajpcell.00186.2007; SLEZAK J, 1995, AM J PATHOL, V147, P772; Song Y, 2006, J PHARMACOL EXP THER, V318, P214, DOI 10.1124/jpet.106.101832; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Xia M, 2004, J MOL CELL CARDIOL, V36, P111, DOI 10.1016/j.yjmcc.2003.10.007; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zhao WY, 2009, INT J EXP PATHOL, V90, P621, DOI 10.1111/j.1365-2613.2009.00682.x; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhou W, 2009, GASTROENTEROLOGY, V137, P1403, DOI 10.1053/j.gastro.2009.06.049; Zimmer T, 2002, AM J PHYSIOL-HEART C, V282, pH1007, DOI 10.1152/ajpheart.00644.2001; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	52	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32738	10.1371/journal.pone.0032738	http://dx.doi.org/10.1371/journal.pone.0032738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22400069	gold, Green Published, Green Submitted			2022-12-25	WOS:000303003500097
J	Natsuizaka, M; Naganuma, S; Kagawa, S; Ohashi, S; Ahmadi, A; Subramanian, H; Chang, S; Nakagawa, KJ; Ji, XJ; Liebhaber, SA; Klein-Szanto, AJ; Nakagawa, H				Natsuizaka, Mitsuteru; Naganuma, Seiji; Kagawa, Shingo; Ohashi, Shinya; Ahmadi, Azal; Subramanian, Harry; Chang, Sanders; Nakagawa, Kei J.; Ji, Xinjun; Liebhaber, Stephen A.; Klein-Szanto, Andres J.; Nakagawa, Hiroshi			Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1 alpha-mediated mRNA transcription and continuous protein synthesis	FASEB JOURNAL			English	Article						cap-dependent translation; internal ribosome entry site	FACTOR-BINDING PROTEIN-3; INDUCIBLE FACTOR (HIF)-1-ALPHA; RIBOSOME ENTRY SITES; GENE-EXPRESSION; TRANSLATIONAL CONTROL; RESPONSIVE ELEMENT; CANDIDATE GENES; BREAST-CANCER; STEM-CELL; P53	Insulin-like growth factor binding protein (IGFBP)-3 regulates cell proliferation and apoptosis in esophageal squamous cell carcinoma (ESCC) cells. We have investigated how the hypoxic tumor microenvironment in ESCC fosters the induction of IGFBP3. RNA interference experiments revealed that hypoxia-inducible factor (HIF)-1 alpha, but not HIF-2 alpha, regulates IGFBP3 mRNA induction. By chromatin immunoprecipitation and transfection assays, HIF-1 alpha was found to transactivate IGFBP3 through a novel hypoxia responsive element (HRE) located at 57 kb upstream from the transcription start site. Metabolic labeling experiments demonstrated hypoxia-mediated inhibition of global protein synthesis. 7-Methyl GTP-cap binding assays suggested that hypoxia suppresses cap-dependent translation. Experiments using pharmacological inhibitors for mammalian target of rapamycin (mTOR) suggested that a relatively weak mTOR activity may be sufficient for cap-dependent translation of IGFBP3 under hypoxic conditions. Bicistronic RNA reporter transfection assays did not validate the possibility of an internal ribosome entry site as a potential mechanism for cap-independent translation for IGFBP3 mRNA. Finally, IGFBP3 mRNA was found enriched to the polysomes. In aggregate, our study establishes IGFBP3 as a direct HIF-1 alpha target gene and that polysome enrichment of IGFBP3 mRNA may permit continuous translation under hypoxic conditions.-Natsuizaka, M., Naganuma, S., Kagawa, S., Ohashi, S., Ahmadi, A., Subramanian, H., Chang, S., Nakagawa, K. J., Ji, X., Liebhaber, S. A., Klein-Szanto, A. J., Nakagawa, H. Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1 alpha-mediated mRNA transcription and continuous protein synthesis. FASEB J. 26, 2620-2630 (2012). www.fasebj.org	[Natsuizaka, Mitsuteru; Naganuma, Seiji; Kagawa, Shingo; Ohashi, Shinya; Ahmadi, Azal; Subramanian, Harry; Chang, Sanders; Nakagawa, Kei J.; Nakagawa, Hiroshi] Univ Penn, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA; [Natsuizaka, Mitsuteru; Naganuma, Seiji; Kagawa, Shingo; Ohashi, Shinya; Ahmadi, Azal; Subramanian, Harry; Chang, Sanders; Nakagawa, Kei J.; Nakagawa, Hiroshi] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Ji, Xinjun; Liebhaber, Stephen A.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Ohashi, Shinya] Kitano Hosp, Div Gastroenterol & Hepatol, Ctr Digest Dis, Tazuke Kofukai Med Res Inst, Osaka, Japan	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Fox Chase Cancer Center; Kitano Hospital	Nakagawa, H (corresponding author), Univ Penn, Div Gastroenterol, Dept Med, 638 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	nakagawh@mail.med.upenn.edu	Ohashi, Shinya/AAD-8920-2022; Natsuizaka, Mitsuteru/F-7300-2012	Natsuizaka, Mitsuteru/0000-0002-1819-1955; Subramanian, Harry/0000-0001-9173-6248; Chang, Sanders/0000-0003-3543-0310	U.S. National Institute of Health (NIH) [R01DK077005, P01CA098101, P30-DK050306, R37-HL65449-MERIT]; University of Pennsylvania University Research Foundation; Japan Society for the Promotion of Science [21790382]; American Gastroenterological Association (AGA) Research Foundation; NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases [P30-DK050306]; AGA-Broad Foundation; NATIONAL CANCER INSTITUTE [P01CA098101, P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL065449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077005, P30DK050306] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania University Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Gastroenterological Association (AGA) Research Foundation; NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGA-Broad Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by U.S. National Institute of Health (NIH) grants R01DK077005 (to M. N., S. K., S. O., and H. N.), P01CA098101 (to H. N., M. N., S. K., S. O., and A. J. P. K.), P30-DK050306 (to A. A., H. S., S. C., and K. J. N.), R37-HL65449-MERIT (to S. A. L.); a University of Pennsylvania University Research Foundation Award (to H. N.); Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists B-21790382 (to S. N.); an American Gastroenterological Association (AGA) Research Foundation Student Fellowship Award (to S. C.) and an AGA-Broad Foundation Student Research Fellowship Award (to K. J. N.); and the NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306) and its core facilities (Molecular Pathology and Imaging, Cell Culture, and Molecular Biology and Gene Expression). The authors thank James J. Lee and Daniela Budo for technical assistance; Dr. Frank S. Lee (University of Pennsylvania) and Dr. David Feldman and Dr. Peter Sarnow (Stanford University, Palo Alto, CA, USA) for reagents; Dr. Regina M. Young and Dr. Phyllis A. Gimotty (University of Pennsylvania) for discussions; and Dr. Louis del Peso (Universidad Autonoma de Madrid, Madrid, Spain) for in silico screening of IGFBP3 HREs and discussions. The authors are appreciative of discussions with members of the laboratory of Dr. Anil K. Rustgi and his editorial help.	Azuma Y, 2003, CLIN CANCER RES, V9, P4944; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; Bourdon JC, 1997, ONCOGENE, V14, P85, DOI 10.1038/sj.onc.1200804; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Carter MS, 2000, J BIOL CHEM, V275, P28301; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chang YS, 2002, CLIN CANCER RES, V8, P3796; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P4203, DOI 10.1002/art.23074; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Feldser D, 1999, CANCER RES, V59, P3915; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gharib SA, 2005, PHYSIOL GENOMICS, V22, P14, DOI 10.1152/physiolgenomics.00265.2004; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Grimberg A, 2005, J CLIN ENDOCR METAB, V90, P3568, DOI 10.1210/jc.2004-1213; Grimberg A, 2000, MOL GENET METAB, V70, P85, DOI 10.1006/mgme.2000.3008; Hanafusa T, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-9; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HINTZ RL, 1991, J UROLOGY, V146, P1160, DOI 10.1016/S0022-5347(17)38031-X; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; Katsuta M, 2005, EXP MOL PATHOL, V78, P123, DOI 10.1016/j.yexmp.2004.11.002; Kimura S, 2004, EUR J CANCER, V40, P1904, DOI 10.1016/j.ejca.2004.04.035; Koong AC, 2000, CANCER RES, V60, P883; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Lee JJ, 2010, CARCINOGENESIS, V31, P427, DOI 10.1093/carcin/bgp326; Lin Q, 2010, CANCER BIOL THER, V9, P949, DOI 10.4161/cbt.9.12.12347; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Matsuyama T, 2005, CANCER SCI, V96, P176, DOI 10.1111/j.1349-7006.2005.00025.x; McIntosh J, 2010, J BIOL CHEM, V285, P38788, DOI 10.1074/jbc.M110.177311; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Peng LH, 2004, MOL ENDOCRINOL, V18, P1109, DOI 10.1210/me.2003-0344; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ragel BT, 2007, NEUROSURG REV, V30, P181, DOI 10.1007/s10143-007-0070-z; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Takaoka M, 2004, CANCER RES, V64, P7711, DOI 10.1158/0008-5472.CAN-04-0715; Takaoka M, 2006, AM J PHYSIOL-GASTR L, V290, pG404, DOI 10.1152/ajpgi.00344.2005; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; Tomii K, 2007, INT J CANCER, V120, P566, DOI 10.1002/ijc.22341; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Yu F, 2001, CANCER RES, V61, P4136	56	37	39	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2620	2630		10.1096/fj.11-198598	http://dx.doi.org/10.1096/fj.11-198598			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415309	Green Published			2022-12-25	WOS:000305017200037
J	Katz, C; Zaltsman-Amir, Y; Mostizky, Y; Kollet, N; Gross, A; Friedler, A				Katz, Chen; Zaltsman-Amir, Yehudit; Mostizky, Yana; Kollet, Neta; Gross, Atan; Friedler, Assaf			Molecular Basis of the Interaction between Proapoptotic Truncated BID (tBID) Protein and Mitochondrial Carrier Homologue 2 (MTCH2) Protein KEY PLAYERS IN MITOCHONDRIAL DEATH PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY; BAX; ACTIVATION; INHIBITORS; APOPTOSIS; THERAPY; DAMAGE; CELLS; LIFE	The molecular basis of the interaction between mitochondrial carrier homologue 2 (MTCH2) and truncated BID (tBID) was characterized. These proteins participate in the apoptotic pathway, and the interaction between them may serve as a target for anticancer lead compounds. In response to apoptotic signals, MTCH2 recruits tBID to the mitochondria, where it activates apoptosis. A combination of peptide arrays screening with biochemical and biophysical techniques was used to characterize the mechanism of the interaction between tBID and MTCH2 at the structural and molecular levels. The regions that mediate the interaction between the proteins were identified. The two specific binding sites between the proteins were determined to be tBID residues 59-73 that bind MTCH2 residues 140-161, and tBID residues 111-125 that bind MTCH2 residues 240-290. Peptides derived from tBID residues 111-125 and 59-73 induced cell death in osteosarcoma cells. These peptides may serve as lead compounds for anticancer drugs that act by targeting the tBID-MTCH2 interaction.	[Zaltsman-Amir, Yehudit; Mostizky, Yana; Gross, Atan] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Katz, Chen; Kollet, Neta; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem	Gross, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	atan.gross@weizmann.ac.il; assaf@chem.ch.huji.ac.il	Gross, Atan/ABC-2640-2020		Israel Science Foundation; United States-Israel Binational Science Foundation; Israel Ministry of Health; European Research Council [203413]	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Ministry of Health; European Research Council(European Research Council (ERC)European Commission)	Supported by grants from the Israel Science Foundation and from the United States-Israel Binational Science Foundation.; Supported by a grant from the Israel Ministry of Health and by a starting grant from the European Research Council under the European Community Seventh Framework Programme (FP7/2007-2013)/European Research Council Grant 203413.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P345; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cogliati S, 2010, CELL RES, V20, P863, DOI 10.1038/cr.2010.100; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; del Arco A, 2005, CELL MOL LIFE SCI, V62, P2204, DOI 10.1007/s00018-005-5197-x; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Grinberg M, 2005, MOL CELL BIOL, V25, P4579, DOI 10.1128/MCB.25.11.4579-4590.2005; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Katz C, 2008, P NATL ACAD SCI USA, V105, P12277, DOI 10.1073/pnas.0711269105; Katz C, 2011, CHEM SOC REV, V40, P2131, DOI 10.1039/c0cs00029a; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Schwarz M, 2007, APOPTOSIS, V12, P869, DOI 10.1007/s10495-007-0748-2; Veresov VG, 2009, EUR BIOPHYS J BIOPHY, V38, P941, DOI 10.1007/s00249-009-0475-4; Wei MC, 2000, GENE DEV, V14, P2060; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yerushalmi GM, 2002, NEOPLASIA, V4, P510, DOI 10.1038/sj.neo.7900272; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	35	29	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15016	15023		10.1074/jbc.M111.328377	http://dx.doi.org/10.1074/jbc.M111.328377			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22416135	Green Published, hybrid			2022-12-25	WOS:000304003200063
J	Kiflemariam, S; Andersson, S; Asplund, A; Ponten, F; Sjoblom, T				Kiflemariam, Sara; Andersson, Sandra; Asplund, Anna; Ponten, Fredrik; Sjoblom, Tobias			Scalable In Situ Hybridization on Tissue Arrays for Validation of Novel Cancer and Tissue-Specific Biomarkers	PLOS ONE			English	Article							HUMAN PROTEIN ATLAS; GROWTH-FACTORS; EXPRESSION; MICROARRAYS; SATB2	Tissue localization of gene expression is increasingly important for accurate interpretation of large scale datasets from expression and mutational analyses. To this end, we have (1) developed a robust and scalable procedure for generation of mRNA hybridization probes, providing >95% first-pass success rate in probe generation to any human target gene and (2) adopted an automated staining procedure for analyses of formalin-fixed paraffin-embedded tissues and tissue microarrays. The in situ mRNA and protein expression patterns for genes with known as well as unknown tissue expression patterns were analyzed in normal and malignant tissues to assess procedure specificity and whether in situ hybridization can be used for validating novel antibodies. We demonstrate concordance between in situ transcript and protein expression patterns of the well-known pathology biomarkers KRT17, CHGA, MKI67, PECAM1 and VIL1, and provide independent validation for novel antibodies to the biomarkers BRD1, EZH2, JUP and SATB2. The present study provides a foundation for comprehensive in situ gene set or transcriptome analyses of human normal and tumor tissues.	[Kiflemariam, Sara; Andersson, Sandra; Asplund, Anna; Ponten, Fredrik; Sjoblom, Tobias] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, Uppsala, Sweden	Uppsala University	Kiflemariam, S (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, Uppsala, Sweden.	tobias.sjoblom@igp.uu.se			Swedish Cancer Foundation [11 0186]; Beijer Foundation; Knut and Alice Wallenberg Foundation [2002.0087]	Swedish Cancer Foundation; Beijer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from the Swedish Cancer Foundation [11 0186] and the Beijer Foundation to TS, and from the Knut and Alice Wallenberg Foundation [2002.0087] to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betsholtz C, 1995, INT J DEV BIOL, V39, P817; Bjorling E, 2008, MOL CELL PROTEOMICS, V7, P825, DOI 10.1074/mcp.M700411-MCP200; Carson JP, 2002, CURR OPIN NEUROBIOL, V12, P562, DOI 10.1016/S0959-4388(02)00356-2; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Henke RT, 2005, HISTOL HISTOPATHOL, V20, P225, DOI 10.14670/HH-20.225; Kampf C., 2004, CLIN PROTEOM, V1, P285, DOI DOI 10.1385/CP:1:3-4:285; Karlgren A, 2009, J VIS EXP; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu WT, 2007, APPL ENVIRON MICROB, V73, P73, DOI 10.1128/AEM.01468-06; Magnusson K, 2011, AM J SURG PATHOL, V35, P937, DOI 10.1097/PAS.0b013e31821c3dae; Paavilainen L, 2010, J HISTOCHEM CYTOCHEM, V58, P237, DOI 10.1369/jhc.2009.954321; Rozen S, 2000, Methods Mol Biol, V132, P365; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575; Xiao YT, 2011, INT J BIOCHEM CELL B, V43, P474, DOI 10.1016/j.biocel.2011.01.005; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441	18	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32927	10.1371/journal.pone.0032927	http://dx.doi.org/10.1371/journal.pone.0032927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412953	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062000022
J	Sacco, RE; Nonnecke, BJ; Palmer, MV; Waters, WR; Lippolis, JD; Reinhardt, TA				Sacco, Randy E.; Nonnecke, Brian J.; Palmer, Mitchell V.; Waters, W. Ray; Lippolis, John D.; Reinhardt, Timothy A.			Differential Expression of Cytokines in Response to Respiratory Syncytial Virus Infection of Calves with High or Low Circulating 25-Hydroxyvitamin D-3	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; INTERFERON REGULATORY FACTOR-1; AIRWAY EPITHELIAL-CELLS; TUMOR-NECROSIS-FACTOR; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; GAMMA-INTERFERON; HOST-RESISTANCE	Deficiency of serum levels of 25-hydroxyvitamin D-3 has been related to increased risk of lower respiratory tract infections in children. Respiratory syncytial virus (RSV) is a leading cause of low respiratory tract infections in infants and young children. The neonatal calf model of RSV infection shares many features in common with RSV infection in infants and children. In the present study, we hypothesized that calves with low circulating levels of 25-hydroxyvitamin D-3 (25(OH)D-3) would be more susceptible to RSV infection than calves with high circulating levels of 25(OH)D-3. Calves were fed milk replacer diets with different levels of vitamin D for a 10 wk period to establish two treatment groups, one with high (177 ng/ml) and one with low (32.5 ng/ml) circulating 25(OH)D-3. Animals were experimentally infected via aerosol challenge with RSV. Data on circulating 25(OH)D-3 levels showed that high and low concentrations of 25(OH)D-3 were maintained during infection. At necropsy, lung lesions due to RSV were similar in the two vitamin D treatment groups. We show for the first time that RSV infection activates the vitamin D intracrine pathway in the inflamed lung. Importantly, however, we observed that cytokines frequently inhibited by this pathway in vitro are, in fact, either significantly upregulated (IL-12p40) or unaffected (IFN-gamma) in the lungs of RSV-infected calves with high circulating levels of 25(OH)D-3. Our data indicate that while vitamin D does have an immunomodulatory role during RSV infection, there was no significant impact on pathogenesis during the early phases of RSV infection. Further examination of the potential effects of vitamin D status on RSV disease resolution will require longer-term studies with immunologically sufficient and deficient vitamin D levels.	[Sacco, Randy E.; Nonnecke, Brian J.; Lippolis, John D.; Reinhardt, Timothy A.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Palmer, Mitchell V.; Waters, W. Ray] ARS, Infect Bacterial Dis Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Sacco, RE (corresponding author), ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA.	randy.sacco@ars.usda.gov	Palmer, Mitchell/R-7091-2018; Reinhardt, Timothy/A-7536-2009	Palmer, Mitchell/0000-0002-5902-3333; Reinhardt, Timothy/0000-0001-5552-2509; Tripp, Ralph/0000-0002-2924-9956; Lippolis, John/0000-0003-2314-4384	USDA	USDA(United States Department of Agriculture (USDA))	Research was conducted at at USDA research facility and all funding was provided through internal USDA research dollars. This project is an intramural project of the UDDA/ARS National Animal Disease Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Harb M, 1999, EUR RESPIR J, V14, P139, DOI 10.1034/j.1399-3003.1999.14a23.x; Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; BECKER S, 1991, J IMMUNOL, V147, P4307; BHALLA AK, 1986, CELL IMMUNOL, V98, P311, DOI 10.1016/0008-8749(86)90291-1; Bikle DD, 2011, VITAM HORM, V86, P1, DOI 10.1016/B978-0-12-386960-9.00001-0; Bruce D, 2010, EXP BIOL MED, V235, P921, DOI 10.1258/ebm.2010.010061; Bruce D, 2009, INT IMMUNOL, V21, P113, DOI 10.1093/intimm/dxn129; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CALI JP, 1973, CLIN CHEM, V19, P1208; Cantorna MT, 1998, TRANSPLANTATION, V66, P828, DOI 10.1097/00007890-199810150-00003; CASTLEMAN WL, 1990, AM J VET RES, V51, P789; Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.3.CO;2-Y; Cohen ML, 2001, KIDNEY INT, V59, P69, DOI 10.1046/j.1523-1755.2001.00467.x; Cohen-Lahav M, 2007, J STEROID BIOCHEM, V103, P558, DOI 10.1016/j.jsbmb.2006.12.093; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Ehrchen J, 2007, FASEB J, V21, P3208, DOI 10.1096/fj.06-7261com; Fach SJ, 2007, VIRAL IMMUNOL, V20, P119, DOI 10.1089/vim.2006.0056; Fach SJ, 2010, VET IMMUNOL IMMUNOP, V136, P55, DOI 10.1016/j.vetimm.2010.02.008; FAGAN DL, 1991, MOL ENDOCRINOL, V5, P179, DOI 10.1210/mend-5-2-179; Flecknoe SJ, 2003, AM J PHYSIOL-LUNG C, V285, pL664, DOI 10.1152/ajplung.00306.2002; Grant CC, 2011, J PAEDIATR CHILD H, V47, P497, DOI 10.1111/j.1440-1754.2010.01868.x; GYETKO MR, 1993, J LEUKOCYTE BIOL, V54, P17, DOI 10.1002/jlb.54.1.17; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Harant H, 1997, EUR J BIOCHEM, V250, P63, DOI 10.1111/j.1432-1033.1997.00063.x; Hewison M, 2011, VITAM HORM, V86, P23, DOI 10.1016/B978-0-12-386960-9.00002-2; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Karatekin G, 2009, EUR J CLIN NUTR, V63, P473, DOI 10.1038/sj.ejcn.1602960; Khoo AL, 2011, CYTOKINE, V55, P294, DOI 10.1016/j.cyto.2011.04.016; LAPIN CD, 1993, PEDIATR PULM, V15, P151, DOI 10.1002/ppul.1950150305; Larsen LE, 2000, ACTA VET SCAND, V41, P1; Lippolis JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025479; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; MCDERMOTT CM, 1985, J DAIRY SCI, V68, P1959, DOI 10.3168/jds.S0022-0302(85)81057-2; Meyerholz DK, 2004, MICROBES INFECT, V6, P1312, DOI 10.1016/j.micinf.2004.08.006; Moore EC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-116; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; NEILSON K A, 1990, Pediatric Pathology, V10, P491; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; Nelson CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015469; NOAH TL, 1995, J INFECT DIS, V171, P584, DOI 10.1093/infdis/171.3.584; PAREKH A C, 1970, Clinica Chimica Acta, V27, P373, DOI 10.1016/0009-8981(70)90288-3; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Pike JW, 2011, REV ENDOCR IN PRESS; PREHN JL, 1992, BLOOD, V80, P2811; REICHEL H, 1987, P NATL ACAD SCI USA, V84, P3385, DOI 10.1073/pnas.84.10.3385; ROOK G, 1986, TUBERCLE, V67, P155, DOI 10.1016/0041-3879(86)90011-5; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; SAGGESE G, 1989, J ENDOCRINOL INVEST, V12, P329, DOI 10.1007/BF03349999; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Stoffels K, 2007, J STEROID BIOCHEM, V103, P567, DOI 10.1016/j.jsbmb.2006.12.091; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P335, DOI 10.1081/IPH-120014721; Takeuchi R, 1998, J VIROL, V72, P837, DOI 10.1128/JVI.72.1.837-840.1998; Takeuchi R, 1998, J VIROL, V72, P4498, DOI 10.1128/JVI.72.5.4498-4502.1998; Vidyarani M, 2007, CYTOKINE, V40, P128, DOI 10.1016/j.cyto.2007.08.005; Walker VP, 2009, PEDIATR RES, V65, p106R, DOI 10.1203/PDR.0b013e31819dba91; Waters WR, 2004, MICROB PATHOGENESIS, V36, P11, DOI 10.1016/j.micpath.2003.08.008; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-08; Williams B, 2008, PEDIATR INFECT DIS J, V27, P941, DOI 10.1097/INF.0b013e31817525df; Woolums AR, 1999, AM J VET RES, V60, P473; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	74	58	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33074	10.1371/journal.pone.0033074	http://dx.doi.org/10.1371/journal.pone.0033074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412984	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000028
J	Buehlmann, C; Hansson, BS; Knaden, M				Buehlmann, Cornelia; Hansson, Bill S.; Knaden, Markus			Desert Ants Learn Vibration and Magnetic Landmarks	PLOS ONE			English	Article							SYSTEMATIC SEARCH; PATH-INTEGRATION; CUTTING ANTS; CATAGLYPHIS; ORIENTATION; HYMENOPTERA; MAGNETORECEPTION; STRIDULATION; NAVIGATION; FIELD	The desert ants Cataglyphis navigate not only by path integration but also by using visual and olfactory landmarks to pinpoint the nest entrance. Here we show that Cataglyphis noda can additionally use magnetic and vibrational landmarks as nest-defining cues. The magnetic field may typically provide directional rather than positional information, and vibrational signals so far have been shown to be involved in social behavior. Thus it remains questionable if magnetic and vibration landmarks are usually provided by the ants' habitat as nest-defining cues. However, our results point to the flexibility of the ants' navigational system, which even makes use of cues that are probably most often sensed in a different context.	[Buehlmann, Cornelia; Hansson, Bill S.; Knaden, Markus] Max Planck Inst Chem Ecol, Jena, Germany	Max Planck Society	Buehlmann, C (corresponding author), Max Planck Inst Chem Ecol, Jena, Germany.	mknaden@ice.mpg.de	Hansson, Bill S/G-2774-2013; Knaden, Markus/E-2151-2015	Hansson, Bill S/0000-0002-4811-1223; Knaden, Markus/0000-0002-6710-1071; Buehlmann, Cornelia/0000-0001-6628-6900	Max Planck Society	Max Planck Society(Max Planck Society)	This study was supported financially by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks AN, 2003, ETHOLOGY, V109, P835, DOI 10.1046/j.0179-1613.2003.00927.x; Boles LC, 2003, NATURE, V421, P60, DOI 10.1038/nature01226; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Cheng K, 2002, PHYSIOL ENTOMOL, V27, P285, DOI 10.1046/j.1365-3032.2002.00298.x; GRAHAM P., 2010, ENCY ANIMAL BEHAV, P167; Kleineidam CJ, 2007, J INSECT PHYSIOL, V53, P478, DOI 10.1016/j.jinsphys.2007.01.011; Knaden M, 2005, ANIM BEHAV, V70, P1349, DOI 10.1016/j.anbehav.2005.03.030; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; Merkle T, 2006, J EXP BIOL, V209, P3545, DOI 10.1242/jeb.02395; Muller M, 2007, NATURWISSENSCHAFTEN, V94, P589, DOI 10.1007/s00114-007-0232-4; MULLER M, 1994, J COMP PHYSIOL A, V175, P525, DOI 10.1007/BF00199474; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Riveros AJ, 2010, ENCY ANIMAL BEHAV, V2, P305; ROCES F, 1993, NATURWISSENSCHAFTEN, V80, P521, DOI 10.1007/BF01140810; Seidl T, 2006, J EXP BIOL, V209, P3336, DOI 10.1242/jeb.02364; Sommer S, 2004, J COMP PHYSIOL A, V190, P1, DOI 10.1007/s00359-003-0465-4; Steck K, 2011, J EXP BIOL, V214, P1307, DOI 10.1242/jeb.053579; Steck K, 2010, ANIM BEHAV, V79, P939, DOI 10.1016/j.anbehav.2010.01.011; Steck K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-5; VOWLES DM, 1954, J EXP BIOL, V31, P356; Wajnberg E, 2010, J R SOC INTERFACE, V7, pS207, DOI 10.1098/rsif.2009.0526.focus; WALKER MM, 1989, J EXP BIOL, V145, P489; WEHNER R, 1979, EXPERIENTIA, V35, P1569, DOI 10.1007/BF01953197; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; Wehner Rudiger, 2008, Navigation. Journal of the Institute of Navigation, V55, P101; Wehner R, 2003, J COMP PHYSIOL A, V189, P579, DOI 10.1007/s00359-003-0431-1; Wehner R, 2006, P NATL ACAD SCI USA, V103, P12575, DOI 10.1073/pnas.0604430103; Wehner R, 2009, MYRMECOL NEWS, V12, P85; Wehner Ruediger, 2003, P9; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Wittlinger M, 2006, SCIENCE, V312, P1965, DOI 10.1126/science.1126912	31	44	44	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33117	10.1371/journal.pone.0033117	http://dx.doi.org/10.1371/journal.pone.0033117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412989	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000303060800081
J	Chang, CT; Ho, TY; Lin, H; Liang, JA; Huang, HC; Li, CC; Lo, HY; Wu, SL; Huang, YF; Hsiang, CY				Chang, Chung-Ta; Ho, Tin-Yun; Lin, Ho; Liang, Ji-An; Huang, Hui-Chi; Li, Chia-Cheng; Lo, Hsin-Yi; Wu, Shih-Lu; Huang, Yi-Fang; Hsiang, Chien-Yun			5-Fluorouracil Induced Intestinal Mucositis via Nuclear Factor-kappa B Activation by Transcriptomic Analysis and In Vivo Bioluminescence Imaging	PLOS ONE			English	Article							HOST-BIOMATERIAL INTERACTION; ALIMENTARY-TRACT MUCOSITIS; ORAL MUCOSITIS; MUCOSAL INJURY; CANCER; CHEMOTHERAPY; EXPRESSION; PATHOBIOLOGY; PATHOGENESIS; PREDICTION	5-Fluorouracil (5-FU) is a commonly used drug for the treatment of malignant cancers. However, approximately 80% of patients undergoing 5-FU treatment suffer from gastrointestinal mucositis. The aim of this report was to identify the drug target for the 5-FU-induced intestinal mucositis. 5-FU-induced intestinal mucositis was established by intraperitoneally administering mice with 100 mg/kg 5-FU. Network analysis of gene expression profile and bioluminescent imaging were applied to identify the critical molecule associated with 5-FU-induced mucositis. Our data showed that 5-FU induced inflammation in the small intestine, characterized by the increased intestinal wall thickness and crypt length, the decreased villus height, and the increased myeloperoxidase activity in tissues and proinflammatory cytokine production in sera. Network analysis of 5-FU-affected genes by transcriptomic tool showed that the expression of genes was regulated by nuclear factor-kappa B (NF-kappa B), and NF-kappa B was the central molecule in the 5-FU-regulated biological network. NF-kappa B activity was activated by 5-FU in the intestine, which was judged by in vivo bioluminescence imaging and immunohistochemical staining. However, 5-aminosalicylic acid (5-ASA) inhibited 5-FU-induced NF-kappa B activation and proinflammatory cytokine production. Moreover, 5-FU-induced histological changes were improved by 5-ASA. In conclusion, our findings suggested that NF-kappa B was the critical molecule associated with the pathogenesis of 5-FU-induced mucositis, and inhibition of NF-kappa B activity ameliorated the mucosal damage caused by 5-FU.	[Chang, Chung-Ta] Far Eastern Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Chang, Chung-Ta; Lin, Ho] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Ho, Tin-Yun; Li, Chia-Cheng; Lo, Hsin-Yi] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan; [Ho, Tin-Yun] China Med Univ, Dept Nucl Med, Taichung, Taiwan; [Liang, Ji-An] China Med Univ Hosp, Dept Radiat Therapy & Oncol, Taichung, Taiwan; [Huang, Hui-Chi] China Med Univ, Sch Pharmaceut Sci & Chinese Med Resources, Taichung, Taiwan; [Wu, Shih-Lu] China Med Univ, Dept Biochem, Taichung, Taiwan; [Huang, Yi-Fang] Chang Gung Mem Hosp, Dept Prosthodont, Tao Yuan, Taiwan; [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung, Taiwan	Far Eastern Memorial Hospital; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; China Medical University Taiwan	Chang, CT (corresponding author), Far Eastern Mem Hosp, Dept Emergency Med, Taipei, Taiwan.	cyhsiang@mail.cmu.edu.tw	Ho, Tin-Yun/O-3889-2015; Huang, Hui-Chi/D-2042-2012; Hsiang, Chien-Yun/O-3853-2015	Huang, Hui-Chi/0000-0002-3645-6726; Lin, Ho/0000-0001-7849-9137; Huang, Yi-Fang/0000-0003-2569-999X; Chang, Chung-Ta/0000-0002-9211-1407	National Science Council; China Medical University [CMU99-S-06, CMU99-S-31, CMU100-S-16, CMU100-S-34, CMU100-TS-14]	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University)	This work was supported by grants from National Science Council and China Medical University (CMU99-S-06, CMU99-S-31, CMU100-S-16, CMU100-S-34, and CMU100-TS-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aota K, 2000, BIOCHEM BIOPH RES CO, V273, P1168, DOI 10.1006/bbrc.2000.3072; Azuma M, 2001, BIOCHEM BIOPH RES CO, V282, P292, DOI 10.1006/bbrc.2001.4571; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bantel H, 2000, AM J GASTROENTEROL, V95, P3452; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bowen JM, 2006, SUPPORT CARE CANCER, V14, P713, DOI 10.1007/s00520-005-0004-7; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; Chang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023682; Cheng HM, 2010, J ETHNOPHARMACOL, V132, P429, DOI 10.1016/j.jep.2010.08.022; GRADISHAR WJ, 1990, ANN ONCOL, V1, P409, DOI 10.1093/oxfordjournals.annonc.a057793; Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005; Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Leitao RFC, 2007, CANCER CHEMOTH PHARM, V59, P603, DOI 10.1007/s00280-006-0301-y; Logan RM, 2007, CANCER TREAT REV, V33, P448, DOI 10.1016/j.ctrv.2007.03.001; Logan R, 2009, CANCER CHEMOTH PHARM, V63, P239, DOI 10.1007/s00280-008-0732-8; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Melo MLP, 2008, CANCER CHEMOTH PHARM, V61, P775, DOI 10.1007/s00280-007-0534-4; Motoori M, 2010, INT J ONCOL, V37, P1113, DOI 10.3892/ijo_00000763; Naidu MUR, 2004, NEOPLASIA, V6, P423, DOI 10.1593/neo.04169; Petty RD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-434; Pritchard DM, 1998, TOXICOL LETT, V103, P19, DOI 10.1016/S0378-4274(98)00273-2; Sausville EA, 2001, HARRISONS PRINCIPLES, P530; Schauer M, 2010, CLIN CANCER RES, V16, P330, DOI 10.1158/1078-0432.CCR-09-1673; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soares PM, 2011, CANC CHEMOT IN PRESS; Sonis SL, 2002, CRIT REV ORAL BIOL M, V13, P380, DOI 10.1177/154411130201300502; Sonis ST, 2004, ORAL ONCOL, V40, P170, DOI 10.1016/S1368-8375(03)00148-9; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Tomita N, 2000, J AM SOC NEPHROL, V11, P1244, DOI 10.1681/ASN.V1171244; Treister Nathaniel, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P123, DOI 10.1097/MOO.0b013e3280523ad6; Tsao DA, 2010, DNA CELL BIOL, V29, P285, DOI 10.1089/dna.2009.1006; Williams PD, 2009, CANCER RES, V69, P8302, DOI 10.1158/0008-5472.CAN-09-0798; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Wu SL, 2009, J PHARMACOL EXP THER, V330, P370, DOI 10.1124/jpet.109.152835; Wu ZQ, 2010, BIOMED PHARMACOTHER, V64, P589, DOI 10.1016/j.biopha.2010.06.006; Wu ZQ, 2011, CANC CHEMOT IN PRESS	40	110	117	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e31808	10.1371/journal.pone.0031808	http://dx.doi.org/10.1371/journal.pone.0031808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412841	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800004
J	de Lartigue, G; de la Serre, CB; Espero, E; Lee, J; Raybould, HE				de lartigue, Guillaume; de la Serre, Claire Barbier; Espero, Elvis; Lee, Jennifer; Raybould, Helen E.			Leptin Resistance in Vagal Afferent Neurons Inhibits Cholecystokinin Signaling and Satiation in Diet Induced Obese Rats	PLOS ONE			English	Article							HIGH-FAT DIETS; CANNABINOID CB1 RECEPTORS; FOOD-INTAKE; NODOSE GANGLION; ZUCKER RAT; FA/FA RAT; EXPRESSION; MICE; HYPERPHAGIA; APPETITE	Background and Aims: The gastrointestinal hormone cholecystokinin (CCK) plays an important role in regulating meal size and duration by activating CCK1 receptors on vagal afferent neurons (VAN). Leptin enhances CCK signaling in VAN via an early growth response 1 (EGR1) dependent pathway thereby increasing their sensitivity to CCK. In response to a chronic ingestion of a high fat diet, VAN develop leptin resistance and the satiating effects of CCK are reduced. We tested the hypothesis that leptin resistance in VAN is responsible for reducing CCK signaling and satiation. Results: Lean Zucker rats sensitive to leptin signaling, significantly reduced their food intake following administration of CCK8S (0.22 nmol/kg, i.p.), while obese Zucker rats, insensitive to leptin, did not. CCK signaling in VAN of obese Zucker rats was reduced, preventing CCK-induced up-regulation of Y2 receptor and down-regulation of melanin concentrating hormone 1 receptor (MCH1R) and cannabinoid receptor (CB1). In VAN from diet-induced obese (DIO) Sprague Dawley rats, previously shown to become leptin resistant, we demonstrated that the reduction in EGR1 expression resulted in decreased sensitivity of VAN to CCK and reduced CCK-induced inhibition of food intake. The lowered sensitivity of VAN to CCK in DIO rats resulted in a decrease in Y2 expression and increased CB1 and MCH1R expression. These effects coincided with the onset of hyperphagia in DIO rats. Conclusions: Leptin signaling in VAN is required for appropriate CCK signaling and satiation. In response to high fat feeding, the onset of leptin resistance reduces the sensitivity of VAN to CCK thus reducing the satiating effects of CCK.	[de lartigue, Guillaume; de la Serre, Claire Barbier; Espero, Elvis; Lee, Jennifer; Raybould, Helen E.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	University of California System; University of California Davis	de Lartigue, G (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	heraybould@ucdavis.edu	de Lartigue, Guillaume/AAJ-7635-2020	de La Serre, Claire/0000-0001-8355-6087	National Institutes of Health [DK41004]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041004, R29DK041004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work funded by National Institutes of Health DK41004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; APONTE GW, 1989, FASEB J, V3, P1949, DOI 10.1096/fasebj.3.8.2721855; Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; Barrachina MD, 1997, P NATL ACAD SCI USA, V94, P10455, DOI 10.1073/pnas.94.19.10455; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Bi S, 2001, AM J PHYSIOL-REG I, V281, pR254, DOI 10.1152/ajpregu.2001.281.1.R254; Bi S, 2007, AM J PHYSIOL-REG I, V293, pR55, DOI 10.1152/ajpregu.00002.2007; Burdyga G, 2006, NEUROSCIENCE, V137, P1405, DOI 10.1016/j.neuroscience.2005.10.057; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Burdyga G, 2002, NEUROSCIENCE, V109, P339, DOI 10.1016/S0306-4522(01)00474-2; Burdyga G, 2008, J NEUROSCI, V28, P11583, DOI 10.1523/JNEUROSCI.2493-08.2008; Burdyga G, 2010, AM J PHYSIOL-GASTR L, V299, pG63, DOI 10.1152/ajpgi.00059.2010; Buyse M, 2001, EUR J NEUROSCI, V14, P64, DOI 10.1046/j.0953-816x.2001.01628.x; Chua SC, 1996, DIABETES, V45, P1141, DOI 10.2337/diabetes.45.8.1141; CLEARY MP, 1980, AM J PHYSIOL, V238, pE284, DOI 10.1152/ajpendo.1980.238.3.E284; Covasa M, 1998, PEPTIDES, V19, P1407, DOI 10.1016/S0196-9781(98)00096-5; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; de Lartigue G, 2010, ENDOCRINOLOGY; De Lartigue G, 2011, AM J PHYSL ENDOCRINO; de Lartigue G, 2007, J NEUROSCI, V27, P2876, DOI 10.1523/JNEUROSCI.5508-06.2007; De Lartigue G, 2010, GASTROENTEROLOGY, V138, P1479, DOI 10.1053/j.gastro.2009.10.034; Dockray GJ, 2011, ACTA PHYSIOL, V201, P313, DOI 10.1111/j.1748-1716.2010.02219.x; Feinle C, 2003, AM J PHYSIOL-GASTR L, V284, pG798, DOI 10.1152/ajpgi.00512.2002; FUCHENG XM, 1995, PFLUG ARCH EUR J PHY, V431, P66, DOI 10.1007/BF00374378; Gaige S, 2002, J PHYSIOL-LONDON, V543, P679, DOI 10.1113/jphysiol.2002.021857; HEDDLE R, 1989, J GASTROEN HEPATOL, V4, P437, DOI 10.1111/j.1440-1746.1989.tb01741.x; Iida M, 1996, BIOCHEM BIOPH RES CO, V224, P597, DOI 10.1006/bbrc.1996.1070; JOHNSON PR, 1991, ANNU REV NUTR, V11, P325, DOI 10.1146/annurev.nu.11.070191.001545; JOHNSON PR, 1971, J LIPID RES, V12, P706; Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266; LAWTON CL, 1993, INT J OBESITY, V17, P409; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618; Paulino G, 2009, AM J PHYSIOL-ENDOC M, V296, pE898, DOI 10.1152/ajpendo.90796.2008; Peiser C, 2002, NEUROSCI LETT, V320, P41, DOI 10.1016/S0304-3940(02)00023-X; Peters JH, 2006, PHYSIOL BEHAV, V89, P477, DOI 10.1016/j.physbeh.2006.06.017; Peters JH, 2006, AM J PHYSIOL-REG I, V290, pR1544, DOI 10.1152/ajpregu.00811.2005; Peters JH, 2004, ENDOCRINOLOGY, V145, P3652, DOI 10.1210/en.2004-0221; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Savastano DM, 2005, J NUTR, V135, P1953, DOI 10.1093/jn/135.8.1953; Stewart JE, 2011, AM J CLIN NUTR, V93, P703, DOI 10.3945/ajcn.110.007583; Stoeckel LE, 2008, PHYSIOL BEHAV, V93, P289, DOI 10.1016/j.physbeh.2007.08.018; Swartz TD, 2010, BRAIN RES, V1308, P79, DOI 10.1016/j.brainres.2009.10.045; Torregrossa AM, 2003, PHYSIOL BEHAV, V78, P19, DOI 10.1016/S0031-9384(02)00888-0; Wang YH, 1997, AM J PHYSIOL-REG I, V273, pR833, DOI 10.1152/ajpregu.1997.273.2.R833; Whited KL, 2006, AM J PHYSIOL-GASTR L, V291, pG156, DOI 10.1152/ajpgi.00569.2005	47	96	96	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32967	10.1371/journal.pone.0032967	http://dx.doi.org/10.1371/journal.pone.0032967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412960	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800065
J	Miedinger, D; Jochmann, A; Schoenenberger, L; Chhajed, PN; Leuppi, JD				Miedinger, David; Jochmann, Anja; Schoenenberger, Lucia; Chhajed, Prashant N.; Leuppi, Joerg D.			Resting and Post Bronchial Challenge Testing Carbon Dioxide Partial Pressure in Individuals with and without Asthma	PLOS ONE			English	Article							HYPERVENTILATION SYNDROME; HYPOCAPNIA; COMMUNITY	Objective: There is conflicting evidence about resting carbon dioxide levels in asthmatic individuals. We wanted to determine if transcutaneously measured carbon dioxide levels prior and during bronchial provocation testing differ according to asthma status reflecting dysfunctional breathing. Methods: We investigated active firefighters and policemen by means of a validated questionnaire on respiratory symptoms, spirometry, bronchial challenge testing with methacholine (MCT) and measurement of transcutaneous blood carbon dioxide partial pressure (PtcCO(2)) at rest prior performing spirometry, one minute and five minutes after termination of MCT. A respiratory physician blinded to the PtcCO(2) results assigned a diagnosis of asthma after reviewing the available study data and the files of the workers medical screening program. Results: The study sample consisted of 128 male and 10 female individuals. Fifteen individuals (11%) had physician-diagnosed asthma. There was no clinically important difference in median PtcCO(2) at rest, one and five minutes after recovery from MCT in asthmatics compared to non-asthmatics (35.6 vs 35.7 mmHg, p = 0.466; 34.7 vs 33.4 mmHg, p = 0.245 and 37.4 vs 36.4 mmHg, p = 0.732). The median drop in PtcCO(2) during MCT and the increase after MCT was lower in asthmatics compared to non-asthmatics (0.1 vs 3.2 mmHg, p = 0.014 and 1.9 vs 2.9 mmHg, p = 0.025). Conclusions: PtcCO(2) levels at rest prior and during recovery after MCT do not differ in individuals with or without physician diagnosed asthma. The fall and subsequent increase in PtcCO(2) levels are higher in non-asthmatics than in asthmatics and seems to be related with increased number of respiratory maneuvers during MCT.	[Miedinger, David; Jochmann, Anja; Schoenenberger, Lucia; Chhajed, Prashant N.; Leuppi, Joerg D.] Univ Basel Hosp, Basel, Switzerland	University of Basel	Miedinger, D (corresponding author), Univ Basel Hosp, Basel, Switzerland.	david.miedinger@unibas.ch	Leuppi, Jörg/W-6798-2019					Bosley CM, 1996, RESP MED, V90, P453, DOI 10.1016/S0954-6111(96)90170-5; Bruton A, 2005, CHEST, V127, P1808, DOI 10.1378/chest.127.5.1808; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; CARR RE, 1994, BEHAV RES THER, V32, P411, DOI 10.1016/0005-7967(94)90004-3; Chhajed PN, 2006, RESPIRATION, V73, P825, DOI 10.1159/000088005; Chhajed PN, 2010, SCAND J CLIN LAB INV, V70, P60, DOI 10.3109/00365510903450106; Folgering H, 1999, Monaldi Arch Chest Dis, V54, P365; Hartwich V, DYNAMICAL PROPERTIES; Hasler G, 2005, AM J RESP CRIT CARE, V171, P1224, DOI 10.1164/rccm.200412-1669OC; HORMBREY J, 1988, EUR RESPIR J, V1, P846; Keeley D, 2001, BRIT MED J, V322, P1075, DOI 10.1136/bmj.322.7294.1075; Koulouris NG, 2004, RESP PHYSIOL NEUROBI, V140, P293, DOI 10.1016/j.resp.2004.01.005; Mustajbegovi J, 2001, AM J IND MED, V40, P55, DOI 10.1002/ajim.1071; Ogura T, 1998, JPN J PHYSIOL, V48, P39, DOI 10.2170/jjphysiol.48.39; Osborne CA, 2000, THORAX, V55, P1016, DOI 10.1136/thorax.55.12.1016; Proietti Lidia, 2005, Med Lav, V96, P24; RODRIGUEZROISIN R, 1991, AM REV RESPIR DIS, V144, P88, DOI 10.1164/ajrccm/144.1.88; Thomas M, 2001, BRIT MED J, V322, P1098, DOI 10.1136/bmj.322.7294.1098; Thomas Mike, 2005, Prim Care Respir J, V14, P78, DOI 10.1016/j.pcrj.2004.10.007; TOELLE BG, 1992, AM REV RESPIR DIS, V146, P633, DOI 10.1164/ajrccm/146.3.633; VANDENELSHOUT FJJ, 1991, THORAX, V46, P28, DOI 10.1136/thx.46.1.28; VANDIXHOORN J, 1985, J PSYCHOSOM RES, V29, P199, DOI 10.1016/0022-3999(85)90042-X; VANSTEENKISTE J, 1991, EUR RESPIR J, V4, P393	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32464	10.1371/journal.pone.0032464	http://dx.doi.org/10.1371/journal.pone.0032464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412876	Green Submitted, gold, Green Published			2022-12-25	WOS:000303060800021
J	Rosenthal, KM; Edwards, LJ; Sabatino, JJ; Hood, JD; Wasserman, HA; Zhu, C; Evavold, BD				Rosenthal, Kristen M.; Edwards, Lindsay J.; Sabatino, Joseph J., Jr.; Hood, Jennifer D.; Wasserman, Heather A.; Zhu, Cheng; Evavold, Brian D.			Low 2-Dimensional CD4 T Cell Receptor Affinity for Myelin Sets in Motion Delayed Response Kinetics	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; C-JUN; REPERTOIRE SELECTION; ANTIGEN PRESENTATION; PEPTIDE; TCR; PHOSPHORYLATION; DIFFERENTIATION; ACTIVATION	T cells recognizing self-peptides that mediate autoimmune disease and those that are responsible for efficacious immunity against pathogens may differ in affinity for antigen due to central and peripheral tolerance mechanisms. Here we utilize prototypical self-reactive (myelin) and viral-specific (LCMV) T cells from T cell receptor (TCR) transgenic mice (2D2 and SMARTA, respectively) to explore affinity differences. The T cells responsive to virus possessed >10,000 fold higher 2D affinity as compared to the self-reactive T cells. Despite their dramatically lower affinity for their cognate ligand, 2D2 T cells respond with complete, albeit delayed, activation (proliferation and cytokine production). SMARTA activation occurs rapidly, achieving peak phosphorylation of p38 (1 minute), Erk (30 minutes), and Jun (3 hours) as well as CD69 and CD25 upregulation (3 and 6 hours, respectively), with a corresponding early initiation of proliferation. 2D2 stimulation with MOG results in altered signaling - no phospho-Erk or phospho-p38 accumulation, significantly delayed activation kinetics of Jun (12 hours), and delayed but sustained SHP-1 activity - as well as delayed CD69 and CD25 expression (12-24 hours), and slow initiation of proliferation. This delay was not intrinsic to the 2D2 T cells, as a more potent antigen with >100-fold increased 2D affinity restored rapid response kinetics in line with those identified for the viral antigen. Taken together, these data demonstrate that time can offset low TCR affinity to attain full activation and suggest a mechanism by which low affinity T cells participate in autoimmune disease.	[Rosenthal, Kristen M.; Edwards, Lindsay J.; Sabatino, Joseph J., Jr.; Hood, Jennifer D.; Wasserman, Heather A.; Evavold, Brian D.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Rosenthal, KM (corresponding author), Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	bevavol@emory.edu		Evavold, Brian/0000-0002-3561-3494	National Multiple Sclerosis Society [RG4482]; National Institutes of Health [NS071518, AI38282]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038282, R01AI038282, R56AI038282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071518, R01NS062358] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Multiple Sclerosis Society (www.nationalmssociety.org) grant RG4482 (to BDE) and the National Institutes of Health (www.nih.gov) grants NS071518 (to BDE) and AI38282 (to CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Alli R, 2008, J IMMUNOL, V181, P136, DOI 10.4049/jimmunol.181.1.136; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anderton SM, 2001, J EXP MED, V193, P1, DOI 10.1084/jem.193.1.1; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Chan C, 2004, P ROY SOC B-BIOL SCI, V271, P931, DOI 10.1098/rspb.2003.2587; Chesla SE, 1998, MOL BIOL CELL, V9, p199A; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FOX BS, 1987, FASEB J, V46, P1046; Frank C, 2004, J BIOL CHEM, V279, P11375, DOI 10.1074/jbc.M309096200; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Irla M, 2010, J EXP MED, V207, P1891, DOI 10.1084/jem.20092627; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Kilgore NE, 2003, J IMMUNOL, V170, P4891, DOI 10.4049/jimmunol.170.10.4891; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Landais E, 2009, J IMMUNOL, V183, P7949, DOI 10.4049/jimmunol.0902493; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Leavenworth JW, 2010, P NATL ACAD SCI USA, V107, P2562, DOI 10.1073/pnas.0914732107; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Margot CD, 2005, J IMMUNOL, V174, P3352, DOI 10.4049/jimmunol.174.6.3352; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Sabatino JJ, 2008, J IMMUNOL, V180, P4451, DOI 10.4049/jimmunol.180.7.4451; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Sabatino JJ, 2010, J NEUROIMMUNE PHARM, V5, P176, DOI 10.1007/s11481-009-9181-3; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schnell FJ, 2009, J IMMUNOL, V182, P1829, DOI 10.4049/jimmunol.0801798; Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153; Tao X, 1997, J IMMUNOL, V158, P4237; Tsukamoto H, 2006, EUR J IMMUNOL, V36, P1926, DOI 10.1002/eji.200535803; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wasserman HA, 2008, J IMMUNOL, V181, P6843, DOI 10.4049/jimmunol.181.10.6843; Wasserman HA, 2008, J IMMUNOL, V180, P7259, DOI 10.4049/jimmunol.180.11.7259; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Whitmire JK, 2006, J IMMUNOL, V176, P3028, DOI 10.4049/jimmunol.176.5.3028; Williams M, 2008, RAPID CULLING CD4 T, P533; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	75	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32562	10.1371/journal.pone.0032562	http://dx.doi.org/10.1371/journal.pone.0032562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412888	gold, Green Submitted, Green Published			2022-12-25	WOS:000303060800029
J	Thu, KL; Vucic, EA; Chari, R; Zhang, W; Lockwood, WW; English, JC; Fu, R; Wang, P; Feng, ZD; MacAulay, CE; Gazdar, AF; Lam, S; Lam, WL				Thu, Kelsie L.; Vucic, Emily A.; Chari, Raj; Zhang, Wei; Lockwood, William W.; English, John C.; Fu, Rong; Wang, Pei; Feng, Ziding; MacAulay, Calum E.; Gazdar, Adi F.; Lam, Stephen; Lam, Wan L.			Lung Adenocarcinoma of Never Smokers and Smokers Harbor Differential Regions of Genetic Alteration and Exhibit Different Levels of Genomic Instability	PLOS ONE			English	Article							SMALL-CELL; CHROMOSOMAL-ABERRATIONS; CANCER GENOME; COPY NUMBER; ARRAY CGH; NONSMOKERS; MUTATIONS; SIGNATURES; RESOLUTION; IMBALANCE	Recent evidence suggests that the observed clinical distinctions between lung tumors in smokers and never smokers (NS) extend beyond specific gene mutations, such as EGFR, EML4-ALK, and KRAS, some of which have been translated into targeted therapies. However, the molecular alterations identified thus far cannot explain all of the clinical and biological disparities observed in lung tumors of NS and smokers. To this end, we performed an unbiased genome-wide, comparative study to identify novel genomic aberrations that differ between smokers and NS. High resolution whole genome DNA copy number profiling of 69 lung adenocarcinomas from smokers (n = 39) and NS (n = 30) revealed both global and regional disparities in the tumor genomes of these two groups. We found that NS lung tumors had a greater proportion of their genomes altered than those of smokers. Moreover, copy number gains on chromosomes 5q, 7p, and 16p occurred more frequently in NS. We validated our findings in two independently generated public datasets. Our findings provide a novel line of evidence distinguishing genetic differences between smoker and NS lung tumors, namely, that the extent of segmental genomic alterations is greater in NS tumors. Collectively, our findings provide evidence that these lung tumors are globally and genetically different, which implies they are likely driven by distinct molecular mechanisms.	[Thu, Kelsie L.; Vucic, Emily A.; Chari, Raj; Lockwood, William W.; MacAulay, Calum E.; Lam, Stephen; Lam, Wan L.] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Chari, Raj] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Zhang, Wei; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Lockwood, William W.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [English, John C.] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Fu, Rong; Wang, Pei; Feng, Ziding] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	British Columbia Cancer Agency; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of British Columbia; Fred Hutchinson Cancer Center	Thu, KL (corresponding author), British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada.	kthu@bccrc.ca	MacAulay, Calum/K-1795-2016; Chari, Raj/G-3285-2019; Lockwood, William W/A-2879-2009	Wang, Pei/0000-0002-6890-6453; Vucic, Emily/0000-0002-2728-8708; Thu, Kelsie/0000-0001-9262-7238; MacAulay, Calum/0000-0003-4440-2792	Canadian Institutes for Health Research (CIHR) [MOP 86731, MOP 94867]; Canadian Cancer Society [CCS20485]; NCI Early Detection Research Network; Canary Foundation; Frederick Banting Canada Graduate Scholarship; Charles Best Canada Graduate Scholarship; Vanier Canada Graduate Scholarship; Banting Postdoctoral fellowship; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canary Foundation; Frederick Banting Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Charles Best Canada Graduate Scholarship; Vanier Canada Graduate Scholarship; Banting Postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by the Canadian Institutes for Health Research (CIHR; MOP 86731, MOP 94867), Canadian Cancer Society (CCS20485), NCI Early Detection Research Network, Canary Foundation, Frederick Banting and Charles Best Canada Graduate Scholarships [KLT, EAV and RC], Vanier Canada Graduate Scholarship [KLT], Banting Postdoctoral fellowship [RC], and CIHR Jean Francois St-Denis Fellowship in Cancer Research [WWL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Broet P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-43; Campbell JM, 2008, GENOME, V51, P1032, DOI 10.1139/G08-086; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Coe BP, 2006, BRIT J CANCER, V94, P1927, DOI 10.1038/sj.bjc.6603167; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Coe BP, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq548; Dasgupta S., 2011, J CELL PHYSL; Job B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015145; Massion PP, 2008, AM J RESP CRIT CARE, V178, P1164, DOI 10.1164/rccm.200801-142OC; Newnham GM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-93; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Powell CA, 2003, LUNG CANCER-J IASLC, V39, P23, DOI 10.1016/S0169-5002(02)00384-7; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rudin CM, 2009, CLIN CANCER RES, V15, P5646, DOI 10.1158/1078-0432.CCR-09-0377; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Sanchez-Cespedes M, 2001, CANCER RES, V61, P1309; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Wong MP, 2002, CANCER RES, V62, P4464	29	55	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33003	10.1371/journal.pone.0033003	http://dx.doi.org/10.1371/journal.pone.0033003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412972	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800073
J	Uchida, T; Furumai, K; Fukuda, T; Akiyama, H; Takezawa, M; Asano, T; Fujimori, F; Uchida, C				Uchida, Takafumi; Furumai, Kengo; Fukuda, Tomokazu; Akiyama, Hirotada; Takezawa, Mika; Asano, Tomoichiro; Fujimori, Fumihiro; Uchida, Chiyoko			Prolyl Isomerase Pin1 Regulates Mouse Embryonic Fibroblast Differentiation into Adipose Cells	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; ACTIVATION; INHIBITOR; BINDING	Background: A peptidyl prolyl cis/trans isomerase, Pin1, regulates insulin signal transduction. Pin1 reduces responses to insulin stimulation by binding CRTC2 (CREB-regulated transcriptional co-activator 2) and PPAR gamma (peroxisome prolifereator-activated receptor gamma), but conversely enhances insulin signaling by binding IRS-1 (insulin receptor substrate-1), Akt kinase, and Smad3. Therefore, it is still unclear whether Pin1 inhibits or enhances adipose cell differentiation. Methodology/Principal Findings: Pin1(-/-) and wild-type mice were fed with high fat diets and adipose tissue weight was measured. Compared to wild-type mice, Pin1(--) mice had lower adipose tissue weight, while the weight of other tissues was similar. Mouse embryo fibroblasts (MEFs), prepared from both groups of mice, were induced to differentiate into adipose cells by stimulation with insulin. However, the rate of differentiation of MEFs from Pin1(-/-) mice was less than that of MEFs from wild-type mice. The rate of insulin-induced MEF cell differentiation in Pin1(-/-) mice was restored by increasing expression of Pin1. We found that Pin1 binds to phosphoThr172- and phosphoSer271-Pro sites in CREB suppress the activity in COS-7 cells. Conclusion and Significance: Pin1 enhanced the uptake of triglycerides and the differentiation of MEF cells into adipose cells in response to insulin stimulation. Results of this study suggest that Pin1 down-regulation could be a potential approach in obesity-related dysfunctions, such as high blood pressure, diabetes, non-alcoholic steatohepatitis.	[Uchida, Takafumi; Furumai, Kengo; Akiyama, Hirotada; Takezawa, Mika] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Sendai, Miyagi 980, Japan; [Uchida, Takafumi; Akiyama, Hirotada; Fujimori, Fumihiro; Uchida, Chiyoko] Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 980, Japan; [Fukuda, Tomokazu] Tohoku Univ, Dept Anim Prod Sci, Sendai, Miyagi 980, Japan; [Asano, Tomoichiro] Hiroshima Univ, Dept Med Sci, Hiroshima, Japan; [Fujimori, Fumihiro] Tokyo Kasei Univ, Dept Environm Educ, Tokyo, Japan; [Uchida, Chiyoko] Ibaraki Univ, Univ Hlth Ctr, Mito, Ibaraki, Japan	Tohoku University; Tohoku University; Tohoku University; Hiroshima University; Ibaraki University	Uchida, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Sendai, Miyagi 980, Japan.	uchidat@biochem.tohoku.ac.jp	Fukuda, Tomokazu/O-1257-2018	Fukuda, Tomokazu/0000-0001-8456-0483; Uchida, Takafumi/0000-0003-3665-4906	Ministry of Education, Culture, Sports, Science and Technology of Japan [20228006]; Grants-in-Aid for Scientific Research [23701104] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Kiban S ID 20228006(Dr. Uchida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Chao SH, 2001, NUCLEIC ACIDS RES, V29, P767, DOI 10.1093/nar/29.3.767; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Fujimoto Y, 2010, J BIOL CHEM, V285, P3126, DOI 10.1074/jbc.M109.055095; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; LAU DC, 2005, AM J PHYSIOL-HEART C, V288, P2031; Liao Y, 2009, ONCOGENE, V28, P2436, DOI 10.1038/onc.2009.98; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Mori T, 2011, BIOCHEM BIOPH RES CO, V406, P439, DOI 10.1016/j.bbrc.2011.02.066; Mori T, 2009, J BIOMOL SCREEN, V14, P419, DOI 10.1177/1087057109333979; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Ryo A, 2005, CLIN CANCER RES, V11, P7523, DOI 10.1158/1078-0432.CCR-05-0457; Tatara Y, 2009, BIOCHEM BIOPH RES CO, V384, P394, DOI 10.1016/j.bbrc.2009.04.144; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1	22	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e31823	10.1371/journal.pone.0031823	http://dx.doi.org/10.1371/journal.pone.0031823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412843	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800006
J	Wen, WW; Franco, J; Chavez-Tovar, VH; Yan, JB; Taba, S				Wen, Weiwei; Franco, Jorge; Chavez-Tovar, Victor H.; Yan, Jianbing; Taba, Suketoshi			Genetic Characterization of a Core Set of a Tropical Maize Race Tuxpeno for Further Use in Maize Improvement	PLOS ONE			English	Article							INBRED LINES; CIMMYT MAIZE; RECURRENT SELECTION; COMBINING ABILITY; SSR MARKERS; DIVERSITY; ACCESSIONS; SIMILARITY; HETEROSIS; GERMPLASM	The tropical maize race Tuxpeno is a well-known race of Mexican dent germplasm which has greatly contributed to the development of tropical and subtropical maize gene pools. In order to investigate how it could be exploited in future maize improvement, a panel of maize germplasm accessions was assembled and characterized using genome-wide Single Nucleotide Polymorphism (SNP) markers. This panel included 321 core accessions of Tuxpeno race from the International Maize and Wheat Improvement Center (CIMMYT) germplasm bank collection, 94 CIMMYT maize lines (CMLs) and 54 U.S. Germplasm Enhancement of Maize (GEM) lines. The panel also included other diverse sources of reference germplasm: 14 U.S. maize landrace accessions, 4 temperate inbred lines from the U. S. and China, and 11 CIMMYT populations (a total of 498 entries with 795 plants). Clustering analyses (CA) based on Modified Rogers Distance (MRD) clearly partitioned all 498 entries into their corresponding groups. No sub clusters were observed within the Tuxpeno core set. Various breeding strategies for using the Tuxpeno core set, based on grouping of the studied germplasm and genetic distance among them, were discussed. In order to facilitate sampling diversity within the Tuxpeno core, a minicore subset of 64 Tuxpeno accessions (20% of its usual size) representing the diversity of the core set was developed, using an approach combining phenotypic and molecular data. Untapped diversity represents further use of the Tuxpeno landrace for maize improvement through the core and/or minicore subset available to the maize community.	[Wen, Weiwei; Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Wen, Weiwei; Chavez-Tovar, Victor H.; Taba, Suketoshi] Int Maize & Wheat Improvement Ctr CIMMYT, El Batan, Mexico; [Franco, Jorge] Int Inst Trop Agr, Ibadan, Nigeria	Huazhong Agricultural University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Institute of Tropical Agriculture (IITA)	Wen, WW (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	wenweiwei1982@gmail.com; s.taba@cgiar.org	Wen, Weiwei/AAU-5240-2021; Franco, Jorge/AAF-4161-2020	Franco, Jorge/0000-0001-8082-4007	Government of Japan; United States Department of Agriculture (USDA)	Government of Japan; United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	The Government of Japan and the United States Department of Agriculture (USDA) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjarnason M, 1994, CIMMYT MAIZE GERMPLA; Bretting P K, 1990, Am J Bot, V77, P211, DOI [10.1002/j.1537-2197.1990.tb13547.x, 10.2307/2444643]; Brush SB, 2007, AGR ECOSYST ENVIRON, V121, P211, DOI 10.1016/j.agee.2006.12.018; Buckler ES, 1999, GENETICS, V153, P415; Ceron-Rojas JJ, 2006, CROP SCI, V46, P1711, DOI 10.2135/cropsci2005.11-0420; CIMMYT, 1998, COMPLETE LISTING IMP; DOEBLEY JF, 1985, AM J BOT, V72, P629, DOI 10.2307/2443674; Doebley John F, 1986, Am J Bot, V73, P64, DOI [10.1002/j.1537-2197.1986.tb09681.x, 10.2307/2444278]; DUVICK DN, 1993, INTERNATIONAL CROP SCIENCE I, P505; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; FISCHER KS, 1987, CROP SCI, V27, P1150, DOI 10.2135/cropsci1987.0011183X002700060013x; Franco J, 2005, CROP SCI, V45, P1035, DOI 10.2135/cropsci2004.0292; Franco J, 1998, CROP SCI, V38, P1688, DOI 10.2135/cropsci1998.0011183X003800060045x; Franco J, 2010, CROP SCI, V50, P105, DOI 10.2135/cropsci2009.01.0053; Goodman M. M., 1988, Corn and corn improvement. Third edition., P33; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; HAN GC, 1991, MAYDICA, V36, P57; Hartkamp A.D., 2000, MAIZE PRODUCTION ENV; JOHNSON EC, 1986, CROP SCI, V26, P253, DOI 10.2135/cropsci1986.0011183X002600020008x; Liu KJ, 2003, GENETICS, V165, P2117; Marita JM, 2000, GENET RESOUR CROP EV, V47, P515, DOI 10.1023/A:1008784610962; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; McClintock B, 1981, CHROMOSOME CONSTITUT; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; MOLL RH, 1965, GENETICS, V52, P139; MUNGOMA C, 1988, CROP SCI, V28, P500, DOI 10.2135/cropsci1988.0011183X002800030015x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M., 1987, MOL EVOLUTIONARY GEN; Ortiz R, 2010, CROP SCI, V50, P13, DOI 10.2135/cropsci2009.06.0297; PANDEY S, 1991, CROP SCI, V31, P285, DOI 10.2135/cropsci1991.0011183X003100020010x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pollak LM, 2003, ADV AGRON, V78, P45, DOI 10.1016/S0065-2113(02)78002-4; Reif J, 2006, THEOR APPL GENET, V113, P177, DOI 10.1007/s00122-006-0283-5; Reif JC, 2005, CROP SCI, V45, P1, DOI 10.2135/cropsci2005.0001; Reif JC, 2003, CROP SCI, V43, P1275, DOI 10.2135/cropsci2003.1275; Corral JAR, 2008, CROP SCI, V48, P1502, DOI 10.2135/cropsci2007.09.0518; Salhuana W, 1998, CROP SCI, V38, P866, DOI 10.2135/cropsci1998.0011183X003800030040x; Salhuana W, 2006, MAYDICA, V51, P339; Salhuana W, 1995, LATIN AM MAIZE PROJE; Sanchez JJ, 2006, MAYDICA, V51, P25; Sanchez JJ, 2000, MAYDICA, V45, P185; Sanchez JJ, 2000, ECON BOT, V54, P43, DOI 10.1007/BF02866599; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sharma L, 2010, GENETICA, V138, P619, DOI 10.1007/s10709-010-9436-1; Smith ME, 1983, AGRONOMY; Taba S, 2003, 7762 UNIQUE ACCESSIO; Taba S., 1997, BIODIVERSITY TRUST, P213; Taba S., 1995, MAIZE GENETIC RESOUR, P7; VASAL SK, 1992, MAYDICA, V37, P217; Vasal SK, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P363; Vasal SK, 1986, CIMMYT RES HIGHLIGHT, P24; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wellhausen EJ, 1978, CORN BREEDING GENETI, P59; Wen WW, 2012, MOL BREEDING, V29, P951, DOI 10.1007/s11032-011-9696-1; Whitehead FC, 2006, MAYDICA, V51, P43; Xia XC, 2005, CROP SCI, V45, P2573, DOI 10.2135/cropsci2005.0246; Xia XC, 2004, CROP SCI, V44, P2230, DOI 10.2135/cropsci2004.2230; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2	63	35	39	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32626	10.1371/journal.pone.0032626	http://dx.doi.org/10.1371/journal.pone.0032626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412898	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800035
J	Luo, LZ; Gopalakrishna-Pillai, S; Nay, SL; Park, SW; Bates, SE; Zeng, XM; Iverson, LE; O'Connor, TR				Luo, Li Z.; Gopalakrishna-Pillai, Sailesh; Nay, Stephanie L.; Park, Sang-Won; Bates, Steven E.; Zeng, Xianmin; Iverson, Linda E.; O'Connor, Timothy R.			DNA Repair in Human Pluripotent Stem Cells Is Distinct from That in Non-Pluripotent Human Cells	PLOS ONE			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; NUCLEOTIDE EXCISION-REPAIR; STRAND BREAK REPAIR; CHROMOSOMAL-ABERRATIONS; MOLECULAR-MECHANISMS; CYCLE ARREST; DAMAGE; GENE; EXPRESSION; APOPTOSIS	The potential for human disease treatment using human pluripotent stem cells, including embryonic stem cells and induced pluripotent stem cells (iPSCs), also carries the risk of added genomic instability. Genomic instability is most often linked to DNA repair deficiencies, which indicates that screening/characterization of possible repair deficiencies in pluripotent human stem cells should be a necessary step prior to their clinical and research use. In this study, a comparison of DNA repair pathways in pluripotent cells, as compared to those in non-pluripotent cells, demonstrated that DNA repair capacities of pluripotent cell lines were more heterogeneous than those of differentiated lines examined and were generally greater. Although pluripotent cells had high DNA repair capacities for nucleotide excision repair, we show that ultraviolet radiation at low fluxes induced an apoptotic response in these cells, while differentiated cells lacked response to this stimulus, and note that pluripotent cells had a similar apoptotic response to alkylating agent damage. This sensitivity of pluripotent cells to damage is notable since viable pluripotent cells exhibit less ultraviolet light-induced DNA damage than do differentiated cells that receive the same flux. In addition, the importance of screening pluripotent cells for DNA repair defects was highlighted by an iPSC line that demonstrated a normal spectral karyotype, but showed both microsatellite instability and reduced DNA repair capacities in three out of four DNA repair pathways examined. Together, these results demonstrate a need to evaluate DNA repair capacities in pluripotent cell lines, in order to characterize their genomic stability, prior to their pre-clinical and clinical use.	[Luo, Li Z.; Nay, Stephanie L.; Park, Sang-Won; Bates, Steven E.; O'Connor, Timothy R.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Gopalakrishna-Pillai, Sailesh; Iverson, Linda E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Stem Cell Biol, Duarte, CA 91010 USA; [Zeng, Xianmin] Buck Inst Age Res, N Bay CIRM Shared Res Lab Stem Cells & Aging, Novato, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Buck Institute for Research on Aging	Luo, LZ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	toconnor@coh.org		O'Connor, Timothy/0000-0001-5848-3592; Luo, Li/0000-0002-8680-4119	California Institute of Regenerative Medicine [RS1-00428-1]; National Institutes of Health (SPORE) [P50 CA107399]; Irell and Manella School of Biological Sciences of City of Hope; City of Hope Comprehensive Cancer Center [NCI 5P30CA033572-27]; Beckman Research Institute of City of Hope; NATIONAL CANCER INSTITUTE [P50CA107399, P30CA033572] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health (SPORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irell and Manella School of Biological Sciences of City of Hope; City of Hope Comprehensive Cancer Center; Beckman Research Institute of City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the California Institute of Regenerative Medicine (RS1-00428-1 to TRO, http://www.cirm.ca.gov/content/sources-genetic-instability-human-embryonic-stem-cells), the National Institutes of Health (SPORE P50 CA107399, S. Forman, http://www.nih.gov/index.html), the Irell and Manella School of Biological Sciences of City of Hope, the City of Hope Comprehensive Cancer Center Grant (NCI 5P30CA033572-27, M. Friedman, http://www.cancer.gov/), and the Beckman Research Institute of City of Hope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Bret R, 2010, Aging (Albany NY), V2, P582; Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Barta T, 2010, STEM CELLS, V28, P1143, DOI 10.1002/stem.451; Bates SE, 2005, NUCLEIC ACIDS RES, V33, P2475, DOI 10.1093/nar/gki542; Boland CR, 1998, CANCER RES, V58, P5248; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Eker APM, 2009, CELL MOL LIFE SCI, V66, P968, DOI 10.1007/s00018-009-8735-0; Fan JH, 2007, ENVIRON MOL MUTAGEN, V48, P491, DOI 10.1002/em.20312; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FLOYD RA, 1989, ARCH BIOCHEM BIOPHYS, V273, P106, DOI 10.1016/0003-9861(89)90167-7; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Furuta T, 2002, CANCER RES, V62, P4899; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Howlett NG, 2006, DNA REPAIR, V5, P251, DOI 10.1016/j.dnarep.2005.10.004; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Koledova Z, 2010, STEM CELLS, V28, P450, DOI 10.1002/stem.311; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Kulms D, 2002, SKIN PHARMACOL APPL, V15, P342, DOI 10.1159/000064539; Kumar R, 1996, CARCINOGENESIS, V17, P485, DOI 10.1093/carcin/17.3.485; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; LAVAL J, 1977, NATURE, V269, P829, DOI 10.1038/269829a0; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEHMANN AR, 1977, CANCER RES, V37, P904; Lyndaker AM, 2009, BIOESSAYS, V31, P315, DOI 10.1002/bies.200800195; MADHANI HD, 1986, CELL, V45, P417, DOI 10.1016/0092-8674(86)90327-2; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; Mollamohammadi S, 2009, HUM REPROD, V24, P2468, DOI 10.1093/humrep/dep244; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; Plaia TW, 2006, STEM CELLS, V24, P531, DOI 10.1634/stemcells.2005-0315; Raha M, 1996, P NATL ACAD SCI USA, V93, P2941, DOI 10.1073/pnas.93.7.2941; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Secretan MB, 2004, MUTAT RES-FUND MOL M, V554, P351, DOI 10.1016/j.mrfmmm.2004.05.016; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; VENEMA J, 1992, J BIOL CHEM, V267, P8852; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yarosh DB, 2005, J INVEST DERMATOL, V125, P1020, DOI 10.1111/j.0022-202X.2005.23858.x; Yarosh DB, 2002, METHODS, V28, P55, DOI 10.1016/S1046-2023(02)00209-8; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng XM, 2004, RESTOR NEUROL NEUROS, V22, P421; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2; Zhou NY, 2003, J MOL BIOL, V332, P337, DOI 10.1016/S0022-2836(03)00793-9	71	33	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e30541	10.1371/journal.pone.0030541	http://dx.doi.org/10.1371/journal.pone.0030541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412831	Green Published, gold			2022-12-25	WOS:000303021100003
J	Mutnal, MB; Hu, SX; Lokensgard, JR				Mutnal, Manohar B.; Hu, Shuxian; Lokensgard, James R.			Persistent Humoral Immune Responses in the CNS Limit Recovery of Reactivated Murine Cytomegalovirus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; B-CELLS; EARLY ANTIGENS; IN-VIVO; INFECTION; VIRUS; INTERFERON; ANTIBODY; ACTIVATION; CLEARANCE	Background: Experimental infection of the mouse brain with murine CMV (MCMV) elicits neuroimmune responses that terminate acute infection while simultaneously preventing extensive bystander damage. Previous studies have determined that CD8(+) T lymphocytes are required to restrict acute, productive MCMV infection within the central nervous system (CNS). In this study, we investigated the contribution of humoral immune responses in control of MCMV brain infection. Methodology/Principal Findings: Utilizing our MCMV brain infection model, we investigated B-lymphocyte-lineage cells and assessed their role in controlling the recovery of reactivated virus from latently infected brain tissue. Brain infiltrating leukocytes were first phenotyped using markers indicative of B-lymphocytes and plasma cells. Results obtained during these studies showed a steady increase in the recruitment of B-lymphocyte-lineage cells into the brain throughout the time-course of viral infection. Further, MCMV-specific antibody secreting cells (ASC) were detected within the infiltrating leukocyte population using an ELISPOT assay. Immunohistochemical studies of brain sections revealed co-localization of CD138(+) cells with either IgG or IgM. Additional immunohistochemical staining for MCMV early antigen 1 (E1, m112-113), a reported marker of viral latency in neurons, confirmed its expression in the brain during latent infection. Finally, using B-cell deficient (Jh(-/-)) mice we demonstrated that B-lymphocytes control recovery of reactivated virus from latently-infected brain tissue. A significantly higher rate of reactivated virus was recovered from the brains of Jh(-/-) mice when compared to Wt animals. Conclusion: Taken together, these results demonstrate that MCMV infection triggers accumulation and persistence of B-lymphocyte-lineage cells within the brain, which produce antibodies and play a significant role in controlling reactivated virus.	[Mutnal, Manohar B.; Hu, Shuxian; Lokensgard, James R.] Univ Minnesota, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Neuroimmunol Lab, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Mutnal, MB (corresponding author), Univ Minnesota, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Neuroimmunol Lab, Minneapolis, MN 55455 USA.	loken006@umn.edu	Mutnal, Manohar B/K-4744-2012		National Institute of Neurological Disorders and Stroke [R01NS-038836]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038836] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by Award Number R01NS-038836 from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2003, AM J PATHOL, V163, P643, DOI 10.1016/S0002-9440(10)63691-7; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742; Burdeinick-Kerr R, 2007, J VIROL, V81, P5628, DOI 10.1128/JVI.01152-06; Busche A, 2009, J VIROL, V83, P4030, DOI 10.1128/JVI.02520-08; Cheeran MCJ, 2007, VIRUS RES, V130, P96, DOI 10.1016/j.virusres.2007.05.022; Cheeran MCJ, 2008, J NEUROVIROL, V14, P437, DOI 10.1080/13550280802356845; Cheeran MCJ, 2005, J NEUROVIROL, V11, P274, DOI 10.1080/13550280590952808; Cheeran MCJ, 2004, J NEUROVIROL, V10, P152, DOI 10.1080/13550280490441130; Fields B. N., 2007, FIELDS VIROLOGY; Fragkoudis R, 2008, J GEN VIROL, V89, P2565, DOI 10.1099/vir.0.2008/002238-0; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; Greene IP, 2008, P NATL ACAD SCI USA, V105, P3575, DOI 10.1073/pnas.0712390105; Griffin D, 1997, IMMUNOL REV, V159, P155, DOI 10.1111/j.1600-065X.1997.tb01013.x; Hooper DC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000535; Hummel M, 2001, J VIROL, V75, P4814, DOI 10.1128/JVI.75.10.4814-4822.2001; IRANI DN, 1991, J IMMUNOL METHODS, V139, P223, DOI 10.1016/0022-1759(91)90192-I; JONJIC S, 1994, J EXP MED, V179, P1713, DOI 10.1084/jem.179.5.1713; JORDAN MC, 1982, J CLIN INVEST, V70, P762, DOI 10.1172/JCI110672; JORDAN MC, 1982, J INFECT DIS, V145, P699, DOI 10.1093/infdis/145.2.699; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; LEVINE B, 1991, SCIENCE, V254, P856, DOI 10.1126/science.1658936; Luker GD, 2003, J VIROL, V77, P11082, DOI 10.1128/JVI.77.20.11082-11093.2003; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Marques CP, 2011, J VIROL, V85, P6136, DOI 10.1128/JVI.00202-11; Marten NW, 2003, J VIROL, V77, P2775, DOI 10.1128/JVI.77.4.2775-2778.2003; Metcalf TU, 2011, J VIROL, V85, P11490, DOI 10.1128/JVI.05379-11; MOCARSKI ES, 1990, CURR TOP MICROBIOL, V154, P47; Mutnal MB, 2011, J NEUROVIROL, V17, P424, DOI 10.1007/s13365-011-0042-5; Mutnal MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016211; Mutnal MB, 2010, J NEUROIMMUNOL, V227, P101, DOI 10.1016/j.jneuroim.2010.06.020; Owens GP, 2006, NEUROL RES, V28, P236, DOI 10.1179/016164106X98099; Parrish-Novak J, 2002, J LEUKOCYTE BIOL, V72, P856; Phares TW, 2011, J VIROL, V85, P2589, DOI 10.1128/JVI.02260-10; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; RABINOVITCH T, 1990, INVEST OPHTH VIS SCI, V31, P657; REDDEHASE MJ, 1985, J VIROL, V55, P264, DOI 10.1128/JVI.55.2.264-273.1985; REDDEHASE MJ, 1987, J VIROL, V61, P3102, DOI 10.1128/JVI.61.10.3102-3108.1987; REDDEHASE MJ, 1994, J EXP MED, V179, P185, DOI 10.1084/jem.179.1.185; ROIZMAN B, 1987, ANNU REV MICROBIOL, V41, P543, DOI 10.1146/annurev.mi.41.100187.002551; Shinmura Y, 1997, AM J PATHOL, V151, P1331; Stewart BS, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-6; STODDART CA, 1994, J VIROL, V68, P6243, DOI 10.1128/JVI.68.10.6243-6253.1994; Tessmer MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001254; TSUTSUI Y, 1995, ARCH VIROL, V140, P1725, DOI 10.1007/BF01384337	46	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e33143	10.1371/journal.pone.0033143	http://dx.doi.org/10.1371/journal.pone.0033143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412996	gold, Green Submitted, Green Published			2022-12-25	WOS:000303021100052
J	Zhang, HM; Dang, H; Kamat, A; Yeh, CK; Zhang, BX				Zhang, Hong-Mei; Dang, Howard; Kamat, Amrita; Yeh, Chih-Ko; Zhang, Bin-Xian			Geldanamycin Derivative Ameliorates High Fat Diet-Induced Renal Failure in Diabetes	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; MITOCHONDRIAL COMPLEX III; HIGH-GLUCOSE; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; BARDOXOLONE METHYL; SKELETAL-MUSCLE; KIDNEY-FUNCTION; IV COLLAGEN; ACID	Diabetic nephropathy is a serious complication of longstanding diabetes and its pathogenesis remains unclear. Oxidative stress may play a critical role in the pathogenesis and progression of diabetic nephropathy. Our previous studies have demonstrated that polyunsaturated fatty acids (PUFA) induce peroxynitrite generation in primary human kidney mesangial cells and heat shock protein 90 beta 1 (hsp90 beta 1) is indispensable for the PUFA action. Here we investigated the effects of high fat diet (HFD) on kidney function and structure of db/db mice, a widely used rodent model of type 2 diabetes. Our results indicated that HFD dramatically increased the 24 h-urine output and worsened albuminuria in db/db mice. Discontinuation of HFD reversed the exacerbated albuminuria but not the increased urine output. Prolonged HFD feeding resulted in early death of db/db mice, which was associated with oliguria and anuria. Treatment with the geldanamycin derivative, 17-(dimethylaminoehtylamino)-17-demethoxygeldanamycin (17-DMAG), an hsp90 inhibitor, preserved kidney function, and ameliorated glomerular and tubular damage by HFD. 17-DMAG also significantly extended survival of the animals and protected them from the high mortality associated with renal failure. The benefit effect of 17-DMAG on renal function and structure was associated with a decreased level of kidney nitrotyrosine and a diminished kidney mitochondrial Ca2+ efflux in HFD-fed db/db mice. These results suggest that hsp90 beta 1 is a potential target for the treatment of nephropathy and renal failure in diabetes.	[Zhang, Hong-Mei] Fourth Mil Med Univ, Dept Clin Oncol, Xijing Hosp, Xian 710032, Peoples R China; [Zhang, Hong-Mei; Kamat, Amrita; Zhang, Bin-Xian] Univ Texas San Antonio, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA; [Dang, Howard; Yeh, Chih-Ko; Zhang, Bin-Xian] Univ Texas San Antonio, Hlth Sci Ctr, Dept Comprehens Dent, San Antonio, TX USA; [Kamat, Amrita; Yeh, Chih-Ko; Zhang, Bin-Xian] S Texas Vet Hlth Care Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA	Air Force Military Medical University; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Zhang, HM (corresponding author), Fourth Mil Med Univ, Dept Clin Oncol, Xijing Hosp, Xian 710032, Peoples R China.	zhangb2@uthscsa.edu		Yeh, Chih-Ko/0000-0001-6611-9942	Mike Hogg Fund; National Institutes of Health (NIH); Department of Veterans Health Care; National Natural Science Foundation of China [30900673]; Natural Science Foundation of Shaanxi Province [SJ08-ZT10]	Mike Hogg Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Health Care; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This work was supported by the Mike Hogg Fund, National Institutes of Health (NIH), The Department of Veterans Health Care, the National Natural Science Foundation of China (No. 30900673), and Natural Science Foundation of Shaanxi Province(SJ08-ZT10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Barutta F, 2008, AM J PHYSIOL-RENAL, V295, pF1817, DOI 10.1152/ajprenal.90234.2008; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Danda RS, 2005, KIDNEY INT, V68, P2562, DOI 10.1111/j.1523-1755.2005.00727.x; DANNE T, 1993, DIABETES, V42, P170, DOI 10.2337/diabetes.42.1.170; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Ghosh S, 2009, AM J PHYSIOL-RENAL, V296, pF700, DOI 10.1152/ajprenal.90548.2008; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; GOLAY A, 1987, METABOLISM, V36, P692, DOI 10.1016/0026-0495(87)90156-9; GROOP LC, 1991, J CLIN ENDOCR METAB, V72, P96, DOI 10.1210/jcem-72-1-96; Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jones SC, 1999, DIABETIC MED, V16, P932, DOI 10.1046/j.1464-5491.1999.00174.x; Kamijo A, 2002, KIDNEY INT, V62, P1628, DOI 10.1046/j.1523-1755.2002.00618.x; KANEDA K, 1992, ACTA PATHOL JAPON, V42, P855; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Krebs M, 2005, DIABETES OBES METAB, V7, P621, DOI 10.1111/j.1463-1326.2004.00439.x; Lauronen J, 2006, APMIS, V114, P440, DOI 10.1111/j.1600-0463.2006.apm_350.x; Liu WH, 2009, MOL CELL BIOCHEM, V325, P99, DOI 10.1007/s11010-008-0024-y; Munusamy S, 2009, FREE RADICAL BIO MED, V46, P1149, DOI 10.1016/j.freeradbiomed.2009.01.022; Nishi Shinichi, 2000, Medical Electron Microscopy, V33, P65, DOI 10.1007/s007950070004; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pergola PE, 2011, AM J NEPHROL, V33, P469, DOI 10.1159/000327599; Phillips AO, 1997, KIDNEY INT, V52, P973, DOI 10.1038/ki.1997.419; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; Saloranta C, 1996, DIABETES METAB REV, V12, P15, DOI 10.1002/(SICI)1099-0895(199603)12:1&lt;15::AID-DMR153&gt;3.0.CO;2-0; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Seron D, 2007, KIDNEY INT, V72, P690, DOI 10.1038/sj.ki.5002396; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sharma K, 2003, AM J PHYSIOL-RENAL, V284, pF1138, DOI 10.1152/ajprenal.00315.2002; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Sumanasekera WK, 2003, BIOCHEMISTRY-US, V42, P10726, DOI 10.1021/bi0347353; Sun L, 2010, AM J PHYSIOL-RENAL, V299, pF1014, DOI 10.1152/ajprenal.00414.2010; Takahashi K, 2011, TOXICOL APPL PHARM, V252, P237, DOI 10.1016/j.taap.2011.02.012; Thuraisingham RC, 2000, KIDNEY INT, V57, P1968, DOI 10.1046/j.1523-1755.2000.00046.x; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Tuo Y, 2011, ENDOCRINE, V39, P128, DOI 10.1007/s12020-010-9432-3; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; van der Loos CM, 2000, J HISTOCHEM CYTOCHEM, V48, P1431, DOI 10.1177/002215540004801013; Visch HJ, 2006, AM J PHYSIOL-CELL PH, V291, pC308, DOI 10.1152/ajpcell.00561.2005; Yi L, 2007, CHEM PHYS LIPIDS, V150, P204, DOI 10.1016/j.chemphyslip.2007.08.002; Zhang BX, 2006, AM J PHYSIOL-CELL PH, V290, pC1321, DOI 10.1152/ajpcell.00335.2005; Zhang HM, 2011, J PINEAL RES, V50, P78, DOI 10.1111/j.1600-079X.2010.00815.x; Zhang HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006048; Zhang H, 2008, J BIOL CHEM, V283, P7580, DOI 10.1074/jbc.M707192200; Zhang H, 2011, J PINEAL RES, V51, P338, DOI 10.1111/j.1600-079X.2011.00894.x; ZIYADEH FN, 1990, AM J PHYSIOL, V259, pF704, DOI 10.1152/ajprenal.1990.259.4.F704	57	18	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32746	10.1371/journal.pone.0032746	http://dx.doi.org/10.1371/journal.pone.0032746			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412919	Green Submitted, Green Published, gold			2022-12-25	WOS:000303021100027
J	McLean, JS; Fansler, SJ; Majors, PD; McAteer, K; Allen, LZ; Shirtliff, ME; Lux, R; Shi, WY				McLean, Jeffrey S.; Fansler, Sarah J.; Majors, Paul D.; McAteer, Kathleen; Allen, Lisa Z.; Shirtliff, Mark E.; Lux, Renate; Shi, Wenyuan			Identifying Low pH Active and Lactate-Utilizing Taxa within Oral Microbiome Communities from Healthy Children Using Stable Isotope Probing Techniques	PLOS ONE			English	Article							DENTAL-CARIES; STREPTOCOCCUS-MUTANS; MOLECULAR ANALYSIS; RIBOSOMAL-RNA; LACTIC-ACID; MICROFLORA; METABOLISM; BACTERIA; LINKING; NMR	Background: Many human microbial infectious diseases including dental caries are polymicrobial in nature. How these complex multi-species communities evolve from a healthy to a diseased state is not well understood. Although many health- or disease-associated oral bacteria have been characterized in vitro, their physiology within the complex oral microbiome is difficult to determine with current approaches. In addition, about half of these species remain uncultivated to date with little known besides their 16S rRNA sequence. Lacking culture-based physiological analyses, the functional roles of uncultivated species will remain enigmatic despite their apparent disease correlation. To start addressing these knowledge gaps, we applied a combination of Magnetic Resonance Spectroscopy (MRS) with RNA and DNA based Stable Isotope Probing (SIP) to oral plaque communities from healthy children for in vitro temporal monitoring of metabolites and identification of metabolically active and inactive bacterial species. Methodology/Principal Findings: Supragingival plaque samples from caries-free children incubated with C-13-substrates under imposed healthy (buffered, pH 7) and diseased states (pH 5.5 and pH 4.5) produced lactate as the dominant organic acid from glucose metabolism. Rapid lactate utilization upon glucose depletion was observed under pH 7 conditions. SIP analyses revealed a number of genera containing cultured and uncultivated taxa with metabolic capabilities at pH 5.5. The diversity of active species decreased significantly at pH 4.5 and was dominated by Lactobacillus and Propionibacterium species, both of which have been previously found within carious lesions from children. Conclusions/Significance: Our approach allowed for identification of species that metabolize carbohydrates under different pH conditions and supports the importance of Lactobacilli and Propionibacterium in the development of childhood caries. Identification of species within healthy subjects that are active at low pH can lead to a better understanding of oral caries onset and generate appropriate targets for preventative measures in the early stages.	[McLean, Jeffrey S.; Allen, Lisa Z.] J Craig Venter Inst, San Diego, CA USA; [Fansler, Sarah J.; Majors, Paul D.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Shirtliff, Mark E.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Lux, Renate; Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [McAteer, Kathleen] Washington State Univ Tri Cities, Richland, WA USA	J. Craig Venter Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; Washington State University	McLean, JS (corresponding author), J Craig Venter Inst, San Diego, CA USA.	jmclean@jcvi.org	Shirtliff, Mark E/H-2563-2017; McLean, Jeffrey S/A-8014-2012; SHI, wen/GPW-9531-2022	Shirtliff, Mark E/0000-0002-8913-3445; McLean, Jeffrey S/0000-0001-9934-5137; 	Department of Energy's Office of Biological and Environmental Research; PNNL; US National Institutes of Health (NIH) National Institutes of Dental and Craniofacial Research [DE020102]; NIGMS (National Institute of General Medical Sciences) [GM95373]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095373] Funding Source: NIH RePORTER	Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE)); PNNL; US National Institutes of Health (NIH) National Institutes of Dental and Craniofacial Research; NIGMS (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was performed in the Environmental Molecular Sciences Laboratory (a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research) located at the Pacific Northwest National Laboratory (PNNL). This work was supported by funding from the PNNL to JSM and PDM; by US National Institutes of Health (NIH) National Institutes of Dental and Craniofacial Research grant DE020102 to WS, PDM, RL, JSM and NIGMS (National Institute of General Medical Sciences) grant GM95373 to JSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Bell TH, 2011, APPL ENVIRON MICROB, V77, P4163, DOI 10.1128/AEM.00172-11; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; Botha S J, 1998, J Dent Assoc S Afr, V53, P3; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Corby PM, 2005, J CLIN MICROBIOL, V43, P5753, DOI 10.1128/JCM.43.11.5753-5759.2005; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dumont MG, 2005, NAT REV MICROBIOL, V3, P499, DOI 10.1038/nrmicro1162; Dumont MG, 2006, CURR OPIN BIOTECH, V17, P57, DOI 10.1016/j.copbio.2006.01.004; Egert M, 2006, TRENDS MICROBIOL, V14, P86, DOI 10.1016/j.tim.2005.12.007; Egert M, 2007, FEMS MICROBIOL ECOL; Foster JS, 2003, BIOL BULL-US, V204, P200, DOI 10.2307/1543559; Gibello A, 1999, APPL ENVIRON MICROB, V65, P4346; Grivet JP, 2003, BIOCHIMIE, V85, P823, DOI 10.1016/j.biochi.2003.08.004; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Hodgson RJ, 2001, J APPL MICROBIOL, V90, P440, DOI 10.1046/j.1365-2672.2001.01263.x; HOSHINO E, 1976, ARCH ORAL BIOL, V21, P677, DOI 10.1016/0003-9969(76)90142-4; HU G, 1972, ARCH ORAL BIOL, V17, P729, DOI 10.1016/0003-9969(72)90199-9; Kanasi E, 2010, CARIES RES, V44, P485, DOI 10.1159/000320158; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Kolenbrander PE, 2007, BIOFILM MODE LIFE ME, P175; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Leighton MP, 2001, MICROBIOL-SGM, V147, P1473, DOI 10.1099/00221287-147-6-1473; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Majors PD, 2005, WATER SCI TECHNOL, V52, P7, DOI 10.2166/wst.2005.0174; Majors PD, 2005, J MICROBIOL METH, V62, P337, DOI 10.1016/j.mimet.2005.04.017; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Marchant S, 2001, CARIES RES, V35, P397, DOI 10.1159/000047482; Marsh P D, 1997, Adv Dent Res, V11, P176; Marsh P D, 1994, Adv Dent Res, V8, P263; MARSH PD, 1995, J IND MICROBIOL, V15, P169, DOI 10.1007/BF01569822; MCKAY L, 1970, J BACTERIOL, V102, P804, DOI 10.1128/JB.102.3.804-809.1970; McLean JS, 2008, ISME J, V2, P121, DOI 10.1038/ismej.2007.107; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Neufeld JD, 2007, MICROB ECOL, V53, P435, DOI 10.1007/s00248-006-9125-x; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Neufeld JD, 2007, ISME J, V1, P103, DOI 10.1038/ismej.2007.30; Radajewski S, 2003, CURR OPIN BIOTECH, V14, P296, DOI 10.1016/S0958-1669(03)00064-8; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; SANDHAM H J, 1970, Archives of Oral Biology, V15, P1285, DOI 10.1016/0003-9969(70)90017-8; SANDHAM H J, 1970, Archives of Oral Biology, V15, P1263, DOI 10.1016/0003-9969(70)90016-6; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Silwood CJL, 1999, NMR BIOMED, V12, P345, DOI 10.1002/(SICI)1099-1492(199910)12:6<345::AID-NBM580>3.0.CO;2-C; Smith SI, 2001, MICROBIOS, V105, P77; Song YL, 2000, FEMS MICROBIOL LETT, V187, P167, DOI 10.1016/S0378-1097(00)00196-8; STEPHAN RM, 1945, J DENT RES, V24, P202; Svec P, 2009, FOLIA MICROBIOL, V54, P53, DOI 10.1007/s12223-009-0008-7; Svec P, 2010, ANTON LEEUW INT J G, V98, P85, DOI 10.1007/s10482-010-9432-6; Tanner ACR, 2011, J CLIN MICROBIOL, V49, P1464, DOI 10.1128/JCM.02427-10; TERLECKYJ B, 1975, INFECT IMMUN, V11, P656, DOI 10.1128/IAI.11.4.656-664.1975; Uhlik O, 2008, SCI TOTAL ENV; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whiteley AS, 2007, NAT PROTOC, V2, P838, DOI 10.1038/nprot.2007.115; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	64	41	42	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32219	10.1371/journal.pone.0032219	http://dx.doi.org/10.1371/journal.pone.0032219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403637	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700034
J	Qiu, XD; Yang, J; Liu, TJ; Jiang, YX; Le, QH; Lu, Y				Qiu, Xiaodi; Yang, Jin; Liu, Tianjin; Jiang, Yongxiang; Le, Qihua; Lu, Yi			Efficient Generation of Lens Progenitor Cells from Cataract Patient-Specific Induced Pluripotent Stem Cells	PLOS ONE			English	Article							POSTERIOR CAPSULE OPACIFICATION; ORGANIZATION; FIBROBLASTS; INDUCTION; INSIGHTS; MOUSE; MODEL; FGF	The development of a technique to induce the transformation of somatic cells to a pluripotent state via the ectopic expression of defined transcription factors was a transformational event in the field of regenerative medicine. The development of this technique also impacted ophthalmology, as patient-specific induced pluripotent stemcells (iPSCs) may be useful resources for some ophthalmological diseases. The lens is a key refractive element in the eye that focuses images of the visual world onto the retina. To establish a new model for drug screening to treat lens diseases and investigating lens aging and development, we examined whether human lens epithelial cells (HLECs) could be induced into iPSCs and if lens-specific differentiation of these cells could be achieved under defined chemical conditions. We first efficiently reprogrammed HLECs from age-related cataract patients to iPSCs with OCT-4, SOX-2, and KLF-4. The resulting HLEC-derived iPS (HLE-iPS) colonies were indistinguishable from human ES cells with respect to morphology, gene expression, pluripotent marker expression and their ability to generate all embryonic germ-cell layers. Next, we performed a 3-step induction procedure: HLE-iPS cells were differentiated into large numbers of lens progenitor-like cells with defined factors (Noggin, BMP and FGF2), and we determined that these cells expressed lens-specific markers (PAX6, SOX2, SIX3, CRYAB, CRYAA, BFSP1, and MIP). In addition, HLE-iPS-derived lens cells exhibited reduced expression of epithelial mesenchymal transition (EMT) markers compared with human embryonic stem cells (hESCs) and fibroblast-derived iPSCs. Our study describes a highly efficient procedure for generating lens progenitor cells from cataract patient HLEC-derived iPSCs. These patient-derived pluripotent cells provide a valuable model for studying the developmental and molecular biological mechanisms that underlie cell determination in lens development and cataract pathophysiology.	[Qiu, Xiaodi; Yang, Jin; Jiang, Yongxiang; Le, Qihua; Lu, Yi] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Liu, Tianjin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Qiu, XD (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China.	luyi0705@gmail.com			National Natural Science Foundation of China [81070717]; Program of Shanghai Subject Chief Scientist [11XD1401200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist	This work was supported by grants from National Natural Science Foundation of China (NO. 81070717) and Program of Shanghai Subject Chief Scientist (11XD1401200). The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Chen YJ, 2008, DEV BIOL, V324, P161, DOI 10.1016/j.ydbio.2008.09.002; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; de Longh RU, 2001, DEVELOPMENT, V128, P3995; Dong LM, 2009, ARCH OPHTHALMOL-CHIC, V127, P1412, DOI 10.1001/archophthalmol.2009.152; Eballe AO, 2011, CLIN OPHTHALMOL, V5, P847, DOI 10.2147/OPTH.S19929; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Faber SC, 2002, DEVELOPMENT, V129, P3727; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; Gunhaga L, 2011, PHILOS T R SOC B, V366, P1193, DOI 10.1098/rstb.2010.0175; Hara T, 2011, ARCH OPHTHALMOL-CHIC, V129, P855, DOI 10.1001/archophthalmol.2011.38; Jin ZB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017084; Lang RA, 2004, INT J DEV BIOL, V48, P783, DOI 10.1387/ijdb.041903rl; Lovicu FJ, 2004, INVEST OPHTH VIS SCI, V45, P1946, DOI 10.1167/iovs.03-1206; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marcantonio JM, 2003, EXP EYE RES, V77, P339, DOI 10.1016/S0014-4835(03)00125-8; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mootha VV, 2004, J CATARACT REFR SURG, V30, P2354, DOI 10.1016/j.jcrs.2004.03.038; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rajagopal R, 2009, DEV BIOL, V335, P305, DOI 10.1016/j.ydbio.2009.08.027; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Robinson ML, 2006, SEMIN CELL DEV BIOL, V17, P726, DOI 10.1016/j.semcdb.2006.10.002; Salm M, 2006, AM J OPHTHALMOL, V142, P976, DOI 10.1016/j.ajo.2006.07.057; Sander K, 2001, INT J DEV BIOL, V45, P1; SCHULZ MW, 1993, DEVELOPMENT, V118, P117; Shirai K, 2004, J CATARACT REFR SURG, V30, P523, DOI 10.1016/S0886-3350(03)00616-3; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thompson AM, 2004, BRIT J OPHTHALMOL, V88, P1042, DOI 10.1136/bjo.2003.032581; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yang CB, 2010, FASEB J, V24, P3274, DOI 10.1096/fj.10-157255; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028	40	31	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32612	10.1371/journal.pone.0032612	http://dx.doi.org/10.1371/journal.pone.0032612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403680	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700077
J	Tennis, MA; VanScoyk, MM; Wilson, LA; Kelley, N; Winn, RA				Tennis, Meredith A.; VanScoyk, Michelle M.; Wilson, Lora A.; Kelley, Nicole; Winn, Robert A.			Methylation of Wnt7a Is Modulated by DNMT1 and Cigarette Smoke Condensate in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; ABERRANT METHYLATION; PROMOTER HYPERMETHYLATION; EXPRESSION; GENE; TRANSFORMATION; CARCINOMA; RASSF1A; GROWTH; FHIT	Wnt7a is known to be a tumor suppressor that is lost in NSCLC, but no mechanism of loss has been established. Methylation of promoter regions has been established as a common mechanism of loss of tumor suppressor expression in NSCLC. We previously demonstrated that loss of Wnt7a in non-transformed lung epithelial cell lines led to increased cell growth, altered 3-D culture growth, and increased migration. The Wnt7a promoter has a higher percentage of methylation in NSCLC tumor tissue compared to matched normal lung tissue and methylation of the promoter region leads to decreased activity. We treated H157 and H1299 NSCLC cell lines with 5-Aza-29-deoxycytidine and detected loss of Wnt7a promoter methylation, increased Wnt7a expression, and increased activity of the Wnt7a lung signaling pathway. When DNMT1 expression was knocked down by shRNA, expression of Wnt7a increased and methylation decreased. Together these data suggest that in NSCLC, Wnt7a is lost by methylation in a subset of tumors and that this methylation is maintained by DNMT1. Restoration of Wnt7a expression through demethylation could be an important therapeutic approach in the treatment of NSCLC.	[Tennis, Meredith A.; VanScoyk, Michelle M.; Wilson, Lora A.; Kelley, Nicole; Winn, Robert A.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Tennis, MA (corresponding author), Univ Colorado, Sch Med, Dept Med, Aurora, CO USA.	Meredith.tennis@gmail.com	Tennis, Meredith/Y-7622-2019	Tennis, Meredith/0000-0002-0619-6732	NIH [CA153268-01]; NATIONAL CANCER INSTITUTE [R01CA138528, R21CA153268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by an NIH R21 award (CA153268-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, CANCER, V117, P1847; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chen C, CANC LETT, V301, P7; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Dammann R, 2001, ONCOGENE, V20, P3563, DOI 10.1038/sj.onc.1204469; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Groeger AM, 1999, J THORAC CARDIOV SUR, V118, P529, DOI 10.1016/S0022-5223(99)70192-3; HIBI K, 1992, ONCOGENE, V7, P445; Huang Y, 2010, ONCOL REP, V23, P177, DOI 10.3892/or_00000620; Kersting M, 2000, J CLIN ONCOL, V18, P3221, DOI 10.1200/JCO.2000.18.18.3221; Kim HJ, 2006, CANCER, V107, P1042, DOI 10.1002/cncr.22087; Kirikoshi H, 2002, INT J ONCOL, V21, P895; Li J, CANC BIOL THER, V10, P617; Lin RK, J CLIN INVEST, V120, P521; Liu F, ONCOGENE, V29, P3650; Liu WB, 2011, TOXICOL APPL PHARM, V251, P70, DOI 10.1016/j.taap.2010.12.002; Maruyama R, 2004, CANCER-AM CANCER SOC, V100, P1472, DOI 10.1002/cncr.20144; Mathers JC, ADV GENET, V71, P3; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Sato N, 2003, CANCER RES, V63, P3735; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Tang MQ, 2009, CURR GENOMICS, V10, P336, DOI 10.2174/138920209788920994; Tennis M, 2010, NEOPLASIA, V12, P244, DOI 10.1593/neo.91690; Tomizawa Y, 2004, LUNG CANCER-J IASLC, V46, P305, DOI 10.1016/j.lungcan.2004.05.003; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Yanagawa N, 2002, JPN J CANCER RES, V93, P1107, DOI 10.1111/j.1349-7006.2002.tb01212.x	29	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32921	10.1371/journal.pone.0032921	http://dx.doi.org/10.1371/journal.pone.0032921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403725	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700122
J	van Leeuwen, CHA; van der Velde, G; van Lith, B; Klaassen, M				van Leeuwen, Casper H. A.; van der Velde, Gerard; van Lith, Bart; Klaassen, Marcel			Experimental Quantification of Long Distance Dispersal Potential of Aquatic Snails in the Gut of Migratory Birds	PLOS ONE			English	Article							POTAMOPYRGUS-ANTIPODARUM; SEED DISPERSAL; RETENTION TIME; TRADE-OFFS; ORGANISMS; WATERBIRDS; FOOD; MALLARDS; INVERTEBRATES; TRANSPORT	Many plant seeds and invertebrates can survive passage through the digestive system of birds, which may lead to long distance dispersal (endozoochory) in case of prolonged retention by moving vectors. Endozoochorous dispersal by waterbirds has nowadays been documented for many aquatic plant seeds, algae and dormant life stages of aquatic invertebrates. Anecdotal information indicates that endozoochory is also possible for fully functional, active aquatic organisms, a phenomenon that we here address experimentally using aquatic snails. We fed four species of aquatic snails to mallards (Anas platyrhynchos), and monitored snail retrieval and survival over time. One of the snail species tested was found to survive passage through the digestive tract of mallards as fully functional adults. Hydrobia (Peringia) ulvae survived up to five hours in the digestive tract. This suggests a maximum potential transport distance of up to 300 km may be possible if these snails are taken by flying birds, although the actual dispersal distance greatly depends on additional factors such as the behavior of the vectors. We put forward that more organisms that acquired traits for survival in stochastic environments such as wetlands, but not specifically adapted for endozoochory, may be sufficiently equipped to successfully pass a bird's digestive system. This may be explained by a digestive trade-off in birds, which maximize their net energy intake rate rather than digestive efficiency, since higher efficiency comes with the cost of prolonged retention times and hence reduces food intake. The resulting lower digestive efficiency allows species like aquatic snails, and potentially other fully functional organisms without obvious dispersal adaptations, to be transported internally. Adopting this view, endozoochorous dispersal may be more common than up to now thought.	[van Leeuwen, Casper H. A.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [van Leeuwen, Casper H. A.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands; [van Leeuwen, Casper H. A.; van der Velde, Gerard] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands; [van der Velde, Gerard] Netherlands Ctr Biodivers Nat, Leiden, Netherlands; [van Lith, Bart; Klaassen, Marcel] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Klaassen, Marcel] Deakin Univ, Ctr Integrat Ecol, Geelong, Vic 3217, Australia	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Radboud University Nijmegen; Radboud University Nijmegen; Naturalis Biodiversity Center; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	van Leeuwen, CHA (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands.	c.vanleeuwen@nioo.knaw.nl	van der Velde, Gerard/C-7776-2011; Klaassen, Marcel/B-4325-2008; Van Leeuwen, Casper H.A./B-9166-2012; KNAW, NIOO-KNAW/A-4320-2012	Klaassen, Marcel/0000-0003-3907-9599; Van Leeuwen, Casper H.A./0000-0003-2833-7775; KNAW, NIOO-KNAW/0000-0002-3835-159X	Royal Netherlands Academy of Arts and Sciences (KNAW)	Royal Netherlands Academy of Arts and Sciences (KNAW)	This work was funded by the Royal Netherlands Academy of Arts and Sciences (KNAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFIK D, 1995, ECOLOGY, V76, P2247, DOI 10.2307/1941699; Albrecht C, 2009, BIOL INVASIONS, V11, P1821, DOI 10.1007/s10530-008-9360-9; Alonso A, 2008, HYDROBIOLOGIA, V614, P107, DOI 10.1007/s10750-008-9529-3; Anders NR, 2009, AQUAT ECOL, V43, P1193, DOI 10.1007/s10452-008-9216-5; ATKINSON KM, 1980, BRIT PHYCOL J, V15, P49, DOI 10.1080/00071618000650061; BALDWIN JR, 1994, MAR BIOL, V120, P627, DOI 10.1007/BF00350084; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; BOAG DA, 1986, CAN J ZOOL, V64, P904, DOI 10.1139/z86-136; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Brendonck L, 1999, BIOL J LINN SOC, V67, P87, DOI 10.1111/j.1095-8312.1999.tb01931.x; Brochet AL, 2010, FRESHWATER BIOL, V55, P1262, DOI 10.1111/j.1365-2427.2009.02350.x; Brochet AL, 2010, HYDROBIOLOGIA, V637, P255, DOI 10.1007/s10750-009-9975-6; Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; Caceres CE, 2002, OECOLOGIA, V131, P402, DOI 10.1007/s00442-002-0897-5; Cadee GC, 1988, CORRESPONDENTIEBLAD, V243, P443; Cadee GC, 2011, PALAIOS, V26, P245, DOI 10.2110/palo.2010.p10-095r; CAMPBELL JW, 1947, IBIS, V89, P429, DOI 10.1111/j.1474-919X.1947.tb04360.x; CASTRO G, 1989, COMP BIOCHEM PHYS A, V92, P271, DOI 10.1016/0300-9629(89)90563-X; Charalambidou I, 2005, FUNCT ECOL, V19, P513, DOI 10.1111/j.1365-2435.2005.00998.x; Charalambidou I, 2005, WETLANDS, V25, P252, DOI 10.1672/2; Charalambidou I, 2003, FUNCT ECOL, V17, P747, DOI 10.1111/j.1365-2435.2003.00787.x; Charalambidou I, 2003, DIVERS DISTRIB, V9, P367, DOI 10.1046/j.1472-4642.2003.00026.x; Charalambidou I, 2003, ARCH HYDROBIOL, V157, P547, DOI 10.1127/0003-9136/2003/0157-0547; Charalambidou I, 2002, ACTA OECOL, V23, P165, DOI 10.1016/S1146-609X(02)01148-7; Clauss M, 2007, OIKOS, V116, P209, DOI [10.1111/j.2006.0030-1299.15461.x, 10.1111/j.0030-1299.2007.15461.x]; CLENCH MH, 1995, CONDOR, V97, P1041, DOI 10.2307/1369542; Combs DL, 1996, J WILDLIFE MANAGE, V60, P603, DOI 10.2307/3802078; Cousens RD, 2010, FUNCT ECOL, V24, P1163, DOI 10.1111/j.1365-2435.2010.01747.x; Cramp S., 1980, HDB BIRDS EUROPE MID, V1st; Darwin C., 1859, ORIGIN SPECIES MEANS; DEVLAMING V, 1968, AM J BOT, V55, P20, DOI 10.2307/2440487; EVANS PR, 1979, OECOLOGIA, V41, P183, DOI 10.1007/BF00345002; Figuerola J, 2004, CAN J ZOOL, V82, P835, DOI 10.1139/Z04-055; Figuerola J, 2003, GLOBAL ECOL BIOGEOGR, V12, P427, DOI 10.1046/j.1466-822X.2003.00043.x; Figuerola J, 2002, ARCH HYDROBIOL, V155, P557; Figuerola J, 2002, J ECOL, V90, P989, DOI 10.1046/j.1365-2745.2002.00734.x; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Figuerola J, 2010, NATURWISSENSCHAFTEN, V97, P555, DOI 10.1007/s00114-010-0671-1; Frisch D, 2007, AQUAT SCI, V69, P568, DOI 10.1007/s00027-007-0915-0; Frisch D, 2007, FUND APPL LIMNOL, V168, P289, DOI 10.1127/1863-9135/2007/0168-0289; GIBSON JS, 1970, J ANIM ECOL, V39, P159, DOI 10.2307/2893; Green AJ, 2008, FRESHWATER BIOL, V53, P380, DOI 10.1111/j.1365-2427.2007.01901.x; Green AJ, 2005, LIMNOL OCEANOGR, V50, P737, DOI 10.4319/lo.2005.50.2.0737; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Green AJ, 2006, BIOL LETT-UK, V2, P55, DOI 10.1098/rsbl.2005.0413; GRUENHAGEN NM, 1990, J WILDLIFE MANAGE, V54, P622, DOI 10.2307/3809359; Hohenlohe PA, 2004, BIOL J LINN SOC, V82, P169, DOI 10.1111/j.1095-8312.2004.00318.x; Janssen AW, 2004, NEDERLANDSE ZOETWATE; KARASOV WH, 1990, PHYSIOL ZOOL, V63, P1248, DOI 10.1086/physzool.63.6.30152643; KEHOE FP, 1988, CAN J ZOOL, V66, P1597, DOI 10.1139/z88-233; Kew H.W., 1893, DISPERSAL SHELLS INQ; Kristiansen J, 1996, HYDROBIOLOGIA, V336, P151, DOI 10.1007/BF00010829; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; MALONE CHARLES R., 1965, J WILDLIFE MANAGE, V29, P529, DOI 10.2307/3798052; Malone CR, 1965, THESIS TEXAS TECHNOL; MILLS EL, 1993, J GREAT LAKES RES, V19, P1, DOI 10.1016/S0380-1330(93)71197-1; Morley NJ, 2008, AQUAT SCI, V70, P107, DOI 10.1007/s00027-007-7052-7; NEWELL RICHARD, 1962, PROC ZOOL SOC LONDON, V138, P49; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Okamura B, 2002, DISPERSAL ECOLOGY, P194; Pollux BJA, 2011, FRESHWATER BIOL, V56, P197, DOI 10.1111/j.1365-2427.2010.02493.x; Pollux BJA, 2005, FRESHWATER BIOL, V50, P232, DOI 10.1111/j.1365-2427.2004.01314.x; PROCTOR VW, 1967, ECOLOGY, V48, P672, DOI 10.2307/1936517; PROP J, 1992, FUNCT ECOL, V6, P180, DOI 10.2307/2389753; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raulings E, 2011, FRESHWATER BIOL, V56, P1390, DOI 10.1111/j.1365-2427.2011.02576.x; Ridley H. N., 1930, DISTRIBUTION PLANTS; Rodrigues D., 2002, Game & Wildlife Science, V19, P55; Soons MB, 2008, J ECOL, V96, P619, DOI 10.1111/j.1365-2745.2008.01372.x; Stadler T, 2005, MOL ECOL, V14, P2465, DOI 10.1111/j.1365-294X.2005.02603.x; SWANSON GA, 1985, J WILDLIFE MANAGE, V49, P197, DOI 10.2307/3801871; Traveset A, 2008, ECOLOGY, V89, P95, DOI 10.1890/07-0094.1; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; Wada S, 2012, J BIOGEOGR, V39, P69, DOI 10.1111/j.1365-2699.2011.02559.x; WELHAM CVJ, 1994, BEHAV ECOL, V5, P1, DOI 10.1093/beheco/5.1.1; Wesselingh FP, 1999, GEOL MIJNBOUW-N J G, V78, P165, DOI 10.1023/A:1003766516646; Whilde A., 1977, Irish Naturalists' Journal, V19, P18; ZWARTS L, 1992, MAR ECOL PROG SER, V83, P113, DOI 10.3354/meps083113	79	79	86	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32292	10.1371/journal.pone.0032292	http://dx.doi.org/10.1371/journal.pone.0032292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403642	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700039
J	Cunningham, MR; McIntosh, KA; Pediani, JD; Robben, J; Cooke, AE; Nilsson, M; Gould, GW; Mundell, S; Milligan, G; Plevin, R				Cunningham, Margaret R.; McIntosh, Kathryn A.; Pediani, John D.; Robben, Joris; Cooke, Alexandra E.; Nilsson, Mary; Gould, Gwyn W.; Mundell, Stuart; Milligan, Graeme; Plevin, Robin			Novel Role for Proteinase-activated Receptor 2 (PAR(2)) in Membrane Trafficking of Proteinase-activated Receptor 4 (PAR(4))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; THROMBIN-RECEPTOR; SURFACE EXPRESSION; ENDOTHELIAL-CELLS; INTRACELLULAR TRAFFICKING; MECHANISMS; INTERNALIZATION; LOCALIZATION; RESENSITIZATION; ARTHRITIS	Proteinase-activated receptors 4 (PAR(4)) is a class A G protein-coupled receptor (GPCR) recognized through the ability of serine proteases such as thrombin and trypsin to mediate receptor activation. Due to the irreversible nature of activation, a fresh supply of receptor is required to be mobilized to the cell surface for responsiveness to agonist to be sustained. Unlike other PAR subtypes, the mechanisms regulating receptor trafficking of PAR(4) remain unknown. Here, we report novel features of the intracellular trafficking of PAR(4) to the plasma membrane. PAR(4) was poorly expressed at the plasma membrane and largely retained in the endoplasmic reticulum (ER) in a complex with the COPI protein subunit beta-COP1. Analysis of the PAR(4) protein sequence identified an arginine-based (RXR) ER retention sequence located within intracellular loop-2 (R(183)AR -> 3 A(183)AA), mutation of which allowed efficient membrane delivery of PAR(4). Interestingly, co-expression with PAR(2) facilitated plasma membrane delivery of PAR(4), an effect produced through disruption of beta-COP1 binding and facilitation of interaction with the chaperone protein 14-3-3 zeta. Intermolecular FRET studies confirmed heterodimerization between PAR(2) and PAR(4). PAR(2) also enhanced glycosylation of PAR(4) and activation of PAR(4) signaling. Our results identify a novel regulatory role for PAR(2) in the anterograde traffic of PAR(4). PAR(2) was shown to both facilitate and abrogate protein interactions with PAR(4), impacting upon receptor localization and cell signal transduction. This work is likely to impact markedly upon the understanding of the receptor pharmacology of PAR(4) in normal physiology and disease.	[Cunningham, Margaret R.; Cooke, Alexandra E.; Mundell, Stuart] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Cunningham, Margaret R.; McIntosh, Kathryn A.; Nilsson, Mary; Plevin, Robin] Univ Strathclyde, Strathclyde Inst Biomed Sci, Dept Physiol & Pharmacol, Glasgow G4 0NR, Lanark, Scotland; [Pediani, John D.; Robben, Joris; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Gould, Gwyn W.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Glasgow G12 8QQ, Lanark, Scotland; [Robben, Joris] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	University of Bristol; University of Strathclyde; University of Glasgow; University of Glasgow; Radboud University Nijmegen	Cunningham, MR (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	margaret.cunningham@bristol.ac.uk	Gould, Gwyn/AAF-6721-2019; Milligan, Graeme/F-9426-2011; Pediani, John/F-2708-2019	Gould, Gwyn/0000-0001-6571-2875; Milligan, Graeme/0000-0002-6946-3519; Pediani, John/0000-0001-6615-537X; Plevin, Robin/0000-0002-7849-1220; Mundell, Stuart/0000-0001-7754-3271; Conibear, Alexandra/0000-0001-5471-1375; Cunningham, Margaret/0000-0001-6454-8671	Wellcome Trust [08444/Z/09/Z]; British Heart Foundation [BHF-FS/05/014]; Medical Research Council [G0900050]; British Pharmacological Society; British Heart Foundation [PG/09/091/28074] Funding Source: researchfish; MRC [G0900050] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Pharmacological Society; British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Wellcome Trust Grant 08444/Z/09/Z (to R. P.), British Heart Foundation Grant BHF-FS/05/014 (to R. P.), and Medical Research Council Grant G0900050 (to G. M.).; Recipient of the 2006 British Pharmacological Society AJ Clark Ph. D. Student award. To whom correspondence should be addressed: School of Physiology and Pharmacology, Medical Sciences Building, University of Bristol, Bristol BS8 1TD, United Kingdom. Tel.: 44-01173311433; E-mail: margaret. cunningham@bristol.ac.uk.	Ando S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-31; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; BARLOWE C, 1993, J BIOL CHEM, V268, P873; Barlowe C, 2000, TRAFFIC, V1, P371, DOI 10.1034/j.1600-0854.2000.010501.x; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bohm SK, 1996, J BIOL CHEM, V271, P22003; BOUTON MC, 1995, BIOCHEM J, V305, P635, DOI 10.1042/bj3050635; Boyd GW, 2003, J BIOL CHEM, V278, P27681, DOI 10.1074/jbc.M304938200; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Gandhi PS, 2011, IUBMB LIFE, V63, P375, DOI 10.1002/iub.461; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Hamilton JR, 2001, CIRC RES, V89, P92, DOI 10.1161/hh1301.092661; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hirano K, 2007, J PHARMACOL EXP THER, V322, P668, DOI 10.1124/jpet.107.121038; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; ISHII K, 1995, J BIOL CHEM, V270, P16435, DOI 10.1074/jbc.270.27.16435; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kanke T, 2001, J BIOL CHEM, V276, P31657, DOI 10.1074/jbc.M100377200; Karpa KD, 1999, MOL PHARMACOL, V56, P1071, DOI 10.1124/mol.56.5.1071; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; Luo WB, 2011, J NEUROCHEM, V117, P71, DOI 10.1111/j.1471-4159.2011.07173.x; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; McDougall JJ, 2009, ARTHRITIS RHEUM-US, V60, P728, DOI 10.1002/art.24300; McIntosh KA, 2007, CURR OPIN PHARMACOL, V7, P334, DOI 10.1016/j.coph.2007.01.002; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; Okamoto Y, 2011, J BIOL CHEM, V286, P7171, DOI 10.1074/jbc.M110.199695; Pagano A, 2001, J NEUROSCI, V21, P1189; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; PLEVIN R, 1994, BRIT J PHARMACOL, V112, P311, DOI 10.1111/j.1476-5381.1994.tb13070.x; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Ren Z, 2003, J NEUROSCI, V23, P6608; Ritchie E, 2007, BRIT J PHARMACOL, V150, P1044, DOI 10.1038/sj.bjp.0707150; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Russell FA, 2009, INFLAMM RES, V58, P119, DOI 10.1007/s00011-009-8087-0; Russell FA, 2010, J NEUROPHYSIOL, V103, P155, DOI 10.1152/jn.00486.2009; Sabri A, 2003, J BIOL CHEM, V278, P11714, DOI 10.1074/jbc.M213091200; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Tiruppathi C, 2000, P NATL ACAD SCI USA, V97, P7440, DOI 10.1073/pnas.97.13.7440; Vivithanaporn P, 2006, J BIOL CHEM, V281, P15475, DOI 10.1074/jbc.M512098200; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wilson S, 2005, J BIOL CHEM, V280, P28663, DOI 10.1074/jbc.M413475200; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Wu CC, 2010, BRIT J PHARMACOL, V161, P643, DOI 10.1111/j.1476-5381.2010.00921.x; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	63	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16656	16669		10.1074/jbc.M111.315911	http://dx.doi.org/10.1074/jbc.M111.315911			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22411985	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000304030900054
J	Bouvier, N; Fougeray, S; Beaune, P; Thervet, E; Pallet, N				Bouvier, Nicolas; Fougeray, Sophie; Beaune, Philippe; Thervet, Eric; Pallet, Nicolas			The Unfolded Protein Response Regulates an Angiogenic Response by the Kidney Epithelium during Ischemic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; RENAL-DISEASE; ER STRESS; A EXPRESSION; TUMOR-GROWTH; HYPOXIA; PATHWAY; INJURY; CELLS; VEGF	Ischemic injuries permanently affect kidney tissue and challenge cell viability, promoting inflammation and fibrogenesis. Ischemia results in nutrient deprivation, which triggers endoplasmic reticulum stress, ultimately resulting in the unfolded protein response (UPR). The aim of this study was to test whether the UPR could promote an angiogenic response independently of the HIF-1 alpha pathway during ischemic stress in the human kidney epithelium. Glucose deprivation induced the secretion of vascular endothelial growth factor A (VEGFA), basic fibroblast growth factor (bFGF) and angiogenin (ANG) in human kidney epithelial cells independently of HIF-1 alpha. Glucose deprivation, but not hypoxia, triggered endoplasmic reticulum stress and activated the UPR. RNA interference-mediated inhibition of the gene encoding the kinase PERK decreased VEGFA and bFGF expression, but neither gene was affected by the inhibition of IRE1 alpha or ATF6. Furthermore, we show that the expression of angiogenin, which inhibits protein synthesis, is regulated by both IRE1 alpha and PERK, which could constitute a complementary function of the UPR in the repression of translation. In a rat model of acute ischemic stress, we show that the UPR is activated in parallel with VEGFA, bFGF, and ANG expression and independently of HIF-1 alpha.	[Bouvier, Nicolas; Fougeray, Sophie; Beaune, Philippe; Thervet, Eric; Pallet, Nicolas] Ctr Univ St Peres, INSERM U775, F-75006 Paris, France; [Thervet, Eric] Hop Europeen Georges Pompidou, Serv Nephrol, F-70115 Paris, France; [Bouvier, Nicolas; Fougeray, Sophie; Beaune, Philippe; Thervet, Eric; Pallet, Nicolas] Univ Paris 05, F-75065 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Pallet, N (corresponding author), Ctr Univ St Peres, INSERM U775, 45 Rue St Peres, F-75006 Paris, France.	npallet@yahoo.fr	Fougeray, Sophie/M-2310-2015	Fougeray, Sophie/0000-0002-5745-3831; Beaune, Philippe/0000-0002-6569-9014; Pallet, Nicolas/0000-0002-8486-3596	Institut National de la Sante et de la Recherche Medicale (INSERM)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by a grant from the Institut National de la Sante et de la Recherche Medicale (INSERM).	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chade AR, 2011, AM J PHYSIOL-REG I, V300, pR783, DOI 10.1152/ajpregu.00657.2010; Choi YJ, 2000, HUM PATHOL, V31, P1491, DOI 10.1053/hupa.2000.20373; Drogat B, 2007, CANCER RES, V67, P6700, DOI 10.1158/0008-5472.CAN-06-3235; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fine L. G., 2008, KIDNEY INT; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Leonard EC, 2008, AM J PHYSIOL-RENAL, V295, pF1648, DOI 10.1152/ajprenal.00099.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Marjon PL, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-4; Mayer G, 2011, NEPHROL DIAL TRANSPL, V26, P1132, DOI 10.1093/ndt/gfq832; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Nakamura M, 2006, NEPHROL DIAL TRANSPL, V21, P1489, DOI 10.1093/ndt/gfl041; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Pallet N, 2008, AM J TRANSPLANT, V8, P2283, DOI 10.1111/j.1600-6143.2008.02396.x; Pallet N, 2005, KIDNEY INT, V67, P2422, DOI 10.1111/j.1523-1755.2005.00350.x; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Racusen LC, 2010, KIDNEY INT, V78, pS27, DOI 10.1038/ki.2010.419; Rajnoch J, 2005, TRANSPL P, V37, P352, DOI 10.1016/j.transproceed.2004.12.154; Reinders MEJ, 2006, J AM SOC NEPHROL, V17, P932, DOI 10.1681/ASN.2005121250; Rudnicki M, 2009, LAB INVEST, V89, P337, DOI 10.1038/labinvest.2008.158; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	38	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14557	14568		10.1074/jbc.M112.340570	http://dx.doi.org/10.1074/jbc.M112.340570			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403402	Green Published, hybrid			2022-12-25	WOS:000304003200022
J	de Baaij, JHF; Stuiver, M; Meij, IC; Lainez, S; Kopplin, K; Venselaar, H; Muller, D; Bindels, RJM; Hoenderop, JGJ				de Baaij, Jeroen H. F.; Stuiver, Marchel; Meij, Iwan C.; Lainez, Sergio; Kopplin, Kathrin; Venselaar, Hanka; Mueller, Dominik; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Membrane Topology and Intracellular Processing of Cyclin M2 (CNNM2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; EPITOPE INSERTION; SIGNAL PEPTIDES; DOMAIN; PROTEIN; CA2+; MUTATIONS; ASSOCIATION; PREDICTION; TRANSPORT	Recently, mutations in the cyclin M2 (CNNM2) gene were identified to be causative for severe hypomagnesemia. In kidney, CNNM2 is a basolaterally expressed protein with predominant expression in the distal convoluted tubule. Transcellular magnesium (Mg2+) reabsorption in the distal convoluted tubule represents the final step before Mg2+ is excreted into the urine, thus fine-tuning its final excretion via a tightly regulated mechanism. The present study aims to get insight in the structure of CNNM2 and to characterize its post-translational modifications. Here, membrane topology studies using intramolecular epitopes and immunocytochemistry showed that CNNM2 has an extracellular N terminus and an intracellular C terminus. This suggests that one of the predicted transmembrane regions might be reentrant. By homology modeling, we demonstrated that the loss-of-function mutation as found in patients disturbs the potential ATP binding by the intracellular cystathionine beta-synthase domains. In addition, the cellular processing pathway of CNNM2 was exposed in detail. In the endoplasmic reticulum, the signal peptidase complex cleaves off a large N-terminal signal peptide of about 64 amino acids. Mutagenesis screening showed that CNNM2 is glycosylated at residue Asn-112, stabilizing CNNM2 on the plasma membrane. Interestingly, co-immunoprecipitation studies evidenced that CNNM2a forms heterodimers with the smaller isoform CNNM2b. These new findings on CNNM2 structure and processing may aid to elucidate the physiological role of CNNM2 in Mg2+ reabsorption in the kidney.	[de Baaij, Jeroen H. F.; Lainez, Sergio; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Stuiver, Marchel; Kopplin, Kathrin; Mueller, Dominik] Charite, Dept Pediat Nephrol, D-13353 Berlin, Germany; [Stuiver, Marchel; Kopplin, Kathrin; Mueller, Dominik] Charite, Ctr Cardiovasc Res, D-10115 Berlin, Germany; [Meij, Iwan C.] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Physiol 286, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@fysiol.umcn.nl	Venselaar, Hanka/D-2009-2016; Hoenderop, Joost G.J./H-8047-2014; de Baaij, Jeroen/P-5704-2015; Bindels, René JM/B-9824-2013	Venselaar, Hanka/0000-0001-9824-6559; Hoenderop, Joost G.J./0000-0002-1816-8544; de Baaij, Jeroen/0000-0003-2372-8486; Bindels, René JM/0000-0003-1167-1339; Stuiver, Marchel/0000-0003-3437-4468	Netherlands Organization for Scientific Research [ZonMw 9120.8026, EURYI 2006]; European Community [EUNEFRON 201590]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission)	This work was supported by the Netherlands Organization for Scientific Research Grants ZonMw 9120.8026 and EURYI 2006 (to J. G. J. H.) and by grants from the European Community, FP7 (EUNEFRON 201590) (to I. C. M. and D. M.).	Alderton A, 2007, J NEUROCHEM, V103, P312, DOI 10.1111/j.1471-1471-4159.2007.04751.x; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; BINDELS RJM, 1991, AM J PHYSIOL, V261, pF799, DOI 10.1152/ajprenal.1991.261.5.F799; Czachorowski M, 2009, BIOCHEMISTRY-US, V48, P8422, DOI 10.1021/bi900606y; Glaudemans B, 2010, KIDNEY INT, V77, P17, DOI 10.1038/ki.2009.358; Garcia IG, 2011, ACTA CRYSTALLOGR F, V67, P349, DOI 10.1107/S1744309110053856; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hiss JA, 2009, BRIEF BIOINFORM, V10, P569, DOI 10.1093/bib/bbp030; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Hofmeister MV, 2009, AM J PHYSIOL-RENAL, V296, pF194, DOI 10.1152/ajprenal.90495.2008; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Kast C, 1997, J BIOL CHEM, V272, P26479, DOI 10.1074/jbc.272.42.26479; KAST C, 1995, BIOCHEMISTRY-US, V34, P4402, DOI 10.1021/bi00013a032; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Meij IC, 2003, NEPHROL DIAL TRANSPL, V18, P512, DOI 10.1093/ndt/18.3.512; Meyer AH, 2002, J NEUROSCI, V22, P7055; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nijenhuis T, 2003, KIDNEY INT, V64, P555, DOI 10.1046/j.1523-1755.2003.00128.x; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sponder G, 2010, MAGNESIUM RES, V23, P105, DOI 10.1684/mrh.2010.0206; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wabakken T, 2003, BIOCHEM BIOPH RES CO, V306, P718, DOI 10.1016/S0006-291X(03)01030-1; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03	41	66	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13644	13655		10.1074/jbc.M112.342204	http://dx.doi.org/10.1074/jbc.M112.342204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22399287	hybrid, Green Published			2022-12-25	WOS:000303996300020
J	Li, Y; Padgett, RW				Li, Ying; Padgett, Richard W.			bantam Is Required for Optic Lobe Development and Glial Cell Proliferation	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; VISUAL-SYSTEM; MICRORNA PATHWAYS; NERVOUS-SYSTEM; PATTERN-FORMATION; GENE-EXPRESSION; GAL4 SYSTEM; DIFFERENTIATION; GROWTH; BRAIN	microRNAs (miRNAs) are small, conserved, non-coding RNAs that contribute to the control of many different cellular processes, including cell fate specification and growth control. Drosophila bantam, a conserved miRNA, is involved in several functions, such as stimulating proliferation and inhibiting apoptosis in the wing disc. Here, we reported the detailed expression pattern of bantam in the developing optic lobe, and demonstrated a new, essential role in promoting proliferation of mitotic cells in the optic lobe, including stem cells and differentiated glial cells. Changes in bantam levels autonomously affected glial cell number and distribution, and non-autonomously affected photoreceptor neuron axon projection patterns. Furthermore, we showed that bantam promotes the proliferation of mitotically active glial cells and affects their distribution, largely through down regulation of the T-box transcription factor, optomotor-blind (omb, Flybase, bifid). Expression of omb can rescue the bantam phenotype, and restore the normal glial cell number and proper glial cell positioning in most Drosophila brains. These results suggest that bantam is critical for maintaining the stem cell pools in the outer proliferation center and glial precursor cell regions of the optic lobe, and that its expression in glial cells is crucial for their proliferation and distribution.	[Li, Ying; Padgett, Richard W.] Rutgers State Univ, Dept Mol Biol & Biochem, Waksman Inst, Canc Inst New Jersey, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Li, Y (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Waksman Inst, Canc Inst New Jersey, Piscataway, NJ 08855 USA.	padgett@waksman.rutgers.edu		Padgett, Richard/0000-0002-5740-3324	National Science Foundation [IOS-06641173]; New Jersey Commission on Spinal Cord Research [CSCR11ERG017]	National Science Foundation(National Science Foundation (NSF)); New Jersey Commission on Spinal Cord Research	Funding: National Science Foundation (IOS-06641173); New Jersey Commission on Spinal Cord Research (CSCR11ERG017); http://www.state.nj.us/health/spinalcord/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bilen J, 2006, CELL CYCLE, V5, P2835, DOI 10.4161/cc.5.24.3579; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; Chotard C, 2007, NEURON GLIA BIOL, V3, P17, DOI 10.1017/S1740925X07000592; Cutforth T, 1997, CURR OPIN NEUROBIOL, V7, P48, DOI 10.1016/S0959-4388(97)80119-5; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5; Emerald BS, 1998, DEV GENES EVOL, V208, P504, DOI 10.1007/s004270050209; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; HALTER DA, 1995, DEVELOPMENT, V121, P317; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Herranz H, 2008, CELL CYCLE, V7, P3335, DOI 10.4161/cc.7.21.6996; Herranz H, 2010, EMBO J, V29, P1688, DOI 10.1038/emboj.2010.69; Hiesinger PR, 1999, J NEUROSCI, V19, P7548, DOI 10.1523/JNEUROSCI.19-17-07548.1999; Hipfner DR, 2002, GENETICS, V161, P1527; Hofmeyer K, 2008, DEV BIOL, V315, P28, DOI 10.1016/j.ydbio.2007.10.011; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Jaklevic B, 2008, DEV BIOL, V320, P122, DOI 10.1016/j.ydbio.2008.04.043; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Jones BW, 2005, DEV BIOL, V278, P265, DOI 10.1016/j.ydbio.2004.11.022; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; KAPHINGST K, 1994, CELL, V78, P437, DOI 10.1016/0092-8674(94)90422-7; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Pflugfelder GO, 2009, J NEUROGENET, V23, P15, DOI 10.1080/01677060802471619; PFLUGFELDER GO, 1990, GENETICS, V126, P91; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; POECK B, 1993, DEVELOPMENT, V117, P1017; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Read RD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000374; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shcherbata HR, 2007, CELL STEM CELL, V1, P698, DOI 10.1016/j.stem.2007.11.007; Soustelle L, 2007, NEURON GLIA BIOL, V3, P5, DOI 10.1017/S1740925X07000464; SUN YH, 1995, GENETICS, V141, P1075; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Ting CY, 2007, CURR OPIN NEUROBIOL, V17, P65, DOI 10.1016/j.conb.2006.12.004; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Van de Bor V, 1999, CELL DEATH DIFFER, V6, P557, DOI 10.1038/sj.cdd.4400517; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wilson V, 2002, GENOME BIOL, V3, P30081, DOI [10.1186/gb-2002-3-6-reviews3008, DOI 10.1186/GB-2002-3-6-REVIEWS3008]; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yang MC, 2005, CYTOKINE GROWTH F R, V16, P387, DOI 10.1016/j.cytogfr.2005.02.008; Yang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000444; Yoshida S, 2005, DEVELOPMENT, V132, P4587, DOI 10.1242/dev.02040	59	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32910	10.1371/journal.pone.0032910	http://dx.doi.org/10.1371/journal.pone.0032910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412948	Green Submitted, Green Published, gold			2022-12-25	WOS:000303062000020
J	Kosaisavee, V; Lek-Uthai, U; Suwanarusk, R; Gruner, AC; Russell, B; Nosten, F; Renia, L; Snounou, G				Kosaisavee, Varakorn; Lek-Uthai, Usa; Suwanarusk, Rossarin; Gruener, Anne Charlotte; Russell, Bruce; Nosten, Francois; Renia, Laurent; Snounou, Georges			Genetic Diversity in New Members of the Reticulocyte Binding Protein Family in Thai Plasmodium vivax Isolates	PLOS ONE			English	Article							YOELII ADHESIVE PROTEINS; RHOPTRY PROTEIN; FALCIPARUM; INVASION; MALARIA; MEROZOITES; IDENTIFICATION; PVRBP-1; PCR	Background: Plasmodium vivax merozoites specifically invade reticulocytes. Until recently, two reticulocyte-binding proteins (Pvrbp1 and Pvrbp2) expressed at the apical pole of the P. vivax merozoite were considered to be involved in reticulocyte recognition. The genome sequence recently obtained for the Salvador I (Sal-I) strain of P. vivax revealed additional genes in this family, and in particular Pvrbp2a, Pvrbp2b (Pvrbp2 has been renamed as Pvrbp2c) and two pseudogenes Pvrbp2d and Pvrbp3. It had been previously found that Pvrbp2c is substantially more polymorphic than Pvrbp1. The primary goal of this study was to ascertain the level of polymorphism of these new genes. Methodology/Principal Findings: The sequence of the Pvrbp2a, Pvrbp2b, Pvrbp2d and Pvrbp3 genes were obtained by amplification/cloning using DNA purified from four isolates collected from patients that acquired the infection in the four cardinal regions of Thailand (west, north, south and east). An additional seven isolates from western Thailand were analyzed for gene copy number variation. There were significant polymorphisms exhibited by these genes (compared to the reference Sal-I strain) with the ratio of mutations leading to a non-synonymous or synonymous amino acid change close to 3: 1 for Pvrbp2a and Pvrbp2b. Although the degree of polymorphism exhibited by these two genes was higher than that of Pvrbp1, it did not reach the exceptional diversity noted for Pvrbp2c. It was interesting to note that variations in the copy number of Pvrbp2a and Pvrbp2b occurred in some isolates. Conclusions/Significance: The evolution of different members of the Pvrbp2 family and their relatively high degree of polymorphism suggests that the proteins encoded by these genes are important for parasite survival and are under immune selection. Our data also shows that there are highly conserved regions in rbp2a and rbp2b, which might provide suitable targets for future vaccine development against the blood stage of P. vivax.	[Kosaisavee, Varakorn; Lek-Uthai, Usa] Mahidol Univ, Fac Publ Hlth, Dept Parasitol & Entomol, Bangkok 10700, Thailand; [Kosaisavee, Varakorn; Renia, Laurent] Mahidol Univ, Fac Grad Studies, Publ Hlth Programme Parasitol, Nakhon Pathom, Thailand; [Suwanarusk, Rossarin; Gruener, Anne Charlotte; Russell, Bruce] Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis, Singapore; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Tak, Singapore; [Nosten, Francois] Ctr Clin Vaccinol & Trop Med, Oxford, England; [Snounou, Georges] INSERM, Unite Mixte Rech S 665, Paris, France; [Snounou, Georges] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France	Mahidol University; Mahidol University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Kosaisavee, V (corresponding author), Mahidol Univ, Fac Publ Hlth, Dept Parasitol & Entomol, Bangkok 10700, Thailand.	georges.snounou@upmc.fr	Nosten, Francois/AAC-5509-2019; Renia, Laurent/E-2117-2011; Suwanarusk, Rossarin/E-2115-2013; Snounou, Georges/F-3352-2011; Russell, Bruce/A-9240-2011	Nosten, Francois/0000-0002-7951-0745; Renia, Laurent/0000-0003-0349-1557; Suwanarusk, Rossarin/0000-0002-7310-245X; Snounou, Georges/0000-0002-6133-6398; Russell, Bruce/0000-0003-2333-4348	Wellcome Trust [089275] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Cantor EM, 2001, MOL BIOCHEM PARASIT, V117, P229, DOI 10.1016/S0166-6851(01)00355-3; Caraballo JR, 2007, VACCINE, V25, P3713, DOI 10.1016/j.vaccine.2006.12.041; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Ferreira ID, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-1; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 2000, MOL BIOCHEM PARASIT, V108, P257, DOI 10.1016/S0166-6851(00)00219-X; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Gruner AC, 2004, MICROBES INFECT, V6, P864, DOI 10.1016/j.micinf.2004.04.004; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; KEEN JK, 1994, MOL BIOCHEM PARASIT, V65, P171, DOI 10.1016/0166-6851(94)90125-2; Meyer EVS, 2009, MOL BIOCHEM PARASIT, V165, P111, DOI 10.1016/j.molbiopara.2009.01.012; Okenu DMN, 2005, MOL BIOCHEM PARASIT, V143, P116, DOI 10.1016/j.molbiopara.2005.04.010; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Polley SD, 2004, TRENDS PARASITOL, V20, P99, DOI 10.1016/j.pt.2003.12.003; Rayner JC, 2005, AM J TROP MED HYG, V72, P666, DOI 10.4269/ajtmh.2005.72.666; Rayner JC, 2004, MOL BIOCHEM PARASIT, V133, P287, DOI 10.1016/j.molbiopara.2003.10.017; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; Taylor HM, 2001, INFECT IMMUN, V69, P3635, DOI 10.1128/IAI.69.6.3635-3645.2001; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; Urquiza M, 2002, PEPTIDES, V23, P2265, DOI 10.1016/S0196-9781(02)00267-X	25	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32105	10.1371/journal.pone.0032105	http://dx.doi.org/10.1371/journal.pone.0032105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403626	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700023
J	Park, YJ; Herman, H; Gao, Y; Lindroth, AM; Hu, BY; Murphy, PJ; Putnam, JR; Soloway, PD				Park, Yoon Jung; Herman, Herry; Gao, Ying; Lindroth, Anders M.; Hu, Benjamin Y.; Murphy, Patrick J.; Putnam, James R.; Soloway, Paul D.			Sequences Sufficient for Programming Imprinted Germline DNA Methylation Defined	PLOS ONE			English	Article							IGF2/H19 LOCUS; CONTROL REGION; IGF2R GENE; H19; MOUSE; EXPRESSION; RASGRF1; CTCF; INHERITANCE; MICE	Epigenetic marks are fundamental to normal development, but little is known about signals that dictate their placement. Insights have been provided by studies of imprinted loci in mammals, where monoallelic expression is epigenetically controlled. Imprinted expression is regulated by DNA methylation programmed during gametogenesis in a sex-specific manner and maintained after fertilization. At Rasgrf1 in mouse, paternal-specific DNA methylation on a differential methylation domain (DMD) requires downstream tandem repeats. The DMD and repeats constitute a binary switch regulating paternal-specific expression. Here, we define sequences sufficient for imprinted methylation using two transgenic mouse lines: One carries the entire Rasgrf1 cluster (RC); the second carries only the DMD and repeats (DR) from Rasgrf1. The RC transgene recapitulated all aspects of imprinting seen at the endogenous locus. DR underwent proper DNA methylation establishment in sperm and erasure in oocytes, indicating the DMD and repeats are sufficient to program imprinted DNA methylation in germlines. Both transgenes produce a DMD-spanning pit-RNA, previously shown to be necessary for imprinted DNA methylation at the endogenous locus. We show that when pit-RNA expression is controlled by the repeats, it regulates DNA methylation in cis only and not in trans. Interestingly, pedigree history dictated whether established DR methylation patterns were maintained after fertilization. When DR was paternally transmitted followed by maternal transmission, the unmethylated state that was properly established in the female germlines could not be maintained. This provides a model for transgenerational epigenetic inheritance in mice.	[Park, Yoon Jung] Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul, South Korea; [Park, Yoon Jung; Herman, Herry; Gao, Ying; Lindroth, Anders M.; Hu, Benjamin Y.; Putnam, James R.; Soloway, Paul D.] Cornell Univ, Div Nutr Sci, Coll Agr & Life Sci, Ithaca, NY 14853 USA; [Murphy, Patrick J.; Soloway, Paul D.] Cornell Univ, Genet & Dev Grad Field, Ithaca, NY USA	Ewha Womans University; Cornell University; Cornell University	Park, YJ (corresponding author), Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul, South Korea.	park.yoonjung@gmail.com; soloway@cornell.edu	Lindroth, Anders M/C-7744-2015; Soloway, Paul/T-8243-2019; Park, Yoon Jung/AAW-2712-2020	Lindroth, Anders M/0000-0002-8291-2745; Soloway, Paul/0000-0003-1967-0437	United States National Institutes of Health [CA098597]; NATIONAL CANCER INSTITUTE [R01CA098597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105243] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the United States National Institutes of Health (grant number CA098597). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscough JFX, 1997, DEVELOPMENT, V124, P3621; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Cranston MJ, 2001, GENOMICS, V73, P98, DOI 10.1006/geno.2001.6514; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Geuns E, 2003, HUM MOL GENET, V12, P2873, DOI 10.1093/hmg/ddg315; HADCHOUEL M, 1987, NATURE, V329, P454, DOI 10.1038/329454a0; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Holmes R, 2006, MOL CELL BIOL, V26, P9564, DOI 10.1128/MCB.00058-06; Jones BK, 2002, HUM MOL GENET, V11, P411, DOI 10.1093/hmg/11.4.411; Kantor B, 2004, HUM MOL GENET, V13, P751, DOI 10.1093/hmg/ddh085; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Park KY, 2004, MOL CELL BIOL, V24, P3588, DOI 10.1128/MCB.24.9.3588-3595.2004; Roemer I, 1997, CURR BIOL, V7, P277, DOI 10.1016/S0960-9822(06)00124-2; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Srivastava M, 2003, J BIOL CHEM, V278, P5977, DOI 10.1074/jbc.M208437200; Srivastava M, 2000, GENE DEV, V14, P1186; Strathdee D, 2008, J BIOL CHEM; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yoon B, 2005, MOL CELL BIOL, V25, P11184, DOI 10.1128/MCB.25.24.11184-11190.2005; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	35	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e33024	10.1371/journal.pone.0033024	http://dx.doi.org/10.1371/journal.pone.0033024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403732	gold, Green Submitted, Green Published			2022-12-25	WOS:000303017700129
J	Boyle, NR; Page, MD; Liu, BS; Blaby, IK; Casero, D; Kropat, J; Cokus, SJ; Hong-Hermesdorf, A; Shaw, J; Karpowicz, SJ; Gallaher, SD; Johnson, S; Benning, C; Pellegrini, M; Grossman, A; Merchant, SS				Boyle, Nanette R.; Page, Mark Dudley; Liu, Bensheng; Blaby, Ian K.; Casero, David; Kropat, Janette; Cokus, Shawn J.; Hong-Hermesdorf, Anne; Shaw, Johnathan; Karpowicz, Steven J.; Gallaher, Sean D.; Johnson, Shannon; Benning, Christoph; Pellegrini, Matteo; Grossman, Arthur; Merchant, Sabeeha S.			Three Acyltransferases and Nitrogen-responsive Regulator Are Implicated in Nitrogen Starvation-induced Triacylglycerol Accumulation in Chlamydomonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; ENDOPLASMIC-RETICULUM; COPPER DEFICIENCY; OIL ACCUMULATION; LIPID-SYNTHESIS; HUMAN GENOME; OLEIC-ACID; PCR DATA; RNA-SEQ; REINHARDTII	Algae have recently gained attention as a potential source for biodiesel; however, much is still unknown about the biological triggers that cause the production of triacylglycerols. We used RNA-Seq as a tool for discovering genes responsible for triacylglycerol (TAG) production in Chlamydomonas and for the regulatory components that activate the pathway. Three genes encoding acyltransferases, DGAT1, DGTT1, and PDAT1, are induced by nitrogen starvation and are likely to have a role in TAG accumulation based on their patterns of expression. DGAT1 and DGTT1 also show increased mRNA abundance in other TAG-accumulating conditions (minus sulfur, minus phosphorus, minus zinc, and minus iron). Insertional mutants, pdat1-1 and pdat1-2, accumulate 25% less TAG compared with the parent strain, CC-4425, which demonstrates the relevance of the trans-acylation pathway in Chlamydomonas. The biochemical functions of DGTT1 and PDAT1 were validated by rescue of oleic acid sensitivity and restoration of TAG accumulation in a yeast strain lacking all acyltransferase activity. Time course analyses suggest than a SQUAMOSA promoter-binding protein domain transcription factor, whose mRNA increases precede that of lipid biosynthesis genes like DGAT1, is a candidate regulator of the nitrogen deficiency responses. An insertional mutant, nrr1-1, accumulates only 50% of the TAG compared with the parental strain in nitrogen-starvation conditions and is unaffected by other nutrient stresses, suggesting the specificity of this regulator for nitrogen-deprivation conditions.	[Boyle, Nanette R.; Page, Mark Dudley; Blaby, Ian K.; Kropat, Janette; Hong-Hermesdorf, Anne; Shaw, Johnathan; Karpowicz, Steven J.; Gallaher, Sean D.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Liu, Bensheng; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Casero, David; Cokus, Shawn J.; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Johnson, Shannon] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Grossman, Arthur] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Casero, David; Pellegrini, Matteo; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Michigan State University; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Los Alamos National Laboratory; Carnegie Institution for Science; University of California System; University of California Los Angeles	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu	Casero, David/E-7365-2010; Johnson, Shannon Lyn/H-2799-2019; Benning, Christoph/Y-2528-2019; Blaby, Ian/C-3292-2014	Casero, David/0000-0002-7347-3330; Johnson, Shannon Lyn/0000-0002-3972-9208; Benning, Christoph/0000-0001-8585-3667; Pellegrini, Matteo/0000-0001-9355-9564; Gallaher, Sean/0000-0002-9773-6051	Air Force Office of Science Research [FA 9550-10-1-0095, FA9550-08-0165]; Department of Energy [DE-EE0003046]; German Academic Exchange Service [D/08/47579]; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; National Institutes of Health [T32 GM07185, T32 ES015457]; Direct For Biological Sciences [0951094] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES015457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	Air Force Office of Science Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Department of Energy(United States Department of Energy (DOE)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM07185 and T32 ES015457 (to S. J. K. and I. K. B). This work was also supported by Air Force Office of Science Research Grants FA 9550-10-1-0095 (to S. M. and M. P.) and FA9550-08-0165 (to C. B.), Department of Energy Contract DE-EE0003046 (to the National Alliance for Advance Biofuels and Bioproducts Consortium, including S. M., M. P., and S. J.), and the German Academic Exchange Service Grant D/08/47579 (to A. H.).; We thank Jane Grimwood (Hudson Alpha) for access to the version 5 assembly prior to release and Sepp Kohlwein (University of Graz) for yeast strains and plasmids. Some sequencing (454 ESTs) was conducted by the United States Department of Energy Joint Genome Institute, which is supported by the Office of Science of the United States Department of Energy under Contract No. DE-AC02-05CH11231.	Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Banilas G, 2011, J EXP BOT, V62, P521, DOI 10.1093/jxb/erq286; Benning C, 2010, ENZYME DIRECTED OIL; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GIROUD C, 1988, PLANT CELL PHYSIOL, V29, P587; Gonzalez-Ballester D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-24; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Goodson C, 2011, EUKARYOT CELL, V10, P1592, DOI 10.1128/EC.05242-11; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HILL KL, 1991, J BIOL CHEM, V266, P15060; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; James GO, 2011, BIORESOURCE TECHNOL, V102, P3343, DOI 10.1016/j.biortech.2010.11.051; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Lacey DJ, 1996, PLANTA, V199, P545, DOI 10.1007/BF00195185; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Li RZ, 2010, LIPIDS, V45, P145, DOI 10.1007/s11745-010-3385-4; Li YT, 2010, BIOTECHNOL BIOENG, V107, P258, DOI 10.1002/bit.22807; Li YT, 2010, METAB ENG, V12, P387, DOI 10.1016/j.ymben.2010.02.002; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Matsui K, 2004, FEBS LETT, V569, P195, DOI 10.1016/j.febslet.2004.05.064; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Merchant S. S., 2012, CURR OPIN BIOTECH, V23, P1; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller R., 2010, PLANT PHYSIOL, V110; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; Moellering ER, 2009, ADV PHOTOSYNTH RESP, V30, P139; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Pollock SV, 2003, PLANT PHYSIOL, V133, P1854, DOI 10.1104/pp.103.032078; Pootakham W, 2010, PLANT PHYSIOL, V153, P1653, DOI 10.1104/pp.110.157875; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Quisel JD, 1996, PLANT PHYSIOL, V111, P839, DOI 10.1104/pp.111.3.839; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Riekhof W.R., 2009, CHLAMYDOMONAS SOURCE, P41; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008; Rossak M, 1997, ARCH BIOCHEM BIOPHYS, V340, P219, DOI 10.1006/abbi.1997.9931; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; SCHNELL RA, 1993, GENETICS, V134, P737; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; STOBART AK, 1986, PLANTA, V169, P33, DOI 10.1007/BF01369772; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Stymne S., 1987, Biochemistry of Plants, V9, P175; Toida J, 1998, BIOSCI BIOTECH BIOCH, V62, P759, DOI 10.1271/bbb.62.759; Vieler A, 2007, CHEM PHYS LIPIDS, V150, P143, DOI 10.1016/j.chemphyslip.2007.06.224; Waltz E, 2009, NAT BIOTECHNOL, V27, P15, DOI [10.1038/461027a, 10.1038/nbt0109-15]; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Weers PMM, 1997, LIMNOL OCEANOGR, V42, P1584, DOI 10.4319/lo.1997.42.7.1584; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Work VH, 2010, EUKARYOT CELL, V9, P1251, DOI 10.1128/EC.00075-10; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xie ZY, 1996, J BIOL CHEM, V271, P4632; Yohn C., 2011, U.S. Patent, Patent No. [US 2011 023406, 2011023406]; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhekisheva M, 2002, J PHYCOL, V38, P325, DOI 10.1046/j.1529-8817.2002.01107.x	82	306	322	3	173	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15811	15825		10.1074/jbc.M111.334052	http://dx.doi.org/10.1074/jbc.M111.334052			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403401	Green Published, hybrid			2022-12-25	WOS:000304006300061
J	Yu, W; Dittenhafer-Reed, KE; Denu, JM				Yu, Wei; Dittenhafer-Reed, Kristin E.; Denu, John M.			SIRT3 Protein Deacetylates Isocitrate Dehydrogenase 2 (IDH2) and Regulates Mitochondrial Redox Status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; CALORIC RESTRICTION; LYSINE ACETYLATION; METABOLISM; CANCER; STRESS; ROS; SUPPRESSOR; HYPOXIA; DAMAGE	Mitochondria play a central role in oxidative energy metabolism and age-related diseases such as cancer. Accumulation of spurious oxidative damage can cause cellular dysfunction. Antioxidant pathways that rely on NADPH are needed for the reduction of glutathione and maintenance of proper redox status. The mitochondrial matrix protein isocitrate dehydrogenase 2 (IDH2) is a major source of NADPH. Previously, we demonstrated that the NAD(+)-dependent deacetylase SIRT3 was essential for the prevention of age-related hearing loss in mice fed a calorically restricted diet. Here we provide direct biochemical and biological evidence establishing an exquisite regulatory relationship between IDH2 and SIRT3 under acute and chronic caloric restriction. The regulated site of acetylation was mapped to Lys-413, an evolutionarily invariant residue. Site-specific, genetic incorporation of N-e-acetyllysine into position 413 of IDH2 revealed that acetylated IDH2 displays a dramatic 44-fold loss in activity. Deacetylation by SIRT3 fully restored maximum IDH2 activity. The ability of SIRT3 to protect cells from oxidative stress was dependent on IDH2, and the deacetylated mimic, IDH2(K413R) variant was able to protect Sirt3(-/-) mouse embryonic fibroblasts from oxidative stress through increased reduced glutathione levels. Together these results uncover a previously unknown mechanism by which SIRT3 regulates IDH2 under dietary restriction. Recent findings demonstrate that IDH2 activities are a major factor in cancer, and as such, these results implicate SIRT3 as a potential regulator of IDH2-dependent functions in cancer cell metabolism.	[Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Wisconsin Inst Discovery 2140, Madison, WI 53715 USA; Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Dept Biomol Chem, Wisconsin Inst Discovery 2140, 330 N Orchard St, Madison, WI 53715 USA.	jmdenu@wisc.edu	YU, WEI/C-3822-2012; YU, WEI/G-4128-2013	Dittenhafer-Reed, Kristin/0000-0001-7317-3912; YU, WEI/0000-0001-9898-4607	National Institutes of Health [GM065386]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, R37GM059785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065386 (to J. M. D.). This work was also supported by the National Science Foundation Graduate Research Fellowship Program (to K. E. D.).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DiMatteo MA, 1997, APOPTOSIS, V2, P164, DOI 10.1023/A:1026412414666; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kornberg A., 1955, METHOD ENZYMOL, V1, P3; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Peng YJ, 2008, PROTEIN SCI, V17, P1542, DOI 10.1110/ps.035675.108; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; UHR ML, 1974, J BIOL CHEM, V249, P2920; Vogel R, 1999, NEUROSCI LETT, V275, P97, DOI 10.1016/S0304-3940(99)00748-X; Wagner G. R., 2012, HUM MOL GEN IN PRESS; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weindruch R., 1988, RETARDATION AGING DI; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yang YJ, 2010, J BIOL CHEM, V285, P7417, DOI 10.1074/jbc.M109.053421; Yin F, 2012, BBA-BIOENERGETICS, V1817, P401, DOI 10.1016/j.bbabio.2011.12.004; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	51	299	308	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14078	14086		10.1074/jbc.M112.355206	http://dx.doi.org/10.1074/jbc.M112.355206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22416140	Green Published, hybrid			2022-12-25	WOS:000303996300061
J	Armon, L; Caplan, SR; Eisenbach, M; Friedrich, BM				Armon, Leah; Caplan, S. Roy; Eisenbach, Michael; Friedrich, Benjamin M.			Testing Human Sperm Chemotaxis: How to Detect Biased Motion in Population Assays	PLOS ONE			English	Article							HUMAN-SPERMATOZOA; FOLLICULAR FACTORS; CELLS; CHEMOATTRACTANT; PROGESTERONE; CAPACITATION; GUIDANCE; TRACKING; EGG	Biased motion of motile cells in a concentration gradient of a chemoattractant is frequently studied on the population level. This approach has been particularly employed in human sperm chemotactic assays, where the fraction of responsive cells is low and detection of biased motion depends on subtle differences. In these assays, statistical measures such as population odds ratios of swimming directions can be employed to infer chemotactic performance. Here, we report on an improved method to assess statistical significance of experimentally determined odds ratios and discuss the strong impact of data correlations that arise from the directional persistence of sperm swimming.	[Armon, Leah; Caplan, S. Roy; Eisenbach, Michael] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Friedrich, Benjamin M.] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; [Friedrich, Benjamin M.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Max Planck Society	Armon, L (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	ben@pks.mpg.de	Friedrich, Benjamin/B-2755-2017; Friedrich, Benjamin M/AAC-8204-2020	Friedrich, Benjamin/0000-0002-9742-6555; Friedrich, Benjamin M/0000-0002-9742-6555; Eisenbach, Michael/0000-0001-9048-4720	German Academic Exchange Service	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	The author Benjamin Friedrich was granted a post-doctoral fellowship by the German Academic Exchange Service for a non-related project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028359; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Doi M., 1986, THEORY POLYM DYNAMIC, V1st ed.; Efron B., 1994, INTRO BOOTSTRAP; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Friedrich BM, 2010, J EXP BIOL, V213, P1226, DOI 10.1242/jeb.039800; Friedrich BM, 2007, P NATL ACAD SCI USA, V104, P13256, DOI 10.1073/pnas.0703530104; Friedrich BM, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026007; Gakamsky A, 2008, INT J DEV BIOL, V52, P481, DOI 10.1387/ijdb.072520ag; Gakamsky A, 2009, HUM REPROD, V24, P1152, DOI 10.1093/humrep/den409; Giojalas LC, 2004, FERTIL STERIL, V82, P247, DOI 10.1016/j.fertnstert.2003.11.046; HAUSER R, 1992, INT J ANDROL, V15, P498, DOI 10.1111/j.1365-2605.1992.tb01143.x; Jaiswal BS, 2002, FERTILIZATION, P57, DOI DOI 10.1016/B978-012311629-1/50005-X; KAPLAN D, 1995, UNDERSTANDING NONLIN; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Lahiri SN, 1999, ANN STAT, V27, P386, DOI 10.1214/aos/1018031117; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; RALT D, 1994, BIOL REPROD, V50, P774, DOI 10.1095/biolreprod50.4.774; Riedel IH, 2005, SCIENCE, V309, P300, DOI 10.1126/science.1110329; Rothschild L., 1963, NATURE, V198, P1221, DOI [10.1038/1981221a0, DOI 10.1038/1981221A0]; Taylor GI, 1920, P LOND MATH SOC, V20, P196; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Theunissen R, 2008, EXP FLUIDS, V44, P591, DOI 10.1007/s00348-007-0418-8; *WHO, 1993, WHO LAB MAN EX HUM S; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; WINET H, 1984, J REPROD FERTIL, V70, P511	29	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32909	10.1371/journal.pone.0032909	http://dx.doi.org/10.1371/journal.pone.0032909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412947	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062000019
J	Gooz, P; Dang, YJ; Higashiyama, S; Twal, WO; Haycraft, CJ; Gooz, M				Gooz, Pal; Dang, Yujing; Higashiyama, Shigeki; Twal, Waleed O.; Haycraft, Courtney J.; Gooz, Monika			A Disintegrin and Metalloenzyme (ADAM) 17 Activation Is Regulated by alpha 5 beta 1 Integrin in Kidney Mesangial Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR RECEPTOR; CONVERTING-ENZYME; IN-VITRO; HB-EGF; METALLOPROTEINASE; DISEASE; PHOSPHORYLATION; TRANSACTIVATION; PROLIFERATION	Background: The disintegrin and metalloenzyme ADAM17 participates in numerous inflammatory and proliferative diseases, and its pathophysiological role was implicated in kidney fibrosis, polycystic kidney disease and other chronic kidney diseases. At present, we have little understanding how the enzyme activity is regulated. In this study we wanted to characterize the role of alpha 5 beta 1 integrin in ADAM17 activity regulation during G protein-coupled receptor (GPCR) stimulation. Methodology/Principal Findings: We showed previously that the profibrotic GPCR agonist serotonin (5-HT) induced kidney mesangial cell proliferation through ADAM17 activation and heparin-binding epidermal growth factor (HB-EGF) shedding. In the present studies we observed that in unstimulated mesangial cell lysates alpha 5 beta 1 integrin co-precipitated with ADAM17 and that 5-HT treatment of the cells induced dissociation of alpha 5 beta 1 integrin from ADAM17. Using fluorescence immunostaining and in situ proximity ligation assay, we identified the perinuclear region as the localization of the ADAM17/alpha 5 beta 1 integrin interaction. In cell-free assays, we showed that purified alpha 5 beta 1 integrin and beta 1 integrin dose-dependently bound to and inhibited activity of recombinant ADAM17. We provided evidence that the conformation of the integrin determines its ADAM17-binding ability. To study the effect of beta 1 integrin on ADAM17 sheddase activity, we employed alkaline phosphatase-tagged HB-EGF. Overexpression of beta 1 integrin lead to complete inhibition of 5-HT-induced HB-EGF shedding and silencing beta 1 integrin by siRNA significantly increased mesangial cells ADAM17 responsiveness to 5-HT. Conclusions/Significance: Our data show for the first time that b1 integrin has an important physiological role in ADAM17 activity regulation. We suggest that regulating alpha 5 beta 1 integrin binding to ADAM17 could be an attractive therapeutic target in chronic kidney diseases.	[Gooz, Pal; Dang, Yujing; Gooz, Monika] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Ctr Regenerat Med CEREM, Dept Biochem & Mol Genet, Matsuyama, Ehime 790, Japan; [Twal, Waleed O.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Haycraft, Courtney J.] Med Univ S Carolina, Coll Dent Med, Charleston, SC 29425 USA	Medical University of South Carolina; Ehime University; Medical University of South Carolina; Medical University of South Carolina	Gooz, P (corresponding author), Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA.	beckm@musc.edu			National Institutes of Health [NIH/NIDDK K01 DK070054, NIH/NIDDK ARRA, 3K01DK070054-05S1]; Dialysis Clinic, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK070054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dialysis Clinic, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (NIH/NIDDK K01 DK070054 and NIH/NIDDK ARRA supplement 3K01DK070054-05S1) and from the Paul Teschan Research Fund of the Dialysis Clinic, Inc. to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Bax DV, 2004, J BIOL CHEM, V279, P22377, DOI 10.1074/jbc.M400180200; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boor P, 2011, CLIN EXP PHARMACOL P, V38, P391, DOI 10.1111/j.1440-1681.2011.05487.x; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Bridges LC, 2005, CURR PHARM DESIGN, V11, P837, DOI 10.2174/1381612053381747; Bridges LC, 2003, BIOCHEMISTRY-US, V42, P3734, DOI 10.1021/bi026871y; Buckley CA, 2005, AM J PHYSIOL-LUNG C, V288, pL1132, DOI 10.1152/ajplung.00429.2004; Chung AWY, 2009, CARDIOVASC RES, V84, P494, DOI 10.1093/cvr/cvp242; Dey M, 2010, J PHARMACOL EXP THER, V334, P775, DOI 10.1124/jpet.110.168054; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; GARNOVSKAYA MN, 1995, MOL PHARMACOL, V48, P230; Gooz P, 2009, BIOCHEM BIOPH RES CO, V380, P33, DOI 10.1016/j.bbrc.2009.01.013; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Kassiri Z, 2009, J AM SOC NEPHROL, V20, P1223, DOI 10.1681/ASN.2008050492; Kovescly CP, 2008, EXPERT OPIN INV DRUG, V17, P451, DOI [10.1517/13543784.17.4.451, 10.1517/13543784.17.4.451 ]; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; Saha A, 2008, AM J PHYSIOL-GASTR L, V294, pG795, DOI 10.1152/ajpgi.00431.2007; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Sahin Umut, 2006, V327, P99; Sharma S, 2011, CURR OPIN NEPHROL HY, V20, P56, DOI 10.1097/MNH.0b013e3283414c88; Singh RJR, 2005, CARDIOVASC RES, V67, P39, DOI 10.1016/j.cardiores.2005.02.020	33	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33350	10.1371/journal.pone.0033350	http://dx.doi.org/10.1371/journal.pone.0033350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413019	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000043
J	Sismanopoulos, N; Delivanis, DA; Alysandratos, KD; Angelidou, A; Vasiadi, M; Therianou, A; Theoharides, TC				Sismanopoulos, Nikolaos; Delivanis, Danae A.; Alysandratos, Konstantinos D.; Angelidou, Asimenia; Vasiadi, Magdalini; Therianou, Anastasia; Theoharides, Theoharis C.			IL-9 Induces VEGF Secretion from Human Mast Cells and IL-9/IL-9 Receptor Genes Are Overexpressed in Atopic Dermatitis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ENHANCING ACTIVITY MEA; FC-EPSILON-RI; VASCULAR-PERMEABILITY; EXPRESSION; HYPERPERMEABILITY; DIFFERENTIATION; INTERLEUKIN-9; INFLAMMATION; ASSOCIATION	Interleukin 9 (IL-9) has been implicated in mast cell-related inflammatory diseases, such as asthma, where vascular endothelial growth factor (VEGF) is involved. Here we report that IL-9 (10-20 ng/ml) induces gene expression and secretion of VEGF from human LAD2. IL-9 does not induce mast cell degranulation or the release of other mediators (IL-1, IL-8, or TNF). VEGF production in response to IL-9 involves STAT-3 activation. The effect is inhibited (about 80%) by the STAT-3 inhibitor, Stattic. Gene-expression of IL-9 and IL-9 receptor is significantly increased in lesional skin areas of atopic dermatitis (AD) patients as compared to normal control skin, while serum IL-9 is not different from controls. These results imply that functional interactions between IL-9 and mast cells leading to VEGF release contribute to the initiation/propagation of the pathogenesis of AD, a skin inflammatory disease.	[Sismanopoulos, Nikolaos; Delivanis, Danae A.; Alysandratos, Konstantinos D.; Angelidou, Asimenia; Vasiadi, Magdalini; Therianou, Anastasia; Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Lab Mol Immunopharmacol & Drug Discovery, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Internal Med, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Med Ctr, Boston, MA USA; [Sismanopoulos, Nikolaos; Alysandratos, Konstantinos D.; Angelidou, Asimenia; Vasiadi, Magdalini; Theoharides, Theoharis C.] Univ Athens, Sch Med, Attikon Gen Hosp, Allergy Clin Res Ctr,Allergy Sect, GR-11527 Athens, Greece; [Therianou, Anastasia] Univ Athens, Sch Med, A Sygros Hosp, Dept Dermatol 1, GR-11527 Athens, Greece	Tufts University; Tufts University; Tufts University; Tufts Medical Center; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens	Sismanopoulos, N (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Lab Mol Immunopharmacol & Drug Discovery, Boston, MA 02111 USA.	theoharis.theoharides@tufts.edu			National Institutes of Health [AR47652]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part from National Institutes of Health grant AR47652 awarded to TCT. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhathena PR, 2000, LUNG, V178, P149, DOI 10.1007/s004080000018; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; Chen L, 2008, MICROCIRCULATION, V15, P49, DOI 10.1080/10739680701418416; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; CHRISTIAN EP, 1989, J PHYSIOL-LONDON, V409, P297, DOI 10.1113/jphysiol.1989.sp017498; Creamer D, 2002, ARCH DERMATOL, V138, P791, DOI 10.1001/archderm.138.6.791; Creamer D, 1996, LANCET, V348, P1101, DOI 10.1016/S0140-6736(05)64447-9; DVORAK HF, 1995, AM J PATHOL, V146, P1029; EKLUND KK, 1993, J IMMUNOL, V151, P4266; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Geck P, 2000, P NATL ACAD SCI USA, V97, P10185, DOI 10.1073/pnas.97.18.10185; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; HULTNER L, 1990, EXP HEMATOL, V18, P873; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; HULTNER L, 1990, EUR J IMMUNOL, V20, P1413, DOI 10.1002/eji.1830200632; IRANI AMA, 1989, ALLERGY, V44, P31; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; Kearley J, 2010, AM J RESP CRIT CARE; KIM YI, 1988, SCIENCE, V239, P405, DOI 10.1126/science.2447652; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Knoops L, 2005, J IMMUNOL, V175, P335, DOI 10.4049/jimmunol.175.1.335; Levitt RC, 1999, J ALLERGY CLIN IMMUN, V103, pS485, DOI 10.1016/S0091-6749(99)70165-X; Liu FT, 2011, CLIN REV ALLERGY IMM; Lora JM, 2003, J ALLERGY CLIN IMMUN, V112, P1119, DOI 10.1016/j.jaci.2003.08.042; Metz M, 2009, CURR OPIN IMMUNOL, V21, P687, DOI 10.1016/j.coi.2009.09.009; Namkung JH, 2011, J DERMATOL SCI, V62, P16, DOI 10.1016/j.jdermsci.2011.01.007; Nowak EC, 2009, J EXP MED; Osterfeld H, 2010, J ALLERGY CLIN IMMUN, V125, P469, DOI 10.1016/j.jaci.2009.09.054; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; SOTER NA, 1989, ALLERGY, V44, P16, DOI 10.1111/j.1398-9995.1989.tb02449.x; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Theoharides TC, 1998, ENDOCRINOLOGY, V139, P403, DOI 10.1210/en.139.1.403; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; Werfel T, 2004, CURR OPIN ALLERGY CL, V4, P379, DOI 10.1097/00130832-200410000-00009; Wiener Z, 2004, CYTOKINE, V26, P122, DOI 10.1016/j.cyto.2004.01.006; Yanaba K, 2011, J RHEUMATOL, V38, P2193, DOI 10.3899/jrheum.110268; Zhang Y, 2006, ARCH DERMATOL RES, V297, P425, DOI 10.1007/s00403-006-0641-9; Zhang Y, 2008, GROWTH FACTORS, V26, P125, DOI 10.1080/08977190802105909	47	48	51	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33271	10.1371/journal.pone.0033271	http://dx.doi.org/10.1371/journal.pone.0033271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413008	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000040
J	Calvo, AC; Manzano, R; Atencia-Cibreiro, G; Olivan, S; Munoz, MJ; Zaragoza, P; Cordero-Vazquez, P; Esteban-Perez, J; Garcia-Redondo, A; Osta, R				Calvo, Ana C.; Manzano, Raquel; Atencia-Cibreiro, Gabriela; Olivan, Sara; Munoz, Maria J.; Zaragoza, Pilar; Cordero-Vazquez, Pilar; Esteban-Perez, Jesus; Garcia-Redondo, Alberto; Osta, Rosario			Genetic Biomarkers for ALS Disease in Transgenic SOD1(G93A) Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SKELETAL-MUSCLE ATROPHY; OXIDATIVE STRESS; MOUSE MODEL; IN-VIVO; GLUCOSE-INTOLERANCE; GLUTATHIONE SYSTEM; PROTEIN; EXPRESSION; DIAGNOSIS	The pathophysiological mechanisms of both familial and sporadic Amyotrophic Lateral Sclerosis (ALS) are unknown, although growing evidence suggests that skeletal muscle tissue is a primary target of ALS toxicity. Skeletal muscle biopsies were performed on transgenic SOD1 G93A mice, a mouse model of ALS, to determine genetic biomarkers of disease longevity. Mice were anesthetized with isoflurane, and three biopsy samples were obtained per animal at the three main stages of the disease. Transcriptional expression levels of seventeen genes, Ankrd1, Calm1, Col19a1, Fbxo32, Gsr, Impa1, Mef2c, Mt2, Myf5, Myod1, Myog, Nnt, Nogo A, Pax7, Rrad, Sln and Snx10, were tested in each muscle biopsy sample. Total RNA was extracted using TRIzol Reagent according to the manufacturer's protocol, and variations in gene expression were assayed by real-time PCR for all of the samples. The Pearson correlation coefficient was used to determine the linear correlation between transcriptional expression levels throughout disease progression and longevity. Consistent with the results obtained from total skeletal muscle of transgenic SOD1(G93A) mice and 74-day-old denervated mice, five genes (Mef2c, Gsr, Col19a1, Calm1 and Snx10) could be considered potential genetic biomarkers of longevity in transgenic SOD1(G93A) mice. These results are important because they may lead to the exploration of previously unexamined tissues in the search for new disease biomarkers and even to the application of these findings in human studies.	[Calvo, Ana C.; Manzano, Raquel; Olivan, Sara; Munoz, Maria J.; Zaragoza, Pilar; Osta, Rosario] Univ Zaragoza, Fac Vet, Aragons Inst Hlth Sci IACS, Lab Genet Bioquim LAGENBIO I3A, Zaragoza, Spain; [Atencia-Cibreiro, Gabriela; Cordero-Vazquez, Pilar; Esteban-Perez, Jesus; Garcia-Redondo, Alberto] Hosp 12 Octubre Madrid, Inst Invest, Unidad ELA, SERMAS, Madrid, Spain; [Atencia-Cibreiro, Gabriela; Cordero-Vazquez, Pilar; Esteban-Perez, Jesus; Garcia-Redondo, Alberto] Ctr Invest Biomed Red Enfermedades Raras CIBERER, U 723, Madrid, Spain	University of Zaragoza; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Calvo, AC (corresponding author), Univ Zaragoza, Fac Vet, Aragons Inst Hlth Sci IACS, Lab Genet Bioquim LAGENBIO I3A, Zaragoza, Spain.	osta@unizar.es	Muñoz, Maria/L-3968-2017; MANZANO, RAQUEL/AAB-1709-2020; Osta, Rosario/R-5410-2019; OLIVAN, SARA/AAR-6768-2020; zaragoza, pilar/AAN-9479-2021; Calvo, Ana/L-2826-2017; martinez, manzano/ACS-3663-2022; REDONDO, ALBERTO GARCÍA/AAD-9453-2020	Muñoz, Maria/0000-0001-8301-6902; MANZANO, RAQUEL/0000-0002-7477-8742; OLIVAN, SARA/0000-0003-0156-4230; Calvo, Ana/0000-0001-5193-7782; martinez, manzano/0000-0002-7477-8742; Osta, Rosario/0000-0001-5687-6704	Caja Navarra: "Tu decides, tu eliges'' from the Fondo de Investigacion Sanitaria of Spain [PI071133, PI10/01787]; Carlos III Health Institute (ISCIII) [PI07/1283, EC08/00049]; Foundation for the Improvement in ALS Research in Spain "FUNDELA''; "No Ilores, no te rindas'' in Barcelona	Caja Navarra: "Tu decides, tu eliges'' from the Fondo de Investigacion Sanitaria of Spain; Carlos III Health Institute (ISCIII)(Instituto de Salud Carlos III); Foundation for the Improvement in ALS Research in Spain "FUNDELA''; "No Ilores, no te rindas'' in Barcelona	This study was supported by grants from Caja Navarra: "Tu decides, tu eliges'', PI071133 and PI10/01787 from the Fondo de Investigacion Sanitaria of Spain and by Carlos III Health Institute (ISCIII) (PI07/1283 and EC08/00049). We gratefully appreciate the support received from the Foundation for the Improvement in ALS Research in Spain "FUNDELA'' and from the benefit act "No Ilores, no te rindas'' in Barcelona. The Biomedical Research Centre Network (CIBER) for Rare Diseases is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuaje F., 2010, BIOINFORMATICS BIOMA; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Baek William S, 2007, Pract Neurol, V7, P74; Berggard T, 2002, J BIOL CHEM, V277, P41954, DOI 10.1074/jbc.M203492200; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Burgunder JM, 2011, EUR J NEUROL, V18, P207, DOI 10.1111/j.1468-1331.2010.03069.x; Calvo AC, 2008, PROTEOMICS, V8, P4338, DOI 10.1002/pmic.200701091; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cluskey S, 2001, J CLIN PATHOL; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; de Carvalho M, 2011, CURR OPIN NEUROL, V24, P497, DOI 10.1097/WCO.0b013e32834916a9; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; DeRuisseau LR, 2009, AM J PHYSIOL-REG I, V297, pR1795, DOI 10.1152/ajpregu.00263.2009; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Douglass CP, 2010, J NEUROL NEUROSUR PS, V81, P646, DOI 10.1136/jnnp.2009.197434; Dudley RWR, 2006, AM J PHYSIOL-REG I, V291, pR704, DOI 10.1152/ajpregu.00031.2006; Dupuis L, 2002, NEUROBIOL DIS, V10, P358, DOI 10.1006/nbdi.2002.0522; Dupuis L, 2009, CURR OPIN PHARMACOL, V9, P341, DOI 10.1016/j.coph.2009.03.007; Dupuis L, 2008, M S-MED SCI, V24, P1077, DOI 10.1051/medsci/200824121077; Fergani A, 2005, NEURODEGENER DIS, V2, P185, DOI 10.1159/000089624; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Halter B, 2010, FREE RADICAL BIO MED, V48, P915, DOI 10.1016/j.freeradbiomed.2010.01.014; Hensley K, 2006, ANTIOXID REDOX SIGN, V8, P2075, DOI 10.1089/ars.2006.8.2075; Ilany J, 2006, P NATL ACAD SCI USA, V103, P4481, DOI 10.1073/pnas.0511246103; Jokic N, 2006, EMBO REP, V7, P1162, DOI 10.1038/sj.embor.7400826; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Laure L, 2009, FEBS J, V276, P669, DOI 10.1111/j.1742-4658.2008.06814.x; Leger B, 2006, FASEB J, V20, P583, DOI 10.1096/fj.05-5249fje; Leger B, 2009, MUSCLE NERVE, V40, P69, DOI 10.1002/mus.21293; Leiter MP, 2010, WORK ENGAGEMENT: A HANDBOOK OF ESSENTIAL THEORY AND RESEARCH, P1; Limon-Pacheco Jorge H., 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P287; Liscic RM, 2008, EUR J NEUROL, V15, P772, DOI 10.1111/j.1468-1331.2008.02195.x; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Magnusson C, 2005, EUR J NEUROSCI, V21, P577, DOI 10.1111/j.1460-9568.2005.03855.x; Manzano R, 2011, NEURODEGENER DIS, V8, P386, DOI 10.1159/000324159; Mitsumoto H, 2008, AMYOTROPH LATERAL SC, V9, P177, DOI 10.1080/17482960801933942; Murillo S, 2009, BIOPSIA MUSCULAR RAT; Musaro Antonio, 2010, World J Biol Chem, V1, P62, DOI 10.4331/wjbc.v1.i5.62; Nakamura K, 2002, PATHOBIOLOGY, V70, P197, DOI 10.1159/000069329; Pradat PF, 2009, MOL DIAGN THER, V13, P115, DOI 10.2165/01250444-200913020-00005; Pradat PF, 2007, ANN NEUROL, V62, P15, DOI 10.1002/ana.21122; Pradat PF, 2009, PRESSE MED, V38, P1843, DOI 10.1016/j.lpm.2009.01.022; Qin BM, 2006, J BIOL CHEM, V281, P36891, DOI 10.1074/jbc.M608884200; Ryberg H, 2008, EXPERT REV PROTEOMIC, V5, P249, DOI 10.1586/14789450.5.2.249; Sakuma K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721219; Siddique N, 2008, PHYS MED REH CLIN N, V19, P429, DOI 10.1016/j.pmr.2008.05.001; Sumiyoshi H, 2004, J CELL BIOL, V166, P591, DOI 10.1083/jcb.200402054; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vasu VT, 2009, FREE RADICAL RES, V43, P106, DOI 10.1080/10715760802616676; White RB, 2008, PHYSIOL GENOMICS, V33, P41, DOI 10.1152/physiolgenomics.00256.2007; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yan R, 2006, CELL MOL LIFE SCI, V63, P877, DOI 10.1007/s00018-005-5338-2; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	61	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32632	10.1371/journal.pone.0032632	http://dx.doi.org/10.1371/journal.pone.0032632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412900	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800037
J	Govindarajan, B; Menon, BB; Spurr-Michaud, S; Rastogi, K; Gilmore, MS; Argueso, P; Gipson, IK				Govindarajan, Bharathi; Menon, Balaraj B.; Spurr-Michaud, Sandra; Rastogi, Komal; Gilmore, Michael S.; Argueeso, Pablo; Gipson, Ilene K.			A Metalloproteinase Secreted by Streptococcus pneumoniae Removes Membrane Mucin MUC16 from the Epithelial Glycocalyx Barrier	PLOS ONE			English	Article							HUMAN CORNEAL-LIMBAL; CELL-SURFACE; OCULAR SURFACE; MONOCLONAL-ANTIBODIES; GENETIC-TRANSFORMATION; VIRULENCE FACTOR; MUCOSAL BARRIER; TETHERED MUCINS; ADHERENCE; CONJUNCTIVITIS	The majority of bacterial infections occur across wet-surfaced mucosal epithelia, including those that cover the eye, respiratory tract, gastrointestinal tract and genitourinary tract. The apical surface of all these mucosal epithelia is covered by a heavily glycosylated glycocalyx, a major component of which are membrane-associated mucins (MAMs). MAMs form a barrier that serves as one of the first lines of defense against invading bacteria. While opportunistic bacteria rely on pre-existing defects or wounds to gain entry to epithelia, non opportunistic bacteria, especially the epidemic disease-causing ones, gain access to epithelial cells without evidence of predisposing injury. The molecular mechanisms employed by these non opportunistic pathogens to breach the MAM barrier remain unknown. To test the hypothesis that disease-causing non opportunistic bacteria gain access to the epithelium by removal of MAMs, corneal, conjunctival, and tracheobronchial epithelial cells, cultured to differentiate to express the MAMs, MUCs 1, 4, and 16, were exposed to a non encapsulated, non typeable strain of Streptococcus pneumoniae (SP168), which causes epidemic conjunctivitis. The ability of strain SP168 to induce MAM ectodomain release from epithelia was compared to that of other strains of S. pneumoniae, as well as the opportunistic pathogen Staphylococcus aureus. The experiments reported herein demonstrate that the epidemic disease-causing S. pneumoniae species secretes a metalloproteinase, ZmpC, which selectively induces ectodomain shedding of the MAM MUC16. Furthermore, ZmpC-induced removal of MUC16 from the epithelium leads to loss of the glycocalyx barrier function and enhanced internalization of the bacterium. These data suggest that removal of MAMs by bacterial enzymes may be an important virulence mechanism employed by disease-causing non opportunistic bacteria to gain access to epithelial cells to cause infection.	[Govindarajan, Bharathi; Menon, Balaraj B.; Spurr-Michaud, Sandra; Rastogi, Komal; Gilmore, Michael S.; Argueeso, Pablo; Gipson, Ilene K.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute	Govindarajan, B (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02215 USA.	ilene.gipson@schepens.harvard.edu		Argueso, Pablo/0000-0001-7321-9503	National Institutes of Health/National Eye Institute [R01 EY018850]; NATIONAL EYE INSTITUTE [R01EY014847, R01EY018850, R01EY003306] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by a grant from the National Institutes of Health/National Eye Institute (R01 EY018850) to IKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso P, 2006, INVEST OPHTH VIS SCI, V47, P113, DOI 10.1167/iovs.05-0735; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Blalock TD, 2008, INVEST OPHTH VIS SCI, V49, P1864, DOI 10.1167/iovs.07-1081; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Camilli R, 2006, MICROBIOL-SGM, V152, P313, DOI 10.1099/mic.0.28417-0; Chen Y, 2007, J BIOL CHEM, V282, P159, DOI 10.1074/jbc.M608542200; Cheon DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004675; Chiavolini D, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-14; DeSouza MM, 1999, J REPROD IMMUNOL, V45, P127, DOI 10.1016/S0165-0378(99)00046-7; Dobay O, 2010, J CLIN PATHOL, V63, P1116, DOI 10.1136/jcp.2010.079780; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Gipson IK, 2008, BIOL REPROD, V78, P134, DOI 10.1095/biolreprod.106.058347; Govindarajan B, 2010, EXP EYE RES, V90, P655, DOI 10.1016/j.exer.2010.02.014; HAMILTON TC, 1983, CANCER RES, V43, P5379; HASE CC, 1993, MICROBIOL REV, V57, P823; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jonckheere N, 2008, EPITHELIAL MUCINS ST; Kardon R, 1999, INVEST OPHTH VIS SCI, V40, P1328; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; Mizgerd JP, 2008, AM J PHYSIOL-LUNG C, V294, pL387, DOI 10.1152/ajplung.00330.2007; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nustad K, 1996, TUMOR BIOL, V17, P196, DOI 10.1159/000217982; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Perez BH, 2008, EXP EYE RES, V87, P400, DOI 10.1016/j.exer.2007.12.008; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Porat N, 2006, J INFECT DIS, V194, P689, DOI 10.1086/506453; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Price MR, 1998, TUMOR BIOL, V19, P1, DOI 10.1159/000056500; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Schultes BC, 1998, CANCER IMMUNOL IMMUN, V46, P201, DOI 10.1007/s002620050479; Senapati S, 2010, TRENDS BIOCHEM SCI, V35, P236, DOI 10.1016/j.tibs.2009.10.003; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Spurr-Michaud S, 2007, EXP EYE RES, V84, P939, DOI 10.1016/j.exer.2007.01.018; Tabery HM, 2003, EYE, V17, P482, DOI 10.1038/sj.eye.6700401; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Williamson YM, 2008, MICROB PATHOGENESIS, V44, P175, DOI 10.1016/j.micpath.2007.08.016	47	68	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32418	10.1371/journal.pone.0032418	http://dx.doi.org/10.1371/journal.pone.0032418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412870	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800017
J	Richa, T; Sivaraman, T				Richa, Tambi; Sivaraman, Thirunavukkarasu			OneG: A Computational Tool for Predicting Cryptic Intermediates in the Unfolding Kinetics of Proteins under Native Conditions	PLOS ONE			English	Article							BETA-SHEET PROTEIN; STATE HYDROGEN-EXCHANGE; NAJA-NAJA-ATRA; TAIWAN COBRA; STRUCTURAL STABILITY; FOLDING PATHWAY; NH EXCHANGE; MS ANALYSIS; NMR; IDENTIFICATION	Understanding the relationships between conformations of proteins and their stabilities is one key to address the protein folding paradigm. The free energy change (Delta G) of unfolding reactions of proteins is measured by traditional denaturation methods and native hydrogen-deuterium (H/D) exchange methods. However, the free energy of unfolding (Delta G(U)) and the free energy of exchange (Delta G(HX)) of proteins are not in good agreement, though the experimental conditions of both methods are well matching to each other. The anomaly is due to any one or combinations of the following reasons: (i) effects of cis-trans proline isomerisation under equilibrium unfolding reactions of proteins (ii) inappropriateness in accounting the baselines of melting curves (iii) presence of cryptic intermediates, which may elude the melting curve analysis and (iv) existence of higher energy metastable states in the H/D exchange reactions of proteins. Herein, we have developed a novel computational tool, OneG, which accounts the discrepancy between Delta G(U) and Delta G(HX) of proteins by systematically accounting all the four factors mentioned above. The program is fully automated and requires four inputs: three-dimensional structures of proteins, Delta G(U), Delta G(U)* and residue-specific Delta GH(X) determined under EX2-exchange conditions in the absence of denaturants. The robustness of the program has been validated using experimental data available for proteins such as cytochrome c and apocytochrome b(562) and the data analyses revealed that cryptic intermediates of the proteins detected by the experimental methods and the cryptic intermediates predicted by the OneG for those proteins were in good agreement. Furthermore, using OneG, we have shown possible existence of cryptic intermediates and metastable states in the unfolding pathways of cardiotoxin III and cobrotoxin, respectively, which are homologous proteins. The unique application of the program to map the unfolding pathways of proteins under native conditions have been brought into fore and the program is publicly available at http://sblab.sastra.edu/oneg.html	[Richa, Tambi; Sivaraman, Thirunavukkarasu] SASTRA Univ, Sch Chem & Biotechnol, Dept Bioinformat, Thanjavur, Tamil Nadu, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Richa, T (corresponding author), SASTRA Univ, Sch Chem & Biotechnol, Dept Bioinformat, Thanjavur, Tamil Nadu, India.	sivaram@scbt.sastra.edu	Tambi, Richa/ABE-6611-2021	Tambi, Richa/0000-0003-2405-2991; Thirunavukkarasu, Sivaraman/0000-0003-0425-588X	SASTRA University; Department of Biotechnology, India [BT/PR13378/GBD/27/262/2009]; SASTRA University, India [TRR/13/Aug/2009]	SASTRA University; Department of Biotechnology, India(Department of Biotechnology (DBT) India); SASTRA University, India	TR gratefully acknowledges 'Teaching Assistance scheme' of SASTRA University for the financial supports. This work was partly supported by research grants from the Department of Biotechnology, India (BT/PR13378/GBD/27/262/2009) and T. R. Rajagopalan memorial research grant (TRR/13/Aug/2009), SASTRA University, India. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington CB, 1997, BIOCHEMISTRY-US, V36, P8686, DOI 10.1021/bi970872m; Arrington CB, 1999, J MOL BIOL, V285, P1265, DOI 10.1006/jmbi.1998.2338; Arrington CB, 2000, J MOL BIOL, V300, P221, DOI 10.1006/jmbi.2000.3859; Bai YW, 2006, CHEM REV, V106, P1757, DOI 10.1021/cr040432i; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; BHASKARAN R, 1994, J MOL BIOL, V235, P1291, DOI 10.1006/jmbi.1994.1082; Bhattacharyya R, 2004, PROTEIN ENG DES SEL, V17, P795, DOI 10.1093/protein/gzh093; Bhuyan AK, 1998, PROTEINS, V30, P295, DOI 10.1002/(SICI)1097-0134(19980215)30:3<295::AID-PROT9>3.0.CO;2-J; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782; Clarke J, 1996, FOLD DES, V1, P243, DOI 10.1016/S1359-0278(96)00038-7; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dobson C.M., 1999, CURR OPIN STRUC BIOL, V9, P99; Dovidchenko NV, 1999, BIOCH MOSC, V74, P888; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Ferraro DM, 2004, BIOCHEMISTRY-US, V43, P587, DOI 10.1021/bi035943y; Fischer G, 2000, CHEM SOC REV, V29, P119, DOI 10.1039/a803742f; Fischer KF, 2000, J MOL BIOL, V302, P701, DOI 10.1006/jmbi.2000.4049; Fuentes EJ, 1998, BIOCHEMISTRY-US, V37, P3687, DOI 10.1021/bi972579s; Grantcharova VP, 1997, BIOCHEMISTRY-US, V36, P15685, DOI 10.1021/bi971786p; Gromiha MM, 2001, J MOL BIOL, V310, P27, DOI 10.1006/jmbi.2001.4775; Hilser VJ, 2006, CHEM REV, V106, P1545, DOI 10.1021/cr040423+; Hsieh HC, 2006, ARCH BIOCHEM BIOPHYS, V447, P147, DOI 10.1016/j.abb.2006.01.003; Huyghues-Despointes B M, 2001, Methods Mol Biol, V168, P69; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Itzhaki LS, 1997, J MOL BIOL, V270, P89, DOI 10.1006/jmbi.1997.1049; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; KUMAR TKS, 1995, BIOCHEM BIOPH RES CO, V207, P536, DOI 10.1006/bbrc.1995.1221; Kumar TKS, 2000, J CHIN CHEM SOC-TAIP, V47, P1009, DOI 10.1002/jccs.200000141; LIN LN, 1983, BIOCHEMISTRY-US, V22, P553, DOI 10.1021/bi00272a005; Llinas M, 1999, NAT STRUCT BIOL, V6, P1072; Mayne L, 2000, PROTEIN SCI, V9, P1873, DOI 10.1110/ps.9.10.1873; Molday RS, 1977, BIOCHEMISTRY-US, V11, P150; Pace C N, 1986, Methods Enzymol, V131, P266; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Pace CN, 1997, PROTEIN STRUCTURE PR, P300; Padmanabhan S, 1997, BIOCHEMISTRY-US, V36, P6424, DOI 10.1021/bi970085p; Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008; Parker MJ, 2000, J MOL BIOL, V300, P1361, DOI 10.1006/jmbi.2000.3922; Plaxco KW, 1996, CURR OPIN STRUC BIOL, V6, P630, DOI 10.1016/S0959-440X(96)80029-7; PRAKASH V, 1981, ARCH BIOCHEM BIOPHYS, V210, P455, DOI 10.1016/0003-9861(81)90209-5; RADFORD SE, 1992, PROTEINS, V14, P237, DOI 10.1002/prot.340140210; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sivaraman T, 1997, BIOCHEM J, V321, P457, DOI 10.1042/bj3210457; Sivaraman T, 2001, NAT STRUCT BIOL, V8, P331, DOI 10.1038/86208; Sivaraman T, 1999, BIOCHEM BIOPH RES CO, V260, P284, DOI 10.1006/bbrc.1999.0901; Sivaraman T, 1998, J BIOL CHEM, V273, P10181, DOI 10.1074/jbc.273.17.10181; Sivaraman T, 1999, ARCH BIOCHEM BIOPHYS, V363, P107, DOI 10.1006/abbi.1998.1057; Sivaraman T, 1999, BIOCHEMISTRY-US, V38, P9899, DOI 10.1021/bi9901230; Sivaraman T, 2000, BIOCHEMISTRY-US, V39, P8705, DOI 10.1021/bi992867j; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; SwintKruse L, 1996, BIOCHEMISTRY-US, V35, P171, DOI 10.1021/bi9517603; Takei L, 2000, P NATL ACAD SCI USA, V97, P10796, DOI 10.1073/pnas.190265797; Tartaglia GG, 2007, STRUCTURE, V15, P139, DOI 10.1016/j.str.2006.12.007; Wall L., 2000, PROGRAMMING PERL; WOODWARD CK, 1994, CURR OPIN STRUC BIOL, V4, P112, DOI 10.1016/S0959-440X(94)90068-X; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yadav S, 2000, ANAL BIOCHEM, V283, P207, DOI 10.1006/abio.2000.4641; Yi Q, 1997, FOLD DES, V2, P271, DOI 10.1016/S1359-0278(97)00038-2; YU C, 1993, BIOCHEMISTRY-US, V32, P2131, DOI 10.1021/bi00060a002; Zhang Y.Z., 1995, THESIS U PENNSYLVANI	66	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32465	10.1371/journal.pone.0032465	http://dx.doi.org/10.1371/journal.pone.0032465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412877	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800022
J	Toyama, T; Tahara, M; Nagamune, K; Arimitsu, K; Hamashima, Y; Palacpac, NMQ; Kawaide, H; Horii, T; Tanabe, K				Toyama, Tomoko; Tahara, Michiru; Nagamune, Kisaburo; Arimitsu, Kenji; Hamashima, Yoshio; Palacpac, Nirianne M. Q.; Kawaide, Hiroshi; Horii, Toshihiro; Tanabe, Kazuyuki			Gibberellin Biosynthetic Inhibitors Make Human Malaria Parasite Plasmodium falciparum Cells Swell and Rupture to Death	PLOS ONE			English	Article							STEROL BIOSYNTHESIS; TOXOPLASMA-GONDII; MITOCHONDRION; FOSMIDOMYCIN; APICOPLAST; ORGANELLE	Malaria remains as one of the most devastating infectious disease, and continues to exact an enormous toll in medical cost and days of labor lost especially in the tropics. Effective malaria control and eventual eradication remain a huge challenge, with efficacious antimalarials as important intervention/management tool. Clearly new alternative drugs that are more affordable and with fewer side effects are desirable. After preliminary in vitro assays with plant growth regulators and inhibitors, here, we focus on biosynthetic inhibitors of gibberellin, a plant hormone with many important roles in plant growth, and show their inhibitory effect on the growth of both apicomplexa, Plasmodium falciparum and Toxoplasma gondii. Treatment of P. falciparum cultures with the gibberellin biosynthetic inhibitors resulted in marked morphological changes that can be reversed to a certain degree under hyperosmotic environment. These unique observations suggest that changes in the parasite membrane permeability may explain the pleiotropic effects observed within the intracellular parasites.	[Toyama, Tomoko; Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Lab Malariol, Suita, Osaka 565, Japan; [Toyama, Tomoko; Palacpac, Nirianne M. Q.; Horii, Toshihiro; Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan; [Tahara, Michiru; Nagamune, Kisaburo] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Arimitsu, Kenji; Hamashima, Yoshio] Kyoto Pharmaceut Univ, Div Med Chem Sci, Yamashina Ku, Kyoto 607, Japan; [Kawaide, Hiroshi] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo, Japan	Osaka University; Osaka University; National Institute of Infectious Diseases (NIID); Kyoto Pharmaceutical University; Tokyo University of Agriculture & Technology	Toyama, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Dermatol, Course Integrated Med, Suita, Osaka, Japan.	toyama-imhp@umin.ac.jp; kztanabe@biken.osaka-u.ac.jp	Kawaide, Hiroshi/F-9243-2013	Kawaide, Hiroshi/0000-0001-6693-1332; Palacpac, Nirianne Marie/0000-0003-4098-3972; Arimitsu, Kenji/0000-0003-2844-1652; Horii, Toshihiro/0000-0002-3000-2045	Ministry of Education, Culture, Sports, Science and Technology [18073013]; Japan Society for the Promotion of Science [18GS03140013]; Grants-in-Aid for Scientific Research [24390103] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology grant (#18073013) and the Japan Society for the Promotion of Science grant (#18GS03140013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; Ben Mamoun C, 2010, DRUG DEVELOP RES, V71, P44, DOI 10.1002/ddr.20347; DIVO AA, 1985, J PROTOZOOL, V32, P442, DOI 10.1111/j.1550-7408.1985.tb04041.x; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; FURUTA R, 1994, ELECTROPHORESIS, V15, P1322, DOI 10.1002/elps.11501501201; GUO DA, 1995, LIPIDS, V30, P203, DOI 10.1007/BF02537823; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; HEDDEN P, 1977, PHYTOCHEMISTRY, V16, P1913, DOI 10.1016/0031-9422(77)80095-2; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; KATO M, 1991, CHEM PHARM BULL, V39, P2498; McFadden DC, 1997, ANTIMICROB AGENTS CH, V41, P1849, DOI 10.1128/AAC.41.9.1849; MIKI T, 1990, PLANT CELL PHYSIOL, V31, P201; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nair SC, 2011, J EXP MED, V208, P1547, DOI 10.1084/jem.20110039; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Palacpac NMQ, 2004, BIOCHEM BIOPH RES CO, V321, P1062, DOI 10.1016/j.bbrc.2004.07.070; PAULS KP, 1982, NEW PHYTOL, V91, P1, DOI 10.1111/j.1469-8137.1982.tb03288.x; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; SAAR J, 1991, BIOCHIM BIOPHYS ACTA, V1075, P93, DOI 10.1016/0304-4165(91)90080-Z; SEO S, 1993, STEROIDS, V58, P74, DOI 10.1016/0039-128X(93)90056-S; TANABE K, 1983, J PROTOZOOL, V30, P707, DOI 10.1111/j.1550-7408.1983.tb05347.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; Wiesner J, 2003, PARASITOL RES, V90, pS71, DOI 10.1007/s00436-002-0770-9; Yoshida Y, 1988, Curr Top Med Mycol, V2, P388; YUAN LC, 1981, ANAT REC, V201, P273, DOI 10.1002/ar.1092010207	34	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32246	10.1371/journal.pone.0032246	http://dx.doi.org/10.1371/journal.pone.0032246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412858	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800012
J	Wang, P; Chen, YM; He, LP; Chen, CG; Zhang, B; Xue, WQ; Su, YX				Wang, Ping; Chen, Yu-ming; He, Li-ping; Chen, Chao-gang; Zhang, Bo; Xue, Wen-qiong; Su, Yi-xiang			Association of Natural Intake of Dietary Plant Sterols with Carotid Intima-Media Thickness and Blood Lipids in Chinese Adults: A Cross-Section Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK; PLASMA-CONCENTRATIONS; PHYSICAL-ACTIVITIES; SERUM-CHOLESTEROL; WOMEN; COMPENDIUM; FREQUENCY; STANOL; MEN	Background: Many studies showed a moderate cholesterol-lowering effect of plant sterols (PS), but increased circulating PS might be atherogenic. We evaluated the associations between natural dietary intake of PS and carotid intima-media thickness (IMT) and serum lipids. Methodology/Principal Findings: This community-based cross-sectional study included 1160 men and 2780 women aged 31-75 years. Dietary intakes were assessed using a food-frequency questionnaire. The IMTs at the common, bifurcation and internal carotid artery segments, and fasting serum total (TC), LDL (LDLc) and HDL (HDLc) cholesterol, and triglycerides (TG) were determined. After adjusting for potential covariates, multivariate analysis showed a dose-dependent inverse association of total PS intake with serum TC, LDLc, non-HDLc in women (P<0.001) and in men (P<0.05). As compared to the lowest quartile of PS intake (<206 mg/d), the multivariate-adjusted means of TC, LDLc and non-HDLc in the highest quartile of PS intake (447 mg/d) decreased by 5.0%, 6.2% and 6.5% in women (P<0.005), and by 6.4%, 7.1% and 6.7% (P<0.05) in men. Although the IMTs tended to be lower with greater intake of dietary PS, only small differences in the left internal IMT between the highest and lowest groups were observed among men (-7.6%) and women (-5.1%) (P<0.05). The multivariate analysis showed no significant mean differences among the PS groups in HDLc, TG and IMTs at other studied sites among men and women (all P>0.05). Conclusions: Greater PS consumption from natural diets is associated with lower serum total, LDL, non-HDL cholesterol and with thinner left internal IMT in women and men.	[Wang, Ping; Chen, Yu-ming; He, Li-ping; Zhang, Bo; Xue, Wen-qiong; Su, Yi-xiang] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Chao-gang] Sun Yat Sen Univ, Dept Clin Nutr, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wang, P (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn; suyx@mail.sysu.edu.cn	ZHANG, BO/K-4561-2013; Chen, Yu/Y-3292-2019	ZHANG, BO/0000-0002-6352-1757; 	Sun Yat-sen University, Guangzhou, China [2007032]; National Natural Science Foundation of China [30872102]	Sun Yat-sen University, Guangzhou, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded jointly by the 5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China (No. 2007032) and National Natural Science Foundation of China (No. 30872102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Andersson SW, 2004, EUR J CLIN NUTR, V58, P1378, DOI 10.1038/sj.ejcn.1601980; Baker William L, 2009, Diabetes Res Clin Pract, V84, pe33, DOI 10.1016/j.diabres.2009.01.015; Chan YM, 2006, NUTR REV, V64, P385, DOI [10.1301/nr.2006.sept.385-402, 10.1111/j.1753-4887.2006.tb00224.x]; Chen YM, 2006, BRIT J NUTR, V96, P745, DOI 10.1079/BJN20061883; Cofan M, 2011, NUTR METAB CARDIOVAS, V21, P651, DOI 10.1016/j.numecd.2010.01.005; Demonty I, 2009, J NUTR, V139, P271, DOI 10.3945/jn.108.095125; Derdemezis CS, 2010, J CARDIOVASC PHARM T, V15, P120, DOI 10.1177/1074248409357921; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Escurriol V, 2010, J LIPID RES, V51, P618, DOI 10.1194/jlr.P000471; Escurriol V, 2009, EUR J NUTR, V48, P373, DOI 10.1007/s00394-009-0024-z; Fassbender K, 2008, ATHEROSCLEROSIS, V196, P283, DOI 10.1016/j.atherosclerosis.2006.10.032; Grundy SM, 2005, AM J CARDIOL, V96, p47D, DOI 10.1016/j.amjcard.2005.03.020; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Han Junhua, 2007, Wei Sheng Yan Jiu, V36, P301; Jimenez-Escrig A, 2006, J AGR FOOD CHEM, V54, P3462, DOI 10.1021/jf053188k; Jones PJH, 1997, CAN J PHYSIOL PHARM, V75, P217, DOI 10.1139/cjpp-75-3-217; Klingberg S, 2008, AM J CLIN NUTR, V87, P993, DOI 10.1093/ajcn/87.4.993; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Luo X, 2011, CLIN RADIOL, V66, P393, DOI 10.1016/j.crad.2010.12.002; MacDonald HM, 2005, PUBLIC HEALTH NUTR, V8, P409, DOI 10.1079/PHN2005705; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Plat J, 2005, AM J CARDIOL, V96, p15D, DOI 10.1016/j.amjcard.2005.03.015; Plat J, 2000, EUR J CLIN NUTR, V54, P671, DOI 10.1038/sj.ejcn.1601071; Qian JC, 2010, B WORLD HEALTH ORGAN, V88, P769, DOI 10.2471/BLT.09.064709; Racette SB, 2010, AM J CLIN NUTR, V91, P32, DOI 10.3945/ajcn.2009.28070; Roman MJ, 2006, VASC MED, V11, P201, DOI 10.1177/1358863x06070511; Sanclemente T, 2012, NUTR METAB CARDIOVAS, V22, P849, DOI 10.1016/j.numecd.2011.01.010; SHULMAN RS, 1976, NEW ENGL J MED, V294, P482, DOI 10.1056/NEJM197602262940907; Strandberg TE, 2010, ATHEROSCLEROSIS, V210, P282, DOI 10.1016/j.atherosclerosis.2009.11.007; Sudhop T, 2002, METABOLISM, V51, P1519, DOI 10.1053/meta.2002.36298; Weingartner O, 2008, J AM COLL CARDIOL, V51, P1553, DOI 10.1016/j.jacc.2007.09.074; Weingartner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013467; Windler E, 2009, ATHEROSCLEROSIS, V203, P284, DOI 10.1016/j.atherosclerosis.2008.06.014; Yang YX, 2004, CHINA FOOD COMPOSITI; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240	39	30	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32736	10.1371/journal.pone.0032736	http://dx.doi.org/10.1371/journal.pone.0032736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412917	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800048
J	Brunner, JM; Plattet, P; Doucey, MA; Rosso, L; Curie, T; Montagner, A; Wittek, R; Vandelvelde, M; Zurbriggen, A; Hirling, H; Desvergne, B				Brunner, Jean-Marc; Plattet, Philippe; Doucey, Marie-Agnes; Rosso, Lia; Curie, Thomas; Montagner, Alexandra; Wittek, Riccardo; Vandelvelde, Marc; Zurbriggen, Andreas; Hirling, Harald; Desvergne, Beatrice			Morbillivirus Glycoprotein Expression Induces ER Stress, Alters Ca2+ Homeostasis and Results in the Release of Vasostatin	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; ENDOPLASMIC-RETICULUM; MEASLES-VIRUS; IN-VITRO; CALRETICULIN; PROTEIN; CALCIUM; INFECTION; CELLS; PERMEABILITY	Although the pathology of Morbillivirus in the central nervous system (CNS) is well described, the molecular basis of neurodegenerative events still remains poorly understood. As a model to explore Morbillivirus-mediated CNS dysfunctions, we used canine distemper virus (CDV) that we inoculated into two different cell systems: a monkey cell line (Vero) and rat primary hippocampal neurons. Importantly, the recombinant CDV used in these studies not only efficiently infects both cell types but recapitulates the uncommon, non-cytolytic cell-to-cell spread mediated by virulent CDVs in brain of dogs. Here, we demonstrated that both CDV surface glycoproteins (F and H) markedly accumulated in the endoplasmic reticulum (ER). This accumulation triggered an ER stress, characterized by increased expression of the ER resident chaperon calnexin and the proapoptotic transcription factor CHOP/GADD 153. The expression of calreticulin (CRT), another ER resident chaperon critically involved in the response to misfolded proteins and in Ca2+ homeostasis, was also upregulated. Transient expression of recombinant CDV F and H surface glycoproteins in Vero cells and primary hippocampal neurons further confirmed a correlation between their accumulation in the ER, CRT upregulation, ER stress and disruption of ER Ca2+ homeostasis. Furthermore, CDV infection induced CRT fragmentation with re-localisation of a CRT amino-terminal fragment, also known as vasostatin, on the surface of infected and neighbouring non-infected cells. Altogether, these results suggest that ER stress, CRT fragmentation and re-localization on the cell surface may contribute to cytotoxic effects and ensuing cell dysfunctions triggered by Morbillivirus, a mechanism that might potentially be relevant for other neurotropic viruses.	[Brunner, Jean-Marc; Rosso, Lia; Curie, Thomas; Montagner, Alexandra; Desvergne, Beatrice] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Brunner, Jean-Marc; Wittek, Riccardo] Univ Lausanne, Inst Biotechnol, Lausanne, Switzerland; [Plattet, Philippe; Vandelvelde, Marc; Zurbriggen, Andreas] Univ Bern, Dept Clin Res & Vet Publ Hlth, Vetsuisse Fac, Bern, Switzerland; [Doucey, Marie-Agnes] Univ Lausanne, CHU Vaudois, Div Expt Oncol, Lausanne, Switzerland; [Hirling, Harald] Ecole Polytech Fed Lausanne, Fac Sci Vie, Brain Mind Inst, CH-1015 Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Brunner, JM (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	philippe.plattet@vetsuisse.unibe.ch	Desvergne, Beatrice/C-8892-2016	Desvergne, Beatrice/0000-0001-5483-288X; Hirling, Harald/0000-0003-2070-100X; Montagner, Alexandra/0000-0002-4800-5105	Etat de Vaud from Swiss National Science Foundation; Etat de Vaud from Leenaards Foundation; Swiss National Science Foundation [3100A0-111974]	Etat de Vaud from Swiss National Science Foundation; Etat de Vaud from Leenaards Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Etat de Vaud (RW, BD), grants from the Swiss National Science Foundation (HH, BD), and the Leenaards Foundation (HH). TC was supported by the Swiss National Science Foundation grant to Dr. Paul Franken (nr. 3100A0-111974). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldabe R, 1997, J VIROL, V71, P6214, DOI 10.1128/JVI.71.8.6214-6217.1997; Beineke A, 2009, VET IMMUNOL IMMUNOP, V127, P1, DOI 10.1016/j.vetimm.2008.09.023; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blechacz B, 2006, HEPATOLOGY, V44, P1465, DOI 10.1002/hep.21437; BOEHM J, 1994, EUR J CLIN INVEST, V24, P248, DOI 10.1111/j.1365-2362.1994.tb01082.x; Brunner JM, 2007, J NEUROCHEM, V103, P1184, DOI 10.1111/j.1471-4159.2007.04819.x; Chen XZ, 2008, J NEUROCHEM, V106, P1563, DOI 10.1111/j.1471-4159.2008.05501.x; Cherpillod P, 1999, J VIROL, V73, P2263, DOI 10.1128/JVI.73.3.2263-2269.1999; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Curie T, 2007, MOL IMAGING, V6, P30, DOI 10.2310/7290.2006.00033; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Eggleton P, 1999, SCAND J IMMUNOL, V49, P466; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Ferreira S, 2005, RHEUMATOLOGY, V44, P434, DOI 10.1093/rheumatology/keh532; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Grote D, 2001, BLOOD, V97, P3746, DOI 10.1182/blood.V97.12.3746; HAMBURGER D, 1991, EXPERIENTIA, V47, P842, DOI 10.1007/BF01922469; Heinzerling L, 2005, BLOOD, V106, P2287, DOI 10.1182/blood-2004-11-4558; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Kunzi V, 2006, J INVEST DERMATOL, V126, P2525, DOI 10.1038/sj.jid.5700529; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MCCAULIFFE DP, 1990, J CLIN INVEST, V86, P332, DOI 10.1172/JCI114704; Mertens E, 2010, VIROLOGY, V399, P176, DOI 10.1016/j.virol.2009.12.036; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Nguyen TQ, 1996, MOL IMMUNOL, V33, P379, DOI 10.1016/0161-5890(95)00149-2; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pike SE, 1999, BLOOD, V94, P2461, DOI 10.1182/blood.V94.7.2461.419a26_2461_2468; Pike SE, 1998, J EXP MED, V188, P2349, DOI 10.1084/jem.188.12.2349; Plattet P, 2004, VIRUS RES, V101, P147, DOI 10.1016/j.virusres.2004.01.002; Plattet P, 2007, J VIROL, V81, P11413, DOI 10.1128/JVI.01287-07; Plattet P, 2009, BIOCHEMISTRY-US, V48, P9112, DOI 10.1021/bi9008566; Rogers KL, 2005, EUR J NEUROSCI, V21, P597, DOI 10.1111/j.1460-9568.2005.03871.x; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Shimomura O, 1997, BIOCHEM J, V326, P297, DOI 10.1042/bj3260297; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; SUMMERS BA, 1994, NEUROPATH APPL NEURO, V20, P525, DOI 10.1111/j.1365-2990.1994.tb01006.x; Suter SE, 2005, CLIN CANCER RES, V11, P1579, DOI 10.1158/1078-0432.CCR-04-1944; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Vandevelde M, 2005, ACTA NEUROPATHOL, V109, P56, DOI 10.1007/s00401-004-0958-4; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Voccoli V, 2007, BRAIN RES, V1147, P1, DOI 10.1016/j.brainres.2007.01.145; Wiener D, 2007, VIRUS RES, V129, P145, DOI 10.1016/j.virusres.2007.07.004; Zipperle L, 2010, J VIROL, V84, P9618, DOI 10.1128/JVI.01077-10	56	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32803	10.1371/journal.pone.0032803	http://dx.doi.org/10.1371/journal.pone.0032803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403712	Green Published, gold			2022-12-25	WOS:000303017700109
J	Collantes-Fernandez, E; Arrighi, RBG; Alvarez-Garcia, G; Weidner, JM; Regidor-Cerrillo, J; Boothroyd, JC; Ortega-Mora, LM; Barragan, A				Collantes-Fernandez, Esther; Arrighi, Romanico B. G.; Alvarez-Garcia, Gema; Weidner, Jessica M.; Regidor-Cerrillo, Javier; Boothroyd, John C.; Ortega-Mora, Luis M.; Barragan, Antonio			Infected Dendritic Cells Facilitate Systemic Dissemination and Transplacental Passage of the Obligate Intracellular Parasite Neospora caninum in Mice	PLOS ONE			English	Article							TOXOPLASMA-GONDII INFECTION; TRANSEPITHELIAL MIGRATION; BALB/C MICE; INVASION; EXPRESSION; PROLIFERATION; EPIDEMIOLOGY; TRANSMISSION; LEUKOCYTES; INDUCTION	The obligate intracellular parasite Neospora caninum disseminates across the placenta and the blood-brain barrier, to reach sites where it causes severe pathology or establishes chronic persistent infections. The mechanisms used by N. caninum to breach restrictive biological barriers remain elusive. To examine the cellular basis of these processes, migration of different N. caninum isolates (Nc-1, Nc-Liverpool, Nc-SweB1 and the Spanish isolates: Nc-Spain 3H, Nc-Spain 4H, Nc-Spain 6, Nc-Spain 7 and Nc-Spain 9) was studied in an in vitro model based on a placental trophoblast-derived BeWo cell line. Here, we describe that infection of dendritic cells (DC) by N. caninum tachyzoites potentiated translocation of parasites across polarized cellular monolayers. In addition, powered by the parasite's own gliding motility, extracellular N. caninum tachyzoites were able to transmigrate across cellular monolayers. Altogether, the presented data provides evidence of two putative complementary pathways utilized by N. caninum, in an isolate-specific fashion, for passage of restrictive cellular barriers. Interestingly, adoptive transfer of tachyzoite-infected DC in mice resulted in increased parasitic loads in various organs, e.g. the central nervous system, compared to infections with free parasites. Inoculation of pregnant mice with infected DC resulted in an accentuated vertical transmission to the offspring with increased parasitic loads and neonatal mortality. These findings reveal that N. caninum exploits the natural cell trafficking pathways in the host to cross cellular barriers and disseminate to deep tissues. The findings are indicative of conserved dissemination strategies among coccidian apicomplexan parasites.	[Collantes-Fernandez, Esther; Arrighi, Romanico B. G.; Weidner, Jessica M.; Barragan, Antonio] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Collantes-Fernandez, Esther; Arrighi, Romanico B. G.; Weidner, Jessica M.; Barragan, Antonio] Swedish Inst Communicable Dis Control, Stockholm, Sweden; [Collantes-Fernandez, Esther; Alvarez-Garcia, Gema; Regidor-Cerrillo, Javier; Ortega-Mora, Luis M.] Univ Complutense Madrid, Fac Vet Sci, Dept Anim Hlth, SALUVET, Madrid, Spain; [Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Complutense University of Madrid; Stanford University	Collantes-Fernandez, E (corresponding author), Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden.	esthercf@vet.ucm.es; antonio.barragan@ki.se	Ortega-Mora, Luis-Miguel/F-1470-2016; Regidor Cerrillo, Javier/F-5736-2016; Collantes-Fernandez, Esther/F-6301-2016; Barragan, Antonio/P-6278-2015; GARCIA, GEMA ALVAREZ/E-3577-2016; Barragan, Antonio/AAL-8618-2020; Ortega-Mora, Luis Miguel/AFT-0684-2022; Regidor-Cerrillo, Javier/O-5066-2019	Ortega-Mora, Luis-Miguel/0000-0002-4986-6783; Regidor Cerrillo, Javier/0000-0001-5831-6970; Collantes-Fernandez, Esther/0000-0002-1601-6889; Barragan, Antonio/0000-0001-7746-9964; GARCIA, GEMA ALVAREZ/0000-0002-6627-7577; Barragan, Antonio/0000-0001-7746-9964; Ortega-Mora, Luis Miguel/0000-0002-4986-6783; Regidor-Cerrillo, Javier/0000-0001-5831-6970; Boothroyd, John C./0000-0001-9719-745X	Swedish Research Council; Ministry of Science and Innovation of Spain [AGL2010-22191]; Spanish Government [2007-1055]; Wenner Gren Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Government(Spanish GovernmentEuropean Commission); Wenner Gren Foundation	This work was supported by grants from the Swedish Research Council (to AB) and from the Ministry of Science and Innovation (AGL2010-22191) of Spain (to LMO). EC was supported by a postdoctoral fellowship from the Spanish Government (no. 2007-1055). JMW is the recipient of a postdoctoral fellowship from the Wenner Gren Foundation. The funders has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber JS, 1995, PARASITOLOGY, V111, P563, DOI 10.1017/S0031182000077039; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Boysen P, 2006, INFECT IMMUN, V74, P953, DOI 10.1128/IAI.74.2.953-960.2006; Buxton D, 2002, TRENDS PARASITOL, V18, P546, DOI 10.1016/S1471-4922(02)02414-5; Collantes-Fernandez E, 2002, J CLIN MICROBIOL, V40, P1194, DOI 10.1128/JCM.40.4.1194-1198.2002; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; Dion S, 2011, INT J PARASITOL, V41, P685, DOI 10.1016/j.ijpara.2011.01.008; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; DUBEY JP, 1988, J AM VET MED ASSOC, V193, P1259; Gomez-Lopez N, 2010, J LEUKOCYTE BIOL, V88, P625, DOI 10.1189/jlb.1209796; HALL JM, 1995, BLOOD, V86, P2829; Hitziger N, 2005, CELL MICROBIOL, V7, P837, DOI 10.1111/j.1462-5822.2005.00517.x; Innes EA, 2002, TRENDS PARASITOL, V18, P497, DOI 10.1016/S1471-4922(02)02372-3; Kim K, 2001, MOL BIOCHEM PARASIT, V113, P309, DOI 10.1016/S0166-6851(01)00212-2; Kim SK, 2007, INFECT IMMUN, V75, P1626, DOI 10.1128/IAI.01862-06; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; Lambert H, 2009, INFECT IMMUN, V77, P1679, DOI 10.1128/IAI.01289-08; Lopez-Perez IC, 2008, VET PARASITOL, V155, P175, DOI 10.1016/j.vetpar.2008.05.018; Lopez-Perez IC, 2006, J PARASITOL, V92, P1286, DOI 10.1645/GE-883R.1; Marugan-Hernandez V, 2011, PARASITOLOGY, V138, P472, DOI 10.1017/S0031182010001666; Mineo TWP, 2010, INT J PARASITOL, V40, P797, DOI 10.1016/j.ijpara.2009.12.003; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Morrison DA, 2002, INT J PARASITOL, V32, P1065, DOI 10.1016/S0020-7519(02)00064-4; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; Pfaff AW, 2005, IMMUNOL CELL BIOL, V83, P483, DOI 10.1111/j.1440-1711.2005.01356.x; Regidor-Cerrillo J, 2008, PARASITOLOGY, V135, P1651, DOI 10.1017/S003118200800509X; Regidor-Cerrillo J, 2006, J PARASITOL, V92, P517, DOI 10.1645/GE-713R.1; Regidor-Cerrillo J, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-41; Regidor-Cerrillo J, 2010, VET RES, V41, DOI 10.1051/vetres/2010024; Risco-Castillo V, 2004, J PARASITOL, V90, P466, DOI 10.1645/GE-3298; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Stenlund S, 1997, PARASITOL RES, V83, P214, DOI 10.1007/s004360050236; Strohbusch M, 2009, PARASITE IMMUNOL, V31, P366, DOI 10.1111/j.1365-3024.2009.01112.x; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Teixeira L, 2010, IMMUNOL CELL BIOL, V88, P79, DOI 10.1038/icb.2009.65; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Williams DJL, 2009, PARASITOLOGY, V136, P1895, DOI 10.1017/S0031182009990588	44	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32123	10.1371/journal.pone.0032123	http://dx.doi.org/10.1371/journal.pone.0032123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403627	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700024
J	Parente, MK; Rozen, R; Cearley, CN; Wolfe, JH				Parente, Michael K.; Rozen, Ramona; Cearley, Cassia N.; Wolfe, John H.			Dysregulation of Gene Expression in a Lysosomal Storage Disease Varies between Brain Regions Implicating Unexpected Mechanisms of Neuropathology	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-VII; CHONDROITIN SULFATE; PATHOGENIC CASCADES; MOUSE; SYSTEM; NEURODEGENERATION; ACTIVATION; MODEL; MICE; IIIB	The characteristic neurological feature of many neurogenetic diseases is intellectual disability. Although specific neuropathological features have been described, the mechanisms by which specific gene defects lead to cognitive impairment remain obscure. To gain insight into abnormal functions occurring secondary to a single gene defect, whole transcriptome analysis was used to identify molecular and cellular pathways that are dysregulated in the brain in a mouse model of a lysosomal storage disorder (LSD) (mucopolysaccharidosis [MPS] VII). We assayed multiple anatomical regions separately, in a large cohort of normal and diseased mice, which greatly increased the number of significant changes that could be detected compared to past studies in LSD models. We found that patterns of aberrant gene expression and involvement of multiple molecular and cellular systems varied significantly between brain regions. A number of changes revealed unexpected system and process alterations, such as up-regulation of the immune system with few inflammatory changes (a significant difference from the closely related MPS IIIb model), down-regulation of major oligodendrocyte genes even though white matter changes are not a feature histopathologically, and a plethora of developmental gene changes. The involvement of multiple neural systems indicates that the mechanisms of neuropathology in this type of disease are much broader than previously appreciated. In addition, the variation in gene dysregulation between brain regions indicates that different neuropathologic mechanisms may predominate within different regions of a diseased brain caused by a single gene mutation.	[Parente, Michael K.; Rozen, Ramona; Cearley, Cassia N.; Wolfe, John H.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Wolfe, John H.] Univ Penn, Sch Vet Med, WF Goodman Ctr Comparat Med Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Parente, MK (corresponding author), Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA.	jhwolfe@vet.upenn.edu		Wolfe, John H./0000-0002-7497-3943	National Institutes of Health (NIH) [R01-NS038690, R01-NS056243]; Ethyl Foerderer Foundation (intramural from Children's Hospital of Philadelphia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038690, R01NS056243] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ethyl Foerderer Foundation (intramural from Children's Hospital of Philadelphia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH) (R01-NS038690; R01-NS056243) and the Ethyl Foerderer Foundation (intramural from Children's Hospital of Philadelphia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Benarroch EE, 2010, NEUROLOGY, V75, P1104, DOI 10.1212/WNL.0b013e3181f3db84; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; BIRKENMEIER EH, 1991, BLOOD, V78, P3081; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Casal ML, 1998, LAB INVEST, V78, P1575; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; de Lecea L, 2008, PEPTIDES, V29, P845, DOI 10.1016/j.peptides.2008.02.009; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; du Souich P, 2009, J CELL MOL MED, V13, P1451, DOI 10.1111/j.1582-4934.2009.00826.x; Ebert S, 2008, J LEUKOCYTE BIOL, V84, P736, DOI 10.1189/jlb.0208138; Edvardson S, 2010, MOL GENET METAB, V101, P228, DOI 10.1016/j.ymgme.2010.06.021; Ginsberg SD, 1999, J NEUROPATH EXP NEUR, V58, P815, DOI 10.1097/00005072-199908000-00004; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Heuer GG, 2002, ANN NEUROL, V52, P762, DOI 10.1002/ana.10373; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huitron-Resendiz S, 2005, J NEUROSCI, V25, P5465, DOI 10.1523/JNEUROSCI.4501-04.2005; Kagawa T, 1997, J NEUROSCI RES, V50, P312, DOI 10.1002/(SICI)1097-4547(19971015)50:2<312::AID-JNR19>3.0.CO;2-9; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Killedar S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-39; Kim JW, 2010, OTOLARYNG HEAD NECK, V143, P837, DOI 10.1016/j.otohns.2010.08.016; Kruer MC, 2010, ANN NEUROL, V68, P611, DOI 10.1002/ana.22122; Langmann T, 2009, NEUROMOL MED, V11, P87, DOI 10.1007/s12017-009-8061-6; Larsen KB, 2010, J HISTOCHEM CYTOCHEM, V58, P669, DOI 10.1369/jhc.2010.955757; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levy B, 1996, ACTA NEUROPATHOL, V92, P562, DOI 10.1007/s004010050562; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Nasrallah I, 2010, P INT SOC MAG RESON, V18, P1039; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nishino J, 2010, J NEUROSCI, V30, P15228, DOI 10.1523/JNEUROSCI.2286-10.2010; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Ono T, 2008, NEUROSCI LETT, V440, P275, DOI 10.1016/j.neulet.2008.05.096; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Papadopouli AE, 2008, HISTOL HISTOPATHOL, V23, P497, DOI 10.14670/HH-23.497; Passini MA, 2001, J VIROL, V75, P12382, DOI 10.1128/JVI.75.24.12382-12392.2001; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Platt FM, 2004, LYSOSOMAL DISORDERS, P32; Polazzi E, 2009, J NEUROCHEM, V110, P545, DOI 10.1111/j.1471-4159.2009.06117.x; Puelles E, 2006, J NEUROSCI, V26, P5955, DOI 10.1523/JNEUROSCI.1097-06.2006; Richard M, 2008, J NEUROSCI RES, V86, P3285, DOI 10.1002/jnr.21779; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rogers N, 2010, NEUROPATH APPL NEURO, V36, P113, DOI [10.1111/j.1365-2990.2009.01063.x, 10.1111/j.1365-2990.2010.01063.x]; Rolls A, 2006, FASEB J, V20, P547, DOI 10.1096/fj.05-4540fje; Ross CJD, 2000, EXP NEUROL, V166, P276, DOI 10.1006/exnr.2000.7531; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saetre P, 2004, MOL BRAIN RES, V126, P198, DOI 10.1016/j.molbrainres.2004.05.003; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Simeone A, 2011, MOL NEUROBIOL, V43, P107, DOI 10.1007/s12035-010-8148-y; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; SNYDER EY, 1995, NATURE, V374, P367, DOI 10.1038/374367a0; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; St John JA, 2005, J COMP NEUROL, V488, P61, DOI 10.1002/cne.20573; STRAMM LE, 1990, EXP EYE RES, V50, P521, DOI 10.1016/0014-4835(90)90041-R; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Tomihara K, 2010, J IMMUNOL, V184, P6151, DOI 10.4049/jimmunol.0903519; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Van Eldik LJ, GLIA PROINFLAMMATORY, P277; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Walkley SU, 2009, J INHERIT METAB DIS, V32, P181, DOI 10.1007/s10545-008-1040-5; Walkley SU, 1998, BRAIN PATHOL, V8, P175; Walton RM, 2007, J NEUROPATH EXP NEUR, V66, P760, DOI 10.1097/nen.0b013e31812571c8; Wang CF, 2007, ANIM GENET, V38, P203, DOI 10.1111/j.1365-2052.2007.01605.x; WITTEN DM, 2007, COMP FOLD CHANGE T S; Wolfe J, 1996, PROTOCOLS GENE TRANS, P263; WOLFE JH, 1992, NATURE, V360, P749, DOI 10.1038/360749a0; Woloszynek JC, 2004, BIOCHEM J, V379, P461, DOI 10.1042/BJ20031048; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Youngentob SL, 2003, J NEUROPHYSIOL, V90, P3864, DOI 10.1152/jn.00806.2002; Zirlinger M, 2001, P NATL ACAD SCI USA, V98, P5270, DOI 10.1073/pnas.091094698	86	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32419	10.1371/journal.pone.0032419	http://dx.doi.org/10.1371/journal.pone.0032419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403656	Green Submitted, gold, Green Published			2022-12-25	WOS:000303017700053
J	Di Lieto, A; Rantamaki, T; Vesa, L; Yanpallewar, S; Antila, H; Lindholm, J; Rios, M; Tessarollo, L; Castren, E				Di Lieto, Antonio; Rantamaki, Tomi; Vesa, Liisa; Yanpallewar, Sudhirkumar; Antila, Hanna; Lindholm, Jesse; Rios, Maribel; Tessarollo, Lino; Castren, Eero			The Responsiveness of TrkB to BDNF and Antidepressant Drugs Is Differentially Regulated during Mouse Development	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; TRUNCATED TRKB.T1; BRAIN; RECEPTOR; MICE; DEPRESSION; PLASTICITY; MODULATION; ACTIVATION	Background: Previous studies suggest that the responsiveness of TrkB receptor to BDNF is developmentally regulated in rats. Antidepressant drugs (AD) have been shown to increase TrkB signalling in the adult rodent brain, and recent findings implicate a BDNF-independent mechanism behind this phenomenon. When administered during early postnatal life, ADs produce long-lasting biochemical and behavioural alterations that are observed in adult animals. Methodology: We have here examined the responsiveness of brain TrkB receptors to BDNF and ADs during early postnatal life of mouse, measured as autophosphorylation of TrkB (pTrkB). Principal Findings: We found that ADs fail to induce TrkB signalling before postnatal day 12 (P12) after which an adult response of TrkB to ADs was observed. Interestingly, there was a temporally inverse correlation between the appearance of the responsiveness of TrkB to systemic ADs and the marked developmental reduction of BDNF-induced TrkB in brain microslices ex vivo. Basal p-TrkB status in the brain of BDNF deficient mice was significantly reduced only during early postnatal period. Enhancing cAMP (cyclic adenosine monophosphate) signalling failed to facilitate TrkB responsiveness to BDNF. Reduced responsiveness of TrkB to BDNF was not produced by the developmental increase in the expression of dominant-negative truncated TrkB. T1 because this reduction was similarly observed in the brain microslices of trkB. T1(-/-) mice. Moreover, postnatal AD administration produced long-lasting behavioural alterations observable in adult mice, but the responses were different when mice were treated during the time when ADs did not (P4-9) or did (P16-21) activate TrkB. Conclusions: We have found that ADs induce the activation of TrkB only in mice older than 2 weeks and that responsiveness of brain microslices to BDNF is reduced during the same time period. Exposure to ADs before and after the age when ADs activate TrkB produces differential long-term behavioural responses in adult mice.	[Di Lieto, Antonio; Rantamaki, Tomi; Vesa, Liisa; Antila, Hanna; Lindholm, Jesse; Castren, Eero] Univ Helsinki, Neurosci Ctr, Sigrid Juselius Lab, Helsinki, Finland; [Yanpallewar, Sudhirkumar; Tessarollo, Lino] NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Rios, Maribel] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Sigrid Juselius Foundation; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tufts University	Di Lieto, A (corresponding author), Univ Helsinki, Neurosci Ctr, Sigrid Juselius Lab, Helsinki, Finland.	eero.castren@helsinki.fi		Antila, Hanna/0000-0001-8317-4564; Castren, Eero/0000-0002-1402-2791; Rantamaki, Tomi/0000-0002-0052-1434	Academy of Finland Center of Excellence; Helsinki Graduate Program in Biotechnology and Molecular Biology; Sigrid Juselius Foundation; United States National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010390] Funding Source: NIH RePORTER	Academy of Finland Center of Excellence(Academy of Finland); Helsinki Graduate Program in Biotechnology and Molecular Biology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); United States National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was financially supported by the Academy of Finland Center of Excellence Programme (E. C.), the Helsinki Graduate Program in Biotechnology and Molecular Biology (L. V.), the Sigrid Juselius Foundation (E. C.) and Intramural Research Program of the United States National Institutes of Health, National Cancer Institute (S.Y. and L. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeles TS, 1998, ARCH BIOCHEM BIOPHYS, V349, P267, DOI 10.1006/abbi.1997.0490; Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; DUMAN R, 2006, BIOL PSYCHIAT; Eide FF, 1996, J NEUROSCI, V16, P3123; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Feng PF, 2001, DEV BRAIN RES, V129, P107, DOI 10.1016/S0165-3806(01)00158-4; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gross C, 2000, BIOL PSYCHIAT, V48, P1157, DOI 10.1016/S0006-3223(00)01041-6; Haapasalo A, 2001, BIOCHEM BIOPH RES CO, V280, P1352, DOI 10.1006/bbrc.2001.4296; Herlenius E, 2004, EXP NEUROL, V190, pS8, DOI 10.1016/j.expneurol.2004.03.027; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; Karpova NN, 2009, EUR NEUROPSYCHOPHARM, V19, P97, DOI 10.1016/j.euroneuro.2008.09.002; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; Koponen E, 2005, CELL MOL NEUROBIOL, V25, P973, DOI 10.1007/s10571-005-8468-z; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Pezet S, 2004, EXPERT OPIN THER TAR, V8, P391, DOI 10.1517/14728222.8.5.391; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Rantamaki T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020567; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Saarelainen T, 2003, J NEUROSCI, V23, P349; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Vogel G, 1990, SCIENCE, V14, P85; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x	41	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32869	10.1371/journal.pone.0032869	http://dx.doi.org/10.1371/journal.pone.0032869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396798	gold, Green Submitted, Green Published			2022-12-25	WOS:000303006500035
J	Liu, HD; Duan, Z; Zheng, H; Hu, DS; Li, M; Tao, YG; Bode, AM; Dong, ZG; Cao, Y				Liu, Haidan; Duan, Zhi; Zheng, Hui; Hu, Duosha; Li, Ming; Tao, Yongguang; Bode, Ann M.; Dong, Zigang; Cao, Ya			EBV-Encoded LMP1 Upregulates Ig kappa 3 ' Enhancer Activity and Ig kappa Expression in Nasopharyngeal Cancer Cells by Activating the Ets-1 through ERKs Signaling	PLOS ONE			English	Article							MEMBRANE-PROTEIN 1; ALPHA HEAVY-CHAIN; TRANSCRIPTION FACTORS; LATENT MEMBRANE-PROTEIN-1; LIGHT-CHAIN; 3 ENHANCER; EPITHELIAL-CELLS; CARCINOMA-CELLS; NUCLEAR-FACTOR; IMMUNOGLOBULIN-G	Accumulating evidence indicates that epithelial cancer cells, including nasopharyngeal carcinoma (NPC) cells, express immunoglobulins (Igs). We previously found that the expression of the kappa light chain protein in NPC cells can be upregulated by the EBV-encoded latent membrane protein 1 (LMP1). In the present study, we used NPC cell lines as models and found that LMP1-augmented kappa production corresponds with elevations in ERKs phosphorylation. PD98059 attenuates LMP1-induced ERKs phosphorylation resulting in decreased expression of the kappa light chain. ERK-specific small interfering RNA blunts LMP1-induced kappa light chain gene expression. Luciferase reporter assays demonstrate that immunoglobulin kappa 3' enhancer (3'E-kappa) is active in Ig kappa-expressing NPC cells and LMP1 upregulates the activity of 3'E-kappa in NPC cells. Moreover, mutation analysis of the PU binding site in 3'E-kappa and inhibition of the MEK/ERKs pathway by PD98059 indicate that the PU site is functional and LMP1-enhanced 3'E-kappa activity is partly regulated by this site. PD98059 treatment also leads to a concentration-dependent inhibition of LMP1-induced Ets-1 expression and phosphorylation, which corresponds with a dose-dependent attenuation of LMP1-induced ERK phosphorylation and kappa light chain expression. Suppression of endogenous Ets-1 by small interfering RNA is accompanied by a decrease of Ig kappa light chain expression. Gel shift assays using nuclear extracts of NPC cells indicate that the transcription factor Ets-1 is recruited by LMP1 to the PU motif within 3'E-kappa in vitro. ChIP assays further demonstrate Ets-1 binding to the PU motif of 3'E-kappa in cells. These results suggest that LMP1 upregulates 3'E-kappa activity and kappa gene expression by activating the Ets-1 transcription factor through the ERKs signaling pathway. Our studies provide evidence for a novel regulatory mechanism of kappa expression, by which virus-encoded proteins activate the kappa 3' enhancer through activating transcription factors in non-B epithelial cancer cells.	[Liu, Haidan; Duan, Zhi; Zheng, Hui; Hu, Duosha; Li, Ming; Tao, Yongguang; Cao, Ya] Cent S Univ, Xiangya Sch Med, Canc Res Inst, Changsha, Hunan, Peoples R China; [Liu, Haidan] Cent S Univ, Xiangya Hosp 2, Clin Ctr Gene Diag & Therapy, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Liu, Haidan] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China; [Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Central South University; Central South University; Central South University; University of Minnesota System	Liu, HD (corresponding author), Cent S Univ, Xiangya Sch Med, Canc Res Inst, Changsha, Hunan, Peoples R China.	zgdong@hi.umn.edu; ycao98@vip.sina.com	Zheng, Hui/ABD-6141-2021		Ministry of Science and Technology of China [2004CB518703]; National High Technology Research and Development Program (863) of China [2006AA 02A 404]; National Nature Science Foundation of China [30471968, 30973399]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National High Technology Research and Development Program (863) of China(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Basic Research and Development Plan (973) of the Ministry of Science and Technology of China (No. 2004CB518703), National High Technology Research and Development Program (863) of China (No. 2006AA 02A 404) and National Nature Science Foundation of China (No. 30471968, No. 30973399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2000, MOL IMMUNOL, V37, P889, DOI 10.1016/S0161-5890(01)00005-0; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Chen ZS, 2009, AM J PATHOL, V174, P1139, DOI 10.2353/ajpath.2009.080879; Costa MW, 1996, BIOCHEMISTRY-US, V35, P8662, DOI 10.1021/bi952801y; Ding L, 2005, INT J BIOCHEM CELL B, V37, P1881, DOI 10.1016/j.biocel.2005.04.012; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Geng LY, 2007, WORLD J GASTROENTERO, V13, P2305, DOI 10.3748/wjg.v13.i16.2305; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Hashimoto S, 1999, INT IMMUNOL, V11, P1423, DOI 10.1093/intimm/11.9.1423; Hayashi R, 1997, J IMMUNOL, V159, P4145; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; JUDDE JG, 1992, MOL CELL BIOL, V12, P5206, DOI 10.1128/MCB.12.11.5206; Kim KR, 2000, ONCOGENE, V19, P1764, DOI 10.1038/sj.onc.1203502; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Li M, 2004, INT J BIOCHEM CELL B, V36, P2250, DOI 10.1016/j.biocel.2004.03.017; Liu HD, 2007, CELL SIGNAL, V19, P419, DOI 10.1016/j.cellsig.2006.07.012; Liu HD, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-92; Lo AKF, 2003, LAB INVEST, V83, P697, DOI 10.1097/01.LAB.0000067480.44925.10; Marecki S, 2002, J INTERF CYTOK RES, V22, P121, DOI 10.1089/107999002753452737; Mei YP, 2006, CANCER LETT, V232, P189, DOI 10.1016/j.canlet.2005.02.010; Meyer KB, 1999, EUR J IMMUNOL, V29, P872, DOI 10.1002/(SICI)1521-4141(199903)29:03<872::AID-IMMU872>3.0.CO;2-X; MEYER KB, 1994, NUCLEIC ACIDS RES, V22, P1576, DOI 10.1093/nar/22.9.1576; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; Morris MA, 2009, FUTURE ONCOL, V5, P811, DOI [10.2217/fon.09.53, 10.2217/FON.09.53]; Mundt CA, 2001, J IMMUNOL, V166, P3315, DOI 10.4049/jimmunol.166.5.3315; Ohtani N, 2003, J CELL BIOL, V162, P173, DOI 10.1083/jcb.200302085; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; PONGUBALA JMR, 1995, J BIOL CHEM, V270, P10304, DOI 10.1074/jbc.270.17.10304; PONGUBALA JMR, 1991, MOL CELL BIOL, V11, P1040, DOI 10.1128/MCB.11.2.1040; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Pongubala JMR, 1997, P NATL ACAD SCI USA, V94, P127, DOI 10.1073/pnas.94.1.127; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; Qiu XY, 2003, CANCER RES, V63, P6488; RAY D, 1992, MOL CELL BIOL, V12, P4297, DOI 10.1128/MCB.12.10.4297; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Sen R, 2004, J EXP MED, V200, P1099, DOI 10.1084/jem.20041255; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; Su GH, 1996, J EXP MED, V184, P203, DOI 10.1084/jem.184.1.203; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Thornburg NJ, 2007, J VIROL, V81, P12954, DOI 10.1128/JVI.01601-07; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; WESTON K, 1988, VIROLOGY, V162, P406, DOI 10.1016/0042-6822(88)90481-3; Yang BS, 1996, MOL CELL BIOL, V16, P538; ZHANG XG, 1994, BLOOD, V83, P3654; Zheng H, 2007, MOL IMMUNOL, V44, P2221, DOI 10.1016/j.molimm.2006.11.010; Zheng H, 2007, CELL BIOL INT, V31, P82, DOI 10.1016/j.cellbi.2006.09.009	54	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32624	10.1371/journal.pone.0032624	http://dx.doi.org/10.1371/journal.pone.0032624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396784	gold, Green Published, Green Submitted			2022-12-25	WOS:000303005000032
J	van der Vaart, E; Verbrugge, R; Hemelrijk, CK				van der Vaart, Elske; Verbrugge, Rineke; Hemelrijk, Charlotte K.			Corvid Re-Caching without 'Theory of Mind': A Model	PLOS ONE			English	Article							WESTERN SCRUB-JAYS; BODY-MASS; APHELOCOMA-CALIFORNICA; TRANSITIVE INFERENCE; CAROLINA CHICKADEES; FOOD; RAVENS; MEMORY; STRATEGIES; CACHES	Scrub jays are thought to use many tactics to protect their caches. For instance, they predominantly bury food far away from conspecifics, and if they must cache while being watched, they often re-cache their worms later, once they are in private. Two explanations have been offered for such observations, and they are intensely debated. First, the birds may reason about their competitors' mental states, with a 'theory of mind'; alternatively, they may apply behavioral rules learned in daily life. Although this second hypothesis is cognitively simpler, it does seem to require a different, ad-hoc behavioral rule for every caching and re-caching pattern exhibited by the birds. Our new theory avoids this drawback by explaining a large variety of patterns as side-effects of stress and the resulting memory errors. Inspired by experimental data, we assume that re-caching is not motivated by a deliberate effort to safeguard specific caches from theft, but by a general desire to cache more. This desire is brought on by stress, which is determined by the presence and dominance of onlookers, and by unsuccessful recovery attempts. We study this theory in two experiments similar to those done with real birds with a kind of 'virtual bird', whose behavior depends on a set of basic assumptions about corvid cognition, and a well-established model of human memory. Our results show that the 'virtual bird' acts as the real birds did; its re-caching reflects whether it has been watched, how dominant its onlooker was, and how close to that onlooker it has cached. This happens even though it cannot attribute mental states, and it has only a single behavioral rule assumed to be previously learned. Thus, our simulations indicate that corvid re-caching can be explained without sophisticated social cognition. Given our specific predictions, our theory can easily be tested empirically.	[van der Vaart, Elske; Verbrugge, Rineke] Univ Groningen, Inst Artificial Intelligence, Groningen, Netherlands	University of Groningen	van der Vaart, E (corresponding author), Univ Groningen, Inst Artificial Intelligence, Groningen, Netherlands.	e.e.van.der.vaart@rug.nl	Verbrugge, Rineke/D-3781-2012; Hemelrijk, Charlotte K./E-4828-2013	Verbrugge, Rineke/0000-0003-3829-0106; Hemelrijk, Charlotte K./0000-0001-6160-077X	Netherlands Organisation for Scientific Research [021.001.089, 277-80-001]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Netherlands Organisation for Scientific Research, www.nwo.nl, through TopTalent Grant 021.001.089 awarded to Elske van der Vaart, and Vici Grant 277-80-001 awarded to Rineke Verbrugge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 2007, CAN HUMAN MIND OCCUR; ANDERSON JR, 1991, PSYCHOL SCI, V2, P396, DOI 10.1111/j.1467-9280.1991.tb00174.x; Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; BOSSEMA I, 1979, BEHAVIOUR, V70, P1, DOI 10.1163/156853979X00016; Bryson JJ, 2007, ANIM COGN, V10, P1, DOI 10.1007/s10071-006-0024-9; Bugnyar T, 2005, P ROY SOC B-BIOL SCI, V272, P1641, DOI 10.1098/rspb.2005.3144; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Bugnyar T, 2006, ANIM COGN, V9, P369, DOI 10.1007/s10071-006-0035-6; Bugnyar T, 2011, P ROY SOC B-BIOL SCI, V278, P634, DOI 10.1098/rspb.2010.1514; Bugnyar Thomas, 2007, Japanese Journal of Animal Psychology, V57, P15, DOI 10.2502/janip.57.1.2; Cheke LG, 2012, BIOL LETTERS, V8, P171, DOI 10.1098/rsbl.2011.0909; Clary D, 2011, ANIM COGN, V14, P735, DOI 10.1007/s10071-011-0408-3; Clayton NS, 2007, PHILOS T R SOC B, V362, P507, DOI 10.1098/rstb.2006.1992; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Clayton NS, 2003, J EXP PSYCHOL-ANIM B, V29, P14, DOI 10.1037//0097-7403.29.1.14; Clayton NS, 2001, J EXP PSYCHOL-ANIM B, V27, P17, DOI 10.1037//0097-7403.27.1.17; Clayton NS, 1999, J EXP PSYCHOL ANIM B, V25, P82, DOI 10.1037/0097-7403.25.1.82; Correia SPC, 2007, CURR BIOL, V17, P856, DOI 10.1016/j.cub.2007.03.063; Dally J. M., 2004, P ROY SOC LOND B BIO, V271, P5387; Dally JM, 2005, ANIM BEHAV, V70, P1251, DOI 10.1016/j.anbehav.2005.02.009; Dally JM, 2005, BEHAVIOUR, V142, P961, DOI 10.1163/1568539055010084; Dally JM, 2006, SCIENCE, V312, P1662, DOI 10.1126/science.1126539; de Kort SR, 2007, J EXP PSYCHOL ANIM B, V33, P361, DOI 10.1037/0097-7403.33.4.361; Emery NJ, 2004, ANIM COGN, V7, P37, DOI 10.1007/s10071-003-0178-7; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; Goodwin D., 1956, Ibis, V98, P186, DOI 10.1111/j.1474-919X.1956.tb03040.x; Grodzinski U, 2010, PHILOS T R SOC B, V365, P977, DOI 10.1098/rstb.2009.0210; Harris A., 2009, P 9 INT C COGN MOD M, P292; HURLY TA, 1992, BEHAV ECOL, V3, P181, DOI 10.1093/beheco/3.2.181; JAMES PC, 1984, ARDEA, V72, P207; JAMES PC, 1983, BEHAVIOUR, V85, P276, DOI 10.1163/156853983X00264; Lucas JR, 2006, HORM BEHAV, V49, P634, DOI 10.1016/j.yhbeh.2005.12.012; LUCAS JR, 1993, ANIM BEHAV, V45, P639, DOI 10.1006/anbe.1993.1080; Lucas JR, 1998, BEHAV ECOL, V9, P193, DOI 10.1093/beheco/9.2.193; LUCAS JR, 1991, ANIM BEHAV, V41, P579, DOI 10.1016/S0003-3472(05)80898-X; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Penn DC, 2007, PHILOS T R SOC B, V362, P731, DOI 10.1098/rstb.2006.2023; Pravosudov VV, 2003, P ROY SOC B-BIOL SCI, V270, P2599, DOI 10.1098/rspb.2003.2551; Pravosudov VV, 1997, BEHAV ECOL, V8, P332, DOI 10.1093/beheco/8.3.332; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Schloegl C, 2007, ANIM BEHAV, V74, P769, DOI 10.1016/j.anbehav.2006.08.017; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Stulp G, 2009, BIOL LETTERS, V5, P583, DOI 10.1098/rsbl.2009.0330; Tomasello Michael, 2006, P371; Tornick JK, 2011, ANIM COGN, V14, P117, DOI 10.1007/s10071-010-0349-2; van der Vaart E, 2011, J EXP PSYCHOL-ANIM B, V37, P330, DOI 10.1037/a0022988; Wein JM, 2011, ANIM BEHAV, V82, P579, DOI 10.1016/j.anbehav.2011.06.020; Wood MA, 2004, PROCEEDINGS OF THE TWENTY-SIXTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P1470; Zinkivskay A, 2009, ANIM COGN, V12, P119, DOI 10.1007/s10071-008-0176-x	52	27	27	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32904	10.1371/journal.pone.0032904	http://dx.doi.org/10.1371/journal.pone.0032904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396799	Green Published, Green Submitted, gold			2022-12-25	WOS:000303005000041
J	Wagner, S; Zensi, A; Wien, SL; Tschickardt, SE; Maier, W; Vogel, T; Worek, F; Pietrzik, CU; Kreuter, J; von Briesen, H				Wagner, Sylvia; Zensi, Anja; Wien, Sascha L.; Tschickardt, Sabrina E.; Maier, Wladislaw; Vogel, Tikva; Worek, Franz; Pietrzik, Claus U.; Kreuter, Joerg; von Briesen, Hagen			Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; E-DERIVED PEPTIDE; 80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLES; PEGYLATED POLYCYANOACRYLATE NANOPARTICLES; POLY(BUTYL CYANOACRYLATE) NANOPARTICLES; APOLIPOPROTEIN-A-I; DRUG-DELIVERY; ELECTRICAL-RESISTANCE; DESOLVATION PROCESS; HSA-NANOPARTICLES	Background: The blood-brain barrier (BBB) represents an insurmountable obstacle for most drugs thus obstructing an effective treatment of many brain diseases. One solution for overcoming this barrier is a transport by binding of these drugs to surface-modified nanoparticles. Especially apolipoprotein E (ApoE) appears to play a major role in the nanoparticle-mediated drug transport across the BBB. However, at present the underlying mechanism is incompletely understood. Methodology/Principal Findings: In this study, the uptake of the ApoE-modified nanoparticles into the brain capillary endothelial cells was investigated to differentiate between active and passive uptake mechanism by flow cytometry and confocal laser scanning microscopy. Furthermore, different in vitro co-incubation experiments were performed with competing ligands of the respective receptor. Conclusions/Significance: This study confirms an active endocytotic uptake mechanism and shows the involvement of low density lipoprotein receptor family members, notably the low density lipoprotein receptor related protein, on the uptake of the ApoE-modified nanoparticles into the brain capillary endothelial cells. This knowledge of the uptake mechanism of ApoE-modified nanoparticles enables future developments to rationally create very specific and effective carriers to overcome the blood-brain barrier.	[Wagner, Sylvia; Wien, Sascha L.; von Briesen, Hagen] Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, St Ingbert, Germany; [Zensi, Anja; Kreuter, Joerg] Goethe Univ Frankfurt, Inst Pharmaceut Technol, Frankfurt, Germany; [Tschickardt, Sabrina E.; Maier, Wladislaw; Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, Mainz, Germany; [Vogel, Tikva] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Vogel, Tikva] NCI, Radiat Biol Branch, NIH, Bethesda, MD 20892 USA; [Worek, Franz] Bundeswehr Inst Pharmacol & Toxicol, Munich, Germany	Fraunhofer Gesellschaft; Goethe University Frankfurt; Johannes Gutenberg University of Mainz; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wagner, S (corresponding author), Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, St Ingbert, Germany.	hagen.briesen@ibmt.fraunhofer.de		Wagner, Sylvia/0000-0001-7922-977X; Worek, Franz/0000-0003-3531-3616	German Bundesministerium fur Bildung und Forschung (BMBF) [01EW1009, 01EW1010]; Deutsche Bundesamt fur Wehrtechnik und Beschaffung [U2.3 E/UR3G/5G031/5A802]	German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Bundesamt fur Wehrtechnik und Beschaffung	This work was financially supported by the German Bundesministerium fur Bildung und Forschung (BMBF) (01EW1009, 01EW1010) and by the Deutsche Bundesamt fur Wehrtechnik und Beschaffung (U2.3 E/UR3G/5G031/5A802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALYAUTDIN R, 1995, EUR J PHARM BIOPHARM, V41, P44; Alyautdin RN, 1997, PHARMACEUT RES, V14, P325, DOI 10.1023/A:1012098005098; Alyautdin RN, 1998, J MICROENCAPSUL, V15, P67, DOI 10.3109/02652049809006836; Begley DJ, 2003, ACTA PAEDIATR, V92, P83, DOI 10.1080/08035320310020904; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; Calvo P, 2001, PHARMACEUT RES, V18, P1157, DOI 10.1023/A:1010931127745; Calvo P, 2001, J NEUROSCI METH, V111, P151, DOI 10.1016/S0165-0270(01)00450-2; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; Friese A, 2000, EUR J PHARM BIOPHARM, V49, P103, DOI 10.1016/S0939-6411(99)00073-9; Gulyaev AE, 1999, PHARM RES-DORDR, V16, P1564, DOI 10.1023/A:1018983904537; Hasadsri L, 2009, J BIOL CHEM, V284, P6972, DOI 10.1074/jbc.M805956200; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hekmatara T, 2009, CLIN NEUROPATHOL, V28, P153; Herz J, 2003, CELL, V112, P289, DOI 10.1016/S0092-8674(03)00073-4; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; Kreuter J, 2003, PHARM RES-DORDR, V20, P409, DOI 10.1023/A:1022604120952; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; KREUTER J, 1995, BRAIN RES, V674, P171, DOI 10.1016/0006-8993(95)00023-J; Kreuter J., 2006, NANOPARTICULATES DRU, P527; Kreuter J, 2006, MICROENCAPSULATION M, P689; Kreuter J, 2007, J CONTROL RELEASE, V118, P54, DOI 10.1016/j.jconrel.2006.12.012; Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0; Leupold E, 2009, BBA-BIOMEMBRANES, V1788, P442, DOI 10.1016/j.bbamem.2008.11.025; Leupold E, 2008, BBA-BIOMEMBRANES, V1778, P2781, DOI 10.1016/j.bbamem.2008.09.008; Luck M, 1997, PLASMAPROTEINADSORPT; Michaelis K, 2006, J PHARMACOL EXP THER, V317, P1246, DOI 10.1124/jpet.105.097139; Neuwelt EA, IMPLICATIONS BLOOD B; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 1997, J CEREBR BLOOD F MET, V17, P713, DOI 10.1097/00004647-199707000-00001; PARDRIDGE WM, 1988, ANNU REV PHARMACOL, V28, P25; Peters-Libeu CA, 2006, J BIOL CHEM, V281, P1073, DOI 10.1074/jbc.M510851200; Petri B, 2007, J CONTROL RELEASE, V117, P51, DOI 10.1016/j.jconrel.2006.10.015; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Rhaese S, 2003, J CONTROL RELEASE, V92, P199, DOI 10.1016/S0168-3659(03)00302-X; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sauer I, 2005, BIOCHEMISTRY-US, V44, P2021, DOI 10.1021/bi048080x; Sauer I, 2006, BBA-BIOMEMBRANES, V1758, P552, DOI 10.1016/j.bbamem.2006.03.017; Schroeder U, 1998, J PHARM SCI-US, V87, P1305, DOI 10.1021/js980084y; Steiniger SCJ, 2004, INT J CANCER, V109, P759, DOI 10.1002/ijc.20048; Ulbrich K, 2009, EUR J PHARM BIOPHARM, V71, P251, DOI 10.1016/j.ejpb.2008.08.021; VOGEL T, 1985, P NATL ACAD SCI USA, V82, P8696, DOI 10.1073/pnas.82.24.8696; Weber C, 2000, INT J PHARM, V194, P91, DOI 10.1016/S0378-5173(99)00370-1; Weber C, 2000, INT J PHARM, V196, P197, DOI 10.1016/S0378-5173(99)00420-2; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Zensi A, 2010, J DRUG TARGET, V18, P842, DOI 10.3109/1061186X.2010.513712; Zensi A, 2009, J CONTROL RELEASE, V137, P78, DOI 10.1016/j.jconrel.2009.03.002	52	154	157	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32568	10.1371/journal.pone.0032568	http://dx.doi.org/10.1371/journal.pone.0032568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396775	Green Submitted, Green Published, gold			2022-12-25	WOS:000303005000029
J	Inazuka, F; Sugiyama, N; Tomita, M; Abe, T; Shioi, G; Esumi, H				Inazuka, Fumika; Sugiyama, Naoyuki; Tomita, Masaru; Abe, Takaya; Shioi, Go; Esumi, Hiroyasu			Muscle-specific Knock-out of NUAK Family SNF1-like Kinase 1 (NUAK1) Prevents High Fat Diet-induced Glucose Intolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED INSULIN-RESISTANCE; MOUSE SKELETAL-MUSCLE; C-THETA; GLYCOGEN-SYNTHASE; TISSUE SITES; CONTRACTION; TRANSPORT; GLUT4; LKB1	NUAK1 is a member of the AMP-activated protein kinase-related kinase family. Recent studies have shown that NUAK1 is involved in cellular senescence and motility in epithelial cells and fibroblasts. However, the physiological roles of NUAK1 are poorly understood because of embryonic lethality in NUAK1 null mice. The purpose of this study was to elucidate the roles of NUAK1 in adult tissues. We determined the tissue distribution of NUAK1 and generated muscle-specific NUAK1 knock-out (MNUAK1KO) mice. For phenotypic analysis, whole body glucose homeostasis and muscle glucose metabolism were examined. Quantitative phosphoproteome analysis of soleus muscle was performed to understand the molecular mechanisms underlying the knock-out phenotype. Nuak1 mRNA was preferentially expressed in highly oxidative tissues such as brain, heart, and soleus muscle. On a high fat diet, MNUAK1KO mice had a lower fasting blood glucose level, greater glucose tolerance, higher insulin sensitivity, and higher concentration of muscle glycogen than control mice. Phosphoproteome analysis revealed that phosphorylation of IRS1 Ser-1097 was markedly decreased in NUAK1-deficient muscle. Consistent with this, insulin signaling was enhanced in the soleus muscle of MNUAK1KO mice, as evidenced by increased phosphorylation of IRS1 Tyr-608, AKT Thr-308, and TBC1D4 Thr-649. These observations suggest that a physiological role of NUAK1 is to suppress glucose uptake through negative regulation of insulin signaling in oxidative muscle.	[Inazuka, Fumika; Esumi, Hiroyasu] Natl Canc Ctr Hosp E, Res Ctr Innovat Oncol, Canc Physiol Project, Kashiwa, Chiba 2778577, Japan; [Inazuka, Fumika; Esumi, Hiroyasu] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778561, Japan; [Sugiyama, Naoyuki; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan; [Abe, Takaya; Shioi, Go] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan	National Cancer Center - Japan; University of Tokyo; Keio University; RIKEN	Esumi, H (corresponding author), Natl Canc Ctr Hosp E, Res Ctr Innovat Oncol, Canc Physiol Project, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	hesumi@ncc.go.jp		Sugiyama, Naoyuki/0000-0001-7633-8495	Ministry of Health, Labour and Welfare Japan	Ministry of Health, Labour and Welfare Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare Japan.	Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Alkhateeb H, 2007, AM J PHYSIOL-ENDOC M, V293, pE783, DOI 10.1152/ajpendo.00685.2006; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; DEFRONZO RA, 1981, J CLIN INVEST, V68, P1468, DOI 10.1172/JCI110399; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hirano M, 2006, DEV DYNAM, V235, P2229, DOI 10.1002/dvdy.20823; Hoppe PE, 2010, GENETICS, V184, P79, DOI 10.1534/genetics.109.110189; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Hou X, 2011, ONCOGENE, V30, P2933, DOI 10.1038/onc.2011.19; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Itani SI, 2001, METABOLISM, V50, P553, DOI 10.1053/meta.2001.22512; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; KIM YB, 1994, BIOCHEM BIOPH RES CO, V202, P519, DOI 10.1006/bbrc.1994.1959; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Kusakai G, 2004, J EXP CLIN CANC RES, V23, P263; LANG CH, 1992, P SOC EXP BIOL MED, V199, P81; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McGee SL, 2006, FASEB J, V20, P348, DOI 10.1096/fj.05-4671fje; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Niesler CU, 2007, EXP PHYSIOL, V92, P207, DOI 10.1113/expphysiol.2006.034736; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; RICHARDSON JM, 1991, J BIOL CHEM, V266, P12690; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; Saito H, 2006, J PROTEOME RES, V5, P1803, DOI 10.1021/pr0601178; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Scott JW, 2007, EMBO J, V26, P806, DOI 10.1038/sj.emboj.7601542; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; SHILLABEER G, 1995, BIOCHEM BIOPH RES CO, V207, P768, DOI 10.1006/bbrc.1995.1253; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; TREADWAY JL, 1994, J BIOL CHEM, V269, P29956; Tsao TS, 1999, DIABETES, V48, P775, DOI 10.2337/diabetes.48.4.775; Yamamoto H, 2008, BIOCHEM BIOPH RES CO, V365, P541, DOI 10.1016/j.bbrc.2007.11.013; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616	59	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16379	16389		10.1074/jbc.M111.302687	http://dx.doi.org/10.1074/jbc.M111.302687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22418434	hybrid, Green Published			2022-12-25	WOS:000304030900029
J	Sundaresan, P; Ravindran, RD; Vashist, P; Shanker, A; Nitsch, D; Talwar, B; Maraini, G; Camparini, M; Nonyane, BAS; Smeeth, L; Chakravarthy, U; Hejtmancik, JF; Fletcher, AE				Sundaresan, Periasamy; Ravindran, Ravilla D.; Vashist, Praveen; Shanker, Ashwini; Nitsch, Dorothea; Talwar, Badrinath; Maraini, Giovanni; Camparini, Monica; Nonyane, Bareng Aletta S.; Smeeth, Liam; Chakravarthy, Usha; Hejtmancik, James F.; Fletcher, Astrid E.			EPHA2 Polymorphisms and Age-Related Cataract in India	PLOS ONE			English	Article							BEAVER DAM EYE; LENS OPACITIES; CORTICAL CATARACT; RISK-FACTORS; ASSOCIATION; POPULATION; DISEASES; NUCLEAR	Objective: We investigated whether previously reported single nucleotide polymorphisms (SNPs) of EPHA2 in European studies are associated with cataract in India. Methods: We carried out a population-based genetic association study. We enumerated randomly sampled villages in two areas of north and south India to identify people aged 40 and over. Participants attended a clinical examination including lens photography and provided a blood sample for genotyping. Lens images were graded by the Lens Opacification Classification System (LOCS III). Cataract was defined as a LOCS III grade of nuclear >= 4, cortical >= 3, posterior sub-capsular (PSC) >= 2, or dense opacities or aphakia/pseudophakia in either eye. We genotyped SNPs rs3754334, rs7543472 and rs11260867 on genomic DNA extracted from peripheral blood leukocytes using TaqMan assays in an ABI 7900 real-time PCR. We used logistic regression with robust standard errors to examine the association between cataract and the EPHA2 SNPs, adjusting for age, sex and location. Results: 7418 participants had data on at least one of the SNPs investigated. Genotype frequencies of controls were in Hardy-Weinberg Equilibrium (p > 0.05). There was no association of rs3754334 with cataract or type of cataract. Minor allele homozygous genotypes of rs7543472 and rs11260867 compared to the major homozygote genotype were associated with cortical cataract, Odds ratio (OR) = 1.8, 95% Confidence Interval (CI) (1.1, 3.1) p = 0.03 and 2.9 (1.2, 7.1) p = 0.01 respectively, and with PSC cataract, OR = 1.5 (1.1, 2.2) p = 0.02 and 1.8 (0.9, 3.6) p = 0.07 respectively. There was no consistent association of SNPs with nuclear cataract or a combined variable of any type of cataract including operated cataract. Conclusions: Our results in the Indian population agree with previous studies of the association of EPHA2 variants with cortical cataracts. We report new findings for the association with PSC which is particularly prevalent in Indians.	[Sundaresan, Periasamy; Shanker, Ashwini] Aravind Eye Hosp, Dr G Venkataswamy Eye Res Inst, Dept Genet, Aravind Med Res Fdn, Madurai, Tamil Nadu, India; [Ravindran, Ravilla D.; Talwar, Badrinath] Aravind Eye Hosp, Pondicherry, India; [Vashist, Praveen] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India; [Nitsch, Dorothea; Nonyane, Bareng Aletta S.; Smeeth, Liam; Fletcher, Astrid E.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Maraini, Giovanni; Camparini, Monica] Univ Parma, Sez Oftalmol, Dipartimento Sci Otorino Odonto Oftalmol & Cerv F, I-43100 Parma, Italy; [Chakravarthy, Usha] Queens Univ Belfast, Ctr Vis & Vasc Sci, Sch Med Dent & Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland; [Hejtmancik, James F.] NEI, Sect Ophthalm Mol Genet, Bethesda, MD 20892 USA	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; University of London; London School of Hygiene & Tropical Medicine; University of Parma; Queens University Belfast; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sundaresan, P (corresponding author), Aravind Eye Hosp, Dr G Venkataswamy Eye Res Inst, Dept Genet, Aravind Med Res Fdn, Madurai, Tamil Nadu, India.	astrid.fletcher@lshtm.ac.uk	.P, Sundaresan/AAR-8426-2021; Nonyane, Bareng A.S./AAC-8118-2020; Smeeth, Liam/X-5862-2018	Nonyane, Bareng A.S./0000-0001-5633-7487; Chakravarthy, Usha/0000-0002-2606-3734; Smeeth, Liam/0000-0002-9168-6022; Nitsch, Dorothea/0000-0001-5767-248X	NATIONAL EYE INSTITUTE [ZIAEY000281, ZIAEY000272] Funding Source: NIH RePORTER; Wellcome Trust [098504, 073300, G082571] Funding Source: Medline; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 1994, AM J EPIDEMIOL, V140, P555; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Hejtmancik JF, 2004, EXP EYE RES, V79, P3, DOI 10.1016/j.exer.2004.03.014; Iyengar SK, 2004, P NATL ACAD SCI USA, V101, P14485, DOI 10.1073/pnas.0400778101; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Klein BEK, 2001, AM J EPIDEMIOL, V154, P207, DOI 10.1093/aje/154.3.207; Krishnaiah S, 2005, INVEST OPHTH VIS SCI, V46, P58, DOI 10.1167/iovs.04-0089; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; MARAINI G, 1991, AM J EPIDEMIOL, V133, P541; Nirmalan PK, 2003, INVEST OPHTH VIS SCI, V44, P4639, DOI 10.1167/iovs.03-0011; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Salm M, 2006, AM J OPHTHALMOL, V142, P976, DOI 10.1016/j.ajo.2006.07.057; Shiels A, 2008, MOL VIS, V14, P2042; Tan W, 2011, MOL VIS, V17, P1553; Vashist P, 2011, OPHTHALMOLOGY, V118, P272, DOI 10.1016/j.ophtha.2010.05.020; World Health Organization, 1985, DIAB MELL REP WHO ST	18	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33001	10.1371/journal.pone.0033001	http://dx.doi.org/10.1371/journal.pone.0033001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412971	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000303062000026
J	Verheij, R; Brenner, E; Smeets, JBJ				Verheij, Rebekka; Brenner, Eli; Smeets, Jeroen B. J.			Grasping Kinematics from the Perspective of the Individual Digits: A Modelling Study	PLOS ONE			English	Article							LEARNED PERCEPTUAL ASSOCIATIONS; OBJECT SIZE; PREHENSION MOVEMENTS; BINOCULAR VISION; ONLINE CONTROL; REACH; COORDINATION; INFORMATION; TRANSPORT; HAND	Grasping is a prototype of human motor coordination. Nevertheless, it is not known what determines the typical movement patterns of grasping. One way to approach this issue is by building models. We developed a model based on the movements of the individual digits. In our model the following objectives were taken into account for each digit: move smoothly to the preselected goal position on the object without hitting other surfaces, arrive at about the same time as the other digit and never move too far from the other digit. These objectives were implemented by regarding the tips of the digits as point masses with a spring between them, each attracted to its goal position and repelled from objects' surfaces. Their movements were damped. Using a single set of parameters, our model can reproduce a wider variety of experimental findings than any previous model of grasping. Apart from reproducing known effects (even the angles under which digits approach trapezoidal objects' surfaces, which no other model can explain), our model predicted that the increase in maximum grip aperture with object size should be greater for blocks than for cylinders. A survey of the literature shows that this is indeed how humans behave. The model can also adequately predict how single digit pointing movements are made. This supports the idea that grasping kinematics follow from the movements of the individual digits.	[Verheij, Rebekka; Brenner, Eli; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Verheij, R (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands.	r.verheij@vu.nl	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843	Netherlands Organization for Scientific Research [453-08-004]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization for Scientific Research (www.nwo.nl), NWO Vici grant 453-08-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2008, CORTEX, V44, P414, DOI 10.1016/j.cortex.2007.08.007; BENNETT KMB, 1994, J GERONTOL, V49, pP1, DOI 10.1093/geronj/49.1.P1; Berthier NE, 1996, J MOTOR BEHAV, V28, P187, DOI 10.1080/00222895.1996.9941744; Biegstraaten M, 2006, EXP BRAIN RES, V171, P347, DOI 10.1007/s00221-005-0271-z; Bongers RM, 2011, HAND APERTURE PATTER; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Brenner E, 1996, EXP BRAIN RES, V111, P473; Carnahan H, 1996, ACTA PSYCHOL, V92, P17, DOI 10.1016/0001-6918(95)00006-2; Carnahan H, 1996, J CLIN EXP NEUROPSYC, V18, P136, DOI 10.1080/01688639608408269; CASTIELLO U, 1993, NEUROPSYCHOLOGIA, V31, P395, DOI 10.1016/0028-3932(93)90162-S; CASTIELLO U, 1992, BEHAV BRAIN RES, V50, P7, DOI 10.1016/S0166-4328(05)80283-9; Castiello U, 2000, NEUROPSYCHOLOGIA, V38, P46, DOI 10.1016/S0028-3932(99)00049-4; CASTIELLO U, 1993, EXP BRAIN RES, V96, P152, DOI 10.1007/BF00230448; Cavina-Pratesi C, 2010, NEUROPSYCHOLOGIA, V48, P226, DOI 10.1016/j.neuropsychologia.2009.09.008; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Christopoulos VN, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000538; FIKES TG, 1994, J MOTOR BEHAV, V26, P325, DOI 10.1080/00222895.1994.9941688; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FLASH T, 1987, BIOL CYBERN, V57, P257, DOI 10.1007/BF00338819; Friedman J, 2009, EXP BRAIN RES, V196, P497, DOI 10.1007/s00221-009-1878-2; Fukui T, 2006, HUM MOVEMENT SCI, V25, P349, DOI 10.1016/j.humov.2006.02.002; Gentilucci M, 2004, EXP BRAIN RES, V157, P496, DOI 10.1007/s00221-004-1863-8; Glover S, 2002, PERCEPT PSYCHOPHYS, V64, P266, DOI 10.3758/BF03195791; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Grant S, 2007, INVEST OPHTH VIS SCI, V48, P1139, DOI 10.1167/iovs.06-0976; Haffenden AM, 2002, EXP BRAIN RES, V147, P485, DOI 10.1007/s00221-002-1250-2; Haffenden AM, 2000, J COGNITIVE NEUROSCI, V12, P950, DOI 10.1162/08989290051137495; HAGGARD P, 1991, NEUROSCI LETT, V122, P103, DOI 10.1016/0304-3940(91)90204-7; Hesse C, 2010, EXP BRAIN RES, V201, P93, DOI 10.1007/s00221-009-2070-4; Hesse C, 2009, HUM MOVEMENT SCI, V28, P415, DOI 10.1016/j.humov.2009.03.001; Hesse C, 2009, J MOTOR BEHAV, V41, P253, DOI 10.3200/JMBR.41.3.253-273; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; Ietswaart M, 2006, NEUROPSYCHOLOGIA, V44, P1175, DOI 10.1016/j.neuropsychologia.2005.10.003; Jackson GM, 2002, HUM MOVEMENT SCI, V21, P317, DOI 10.1016/S0167-9457(02)00118-5; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; Jeannerod M., 1981, ATTENTION PERFORM, P153; Kleinholdermann U, 2007, EXP BRAIN RES, V180, P415, DOI 10.1007/s00221-007-0867-6; Kritikos A, 1998, EXP BRAIN RES, V119, P9, DOI 10.1007/s002210050314; Kudoh N, 1997, EXP BRAIN RES, V117, P457, DOI 10.1007/s002210050241; Kuhtz-Buschbeck JP, 1998, BEHAV BRAIN RES, V93, P131, DOI 10.1016/S0166-4328(97)00147-2; Loftus A, 2004, EXP BRAIN RES, V158, P317, DOI 10.1007/s00221-004-1905-2; Lommertzen J, 2009, LECT NOTES COMPUT SC, V5499, P188, DOI 10.1007/978-3-642-02565-5_11; Marotta JJ, 1997, EXP BRAIN RES, V116, P113, DOI 10.1007/PL00005731; Marteniuk RG, 2000, MOTOR CONTROL, V4, P165, DOI 10.1123/mcj.4.2.165; MARTENIUK RG, 1990, HUM MOVEMENT SCI, V9, P149, DOI 10.1016/0167-9457(90)90025-9; Mason AH, 2009, HUM MOVEMENT SCI, V28, P48, DOI 10.1016/j.humov.2008.09.002; Melmoth DR, 2006, EXP BRAIN RES, V171, P371, DOI 10.1007/s00221-005-0273-x; Meulenbroek RGJ, 2001, EXP BRAIN RES, V138, P219, DOI 10.1007/s002210100690; Molina-Vilaplana J, 2007, NEUROCOMPUTING, V71, P411, DOI 10.1016/j.neucom.2007.08.017; Mon-Williams M, 2001, EXP BRAIN RES, V137, P497; MORASSO P, 1981, EXP BRAIN RES, V42, P223; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; Paulignan Y, 1997, EXP BRAIN RES, V114, P226, DOI 10.1007/PL00005631; Rand MK, 2008, EXP BRAIN RES, V188, P263, DOI 10.1007/s00221-008-1361-5; Rosenbaum DA, 2001, PSYCHOL REV, V108, P709, DOI 10.1037//0033-295X.108.4.709; Rosenbaum DA, 1999, EXP BRAIN RES, V128, P92, DOI 10.1007/s002210050823; Rosenbaum DA, 1999, MOTOR CONTROL, V3, P289, DOI 10.1123/mcj.3.3.289; Saling M, 1996, EXP BRAIN RES, V108, P493; Saling M, 1996, BEHAV BRAIN RES, V80, P153, DOI 10.1016/0166-4328(96)00030-7; Savelsbergh GJP, 1996, HUM MOVEMENT SCI, V15, P115, DOI 10.1016/0167-9457(95)00039-9; Schillings JJ, 1996, DECOMPOSING TRAJECTO; SERVOS P, 1994, EXP BRAIN RES, V98, P119; SERVOS P, 1992, VISION RES, V32, P1513, DOI 10.1016/0042-6989(92)90207-Y; Servos P, 2000, EXP BRAIN RES, V130, P35, DOI 10.1007/s002210050004; Simmons G, 2006, BIOL CYBERN, V94, P393, DOI 10.1007/s00422-006-0053-0; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Smeets JBJ, 2002, EXP BRAIN RES, V144, P132, DOI 10.1007/s00221-002-1056-2; Smeets JBJ, 2002, BEHAV BRAIN RES, V136, P427, DOI 10.1016/S0166-4328(02)00189-4; Smeets JBJ, 2001, EXP BRAIN RES, V139, P92, DOI 10.1007/s002210100748; Smeets JBJ, 2010, EXP BRAIN RES, V203, P339, DOI 10.1007/s00221-010-2236-0; Steenbergen B, 1999, MOTOR CONTROL, V3, P302, DOI 10.1123/mcj.3.3.302; Timmann D, 1996, EXP BRAIN RES, V108, P486; Tresilian JR, 1997, EXP BRAIN RES, V115, P283, DOI 10.1007/PL00005697; Tresilian JR, 1998, EXP BRAIN RES, V120, P352, DOI 10.1007/s002210050409; Ulloa A, 2003, NEURAL NETWORKS, V16, P1141, DOI 10.1016/S0893-6080(03)00079-0; van de Kamp C, 2007, EXP BRAIN RES, V182, P27, DOI 10.1007/s00221-007-0968-2; Whitwell RL, 2008, EXP BRAIN RES, V188, P603, DOI 10.1007/s00221-008-1395-8; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; WOLPERT DM, 1994, EXP BRAIN RES, V98, P153; ZAAL FTJM, 1993, HUM MOVEMENT SCI, V12, P339, DOI 10.1016/0167-9457(93)90023-I; Zoia S, 2006, DEV NEUROPSYCHOL, V30, P719, DOI 10.1207/s15326942dn3002_4	81	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33150	10.1371/journal.pone.0033150	http://dx.doi.org/10.1371/journal.pone.0033150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	929KK	22412997	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800084
J	Tordjman, S; Anderson, GM; Botbol, M; Toutain, A; Sarda, P; Carlier, M; Saugier-Veber, P; Baumann, C; Cohen, D; Lagneaux, C; Tabet, AC; Verloes, A				Tordjman, Sylvie; Anderson, George M.; Botbol, Michel; Toutain, Annick; Sarda, Pierre; Carlier, Michele; Saugier-Veber, Pascale; Baumann, Clarisse; Cohen, David; Lagneaux, Celine; Tabet, Anne-Claude; Verloes, Alain			Autistic Disorder in Patients with Williams-Beuren Syndrome: A Reconsideration of the Williams-Beuren Syndrome Phenotype	PLOS ONE			English	Article							DEVELOPMENTAL LANGUAGE DISORDERS; ELFIN FACIES SYNDROME; MENTAL-RETARDATION; YOUNG-CHILDREN; ELASTIN GENE; PERSONALITY-CHARACTERISTICS; HIGH-LEVEL; SPECTRUM; ADOLESCENTS; DELETION	Background: Williams-Beuren syndrome (WBS), a rare developmental disorder caused by deletion of contiguous genes at 7q11.23, has been characterized by strengths in socialization (overfriendliness) and communication (excessive talkativeness). WBS has been often considered as the polar opposite behavioral phenotype to autism. Our objective was to better understand the range of phenotypic expression in WBS and the relationship between WBS and autistic disorder. Methodology: The study was conducted on 9 French individuals aged from 4 to 37 years old with autistic disorder associated with WBS. Behavioral assessments were performed using Autism Diagnostic Interview-Revised (ADI-R) and Autism Diagnostic Observation Schedule (ADOS) scales. Molecular characterization of the WBS critical region was performed by FISH. Findings: FISH analysis indicated that all 9 patients displayed the common WBS deletion. All 9 patients met ADI-R and ADOS diagnostic criteria for autism, displaying stereotypies and severe impairments in social interaction and communication (including the absence of expressive language). Additionally, patients showed improvement in social communication over time. Conclusions: The results indicate that comorbid autism and WBS is more frequent than expected and suggest that the common WBS deletion can result in a continuum of social communication impairment, ranging from excessive talkativeness and overfriendliness to absence of verbal language and poor social relationships. Appreciation of the possible co-occurrence of WBS and autism challenges the common view that WBS represents the opposite behavioral phenotype of autism, and might lead to improved recognition of WBS in individuals diagnosed with autism.	[Tordjman, Sylvie; Botbol, Michel] Univ Rennes 1, Guillaume Regnier Hosp, Dept Child & Adolescent Psychiat, Rennes, France; [Tordjman, Sylvie] Univ Paris 05, Lab Psychol Percept, Paris, France; [Tordjman, Sylvie] CNRS, UMR 8158, Paris, France; [Anderson, George M.; Baumann, Clarisse] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Toutain, Annick] Tours Univ Hosp, Dept Genet, Tours, France; [Sarda, Pierre] Montpellier Univ Hosp, Dept Genet, Montpellier, France; [Carlier, Michele] Aix Marseille Univ, UMR 7290, CNRS, Lab Psychol Cognit, Marseille, France; [Carlier, Michele] Inst Univ France, Marseille, France; [Saugier-Veber, Pascale] Rouen Univ Hosp, Dept Genet, Rouen, France; [Cohen, David] Univ Paris 06, Hosp Pitie Salpetriere, Dept Child & Adolescent Psychiat, Paris, France; [Lagneaux, Celine; Tabet, Anne-Claude; Verloes, Alain] Robert Debre Univ Hosp, AP HP, Dept Genet, Paris, France	CHU Rennes; Universite de Rennes; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Yale University; CHU Tours; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut Universitaire de France; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP	Tordjman, S (corresponding author), Univ Rennes 1, Guillaume Regnier Hosp, Dept Child & Adolescent Psychiat, Rennes, France.	s.tordjman@yahoo.fr	/AAK-8500-2021; VERLOES, Alain/E-7287-2014	VERLOES, Alain/0000-0003-4819-0264; Toutain, Annick/0000-0002-5999-5300; Saugier-Veber, Pascale/0000-0002-8045-6432	INSERM CRE [931009]	INSERM CRE	INSERM CRE 931009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4; Anastasi A., 1988, PSYCHOL TESTING; Anderson GM, 2002, MOL PSYCHIATR, V7, P831, DOI 10.1038/sj.mp.4001099; AUGUST GJ, 1989, J AUTISM DEV DISORD, V19, P137, DOI 10.1007/BF02212725; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; BENNETT FC, 1978, PEDIATRICS, V61, P303; Berg JS, 2007, GENET MED, V9, P427, DOI 10.1097/GIM.0b013e3180986192; BEUREN AJ, 1962, CIRCULATION, V26, P1235, DOI 10.1161/01.CIR.26.6.1235; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; BROOK SL, 1992, J AUTISM DEV DISORD, V22, P61, DOI 10.1007/BF01046403; Brune CW, 2006, AM J PSYCHIAT, V163, P2148, DOI 10.1176/appi.ajp.163.12.2148; BRYSON SE, 1997, HDB AUTISM PERVASIVE, P41; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; Davies M, 1998, BRIT J PSYCHIAT, V172, P273, DOI 10.1192/bjp.172.3.273; Depienne C, 2007, J MED GENET, V44, P452, DOI 10.1136/jmg.2006.047092; Deruelle C, 1999, BRAIN COGNITION, V41, P276, DOI 10.1006/brcg.1999.1127; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Frigerio E, 2006, NEUROPSYCHOLOGIA, V44, P254, DOI 10.1016/j.neuropsychologia.2005.05.008; Gagliardi C, 2003, J MED GENET, V40, P526, DOI 10.1136/jmg.40.7.526; GILLBERG C, 1994, J AUTISM DEV DISORD, V24, P381, DOI 10.1007/BF02172235; Gosch A, 1997, DEV MED CHILD NEUROL, V39, P527; Grant J, 2002, J CHILD LANG, V29, P403, DOI 10.1017/S030500090200510X; Gray V, 2006, NEUROPSYCHOLOGIA, V44, P679, DOI 10.1016/j.neuropsychologia.2005.08.007; GREENBERG F, 1990, AM J MED GENET, P85; Herguner S, 2006, WORLD J BIOL PSYCHIA, V7, P186, DOI 10.1080/15622970600584221; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; JONES KL, 1975, J PEDIATR-US, V86, P718, DOI 10.1016/S0022-3476(75)80356-8; Jones W, 2000, J COGNITIVE NEUROSCI, V12, P30, DOI 10.1162/089892900561968; Kanner L, 1943, NERV CHILD, V2, P217; Karmiloff-Smith A, 2004, J CHILD PSYCHOL PSYC, V45, P1258, DOI 10.1111/j.1469-7610.2004.00322.x; Karmiloff-Smith A, 1998, TRENDS COGN SCI, V2, P389, DOI 10.1016/S1364-6613(98)01230-3; KarmiloffSmith A, 1997, CHILD DEV, V68, P246, DOI 10.1111/j.1467-8624.1997.tb01938.x; Klein-Tasman BP, 2007, CHILD NEUROPSYCHOL, V13, P444, DOI 10.1080/09297040601033680; Klein-Tasman BP, 2011, J AUTISM DEV DISORD, V41, P341, DOI 10.1007/s10803-010-1060-5; Klein-Tasman BP, 2009, J DEV BEHAV PEDIATR, V30, P289, DOI 10.1097/DBP.0b013e3181ad1f9a; Klein-Tasman BP, 2003, DEV NEUROPSYCHOL, V23, P269, DOI 10.1207/S15326942DN231&2_12; Laing E, 2002, DEVELOPMENTAL SCI, V5, P233; Laws G, 2004, INT J LANG COMM DIS, V39, P45, DOI 10.1080/13682820310001615797; Levitin DJ, 2004, CHILD NEUROPSYCHOL, V10, P223, DOI 10.1080/09297040490909288; Leyfer OT, 2006, AM J MED GENET B, V141B, P615, DOI 10.1002/ajmg.b.30344; Lincoln AJ, 2007, J AM ACAD CHILD PSY, V46, P323, DOI 10.1097/chi.0b013e31802b9522; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Magano LF, 2001, EUR J HUM GENET, V9, P244; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Mervis CB, 2007, MENT RETARD DEV D R, V13, P3, DOI 10.1002/mrdd.20140; Mervis CB, 1999, AM J HUM GENET, V65, P1222, DOI 10.1086/302633; Mervis CB, 2001, AM J MENT RETARD, V106, P82, DOI 10.1352/0895-8017(2001)106<0082:ABOTYO>2.0.CO;2; Mervis CB, 2000, MENT RETARD DEV D R, V6, P148; Mervis CB, 2000, DEV NEUROPSYCHOL, V17, P111, DOI 10.1207/S15326942DN1701_07; Metcalfe K, 2000, EUR J HUM GENET, V8, P955, DOI 10.1038/sj.ejhg.5200564; Miles JH, 2000, AM J MED GENET, V91, P245, DOI 10.1002/(SICI)1096-8628(20000410)91:4<245::AID-AJMG1>3.3.CO;2-U; Mises R, 1993, 10OMS CIM; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; OLSON TM, 1995, HUM MOL GENET, V4, P1677, DOI 10.1093/hmg/4.9.1677; Paterson SJ, 1999, SCIENCE, V286, P2355, DOI 10.1126/science.286.5448.2355; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Rapin I, 1996, J CHILD PSYCHOL PSYC, V37, P643, DOI 10.1111/j.1469-7610.1996.tb01456.x; REISS AL, 1985, J PEDIATR-US, V106, P247, DOI 10.1016/S0022-3476(85)80296-1; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sarimski K, 1997, EUR CHILD ADOLES PSY, V6, P26, DOI 10.1007/BF00573637; Saugier-Veber P, 2006, EUR J HUM GENET, V14, P1009, DOI 10.1038/sj.ejhg.5201661; Shields J, 1996, DEV MED CHILD NEUROL, V38, P473; Somerville MJ, 2005, NEW ENGL J MED, V16, P353; Stojanovik V, 2001, INT J LANG COMM DIS, V36, P234, DOI 10.3109/13682820109177890; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Sullivan K, 1999, AM J MENT RETARD, V104, P523, DOI 10.1352/0895-8017(1999)104<0523:SBAIWS>2.0.CO;2; Sullivan K, 2003, DEV NEUROPSYCHOL, V23, P85, DOI 10.1207/S15326942DN231&2_5; Sung YJ, 2005, AM J HUM GENET, V76, P68, DOI 10.1086/426951; Tager-Flusberg H, 2000, COGNITION, V76, P59, DOI 10.1016/S0010-0277(00)00069-X; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tassabehji M, 1998, HUM MOL GENET, V7, P1021, DOI 10.1093/hmg/7.6.1021; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Thomas ML, 2002, 9 INT PROF M WILL SY; Thomas MSC, 2001, LANG COGNITIVE PROC, V16, P143, DOI 10.1080/01690960042000021; Tordjman S, 2005, BIOL PSYCHIAT, V57, P134, DOI 10.1016/j.biopsych.2004.11.003; TORDJMAN S, 2001, MOL PSYCHIATR, V5, P831; UDWIN O, 1991, J CLIN EXP NEUROPSYC, V13, P232, DOI 10.1080/01688639108401040; Van der Aa N, 2009, EUR J MED GENET, V52, P94, DOI 10.1016/j.ejmg.2009.02.006; van Lieshout CFM, 1998, J CHILD PSYCHOL PSYC, V39, P699, DOI 10.1017/S002196309800256X; Vicari S, 2002, NEUROPSYCHOLOGIA, V40, P2461, DOI 10.1016/S0028-3932(02)00083-0; Volterra V, 1996, CORTEX, V32, P663, DOI 10.1016/S0010-9452(96)80037-2; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311	94	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e30778	10.1371/journal.pone.0030778	http://dx.doi.org/10.1371/journal.pone.0030778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928XD	22412832	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100004
J	Disanto, G; Sandve, GK; Berlanga-Taylor, AJ; Morahan, JM; Dobson, R; Giovannoni, G; Ramagopalan, SV				Disanto, Giulio; Sandve, Geir Kjetil; Berlanga-Taylor, Antonio J.; Morahan, Julia M.; Dobson, Ruth; Giovannoni, Gavin; Ramagopalan, Sreeram V.			Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells	PLOS ONE			English	Article							RITUXIMAB; CXCL13; RISK; MS	More than 50 genomic regions have now been shown to influence the risk of multiple sclerosis (MS). However, the mechanisms of action, and the cell types in which these associated variants act at the molecular level remain largely unknown. This is especially true for associated regions containing no known genes. Given the evidence for a role for B cells in MS, we hypothesized that MS associated genomic regions co-localized with regions which are functionally active in B cells. We used publicly available data on 1) MS associated regions and single nucleotide polymorphisms (SNPs) and 2) chromatin profiling in B cells as well as three additional cell types thought to be unrelated to MS (hepatocytes, fibroblasts and keratinocytes). Genomic intervals and SNPs were tested for overlap using the Genomic Hyperbrowser. We found that MS associated regions are significantly enriched in strong enhancer, active promoter and strong transcribed regions (p = 0.00005) and that this overlap is significantly higher in B cells than control cells. In addition, MS associated SNPs also land in active promoter (p = 0.00005) and enhancer regions more than expected by chance (strong enhancer p = 0.0006; weak enhancer p = 0.00005). These results confirm the important role of the immune system and specifically B cells in MS and suggest that MS risk variants exert a gene regulatory role. Previous studies assessing MS risk variants in T cells may be missing important effects in B cells. Similar analyses in other immunological cell types relevant to MS and functional studies are necessary to fully elucidate how genes contribute to MS pathogenesis.	[Disanto, Giulio; Berlanga-Taylor, Antonio J.; Morahan, Julia M.; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Disanto, Giulio; Morahan, Julia M.; Ramagopalan, Sreeram V.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci Clin Neurol, Oxford OX3 9DU, England; [Sandve, Geir Kjetil] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Berlanga-Taylor, Antonio J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Dobson, Ruth; Giovannoni, Gavin; Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oslo; University of Oxford; University of London; Queen Mary University London	Disanto, G (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	s.ramagopalan@qmul.ac.uk		Morahan, Julia/0000-0001-9278-0603; McKeating, Jane/0000-0002-7229-5886; Sandve, Geir Kjetil/0000-0002-4959-1409	FISM-Fondazione Italiana Sclerosi Multipla [2010/B/5]; EMBIO at the University of Oslo; National Council for Science and Technology (CONACyT), Mexico; Multiple Sclerosis Society of Great Britain and Northern Ireland; MS Society of Australia; joint ABN/Multiple Sclerosis Society of Great Britain; Bayer Schering Pharma; Biogen Idec; Merck Serono; Novartis; UCB; Merz Pharmaceuticals; LLC; Teva Pharmaceutical Industries Ltd.; sanofiaventis; GW Pharma; Ironwood; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of Great Britain; Northern Ireland; Medical Research Council [G0801976]; Wellcome Trust [075491/Z/04]; MRC [G0801975, G0801976] Funding Source: UKRI; Medical Research Council [G0801975] Funding Source: researchfish	FISM-Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); EMBIO at the University of Oslo; National Council for Science and Technology (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Multiple Sclerosis Society of Great Britain and Northern Ireland; MS Society of Australia; joint ABN/Multiple Sclerosis Society of Great Britain; Bayer Schering Pharma(Bayer AG); Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); UCB(UCB Pharma SA); Merz Pharmaceuticals; LLC; Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); sanofiaventis(Sanofi-Aventis); GW Pharma; Ironwood; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of Great Britain; Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Disanto is funded by research fellowship FISM-Fondazione Italiana Sclerosi Multipla-Cod.: 2010/B/5. Dr. Kjetil is supported by EMBIO at the University of Oslo. Dr. Berlanga-Taylor is funded by the National Council for Science and Technology (CONACyT), Mexico, and the Multiple Sclerosis Society of Great Britain and Northern Ireland. Dr. Morahan is funded by the MS Society of Australia and the UK. Dr. Dobson is funded by a joint ABN/Multiple Sclerosis Society of Great Britain Clinical Research Fellowship. Dr. Giovannoni serves on scientific advisory boards for Merck Serono and Biogen Idec and Vertex Pharmaceuticals; has served on the editorial board of Multiple Sclerosis; has received speaker honoraria from Bayer Schering Pharma, Merck Serono, Biogen Idec, Pfizer Inc, Teva Pharmaceutical Industries Ltd.-sanofiaventis, Vertex Pharmaceuticals, Genzyme Corporation, Ironwood, and Novartis; has served as a consultant for Bayer Schering Pharma, Biogen Idec, GlaxoSmithKline, Merck Serono, Protein Discovery Laboratories, Teva Pharmaceutical Industries Ltd.-sanofiaventis, UCB, Vertex Pharmaceuticals, GW Pharma, Novartis, and FivePrime; serves on the speakers bureau for Merck Serono; and has received research support from Bayer Schering Pharma, Biogen Idec, Merck Serono, Novartis, UCB, Merz Pharmaceuticals, LLC, Teva Pharmaceutical Industries Ltd.-sanofiaventis, GW Pharma, and Ironwood. Dr. Ramagopalan receives research support from the Multiple Sclerosis Society of Canada Scientific Research Foundation and the Multiple Sclerosis Society of Great Britain and Northern Ireland. This work was supported by the Medical Research Council (G0801976), the Wellcome Trust (075491/Z/04), and by a research fellowship FISM Fondazione Italiana Sclerosi Multipla-Cod.: 2010/B/5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Barun B, 2011, CLIN IMMUNOL; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Brettschneider J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007638; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P292, DOI 10.1136/jnnp.2008.150896; Kasper LH, 2010, NEUROLOGY, V74, pS2, DOI 10.1212/WNL.0b013e3181c97c8f; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Piccio L, 2010, ARCH NEUROL-CHICAGO, V67, P707, DOI 10.1001/archneurol.2010.99; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schneider R, 2011, J IMMUNOL, V187, P4119, DOI 10.4049/jimmunol.1100885; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; von Budingen HC, 2011, CURR OPIN IMMUNOL	21	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32281	10.1371/journal.pone.0032281	http://dx.doi.org/10.1371/journal.pone.0032281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396755	Green Published, gold			2022-12-25	WOS:000303006500014
J	Hove, MJ; Suzuki, K; Uchitomi, H; Orimo, S; Miyake, Y				Hove, Michael J.; Suzuki, Kazuki; Uchitomi, Hirotaka; Orimo, Satoshi; Miyake, Yoshihiro			Interactive Rhythmic Auditory Stimulation Reinstates Natural 1/f Timing in Gait of Parkinson's Patients	PLOS ONE			English	Article							FRACTAL DYNAMICS; SENSORIMOTOR SYNCHRONIZATION; BASAL GANGLIA; DISEASE; MOVEMENT; POWER; PREDICTABILITY; FLUCTUATION; INTERVALS	Parkinson's disease (PD) and basal ganglia dysfunction impair movement timing, which leads to gait instability and falls. Parkinsonian gait consists of random, disconnected stride times-rather than the 1/f structure observed in healthy gait-and this randomness of stride times (low fractal scaling) predicts falling. Walking with fixed-tempo Rhythmic Auditory Stimulation (RAS) can improve many aspects of gait timing; however, it lowers fractal scaling (away from healthy 1/f structure) and requires attention. Here we show that interactive rhythmic auditory stimulation reestablishes healthy gait dynamics in PD patients. In the experiment, PD patients and healthy participants walked with a) no auditory stimulation, b) fixed-tempo RAS, and c) interactive rhythmic auditory stimulation. The interactive system used foot sensors and nonlinear oscillators to track and mutually entrain with the human's step timing. Patients consistently synchronized with the interactive system, their fractal scaling returned to levels of healthy participants, and their gait felt more stable to them. Patients and healthy participants rarely synchronized with fixed-tempo RAS, and when they did synchronize their fractal scaling declined from healthy 1/f levels. Five minutes after removing the interactive rhythmic stimulation, the PD patients' gait retained high fractal scaling, suggesting that the interaction stabilized the internal rhythm generating system and reintegrated timing networks. The experiment demonstrates that complex interaction is important in the (re) emergence of 1/f structure in human behavior and that interactive rhythmic auditory stimulation is a promising therapeutic tool for improving gait of PD patients.	[Hove, Michael J.; Suzuki, Kazuki; Uchitomi, Hirotaka; Miyake, Yoshihiro] Tokyo Inst Technol, Yokohama, Kanagawa 227, Japan; [Hove, Michael J.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Orimo, Satoshi] Kanto Cent Hosp, Dept Neurol, Tokyo, Japan	Tokyo Institute of Technology; Max Planck Society	Hove, MJ (corresponding author), Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 227, Japan.	hove@cbs.mpg.de			Japan Society for the Promotion of Science; Fulbright Fellowship	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fulbright Fellowship	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid to Dr. Miyake and a Fulbright Fellowship to Dr. Hove. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bartsch R, 2007, PHYSICA A, V383, P455, DOI 10.1016/j.physa.2007.04.120; BROTCHIE P, 1991, BRAIN, V114, P1685, DOI 10.1093/brain/114.4.1685; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Chen YQ, 2001, J MOTOR BEHAV, V33, P3, DOI 10.1080/00222890109601897; CUNNINGTON R, 1995, BRAIN, V118, P935, DOI 10.1093/brain/118.4.935; Delignieres D, 2009, J APPL PHYSIOL, V106, P1272, DOI 10.1152/japplphysiol.90757.2008; Fisher NI, 1995, STAT ANAL CIRCULAR D; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Ihlen EAF, 2010, J EXP PSYCHOL GEN, V139, P436, DOI 10.1037/a0019098; Jankovic J, PARKINSONS DIS MOVEM; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kello CT, 2010, TRENDS COGN SCI, V14, P223, DOI 10.1016/j.tics.2010.02.005; Kelso JAS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005749; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Miyake Y., 1994, Proceedings. 3rd IEEE International Workshop on Robot and Human Communication. RO-MAN '94 Nagoya (Cat. No.94TH0679-1), P118, DOI 10.1109/ROMAN.1994.365945; Miyake Y, 1997, IEEE SYS MAN CYBERN, P293, DOI 10.1109/ICSMC.1997.625765; Miyake Y, 2004, TRANSACTION SOC INST, P195; Miyake Y, 2009, IEEE T ROBOT, V25, P638, DOI 10.1109/TRO.2009.2020350; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Muto T, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P1240, DOI 10.1109/ICCME.2007.4381942; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pierrynowski MR, 2005, GAIT POSTURE, V22, P46, DOI 10.1016/j.gaitpost.2004.06.007; Rankin SK, 2009, MUSIC PERCEPT, V26, P401, DOI 10.1525/MP.2009.26.5.401; Repp BH, 2006, ACTA PSYCHOL, V121, P81, DOI 10.1016/j.actpsy.2005.06.006; Repp BH, 2003, J EXP PSYCHOL HUMAN, V29, P290, DOI 10.1037/0096-1523.29.2.290; Repp BH, 2008, HUM MOVEMENT SCI, V27, P423, DOI 10.1016/j.humov.2008.02.016; Rubinstein TC, 2002, MOVEMENT DISORD, V17, P1148, DOI 10.1002/mds.10259; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; SCHMIDT RC, 1991, J EXP PSYCHOL HUMAN, V17, P635, DOI 10.1037/0096-1523.17.3.635; Schwartze M, 2010, BEHAV BRAIN RES; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; Torre K, 2009, HUM MOVEMENT SCI, V28, P297, DOI 10.1016/j.humov.2009.01.001	50	117	121	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32600	10.1371/journal.pone.0032600	http://dx.doi.org/10.1371/journal.pone.0032600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396783	Green Published, gold			2022-12-25	WOS:000303006500029
J	Yue, XS; Fujishiro, M; Nishioka, C; Arai, T; Takahashi, E; Gong, JS; Akaike, T; Ito, Y				Yue, Xiao-Shan; Fujishiro, Masako; Nishioka, Chieko; Arai, Takashi; Takahashi, Eiki; Gong, Jian-Sheng; Akaike, Toshihiro; Ito, Yoshihiro			Feeder Cells Support the Culture of Induced Pluripotent Stem Cells Even after Chemical Fixation	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; SYNTHETIC-POLYMER COATINGS; SELF-RENEWAL; DIFFERENTIATION; DERIVATION; GROWTH; IMMOBILIZATION; GENERATION; MURINE; LIF	Chemically fixed mouse embryonic fibroblasts (MEFs), instead of live feeder cells, were applied to the maintenance of mouse induced pluripotent stem (miPS) cells. Formaldehyde and glutaraldehyde were used for chemical fixation. The chemically fixed MEF feeders maintained the pluripotency of miPS cells, as well as their undifferentiated state. Furthermore, the chemically fixed MEF feeders were reused several times without affecting their functions. These results indicate that chemical fixation can be applied to modify biological feeders chemically, without losing their original functions. Chemically fixed MEF feeders will be applicable to other stem cell cultures as a reusable extracellular matrix candidate that can be preserved on a long-term basis.	[Yue, Xiao-Shan; Fujishiro, Masako; Gong, Jian-Sheng; Ito, Yoshihiro] RIKEN Adv Sci Inst, Nano Med Engn Lab, Wako, Saitama, Japan; [Yue, Xiao-Shan; Akaike, Toshihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Nishioka, Chieko; Arai, Takashi; Takahashi, Eiki] RIKEN Brain Sci Inst, Res Resources Ctr, Support Unit Anim Resources Dev, Wako, Saitama, Japan	RIKEN; Tokyo Institute of Technology; RIKEN	Yue, XS (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	y-ito@riken.jp	Ito, Yoshihiro/F-4370-2012; Takahashi, Eiki/N-6998-2015; Ito, Yoshihiro/T-1095-2019	Ito, Yoshihiro/0000-0002-1154-253X	Ministry of Education, Sports, Science and Technology of Japan; Global COE Program; Grants-in-Aid for Scientific Research [22220009, 23220014] Funding Source: KAKEN	Ministry of Education, Sports, Science and Technology of Japan(Core Research for Evolutional Science and Technology (CREST)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by grants from the Ministry of Education, Sports, Science and Technology of Japan. This work was supported financially by a Grant-in-Aid from the Global COE Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222; Baker M, 2011, NAT METHODS, V8, P293, DOI 10.1038/nmeth0411-293; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Dickinson LE, 2011, MACROMOL BIOSCI, V11, P36, DOI 10.1002/mabi.201000245; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Ito Y, 2007, J BIOSCI BIOENG, V103, P113, DOI 10.1263/jbb.103.113; Ito Y, 2006, J BIOSCI BIOENG, V102, P467, DOI 10.1263/jbb.102.467; Konno T, 2006, J BIOSCI BIOENG, V102, P304, DOI 10.1263/jbb.102.304; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Lee JH, 2009, FERTIL STERIL, V92, P1133, DOI 10.1016/j.fertnstert.2008.07.1733; Li L, 2010, NAT METHODS, V7, P989, DOI DOI 10.1038/NMETH.1532; Loh XJ, 2009, MACROMOL BIOSCI, V9, P1069, DOI 10.1002/mabi.200900081; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Makino H, 2004, J BIOSCI BIOENG, V98, P374, DOI 10.1263/jbb.98.374; Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015; Nandivada H, 2011, NAT PROTOC, V6, P1037, DOI 10.1038/nprot.2011.342; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yue XS, 2010, BIOMATERIALS, V31, P5287, DOI 10.1016/j.biomaterials.2010.03.035	30	27	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32707	10.1371/journal.pone.0032707	http://dx.doi.org/10.1371/journal.pone.0032707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396791	Green Published, gold, Green Submitted			2022-12-25	WOS:000303006500033
J	Goehring, I; Gerencser, AA; Schmidt, S; Brand, MD; Mulder, H; Nicholls, DG				Goehring, Isabel; Gerencser, Akos A.; Schmidt, Sara; Brand, Martin D.; Mulder, Hindrik; Nicholls, David G.			Plasma Membrane Potential Oscillations in Insulin Secreting Ins-1 832/13 Cells Do Not Require Glycolysis and Are Not Initiated by Fluctuations in Mitochondrial Bioenergetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; CYTOPLASMIC FREE CA2+; OXYGEN-CONSUMPTION; GLUCOSE; METABOLISM; CALCIUM; ISLETS; VISUALIZATION; EXOCYTOSIS; ENERGETICS	Oscillations in plasma membrane potential play a central role in glucose-induced insulin secretion from pancreatic beta-cells and related insulinoma cell lines. We have employed a novel fluorescent plasma membrane potential (Delta psi(p)) indicator in combination with indicators of cytoplasmic free Ca2+ ([Ca2+](c)), mitochondrial membrane potential (Delta psi(m)), matrix ATP concentration, and NAD(P)H fluorescence to investigate the role of mitochondria in the generation of plasma membrane potential oscillations in clonal INS-1 832/13 beta-cells. Elevated glucose caused oscillations in plasma membrane potential and cytoplasmic free Ca2+ concentration over the same concentration range required for insulin release, although considerable cell-to-cell heterogeneity was observed. Exogenous pyruvate was as effective as glucose in inducing oscillations, both in the presence and absence of 2.8mM glucose. Increased glucose and pyruvate each produced a concentration-dependent mitochondrial hyperpolarization. The causal relationships between pairs of parameters (Delta psi(p) and [Ca2+](c), Delta psi(p) and NAD(P)H, matrix ATP and [Ca2+](c), and Delta psi(m) and [Ca2+](c)) were investigated at single cell level. It is concluded that, in these beta-cells, depolarizing oscillations in Delta psi(p) are not initiated by mitochondrial bioenergetic changes. Instead, regardless of substrate, it appears that the mitochondria may simply be required to exceed a critical bioenergetic threshold to allow release of insulin. Once this threshold is exceeded, an autonomous Delta psi(p) oscillatory mechanism is initiated.	[Nicholls, David G.] Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Mol Metab,CRC, S-20502 Malmo, Sweden; [Gerencser, Akos A.; Brand, Martin D.; Nicholls, David G.] Buck Inst Res Aging, Novato, CA 94945 USA	Lund University; Buck Institute for Research on Aging	Nicholls, DG (corresponding author), Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Mol Metab,CRC, S-20502 Malmo, Sweden.	david.nicholls@med.lu.se	Brand, Martin D/A-9423-2012; NICHOLLS, DAVID G/K-4300-2012; Mulder, Hindrik/E-1045-2012	Brand, Martin D/0000-0003-4418-6153; Mulder, Hindrik/0000-0002-6593-8417	National Institutes of Health [P01 AG025901, P30 AG025708]; Swedish Research Council; Knut and Alice Wallenberg Foundation; NATIONAL INSTITUTE ON AGING [P01AG025901, P30AG025708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG025901 and P30 AG025708. This work was also supported by the Swedish Research Council and the Knut and Alice Wallenberg Foundation (to I. G., S. S., and H. M.).	Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Beauvois MC, 2006, AM J PHYSIOL-CELL PH, V290, pC1503, DOI 10.1152/ajpcell.00400.2005; Bergsten P, 2002, DIABETES, V51, pS171, DOI 10.2337/diabetes.51.2007.S171; Bertram R., 2007, AM J PHYSIOL-ENDOC M, V56, pE890; Brown LJ, 2009, J BIOL CHEM, V284, P35359, DOI 10.1074/jbc.M109.040394; Civelek VN, 1997, DIABETES, V46, P51, DOI 10.2337/diabetes.46.1.51; Cunningham MD, 1999, METH MOL B, V128, P179; Dahgren GM, 2005, BBA-GEN SUBJECTS, V1724, P23, DOI 10.1016/j.bbagen.2005.04.007; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; DUCHEN MR, 1992, J PHYSIOL-LONDON, V450, P33, DOI 10.1113/jphysiol.1992.sp019115; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; GILON P, 1993, J BIOL CHEM, V268, P22265; GILON P, 1992, J BIOL CHEM, V267, P20713; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Heart E., 2005, AM J PHYSIOL-ENDOC M, V290, P143; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; Hjortoe GM, 2004, ACTA DIABETOL, V41, P185, DOI 10.1007/s00592-004-0164-9; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; Kanno T, 2004, METHODS, V33, P302, DOI 10.1016/j.ymeth.2004.01.003; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kindmark H, 2001, J BIOL CHEM, V276, P34530, DOI 10.1074/jbc.M102492200; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Krippeit-Drews P, 2000, BIOCHEM BIOPH RES CO, V267, P179, DOI 10.1006/bbrc.1999.1921; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Magnus G, 1997, AM J PHYSIOL-CELL PH, V273, pC717, DOI 10.1152/ajpcell.1997.273.2.C717; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Nilsson T, 1996, BIOCHEM J, V314, P91, DOI 10.1042/bj3140091; Nunemaker CS, 2004, ENDOCRINE, V25, P61, DOI 10.1385/ENDO:25:1:61; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; PRALONG WF, 1994, J BIOL CHEM, V269, P27310; Rutter GA, 2004, CELL BIOCHEM BIOPHYS, P179; Song SH, 2000, J CLIN ENDOCR METAB, V85, P4491, DOI 10.1210/jc.85.12.4491; Ullrich S, 1996, PFLUG ARCH EUR J PHY, V432, P630, DOI 10.1007/s004240050179; Ward MW, 2000, J NEUROSCI, V20, P7208; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302	51	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15706	15717		10.1074/jbc.M111.314567	http://dx.doi.org/10.1074/jbc.M111.314567			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418435	hybrid, Green Published			2022-12-25	WOS:000304006300049
J	Lei, W; Feng, XH; Deng, WB; Ni, H; Zhang, ZR; Jia, B; Yang, XL; Wang, TS; Liu, JL; Su, RW; Liang, XH; Qi, QR; Yang, ZM				Lei, Wei; Feng, Xu-Hui; Deng, Wen-Bo; Ni, Hua; Zhang, Zhi-Rong; Jia, Bo; Yang, Xin-Ling; Wang, Tong-Song; Liu, Ji-Long; Su, Ren-Wei; Liang, Xiao-Huan; Qi, Qian-Rong; Yang, Zeng-Ming			Progesterone and DNA Damage Encourage Uterine Cell Proliferation and Decidualization through Up-regulating Ribonucleotide Reductase 2 Expression during Early Pregnancy in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIAL STROMAL CELLS; EMBRYO IMPLANTATION; MOUSE UTERUS; DIFFERENTIAL EXPRESSION; TOPOISOMERASE-I; GENE-EXPRESSION; REPLICATION; SUBUNIT; CHECKPOINT; INHIBITION	Embryo implantation into the maternal uterus is a crucial step for the successful establishment of mammalian pregnancy. Following the attachment of embryo to the uterine luminal epithelium, uterine stromal cells undergo steroid hormone-dependent decidualization, which is characterized by stromal cell proliferation and differentiation. The mechanisms underlying steroid hormone-induced stromal cell proliferation and differentiation during decidualization are still poorly understood. Ribonucleotide reductase, consisting of two subunits (RRM1 and RRM2), is a rate-limiting enzyme in deoxynucleotide production for DNA synthesis and plays an important role in cell proliferation and tumorgenicity. Based on our microarray analysis, Rrm2 expression was significantly higher at implantation sites compared with interimplantation sites in mouse uterus. However, the expression, regulation, and function of RRM2 in mouse uterus during embryo implantation and decidualization are still unknown. Here we show that although both RRM1 and RRM2 expression are markedly induced in mouse uterine stromal cells undergoing decidualization, only RRM2 is regulated by progesterone, a key regulator of decidualization. Further studies showed that the induction of progesterone on RRM2 expression in stromal cells is mediated by the AKT/c-MYC pathway. RRM2 can also be induced by replication stress and DNA damage during decidualization through the ATR/ATM-CHK1-E2F1 pathway. The weight of implantation sites and deciduoma was effectively reduced by specific inhibitors for RRM2. The expression of decidual/trophoblast prolactin-related protein (Dtprp), a reliable marker for decidualization in mice, was significantly reduced in deciduoma and steroid-induced decidual cells after HU treatment. Therefore, RRM2 may be an important effector of progesterone signaling to induce cell proliferation and decidualization in mouse uterus.	[Lei, Wei; Wang, Tong-Song; Liu, Ji-Long; Qi, Qian-Rong; Yang, Zeng-Ming] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China; [Lei, Wei; Ni, Hua; Su, Ren-Wei] NE Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China; [Feng, Xu-Hui; Deng, Wen-Bo; Zhang, Zhi-Rong; Jia, Bo; Yang, Xin-Ling; Liang, Xiao-Huan; Yang, Zeng-Ming] Xiamen Univ, Coll Life Sci, Xiamen 361005, Peoples R China	Shantou University; Northeast Agricultural University - China; Xiamen University	Yang, ZM (corresponding author), Shantou Univ, Dept Biol, Shantou 515063, Peoples R China.	zmyang@stu.edu.cn	yang, xin/HGU-9981-2022; feng, xuhui/D-9450-2017; Lei, Wei/N-7611-2013; Lei, Wei/I-3640-2014; ZHANG, Zhirong/A-3422-2015; Qi, Qian-Rong/AAV-7553-2020; Yang, xinling/HHC-1621-2022; Yang, ZM/G-4627-2010; feng, xuhui/AAD-9832-2019	feng, xuhui/0000-0003-4649-183X; Lei, Wei/0000-0002-8342-8859; ZHANG, Zhirong/0000-0002-7331-783X; Qi, Qian-Rong/0000-0003-0276-7187; Liu, Ji-Long/0000-0002-6948-2576	National Basic Research Program of China [2011CB944402]; National Natural Science Foundation of China [30930013, 31071276]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2011CB944402 and National Natural Science Foundation of China Grants 30930013 and 31071276.	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; ANSELL JD, 1974, J EMBRYOL EXP MORPH, V31, P223; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Dominguez-Caceres MA, 2004, ONCOGENE, V23, P7378, DOI 10.1038/sj.onc.1208002; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; Franco HL, 2008, SEMIN CELL DEV BIOL, V19, P178, DOI 10.1016/j.semcdb.2007.12.001; Fritzer-Szekeres M, 2002, BIOCHEM PHARMACOL, V64, P481, DOI 10.1016/S0006-2952(02)01186-3; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Herrler Andreas, 2003, Reprod Biomed Online, V6, P244; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Hu Zhang-Zhi, 2008, J Proteomics Bioinform, V1, P47; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Kajihara T, 2011, PLACENTA, V32, P592, DOI 10.1016/j.placenta.2011.05.002; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kimura F, 2001, GYNECOL ENDOCRINOL, V15, P426, DOI 10.1080/713602980; Kuschak TI, 1999, GENE, V238, P351, DOI 10.1016/S0378-1119(99)00341-8; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Ma XH, 2006, J BIOL CHEM, V281, P9351, DOI 10.1074/jbc.M511512200; Ma XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026774; MANN GJ, 1988, CANCER RES, V48, P5151; Ni H, 2002, BIOL REPROD, V67, P351, DOI 10.1095/biolreprod67.1.351; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Paria BC, 1999, ENDOCRINOLOGY, V140, P2704, DOI 10.1210/en.140.6.2704; Reese J, 2001, J BIOL CHEM, V276, P44137, DOI 10.1074/jbc.M107563200; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Saban N, 2009, CANCER CHEMOTH PHARM, V64, P213, DOI 10.1007/s00280-009-0991-z; Shao JM, 2004, CANCER RES, V64, P1, DOI 10.1158/0008-5472.CAN-03-3048; Spencer F, 2000, J APPL TOXICOL, V20, P407, DOI 10.1002/1099-1263(200009/10)20:5<407::AID-JAT704>3.0.CO;2-T; SZEKERES T, 1994, CANCER CHEMOTH PHARM, V34, P63, DOI 10.1007/BF00686113; Tan Y, 2004, DEV BIOL, V265, P181, DOI 10.1016/j.ydbio.2003.09.019; Wang CX, 2006, PLANT CELL, V18, P350, DOI 10.1105/tpc.105.037044; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BS, 2003, CANCER RES, V63, P6583	49	55	58	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15174	15192		10.1074/jbc.M111.308023	http://dx.doi.org/10.1074/jbc.M111.308023			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403396	hybrid, Green Published			2022-12-25	WOS:000304006300003
J	Laussmann, MA; Passante, E; Hellwig, CT; Tomiczek, B; Flanagan, L; Prehn, JHM; Huber, HJ; Rehm, M				Laussmann, Maike A.; Passante, Egle; Hellwig, Christian T.; Tomiczek, Bartlomiej; Flanagan, Lorna; Prehn, Jochen H. M.; Huber, Heinrich J.; Rehm, Markus			Proteasome Inhibition Can Impair Caspase-8 Activation upon Submaximal Stimulation of Apoptotic Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; CYTOCHROME-C; DEATH; PATHWAY; PS-341; FLIP; REVEALS; PROTEIN; BAX; RESISTANCE	Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) can induce extrinsic apoptosis, resulting in caspase-8 activation, but may also initiate transcription-dependent pro-survival signaling. Proteasome inhibitors were suggested to promote TRAIL signal transduction through the death-inducing signaling complex (DISC) by modulating the relative abundance of core DISC components, thereby enhancing caspase-8 activation and apoptosis. To test this hypothesis, we quantified the changes in DISC protein levels as an early consequence of proteasome inhibition in HeLa cervical cancer cells and, based on these data, mathematically modeled the proapoptotic TRAIL signaling toward caspase-8 activation. Modeling results surprisingly suggested that caspase-8 activation might be delayed in presence of proteasome inhibitors, in particular at submaximal TRAIL doses. Subsequent FRET-based single cell time-lapse imaging at conditions where transcription dependent pro-survival signaling was blocked confirmed this hypothesis: caspase-8 activity was delayed by hours in the presence of proteasome inhibitors epoxomicin or bortezomib. Corresponding delays were detected for effector caspase processing and cell death. Contrary to current models, we therefore provide evidence that synergies between TRAIL and proteasome inhibitors do not result from changes in the levels of core DISC signaling proteins.	[Laussmann, Maike A.; Passante, Egle; Hellwig, Christian T.; Tomiczek, Bartlomiej; Flanagan, Lorna; Prehn, Jochen H. M.; Huber, Heinrich J.; Rehm, Markus] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Passante, Egle; Hellwig, Christian T.; Flanagan, Lorna; Prehn, Jochen H. M.; Huber, Heinrich J.; Rehm, Markus] Royal Coll Surgeons Ireland, Ctr Syst Med, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Rehm, M (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, RCSI York House,York St, Dublin 2, Ireland.	mrehm@rcsi.ie	Rehm, Markus/C-3398-2012; Prehn, Jochen HM/A-3928-2010	Rehm, Markus/0000-0001-6149-9261; Prehn, Jochen HM/0000-0003-3479-7794; Tomiczek, Bartlomiej/0000-0001-9295-663X	Science Foundation Ireland [07/RFP/BICF601, 06/UR/B920]; Health Research Board Ireland [(RP/2006/258, RP/2008/7]; Royal College of Surgeons in Ireland Research Committee; National Biophotonics and Imaging Platform (HEA PRTLI Cycle 4); European Union	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board Ireland; Royal College of Surgeons in Ireland Research Committee; National Biophotonics and Imaging Platform (HEA PRTLI Cycle 4); European Union(European Commission)	This work was supported by grants from the Science Foundation Ireland (07/RFP/BICF601), the Health Research Board Ireland (RP/2006/258, RP/2008/7), the Royal College of Surgeons in Ireland Research Committee, the National Biophotonics and Imaging Platform (HEA PRTLI Cycle 4), and the European Union Framework Programme 7 (APO-SYS).; Supported by an undergraduate research experience and knowledge award from the Science Foundation Ireland (06/UR/B920).	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Brancolini Claudio, 2008, Curr Mol Pharmacol, V1, P24; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Concannon CG, 2007, ONCOGENE, V26, P1681, DOI 10.1038/sj.onc.1209974; Cusack JC, 2001, CANCER RES, V61, P3535; Dussmann H, 2010, CELL DEATH DIFFER, V17, P278, DOI 10.1038/cdd.2009.123; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Guo F, 2004, CANCER RES, V64, P2580, DOI 10.1158/0008-5472.CAN-03-2629; Harper N, 2003, J BIOL CHEM, V278, P44338, DOI 10.1074/jbc.M307376200; He Q, 2004, ONCOGENE, V23, P2554, DOI 10.1038/sj.onc.1207351; Hellwig CT, 2008, J BIOL CHEM, V283, P21676, DOI 10.1074/jbc.M802889200; Hellwig CT, 2012, MOL CANCER THER, V11, P3, DOI 10.1158/1535-7163.MCT-11-0434; Huber HJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.2; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Konstantinova IM, 2008, INT REV CEL MOL BIO, V267, P59, DOI 10.1016/S1937-6448(08)00602-3; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Laussmann MA, 2011, CELL DEATH DIFFER, V18, P1584, DOI 10.1038/cdd.2011.27; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Sayers TJ, 2003, BLOOD, V102, P303, DOI 10.1182/blood-2002-09-2975; Soderstrom TS, 2002, J IMMUNOL, V169, P2851, DOI 10.4049/jimmunol.169.6.2851; Sohn D, 2006, MOL CELL BIOL, V26, P1967, DOI 10.1128/MCB.26.5.1967-1978.2006; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152	36	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14402	14411		10.1074/jbc.M111.304378	http://dx.doi.org/10.1074/jbc.M111.304378			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22408249	Green Published, hybrid			2022-12-25	WOS:000304003200008
J	Chen, YJ; Magnani, D; Theil, T; Pratt, T; Price, DJ				Chen, Yijing; Magnani, Dario; Theil, Thomas; Pratt, Thomas; Price, David J.			Evidence That Descending Cortical Axons Are Essential for Thalamocortical Axons to Cross the Pallial-Subpallial Boundary in the Embryonic Forebrain	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; CEREBRAL-CORTEX; CELL-MIGRATION; DORSAL TELENCEPHALON; CONNECTIONS; GROWTH; PAX6; NEUREGULIN-1; PROJECTIONS; THALAMUS	Developing thalamocortical axons traverse the subpallium to reach the cortex located in the pallium. We tested the hypothesis that descending corticofugal axons are important for guiding thalamocortical axons across the pallial-subpallial boundary, using conditional mutagenesis to assess the effects of blocking corticofugal axonal development without disrupting thalamus, subpallium or the pallial-subpallial boundary. We found that thalamic axons still traversed the subpallium in topographic order but did not cross the pallial-subpallial boundary. Co-culture experiments indicated that the inability of thalamic axons to cross the boundary was not explained by mutant cortex developing a long-range chemorepulsive action on thalamic axons. On the contrary, cortex from conditional mutants retained its thalamic axonal growth-promoting activity and continued to express Nrg-1, which is responsible for this stimulatory effect. When mutant cortex was replaced with control cortex, corticofugal efferents were restored and thalamic axons from conditional mutants associated with them and crossed the pallial-subpallial boundary. Our study provides the most compelling evidence to date that cortical efferents are required to guide thalamocortical axons across the pallial-subpallial boundary, which is otherwise hostile to thalamic axons. These results support the hypothesis that thalamic axons grow from subpallium to cortex guided by cortical efferents, with stimulation from diffusible cortical growth-promoting factors.	[Chen, Yijing; Magnani, Dario; Theil, Thomas; Pratt, Thomas; Price, David J.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Chen, YJ (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	David.Price@ed.ac.uk		Chen, Yijing/0000-0001-8109-2207; Pratt, Thomas/0000-0002-7105-3527; Theil, Thomas/0000-0001-6590-8309; Price, David/0000-0002-5318-307X	Wellcome Trust [08420]; Medical Research Council [G0800429]; Medical Research Council [G0801359, MR/J003662/1] Funding Source: researchfish; MRC [G0801359, MR/J003662/1, G0800429] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Wellcome Trust (grant number 08420) and the Medical Research Council (grant number G0800429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; BENTLEY D, 1983, NATURE, V304, P62, DOI 10.1038/304062a0; BHAT RV, 1994, J NEUROSCI, V14, P3059; Bielle F, 2011, NEURON, V69, P1085, DOI 10.1016/j.neuron.2011.02.026; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Braisted JE, 2009, CEREB CORTEX, V19, pI144, DOI 10.1093/cercor/bhp035; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; Carney RSE, 2009, CEREB CORTEX, V19, P745, DOI 10.1093/cercor/bhn123; Chapouton P, 2001, DEVELOPMENT, V128, P5149; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Inoue T, 2001, DEVELOPMENT, V128, P561; Ivaniutsin U, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-3; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jones L, 2002, DEVELOPMENT, V129, P5041; Liu Y, 2005, DEV BIOL, V283, P437, DOI 10.1016/j.ydbio.2005.04.038; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Metin C, 1996, J NEUROSCI, V16, P3219; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Molnar Z, 2003, CEREB CORTEX, V13, P661, DOI 10.1093/cercor/13.6.661; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Mort RL, 2009, J ANAT, V215, P698, DOI 10.1111/j.1469-7580.2009.01150.x; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Powell AW, 2008, PLOS BIOL, V6, P1047, DOI 10.1371/journal.pbio.0060116; Pratt T, 2000, DEVELOPMENT, V127, P5167; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; RENNIE S, 1994, NEUROSCIENCE, V61, P547, DOI 10.1016/0306-4522(94)90433-2; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tian NM, 2008, DEVELOPMENT, V135, P4081, DOI 10.1242/dev.023572; Toresson H, 2000, DEVELOPMENT, V127, P4361; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Votin V, 2005, J CELL SCI, V118, P5699, DOI 10.1242/jcs.02679; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zaki PA, 2003, CURR OPIN GENET DEV, V13, P423, DOI 10.1016/S0959-437X(03)00084-4; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244	43	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33105	10.1371/journal.pone.0033105	http://dx.doi.org/10.1371/journal.pone.0033105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412988	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000032
J	Foreman, HCC; Van Scoy, S; Cheng, TF; Reich, NC				Foreman, Hui-Chen Chang; Van Scoy, Sarah; Cheng, Tsu-Fan; Reich, Nancy C.			Activation of Interferon Regulatory Factor 5 by Site Specific Phosphorylation	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NF-KAPPA-B; TOLL-LIKE RECEPTOR; NOD-LIKE RECEPTORS; TRANSCRIPTION FACTORS; POLYUBIQUITIN CHAINS; SIGNALING PATHWAYS; IMMUNE-RESPONSES; INNATE IMMUNITY; NUCLEAR EXPORT	The cellular defense to infection depends on accurate activation of transcription factors and expression of select innate immunity genes. Interferon regulatory factor 5 (IRF5), a risk factor for systemic lupus erythematosus, is activated in response to pathogen recognition receptor engagement and downstream effector molecules. We find the nucleotide-binding oligomerization domain containing protein 2 (NOD2) receptor to be a significant activator of IRF5. Phosphorylation is key to the regulation of IRF5, but the precise phosphorylation sites in IRF5 remained to be identified. We used mass spectrometry to identify for the first time specific residues that are phosphorylated in response to TANK-binding kinase-1 (TBK-1), tumor necrosis factor receptor-associated factor 6 (TRAF6), or receptor interacting protein 2 (RIP2). RIP2, a kinase known to function downstream of NOD2, was the most effective activator of IRF5-regulated gene expression. To determine if the phosphorylated residues are required or sufficient for IRF5 activity, aspartic acid phosphomimetic substitutions or inactivating alanine substitutions were tested. Phosphorylation of carboxyl serines 451 and 462 appear the primary trigger of IRF5 function in nuclear accumulation, transcription, and apoptosis. Results indicate polyubiquitination of IRF5 does not play a major role in its transcriptional activity, and that ubiquitination and phosphorylation are independent modifications.	[Foreman, Hui-Chen Chang; Van Scoy, Sarah; Cheng, Tsu-Fan; Reich, Nancy C.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Foreman, HCC (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	nancy.reich@stonybrook.edu	Foreman, Hui-Chen (Jane)/GMW-4448-2022	Foreman, Hui-Chen (Jane)/0000-0001-9640-9780	NIH [R21AI067885, R01CA122910-03S1]; NATIONAL CANCER INSTITUTE [R01CA122910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH R21AI067885 and R01CA122910-03S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Ferreiro-Neira I, 2007, GENES IMMUN, V8, P429, DOI 10.1038/sj.gene.6364407; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu GD, 2009, J BIOL CHEM, V284, P2767, DOI 10.1074/jbc.M804744200; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Kelly JA, 2008, GENES IMMUN, V9, P187, DOI 10.1038/gene.2008.4; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kokkinakis DM, 2004, CANCER RES, V64, P7513, DOI 10.1158/0008-5472.CAN-04-0592; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lien CY, 2010, P NATL ACAD SCI USA, V107, P4664, DOI 10.1073/pnas.0911193107; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Magalhaes JG, 2011, EUR J IMMUNOL, V41, P1445, DOI 10.1002/eji.201040827; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Ning SB, 2010, J VIROL, V84, P6130, DOI 10.1128/JVI.00364-10; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Richez C, 2010, JOINT BONE SPINE, V77, P525, DOI 10.1016/j.jbspin.2010.08.005; Richez C, 2010, J IMMUNOL, V184, P796, DOI 10.4049/jimmunol.0901748; Savitsky DA, 2010, P NATL ACAD SCI USA, V107, P10154, DOI 10.1073/pnas.1005599107; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Tada Y, 2011, ARTHRITIS RHEUM-US, V63, P738, DOI 10.1002/art.30183; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	59	53	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33098	10.1371/journal.pone.0033098	http://dx.doi.org/10.1371/journal.pone.0033098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412986	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062000030
J	Jennings, ME; Quick, LN; Ubol, N; Shrom, S; Dollahon, N; Wilson, JW				Jennings, Matthew E.; Quick, Laura N.; Ubol, Nicha; Shrom, Sally; Dollahon, Norman; Wilson, James W.			Characterization of Salmonella Type III Secretion Hyper-Activity Which Results in Biofilm-Like Cell Aggregation	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PATHOGENICITY ISLAND-2; MOLECULAR-BASIS; NEEDLE LENGTH; SYSTEM; PROTEIN; TYPHIMURIUM; GENES; EXPRESSION	We have previously reported the cloning of the Salmonella enterica serovar Typhimurium SPI-1 secretion system and the use of this clone to functionally complement a Delta SPI-1 strain for type III secretion activity. In the current study, we discovered that S. Typhimurium cultures containing cloned SPI-1 display an adherent biofilm and cell clumps in the media. This phenotype was associated with hyper-expression of SPI-1 type III secretion functions. The biofilm and cell clumps were associated with copious amounts of secreted SPI-1 protein substrates SipA, SipB, SipC, SopB, SopE, and SptP. We used a C-terminally FLAG-tagged SipA protein to further demonstrate SPI-1 substrate association with the cell aggregates using fluorescence microscopy and immunogold electron microscopy. Different S. Typhimurium backgrounds and both flagellated and nonflagellated strains displayed the biofilm phenotype. Mutations in genes essential for known bacterial biofilm pathways (bcsA, csgBA, bapA) did not affect the biofilms formed here indicating that this phenomenon is independent of established biofilm mechanisms. The SPI-1-mediated biofilm was able to massively recruit heterologous non-biofilm forming bacteria into the adherent cell community. The results indicate a bacterial aggregation phenotype mediated by elevated SPI-1 type III secretion activity with applications for engineered biofilm formation, protein purification strategies, and antigen display.	[Jennings, Matthew E.; Quick, Laura N.; Ubol, Nicha; Shrom, Sally; Dollahon, Norman; Wilson, James W.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Jennings, Matthew E.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Quick, Laura N.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Villanova University; University of Arkansas System; University of Arkansas Fayetteville; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Jennings, ME (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.	james.w.wilson@villanova.edu			Villanova University	Villanova University	Funding provided by Villanova University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001250; Ausubel FM, CURRENT PROTOCOLS MO; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Chang JH, 2007, MOL MICROBIOL, V66, P1548, DOI 10.1111/j.1365-2958.2007.06024.x; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Crepin VF, 2005, J MOL BIOL, V350, P42, DOI 10.1016/j.jmb.2005.04.060; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eichelberg K, 2000, INFECT IMMUN, V68, P2735, DOI 10.1128/IAI.68.5.2735-2743.2000; Epstein EA, 2009, J BACTERIOL, V191, P608, DOI 10.1128/JB.01244-08; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Ham JH, 1998, P NATL ACAD SCI USA, V95, P10206, DOI 10.1073/pnas.95.17.10206; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Hansen-Wester I, 2004, INFECT IMMUN, V72, P2879, DOI 10.1128/IAI.72.5.2879-2888.2004; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Inclan YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015867; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Kuchma SL, 2005, J BACTERIOL, V187, P1441, DOI 10.1128/JB.187.4.1441-1454.2005; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Lee CA, 2000, P NATL ACAD SCI USA, V97, P12283, DOI 10.1073/pnas.97.22.12283; Li CM, 2007, FEMS MICROBIOL LETT, V269, P104, DOI 10.1111/j.1574-6968.2006.00612.x; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Miller WG, 1997, GENE, V191, P149, DOI 10.1016/S0378-1119(97)00051-6; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Myeni SK, 2010, J BIOL CHEM, V285, P13357, DOI 10.1074/jbc.M109.094045; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; Panthel K, 2008, INT J MED MICROBIOL, V298, P99, DOI 10.1016/j.ijmm.2007.07.002; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Read ST, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-98; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Valdez Y, 2009, CURR TOP MICROBIOL, V337, P93, DOI 10.1007/978-3-642-01846-6_4; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Whitchurch CB, 2005, MOL MICROBIOL, V55, P1357, DOI 10.1111/j.1365-2958.2005.04479.x; Wilson JW, 2007, APPL ENVIRON MICROB, V73, P5911, DOI 10.1128/AEM.00952-07; Wilson JW, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-2; Wilson JW, 2006, J BIOTECHNOL, V122, P147, DOI 10.1016/j.jbiotec.2005.09.005; Wilson JW, 2004, J MICROBIOL METH, V57, P297, DOI 10.1016/j.mimet.2004.01.007; Wood TK, 2011, TRENDS BIOTECHNOL, V29, P87, DOI 10.1016/j.tibtech.2010.11.001; Xiong GS, 2010, INT J CANCER, V126, P2622, DOI 10.1002/ijc.24957; Yap MN, 2005, J BACTERIOL, V187, P639, DOI 10.1128/JB.187.2.639-648.2005; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	59	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33080	10.1371/journal.pone.0033080	http://dx.doi.org/10.1371/journal.pone.0033080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412985	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000029
J	Sivaprasad, S; Gupta, B; Gulliford, MC; Dodhia, H; Mohamed, M; Nagi, D; Evans, JR				Sivaprasad, Sobha; Gupta, Bhaskar; Gulliford, Martin C.; Dodhia, Hiten; Mohamed, Moin; Nagi, Dinesh; Evans, Jennifer R.			Ethnic Variations in the Prevalence of Diabetic Retinopathy in People with Diabetes Attending Screening in the United Kingdom (DRIVE UK)	PLOS ONE			English	Article							POPULATION; DISEASE; COHORT; ADULTS	Aims: To compare the prevalence of diabetic retinopathy (DR) in people of various ethnic groups with diabetes in the United Kingdom (UK). Methods: The Diabetic Retinopathy In Various Ethnic groups in UK (DRIVE UK) Study is a cross-sectional study on the ethnic variations of the prevalence of DR and visual impairment in two multi-racial cohorts in the UK. People on the diabetes register in West Yorkshire and South East London who were screened, treated or monitored between April 2008 to July 2009 (London) or August 2009 (West Yorkshire) were included in the study. Data included age, sex, ethnic group, type of diabetes, presenting visual acuity and the results of grading of diabetic retinopathy. Prevalence estimates for the ethnic groups were age-standardised to the white European population for comparison purposes. Results: Out of 57,144 people on the two diabetic registers, data were available on 50,285 individuals (88.0%), of these 3,323 had type 1 and 46,962 had type 2 diabetes. In type 2 diabetes, the prevalence of any DR was 38.0% (95% confidence interval(CI) 37.4% to 38.5%) in white Europeans compared to 52.4% (51.2% to 53.6%) in African/Afro-Caribbeans and 42.3% (40.3% to 44.2%) in South Asians. Similarly, sight threatening DR was also significantly more prevalent in Afro-Caribbeans (11.5%, 95% CI 10.7% to 12.3%) and South Asians (10.3%, 9.0% to 11.5%) compared to white Europeans (5.5%, 5.3% to 5.8%). Differences observed in Type 1 diabetes did not achieve conventional levels of statistical significance, but there were lower numbers for these analyses. Conclusions: Minority ethnic communities with type 2 diabetes in the UK are more prone to diabetic retinopathy, including sight-threatening retinopathy and maculopathy compared to white Europeans.	[Sivaprasad, Sobha; Gupta, Bhaskar] Kings Coll Hosp NHS Fdn Trust, London, England; [Gulliford, Martin C.] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Dodhia, Hiten] Lambeth NHS Primary Care Trust, London, England; [Nagi, Dinesh] Mid Yorkshire NHS Trust, Wakefield, W Yorkshire, England; [Evans, Jennifer R.] London Sch Hyg & Trop Med, London WC1, England; [Mohamed, Moin] St Thomas Hosp NHS Fdn, London, England	King's College Hospital NHS Foundation Trust; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Sivaprasad, S (corresponding author), Kings Coll Hosp NHS Fdn Trust, London, England.	senswathi@aol.com	Gulliford, Martin C/I-8606-2018; Sivaprasad, S./D-6876-2015	Gulliford, Martin C/0000-0003-1898-9075; Sivaprasad, S./0000-0001-8952-0659	Guide Dogs For the Blind Association [OR-2008-04d]	Guide Dogs For the Blind Association	This work was supported by Guide Dogs For the Blind Association: Grant No: OR-2008-04d. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2005, DIABETES, V54, P2188; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Bojestig M, 1998, DIABETIC MED, V15, P863, DOI 10.1002/(SICI)1096-9136(199810)15:10<863::AID-DIA665>3.3.CO;2-F; Chaturvedi N, 1996, BMJ-BRIT MED J, V313, P848; CRUICKSHANK JK, 1987, DIABETES CARE, V10, P170, DOI 10.2337/diacare.10.2.170; Diabetes UK, 2010, DIAB UK 2010 KEY STA; Emanuele N, 2005, DIABETES CARE, V28, P1954, DOI 10.2337/diacare.28.8.1954; Garvican L, 2003, QUALITY ASSURANCE NA; Heintz E, 2010, DIABETOLOGIA, V53, P2147, DOI 10.1007/s00125-010-1836-3; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Klein R, 2002, BRIT J OPHTHALMOL, V86, P84, DOI 10.1136/bjo.86.1.84; Klein R, 2002, OPHTHALMOLOGY, V109, P1225, DOI 10.1016/S0161-6420(02)01074-6; Raymond NT, 2009, DIABETES CARE, V32, P410, DOI 10.2337/dc08-1422; UK National Screening Committee, 2007, ESS EL DEV DIAB RET; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yorkshire and the Humber Quality Observatory (YHQO), 2011, APHO DIAB PREV MOD E; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	21	79	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32182	10.1371/journal.pone.0032182	http://dx.doi.org/10.1371/journal.pone.0032182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412857	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000303062000006
J	Klompmaker, AA; Fraaije, RHB				Klompmaker, Adiel A.; Fraaije, Rene H. B.			Animal Behavior Frozen in Time: Gregarious Behavior of Early Jurassic Lobsters within an Ammonoid Body Chamber	PLOS ONE			English	Article							LOWER TOARCIAN; SHELLS; CRAB; DECAPODA; MINERALIZATION; TRILOBITES; CRUSTACEA; ANOMURA; DECAY; MODE	Direct animal behavior can be inferred from the fossil record only in exceptional circumstances. The exceptional mode of preservation of ammonoid shells in the Posidonia Shale (Lower Jurassic, lower Toarcian) of Dotternhausen in southern Germany, with only the organic periostracum preserved, provides an excellent opportunity to observe the contents of the ammonoid body chamber because this periostracum is translucent. Here, we report upon three delicate lobsters preserved within a compressed ammonoid specimen of Harpoceras falciferum. We attempt to explain this gregarious behavior. The three lobsters were studied using standard microscopy under low angle light. The lobsters belong to the extinct family of the Eryonidae; further identification was not possible. The organic material of the three small lobsters is preserved more than halfway into the ammonoid body chamber. The lobsters are closely spaced and are positioned with their tails oriented toward each other. The specimens are interpreted to represent corpses rather than molts. The lobsters probably sought shelter in preparation for molting or against predators such as fish that were present in Dotternhausen. Alternatively, the soft tissue of the ammonoid may have been a source of food that attracted the lobsters, or it may have served as a long-term residency for the lobsters (inquilinism). The lobsters represent the oldest known example of gregariousness amongst lobsters and decapods in the fossil record. Gregarious behavior in lobsters, also known for extant lobsters, thus developed earlier in earth's history than previously known. Moreover, this is one of the oldest known examples of decapod crustaceans preserved within cephalopod shells.	[Klompmaker, Adiel A.] Kent State Univ, Dept Geol, Kent, OH 44242 USA; [Fraaije, Rene H. B.] Oertijdmuseum Groene Poort, Boxtel, Netherlands	Kent State University; Kent State University Kent; Kent State University Salem	Klompmaker, AA (corresponding author), Kent State Univ, Dept Geol, Kent, OH 44242 USA.	adielklompmaker@gmail.com						Ahyong Shane T., 2009, Crustacean Issues, V18, P369; Aiken D.E., 1980, P91; [Anonymous], 1969, TREATISE INVERTEBRAT; Atema Jelle, 1995, P313, DOI 10.1016/B978-012247570-2/50035-9; Bell Mike C., 2006, P412, DOI 10.1002/9780470995969.ch13; Beurlen K., 1928, Palaeontographica Stuttgart, V70, P115; BEURLEN KARL, 1944, NEUES JAHRB MINERAL USW ABHANDL ABT B, V88, P374; BEURLEN KARL, 1930, NEUES JAHRB MINERAL GEOL U PALAONT ABT B, V64, P219; Bishop G. A., 1986, SEPM FIELD GUIDEBOOK, P297; BISHOP GA, 1986, J CRUSTACEAN BIOL, V6, P326, DOI 10.2307/1548174; Brenner K., 1976, Neues Jb Geol Paleont Abh, V151, P101; Brenner K, 1976, ZENTRALBLATT GEOLO 2, V5, P223; BRIGGS DEG, 1994, PALAIOS, V9, P431, DOI 10.2307/3515135; Bromley R.G., 1972, GRONLANDS GEOLOGISKE, V49, P15; Butler Mark J., 2006, P263, DOI 10.1002/9780470995969.ch8; Chatterton BDE, 2003, SPEC PAP PALAEONTOL, P157; Childers M, 2006, LASER SURG MED, P24; Childress MJ, 2001, ANIM BEHAV, V62, P465, DOI 10.1006/anbe.2001.1760; Dam Gregers, 1998, Geology of Greenland Survey Bulletin, V175, P1; Davis RA, 2001, LETHAIA, V34, P37; De Grave S, 2009, RAFFLES B ZOOL, P1; Dolan TW, 2006, J CRUSTACEAN BIOL, V26, P565, DOI 10.1651/S-2742.1; Donahue MJ, 2004, MAR ECOL PROG SER, V267, P219, DOI 10.3354/meps267219; Dworschak P.C., 1988, Senckenbergiana Maritima, V20, P1; Ernst G., 1967, Palaeontologische Zeitschrift, V41, P211; Fatka O, 2009, MEM ASSOC AUSTRALAS, V37, P481; FELDMANN RM, 1977, J PALEONTOL, V51, P1161; Feldmann RM, 2007, J PALEONTOL, V81, P405, DOI 10.1666/0022-3360(2007)81[405:ANFGAS]2.0.CO;2; Forster R., 1967, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie, V128, P136; Forster R., 1973, Bericht Nat Ges Hannover, VNo. 117, P149; Fraaije RHB, 2006, REV MEX CIENC GEOL, V23, P361; Fraaije RHB, 2003, PALAEONTOLOGY, V46, P53, DOI 10.1111/1475-4983.00286; FRAAYE R, 1995, PALAEONTOLOGY, V38, P63; Fraaye R.H.B., 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V9, P541; Groeneveld Johan C., 2006, P385, DOI 10.1002/9780470995969.ch12; Hagdorn H, 1999, ECHINODERM RES 1998; Hauff B., 1981, HOLZMADENBUCH; Herrick F. H., 1911, B US BUR FISH, V29, P1; Hof CHJ, 1997, PALAIOS, V12, P420, DOI 10.2307/3515381; Holzapfel H.-W., 1984, Geologica et Palaeontologica, V18, P81; Hyzny Matus, 2011, Bulletin of the Mizunami Fossil Museum, V37, P37; Jager M, 1997, PALAEONTOLOGY, V40, P557; Jager M, 1990, FOSSILIEN, V7, P274; Jager M, 1991, FOSSILIEN, V8, P33; Jagt JWM, 2006, REV MEX CIENC GEOL, V23, P364; Karasawa Hiroaki, 2003, Paleontological Research, V7, P357, DOI 10.2517/prpsj.7.357; Karasawa Hiroaki, 2006, Bulletin of the Mizunami Fossil Museum, V33, P127; Klompmaker AA, 2011, PALAEONTOL ELECTRON, V14; Klompmaker AA, 2009, PALAEOGEOGR PALAEOCL, V280, P245, DOI 10.1016/j.palaeo.2009.06.013; Krause PG, 1981, Z DEUT GEOL GESELLSC, V43, P171; KUHN OSKAR, 1952, PALAEONTOGRAPHICA, V101A, P153; Lawton Peter, 1995, P47, DOI 10.1016/B978-012247570-2/50026-8; MAEDA H, 1991, LETHAIA, V24, P69, DOI 10.1111/j.1502-3931.1991.tb01181.x; MATSUMOTO T, 1979, P JPN ACAD B-PHYS, V55, P115, DOI 10.2183/pjab.55.115; Mertin H., 1941, NOVA ACTA LEOPOLDINA, V10, P149; Mourik Anja A., 2005, Bulletin of the Mizunami Fossil Museum, V32, P1; Mundlos R., 1970, Neues Jb. Geol. Palaont. Mh., V1970, P18; PRYOR WA, 1975, GEOL SOC AM BULL, V86, P1244, DOI 10.1130/0016-7606(1975)86<1244:BSAAOA>2.0.CO;2; Radwanski A, 2009, ACTA GEOL POL, V59, P459; Rohl HJ, 2005, SOC SEDIMENT GEOL SP, V82, P165; Rohl HJ, 2001, PALAEOGEOGR PALAEOCL, V165, P27, DOI 10.1016/S0031-0182(00)00152-8; Sampedro MP, 2004, J CRUSTACEAN BIOL, V24, P168, DOI 10.1651/C-2404; Schulz Manfred, 2002, Veroeffentlichungen des Naturkundemuseums Erfurt, V21, P15; Schweitzer Carrie E., 2010, V10, P1; Schweitzer CE, 2002, J CRUSTACEAN BIOL, V22, P938, DOI 10.1651/0278-0372(2002)022[0938:NEDTAB]2.0.CO;2; Seilacher A., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1982, P98; Spanier Ehud, 2006, P462, DOI 10.1002/9780470995969.ch14; STEVENS GR, 1985, NEW ZEAL J GEOL GEOP, V28, P153, DOI 10.1080/00288306.1985.10422282; Stewart J.D., 1990, P51; Stewart JD, 1990, NIOBRARA CHALK EXCUR, P31; Taverne N., 2000, GEA, V2000, P9; Tsujita Cameron J., 2003, Journal of Taphonomy, V1, P185; van Bakel BWM, 2008, NEUES JAHRB GEOL P-A, V250, P137, DOI 10.1127/0077-7749/2008/0250-0137; VAN STRAELEN V., 1929, B ACAD ROYALE BELGE, V15, P741; Vullo R, 2009, LETHAIA, V42, P462, DOI 10.1111/j.1502-3931.2009.00153.x; WAGELE JW, 1989, Z ZOOL SYST EVOL, V27, P297; Wahle Richard, 2006, P1, DOI 10.1002/9780470995969.ch1; Wani R, 2006, PALAIOS, V21, P289, DOI 10.2110/palo.2004.p04-92; WILEY E O, 1981, Journal of Vertebrate Paleontology, V1, P43; Wilson SK, 2005, MAR BIOL, V147, P179, DOI 10.1007/s00227-005-1556-2; WRIGHT CW, 1972, BRIT CRETACEOUS CRAB	81	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e31893	10.1371/journal.pone.0031893	http://dx.doi.org/10.1371/journal.pone.0031893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412846	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800007
J	Kwon, RY; Meays, DR; Meilan, AS; Jones, J; Miramontes, R; Kardos, N; Yeh, JC; Frangos, JA				Kwon, Ronald Y.; Meays, Diana R.; Meilan, Alexander S.; Jones, Jeremiah; Miramontes, Rosa; Kardos, Natalie; Yeh, Jiunn-Chern; Frangos, John A.			Skeletal Adaptation to Intramedullary Pressure-Induced Interstitial Fluid Flow Is Enhanced in Mice Subjected to Targeted Osteocyte Ablation	PLOS ONE			English	Article							LACUNAR-CANALICULAR SYSTEM; IN-VIVO; CORTICAL BONE; SHEAR-STRESS; FLUORESCENCE RECOVERY; SOLUTE TRANSPORT; LONG BONES; CELLS; PROSTAGLANDIN; MATRIX	Interstitial fluid flow (IFF) is a potent regulatory signal in bone. During mechanical loading, IFF is generated through two distinct mechanisms that result in spatially distinct flow profiles: poroelastic interactions within the lacunar-canalicular system, and intramedullary pressurization. While the former generates IFF primarily within the lacunar-canalicular network, the latter generates significant flow at the endosteal surface as well as within the tissue. This gives rise to the intriguing possibility that loading-induced IFF may differentially activate osteocytes or surface-residing cells depending on the generating mechanism, and that sensation of IFF generated via intramedullary pressurization may be mediated by a non-osteocytic bone cell population. To begin to explore this possibility, we used the Dmp1-HBEGF inducible osteocyte ablation mouse model and a microfluidic system for modulating intramedullary pressure (ImP) to assess whether structural adaptation to ImP-driven IFF is altered by partial osteocyte depletion. Canalicular convective velocities during pressurization were estimated through the use of fluorescence recovery after photobleaching and computational modeling. Following osteocyte ablation, transgenic mice exhibited severe losses in bone structure and altered responses to hindlimb suspension in a compartment-specific manner. In pressure-loaded limbs, transgenic mice displayed similar or significantly enhanced structural adaptation to Imp-driven IFF, particularly in the trabecular compartment, despite up to,50% of trabecular lacunae being uninhabited following ablation. Interestingly, regression analysis revealed relative gains in bone structure in pressure-loaded limbs were correlated with reductions in bone structure in unpressurized control limbs, suggesting that adaptation to ImP-driven IFF was potentiated by increases in osteoclastic activity and/or reductions in osteoblastic activity incurred independently of pressure loading. Collectively, these studies indicate that structural adaptation to ImP-driven IFF can proceed unimpeded following a significant depletion in osteocytes, consistent with the potential existence of a non-osteocytic bone cell population that senses ImP-driven IFF independently and potentially parallel to osteocytic sensation of poroelasticity-derived IFF.	[Kwon, Ronald Y.; Meays, Diana R.; Meilan, Alexander S.; Jones, Jeremiah; Miramontes, Rosa; Kardos, Natalie; Yeh, Jiunn-Chern; Frangos, John A.] La Jolla Bioengn Inst, La Jolla, CA 92093 USA	La Jolla Bioengineering Institute	Kwon, RY (corresponding author), La Jolla Bioengn Inst, La Jolla, CA 92093 USA.	frangos@ljbi.org			National Institutes of Health [F32 AR056934, R01 AR046797]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046797, F32AR056934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (www.nih.gov) grants F32 AR056934 (Dr. Kwon) and R01 AR046797 (Dr. Frangos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Brighton CT, 1996, J BONE JOINT SURG AM, V78A, P1337, DOI 10.2106/00004623-199609000-00007; BRYANT JD, 1983, J BIOMECH, V16, P659, DOI 10.1016/0021-9290(83)90117-3; Caulkins C, 2009, J ORTHOP RES, V27, P651, DOI 10.1002/jor.20780; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Forwood MR, 1998, ANAT REC, V252, P580, DOI 10.1002/(SICI)1097-0185(199812)252:4<580::AID-AR8>3.0.CO;2-S; Gardinier JD, 2010, BONE, V46, P1075, DOI 10.1016/j.bone.2010.01.371; Jacobs CR, 2010, ANNU REV BIOMED ENG, V12, P369, DOI 10.1146/annurev-bioeng-070909-105302; Kim CH, 2006, BONE, V39, P1043, DOI 10.1016/j.bone.2006.05.017; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; Kwon RY, 2007, J BIOMECH, V40, P3162, DOI 10.1016/j.jbiomech.2007.04.003; Kwon RY, 2010, FASEB J, V24, P2859, DOI 10.1096/fj.09-148007; Kwon RY, 2010, J BONE MINER RES, V25, P1798, DOI 10.1002/jbmr.74; Kwon RY, 2010, CELL MOL BIOENG, V3, P296, DOI 10.1007/s12195-010-0129-8; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; McAllister TN, 2000, BIOCHEM BIOPH RES CO, V270, P643, DOI 10.1006/bbrc.2000.2467; Mortensen EN, 1998, GRAPH MODEL IM PROC, V60, P349, DOI 10.1006/gmip.1998.0480; Nagatomi J, 2001, TISSUE ENG, V7, P717, DOI 10.1089/107632701753337672; PIEKARSKI K, 1977, NATURE, V269, P80, DOI 10.1038/269080a0; PRICE C, 2010, T ORTHOP RES SOC, V35; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin YX, 2009, J BIOMECH, V42, P140, DOI 10.1016/j.jbiomech.2008.10.018; Qin YX, 2003, J BIOMECH, V36, P1427, DOI 10.1016/S0021-9290(03)00127-1; Qin YX, 2002, ANN BIOMED ENG, V30, P693, DOI 10.1114/1.1483863; Roelofsen J, 1995, J BIOMECH, V28, P1493, DOI 10.1016/0021-9290(95)00097-6; Stevens HY, 2006, BONE, V39, P565, DOI 10.1016/j.bone.2006.03.007; Stevens HY, 2008, DIS MODEL MECH, V1, P175, DOI 10.1242/dmm.000547; Su M, 2006, ANN BIOMED ENG, V34, P1600, DOI 10.1007/s10439-006-9171-z; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Tarbell JM, 1999, J APPL PHYSIOL, V87, P261, DOI 10.1152/jappl.1999.87.1.261; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Wang LY, 2005, P NATL ACAD SCI USA, V102, P11911, DOI 10.1073/pnas.0505193102; WASSERMA.F, 1965, Z ZELLFORSCH MIK ANA, V67, P636, DOI 10.1007/BF00340329; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; You LD, 2004, ANAT REC PART A, V278A, P505, DOI 10.1002/ar.a.20050; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhang P, 2006, J APPL PHYSIOL, V100, P1452, DOI 10.1152/japplphysiol.00997.2005; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023516; Zhou XZ, 2008, ANN BIOMED ENG, V36, P1961, DOI 10.1007/s10439-008-9566-0; Zilber S, 2008, J BIOMED MATER RES B, V84B, P286, DOI 10.1002/jbm.b.30872	46	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33336	10.1371/journal.pone.0033336	http://dx.doi.org/10.1371/journal.pone.0033336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22413015	Green Submitted, gold, Green Published			2022-12-25	WOS:000303060800091
J	Rizzo, AM; Corsetto, PA; Montorfano, G; Milani, S; Zava, S; Tavella, S; Cancedda, R; Berra, B				Rizzo, Angela Maria; Corsetto, Paola Antonia; Montorfano, Gigliola; Milani, Simona; Zava, Stefania; Tavella, Sara; Cancedda, Ranieri; Berra, Bruno			Effects of Long-Term Space Flight on Erythrocytes and Oxidative Stress of Rodents	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; RED-BLOOD-CELL; SPACEFLIGHT; MICROGRAVITY; SUPEROXIDE; PROTECTION; DISEASE; HUMANS; HEALTH; DAMAGE	Erythrocyte and hemoglobin losses have been frequently observed in humans during space missions; these observations have been designated as "space anemia". Erythrocytes exposed to microgravity have a modified rheology and undergo hemolysis to a greater extent. Cell membrane composition plays an important role in determining erythrocyte resistance to mechanical stress and it is well known that membrane composition might be influenced by external events, such as hypothermia, hypoxia or gravitational strength variations. Moreover, an altered cell membrane composition, in particular in fatty acids, can cause a greater sensitivity to peroxidative stress, with increase in membrane fragility. Solar radiation or low wavelength electromagnetic radiations (such as gamma rays) from the Earth or the space environment can split water to generate the hydroxyl radical, very reactive at the site of its formation, which can initiate chain reactions leading to lipid peroxidation. These reactive free radicals can react with the non-radical molecules, leading to oxidative damage of lipids, proteins and DNA, etiologically associated with various diseases and morbidities such as cancer, cell degeneration, and inflammation. Indeed, radiation constitutes on of the most important hazard for humans during long-term space flights. With this background, we participated to the MDS tissue-sharing program performing analyses on mice erythrocytes flown on the ISS from August to November 2009. Our results indicate that space flight induced modifications in cell membrane composition and increase of lipid peroxidation products, in mouse erythrocytes. Moreover, antioxidant defenses in the flight erythrocytes were induced, with a significant increase of glutathione content as compared to both vivarium and ground control erythrocytes. Nonetheless, this induction was not sufficient to prevent damages caused by oxidative stress. Future experiments should provide information helpful to reduce the effects of oxidative stress exposure and space anemia, possibly by integrating appropriate dietary elements and natural compounds that could act as antioxidants.	[Rizzo, Angela Maria; Corsetto, Paola Antonia; Montorfano, Gigliola; Milani, Simona; Zava, Stefania; Berra, Bruno] Univ Milan, Dipartimento Sci Mol Applicate Biosistemi, DiSMAB, Milan, Italy; [Tavella, Sara; Cancedda, Ranieri] Univ Genoa, Genoa, Italy; [Tavella, Sara; Cancedda, Ranieri] Ist Nazl Ric Canc, I-16132 Genoa, Italy	University of Milan; University of Genoa; University of Genoa; IRCCS AOU San Martino IST	Rizzo, AM (corresponding author), Univ Milan, Dipartimento Sci Mol Applicate Biosistemi, DiSMAB, Milan, Italy.	angelamaria.rizzo@unimi.it	RIzzo, Angela Maria/E-4786-2012; Tavella, Sara/D-3011-2017; CORSETTO, PAOLA ANTONIA/O-2244-2015	RIzzo, Angela Maria/0000-0002-8582-0432; Tavella, Sara/0000-0003-1478-4910; CORSETTO, PAOLA ANTONIA/0000-0003-3849-8548	Italian Space Agency	Italian Space Agency(Agenzia Spaziale Italiana (ASI))	The study was funded by the Italian Space Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI, 1984, METHOD ENZYMOL, V105, P121, DOI DOI 10.1016/S0076-6879(84)05016-3; Alfrey CP, 1996, J APPL PHYSIOL, V81, P98, DOI 10.1152/jappl.1996.81.1.98; Ballas SK, 2006, TRANSFUSION, V46, P105, DOI 10.1111/j.1537-2995.2006.00679.x; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Beutler E., 1984, GLUTATHIONE RED CELL; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; FLEMING SD, 1991, J LEUKOCYTE BIOL, V50, P69, DOI 10.1002/jlb.50.1.69; Ghosh N, 2011, FREE RADICAL RES, V45, P888, DOI 10.3109/10715762.2011.574290; GLASS GA, 1984, BIOCHEM J, V218, P531, DOI 10.1042/bj2180531; Gridley DS, 2003, J APPL PHYSIOL, V94, P2095, DOI 10.1152/japplphysiol.01053.2002; Griffith O.W., 1985, METHODS ENZYMATIC AN, V7, P521; Grigoriev AI, 2004, J GRAVIT PHYSL, V11, P79; Guillot C, 2008, J ELECTROMYOGR KINES, V18, P276, DOI 10.1016/j.jelekin.2006.10.001; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Liu Y, 2009, BASIC APPL MYOL, V19, P87; PAOLETTI F, 1990, METHOD ENZYMOL, V186, P209; Papas AM, 1996, LIPIDS, V31, pS77, DOI 10.1007/BF02637055; Pinto C, 1984, ARCH BIOCHEM BIOPHYS, V228, P1; PROHASKA JR, 1976, J NEUROCHEM, V27, P1379, DOI 10.1111/j.1471-4159.1976.tb02619.x; Rizzo AM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-7; Rizzo AM, 2009, CELL BIOL INT, V33, P893, DOI 10.1016/j.cellbi.2009.04.015; Rondanelli M, 2011, J NUTR HEALTH AGING, V15, P37, DOI 10.1007/s12603-011-0011-y; Schimmerling W, 2010, RADIAT ENVIRON BIOPH, V49, P325, DOI 10.1007/s00411-010-0286-0; Simopoulos AP, 2011, WORLD REV NUTR DIET, V102, P10, DOI 10.1159/000327785; Smith SM, 2002, NUTRITION, V18, P864, DOI 10.1016/S0899-9007(02)00912-7; Stein TP, 2002, NUTRITION, V18, P867, DOI 10.1016/S0899-9007(02)00938-3; Stojiljkovic V, 2005, ANN NY ACAD SCI, V1048, P373, DOI 10.1196/annals.1342.042; Trost Z, 2010, BONE, V46, P72, DOI 10.1016/j.bone.2009.09.015; Voulgaridou GP, 2001, MUTAT RES, V711, P13; WEY HE, 1993, TOXICOL APPL PHARM, V120, P72, DOI 10.1006/taap.1993.1088; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	31	51	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32361	10.1371/journal.pone.0032361	http://dx.doi.org/10.1371/journal.pone.0032361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412864	Green Published, gold			2022-12-25	WOS:000303060800014
J	Roede, JR; Park, Y; Li, SZ; Strobel, FH; Jones, DP				Roede, James R.; Park, Youngja; Li, Shuzhao; Strobel, Frederick H.; Jones, Dean P.			Detailed Mitochondrial Phenotyping by High Resolution Metabolomics	PLOS ONE			English	Article							GENDER-DIFFERENCES; METABOLISM; DISEASE; IDENTIFICATION; DYSFUNCTION	Mitochondrial phenotype is complex and difficult to define at the level of individual cell types. Newer metabolic profiling methods provide information on dozens of metabolic pathways from a relatively small sample. This pilot study used "top-down'' metabolic profiling to determine the spectrum of metabolites present in liver mitochondria. High resolution mass spectral analyses and multivariate statistical tests provided global metabolic information about mitochondria and showed that liver mitochondria possess a significant phenotype based on gender and genotype. The data also show that mitochondria contain a large number of unidentified chemicals.	[Roede, James R.; Park, Youngja; Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Li, Shuzhao] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Ctr, Atlanta, GA 30322 USA; [Strobel, Frederick H.] Emory Univ, Mass Spectrometry Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Roede, JR (corresponding author), Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA.	dpjones@emory.edu		Li, Shuzhao/0000-0002-7386-2539; Park, Youngja/0000-0002-1310-148X	National Institute of Environmental Health Sciences at the National Institutes of Health [R01 ES009047, T32 ES012870, F32 ES019821]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870, F32ES019821, R01ES009047] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funding from the National Institute of Environmental Health Sciences at the National Institutes of Health (R01 ES009047 to D.P.J.; T32 ES012870 and F32 ES019821 to J.R.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola-Erkkila S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076; Balcke GU, 2011, TOXICOL LETT, V203, P200, DOI 10.1016/j.toxlet.2011.03.013; BAXEVANIS AD, 2006, CURR PROTOC BIOINFOR, pCH1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brody T., 1994, NUTR BIOCH; Brown M, 2009, ANALYST, V134, P1322, DOI 10.1039/b901179j; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Chen JQ, 2004, ANN NY ACAD SCI, V1028, P258, DOI 10.1196/annals.1322.030; Chen Y, 2006, TOXICOL APPL PHARM, V216, P256, DOI 10.1016/j.taap.2006.05.006; Drechsel DA, 2009, TOXICOL SCI, V112, P427, DOI 10.1093/toxsci/kfp223; Guevara R, 2011, CELL PHYSIOL BIOCHEM, V27, P201, DOI 10.1159/000327945; He M, 2008, TOXICOL SCI, V105, P44, DOI 10.1093/toxsci/kfn116; Johnson JM, 2010, ANALYST, V135, P2864, DOI 10.1039/c0an00333f; Joyner PM, 2010, J PROTEOME RES, V9, P404, DOI 10.1021/pr900734g; Lamont LS, 2003, J APPL PHYSIOL, V95, P1259, DOI 10.1152/japplphysiol.01028.2002; Lamont LS, 2001, J APPL PHYSIOL, V91, P357, DOI 10.1152/jappl.2001.91.1.357; Liu YR, 2010, J PHARMACEUT BIOMED, V52, P136, DOI 10.1016/j.jpba.2009.12.026; Maceluch Jaros Aw, 2006, Pediatr Endocrinol Rev, V4, P117; Manna SK, 2010, J PROTEOME RES, V9, P4176, DOI 10.1021/pr100452b; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; Mayr M, 2009, J MOL CELL CARDIOL, V46, P268, DOI 10.1016/j.yjmcc.2008.10.008; Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966; Mervaala E, 2010, HYPERTENSION, V55, P508, DOI 10.1161/HYPERTENSIONAHA.109.145490; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mitsubuchi H, 2005, J NUTR, V135, p1565S, DOI 10.1093/jn/135.6.1565S; Nagrath D, 2011, BBA-BIOENERGETICS, V1807, P650, DOI 10.1016/j.bbabio.2011.03.006; Park Y, 2011, J NUTR, V141, P1424, DOI 10.3945/jn.111.138875; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Roede JR, 2010, ENVIRON MOL MUTAGEN, V51, P380, DOI 10.1002/em.20553; SAVAGE MK, 1991, ARCH BIOCHEM BIOPHYS, V290, P51, DOI 10.1016/0003-9861(91)90590-F; Soltow QA, 2011, METABOLOMICS; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Xu QW, 2011, J BIOMOL NMR, V49, P207, DOI 10.1007/s10858-011-9482-8; Yu TW, 2009, BIOINFORMATICS, V25, P1930, DOI 10.1093/bioinformatics/btp291	39	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e33020	10.1371/journal.pone.0033020	http://dx.doi.org/10.1371/journal.pone.0033020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412977	Green Submitted, Green Published, gold			2022-12-25	WOS:000303021100046
J	Schubert, C; Geser, W; Noisternig, B; Fuchs, D; Welzenbach, N; Konig, P; Schussler, G; Ocana-Peinado, FM; Lampe, A				Schubert, Christian; Geser, Willi; Noisternig, Bianca; Fuchs, Dietmar; Welzenbach, Natalie; Koenig, Paul; Schuessler, Gerhard; Ocana-Peinado, Francisco M.; Lampe, Astrid			Stress System Dynamics during "Life As It Is Lived": An Integrative Single-Case Study on a Healthy Woman	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; DAILY PSYCHOSOCIAL STRESSORS; ACUTE MENTAL STRESS; PSYCHOLOGICAL STRESS; LUPUS-ERYTHEMATOSUS; DAILY EVENTS; CORTISOL RESPONSES; NEOPTERIN; NEUROENDOCRINE; INTERLEUKIN-6	Little is known about the dynamic characteristics of stress system activity during "life as it is lived". Using as representative a study design as possible, this investigation sought to gain insights into this area. A healthy 25-year-old woman collected her entire urine over a period of 63 days in 12-h intervals (126 measurements) to determine cortisol and neopterin (immune activation marker) levels. In addition, she filled out questionnaires on emotional state and daily routine in 12-h intervals, and was interviewed weekly to identify emotionally negative and positive everyday incidents. Adjusted cross-correlational analyses revealed that stressful incidents were associated with cyclic response patterns in both urinary cortisol and urinary neopterin concentrations. Urinary cortisol levels first decreased 12-24 h after stressful incidents occurred (lag 1: -.178; p = 0.048) and then increased a total of 72-84 h later (lag 6: +.224; p = 0.013). Urinary neopterin levels first increased 0-12 h before the occurrence of stressful incidents (-lag 1: +.185; p = 0.040) and then decreased a total of 48-60 h following such stressors (lag 4: -.181; p = 0.044). Decreases in urinary neopterin levels were also found 24-36 and 48-60 h after increases in pensiveness (lag 2: -.215; p = 0.017) and depressiveness (lag 4: -.221; p = 0.014), respectively. Findings on emotionally positive incidents sharply contrasted with those dealing with negative experiences. Positive incidents were followed first by urinary cortisol concentration increases within 12 h (lag 0: +.290; p = 0.001) and then by decreases after a total of 60-72 h (lag 5: -.186; p = 0.039). Urinary neopterin levels first decreased 12-24 h before positive incidents occurred (-lag 2: -.233; p = 0.010) and then increased a total of 12-24 h following these incidents (lag 1: +.222; p = 0.014). As with previous investigations on patients with systemic lupus erythematosus (SLE), this study showed that stress system response can be considerably longer and more complex and differentiated than findings from conventional group studies have suggested. Further integrative single-case studies will need to be conducted in order to draw firm conclusions about stress system dynamics under real-life conditions.	[Schubert, Christian; Noisternig, Bianca; Schuessler, Gerhard; Lampe, Astrid] Innsbruck Med Univ, Clin Dept Med Psychol, Innsbruck, Austria; [Geser, Willi] Univ Innsbruck, Inst Psychol, A-6020 Innsbruck, Austria; [Fuchs, Dietmar; Welzenbach, Natalie] Innsbruck Med Univ, Bioctr, Div Biol Chem, Innsbruck, Austria; [Koenig, Paul] Innsbruck Med Univ, Clin Dept Internal Med, Innsbruck, Austria; [Ocana-Peinado, Francisco M.] Univ Granada, Dept Stat & Operat Res, Granada, Spain	Medical University of Innsbruck; University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; University of Granada	Schubert, C (corresponding author), Innsbruck Med Univ, Clin Dept Med Psychol, Innsbruck, Austria.	christian.schubert@i-med.ac.at	Fuchs, Dietmar/AAL-8011-2021	Fuchs, Dietmar/0000-0003-1627-9563	University Clinics Tirol (MFF Tirol) [42]; Leopold-Franzens-Universitat Innsbruck	University Clinics Tirol (MFF Tirol); Leopold-Franzens-Universitat Innsbruck	This study was supported by a grant from the University Clinics Tirol (MFF Tirol, No. 42, http://www.mff-tirol.at/) and by a fellowship (Mag. Noisternig) from the Leopold-Franzens-Universitat Innsbruck (http://www.uibk.ac.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2006, P NATL ACAD SCI USA, V103, P17058, DOI 10.1073/pnas.0605053103; Allport G.W., 1942, SOCIAL SCI RES COUNC, V49; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bartlett M. S., 1955, INTRO STOCHASTIC PRO; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Besedovsky HO., 1991, PSYCHONEUROIMMUNOLOG, pp. 589, DOI [10.1159/000452902, DOI 10.1159/000452902]; Box G.E.P., 1976, TIME SERIES ANAL FOR; Brockwell P. J., 2002, INTRO TIME SERIES FO; BROWN G. W., 1989, LIFE EVENTS ILLNESS, P3; BROWN WA, 1993, PSYCHOSOM MED, V55, P458, DOI 10.1097/00006842-199309000-00009; Brunswik E., 1956, PERCEPTION REPRESENT; Brydon L, 2005, BRAIN BEHAV IMMUN, V19, P540, DOI 10.1016/j.bbi.2004.12.003; Buchanan TW, 1999, PSYCHONEUROENDOCRINO, V24, P227, DOI 10.1016/S0306-4530(98)00078-X; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Dahlgren A, 2009, BIOL PSYCHOL, V82, P149, DOI 10.1016/j.biopsycho.2009.07.001; Debus G., 1978, EIGENSCHAFTSWORTERLI; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; DUNBAR PR, 1993, AUST NZ J PSYCHIAT, V27, P495, DOI 10.3109/00048679309075808; Ehlert U, 2001, BIOL PSYCHOL, V57, P141, DOI 10.1016/S0301-0511(01)00092-8; Ellins E, 2008, BRAIN BEHAV IMMUN, V22, P941, DOI 10.1016/j.bbi.2008.01.009; Eriksen HR, 1999, PSYCHIAT RES, V85, P39, DOI 10.1016/S0165-1781(98)00141-3; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; FLESHNER M, 1995, ENDOCRINOLOGY, V136, P5336, DOI 10.1210/en.136.12.5336; FUCHS D, 1993, INT ARCH ALLERGY IMM, V101, P1, DOI 10.1159/000236491; FUCHS D, 1992, CRIT REV CL LAB SCI, V29, P307, DOI 10.3109/10408369209114604; FUTTERMAN AD, 1994, PSYCHOSOM MED, V56, P499, DOI 10.1097/00006842-199411000-00005; Gerin W, 1998, J PSYCHOSOM RES, V44, P209, DOI 10.1016/S0022-3999(97)00207-9; Gutierrez MA, 1998, LUPUS, V7, P404, DOI 10.1191/096120398678920343; Hanson EKS, 2000, ANN BEHAV MED, V22, P316, DOI 10.1007/BF02895668; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; HU YH, 1993, INT ARCH ALLERGY IMM, V102, P232, DOI 10.1159/000236531; HUBERT W, 1990, BIOL PSYCHOL, V31, P73, DOI 10.1016/0301-0511(90)90079-C; HUBERT W, 1991, INT J PSYCHOPHYSIOL, V11, P131, DOI 10.1016/0167-8760(91)90005-I; Huether G, 1999, PSYCHIAT RES, V87, P83, DOI 10.1016/S0165-1781(99)00044-X; Huppe M, 1983, UNTERSUCHUNGEN EWL 6; Ilias Ioannis, 2002, Endocr Regul, V36, P63; Jacobs N, 2007, BIOL PSYCHOL, V74, P60, DOI 10.1016/j.biopsycho.2006.07.002; Jacobs R, 2001, RHEUMATOLOGY, V40, P868, DOI 10.1093/rheumatology/40.8.868; Jenkins G. M., 1969, SPECTRAL ANAL ITS AP; KAPPEL M, 1991, J APPL PHYSIOL, V70, P2530, DOI 10.1152/jappl.1991.70.6.2530; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; Kirschbaum C., 2000, ENCY STRESS, V3, P379, DOI DOI 10.1159/000118611; KNAPP PH, 1992, PSYCHOSOM MED, V54, P133, DOI 10.1097/00006842-199203000-00002; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; Lazarus R.S., 1991, EMOTION ADAPTATION; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lipsitz Lewis A, 2004, Sci Aging Knowledge Environ, V2004, ppe16; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; LUNDBERG U, 1990, PHARMACOL BIOCHEM BE, V37, P697, DOI 10.1016/0091-3057(90)90550-2; Lutkepohl H., 2005, NEW INTRO MULTIPLE T, DOI DOI 10.1007/078-3-540-27752-1; Makino S, 2002, PHARMACOL BIOCHEM BE, V73, P147, DOI 10.1016/S0091-3057(02)00791-8; MCCRAE RR, 1990, STRESS MEDICINE, V6, P237, DOI 10.1002/smi.2460060309; McQuaid JR, 2000, J ABNORM PSYCHOL, V109, P787, DOI 10.1037/0021-843X.109.4.787; Michaud K, 2008, STRESS, V11, P177, DOI 10.1080/10253890701727874; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pecoraro N, 2006, PROG NEUROBIOL, V79, P247, DOI 10.1016/j.pneurobio.2006.07.004; Porta A, 2007, IEEE T BIO-MED ENG, V54, P94, DOI 10.1109/TBME.2006.883789; Posener JA, 1998, PSYCHONEUROENDOCRINO, V23, P371, DOI 10.1016/S0306-4530(98)00006-7; Righter SD, 1996, J CLIN ENDOCR METAB, V81, P1956, DOI 10.1210/jc.81.5.1956; Rohleder N, 2006, LIFE SCI, V78, P3082, DOI 10.1016/j.lfs.2005.12.016; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Roy MP, 2004, HORM BEHAV, V46, P618, DOI 10.1016/j.yhbeh.2004.06.015; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Savitz DA, 1998, AM J EPIDEMIOL, V147, P813, DOI 10.1093/oxfordjournals.aje.a009532; SCHEDLOWSKI M, 1993, NEUROPSYCHOBIOLOGY, V28, P87, DOI 10.1159/000119006; SCHEDLOWSKI M, 1993, J CLIN IMMUNOL, V13, P119, DOI 10.1007/BF00919268; Schlotz W, 2008, PSYCHOSOM MED, V70, P787, DOI 10.1097/PSY.0b013e3181810658; Schubert C, 2002, PSYCHOTHER PSYCHOSOM, V71, P123, DOI 10.1159/000049356; Schubert C, 2003, PSYCHONEUROENDOCRINO, V28, P459, DOI 10.1016/S0306-4530(02)00034-3; Schubert C, 1999, PSYCHOSOM MED, V61, P876, DOI 10.1097/00006842-199911000-00024; Schubert C, 2006, STRESS HEALTH, V22, P215, DOI 10.1002/smi.1096; Schubert Christian, 2009, Stress, V12, P464, DOI 10.1080/10253890802603925; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; SELIGMAN MEP, 1980, BEHAV RES THER, V18, P462, DOI 10.1016/0005-7967(80)90012-1; Smyth J, 1998, PSYCHONEUROENDOCRINO, V23, P353, DOI 10.1016/S0306-4530(98)00008-0; SPSS Inc, 2005, SPSS TRENDS 14 0; Stalder T, 2010, PSYCHONEUROENDOCRINO, V35, P209, DOI 10.1016/j.psyneuen.2009.06.006; Steptoe A, 2001, CLIN SCI, V101, P185, DOI 10.1042/CS20010038; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; STONE AA, 1987, J PERS SOC PSYCHOL, V52, P988, DOI 10.1037/0022-3514.52.5.988; STONE AA, 1994, HEALTH PSYCHOL, V13, P440, DOI 10.1037/0278-6133.13.5.440; Stone AA, 1996, INT J BEHAV MED, V3, P1, DOI 10.1207/s15327558ijbm0301_1; Straub RH, 1998, J CLIN ENDOCR METAB, V83, P2012, DOI 10.1210/jcem.83.6.4876; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Turner J. Rick, 1994, Annals of Behavioral Medicine, V16, P12; Valdimarsdottir HB, 1997, CRIT REV ORAL BIOL M, V8, P461, DOI 10.1177/10454411970080040601; Van Doornen LJP, 1992, INDIVIDUAL DIFFERENC, P63; vanEck M, 1996, PSYCHOSOM MED, V58, P447, DOI 10.1097/00006842-199609000-00007; vanEck MMM, 1996, BIOL PSYCHOL, V43, P69, DOI 10.1016/0301-0511(95)05159-7; von Kanel R, 2006, BRAIN BEHAV IMMUN, V20, P40, DOI 10.1016/j.bbi.2005.03.013; Yin R. K., 2011, APPL CASE STUDY RES; Zietz B, 2000, J RHEUMATOL, V27, P911	97	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e29415	10.1371/journal.pone.0029415	http://dx.doi.org/10.1371/journal.pone.0029415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928WA	22403606	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700003
J	Singleton, CK; Xiong, YH; Kirsten, JH; Pendleton, KP				Singleton, Charles K.; Xiong, Yanhua; Kirsten, Janet H.; Pendleton, Kelsey P.			eIF2 alpha Kinases Regulate Development through the BzpR Transcription Factor in Dictyostelium discoideum	PLOS ONE			English	Article							OPEN READING FRAMES; GENE-EXPRESSION; INITIATION FACTOR-2-ALPHA; TRANSLATIONAL CONTROL; PHOSPHORYLATION; CELLS; REINITIATION; GCN4; RNA; DISTINCT	Background: A major mechanism of translational regulation in response to a variety of stresses is mediated by phosphorylation of eIF2 alpha to reduce delivery of initiator tRNAs to scanning ribosomes. For some mRNAs, often encoding a bZIP transcription factor, eIF2 alpha phosphorylation leads to enhanced translation due to delayed reinitiation at upstream open reading frames. Dictyostelium cells possess at least three eIF2 alpha kinases that regulate various portions of the starvation-induced developmental program. Cells possessing an eIF2 alpha that cannot be phosphorylated (BS167) show abnormalities in growth and development. We sought to identify a bZIP protein in Dictyostelium whose production is controlled by the eIF2a regulatory system. Principal Findings: Cells disrupted in the bzpR gene had similar developmental defects as BS167 cells, including small entities, stalk defects, and reduced spore viability. beta-galactosidase production was used to examine translation from mRNA containing the bzpR 5' UTR. While protein production was readily apparent and regulated temporally and spatially in wild type cells, essentially no beta-galactosidase was produced in developing BS167 cells even though the lacZ mRNA levels were the same as those in wild type cells. Also, no protein production was observed in strains lacking IfkA or IfkB eIF2 alpha kinases. GFP fusions, with appropriate internal controls, were used to directly demonstrate that the bzpR 5' UTR, possessing 7 uORFs, suppressed translation by 12 fold. Suppression occurred even when all but one uORF was deleted, and translational suppression was removed when the ATG of the single uORF was mutated. Conclusions: The findings indicate that BzpR regulates aspects of the development program in Dictyostelium, serving as a downstream effector of eIF2 alpha phosphorylation. Its production is temporally and spatially regulated by eIF2 alpha phosphorylation by IfkA and IfkB and through the use of uORFs within the bzpR 59 UTR.	[Singleton, Charles K.; Xiong, Yanhua; Kirsten, Janet H.; Pendleton, Kelsey P.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA	Vanderbilt University	Singleton, CK (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA.	charles.k.singleton@vanderbilt.edu			National Science Foundation (NSF) Integrative Organismal Systems (IOS) [0639836]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Science Foundation (NSF) Integrative Organismal Systems (IOS)(National Science Foundation (NSF)); Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported in part by National Science Foundation (NSF) Integrative Organismal Systems (IOS) 0639836. The VMC Flow Cytometry Shared Resource in which some experiments were performed is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Bowman RL, 2011, EUKARYOT CELL, V10, P494, DOI 10.1128/EC.00270-10; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; COCUCCI SM, 1970, J CELL BIOL, V45, P399, DOI 10.1083/jcb.45.2.399; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; EARLY AE, 1993, DEVELOPMENT, V118, P353; Fang Rui, 2003, BMC Dev Biol, V3, P3, DOI 10.1186/1471-213X-3-3; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; HUANG E, 2005, DICTYOSTELIUM GENOMI; Jermyn K, 1996, DEVELOPMENT, V122, P753; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pekovich SR, 1998, J NUTR, V128, P683, DOI 10.1093/jn/128.4.683; Puta F, 1998, FOLIA BIOL-PRAGUE, V44, P185; Rai M, 2006, DIFFERENTIATION, V74, P583, DOI 10.1111/j.1432-0436.2006.00085.x; ROUSSOU I, 1988, MOL CELL BIOL, V8, P2132, DOI 10.1128/MCB.8.5.2132; Singleton CK, 1996, BIOCHEMISTRY-US, V35, P15865, DOI 10.1021/bi9616920; SINGLETON CK, 1987, DEV BIOL, V119, P433, DOI 10.1016/0012-1606(87)90047-9; Sternfeld J, 1998, DEV GENES EVOL, V208, P487, DOI 10.1007/s004270050207; STERNFELD J, 1982, DEV BIOL, V93, P111, DOI 10.1016/0012-1606(82)90244-5; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; Yamada Y, 2010, DEV BIOL, V339, P390, DOI 10.1016/j.ydbio.2009.12.045; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; ZHANG Q, 1995, THESIS VANDERBILT U; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	33	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32500	10.1371/journal.pone.0032500	http://dx.doi.org/10.1371/journal.pone.0032500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403666	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700063
J	Spanou, C; Veskoukis, AS; Kerasioti, T; Kontou, M; Angelis, A; Aligiannis, N; Skaltsounis, AL; Kouretas, D				Spanou, Chrysoula; Veskoukis, Aristidis S.; Kerasioti, Thalia; Kontou, Maria; Angelis, Apostolos; Aligiannis, Nektarios; Skaltsounis, Alexios-Leandros; Kouretas, Dimitrios			Flavonoid Glycosides Isolated from Unique Legume Plant Extracts as Novel Inhibitors of Xanthine Oxidase	PLOS ONE			English	Article							LIVER ALDEHYDE OXIDASE; BOVINE-MILK; GUINEA-PIG; KAEMPFEROL GLYCOSIDES; SUBSTRATE-SPECIFICITY; OXIDATIVE STRESS; IN-VITRO; DEHYDROGENASE; LEAVES; ANTIOXIDANT	Legumes and the polyphenolic compounds present in them have gained a lot of interest due to their beneficial health implications. Dietary polyphenolic compounds, especially flavonoids, exert antioxidant properties and are potent inhibitors of xanthine oxidase (XO) activity. XO is the main contributor of free radicals during exercise but it is also involved in pathogenesis of several diseases such as vascular disorders, cancer and gout. In order to discover new natural, dietary XO inhibitors, some polyphenolic fractions and pure compounds isolated from two legume plant extracts were tested for their effects on XO activity. The fractions isolated from both Vicia faba and Lotus edulis plant extracts were potent inhibitors of XO with IC50 values range from 40-135 mu g/mL and 55-260 mu g/mL, respectively. All the pure polyphenolic compounds inhibited XO and their K-i values ranged from 13-767 mu M. Ten of the compounds followed the non competitive inhibitory model whereas one of them was a competitive inhibitor. These findings indicate that flavonoid isolates from legume plant extracts are novel, natural XO inhibitors. Their mode of action is under investigation in order to examine their potential in drug design for diseases related to overwhelming XO action.	[Spanou, Chrysoula; Veskoukis, Aristidis S.; Kerasioti, Thalia; Kontou, Maria; Kouretas, Dimitrios] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Angelis, Apostolos; Aligiannis, Nektarios; Skaltsounis, Alexios-Leandros] Univ Athens, Sch Pharm, Div Pharmacognosy & Nat Prod Chem, Athens, Greece	University of Thessaly; National & Kapodistrian University of Athens	Spanou, C (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece.	dkouret@uth.gr	Angelis, Apostolis/AAR-5065-2020; KOURETAS, DEMETRIOS/ABE-8519-2020; skaltsounis, alexios leandros/AAE-9617-2019	Angelis, Apostolis/0000-0002-5100-0321; KOURETAS, DEMETRIOS/0000-0002-7469-6640; ALIGIANNIS, NEKTARIOS/0000-0002-3335-8135				Agrawal PK., 1989, CARBON 13 NMR FLAVON; BEEDHAM C, 1995, ARCH BIOCHEM BIOPHYS, V319, P481, DOI 10.1006/abbi.1995.1320; Borges F, 2002, CURR MED CHEM, V9, P195, DOI 10.2174/0929867023371229; Burust N, 1989, PHYTOCHEMISTRY, V49, P241; Campos-Vega R, 2010, FOOD RES INT, V43, P461, DOI 10.1016/j.foodres.2009.09.004; Cos P, 1998, J NAT PROD, V61, P71, DOI 10.1021/np970237h; Cotelle Nicole, 2001, Current Topics in Medicinal Chemistry, V1, P569, DOI 10.2174/1568026013394750; Dew TP, 2005, J AGR FOOD CHEM, V53, P6510, DOI 10.1021/jf050716j; Eger BT, 2000, ACTA CRYSTALLOGR D, V56, P1656, DOI 10.1107/S0907444900012890; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Gomez-Cabrera MC, 2005, J PHYSIOL-LONDON, V567, P113, DOI 10.1113/jphysiol.2004.080564; Halliwell B, 1996, HDB ANTIOXIDANTS; Hasan A, 1996, PHYTOCHEMISTRY, V43, P1115, DOI 10.1016/S0031-9422(96)00416-5; Huang S, 2007, SONN ZHONGCAOYAO, V38, P1313; KELLEY WN, 1970, SCIENCE, V169, P388, DOI 10.1126/science.169.3943.388; KRENITSKY TA, 1986, ARCH BIOCHEM BIOPHYS, V247, P108, DOI 10.1016/0003-9861(86)90539-4; Lru Q, 1994, PHYTOCHEMISTRY, V36, P229; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MULINACCI N, 1995, PHYTOCHEMISTRY, V38, P531, DOI 10.1016/0031-9422(94)00554-7; Nagao A, 1999, BIOSCI BIOTECH BIOCH, V63, P1787, DOI 10.1271/bbb.63.1787; NAKANO K, 1983, PHYTOCHEMISTRY, V22, P2831, DOI 10.1016/S0031-9422(00)97707-0; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Panoutsopoulos GI, 2004, ACTA BIOCHIM POL, V51, P943; Panoutsopoulos GI, 2004, CHEM RES TOXICOL, V17, P1368, DOI 10.1021/tx030059u; PARKS DA, 1986, ACTA PHYSIOL SCAND, V126, P87; Perez-Castorena AL, 1997, PHYTOCHEMISTRY, V46, P1297, DOI 10.1016/S0031-9422(97)00509-8; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rochfort S, 2007, J AGR FOOD CHEM, V55, P7981, DOI 10.1021/jf071704w; Shen YB, 2001, J WOOD SCI, V47, P145, DOI 10.1007/BF00780564; Spanou C, 2007, ANTICANCER RES, V27, P3403; Spanou C, 2008, J AGR FOOD CHEM, V56, P6967, DOI 10.1021/jf800842p; Spanou CI, 2011, J PHYSL BIO IN PRESS; Sweeney AP, 2001, J ETHNOPHARMACOL, V75, P273, DOI 10.1016/S0378-8741(01)00176-3; Takaya Y, 2003, J AGR FOOD CHEM, V51, P8061, DOI 10.1021/jf0346206; Takeda Y, 1997, PHYTOCHEMISTRY, V44, P1335, DOI 10.1016/S0031-9422(96)00751-0; TOMASLORENTE F, 1989, PHYTOCHEMISTRY, V28, P1993, DOI 10.1016/S0031-9422(00)97908-1; Van Hoorn DEC, 2002, EUR J PHARMACOL, V451, P111, DOI 10.1016/S0014-2999(02)02192-1; Vermeris W., 2006, PHENOLIC COMPOUND BI; Veskoukis AS, 2006, EUR J DRUG METAB PH, V31, P11, DOI 10.1007/BF03190636; Veskoukis AS, 2008, APPL PHYSIOL NUTR ME, V33, P1140, DOI 10.1139/H08-102; Wang W, 2009, CHEM PHARM BULL, V57, P636, DOI 10.1248/cpb.57.636; WOOLFOLK CA, 1977, J BACTERIOL, V130, P1175, DOI 10.1128/JB.130.3.1175-1191.1977; Yamano Y, 2005, CHEM PHARM BULL, V53, P541, DOI 10.1248/cpb.53.541; Yoshimitsu H, 2007, J NAT MED-TOKYO, V61, P334, DOI 10.1007/s11418-007-0142-y	44	48	50	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32214	10.1371/journal.pone.0032214	http://dx.doi.org/10.1371/journal.pone.0032214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396752	gold, Green Published, Green Submitted			2022-12-25	WOS:000303006500012
J	Gisabella, B; Bolshakov, VY; Benes, FM				Gisabella, Barbara; Bolshakov, Vadim Y.; Benes, Francine M.			Kainate Receptor-Mediated Modulation of Hippocampal Fast Spiking Interneurons in a Rat Model of Schizophrenia	PLOS ONE			English	Article							AREA CA1; FREQUENCY ADAPTATION; SYNAPTIC ACTIVATION; RECOGNITION MEMORY; PYRAMIDAL NEURONS; BIPOLAR DISORDER; I-H; MECHANISMS; CELLS; OSCILLATIONS	Kainate receptor (KAR) subunits are believed to be involved in abnormal GABAergic neurotransmission in the hippocampus (HIPP) in schizophrenia (SZ) and bipolar disorder. Postmortem studies have shown changes in the expression of the GluR5/6 subunits of KARs in the stratum oriens (SO) of sectors CA2/3, where the basolateral amygdala (BLA) sends a robust projection. Previous work using a rat model of SZ demonstrated that BLA activation leads to electrophysiological changes in fast-spiking interneurons in SO of CA2/3. The present study explores KAR modulation of interneurons in CA2/3 in response to BLA activation. Intrinsic firing properties of these interneurons through KAR-mediated activity were measured with patch-clamp recordings from rats that received 15 days of picrotoxin infusion into the BLA. Chronic BLA activation induced changes in the firing properties of CA2/3 interneurons associated with modifications in the function of KARs. Specifically, the responsiveness of these interneurons to activation of KARs was diminished in picrotoxin-treated rats, while the after-hyperpolarization (AHP) amplitude was increased. In addition, we tested blockers of KAR subunits which have been shown to have altered gene expression in SO sector CA2/3 of SZ subjects. The GluR5 antagonist UBP296 further decreased AP frequency and increased AHP amplitude in picrotoxin-treated rats. Application of the GluR6/7 antagonist NS102 suggested that activation of GluR6/7 KARs may be required to maintain the high firing rates in SO interneurons in the presence of KA. Moreover, the GluR6/7 KAR-mediated signaling may be suppressed in PICRO-treated rats. Our findings indicate that glutamatergic activity from the BLA may modulate the firing properties of CA2/3 interneurons through GluR5 and GluR6/7 KARs. These receptors are expressed in GABAergic interneurons and play a key role in the synchronization of gamma oscillations. Modulation of interneuronal activity through KARs in response to amygdala activation may lead to abnormal oscillatory rhythms reported in SZ subjects.	[Gisabella, Barbara; Benes, Francine M.] McLean Hosp, Program Struct & Mol Neurosci, Belmont, MA 02178 USA; [Gisabella, Barbara; Bolshakov, Vadim Y.; Benes, Francine M.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Bolshakov, Vadim Y.; Benes, Francine M.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gisabella, B (corresponding author), McLean Hosp, Program Struct & Mol Neurosci, 115 Mill St, Belmont, MA 02178 USA.	fbenes@mclean.harvard.edu			National Institutes of Health [MH42261, MH77175]; William P. and Henry B. Test Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042261, R37MH042261, R01MH077175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William P. and Henry B. Test Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by grants from the National Institutes of Health (MH42261 and MH77175) and the William P. and Henry B. Test Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim AM, 2005, BRIT J PSYCHIAT, V187, P500, DOI 10.1192/bjp.187.6.500; Achim AM, 2003, BRAIN COGNITION, V53, P121, DOI 10.1016/S0278-2626(03)00092-7; Aleman A, 1999, AM J PSYCHIAT, V156, P1358; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Benes FM, 1999, BIOL PSYCHIAT, V46, P589, DOI 10.1016/S0006-3223(99)00136-5; Benes FM, 1996, SYNAPSE, V22, P338; Benes FM, 2000, BRAIN RES REV, V31, P251, DOI 10.1016/S0165-0173(99)00041-7; Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Benes FM, 2008, P NATL ACAD SCI USA, V105, P20935, DOI 10.1073/pnas.0810153105; Boehlen A, 2009, BRAIN RES, V1295, P44, DOI 10.1016/j.brainres.2009.08.031; Brown JT, 2006, NEUROPHARMACOLOGY, V50, P47, DOI 10.1016/j.neuropharm.2005.07.017; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Cunningham MG, 2008, J NEUROSCI METH, V167, P213, DOI [10.1016/j.jneumeth.2007.08.016, 10.3791/716]; Danion JM, 1999, ARCH GEN PSYCHIAT, V56, P639, DOI 10.1001/archpsyc.56.7.639; Deakin JFW, 1997, J PSYCHIATR RES, V31, P277, DOI 10.1016/S0022-3956(96)00042-8; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gisabella B, 2005, P NATL ACAD SCI USA, V102, P13301, DOI 10.1073/pnas.0506034102; Gisabella B, 2009, BIOL PSYCHIAT, V65, P464, DOI 10.1016/j.biopsych.2008.09.016; Harrison PJ, 2003, ANN NY ACAD SCI, V1003, P94, DOI 10.1196/annals.1300.006; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Huxter JR, 2007, J NEUROSCI, V27, P2212, DOI 10.1523/JNEUROSCI.3954-06.2007; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Karson MA, 2009, J NEUROSCI, V29, P4140, DOI 10.1523/JNEUROSCI.5264-08.2009; Konradi C, 2011, SCHIZOPHR RES; Konradi C, 2011, ARCH GEN PSYCHIAT, V68, P340, DOI 10.1001/archgenpsychiatry.2010.175; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; LORENZON NM, 1992, J NEUROPHYSIOL, V67, P350, DOI 10.1152/jn.1992.67.2.350; Lupica CR, 2001, J NEUROPHYSIOL, V86, P261, DOI 10.1152/jn.2001.86.1.261; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Melyan Z, 2004, J NEUROSCI, V24, P4530, DOI 10.1523/JNEUROSCI.5356-03.2004; Miles GB, 2005, J PHYSIOL-LONDON, V566, P519, DOI 10.1113/jphysiol.2005.086033; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Paternain AV, 1996, EUR J NEUROSCI, V8, P2129, DOI 10.1111/j.1460-9568.1996.tb00734.x; Powers RK, 1999, J PHYSIOL-PARIS, V93, P101, DOI 10.1016/S0928-4257(99)80141-7; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Takigawa T, 2003, J NEUROPHYSIOL, V89, P2238, DOI 10.1152/jn.00957.2002; TSAI GC, 1995, ARCH GEN PSYCHIAT, V52, P829; Valenti O, 2011, J NEUROSCI, V31, P12330, DOI 10.1523/JNEUROSCI.2808-11.2011; VERDOORN TA, 1994, EUR J PHARM-MOLEC PH, V269, P43, DOI 10.1016/0922-4106(94)90024-8; Vesikansa A, 2007, J PHYSIOL-LONDON, V583, P145, DOI 10.1113/jphysiol.2007.133975; Wondolowski J, 2009, J NEUROSCI, V29, P563, DOI 10.1523/JNEUROSCI.4788-08.2009; Yang EJ, 2007, J PHYSIOL-LONDON, V578, P259, DOI 10.1113/jphysiol.2006.118448	51	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32483	10.1371/journal.pone.0032483	http://dx.doi.org/10.1371/journal.pone.0032483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396770	Green Submitted, gold, Green Published			2022-12-25	WOS:000303005000026
J	Srikanthan, P; Hevener, AL; Karlamangla, AS				Srikanthan, Preethi; Hevener, Andrea L.; Karlamangla, Arun S.			Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; SKELETAL-MUSCLE MASS; FAT; OLDER	Background: Sarcopenia often co-exists with obesity, and may have additive effects on insulin resistance. Sarcopenic obese individuals could be at increased risk for type 2 diabetes. We performed a study to determine whether sarcopenia is associated with impairment in insulin sensitivity and glucose homeostasis in obese and non-obese individuals. Methodology: We performed a cross-sectional analysis of National Health and Nutrition Examination Survey III data utilizing subjects of 20 years or older, non-pregnant (N = 14,528). Sarcopenia was identified from bioelectrical impedance measurement of muscle mass. Obesity was identified from body mass index. Outcomes were homeostasis model assessment of insulin resistance (HOMA IR), glycosylated hemoglobin level (HbA1C), and prevalence of pre-diabetes (6.0 <= HbA1C<6.5 and not on medication) and type 2 diabetes. Covariates in multiple regression were age, educational level, ethnicity and sex. Principal Findings: Sarcopenia was associated with insulin resistance in non-obese ( HOMA IR ratio 1.39, 95% confidence interval (CI) 1.26 to 1.52) and obese individuals (HOMA-IR ratio 1.16, 95% CI 1.12 to 1.18). Sarcopenia was associated with dysglycemia in obese individuals (HbA1C ratio 1.021, 95% CI 1.011 to 1.043) but not in non-obese individuals. Associations were stronger in those under 60 years of age. We acknowledge that the cross-sectional study design limits our ability to draw causal inferences. Conclusions: Sarcopenia, independent of obesity, is associated with adverse glucose metabolism, and the association is strongest in individuals under 60 years of age, which suggests that low muscle mass may be an early predictor of diabetes susceptibility. Given the increasing prevalence of obesity, further research is urgently needed to develop interventions to prevent sarcopenic obesity and its metabolic consequences.	[Srikanthan, Preethi; Karlamangla, Arun S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Gerontol, Los Angeles, CA 90095 USA; [Hevener, Andrea L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Srikanthan, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Gerontol, Los Angeles, CA 90095 USA.	psrikanthan@mednet.ucla.edu			National Institute on Aging [5R01AG26105-3, 5P30 AG028748]; National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95165, N01-HC-95169]; National Institutes of Health [DK060484, DK073227]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC095165, N01HC095159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, R43HL095169, R21HL095165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK060484, R21DK073227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026105, P30AG028748] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	A. Karlamangla is supported by the National Institute on Aging under grants 5R01AG26105-3 (PI: Karlamangla) and 5P30 AG028748 (PI: Reuben). P. Srikanthan is supported by the Multiethnic Study on Atherosclerosis by contracts N01-HC-95159 through N01-HC-95165 and N01-HC-95169 from the National Heart, Lung, and Blood Institute. A. Hevener is supported by the National Institutes of Health (DK060484, DK073227). The funding sources had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Aubertin-Leheudre M, 2006, OBESITY, V14, P2277, DOI 10.1038/oby.2006.267; Baumgartner RN, 1996, AM J CLIN NUTR, V63, P365, DOI 10.1093/ajcn/63.3.365; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; Davison KK, 2002, J AM GERIATR SOC, V50, P1802, DOI 10.1046/j.1532-5415.2002.50508.x; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Guo ZK, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-18; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Nader GA, 2001, J APPL PHYSIOL, V90, P1936, DOI 10.1152/jappl.2001.90.5.1936; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; *NCHS, 1996, 3 NAT HLTH NUTR EX S; Novak ML, 2009, AM J PHYSIOL-REG I, V296, pR1132, DOI 10.1152/ajpregu.90874.2008; Pedersen BK, 2010, J PHYSIOL-LONDON, V588, P21, DOI 10.1113/jphysiol.2009.184747; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Roubenoff R, 2001, CAN J APPL PHYSIOL, V26, P78, DOI 10.1139/h01-006; Stephen WC, 2009, J NUTR HEALTH AGING, V13, P460, DOI 10.1007/s12603-009-0084-z; Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1191, DOI 10.1152/ajpendo.00416.2001; Theuma P, 2004, METAB SYNDR RELAT D, V2, P105, DOI 10.1089/met.2004.2.105; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Walsh K, 2009, CIRC J, V73, P13, DOI 10.1253/circj.CJ-08-0961	25	360	376	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10805	10.1371/journal.pone.0010805	http://dx.doi.org/10.1371/journal.pone.0010805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603PW	22421977	Green Published, gold, Green Submitted			2022-12-25	WOS:000278221500009
J	Aryal, RP; Ju, TZ; Cummings, RD				Aryal, Rajindra P.; Ju, Tongzhong; Cummings, Richard D.			Tight Complex Formation between Cosmc Chaperone and Its Specific Client Non-native T-synthase Leads to Enzyme Activity and Client-driven Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN O-GLYCOSYLATION; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; CORE-1 BETA-1,3-GALACTOSYLTRANSFERASE; DROSOPHILA-MELANOGASTER; IDENTIFICATION; PURIFICATION; INFLAMMATION; EXPRESSION; MUTATIONS	The interaction of the endoplasmic reticulum molecular chaperone Cosmc with its specific client T-synthase (Core 1 beta 1-3-galactosyltransferase) is required for folding of the enzyme and eventual movement of the T-synthase to the Golgi, but the mechanism of interaction is unclear. Here we show that the lumenal domain of recombinant Cosmc directly interacts specifically in either free form or covalently bound to solid supports with denatured T-synthase but not with the active dimeric form of the enzyme. This leads to formation of a relatively stable complex of Cosmc and denatured T-synthase accompanied by formation of reactivated enzyme in an ATP-independent fashion that is not regulated by redox, calcium, pH, or intermolecular disulfide bond formation. The partly refolded and active T-synthase remains tightly bound noncovalently to Cosmc. Dissociation of T-synthase from the complex is promoted by further interactions of the complex with free forms of either native or non-native T-synthase. Taken together, these results demonstrate a novel mechanism in which Cosmc cycles to bind non-native T-synthase, leading to enzyme activity and release in a client-driven process.	[Aryal, Rajindra P.; Ju, Tongzhong; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Cummings, RD (corresponding author), O Wayne Rollins Res Ctr, 1510 Clifton Rd,Suite 4001, Atlanta, GA 30322 USA.	rdcummi@emory.edu		Ju, Tongzhong/0000-0002-4429-1976; Aryal, Rajindra P/0000-0001-8718-636X	National Institutes of Health [RO1 GM068559]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM068559 (to R. D. C.).	Alexander WS, 2006, P NATL ACAD SCI USA, V103, P16442, DOI 10.1073/pnas.0607872103; Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; Betts S, 1999, STRUCT FOLD DES, V7, pR131, DOI 10.1016/S0969-2126(99)80078-1; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brillet T, 2010, J BIOL CHEM, V285, P17986, DOI 10.1074/jbc.M109.098491; Brockhausen I, 1998, ACTA ANAT, V161, P36; Brockhausen I, 2009, ESSENTIALS GLYCOBIOL, P115; Crew VK, 2008, BRIT J HAEMATOL, V142, P657, DOI 10.1111/j.1365-2141.2008.07215.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellis R J, 1990, Semin Cell Biol, V1, P1; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fomenko DE, 2002, PROTEIN SCI, V11, P2285, DOI 10.1110/ps.0218302; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Huang BX, 2004, J AM SOC MASS SPECTR, V15, P1237, DOI 10.1016/j.jasms.2004.05.004; Huang HH, 2010, J CELL BIOL, V190, P893, DOI 10.1083/jcb.201004102; Inoue S, 2000, BIOCHEM BIOPH RES CO, V268, P553, DOI 10.1006/bbrc.2000.2170; Johswich A, 2009, J CELL BIOL, V184, P173, DOI 10.1083/jcb.200801071; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2006, GLYCOBIOLOGY, V16, P947, DOI 10.1093/glycob/cwl008; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Kumagai T, 2010, GLYCOCONJUGATE J, V27, P685, DOI 10.1007/s10719-010-9313-2; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YH, 2002, BIOCHEMISTRY-US, V41, P4921, DOI 10.1021/bi011894i; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; McCormick CD, 2004, OPHTHAL PLAST RECONS, V20, P347, DOI 10.1097/01.IOP.0000134248.64325.C7; McEver RP, 1997, J CLIN INVEST, V100, pS97; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; Narimatsu Y, 2008, BIOCHEM BIOPH RES CO, V366, P199, DOI 10.1016/j.bbrc.2007.11.121; Narimatsu Y, 2011, FEBS LETT, V585, P1276, DOI 10.1016/j.febslet.2011.04.010; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; RAO PV, 1993, BIOCHEM BIOPH RES CO, V190, P786, DOI 10.1006/bbrc.1993.1118; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Sun QA, 2011, J BIOL CHEM, V286, P11529, DOI 10.1074/jbc.M110.173591; Szolajska E, 2011, CELL MOL LIFE SCI, V68, P3307, DOI 10.1007/s00018-011-0740-4; Trilla JA, 1999, J CELL BIOL, V145, P1153, DOI 10.1083/jcb.145.6.1153; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yoshida H, 2008, GLYCOBIOLOGY, V18, P1094, DOI 10.1093/glycob/cwn094; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566	55	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15317	15329		10.1074/jbc.M111.312587	http://dx.doi.org/10.1074/jbc.M111.312587			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416136	Green Published, hybrid			2022-12-25	WOS:000304006300015
J	Brodehl, A; Hedde, PN; Dieding, M; Fatima, A; Walhorn, V; Gayda, S; Saric, T; Klauke, B; Gummert, J; Anselmetti, D; Heilemann, M; Nienhaus, GU; Milting, H				Brodehl, Andreas; Hedde, Per Niklas; Dieding, Mareike; Fatima, Azra; Walhorn, Volker; Gayda, Susan; Saric, Tomos; Klauke, Baerbel; Gummert, Jan; Anselmetti, Dario; Heilemann, Mike; Nienhaus, Gerd Ulrich; Milting, Hendrik			Dual Color Photoactivation Localization Microscopy of Cardiomyopathy-associated Desmin Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; INTERMEDIATE-FILAMENTS; MARKER PROTEIN; MUTATIONS; SKELETAL; EOSFP; MYOPATHY; BIOLOGY	Mutations in the DES gene coding for the intermediate filament protein desmin may cause skeletal and cardiac myopathies, which are frequently characterized by cytoplasmic aggregates of desmin and associated proteins at the cellular level. By atomic force microscopy, we demonstrated filament formation defects of desmin mutants, associated with arrhythmogenic right ventricular cardiomyopathy. To understand the pathogenesis of this disease, it is essential to analyze desmin filament structures under conditions in which both healthy and mutant desmin are expressed at equimolar levels mimicking an in vivo situation. Here, we applied dual color photoactivation localization microscopy using photoactivatable fluorescent proteins genetically fused to desmin and characterized the heterozygous status in living cells lacking endogenous desmin. In addition, we applied fluorescence resonance energy transfer to unravel short distance structural patterns of desmin mutants in filaments. For the first time, we present consistent high resolution data on the structural effects of five heterozygous desmin mutations on filament formation in vitro and in living cells. Our results may contribute to the molecular understanding of the pathological filament formation defects of heterozygous DES mutations in cardiomyopathies.	[Brodehl, Andreas; Klauke, Baerbel; Milting, Hendrik] Ruhr Univ Bochum, E&H Klessmann Inst Cardiovasc Res & Dev, Heart & Diabet Ctr NRW, D-32545 Bad Oeynhausen, Germany; [Gummert, Jan] Ruhr Univ Bochum, Clin Cardiothorac Surg, Heart & Diabet Ctr NRW, D-32545 Bad Oeynhausen, Germany; [Hedde, Per Niklas; Gayda, Susan; Nienhaus, Gerd Ulrich] Karlsruhe Inst Technol, Inst Appl Phys, D-76128 Karlsruhe, Germany; [Hedde, Per Niklas; Gayda, Susan; Nienhaus, Gerd Ulrich] Karlsruhe Inst Technol, Ctr Funct Nanostruct, D-76128 Karlsruhe, Germany; [Dieding, Mareike; Walhorn, Volker; Anselmetti, Dario] Univ Bielefeld, Fac Phys, D-33615 Bielefeld, Germany; [Dieding, Mareike; Walhorn, Volker; Anselmetti, Dario] Univ Bielefeld, Bielefeld Inst Biophys & Nanosci BINAS, D-33615 Bielefeld, Germany; [Fatima, Azra; Saric, Tomos] Univ Cologne, Med Ctr, Inst Neurophysiol, D-50931 Cologne, Germany; [Heilemann, Mike] Univ Wurzburg, Dept Biotechnol & Biophys, D-97074 Wurzburg, Germany; [Nienhaus, Gerd Ulrich] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Ruhr University Bochum; Ruhr University Bochum; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Bielefeld; University of Bielefeld; University of Cologne; University of Wurzburg; University of Illinois System; University of Illinois Urbana-Champaign	Milting, H (corresponding author), Ruhr Univ Bochum, E&H Klessmann Inst Cardiovasc Res & Dev, Heart & Diabet Ctr NRW, D-32545 Bad Oeynhausen, Germany.	hmilting@hdz-nrw.de	Saric, Tomo/B-3415-2015; Walhorn, Volker/F-3803-2011; Brodehl, Andreas/C-6450-2013; Nienhaus, Gerd Ulrich/G-8698-2012; Anselmetti, Dario/F-1664-2011	Saric, Tomo/0000-0001-8344-1095; Brodehl, Andreas/0000-0001-9202-2343; Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Anselmetti, Dario/0000-0002-8720-4369; Heilemann, Mike/0000-0002-9821-3578	German Ministry of Education and Research (BMBF) [O1 GN 0824]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Grant O1 GN 0824 from the German Ministry of Education and Research (BMBF) to (T. S.).	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando S, 2004, BBA-PROTEINS PROTEOM, V1702, P53, DOI 10.1016/j.bbapap.2004.07.008; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Bar H, 2010, J MOL BIOL, V397, P1188, DOI 10.1016/j.jmb.2010.02.024; Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; Bar H, 2007, HUM MUTAT, V28, P374, DOI 10.1002/humu.20459; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Chernyatina A. A., 2011, 7 EUR C INT FIL HLTH; Chourbagi O, 2011, EXP CELL RES, V317, P886, DOI 10.1016/j.yexcr.2011.01.013; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Dalakas MC, 2003, NEUROMUSCULAR DISORD, V13, P252, DOI 10.1016/S0960-8966(02)00271-7; Fuchs J, 2010, NAT METHODS, V7, P627, DOI [10.1038/NMETH.1477, 10.1038/nmeth.1477]; Goldfarb LG, 2009, J CLIN INVEST, V119, P1806, DOI 10.1172/JCI38027; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Gupta MK, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-98; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; Hedde Per Niklas, 2010, Biophys Rev, V2, P147, DOI 10.1007/s12551-010-0037-0; Hedde PN, 2009, NAT METHODS, V6, P689, DOI 10.1038/nmeth1009-689; Helfand BT, 2003, ANNU REV CELL DEV BI, V19, P445, DOI 10.1146/annurev.cellbio.19.111401.092306; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hong D, 2011, NEUROPATH APPL NEURO, V37, P257, DOI 10.1111/j.1365-2990.2010.01112.x; KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x; KITAMURA S, 1989, J BIOL CHEM, V264, P5674; Klauke B, 2010, HUM MOL GENET, V19, P4595, DOI 10.1093/hmg/ddq387; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Levin J, 2010, J NEUROPATH EXP NEUR, V69, P415, DOI 10.1097/NEN.0b013e3181d71305; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Nienhaus K, 2005, P NATL ACAD SCI USA, V102, P9156, DOI 10.1073/pnas.0501874102; Otten E, 2010, HEART RHYTHM, V7, P1058, DOI 10.1016/j.hrthm.2010.04.023; Pica EC, 2008, NEUROMUSCULAR DISORD, V18, P178, DOI 10.1016/j.nmd.2007.09.011; RAATS JMH, 1990, J CELL BIOL, V111, P1971, DOI 10.1083/jcb.111.5.1971; Sharma S, 2009, J MOL MED, V87, P1207, DOI 10.1007/s00109-009-0521-9; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; van Spaendonck-Zwarts K., 2010, CLIN GENET, V89, P354; van Tintelen JP, 2009, HEART RHYTHM, V6, P1574, DOI 10.1016/j.hrthm.2009.07.041; Vernengo L, 2010, NEUROMUSCULAR DISORD, V20, P178, DOI 10.1016/j.nmd.2010.01.001; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wiedenmann J, 2011, J BIOPHOTONICS, V4, P377, DOI 10.1002/jbio.201000122; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	47	39	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16047	16057		10.1074/jbc.M111.313841	http://dx.doi.org/10.1074/jbc.M111.313841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403400	Green Published, hybrid			2022-12-25	WOS:000304006300082
J	DeAngelis, JP; Wakabayashi, H; Fay, PJ				DeAngelis, Jennifer P.; Wakabayashi, Hironao; Fay, Philip J.			Sequences Flanking Arg(336) in Factor VIIIa Modulate Factor Xa-catalyzed Cleavage Rates at this Site and Cofactor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-PROTEIN-C; THROMBIN GENERATION; A1/A3-C1-C2 DIMER; A1 SUBUNIT; FACTOR-IXA; A2 DOMAIN; RESIDUES; INACTIVATION; MECHANISMS; IDENTIFICATION	Factor (F)VIII can be activated to FVIIIa by FXa following cleavages at Arg(372), Arg(740), and Arg(1689). FXa also cleaves FVIII/FVIIIa at Arg(336) and Arg(562) resulting in inactivation of the cofactor. These inactivating cleavages occur on a slower time scale than the activating ones. We assessed the contributions to cleavage rate and cofactor function of residues flanking Arg(336), the primary site yielding FVIII(a) inactivation, following replacement of these residues with those flanking the faster-reacting Arg(740) and Arg(372) sites and the slower-reacting Arg(562) site. Replacing P4-P3' residues flanking Arg(336) with those from Arg(372) or Arg(740) resulted in similar to 4-6-fold increases in rates of FXa-catalyzed inactivation of FVIIIa, which paralleled the rates of proteolysis at Arg(336). Examination of partial sequence replacements showed a predominant contribution of prime residues flanking the scissile bonds to the enhanced rates. Conversely, replacement of this sequence with residues flanking the slow-reacting Arg(562) site yielded inactivation and cleavage rates that were similar to 40% that of the WT values. The capacity for FXa to activate FVIII variants where cleavage at Arg(336) was accelerated due to flanking sequence replacement showed marked reductions in peak activity, whereas reducing the cleavage rate at this site enhanced peak activity. Furthermore, plasma-based thrombin generation assays employing the variants revealed significant reductions in multiple parameter values with acceleration of Arg(336) cleavage suggesting increased down-regulation of FXase. Overall, these results are consistent with a model of competition for activating and inactivating cleavages catalyzed by FXa that is modulated in large part by sequences flanking the scissile bonds.	[DeAngelis, Jennifer P.; Wakabayashi, Hironao; Fay, Philip J.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL76213, HL38199]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199, R01HL076213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL76213 and HL38199.	Ansong C, 2006, J THROMB HAEMOST, V4, P842, DOI 10.1111/j.1538-7836.2006.01831.x; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Bode W, 1997, THROMB HAEMOSTASIS, V78, P501; DeAngelis JP, 2011, THROMB RES, V128, P470, DOI 10.1016/j.thromres.2011.03.007; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; Fay PJ, 2005, BLOOD REV, V19, P15, DOI 10.1016/j.blre.2004.02.003; FAY PJ, 1994, J BIOL CHEM, V269, P20522; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HEMKER HC, 1995, THROMB HAEMOSTASIS, V74, P134; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Nogami K, 2005, BLOOD, V105, P4362, DOI 10.1182/blood-2004-10-3939; Nogami K, 2004, J BIOL CHEM, V279, P33104, DOI 10.1074/jbc.M405537200; Nogami K, 2003, J BIOL CHEM, V278, P1634, DOI 10.1074/jbc.M209811200; Nogami K, 2004, J BIOL CHEM, V279, P15763, DOI 10.1074/jbc.M400568200; Nogami K, 1999, J BIOL CHEM, V274, P31000, DOI 10.1074/jbc.274.43.31000; Nogami K, 2003, J BIOL CHEM, V278, P16502, DOI 10.1074/jbc.M213044200; Nogami K, 2007, J BIOL CHEM, V282, P5287, DOI 10.1074/jbc.M607816200; Plantier JL, 2010, J THROMB HAEMOST, V8, P286, DOI 10.1111/j.1538-7836.2009.03675.x; Varfaj F, 2007, J BIOL CHEM, V282, P20264, DOI 10.1074/jbc.M701327200; Varfaj F, 2006, BIOCHEM J, V396, P355, DOI 10.1042/BJ20060117; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158	32	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15409	15417		10.1074/jbc.M111.333948	http://dx.doi.org/10.1074/jbc.M111.333948			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411993	hybrid, Green Published			2022-12-25	WOS:000304006300022
J	Chen, JM; Herrup, K				Chen, Jianmin; Herrup, Karl			Glutamine Acts as a Neuroprotectant against DNA Damage, Beta-Amyloid and H2O2-Induced Stress	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMINO-ACIDS; CEREBROSPINAL-FLUID; TRANSGENIC MICE; IN-VIVO; SYNTHETASE; BRAIN; ASTROCYTES; PROTEINS; DYSFUNCTION	Glutamine is the most abundant free amino acid in the human blood stream and is 'conditionally essential' to cells. Its intracellular levels are regulated both by the uptake of extracellular glutamine via specific transport systems and by its intracellular synthesis by glutamine synthetase (GS). Adding to the regulatory complexity, when extracellular glutamine is reduced GS protein levels rise. Unfortunately, this excess GS can be maladaptive. GS overexpression is neurotoxic especially if the cells are in a low-glutamine medium. Similarly, in low glutamine, the levels of multiple stress response proteins are reduced rendering cells hypersensitive to H2O2, zinc salts and DNA damage. These altered responses may have particular relevance to neurodegenerative diseases of aging. GS activity and glutamine levels are lower in the Alzheimer's disease (AD) brain, and a fraction of AD hippocampal neurons have dramatically increased GS levels compared with control subjects. We validated the importance of these observations by showing that raising glutamine levels in the medium protects cultured neuronal cells against the amyloid peptide, Ab. Further, a 10-day course of dietary glutamine supplementation reduced inflammation-induced neuronal cell cycle activation, tau phosphorylation and ATM-activation in two different mouse models of familial AD while raising the levels of two synaptic proteins, VAMP2 and synaptophysin. Together, our observations suggest that healthy neuronal cells require both intracellular and extracellular glutamine, and that the neuroprotective effects of glutamine supplementation may prove beneficial in the treatment of AD.	[Chen, Jianmin; Herrup, Karl] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Chen, JM (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	chen@biology.rutgers.edu	Herrup, Karl/C-5313-2014	Herrup, Karl/0000-0001-7786-5844	Alzheimer's Association; NIA [AG024494]; NINDS [NS20591]; Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024494] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by funding awarded to KH from the Alzheimer's Association - Zenith Award, NIA (AG024494), NINDS (NS20591), and Rutgers University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2007, FRONT BIOSCI-LANDMRK, V12, P332, DOI 10.2741/2067; Antuono PG, 2001, NEUROLOGY, V56, P737, DOI 10.1212/WNL.56.6.737; Berg RMG, 2010, CRIT CARE, V14, DOI 10.1186/cc8873; Best BP, 2009, REJUV RES, V12, P199, DOI 10.1089/rej.2009.0847; Boyd-Kimball D, 2005, BRAIN RES, V1044, P206, DOI 10.1016/j.brainres.2005.02.086; Brasse-Lagnel C, 2009, FEBS J, V276, P1826, DOI 10.1111/j.1742-4658.2009.06920.x; Burbaeva GS, 2005, NEUROCHEM RES, V30, P1443, DOI 10.1007/s11064-005-8654-x; Busser J, 1998, J NEUROSCI, V18, P2801; Butterfield DA, 2006, NEUROBIOL DIS, V22, P223, DOI 10.1016/j.nbd.2005.11.002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Eid T, 2008, BRAIN, V131, P2061, DOI 10.1093/brain/awn133; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Fernandes SP, 2011, NEUROSCI LETT, V490, P27, DOI 10.1016/j.neulet.2010.12.019; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; GUNNERSEN D, 1992, P NATL ACAD SCI USA, V89, P11949, DOI 10.1073/pnas.89.24.11949; Haberle J, 2005, NEW ENGL J MED, V353, P1926, DOI 10.1056/NEJMoa050456; Hattori N, 2002, NEUROREPORT, V13, P183, DOI 10.1097/00001756-200201210-00041; He YJ, 2010, GLIA, V58, P741, DOI 10.1002/glia.20960; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Kuhn KS, 2010, EUR J NUTR, V49, P197, DOI 10.1007/s00394-009-0082-2; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lee A, 2010, J CHEM NEUROANAT, V39, P211, DOI 10.1016/j.jchemneu.2009.12.002; Li L, 2011, INT J ALZHEIMERS DIS; Lin AP, 2003, MAGN RESON MATER PHY, V16, P29, DOI 10.1007/s10334-003-0004-x; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; RIVETT AJ, 1985, J BIOL CHEM, V260, P300; Robinson SR, 2000, NEUROCHEM INT, V36, P471, DOI 10.1016/S0197-0186(99)00150-3; Robinson SR, 2001, J NEUROSCI RES, V66, P972, DOI 10.1002/jnr.10057; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Savarese DMF, 2003, CANCER TREAT REV, V29, P501, DOI 10.1016/S0305-7372(03)00133-6; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; Tumani H, 1999, ARCH NEUROL-CHICAGO, V56, P1241, DOI 10.1001/archneur.56.10.1241; Varvel NH, 2009, J CLIN INVEST, V119, P3692, DOI 10.1172/JCI39716; Vilenchik MM, 2000, P NATL ACAD SCI USA, V97, P5381, DOI 10.1073/pnas.090099497; Visalli V, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-106; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	44	50	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33177	10.1371/journal.pone.0033177	http://dx.doi.org/10.1371/journal.pone.0033177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413000	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062000034
J	Deeds, EJ; Krivine, J; Feret, J; Danos, V; Fontana, W				Deeds, Eric J.; Krivine, Jean; Feret, Jerome; Danos, Vincent; Fontana, Walter			Combinatorial Complexity and Compositional Drift in Protein Interaction Networks	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; GLOBAL ANALYSIS; IDENTIFICATION; ASSOCIATION; DYNAMICS	The assembly of molecular machines and transient signaling complexes does not typically occur under circumstances in which the appropriate proteins are isolated from all others present in the cell. Rather, assembly must proceed in the context of large-scale protein-protein interaction (PPI) networks that are characterized both by conflict and combinatorial complexity. Conflict refers to the fact that protein interfaces can often bind many different partners in a mutually exclusive way, while combinatorial complexity refers to the explosion in the number of distinct complexes that can be formed by a network of binding possibilities. Using computational models, we explore the consequences of these characteristics for the global dynamics of a PPI network based on highly curated yeast two-hybrid data. The limited molecular context represented in this data-type translates formally into an assumption of independent binding sites for each protein. The challenge of avoiding the explicit enumeration of the astronomically many possibilities for complex formation is met by a rule-based approach to kinetic modeling. Despite imposing global biophysical constraints, we find that initially identical simulations rapidly diverge in the space of molecular possibilities, eventually sampling disjoint sets of large complexes. We refer to this phenomenon as "compositional drift''. Since interaction data in PPI networks lack detailed information about geometric and biological constraints, our study does not represent a quantitative description of cellular dynamics. Rather, our work brings to light a fundamental problem (the control of compositional drift) that must be solved by mechanisms of assembly in the context of large networks. In cases where drift is not (or cannot be) completely controlled by the cell, this phenomenon could constitute a novel source of phenotypic heterogeneity in cell populations.	[Fontana, Walter] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Deeds, Eric J.] Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA; [Deeds, Eric J.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Krivine, Jean] Univ Paris 07, Lab PPS, F-75230 Paris, France; [Krivine, Jean; Feret, Jerome] CNRS, F-75230 Paris, France; [Feret, Jerome] ENS, Ecole Normale Super, INRIA, Lab Informat, F-75230 Paris, France; [Fontana, Walter] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland	Harvard University; Harvard Medical School; University of Kansas; University of Kansas; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Inria; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Edinburgh	Deeds, EJ (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	walter@hms.harvard.edu		FERET, Jerome/0000-0002-2601-2785	National Research Service Award [F32 GM080123-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080123] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research has been supported by National Research Service Award F32 GM080123-03 to EJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Blinov ML, 2006, LECT NOTES COMPUT SC, V4230, P89; Blinov ML, 2004, BIOINFORMATICS, V20, P3289, DOI 10.1093/bioinformatics/bth378; Bougouffa S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-448; Camacho CJ, 2000, BIOPHYS J, V78, P1094, DOI 10.1016/S0006-3495(00)76668-9; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Danos V, 2004, THEOR COMPUT SCI, V325, P69, DOI 10.1016/j.tcs.2004.03.065; Danos V, 2008, LECT N BIOINFORMAT, V5054, P103, DOI 10.1007/978-3-540-68413-8_8; Danos V, 2008, LECT NOTES COMPUT SC, V4905, P83, DOI 10.1007/978-3-540-78163-9_11; Danos V, 2007, LECT NOTES COMPUT SC, V4807, P139; Danos V, 2007, LECT NOTES COMPUT SC, V4703, P17; Danos V, 2009, LECT NOTES COMPUT SC, V5750, P116; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Deeds EJ, 2006, P NATL ACAD SCI USA, V103, P311, DOI 10.1073/pnas.0509715102; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Harmer R, 2010, CHAOS, V20, DOI 10.1063/1.3491100; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Hlavacek WS, 2003, BIOTECHNOL BIOENG, V84, P783, DOI 10.1002/bit.10842; HORTON N, 1992, PROTEIN SCI, V1, P169; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD195, DOI 10.1093/nar/gkj017; Maslov S, 2007, P NATL ACAD SCI USA, V104, P13655, DOI 10.1073/pnas.0702905104; Mayer Bruce J., 2009, Journal of Biology (London), V8, P81, DOI 10.1186/jbiol185; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Pang XD, 2011, BIOPHYS J, V101, P1175, DOI 10.1016/j.bpj.2011.06.056; Perktold A, 2007, FEMS YEAST RES, V7, P629, DOI 10.1111/j.1567-1364.2007.00226.x; Saiz L, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100061; Shakhnovich E, 2006, CHEM REV, V106, P1559, DOI 10.1021/cr040425u; Shedden K, 2002, NUCLEIC ACIDS RES, V30, P2920, DOI 10.1093/nar/gkf414; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Thomas A, 2003, BIOCHEM SOC T, V31, P1491; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Yang J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031910; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang JS, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.48; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	56	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32032	10.1371/journal.pone.0032032	http://dx.doi.org/10.1371/journal.pone.0032032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412851	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062000004
J	Yamauchi, Y; Izumi, Y; Hashimoto, K; Yashiro, H; Inoue, M; Nakatsuka, S; Goto, T; Anraku, M; Ohtsuka, T; Kohno, M; Kawamura, M; Nomori, H				Yamauchi, Yoshikane; Izumi, Yotaro; Hashimoto, Kohei; Yashiro, Hideki; Inoue, Masanori; Nakatsuka, Seishi; Goto, Taichiro; Anraku, Masaki; Ohtsuka, Takashi; Kohno, Mitsutomo; Kawamura, Masafumi; Nomori, Hiroaki			Percutaneous Cryoablation for the Treatment of Medically Inoperable Stage I Non-Small Cell Lung Cancer	PLOS ONE			English	Article							CHARLSON COMORBIDITY INDEX; RADIOFREQUENCY ABLATION; NONSURGICAL CANDIDATES; RADIOTHERAPY; VALIDATION	Background: To evaluate the midterm results of percutaneous cryoablation for medically inoperable stage I non-small cell lung cancer. Methodology/Principal Findings: Between January 2004 and June 2010, 160 patients underwent computer tomography guided percutaneous cryoablation for lung tumors at our institution. Of these patients, histologically proven stage I lung cancer patients with more than one year of follow-up, were retrospectively reviewed. All of these patients were considered to be medically inoperable with Charlson comorbidity index of 3 or greater. Follow-up was based primarily on computed tomography. There were 22 patients with 34 tumors who underwent 25 sessions of cryoablation treatment. Complications were pneumothoraces in 7 treatments ( 28%, chest tube required in one treatment), and pleural effusions in 8 treatments (31%). The observation period ranged from 12-68 months, average 29 +/- 19 months, median 23 months. Local tumor progression was observed in one tumor (3%). Mean local tumor progression-free interval was 69 +/- 2 months. One patient died of lung cancer progression at 68 months. Two patients died of acute exacerbations of idiopathic pulmonary fibrosis which were not considered to be directly associated with cryoablation, at 12 and 18 months, respectively. The overall 2- and 3-year survivals were 88% and 88%, respectively. Mean overall survival was 62 +/- 4 months. Median overall survival was 68 months. The disease-free 2- and 3-year survivals were 78% and 67%, respectively. Mean disease-free survival was 46 +/- 6 months. Pulmonary function tests were done in 16 patients (18 treatments) before and after cryoablation. Percentage of predicted vital capacity, and percentage of predicted forced expiratory volume in 1 second, did not differ significantly before and after cryoablation (93 +/- 23 versus 90 +/- 21, and 70 +/- 11 versus 70 +/- 12, respectively). Conclusions/Significance: Although further accumulation of data is necessary regarding efficacy, cryoablation may be a feasible option in medically inoperable stage I lung cancer patients.	[Yamauchi, Yoshikane; Izumi, Yotaro; Hashimoto, Kohei; Goto, Taichiro; Anraku, Masaki; Ohtsuka, Takashi; Kohno, Mitsutomo; Nomori, Hiroaki] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Yashiro, Hideki; Inoue, Masanori; Nakatsuka, Seishi] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo 160, Japan; [Kawamura, Masafumi] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan	Keio University; Keio University; Teikyo University	Yamauchi, Y (corresponding author), Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.	yotaroizumi@a2.keio.jp	Yamauchi, Yoshikane/I-1952-2019; Anraku, Masaki/Y-1246-2018; OHTSUKA, TAKASHI/I-3988-2019; Goto, Taichiro/AAM-5276-2020	Yamauchi, Yoshikane/0000-0002-3374-2399; Anraku, Masaki/0000-0002-2710-3486; OHTSUKA, TAKASHI/0000-0002-8039-9159; Goto, Taichiro/0000-0002-2560-3639				Birim O, 2005, EUR J CARDIO-THORAC, V28, P759, DOI 10.1016/j.ejcts.2005.06.046; Birim O, 2003, EUR J CARDIO-THORAC, V23, P30, DOI 10.1016/S1010-7940(02)00721-2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Eradat J, 2011, CANCER J, V17, P38, DOI 10.1097/PPO.0b013e31820a0948; Fernando HC, 2005, J THORAC CARDIOV SUR, V129, P639, DOI 10.1016/j.jtcvs.2004.10.019; Hiraki T, 2007, J THORAC CARDIOV SUR, V134, P1306, DOI 10.1016/j.jtcvs.2007.07.013; Kawamura M, 2006, J THORAC CARDIOV SUR, V131, P1007, DOI 10.1016/j.jtcvs.2005.12.051; Kunkle DA, 2008, CANCER, V113, P2671, DOI 10.1002/cncr.23896; Lanuti M, 2009, J THORAC CARDIOV SUR, V137, P160, DOI 10.1016/j.jtcvs.2008.08.034; Onishi H, 2010, INT J RAD ONCOLOGY B; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Pennathur A, 2007, J THORAC CARDIOV SUR, V134, P857, DOI 10.1016/j.jtcvs.2007.04.060; Pennathur A, 2010, SEMIN THORAC CARDIOV, V22, P53, DOI 10.1053/j.semtcvs.2010.06.002; Takeda A, 2009, INT J RADIAT ONCOL, V73, P442, DOI 10.1016/j.ijrobp.2008.04.043; Wang HW, 2005, RADIOLOGY, V235, P289, DOI 10.1148/radiol.2351030747; Yamauclii Y, 2009, CAN KAGAKU RYOHO, V36, P1259; Zemlyak A, 2010, J AM COLL SURGEONS, V211, P68, DOI 10.1016/j.jamcollsurg.2010.03.020	17	56	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33223	10.1371/journal.pone.0033223	http://dx.doi.org/10.1371/journal.pone.0033223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413004	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062000037
J	Cao, L; Zhang, YP; Cao, YX; Edvinsson, L; Xu, CB				Cao, Lei; Zhang, Yaping; Cao, Yong-Xiao; Edvinsson, Lars; Xu, Cang-Bao			Cigarette Smoke Upregulates Rat Coronary Artery Endothelin Receptors In Vivo	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; ETA-RECEPTOR; SUBARACHNOID HEMORRHAGE; B-RECEPTOR; INCREASED EXPRESSION; CEREBRAL-ARTERIES; INHIBITOR GW5074; BLOOD-FLOW; KINASE; ANTAGONIST	Background: Cigarette smoking is a strong cardiovascular risk factor and endothelin (ET) receptors are related to coronary artery diseases. The present study established an in vivo secondhand smoke (SHS) exposure model and investigated the hypothesis that cigarette smoke induces ET receptor upregulation in rat coronary arteries and its possible underlying mechanisms. Methodology/Principal Findings: Rats were exposed to SHS for 200 min daily for 8 weeks. The coronary arteries were isolated and examined. The vasoconstriction was studied by a sensitive myograph. The expression of mRNA and protein for receptors was examined by real-time PCR, Western blot and immunofluorescence. Compared to fresh air exposure, SHS increased contractile responses mediated by endothelin type A (ETA) and type B (ETB) receptors in coronary arteries. In parallel, the expression of mRNA and protein for ETA and ETB receptors of smoke exposed rats were higher than that of animals exposed to fresh air, suggesting that SHS upregulates ETA and ETB receptors in coronary arteries in vivo. Immunofluorescence staining showed that the enhanced receptor expression was localized to the smooth muscle cells of coronary arteries. The protein levels of phosphorylated (p)-Raf-1 and p-ERK1/2 in smoke exposed rats were significantly higher than in control rats, demonstrating that SHS induces the activation of the Raf/ERK/MAPK pathway. Treatment with Raf-1 inhibitor GW5074 suppressed SHS-induced enhanced contraction mediated by ETA receptors, and inhibited the elevated mRNA and protein levels of ETA and ETB receptors caused by SHS. The results of correlation and regression analysis showed that phosphorylation of Raf and ERK1/2 were independent determinants to affect protein expression of ETB and ETA receptors. Conclusions/Significance: Cigarette smoke upregulates ETB and ETA receptors in rat coronary artery, which is associated with the activation of the Raf/ERK/MAPK pathway.	[Cao, Lei; Zhang, Yaping; Edvinsson, Lars; Xu, Cang-Bao] Lund Univ, Inst Clin Sci Lund, Div Expt Vasc Res, Lund, Sweden; [Cao, Yong-Xiao] Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian, Shaanxi, Peoples R China	Lund University; Xi'an Jiaotong University	Cao, L (corresponding author), Lund Univ, Inst Clin Sci Lund, Div Expt Vasc Res, Lund, Sweden.	Cang-Bao.Xu@med.lu.se		Xu, Cang-Bao/0000-0003-3421-3306; Edvinsson, Lars/0000-0002-1805-1346; Zhang, Yaping/0000-0002-9264-3120	Swedish Research Council [5958]; Flight Attendant Medical Research Institute, USA; National Natural Science Foundation of China [30772566]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Flight Attendant Medical Research Institute, USA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Swedish Research Council (grant no. 5958), the Flight Attendant Medical Research Institute, USA, and the National Natural Science Foundation of China (30772566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adner M, 2001, BRIT J PHARMACOL, V133, P927, DOI 10.1038/sj.bjp.0704135; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Ansar S, 2007, AM J PHYSIOL-HEART C, V293, pH3750, DOI 10.1152/ajpheart.00857.2007; Barton M, 2000, Curr Hypertens Rep, V2, P84, DOI 10.1007/s11906-000-0064-5; Beg SAS, 2006, J CEREBR BLOOD F MET, V26, P846, DOI 10.1038/sj.jcbfm.9600236; Campisi R, 1998, CIRCULATION, V98, P119, DOI 10.1161/01.CIR.98.2.119; Cannan CR, 1996, CIRCULATION, V93, P646, DOI 10.1161/01.CIR.93.4.646; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Dagassan PH, 1996, J CARDIOVASC PHARM, V27, P147, DOI 10.1097/00005344-199601000-00023; Dawson DA, 1999, NEUROCHEM RES, V24, P1499, DOI 10.1023/A:1021139713026; Dimitrijevic I, 2009, HEART VESSELS, V24, P393, DOI 10.1007/s00380-008-1136-8; Dimitrijevic I, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-40; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Edvinsson LI, 2011, J CEREB BLOOD FLOW M; Eskesen K, 2006, EUR J PHARMACOL, V539, P192, DOI 10.1016/j.ejphar.2006.04.024; Fujita K, 1996, JPN J PHARMACOL, V70, P313, DOI 10.1254/jjp.70.313; HAAK T, 1994, METABOLISM, V43, P267, DOI 10.1016/0026-0495(94)90091-4; Hansen-Schwartz J, 2003, NEUROSURGERY, V52, P1188, DOI 10.1227/01.NEU.0000058467.82442.64; Henriksson M, 2007, EXP BRAIN RES, V178, P470, DOI 10.1007/s00221-006-0753-7; Hirano M, 1996, J BIOL CHEM, V271, P13234, DOI 10.1074/jbc.271.22.13234; Huckle WR, 2001, CIRCULATION, V103, P1899; Iwasa S, 1999, ATHEROSCLEROSIS, V146, P93, DOI 10.1016/S0021-9150(99)00134-3; Kobayashi T, 2000, PATHOL INT, V50, P929, DOI 10.1046/j.1440-1827.2000.01152.x; Kowala MC, 2004, J PHARMACOL EXP THER, V309, P275, DOI 10.1124/jpet.103.055855; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lei Y, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-71; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li J, 2008, EUR J PHARMACOL, V588, P280, DOI 10.1016/j.ejphar.2008.04.038; Nohria A, 2003, HYPERTENSION, V42, P43, DOI 10.1161/01.HYP.0000074426.71392.D8; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Prasad D S, 2009, Indian J Med Sci, V63, P520; QUILLEN JE, 1993, J AM COLL CARDIOL, V22, P642, DOI 10.1016/0735-1097(93)90170-6; Rahman MM, 2007, CURR VASC PHARMACOL, V5, P276, DOI 10.2174/157016107782023406; Rahman MM, 2007, VASC PHARMACOL, V46, P35, DOI 10.1016/j.vph.2006.06.006; Sandhu H, 2010, TOXICOL APPL PHARM, V249, P25, DOI 10.1016/j.taap.2010.08.010; Tanus-Santos JE, 2000, EUR J PHARMACOL, V396, P33, DOI 10.1016/S0014-2999(00)00194-1; Wackenfors A, 2004, EUR J PHARMACOL, V484, P103, DOI 10.1016/j.ejphar.2003.11.001; Xu CB, 2010, BASIC CLIN PHARMACOL, V107, P940, DOI 10.1111/j.1742-7843.2010.00610.x; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhang JY, 2009, ARCH PHARM RES, V32, P1475, DOI 10.1007/s12272-009-2019-y; Zhang YP, 2010, THESCIENTIFICWORLDJO, V10, P2157, DOI 10.1100/tsw.2010.204	42	37	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33008	10.1371/journal.pone.0033008	http://dx.doi.org/10.1371/journal.pone.0033008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412974	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800075
J	Halfon, P; Ouzan, D; Khiri, H; Penaranda, G; Castellani, P; Oules, V; Kahloun, A; Amrani, N; Fanteria, L; Martineau, A; Naldi, L; Bourliere, M				Halfon, Philippe; Ouzan, Denis; Khiri, Hacene; Penaranda, Guillaume; Castellani, Paul; Oules, Valerie; Kahloun, Asma; Amrani, Nolwenn; Fanteria, Lise; Martineau, Agnes; Naldi, Lou; Bourliere, Marc			Detection of IL28B SNP DNA from Buccal Epithelial Cells, Small Amounts of Serum, and Dried Blood Spots	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENETIC-VARIATION; GENOME-WIDE; SPONTANEOUS CLEARANCE; POLYMORPHISM; EXTRACTION; EXPRESSION	Background & Aims: Point mutations in the coding region of the interleukin 28 gene (rs12979860) have recently been identified for predicting the outcome of treatment of hepatitis C virus infection. This polymorphism detection was based on whole blood DNA extraction. Alternatively, DNA for genetic diagnosis has been derived from buccal epithelial cells (BEC), dried blood spots (DBS), and genomic DNA from serum. The aim of the study was to investigate the reliability and accuracy of alternative routes of testing for single nucleotide polymorphism allele rs12979860CC. Methods: Blood, plasma, and sera samples from 200 patients were extracted (400 mu L). Buccal smears were tested using an FTA card. To simulate postal delay, we tested the influence of storage at ambient temperature on the different sources of DNA at five time points (baseline, 48 h, 6 days, 9 days, and 12 days) Results: There was 100% concordance between blood, plasma, sera, and BEC, validating the use of DNA extracted from BEC collected on cytology brushes for genetic testing. Genetic variations in HPTR1 gene were detected using smear technique in blood smear (3620 copies) as well as in buccal smears (5870 copies). These results are similar to those for whole blood diluted at 1/10. A minimum of 0.04 mu L, 4 mu L, and 40 mu L was necessary to obtain exploitable results respectively for whole blood, sera, and plasma. No significant variation between each time point was observed for the different sources of DNA. IL28B SNPs analysis at these different time points showed the same results using the four sources of DNA. Conclusion: We demonstrated that genomic DNA extraction from buccal cells, small amounts of serum, and dried blood spots is an alternative to DNA extracted from peripheral blood cells and is helpful in retrospective and prospective studies for multiple genetic markers, specifically in hard-to-reach individuals.	[Halfon, Philippe; Khiri, Hacene; Penaranda, Guillaume; Amrani, Nolwenn; Fanteria, Lise; Martineau, Agnes; Naldi, Lou] Hop Ambroise Pare, Lab Alphabio, Marseille, France; [Ouzan, Denis] Inst Arnault Tzanck, St Laurent Du Var, France; [Castellani, Paul; Oules, Valerie; Kahloun, Asma; Bourliere, Marc] Hop St Joseph, Dept Hepatogastroenterol, Marseille, France		Halfon, P (corresponding author), Hop Ambroise Pare, Lab Alphabio, Marseille, France.	philippe.halfon@alphabio.fr		PENARANDA, Guillaume/0000-0002-7461-4254				Abdelwhab EM, 2011, J VIROL METHODS, V174, P120, DOI 10.1016/j.jviromet.2011.03.017; Al Safar HS, 2011, APPL MICROBIOL BIOT, V89, P807, DOI 10.1007/s00253-010-2926-3; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Halfon P, 2011, EUR J GASTROEN HEPAT, V23, P931, DOI 10.1097/MEG.0b013e328349d0ef; Ilveskoski E, 1998, J NEUROSCI METH, V79, P5, DOI 10.1016/S0165-0270(97)00157-X; Jen J, 2000, ANN NY ACAD SCI, V906, P8; Lin ZW, 1998, BIOTECHNIQUES, V24, P937, DOI 10.2144/98246bm07; Lin ZW, 2000, BIOTECHNIQUES, V29, P460, DOI 10.2144/00293bm10; Lin ZW, 2002, PHYSIOL GENOMICS, V11, P235, DOI 10.1152/physiolgenomics.00061.2002; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; McClure Matthew C, 2009, BMC Res Notes, V2, P107, DOI 10.1186/1756-0500-2-107; Mead R, 2011, BRIT J CANC; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Stroun M, 2000, ANN NY ACAD SCI, V906, P161; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Wang YH, 2011, J AUTOIMMUN, V37, P18, DOI 10.1016/j.jaut.2011.03.002; Wei XR, 2011, J CLIN VIROL, V50, P148, DOI 10.1016/j.jcv.2010.11.006; Wolfgramm ED, 2009, FORENSIC SCI INT-GEN, V3, P125, DOI 10.1016/j.fsigen.2008.11.008; Wong HY, 2011, FORENSIC SCI INT GEN	26	8	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33000	10.1371/journal.pone.0033000	http://dx.doi.org/10.1371/journal.pone.0033000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412970	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800072
J	Pitt, C; Diawara, H; Ouedraogo, DJ; Diarra, S; Kabore, H; Kouela, K; Traore, A; Dicko, A; Konate, AT; Chandramohan, D; Diallo, DA; Greenwood, B; Conteh, L				Pitt, Catherine; Diawara, Halimatou; Ouedraogo, Dimlawende J.; Diarra, Samba; Kabore, Habibou; Kouela, Kibsbila; Traore, Abdoulaye; Dicko, Alassane; Konate, Amadou T.; Chandramohan, Daniel; Diallo, Diadier A.; Greenwood, Brian; Conteh, Lesong			Intermittent Preventive Treatment of Malaria in Children: A Qualitative Study of Community Perceptions and Recommendations in Burkina Faso and Mali	PLOS ONE			English	Article							INFANTS IPTI; VACCINE TRIAL; CHILDHOOD MORTALITY; SAMPLING DESIGNS; EXPANDED PROGRAM; IMMUNIZATION; SCIENCE; HEALTH; NETS	Background:Intermittent preventive treatment of malaria in children (IPTc) is a highly efficacious method of malaria control where malaria transmission is highly seasonal. However, no studies published to date have examined community perceptions of IPTc. Methods: A qualitative study was undertaken in parallel with a double-blind, placebo-controlled, randomized trial of IPTc conducted in Mali and Burkina Faso in 2008-2009 to assess community perceptions of and recommendations for IPTc. Caregivers and community health workers (CHWs) were purposively sampled. Seventy-two in-depth individual interviews and 23 focus group discussions were conducted. Findings: Widespread perceptions of health benefits for children led to enthusiasm for the trial and for IPTc specifically. Trust in and respect for those providing the tablets and a sense of obligation to the community to participate in sanctioned activities favoured initial adoption. IPTc fits in well with existing understandings of childhood illness. Participants did not express concerns about the specific drugs used for IPTc or about providing tablets to children without symptoms of malaria. There was no evidence that IPTc was perceived as a substitute for bed net usage, nor did it inhibit care seeking. Participants recommended that distribution be "closer to the population'', but expressed concern over caregivers' ability to administer tablets at home. Conclusions: The trial context mediated perceptions of IPTc. Nonetheless, the results indicate that community perceptions of IPTc in the settings studied were largely favourable and that the delivery strategy rather than the tablets themselves presented the main areas of concern for caregivers and CHWs. The study identifies a number of key questions to consider in planning an IPTc distribution strategy. Single-dose formulations could increase the success of IPTc implementation, as could integration of IPTc within a package of activities, such as bed net distribution and free curative care, for which demand is already high.	[Pitt, Catherine] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Diawara, Halimatou; Diarra, Samba; Dicko, Alassane] Malaria Res & Training Ctr, Bamako, Mali; [Diawara, Halimatou; Diarra, Samba; Dicko, Alassane] Univ Bamako, Dept Publ Hlth, Fac Med Pharm & Dent, Bamako, Mali; [Ouedraogo, Dimlawende J.; Kabore, Habibou; Kouela, Kibsbila; Traore, Abdoulaye; Konate, Amadou T.] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Chandramohan, Daniel; Diallo, Diadier A.; Greenwood, Brian] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Conteh, Lesong] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Bamako; University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Pitt, C (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	catherine.pitt@lshtm.ac.uk	Pitt, Catherine K/K-3001-2012; Conteh, Lesong/ABE-9550-2020	Pitt, Catherine K/0000-0003-4967-8966; Conteh, Lesong/0000-0002-0719-3672	Bill and Melinda Gates Foundation [41783]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by a grant to the London School of Hygiene and Tropical Medicine from the Bill and Melinda Gates Foundation (grant number 41783). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Alaii JA, 2003, AM J TROP MED HYG, V68, P128, DOI 10.4269/ajtmh.2003.68.128; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2003, DIFFUSIONS INNOVATIO; [Anonymous], 2004, STRATEGIC FRAMEWORK; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Bojang KA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000409; Cairns M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009467; de Sousa A, 2010, LANCET, V375, P121, DOI 10.1016/S0140-6736(10)60047-5; Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407; Esse C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-224; Etard JF, 2004, INT J EPIDEMIOL, V33, P1286, DOI 10.1093/ije/dyh259; Fairhead J, 2006, J BIOSOC SCI, V38, P103, DOI 10.1017/S0021932005000945; Geissler PW, 2008, SOC SCI MED, V67, P696, DOI 10.1016/j.socscimed.2008.02.004; Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003; Greenwood B, REV INTERMITTENT PRE, P983; Griffin JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012618; Gysels M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-191; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Konate AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000408; Kweku M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007256; Mangham LJ, 2010, HEALTH POLICY PLANN, V25, P85, DOI 10.1093/heapol/czp066; McPake B, 2011, HEALTH POLICY PLANN, V26, pII104, DOI 10.1093/heapol/czr064; Montgomery CM, 2010, SOC SCI MED, V70, P1648, DOI 10.1016/j.socscimed.2010.01.020; Muela SH, 2002, SOC SCI MED, V55, P403; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Onwuegbuzie AJ, 2007, QUAL REP, V12, P238; Onwuegbuzie AJ, 2007, QUAL REP, V12, P281; Pool R, 2006, TROP MED INT HEALTH, V11, P1670, DOI 10.1111/j.1365-3156.2006.01725.x; Pool R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-213; Sandelowski M, 1995, RES NURSING HLTH, V18; Schellenberg JRMA, 2010, AM J TROP MED HYG, V82, P772, DOI 10.4269/ajtmh.2010.09-0207; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976	36	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32900	10.1371/journal.pone.0032900	http://dx.doi.org/10.1371/journal.pone.0032900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	928XD	22412946	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000303021100039
J	Teng, MX; Balch, C; Liu, YL; Li, M; Huang, THM; Wang, YD; Nephew, KP; Li, L				Teng, Mingxiang; Balch, Curt; Liu, Yunlong; Li, Meng; Huang, Tim H. M.; Wang, Yadong; Nephew, Kenneth P.; Li, Lang			The Influence of cis-Regulatory Elements on DNA Methylation Fidelity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; CPG ISLANDS; GENE-EXPRESSION; CHROMATIN; PATTERNS; DNMT1; MAINTENANCE; HYPERMETHYLATION; EPIGENETICS; RESISTANCE	It is now established that, as compared to normal cells, the cancer cell genome has an overall inverse distribution of DNA methylation ("methylome''), i.e., predominant hypomethylation and localized hypermethylation, within "CpG islands'' (CGIs). Moreover, although cancer cells have reduced methylation "fidelity'' and genomic instability, accurate maintenance of aberrant methylomes that underlie malignant phenotypes remains necessary. However, the mechanism(s) of cancer methylome maintenance remains largely unknown. Here, we assessed CGI methylation patterns propagated over 1, 3, and 5 divisions of A2780 ovarian cancer cells, concurrent with exposure to the DNA cross-linking chemotherapeutic cisplatin, and observed cell generation-successive increases in total hyper- and hypo-methylated CGIs. Empirical Bayesian modeling revealed five distinct modes of methylation propagation: (1) heritable (i.e., unchanged) high-methylation (1186 probe loci in CGI microarray); (2) heritable (i.e., unchanged) low-methylation (286 loci); (3) stochastic hypermethylation (i.e., progressively increased, 243 loci); (4) stochastic hypomethylation (i.e., progressively decreased, 247 loci); and (5) considerable "random'' methylation (582 loci). These results support a "stochastic model'' of DNA methylation equilibrium deriving from the efficiency of two distinct processes, methylation maintenance and de novo methylation. A role for cis-regulatory elements in methylation fidelity was also demonstrated by highly significant (p < 2.2x10(-5)) enrichment of transcription factor binding sites in CGI probe loci showing heritably high (118 elements) and low (47 elements) methylation, and also in loci demonstrating stochastic hyper-(30 elements) and hypo-(31 elements) methylation. Notably, loci having "random'' methylation heritability displayed nearly no enrichment. These results demonstrate an influence	[Teng, Mingxiang; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China; [Liu, Yunlong; Li, Lang] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA; [Teng, Mingxiang; Liu, Yunlong; Li, Lang] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Balch, Curt; Li, Meng; Nephew, Kenneth P.] Indiana Univ, Med Sci Program, Bloomington, IN USA; [Balch, Curt; Liu, Yunlong; Nephew, Kenneth P.; Li, Lang] Indiana Univ Melvin & Bren Simon Canc, Indianapolis, IN USA; [Huang, Tim H. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Li, Lang] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indiana Inst Personalized Med, Indianapolis, IN USA; [Nephew, Kenneth P.; Li, Lang] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN USA	Harbin Institute of Technology; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Teng, MX (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China.	ydwang@hit.edu.cn; knephew@indiana.edu; lali@iupui.edu		Teng, Mingxiang/0000-0002-8536-8941	Indiana Genomics Initiative of Indiana University, INGEN; Lilly Endowment, Inc.; National Cancer Institute [CA113001, CA085289]; Walther Cancer Foundation (Indianapolis, IN); China Natural Science Foundation [60973078]; NATIONAL CANCER INSTITUTE [R01CA085289] Funding Source: NIH RePORTER	Indiana Genomics Initiative of Indiana University, INGEN; Lilly Endowment, Inc.; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Walther Cancer Foundation (Indianapolis, IN); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to thank Dr. Fang Fang (Medical Sciences, Indiana University), Thomas Chen (a summer fellow of the National Cancer Institute's Integrative Cancer Biology Program) for computational assistance, and Dave Miller, for valuable discussions. The gene expression microarray studies were carried out using the facilities of the Center for Medical Genomics at Indiana University School of Medicine. The Center for Medical Genomics is supported in part by the Indiana Genomics Initiative of Indiana University, INGEN, which is supported in part by the Lilly Endowment, Inc.; This work was supported by National Cancer Institute Awards [CA113001 to TH-MH. and KPN, CA085289 to KPN]; Walther Cancer Foundation (Indianapolis, IN); and China Natural Science Foundation [60973078 to YW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbosh PH, 2006, CANCER RES, V66, P5582, DOI 10.1158/0008-5472.CAN-05-3575; Ahluwalia A, 2001, GYNECOL ONCOL, V82, P261, DOI 10.1006/gyno.2001.6291; Allis CD, 2007, EPIGENETICS, Vx, P502; Balch C, 2005, MOL CANCER THER, V4, P1505, DOI 10.1158/1535-7163.MCT-05-0216; Barrero MJ, 2010, CELL STEM CELL, V7, P565, DOI 10.1016/j.stem.2010.10.009; Baylin SB, 2011, NAT MED, V17, P288, DOI 10.1038/nm0311-288; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen ZX, 2005, BIOCHEM CELL BIOL, V83, P438, DOI 10.1139/O05-138; Choy MK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-519; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Dabney AR, 2007, BIOSTATISTICS, V8, P128, DOI 10.1093/biostatistics/kxj038; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Estecio MRH, 2011, FEBS LETT, V585, P2078, DOI 10.1016/j.febslet.2010.12.001; Esteller M, 2009, EPIGENETICS BIOL MED, Vxii, P297; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Grasser KD, 2007, BBA-GENE STRUCT EXPR, V1769, P346, DOI 10.1016/j.bbaexp.2006.12.004; Ha K, 2011, HUM MOL GENET, V20, P126, DOI 10.1093/hmg/ddq451; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jeong J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-55; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Landolin JM, 2010, GENOME RES, V20, P890, DOI 10.1101/gr.100370.109; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Li J, 2007, ONCOGENE, V26, P2860, DOI 10.1038/sj.onc.1210086; Li L, 2006, BIOINFORMATICS, V22, P2210, DOI 10.1093/bioinformatics/btl329; Li M, 2008, BIOINFORMATICS, V24, P1745, DOI 10.1093/bioinformatics/btn256; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mohammad HP, 2010, NAT BIOTECHNOL, V28, P1033, DOI 10.1038/nbt1010-1033; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Ooi SKT, 2008, CURR BIOL, V18, pR174, DOI 10.1016/j.cub.2007.12.045; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; Pillus L, 2008, CURR OPIN CELL BIOL, V20, P326, DOI 10.1016/j.ceb.2008.04.009; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Riggs AD, 2004, P NATL ACAD SCI USA, V101, P4, DOI 10.1073/pnas.0307781100; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Shen LL, 2007, CANCER RES, V67, P11335, DOI 10.1158/0008-5472.CAN-07-1502; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Snow JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001103; SORENSON CM, 1988, CANCER RES, V48, P4484; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Strassburger K, 2008, STAT MED, V27, P4914, DOI 10.1002/sim.3338; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Tost Joerg, 2008, P63; Ushijima T, 2005, CANCER RES, V65, P11; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xie H, 2011, NUCL ACIDS RES; Yan Pearlly S, 2002, Methods Mol Biol, V200, P87; Yu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029450; Zaidi SK, 2011, J BIOL CHEM, V286, P18355, DOI 10.1074/jbc.R110.197061	78	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32928	10.1371/journal.pone.0032928	http://dx.doi.org/10.1371/journal.pone.0032928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412954	Green Submitted, gold, Green Published			2022-12-25	WOS:000303021100041
J	Wei, XR; Qiu, LP; Shao, MG; Zhang, XC; Gale, WJ				Wei, Xiaorong; Qiu, Liping; Shao, Mingan; Zhang, Xingchang; Gale, William J.			The Accumulation of Organic Carbon in Mineral Soils by Afforestation of Abandoned Farmland	PLOS ONE			English	Article							LAND-USE CHANGE; OLD-GROWTH FORESTS; NATURAL-ABUNDANCE; C-13; STOCKS; FRACTIONATION; NITROGEN	The afforestation of abandoned farmland significantly influences soil organic carbon (OC). However, the dynamics between OC inputs after afforestation and the original OC are not well understood. To learn more about soil OC dynamics after afforestation of farmland, we measured the soil OC content in paired forest and farmland plots in Shaanxi Province, China. The forest plots had been established on farmland 18, 24, 48, 100, and 200 yr previously. The natural C-13 abundance of soil organic matter was also analyzed to distinguish between crop-and forest-derived C in the afforested soils. We observed a nonlinear accumulation of total OC in the 0-80 cm depth of the mineral soil across time. Total soil OC accumulated more rapidly under forest stands aged 18 to 48 yr than under forest stands aged 100 or 200 yrs. The rate of OC accumulation was also greater in the 0-10 cm depth than in the 10-80 cm depth. Forest-derived OC in afforested soils also accumulated nonlinearly across time, with the greatest increase in the 0-20 cm depth. Forest-derived OC in afforest soils accounted for 52-86% of the total OC in the 0-10 cm depth, 36-61% of the total OC in the 10-20 cm depth, and 11-50% of the total OC in the 20-80 cm depth. Crop-derived OC concentrations in the 0-20 cm depth decreased slightly after afforestation, but there was no change in crop-derived OC concentrations in the 20-80 cm depth. The results of our study support the claim that afforestation of farmland can sequester atmospheric CO2 by increasing soil OC stocks. Changes in the OC stocks of mineral soils after afforestation appear to be influenced mainly by the input of forest-derived C rather than by the loss of original OC.	[Wei, Xiaorong; Qiu, Liping; Shao, Mingan; Zhang, Xingchang] NW A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Gale, William J.] NW A&F Univ, Coll Resources & Environm, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Wei, XR (corresponding author), NW A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	xrwei78@163.com			National Natural Science Foundation of China [40801111, 40901145]; Special Foundation for State Major Basic Research Program of China [SQ2012FY4910023]; Science and Technology Development Research Program in Shaanxi Province [2011KJXX25]; Program for Youthful Talents in Northwest A F University; Northwest A F University [QN2011147]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation for State Major Basic Research Program of China; Science and Technology Development Research Program in Shaanxi Province; Program for Youthful Talents in Northwest A F University; Northwest A F University	This study was supported by the National Natural Science Foundation of China (40801111, 40901145), Special Foundation for State Major Basic Research Program of China (SQ2012FY4910023), Science and Technology Development Research Program in Shaanxi Province (2011KJXX25), the Program for Youthful Talents in Northwest A & F University, and the Program from Northwest A & F University (QN2011147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora VK, 2010, GLOBAL CHANGE BIOL, V16, P3327, DOI 10.1111/j.1365-2486.2010.02202.x; BALESDENT J, 1987, SOIL BIOL BIOCHEM, V19, P25, DOI 10.1016/0038-0717(87)90120-9; BENNER R, 1987, NATURE, V329, P708, DOI 10.1038/329708a0; Bostrom B, 2007, OECOLOGIA, V153, P89, DOI 10.1007/s00442-007-0700-8; DeGryze S, 2004, GLOBAL CHANGE BIOL, V10, P1120, DOI 10.1111/j.1529-8817.2003.00786.x; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; HOUGHTON RA, 1995, GLOB CHANGE BIOL, V1, P275, DOI 10.1111/j.1365-2486.1995.tb00026.x; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Maia SMF, 2010, GLOBAL CHANGE BIOL, V16, P2775, DOI 10.1111/j.1365-2486.2009.02105.x; Marin-Spiotta E, 2009, GLOBAL CHANGE BIOL, V15, P1584, DOI 10.1111/j.1365-2486.2008.01805.x; MARY B, 1992, SOIL BIOL BIOCHEM, V24, P1065, DOI 10.1016/0038-0717(92)90037-X; *MFE, 2008, NZ GREENH GAS INV 19; Moyes AB, 2010, PLANT CELL ENVIRON, V33, P1804, DOI 10.1111/j.1365-3040.2010.02185.x; NADELHOFFER KF, 1988, SOIL SCI SOC AM J, V52, P1633, DOI 10.2136/sssaj1988.03615995005200060024x; Neill C, 1996, OECOLOGIA, V107, P113, DOI 10.1007/BF00582241; Osher LJ, 2003, BIOGEOCHEMISTRY, V65, P213, DOI 10.1023/A:1026048612540; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Paul KI, 2003, ECOL MODEL, V164, P137, DOI 10.1016/S0304-3800(03)00027-9; Paul S, 2008, BIOGEOCHEMISTRY, V323, P309; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Powers JS, 2005, BIOGEOCHEMISTRY, V72, P315, DOI 10.1007/s10533-004-0368-7; QIU L, 2007, CHANGE SOIL QUALITY; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; SAS, 1999, SAS US GUID; Smal H, 2008, PLANT SOIL, V305, P171, DOI 10.1007/s11104-008-9538-z; Tang JW, 2009, GLOBAL CHANGE BIOL, V15, P145, DOI 10.1111/j.1365-2486.2008.01741.x; Thapa P, 2020, CAMMUNICATION JUL; Turk JK, 2009, SOIL SCI SOC AM J, V73, P1504, DOI 10.2136/sssaj2008.0106; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wei XR, 2010, PLANT SOIL, V331, P165, DOI 10.1007/s11104-009-0243-3; Wei XR, 2009, BIOGEOCHEMISTRY, V96, P149, DOI 10.1007/s10533-009-9350-8; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x; Yang H.J., 2005, J CHIN HIST GEOG, V20, P125; Zach A, 2006, SOIL SCI SOC AM J, V70, P1541, DOI 10.2136/sssaj2005.0119; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168	41	33	38	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32054	10.1371/journal.pone.0032054	http://dx.doi.org/10.1371/journal.pone.0032054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412854	Green Published, Green Submitted, gold			2022-12-25	WOS:000303021100011
J	Mirochnik, Y; Veliceasa, D; Williams, L; Maxwell, K; Yemelyanov, A; Budunova, I; Volpert, OV				Mirochnik, Yelena; Veliceasa, Dorina; Williams, Latanya; Maxwell, Kelly; Yemelyanov, Alexander; Budunova, Irina; Volpert, Olga V.			Androgen Receptor Drives Cellular Senescence	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; TUMOR-SUPPRESSOR; CYCLE ARREST; MOUSE MODEL; STEM-CELLS; IN-VIVO; GROWTH; PROGRESSION; PROLIFERATION; PROTEIN	The accepted androgen receptor (AR) role is to promote proliferation and survival of prostate epithelium and thus prostate cancer progression. While growth-inhibitory, tumor-suppressive AR effects have also been documented, the underlying mechanisms are poorly understood. Here, we for the first time link AR anti-cancer action with cell senescence in vitro and in vivo. First, AR-driven senescence was p53-independent. Instead, AR induced p21, which subsequently reduced Delta N isoform of p63. Second, AR activation increased reactive oxygen species (ROS) and thereby suppressed Rb phosphorylation. Both pathways were critical for senescence as was proven by p21 and Rb knock-down and by quenching ROS with N-Acetyl cysteine and p63 silencing also mimicked AR-induced senescence. The two pathways engaged in a cross-talk, likely via PML tumor suppressor, whose localization to senescence-associated chromatin foci was increased by AR activation. All these pathways contributed to growth arrest, which resolved in senescence due to concomitant lack of p53 and high mTOR activity. This is the first demonstration of senescence response caused by a nuclear hormone receptor.	[Mirochnik, Yelena; Veliceasa, Dorina; Williams, Latanya; Maxwell, Kelly; Volpert, Olga V.] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Yemelyanov, Alexander; Budunova, Irina] Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Mirochnik, Y (corresponding author), Northwestern Univ, Dept Urol, Chicago, IL 60611 USA.	olgavolp@northwestern.edu			PI endowment fund (O'Conor Family endowment); National Institutes of Health Cancer Institute [R01 CA118890]; ACS IL Division [160185]; NATIONAL CANCER INSTITUTE [R01CA118890] Funding Source: NIH RePORTER	PI endowment fund (O'Conor Family endowment); National Institutes of Health Cancer Institute; ACS IL Division; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the PI endowment fund (O'Conor Family endowment, to Olga Volpert), National Institutes of Health Cancer Institute grant R01 CA118890 (to PI Budunova) and ACS IL Division, grant 160185 (to PI Yemelyanov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudry VG, 2009, CELL STEM CELL, V5, P1, DOI 10.1016/j.stem.2009.06.015; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Blagosklonny MV, 2009, CELL CYCLE, V8, P1883, DOI 10.4161/cc.8.12.8815; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Calabro V, 2004, MOL CELL BIOL, V24, P8529, DOI 10.1128/MCB.24.19.8529-8540.2004; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974; Chopra DP, 1996, J CELL PHYSIOL, V169, P269, DOI 10.1002/(SICI)1097-4652(199611)169:2<269::AID-JCP6>3.0.CO;2-M; Cinar B, 2007, J BIOL CHEM; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Culig Z, 2006, J CELL BIOCHEM, V99, P373, DOI 10.1002/jcb.20898; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; Eder Iris E, 2005, Future Oncol, V1, P93; Ferbeyre G, 2002, LEUKEMIA, V16, P1918, DOI 10.1038/sj.leu.2402722; Gavrielides MV, 2006, CANCER RES, V66, P11792, DOI 10.1158/0008-5472.CAN-06-1139; Gleave M, 1998, PROSTATE CANCER P D, V1, P289, DOI 10.1038/sj.pcan.4500260; Grisanzio C, 2008, J CELL BIOCHEM, V103, P1354, DOI 10.1002/jcb.21555; Guo XC, 2007, CELL CYCLE, V6, P305, DOI 10.4161/cc.6.3.3794; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; HARPER JW, 1993, CELL, V75, P805; Hayward SW, 2001, CANCER RES, V61, P8135; Hess-Wilson JK, 2006, CANCER RES, V66, P11998, DOI 10.1158/0008-5472.CAN-06-2249; Isaacs JT, 2008, PROSTATE, V68, P1025, DOI 10.1002/pros.20763; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Kasper S, 2005, J CELL BIOCHEM, V94, P279, DOI 10.1002/jcb.20339; Keyes WM, 2006, CELL CYCLE, V5, P260, DOI 10.4161/cc.5.3.2415; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Khan MM, 2001, J BIOL CHEM, V276, P43491, DOI 10.1074/jbc.C100532200; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; Li JP, 2005, ONCOGENE, V24, P5510, DOI 10.1038/sj.onc.1208693; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mehraein-Ghomi F, 2008, PROSTATE, V68, P924, DOI 10.1002/pros.20737; Nelius T, 2007, INT J CANCER, V121, P999, DOI 10.1002/ijc.22802; O'Mahony OA, 2008, MOL CANCER RES, V6, P1691, DOI 10.1158/1541-7786.MCR-08-0273; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Rambeaud JJ, 1999, EUR UROL, V35, P32, DOI 10.1159/000052305; Reiner T, 2007, MOL CANCER RES, V5, P1171, DOI 10.1158/1541-7786.MCR-07-0024; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Signoretti S, 2006, CELL CYCLE, V5, P138, DOI 10.4161/cc.5.2.2340; Stewart JR, 2005, MOL CANCER THER, V4, P726, DOI 10.1158/1535-7163.MCT-05-0013; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tokar EJ, 2005, DIFFERENTIATION, V73, P463, DOI 10.1111/j.1432-0436.2005.00047.x; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Vander Griend DJ, 2007, CELL CYCLE, V6, P647, DOI 10.4161/cc.6.6.4028; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Wang XT, 2004, CANCER RES, V64, P1377, DOI 10.1158/0008-5472.CAN-03-2428; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472	66	39	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31052	10.1371/journal.pone.0031052	http://dx.doi.org/10.1371/journal.pone.0031052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403609	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700006
J	Moserova, I; Kralova, J				Moserova, Irena; Kralova, Jarmila			Role of ER Stress Response in Photodynamic Therapy: ROS Generated in Different Subcellular Compartments Trigger Diverse Cell Death Pathways	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; INDUCED APOPTOSIS; GENE-EXPRESSION; MOLECULAR EFFECTORS; TERMINAL KINASE; CARCINOMA-CELLS; SINGLET OXYGEN; CANCER-CELLS; FREE CALCIUM	We have analyzed the molecular mechanisms of photoinduced cell death using porphyrins with similar structure differing only in the position of the ethylene glycol (EG) chain on the phenyl ring. Meta-and para-positioned EG chains targeted porphyrins to different subcellular compartments. After photoactivation, both types of derivatives induced death of tumor cells via reactive oxygen species (ROS). Para derivatives pTPP(EG) 4 and pTPPF(EG) 4 primarily accumulated in lysosomes activated the p38 MAP kinase cascade, which in turn induced the mitochondrial apoptotic pathway. In contrast, meta porphyrin derivative mTPP(EG) 4 localized in the endoplasmic reticulum (ER) induced dramatic changes in Ca2+ homeostasis manifested by Ca2+ rise in the cytoplasm, activation of calpains and stress caspase-12 or caspase-4. ER stress developed into unfolded protein response. Immediately after irradiation the PERK pathway was activated through phosphorylation of PERK, eIF2 alpha and induction of transcription factors ATF4 and CHOP, which regulate stress response genes. PERK knockdown and PERK deficiency protected cells against mTPP(EG) 4-mediated apoptosis, confirming the causative role of the PERK pathway.	[Moserova, Irena; Kralova, Jarmila] Acad Sci Czech Republ, Dept Mol Virol, Inst Mol Genet, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Moserova, I (corresponding author), Acad Sci Czech Republ, Dept Mol Virol, Inst Mol Genet, Prague, Czech Republic.	kralova@img.cas.cz	Kralova, Jarmila/G-3834-2014	Kralova, Jarmila/0000-0002-4735-8857	Ministry of Education of the Czech Republic [LC06077]; Grant Agency of the Czech Republic [203/09/1311, P303/11/1291]; Grant Agency of the Academy of Sciences of the Czech Republic [AV0Z50520514]	Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	This work was supported by grants from the Ministry of Education of the Czech Republic (LC06077), by the Grant Agency of the Czech Republic (grant 203/09/1311, P303/11/1291) and Project AV0Z50520514 awarded by the Grant Agency of the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RD, 2004, CANCER LETT, V216, P183, DOI 10.1016/j.canlet.2004.07.006; Almeida RD, 2004, BBA-REV CANCER, V1704, P59, DOI 10.1016/j.bbcan.2004.05.003; Assefa Z, 1999, J BIOL CHEM, V274, P8788, DOI 10.1074/jbc.274.13.8788; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Buytaert E, 2008, ONCOGENE, V27, P1916, DOI 10.1038/sj.onc.1210825; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Buytaert E, 2006, FASEB J, V20, P756, DOI 10.1096/fj.05-4305fje; Ding XM, 2004, CANCER LETT, V216, P43, DOI 10.1016/j.canlet.2004.07.005; Diwakarla S, 2009, CELL MOL LIFE SCI, V66, P156, DOI 10.1007/s00018-008-8490-7; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Gomez-Vicente V, 2005, CELL DEATH DIFFER, V12, P796, DOI 10.1038/sj.cdd.4401621; Granville DJ, 2001, CELL CALCIUM, V30, P343, DOI 10.1054/ceca.2001.0243; Grebenova D, 2003, J PHOTOCH PHOTOBIO B, V69, P71, DOI 10.1016/S1011-1344(02)00410-4; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HENDERSON BW, 1992, PHOTOCHEM PHOTOBIOL, V55, P145, DOI 10.1111/j.1751-1097.1992.tb04222.x; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P381, DOI 10.1016/0891-5849(95)00015-P; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hubmer A, 1996, PHOTOCHEM PHOTOBIOL, V64, P211, DOI 10.1111/j.1751-1097.1996.tb02444.x; Ichinose S, 2006, INT J ONCOL, V29, P349; Inanami O, 1999, PHOTOCHEM PHOTOBIOL, V70, P650, DOI 10.1562/0031-8655(1999)070<0650:EOBAAF>2.3.CO;2; Karmakar S, 2007, NEUROSCI LETT, V415, P242, DOI 10.1016/j.neulet.2007.01.071; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaul A, 2009, NEOPLASIA, V11, P823, DOI 10.1593/neo.09388; Kessel D, 2005, CELL DEATH DIFFER, V12, P502, DOI 10.1038/sj.cdd.4401579; Kessel D, 2005, PHOTOCHEM PHOTOBIOL, V81, P569, DOI 10.1562/2004-12-16-RA-403.1; Kessel D, 2002, PHOTOCH PHOTOBIO SCI, V1, P837, DOI 10.1039/b206046a; Kessel D, 2001, PHOTOCHEM PHOTOBIOL, V74, P318, DOI 10.1562/0031-8655(2001)074<0318:ETBITT>2.0.CO;2; Kim HRC, 1999, CANCER RES, V59, P3429; Koon HK, 2010, CELL BIOCHEM FUNCT, V28, P239, DOI 10.1002/cbf.1650; Kralova J, 2008, ONCOGENE, V27, P3010, DOI 10.1038/sj.onc.1210960; Kralova J, 2003, J MED CHEM, V46, P2049, DOI 10.1021/jm021060d; Kralova J, 2008, J MED CHEM, V51, P5964, DOI 10.1021/jm8002119; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lee SY, 2008, CELL MICROBIOL, V10, P770, DOI 10.1111/j.1462-5822.2007.01083.x; Liao PC, 2008, J CELL BIOCHEM, V104, P1509, DOI 10.1002/jcb.21730; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mak NK, 2004, BIOCHEM PHARMACOL, V68, P2387, DOI 10.1016/j.bcp.2004.08.024; Marchal S, 2007, BRIT J CANCER, V96, P944, DOI 10.1038/sj.bjc.6603631; Matsuzaki S, 2010, NEUROCHEM INT, V56, P352, DOI 10.1016/j.neuint.2009.11.007; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; O'Connor AE, 2012, INT J CANCER, V130, P705, DOI 10.1002/ijc.26073; Ogata M, 2003, PHOTOCHEM PHOTOBIOL, V78, P241, DOI 10.1562/0031-8655(2003)078<0241:CACACB>2.0.CO;2; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PENNING LC, 1992, BIOCHIM BIOPHYS ACTA, V1107, P255, DOI 10.1016/0005-2736(92)90412-F; Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424; Price M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1177, DOI 10.1111/j.1751-1097.2009.00555.x; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; SAMIS JA, 1991, BIOCHEM J, V276, P293, DOI 10.1042/bj2760293; Sanovic R, 2009, INT J ONCOL, V35, P921, DOI 10.3892/ijo_00000407; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shahzidi S, 2011, PHOTOCH PHOTOBIO SCI, V10, P1773, DOI 10.1039/c1pp05169e; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tong ZM, 2003, J PHOTOCH PHOTOBIO B, V71, P77, DOI 10.1016/j.jphotobiol.2003.08.001; Usuda J, 2003, PHOTOCHEM PHOTOBIOL, V78, P1, DOI 10.1562/0031-8655(2003)078<0001:ABTPLO>2.0.CO;2; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; Vittar NBR, 2010, INT J BIOCHEM CELL B, V42, P1123, DOI 10.1016/j.biocel.2010.03.019; Weyergang A, 2008, MOL CANCER THER, V7, P1740, DOI 10.1158/1535-7163.MCT-08-0020; Wong S, 2004, LASER SURG MED, V35, P336, DOI 10.1002/lsm.20110; Wu RWK, 2011, PHOTODIAGN PHOTODYN, V8, P254, DOI 10.1016/j.pdpdt.2010.12.002; Xue LY, 1999, CELL DEATH DIFFER, V6, P855, DOI 10.1038/sj.cdd.4400558; Xue LY, 2001, ONCOGENE, V20, P3420, DOI 10.1038/sj.onc.1204441; Yoo JO, 2011, J CELL BIOCHEM, V112, P3061, DOI 10.1002/jcb.23231; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003; Zhou ZX, 2003, BBA-MOL CELL RES, V1593, P191, DOI 10.1016/S0167-4889(02)00386-5; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	70	72	72	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32972	10.1371/journal.pone.0032972	http://dx.doi.org/10.1371/journal.pone.0032972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403731	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700128
J	Su, Y; Cheng, X; Tan, YH; Hu, YH; Zhou, Y; Liu, JN; Xu, YF; Xie, YL; Wang, CY; Gao, YD; Wang, JX; Cheng, T; Yang, CZ; Xiong, DS; Miao, H				Su, Ye; Cheng, Xin; Tan, Yaohong; Hu, Yunhui; Zhou, Yuan; Liu, Juanni; Xu, Yuanfu; Xie, Yinliang; Wang, Caiyun; Gao, Yingdai; Wang, Jianxiang; Cheng, Tao; Yang, Chunzheng; Xiong, Dongsheng; Miao, Hua			Synthesis of a Dual Functional Anti-MDR Tumor Agent PH II-7 with Elucidations of Anti-Tumor Effects and Mechanisms	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MEDIATED MULTIDRUG-RESISTANCE; JUN NH2-TERMINAL KINASE; BREAST-CARCINOMA CELLS; LARGE GENE LISTS; CANCER-CELLS; S-PHASE; FLOW-CYTOMETRY; C-FOS; GLYCOPROTEIN EXPRESSION	Multidrug resistance mediated by P-glycoprotein in cancer cells has been a major issue that cripples the efficacy of chemotherapy agents. Aimed for improved efficacy against resistant cancer cells, we designed and synthesized 25 oxindole derivatives based on indirubin by structure-activity relationship analysis. The most potent one was named PH II-7, which was effective against 18 cancer cell lines and 5 resistant cell lines in MTT assay. It also significantly inhibited the resistant xenograft tumor growth in mouse model. In cell cycle assay and apoptosis assay conducted with flow cytometry, PH II-7 induced S phase cell cycle arrest and apoptosis even in resistant cells. Consistently revealed by real-time PCR, it modulates the expression of genes related to the cell cycle and apoptosis in these cells, which may contributes to its efficacy against them. By side-chain modification and FITC-labeling of PH II-7, we were able to show with confocal microscopy that not only it was not pumped by P-glycoprotein, it also attenuated the efflux of Adriamycin by P-glycoprotein in MDR tumor cells. Real-time PCR and western blot analysis showed that PH II-7 down-regulated MDR1 gene via protein kinase C alpha (PKCA) pathway, with c-FOS and c-JUN as possible mediators. Taken together, PH II-7 is a dual-functional compound that features both the cytotoxicity against cancer cells and the inhibitory effect on P-gp mediated drug efflux.	[Su, Ye; Cheng, Xin; Tan, Yaohong; Hu, Yunhui; Zhou, Yuan; Liu, Juanni; Xu, Yuanfu; Xie, Yinliang; Wang, Caiyun; Gao, Yingdai; Wang, Jianxiang; Cheng, Tao; Yang, Chunzheng; Xiong, Dongsheng] Chinese Acad Med Sci, Inst Hematol, Dept Pharm, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Su, Ye; Cheng, Xin; Tan, Yaohong; Hu, Yunhui; Zhou, Yuan; Liu, Juanni; Xu, Yuanfu; Xie, Yinliang; Wang, Caiyun; Gao, Yingdai; Wang, Jianxiang; Cheng, Tao; Yang, Chunzheng; Xiong, Dongsheng] Chinese Acad Med Sci, Hosp Blood Dis, Tianjin, Peoples R China; [Su, Ye; Cheng, Xin; Tan, Yaohong; Hu, Yunhui; Zhou, Yuan; Liu, Juanni; Xu, Yuanfu; Xie, Yinliang; Wang, Caiyun; Gao, Yingdai; Wang, Jianxiang; Cheng, Tao; Yang, Chunzheng; Xiong, Dongsheng] Peking Union Med Coll, Tianjin, Peoples R China; [Cheng, Xin] Chinese Acad Sci, Inst Zool, Lab Mol Carcinogenesis & Targeted Therapy Canc, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Su, Ye] Univ Western Ontario, Dept Med, Matthew Mailing Ctr Translat Transplant Studies, London, ON N6A 3K7, Canada; [Miao, Hua] Broad Inst Harvard & Massachusetts Inst Technol, Chem Biol Program, Cambridge, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Zoology, CAS; Western University (University of Western Ontario); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Su, Y (corresponding author), Chinese Acad Med Sci, Inst Hematol, Dept Pharm, State Key Lab Expt Hematol, Tianjin, Peoples R China.	dsxiong@ihcams.ac.cn; miaohua00@gmail.com		Cheng, Tao/0000-0002-5925-2769	Chinese National Natural Sciences Foundation [30873091, 30971291, 30701012]; Natural Science Foundation of Tianjin [08ZCGHHZ00900]; Tianjin Municipal [07JCZDJC04900]	Chinese National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Tianjin Municipal	This work was supported by grants from the Chinese National Natural Sciences Foundation (Grant No. 30873091, 30971291 and 30701012) and the Natural Science Foundation of Tianjin (Grant No. 08ZCGHHZ00900) and by grants from Tianjin Municipal Basic Research Priorities Program (No. 07JCZDJC04900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 1998, GASTROENTEROLOGY, V114, P503, DOI 10.1016/S0016-5085(98)70533-5; AHMAD S, 1993, MOL PHARMACOL, V43, P858; Allen JD, 2002, MOL CANCER THER, V1, P427; [Anonymous], 1983, CHIN TRADIT HERB DRU; Baer MR, 2002, BLOOD, V100, P1224, DOI 10.1182/blood.V100.4.1224.h81602001224_1224_1232; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Bartsevich VV, 2000, MOL PHARMACOL, V58, P1; Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; BHUSHAN A, 1992, MOL PHARMACOL, V42, P69; Byrne JL, 1999, LEUKEMIA, V13, P786, DOI 10.1038/sj.leu.2401406; CHAUDHARY PM, 1992, ONCOL RES, V4, P281; Chen C, 2011, J CANCER RES CLIN, V137, P9, DOI 10.1007/s00432-010-0854-3; CHEN DH, 1984, CHINESE TRAD HERBAL, V15, P6; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Daenen S, 2004, LEUKEMIA RES, V28, P1057, DOI 10.1016/j.leukres.2004.03.001; DANO K, 1973, BIOCHIM BIOPHYS ACTA, V323, P466, DOI 10.1016/0005-2736(73)90191-0; Daschner PJ, 1999, BREAST CANCER RES TR, V53, P229, DOI 10.1023/A:1006138803392; Davies TG, 2001, STRUCTURE, V9, P389, DOI 10.1016/S0969-2126(01)00598-6; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; DURAND RE, 1981, CANCER RES, V41, P3489; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Gill PK, 2001, EUR J BIOCHEM, V268, P4151, DOI 10.1046/j.1432-1327.2001.02326.x; Gottifredi V, 2004, J BIOL CHEM, V279, P5802, DOI 10.1074/jbc.M310373200; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Institute of Hematology Chinese Academy of Medical Sciences, 1979, CHINESE J INTERN MED, V15, P86; Jedlitschky G, 1997, BIOCHEM J, V327, P305, DOI 10.1042/bj3270305; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kameswaran TR, 2008, BIOMED PHARMACOTHER; Keppler D, 1997, BIOL CHEM, V378, P787; Lampidis TJ, 1997, BIOCHEMISTRY-US, V36, P2679, DOI 10.1021/bi9614489; Lin HL, 1999, BRIT J CANCER, V81, P416, DOI 10.1038/sj.bjc.6690710; Linenberger ML, 2001, BLOOD, V98, P988, DOI 10.1182/blood.V98.4.988; List AF, 2001, BLOOD, V98, P3212, DOI 10.1182/blood.V98.12.3212; Liu M, 2007, J BIOL CHEM, V282, P17581, DOI 10.1074/jbc.M702206200; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; MERLIN JL, 1994, BLOOD, V84, P262; Minderman H, 2004, CLIN CANCER RES, V10, P1826, DOI 10.1158/1078-0432.CCR-0914-3; Osborn MT, 1999, ONCOGENE, V18, P5756, DOI 10.1038/sj.onc.1202943; Pallis M, 2000, BLOOD, V95, P2897, DOI 10.1182/blood.V95.9.2897.009k14_2897_2904; Pallis M, 2002, LEUKEMIA LYMPHOMA, V43, P1221, DOI 10.1080/10428190290026277; Park JW, 2001, BIOCHEM BIOPH RES CO, V280, P244, DOI 10.1006/bbrc.2000.4105; Perabo FGE, 2006, ANTICANCER RES, V26, P2129; Perez J, 2011, ANTICANCER RES, V31, P2813; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; Sharom FJ, 1999, BIOCHEM PHARMACOL, V58, P571, DOI 10.1016/S0006-2952(99)00139-2; SONNEVELD P, 1981, LEUKEMIA RES, V5, P251, DOI 10.1016/0145-2126(81)90110-7; Stewart A, 2000, CLIN CANCER RES, V6, P4186; Suh HW, 2004, ARCH PHARM RES, V27, P396, DOI 10.1007/BF02980080; Susa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010764; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Takebayashi Y, 2001, INT J MOL MED, V7, P397; TAMIR A, 1991, IMMUNOL LETT, V27, P95, DOI 10.1016/0165-2478(91)90134-V; TAPIERO H, 1982, CYTOMETRY, V2, P298; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; WANG HL, 1992, EXP CELL RES, V203, P47, DOI 10.1016/0014-4827(92)90038-A; Wattel E, 1999, ADV EXP MED BIOL, V457, P35; Watts GS, 2001, J PHARMACOL EXP THER, V299, P434; Wu G.Y., 1980, CHIN MED J, V60, P451; Xiu M, 2003, MOL CELL BIOL, V23, P8890, DOI 10.1128/MCB.23.23.8890-8901.2003; Xu D, 2002, J PHARMACOL EXP THER, V302, P963, DOI 10.1124/jpet.102.033639; Yan F, 2008, BIOL PHARM BULL, V31, P1258, DOI 10.1248/bpb.31.1258; YU G, 1991, CANCER COMMUN, V3, P181, DOI 10.3727/095535491820873263; Yu XF, 2006, BIOCHEM BIOPH RES CO, V342, P286, DOI 10.1016/j.bbrc.2006.01.147; Zhang WH, 2008, CELL CYCLE, V7, P1668, DOI 10.4161/cc.7.11.5982; Zheng Q.T, 1979, COMM CHIN HERB MED, V10, P19; Zheng Q.T., 1979, COMM CHIN HERB MED, V10, P35; Zhou J, 2006, CANCER RES, V66, P445, DOI 10.1158/0008-5472.CAN-05-1779; ZHU YP, 1995, PHARM WORLD SCI, V17, P103, DOI 10.1007/BF01872386	74	14	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32782	10.1371/journal.pone.0032782	http://dx.doi.org/10.1371/journal.pone.0032782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403708	gold, Green Submitted, Green Published			2022-12-25	WOS:000303017700105
J	Xu, Y; Fang, F; Clair, DKS; Clair, WHS				Xu, Yong; Fang, Fang; Clair, Daret K. St.; Clair, William H. St.			Inverse Relationship between PSA and IL-8 in Prostate Cancer: An Insight into a NF-kappa B-Mediated Mechanism	PLOS ONE			English	Article							IONIZING-RADIATION; ANDROGEN RECEPTOR; CELLS; INTERLEUKIN-8; EXPRESSION; ANTIGEN; TRANSCRIPTION; PROGRESSION; ACTIVATION; PATHWAYS	Background: Prostate specific antigen (PSA) is traditionally used as an indicator for the presence of prostate cancer (PCa) and radiotherapy is generally used to treat inoperable and locally advanced PCa. However, how cellular PSA level is associated with sensitivity of PCa to radiotherapy is unknown. The previous finding that the RelB-based NF-kappa B alternative pathway differentially regulates PSA and interleukin-8 (IL-8) in aggressive PCa has directed our attention to the role of RelB in the response of PCa to radiotherapy. Methodology/Principal Findings: RelB and its targets PSA and IL-8 in PCa cells were manipulated by ectopic expression in PCa cells with a low endogenous level of RelB (LNCaP) and by RNAi-based knock-down in PCa cells with a high constitutive level of RelB (PC3). The effects of RelB, PSA and IL-8 on the response of PCa to radiation treatment were examined in vitro and in xenograft tumors. RelB regulates PSA and IL-8 in an inverse manner. When the cellular levels of PSA and IL-8 were directly modulated by genetic manipulations or by the addition of recombinant proteins, the results demonstrate that up-regulation of IL-8 enhanced radioresistance of PCa cells and concurrently down-regulated PSA. In contrast, up-regulation of PSA resulted in reduced radioresistance with concurrent down-regulation of IL-8. Conclusion/Significance: RelB plays a critical role in the response of PCa to radiotherapy and the inverse expression of IL-8 and PSA. The results identify a previously unrecognized relationship between IL-8 and PSA in the response of PCa cells to radiotherapy.	[Xu, Yong; Clair, Daret K. St.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Fang, Fang; Clair, William H. St.] Univ Kentucky, Dept Radiat Med, Lexington, KY USA	University of Kentucky; University of Kentucky	Xu, Y (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA.	stclair@uky.edu			National Institutes of Health [CA 49797, CA 11580]; NATIONAL CANCER INSTITUTE [R01CA143428, R01CA049797, R29CA049797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA 49797 to DKS and CA 11580 to WHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Ahmed KM, 2007, CURR CANCER DRUG TAR, V7, P335; ANTWERP DJV, 1996, SCIENCE, V274, P787; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Caruso DJ, 2008, CLIN CANCER RES, V14, P4111, DOI 10.1158/1078-0432.CCR-08-0738; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Freedland SJ, 2011, CANCER-AM CANCER SOC, V117, P1123, DOI 10.1002/cncr.25477; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; Herschman JD, 1997, UROLOGY, V50, P239, DOI 10.1016/S0090-4295(97)00209-4; Howlader NNA, 2010, SEER CANC STAT REV 1; Josson S, 2006, ONCOGENE, V25, P1554, DOI 10.1038/sj.onc.1209186; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Korkaya H, 2011, CLIN CANC RES   0617; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Singh RK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-57; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Thames HD, 2006, INT J RADIAT ONCOL, V65, P975, DOI 10.1016/j.ijrobp.2006.02.043; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xu Y, MOL CANC THER, V6, P2048; Xu Y, 2008, MOL CANCER THER, V7, P2367, DOI 10.1158/1535-7163.MCT-08-0238; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635	35	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32905	10.1371/journal.pone.0032905	http://dx.doi.org/10.1371/journal.pone.0032905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403723	gold, Green Submitted, Green Published			2022-12-25	WOS:000303017700120
J	Gu, C; Shabab, M; Strasser, R; Wolters, PJ; Shindo, T; Niemer, M; Kaschani, F; Mach, L; van der Hoorn, RAL				Gu, Christian; Shabab, Mohammed; Strasser, Richard; Wolters, Pieter J.; Shindo, Takayuki; Niemer, Melanie; Kaschani, Farnusch; Mach, Lukas; van der Hoorn, Renier A. L.			Post-Translational Regulation and Trafficking of the Granulin-Containing Protease RD21 of Arabidopsis thaliana	PLOS ONE			English	Article							CYSTEINE PROTEASE; PHYTOPHTHORA-INFESTANS; MONOCLONAL-ANTIBODY; DISEASE RESISTANCE; CRYSTAL-STRUCTURE; CYSTATIN COMPLEX; PROCATHEPSIN-B; CELL-DEATH; IN-VITRO; TOMATO	RD21-like proteases are ubiquitous, plant-specific papain-like proteases typified by carrying a C-terminal granulin domain. RD21-like proteases are involved in immunity and associated with senescence and various types of biotic and abiotic stresses. Here, we interrogated Arabidopsis RD21 regulation and trafficking by site-directed mutagenesis, agroinfiltration, western blotting, protease activity profiling and protein degradation. Using an introduced N-glycan sensor, deglycosylation experiments and glyco-engineered N. benthamiana plants, we show that RD21 passes through the Golgi where it becomes fucosylated. Our studies demonstrate that RD21 is regulated at three post-translational levels. Prodomain removal is not blocked in the catalytic Cys mutant, indicating that RD21 is activated by a proteolytic cascade. However, RD21 activation in Arabidopsis does not require vacuolar processing enzymes (VPEs) or aleurain-like protease AALP. In contrast, granulin domain removal requires the catalytic Cys and His residues and is therefore autocatalytic. Furthermore, SDS can (re-) activate latent RD21 in Arabidopsis leaf extracts, indicating the existence of a third layer of post-translational regulation, possibly mediated by endogenous inhibitors. RD21 causes a dominant protease activity in Arabidopsis leaf extracts, responsible for SDS-induced proteome degradation.	[Gu, Christian; Shabab, Mohammed; Wolters, Pieter J.; Shindo, Takayuki; Kaschani, Farnusch; van der Hoorn, Renier A. L.] Max Planck Inst Plant Breeding Res, Max Planck Soc, Chem Genom Ctr, Plant Chemet Lab, Cologne, Germany; [Strasser, Richard; Niemer, Melanie; Mach, Lukas] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria	Max Planck Society; University of Natural Resources & Life Sciences, Vienna	Gu, C (corresponding author), Max Planck Inst Plant Breeding Res, Max Planck Soc, Chem Genom Ctr, Plant Chemet Lab, Cologne, Germany.	hoorn@mpipz.mpg.de	Wolters, Pieter Jacobus/M-7613-2013; Strasser, Richard/AAD-2916-2020; Wolters, Pieter Jacobus/P-2961-2019; van der Hoorn, Renier/AAU-1005-2020	Wolters, Pieter Jacobus/0000-0001-5941-9189; Wolters, Pieter Jacobus/0000-0001-5941-9189; van der Hoorn, Renier/0000-0002-3692-7487; Kaschani, Farnusch/0000-0001-6572-3232; Strasser, Richard/0000-0001-8764-6530; Mach, Lukas/0000-0001-9013-5408	Max Planck Society; International Max Planck Research School (IMPRS); Deutsche Forschungsgemeinschaft [3983/7-1]; Austrian Science Fund [W1224-B09]	Max Planck Society(Max Planck Society); International Max Planck Research School (IMPRS); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF))	This work was financially supported by the Max Planck Society, the International Max Planck Research School (IMPRS), the Deutsche Forschungsgemeinschaft (project HO 3983/7-1), and the Austrian Science Fund (project W1224-B09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SU, 2000, J CELL BIOL, V149, P1335, DOI 10.1083/jcb.149.7.1335; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bozkurt TO, 2011, P NATL ACAD IN PRESS; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; DRENTH J, 1968, NATURE, V218, P929, DOI 10.1038/218929a0; FAYE L, 1986, EUR J BIOCHEM, V158, P655, DOI 10.1111/j.1432-1033.1986.tb09803.x; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; Halls CE, 2005, PLANT SCI, V168, P1267, DOI 10.1016/j.plantsci.2005.01.004; Hayashi Y, 2001, PLANT CELL PHYSIOL, V42, P894, DOI 10.1093/pcp/pce144; HOLWERDA BC, 1990, PLANT CELL, V2, P1091, DOI 10.1105/tpc.2.11.1091; Kaschani F, 2009, PLANT J, V57, P373, DOI 10.1111/j.1365-313X.2008.03683.x; Kaschani F, 2010, PLANT PHYSIOL, V154, P1794, DOI 10.1104/pp.110.158030; KOIZUMI M, 1993, GENE, V129, P175, DOI 10.1016/0378-1119(93)90266-6; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Lampl N, 2010, J BIOL CHEM, V285, P13550, DOI 10.1074/jbc.M109.095075; MACH L, 1994, J BIOL CHEM, V269, P13030; Maley F, 1989, ANAL BIOCHEM, V180, P15; Martinez DE, 2007, J EXP BOT, V58, P1099, DOI 10.1093/jxb/erl270; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; MENARD R, 1990, BIOCHEMISTRY-US, V29, P6706, DOI 10.1021/bi00480a021; Nissen MS, 2009, PLANT CELL, V21, P861, DOI 10.1105/tpc.108.064717; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; Pogue GP, 2010, PLANT BIOTECHNOL J, V8, P638, DOI 10.1111/j.1467-7652.2009.00495.x; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; Schoberer J, 2011, MOL PLANT, V4, P220, DOI 10.1093/mp/ssq082; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; Shindo T, 2011, ROLE IMMUNITY UNPUB; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Tajima T, 2011, PHYSIOL PLANTARUM, V141, P97, DOI 10.1111/j.1399-3054.2010.01425.x; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; Van der Hoorn RAL, 2003, PLANT J, V35, P305, DOI 10.1046/j.1365-313X.2003.01803.x; Van der Hoorn RAL, 2000, MOL PLANT MICROBE IN, V13, P439, DOI 10.1094/MPMI.2000.13.4.439; Van der Hoorn RAL, 2011, PROBES ACTIVITY BASE; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; VARUGHESE KI, 1989, BIOCHEMISTRY-US, V28, P1330, DOI 10.1021/bi00429a058; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang Z, 2008, NAT CHEM BIOL, V4, P557, DOI 10.1038/nchembio.104; Yamada K, 2001, PLANT PHYSIOL, V127, P1626, DOI 10.1104/pp.010551; Yamada T, 1998, PLANT CELL PHYSIOL, V39, P106, DOI 10.1093/oxfordjournals.pcp.a029281; Yamada T, 2000, PLANT CELL PHYSIOL, V41, P185, DOI 10.1093/pcp/41.2.185; Yamada T, 2001, PLANT CELL PHYSIOL, V42, P710, DOI 10.1093/pcp/pce089	48	64	66	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32422	10.1371/journal.pone.0032422	http://dx.doi.org/10.1371/journal.pone.0032422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396764	Green Published, Green Submitted, gold			2022-12-25	WOS:000303006500016
J	Lorz, AN; Linse, K; Smith, PJ; Steinke, D				Loerz, Anne-Nina; Linse, Katrin; Smith, Peter J.; Steinke, Dirk			First Molecular Evidence for Underestimated Biodiversity of Rhachotropis (Crustacea, Amphipoda), with Description of a New Species	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; DNA; BARCODE; DIET	The crustacean genus Rhachotropis has a worldwide distribution and amongst the largest bathymetric range known from any amphipod genus. DNA barcoding of new material from around New Zealand and the Ross Sea indicated depth-related biogeographic patterns. New Zealand Rhachotropis do not form a monophyletic clade. Species from bathyal depths on the Chatham Rise, east of New Zealand, show lower sequence divergence to bathyal species from California and the Arctic than to abyssal New Zealand species. Species sampled in the Kermadec Trench, north of New Zealand below 5000 m, seem to be more closely related to Ross Sea abyssal species than to the New Zealand shelf species. The worldwide geographic and bathymetric distribution for all Rhachotropis species is presented here. Depth may have a greater influence on phylogeny than geographic distance. Molecular and morphological investigations of Rhachotropis specimens from the Chatham Rise, New Zealand revealed a species new to science which is described in detail, including scanning electron microscopy. This increases the number of described species of Rhachotropis to 60 worldwide.	[Loerz, Anne-Nina] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Linse, Katrin] British Antarctic Survey, Cambridge CB3 0ET, England; [Smith, Peter J.] Museum Victoria, Melbourne, Vic, Australia; [Steinke, Dirk] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Museum Victoria; University of Guelph	Lorz, AN (corresponding author), Natl Inst Water & Atmospher Res, Wellington, New Zealand.	Anne-Nina.Loerz@niwa.co.nz	Steinke, Dirk/D-4700-2009	Steinke, Dirk/0000-0002-8992-575X; Linse, Katrin/0000-0003-3477-3047	New Zealand Government [So001IPY, IPY2007-01]; Ministry of Fisheries Science Team; Ocean Survey 20/20 CAML Advisory Group (Land Information New Zealand, Ministry of Fisheries, Antarctica New Zealand, Ministry of Foreign Affairs and Trade, and National Institute of Water and Atmosphere Ltd); Foundation of Research and Science [BBDB1202]; Nippon Foundation; Canadian Centre for DNA Barcoding, from the Ontario Genomics Institute [2008-OGI-ICI-03]; Genome Canada; Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Research Council of Canada; Alfred P. Sloan Foundation; British Antarctic Core program "Polar Science for Planet Earth"; Natural Environmental Research Council; National Institute of Water and Atmosphere Ltd.; Natural Environment Research Council [bas0100026] Funding Source: researchfish; NERC [bas0100026] Funding Source: UKRI	New Zealand Government; Ministry of Fisheries Science Team; Ocean Survey 20/20 CAML Advisory Group (Land Information New Zealand, Ministry of Fisheries, Antarctica New Zealand, Ministry of Foreign Affairs and Trade, and National Institute of Water and Atmosphere Ltd); Foundation of Research and Science; Nippon Foundation(Nippon Foundation); Canadian Centre for DNA Barcoding, from the Ontario Genomics Institute; Genome Canada(Genome Canada); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); British Antarctic Core program "Polar Science for Planet Earth"; Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Institute of Water and Atmosphere Ltd.; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the New Zealand Government under the New Zealand International Polar Year - Census of Antarctic Marine Life Project (Phase 1: So001IPY; Phase 2: IPY2007-01). The authors gratefully acknowledge project governance provided by the Ministry of Fisheries Science Team and the Ocean Survey 20/20 CAML Advisory Group (Land Information New Zealand, Ministry of Fisheries, Antarctica New Zealand, Ministry of Foreign Affairs and Trade, and National Institute of Water and Atmosphere Ltd). ANL was also supported by the Foundation of Research and Science taxonomy project BBDB1202. The Kermadec trench specimen was collected during HADEEP 6 (KAH0910) funded by the Nippon Foundation. Sequencing was supported by funding to the International Barcode of Life Project (iBOL) through the Canadian Centre for DNA Barcoding, from the Ontario Genomics Institute (2008-OGI-ICI-03), Genome Canada, the Ontario Ministry of Research and Innovation, and the Natural Sciences and Engineering Research Council of Canada. DS was supported by funding from the Alfred P. Sloan Foundation to MarBOL. KL was supported by the British Antarctic Core program "Polar Science for Planet Earth" funded by the Natural Environmental Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by the National Institute of Water and Atmosphere Ltd., of whom ANL is also an employee. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bellan-Santini D, 2006, J NAT HIST, V40, P1407, DOI 10.1080/00222930600956809; BOUSFIELD EL, 1995, J CRUSTACEAN BIOL, V15, P746, DOI 10.2307/1548823; Brandt A, 2009, DEEP-SEA RES PT I, V56, P2013, DOI 10.1016/j.dsr.2009.06.007; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Carreon-Martinez L, 2011, J FISH BIOL, V78, P1170, DOI 10.1111/j.1095-8649.2011.02925.x; Cartes JE, 1999, J NAT HIST, V33, P1133, DOI 10.1080/002229399299978; Coleman Charles Oliver, 2009, Zoosystematics and Evolution, V85, P305, DOI 10.1002/zoos.200900008; Coleman CO, 2003, ORG DIVERS EVOL, V3; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; d'Udekem d'Acoz C, 2007, B MUSEO CIVICO STORI, V31, P31; Dunn MR, 2010, DEEP-SEA RES PT I, V57, P923, DOI 10.1016/j.dsr.2010.02.006; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Griffiths HJ, 2011, DEEP-SEA RES PT II, V58, P18, DOI 10.1016/j.dsr2.2010.10.008; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Held C, 2007, POLAR BIOL, V30, P513, DOI 10.1007/s00300-006-0210-x; HESSLER RR, 1975, MAR BIOL, V32, P155, DOI 10.1007/BF00388508; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jamieson AJ, 2010, TRENDS ECOL EVOL, V25, P190, DOI 10.1016/j.tree.2009.09.009; Lorz AN, 2010, ZOOTAXA, P22; Lorz AN, 2009, ZOOKEYS, P91, DOI 10.3897/zookeys.18.103; Lorz A-N, 2012, HIGH GENETIC DIVERSI, DOI [10.1007/s1526-011-0098-8, DOI 10.1007/S1526-011-0098-8]; Lorz AN, 2004, MOL PHYLOGENET EVOL, V31, P4, DOI 10.1016/j.ympev.2003.07.019; Lowry JK, 2005, P BIOL SOC WASH, V118, P38, DOI 10.2988/0006-324X(2005)118[38:NCAEAF]2.0.CO;2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Smith PJ, 2008, J FISH BIOL, V72, P464, DOI 10.1111/j.1095-8649.2007.01745.x; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Whitworth T, 1999, PROG OCEANOGR, V43, P1, DOI 10.1016/S0079-6611(99)00005-1; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005	36	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32365	10.1371/journal.pone.0032365	http://dx.doi.org/10.1371/journal.pone.0032365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396761	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000303005000023
J	Waluk, DP; Sucharski, F; Sipos, L; Silberring, J; Hunt, MC				Waluk, Dominik P.; Sucharski, Filip; Sipos, Laszlo; Silberring, Jerzy; Hunt, Mary C.			Reversible Lysine Acetylation Regulates Activity of Human Glycine N-Acyltransferase-like 2 (hGLYATL2) IMPLICATIONS FOR PRODUCTION OF GLYCINE-CONJUGATED SIGNALING MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; ARACHIDONOYL GLYCINE; ACYL GLYCINES; IN-VITRO; IDENTIFICATION; METABOLISM; ACIDS; ARACHIDONYLGLYCINE; ANANDAMIDE; DIVERSITY	Lysine acetylation is a major post-translational modification of proteins and regulates many physiological processes such as metabolism, cell migration, aging, and inflammation. Proteomic studies have identified numerous lysine-acetylated proteins in human and mouse models (Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., Grishin, N. V., White, M., Yang, X. J., and Zhao, Y. (2006) Mol. Cell 23, 607-618). One family of proteins identified in this study was the murine glycine N-acyltransferase (GLYAT) enzymes, which are acetylated on lysine 19. Lysine 19 is a conserved residue in human glycine N-acyltransferase-like 2 (hGLYATL2) and in several other species, showing that this residue may be important for enzyme function. Mutation of lysine 19 in recombinant hGLYATL2 to glutamine (K19Q) and arginine (K19R) resulted in a 50-80% lower production of N-oleoyl glycine and N-arachidonoylglycine, indicating that lysine 19 is important for enzyme function. LC/MS/MS confirmed that Lys-19 is not acetylated in wild-type hGLYATL2, indicating that Lys-19 requires to be deacetylated for full activity. The hGLYATL2 enzyme conjugates medium-and long-chain saturated and unsaturated acyl-CoA esters to glycine, resulting in the production of N-oleoyl glycine and also N-arachidonoyl glycine. N-Oleoyl glycine and N-arachidonoyl glycine are structurally and functionally related to endocannabinoids and have been identified as signaling molecules that regulate functions like the perception of pain and body temperature and also have anti-inflammatory properties. In conclusion, acetylation of lysine(s) in hGLYATL2 regulates the enzyme activity, thus linking post-translational modification of proteins with the production of biological signaling molecules, the N-acyl glycines.	[Hunt, Mary C.] Dublin Inst Technol, Sch Biol Sci, Dublin 8, Ireland; Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Sucharski, Filip; Silberring, Jerzy] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biochem & Neurobiol, PL-30059 Krakow, Poland	Technological University Dublin; Stockholm University; AGH University of Science & Technology	Hunt, MC (corresponding author), Dublin Inst Technol, Sch Biol Sci, Kevin St, Dublin 8, Ireland.	mary.hunt@dit.ie	Silberring, Jerzy/AGA-5631-2022	Silberring, Jerzy/0000-0002-4362-8362; Hunt, Mary/0000-0001-6415-2992	Swedish Research Council; Carl Tryggers Foundation; Professor Nanna Svartz Fond; Ake Wibergs Stiftelse; fellowship Doctus-Lesser Poland donation program for PhD students	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Foundation; Professor Nanna Svartz Fond; Ake Wibergs Stiftelse; fellowship Doctus-Lesser Poland donation program for PhD students	This work was supported by the Swedish Research Council, Carl Tryggers Foundation, Professor Nanna Svartz Fond, and Ake Wibergs Stiftelse and by the fellowship Doctus-Lesser Poland donation program for PhD students.	Badenhorst CPS, 2012, DRUG METAB DISPOS, V40, P346, DOI 10.1124/dmd.111.041657; Bienvenut WV, 2011, PROTEOMICS, V11, P1734, DOI 10.1002/pmic.201000634; Bradshaw HB, 2009, VITAM HORM, V81, P191, DOI 10.1016/S0083-6729(09)81008-X; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Burstein SH, 2000, PROSTAG OTH LIPID M, V61, P29, DOI 10.1016/S0090-6980(00)00053-8; Burstein S, 2008, NEUROPHARMACOLOGY, V55, P1259, DOI 10.1016/j.neuropharm.2007.11.011; Chaturvedi S, 2006, PROSTAG OTH LIPID M, V81, P136, DOI 10.1016/j.prostaglandins.2006.09.001; Close P, 2010, CELL MOL LIFE SCI, V67, P1255, DOI 10.1007/s00018-009-0252-7; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; GREGERSEN N, 1986, BIOCHEM MED METAB B, V35, P210, DOI 10.1016/0885-4505(86)90076-9; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hannedouche S., 2010, U.S.A, Patent No. [7824866B2, 7824866]; Hiley CR, 2007, CARDIOVASC DRUG REV, V25, P46, DOI 10.1111/j.1527-3466.2007.00004.x; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Knights KM, 2007, EXPERT OPIN DRUG MET, V3, P159, DOI 10.1517/17425255.3.2.159; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Mccue JM, 2008, BIOCHEM BIOPH RES CO, V365, P322, DOI 10.1016/j.bbrc.2007.10.175; McHugh D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-44; Merkler DJ, 2004, BIOCHEMISTRY-US, V43, P12667, DOI 10.1021/bi049529p; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; PHILLIPS DM, 1963, BIOCHEM J, V87, P258, DOI 10.1042/bj0870258; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Riccio A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3103pe1; SCHACHTER D, 1954, J BIOL CHEM, V208, P263; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Waluk DP, 2010, FASEB J, V24, P2795, DOI 10.1096/fj.09-148551; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yu W, 2009, J BIOL CHEM, V284, P13669, DOI 10.1074/jbc.M901921200; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	37	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16158	16167		10.1074/jbc.M112.347260	http://dx.doi.org/10.1074/jbc.M112.347260			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22408254	Green Published, hybrid			2022-12-25	WOS:000304030900008
J	Koshimizu, T; Kawai, M; Kondou, H; Tachikawa, K; Sakai, N; Ozono, K; Michigami, T				Koshimizu, Takao; Kawai, Masanobu; Kondou, Hiroki; Tachikawa, Kanako; Sakai, Norio; Ozono, Keiichi; Michigami, Toshimi			Vinculin Functions as Regulator of Chondrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTROPHIC CHONDROCYTE DIFFERENTIATION; TYROSINE-PHOSPHATASE SHP-2; ACTIVATED PROTEIN-KINASE; GENE-TRAP MUTAGENESIS; BINDING-SITE; MAP KINASE; CELL-LINE; IN-VITRO; EXPRESSION; CARTILAGE	To identify the genes involved in chondrocytic differentiation, we applied gene trap mutagenesis to a murine mesenchymal chondrogenic cell line ATDC5 and isolated a clone in which the gene encoding vinculin was trapped. The trapped allele was assumed to express a fusion protein containing a truncated vinculin lacking the tail domain and the geo product derived from the trap vector. The truncated vinculin was suggested to exert a dominant negative effect. Impaired functioning of vinculin caused by gene trapping in ATDC5 cells or knockdown in primary chondrocytes resulted in the reduced expression of chondrocyte-specific genes, including Col2a1, aggrecan, and Col10a1. The expression of Runx2 also was suppressed by the dysfunctional vinculin. On the other hand, the expression of Sox9, encoding a key transcription factor for chondrogenesis, was retained. Knockdown of vinculin in metatarsal organ cultures impaired the growth of the explants and reduced the expression of Col2a1 and aggrecan. Gene trapping or knockdown of vinculin decreased the phosphorylation of ERK1/2 but increased that of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP2) and Akt during chondrocytic differentiation, suggesting a disturbance of signaling by insulin-like growth factor I (IGF-I). Knockdown of vinculin in the metatarsal organ culture abrogated the IGF-I-induced growth and inhibited the up-regulation of Col2a1 and aggrecan expression by IGF-I. Loss of vinculin function in differentiating chondrocytes impaired the activation of the p38 MAPK pathway also, suggesting its involvement in the regulation of chondrogenesis by vinculin. Our results indicate a tissue-specific function of vinculin in cartilage whereby it controls chondrocytic differentiation.	[Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi, Osaka 5941101, Japan; [Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan; [Sakai, Norio; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Sakai, Norio; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat & Neonatal Perinatal Res, Suita, Osaka 5650871, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; Osaka University	Michigami, T (corresponding author), Osaka Med Ctr, Dept Bone & Mineral Res, 840 Murodo Cho, Izumi, Osaka 5941101, Japan.	michigami@mch.pref.osaka.jp	Michigami, Toshimi/AAU-2326-2021	Kawai, Masanobu/0000-0003-4466-1559	Ministry of Education, Science, and Culture of Japan; Foundation of Growth Science; Grants-in-Aid for Scientific Research [23591227] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation of Growth Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (to T. M.) and a grant from the Foundation of Growth Science (to T. M.).	Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251, DOI 10.14670/HH-22.1251; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Haaijman A, 1997, J BONE MINER RES, V12, P1815, DOI 10.1359/jbmr.1997.12.11.1815; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Ihara-Watanabe M, 2004, J CELL BIOCHEM, V93, P418, DOI 10.1002/jcb.20185; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1995, BIOCHEM BIOPH RES CO, V210, P159, DOI 10.1006/bbrc.1995.1641; JONES P, 1989, J CELL BIOL, V109, P2917, DOI 10.1083/jcb.109.6.2917; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; MacGillivray M, 2003, J BIOL CHEM, V278, P27190, DOI 10.1074/jbc.M213083200; Mainguy G, 2000, NAT BIOTECHNOL, V18, P746, DOI 10.1038/77312; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Namdari S, 2008, ARTHRITIS RHEUM, V58, P3520, DOI 10.1002/art.23999; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Uchihashi T, 2007, BONE, V41, P1025, DOI 10.1016/j.bone.2007.08.028; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; VOLBERG T, 1995, J CELL SCI, V108, P2253; Xu WM, 1998, DEVELOPMENT, V125, P327; Xu WM, 1998, J CELL SCI, V111, P1535; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	43	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15760	15775		10.1074/jbc.M111.308072	http://dx.doi.org/10.1074/jbc.M111.308072			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416133	Green Published, hybrid			2022-12-25	WOS:000304006300054
J	Herr, RA; Wang, XL; Loh, J; Virgin, HW; Hansen, TH				Herr, Roger A.; Wang, Xiaoli; Loh, Joy; Virgin, Herbert W.; Hansen, Ted H.			Newly Discovered Viral E3 Ligase pK3 Induces Endoplasmic Reticulum-associated Degradation of Class I Major Histocompatibility Proteins and Their Membrane-bound Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; PEPTIDE-LOADING COMPLEX; UBIQUITIN LIGASES; DOWN-REGULATION; HERPESVIRUS K3; IMMUNE EVASION; CELL-SURFACE; TRANSMEMBRANE HELIX; FINGER PROTEIN; TAPASIN	Viral immune invasion proteins are highly effective probes for studying physiological pathways. We report here the characterization of a new viral ubiquitin ligase pK3 expressed by rodent herpesvirus Peru (RHVP) that establishes acute and latent infection in laboratory mice. Our findings show that pK3 binds directly and specifically to class I major histocompatibility proteins (MHCI) in a transmembrane-dependent manner. This binding results in the rapid degradation of the pK3/MHCI complex by a mechanism dependent upon catalytically active pK3. Subsequently, the rapid degradation of pK3/MHCI secondarily causes the slow degradation of membrane bound components of the MHCI peptide loading complex, tapasin, and transporter associated with antigen processing (TAP). Interestingly, this secondary event occurs by cellular endoplasmic reticulum-associated degradation. Cumulatively, our findings show pK3 uses a unique mechanism of substrate detection and degradation compared with other viral or cellular E3 ligases. More importantly, our findings reveal that in the absence of nascent MHCI proteins in the endoplasmic reticulum, the transmembrane proteins TAP and tapasin that facilitate peptide binding to MHCI proteins are degraded by cellular quality control mechanisms.	[Herr, Roger A.; Wang, Xiaoli; Loh, Joy; Virgin, Herbert W.; Hansen, Ted H.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Hansen, TH (corresponding author), 660 S Euclid Ave, St Louis, MO 63110 USA.	hansen@wustl.edu		Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health [R01 AI019687, R01 CA096511]; Project 3 [U54 AI057160]; Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research; NATIONAL CANCER INSTITUTE [R01CA096511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019687, U54AI057160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project 3; Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by a National Institutes of Health grants R01 AI019687, R01 CA096511, and Project 3 of U54 AI057160. This work was also supported by the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research.	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Corcoran K, 2009, J BIOL CHEM, V284, P17475, DOI 10.1074/jbc.M808258200; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; CRUMPACKER DB, 1992, J IMMUNOL, V148, P3004; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Fruh K, 2002, VIRUS RES, V88, P55, DOI 10.1016/S0168-1702(02)00120-X; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Harris MR, 2001, J IMMUNOL, V166, P6686, DOI 10.4049/jimmunol.166.11.6686; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hirsch C, 2004, BBA-MOL CELL RES, V1695, P215, DOI 10.1016/j.bbamcr.2004.10.006; Hjerpe R, 2008, BIOCHEM SOC T, V36, P823, DOI 10.1042/BST0360823; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Ishido S, 2010, MOL CELLS, V29, P229, DOI 10.1007/s10059-010-0051-x; Kreft SG, 2011, J BIOL CHEM, V286, P20163, DOI 10.1074/jbc.M110.196360; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Loh J, 2011, J VIROL, V85, P2642, DOI 10.1128/JVI.01661-10; Lorenzo ME, 2002, J VIROL, V76, P5522, DOI 10.1128/JVI.76.11.5522-5531.2002; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Myers NB, 2000, J IMMUNOL, V165, P5656, DOI 10.4049/jimmunol.165.10.5656; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Papadopoulos M, 2007, J BIOL CHEM, V282, P9401, DOI 10.1074/jbc.M610429200; Petersen JL, 2005, J IMMUNOL, V174, P962, DOI 10.4049/jimmunol.174.2.962; Raghuraman G, 2002, J BIOL CHEM, V277, P41786, DOI 10.1074/jbc.M207128200; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Sanchez DJ, 2005, J CLIN INVEST, V115, P1369, DOI 10.1172/JCI200524041; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Simone LC, 2009, MOL IMMUNOL, V46, P2147, DOI 10.1016/j.molimm.2009.03.006; Simone LC, 2009, IMMUNOGENETICS, V61, P43, DOI 10.1007/s00251-008-0335-x; SMITH JD, 1993, J EXP MED, V178, P2035, DOI 10.1084/jem.178.6.2035; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wang XL, 2008, SEMIN CANCER BIOL, V18, P441, DOI 10.1016/j.semcancer.2008.09.002; Wang XL, 2005, J VIROL, V79, P4099, DOI 10.1128/JVI.79.7.4099-4108.2005; Wang XL, 2004, J VIROL, V78, P8673, DOI 10.1128/JVI.78.16.8673-8686.2004; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Yu YYL, 1999, INT IMMUNOL, V11, P1897, DOI 10.1093/intimm/11.12.1897; Yu YYL, 2002, J VIROL, V76, P2796, DOI 10.1128/JVI.76.6.2796-2803.2002	57	12	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14467	14479		10.1074/jbc.M111.325340	http://dx.doi.org/10.1074/jbc.M111.325340			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403403	hybrid, Green Published			2022-12-25	WOS:000304003200014
J	Mir, SUR; Jin, L; Craven, RJ				Mir, Shakeel U. R.; Jin, Ling; Craven, Rolf J.			Neutrophil Gelatinase-associated Lipocalin ( NGAL) Expression Is Dependent on the Tumor-associated Sigma-2 Receptor S2R(Pgrmc1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-BINDING PROTEIN; MEMBRANE COMPONENT 1; PROGESTERONES ANTIAPOPTOTIC ACTION; BREAST-CANCER CELLS; INNER ZONE ANTIGEN; SACCHAROMYCES-CEREVISIAE; ANTINEOPLASTIC DRUGS; GENE-EXPRESSION; DOMAIN PROTEIN; YEAST DAP1P	Tumor invasion is a critical step in the spread of cancer. S2R (sigma-2 receptor)/Pgrmc1 (progesterone receptor membrane component 1) is a cytochrome b(5)-related drug-binding orphan receptor essential for tumor formation and invasion. Secretory proteins drive these processes, so we screened for S2R(Pgrmc1)-dependent secreted proteins using antibody arrays. S2R(Pgrmc1) markedly regulated the expression of NGAL/LCN2 (neutrophil gelatinase-associated lipocalin/lipocalin 2), a secreted glycoprotein that binds to MMP-9 (matrix metalloproteinase 9) and protects it from degradation. S2RPgrmc1 knock-down blocked NGAL/LCN2 expression at the protein and RNA levels and decreased MMP9 activity. NGAL expression was required for MMP-9 activity and tumor formation. S2R(Pgrmc1) associates with EGFR and increases EGFR levels at the plasma membrane, and the EGFR inhibitors erlotinib and AG1478, as well as Akt and ERK inhibitors, suppressed the NGAL/LCN2 RNA and protein levels. NGAL is transcriptionally regulated by NF kappa B, and S2R(Pgrmc1) knock-down decreased the NF kappa B subunit p65/RelA acetylation, phosphorylation, and activation. In S2R(Pgrmc1) knock-down cells, p65 acetylation was reversed by inhibitors of histone deacetylase 1, and the inhibitors partially restored NGAL levels. Our results are consistent with a model in which S2R(Pgrmc1) increases NGAL/LCN2 levels by activating NF kappa B via EGFR.	[Mir, Shakeel U. R.; Jin, Ling; Craven, Rolf J.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky	Craven, RJ (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, Markey Canc Ctr, Lexington, KY 40536 USA.	rolf.craven@uky.edu			Kentucky Lung Cancer Research Program; Kentucky Science and Education Fund	Kentucky Lung Cancer Research Program; Kentucky Science and Education Fund	This work was supported by the Kentucky Lung Cancer Research Program, Cycles 8 and 10, and by the Kentucky Science and Education Fund.	Ahmed IS, 2010, J BIOL CHEM, V285, P24775, DOI 10.1074/jbc.M110.134585; Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Bolignano D, 2010, CANCER LETT, V288, P10, DOI 10.1016/j.canlet.2009.05.027; Borras C, 2011, FREE RADICAL RES, V45, P643, DOI 10.3109/10715762.2011.571685; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Craven RJ, 2007, J BIOL CHEM, V282, P36543, DOI 10.1074/jbc.M706770200; Crawford KW, 2002, CANCER RES, V62, P313; Crudden G, 2006, J PHARMACOL EXP THER, V316, P448, DOI 10.1124/jpet.105.094631; Crudden G, 2005, TUMOR BIOL, V26, P142, DOI 10.1159/000086485; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Doyle K, 2010, J BIOL CHEM, V285, P17417, DOI 10.1074/jbc.M109.089250; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Falkenstein E, 1996, BIOCHEM BIOPH RES CO, V229, P86, DOI 10.1006/bbrc.1996.1761; Gerdes D, 1998, BIOL CHEM, V379, P907; Ghosh K, 2005, BIOCHEMISTRY-US, V44, P16729, DOI 10.1021/bi0511585; Hand RA, 2003, J CELL BIOCHEM, V90, P534, DOI 10.1002/jcb.10648; Hand RA, 2003, EUKARYOT CELL, V2, P306, DOI 10.1128/EC.2.2.306-317.2003; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; KROES RA, 1991, P NATL ACAD SCI USA, V88, P4825, DOI 10.1073/pnas.88.11.4825; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Laurent-Matha V, 2006, J BIOCHEM, V139, P363, DOI 10.1093/jb/mvj037; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Li SH, 2009, CANCER RES, V69, P9163, DOI 10.1158/0008-5472.CAN-09-2483; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Mallory JC, 2005, MOL PHARMACOL, V68, P1747, DOI 10.1124/mol.105.016519; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; Mifsud W, 2002, GENOME BIOL, V3; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Min L, 2004, MOL CELL ENDOCRINOL, V215, P143, DOI 10.1016/j.mce.2003.11.025; Neubauer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2155; Nuntagowat C, 2010, CLIN EXP METASTAS, V27, P295, DOI 10.1007/s10585-010-9327-y; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Ostenfeld MS, 2005, CANCER RES, V65, P8975, DOI 10.1158/0008-5472.CAN-05-0269; Peluso JJ, 2006, ENDOCRINOLOGY, V147, P3133, DOI 10.1210/en.2006-0114; Peluso JJ, 2005, BIOL REPROD, V73, P261, DOI 10.1095/biolreprod.105.041061; Peluso JJ, 2008, J CLIN ENDOCR METAB, V93, P1592, DOI 10.1210/jc.2007-2771; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Richardson DR, 2005, CELL, V123, P1175, DOI 10.1016/j.cell.2005.12.008; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Thompson AM, 2007, BIOCHEMISTRY-US, V46, P14629, DOI 10.1021/bi7013739; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Wehling M, 2007, STEROIDS, V72, P107, DOI 10.1016/j.steroids.2006.11.007; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yoshitani N, 2005, PROTEOMICS, V5, P1472, DOI 10.1002/pmic.200401032	52	27	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14494	14501		10.1074/jbc.M111.324921	http://dx.doi.org/10.1074/jbc.M111.324921			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22418433	hybrid, Green Published			2022-12-25	WOS:000304003200016
J	Ye, MY; Khoo, KK; Xu, SQ; Zhou, M; Boonyalai, N; Perugini, MA; Shao, XX; Chi, CW; Galea, CA; Wang, CG; Norton, RS				Ye, Mingyu; Khoo, Keith K.; Xu, Shaoqiong; Zhou, Mi; Boonyalai, Nonlawat; Perugini, Matthew A.; Shao, Xiaoxia; Chi, Chengwu; Galea, Charles A.; Wang, Chunguang; Norton, Raymond S.			A Helical Conotoxin from Conus imperialis Has a Novel Cysteine Framework and Defines a New Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH SOURCE; CBL-B; NMR; THERAPEUTICS; PROGRAM; VENOMS; LEADS	Cone snail venoms are a rich source of peptides, many of which are potent and selective modulators of ion channels and receptors. Here we report the isolation and characterization of two novel conotoxins from the venom of Conus imperialis. These two toxins contain a novel cysteine framework, C-C-C-CC-C, which has not been found in other conotoxins described to date. We name it framework XXIII and designate the two toxins im23a and im23b; cDNAs of these toxins exhibit a novel signal peptide sequence, which defines a new K-superfamily. The disulfide connectivity of im23a has been mapped by chemical mapping of partially reduced intermediates and by NMR structure calculations, both of which establish a I-II, III-IV, V-VI pattern of disulfide bridges. This pattern was also confirmed by synthesis of im23a with orthogonal protection of individual cysteine residues. The solution structure of im23a reveals that im23a adopts a novel helical hairpin fold. A cluster of acidic residues on the surface of the molecule is able to bind calcium. The biological activity of the native and recombinant peptides was tested by injection into mice intracranially and intravenously to assess the effects on the central and peripheral nervous systems, respectively. Intracranial injection of im23a or im23b into mice induced excitatory symptoms; however, the biological target of these new toxins has yet to be identified.	[Ye, Mingyu; Xu, Shaoqiong; Zhou, Mi; Shao, Xiaoxia; Chi, Chengwu; Wang, Chunguang] Tongji Univ, Inst Prot Res, Shanghai 20092, Peoples R China; [Khoo, Keith K.; Galea, Charles A.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Khoo, Keith K.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Khoo, Keith K.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Boonyalai, Nonlawat] Kasetsart Univ, Dept Biochem, Fac Sci, Bangkok 10900, Thailand; [Perugini, Matthew A.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Chi, Chengwu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Tongji University; Monash University; Walter & Eliza Hall Institute; University of Melbourne; Kasetsart University; La Trobe University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, CG (corresponding author), Tongji Univ, Inst Prot Res, 1239 Siping Rd, Shanghai 20092, Peoples R China.	chunguangwang@tongji.edu.cn; ray.norton@monash.edu	Ye, Mingyu/R-6778-2017; Khoo, Keith/N-5468-2019; Galea, Charles/C-5074-2013; Boonyalai, Nonlawat/O-6446-2018; Galea, Charles/O-8800-2014	Ye, Mingyu/0000-0001-8560-4345; Khoo, Keith/0000-0002-3334-6564; Galea, Charles/0000-0003-0485-7709; Boonyalai, Nonlawat/0000-0002-9058-0840; Galea, Charles/0000-0003-2730-1105; Norton, Raymond/0000-0001-8893-0584; Perugini, Matthew/0000-0001-8052-5584	Chinese Ministry of Science and Technology [2010CB529802]; Chinese Ministry of Education [NCET-10-0604]; Australian National Health and Medical Research Council	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Chinese Ministry of Science and Technology Grant 2010CB529802 and by Chinese Ministry of Education Grant NCET-10-0604.; Supported by the Australian National Health and Medical Research Council.	Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Buczek O, 2007, BIOCHEMISTRY-US, V46, P9929, DOI 10.1021/bi700797f; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Livett BG, 2004, CURR MED CHEM, V11, P1715, DOI 10.2174/0929867043364928; McIntosh J M, 1999, Methods Enzymol, V294, P605; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Norton RS, 2010, MOLECULES, V15, P2825, DOI 10.3390/molecules15042825; Pallaghy PK, 1997, FEBS LETT, V419, P191, DOI 10.1016/S0014-5793(97)01452-X; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Zhou ZR, 2008, PROTEIN SCI, V17, P1805, DOI 10.1110/ps.036384.108	26	28	35	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14973	14983		10.1074/jbc.M111.334615	http://dx.doi.org/10.1074/jbc.M111.334615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399292	Green Published, hybrid			2022-12-25	WOS:000304003200059
J	Yamaguchi, F; Umeda, Y; Shimamoto, S; Tsuchiya, M; Tokumitsu, H; Tokuda, M; Kobayashi, R				Yamaguchi, Fuminori; Umeda, Yoshinori; Shimamoto, Seiko; Tsuchiya, Mitsumasa; Tokumitsu, Hiroshi; Tokuda, Masaaki; Kobayashi, Ryoji			S100 Proteins Modulate Protein Phosphatase 5 Function A LINK BETWEEN CA(2+) SIGNAL TRANSDUCTION AND PROTEIN DEPHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; ABNORMALLY PHOSPHORYLATED-TAU; ALZHEIMERS-DISEASE; SERINE/THREONINE PHOSPHATASE; FEEDBACK-REGULATION; TPR DOMAIN; BINDING; FAMILY; BRAIN; PROTEIN-PHOSPHATASE-5	PP5 is a unique member of serine/threonine phosphatases comprising a regulatory tetratricopeptide repeat (TPR) domain and functions in signaling pathways that control many cellular responses. We reported previously that Ca2+/S100 proteins directly associate with several TPR-containing proteins and lead to dissociate the interactions of TPR proteins with their client proteins. Here, we identified protein phosphatase 5 (PP5) as a novel target of S100 proteins. In vitro binding studies demonstrated that S100A1, S100A2, S100A6, and S100B proteins specifically interact with PP5-TPR and inhibited the PP5-Hsp90 interaction. In addition, the S100 proteins activate PP5 by using a synthetic phosphopeptide and a physiological protein substrate, Tau. Overexpression of S100A1 in COS-7 cells induced dephosphorylation of Tau. However, S100A1 and permanently active S100P inhibited the apoptosis signal-regulating kinase 1 (ASK1) and PP5 interaction, resulting the inhibition of dephosphorylation of phospho-ASK1 by PP5. The association of the S100 proteins with PP5 provides a Ca2+-dependent regulatory mechanism for the phosphorylation status of intracellular proteins through the regulation of PP5 enzymatic activity or PP5-client protein interaction.	[Shimamoto, Seiko; Tsuchiya, Mitsumasa; Tokumitsu, Hiroshi; Kobayashi, Ryoji] Kagawa Univ, Fac Med, Dept Signal Transduct Sci, Miki, Kagawa 7610793, Japan; [Yamaguchi, Fuminori; Tokuda, Masaaki] Kagawa Univ, Fac Med, Dept Cell Physiol, Miki, Kagawa 7610793, Japan; [Umeda, Yoshinori] Kagawa Univ, Fac Agr, Dept Life Sci, Miki, Kagawa 7610795, Japan	Kagawa University; Kagawa University; Kagawa University	Kobayashi, R (corresponding author), Kagawa Univ, Fac Med, Dept Signal Transduct Sci, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	ryoji@med.kagawa-u.ac.jp	Tokumitsu, Hiroshi/M-3978-2015	Tokumitsu, Hiroshi/0000-0002-2193-6794	Kagawa University	Kagawa University	This research is supported by the Kagawa University Characteristic Prior Research Fund 2010.	Austermann J, 2009, BBA-MOL CELL RES, V1793, P1078, DOI 10.1016/j.bbamcr.2008.11.012; BECKER W, 1994, J BIOL CHEM, V269, P22586; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; Fujisawa T, 2007, MOL BIOTECHNOL, V37, P13, DOI 10.1007/s12033-007-0053-x; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Gong CX, 2004, J NEUROCHEM, V88, P298, DOI 10.1046/j.1471-4159.2003.02147.x; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; GONG CX, 1994, FEBS LETT, V341, P94, DOI 10.1016/0014-5793(94)80247-5; GONG CX, 1994, J NEUROCHEM, V62, P803; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Ramsey AJ, 2000, J BIOL CHEM, V275, P17857, DOI 10.1074/jbc.M001625200; Ramsey AJ, 2002, BIOCHEMISTRY-US, V41, P5625, DOI 10.1021/bi016090h; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Sanchez-Ortiz E, 2009, J NEUROCHEM, V111, P391, DOI 10.1111/j.1471-4159.2009.06337.x; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shimamoto S, 2008, J BIOL CHEM, V283, P28246, DOI 10.1074/jbc.M801473200; Shimamoto S, 2010, FEBS LETT, V584, P1119, DOI 10.1016/j.febslet.2010.02.055; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; YAMAMOTO H, 1988, J NEUROCHEM, V50, P1614, DOI 10.1111/j.1471-4159.1988.tb03051.x; Yamashita K, 1999, PROTEIN EXPRES PURIF, V16, P47, DOI 10.1006/prep.1998.1026; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Zeke T, 2005, BIOCHEM J, V385, P45, DOI 10.1042/BJ20040690	38	47	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13787	13798		10.1074/jbc.M111.329771	http://dx.doi.org/10.1074/jbc.M111.329771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22399290	Green Published, hybrid			2022-12-25	WOS:000303996300034
J	Frey, E; Tischlinger, H				Frey, Eberhard; Tischlinger, Helmut			The Late Jurassic Pterosaur Rhamphorhynchus, a Frequent Victim of the Ganoid Fish Aspidorhynchus?	PLOS ONE			English	Article							FRANCONIAN ALB	Associations of large vertebrates are exceedingly rare in the Late Jurassic Solnhofen Limestone of Bavaria, Southern Germany. However, there are five specimens of medium-sized pterosaur Rhamphorhynchus that lie adjacent to the rostrum of a large individual of the ganoid fish Aspidorhynchus. In one of these, a small leptolepidid fish is still sticking in the esophagus of the pterosaur and its stomach is full of fish debris. This suggests that the Rhamphorhynchus was seized during or immediately after a successful hunt. According to the fossil record, Rhamphorhynchus frequently were accidentally seized by large Aspidorhnychus. In some cases the fibrous tissue of the wing membrane got entangled with the rostral teeth such that the fish was unable to get rid of the pterosaur. Such encounters ended fatally for both. Intestinal contents of Aspidorhynchus-type fishes are known and mostly comprise fishes and in one single case a Homoeosaurus. Obviously Rhamphorhynchus did not belong to the prey spectrum of Aspidorhynchus.	[Frey, Eberhard] Staatliches Museum Nat Kunde Karlsruhe, Karlsruhe, Germany		Frey, E (corresponding author), Staatliches Museum Nat Kunde Karlsruhe, Karlsruhe, Germany.	dinofrey@aol.com						Arratia G, 2010, FOSS REC, V13, P317, DOI 10.1002/mmng.201000005; Barthel K.W., 1990, SOLNHOFEN STUDY MESO; Brown Barnum, 1943, NAT HIST [NEW YORK], V52, P104; Buffetaut E, 2004, NATURE, V430, P33, DOI 10.1038/430033a; CURRIE PJ, 1995, CAN J EARTH SCI, V32, P922, DOI 10.1139/e95-077; Dalla Vecchia FM., 1989, GORTANIA, V10, P121; DILL LM, 1977, BEHAV ECOL SOCIOBIOL, V2, P169, DOI 10.1007/BF00361900; DODRILL JW, 1978, AUK, V95, P585; Eastman C. R., 1911, Annals of the Carnegie Museum, V8; Eastman CR, 1914, MEM CARNEGIE MUS, V6, P349; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; Grande L, 1980, PALEONTOLOGY GREEN R; Gross Liza, 2007, PLoS Biol, V5, pe217, DOI 10.1371/journal.pbio.0050217; Gunther A., 1985, Praeparator, V31, P163; Hone DWE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009223; Humphries S, 2007, PLOS BIOL, V5, P1647, DOI 10.1371/journal.pbio.0050204; Johnson RL, 2006, S AFRICAN J WILDLIFE, V36, P1; Kellner AWA, 2010, ALCHERINGA, V34, P219, DOI 10.1080/03115511003656552; Kellner AWA, 2010, P ROY SOC B-BIOL SCI, V277, P321, DOI 10.1098/rspb.2009.0846; Kellner AWA, 2002, SCIENCE, V297, P389, DOI 10.1126/science.1073186; Kellner AWA, 2006, PTEROSAUROS SENHORES; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Keupp H, 2007, NEUES JAHRB GEOL P-A, V245, P3, DOI 10.1127/0077-7749/2007/0245-0003; Kuhn O, 1977, NEUE BREHM BUCHEREI, V318, P140; Lowry D, 2005, ENVIRON BIOL FISH, V73, P453, DOI 10.1007/s10641-005-3214-4; Lu Junchang, 2006, Journal of the Paleontological Society of Korea, V22, P239; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Martill D.M., 1993, FOSSILS SANTANA CRAT, V5; Pinheiro FL, 2011, ACTA PALAEONTOL POL, V56, P567, DOI 10.4202/app.2010.0057; Schaller D, 1983, THESIS LUDWIG MAXIMI; Schwark L, 1998, ORG GEOCHEM, V29, P1921, DOI 10.1016/S0146-6380(98)00192-2; Schweigert G, 2007, NEUES JAHRB GEOL P-A, V245, P117, DOI 10.1127/0077-7749/2007/0245-0117; Tischlinger H., 2002, ARCHAEOPTERYX, V20, P1; Unwin D., 2007, CRATO FOSSIL BEDS BR, P475, DOI 10.1017/CBO9780511535512.018; Viohl G., 1987, Archaeopteryx, V5, P33; Viohl Gunter, 1998, Archaeopteryx, V16, P37; Wang XL, 2010, AN ACAD BRAS CIENC, V82, P1045, DOI 10.1590/S0001-37652010000400024; Wang XL, 2009, AN ACAD BRAS CIENC, V81, P793, DOI 10.1590/S0001-37652009000400016; Wellnhofer P., 1975, PALAONTOGRAPHICA A, V148, P1; Wellnhofer P., 1970, ABH BAYER AKAD WISS, V141, P1; Wellnhofer P., 1991, ILLUSTRATED ENCY PTE, P192; WILD R, 1978, Bollettino della Societa Paleontologica Italiana, V17, P176	42	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e31945	10.1371/journal.pone.0031945	http://dx.doi.org/10.1371/journal.pone.0031945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412850	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800009
J	Deliberato, RO; Marra, AR; Correa, TD; Martino, MD; Correa, L; dos Santos, OFP; Edmond, MB				Deliberato, Rodrigo Octavio; Marra, Alexandre R.; Correa, Thiago Domingos; Martino, Marines Dalla Vale; Correa, Luci; Pavao dos Santos, Oscar Fernando; Edmond, Michael B.			Catheter Related Bloodstream Infection (CR-BSI) in ICU Patients: Making the Decision to Remove or Not to Remove the Central Venous Catheter	PLOS ONE			English	Article							DIAGNOSIS; HOSPITALS; SEVERITY; TIME	Background: Approximately 150 million central venous catheters (CVC) are used each year in the United States. Catheter-related bloodstream infections (CR-BSI) are one of the most important complications of the central venous catheters (CVCs). Our objective was to compare the in-hospital mortality when the catheter is removed or not removed in patients with CR-BSI. Methods: We reviewed all episodes of CR-BSI that occurred in our intensive care unit (ICU) from January 2000 to December 2008. The standard method was defined as a patient with a CVC and at least one positive blood culture obtained from a peripheral vein and a positive semi quantitative (>15 CFU) culture of a catheter segment from where the same organism was isolated. The conservative method was defined as a patient with a CVC and at least one positive blood culture obtained from a peripheral vein and one of the following: (1) differential time period of CVC culture versus peripheral culture positivity of more than 2 hours, or (2) simultaneous quantitative blood culture with >= 5:1 ratio (CVC versus peripheral). Results: 53 CR-BSI (37 diagnosed by the standard method and 16 by the conservative method) were diagnosed during the study period. There was a no statistically significant difference in the in-hospital mortality for the standard versus the conservative method (57% vs. 75%, p = 0.208) in ICU patients. Conclusion: In our study there was a no statistically significant difference between the standard and conservative methods in-hospital mortality.	[Deliberato, Rodrigo Octavio; Marra, Alexandre R.; Correa, Thiago Domingos; Pavao dos Santos, Oscar Fernando] Hosp Israelita Albert Einstein, Crit Care Unit, Sao Paulo, Brazil; [Martino, Marines Dalla Vale] Hosp Israelita Albert Einstein, Microbiol Lab Dept, Sao Paulo, Brazil; [Correa, Luci] Hosp Israelita Albert Einstein, Infect Control Unit, Sao Paulo, Brazil; [Edmond, Michael B.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA USA	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Virginia Commonwealth University	Deliberato, RO (corresponding author), Hosp Israelita Albert Einstein, Crit Care Unit, Sao Paulo, Brazil.	rodrigo.deliberato@einstein.br	Santos, Oscar Fernando Pavão dos/B-8761-2017	Santos, Oscar Fernando Pavão dos/0000-0002-8731-1201; Edmond, Michael/0000-0002-4144-8974; Domingos Correa, Thiago/0000-0001-9546-3910				[Anonymous], CLABSI PROT FORMS; [Anonymous], PROT 5 MILL LIV HARM; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Blot F, 1999, LANCET, V354, P1071, DOI 10.1016/S0140-6736(98)11134-0; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bouza E, 2004, CLIN MICROBIOL INFEC, V10, P838, DOI 10.1111/j.1469-0691.2004.00936.x; Bouza E, 2002, CLIN MICROBIOL INFEC, V8, P265, DOI 10.1046/j.1469-0691.2002.00385.x; Bouza E, 2007, CLIN INFECT DIS, V44, P820, DOI 10.1086/511865; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; FAGON JY, 1993, INTENS CARE MED, V19, P137, DOI 10.1007/BF01720528; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Marra AR, 2011, J CLIN MICROBIOL, V49, P1866, DOI 10.1128/JCM.00376-11; Martin G, 2009, CRIT CARE, V13, DOI 10.1186/cc7936; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Shiramizo SCPL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026790; REX JH, 1995, CLIN INFECT DIS, V21, P994, DOI 10.1093/clinids/21.4.994; Safdar N, 2005, ANN INTERN MED, V142, P451, DOI 10.7326/0003-4819-142-6-200503150-00011; Thom KA, 2008, INFECT CONT HOSP EP, V29, P1048, DOI 10.1086/591453; Vandijck DM, 2006, J INFECTION, V53, P289, DOI 10.1016/j.jinf.2005.11.018; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	25	14	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32687	10.1371/journal.pone.0032687	http://dx.doi.org/10.1371/journal.pone.0032687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403696	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700093
J	Gordon, MM; Moser, AM; Rubin, E				Gordon, Michal Markovich; Moser, Asher M.; Rubin, Eitan			Unsupervised Analysis of Classical Biomedical Markers: Robustness and Medical Relevance of Patient Clustering Using Bioinformatics Tools	PLOS ONE			English	Article							PERSONALIZED MEDICINE; GENE-EXPRESSION; HEALTH-CARE; DISEASE; CLASSIFICATION; ANEMIA	Motivation: It has been proposed that clustering clinical markers, such as blood test results, can be used to stratify patients. However, the robustness of clusters formed with this approach to data pre-processing and clustering algorithm choices has not been evaluated, nor has clustering reproducibility. Here, we made use of the NHANES survey to compare clusters generated with various combinations of pre-processing and clustering algorithms, and tested their reproducibility in two separate samples. Method: Values of 44 biomarkers and 19 health/life style traits were extracted from the National Health and Nutrition Examination Survey (NHANES). The 1999-2002 survey was used for training, while data from the 2003-2006 survey was tested as a validation set. Twelve combinations of pre-processing and clustering algorithms were applied to the training set. The quality of the resulting clusters was evaluated both by considering their properties and by comparative enrichment analysis. Cluster assignments were projected to the validation set (using an artificial neural network) and enrichment in health/life style traits in the resulting clusters was compared to the clusters generated from the original training set. Results: The clusters obtained with different pre-processing and clustering combinations differed both in terms of cluster quality measures and in terms of reproducibility of enrichment with health/life style properties. Z-score normalization, for example, dramatically improved cluster quality and enrichments, as compared to unprocessed data, regardless of the clustering algorithm used. Clustering diabetes patients revealed a group of patients enriched with retinopathies. This could indicate that routine laboratory tests can be used to detect patients suffering from complications of diabetes, although other explanations for this observation should also be considered. Conclusions: Clustering according to classical clinical biomarkers is a robust process, which may help in patient stratification. However, optimization of the pre-processing and clustering process may be still required.	[Gordon, Michal Markovich; Rubin, Eitan] Ben Gurion Univ Negev, Sharaga Segal Dept Microbiol & Immunol, Beer Sheva, Israel; [Gordon, Michal Markovich; Rubin, Eitan] Natl Inst Biotechnol Negev, Beer Sheva, Israel; [Moser, Asher M.] Soroka Med Ctr, Dept Pediat Hematol & Oncol, Beer Sheva, Israel; [Moser, Asher M.] Ben Gurion Univ Negev, Dept Pediat Hematooncol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Gordon, MM (corresponding author), Ben Gurion Univ Negev, Sharaga Segal Dept Microbiol & Immunol, Beer Sheva, Israel.	erubin@bgu.ac.il	MOSER, ASHER M/F-1873-2012; Rubin, Eitan/E-5256-2011	Rubin, Eitan/0000-0002-7807-4005	National Institute for Biotechnology in the Negev; Israeli Council for Higher Education	National Institute for Biotechnology in the Negev; Israeli Council for Higher Education	This work was supported by the National Institute for Biotechnology in the Negev and by the Israeli Council for Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen David P, 2007, AMIA Annu Symp Proc, P115; Claycamp HG, 2001, HEALTH PHYS, V81, P522, DOI 10.1097/00004032-200111000-00006; Dietel M, 2006, VIRCHOWS ARCH, V448, P744, DOI 10.1007/s00428-006-0189-2; Fisher R. A., 1915, BIOMETRIKA, P507, DOI DOI 10.2307/2331838; Fliss A, 2008, AMIA SUMM TRANSL BIO; Geifman N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-229; GROENEVELD RA, 1984, J R STAT SOC D-STAT, V33, P391; Hartigan J., 1975, CLUSTERING ALGORITHM; Johnson ST, 2007, TRANSFUSION, V47, P697, DOI 10.1111/j.1537-2995.2007.01173.x; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; LEWIS B, 1972, EUR J CLIN INVEST, V2, P445, DOI 10.1111/j.1365-2362.1972.tb00676.x; Marso SP, 2006, J AM COLL CARDIOL, V47, P921, DOI 10.1016/j.jacc.2005.09.065; Rubin E, 2011, ARCH GYNECOL OBSTET, V283, P173, DOI 10.1007/s00404-009-1306-7; Shahar Y, 1996, ARTIF INTELL MED, V8, P267, DOI 10.1016/0933-3657(95)00036-4; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Simon SR, 2007, ARCH INTERN MED, V167, P507, DOI 10.1001/archinte.167.5.507; Smith J, 2005, STUD HEALTH TECHNOL, V116, P27; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693; Wierzbicki AS, 2003, PHARMACOL THERAPEUT, V99, P95, DOI 10.1016/S0163-7258(03)00055-X; Wilson JF, 2007, ANN INTERN MED, V146, P473, DOI 10.7326/0003-4819-146-6-200703200-00027	22	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e29578	10.1371/journal.pone.0029578	http://dx.doi.org/10.1371/journal.pone.0029578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403607	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700004
J	Kolbe, DL; DeLoia, JA; Porter-Gill, P; Strange, M; Petrykowska, HM; Guirguis, A; Krivak, TC; Brody, LC; Elnitski, L				Kolbe, Diana L.; DeLoia, Julie A.; Porter-Gill, Patricia; Strange, Mary; Petrykowska, Hanna M.; Guirguis, Alfred; Krivak, Thomas C.; Brody, Lawrence C.; Elnitski, Laura			Differential Analysis of Ovarian and Endometrial Cancers Identifies a Methylator Phenotype	PLOS ONE			English	Article							GENE-EXPRESSION; SEROUS CARCINOMA; LOW-GRADE; MODEL; TUMORS; CARCINOGENESIS; MUTATIONS; PROFILES; PATTERNS; TP53	Despite improved outcomes in the past 30 years, less than half of all women diagnosed with epithelial ovarian cancer live five years beyond their diagnosis. Although typically treated as a single disease, epithelial ovarian cancer includes several distinct histological subtypes, such as papillary serous and endometrioid carcinomas. To address whether the morphological differences seen in these carcinomas represent distinct characteristics at the molecular level we analyzed DNA methylation patterns in 11 papillary serous tumors, 9 endometrioid ovarian tumors, 4 normal fallopian tube samples and 6 normal endometrial tissues, plus 8 normal fallopian tube and 4 serous samples from TCGA. For comparison within the endometrioid subtype we added 6 primary uterine endometrioid tumors and 5 endometrioid metastases from uterus to ovary. Data was obtained from 27,578 CpG dinucleotides occurring in or near promoter regions of 14,495 genes. We identified 36 locations with significant increases or decreases in methylation in comparisons of serous tumors and normal fallopian tube samples. Moreover, unsupervised clustering techniques applied to all samples showed three major profiles comprising mostly normal samples, serous tumors, and endometrioid tumors including ovarian, uterine and metastatic origins. The clustering analysis identified 60 differentially methylated sites between the serous group and the normal group. An unrelated set of 25 serous tumors validated the reproducibility of the methylation patterns. In contrast, >1,000 genes were differentially methylated between endometrioid tumors and normal samples. This finding is consistent with a generalized regulatory disruption caused by a methylator phenotype. Through DNA methylation analyses we have identified genes with known roles in ovarian carcinoma etiology, whereas pathway analyses provided biological insight to the role of novel genes. Our finding of differences between serous and endometrioid ovarian tumors indicates that intervention strategies could be developed to specifically address subtypes of epithelial ovarian cancer.	[Kolbe, Diana L.; Petrykowska, Hanna M.; Elnitski, Laura] NHGRI, DIR GTB Genom Funct Anal Sect, NIH, Bethesda, MD 20892 USA; [Porter-Gill, Patricia; Brody, Lawrence C.] NHGRI, DIR GTB Mol Pathogenesis Sect, NIH, Bethesda, MD 20892 USA; [DeLoia, Julie A.; Strange, Mary; Krivak, Thomas C.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [DeLoia, Julie A.] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA; [Guirguis, Alfred] Rush Univ, Dept Obstet & Gynecol, Chicago, IL 60612 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; Rush University	Kolbe, DL (corresponding author), NHGRI, DIR GTB Genom Funct Anal Sect, NIH, Bethesda, MD 20892 USA.	elnitski@mail.nih.gov	Elnitski, Laura/AAD-3595-2021	Strange, Mary/0000-0003-3269-4185; Elnitski, Laura/0000-0003-1065-019X	National Human Genome Research Institute, National Institutes of Health; DoD GOC [04-124]; Magee Womens Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000120, ZIAHG200323] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); DoD GOC; Magee Womens Research Institute(University of Pittsburgh); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding is provided by The Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (LE and LB), DoD GOC# 04-124 and Magee Womens Research Institute/Scaife Grant (TCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603; Balch C, 2009, ENDOCRINOLOGY, V150, P4003, DOI 10.1210/en.2009-0404; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cho KR, 2009, ARCH PATHOL LAB MED, V133, P1775, DOI 10.1043/1543-2165-133.11.1775; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Donninger H, 2004, ONCOGENE, V23, P8065, DOI 10.1038/sj.onc.1207959; Fehrmann RSN, 2007, ONCOLOGIST, V12, P960, DOI 10.1634/theoncologist.12-8-960; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Folkins AK, 2009, GYNECOL ONCOL, V113, P391, DOI 10.1016/j.ygyno.2009.01.013; Guirguis A, 2008, GYNECOL ONCOL, V108, P370, DOI 10.1016/j.ygyno.2007.10.008; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Houshdaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009359; Huang J, 2011, GENE CHROMOSOME CANC, V50, P606, DOI 10.1002/gcc.20883; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Kawakami T, 2004, ONCOGENE, V23, P6163, DOI 10.1038/sj.onc.1207808; Kolasa IK, 2006, GYNECOL ONCOL, V103, P692, DOI 10.1016/j.ygyno.2006.05.007; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Mandai M, 2009, INT J CLIN ONCOL, V14, P383, DOI 10.1007/s10147-009-0935-y; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; McCluggage WG, 2008, J CLIN PATHOL, V61, P152, DOI 10.1136/jcp.2007.049478; Ni X, 2005, TRANSCRIPTIONAL PROT; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Plumb JA, 2003, MOL CANCER THER, V2, P721; Rask K, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-62; Ricci R, 2003, DIAGN MOL PATHOL, V12, P71, DOI 10.1097/00019606-200306000-00002; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Senturk E, 2010, GYNECOL ONCOL, V119, P376, DOI 10.1016/j.ygyno.2010.07.026; Shih IM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.08.003; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Singer G, 2002, AM J PATHOL, V160, P1223, DOI 10.1016/S0002-9440(10)62549-7; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; van Niekerk CC, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/465162; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Vigano P, 2007, FERTIL STERIL, V88, P588, DOI 10.1016/j.fertnstert.2006.11.180; Whitcomb BP, 2003, CLIN CANCER RES, V9, P2277; Wong Alice S T, 2003, Reprod Biol Endocrinol, V1, P70, DOI 10.1186/1477-7827-1-70; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016	40	31	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32941	10.1371/journal.pone.0032941	http://dx.doi.org/10.1371/journal.pone.0032941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403726	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000303017700123
J	Morin, E; Laroulandie, V				Morin, Eugene; Laroulandie, Veronique			Presumed Symbolic Use of Diurnal Raptors by Neanderthals	PLOS ONE			English	Article							HOWIESONS POORT; MIDDLE; CAVE	In Africa and western Eurasia, occurrences of burials and utilized ocher fragments during the late Middle and early Late Pleistocene are often considered evidence for the emergence of symbolically-mediated behavior. Perhaps less controversial for the study of human cognitive evolution are finds of marine shell beads and complex designs on organic and mineral artifacts in early modern human (EMH) assemblages conservatively dated to approximate to 100-60 kilo-years (ka) ago. Here we show that, in France, Neanderthals used skeletal parts of large diurnal raptors presumably for symbolic purposes at Combe-Grenal in a layer dated to marine isotope stage (MIS) 5b (approximate to 90 ka) and at Les Fieux in stratigraphic units dated to the early/middle phase of MIS 3 (60-40 ka). The presence of similar objects in other Middle Paleolithic contexts in France and Italy suggest that raptors were used as means of symbolic expression by Neanderthals in these regions.	[Morin, Eugene] Trent Univ, Dept Anthropol, Peterborough, ON K9J 7B8, Canada; [Laroulandie, Veronique] Univ Bordeaux, UMR 5199, CNRS, PACEA, Talence, France	Trent University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux	Morin, E (corresponding author), Trent Univ, Dept Anthropol, Peterborough, ON K9J 7B8, Canada.	eugenemorin@trentu.ca	Laroulandie, Véronique/AAD-6860-2019	Laroulandie, Véronique/0000-0002-9745-6578	Social Sciences and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was funded by the Social Sciences and Humanities Research Council of Canada (www.sshrc-crsh.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; Blasco R, 2012, QUAT INT IN PRESS; Bordes F, 1972, TALE 2 CAVES; Delpech F., 1996, PAL O, V8, P31, DOI [10.3406/pal.1996.905, DOI 10.3406/PAL.1996.905]; Dibble Harold L., 2009, Paleoanthropology, V2009, P182; Discamps E, 2011, QUATERNARY SCI REV, V30, P2755, DOI 10.1016/j.quascirev.2011.06.009; Faivre JP, 2006, BULL SOC PREHIST FR, V103, P17, DOI 10.3406/bspf.2006.13393; Gaudzinski-Windheuser S, 2009, VERTEBR PALEOBIOL PA, P99, DOI 10.1007/978-1-4020-9699-0_7; Gerbe M, 2012, ACT 27 C PR IN PRESS; Goni MFS, 2008, QUATERNARY SCI REV, V27, P1136, DOI 10.1016/j.quascirev.2008.03.003; Guadelli JL, 1987, THESIS U BORDEAUX 1; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2011, CURR ANTHROPOL, V52, P361, DOI 10.1086/660022; Jeannet M, 2010, ECOLOGIE QUANTIFIEE; JUANES F, 1986, AM NAT, V128, P921, DOI 10.1086/284613; Kuhn S.L., 2004, J ISRAEL PREHISTORIC, V34, P5; Laquay G, 1981, THESIS U BORDEAUX 1, P1; Laroulandie V, 2004, PETITS ANIMAUX SOC H, P163; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Mellars P, 2010, P NATL ACAD SCI USA, V107, P20147, DOI 10.1073/pnas.1014588107; Morin E., 2012, REASSESSING IN PRESS; MOURERCHAUVIRE C, 1975, THESIS U CLAUDE BERN; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Roger T., 2004, THESIS MUSEUM NATL H; Salgueiro E, 2010, QUATERNARY SCI REV, V29, P680, DOI 10.1016/j.quascirev.2009.11.013; Soressi M, 2008, MEM SOC PREHISTORIQU, V47, P95; Soressi M., 2007, NEANDERTALIENS BIOL, V23, P297, DOI DOI 10.1183/09031936.00022909; Stiner MC, 2000, CURR ANTHROPOL, V41, P39, DOI 10.1086/300102; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Urich K., 1994, COMP ANIMAL BIOCH; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	32	111	111	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32856	10.1371/journal.pone.0032856	http://dx.doi.org/10.1371/journal.pone.0032856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403717	gold, Green Published			2022-12-25	WOS:000303017700114
J	Nurzia, E; Narzi, D; Cauli, A; Mathieu, A; Tedeschi, V; Caristi, S; Sorrentino, R; Bockmann, RA; Fiorillo, MT				Nurzia, Elisa; Narzi, Daniele; Cauli, Alberto; Mathieu, Alessandro; Tedeschi, Valentina; Caristi, Silvana; Sorrentino, Rosa; Boeckmann, Rainer A.; Fiorillo, Maria Teresa			Interaction Pattern of Arg 62 in the A-Pocket of Differentially Disease-Associated HLA-B27 Subtypes Suggests Distinct TCR Binding Modes	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; MOLECULAR-DYNAMICS; ANKYLOSING-SPONDYLITIS; CONFORMATIONAL-CHANGES; PEPTIDES; COMPLEX; RECOGNITION; ANTIGEN; PROTEINS; HLA-B-ASTERISK-2705	The single amino acid replacement Asp116His distinguishes the two subtypes HLA-B*2705 and HLA-B*2709 which are, respectively, associated and non-associated with Ankylosing Spondylitis, an autoimmune chronic inflammatory disease. The reason for this differential association is so far poorly understood and might be related to subtype-specific HLA: peptide conformations as well as to subtype/peptide-dependent dynamical properties on the nanoscale. Here, we combine functional experiments with extensive molecular dynamics simulations to investigate the molecular dynamics and function of the conserved Arg62 of the alpha 1-helix for both B27 subtypes in complex with the self-peptides pVIPR (RRKWRRWHL) and TIS (RRLPIFSRL), and the viral peptides pLMP2 (RRRWRRLTV) and NPflu (SRYWAIRTR). Simulations of HLA: peptide systems suggest that peptide-stabilizing interactions of the Arg62 residue observed in crystal structures are metastable for both B27 subtypes under physiological conditions, rendering this arginine solvent-exposed and, probably, a key residue for TCR interaction more than peptide-binding. This view is supported by functional experiments with conservative (R62K) and non-conservative (R62A) B*2705 and B*2709 mutants that showed an overall reduction in their capability to present peptides to CD8+ T cells. Moreover, major subtype-dependent differences in the peptide recognition suggest distinct TCR binding modes for the B*2705 versus the B*2709 subtype.	[Nurzia, Elisa; Sorrentino, Rosa] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy; [Narzi, Daniele; Boeckmann, Rainer A.] Univ Erlangen Nurnberg, Dept Biol, Erlangen, Germany; [Cauli, Alberto; Mathieu, Alessandro] Univ Cagliari, Dept Med Sci, Chair Rheumatol 2, Cagliari, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; University of Erlangen Nuremberg; University of Cagliari	Nurzia, E (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy.	rainer.boeckmann@biologie.uni-erlangen.de; mariateresa.fiorillo@uniroma1.it	Böckmann, Rainer A/G-7863-2015; Sorrentino, Rosa/G-5472-2012	Böckmann, Rainer A/0000-0002-9325-5162; Sorrentino, Rosa/0000-0002-9632-2383; caristi, silvana/0000-0002-0016-7498; FIORILLO, Maria Teresa/0000-0002-6859-5851; Narzi, Daniele/0000-0003-2731-6286	VolkswagenStiftung [I/82735, I/82733]; Fondazione Pasteur-Cenci Bolognetti	VolkswagenStiftung(Volkswagen); Fondazione Pasteur-Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by VolkswagenStiftung (Grant I/82735 to MTF and Grant I/82733 to DN and RAB) http://www.volkswagen-stiftung.de/ and by Fondazione Pasteur-Cenci Bolognetti to RS. http://www.istitutopasteur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BOWNESS P, 1994, EUR J IMMUNOL, V24, P2357, DOI 10.1002/eji.1830241015; BOWNESS P, 1993, EUR J IMMUNOL, V23, P1417, DOI 10.1002/eji.1830230702; BREWERTON DA, 1973, LANCET, V1, P904; BROOKS JM, 1993, J EXP MED, V178, P879, DOI 10.1084/jem.178.3.879; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; DELPORTO P, 1994, J IMMUNOL, V153, P3093; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Fiorillo MT, 2009, ADV EXP MED BIOL, V649, P255; Fiorillo MT, 1997, EUR J IMMUNOL, V27, P368, DOI 10.1002/eji.1830270205; Fiorillo MT, 2000, J CLIN INVEST, V106, P47, DOI 10.1172/JCI9295; Fiorillo MT, 1998, EUR J IMMUNOL, V28, P2508, DOI 10.1002/(SICI)1521-4141(199808)28:08<2508::AID-IMMU2508>3.0.CO;2-1; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; Gakamsky DM, 2004, P NATL ACAD SCI USA, V101, P9063, DOI 10.1073/pnas.0402840101; Gomez P, 2009, J IMMUNOL, V182, P446, DOI 10.4049/jimmunol.182.1.446; GonzalezRoces S, 1997, TISSUE ANTIGENS, V49, P116, DOI 10.1111/j.1399-0039.1997.tb02724.x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hillig RC, 2004, J BIOL CHEM, V279, P652, DOI 10.1074/jbc.M307457200; Hulsmeyer M, 2005, J MOL BIOL, V346, P1367, DOI 10.1016/j.jmb.2004.12.047; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Khan MA, 2007, AUTOIMMUN REV, V6, P183, DOI 10.1016/j.autrev.2006.11.003; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Li XAC, 2010, CURR OPIN ORGAN TRAN, V15, P499, DOI 10.1097/MOT.0b013e32833bfb33; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; Narzi D, 2008, J BIOL CHEM, V283, P23093, DOI 10.1074/jbc.M710234200; Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Nurzia E, 2010, CLIN IMMUNOL, V135, P476, DOI 10.1016/j.clim.2010.01.009; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Paladini F, 2005, ARTHRITIS RHEUM-US, V52, P3319, DOI 10.1002/art.21308; Pohlmann T, 2004, J BIOL CHEM, V279, P28197, DOI 10.1074/jbc.C400128200; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Reveille JD, 2009, ADV EXP MED BIOL, V649, P159; ROGNAN D, 1994, BIOCHEMISTRY-US, V33, P11476, DOI 10.1021/bi00204a009; Rognan D, 1997, J COMPUT AID MOL DES, V11, P463, DOI 10.1023/A:1007963901092; ROTZSCHKE O, 1994, IMMUNOGENETICS, V39, P74; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sathiamurthy M, 2003, TISSUE ANTIGENS, V61, P12, DOI 10.1034/j.1399-0039.2003.610102.x; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Sieker F, 2008, MOL IMMUNOL, V45, P3714, DOI 10.1016/j.molimm.2008.06.009; Sieker F, 2007, PROTEIN SCI, V16, P299, DOI 10.1110/ps.062568407; STAM NJ, 1986, J IMMUNOL, V137, P2299; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; van Gunsteren WF, 2002, HELV CHIM ACTA, V85, P3113, DOI 10.1002/1522-2675(200210)85:10<3113::AID-HLCA3113>3.0.CO;2-0; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Webb AI, 2004, J IMMUNOL, V173, P402, DOI 10.4049/jimmunol.173.1.402; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Ziegler A, 2009, ADV EXP MED BIOL, V649, P177	64	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32865	10.1371/journal.pone.0032865	http://dx.doi.org/10.1371/journal.pone.0032865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403718	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700115
J	Papp, AC; Pinsonneault, JK; Wang, DX; Newman, LC; Gong, Y; Johnson, JA; Pepine, CJ; Kumari, M; Hingorani, AD; Talmud, PJ; Shah, S; Humphries, SE; Sadee, W				Papp, Audrey C.; Pinsonneault, Julia K.; Wang, Danxin; Newman, Leslie C.; Gong, Yan; Johnson, Julie A.; Pepine, Carl J.; Kumari, Meena; Hingorani, Aroon D.; Talmud, Philippa J.; Shah, Sonia; Humphries, Steve E.; Sadee, Wolfgang			Cholesteryl Ester Transfer Protein (CETP) Polymorphisms Affect mRNA Splicing, HDL Levels, and Sex-Dependent Cardiovascular Risk	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TAQIB POLYMORPHISM; GENE-EXPRESSION; ARTERY-DISEASE; ASSOCIATION; PRAVASTATIN; PROGRESSION; HAPLOTYPES; PHENOTYPES; VARIANTS	Polymorphisms in and around the Cholesteryl Ester Transfer Protein (CETP) gene have been associated with HDL levels, risk for coronary artery disease (CAD), and response to therapy. The mechanism of action of these polymorphisms has yet to be defined. We used mRNA allelic expression and splice isoform measurements in human liver tissues to identify the genetic variants affecting CETP levels. Allelic CETP mRNA expression ratios in 56 human livers were strongly associated with several variants 2.5-7 kb upstream of the transcription start site (e.g., rs247616 p = 6.4x10(-5), allele frequency 33%). In addition, a common alternatively spliced CETP isoform lacking exon 9 (Delta 9), has been shown to prevent CETP secretion in a dominant-negative manner. The Delta 9 expression ranged from 10 to 48% of total CETP mRNA in 94 livers. Increased formation of this isoform was exclusively associated with an exon 9 polymorphism rs5883-C>T (p = 6.8x10(-10)) and intron 8 polymorphism rs9930761-T>C (5.6x10(-8)) (in high linkage disequilibrium with allele frequencies 6-7%). rs9930761 changes a key splicing branch point nucleotide in intron 8, while rs5883 alters an exonic splicing enhancer sequence in exon 9. The effect of these polymorphisms was evaluated in two clinical studies. In the Whitehall II study of 4745 subjects, both rs247616 and rs5883T/rs9930761C were independently associated with increased HDL-C levels in males with similar effect size (rs247616 p = 9.6x10(-28) and rs5883 p = 8.6x10(-10), adjusted for rs247616). In an independent multiethnic US cohort of hypertensive subjects with CAD (INVEST-GENE), rs5883T/rs9930761C alone were significantly associated with increased incidence of MI, stroke, and all-cause mortality in males (rs5883: OR 2.36 (CI 1.29-4.30), p = 0.005, n = 866). These variants did not reach significance in females in either study. Similar to earlier results linking low CETP activity with poor outcomes in males, our results suggest genetic, sex-dependent CETP splicing effects on cardiovascular risk by a mechanism independent of circulating HDL-C levels.	[Papp, Audrey C.; Pinsonneault, Julia K.; Wang, Danxin; Newman, Leslie C.; Sadee, Wolfgang] Ohio State Univ, Coll Med, Dept Pharmacol, Program Pharmacogen, Columbus, OH 43210 USA; [Gong, Yan; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharm Practice, Gainesville, FL USA; [Pepine, Carl J.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL USA; [Kumari, Meena; Hingorani, Aroon D.; Shah, Sonia] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London, England; [Talmud, Philippa J.; Humphries, Steve E.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, BHF Labs, London, England; [Humphries, Steve E.] UCL, UCL Genet Inst, London, England	University System of Ohio; Ohio State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of London; University College London; University of London; University College London; University of London; University College London	Papp, AC (corresponding author), Ohio State Univ, Coll Med, Dept Pharmacol, Program Pharmacogen, Columbus, OH 43210 USA.	papp.2@osu.edu	Wang, Danxin/I-5810-2019; Shah, Sonia/N-7547-2013	Wang, Danxin/0000-0002-7134-3065; Shah, Sonia/0000-0001-5860-4526; Kumari, Meena/0000-0001-9716-1035; Hingorani, Aroon/0000-0001-8365-0081; Talmud, Philippa/0000-0002-5560-1933; Humphries, Stephen E/0000-0002-8221-6547	National Institutes of Health (NIH); General Medical Sciences [GM61390, U01 GM092655]; British Heart Foundation (BHF) [PG/07/133/24260, RG/08/008, SP/07/007/23671, RG008/08, FS/2005/125]; Medical Research Council; Health and Safety Executive; Department of Health; National Institute on Aging [AG13196]; US, NIH; Agency for Health Care Policy Research [HS06516]; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; NIH [HL074730, HL69758, HL077113, GM074492, RR017568]; Abbott Pharmaceuticals; Florida Opportunity Fund; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017568] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069758, R01HL074730, P50HL077113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061390, U19GM061390, U01GM074492, U01GM092655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R37AG013196] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674, SP/07/007/23671, RG/08/008/25291] Funding Source: researchfish; Medical Research Council [G0902037, G8802774, G19/35, G0100222] Funding Source: researchfish; MRC [G0902037] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); British Heart Foundation (BHF)(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health and Safety Executive; Department of Health; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Pharmaceuticals(Abbott Laboratories); Florida Opportunity Fund; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was in part supported by National Institutes of Health (NIH) grants from the General Medical Sciences GM61390, U01 GM092655 to WS. The work on Whitehall II was supported by the British Heart Foundation (BHF) PG/07/133/24260, RG/08/008, SP/07/007/23671 and a Senior Fellowship to ADH (FS/2005/125). SEH is a BHF Chairholder. The WH-II study has been supported by grants from the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Institute on Aging (AG13196), US, NIH; Agency for Health Care Policy Research (HS06516); and the John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health). PJT and SEH are funded by the British Heart Foundation (RG008/08). ADH is a British Heart Foundation Senior Fellow (FS/2005/125). INVEST-GENES was funded by NIH grants HL074730, HL69758, HL077113, GM074492 and RR017568. CP and JAJ recieved a grant from Abbott Pharmaceuticals and the Florida Opportunity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguelova M, 2003, MOL PSYCHIATR, V8, P574, DOI 10.1038/sj.mp.4001328; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bauerfeind A, 2002, HUM HERED, V54, P166, DOI 10.1159/000070662; Beitelshees AL, 2007, PHARMACOGENET GENOM, V17, P719, DOI 10.1097/FPC.0b013e32810f2e3c; Boekholdt SM, 2005, CIRCULATION, V111, P278, DOI 10.1161/01.CIR.0000153341.46271.40; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; Carlquist JF, 2003, AM HEART J, V146, P1007, DOI 10.1016/S0002-8703(03)00501-5; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Corbex M, 2000, GENET EPIDEMIOL, V19, P64, DOI 10.1002/1098-2272(200007)19:1<64::AID-GEPI5>3.0.CO;2-E; Corella D, 2000, ATHEROSCLEROSIS, V152, P367, DOI 10.1016/S0021-9150(99)00477-3; de Grooth GJ, 2004, J AM COLL CARDIOL, V43, P854, DOI 10.1016/j.jacc.2003.08.056; Dessi M, 1997, MOL CELL BIOCHEM, V177, P107, DOI 10.1023/A:1006823601032; Frisdal E, 2005, HUM MOL GENET, V14, P2607, DOI 10.1093/hmg/ddi291; INAZU A, 1992, BIOCHEMISTRY-US, V31, P2352, DOI 10.1021/bi00123a021; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Klerkx AHEM, 2004, EUR J CLIN INVEST, V34, P21, DOI 10.1111/j.1365-2362.2004.01281.x; Kuivenhoven JA, 1998, NEW ENGL J MED, V338, P86, DOI 10.1056/NEJM199801083380203; Lange RA, 2008, EUR HEART J, V29, P2708, DOI 10.1093/eurheartj/ehn450; Lira ME, 2008, J LIPID RES, V49, P1955, DOI 10.1194/jlr.M800078-JLR200; Lu H, 2003, J MOL MED-JMM, V81, P246, DOI 10.1007/s00109-002-0414-7; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McCaskie PA, 2007, HUM GENET, V121, P401, DOI 10.1007/s00439-007-0326-2; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ordovas JM, 2000, ARTERIOSCL THROM VAS, V20, P1323, DOI 10.1161/01.ATV.20.5.1323; Papp AC, 2003, BIOTECHNIQUES, V34, P1068, DOI 10.2144/03345dd03; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Regieli JJ, 2008, EUR HEART J, V29, P2792, DOI 10.1093/eurheartj/ehn465; Spielmann N, 2007, PHYSIOL GENOMICS, V31, P25, DOI 10.1152/physiolgenomics.00281.2006; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Vasan RS, 2009, CIRCULATION, V120, P2414, DOI 10.1161/CIRCULATIONAHA.109.872705; Yang TP, 1996, J BIOL CHEM, V271, P12603, DOI 10.1074/jbc.271.21.12603; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	35	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31930	10.1371/journal.pone.0031930	http://dx.doi.org/10.1371/journal.pone.0031930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403620	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700017
J	Yang, Z; Lu, K; Chen, YF; Montagnes, DJS				Yang, Zhou; Lu, Kai; Chen, Yafen; Montagnes, David J. S.			The Interactive Effects of Ammonia and Microcystin on Life-History Traits of the Cladoceran Daphnia magna: Synergistic or Antagonistic?	PLOS ONE			English	Article							UN-IONIZED AMMONIA; CARP CARASSIUS-AURATUS; WASTE TREATMENT POND; OXIDATIVE STRESS; CYANOBACTERIAL TOXINS; POPULATION-GROWTH; CHRONIC TOXICITY; LAKE TAIHU; WATER; LR	The occurrence of Microcystis blooms is a worldwide concern that has caused numerous adverse effects on water quality and lake ecology. Elevated ammonia and microcystin concentrations co-occur during the degradation of Microcystis blooms and are toxic to aquatic organisms; we studied the relative and combined effects of these on the life history of the model organism Daphnia magna. Ammonia and microcystin-LR treatments were: 0, 0.366, 0.581 mg L-1 and 0, 10, 30, 100 mu g L-1, respectively. Experiments followed a fully factorial design. Incubations were 14 d and recorded the following life-history traits: number of moults, time to first batch of eggs, time to first clutch, size at first batch of eggs, size at first clutch, number of clutches per female, number of offspring per clutch, and total offspring per female. Both ammonia and microcystin were detrimental to most life-history traits. Interactive effects of the toxins occurred for five traits: the time to first batch of eggs appearing in the brood pouch, time to first clutch, size at first clutch, number of clutches, and total offspring per female. The interactive effects of ammonia and microcystin appeared to be synergistic on some parameters (e.g., time to first eggs) and antagonistic on others (e.g., total offspring per female). In conclusion, the released toxins during the degradation of Microcystis blooms would result, according to our data, in substantially negative effect on D. magna.	[Yang, Zhou; Lu, Kai] Nanjing Normal Univ, Sch Biol Sci, Jiangsu Prov Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Yang, Zhou; Chen, Yafen] Chinese Acad Sci, State Key Lab Lake Sci & Environm, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China; [Montagnes, David J. S.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	Nanjing Normal University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; University of Liverpool	Yang, Z (corresponding author), Nanjing Normal Univ, Sch Biol Sci, Jiangsu Prov Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	yangzhou@njnu.edu.cn	Lyu, Kai/L-6086-2016; Yang, Zhou/H-3407-2011	Lyu, Kai/0000-0001-5616-538X; Yang, Zhou/0000-0001-9664-7105	National Basic Research Program of China [2008CB418102]; Natural Science Foundation of Jiangsu Province [BK2011073]; Open Foundation of State Key Laboratory of Lake Science and Environment [2010SKL009]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Open Foundation of State Key Laboratory of Lake Science and Environment; Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the National Basic Research Program of China (2008CB418102), the Natural Science Foundation of Jiangsu Province (BK2011073), the Open Foundation of State Key Laboratory of Lake Science and Environment (2010SKL009), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LL, 2010, ENVIRON INT, V36, P226, DOI 10.1016/j.envint.2009.10.010; Andersen HB, 1998, B ENVIRON CONTAM TOX, V61, P116, DOI 10.1007/s001289900737; Arauzo M, 2003, WATER RES, V37, P2547, DOI 10.1016/S0043-1354(03)00023-X; Arauzo M, 2003, WATER RES, V37, P1048, DOI 10.1016/S0043-1354(02)00454-2; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; CARMICHAEL WW, 1994, SCI AM, V270, P78, DOI 10.1038/scientificamerican0194-78; Cazenave J, 2006, ENVIRON TOXICOL, V21, P22, DOI 10.1002/tox.20151; Chen J, 2009, SCI TOTAL ENVIRON, V407, P3317, DOI 10.1016/j.scitotenv.2009.02.005; Chen W, 2005, ENVIRON TOXICOL, V20, P323, DOI 10.1002/tox.20108; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Codd GA, 2000, ECOL ENG, V16, P51, DOI 10.1016/S0925-8574(00)00089-6; Codd GA, 1995, WATER SCI TECHNOL, V32, P149, DOI 10.1016/0273-1223(95)00692-3; CODD GA, 1989, WATER SCI TECHNOL, V21, P1; Connon R, 2008, ENVIRON SCI TECHNOL, V42, P2181, DOI 10.1021/es702469b; Dabrunz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020112; Dao TS, 2010, TOXICON, V55, P1244, DOI 10.1016/j.toxicon.2010.01.014; de Figueiredo DR, 2004, ECOTOX ENVIRON SAFE, V59, P151, DOI 10.1016/j.ecoenv.2004.04.006; DEMOTT WR, 1991, LIMNOL OCEANOGR, V36, P1346, DOI 10.4319/lo.1991.36.7.1346; EMERSON K, 1975, J FISH RES BOARD CAN, V32, P2379, DOI 10.1139/f75-274; Foss A, 2009, AQUACULTURE, V296, P45, DOI 10.1016/j.aquaculture.2009.07.013; Frazier BE, 1996, ENVIRON TOXICOL CHEM, V15, P92, DOI 10.1002/etc.5620150204; Ghadouani A, 2004, LIMNOL OCEANOGR, V49, P666, DOI 10.4319/lo.2004.49.3.0666; Guo NC, 2006, ENVIRON POLLUT, V143, P513, DOI 10.1016/j.envpol.2005.11.044; Hannas BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012453; Hietala J, 1997, J PLANKTON RES, V19, P917, DOI 10.1093/plankt/19.7.917; JONES GJ, 1994, WATER RES, V28, P871, DOI 10.1016/0043-1354(94)90093-0; Jos A, 2005, AQUAT TOXICOL, V72, P261, DOI 10.1016/j.aquatox.2005.01.003; Kotak BG, 1996, TOXICON, V34, P517, DOI 10.1016/0041-0101(96)00009-8; Lahti K, 1997, WATER RES, V31, P1005, DOI 10.1016/S0043-1354(96)00353-3; LaurenMaatta C, 1997, FRESHWATER BIOL, V37, P635, DOI 10.1046/j.1365-2427.1997.00189.x; Leung J, 2011, AQUACULTURE, V310, P401, DOI 10.1016/j.aquaculture.2010.11.015; Lurling M, 2003, ENVIRON TOXICOL CHEM, V22, P1281, DOI [10.1002/etc.5620220614, 10.1897/1551-5028(2003)022&lt;1281:LHCODE&gt;2.0.CO;2]; Mangas-Ramirez E, 2001, B ENVIRON CONTAM TOX, V67, P834; Martinez-Jeronimo F, 2000, ENVIRON TOXICOL, V15, P155, DOI 10.1002/1522-7278(2000)15:3<155::AID-TOX1>3.0.CO;2-X; Mikhailov A, 2003, CHEM-BIOL INTERACT, V142, P223, DOI 10.1016/S0009-2797(02)00075-3; MONSERRAT JM, 2003, COMMENTS TOXICOL, V9, P89; Ortiz-Rodriguez R, 2010, TOXICON, V56, P1342, DOI 10.1016/j.toxicon.2010.07.020; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pflugmacher S, 2004, AQUAT TOXICOL, V70, P169, DOI 10.1016/j.aquatox.2004.06.010; Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6250, DOI 10.1021/es8010783; REINIKAINEN M, 1994, LIMNOL OCEANOGR, V39, P424, DOI 10.4319/lo.1994.39.2.0424; Reinikainen M, 2001, ENVIRON TOXICOL, V16, P444, DOI 10.1002/tox.10003; Reynolds CS, ECOLOGY FRESHWATER P; Rohrlack T, 1999, APPL ENVIRON MICROB, V65, P737; Rohrlack T, 1999, J PLANKTON RES, V21, P1489, DOI 10.1093/plankt/21.8.1489; Sarnelle O, 2005, LIMNOL OCEANOGR, V50, P1565, DOI 10.4319/lo.2005.50.5.1565; Schram E, 2010, AQUACULTURE, V306, P108, DOI 10.1016/j.aquaculture.2010.06.005; Seda J, 2011, J LIMNOL, V70, P337, DOI 10.4081/jlimnol.2011.337; Svrcek C, 2004, J ENVIRON ENG SCI, V3, P155, DOI 10.1139/S04-010; Tan QG, 2011, ENVIRON SCI TECHNOL, V45, P1970, DOI 10.1021/es102453b; Tillmanns AR, 2008, FUND APPL LIMNOL, V171, P285, DOI 10.1127/1863-9135/2008/0171-0285; Wilson AE, 2008, CAN J FISH AQUAT SCI, V65, P1487, DOI 10.1139/F08-067; Wilson AE, 2007, LIMNOL OCEANOGR, V52, P1467, DOI 10.4319/lo.2007.52.4.1467; Wilson AE, 2006, LIMNOL OCEANOGR, V51, P1915, DOI 10.4319/lo.2006.51.4.1915; Xiang FH, 2010, B ENVIRON CONTAM TOX, V84, P708, DOI 10.1007/s00128-010-0017-x; Yang W, 2010, BIOCHEM SYST ECOL, V38, P557, DOI 10.1016/j.bse.2010.06.005; Yang W, 2010, J FRESHWATER ECOL, V25, P297, DOI 10.1080/02705060.2010.9665080; Yang Z, 2011, J HAZARD MATER, V190, P113, DOI 10.1016/j.jhazmat.2011.03.002; Zhang XJ, 2010, J HAZARD MATER, V182, P130, DOI 10.1016/j.jhazmat.2010.06.006; Zhang XZ, 2008, TOXICON, V51, P449, DOI 10.1016/j.toxicon.2007.11.005	61	45	45	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32285	10.1371/journal.pone.0032285	http://dx.doi.org/10.1371/journal.pone.0032285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403641	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700038
J	Wan, S; Pestka, S; Jubin, RG; Lyu, YL; Tsai, YC; Liu, LF				Wan, Shan; Pestka, Sidney; Jubin, Ronald G.; Lyu, Yi Lisa; Tsai, Yu-Chen; Liu, Leroy F.			Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-CELLS; T-CELLS; CYCLOPHOSPHAMIDE; ACTIVATION; PROTEIN; IMMUNOTHERAPY; CAMPTOTHECIN; INHIBITORS; RATIONALE	Low doses of anticancer drugs have been shown to enhance antitumor immune response and increase the efficacy of immunotherapy. The molecular basis for such effects remains elusive, although selective depletion of T regulatory cells has been demonstrated. In the current studies, we demonstrate that topotecan (TPT), a topoisomerase I-targeting drug with a well-defined mechanism of action, stimulates major histocompatibility complex class I (MHC I) expression in breast cancer cells through elevated expression/secretion of interferon-beta (IFN-beta) and activation of type I IFN signaling. First, we show that TPT treatment elevates the expression of both total and cell-surface MHC I in breast cancer cells. Second, conditioned media from TPT-treated breast cancer ZR-75-1 cells induce elevated expression of cell-surface MHC I in drug-naive recipient cells, suggesting the involvement of cytokines and/or other secreted molecules. Consistently, TPT-treated cells exhibit elevated expression of multiple cytokines such as IFN-beta, TNF-alpha, IL-6 and IL-8. Third, either knocking down the type I interferon receptor subunit 1 (IFNAR1) or addition of neutralizing antibody against IFN-beta results in reduced MHC I expression in TPT-treated cells. Together, these results suggest that TPT induces increased IFN-beta autocrine/paracrine signaling through type I IFN receptor, resulting in the elevated MHC I expression in tumor cells. Studies have also demonstrated that other chemotherapeutic agents (e. g. etoposide, cisplatin, paclitaxel and vinblastine) similarly induce increased IFN-beta secretion and elevated MHC I expression. In addition, conditioned media from gamma-irradiated donor cells are shown to induce IFN-beta-dependent MHC I expression in unirradiated recipient cells. In the aggregate, our results suggest that many cancer therapeutics induce elevated tumor antigen presentation through MHC I, which could represent a common mechanism for enhanced antitumor immune response through T cell cytotoxicity during metronomic chemotherapy, as well as increased efficacy of combined chemo- (or radio-)/immuno-therapy.	[Wan, Shan; Lyu, Yi Lisa; Tsai, Yu-Chen; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Pestka, Sidney] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Pestka, Sidney; Jubin, Ronald G.] PBL InterferonSource, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wan, S (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	lliu@umdnj.edu		Liu, Leroy/0000-0001-9396-763X	National Institutes of Health [RO1-CA39662, RO1-CA102463]; NATIONAL CANCER INSTITUTE [R01CA102463, R01CA039662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants RO1-CA39662 and RO1-CA102463 (http://grants.nih.gov/grants/funding/r01.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2006, CYTOKINE GROWTH F R, V17, P411, DOI 10.1016/j.cytogfr.2006.10.001; Bander NH, 1997, PROSTATE, V33, P233, DOI 10.1002/(SICI)1097-0045(19971201)33:4<233::AID-PROS2>3.0.CO;2-I; BERD D, 1987, CANCER RES, V47, P3317; Borgne A, 2006, ONCOGENE, V25, P7361, DOI 10.1038/sj.onc.1209718; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chopra V, 1997, J CANCER RES CLIN, V123, P167, DOI 10.1007/BF01214669; Chopra V, 1996, Cancer J Sci Am, V2, P279; Das KC, 1997, J BIOL CHEM, V272, P14914, DOI 10.1074/jbc.272.23.14914; Demidem A, 2006, INT J CANCER, V119, P992, DOI 10.1002/ijc.21761; Emens LA, 2005, CANCER RES, V65, P8059, DOI 10.1158/0008-5472.CAN-05-1797; Emens LA, 2010, CANCER J, V16, P9; Fonsatti E, 2007, CLIN CANCER RES, V13, P3333, DOI 10.1158/1078-0432.CCR-06-3091; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Habraken Y, 2001, BIOCHEM PHARMACOL, V62, P603, DOI 10.1016/S0006-2952(01)00709-2; Hall EJ, 2003, HEALTH PHYS, V85, P5; HSIANG YH, 1989, CANCER RES, V49, P5077; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Janeway CA, 2001, IMMUNOBIOLOGY; Kargiotis O, 2010, J NEURO-ONCOL, V100, P323, DOI 10.1007/s11060-010-0199-4; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Laheru D, 2008, CLIN CANCER RES, V14, P1455, DOI 10.1158/1078-0432.CCR-07-0371; Levina V, 2008, INT J CANCER, V123, P2031, DOI 10.1002/ijc.23732; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACDONALD NJ, 1990, CELL, V60, P767, DOI 10.1016/0092-8674(90)90091-R; Machiels JPH, 2001, CANCER RES, V61, P3689; Mokyr MB, 2006, CANCER IMMUNOL IMMUN, V55, P459, DOI 10.1007/s00262-005-0029-2; Morotti A, 2006, AM J HEMATOL, V81, P938, DOI 10.1002/ajh.20732; Nio Y, 2003, ANTICANCER RES, V20, P7; Ohtsukasa S, 2003, J CANCER RES CLIN, V129, P719, DOI 10.1007/s00432-003-0492-0; Pasquier E, 2010, NAT REV CLIN ONCOL, V7, P455, DOI 10.1038/nrclinonc.2010.82; PEKAREK LA, 1993, CANCER RES, V53, P1978; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Proietti E, 1998, J CLIN INVEST, V101, P429, DOI 10.1172/JCI1348; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Salem ML, 2007, J IMMUNOTHER, V30, P40, DOI 10.1097/01.cji.0000211311.28739.e3; Schiavoni G, 2000, BLOOD, V95, P2024, DOI 10.1182/blood.V95.6.2024; Staudt LM, 2010, COLD SPRING HARBOR P, V2; Stefanis L, 1999, J NEUROSCI, V19, P6235; Sun Z, 2002, SHOCK, V18, P8; Teicher BA, 2008, BIOCHEM PHARMACOL, V75, P1262, DOI 10.1016/j.bcp.2007.10.016; Teitz-Tennenbaum S, 2003, CANCER RES, V63, P8466; Tseng CW, 2008, CLIN CANCER RES, V14, P3185, DOI 10.1158/1078-0432.CCR-08-0037; Vicari AP, 2009, CANCER IMMUNOL IMMUN, V58, P615, DOI 10.1007/s00262-008-0586-2; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yeh PY, 2004, J BIOL CHEM, V279, P26143, DOI 10.1074/jbc.M402362200; Zanon RG, 2010, NEUROPATH APPL NEURO, V36, P515, DOI 10.1111/j.1365-2990.2010.01095.x; Zhang L, 2008, MED HYPOTHESES, V71, P802, DOI 10.1016/j.mehy.2008.06.022	51	177	186	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32542	10.1371/journal.pone.0032542	http://dx.doi.org/10.1371/journal.pone.0032542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396773	Green Published, Green Submitted, gold			2022-12-25	WOS:000303005000027
J	Yang, HJ; Hsu, CL; Yang, JY; Yang, WY				Yang, Huei-Jiun; Hsu, Chia-Ling; Yang, Jin-Yi; Yang, Wei Yuan			Monodansylpentane as a Blue-Fluorescent Lipid-Droplet Marker for Multi-Color Live-Cell Imaging	PLOS ONE			English	Article							LYSOSOMOTROPIC AGENT MONODANSYLCADAVERINE; GENERATION MICROSCOPY; PROTEIN; PROBE; BEHAVIOR; TIME; FAT	Lipid droplets (LDs) are dynamic cellular organelles responsible for the storage of neutral lipids, and are associated with a multitude of metabolic syndromes. Here we report monodansylpentane (MDH) as a high contrast blue-fluorescent marker for LDs. The unique spectral properties make MDH easily combinable with other green and red fluorescent reporters for multicolor fluorescence imaging. MDH staining does not apparently affect LD trafficking, and the dye is extraordinarily photo-stable. Taken together MDH represents a reliable tool to use for the investigation of dynamic LD regulation within living cells using fluorescence microscopy.	[Yang, Huei-Jiun; Hsu, Chia-Ling; Yang, Jin-Yi; Yang, Wei Yuan] Natl Taiwan Univ, Acad Sinica, Inst Biol Chem, Taipei 10764, Taiwan; [Yang, Huei-Jiun; Yang, Wei Yuan] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Yang, HJ (corresponding author), Natl Taiwan Univ, Acad Sinica, Inst Biol Chem, Taipei 10764, Taiwan.	weiyang@gate.sinica.edu.tw	Yang, Wei Yuan/B-4474-2011		National Science Council in Taiwan [NSC-98-2311-B-001-006-MY3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	Funding was provided in part by the NSC-98-2311-B-001-006-MY3 grant from the National Science Council in Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp = 7). Dr. Chia-Ling Hsu acknowledges the Academia Sinica Postdoctoral Fellows Program (http://aao.sinica.edu.tw/english/pro_pfp.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Beller M, 2010, FEBS LETT, V584, P2176, DOI 10.1016/j.febslet.2010.03.022; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Courty S, 2006, NANO LETT, V6, P1491, DOI 10.1021/nl060921t; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; GHIGGINO KP, 1981, BIOCHEMISTRY-US, V20, P5381, DOI 10.1021/bi00522a005; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Jungst C., 2011, J BIOPHOTONICS; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee JH, 2011, CHEM COMMUN, V47, P7500, DOI 10.1039/c1cc11253h; LI YH, 1975, J AM CHEM SOC, V97, P3118, DOI 10.1021/ja00844a033; Lyn RK, 2010, BIOCHEM BIOPH RES CO, V399, P518, DOI 10.1016/j.bbrc.2010.07.101; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mizushima N, 2003, INT J BIOCHEM CELL B, V35, P553, DOI 10.1016/S1357-2725(02)00343-6; Murphy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015030; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; NARAYANAN R, 1976, BIOCHEM BIOPH RES CO, V70, P1122, DOI 10.1016/0006-291X(76)91019-6; Niemann A, 2000, J HISTOCHEM CYTOCHEM, V48, P251, DOI 10.1177/002215540004800210; Niemann A, 2001, J HISTOCHEM CYTOCHEM, V49, P177, DOI 10.1177/002215540104900205; Ohsaki Y, 2010, HISTOCHEM CELL BIOL, V133, P477, DOI 10.1007/s00418-010-0678-x; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tsien RY, 2009, ANGEW CHEM INT EDIT, V48, P5612, DOI 10.1002/anie.200901916; Wang MC, 2011, NAT METHODS, V8, P135, DOI 10.1038/NMETH.1556; Watanabe T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-38; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991	34	45	45	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32693	10.1371/journal.pone.0032693	http://dx.doi.org/10.1371/journal.pone.0032693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396789	gold, Green Published, Green Submitted			2022-12-25	WOS:000303005000034
J	Fang, D; Pan, C; Lin, HJ; Lin, Y; Zhang, GY; Wang, HZ; He, MX; Xie, LP; Zhang, RQ				Fang, Dong; Pan, Cong; Lin, Huijuan; Lin, Ya; Zhang, Guiyou; Wang, Hongzhong; He, Maoxian; Xie, Liping; Zhang, Rongqing			Novel Basic Protein, PfN23, Functions as Key Macromolecule during Nacre Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX PROTEIN; CALCIUM-CARBONATE; PEARL OYSTER; PRISMATIC LAYER; DUAL ROLE; SHELL; BIOMINERALIZATION; MINERALIZATION; CRYSTALLIZATION; ARAGONITE	The fine microstructure of nacre (mother of pearl) illustrates the beauty of nature. Proteins found in nacre were believed to be "natural hands" that control nacre formation. In the classical view of nacre formation, nucleation of the main minerals, calcium carbonate, is induced on and by the acidic proteins in nacre. However, the basic proteins were not expected to be components of nacre. Here, we reported that a novel basic protein, PfN23, was a key accelerator in the control over crystal growth in nacre. The expression profile, in situ immunostaining, and in vitro immunodetection assays showed that PfN23 was localized within calcium carbonate crystals in the nacre. Knocking down the expression of PfN23 in adults via double-stranded RNA injection led to a disordered nacre surface in adults. Blocking the translation of PfN23 in embryos using morpholino oligomers led to the arrest of larval development. The in vitro crystallization assay showed that PfN23 increases the rate of calcium carbonate deposition and induced the formation of aragonite crystals with characteristics close to nacre. In addition, we constructed the peptides and truncations of different regions of this protein and found that the positively charged C-terminal region was a key region for the function of PfN23 Taken together, the basic protein PfN23 may be a key accelerator in the control of crystal growth in nacre. This provides a valuable balance to the classic view that acidic proteins control calcium carbonate deposition in nacre.	[Fang, Dong; Pan, Cong; Lin, Huijuan; Lin, Ya; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Fang, Dong; Pan, Cong; Lin, Huijuan; Lin, Ya; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China; [He, Maoxian] Chinese Acad Sci, Guangzhou 510301, Guangdong, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences	Xie, LP (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Rm 206,Old Bldg, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, 40876068, U0831001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090002110055]; Tsinghua University [20111080964]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tsinghua University	This work was supported by National Basic Research Program of China Grant 2010CB126405, National High Technology Research and Development Program of China 2010AA09Z405, National Natural Science Foundation of China Grants 31172382, 40876068, and U0831001 (Joint Fund with Guangdong), Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20090002110055, and Independent Research Projects of Tsinghua University Grant 20111080964.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BORBAS JE, 1991, J EXP ZOOL, V258, P1, DOI 10.1002/jez.1402580102; Chan XY, 2011, DEV BIOL, V349, P102, DOI 10.1016/j.ydbio.2010.10.001; Contri MB, 1996, AM J PATHOL, V148, P569; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Feng Q., 2011, PRINCIPLES CALCIUM B, P141; Fujimura Takuya, 1995, Venus the Japanese Journal of Malacology, V54, P25; Glazer L, 2010, J BIOL CHEM, V285, P12831, DOI 10.1074/jbc.M109.071068; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Henry JQ, 2010, INTEGR COMP BIOL, V50, P707, DOI 10.1093/icb/icq076; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; KITANO Y, 1962, J GEOPHYS RES, V67, P4873, DOI 10.1029/JZ067i012p04873; Kniep R., 2010, FLUORAPATITE GELATIN, P73; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Li XD, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.075502; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; LOWENSTAM HA, 1975, SCIENCE, V188, P363, DOI 10.1126/science.1118730; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Mann K, 2007, BIOPHYS J, V93, P1246, DOI 10.1529/biophysj.106.100636; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Rabinowitz JS, 2008, CURR BIOL, V18, P331, DOI 10.1016/j.cub.2008.01.055; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; SIMKISS K, 1977, CALC TISS RES, V24, P199, DOI 10.1007/BF02223316; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; WILKINSON BH, 1979, GEOLOGY, V7, P524, DOI 10.1130/0091-7613(1979)7<524:BPATEO>2.0.CO;2; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004	45	48	52	2	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15776	15785		10.1074/jbc.M112.341594	http://dx.doi.org/10.1074/jbc.M112.341594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416139	Green Published, hybrid			2022-12-25	WOS:000304006300055
J	Zhdanova, IV; Masuda, K; Bozhokin, SV; Rosene, DL; Gonzalez-Martinez, J; Schettler, S; Samorodnitsky, E				Zhdanova, Irina V.; Masuda, Ken; Bozhokin, Sergey V.; Rosene, Douglas L.; Gonzalez-Martinez, Janis; Schettler, Steven; Samorodnitsky, Eric			Familial Circadian Rhythm Disorder in the Diurnal Primate, Macaca mulatta	PLOS ONE			English	Article							SLEEP-PHASE SYNDROME; CLOCK GENE; 3'-UNTRANSLATED REGION; SUPRACHIASMATIC NUCLEI; LENGTH POLYMORPHISM; DAILY MELATONIN; ASSOCIATION; PER3; NEURONS; PERIOD	In view of the inverse temporal relationship of central clock activity to physiological or behavioral outputs in diurnal and nocturnal species, understanding the mechanisms and physiological consequences of circadian disorders in humans would benefit from studies in a diurnal animal model, phylogenetically close to humans. Here we report the discovery of the first intrinsic circadian disorder in a family of diurnal non-human primates, the rhesus monkey. The disorder is characterized by a combination of delayed sleep phase, relative to light-dark cycle, mutual desynchrony of intrinsic rhythms of activity, food intake and cognitive performance, enhanced nighttime feeding or, in the extreme case, intrinsic asynchrony. The phenotype is associated with normal length of intrinsic circadian period and requires an intact central clock, as demonstrated by an SCN lesion. Entrainment to different photoperiods or melatonin administration does not eliminate internal desynchrony, though melatonin can temporarily reinstate intrinsic activity rhythms in the animal with intrinsic asynchrony. Entrainment to restricted feeding is highly effective in animals with intrinsic or SCN lesion-induced asynchrony. The large isolated family of rhesus macaques harboring the disorder provides a powerful new tool for translational research of regulatory circuits underlying circadian disorders and their effective treatment.	[Zhdanova, Irina V.; Masuda, Ken; Rosene, Douglas L.; Schettler, Steven; Samorodnitsky, Eric] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Bozhokin, Sergey V.] St Petersburg State Polytech Univ, Dept Theoret Phys, St Petersburg, Russia; [Gonzalez-Martinez, Janis] Univ Puerto Rico, Caribbean Primate Res Ctr, San Juan, PR 00936 USA	Boston University; Peter the Great St. Petersburg Polytechnic University; University of Puerto Rico; University of Puerto Rico Mayaguez	Zhdanova, IV (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	zhdanova@bu.edu	Rosene, Douglas L/G-1973-2015	Bozhokin, Sergey/0000-0001-5653-6574; Zhdanova, Irina/0000-0002-8401-9571; Rosene, Douglas/0000-0001-8719-1441	National Institutes of Health/National Institute on Aging (NIH/NIA) [AG017636]; Chaikin-Wile Foundation; NATIONAL INSTITUTE ON AGING [R01AG017636] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Chaikin-Wile Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from National Institutes of Health/National Institute on Aging (NIH/NIA) (AG017636 to IZ) and Chaikin-Wile Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2001, EUR J NEUROSCI, V14, P1121, DOI 10.1046/j.0953-816x.2001.01732.x; Allison KC, 2010, INT J EAT DISORDER, V43, P241, DOI 10.1002/eat.20693; Archer SN, 2010, SLEEP, V33, P695, DOI 10.1093/sleep/33.5.695; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Bozhokin SV, 2010, TECH PHYS+, V55, P1248, DOI 10.1134/S1063784210090033; Buccafusco JJ, 2002, J MOL NEUROSCI, V19, P179, DOI 10.1007/s12031-002-0030-6; Campbell SS, 2007, SLEEP, V30, P1225, DOI 10.1093/sleep/30.9.1225; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Gery S, 2010, CELL CYCLE, V9, P1097, DOI 10.4161/cc.9.6.11046; GILLETTE MU, 1995, CIBA F SYMP, V183, P134; Goel N, 2009, J BIOL RHYTHM, V24, P85, DOI 10.1177/0748730408328914; Howell MJ, 2009, SLEEP MED REV, V13, P23, DOI 10.1016/j.smrv.2008.07.005; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kissling C, 2008, AM J MED GENET B, V147B, P333, DOI 10.1002/ajmg.b.30602; Kripke Daniel F, 2008, J Circadian Rhythms, V6, P6, DOI 10.1186/1740-3391-6-6; Labyak SE, 1997, AM J PHYSIOL-REG I, V273, pR1058, DOI 10.1152/ajpregu.1997.273.3.R1058; Lewy AJ, 2005, CHRONOBIOL INT, V22, P1093, DOI 10.1080/07420520500398064; Lewy AJ, 2009, CURR PSYCHIAT REP, V11, P459, DOI 10.1007/s11920-009-0070-5; Mallat S., 2010, WAVELET TOUR SIGNAL; Masuda K, 2010, J BIOL RHYTHM, V25, P361, DOI 10.1177/0748730410379382; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Osland TM, 2011, CHRONOBIOL INT; Pereira DS, 2005, SLEEP, V28, P29; Phillips AJK, 2011, J BIOL RHYTHM, V26, P441, DOI 10.1177/0748730411414163; Pittendrigh CS., 1976, J COMP PHYSIOL A, V106, P333; REPPERT SM, 1981, J NEUROSCI, V1, P1414; REPPERT SM, 1984, BRAIN RES, V307, P384, DOI 10.1016/0006-8993(84)90501-8; REPPERT SM, 1981, BRAIN RES, V223, P313, DOI 10.1016/0006-8993(81)91144-6; Rosenwasser AM, 2010, NEUROSCI BIOBEHAV R, V34, P1249, DOI 10.1016/j.neubiorev.2010.03.004; Sack RL, 2007, SLEEP, V30, P1484, DOI 10.1093/sleep/30.11.1484; SHIBATA S, 1989, NEUROSCI LETT, V97, P140, DOI 10.1016/0304-3940(89)90153-5; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; STEHLE J, 1989, J NEURAL TRANSM-GEN, V78, P173, DOI 10.1007/BF01252503; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; van Geijlswijk IM, 2010, PSYCHOPHARMACOLOGY, V212, P379, DOI 10.1007/s00213-010-1962-0; WEITZMAN ED, 1981, ARCH GEN PSYCHIAT, V38, P737; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Xu XH, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-48; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323; Zhdanova IV, 2011, J BIOL RHYTHM, V26, P149, DOI 10.1177/0748730410395849; Zhdanova I V, 1998, Sleep Res Online, V1, P114; Zhdanova IV, 2005, SLEEP MED REV, V9, P51, DOI 10.1016/j.smrv.2004.04.003; Zhdanova IV, 2002, PHYSIOL BEHAV, V75, P523, DOI 10.1016/S0031-9384(02)00654-6	48	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33327	10.1371/journal.pone.0033327	http://dx.doi.org/10.1371/journal.pone.0033327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413014	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000042
J	Cirone, M; Di Renzo, L; Lotti, LV; Conte, V; Trivedi, P; Santarelli, R; Gonnella, R; Frati, L; Faggioni, A				Cirone, Mara; Di Renzo, Livia; Lotti, Lavinia Vittoria; Conte, Valeria; Trivedi, Pankaj; Santarelli, Roberta; Gonnella, Roberta; Frati, Luigi; Faggioni, Alberto			Primary Effusion Lymphoma Cell Death Induced by Bortezomib and AG 490 Activates Dendritic Cells through CD91	PLOS ONE			English	Article							SHOCK-PROTEIN RECEPTOR; DYING TUMOR-CELLS; EXPOSURE; CANCER; CALRETICULIN; APOPTOSIS; DIFFERENTIATION; IMMUNOGENICITY; CHEMOTHERAPY; INHIBITION	To understand how cytotoxic agent-induced cancer cell death affects the immune system is of fundamental importance to stimulate immune response to counteract the high mortality due to cancer. Here we compared the immunogenicity of Primary Effusion Lymphoma (PEL) cell death induced by anticancer drug Bortezomib (Velcade) and Tyrphostin AG 490, a Janus Activated Kinase 2/signal trasducer and activator of transcription-3 (JAK2/STAT3) inhibitor. We show that both treatments were able to induce PEL apoptosis with similar kinetics and promote dendritic cells (DC) maturation. The surface expression of molecules involved in immune activation, namely calreticulin (CRT), heat shock proteins (HSP) 90 and 70 increased in dying cells. This was correlated with DC activation. We found that PEL cell death induced by Bortezomib was more effective in inducing uptake by DC compared to AG 490 or combination of both drugs. However the DC activation induced by all treatments was completely inhibited when these cells were pretreated with a neutralizing antiboby directed against the HSP90/70 and CRT common receptor, CD91. The activation of DC by Bortezomib and AG 490 treated PEL cells, as seen in the present study, might have important implications for a combined chemo and immunotherapy in such patients.	[Cirone, Mara; Di Renzo, Livia; Lotti, Lavinia Vittoria; Conte, Valeria; Trivedi, Pankaj; Santarelli, Roberta; Gonnella, Roberta; Frati, Luigi; Faggioni, Alberto] Univ Roma La Sapienza, Dept Expt Med, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome	Cirone, M (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy.	mara.cirone@uniroma1.it	Gonnella, Roberta/Y-5564-2019; Gonnella, Roberta/R-2028-2016; Santarelli, Roberta/K-5434-2015; Frati, Luigi/ABI-7437-2020; Di Renzo, Livia/D-1143-2013	Gonnella, Roberta/0000-0003-4894-4986; Gonnella, Roberta/0000-0003-4894-4986; Santarelli, Roberta/0000-0002-9416-7594; Di Renzo, Livia/0000-0003-3807-0760	Ministero dell'Istruzione; dell'Universita e della Ricerca; Associazione Italiana per la ricerca sul Cancro; Ministero della salute [ISS 9ACF/1]; Pasteur Cenci-Bolognetti foundation	Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero della salute(Ministry of Health, Italy); Pasteur Cenci-Bolognetti foundation(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was partially supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, Associazione Italiana per la ricerca sul Cancro, progetto strategico ISS 9ACF/1 of Ministero della salute, and Pasteur Cenci-Bolognetti foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Aoki Y, 2003, SEMIN HEMATOL, V40, P143, DOI 10.1016/S0037-1963(03)70006-7; Apetoh L, 2008, CANCER RES, V68, P4026, DOI 10.1158/0008-5472.CAN-08-0427; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Bharadwaj U, 2007, CANCER RES, V67, P5479, DOI 10.1158/0008-5472.CAN-06-3963; Binder RJ, 2004, P NATL ACAD SCI USA, V101, P6128, DOI 10.1073/pnas.0308180101; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chaput N, 2007, J MOL MED, V85, P1069, DOI 10.1007/s00109-007-0214-1; Chari A, 2010, BIOL-TARGETS THER, V4, P273, DOI 10.2147/BTT.S3419; Cirone M, 2010, INT J IMMUNOPATH PH, V23, P1079, DOI 10.1177/039463201002300412; Cirone M, 2008, IMMUNOL LETT, V120, P37, DOI 10.1016/j.imlet.2008.06.011; Demaria S, 2005, J LEUKOCYTE BIOL, V77, P361, DOI 10.1189/jlb.0804478; Facciponte JG, 2005, IMMUNOL INVEST, V34, P325, DOI 10.1081/IMM-200064505; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Haynes NM, 2008, CURR OPIN IMMUNOL, V20, P545, DOI 10.1016/j.coi.2008.05.008; Kebba A, 2005, J LEUKOCYTE BIOL, V78, P37, DOI 10.1189/jlb.0105049; Kepp O, 2009, APOPTOSIS, V14, P364, DOI 10.1007/s10495-008-0303-9; Li CY, 2009, MOL CANCER THER, V8, P2211, DOI 10.1158/1535-7163.MCT-09-0327; Ma YT, 2011, CURR OPIN IMMUNOL, V23, P146, DOI 10.1016/j.coi.2010.09.008; Martins I, 2011, ONCOGENE, V30, P1147, DOI 10.1038/onc.2010.500; Matta H, 2005, CANCER BIOL THER, V4, P77, DOI 10.4161/cbt.4.1.1379; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Nencioni A, 2006, EUR J IMMUNOL, V36, P681, DOI 10.1002/eji.200535298; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Petersen TR, 2010, CRIT REV IMMUNOL, V30, P345, DOI 10.1615/CritRevImmunol.v30.i4.30; Spisek R, 2007, CELL CYCLE, V6, P1962, DOI 10.4161/cc.6.16.4601; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Stebbing J, 2003, BLOOD, V102, P1806, DOI 10.1182/blood-2003-03-0891; Stebbing J, 2003, BLOOD, V101, P4000, DOI 10.1182/blood-2002-11-3353; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Tesniere A, 2008, CURR OPIN IMMUNOL, V20, P504, DOI 10.1016/j.coi.2008.05.007; Zappasodi R, 2010, CANCER RES, V70, P9062, DOI 10.1158/0008-5472.CAN-10-1825; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	35	63	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e31732	10.1371/journal.pone.0031732	http://dx.doi.org/10.1371/journal.pone.0031732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412839	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800003
J	Ghadami, M; El-Demerdash, E; Zhang, D; Salama, SA; Binhazim, AA; Archibong, AE; Chen, XL; Ballard, BR; Sairam, MR; Al-Hendy, A				Ghadami, Mohsen; El-Demerdash, Ebtehal; Zhang, Dong; Salama, Salama A.; Binhazim, Awadh A.; Archibong, Anthony E.; Chen, Xinlei; Ballard, Billy R.; Sairam, M. Ram; Al-Hendy, Ayman			Bone Marrow Transplantation Restores Follicular Maturation and Steroid Hormones Production in a Mouse Model for Primary Ovarian Failure	PLOS ONE			English	Article							STEM-CELLS; TARGETED DISRUPTION; LUTEINIZING-HORMONE; CLINICAL-FEATURES; RECEPTOR; MUTATION; EXPRESSION; PHENOTYPE; OOCYTES; MICE	Recent studies suggest that bone marrow stem cells (BMSCs) are promising grafts to treat a variety of diseases, including reproductive dysfunction. Primary ovarian failure is characterized by amenorrhea and infertility in a normal karyotype female, with an elevated serum level of follicle-stimulating hormone (FSH) and a decrease level of estrogen caused by a mutation in FSH receptor (FSHR) gene. Currently, there is no effective treatment for this condition. The phenotype of FSHR (-/-) mouse, FORKO (follitropin receptor knockout), is a suitable model to study ovarian failure in humans. Female FORKO mice have elevated FSH, decreased estrogen levels, are sterile because of the absence of folliculogenesis, and display thin uteri and small nonfunctional ovaries. In this study, we determined the effects of BMSC transplantation on reproductive physiology in this animal model. Twenty four hours post BMSC transplantation, treated animals showed detectable estroidogeneic changes in daily vaginal smear. Significant increase in total body weight and reproductive organs was observed in treated animals. Hemotoxylin and eosin (H&E) evaluation of the ovaries demonstrated significant increase in both the maturation and the total number of the follicles in treated animals. The FSH dropped to 40-50% and estrogen increased 4-5.5 times in the serum of treated animals compared to controls. The FSHR mRNA was detected in the ovaries of treated animals. Our results show that intravenously injected BMSCs were able to reach the ovaries of FORKO mice, differentiate and express FHSR gene, make FSHR responsive to FSH, resume estrogen hormone production, and restore folliculogenesis.	[Ghadami, Mohsen; Zhang, Dong; Archibong, Anthony E.; Al-Hendy, Ayman] Univ Tehran Med Sci, Sch Med, Endocrine & Metab Res Inst, Tehran, Iran; [Ghadami, Mohsen; Zhang, Dong; Archibong, Anthony E.; Al-Hendy, Ayman] Univ Tehran Med Sci, Sch Med, Dept Med Genet, Tehran, Iran; [Ghadami, Mohsen] Meharry Med Coll, Sch Med, Ctr Womens Hlth Res, Dept Obstet & Gynecol, Nashville, TN 37208 USA; [Ghadami, Mohsen] Tehran Univ Med Sci Branch, Iranian Acad Ctr Educ Culture & Res, Tehran, Iran; [El-Demerdash, Ebtehal] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Salama, Salama A.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Binhazim, Awadh A.; Ballard, Billy R.] Meharry Med Coll, Sch Med, Dept Pathol, Nashville, TN 37208 USA; [Chen, Xinlei; Sairam, M. Ram] Univ Montreal, Clin Res Inst Montreal, Montreal, PQ, Canada	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Meharry Medical College; Academic Center for Education, Culture & Research (ACECR); Egyptian Knowledge Bank (EKB); Ain Shams University; Baylor College of Medicine; Meharry Medical College; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Ghadami, M (corresponding author), Univ Tehran Med Sci, Sch Med, Endocrine & Metab Res Inst, Tehran, Iran.	ahendy@mmc.edu	Al-hendy, Ayman/J-9324-2019; El-Demerdash, Ebtehal/ABE-6729-2020		National Institutes of Health [R21HD046639]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD046639] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work was supported by grant R21HD046639 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittomaki K, 1996, J CLIN ENDOCR METAB, V81, P3722, DOI 10.1210/jc.81.10.3722; Allen LA, 2003, HUM REPROD, V18, P251, DOI 10.1093/humrep/deg046; Balla A, 2003, BIOL REPROD, V69, P1281, DOI 10.1095/biolreprod.103.015552; Beau I, 1998, J CLIN INVEST, V102, P1352, DOI 10.1172/JCI3795; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Doherty E, 2002, J CLIN ENDOCR METAB, V87, P1151, DOI 10.1210/jc.87.3.1151; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; FALLEST PC, 1995, BIOL REPROD, V53, P103, DOI 10.1095/biolreprod53.1.103; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; GAY V L, 1970, Federation Proceedings, V29, P1880; Ghadami M, 2009, REPROD SCI, V16, p189A; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; JONES GS, 1969, AM J OBSTET GYNECOL, V104, P597, DOI 10.1016/S0002-9378(16)34255-7; KINCH RAH, 1965, AM J OBSTET GYNECOL, V91, P630; Lee HJ, 2007, J CLIN ONCOL, V25, P3198, DOI 10.1200/JCO.2006.10.3028; Lue Y, 2007, AM J PATHOL, V170, P899, DOI 10.2353/ajpath.2007.060543; Maeda K.-I., 2000, HDB EXPT ANIMALS LAB, P145; MATTERI RL, 1987, DOMEST ANIM ENDOCRIN, V4, P157, DOI 10.1016/0739-7240(87)90011-7; Ohkura S, 2000, ENDOCRINOLOGY, P401; REBAR RW, 1990, FERTIL STERIL, V53, P804; REINDOLLAR RH, 1984, J REPROD MED, V29, P391; Rugh R, 1980, REPROD SYSTEMS ADULT, P7; Selesniemi K, 2009, AGING-US, V1, P49; SIMPSON J L, 1971, Birth Defects Original Article Series, V7, P215; Sklar C, 1999, MED PEDIATR ONCOL, V33, P2; TALBERT LM, 1984, FERTIL STERIL, V42, P741; Touraine P, 1999, MOL ENDOCRINOL, V13, P1844, DOI 10.1210/me.13.11.1844; VANCAMPENHOUT J, 1972, OBSTET GYNECOL, V40, P6; WALMER DK, 1992, ENDOCRINOLOGY, V131, P1458, DOI 10.1210/en.131.3.1458; WENTZ AC, 1996, REPROD ENDOCRINOLOGY, P13885	34	29	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32462	10.1371/journal.pone.0032462	http://dx.doi.org/10.1371/journal.pone.0032462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412875	Green Published, gold			2022-12-25	WOS:000303060800020
J	Lu, CW; Shao, CX; Cobos, E; Singh, KP; Gao, WM				Lu, Chuanwen; Shao, Changxia; Cobos, Everardo; Singh, Kamaleshwar P.; Gao, Weimin			Chemotherapeutic Sensitization of Leptomycin B Resistant Lung Cancer Cells by Pretreatment with Doxorubicin	PLOS ONE			English	Article							ORDER CHROMOSOME STRUCTURE; P53 NUCLEAR ACCUMULATION; WILD-TYPE P53; P53-DEPENDENT APOPTOSIS; FUNCTIONAL DOMAIN; EXPORT; PROTEIN; INHIBITION; PHOSPHORYLATION; IDENTIFICATION	The development of novel targeted therapies has become an important research focus for lung cancer treatment. Our previous study has shown leptomycin B (LMB) significantly inhibited proliferation of lung cancer cells; however, p53 wild type lung cancer cells were resistant to LMB. Therefore, the objective of this study was to develop and evaluate a novel therapeutic strategy to sensitize LMB-resistant lung cancer cells by combining LMB and doxorubicin (DOX). Among the different treatment regimens, pretreatment with DOX (pre-DOX) and subsequent treatment with LMB to A549 cells significantly decreased the 50% inhibitory concentration (IC50) as compared to that of LMB alone (4.4 nM vs. 10.6 nM, P<0.05). Analysis of cell cycle and apoptosis by flow cytometry further confirmed the cytotoxic data. To investigate molecular mechanisms for this drug combination effects, p53 pathways were analyzed by Western blot, and nuclear proteome was evaluated by two dimensional-difference gel electrophoresis (2D-DIGE) and mass spectrometry. In comparison with control groups, the levels of p53, phospho-p53 (ser15), and p21 proteins were significantly increased while phospho-p53 (Thr55) and survivin were significantly decreased after treatments of pre-DOX and LMB (P<0.05). The 2D-DIGE/MS analysis identified that sequestosome 1 (SQSTM1/p62) had a significant increase in pre-DOX and LMB-treated cells (P<0.05). In conclusion, our results suggest that drug-resistant lung cancer cells with p53 wild type could be sensitized to cell death by scheduled combination treatment of DOX and LMB through activating and restoring p53 as well as potentially other signaling pathway(s) involving sequestosome 1.	[Lu, Chuanwen; Shao, Changxia; Singh, Kamaleshwar P.; Gao, Weimin] Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth, Lubbock, TX 79409 USA; [Cobos, Everardo; Gao, Weimin] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Lu, CW (corresponding author), Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth, Lubbock, TX 79409 USA.	weimin.gao@tiehh.ttu.edu	Singh, Kamaleshwar Prasad/AAE-9166-2020	cobos, everardo/0000-0001-5799-0074				Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; AmericanCancerSociety, 2011, CANC FACTS FIG 2011; Blagosklonny MV, 2002, ONCOGENE, V21, P6249, DOI 10.1038/sj.onc.1205793; Cai X, 2008, P NATL ACAD SCI USA, V105, P16958, DOI 10.1073/pnas.0804608105; Carbone DP, 2011, CLIN LUNG CANCER, V12, P261, DOI 10.1016/j.cllc.2011.06.002; Cetin Karynsa, 2011, Clin Epidemiol, V3, P139, DOI 10.2147/CLEP.S17191; Chen LX, 2011, ONCOL REP, V26, P223, DOI 10.3892/or.2011.1279; Chen LX, 2010, TOXICOL SCI, V116, P206, DOI 10.1093/toxsci/kfq123; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Coory M, 2008, LUNG CANCER, V60, P14, DOI 10.1016/j.lungcan.2008.01.008; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ESRIG D, 1994, NEW ENGL J MED, V331, P1259, DOI 10.1056/NEJM199411103311903; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; Ikeda M, 2007, CANCER LETT, V248, P292, DOI 10.1016/j.canlet.2006.08.005; Knauer SK, 2007, FASEB J, V21, P207, DOI 10.1096/fj.06-5741com; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Lain S, 1999, EXP CELL RES, V253, P315, DOI 10.1006/excr.1999.4672; Lain S, 1999, EXP CELL RES, V248, P457, DOI 10.1006/excr.1999.4433; Lecane PS, 2003, PROSTATE, V54, P258, DOI 10.1002/pros.10197; Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lu J, 2008, BIOCHEM BIOPH RES CO, V369, P948, DOI 10.1016/j.bbrc.2008.02.122; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Meek DW, 1998, CELL SIGNAL, V10, P159, DOI 10.1016/S0898-6568(97)00119-8; Mercadante S, 2010, LUNG CANCER, V68, P10, DOI 10.1016/j.lungcan.2009.11.004; Mi J, 2008, MOL THER, V16, P66, DOI 10.1038/sj.mt.6300320; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; NISHI K, 1994, J BIOL CHEM, V269, P6320; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Ogura M, 2001, Gan To Kagaku Ryoho, V28, P1331; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Outomuro D, 2007, INT J CARDIOL, V117, P6, DOI 10.1016/j.ijcard.2006.05.005; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Park I, 1995, P NATL ACAD SCI USA, V92, P12338, DOI 10.1073/pnas.92.26.12338; Provencio M, 2009, CLIN LUNG CANCER, V10, P295, DOI 10.3816/CLC.2009.n.041; Rachubinski RA, 1999, J BIOL CHEM, V274, P18278, DOI 10.1074/jbc.274.26.18278; Riganti C, 2005, CANCER RES, V65, P516; Sardao VA, 2009, CANCER CHEMOTH PHARM, V64, P811, DOI 10.1007/s00280-009-0932-x; Shao CX, 2011, CANCER CHEMOTH PHARM, V67, P1369, DOI 10.1007/s00280-010-1434-6; Shao CX, 2011, NUTRITION, V27, P681, DOI 10.1016/j.nut.2010.05.019; Smart P, 1999, ONCOGENE, V18, P7378, DOI 10.1038/sj.onc.1203260; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Turner JG, 2008, CURR MED CHEM, V15, P2648, DOI 10.2174/092986708786242859; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Yao Y, 2009, ONCOL REP, V21, P229, DOI 10.3892/or_00000213; YOSHIDA M, 1990, EXP CELL RES, V187, P150, DOI 10.1016/0014-4827(90)90129-X; You J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255103; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	64	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32895	10.1371/journal.pone.0032895	http://dx.doi.org/10.1371/journal.pone.0032895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412944	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800060
J	Monaco, E; Bionaz, M; Rodriguez-Zas, S; Hurley, WL; Wheeler, MB				Monaco, Elisa; Bionaz, Massimo; Rodriguez-Zas, Sandra; Hurley, Walter L.; Wheeler, Matthew B.			Transcriptomics Comparison between Porcine Adipose and Bone Marrow Mesenchymal Stem Cells during In Vitro Osteogenic and Adipogenic Differentiation	PLOS ONE			English	Article							LARGE GENE LISTS; DAVID BIOINFORMATICS RESOURCES; PERIPARTURIENT DAIRY-COWS; STROMAL CELLS; PROGENITOR CELLS; TISSUE ANGIOGENESIS; FUNCTIONAL-ANALYSIS; ENDOTHELIAL-CELLS; NITRIC-OXIDE; PPAR-GAMMA	Bone-marrow mesenchymal stem cells (BMSC) are considered the gold standard for use in tissue regeneration among mesenchymal stem cells (MSC). The abundance and ease of harvest make the adipose-derived stem cells (ASC) an attractive alternative to BMSC. The aim of the present study was to compare the transcriptome of ASC and BMSC, respectively isolated from subcutaneous adipose tissue and femur of 3 adult pigs, during in vitro osteogenic and adipogenic differentiation for up to four weeks. At 0, 2, 7, and 21 days of differentiation RNA was extracted for microarray analysis. A False Discovery Rate <= 0.05 for overall interactions effect and P<0.001 between comparisons were used to determine differentially expressed genes (DEG). Ingenuity Pathway Analysis and DAVID performed the functional analysis of the DEG. Functional analysis of highest expressed genes in MSC and genes more expressed in MSC vs. fully differentiated tissues indicated low immunity and high angiogenic capacity. Only 64 genes were differentially expressed between ASC and BMSC before differentiation. The functional analysis uncovered a potential larger angiogenic, osteogenic, migration, and neurogenic capacity in BMSC and myogenic capacity in ASC. Less than 200 DEG were uncovered between ASC and BMSC during differentiation. Functional analysis also revealed an overall greater lipid metabolism in ASC, while BMSC had a greater cell growth and proliferation. The time course transcriptomic comparison between differentiation types uncovered <500 DEG necessary to determine cell fate. The functional analysis indicated that osteogenesis had a larger cell proliferation and cytoskeleton organization with a crucial role of G-proteins. Adipogenesis was driven by PPAR signaling and had greater angiogenesis, lipid metabolism, migration, and tumorigenesis capacity. Overall the data indicated that the transcriptome of the two MSC is relatively similar across the conditions studied. In addition, functional analysis data might indicate differences in therapeutic application.	[Monaco, Elisa; Bionaz, Massimo; Hurley, Walter L.; Wheeler, Matthew B.] Univ Illinois, Dept Anim Sci, Lab Stem Cell Biol & Engn, Urbana, IL 61801 USA; [Monaco, Elisa; Bionaz, Massimo; Rodriguez-Zas, Sandra; Wheeler, Matthew B.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Monaco, E (corresponding author), Univ Illinois, Dept Anim Sci, Lab Stem Cell Biol & Engn, 328 Mumford Hall, Urbana, IL 61801 USA.	mbwheele@illinois.edu	Bionaz, Massimo/I-4222-2018	Bionaz, Massimo/0000-0002-0674-1892; Wheeler, Matthew/0000-0001-5589-357X	Illinois Regenerative Medicine Institute [63080017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068946] Funding Source: NIH RePORTER	Illinois Regenerative Medicine Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Illinois Regenerative Medicine Institute supported this project with grant #63080017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Arakawa H, 1998, P NATL ACAD SCI USA, V95, P4573, DOI 10.1073/pnas.95.8.4573; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bonaros N, 2009, J THORAC CARDIOV SUR, V137, P846, DOI 10.1016/j.jtcvs.2008.09.041; Burns JS, 2010, TISSUE ENG PT A, V16, P2331, DOI [10.1089/ten.tea.2009.0735, 10.1089/ten.TEA.2009.0735]; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Cho HH, 2006, STEM CELLS DEV, V15, P853, DOI 10.1089/scd.2006.15.853; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Dinser R, 2009, J TISSUE ENG REGEN M, V3, P124, DOI 10.1002/term.148; Dong Xiao-Hong, 2007, Zhonghua Zheng Xing Wai Ke Za Zhi, V23, P151; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Edwards Claire M, 2008, Int J Med Sci, V5, P263; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Frayn KN, 2010, ACTA PHYSIOL, V199, P509, DOI 10.1111/j.1748-1716.2010.02128.x; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Funderburgh JL, 2002, IUBMB LIFE, V54, P187, DOI 10.1080/15216540214932; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hall B, 2007, INT J HEMATOL, V86, P8, DOI 10.1532/IJH97.06230; Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hergeth SP, 2008, EXP HEMATOL, V36, P1022, DOI 10.1016/j.exphem.2008.03.013; Hirashima M, 2009, ANAT SCI INT, V84, P95, DOI 10.1007/s12565-009-0026-1; Hsu YC, 2010, J BIOL CHEM, V285, P13885, DOI 10.1074/jbc.M109.081463; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jansen BJH, 2010, STEM CELLS DEV, V19, P481, DOI 10.1089/scd.2009.0288; Jochheim-Richter A, 2006, DIFFERENTIATION, V74, P167, DOI 10.1111/j.1432-0436.2006.00066.x; Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Kim D, 2010, CELL TISSUE RES, V341, P359, DOI 10.1007/s00441-010-1015-3; Kistler WS, 2009, GENE EXPR PATTERNS, V9, P515, DOI 10.1016/j.gep.2009.07.004; Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367; Koga H, 2009, KNEE SURG SPORT TR A, V17, P1289, DOI 10.1007/s00167-009-0782-4; Krawczyk M, 2004, J IMMUNOL, V173, P6200, DOI 10.4049/jimmunol.173.10.6200; Lamba P, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-31; Lamkhioued B, 2003, J IMMUNOL, V170, P537, DOI 10.4049/jimmunol.170.1.537; Langer DA, 2006, J HEPATOL, V44, P209, DOI 10.1016/j.jhep.2005.10.004; Lapi Simone, 2008, BMC Res Notes, V1, P53, DOI 10.1186/1756-0500-1-53; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; LARRODERA P, 1990, CELL, V61, P1113, DOI 10.1016/0092-8674(90)90074-O; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Li L, 2010, J CELL PHYSL; Liang SX, 2010, INT J CARDIOL, V138, P40, DOI 10.1016/j.ijcard.2008.08.032; Liau SS, 2008, CANCER-AM CANCER SOC, V113, P302, DOI 10.1002/cncr.23560; Lin CS, 2008, ASIAN J ANDROL, V10, P171, DOI 10.1111/j.1745-7262.2008.00389.x; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Monaco E, 2009, OPEN TISSUE ENG REGE, V2, P20, DOI DOI 10.2174/1875043500902010020; Noel D, 2008, EXP CELL RES, V314, P1575, DOI 10.1016/j.yexcr.2007.12.022; Oedayrajsingh-Varma MJ, 2006, CYTOTHERAPY, V8, P166, DOI 10.1080/14653240600621125; Ogura Naomi, 2004, J Oral Sci, V46, P207, DOI 10.2334/josnusd.46.207; Park JG, 1999, EMBO J, V18, P4004, DOI 10.1093/emboj/18.14.4004; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Peng HZ, 2009, J BIOL CHEM, V284, P35670, DOI 10.1074/jbc.M109.032086; Phillips R., 1986, MODELS; Piantoni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-331; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; PUSIC I, 2010, CURR OPIN HEMATOL; Rada T, 2009, TISSUE ENG PART B-RE, V15, P113, DOI 10.1089/ten.teb.2008.0423; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Sadan O, 2009, EXPERT OPIN BIOL TH, V9, P1487, DOI 10.1517/14712590903321439; Sengenes C, 2007, STEM CELLS, V25, P2269, DOI 10.1634/stemcells.2007-0180; Slynarski K, 2006, TRANSPL P, V38, P318, DOI 10.1016/j.transproceed.2005.12.075; Smidt MP, 2000, J NEUROCHEM, V75, P1818, DOI 10.1046/j.1471-4159.2000.0751818.x; Spiegelman BM, 1997, BIOCHIMIE, V79, P111, DOI 10.1016/S0300-9084(97)81500-3; Spiryda LB, 1998, J NEUROSCI RES, V54, P137, DOI 10.1002/(SICI)1097-4547(19981015)54:2<137::AID-JNR2>3.0.CO;2-F; Tse HF, 2007, CURR VASC PHARMACOL, V5, P103, DOI 10.2174/157016107780368299; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Vartak N, 2010, EMBO J, V29, P2689, DOI 10.1038/emboj.2010.184; Veyrat-Masson R, 2007, BRIT J HAEMATOL, V139, P312, DOI 10.1111/j.1365-2141.2007.06786.x; Viswanathan A, 2007, STEM CELLS, V25, P1263, DOI 10.1634/stemcells.2006-0522; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Yamamura S, 2010, MOL CANCER THER, V9, P1680, DOI 10.1158/1535-7163.MCT-10-0012; Yu JM, 2008, STEM CELLS DEV, V17, P463, DOI 10.1089/scd.2007.0181; Zavan B, 2010, NEUROL RES, V32, P47, DOI 10.1179/174313209X385743; Zhang KQ, 2010, UROL INT, V84, P94, DOI 10.1159/000273474; Zhao SH, 2005, GENOMICS, V86, P618, DOI 10.1016/j.ygeno.2005.08.001; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	88	55	61	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32481	10.1371/journal.pone.0032481	http://dx.doi.org/10.1371/journal.pone.0032481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412878	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800023
J	Sremba, AL; Hancock-Hanser, B; Branch, TA; LeDuc, RL; Baker, CS				Sremba, Angela L.; Hancock-Hanser, Brittany; Branch, Trevor A.; LeDuc, Rick L.; Baker, C. Scott			Circumpolar Diversity and Geographic Differentiation of mtDNA in the Critically Endangered Antarctic Blue Whale (Balaenoptera musculus intermedia)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DIVERSITY; POPULATION-STRUCTURE; HUMPBACK WHALES; MICROSATELLITE LOCI; GENETIC IDENTIFICATION; SOUTHERN-HEMISPHERE; BEAKED-WHALES; NORTH; SOFTWARE; AMPLIFICATION	The Antarctic blue whale (Balaenoptera musculus intermedia) was hunted to near extinction between 1904 and 1972, declining from an estimated initial abundance of more than 250,000 to fewer than 400. Here, we describe mtDNA control region diversity and geographic differentiation in the surviving population of the Antarctic blue whale, using 218 biopsy samples collected under the auspices of the International Whaling Commission (IWC) during research cruises from 1990-2009. Microsatellite genotypes and mtDNA sequences identified 166 individuals among the 218 samples and documented movement of a small number of individuals, including a female that traveled at least 6,650 km or 131 degrees longitude over four years. mtDNA sequences from the 166 individuals were aligned with published sequences from 17 additional individuals, resolving 52 unique haplotypes from a consensus length of 410 bp. From this minimum census, a rarefaction analysis predicted that only 72 haplotypes (95% CL, 64, 86) have survived in the contemporary population of Antarctic blue whales. However, haplotype diversity was relatively high (0.968 +/- 0.004), perhaps as a result of the longevity of blue whales and the relatively recent timing of the bottleneck. Despite the potential for circumpolar dispersal, we found significant differentiation in mtDNA diversity (F-ST = 0.032, p<0.005) and microsatellite alleles (F-ST = 0.005, p<0.05) among the six Antarctic Areas historically used by the IWC for management of blue whales.	[Sremba, Angela L.; Baker, C. Scott] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Sremba, Angela L.; Baker, C. Scott] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA; [Hancock-Hanser, Brittany; LeDuc, Rick L.] Natl Ocean & Atmospher Adm, Protected Resources Div, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	Oregon State University; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Sremba, AL (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA.	Srembaa@onid.orst.edu			Oregon State University Hatfield Marine Science Center; Marine Mammal Institute	Oregon State University Hatfield Marine Science Center; Marine Mammal Institute	Funding for this study was provided by the Oregon State University Hatfield Marine Science Center Mamie Markham Research Award and the Marine Mammal Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Amos Bill, 1996, Report of the International Whaling Commission, V46, P657; Attard CRM, 2010, CONSERV GENET, V11, P2437, DOI 10.1007/s10592-010-0121-9; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Baker CS, 1998, MOL ECOL, V7, P695, DOI 10.1046/j.1365-294x.1998.00384.x; Berube M, 2002, CONSERV GENET, V3, P183, DOI 10.1023/A:1015224730394; Berube M, 2000, MOL ECOL, V9, P2181; Branch TA, 2007, MAR MAMMAL SCI, V23, P803, DOI 10.1111/j.1748-7692.2007.00137.x; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Branch T. A., 2001, Journal of Cetacean Research and Management, V3, P143; Branch TA, 2009, MAR MAMMAL SCI, V25, P833, DOI 10.1111/j.1748-7692.2009.00292.x; Branch T.A, 2007, J CETACEAN RES MANAG, V9, P87; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Branch TA, 2008, SC60SH10 IN WHAL COM; Branch TA, 2008, SC60SH7 INT WHAL COM; Branch TA, 2008, SC60SH9 INT WHAL COM; Calambokidis J, 2001, MAR MAMMAL SCI, V17, P769, DOI 10.1111/j.1748-7692.2001.tb01298.x; Dalebout ML, 1998, MOL ECOL, V7, P687, DOI 10.1046/j.1365-294x.1998.00380.x; Dalebout ML, 2004, J HERED, V95, P459, DOI 10.1093/jhered/esh054; Donovan G.P., 1991, Reports of the International Whaling Commission Special Issue, P39; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ensor P, 2006, SC58IA1 IWCSOWER; Ensor P, 2007, SC59IA1 IWCSOWER; Ensor P, 2008, SC60IA1 IWCSOWER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Gilson A, 1998, CALIF FISH GAME, V84, P159; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hardy AC, 1940, GEOGR J, V96, P345, DOI 10.2307/1788808; Ichihara T., 1966, WHALES DOLPHINS PORP, P79, DOI 10.1525/9780520321373-008; IWC, 2009, J CETACEAN RES MANAG, V11, P220; Jackson JA, 2008, MOL ECOL, V17, P236, DOI 10.1111/j.1365-294X.2007.03497.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Larsen AH, 1996, P ROY SOC B-BIOL SCI, V263, P1611, DOI 10.1098/rspb.1996.0236; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Leduc R.G., 2007, Journal of Cetacean Research and Management, V9, P73; LeDuc R.G., 2001, Journal of Cetacean Research and Management Special Issue, V2, P287; LeDuc R. G., 2002, Journal of Cetacean Research and Management, V4, P1; Lindqvist C, 2009, MAR MAMMAL SCI, V25, P229, DOI 10.1111/j.1748-7692.2008.00248.x; Lockyer C., 1984, REP INT WHAL COMMN S, V6, P27; Mackintosh NA, 1942, DISCOVERY REPORTS; Malik S, 2000, MAR MAMMAL SCI, V16, P545, DOI 10.1111/j.1748-7692.2000.tb00950.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Olavarria C, 2007, MAR ECOL PROG SER, V330, P257, DOI 10.3354/meps330257; Olson PA, 2008, SC60SH29 INT WHAL CO; Palsboll PJ, 1997, MOL ECOL, V6, P893; Pastene LA, 2007, MOL ECOL, V16, P1481, DOI 10.1111/j.1365-294X.2007.03244.x; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Raymond M, 1995, J HEREDITY, V86; Rooney AP, 2001, EVOLUTION, V55, P1678; Rosenbaum HC, 2000, MOL ECOL, V9, P1793, DOI 10.1046/j.1365-294x.2000.01066.x; Rosenbaum HC, 2000, CONSERV BIOL, V14, P1837, DOI 10.1111/j.1523-1739.2000.99310.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruegg KC, 2010, MOL ECOL, V19, P281, DOI 10.1111/j.1365-294X.2009.04447.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHLOTTERER C, 1991, NATURE, V354, P63, DOI 10.1038/354063a0; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Stevick PT, 2006, J ZOOL, V270, P244, DOI 10.1111/j.1469-7998.2006.00128.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Tonnessen JN., 1982, HIST MODERN WHALING; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waldick RC, 1999, MOL ECOL, V8, P1763, DOI 10.1046/j.1365-294x.1999.00723-6.x; Waples RS, 2006, ENDANGERED SPECIES A	74	29	32	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32579	10.1371/journal.pone.0032579	http://dx.doi.org/10.1371/journal.pone.0032579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412889	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800030
J	Eneslatt, K; Normark, M; Bjork, R; Rietz, C; Zingmark, C; Wolfraim, LA; Stoven, S; Sjostedt, A				Eneslatt, Kjell; Normark, Monica; Bjork, Rafael; Rietz, Cecilia; Zingmark, Carl; Wolfraim, Lawrence A.; Stoven, Svenja; Sjostedt, Anders			Signatures of T Cells as Correlates of Immunity to Francisella tularensis	PLOS ONE			English	Article							MEDIATED-IMMUNITY; GAMMA-INTERFERON; TUBERCULOSIS; MEMORY; INFECTION; VACCINE; RESPONSES; PROTECTION; RESISTANCE; TULAREMIA	Tularemia or vaccination with the live vaccine strain (LVS) of Francisella tularensis confers long-lived cell-mediated immunity. We hypothesized that this immunity depends on polyfunctional memory T cells, i.e., CD4(+) and/or CD8(+) T cells with the capability to simultaneously express several functional markers. Multiparametric flow cytometry, measurement of secreted cytokines, and analysis of lymphocyte proliferation were used to characterize in vitro recall responses of peripheral blood mononuclear cells (PBMC) to killed F. tularensis antigens from the LVS or Schu S4 strains. PBMC responses were compared between individuals who had contracted tularemia, had been vaccinated, or had not been exposed to F. tularensis (naive). Significant differences were detected between either of the immune donor groups and naive individuals for secreted levels of IL-5, IL-6, IL-10, IL-12, IL-13, IFN-gamma, MCP-1, and MIP-1 beta. Expression of IFN-gamma, MIP-1 beta, and CD107a by CD4(+)CD45RO(+) or CD8(+) CD45RO(+) T cells correlated to antigen concentrations. In particular, IFN-gamma and MIP-1 beta strongly discriminated between immune and naive individuals. Only one cytokine, IL-6, discriminated between the two groups of immune individuals. Notably, IL-2- or TNF-alpha-secretion was low. Our results identify functional signatures of T cells that may serve as correlates of immunity and protection against F. tularensis.	[Eneslatt, Kjell; Normark, Monica; Bjork, Rafael; Rietz, Cecilia; Zingmark, Carl; Stoven, Svenja; Sjostedt, Anders] Umea Univ, Dept Clin Microbiol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Wolfraim, Lawrence A.] DynPort Vaccine Co, Frederick, MD USA	Umea University	Eneslatt, K (corresponding author), Umea Univ, Dept Clin Microbiol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.	anders.sjostedt@climi.umu.se	Sjöstedt, Anders/AAC-6575-2020	Sjöstedt, Anders/0000-0002-0768-8405	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200500041C]; Swedish Medical Research Council [2010-9485]; Medical Faculty, Umea University, Umea, Sweden	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Medical Faculty, Umea University, Umea, Sweden	This work was funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, Contract No. HHSN266200500041C. Grant support was also obtained from the Swedish Medical Research Council (2010-9485) and the Medical Faculty, Umea University, Umea, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external sources of funding.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; ANTHONY LSD, 1987, MICROB PATHOGENESIS, V2, P3, DOI 10.1016/0882-4010(87)90110-0; ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Bell EB, 2008, TRENDS IMMUNOL, V29, P405, DOI 10.1016/j.it.2008.06.002; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chizzolini C, 2003, ARTHRITIS RHEUM-US, V48, P2593, DOI 10.1002/art.11129; Colpitts SL, 2009, J IMMUNOL, V182, P5702, DOI 10.4049/jimmunol.0803450; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan J Wayne, 2004, Expert Rev Vaccines, V3, P307; Cowley SC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00026; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Eneslatt K, 2011, EUR J IMMUNOL, V41, P974, DOI 10.1002/eji.201040923; ERICSSON M, 1994, J INFECT DIS, V170, P110, DOI 10.1093/infdis/170.1.110; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Frevert U, 2009, INT J PARASITOL, V39, P119, DOI 10.1016/j.ijpara.2008.06.014; Hale-Donze H, 2002, J IMMUNOL, V169, P3854, DOI 10.4049/jimmunol.169.7.3854; Harashima A, 2009, MOL IMMUNOL, V46, P3310, DOI 10.1016/j.molimm.2009.07.023; KOSTIALA AAI, 1975, IMMUNOLOGY, V28, P855; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Libri V, 2011, IMMUNOLOGY, V132, P326, DOI 10.1111/j.1365-2567.2010.03386.x; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Pahar B, 2006, EUR J IMMUNOL, V36, P583, DOI 10.1002/eji.200535520; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013349; SJOSTEDT A, 1992, IMMUNOLOGY, V76, P584; SURCEL HM, 1991, INFECT IMMUN, V59, P1948, DOI 10.1128/IAI.59.6.1948-1953.1991; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; TARNVIK A, 1989, REV INFECT DIS, V11, P440; TARNVIK A, 1985, J CLIN MICROBIOL, V22, P527; Winkler S, 2005, MICROBES INFECT, V7, P1161, DOI 10.1016/j.micinf.2005.03.020; Zhou W, 2007, VIRAL IMMUNOL, V20, P379, DOI 10.1089/vim.2007.0030	39	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32367	10.1371/journal.pone.0032367	http://dx.doi.org/10.1371/journal.pone.0032367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412866	Green Submitted, gold, Green Published			2022-12-25	WOS:000303021100015
J	Wang, CG; Han, SJ; Zhou, YM; Yan, CF; Cheng, XB; Zheng, XB; Li, MH				Wang, Cunguo; Han, Shijie; Zhou, Yumei; Yan, Caifeng; Cheng, Xubing; Zheng, Xingbo; Li, Mai-He			Responses of Fine Roots and Soil N Availability to Short-Term Nitrogen Fertilization in a Broad-Leaved Korean Pine Mixed Forest in Northeastern China	PLOS ONE			English	Article							NORWAY SPRUCE FOREST; CARBON ALLOCATION; BIOMASS; TURNOVER; DYNAMICS; ECOSYSTEMS; PLANTATION; DEPOSITION; CHEMISTRY; STAND	Knowledge of the responses of soil nitrogen (N) availability, fine root mass, production and turnover rates to atmospheric N deposition is crucial for understanding fine root dynamics and functioning in forest ecosystems. Fine root biomass and necromass, production and turnover rates, and soil nitrate-N and ammonium-N in relation to N fertilization (50 kg N ha(-1) year(-1)) were investigated in a temperate forest over the growing season of 2010, using sequential soil cores and ingrowth cores methods. N fertilization increased soil nitrate-N by 16% (P<0.001) and ammonium-N by 6% (P<0.01) compared to control plots. Fine root biomass and necromass in 0-20 cm soil were 13% (4.61 vs. 5.23 Mg ha(-1), P<0.001) and 34% (1.39 vs. 1.86 Mg ha(-1), P<0.001) less in N fertilization plots than those in control plots. The fine root mass was significantly negatively correlated with soil N availability and nitrate-N contents, especially in 0-10 cm soil layer. Both fine root production and turnover rates increased with N fertilization, indicating a rapid underground carbon cycling in environment with high nitrogen levels. Although high N supply has been widely recognized to promote aboveground growth rates, the present study suggests that high levels of nitrogen supply may reduce the pool size of the underground carbon. Hence, we conclude that high levels of atmospheric N deposition will stimulate the belowground carbon cycling, leading to changes in the carbon balance between aboveground and underground storage. The implications of the present study suggest that carbon model and prediction need to take the effects of nitrogen deposition on underground system into account.	[Wang, Cunguo; Han, Shijie; Zhou, Yumei; Yan, Caifeng; Cheng, Xubing; Zheng, Xingbo; Li, Mai-He] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Wang, Cunguo; Yan, Caifeng; Cheng, Xubing; Zheng, Xingbo] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Li, Mai-He] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Wang, CG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	hansj@iae.ac.cn; maihe.li@wsl.ch	Li, Mai-He/L-6390-2013; Zhou, Yu/HHN-3071-2022	Li, Mai-He/0000-0002-7029-2841; 	National Basic Research Program of China [2011CB403200]; National Natural Science Foundation of China [40930107]; Chinese Academy of Sciences [KSCX-YW-Z-1022]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	Financial support was obtained from National Basic Research Program of China (NO. 2011CB403200), National Natural Science Foundation of China (NO. 40930107) and Knowledge Innovation Program of Chinese Academy of Sciences (NO. KSCX-YW-Z-1022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; Adamek M, 2011, J TROP ECOL, V27, P73, DOI 10.1017/S0266467410000507; [Anonymous], 2017, STANDARD METHODS EXA; Burton AJ, 2000, OECOLOGIA, V125, P389, DOI 10.1007/s004420000455; Chappell HN, 1999, SOIL SCI SOC AM J, V63, P1448; Cheng YunHuan, 2005, Acta Phytoecologica Sinica, V29, P403; CLEMENSSONLINDELL A, 1995, PLANT SOIL, V168, P167, DOI 10.1007/BF00029325; DORICH RA, 1983, SOIL SCI SOC AM J, V47, P833, DOI 10.2136/sssaj1983.03615995004700040042x; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Finer L, 2011, FOREST ECOL MANAG, V261, P265, DOI 10.1016/j.foreco.2010.10.016; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Gundersen P, 1998, FOREST ECOL MANAG, V101, P37, DOI 10.1016/S0378-1127(97)00124-2; Guo Da-li, 2007, Yingyong Shengtai Xuebao, V18, P2354; HAYNES BE, 1995, TREE PHYSIOL, V15, P317, DOI 10.1093/treephys/15.5.317; Helmisaari HS, 1999, FOREST ECOL MANAG, V119, P99, DOI 10.1016/S0378-1127(98)00514-3; Hendricks JJ, 2006, J ECOL, V94, P40, DOI 10.1111/j.1365-2745.2005.01067.x; Hertel D, 2002, PLANT SOIL, V239, P237, DOI 10.1023/A:1015030320845; Hogberg P, 2006, GLOBAL CHANGE BIOL, V12, P489, DOI 10.1111/j.1365-2486.2006.01102.x; Hu YL, 2010, PLANT SOIL, V333, P81, DOI 10.1007/s11104-010-0321-6; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Jourdan C, 2008, FOREST ECOL MANAG, V256, P396, DOI 10.1016/j.foreco.2008.04.034; Konopka B, 2006, FOREST ECOL MANAG, V225, P278, DOI 10.1016/j.foreco.2006.01.004; [刘琪璟 LIU Qi-Jing], 2009, [生态学报, Acta Ecologica Sinica], V29, P5656; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; Lukac M, 2010, PLANT SOIL, V331, P505, DOI 10.1007/s11104-009-0271-z; MCCLAUGHERTY CA, 1982, ECOLOGY, V63, P1481, DOI 10.2307/1938874; Mei L, 2010, J FOREST RES-JPN, V15, P194, DOI 10.1007/s10310-009-0176-y; Mei Li, 2008, Shengtaixue Zazhi, V27, P1663; Moore JD, 2009, ENVIRON MONIT ASSESS, V155, P177, DOI 10.1007/s10661-008-0427-y; Nadelhoffer KJ, 2000, NEW PHYTOL, V147, P131, DOI 10.1046/j.1469-8137.2000.00677.x; Nadelhoffer KJ, 2004, FOREST ECOL MANAG, V196, P89, DOI 10.1016/j.foreco.2004.03.014; NADELHOFFER KJ, 1992, ECOLOGY, V73, P1139, DOI 10.2307/1940664; Neatrour MA, 2005, CAN J FOREST RES, V35, P2934, DOI 10.1139/X05-217; Nordin A, 2005, AMBIO, V34, P20, DOI 10.1639/0044-7447(2005)034[0020:NDATBO]2.0.CO;2; Ostonen I, 2005, FOREST ECOL MANAG, V212, P264, DOI 10.1016/j.foreco.2005.03.064; Persson H, 2002, FOREST ECOL MANAG, V168, P29, DOI 10.1016/S0378-1127(01)00726-5; Persson HA, 2010, PLANT SOIL, V330, P329, DOI 10.1007/s11104-009-0206-8; Pregitzer KS, 2000, ECOL APPL, V10, P18, DOI 10.1890/1051-0761(2000)010[0018:IEOACA]2.0.CO;2; Ring E, 2006, CAN J FOREST RES, V36, P153, DOI [10.1139/x05-242, 10.1139/X05-242]; Ring E, 2011, CAN J FOREST RES, V41, P279, DOI 10.1139/X10-208; Shan J.P., 1993, CHIN J APPL ECOL, V4, P241; Shemesh H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010824; Son Y, 2003, ECOL RES, V18, P339, DOI 10.1046/j.1440-1703.2003.00559.x; VOGT KA, 1986, ADV ECOL RES, V15, P303, DOI 10.1016/S0065-2504(08)60122-1; Vogt KA, 1996, PLANT SOIL, V187, P159, DOI 10.1007/BF00017088; Vogt KA, 1998, PLANT SOIL, V200, P71, DOI 10.1023/A:1004313515294; Wang Shu-tang, 2010, Yingyong Shengtai Xuebao, V21, P583; West JB, 2004, FOREST ECOL MANAG, V189, P397, DOI 10.1016/j.foreco.2003.09.009; Xiao CW, 2008, FOREST ECOL MANAG, V255, P765, DOI 10.1016/j.foreco.2007.09.062; Yang LY, 2010, FORESTRY, V83, P379, DOI 10.1093/forestry/cpq020; Yang LiYun, 2005, Journal of Beijing Forestry University, V27, P1; Yuan ZY, 2010, CRIT REV PLANT SCI, V29, P204, DOI 10.1080/07352689.2010.483579; Zhang Chun-yu, 2006, Forest Research, V19, P347; Zhou YM, 2011, TREE PHYSIOL, V31, P707, DOI 10.1093/treephys/tpr066	54	43	56	12	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e31042	10.1371/journal.pone.0031042	http://dx.doi.org/10.1371/journal.pone.0031042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412833	Green Published, Green Submitted, gold			2022-12-25	WOS:000303021100005
J	Madin, EMP; Gaines, SD; Madin, JS; Link, AK; Lubchenco, PJ; Selden, RL; Warner, RR				Madin, Elizabeth M. P.; Gaines, Steven D.; Madin, Joshua S.; Link, Anne-Katrin; Lubchenco, Peggy J.; Selden, Rebecca L.; Warner, Robert R.			Do Behavioral Foraging Responses of Prey to Predators Function Similarly in Restored and Pristine Foodwebs?	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; TROPHIC CASCADES; MARINE RESERVES; HERBIVORE BEHAVIOR; SCARUS-ISERTI; CORAL-REEFS; ISLANDS; AVAILABILITY; PARROTFISH; COMMUNITY	Efforts to restore top predators in human-altered systems raise the question of whether rebounds in predator populations are sufficient to restore pristine foodweb dynamics. Ocean ecosystems provide an ideal system to test this question. Removal of fishing in marine reserves often reverses declines in predator densities and size. However, whether this leads to restoration of key functional characteristics of foodwebs, especially prey foraging behavior, is unclear. The question of whether restored and pristine foodwebs function similarly is nonetheless critically important for management and restoration efforts. We explored this question in light of one important determinant of ecosystem function and structure herbivorous prey foraging behavior. We compared these responses for two functionally distinct herbivorous prey fishes (the damselfish Plectroglyphidodon dickii and the parrotfish Chlorurus sordidus) within pairs of coral reefs in pristine and restored ecosystems in two regions of these species' biogeographic ranges, allowing us to quantify the magnitude and temporal scale of this key ecosystem variable's recovery. We demonstrate that restoration of top predator abundances also restored prey foraging excursion behaviors to a condition closely resembling those of a pristine ecosystem. Increased understanding of behavioral aspects of ecosystem change will greatly improve our ability to predict the cascading consequences of conservation tools aimed at ecological restoration, such as marine reserves.	[Madin, Elizabeth M. P.; Selden, Rebecca L.; Warner, Robert R.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Madin, Elizabeth M. P.; Madin, Joshua S.; Link, Anne-Katrin] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Gaines, Steven D.; Lubchenco, Peggy J.; Warner, Robert R.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Gaines, Steven D.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Macquarie University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Madin, EMP (corresponding author), Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia.	elizabeth.madin@uts.edu.au	Gaines, Steven/Y-3234-2019; Warner, Robert R./M-5342-2013	Warner, Robert R./0000-0002-3299-5685; Madin, Joshua/0000-0002-5005-6227; Selden, Rebecca/0000-0001-7956-5984	U.S. National Science Foundation; Andrew W. Mellon Foundation; U.S. Department of Homeland Security; National Geographic Society; MarIsla Foundation; Myers Oceanographic Trust; Sigma Xi Scientific Research Society; Worster Family Trust; University of California Santa Barbara (UCSB) Departments of Ecology, Evolution and Marine Biology and Geography; Office Of The Director [0853117] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Andrew W. Mellon Foundation; U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); National Geographic Society(National Geographic Society); MarIsla Foundation; Myers Oceanographic Trust; Sigma Xi Scientific Research Society; Worster Family Trust; University of California Santa Barbara (UCSB) Departments of Ecology, Evolution and Marine Biology and Geography; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was funded by the U.S. National Science Foundation, the Andrew W. Mellon Foundation, the U.S. Department of Homeland Security, the National Geographic Society, the MarIsla Foundation, the Myers Oceanographic Trust, the Sigma Xi Scientific Research Society, the Worster Family Trust, and University of California Santa Barbara (UCSB) Departments of Ecology, Evolution and Marine Biology and Geography. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock RC, 1999, MAR ECOL PROG SER, V189, P125, DOI 10.3354/meps189125; Babcock RC, 2010, P NATL ACAD IN PRESS; Bock CE, 2007, ECOLOGY, V88, P1322, DOI 10.1890/06-0654; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; CLIFTON KE, 1989, ANIM BEHAV, V37, P90, DOI 10.1016/0003-3472(89)90009-2; CLIFTON KE, 1995, MAR ECOL PROG SER, V116, P39, DOI 10.3354/meps116039; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Halpern BS, 2003, ECOL APPL, V13, pS117; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Helfrich PT, 1968, PAPERS BP BISHOP MUS, V23, P305; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; Madin EMP, 2010, AM NAT, V176, P785, DOI 10.1086/657039; McDonald A.D., 2004, EFFECTS LINE FISHING; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; RANDALL JE, 1980, FISH B-NOAA, V78, P201; Ripple WJ, 2006, FOREST ECOL MANAG, V230, P96, DOI 10.1016/j.foreco.2006.04.023; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Russ GR, 1998, CORAL REEFS, V17, P383, DOI 10.1007/s003380050144; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x	29	12	14	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32390	10.1371/journal.pone.0032390	http://dx.doi.org/10.1371/journal.pone.0032390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403650	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700047
J	Ai, J; Xin, XL; Zheng, MY; Wang, SA; Peng, SY; Li, J; Wang, LM; Jiang, HL; Geng, MY				Ai, Jing; Xin, Xianliang; Zheng, Mingyue; Wang, Shuai; Peng, Shuying; Li, Jing; Wang, Limei; Jiang, Hualiang; Geng, Meiyu			A Triad of Lys12, Lys41, Arg78 Spatial Domain, a Novel Identified Heparin Binding Site on Tat Protein, Facilitates Tat-Driven Cell Adhesion	PLOS ONE			English	Article								Tat protein, released by HIV-infected cells, has a battery of important biological effects leading to distinct AIDS-associated pathologies. Cell surface heparan sulfate protoglycans (HSPGs) have been accepted as endogenous Tat receptors, and the Tat basic domain has been identified as the heparin binding site. However, findings that deletion or substitution of the basic domain inhibits but does not completely eliminate Tat-heparin interactions suggest that the basic domain is not the sole Tat heparin binding site. In the current study, an approach integrating computational modeling, mutagenesis, biophysical and cell-based assays was used to elucidate a novel, high affinity heparin-binding site: a Lys12, Lys41, Arg78 (KKR) spatial domain. This domain was also found to facilitate Tat-driven beta 1 integrin activation, producing subsequent SLK cell adhesion in an HSPG-dependent manner, but was not involved in Tat internalization. The identification of this new heparin binding site may foster further insight into the nature of Tat-heparin interactions and subsequent biological functions, facilitating the rational design of new therapeutics against Tat-mediated pathological events.	[Ai, Jing; Xin, Xianliang; Li, Jing; Wang, Limei; Geng, Meiyu] Ocean Univ China, Dept Pharmacol & Glycobiol, Marine Drug & Food Inst, Qingdao, Peoples R China; [Wang, Shuai; Geng, Meiyu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Anti tumor Pharmacol, Shanghai, Peoples R China; [Zheng, Mingyue; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai, Peoples R China; [Peng, Shuying] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Anal Chem, Lab Mass Spectrometry, Shanghai, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Ai, J (corresponding author), Ocean Univ China, Dept Pharmacol & Glycobiol, Marine Drug & Food Inst, Qingdao, Peoples R China.	hljiang@mail.shcnc.ac.cn; gengmy@ouc.edu.cn	Zheng, Mingyue/Z-3582-2019; Zheng, Mingyue/HHZ-4062-2022; Zheng, Mingyue/B-4860-2010; Zheng, Mingyue/AAJ-8027-2020	Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092	National Basic Research Program of China [2003CB716400]; Natural Science Foundation of China for Distinguished Young Scholars [30725046]; Natural Science Foundation of Shandong Province [y2004c19]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by National Basic Research Program Grant (2003CB716400) of China, Natural Science Foundation of China for Distinguished Young Scholars (30725046) Natural Science Foundation of Shandong Province(y2004c19).	Barillari G, 1999, BLOOD, V94, P663; Barillari G, 2002, CLIN MICROBIOL REV, V15, P310, DOI 10.1128/CMR.15.2.310-326.2002; BICH C, 2007, ANAL BIOCH; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CAPUTO A, 1999, RRD VIROLOGY III, V1, P753; COLE C, 2008, NUCL ACIDS RES; CULLEN BR, 1990, CELL, V63, P655, DOI 10.1016/0092-8674(90)90129-3; Dewhurst S, 1996, MOL MED TODAY, V2, P16, DOI 10.1016/1357-4310(96)88754-5; Fittipaldi A, 2005, ADV DRUG DELIVER REV, V57, P597, DOI 10.1016/j.addr.2004.10.011; Fournier HN, 2002, J BIOL CHEM, V277, P20895, DOI 10.1074/jbc.M200200200; GARRETT MM, 1999, J COMPUT CHEM, V19, P1639; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; Katsuraya K, 1999, CARBOHYD RES, V315, P234, DOI 10.1016/S0008-6215(98)00315-2; Li FC, 2003, CHINESE J ANAL CHEM, V31, P266; Liu HY, 2005, GLYCOBIOLOGY, V15, P501, DOI 10.1093/glycob/cwi031; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Mulloy B, 2005, AN ACAD BRAS CIENC, V77, P651, DOI 10.1590/S0001-37652005000400007; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; Nguyen B, 2007, METHODS, V42, P150, DOI 10.1016/j.ymeth.2006.09.009; Noonan D, 2000, Adv Pharmacol, V48, P229; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Pattnaik P, 2005, APPL BIOCHEM BIOTECH, V126, P79, DOI 10.1385/ABAB:126:2:079; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Rusnati M, 1998, J BIOL CHEM, V273, P16027, DOI 10.1074/jbc.273.26.16027; Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Rusnati Marco, 2002, Angiogenesis, V5, P141, DOI 10.1023/A:1023892223074; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2662	10.1371/journal.pone.0002662	http://dx.doi.org/10.1371/journal.pone.0002662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	22423313	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200008
J	Du, M; Wang, GZ; Ismail, TM; Gross, S; Fernig, DG; Barraclough, R; Rudland, PS				Du, Min; Wang, Guozheng; Ismail, Thamir M.; Gross, Stephane; Fernig, David G.; Barraclough, Roger; Rudland, Philip S.			S100P Dissociates Myosin IIA Filaments and Focal Adhesion Sites to Reduce Cell Adhesion and Enhance Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFETIME IMAGING MICROSCOPY; CALCIUM-BINDING PROTEIN; HEAVY-CHAIN PHOSPHORYLATION; METASTASIS-INDUCING PROTEIN; PANCREATIC-CANCER GROWTH; NONMUSCLE MYOSIN; BREAST-CANCER; MTS1 S100A4; IN-VITRO; CENTER STAGE	S100 proteins promote cancer cell migration and metastasis. To investigate their roles in the process of migration we have constructed inducible systems for S100P in rat mammary and human HeLa cells that show a linear relationship between its intracellular levels and cell migration. S100P, like S100A4, differentially interacts with the isoforms of nonmuscle myosin II (NMIIA, K-d = 0.5 mu M; IIB, K-d = 8 mu M; IIC, K-d = 1.0 mu M). Accordingly, S100P dissociates NMIIA and IIC filaments but not IIB in vitro. NMIIA knockdown increases migration in non-induced cells and there is no further increase upon induction of S100P, whereas NMIIB knockdown reduces cell migration whether or not S100P is induced. NMIIC knockdown does not affect S100P-enhanced cell migration. Further study shows that NMIIA physically interacts with S100P in living cells. In the cytoplasm, S100P occurs in discrete nodules along NMIIA-containing filaments. Induction of S100P causes more peripheral distribution of NMIIA filaments. This change is paralleled by a significant drop in vinculin-containing, actin-terminating focal adhesion sites ( FAS) per cell. The induction of S100P, consequently, causes significant reduction in cellular adhesion. Addition of a focal adhesion kinase ( FAK) inhibitor reduces disassembly of FAS and thereby suppresses S100P-enhanced cell migration. In conclusion, this work has demonstrated a mechanism whereby the S100P-induced dissociation of NMIIA filaments leads to a weakening of FAS, reduced cell adhesion, and enhanced cell migration, the first major step in the metastatic cascade.	[Wang, Guozheng] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7ZB, Merseyside, England; [Du, Min; Ismail, Thamir M.; Fernig, David G.; Barraclough, Roger; Rudland, Philip S.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Gross, Stephane] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Liverpool; University of Liverpool; Aston University	Wang, GZ (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Crown St, Liverpool L69 7ZB, Merseyside, England.	wangg@liv.ac.uk; rudland@liv.ac.uk	Fernig, David G/A-3590-2008; Barraclough, Roger/AAH-6516-2020	Fernig, David G/0000-0003-4875-4293; gross, stephane/0000-0002-0867-8866; Barraclough, Roger/0000-0002-7203-1194	Cancer and Polio Research Fund; North West Cancer Research Fund	Cancer and Polio Research Fund; North West Cancer Research Fund	This work was supported by the Cancer and Polio Research Fund and the North West Cancer Research Fund.	ALBINI A, 1987, CANCER RES, V47, P3239; Anderson S, 2004, EXP CELL RES, V298, P574, DOI 10.1016/j.yexcr.2004.05.005; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Arumugam T, 2006, J NATL CANCER I, V98, P1806, DOI 10.1093/jnci/djj498; Badyal SK, 2011, J MOL BIOL, V405, P1004, DOI 10.1016/j.jmb.2010.11.036; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Bronckart Y, 2001, HISTOL HISTOPATHOL, V16, P707, DOI 10.14670/HH-16.707; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; Chen HL, 2001, BIOCHEM BIOPH RES CO, V286, P1212, DOI 10.1006/bbrc.2001.5517; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168; DAVIES BR, 1993, ONCOGENE, V8, P999; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Elangovan M, 2002, J MICROSC-OXFORD, V205, P3, DOI 10.1046/j.0022-2720.2001.00984.x; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fernig D G, 2001, Methods Mol Biol, V171, P505; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; FORD HL, 1995, ONCOGENE, V10, P1597; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; GIBBS FEM, 1994, J BIOL CHEM, V269, P18992; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Ismail T. M., 2011, MONTR INT S ANG MET, P101; Ismail TM, 2010, J BIOL CHEM, V285, P914, DOI 10.1074/jbc.M109.010892; Ismail TM, 2008, CARCINOGENESIS, V29, P2259, DOI 10.1093/carcin/bgn217; Jenkinson SR, 2004, BRIT J CANCER, V90, P253, DOI 10.1038/sj.bjc.6601483; Kriajevska M, 1998, J BIOL CHEM, V273, P9852, DOI 10.1074/jbc.273.16.9852; Kriajevska M, 2000, BBA-MOL CELL RES, V1498, P252, DOI 10.1016/S0167-4889(00)00100-2; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamartina S, 2003, MOL THER, V7, P271, DOI 10.1016/S1525-0016(02)00051-5; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Li ZH, 2010, MOL BIOL CELL, V21, P2598, DOI 10.1091/mbc.E09-07-0609; Liu ZA, 2010, BRIT J PHARMACOL, V159, P304, DOI 10.1111/j.1476-5381.2009.00477.x; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Murakami N, 1995, BIOCHEMISTRY-US, V34, P16046, DOI 10.1021/bi00049a019; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pepperkok R, 1999, CURR BIOL, V9, P269, DOI 10.1016/S0960-9822(99)80117-1; Perez D, 2007, J INVEST SURG, V20, P181, DOI 10.1080/08941930701366349; Ren XD, 2000, J CELL SCI, V113, P3673; Rudland PS, 2000, CANCER RES, V60, P1595; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sieg DJ, 1999, J CELL SCI, V112, P2677; Swailes NT, 2006, J CELL SCI, V119, P3561, DOI 10.1242/jcs.03096; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Uren D, 2000, J CLIN INVEST, V105, P663, DOI 10.1172/JCI8199; Vallely KM, 2002, BIOCHEMISTRY-US, V41, P12670, DOI 10.1021/bi020365r; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wang GZ, 2005, ONCOGENE, V24, P1445, DOI 10.1038/sj.onc.1208291; Wang GZ, 2004, BIOCHEM J, V382, P375, DOI 10.1042/BJ20040142; Wang GZ, 2000, J BIOL CHEM, V275, P11141, DOI 10.1074/jbc.275.15.11141; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Wang ZG, 2008, ONCOL REP, V20, P1473, DOI 10.3892/or_00000168; Watanabe T, 2005, NOVART FDN SYMP, V269, P223; Watanabe T, 2005, NOVART FDN SYMP, V269, P101; Watanabe Takashi, 2005, Novartis Found Symp, V269, P92; Whiteman HJ, 2007, CANCER RES, V67, P8633, DOI 10.1158/0008-5472.CAN-07-0545; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744; Zhang HM, 2003, J MOL BIOL, V325, P785, DOI 10.1016/S0022-2836(02)01278-0; Zhang S, 2005, ONCOGENE, V24, P4401, DOI 10.1038/sj.onc.1208663; Zhang S, 2005, EUR BIOPHYS J BIOPHY, V34, P19, DOI 10.1007/s00249-004-0428-x	85	47	49	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15330	15344		10.1074/jbc.M112.349787	http://dx.doi.org/10.1074/jbc.M112.349787			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22399300	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-25	WOS:000304006300016
J	Truong, K; Lee, TD; Chen, Y				Khue Truong; Lee, Terry D.; Chen, Yuan			Small Ubiquitin-like Modifier (SUMO) Modification of E1 Cys Domain Inhibits E1 Cys Domain Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING ENZYME; E1-E2 INTERACTION; HEAT-SHOCK; E3 LIGASE; IDENTIFICATION; CONJUGATION; BINDING; UBC9; SITE; E2	Although it is well established that ubiquitin-like modifications are tightly regulated, it has been unclear how their E1 activities are controlled. In this study, we found that the SAE2 subunit of the small ubiquitin-like modifier (SUMO) E1 is auto-SUMOylated at residue Lys-236, and SUMOylation was catalyzed by Ubc9 at several additional Lys residues surrounding the catalytic Cys-173 of SAE2. AutoSUMOylation of SAE2 did not affect SUMO adenylation or formation of E1.SUMO thioester, but did significantly inhibit the transfer of SUMO from E1 to E2 and overall SUMO conjugations to target proteins due to the altered interaction between E1 and E2. Upon heat shock, SUMOylation of SAE2 was reduced, which corresponded with an increase in global SUMOylation, suggesting that SUMOylation of the Cys domain of SAE2 is a mechanism for "storing" a pool of E1 that can be quickly activated in response to environmental changes. This study is the first to show how E1 activity is controlled by post-translational modifications, and similar regulation likely exists across the homologous E1s of ubiquitin-like modifications.	[Khue Truong; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Khue Truong] City Hope Natl Med Ctr, Beckman Res Inst, Grad Sch Biol Sci, Duarte, CA 91010 USA; [Lee, Terry D.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Chen, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, 1450 E Duarte Rd, Duarte, CA 91010 USA.	ychen@coh.org			National Institutes of Health through the NIGMS [R01 GM086171, R01 GM074748]; National Institutes of Health [P30 CA033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086171, R01GM074748] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM086171 and R01 GM074748 (to Y. C.) through the NIGMS and National Institutes of Health Grant P30 CA033572 from the NCI.	Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Evans TC, 1999, BIOPOLYMERS, V51, P333, DOI 10.1002/(SICI)1097-0282(1999)51:5<333::AID-BIP3>3.3.CO;2-R; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Miller MJ, 2011, PLANT SIGNAL BEHAV, V6, P130, DOI 10.4161/psb.6.1.14256; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sramko M, 2006, J BIOL CHEM, V281, P40065, DOI 10.1074/jbc.M609404200; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Truong K, 2011, BIOCHEMISTRY-US, V50, P5757, DOI 10.1021/bi2001856; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2010, J BIOL CHEM, V285, P33457, DOI 10.1074/jbc.M110.135582; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257	33	24	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15154	15163		10.1074/jbc.M112.353789	http://dx.doi.org/10.1074/jbc.M112.353789			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403398	hybrid, Green Published			2022-12-25	WOS:000304006300001
J	Dai, RY; Li, JJ; Fu, J; Chen, Y; Yu, LX; Zhao, XF; Qian, YW; Zhang, HL; Chen, HY; Ren, YB; Su, B; Luo, T; Zhu, JJ; Wang, HY				Dai, Rongyang; Li, Juanjuan; Fu, Jing; Chen, Yao; Yu, Lexing; Zhao, Xiaofang; Qian, Youwen; Zhang, Huilu; Chen, Haiyang; Ren, Yibin; Su, Bo; Luo, Tao; Zhu, Junjie; Wang, Hongyang			Disturbance of Ca2+ Homeostasis Converts Pro-Met into Non-canonical Tyrosine Kinase p190Met(NC) in Response to Endoplasmic Reticulum Stress in MHCC97 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; HEPATOCYTE GROWTH-FACTOR; HUMAN HEPATOCELLULAR-CARCINOMA; ER STRESS; C-MET; INDUCED APOPTOSIS; REGULATOR GRP78/BIP; ADAPTIVE CAPACITY; INVASIVE GROWTH; CHAPERONE GRP78	c-Met, the tyrosine-kinase receptor for hepatocyte growth factor, plays a critical role in the tumorigenesis of hepatocellular carcinoma (HCC). However, the underlying mechanism remains incompletely understood. The mature c-Met protein p190Met(alpha beta) (consists of a alpha subunit and a beta subunit) is processed from pro-Met. Here we show that pro-Met is processed into p190Met(NC) by sarco/endoplasmic reticulum calcium-ATPase (SERCA) inhibitor thapsigargin. p190MetNC compensates for the degradation of p190Met(alpha beta) and protects human HCC cells from apoptosis mediated by endoplasmic reticulum (ER) stress. In comparison with p190Met(alpha beta), p190Met(NC) is not cleaved and is expressed as a single-chain polypeptide. Thapsigargin-initiated p190Met(NC) expression depends on the disturbance of ER calcium homeostasis. Once induced, p190Met(NC) is activated independent of hepatocyte growth factor engagement. p190Met(NC) contributes to sustained high basal activation of c-Met downstream pathways during ER calcium disturbance-mediated ER stress. Both p38 MAPK-promoted glucose-regulated protein 78 (GRP78) expression and sustained high basal activation of PI3K/Akt and MEK/ERK are involved in the cytoprotective function of p190Met(NC). Importantly, the expression of p190Met(NC) is detected in some HCC cases. Taken together, these data provide a potential mechanism to explain how c-Met promotes HCC cells survival in response to ER stress. We propose that context-specific processing of c-Met protein is implicated in HCC progression in stressful microenvironments.	[Dai, Rongyang; Li, Juanjuan; Fu, Jing; Chen, Yao; Yu, Lexing; Zhao, Xiaofang; Qian, Youwen; Zhang, Huilu; Chen, Haiyang; Ren, Yibin; Su, Bo; Luo, Tao; Zhu, Junjie; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China; [Dai, Rongyang; Wang, Hongyang] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Inst Canc, Renji Hosp, Shanghai 200032, Peoples R China; [Dai, Rongyang] Luzhou Med Coll, Dept Biochem, Luzhou 646000, Sichuan, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; Southwest Medical University	Wang, HY (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China.	hywangk@vip.sina.com	Yu, Lexing/AGP-5427-2022	Yu, Lexing/0000-0001-9619-8004; Dai, Rong-yang/0000-0002-7126-1713	National Natural Science Foundation of China [81000886, 81170377, 81101714, 30921006, 91029732]; State Key Project for Infectious Diseases [2012ZX10002-009]; New Century Excellent Talents in University; State Key Laboratory of Oncogenes and Related Genes [91-10-02, 90-10-03, 90-09-06, 10JC1418500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Project for Infectious Diseases; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Oncogenes and Related Genes	This work was supported by the projects from National Natural Science Foundation of China (81000886, 81170377, 81101714, 30921006, 91029732), the State Key Project for Infectious Diseases (2012ZX10002-009), New Century Excellent Talents in University, and the State Key Laboratory of Oncogenes and Related Genes (91-10-02, 90-10-03, 90-09-06), and 10JC1418500.	Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Dai RY, 2010, FOLIA BIOL-PRAGUE, V56, P37; Dai RY, 2009, CELL RES, V19, P1243, DOI 10.1038/cr.2009.104; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Desiderio MA, 2007, CELL MOL LIFE SCI, V64, P1341, DOI 10.1007/s00018-007-7050-x; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; GIORDANO S, 1989, ONCOGENE, V4, P1383; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu YF, 2011, CELL RES, V21, P867, DOI 10.1038/cr.2011.75; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; MONDINO A, 1991, MOL CELL BIOL, V11, P6084, DOI 10.1128/MCB.11.12.6084; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Novosyadlyy R, 2008, CELL DEATH DIFFER, V15, P1304, DOI 10.1038/cdd.2008.52; Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ou DSC, 2011, CELL RES, V21, P642, DOI 10.1038/cr.2011.10; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yeung BHY, 2008, ONCOGENE, V27, P6782, DOI 10.1038/onc.2008.290; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Zhang LJ, 2009, CANCER LETT, V274, P40, DOI 10.1016/j.canlet.2008.08.030	44	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14586	14597		10.1074/jbc.M111.333435	http://dx.doi.org/10.1074/jbc.M111.333435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22418436	hybrid, Green Published			2022-12-25	WOS:000304003200025
J	Bond, ME; Babcock, EA; Pikitch, EK; Abercrombie, DL; Lamb, NF; Chapman, DD				Bond, Mark E.; Babcock, Elizabeth A.; Pikitch, Ellen K.; Abercrombie, Debra L.; Lamb, Norlan F.; Chapman, Demian D.			Reef Sharks Exhibit Site-Fidelity and Higher Relative Abundance in Marine Reserves on the Mesoamerican Barrier Reef	PLOS ONE			English	Article							DE-NORONHA ARCHIPELAGO; FISH ASSEMBLAGES; CARCHARHINUS-PEREZI; MOVEMENT PATTERNS; PROTECTED AREAS; BAITED VIDEO; HABITAT USE; CONSERVATION; COMMUNITIES; POPULATIONS	Carcharhinid sharks can make up a large fraction of the top predators inhabiting tropical marine ecosystems and have declined in many regions due to intense fishing pressure. There is some support for the hypothesis that carcharhinid species that complete their life-cycle within coral reef ecosystems, hereafter referred to as "reef sharks'', are more abundant inside no-take marine reserves due to a reduction in fishing pressure (i.e., they benefit from marine reserves). Key predictions of this hypothesis are that (a) individual reef sharks exhibit high site-fidelity to these protected areas and (b) their relative abundance will generally be higher in these areas compared to fished reefs. To test this hypothesis for the first time in Caribbean coral reef ecosystems we combined acoustic monitoring and baited remote underwater video (BRUV) surveys to measure reef shark site-fidelity and relative abundance, respectively. We focused on the Caribbean reef shark (Carcharhinus perezi), the most common reef shark in the Western Atlantic, at Glover's Reef Marine Reserve (GRMR), Belize. Acoustically tagged sharks (N = 34) were detected throughout the year at this location and exhibited strong site-fidelity. Shark presence or absence on 200 BRUVs deployed at GRMR and three other sites (another reserve site and two fished reefs) showed that the factor "marine reserve'' had a significant positive effect on reef shark presence. We rejected environmental factors or site-environment interactions as predominant drivers of this pattern. These results are consistent with the hypothesis that marine reserves can benefit reef shark populations and we suggest new hypotheses to determine the underlying mechanism(s) involved: reduced fishing mortality or enhanced prey availability.	[Bond, Mark E.; Pikitch, Ellen K.; Chapman, Demian D.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA; [Babcock, Elizabeth A.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Abercrombie, Debra L.] Port Jefferson Stn, New York, NY USA; [Lamb, Norlan F.] Absolondna, Dangriga, Belize	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Miami	Bond, ME (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA.	markbond8@gmail.com	Babcock, Elizabeth A/E-7753-2013	Babcock, Elizabeth A/0000-0002-2279-6762; Abercrombie, Debra/0000-0002-2572-1862	Roe Foundation; Pew Charitable Trust	Roe Foundation; Pew Charitable Trust	Funding: The Roe Foundation; The Pew Charitable Trust (www.pewtrusts.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; AU DW, 2008, SHARKS OPEN OCEAN BI, P298, DOI DOI 10.1002/9781444302516.CH26; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bates D, 2010, LME4 LINEAR MIXED LI; Brooks Edward J., 2011, Endangered Species Research, V13, P231, DOI 10.3354/esr00331; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Chapman DD, 2007, MAR ECOL PROG SER, V344, P271, DOI 10.3354/meps06941; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno LJV, 1984, FAO FISH SYNOPSIS, V4; Dale Jonathan J., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/725602; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Garla RC, 2006, FISH RES, V81, P236, DOI 10.1016/j.fishres.2006.07.003; Garla RC, 2006, MAR BIOL, V149, P189, DOI 10.1007/s00227-005-0201-4; Gibson J., 2004, MARINE RESERVES GUID, P287; Grubbs RD, 2010, CRC MAR BIOL SER, P319; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Jacobson LD, 1992, CAN J FISH AQUAT SCI, V49, P2525; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Maljkovic A, 2011, BIOL CONSERV, V144, P859, DOI 10.1016/j.biocon.2010.11.019; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Meekan M, 2004, NONDESTRUCTIVE TECHN; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Musick JA, 1999, AM FISH S S, V23, P1; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Pikitch EK, 2005, MAR ECOL PROG SER, V302, P187, DOI 10.3354/meps302187; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Rosa RS, 2006, IUCN 2010 IUCN RED L; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Russ GR, 2003, ECOL APPL, V13, P1553, DOI 10.1890/01-5341; Sobel JA, 2004, MARINE RESERVES GUID; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; Tavares Rafael, 2009, Pan-American Journal of Aquatic Sciences, V4, P500; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Watson DL, 2007, MAR BIOL, V152, P1197, DOI 10.1007/s00227-007-0767-0; Watson DL, 2009, MAR ECOL PROG SER, V384, P241, DOI 10.3354/meps08009; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6	47	142	144	5	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32983	10.1371/journal.pone.0032983	http://dx.doi.org/10.1371/journal.pone.0032983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412965	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062000024
J	Hagedorn, M; Carter, V; Martorana, K; Paresa, MK; Acker, J; Baums, IB; Borneman, E; Brittsan, M; Byers, M; Henley, M; Laterveer, M; Leong, JA; McCarthy, M; Meyers, S; Nelson, BD; Petersen, D; Tiersch, T; Uribe, RC; Woods, E; Wildt, D				Hagedorn, Mary; Carter, Virginia; Martorana, Kelly; Paresa, Malia K.; Acker, Jason; Baums, Iliana B.; Borneman, Eric; Brittsan, Michael; Byers, Michael; Henley, Michael; Laterveer, Michael; Leong, Jo-Ann; McCarthy, Megan; Meyers, Stuart; Nelson, Brian D.; Petersen, Dirk; Tiersch, Terrence; Uribe, Rafael Cuevas; Woods, Erik; Wildt, David			Preserving and Using Germplasm and Dissociated Embryonic Cells for Conserving Caribbean and Pacific Coral	PLOS ONE			English	Article							REGION-WIDE DECLINES; ACROPORA-PALMATA; SPERM CRYOPRESERVATION; CLIMATE-CHANGE; PHASE-SHIFTS; REEF; CONSERVATION; RECRUITMENT; POPULATIONS; RESILIENCE	Coral reefs are experiencing unprecedented degradation due to human activities, and protecting specific reef habitats may not stop this decline, because the most serious threats are global (i.e., climate change), not local. However, ex situ preservation practices can provide safeguards for coral reef conservation. Specifically, modern advances in cryobiology and genome banking could secure existing species and genetic diversity until genotypes can be introduced into rehabilitated habitats. We assessed the feasibility of recovering viable sperm and embryonic cells post-thaw from two coral species, Acropora palmata and Fungia scutaria that have diffferent evolutionary histories, ecological niches and reproductive strategies. In vitro fertilization (IVF) of conspecific eggs using fresh (control) spermatozoa revealed high levels of fertilization (> 90% in A. palmata;> 84% in F. scutaria; P > 0.05) that were unaffected by tested sperm concentrations. A solution of 10% dimethyl sulfoxide (DMSO) at cooling rates of 20 to 30 degrees C/min most successfully cryopreserved both A. palmata and F. scutaria spermatozoa and allowed producing developing larvae in vitro. IVF success under these conditions was 65% in A. palmata and 53% in F. scutaria on particular nights; however, on subsequent nights, the same process resulted in little or no IVF success. Thus, the window for optimal freezing of high quality spermatozoa was short (similar to 5 h for one night each spawning cycle). Additionally, cryopreserved F. scutaria embryonic cells had, 50% post-thaw viability as measured by intact membranes. Thus, despite some differences between species, coral spermatozoa and embryonic cells are viable after low temperature (-196 degrees C) storage, preservation and thawing. Based on these results, we have begun systematically banking coral spermatozoa and embryonic cells on a large-scale as a support approach for preserving existing bio- and genetic diversity found in reef systems.	[Hagedorn, Mary; Carter, Virginia; Martorana, Kelly; Paresa, Malia K.; Wildt, David] Smithsonian Conservat Biol Inst, Dept Reprod Sci, Front Royal, VA USA; [Hagedorn, Mary; Carter, Virginia; Martorana, Kelly; Paresa, Malia K.; Leong, Jo-Ann] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Acker, Jason] Univ Alberta, Lab Med & Pathol, Edmonton, AB, Canada; [Baums, Iliana B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Borneman, Eric] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Brittsan, Michael] Columbus Zoo & Aquarium, Powell, OH USA; [Byers, Michael; Woods, Erik] Gen BioTechnol, Indianapolis, IN USA; [Henley, Michael] Smithsonian Natl Zool Pk, Invertebrate Exhibit, Washington, DC USA; [Laterveer, Michael; Petersen, Dirk] Rotterdam Zoo, Rotterdam, Netherlands; [McCarthy, Megan; Meyers, Stuart] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Nelson, Brian D.] Cent Wharf, New England Aquarium, Dept Fishes, Boston, MA USA; [Tiersch, Terrence; Uribe, Rafael Cuevas] Louisiana State Univ, Ctr Agr, Aquaculture Res Stn, Baton Rouge, LA 70803 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Hawaii System; University of Alberta; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Houston System; University of Houston; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of California System; University of California Davis; Louisiana State University System; Louisiana State University	Hagedorn, M (corresponding author), Smithsonian Conservat Biol Inst, Dept Reprod Sci, Front Royal, VA USA.	hagedornm@si.edu	Baums, Iliana Brigitta/G-6435-2010; Leong, Jo-Ann/ABE-1443-2021	Baums, Iliana Brigitta/0000-0001-6463-7308; Acker, Jason/0000-0002-1445-827X	National Oceanic and Atmospheric Administration [NA07NMF4630109, NA NA08NMF4630462]; National Science Foundation [OCE - 0825979]; Morris Animal Foundation [D07ZO-053]; Columbus Zoo and Aquarium Conservation Fund; Rotterdam Zoo, Green Foundation; Clyde and Connie Woodburn Foundation; Smithsonian Institution; Louisiana State University Agricultural Center; University of California Davis; Canadian Natural Sciences and Engineering Research Council (NSERC); Hawaii Institute of Marine Biology; Division Of Ocean Sciences [0825979] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); Morris Animal Foundation; Columbus Zoo and Aquarium Conservation Fund; Rotterdam Zoo, Green Foundation; Clyde and Connie Woodburn Foundation; Smithsonian Institution(Smithsonian Institution); Louisiana State University Agricultural Center; University of California Davis(University of California System); Canadian Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hawaii Institute of Marine Biology; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by: National Oceanic and Atmospheric Administration (grant # NA07NMF4630109 to MH; grant # NA NA08NMF4630462 to IB); National Science Foundation (OCE - 0825979 to IB); Morris Animal Foundation (grant # D07ZO-053 to MH); Columbus Zoo and Aquarium Conservation Fund (to MH); Rotterdam Zoo, Green Foundation, Clyde and Connie Woodburn Foundation (to SECORE); Smithsonian Institution, Louisiana State University Agricultural Center, University of California Davis and Hawaii Institute of Marine Biology and the Canadian Natural Sciences and Engineering Research Council (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; [Anonymous], 2008, FED REGISTER, P72210; [Anonymous], 2008, FED REGISTER, P64264; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; BALLOU JD, 1992, CRYOBIOLOGY, V29, P19, DOI 10.1016/0011-2240(92)90003-K; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Bavister BD, 2002, REPRODUCTION, V124, P181, DOI 10.1530/rep.0.1240181; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bruckner A.W, 2002, NOAA TECHNICAL MEMOR; Buddemeier RW, 2003, SCIENCE, V302, P391; Dobson A, 2000, SCIENCE, V288, P985, DOI 10.1126/science.288.5468.985; Domart-Coulon IJ, 2004, MAR BIOL, V144, P583, DOI 10.1007/s00227-003-1227-0; Domart-Coulon IJ, 2001, P NATL ACAD SCI USA, V98, P11885, DOI 10.1073/pnas.211439698; Dong QX, 2005, CRYOBIOLOGY, V50, P1, DOI 10.1016/j.cryobiol.2004.09.003; Downs CA, 2010, ECOTOXICOLOGY, V19, P171, DOI 10.1007/s10646-009-0403-5; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; Falciatori Ilaria, 2008, V450, P181, DOI 10.1007/978-1-60327-214-8_13; Fogarty N.D., 2010, THESIS FLORIDA STATE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GARNER DL, 1994, J ANDROL, V15, P620; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Grober-Dunsmore R, 2006, MAR ECOL PROG SER, V321, P123, DOI 10.3354/meps321123; Hagedorn M, 2006, CRYOBIOLOGY, V52, P454, DOI 10.1016/j.cryobiol.2006.03.001; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOGARTH WT, 2006, FED REGISTER, P26852; Holt WV, 1999, REV REPROD, V4, P143, DOI 10.1530/revreprod/4.3.143; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Iguchi A, 2009, ZYGOTE, V17, P225, DOI 10.1017/S096719940900519X; IMADE GE, 1993, ARCH ANDROLOGY, V31, P17, DOI 10.3109/01485019308988375; Khalesi MK, 2008, IN VITRO CELL DEV-AN, V44, P330, DOI 10.1007/s11626-008-9128-7; Krupp D.A., 1983, Coral Reefs, V2, P159, DOI 10.1007/BF00336722; Macintyre IG, 2007, CORAL REEFS, V26, P757, DOI 10.1007/s00338-007-0268-0; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Morita M, 2006, J EXP BIOL, V209, P4574, DOI 10.1242/jeb.02500; Nzali LM, 1998, AMBIO, V27, P717; Okubo N, 2007, ZOOL SCI, V24, P1169, DOI 10.2108/zsj.24.1169; Paniagua-Chavez CG, 1998, J SHELLFISH RES, V17, P231; Petersen D, 2008, CORAL REEFS, V27, P715, DOI 10.1007/s00338-008-0385-4; Petersen D, 2008, AQUACULTURE, V277, P174, DOI 10.1016/j.aquaculture.2008.02.034; RANA KJ, 1989, AQUACULTURE, V76, P335, DOI 10.1016/0044-8486(89)90085-9; Reyes-Bermudez A, 2009, CORAL REEFS, V28, P859, DOI 10.1007/s00338-009-0527-3; Schwarz JA, 1999, BIOL BULL-US, V196, P70, DOI 10.2307/1543169; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Tervit HR, 2005, CRYOBIOLOGY, V51, P142, DOI 10.1016/j.cryobiol.2005.06.001; Tiersch T. R., 2011, ADV WORLD AQUACULTUR; Veron JEN, 2008, CORAL REEFS, V27, P459, DOI 10.1007/s00338-008-0381-8; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Veron JEN, 2000, CORALS WORLD, V3; Wildt DE, 2010, MOL REPROD DEV, V77, P397, DOI 10.1002/mrd.21137; Wildt DE, 1997, BIOSCIENCE, V47, P689, DOI 10.2307/1313209; Wildt DE, 2001, J REP FER S, P295; Williams DE, 2008, CORAL REEFS, V27, P697, DOI 10.1007/s00338-008-0386-3; Wolf KN, 2000, ZOO BIOL, V19, P517, DOI 10.1002/1098-2361(2000)19:6<517::AID-ZOO4>3.3.CO;2-M; Young WP, 2009, SALMONID GAMETE PRES, P1; Zubillaga AL, 2008, CORAL REEFS, V27, P63, DOI 10.1007/s00338-007-0291-1	64	40	40	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33354	10.1371/journal.pone.0033354	http://dx.doi.org/10.1371/journal.pone.0033354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413020	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062000044
J	Versluis, B; Dremmen, MHG; Nelemans, PJ; Wildberger, JE; Schurink, GW; Leiner, T; Backes, WH				Versluis, Bas; Dremmen, Marjolein H. G.; Nelemans, Patty J.; Wildberger, Joachim E.; Schurink, Geert-Willem; Leiner, Tim; Backes, Walter H.			MRI of Arterial Flow Reserve in Patients with Intermittent Claudication: Feasibility and Initial Experience	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; BLOOD-FLOW; REACTIVE HYPEREMIA; SKELETAL-MUSCLE; CORONARY FLOW; SMALL VESSELS; CONTRAST; DISEASE; VELOCITY; ANGIOGRAPHY	Objectives: The aim of this work was to develop a MRI method to determine arterial flow reserve in patients with intermittent claudication and to investigate whether this method can discriminate between patients and healthy control subjects. Methods: Ten consecutive patients with intermittent claudication and 10 healthy control subjects were included. All subjects underwent vector cardiography triggered quantitative 2D cine MR phase-contrast imaging to obtain flow waveforms of the popliteal artery at rest and during reactive hyperemia. Resting flow, maximum hyperemic flow and absolute flow reserve were determined and compared between the two groups by two independent MRI readers. Also, interreader reproducibility of flow measures was reported. Results: Resting flow was lower in patients compared to controls (4.9 +/- 1.6 and 11.1 +/- 3.2 mL/s in patients and controls, respectively (p<0.01)). Maximum hyperemic flow was 7.3 +/- 2.9 and 16.4 +/- 3.2 mL/s (p<0.01) and the absolute flow reserve was 2.4 +/- 1.6 and 5.3 +/- 1.3 mL/s (p<0.01), respectively in patients and controls. The interreader coefficient of variation was below 10% for all measures in both patients and controls. Conclusions: Quantitative 2D MR cine phase-contrast imaging is a promising method to determine flow reserve measures in patients with peripheral arterial disease and can be helpful to discriminate patients with intermittent claudication from healthy controls.	[Versluis, Bas; Dremmen, Marjolein H. G.; Wildberger, Joachim E.; Backes, Walter H.] Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands; [Schurink, Geert-Willem] Maastricht Univ, Dept Surg, Med Ctr, Maastricht, Netherlands; [Nelemans, Patty J.] Maastricht Univ, Dept Epidemiol, Med Ctr, Maastricht, Netherlands; [Versluis, Bas; Wildberger, Joachim E.; Leiner, Tim; Backes, Walter H.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center	Versluis, B (corresponding author), Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands.	w.backes@mumc.nl		Wildberger, Joachim/0000-0002-4810-6854; Backes, Walter H/0000-0001-7905-0681	Department of Radiology, Maastricht University Medical Center (MUMC+)	Department of Radiology, Maastricht University Medical Center (MUMC+)	This study was internally funded by the Department of Radiology, Maastricht University Medical Center (MUMC+)(Head of department: prof. Dr. Wildberger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qaisi M, 2009, VASC HEALTH RISK MAN, V5, P833; Aslam F, 2009, SOUTH MED J, V102, P1141, DOI 10.1097/SMJ.0b013e3181bb9ab8; Bakker CJG, 1995, MAGN RESON IMAGING, V13, P959, DOI 10.1016/0730-725X(95)02005-E; Bakker CJG, 1999, JMRI-J MAGN RESON IM, V9, P119, DOI 10.1002/(SICI)1522-2586(199901)9:1<119::AID-JMRI16>3.3.CO;2-6; Begelman Susan M, 2006, Cleve Clin J Med, V73 Suppl 4, pS22; Bishara RA, 2004, INT ANGIOL, V23, P368; Bland JM, 1996, BRIT MED J, V313, P744; Box FMA, 2003, INVEST RADIOL, V38, P567, DOI 10.1097/01.RLI.0000077125.58014.36; Bragadeesh T, 2005, J AM COLL CARDIOL, V45, P780, DOI 10.1016/j.jacc.2004.11.045; BRENER BJ, 1974, CIRCULATION, V50, P259; Brevetti LS, 2001, J SURG RES, V98, P21, DOI 10.1006/jsre.2001.6161; COFFMAN JD, 1960, AM J PHYSIOL, V199, P1143, DOI 10.1152/ajplegacy.1960.199.6.1143; Corcoran HA, 2009, J CARDIOVASC PHARM, V53, P446, DOI 10.1097/FJC.0b013e3181a6aa62; Creager M A, 1997, Vasc Med, V2, P231; de Vries M, 2005, J MAGN RESON IMAGING, V21, P37, DOI 10.1002/jmri.20240; Dumoulin C L, 1995, Magn Reson Imaging Clin N Am, V3, P399; Duteil S, 2006, MAGN RESON MED, V55, P450, DOI 10.1002/mrm.20760; Galderisi M, 2008, DRUGS, V68, P579, DOI 10.2165/00003495-200868050-00002; Hadlock J, 2009, ULTRASOUND MED BIOL, V35, P949, DOI 10.1016/j.ultrasmedbio.2008.12.012; Henk CB, 2003, EUR J RADIOL, V48, P274, DOI 10.1016/S0720-048X(03)00042-1; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; HOFFMAN JIE, 1984, CIRCULATION, V70, P153, DOI 10.1161/01.CIR.70.2.153; Hoogeveen RM, 1999, MAGNET RESON MED, V41, P520, DOI 10.1002/(SICI)1522-2594(199903)41:3<520::AID-MRM14>3.0.CO;2-A; Hudlicka O, 2009, J VASC RES, V46, P504, DOI 10.1159/000226127; Jansen JFA, 2007, INVEST RADIOL, V42, P327, DOI 10.1097/01.rli.0000262757.10271.e5; Kido M, 2007, BRIT J DERMATOL, V157, P690, DOI 10.1111/j.1365-2133.2007.08093.x; Kinney TB, 1996, AM J ROENTGENOL, V166, P277, DOI 10.2214/ajr.166.2.8553930; Klein WM, 2003, J VASC SURG, V38, P1060, DOI 10.1016/S0741-5214(03)00706-7; Koelemay MJW, 1996, BRIT J SURG, V83, P404, DOI 10.1002/bjs.1800830336; Ledermann HP, 2006, CIRCULATION, V113, P2929, DOI 10.1161/CIRCULATIONAHA.105.605717; Leiner T, 2005, RADIOLOGY, V235, P699, DOI 10.1148/radiol.2352040089; Leiner T, 2004, J MAGN RESON IMAGING, V20, P417, DOI 10.1002/jmri.20129; Lindner JR, 2008, JACC-CARDIOVASC IMAG, V1, P343, DOI 10.1016/j.jcmg.2008.04.001; Machida H, 2010, JPN J RADIOL, V28, P571, DOI 10.1007/s11604-010-0472-7; MATHIEN GM, 1990, AM J PHYSIOL, V258, pH759, DOI 10.1152/ajpheart.1990.258.3.H759; MAY AG, 1963, SURGERY, V54, P250; MEYER RA, 1993, MAGN RESON IMAGING, V11, P1085, DOI 10.1016/0730-725X(93)90235-6; Mohajer K, 2006, J MAGN RESON IMAGING, V23, P355, DOI 10.1002/jmri.20514; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Pena CS, 1996, AM J ROENTGENOL, V167, P153, DOI 10.2214/ajr.167.1.8659362; Prakash A, 2006, J MAGN RESON IMAGING, V24, P676, DOI 10.1002/jmri.20654; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Stein R, 2006, VASC MED, V11, P29, DOI 10.1191/1358863x06vm663oa; Thompson RB, 2005, MAGNET RESON MED, V54, P289, DOI 10.1002/mrm.20535; van Langen H, 2009, VASC MED, V14, P221, DOI 10.1177/1358863X08101017; Versluis B, 2011, INVEST RADIOL, V46, P11, DOI 10.1097/RLI.0b013e3181f2bfb8; WALKER MF, 1988, J COMPUT ASSIST TOMO, V12, P304, DOI 10.1097/00004728-198803000-00021	47	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e31514	10.1371/journal.pone.0031514	http://dx.doi.org/10.1371/journal.pone.0031514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412836	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062000001
J	Bonvicini, F; Manaresi, E; Di Furio, F; De Falco, L; Gallinella, G				Bonvicini, Francesca; Manaresi, Elisabetta; Di Furio, Francesca; De Falco, Luisa; Gallinella, Giorgio			Parvovirus B19 DNA CpG Dinucleotide Methylation and Epigenetic Regulation of Viral Expression	PLOS ONE			English	Article							CELLULAR TRANSCRIPTION FACTORS; P6 PROMOTER; INFECTIOUS CLONE; CYCLE ARREST; NS1 PROTEIN; GENOME; CELLS; ELEMENTS; REPLICATION; SEQUENCES	CpG DNA methylation is one of the main epigenetic modifications playing a role in the control of gene expression. For DNA viruses whose genome has the ability to integrate in the host genome or to maintain as a latent episome, a correlation has been found between the extent of DNA methylation and viral quiescence. No information is available for Parvovirus B19, a human pathogenic virus, which is capable of both lytic and persistent infections. Within Parvovirus B19 genome, the inverted terminal regions display all the characteristic signatures of a genomic CpG island; therefore we hypothesised a role of CpG dinucleotide methylation in the regulation of viral genome expression. The analysis of CpG dinucleotide methylation of Parvovirus B19 DNA was carried out by an aptly designed quantitative real-time PCR assay on bisulfite-modified DNA. The effects of CpG methylation on the regulation of viral genome expression were first investigated by transfection of either unmethylated or in vitro methylated viral DNA in a model cell line, showing that methylation of viral DNA was correlated to lower expression levels of the viral genome. Then, in the course of in vitro infections in different cellular environments, it was observed that absence of viral expression and genome replication were both correlated to increasing levels of CpG methylation of viral DNA. Finally, the presence of CpG methylation was documented in viral DNA present in bioptic samples, indicating the occurrence and a possible role of this epigenetic modification in the course of natural infections. The presence of an epigenetic level of regulation of viral genome expression, possibly correlated to the silencing of the viral genome and contributing to the maintenance of the virus in tissues, can be relevant to the balance and outcome of the different types of infection associated to Parvovirus B19.	[Bonvicini, Francesca; Manaresi, Elisabetta; Di Furio, Francesca; De Falco, Luisa; Gallinella, Giorgio] Univ Bologna, Div Microbiol, Dept Hematol & Oncol Sci, Bologna, Italy	University of Bologna	Bonvicini, F (corresponding author), Univ Bologna, Div Microbiol, Dept Hematol & Oncol Sci, Bologna, Italy.	giorgio.gallinella@unibo.it	Gallinella, Giorgio/H-6864-2017	Gallinella, Giorgio/0000-0003-1118-6341	University of Bologna [RFO 2008 2010]	University of Bologna	The work has been supported by funds from University of Bologna to Dr. Gallinella (RFO 2008 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bonvicini F, 2006, VIROLOGY, V347, P447, DOI 10.1016/j.virol.2005.12.014; Bonvicini F, 2010, DERMATOLOGY, V220, P138, DOI 10.1159/000277431; Bonvicini F, 2008, VIROLOGY, V381, P168, DOI 10.1016/j.virol.2008.09.002; Broliden K, 2006, J INTERN MED, V260, P285, DOI 10.1111/j.1365-2796.2006.01697.x; Burns K, 2007, FIELDS VIROLOGY, P2437; Chen AY, 2010, J VIROL, V84, P12385, DOI 10.1128/JVI.01229-10; Chisaka H, 2003, REV MED VIROL, V13, P347, DOI 10.1002/rmv.395; COTMORE SF, 1984, SCIENCE, V226, P1161, DOI 10.1126/science.6095448; Cotmore SF, 2007, ADV VIRUS RES, V70, P183, DOI 10.1016/S0065-3527(07)70005-2; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; DEISS V, 1990, VIROLOGY, V175, P247, DOI 10.1016/0042-6822(90)90205-6; Fernandez AF, 2010, ONCOGENE, V29, P1405, DOI 10.1038/onc.2009.517; Filippone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009496; Gallinella G, 2004, CLIN CHEM, V50, P759, DOI 10.1373/clinchem.2003.027292; Gallinella G, 2000, VIROLOGY, V278, P361, DOI 10.1006/viro.2000.0673; Gareus R, 1998, J VIROL, V72, P609, DOI 10.1128/JVI.72.1.609-616.1998; Guan WX, 2009, J VIROL, V83, P9541, DOI 10.1128/JVI.00702-09; Guo YM, 2010, BLOOD, V115, P4569, DOI 10.1182/blood-2009-08-239202; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Morita E, 2003, J VIROL, V77, P2915, DOI 10.1128/JVI.77.5.2915-2921.2003; Munakata Y, 2006, VIROLOGY, V345, P251, DOI 10.1016/j.virol.2005.09.040; Norja P, 2006, P NATL ACAD SCI USA, V103, P7450, DOI 10.1073/pnas.0602259103; OZAWA K, 1987, BLOOD, V70, P384, DOI 10.1182/blood.V70.2.384.384; OZAWA K, 1987, J VIROL, V61, P2627, DOI 10.1128/JVI.61.8.2627-2630.1987; OZAWA K, 1987, J VIROL, V61, P2395, DOI 10.1128/JVI.61.8.2395-2406.1987; Pasquinelli G, 2009, J CLIN VIROL, V44, P33, DOI 10.1016/j.jcv.2008.10.008; Pironi L, 2009, J CLIN MICROBIOL, V47, P1591, DOI 10.1128/JCM.00706-08; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Raab U, 2002, VIROLOGY, V293, P86, DOI 10.1006/viro.2001.1285; Raab U, 2001, J GEN VIROL, V82, P1473, DOI 10.1099/0022-1317-82-6-1473; Servant-Delmas A, 2010, J VIROL, V84, P9658, DOI 10.1128/JVI.00684-10; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tassinari D, 2009, BMJ CASE REP; Tolfvenstam T, 2009, SEMIN FETAL NEONAT M, V14, P218, DOI 10.1016/j.siny.2009.01.007; von Landenberg P, 2007, AUTOIMMUN REV, V6, P278, DOI 10.1016/j.autrev.2006.09.006; Wan ZH, 2010, J CLIN INVEST, V120, P3530, DOI 10.1172/JCI41805; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zhi N, 2004, VIROLOGY, V318, P142, DOI 10.1016/j.virol.2003.09.011; Zhi N, 2006, J VIROL, V80, P5941, DOI 10.1128/JVI.02430-05	42	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33316	10.1371/journal.pone.0033316	http://dx.doi.org/10.1371/journal.pone.0033316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22413013	gold, Green Submitted, Green Published			2022-12-25	WOS:000303060800090
J	Whitaker, GM; Lynn, FC; McIntosh, CHS; Accili, EA				Whitaker, Gina M.; Lynn, Francis C.; McIntosh, Christopher H. S.; Accili, Eric A.			Regulation of GIP and GLP1 Receptor Cell Surface Expression by N-Glycosylation and Receptor Heteromerization	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GASTRIC-INHIBITORY POLYPEPTIDE; DEPENDENT INSULINOTROPIC POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; LINKED GLYCOSYLATION; SIGNAL-TRANSDUCTION; DIMERIZATION; FAMILY; OLIGOMERIZATION; DEGRADATION	In response to a meal, Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) are released from gut endocrine cells into the circulation and interact with their cognate G-protein coupled receptors (GPCRs). Receptor activation results in tissue-selective pleiotropic responses that include augmentation of glucose-induced insulin secretion from pancreatic beta cells. N-glycosylation and receptor oligomerization are co-translational processes that are thought to regulate the exit of functional GPCRs from the ER and their maintenance at the plasma membrane. Despite the importance of these regulatory processes, their impact on functional expression of GIP and GLP-1 receptors has not been well studied. Like many family B GPCRs, both the GIP and GLP-1 receptors possess a large extracellular N-terminus with multiple consensus sites for Asn-linked (N)-glycosylation. Here, we show that each of these Asn residues is glycosylated when either human receptor is expressed in Chinese hamster ovary cells. N-glycosylation enhances cell surface expression and function in parallel but exerts stronger control over the GIP receptor than the GLP-1 receptor. N-glycosylation mainly lengthens receptor half-life by reducing degradation in the endoplasmic reticulum. N-glycosylation is also required for expression of the GIP receptor at the plasma membrane and efficient GIP potentiation of glucose-induced insulin secretion from the INS-1 pancreatic beta cell line. Functional expression of a GIP receptor mutant lacking N-glycosylation is rescued by co-expressed wild type GLP1 receptor, which, together with data obtained using Bioluminescence Resonance Energy Transfer, suggests formation of a GIP-GLP1 receptor heteromer.	[Whitaker, Gina M.; Accili, Eric A.] Univ British Columbia, Cardiovasc Res Grp, Vancouver, BC V5Z 1M9, Canada; [Whitaker, Gina M.; Lynn, Francis C.; McIntosh, Christopher H. S.; Accili, Eric A.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Lynn, Francis C.] Univ British Columbia, Dept Surg, Vancouver, BC V5Z 1M9, Canada; [McIntosh, Christopher H. S.] Univ British Columbia, Diabet Res Grp, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Whitaker, GM (corresponding author), Univ British Columbia, Cardiovasc Res Grp, Vancouver, BC V5Z 1M9, Canada.	eaaccili@interchange.ubc.ca		Lynn, Francis/0000-0001-9318-1063	Canadian Institutes of Health Research; Heart and Stroke Foundation of British Columbia and Yukon; Juvenile Diabetes Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia and Yukon; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	G.M.W. was supported by a Doctoral Research Award from the Canadian Institutes of Health Research. This study was also supported by operating funds from the Canadian Institutes for Health Research (C.H.M.) and the Heart and Stroke Foundation of British Columbia and Yukon (E.A.A.). E.A.A. is also the recipient of a Tier II Canada Research Chair. F.C.L. is supported by operating funds from the Juvenile Diabetes Research Foundation and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIRANOFF B, 1986, EUR J BIOCHEM, V159, P353, DOI 10.1111/j.1432-1033.1986.tb09875.x; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Fernandes H, 2001, J BIOL CHEM, V276, P5375, DOI 10.1074/jbc.M005599200; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; GOKE R, 1994, PEPTIDES, V15, P675, DOI 10.1016/0196-9781(94)90095-7; GREMLICH S, 1995, DIABETES, V44, P1202, DOI 10.2337/diabetes.44.10.1202; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Harikumar KG, 2008, J MOL NEUROSCI, V36, P279, DOI 10.1007/s12031-008-9060-z; He JQ, 2002, BIOCHEM BIOPH RES CO, V297, P565, DOI 10.1016/S0006-291X(02)02259-3; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hojberg PV, 2009, DIABETOLOGIA, V52, P199, DOI 10.1007/s00125-008-1195-5; Langer I, 2008, BBA-MOL CELL RES, V1783, P1663, DOI 10.1016/j.bbamcr.2008.03.013; Lynn FC, 2002, FASEB J, V16, P91, DOI 10.1096/fj.02-0243fje; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; Michineau S, 2006, BIOCHEMISTRY-US, V45, P2699, DOI 10.1021/bi051674v; Michineau S, 2004, BIOL CHEM, V385, P49, DOI 10.1515/BC.2004.007; Milligan G., 2009, BR J PHARM; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Mody N, 1999, NEUROPHARMACOLOGY, V38, P1485, DOI 10.1016/S0028-3908(99)00099-4; Moens K, 1996, DIABETES, V45, P257, DOI 10.2337/diabetes.45.2.257; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vrecl M, 2006, J RECEPT SIG TRANSD, V26, P505, DOI 10.1080/10799890600932253; Wanamaker CP, 2005, J BIOL CHEM, V280, P33800, DOI 10.1074/jbc.M501813200; Whitaker GM, 2007, J BIOL CHEM, V282, P22900, DOI 10.1074/jbc.M610978200; Whitaker Gina M., 2008, V491, P189, DOI 10.1007/978-1-59745-526-8_15; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Widmann C, 1996, MOL ENDOCRINOL, V10, P62, DOI 10.1210/me.10.1.62; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Zhong XT, 2004, FEBS LETT, V562, P111, DOI 10.1016/S0014-5793(04)00191-7	44	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32675	10.1371/journal.pone.0032675	http://dx.doi.org/10.1371/journal.pone.0032675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412906	gold, Green Submitted, Green Published			2022-12-25	WOS:000303060800041
J	Chen, QH; Lu, L; Hua, HX; Zhou, F; Lu, LX; Lin, YJ				Chen, Qiuhong; Lu, Lin; Hua, Hongxia; Zhou, Fei; Lu, Liaoxun; Lin, Yongjun			Characterization and Comparative Analysis of Small RNAs in Three Small RNA Libraries of the Brown Planthopper (Nilaparvata lugens)	PLOS ONE			English	Article							GERMLINE DEVELOPMENT; ENDOGENOUS SIRNAS; PIRNA BIOGENESIS; INSECT MICRORNAS; DROSOPHILA; INTERFERENCE; EVOLUTION; GROWTH; EXPRESSION; GENES	Background: The brown planthopper (BPH), Nilaparvata lugens (Sta;l), which belongs to Homopteran, Delphacidae, is one of the most serious and destructive pests of rice. Feeding BPH with homologous dsRNA in vitro can lead to the death of BPH, which gives a valuable clue to the prevention and control of this pest, however, we know little about its small RNA world. Methodology/Principal Findings: Small RNA libraries for three developmental stages of BPH (CX-male adult, CC-female adult, CY-last instar female nymph) had been constructed and sequenced. It revealed a prolific small RNA world of BPH. We obtained a final list of 452 (CX), 430 (CC), and 381 (CY) conserved microRNAs (miRNAs), respectively, as well as a total of 71 new miRNAs in the three libraries. All the miRNAs had their own expression profiles in the three libraries. The phylogenic evolution of the miRNA families in BPH was consistent with other species. The new miRNA sequences demonstrated some base biases. Conclusion: Our study discovered a large number of small RNAs through deep sequencing of three small RNA libraries of BPH. Many animal-conserved miRNA families as well as some novel miRNAs have been detected in our libraries. This is the first achievement to discover the small RNA world of BPH. A lot of new valuable information about BPH small RNAs has been revealed which was helpful for studying insect molecular biology and insect resistant research.	[Chen, Qiuhong; Lu, Lin; Zhou, Fei; Lu, Liaoxun; Lin, Yongjun] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Chen, Qiuhong; Lu, Lin; Zhou, Fei; Lu, Liaoxun; Lin, Yongjun] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan, Peoples R China; [Hua, Hongxia] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Chen, QH (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	yongjunlin@mail.hzau.edu.cn	Chen, QH/GXH-3158-2022	Lu, Liaoxun/0000-0002-5342-2720	National Program of Transgenic Variety Development of China [2011ZX08001-001]; National Natural Science Foundation of China [30921091]	National Program of Transgenic Variety Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Program of Transgenic Variety Development of China (2011ZX08001-001) and the National Natural Science Foundation of China (30921091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Bejarano F, 2010, DEV BIOL, V338, P63, DOI 10.1016/j.ydbio.2009.11.025; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chellappan P, 2010, NUCLEIC ACIDS RES, V38, P6883, DOI 10.1093/nar/gkq590; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Chen X, 2010, INSECT MOL BIOL, V19, P799, DOI 10.1111/j.1365-2583.2010.01039.x; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x; Halic M, 2009, CELL, V138, P1058, DOI 10.1016/j.cell.2009.08.030; Hao LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-55; Hilgers V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000396; Hipfner DR, 2002, GENETICS, V161, P1527; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jia QD, 2010, J INSECT PHYSIOL, V56, P1763, DOI 10.1016/j.jinsphys.2010.07.007; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Kidner CA, 2010, J GENET GENOMICS, V37, P13, DOI 10.1016/S1673-8527(09)60021-7; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Legeai F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-281; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Marco A, 2010, GENOME BIOL EVOL, V2, P686, DOI 10.1093/gbe/evq053; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Pek JW, 2009, DEV CELL, V17, P417, DOI 10.1016/j.devcel.2009.07.017; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Silver SJ, 2007, P NATL ACAD SCI USA, V104, P18151, DOI 10.1073/pnas.0706673104; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Teleman AA, 2006, GENE DEV, V20, P913; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Weinberg MS, 2010, GENOME MED, V2, DOI 10.1186/gm149; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Yelina NE, 2010, P NATL ACAD SCI USA, V107, P13948, DOI 10.1073/pnas.0911341107; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094	55	27	30	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32860	10.1371/journal.pone.0032860	http://dx.doi.org/10.1371/journal.pone.0032860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412935	Green Submitted, gold, Green Published			2022-12-25	WOS:000303021100035
J	Hong, T; Gurian, PL; Huang, Y; Haas, CN				Hong, Tao; Gurian, Patrick L.; Huang, Yin; Haas, Charles N.			Prioritizing Risks and Uncertainties from Intentional Release of Selected Category A Pathogens	PLOS ONE			English	Article							PASTEURELLA-TULARENSIS; BACILLUS-ANTHRACIS; FRANCISELLA-TULARENSIS; QUANTITATIVE PCR; AEROSOL SURVIVAL; WARFARE AGENTS; INFECTION; VIRUS; MODEL; BIOTERRORISM	This paper synthesizes available information on five Category A pathogens (Bacillus anthracis, Yersinia pestis, Francisella tularensis, Variola major and Lassa) to develop quantitative guidelines for how environmental pathogen concentrations may be related to human health risk in an indoor environment. An integrated model of environmental transport and human health exposure to biological pathogens is constructed which 1) includes the effects of environmental attenuation, 2) considers fomite contact exposure as well as inhalational exposure, and 3) includes an uncertainty analysis to identify key input uncertainties, which may inform future research directions. The findings provide a framework for developing the many different environmental standards that are needed for making risk-informed response decisions, such as when prophylactic antibiotics should be distributed, and whether or not a contaminated area should be cleaned up. The approach is based on the assumption of uniform mixing in environmental compartments and is thus applicable to areas sufficiently removed in time and space from the initial release that mixing has produced relatively uniform concentrations. Results indicate that when pathogens are released into the air, risk from inhalation is the main component of the overall risk, while risk from ingestion (dermal contact for B. anthracis) is the main component of the overall risk when pathogens are present on surfaces. Concentrations sampled from untracked floor, walls and the filter of heating ventilation and air conditioning (HVAC) system are proposed as indicators of previous exposure risk, while samples taken from touched surfaces are proposed as indicators of future risk if the building is reoccupied. A Monte Carlo uncertainty analysis is conducted and input-output correlations used to identify important parameter uncertainties. An approach is proposed for integrating these quantitative assessments of parameter uncertainty with broader, qualitative considerations to identify future research priorities.	[Hong, Tao] US EPA, Natl Exposure Res Lab, Athens, GA USA; [Gurian, Patrick L.; Haas, Charles N.] Drexel Univ, Dept Civil Architectural & Environm Engn, Philadelphia, PA 19104 USA; [Huang, Yin] US FDA, Off Biostat & Epidemiol, Rockville, MD 20857 USA	United States Environmental Protection Agency; Drexel University; US Food & Drug Administration (FDA)	Hong, T (corresponding author), US EPA, Natl Exposure Res Lab, Athens, GA USA.	hongtao510@gmail.com	Haas, Charles N/G-8830-2011; Gurian, Patrick L/A-8365-2013	Haas, Charles N/0000-0002-9255-9930; Gurian, Patrick L/0000-0001-7456-9740	Center for Advancing Microbial Risk Assessment; United States Environmental Protection Agency; United States Department of Homeland Security, under Science to Achieve Results (STAR) [R83236201]	Center for Advancing Microbial Risk Assessment; United States Environmental Protection Agency(United States Environmental Protection Agency); United States Department of Homeland Security, under Science to Achieve Results (STAR)	This research was funded through the Center for Advancing Microbial Risk Assessment, supported by the United States Environmental Protection Agency and United States Department of Homeland Security, under the Science to Achieve Results (STAR) grant program (grant number:R83236201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208; Altboum Z, 2002, INFECT IMMUN, V70, P6231, DOI 10.1128/IAI.70.11.6231-6241.2002; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Bae SW, 2009, APPL ENVIRON MICROB, V75, P2940, DOI 10.1128/AEM.01333-08; Bartrand TA, 2008, RISK ANAL, V28, P1115, DOI 10.1111/j.1539-6924.2008.01067.x; Block SM, 2002, MOL BIOL CELL, V13, p1A; Bushon R, 2010, LETT APPL MICROBIOL, V50, P276, DOI 10.1111/j.1472-765X.2009.02788.x; Busson B, 1911, BEITRAG KENNTNIS LEB; Centers for Disease Control and Prevention website, BIOT AG DIS; CLTV website, CLEAN ANTHR WILL COS; COX CS, 1972, APPL MICROBIOL, V23, P1; COX CS, 1971, APPL MICROBIOL, V21, P482, DOI 10.1128/AEM.21.3.482-486.1971; DAY WC, 1972, INFECT IMMUN, V5, P77, DOI 10.1128/IAI.5.1.77-82.1972; Djavani M, 2000, VACCINE, V18, P1543, DOI 10.1016/S0264-410X(99)00439-9; Dorevitch S, 2010, ENVIRON HEALTH PERSP, V118, P871, DOI 10.1289/ehp.0901627; EHRLICH R, 1973, APPL MICROBIOL, V25, P369, DOI 10.1128/AEM.25.3.369-372.1973; Ferguson AC, 2006, J EXPO SCI ENV EPID, V16, P287, DOI 10.1038/sj.jea.7500459; Graham-Smith GS, 1930, J HYG-CAMBRIDGE, V30, P213, DOI 10.1017/S0022172400010391; Haas C.N., 1999, QUANTITATIVE MICROBI; Haas CN, 2002, RISK ANAL, V22, P455, DOI 10.1111/0272-4332.00035; Hardestam J, 2007, APPL ENVIRON MICROB, V73, P2547, DOI 10.1128/AEM.02869-06; HARPER G. J., 1963, ARCH GES VIRUSFORSCH, V13, P64, DOI 10.1007/BF01243824; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; Hong T, 2009, ESTIMATING RISK EXPO; Hong T, 2010, RISK ANAL, V30, P1602, DOI 10.1111/j.1539-6924.2010.01443.x; Huang Y, 2010, IEEE SENS J, V10, P668, DOI 10.1109/JSEN.2009.2038659; Julian TR, 2009, RISK ANAL, V29, P617, DOI 10.1111/j.1539-6924.2008.01193.x; Lai ACK, 2000, J AEROSOL SCI, V31, P463; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lesperance A, 2008, CATASTROPHIC INCIDEN; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; MAHL MC, 1975, CAN J MICROBIOL, V21, P819, DOI 10.1139/m75-121; MARSHALL RG, 1961, J BACTERIOL, V82, P15, DOI 10.1128/JB.82.1.15-19.1961; Mitchell-Blackwood J, 2010, HUMAN ECOLO IN PRESS; Mitscherlich E., 1984, MICROBIAL SURVIVAL E; MORGAN MG, 1985, ENVIRON SCI TECHNOL, V19, P662, DOI 10.1021/es00138a002; NAZAROFF WW, 1989, ENVIRON SCI TECHNOL, V23, P157, DOI 10.1021/es00179a003; Nicas M, 2008, J OCCUP ENVIRON HYG, V5, P347, DOI 10.1080/15459620802003896; Nicas M, 2006, RISK ANAL, V26, P1085, DOI 10.1111/j.1539-6924.2006.00802.x; NOVEL R, 1947, SCHWEIZ Z PATHOL BAK, V10, P180; Pohanka M, 2009, FOLIA MICROBIOL, V54, P263, DOI 10.1007/s12223-009-0046-1; Price PN, 2009, ENVIRON SCI TECHNOL, V43, P1783, DOI 10.1021/es802506p; Roman S., 2008, ADV LINEAR ALGEBRA, V3rd ed.; Rose LJ, 2003, APPL ENVIRON MICROB, V69, P2166, DOI 10.1128/AEM.69.4.2166-2171.2003; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sabelnikov A, 2006, INT J ENVIRON HEAL R, V16, P241, DOI 10.1080/09603120600734105; Sextro R. G., 2002, P IND AIR 2002 C MON, P506; Sinclair R, 2008, APPL ENVIRON MICROB, V74, P555, DOI 10.1128/AEM.02167-07; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-25; STEPHENSON EH, 1984, J MED VIROL, V14, P295, DOI 10.1002/jmv.1890140402; SZEKELY AV, 2003, Z HYG INFEKTIONSKR, V44, P359; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Titball RW, 2003, ASM NEWS, V69, P558; Waterer GW, 2009, RESPIROLOGY, V14, P5, DOI 10.1111/j.1440-1843.2008.01446.x; Webb GF, 2003, P NATL ACAD SCI USA, V100, P4355, DOI 10.1073/pnas.0830963100; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wein LM, 2009, RISK ANAL, V29, P949, DOI 10.1111/j.1539-6924.2009.01232.x; West JS, 2008, TRENDS MICROBIOL, V16, P380, DOI 10.1016/j.tim.2008.05.004; WILKINSO.TR, 1966, APPL MICROBIOL, V14, P303, DOI 10.1128/AEM.14.3.303-307.1966; WON WD, 1966, APPL MICROBIOL, V14, P742, DOI 10.1128/AEM.14.5.742-745.1966; XU MD, 1994, AEROSOL SCI TECH, V20, P194, DOI 10.1080/02786829408959676	61	13	13	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32732	10.1371/journal.pone.0032732	http://dx.doi.org/10.1371/journal.pone.0032732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412915	gold, Green Published			2022-12-25	WOS:000303021100025
J	Lodge, R; Ouellet, M; Barat, C; Andreani, G; Kumar, P; Tremblay, MJ				Lodge, Robert; Ouellet, Michel; Barat, Corinne; Andreani, Guadalupe; Kumar, Pranav; Tremblay, Michel J.			HIV-1 Promotes Intake of Leishmania Parasites by Enhancing Phosphatidylserine-Mediated, CD91/LRP-1-Dependent Phagocytosis in Human Macrophages	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE-DERIVED MACROPHAGES; HUMAN LYMPHOID-TISSUE; APOPTOTIC CELLS; TAT PROTEIN; TNF-ALPHA; TGF-BETA; TYPE-1 REPLICATION; T-CELLS; RECEPTOR	Over the past decade, the number of reported human immunodeficiency virus type-1 (HIV-1)/Leishmania co-infections has risen dramatically, particularly in regions where both diseases are endemic. Although it is known that HIV-1 infection leads to an increase in susceptibility to Leishmania infection and leishmaniasis relapse, little remains known on how HIV-1 contributes to Leishmania parasitaemia. Both pathogens infect human macrophages, and the intracellular growth of Leishmania is increased by HIV-1 in co-infected cultures. We now report that uninfected bystander cells, not macrophages productively infected with HIV-1, account for enhanced phagocytosis and higher multiplication of Leishmania parasites. This effect can be driven by HIV-1 Tat protein and transforming growth factor-beta (TGF-beta). Furthermore, we show for the first time that HIV-1 infection increases surface expression of phosphatidylserine receptor CD91/LRP-1 on human macrophages, thereby leading to a Leishmania uptake by uninfected bystander cells in HIV-1-infected macrophage populations. The more important internalization of parasites is due to interactions between the scavenger receptor CD91/LRP-1 and phosphatidylserine residues exposed at the surface of Leishmania. We determined also that enhanced CD91/LRP-1 surface expression occurs rapidly following HIV-1 infection, and is triggered by the activation of extracellular TGF-beta. Thus, these results establish an intricate link between HIV-1 infection, Tat, surface CD91/LRP-1, TGF-beta, and enhanced Leishmania phosphatidylserine-mediated phagocytosis.	[Lodge, Robert; Ouellet, Michel; Barat, Corinne; Andreani, Guadalupe; Kumar, Pranav; Tremblay, Michel J.] Univ Laval, Ctr Hosp Univ Quebec CHUL, Ctr Rech Infectiol, Quebec City, PQ, Canada; [Lodge, Robert; Ouellet, Michel; Barat, Corinne; Andreani, Guadalupe; Kumar, Pranav; Tremblay, Michel J.] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Lodge, R (corresponding author), Univ Laval, Ctr Hosp Univ Quebec CHUL, Ctr Rech Infectiol, Quebec City, PQ, Canada.	michel.j.tremblay@crchul.ulaval.ca	Ouellet, Michel/C-9942-2015; Barat, Corinne/GWZ-4685-2022; Ouellet, Michel/ABC-3759-2020	Ouellet, Michel/0000-0002-2353-7535; Ouellet, Michel/0000-0002-2353-7535; Kumar, Pranav/0000-0002-9135-2217	CIHR [MOP-84555]	CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by an operating grant to M.J.T. from the CIHR HIV/AIDS Research Program (MOP-84555). M.J.T. is the recipient of the Canada Research Chair in Human Immuno Retrovirology (Tier 1 level). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Azzam R, 2006, AIDS RES HUM RETROV, V22, P619, DOI 10.1089/aid.2006.22.619; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Barcinski Marcello A, 2003, Kinetoplastid Biol Dis, V2, P6, DOI 10.1186/1475-9292-2-6; Barreto-de-Souza V, 2008, MICROBES INFECT, V10, P642, DOI 10.1016/j.micinf.2008.02.014; Barreto-De-Souza V, 2006, J INFECT DIS, V194, P846, DOI 10.1086/506618; Bounou S, 2002, J VIROL, V76, P1004, DOI 10.1128/JVI.76.3.1004-1014.2002; Bratton DL, 2008, CURR BIOL, V18, pR76, DOI 10.1016/j.cub.2007.11.024; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Cruz I, 2006, INDIAN J MED RES, V123, P357; Dedet JP, 2000, J EUKARYOT MICROBIOL, V47, P37, DOI 10.1111/j.1550-7408.2000.tb00008.x; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Garg R, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000441; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Imbeault M, 2009, VIROLOGY, V393, P160, DOI 10.1016/j.virol.2009.07.009; Kedzierska K, 2003, J CLIN VIROL, V26, P247, DOI 10.1016/S1386-6532(02)00123-3; Kedzierska K, 2002, J IMMUNOL, V168, P2895, DOI 10.4049/jimmunol.168.6.2895; Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Leghmari K, 2008, CELL IMMUNOL, V254, P46, DOI 10.1016/j.cellimm.2008.06.011; Leitlein J, 2001, J IMMUNOL, V166, P7238, DOI 10.4049/jimmunol.166.12.7238; Lima RG, 2002, J INFECT DIS, V185, P1561, DOI 10.1086/340412; Lima RG, 2006, AIDS RES HUM RETROV, V22, P763, DOI 10.1089/aid.2006.22.763; Maiti SN, 2008, J BIOL CHEM, V283, P3761, DOI 10.1074/jbc.M704990200; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; NUNES I, 1995, J IMMUNOL, V155, P1450; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Pugliese A, 2005, CLIN DIAGN LAB IMMUN, V12, P889, DOI 10.1128/CDLI.12.8.889-895.2005; Raesl G, 2007, CURR OPIN IMMUNOL, V19, P454, DOI 10.1016/j.coi.2007.05.007; Rubartelli A, 1998, IMMUNOL TODAY, V19, P543, DOI 10.1016/S0167-5699(98)01351-6; Savill J, 2007, IMMUNITY, V27, P830, DOI 10.1016/j.immuni.2007.12.002; Van Zandbergen G, 2007, AUTOIMMUNITY, V40, P349, DOI 10.1080/08916930701356960; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; Wanderley JLM, 2005, BRAZ J MED BIOL RES, V38, P807, DOI 10.1590/S0100-879X2005000600001; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Wu YT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-61; ZAULI G, 1992, BLOOD, V80, P3036; Zhao CQ, 2006, J GEN VIROL, V87, P1295, DOI 10.1099/vir.0.81647-0; Zhao CQ, 2004, J IMMUNOL, V172, P3086, DOI 10.4049/jimmunol.172.5.3086; Zhao CQ, 2004, CLIN IMMUNOL, V113, P81, DOI 10.1016/j.clim.2004.06.003	50	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32761	10.1371/journal.pone.0032761	http://dx.doi.org/10.1371/journal.pone.0032761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412921	Green Submitted, Green Published, gold			2022-12-25	WOS:000303021100028
J	Stax, MJ; Kootstra, NA; Wout, ABV; Tanck, MWT; Bakker, M; Pollakis, G; Paxton, WA				Stax, Martijn J.; Kootstra, Neeltje A.; van 't Wout, Angelique B.; Tanck, Michael W. T.; Bakker, Margreet; Pollakis, Georgios; Paxton, William A.			HIV-1 Disease Progression Is Associated with Bile-Salt Stimulated Lipase (BSSL) Gene Polymorphism	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-LYMPHOCYTES; BINDS DC-SIGN; HUMAN-MILK; DENDRITIC CELLS; DEPENDENT LIPASE; TRANSMISSION; INFECTION; TYPE-1; PATHOGENESIS	Background: DC-SIGN expressed by dendritic cells captures HIV-1 resulting in trans-infection of CD4+ T-lymphocytes. However, BSSL (bile-salt stimulated lipase) binding to DC-SIGN interferes with HIV-1 capture. DC-SIGN binding properties of BSSL associate with the polymorphic repeated motif of BSSL exon 11. Furthermore, BSSL binds to HIV-1 co-receptor CXCR4. We hypothesized that BSSL modulates HIV-1 disease progression and emergence of CXCR4 using HIV-1 (X4) variants. Results: The relation between BSSL genotype and HIV-1 disease progression and emergence of X4 variants was studied using Kaplan Meier and multivariate Cox proportional hazard analysis in a cohort of HIV-1 infected men having sex with men (n = 334, with n = 130 seroconverters). We analyzed the association of BSSL genotype with set-point viral load and CD4 cell count, both pre-infection and post-infection at viral set-point. The number of repeats in BSSL exon 11 were highly variable ranging from 10 to 18 in seropositive individuals and from 5-17 in HRSN with 16 repeats being dominant (>80% carry at least one allele with 16 repeats). We defined 16 to 18 repeats as high (H) and less than 16 repeats as low (L) repeat numbers. Homozygosity for the high (H) repeat number BSSL genotype (HH) correlated with high CD4 cell numbers prior to infection (p = 0.007). In HIV-1 patients, delayed disease progression was linked to the HH BSSL genotype (RH = 0.462 CI = 0.282-0.757, p = 0.002) as was delayed emergence of X4 variants (RH = 0.525, 95% CI = 0.290-0.953, p = 0.034). The LH BSSL genotype, previously found to be associated with enhanced DC-SIGN binding of human milk, was identified to correlate with accelerated disease progression in our cohort of HIV-1 infected MSM (RH = 0.517, 95% CI = 0.328-0.818, p = 0.005). Conclusion: We identify BSSL as a marker for HIV-1 disease progression and emergence of X4 variants. Additionally, we identified a relation between BSSL genotype and CD4 cell counts prior to infection.	[Stax, Martijn J.; Bakker, Margreet; Pollakis, Georgios; Paxton, William A.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Kootstra, Neeltje A.; van 't Wout, Angelique B.] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, Dept Expt Immunol,Sanquin Res, NL-1105 AZ Amsterdam, Netherlands; [Kootstra, Neeltje A.; van 't Wout, Angelique B.] Univ Amsterdam, Acad Med Ctr, CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Tanck, Michael W. T.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat KEBB, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Stax, MJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.a.paxton@amc.uva.nl	paxton, william/R-9747-2019; Georgios, Pollakis/Y-2341-2019	Pollakis, Georgios/0000-0002-9659-5461; Kootstra, Neeltje A./0000-0001-9429-7754; Paxton, William/0000-0001-5200-0801; Tanck, Michael/0000-0001-9828-4459; Paxton, William/0000-0002-2654-5186	Dutch AIDS fund [2005024]	Dutch AIDS fund	This study was funded by a Dutch AIDS fund grant (2005024). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Aubert-Jousset E, 2004, STRUCTURE, V12, P1437, DOI 10.1016/j.str.2004.05.016; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Koizumi Y, 2007, AIDS RES HUM RETROV, V23, P713, DOI 10.1089/aid.2006.0225; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; KOOT M, 1992, AIDS, V6, P49, DOI 10.1097/00002030-199201000-00006; Koot M, 1999, J INFECT DIS, V179, P254, DOI 10.1086/314539; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Liu HL, 2004, J INFECT DIS, V190, P1055, DOI 10.1086/423209; McKillop AM, 1998, PEDIATR RES, V43, P101, DOI 10.1203/00006450-199801000-00015; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06; OBRIEN TR, 1994, J ACQ IMMUN DEF SYND, V7, P705; Panicot-Dubois L, 2007, J CLIN INVEST, V117, P3708, DOI 10.1172/JCI32655; Paxton WA, 1998, SEMIN IMMUNOL, V10, P187, DOI 10.1006/smim.1998.0132; Saeland E, 2009, MOL IMMUNOL, V46, P2309, DOI 10.1016/j.molimm.2009.03.025; Shapiro RL, 2009, J INFECT DIS, V199, P414, DOI 10.1086/596034; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Stax MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017316; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Van Liempt E, 2004, J BIOL CHEM, V279, P33161, DOI 10.1074/jbc.M404988200; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; van Montfort T, 2008, J VIROL, V82, P7886, DOI 10.1128/JVI.00245-08; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Yearley JH, 2008, DEV COMP IMMUNOL, V32, P1510, DOI 10.1016/j.dci.2008.06.006	38	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32534	10.1371/journal.pone.0032534	http://dx.doi.org/10.1371/journal.pone.0032534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412885	Green Published, gold			2022-12-25	WOS:000303021100018
J	Giardina, F; Gosoniu, L; Konate, L; Diouf, MB; Perry, R; Gaye, O; Faye, O; Vounatsou, P				Giardina, Federica; Gosoniu, Laura; Konate, Lassana; Diouf, Mame Birame; Perry, Robert; Gaye, Oumar; Faye, Ousmane; Vounatsou, Penelope			Estimating the Burden of Malaria in Senegal: Bayesian Zero-Inflated Binomial Geostatistical Modeling of the MIS 2008 Data	PLOS ONE			English	Article							VARIABLE SELECTION; RISK; WEST	The Research Center for Human Development in Dakar (CRDH) with the technical assistance of ICF Macro and the National Malaria Control Programme (NMCP) conducted in 2008/2009 the Senegal Malaria Indicator Survey (SMIS), the first nationally representative household survey collecting parasitological data and malaria-related indicators. In this paper, we present spatially explicit parasitaemia risk estimates and number of infected children below 5 years. Geostatistical Zero-Inflated Binomial models (ZIB) were developed to take into account the large number of zero-prevalence survey locations (70%) in the data. Bayesian variable selection methods were incorporated within a geostatistical framework in order to choose the best set of environmental and climatic covariates associated with the parasitaemia risk. Model validation confirmed that the ZIB model had a better predictive ability than the standard Binomial analogue. Markov chain Monte Carlo (MCMC) methods were used for inference. Several insecticide treated nets (ITN) coverage indicators were calculated to assess the effectiveness of interventions. After adjusting for climatic and socio-economic factors, the presence of at least one ITN per every two household members and living in urban areas reduced the odds of parasitaemia by 86% and 81% respectively. Posterior estimates of the ORs related to the wealth index show a decreasing trend with the quintiles. Infection odds appear to be increasing with age. The population-adjusted prevalence ranges from 0.12% in Thille-Boubacar to 13.1% in Dabo. Tambacounda has the highest population-adjusted predicted prevalence (8.08%) whereas the region with the highest estimated number of infected children under the age of 5 years is Kolda (13940). The contemporary map and estimates of malaria burden identify the priority areas for future control interventions and provide baseline information for monitoring and evaluation. Zero-Inflated formulations are more appropriate in modeling sparse geostatistical survey data, expected to arise more frequently as malaria research is focused on elimination.	[Giardina, Federica; Gosoniu, Laura; Vounatsou, Penelope] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Giardina, Federica; Gosoniu, Laura; Vounatsou, Penelope] Univ Basel, Basel, Switzerland; [Konate, Lassana; Faye, Ousmane] UCAD Dakar, Fac Sci & Tech, Dakar, Senegal; [Diouf, Mame Birame] Natl Malaria Control Programme, Dakar, Senegal; [Perry, Robert] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Gaye, Oumar] UCAD Dakar, Fac Med Pharm & Odontol, Dakar, Senegal	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University Cheikh Anta Diop Dakar; Centers for Disease Control & Prevention - USA; University Cheikh Anta Diop Dakar	Giardina, F (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	penelope.vounatsou@unibas.ch	Giardina, Federica/AAR-8361-2021	Giardina, Federica/0000-0002-3710-0940; Vounatsou, Penelope/0000-0002-4904-5352	Swiss-South Africa Joint Research Project [IZLSZ3 122926]; Bill and Melinda Gates Foundation [OPP1032350]	Swiss-South Africa Joint Research Project; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This investigation was conducted as part of the Swiss-South Africa Joint Research Project No. IZLSZ3 122926. The authors also thank the Bill and Melinda Gates Foundation (Project No. OPP1032350) for financial contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal DK, 2002, ENVIRON ECOL STAT, V9, P341, DOI 10.1023/A:1020910605990; Amek N, 2011, SPAT SPATIO-TEMPORAL, V2, P283, DOI 10.1016/j.sste.2011.08.001; [Anonymous], COLL DISS DAT DEM YB; [Anonymous], ROLL BACK MAL PROGR; Dellaportas P, 2002, STAT COMPUT, V12, P27, DOI 10.1023/A:1013164120801; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; GELFAND AE, 1995, BIOMETRIKA, V82, P479, DOI 10.1093/biomet/82.3.479; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Gosoniu L, 2006, GEOSPATIAL HEALTH, V1, P127, DOI 10.4081/gh.2006.287; Gosoniu L, 2009, COMPUT STAT DATA AN, V53, P3358, DOI 10.1016/j.csda.2009.02.022; Gosoniu L, 2011, PLOS ONE IN PRESS; Gosoniu L, 2011, PARASITES VECT UNPUB; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Kilian A, 2010, REV DELIVERY STRATEG; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MARA/ARMA, 1998, 1 MARAARMA COLL; Musenge E, 2011, SPAT SPATIO-TEMPORAL, V2, P205, DOI 10.1016/j.sste.2011.07.001; Ndiaye S., 2009, ENQUETE NATL PALUDIS; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; PULL JH, 1974, B WORLD HEALTH ORGAN, V51, P507; Riedel N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-37; Rutstein SO, 2004, DHS COMP REPORTS, V6; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Thwing JI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-86; *WHO, 2009, WORLD MAL REP; WHO. World Heath Organization, 2008, WORLD HLTH REP; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	32	47	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32625	10.1371/journal.pone.0032625	http://dx.doi.org/10.1371/journal.pone.0032625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403684	Green Published, Green Accepted, gold			2022-12-25	WOS:000303017700081
J	Heo, JY; Park, JH; Kim, SJ; Seo, KS; Han, JS; Lee, SH; Kim, JM; Park, JI; Park, SK; Lim, K; Hwang, BD; Shong, M; Kweon, GR				Heo, Jun Young; Park, Ji Hoon; Kim, Soung Jung; Seo, Kang Sik; Han, Jeong Su; Lee, Sang Hee; Kim, Jin Man; Park, Jong Il; Park, Seung Kiel; Lim, Kyu; Hwang, Byung Doo; Shong, Minho; Kweon, Gi Ryang			DJ-1 Null Dopaminergic Neuronal Cells Exhibit Defects in Mitochondrial Function and Structure: Involvement of Mitochondrial Complex I Assembly	PLOS ONE			English	Article							PARKINSONS-DISEASE; PROTEIN DJ-1; DYNAMICS; DEFICIENCY; FISSION; GENE; FRAGMENTATION; PATHOGENESIS; AUTOPHAGY; BALANCE	DJ-1 is a Parkinson's disease-associated gene whose protein product has a protective role in cellular homeostasis by removing cytosolic reactive oxygen species and maintaining mitochondrial function. However, it is not clear how DJ-1 regulates mitochondrial function and why mitochondrial dysfunction is induced by DJ-1 deficiency. In a previous study we showed that DJ-1 null dopaminergic neuronal cells exhibit defective mitochondrial respiratory chain complex I activity. In the present article we investigated the role of DJ-1 in complex I formation by using blue native-polyacrylamide gel electrophoresis and 2-dimensional gel analysis to assess native complex status. On the basis of these experiments, we concluded that DJ-1 null cells have a defect in the assembly of complex I. Concomitant with abnormal complex I formation, DJ-1 null cells show defective supercomplex formation. It is known that aberrant formation of the supercomplex impairs the flow of electrons through the channels between respiratory chain complexes, resulting in mitochondrial dysfunction. We took two approaches to study these mitochondrial defects. The first approach assessed the structural defect by using both confocal microscopy with MitoTracker staining and electron microscopy. The second approach assessed the functional defect by measuring ATP production, O-2 consumption, and mitochondrial membrane potential. Finally, we showed that the assembly defect as well as the structural and functional abnormalities in DJ-1 null cells could be reversed by adenovirus-mediated overexpression of DJ-1, demonstrating the specificity of DJ-1 on these mitochondrial properties. These mitochondrial defects induced by DJ-1mutation may be a pathological mechanism for the degeneration of dopaminergic neurons in Parkinson's disease.	[Heo, Jun Young; Park, Ji Hoon; Seo, Kang Sik; Han, Jeong Su; Park, Jong Il; Park, Seung Kiel; Lim, Kyu; Hwang, Byung Doo; Kweon, Gi Ryang] Chungnam Natl Univ, Sch Med, Dept Biochem, Taejon, South Korea; [Kim, Soung Jung; Shong, Minho] Chungnam Natl Univ, Sch Med, Dept Internal Med, Res Ctr Endocrine & Metab Dis, Taejon, South Korea; [Lee, Sang Hee; Kim, Jin Man] Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon, South Korea; [Kweon, Gi Ryang] Chungnam Natl Univ, Sch Med, Res Inst Med Sci, Taejon, South Korea; [Heo, Jun Young; Lim, Kyu] Chungnam Natl Univ, Sch Med, Infect Signaling Network Res Ctr, Taejon, South Korea	Chungnam National University; Chungnam National University; Chungnam National University; Chungnam National University; Chungnam National University	Heo, JY (corresponding author), Chungnam Natl Univ, Sch Med, Dept Biochem, Taejon, South Korea.	mitochondria@cnu.ac.kr	/H-7803-2012	park, jong-il/0000-0003-3095-3323; shong, minho/0000-0002-0247-7115; Heo, Jun Young/0000-0002-0859-0063; Han, Jeongsu/0000-0001-6524-9841; KIM, JIN MAN/0000-0003-0905-9730	National Research Foundation of Korea(NRF); Ministry of Education, Science and Technology [2011-0011365]; Korea government(MEST) [2010-0020527]; Ministry of Health & Welfare, Republic of Korea [A100588]	National Research Foundation of Korea(NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology(2011-0011365), by the Korea government(MEST)(2010-0020527) and by a grant of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea(A100588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bueler H, 2010, APOPTOSIS, V15, P1336, DOI 10.1007/s10495-010-0465-0; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Burbulla LF, 2010, EUR J CLIN INVEST, V40, P1048, DOI 10.1111/j.1365-2362.2010.02354.x; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Ferreira M, 2011, NEUROGENETICS, V12, P9, DOI 10.1007/s10048-010-0265-2; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hayashi T, 2009, BIOCHEM BIOPH RES CO, V390, P667, DOI 10.1016/j.bbrc.2009.10.025; Hong H, 2004, LIFE SCI, V74, P2959, DOI 10.1016/j.lfs.2003.09.074; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Kwon HJ, 2011, TOXICOL LETT, V202, P85, DOI 10.1016/j.toxlet.2011.01.018; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lenaz G, 2010, BBA-BIOENERGETICS, V1797, P633, DOI 10.1016/j.bbabio.2010.01.025; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Martin MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211	35	72	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32629	10.1371/journal.pone.0032629	http://dx.doi.org/10.1371/journal.pone.0032629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403686	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700083
J	Johnson, WA; Carder, JW				Johnson, Wayne A.; Carder, Justin W.			Drosophila Nociceptors Mediate Larval Aversion to Dry Surface Environments Utilizing Both the Painless TRP Channel and the DEG/ENaC Subunit, PPK1	PLOS ONE			English	Article							SENSING ION CHANNELS; PUPATION HEIGHT; MECHANISMS; BEHAVIOR; NEURONS; TOUCH; HEARING; THERMOSENSATION; HYGROSENSATION; IDENTIFICATION	A subset of sensory neurons embedded within the Drosophila larval body wall have been characterized as high-threshold polymodal nociceptors capable of responding to noxious heat and noxious mechanical stimulation. They are also sensitized by UV-induced tissue damage leading to both thermal hyperalgesia and allodynia very similar to that observed in vertebrate nociceptors. We show that the class IV multiple-dendritic(mdIV) nociceptors are also required for a normal larval aversion to locomotion on to a dry surface environment. Drosophila melanogaster larvae are acutely susceptible to desiccation displaying a strong aversion to locomotion on dry surfaces severely limiting the distance of movement away from a moist food source. Transgenic inactivation of mdIV nociceptor neurons resulted in larvae moving inappropriately into regions of low humidity at the top of the vial reflected as an increased overall pupation height and larval desiccation. This larval lethal desiccation phenotype was not observed in wild-type controls and was completely suppressed by growth in conditions of high humidity. Transgenic hyperactivation of mdIV nociceptors caused a reciprocal hypersensitivity to dry surfaces resulting in drastically decreased pupation height but did not induce the writhing nocifensive response previously associated with mdIV nociceptor activation by noxious heat or harsh mechanical stimuli. Larvae carrying mutations in either the Drosophila TRP channel, Painless, or the degenerin/epithelial sodium channel subunit Pickpocket1(PPK1), both expressed in mdIV nociceptors, showed the same inappropriate increased pupation height and lethal desiccation observed with mdIV nociceptor inactivation. Larval aversion to dry surfaces appears to utilize the same or overlapping sensory transduction pathways activated by noxious heat and harsh mechanical stimulation but with strikingly different sensitivities and disparate physiological responses.	[Johnson, Wayne A.; Carder, Justin W.] Univ Iowa, Dept Mol Physiol & Biophys, Roy & Lucille J Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Johnson, WA (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy & Lucille J Carver Coll Med, Iowa City, IA 52242 USA.	wayne-a-johnson@uiowa.edu		Johnson, Wayne/0000-0002-6961-5498	NSF; NIH [NS066287]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS066287] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Fly stocks were obtained from the Bloomington Drosophila Stock Center supported by NSF and NIH. We thank Toshi Kitamoto and Ben Aldrich for helpful comments on the manuscript.; This work was supported by National Institutes of Health grant NS066287 to WAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Ainsley JA, 2008, DEV BIOL, V322, P46, DOI 10.1016/j.ydbio.2008.07.003; Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; Babcock DT, 2009, CURR BIOL, V19, P799, DOI 10.1016/j.cub.2009.03.062; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BAUER SJ, 1988, BEHAV GENET, V18, P81, DOI 10.1007/BF01067077; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bodenstein D., 1950, BIOL DROSOPHILA, P275; Brierley SM, 2010, AUTON NEUROSCI-BASIC, V153, P58, DOI 10.1016/j.autneu.2009.07.017; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Corey DP, 2003, NEURON, V39, P585, DOI 10.1016/S0896-6273(03)00505-1; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; DESOUZA HML, 1970, AM NAT, V104, P175, DOI 10.1086/282648; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Duggan A, 2000, CURR BIOL, V10, pR384, DOI 10.1016/S0960-9822(00)00478-4; Eberl DF, 1999, CURR OPIN NEUROBIOL, V9, P389, DOI 10.1016/S0959-4388(99)80058-0; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Gong ZF, 2009, BIOCHEM BIOPH RES CO, V382, P395, DOI 10.1016/j.bbrc.2009.03.033; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Gu QH, 2010, PHARMACEUTICALS, V3, P1411, DOI 10.3390/ph3051411; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; ITOH T, 1984, ZOOL SCI, V1, P533; Iwasaki M, 1995, ZOOL SCI, V12, P725, DOI 10.2108/zsj.12.725; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Paranjpe DA, 2004, J GENET, V83, P73, DOI 10.1007/BF02715831; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Riedl CAL, 2007, FLY, V1, P23, DOI 10.4161/fly.3830; RINGO J, 1983, BEHAV GENET, V13, P17, DOI 10.1007/BF01071741; RODRIGUEZ L, 1992, J EVOLUTION BIOL, V5, P61, DOI 10.1046/j.1420-9101.1992.5010061.x; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; SCHNEBEL EM, 1986, BEHAV GENET, V16, P407, DOI 10.1007/BF01071320; SOKAL ROBERT R., 1960, ANN ENT SOC AMER, V53, P174; SOKOLOWSKI MB, 1989, HEREDITY, V62, P177, DOI 10.1038/hdy.1989.26; SOKOLOWSKI MB, 1985, J INSECT PHYSIOL, V31, P857, DOI 10.1016/0022-1910(85)90103-9; SOKOLOWSKI MB, 1983, BEHAV GENET, V13, P267, DOI 10.1007/BF01071872; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Wegman LJ, 2010, DEV BIOL, V345, P170, DOI 10.1016/j.ydbio.2010.07.004; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YOKOHARI F, 1976, J COMP PHYSIOL, V106, P137, DOI 10.1007/BF00620495; YOKOHARI F, 1978, J COMP PHYSIOL, V124, P53, DOI 10.1007/BF00656391; Zhong L, 2010, CURR BIOL, V20, P1	75	28	29	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32878	10.1371/journal.pone.0032878	http://dx.doi.org/10.1371/journal.pone.0032878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403719	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700116
J	Lebrun, P; Raze, D; Fritzinger, B; Wieruszeski, JM; Biet, F; Dose, A; Carpentier, M; Schwarzer, D; Allain, F; Lippens, G; Locht, C				Lebrun, Pierre; Raze, Dominique; Fritzinger, Bernd; Wieruszeski, Jean-Michel; Biet, Franck; Dose, Alexander; Carpentier, Mathieu; Schwarzer, Dirk; Allain, Fabrice; Lippens, Guy; Locht, Camille			Differential Contribution of the Repeats to Heparin Binding of HBHA, a Major Adhesin of Mycobacterium tuberculosis	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; HEMAGGLUTININ ADHESIN; CHEMICAL-SHIFT; GROWTH-FACTOR; IDENTIFICATION; SULFATE; DISSEMINATION; DOMAIN; SITES	Background: Tuberculosis remains one of the most important causes of global mortality and morbidity, and the molecular mechanisms of the pathogenesis are still incompletely understood. Only few virulence factors of the causative agent Mycobacterium tuberculosis are known. One of them is the heparin-binding haemagglutinin (HBHA), an important adhesin for epithelial cells and an extrapulmonary dissemination factor. HBHA mediates mycobacterial adherence to epithelial cells via the interactions of its C-terminal, lysine rich repeat domain with sulfated glycoconjugates on the surface of epithelial cells. Methodology/Principal Findings: Using defined heparin sulfate (HS) analogs, we determined the minimal heparin fragment length for HBHA binding and structural adaptations of the HBHA heparin-binding domain (HBD) upon binding to heparin. The NMR studies show significant shifts of all residues in the HBD upon interaction with heparin, with stronger shifts in the last repeats compared to the upstream repeats, and indicated that the HS fragments with 14 sugar units cover the entire C-terminal lysine-rich domain of HBHA. The differential implication of the repeats is determined by the relative position of prolines and lysines within each repeat, and may contribute to binding specificity. GAG binding induces a non-homogeneous structural rearrangement in the HBD, with stabilization of a nascent a-helix only in the last penta-repeats. Conclusion/Significance: Mycobacterial HBHA undergoes structural adaptation upon interaction with GAGs, which is likely involved in binding specificities of the adhesin, and mycobacterial pathogens may use HBD polymorphisms for host or organ specificity. Further studies will aim at decoding the complementarity between HBD repeats and HS sequence.	[Lebrun, Pierre; Raze, Dominique; Locht, Camille] INSERM U1019, Lille, France; [Lebrun, Pierre; Raze, Dominique; Locht, Camille] CNRS UMR 8204, Lille, France; [Lebrun, Pierre; Raze, Dominique; Locht, Camille] Inst Pasteur, Ctr Infect & Immun Lille, Lille, France; [Lebrun, Pierre; Raze, Dominique; Fritzinger, Bernd; Wieruszeski, Jean-Michel; Carpentier, Mathieu; Allain, Fabrice; Lippens, Guy; Locht, Camille] Univ Lille Nord France, Lille, France; [Fritzinger, Bernd; Wieruszeski, Jean-Michel; Carpentier, Mathieu; Allain, Fabrice; Lippens, Guy] CNRS Struct & Funct Glycobiol UMR8576, Villeneuve Dascq, France; [Dose, Alexander; Schwarzer, Dirk] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Biet, Franck] INRA, UR1282, Infectiol Anim Sante Publ IASP 311, F-37380 Nouzilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Eberhard Karls University of Tubingen; INRAE	Lebrun, P (corresponding author), INSERM U1019, Lille, France.	guy.lippens@univ-lille1.fr	Raze, Dominique/F-3965-2018; Biet, Franck/ABA-4151-2021; Locht, Camille/L-3516-2018	Raze, Dominique/0000-0001-5836-063X; Biet, Franck/0000-0001-8425-6158; Allain, Fabrice/0000-0002-4484-6302; Locht, Camille/0000-0001-7295-7336; Schwarzer, Dirk/0000-0002-7477-3319; Dose, Alexander/0000-0001-9054-8165	Ministere de l'Education Nationale et de la Recherche; Region Nord; CNRS; Pasteur Institute of Lille; European Community; French Research Ministry; University of Sciences and Technologies of Lille I; TGE RMN THC (France) [FR-3050]	Ministere de l'Education Nationale et de la Recherche; Region Nord(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; European Community(European Commission); French Research Ministry(Ministry of Research, France); University of Sciences and Technologies of Lille I; TGE RMN THC (France)	P.L holds a fellowship from the Ministere de l'Education Nationale et de la Recherche. The NMR facilities were funded by the Region Nord, CNRS, the Pasteur Institute of Lille, European Community (FEDER), French Research Ministry, and the University of Sciences and Technologies of Lille I. The authors acknowledge support from the TGE RMN THC (FR-3050, France)(Tres grande Infrastructure Resonance Magnetique Nucleaire). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo J, 2005, GLYCOBIOLOGY, V15, P1008, DOI 10.1093/glycob/cwi091; Biet F, 2007, MICROBES INFECT, V9, P175, DOI 10.1016/j.micinf.2006.11.007; Blaum BS, 2010, J AM CHEM SOC, V132, P6374, DOI 10.1021/ja1000517; Caldwell EEO, 1996, INT J BIOCHEM CELL B, V28, P203, DOI 10.1016/1357-2725(95)00123-9; Canales A, 2006, FEBS J, V273, P4716, DOI 10.1111/j.1742-4658.2006.05474.x; Dull RO, 2003, AM J PHYSIOL-LUNG C, V285, pL986, DOI 10.1152/ajplung.00022.2003; Esposito C, 2008, J BACTERIOL, V190, P4749, DOI 10.1128/JB.01988-07; Esposito C, 2010, FEBS LETT, V584, P1091, DOI 10.1016/j.febslet.2010.02.044; Guerrero GG, 2010, VACCINE, V28, P4340, DOI 10.1016/j.vaccine.2010.04.062; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Lefrancois LH, 2011, MICROBES INFECT, V13, P585, DOI 10.1016/j.micinf.2011.02.002; Locht C, 2008, MYCOBACTERIAL CELL ENVELOPE, P305; Locht C, 2007, EXPERT OPIN BIOL TH, V7, P1665, DOI 10.1517/14712598.7.11.1665; Lomino JV, 2011, J BACTERIOL, V193, P2089, DOI 10.1128/JB.01231-10; Menozzi FD, 2006, MICROBES INFECT, V8, P1, DOI 10.1016/j.micinf.2005.03.023; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Menozzi FD, 1998, P NATL ACAD SCI USA, V95, P12625, DOI 10.1073/pnas.95.21.12625; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Parra M, 2004, INFECT IMMUN, V72, P6799, DOI 10.1128/IAI.72.12.6799-6805.2004; Pessolani MCV, 2003, MICROBES INFECT, V5, P677, DOI 10.1016/S1286-4579(03)00098-4; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Pethe K, 2001, MOL MICROBIOL, V39, P89, DOI 10.1046/j.1365-2958.2001.02206.x; Pethe K, 2000, J BIOL CHEM, V275, P14273, DOI 10.1074/jbc.275.19.14273; Rouanet Carine, 2010, Expert Rev Respir Med, V4, P339, DOI 10.1586/ers.10.25; Rouanet C, 2009, MICROBES INFECT, V11, P995, DOI 10.1016/j.micinf.2009.07.005; Rullo A, 2010, BIOPOLYMERS, V93, P290, DOI 10.1002/bip.21339; Saito A, 1986, 13C NMR MAGN RESON C, V24, P835; Sambrook J., MOL CLONING LAB MANU; Sauton B, 1912, CR HEBD ACAD SCI, V155, P860; Shih PC, 2009, J BIOL CHEM, V284, P36535, DOI 10.1074/jbc.M109.037267; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Vanpouille C, 2004, BIOCHEM J, V382, P733, DOI 10.1042/BJ20031453; Vanwildemeersch M, 2006, J BIOL CHEM, V281, P10298, DOI 10.1074/jbc.M508483200; Verbelen C, 2008, J BACTERIOL, V190, P7614, DOI 10.1128/JB.00974-08; WEISEMANN R, 1993, J BIOMOL NMR, V3, P113; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q	42	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32421	10.1371/journal.pone.0032421	http://dx.doi.org/10.1371/journal.pone.0032421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403657	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700054
J	Rook, M; Vargas, J; Caughey, A; Bacchetti, P; Rosenthal, P; Bull, L				Rook, Michelle; Vargas, Juan; Caughey, Aaron; Bacchetti, Peter; Rosenthal, Philip; Bull, Laura			Fetal Outcomes in Pregnancies Complicated by Intrahepatic Cholestasis of Pregnancy in a Northern California Cohort	PLOS ONE			English	Article							BILE-ACID LEVELS; AMNIOTIC-FLUID	Background: Intrahepatic cholestasis of pregnancy (ICP) has important fetal implications. There is increased risk for poor fetal outcomes, including preterm delivery, meconium staining of amniotic fluid, respiratory distress, fetal distress and demise. Methods: One hundred and one women diagnosed with ICP between January 2005 and March 2009 at San Francisco General Hospital were included in this study. Single predictor logistic regression models were used to assess the associations of maternal clinical and biochemical predictors with fetal complications. Clinical predictors analyzed included age, race/ethnicity, gravidity, parity, history of liver or biliary disease, history of ICP in previous pregnancies, and induction. Biochemical predictors analyzed included serum aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total bilirubin, direct bilirubin, albumin, total protein, and total bile acids (TBA). Results: The prevalence of ICP was 1.9%. Most were Latina (90%). Labor was induced in the majority (87%) and most were delivered by normal spontaneous vaginal delivery (84%). Fetal complications occurred in 33% of the deliveries, with respiratory distress accounting for the majority of complications. There were no statistically significant clinical or biochemical predictors associated with an increased risk of fetal complications. Elevated TBA had little association with fetal complications until reaching greater than 100 mmoL/L, with 3 out of 5 having reported complications. ICP in previous pregnancies was associated with decreased risk of fetal complications (OR 0.21, p = 0.046). There were no cases of late term fetal demise. Conclusions: Maternal clinical and laboratory features, including elevated TBA, did not appear to be substantial predictors of fetal complications in ICP.	[Rook, Michelle; Rosenthal, Philip] Univ Calif San Francisco, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, San Francisco, CA 94143 USA; [Vargas, Juan; Caughey, Aaron] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Vargas, Juan] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Rosenthal, Philip] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Bull, Laura] Univ Calif San Francisco, Liver Ctr Lab, San Francisco, CA 94143 USA; [Bull, Laura] Univ Calif San Francisco, Dept Med, Inst Human Genet, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rook, M (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, San Francisco, CA 94143 USA.	lbull@medsfgh.ucsf.edu			National Institutes of Health [T32 DK007762, R01 DK58214, UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058214, T32DK007762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grants T32 DK007762 (to MR), R01 DK58214 (to LNB), UL1 RR024131 (to PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for the study.	Alsulyman OM, 1996, AM J OBSTET GYNECOL, V175, P957, DOI 10.1016/S0002-9378(96)80031-7; Arrese Marco, 2006, Ann Hepatol, V5, P202; Blackwell SC, 2002, FETAL DIAGN THER, V17, P78, DOI 10.1159/000048013; Egerman RS, 2004, HEPATOLOGY, V40, P287, DOI 10.1002/hep.20347; FISK NM, 1988, BRIT J OBSTET GYNAEC, V95, P1137, DOI 10.1111/j.1471-0528.1988.tb06791.x; Glantz A, 2005, HEPATOLOGY, V42, P1399, DOI 10.1002/hep.20952; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Hills BA, 1997, ARCH DIS CHILD, V77, P120, DOI 10.1136/adc.77.2.120; KANEKO T, 1990, CRIT CARE MED, V18, P77, DOI 10.1097/00003246-199001000-00017; Kondrackiene J, 2008, WORLD J GASTROENTERO, V14, P5781, DOI 10.3748/wjg.14.5781; Kondrackiene J, 2007, WORLD J GASTROENTERO, V13, P6226, DOI 10.3748/wjg.13.6226; LAATIKAINEN T, 1984, INT J GYNECOL OBSTET, V22, P91, DOI 10.1016/0020-7292(84)90019-5; Laifer S A, 2001, J Matern Fetal Med, V10, P131, DOI 10.1080/714052719; Lee RH, 2006, J PERINATOL, V26, P527, DOI 10.1038/sj.jp.7211545; Oyelese Y, 2006, OBSTET GYNECOL, V108, P345, DOI 10.1097/01.AOG.0000226853.85609.8d; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Pusl T, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-26; RIOSECO AJ, 1994, AM J OBSTET GYNECOL, V170, P890, DOI 10.1016/S0002-9378(94)70304-3; Zapata R, 2005, LIVER INT, V25, P548, DOI 10.1111/j.1478-3231.2004.0996.x; Zecca E, 2006, PEDIATRICS, V117, P1669, DOI 10.1542/peds.2005-1801; Zecca E, 2008, PEDIATRICS, V121, pE146, DOI 10.1542/peds.2007-1220	21	85	89	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e28343	10.1371/journal.pone.0028343	http://dx.doi.org/10.1371/journal.pone.0028343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403605	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700002
J	Welsh, JQ; Bellwood, DR				Welsh, Justin Q.; Bellwood, David R.			Regional Endothermy in a Coral Reef Fish?	PLOS ONE			English	Article							HERBIVOROUS FISHES; BEHAVIORAL THERMOREGULATION; NUTRITIONAL ECOLOGY; TROPHIC STATUS; HEAT-TRANSFER; EYE HEATER; MARINE; TEMPERATURE; WATER; PARROTFISHES	Although a few pelagic species exhibit regional endothermy, most fish are regarded as ectotherms. However, we document significant regional endothermy in a benthic reef fish. Individual steephead parrotfish, Chlorurus microrhinos (Labridae, formerly Scaridae) were tagged and their internal temperatures were monitored for a 24 h period using active acoustic telemetry. At night, on the reef, C. microrhinos were found to maintain a consistent average peritoneal cavity temperature 0.16 +/- 0.005 degrees C (SE) warmer than ambient. Diurnal internal temperatures were highly variable for individuals monitored on the reef, while in tank-based trials, peritoneal cavity temperatures tracked environmental temperatures. The mechanisms responsible for a departure of the peritoneal cavity temperature from environmental temperature occurred in C. microrhinos are not yet understood. However, the diet and behavior of the species suggests that heat in the peritoneal cavity may result primarily from endogenous thermogenesis coupled with physiological heat retention mechanisms. The presence of limited endothermy in C. microrhinos indicates that a degree of uncertainty may exist in the manner that reef fish respond to their thermal environment. At the very least, they do not always appear to respond to environmental temperatures as neutral thermal vessels and do display limited, but significant, visceral warming.	[Welsh, Justin Q.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Welsh, JQ (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	justin.welsh@my.jcu.edu.au			Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (DRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; BARTHOLO.GA, 1965, COMP BIOCHEM PHYSIOL, V16, P573, DOI 10.1016/0010-406X(65)90320-8; BELLWOOD DR, 1995, MAR ECOL PROG SER, V117, P127, DOI 10.3354/meps117127; BELLWOOD DR, 1995, MAR BIOL, V121, P419, DOI 10.1007/BF00349451; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BERMAN CH, 1991, J FISH BIOL, V39, P301, DOI 10.1111/j.1095-8649.1991.tb04364.x; Bernal D, 2005, NATURE, V437, P1349, DOI 10.1038/nature04007; BLOCK BA, 1986, J MORPHOL, V190, P169, DOI 10.1002/jmor.1051900203; BLOCK BA, 1994, ENVIRON BIOL FISH, V40, P283, DOI 10.1007/BF00002518; BLOCK BA, 1987, NEWS PHYSIOL SCI, V2, P208; BRILL RW, 1994, ENVIRON BIOL FISH, V40, P109, DOI 10.1007/BF00002538; CAREY FG, 1973, SCI AM, V228, P36, DOI 10.1038/scientificamerican0273-36; CAREY FG, 1971, AM ZOOL, V11, P137; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 1998, ANNU REV ECOL SYST, V29, P375, DOI 10.1146/annurev.ecolsys.29.1.375; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Choat JH, 1991, ECOLOGY FISHES CORAL, P121; CLEMENTS KD, 1995, PHYSIOL ZOOL, V68, P355, DOI 10.1086/physzool.68.3.30163774; Clements Kendall D., 1997, P156; Crossman DJ, 2005, MAR ECOL PROG SER, V296, P129, DOI 10.3354/meps296129; Donelson JM, 2010, MAR ECOL PROG SER, V401, P233, DOI 10.3354/meps08366; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; HOLLAND KN, 1994, ENVIRON BIOL FISH, V40, P319, DOI 10.1007/BF00002520; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; HULL D, 1965, J PHYSIOL-LONDON, V181, P449, DOI 10.1113/jphysiol.1965.sp007773; JOBLING M, 1981, J FISH BIOL, V18, P385, DOI 10.1111/j.1095-8649.1981.tb03780.x; LINDSEY CC, 1968, J FISH RES BOARD CAN, V25, P1987, DOI 10.1139/f68-175; MORROW JE, 1950, COPEIA, P108, DOI 10.2307/1438953; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; REYNOLDS WW, 1981, ENVIRON BIOL FISH, V6, P347, DOI 10.1007/BF00005763; REYNOLDS WW, 1980, OIKOS, V34, P356, DOI 10.2307/3544295; STEVENS ED, 1970, CAN J ZOOLOG, V48, P221, DOI 10.1139/z70-036; STEVENS ED, 1976, J EXP BIOL, V65, P131; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; WEBSTER AJF, 1973, BRIT J NUTR, V29, P279, DOI 10.1079/BJN19730102; Welsh JQ, 2012, CORAL REEFS, V31, P55, DOI 10.1007/s00338-011-0813-8; WHITTOW GC, 1987, MAR MAMMAL SCI, V3, P220, DOI 10.1111/j.1748-7692.1987.tb00165.x; WIKELSKI M, 1994, BEHAVIOUR, V128, P255, DOI 10.1163/156853994X00280; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279	45	6	6	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e33187	10.1371/journal.pone.0033187	http://dx.doi.org/10.1371/journal.pone.0033187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403736	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000303017700134
J	Chagraoui, H; Porcher, C				Chagraoui, Hedia; Porcher, Catherine			Establishment of an ES Cell-Derived Murine Megakaryocytic Cell Line, MKD1, with Features of Primary Megakaryocyte Progenitors	PLOS ONE			English	Article							ERYTHROPOIETIN RECEPTOR; ERYTHROID-CELLS; VALPROIC ACID; YOLK-SAC; C-MPL; MEGAKARYOPOIESIS; DIFFERENTIATION; THROMBOPOIETIN; GENE; INHIBITION	Because of the scarcity of megakaryocytes in hematopoietic tissues, studying megakaryopoiesis heavily relies on the availability of appropriate cellular models. Here, we report the establishment of a new mouse embryonic stem (ES) cell-derived megakaryocytic cell line, MKD1. The cells are factor-dependent, their cell surface immunophenotype and gene expression profile closely resemble that of primary megakaryocyte progenitors (MkPs) and they further differentiate along the megakaryocyte lineage upon valproic acid treatment. At a functional level, we show that ablation of SCL expression, a transcription factor critical for MkP maturation, leads to gene expression alterations similar to that observed in primary, Scl-excised MkPs. Moreover, the cell line is amenable to biochemical and transcriptional analyses, as we report for GpVI, a direct target of SCL. Thus, the MKD1 cell line offers a pertinent experimental model to study the cellular and molecular mechanisms underlying MkP biology and more broadly megakaryopoiesis.	[Chagraoui, Hedia; Porcher, Catherine] Univ Oxford, John Radcliffe Hosp, MRC Mol Haematol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford	Chagraoui, H (corresponding author), Univ Oxford, John Radcliffe Hosp, MRC Mol Haematol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	hedia.chagraoui@imm.ox.ac.uk	Porcher, Catherine/D-7026-2016		Medical Research Council; Medical Research Council [MC_UU_12009/9, MC_U137961142, G1000801d] Funding Source: researchfish; MRC [MC_U137961142, MC_UU_12009/9] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile G, 2005, BLOOD CELL MOL DIS, V35, P241, DOI 10.1016/j.bcmd.2005.06.011; Chagraoui H, 2011, BLOOD, V118, P723, DOI 10.1182/blood-2011-01-328765; CHENAILLE PJ, 1990, BLOOD, V76, P508; DESAUVAGE FJ, 1994, NATURE, V369, P533, DOI 10.1038/369533a0; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Dolzhanskiy A, 1998, BRIT J HAEMATOL, V100, P415, DOI 10.1046/j.1365-2141.1998.00579.x; Dumon S, 2006, EXP HEMATOL, V34, P654, DOI 10.1016/j.exphem.2006.01.014; Goncalves F, 1998, LEUKEMIA, V12, P1355, DOI 10.1038/sj.leu.2401122; Hamlett I, 2008, BLOOD, V112, P2738, DOI 10.1182/blood-2008-03-146605; HAWLEY RG, 1994, ONCOGENE, V9, P1; ISHIDA Y, 1993, EXP HEMATOL, V21, P289; KAJIGAYA S, 1988, JPN J CANCER RES, V79, P726, DOI 10.1111/j.1349-7006.1988.tb02229.x; Kawada H, 2001, INT J HEMATOL, V73, P463, DOI 10.1007/BF02994008; Keller G, 1998, BLOOD, V92, P877, DOI 10.1182/blood.V92.3.877.415k11_877_887; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; Liu B, 2010, EXP HEMATOL, V38, P685, DOI 10.1016/j.exphem.2010.03.019; McGrath KE, 2005, EXP HEMATOL, V33, P1021, DOI 10.1016/j.exphem.2005.06.012; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; Rouleau C, 2004, EXP HEMATOL, V32, P140, DOI 10.1016/j.exphem.2003.10.015; Saito H, 1997, BAILLIERE CLIN HAEM, V10, P47, DOI 10.1016/S0950-3536(97)80050-9; SCHMITZ B, 1994, EUR J HAEMATOL, V52, P267; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Schweinfurth N, 2010, PLATELETS, V21, P648, DOI 10.3109/09537104.2010.513748; Vulcano F, 2006, EXP CELL RES, V312, P1590, DOI 10.1016/j.yexcr.2006.01.017; WEINSTEIN R, 1981, BLOOD, V58, P110; Xu MJ, 2001, BLOOD, V97, P2016, DOI 10.1182/blood.V97.7.2016	28	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32981	10.1371/journal.pone.0032981	http://dx.doi.org/10.1371/journal.pone.0032981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396803	gold, Green Published, Green Submitted			2022-12-25	WOS:000303006500039
J	Townsend, SW; Deschner, T; Zuberbuhler, K				Townsend, Simon W.; Deschner, Tobias; Zuberbuehler, Klaus			Female Chimpanzees Use Copulation Calls Flexibly to Prevent Social Competition	PLOS ONE			English	Article							WILD CHIMPANZEES; RHESUS-MONKEY; MATE CHOICE; VOCALIZATIONS; FREQUENCY; STRATEGIES; AVOIDANCE; PREGNANCY; PATTERNS; SUCCESS	The adaptive function of copulation calls in female primates has been debated for years. One influential idea is that copulation calls are a sexually selected trait, which enables females to advertise their receptive state to males. Male-male competition ensues and females benefit by getting better mating partners and higher quality offspring. We analysed the copulation calling behaviour of wild female chimpanzees (Pan troglodytes schweinfurthii) at Budongo Forest, Uganda, but found no support for the male-male competition hypothesis. Hormone analysis showed that the calling behaviour of copulating females was unrelated to their fertile period and likelihood of conception. Instead, females called significantly more while with high-ranking males, but suppressed their calls if high-ranking females were nearby. Copulation calling may therefore be one potential strategy employed by female chimpanzees to advertise receptivity to high-ranked males, confuse paternity and secure future support from these socially important individuals. Competition between females can be dangerously high in wild chimpanzees, and our results indicate that females use their copulation calls strategically to minimise the risks associated with such competition.	[Townsend, Simon W.; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Townsend, Simon W.; Zuberbuehler, Klaus] Budongo Conservat Field Stn, Masindi, Uganda; [Deschner, Tobias] Max Planck Inst Evol Anthropol, Leipzig, Germany	University of St Andrews; Max Planck Society	Townsend, SW (corresponding author), Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland.	kz3@st-and.ac.uk	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X	Biotechnology and Biological Sciences Research Council of the United Kingdom [studentship, BB/D002559/1]; EU Pathfinder FP-6 What it means to be human; German Max Planck Society; Royal Zoological Society of Scotland; Biotechnology and Biological Sciences Research Council [BB/D002559/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Pathfinder FP-6 What it means to be human; German Max Planck Society(Max Planck Society); Royal Zoological Society of Scotland; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study has been funded by a studentship provided by the Biotechnology and Biological Sciences Research Council of the United Kingdom to ST in addition to BBSRC BB/D002559/1 and EU Pathfinder FP-6 What it means to be human grants to KZ. Hormone analysis was funded through the German Max Planck Society. The Budongo Forest Project receives core funding from the Royal Zoological Society of Scotland. The funders did not have a role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; BEILHARZ R. G., 1963, ANIMAL BEHAVIOUR, V11, P522, DOI 10.1016/0003-3472(63)90273-2; Boesch C, 2000, CHIMPANZEES TAI FORE; Bygott JD., 1979, GREAT APES, P405; COX CR, 1977, AM NAT, V111, P317, DOI 10.1086/283163; Dahl JF, 1999, J MED PRIMATOL, V28, P129, DOI 10.1111/j.1600-0684.1999.tb00260.x; Deschner T, 2004, HORM BEHAV, V46, P204, DOI 10.1016/j.yhbeh.2004.03.013; Deschner T, 2003, ANIM BEHAV, V66, P551, DOI 10.1006/anbe.2003.2210; DEWAAL F, 1982, CHIMPANZEE POLITICS; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; EAST M, 1989, J ZOOL, V219, P690, DOI 10.1111/j.1469-7998.1989.tb02614.x; FURUICHI T, 1987, PRIMATES, V28, P309, DOI 10.1007/BF02381014; GAGE MJG, 1994, FUNCT ECOL, V8, P594, DOI 10.2307/2389920; Goodall J., 1986, CHIMPANZEES GOMBE PA; HAMILTON WJ, 1978, SCIENCE, V200, P1405, DOI 10.1126/science.663622; Hasegawa T., 1983, J ETHOL, V1, P75, DOI DOI 10.1007/BF02347833; Hauser, 1996, EVOL COMMUN; Hauser MD, 2007, ANIM BEHAV, V73, P1059, DOI 10.1016/j.anbehav.2006.11.006; HAUSER MD, 1993, P ROY SOC B-BIOL SCI, V254, P93, DOI 10.1098/rspb.1993.0132; HAUSER MD, 1990, ANIM BEHAV, V39, P596, DOI 10.1016/S0003-3472(05)80427-0; Heistermann M, 1996, BIOL REPROD, V55, P844, DOI 10.1095/biolreprod55.4.844; Henzi SP, 1996, ANIM BEHAV, V51, P233; KAHLENBERG SM, INT J PRIMA IN PRESS; Langmore NE, 1996, P ROY SOC B-BIOL SCI, V263, P141, DOI 10.1098/rspb.1996.0022; MARSON J, 1989, J REPROD FERTIL, V85, P43; MATOCHIK JA, 1992, PHYSIOL BEHAV, V51, P783, DOI 10.1016/0031-9384(92)90116-J; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Newton-Fisher NE, 1997, THESIS U CAMBRIDGE; Newton-Fisher NE, 2006, INT J PRIMATOL, V27, P1589, DOI 10.1007/s10764-006-9087-3; Nikitopoulos E, 2004, INT J PRIMATOL, V25, P659, DOI 10.1023/B:IJOP.0000023579.30595.ae; Nishida T., 1989, P68; O'Hara SJ, 2006, FOLIA PRIMATOL, V77, P353, DOI 10.1159/000093700; OCONNELL SM, 1994, ANIM BEHAV, V48, P687, DOI 10.1006/anbe.1994.1288; ODA R, 1995, FOLIA PRIMATOL, V64, P132, DOI 10.1159/000156843; Packer C, 2001, SCIENCE, V293, P690, DOI 10.1126/science.1062320; Pfefferle D, 2008, P R SOC B, V275, P571, DOI 10.1098/rspb.2007.1499; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Pradhan GR, 2006, BEHAV ECOL SOCIOBIOL, V59, P333, DOI 10.1007/s00265-005-0075-y; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; PUSEY AE, 1980, ANIM BEHAV, V28, P543, DOI 10.1016/S0003-3472(80)80063-7; PUSEY AE, INT J PRIMA IN PRESS; Reynolds V., 2005, CHIMPANZEES BUDONGO; Schaller G. B., 1972, SERENGETI LION STUDY; Semple S, 1998, P ROY SOC B-BIOL SCI, V265, P287, DOI 10.1098/rspb.1998.0294; Semple S, 2002, AM J PRIMATOL, V56, P43, DOI 10.1002/ajp.1062; Semple S, 2001, ANIM BEHAV, V61, P1023, DOI 10.1006/anbe.2001.1692; Semple S, 2000, P ROY SOC B-BIOL SCI, V267, P707, DOI 10.1098/rspb.2000.1060; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Townsend SW, 2007, CURR BIOL, V17, pR355, DOI 10.1016/j.cub.2007.03.020; TUTIN CEG, 1979, BEHAV ECOL SOCIOBIOL, V6, P29, DOI 10.1007/BF00293242; van Schaik Carel P., 2000, P27, DOI 10.1017/CBO9780511542312.004; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Wittig RM, 2003, INT J PRIMATOL, V24, P847, DOI 10.1023/A:1024632923180	58	77	77	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2431	10.1371/journal.pone.0002431	http://dx.doi.org/10.1371/journal.pone.0002431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	22423311	Green Published, Green Submitted, gold			2022-12-25	WOS:000263280700016
J	Carrara, G; Saraiva, N; Gubser, C; Johnson, BF; Smith, GL				Carrara, Guia; Saraiva, Nuno; Gubser, Caroline; Johnson, Benjamin F.; Smith, Geoffrey L.			Six-transmembrane Topology for Golgi Anti-apoptotic Protein (GAAP) and Bax Inhibitor 1 (BI-1) Provides Model for the Transmembrane Bax Inhibitor-containing Motif (TMBIM) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM; VIRUS; GENE; IDENTIFICATION; PROTECTION; HOMOLOGS; VACCINIA; VECTOR	The Golgi anti-apoptotic protein (GAAP) is a hydrophobic Golgi protein that regulates intracellular calcium fluxes and apoptosis. GAAP is highly conserved throughout eukaryotes and some strains of vaccinia virus (VACV) and camelpox virus. Based on sequence, phylogeny, and hydrophobicity, GAAPs were classified within the transmembrane Bax inhibitor-containing motif (TMBIM) family. TMBIM members are anti-apoptotic and were predicted to have seven-transmembrane domains (TMDs). However, topology prediction programs are inconsistent and predicted that GAAP and other TMBIM members have six or seven TMDs. To address this discrepancy, we mapped the transmembrane topology of viral (vGAAP) and human (hGAAP), as well as Bax inhibitor (BI-1). Data presented show a six-, not seven-, transmembrane topology for vGAAP with a putative reentrant loop at the C terminus and both termini located in the cytosol. We find that this topology is also conserved in hGAAP and BI-1. This places the charged C terminus in the cytosol, and mutation of these charged residues in hGAAP ablated its anti-apoptotic function. Given the highly conserved hydrophobicity profile within the TMBIM family and recent phylogenetic data indicating that a GAAP-like protein may have been the ancestral progenitor of a subset of the TMBIM family, we propose that this vGAAP topology may be used as a model for the remainder of the TMBIM family of proteins. The topology described provides valuable information on the structure and func-tion of an important but poorly understood family of proteins.	[Carrara, Guia; Saraiva, Nuno; Gubser, Caroline; Johnson, Benjamin F.; Smith, Geoffrey L.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Carrara, Guia; Saraiva, Nuno; Gubser, Caroline; Johnson, Benjamin F.; Smith, Geoffrey L.] Univ London Imperial Coll Sci Technol & Med, Virol Sect, Dept Med, London W2 1PG, England	University of Cambridge; Imperial College London	Smith, GL (corresponding author), Wellcome Trust Res Labs, London, England.	gls37@cam.ac.uk	Smith, Geoffrey L/G-2894-2012; Saraiva, Nuno/I-9299-2019	Saraiva, Nuno/0000-0003-1333-9137; Johnson, Benjamin/0000-0001-5991-7612; Gubser Keller, Caroline/0000-0001-9459-6076; Smith, Geoffrey L/0000-0002-3730-9955	Medical Research Council; Medical Research Council [G0900224] Funding Source: researchfish; MRC [G0900224] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Medical Research Council.	Ahn T, 2009, FEBS J, V276, P2285, DOI 10.1111/j.1742-4658.2009.06956.x; ALCAMI A, 1995, J VIROL, V69, P4633; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Bultynck G, 2012, J BIOL CHEM, V287, P2544, DOI 10.1074/jbc.M111.275354; Cebulski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020882; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Gubser C, 2002, J GEN VIROL, V83, P855, DOI 10.1099/0022-1317-83-4-855; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Henke N, 2011, CELL CALCIUM, V50, P251, DOI 10.1016/j.ceca.2011.05.005; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee GH, 2010, MOL CELL BIOL, V30, P1800, DOI 10.1128/MCB.01357-09; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Nuara AA, 2008, P NATL ACAD SCI USA, V105, P1861, DOI 10.1073/pnas.0705753105; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; WALTER L, 1995, GENOMICS, V28, P301, DOI 10.1006/geno.1995.1145; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; Zhou JH, 2008, COMPUT BIOL CHEM, V32, P159, DOI 10.1016/j.compbiolchem.2008.01.002	30	37	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15896	15905		10.1074/jbc.M111.336149	http://dx.doi.org/10.1074/jbc.M111.336149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418439	hybrid, Green Published			2022-12-25	WOS:000304006300068
J	Boissel, L; Fillatre, J; Moreau, J				Boissel, Laurent; Fillatre, Jonathan; Moreau, Jacques			Identification and Characterization of the RLIP/RALBP1 Interacting Protein Xreps1 in Xenopus laevis Early Development	PLOS ONE			English	Article							RAL-BINDING PROTEIN-1; EH DOMAIN; PUTATIVE EFFECTOR; GTPASE; ENDOCYTOSIS; TARGET; INVOLVEMENT; EXPRESSION; HOMOLOGY; CLONING	Background: The FGF/Ras/Ral/RLIP pathway is required for the gastrulation process during the early development of vertebrates. The Ral Interacting Protein (RLIP also known as RalBP1) interacts with GTP-bound Ral proteins. RLIP/RalBP1 is a modular protein capable of participating in many cellular functions. Methodology/Principal Findings: To investigate the role of RLIP in early development, a two-hybrid screening using a library of maternal cDNAs of the amphibian Xenopus laevis was performed. Xreps1 was isolated as a partner of RLIP/RalBP1 and its function was studied. The mutual interacting domains of Xreps1 and Xenopus RLIP (XRLIP) were identified. Xreps1 expressed in vivo, or synthesized in vitro, interacts with in vitro expressed XRLIP. Interestingly, targeting of Xreps1 or the Xreps1-binding domain of XRLIP (XRLIP(469-636)) to the plasma membrane through their fusion to the CAAX sequence induces a hyperpigmentation phenotype of the embryo. This hyperpigmented phenotype induced by XRLIP(469-636)CAAX can be rescued by co-expression of a deletion mutant of Xreps1 restricted to the RLIP-binding domain (Xreps1(RLIP-BD)) but not by co-expression of a cDNA coding for a longer form of Xreps1. Conclusion/Significance: We demonstrate here that RLIP/RalBP1, an effector of Ral involved in receptor-mediated endocytosis and in the regulation of actin dynamics during embryonic development, also interacts with Reps1. Although these two proteins are present early during embryonic development, they are active only at the end of gastrulation. Our results suggest that the interaction between RLIP and Reps1 is negatively controlled during the cleavage stage of development, which is characterized by rapid mitosis. Later in development, Reps1 is required for the normal function of the ectodermic cell, and its targeting into the plasma membrane affects the stability of the ectoderm.	[Boissel, Laurent; Fillatre, Jonathan; Moreau, Jacques] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Boissel, L (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR7592, Paris, France.	moreau.jacques@ijm.univ-paris-diderot.fr			Centre National pour la Recherche Scientifique, "l'Association pour la Recherche sur le Cancer''; GEFLUC	Centre National pour la Recherche Scientifique, "l'Association pour la Recherche sur le Cancer''; GEFLUC	This work was supported by the Centre National pour la Recherche Scientifique, "l'Association pour la Recherche sur le Cancer'' and "GEFLUC''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Carballada R, 2001, DEVELOPMENT, V128, P35; GURDON JB, 1983, METHOD ENZYMOL, V101, P370; GUSSE M, 1989, MOL CELL BIOL, V9, P5395, DOI 10.1128/MCB.9.12.5395; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Iouzalen N, 1998, BIOCHEM BIOPH RES CO, V250, P359, DOI 10.1006/bbrc.1998.9336; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kawasaki H, 2011, CURR PROBL DERMATOL, V41, P35, DOI 10.1159/000323291; Kim S, 2001, BIOCHEMISTRY-US, V40, P6776, DOI 10.1021/bi002700m; Lebreton S, 2004, MECH DEVELOP, V121, P1481, DOI 10.1016/j.mod.2004.07.008; Lebreton S, 2003, J CELL SCI, V116, P4651, DOI 10.1242/jcs.00763; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; MACNICOL AM, 1993, CELL, V73, P571, DOI 10.1016/0092-8674(93)90143-E; Mark BL, 1996, BIOCHEM BIOPH RES CO, V225, P40, DOI 10.1006/bbrc.1996.1128; Matsuzaki T, 2002, J BIOL CHEM, V277, P19008, DOI 10.1074/jbc.M112472200; McLean W H Irwin, 2011, F1000 Med Rep, V3, P2, DOI 10.3410/M3-2; Moreau J, 1999, DEV BIOL, V209, P268, DOI 10.1006/dbio.1999.9254; MOREAU J, 1995, MOL REPROD DEV, V41, P1, DOI 10.1002/mrd.1080410102; Morinaka K, 1999, ONCOGENE, V18, P5915, DOI 10.1038/sj.onc.1202974; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Park SH, 1995, ONCOGENE, V11, P2349; Polzin A, 2002, MOL CELL BIOL, V22, P1714, DOI 10.1128/MCB.22.6.1714-1722.2002; PYPAERT M, 1991, J CELL BIOL, V114, P1159, DOI 10.1083/jcb.114.6.1159; REGEN CM, 1986, DEV BIOL, V113, P147, DOI 10.1016/0012-1606(86)90117-X; Rosse C, 2003, J BIOL CHEM, V278, P30597, DOI 10.1074/jbc.M302191200; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P1074, DOI 10.1016/j.bcp.2008.11.013; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Wang L, 2004, J BIOL CHEM, V279, P19875, DOI 10.1074/jbc.M400522200; Wu Z, 2010, NEOPLASIA, V12, P1003, DOI 10.1593/neo.101080; Xu J, 2001, BBA-GENE STRUCT EXPR, V1522, P118, DOI 10.1016/S0167-4781(01)00310-4; Yamaguchi A, 1997, J BIOL CHEM, V272, P31230, DOI 10.1074/jbc.272.50.31230	37	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e33193	10.1371/journal.pone.0033193	http://dx.doi.org/10.1371/journal.pone.0033193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22413001	Green Submitted, gold, Green Published			2022-12-25	WOS:000303062000035
J	Grellet-Tinner, G; Codrea, V; Folie, A; Higa, A; Smith, T				Grellet-Tinner, Gerald; Codrea, Vlad; Folie, Annelise; Higa, Alessandra; Smith, Thierry			First Evidence of Reproductive Adaptation to "Island Effect" of a Dwarf Cretaceous Romanian Titanosaur, with Embryonic Integument In Ovo	PLOS ONE			English	Article							NEST-SITE SELECTION; HATEG BASIN; AUCA-MAHUEVO; HAWTHORNE FORMATION; SOUTHERN GEORGIA; DINOSAUR EGGS; RAUL MARE; SAUROPODS; ARGENTINA; PRESERVATION	Background: The Cretaceous vertebrate assemblages of Romania are famous for geographically endemic dwarfed dinosaur taxa. We report the first complete egg clutches of a dwarf lithostrotian titanosaur, from Totesti, Romania, and its reproductive adaptation to the "island effect''. Methodology/Findings: The egg clutches were discovered in sequential sedimentary layers of the Maastrichtian Sanpetru Formation, Totesti. The occurrence of 11 homogenous clutches in successive strata suggests philopatry by the same dinosaur species, which laid clutches averaging four,12 cm diameters eggs. The eggs and eggshells display numerous characters shared with the positively identified material from egg-bearing level 4 of the Auca Mahuevo (Patagonia, Argentina) nemegtosaurid lithostrotian nesting site. Microscopic embryonic integument with bacterial evidences was recovered in one egg. The millimeter-size embryonic integument displays micron size dermal papillae implying an early embryological stage at the time of death, likely corresponding to early organogenesis before the skeleton formation. Conclusions/Significance: The shared oological characters between the Hat, eg specimens and their mainland relatives suggest a highly conservative reproductive template, while the nest decrease in egg numbers per clutch may reflect an adaptive trait to a smaller body size due to the "island effect''. The combined presence of the lithostrotian egg and its embryo in the Early Cretaceous Gobi coupled with the oological similarities between the Hat, eg and Auca Mahuevo oological material evidence that several titanosaur species migrated from Gondwana through the Hat, eg Island before or during the Aptian/Albian. It also suggests that this island might have had episodic land bridges with the rest of the European archipelago and Asia deep into the Cretaceous.	[Grellet-Tinner, Gerald] Field Museum, Chicago, IL USA; [Grellet-Tinner, Gerald] Journey Museum, Rapid City, SD USA; [Grellet-Tinner, Gerald] Consejo Nacl Invest Cient & Tecn, CRILAR, Anillaco, La Rioja, Argentina; [Codrea, Vlad] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania; [Folie, Annelise; Smith, Thierry] Royal Belgian Inst Nat Sci, Direct Earth & Hist Life, Brussels, Belgium; [Higa, Alessandra] Oglala Lakota Coll, Fac Math, Kyle, SD USA; [Higa, Alessandra] Oglala Lakota Coll, Dept Sci, Kyle, SD USA	Field Museum of Natural History (Chicago); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Babes Bolyai University from Cluj; Royal Belgian Institute of Natural Sciences	Grellet-Tinner, G (corresponding author), Field Museum, Chicago, IL USA.	Locarnolugano@gmail.com	Codrea, Vlad/C-2721-2011	Codrea, Vlad/0000-0002-5575-4139; Folie, Annelise/0000-0002-5839-4212; Codrea, Vlad Aurel/0000-0002-3992-955X; Smith, Thierry/0000-0002-1795-2564	RBINS; FNRS; NSF OISE [1023978]; AMMRF TAP; National University Research Council CNCS [PN-II-ID-PCE-2011-3-0381]; Belgian Science Policy Office [MO/36/001]	RBINS; FNRS(Fonds de la Recherche Scientifique - FNRS); NSF OISE(National Science Foundation (NSF)); AMMRF TAP; National University Research Council CNCS(Consiliul National al Cercetarii Stiintifice (CNCS)); Belgian Science Policy Office(Belgian Federal Science Policy Office)	Fieldwork was supported by the RBINS and by travel grants from the FNRS (to A. F. and T. S.). Field vehicles and technical equipment were kindly supplied by Belgian companies Fabricom and Ford Motor. Funding for this research was provided by NSF OISE grant 1023978 and partly by an AMMRF TAP grant for fossil microcharacterization (to GGT), National University Research Council CNCS grant PN-II-ID-PCE-2011-3-0381 (to VC), Belgian Science Policy Office Project MO/36/001 (to Pierre Bultynck and T. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L, 2001, J ANAT, V198, P265, DOI 10.1046/j.1469-7580.2001.19830265.x; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; Bojar AV, 2011, GEOCHRONOMETRIA, V38, P182, DOI 10.2478/s13386-011-0023-8; Brazaitis P, 2011, HIST BIOL, V23, P73, DOI 10.1080/08912963.2011.560723; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; BROWN G, 1984, PHILOS T R SOC A, V311, P221, DOI 10.1098/rsta.1984.0025; Brown GP, 2007, BIOL LETTERS, V3, P131, DOI 10.1098/rsbl.2006.0605; Chen TC, 2001, ZOOL SCI, V18, P591, DOI 10.2108/zsj.18.591; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Chiappe LM, 2004, PALAIOS, V19, P89, DOI 10.1669/0883-1351(2004)019<0089:NSFSSC>2.0.CO;2; Codrea V, 2002, CR PALEVOL, V1, P173, DOI 10.1016/S1631-0683(02)00021-0; Coria RA, 2007, J PALEONTOL, V81, P1528, DOI 10.1666/05-150.1; Csiki Zoltan, 1999, Oryctos, V2, P93; Csiki Z, 2010, NEUES JAHRB GEOL P-A, V258, P297, DOI 10.1127/0077-7749/2010/0098; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; Csontos L, 2004, PALAEOGEOGR PALAEOCL, V210, P1, DOI 10.1016/j.palaeo.2004.02.033; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Deeming DC, 2006, PALAEONTOLOGY, V49, P171, DOI 10.1111/j.1475-4983.2005.00536.x; Dercourt J., 2000, ATLAS PERI TETHYS PA; Dercourt J, 1993, ATLAS TETHYS PALAEOE; Eikenberg J, 2001, QUATERNARY SCI REV, V20, P1935, DOI 10.1016/S0277-3791(01)00020-8; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Freedberg S, 2001, EVOLUTION, V55, P1049, DOI 10.1554/0014-3820(2001)055[1049:CIAAMF]2.0.CO;2; FURBISH WJ, 1976, CLAY MINER, V11, P147, DOI 10.1180/claymin.1976.011.2.06; Garcia RA, 2010, AMEGHINIANA, V47, P409, DOI 10.5710/AMGH.v47i4.4; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Goth Ann, 1997, Annual Review of the World Pheasant Association, V1996-1997, P43; Grellet-Tinner G, 2006, ALCHERINGA, V30, P141, DOI 10.1080/03115510608619350; Grellet-Tinner G, 2005, J VERTEBR PALEONTOL, V25, P99, DOI 10.1671/0272-4634(2005)025[0099:MTOTDE]2.0.CO;2; Grellet-Tinner G, 2004, CAN J EARTH SCI, V41, P949, DOI 10.1139/E04-049; Grellet-Tinner G, 2000, 1 INT S DIN EGGS BAB, P61; Grellet-Tinner G, 2006, CAN J EARTH SCI, V43, P705, DOI 10.1139/E06-033; Grellet-Tinner G, 2012, PALAIOS, V27, P35, DOI 10.2110/palo.2011.p11-061r; Grellet-Tinner G, 2011, GONDWANA RES, V20, P621, DOI 10.1016/j.gr.2011.02.007; Grellet-Tinner G, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1031; Grigorescu D, 2010, PALAEOGEOGR PALAEOCL, V293, P360, DOI 10.1016/j.palaeo.2010.03.031; Grigorescu D, 2010, PALAEOGEOGR PALAEOCL, V293, P271, DOI 10.1016/j.palaeo.2010.01.030; Grigorescu D, 2010, AMEGHINIANA, V47, P89, DOI 10.5710/AMGH.v47i1.9; Grigorescu Dan, 2005, Acta Palaeontologica Romaniae, V5, P191; Guo Peng, 2008, Sichuan Journal of Zoology, V27, P321; Gupta NS, 2008, CRETACEOUS RES, V29, P1, DOI 10.1016/j.cretres.2006.12.009; Huang S, 2009, MOL PHYLOGENET EVOL, V51, P438, DOI 10.1016/j.ympev.2009.02.013; Canudo JI, 2009, B SOC GEOL FR, V180, P5, DOI 10.2113/gssgfbull.180.1.5; Kamel SJ, 2005, ANIM BEHAV, V70, P819, DOI 10.1016/j.anbehav.2005.01.006; Kardong KV, 2001, VERTEBRATES COMP ANA; Kolbe JJ, 2002, ECOLOGY, V83, P269, DOI 10.1890/0012-9658(2002)083[0269:IONSSO]2.0.CO;2; Krautner HG, 1986, DIONYZ STUR I GEOLOG, V70-71, P373; Krekeler M, 2004, GEOL SOC AM ABSTR, V36, P114; Krekeler MPS, 2004, CLAY CLAY MINER, V52, P263, DOI 10.1346/CCMN.2004.0520302; Krekeler MPS, 2004, CLAY CLAY MINER, V52, P253, DOI 10.1346/CCMN.2004.0520301; KURZANOV SM, 1983, PALEONTOL ZH, P90; Nopesa F., 1915, Jahrb Kgl Ungar Geol Reich Budapest, V23, P1; Nowinski A., 1971, Palaeontologia Polonica, VNo. 25, P57; Osi A, 2010, CRETACEOUS RES, V31, P304, DOI 10.1016/j.cretres.2010.01.001; Osi A, 2010, NATURE, V465, P466, DOI 10.1038/nature09019; Pereda-Suberbiola X, 2009, B SOC GEOL FR, V180, P57, DOI 10.2113/gssgfbull.180.1.57; Prieto-Marquez A, 2009, CRETACEOUS RES, V30, P1238, DOI 10.1016/j.cretres.2009.06.005; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Russo-Sandulescu D., 1979, REV ROUM GEOL GEOPHY, V23, P149; Sas I, 2010, NORTH-WEST J ZOOL, V6, P128; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R, 1996, ECOLOGY, V77, P1808, DOI 10.2307/2265785; Smith Thierry, 2002, Studia Universitatis Babes-Bolyai Geologia, P321; Smith T, 2010, NATURWISSENSCHAFTEN, V97, P417, DOI 10.1007/s00114-010-0651-5; Spearman R. I. C., 1969, Journal of the Linnean Society Zoology, V48, P453; Stefan A, 1988, D S I GEOL GEOFIZ, V72-73, P195; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Tazaki K, 2006, DEV CLAY SCI, V1, P477, DOI 10.1016/S1572-4352(05)01014-7; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Van Itterbeeck J, 2004, CRETACEOUS RES, V25, P517, DOI 10.1016/j.cretres.2004.04.004; Van Itterbeeck J, 2005, GEOL CARPATH, V56, P137; Vickaryous MK, 2009, J ANAT, V214, P441, DOI 10.1111/j.1469-7580.2008.01043.x; Weishampel D. B., 1991, NATL GEOGRAPHIC RES, V7, P68; Weishampel DB, 2010, PALAEOGEOGR PALAEOCL, V293, P419, DOI 10.1016/j.palaeo.2010.03.024; WERNER DI, 1983, AM NAT, V121, P757, DOI 10.1086/284103; West JB, 1990, RESP PHYSL ESSENTIAL, V4th, P23; Wilby Philip R., 1997, Geobios Memoire Special (Villeurbanne), V20, P493; Wilson JA, 2003, J SYST PALAEONTOL, V1, P125, DOI 10.1017/S1477201903001044; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wu CS, 2005, HERPETOLOGICA, V61, P35, DOI 10.1655/04-50; Wu P, 2004, INT J DEV BIOL, V48, P249, DOI 10.1387/ijdb.15272390; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663	82	35	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32051	10.1371/journal.pone.0032051	http://dx.doi.org/10.1371/journal.pone.0032051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412852	gold, Green Submitted, Green Published			2022-12-25	WOS:000303062000005
J	Ospeck, M				Ospeck, Mark			Fast Negative Feedback Enables Mammalian Auditory Nerve Fibers to Encode a Wide Dynamic Range of Sound Intensities	PLOS ONE			English	Article							BASILAR-MEMBRANE; AFFERENT SYNAPSE; GUINEA-PIG; NEURONS; CURRENTS; COCHLEA; LINEARIZATION; STIMULATION; ADAPTATION; CHANNELS	Mammalian auditory nerve fibers (ANF) are remarkable for being able to encode a 40 dB, or hundred fold, range of sound pressure levels into their firing rate. Most of the fibers are very sensitive and raise their quiescent spike rate by a small amount for a faint sound at auditory threshold. Then as the sound intensity is increased, they slowly increase their spike rate, with some fibers going up as high as similar to 300 Hz. In this way mammals are able to combine sensitivity and wide dynamic range. They are also able to discern sounds embedded within background noise. ANF receive efferent feedback, which suggests that the fibers are readjusted according to the background noise in order to maximize the information content of their auditory spike trains. Inner hair cells activate currents in the unmyelinated distal dendrites of ANF where sound intensity is rate-coded into action potentials. We model this spike generator compartment as an attenuator that employs fast negative feedback. Input current induces rapid and proportional leak currents. This way ANF are able to have a linear frequency to input current (f-I) curve that has a wide dynamic range. The ANF spike generator remains very sensitive to threshold currents, but efferent feedback is able to lower its gain in response to noise.				mospeck@yahoo.com						Abbott LF, 1992, SINGLE NEURON DYNAMI; Brown MC, 1999, FUNDAMENTAL NEUROSCI, P791; Chen C, 1997, HEARING RES, V110, P179, DOI 10.1016/S0378-5955(97)00078-6; DeFelice LJ, 1981, INTRO MEMBRANE NOISE, P232; Ermentrout B, 1998, NEURAL COMPUT, V10, P1721, DOI 10.1162/089976698300017106; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Fuchs PA, 2010, OXFORD HDB AUDITORY, P259; Grant L, 2010, J NEUROSCI, V30, P4210, DOI 10.1523/JNEUROSCI.4439-09.2010; Heil P, 2007, J NEUROSCI, V27, P8457, DOI 10.1523/JNEUROSCI.1512-07.2007; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hong S, 2008, PLOS COMP BIO, V4, P1; Horowitz P, 1989, ART ELECT, P175; Hossain WA, 2005, J NEUROSCI, V25, P6857, DOI 10.1523/JNEUROSCI.0123-05.2005; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Jagger DJ, 2002, NEUROSCIENCE, V109, P169, DOI 10.1016/S0306-4522(01)00454-7; Kiang NYS, 1965, DISCHARGE PATTERNS S; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Murugasu E, 1996, J NEUROSCI, V16, P325; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; Sekizawa SI, 1999, J NEUROPHYSIOL, V81, P2937, DOI 10.1152/jn.1999.81.6.2937; Szabo ZS, 2002, EUR J NEUROSCI, V16, P1887, DOI 10.1046/j.1460-9568.2002.02258.x; TEICH MC, 1985, J ACOUST SOC AM, V77, P1110, DOI 10.1121/1.392176; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; Wen B, 2009, J NEUROSCI, V29, P13797, DOI 10.1523/JNEUROSCI.5610-08.2009; WINSLOW RL, 1987, J NEUROPHYSIOL, V57, P1002, DOI 10.1152/jn.1987.57.4.1002; Yi EY, 2010, J NEUROPHYSIOL, V103, P2532, DOI 10.1152/jn.00506.2009; YU XL, 1989, IEEE T BIO-MED ENG, V36, P36, DOI 10.1109/10.16447	27	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2012	7	3							e32384	10.1371/journal.pone.0032384	http://dx.doi.org/10.1371/journal.pone.0032384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KT	22412868	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062000009
J	Conte, A; Rocchi, L; Nardella, A; Dispenza, S; Scontrini, A; Khan, N; Berardelli, A				Conte, Antonella; Rocchi, Lorenzo; Nardella, Andrea; Dispenza, Sabrina; Scontrini, Alessandra; Khan, Nashaba; Berardelli, Alfredo			Theta-Burst Stimulation-Induced Plasticity over Primary Somatosensory Cortex Changes Somatosensory Temporal Discrimination in Healthy Humans	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; WORKING-MEMORY; TIME PERCEPTION; MOTOR CORTEX; PREFRONTAL CORTEX; BRAIN ACTIVATION; MEDIAN NERVE; CEREBELLUM; NETWORKS; RTMS	Background: The somatosensory temporal discrimination threshold (STDT) measures the ability to perceive two stimuli as being sequential. Precisely how the single cerebral structures contribute in controlling the STDT is partially known and no information is available about whether STDT can be modulated by plasticity-inducing protocols. Methodology/Principal Findings: To investigate how the cortical and cerebellar areas contribute to the STDT we used transcranial magnetic stimulation and a neuronavigation system. We enrolled 18 healthy volunteers and 10 of these completed all the experimental sessions, including the control experiments. STDT was measured on the left hand before and after applying continuous theta-burst stimulation (cTBS) on the right primary somatosensory area (S1), pre-supplementary motor area (pre-SMA), right dorsolateral prefrontal cortex (DLPFC) and left cerebellar hemisphere. We then investigated whether intermittent theta-burst stimulation (iTBS) on the right S1 improved the STDT. After right S1 cTBS, STDT values increased whereas after iTBS to the same cortical site they decreased. cTBS over the DLPFC and left lateral cerebellum left the STDT statistically unchanged. cTBS over the pre-SMA also left the STDT statistically unchanged, but it increased the number of errors subjects made in distinguishing trials testing a single stimulus and those testing paired stimuli. Conclusions/Significance: Our findings obtained by applying TBS to the cortical areas involved in processing sensory discrimination show that the STDT is encoded in S1, possibly depends on intrinsic S1 neural circuit properties, and can be modulated by plasticity-inducing TBS protocols delivered over S1. Our findings, giving further insight into mechanisms involved in somatosensory temporal discrimination, help interpret STDT abnormalities in movement disorders including dystonia and Parkinson's disease.	[Conte, Antonella; Nardella, Andrea; Dispenza, Sabrina; Berardelli, Alfredo] IRCCS Neuromed Inst, Pozzilli, IS, Italy; [Rocchi, Lorenzo; Scontrini, Alessandra; Khan, Nashaba; Berardelli, Alfredo] Univ Roma La Sapienza, Dept Neurol & Psychiat, Rome, Italy	IRCCS Neuromed; Sapienza University Rome	Conte, A (corresponding author), IRCCS Neuromed Inst, Pozzilli, IS, Italy.	alfredo.berardelli@uniroma1.it	Rocchi, Lorenzo/K-7983-2016; Conte, Antonella/J-4508-2012	Rocchi, Lorenzo/0000-0003-3979-156X; BERARDELLI, Alfredo/0000-0003-3598-3142; Conte, Antonella/0000-0002-6338-2961	Neuromed IRCCS	Neuromed IRCCS	The experiments were supported by research funding provided by Neuromed IRCCS. The funders however, had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLISON T, 1991, J NEUROPHYSIOL, V66, P64, DOI 10.1152/jn.1991.66.1.64; ALLISON T, 1989, J NEUROPHYSIOL, V62, P694, DOI 10.1152/jn.1989.62.3.694; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Boakye M, 2000, J NEUROSURG, V93, P774, DOI 10.3171/jns.2000.93.5.0774; Bolognini N, 2010, J COGNITIVE NEUROSCI, V22, P1201, DOI 10.1162/jocn.2009.21267; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Chen CY, 2009, NEUROIMAGE, V44, P537, DOI 10.1016/j.neuroimage.2008.09.005; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Contarino MF, 2007, CLIN NEUROPHYSIOL, V118, P2195, DOI 10.1016/j.clinph.2007.07.004; Conte A, 2010, BRAIN, V133, P2656, DOI 10.1093/brain/awq191; Del Olmo MF, 2007, J NEUROPHYSIOL, V98, P145, DOI 10.1152/jn.01088.2006; Fierro B, 2007, EXP BRAIN RES, V176, P440, DOI 10.1007/s00221-006-0628-y; Fiorio M, 2008, J NEUROL NEUROSUR PS, V79, P796, DOI 10.1136/jnnp.2007.131524; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Hannula H, 2008, NEUROSCI LETT, V437, P144, DOI 10.1016/j.neulet.2008.03.093; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 2004, BRAIN, V127, P561, DOI 10.1093/brain/awh065; Harrington DL, 1998, J NEUROSCI, V18, P1085; Herwig U, 2001, PSYCHIAT RES-NEUROIM, V108, P123, DOI 10.1016/S0925-4927(01)00121-4; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ishikawa S, 2007, CLIN NEUROPHYSIOL, V118, P1033, DOI 10.1016/j.clinph.2007.02.003; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Koch G, 2003, NEUROLOGY, V60, P1844, DOI 10.1212/WNL.60.11.1844; Koch G, 2002, NEUROLOGY, V59, P1658, DOI 10.1212/01.WNL.0000032504.45792.8F; Koch G, 2007, EXP BRAIN RES, V179, P291, DOI 10.1007/s00221-006-0791-1; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Koch G, 2008, CLIN NEUROPHYSIOL, V119, P2559, DOI 10.1016/j.clinph.2008.08.008; Kotani S, 2003, BRAIN RES, V994, P193, DOI 10.1016/j.brainres.2003.09.036; LACRUZ F, 1991, J NEUROL NEUROSUR PS, V54, P1077, DOI 10.1136/jnnp.54.12.1077; Lee KH, 2007, J COGNITIVE NEUROSCI, V19, P147, DOI 10.1162/jocn.2007.19.1.147; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Mendrek A, 2005, PSYCHOL MED, V35, P187, DOI 10.1017/S0033291704003228; Mimura M, 2000, J INT NEUROPSYCH SOC, V6, P517, DOI 10.1017/S1355617700655017; Oliveri M, 2005, NEUROSCI LETT, V376, P188, DOI 10.1016/j.neulet.2004.11.053; Pastor MA, 2004, J NEUROSCI, V24, P2585, DOI 10.1523/JNEUROSCI.4210-03.2004; Pouthas V, 2000, HUM BRAIN MAPP, V10, P49, DOI 10.1002/(SICI)1097-0193(200006)10:2<49::AID-HBM10>3.0.CO;2-8; Ragert P, 2008, EXP BRAIN RES, V184, P1, DOI 10.1007/s00221-007-1073-2; Rai N, 2012, CLIN NEUROPHYSIOL, V123, P1226, DOI 10.1016/j.clinph.2011.09.026; RAMMSAYER TH, 1991, PERCEPT PSYCHOPHYS, V50, P565, DOI 10.3758/BF03207541; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Sanger TD, 2001, MOVEMENT DISORD, V16, P94, DOI 10.1002/1531-8257(200101)16:1<94::AID-MDS1020>3.0.CO;2-O; Schneider SA, 2010, MOVEMENT DISORD, V25, P76, DOI 10.1002/mds.22825; Scontrini A, 2009, J NEUROL NEUROSUR PS, V80, P1315, DOI 10.1136/jnnp.2009.178236; Scontrini A, 2011, MOVEMENT DISORD, V26, P742, DOI 10.1002/mds.23447; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamura Y, 2008, MOVEMENT DISORD, V23, P558, DOI 10.1002/mds.21870; Tan HY, 2005, AM J PSYCHIAT, V162, P1849, DOI 10.1176/appi.ajp.162.10.1849; Tegenthoff M, 2005, PLOS BIOL, V3, P2031, DOI 10.1371/journal.pbio.0030362	57	71	71	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32979	10.1371/journal.pone.0032979	http://dx.doi.org/10.1371/journal.pone.0032979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412964	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800068
J	Pang, Y; Zhou, Y; Zhao, B; Liu, G; Jiang, GL; Xia, H; Song, YY; Shang, YY; Wang, SF; Zhao, YL				Pang, Yu; Zhou, Yang; Zhao, Bing; Liu, Guan; Jiang, Guanglu; Xia, Hui; Song, Yuanyuan; Shang, Yuanyuan; Wang, Shengfen; Zhao, Yan-lin			Spoligotyping and Drug Resistance Analysis of Mycobacterium tuberculosis Strains from National Survey in China	PLOS ONE			English	Article							BEIJING GENOTYPE; MOLECULAR EPIDEMIOLOGY; SURVEILLANCE; POPULATION; PROVINCES; SPREAD; REGION	Background: Tuberculosis (TB), caused by Mycobacterium tuberculosis complex (MTBC), is one of the major causes of death in the world today. Although China has the second largest global case rate of tuberculosis, a systematic study of TB prevalence in China has not been completed. From 2006 to 2007, the base line surveillance of tuberculosis was carried out by Ministry of Health, and more than 4000 representative strains were selected from 31 provinces in China. Methodology/Principal Findings: The aim of the present research was to survey the genotypes of representative Mycobacterium tuberculosis (M. tuberculosis) strains from China using spacer oligonucleotide typing (spoligotyping), and to analyze the relationship between genotype and drug resistance for the first time. A total of 4017 clinical isolates were collected from 2007 to 2008 throughout China. Among those M. tuberculosis isolates, 2500 (62.2%) isolates were Beijing genotypes. The percentage of Beijing genotypes in northern China was higher than in southern China (76.5% vs. 53.2%). Additionally, the frequencies of rifampin-resistant, ofloxacin-resistant and multidrug-resistant isolates were significantly higher in Beijing genotype strains than non-Beijing strains. Furthermore, a novel genotype named "China Southern genotype (CS)'' was only isolated from Fujian and Guangdong provinces. Hence, it is very practical to uncover the reason for prevalence of the CS type in southern China. Conclusions/Significance: In conclusion, Beijing family genotypes were still the predominant genotype throughout China, which exhibited a greater correlation with rifampin-resistance, ofloxacin-resistance and MDR phenotypes than other TB spoligotypes, and some regions of China showed several unique characters in the distribution of M. tuberculosis genotypes. Our research represents an important contribution for the TB control and research community, which completes broad pictures on drug resistance levels and distribution of M. tuberculosis strain types over China.	[Pang, Yu; Zhou, Yang; Zhao, Bing; Xia, Hui; Song, Yuanyuan; Wang, Shengfen; Zhao, Yan-lin] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Liu, Guan; Jiang, Guanglu; Shang, Yuanyuan] Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Pang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China.	zhaoyanlin@chinatb.org			National Grant Research Program of China [2008ZX10003-009]	National Grant Research Program of China	This study was supported by the National Grant Research Program of China (2008ZX10003-009). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Rodriguez N, 2009, J CLIN MICROBIOL, V47, P2026, DOI 10.1128/JCM.02308-08; An DD, 2009, ANTIMICROB AGENTS CH, V53, P4835, DOI 10.1128/AAC.00541-09; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chan MY, 2001, EPIDEMIOL INFECT, V127, P169, DOI 10.1017/S0950268801005659; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Gori A, 2005, EMERG INFECT DIS, V11, P1242, DOI 10.3201/1108.040982; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Higgs BW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001284; Jou RW, 2005, J CLIN MICROBIOL, V43, P95, DOI 10.1128/JCM.43.1.95-100.2005; Kam KM, 2005, J CLIN MICROBIOL, V43, P306, DOI 10.1128/JCM.43.1.306-313.2005; Khue PM, 2007, EUR RESPIR J, V30, P937, DOI 10.1183/09031936.00037207; Li WM, 2005, INT J TUBERC LUNG D, V9, P1314; Lillebaek T, 2003, EMERG INFECT DIS, V9, P1553, DOI 10.3201/eid0912.030276; Liu JJ, 2005, INT J TUBERC LUNG D, V9, P450; Masjedi MR, 2006, CLIN INFECT DIS, V43, P841, DOI 10.1086/507542; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Nikolayevskyy V, 2006, EMERG INFECT DIS, V12, P1406, DOI 10.3201/eid1209.041623; Pannell CW, 2011, EURASIAN GEOGR ECON, V52, P105, DOI 10.2747/1539-7216.52.1.105; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Prodinger WM, 2001, EMERG INFECT DIS, V7, P483, DOI 10.3201/eid0703.017330; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Tanveer M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-171; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; *WHO, 2008, WHOHTMTB2008394; Zhao Y, 2011, INFECT GENE IN PRESS	33	103	120	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32976	10.1371/journal.pone.0032976	http://dx.doi.org/10.1371/journal.pone.0032976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412962	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800067
J	Rajecki, M; Sarparanta, M; Hakkarainen, T; Tenhunen, M; Diaconu, I; Kuhmonen, V; Kairemo, K; Kanerva, A; Airaksinen, AJ; Hemminki, A				Rajecki, Maria; Sarparanta, Mirkka; Hakkarainen, Tanja; Tenhunen, Mikko; Diaconu, Iulia; Kuhmonen, Venla; Kairemo, Kalevi; Kanerva, Anna; Airaksinen, Anu J.; Hemminki, Akseli			SPECT/CT Imaging of hNIS - Expression after Intravenous Delivery of an Oncolytic Adenovirus and I-131	PLOS ONE			English	Article							CONDITIONALLY REPLICATING ADENOVIRUS; IN-VIVO; PROSTATE-CANCER; GENE-EXPRESSION; OVARIAN-CANCER; SODIUM/IODIDE SYMPORTER; ANTITUMOR EFFICACY; PHYLLODES TUMOR; IODIDE; THERAPY	Oncolytic adenoviruses can be engineered for better tumor selectivity, gene delivery and be armed for imaging and concentrating radionuclides into tumors for synergistic oncolysis. We constructed Ad5/3-hTERT-hNIS where replication is controlled by hTERT-promoter. Ad5/3-hTERT-hNIS expresses hNIS for imaging of transgene expression and for treatment of infected tumors by radioiodine. Ad5/3-hTERT-hNIS efficiently killed prostate cancer cells and induced iodine uptake in vitro and in vivo after intratumoral virus administration. Survival of mice treated with intravenous Ad5/3-hTERT-hNIS significantly prolonged survival over mock or radioiodine only but the combination of virus with radioiodine was not more effective than virus alone. Temporal and spatial changes in hNIS-expression during therapy were detected with SPECT, demonstrating feasibility of evaluation of the combination therapy with hNIS-expressing adenoviruses and radioiodide.	[Rajecki, Maria; Hakkarainen, Tanja; Diaconu, Iulia; Kanerva, Anna; Hemminki, Akseli] Univ Helsinki, Transplantat Lab, Haartman Inst, Canc Gene Therapy Grp,Mol Canc Biol Program, Helsinki, Finland; [Rajecki, Maria; Hakkarainen, Tanja; Diaconu, Iulia; Kanerva, Anna; Hemminki, Akseli] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland; [Sarparanta, Mirkka; Kuhmonen, Venla; Airaksinen, Anu J.] Univ Helsinki, Lab Radiochem, Helsinki, Finland; [Tenhunen, Mikko; Kairemo, Kalevi] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Kairemo, Kalevi] Int Comprehens Canc Ctr Docrates, Helsinki, Finland; [Kanerva, Anna] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Rajecki, M (corresponding author), Univ Helsinki, Transplantat Lab, Haartman Inst, Canc Gene Therapy Grp,Mol Canc Biol Program, Helsinki, Finland.	akseli.hemminki@helsinki.fi	Sarparanta, Mirkka/B-8375-2013; Airaksinen, Anu/AAA-5864-2020; Airaksinen, Anu J/N-9070-2014	Sarparanta, Mirkka/0000-0002-2956-4366; Airaksinen, Anu/0000-0002-5943-3105; Airaksinen, Anu J/0000-0002-5943-3105	Helsinki Biomedical Graduate School; Finnish Foundation for Research on Viral Diseases; Emil Aaltonen foundation; Biomedicum Helsinki Foundation; Irja Karvonen's Cancer Foundation; Jalmari and Rauha Ahokas Foundation; The Finnish Medical Foundation; K. Albin Johansson Foundation; Jenny and Antti Wihuri Foundation; Drug Discovery Graduate School; European Research Council; ASCO Foundation; HUCH; Sigrid Juselius Foundation; Academy of Finland; Biocentrum Helsinki; Biocenter Finland; University of Helsinki	Helsinki Biomedical Graduate School; Finnish Foundation for Research on Viral Diseases(Finnish IT center for science); Emil Aaltonen foundation; Biomedicum Helsinki Foundation; Irja Karvonen's Cancer Foundation; Jalmari and Rauha Ahokas Foundation; The Finnish Medical Foundation; K. Albin Johansson Foundation; Jenny and Antti Wihuri Foundation; Drug Discovery Graduate School; European Research Council(European Research Council (ERC)European Commission); ASCO Foundation; HUCH; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Biocentrum Helsinki; Biocenter Finland; University of Helsinki	The study was supported by the Helsinki Biomedical Graduate School (www.hbgs.helsinki.fi) and grants from Finnish Foundation for Research on Viral Diseases (www.virustauti.fi), Emil Aaltonen foundation (www.emilaaltonen.fi), Biomedicum Helsinki Foundation (www.biomedicum.fi), Irja Karvonen's Cancer Foundation (www.karvonensaatio.fi), Jalmari and Rauha Ahokas Foundation (www.ahokkaansaatio.org), The Finnish Medical Foundation (www.laaketieteensaatio.fi), K. Albin Johansson Foundation (www.foundationweb.net/johansson/), Jenny and Antti Wihuri Foundation (www.wihurinrahasto.fi), Drug Discovery Graduate School (ddgs.utu.fi), European Research Council (erc.europa.eu), ASCO Foundation (www.asco.org), HUCH Research Funds (EVO), Sigrid Juselius Foundation (www.sigridjuselius.fi/foundation), Academy of Finland (www.aka.fi), Biocentrum Helsinki (www.helsinki.fi/biocentrum), Biocenter Finland (www.biocenter.fi) and University of Helsinki (www.helsinki.fi). Akseli Hemminki is K. Albin Johansson Research Professor of the Foundation for the Finnish Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiainen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013859; Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Berk AJ, 2006, FIELDS VIROLOGY, P2355; Bostwick DG, 2004, J UROLOGY, V172, P894, DOI 10.1097/01.ju.0000134580.71261.57; CARRASCO N, 1993, BIOCHIM BIOPHYS ACTA, V1154, P65, DOI 10.1016/0304-4157(93)90017-I; Chen Y, 2001, CANCER RES, V61, P5453; Cho JY, 2002, GENE THER, V9, P1139, DOI 10.1038/sj.gt.3301787; Dahse R, 1997, CLIN CHEM, V43, P708; Dilley J, 2005, CANCER GENE THER, V12, P715, DOI 10.1038/sj.cgt.7700835; Douglas JT, 2001, CANCER RES, V61, P813; Eng PHK, 1999, ENDOCRINOLOGY, V140, P3404, DOI 10.1210/en.140.8.3404; Freytag SO, 1998, HUM GENE THER, V9, P1323, DOI 10.1089/hum.1998.9.9-1323; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gunes C, 2000, CANCER RES, V60, P2116; Haberkorn U, 2001, EXP CLIN ENDOCR DIAB, V109, P60, DOI 10.1055/s-2001-11010; Hakkarainen T, 2009, CLIN CANCER RES, V15, P5396, DOI 10.1158/1078-0432.CCR-08-2571; Hingorani M, 2008, CLIN CANCER RES, V14, P4915, DOI 10.1158/1078-0432.CCR-07-4049; Horikawa I, 1999, CANCER RES, V59, P826; Huang P, 2008, CANCER GENE THER, V15, P315, DOI 10.1038/cgt.2008.3; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2005, ANN MED, V37, P33, DOI 10.1080/07853890410018934; Kanerva A, 2003, MOL THER, V8, P449, DOI 10.1016/S1525-0016(03)00200-4; Kanerva A, 2005, GENE THER, V12, P87, DOI 10.1038/sj.gt.3302387; Kanerva A, 2004, INT J CANCER, V110, P475, DOI 10.1002/ijc.20129; Kawashima T, 2004, CLIN CANCER RES, V10, P285, DOI 10.1158/1078-0432.CCR-1075-3; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Liikanen I, 2011, MOL THER, V19, P1858, DOI 10.1038/mt.2011.144; Liu TC, 2007, CANCER RES, V67, P429, DOI 10.1158/0008-5472.CAN-06-2871; MacLaren DC, 1999, GENE THER, V6, P785, DOI 10.1038/sj.gt.3300877; Merron A, 2010, EUR J NUCL MED MOL I; MISAKI T, 1994, J NUCL MED, V35, P474; Montiel-Equihua CA, 2008, CANCER GENE THER, V15, P465, DOI 10.1038/cgt.2008.6; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Nokisalmi P, 2010, CLIN CANCER RES, V16, P3035, DOI 10.1158/1078-0432.CCR-09-3167; Pajonk F, 2010, STEM CELLS, V28, P639, DOI 10.1002/stem.318; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Rajecki M, 2007, MOL CANCER THER, V6, P742, DOI 10.1158/1535-7163.MCT-06-0403; Rajecki M, 2011, MOL THER, V19, P629, DOI 10.1038/mt.2011.31; Rajecki M, 2009, INT J CANCER, V125, P2441, DOI 10.1002/ijc.24608; Raki M, 2008, GYNECOL ONCOL, V108, P166, DOI 10.1016/j.ygyno.2007.09.013; Raki M, 2011, J GENE MED, V13, P253, DOI 10.1002/jgm.1565; Saukkonen K, 2004, EXPERT OPIN BIOL TH, V4, P683, DOI 10.1517/eobt.4.5.683.31060; SAWIN CT, 1977, J CLIN ENDOCR METAB, V44, P273, DOI 10.1210/jcem-44-2-273; Scipioni A, 2007, THYROID, V17, P613, DOI 10.1089/thy.2007.0064; Small EJ, 2006, MOL THER, V14, P107, DOI 10.1016/j.ymthe.2006.02.011; Spitzweg C, 1998, J CLIN ENDOCR METAB, V83, P1746, DOI 10.1210/jc.83.5.1746; Spitzweg C, 2001, GENE THER, V8, P1524, DOI 10.1038/sj.gt.3301558; Stabin MG, 1996, RAD DOSE ESTIMATES R; Strauss R, 2009, CANCER RES, V69, P5115, DOI 10.1158/0008-5472.CAN-09-0645; Su CQ, 2004, J CANCER RES CLIN, V130, P591, DOI 10.1007/s00432-004-0577-4; Taira N, 2007, JPN J CLIN ONCOL, V37, P730, DOI 10.1093/jjco/hym099; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; Trujillo MA, 2010, GENE THER, V17, P1325, DOI 10.1038/gt.2010.63; Verger P, 2001, THYROID, V11, P353, DOI 10.1089/10507250152039082; Waerzeggers Y, 2009, METHODS, V48, P146, DOI 10.1016/j.ymeth.2009.03.007; Wang H, 2010, NAT MED; Wirth T, 2003, CANCER RES, V63, P3181; Zuckier LS, 2004, J NUCL MED, V45, P500	61	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32871	10.1371/journal.pone.0032871	http://dx.doi.org/10.1371/journal.pone.0032871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412937	Green Published, gold, Green Submitted			2022-12-25	WOS:000303060800057
J	Schlatter, ID; Meira, M; Ueberschlag, V; Hoepfner, D; Movva, R; Hynes, NE				Schlatter, Ivan D.; Meira, Maria; Ueberschlag, Vanessa; Hoepfner, Dominic; Movva, Rao; Hynes, Nancy E.			MHO1, an Evolutionarily Conserved Gene, Is Synthetic Lethal with PLC1; Mho1p Has a Role in Invasive Growth	PLOS ONE			English	Article							FILAMENTOUS GROWTH; INOSITOL HEXAKISPHOSPHATE; PHOSPHOLIPASE-C; ASHBYA-GOSSYPII; PROTEIN; KINASE; DNA; EXPRESSION; PYROPHOSPHATES; DISRUPTION	The novel protein Memo (Mediator of ErbB2 driven cell motility) was identified in a screen for ErbB2 interacting proteins and found to have an essential function in cell motility. Memo is evolutionarily conserved with homologs found in all branches of life; the human and yeast proteins have a similarity of >50%. In the present study we used the model organism S. cerevisiae to characterize the Memo-homologue Mho1 (Yjr008wp) and to investigate its function in yeast. In a synthetic lethal screen we found MHO1 as a novel synthetic lethal partner of PLC1, which encodes the single phospholipase C in yeast. Double-deleted cells lacking MHO1 and PLC1, proliferate for up to ten generations. Introduction of human Memo into the memo Delta plc1 Delta strain rescued the synthetic lethal phenotype suggesting that yeast and human proteins have similar functions. Mho1 is present in the cytoplasm and the nucleus of yeast cells; the same distribution of Memo was found in mammalian cells. None of the Memo homologues have a characteristic nuclear localization sequence, however, a conserved nuclear export sequence is found in all. In mammalian cells, blocking nuclear export with Leptomycin B led to nuclear Memo accumulation, suggesting that it is actively exported from the nucleus. In yeast MHO1 expression is induced by stress conditions. Since invasive growth in S. cerevisiea is also stress-induced, we tested Mho1's role in this response. MHO1 deletion had no effect on invasion induced by nutrient deprivation, however, Mho1 overexpression blocked the invasive ability of yeast cells, suggesting that Mho1 might be acting in a dominant negative manner. Taken together, our results show that MHO1 is a novel synthetic lethal interactor with PLC1, and that both gene products are required for proliferation. Moreover, a role for Memo in cell motility/invasion appears to be conserved across species.	[Schlatter, Ivan D.; Meira, Maria; Ueberschlag, Vanessa; Hynes, Nancy E.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Hoepfner, Dominic; Movva, Rao] Novartis Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis	Schlatter, ID (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	nancy.hynes@fmi.ch			Novartis Research Foundation; Swiss Science Foundation [31003A-121574]	Novartis Research Foundation; Swiss Science Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Novartis Research Foundation and the Swiss Science Foundation (# 31003A-121574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826; Ashby SF, 1926, ANN BOT-LONDON, V40, P69, DOI 10.1093/oxfordjournals.aob.a090018; Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563; Brachmann CB, 1998, YEAST, V14, P115; Desai P, 2009, MOL GENET GENOMICS, V281, P511, DOI 10.1007/s00438-009-0427-9; El Alami M, 2003, MOL MICROBIOL, V49, P457, DOI 10.1046/j.1365-2958.2003.03562.x; Feng YC, 2001, P NATL ACAD SCI USA, V98, P875, DOI 10.1073/pnas.021558098; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gietz RD, 2006, METHOD MOL BIOL, V313, P20; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Goldstein AL, 1999, YEAST, V15, P53; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197; HUANG KN, 1995, GENETICS, V141, P1275; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Jones SK, 2011, FUNGAL GENET BIOL, V48, P668, DOI 10.1016/j.fgb.2011.04.001; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Philippsen P, 2005, CURR OPIN MICROBIOL, V8, P370, DOI 10.1016/j.mib.2005.06.021; Qiu C, 2008, J BIOL CHEM, V283, P40; Romero C, 2006, J BIOL CHEM, V281, P5677, DOI 10.1074/jbc.M506728200; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; SIKORSKI RS, 1989, GENETICS, V122, P19; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; STEINER S, 1995, GENETICS, V140, P973; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0; Wendland J, 2005, NAT REV MICROBIOL, V3, P421, DOI 10.1038/nrmicro1148; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107	49	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32501	10.1371/journal.pone.0032501	http://dx.doi.org/10.1371/journal.pone.0032501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412880	Green Submitted, gold, Green Published			2022-12-25	WOS:000303060800025
J	Seidl, R; Blennow, K				Seidl, Rupert; Blennow, Kristina			Pervasive Growth Reduction in Norway Spruce Forests following Wind Disturbance	PLOS ONE			English	Article							SCOTS PINE GROWTH; PRINCIPAL COMPONENTS; STORM DAMAGE; CLIMATE; PROBABILITY; MOUNTAINS; DYNAMICS; DECLINE; EVENTS; EUROPE	Background: In recent decades the frequency and severity of natural disturbances by e. g., strong winds and insect outbreaks has increased considerably in many forest ecosystems around the world. Future climate change is expected to further intensify disturbance regimes, which makes addressing disturbances in ecosystem management a top priority. As a prerequisite a broader understanding of disturbance impacts and ecosystem responses is needed. With regard to the effects of strong winds - the most detrimental disturbance agent in Europe - monitoring and management has focused on structural damage, i.e., tree mortality from uprooting and stem breakage. Effects on the functioning of trees surviving the storm (e.g., their productivity and allocation) have been rarely accounted for to date. Methodology/Principal Findings: Here we show that growth reduction was significant and pervasive in a 6.79.million hectare forest landscape in southern Sweden following the storm Gudrun (January 2005). Wind-related growth reduction in Norway spruce (Picea abies (L.) Karst.) forests surviving the storm exceeded 10% in the worst hit regions, and was closely related to maximum gust wind speed (R-2 = 0.849) and structural wind damage (R-2 = 0.782). At the landscape scale, wind-related growth reduction amounted to 3.0 million m(3) in the three years following Gudrun. It thus exceeds secondary damage from bark beetles after Gudrun as well as the long-term average storm damage from uprooting and stem breakage in Sweden. Conclusions/Significance: We conclude that the impact of strong winds on forest ecosystems is not limited to the immediately visible area of structural damage, and call for a broader consideration of disturbance effects on ecosystem structure and functioning in the context of forest management and climate change mitigation.	[Seidl, Rupert; Blennow, Kristina] Swedish Univ Agr Sci, Fac Landscape Planning Hort & Agr Sci, Alnarp, Sweden; [Seidl, Rupert] Univ Nat Resources & Life Sci BOKU, Inst Silviculture, Vienna, Austria	Swedish University of Agricultural Sciences; University of Natural Resources & Life Sciences, Vienna	Seidl, R (corresponding author), Swedish Univ Agr Sci, Fac Landscape Planning Hort & Agr Sci, Alnarp, Sweden.	kristina.blennow@slu.se	Blennow, Kristina/D-7388-2016; Seidl, Rupert/ABE-6078-2020; Seidl, Rupert/A-4858-2013	Blennow, Kristina/0000-0002-7602-5322; Seidl, Rupert/0000-0002-3338-3402; 	European Community [237085]; EU [226544]; foundation for strategic environmental research programme Mistra-SWECIA	European Community(European Commission); EU(European Commission); foundation for strategic environmental research programme Mistra-SWECIA	Rupert Seidl was supported by a Marie Curie Fellowship within the European Community's Seventh Framework Program ("iLand - A framework for individual-based forest landscape modeling under changing climate and disturbance regimes,'' grant 237085). The study was further supported by the EU project MOTIVE ("Models for adaptive forest management,'' grant 226544) (www.motive-project.net) and the foundation for strategic environmental research programme Mistra-SWECIA (www.mistra-swecia.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], JAPAN J FOR RES; Blennow K, 2008, CLIMATIC CHANGE, V87, P347, DOI 10.1007/s10584-007-9290-z; Blennow K, 2010, CLIMATIC CHANGE, V99, P261, DOI 10.1007/s10584-009-9698-8; Bolte A, 2010, EUR J FOREST RES, V129, P261, DOI 10.1007/s10342-009-0323-1; Box G., 1970, TIME SERIES ANAL; Busby PE, 2008, CAN J FOREST RES, V38, P2942, DOI 10.1139/X08-139; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; CARPENTER SR, 1990, ECOLOGY, V71, P2038, DOI 10.2307/1938617; CHRISTIANSEN E, 1987, FOREST ECOL MANAG, V22, P89, DOI 10.1016/0378-1127(87)90098-3; Coutand C., 2009, ANN BOT, V101, P1421; Everham EM, 1996, BOT REV, V62, P113, DOI 10.1007/BF02857920; Fekedulegn BD, 2002, NE721 DEP AGR FORES; Fritts H. C., 1976, TREE RINGS CLIMATE; Gough CM, 2008, AGR FOREST METEOROL, V148, P158, DOI 10.1016/j.agrformet.2007.08.004; Grudd H, 2008, CLIM DYNAM, V31, P843, DOI 10.1007/s00382-007-0358-2; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Hadley KS, 2011, CAN J FOREST RES, V41, P1121, DOI [10.1139/X11-030, 10.1139/x11-030]; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; JOLLIFFE IT, 1982, APPL STAT-J ROY ST C, V31, P300, DOI 10.2307/2348005; Jonsson B, 1969, 16 I SKOGSPR; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Komonen A, 2011, J APPL ENTOMOL, V135, P132, DOI 10.1111/j.1439-0418.2010.01520.x; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Langstrom B, 2009, P IUFRO WORK PART 7; Linderholm HW, 2002, ARCT ANTARCT ALP RES, V34, P440, DOI 10.2307/1552202; Linderholm HW, 2002, CAN J FOREST RES, V32, P1400, DOI [10.1139/x02-071, 10.1139/X02-071]; Linderson H, 2003, 38 LUND U; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lindroth A, 2009, GLOBAL CHANGE BIOL, V15, P346, DOI 10.1111/j.1365-2486.2008.01719.x; McDowall D., 1980, INTERRUPTED TIME SER; MERRENS EJ, 1992, J ECOL, V80, P787, DOI 10.2307/2260866; MORZUCH BJ, 1991, FOREST SCI, V37, P191; NFI, 2011, STAT SKOG RIKSS; Nielsen C. N., 2004, DST - Dansk Skovbrugs Tidsskrift, V89, P115; Nielsen CN, 2011, SKOVEN, V3, P137; Nieuwenhuis M, 2001, FORESTRY, V74, P383, DOI 10.1093/forestry/74.4.383; Nilsson C, 2004, FOREST ECOL MANAG, V199, P165, DOI 10.1016/j.foreco.2004.07.031; Petritsch R, 2007, FOREST ECOL MANAG, V242, P324, DOI 10.1016/j.foreco.2007.01.050; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reubens B, 2009, TREES-STRUCT FUNCT, V23, P1213, DOI 10.1007/s00468-009-0360-x; Schelhaas MJ, 2003, GLOBAL CHANGE BIOL, V9, P1620, DOI 10.1046/j.1365-2486.2003.00684.x; Seidl R, 2011, GLOBAL CHANGE BIOL, V17, P2842, DOI 10.1111/j.1365-2486.2011.02452.x; Seidl R, 2011, CLIMATIC CHANGE, V106, P225, DOI 10.1007/s10584-010-9899-1; Seidl R, 2011, ECOL MODEL, V222, P903, DOI 10.1016/j.ecolmodel.2010.09.040; Seidl R, 2009, REG ENVIRON CHANGE, V9, P101, DOI 10.1007/s10113-008-0068-2; Selas V, 2002, CAN J FOREST RES, V32, P217, DOI 10.1139/X01-192; *SKOGSST, 2006, STORM 2005 SKOGL AN; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Ueda M, 2004, TREE PHYSIOL, V24, P701, DOI 10.1093/treephys/24.6.701; Usbeck T, 2010, AGR FOREST METEOROL, V150, P47, DOI 10.1016/j.agrformet.2009.08.010; Valinger E, 2011, FOREST ECOL MANAG, V262, P398, DOI 10.1016/j.foreco.2011.04.004; Vargas R, 2009, NEW PHYTOL, V182, P710, DOI 10.1111/j.1469-8137.2009.02789.x; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Zielonka T, 2009, CAN J FOREST RES, V39, P2215, DOI 10.1139/X09-130; Zweifel R, 2010, NEW PHYTOL, V187, P819, DOI 10.1111/j.1469-8137.2010.03301.x	56	33	34	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33301	10.1371/journal.pone.0033301	http://dx.doi.org/10.1371/journal.pone.0033301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22413012	Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800089
J	Barblu, L; Herbeuval, JP				Barblu, Lucie; Herbeuval, Jean-Philippe			Three-Dimensional Microscopy Characterization of Death Receptor 5 Expression by Over-Activated Human Primary CD4(+) T Cells and Apoptosis	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; TRAIL-INDUCED APOPTOSIS; FAS LIGAND; TUMORICIDAL ACTIVITY; GENE-THERAPY; CANCER-CELLS; APO2 LIGAND; IFN-ALPHA; TNF; INDUCTION	Activation-induced cell death is a natural process that prevents tissue damages from over-activated immune cells. TNF-Related apoptosis ligand (TRAIL), a TNF family member, induces apoptosis of infected and tumor cells by binding to one of its two death receptors, DR4 or DR5. TRAIL was reported to be secreted by phytohemagglutinin (PHA)-stimulated CD4(+) T cells in microvesicles. We investigate here TRAIL and DR5 regulation by activated primary CD4(+) T cells and its consequence on cell death. We observed that PHA induced CD4(+) T cell apoptosis in a dose-dependent manner. Thus, we investigated molecules involved in PHA-mediated cell death and demonstrated that TRAIL and DR5 were over-expressed on the plasma membrane of PHA-stimulated CD4(+) T cells. Surprisingly, DR5 was constitutively expressed in naive CD4(+) T cells at messenger RNA (mRNA) and protein levels. Thus, using 3 dimensional microscopy and intracellular staining assays, we show that DR5 is constitutively expressed in CD4(+) T cells and is pre-stocked in the cytoplasm. When cells are stimulated by PHA, DR5 is relocalized from cytoplasm to plasma membrane. Small interference RNA (siRNA) and blocking antibody assays demonstrate that TRAIL/DR5 interaction is mainly responsible for PHA-mediated CD4(+) T cell apoptosis. Thus, membrane DR5 expression leading to TRAIL-mediated apoptosis may represent one of the pathways responsible for eradication of over-activated CD4(+) T cells during immune responses.	[Barblu, Lucie; Herbeuval, Jean-Philippe] Univ Paris 05, CNRS, UMR 8147, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Barblu, L (corresponding author), Univ Paris 05, CNRS, UMR 8147, Paris, France.	jean-philippe.herbeuval@parisdescartes.fr	Serei, Virian D/B-4616-2015; Herbeuval, Jean-Philippe/AHA-2439-2022		Agence Nationale de la Recherche sur le Sida (ANRS)	Agence Nationale de la Recherche sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR))	Agence Nationale de la Recherche sur le Sida (ANRS) financially supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosque A, 2005, EUR J IMMUNOL, V35, P1812, DOI 10.1002/eji.200526046; Bosque A, 2005, J LEUKOCYTE BIOL, V77, P568, DOI 10.1189/jlb.0904514; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; Ehrlich S, 2003, CYTOKINE, V24, P244, DOI 10.1016/S1043-4666(03)00094-2; Gasper-Smith N, 2008, J VIROL, V82, P7700, DOI 10.1128/JVI.00605-08; Golstein P, 1997, CURR BIOL, V7, pR750, DOI 10.1016/S0960-9822(06)90000-1; Griffith Thomas S., 2009, V542, P315, DOI 10.1007/978-1-59745-561-9_17; Griffith TS, 2009, CURR GENE THER, V9, P9, DOI 10.2174/156652309787354612; Griffith TS, 1998, J IMMUNOL, V161, P2833; Griffith TS, 2001, MOL THER, V4, P257, DOI 10.1006/mthe.2001.0439; Griffith TS, 2000, J IMMUNOL, V165, P2886, DOI 10.4049/jimmunol.165.5.2886; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Gura T, 1997, SCIENCE, V277, P768, DOI 10.1126/science.277.5327.768; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Herbeuval JP, 2009, AIDS, V23, P35, DOI 10.1097/QAD.0b013e32831cb907; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Herbeuval JP, 2005, BLOOD, V105, P2458, DOI 10.1182/blood-2004-08-3058; Herbeuval JP, 2003, JNCI-J NATL CANCER I, V95, P611, DOI 10.1093/jnci/95.8.611; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Lichtner M, 2004, AIDS RES HUM RETROV, V20, P175, DOI 10.1089/088922204773004897; Martinez-Lorenzo MJ, 1998, EUR J IMMUNOL, V28, P2714, DOI 10.1002/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; Monleon I, 2001, J IMMUNOL, V167, P6736, DOI 10.4049/jimmunol.167.12.6736; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1996, ADV EXP MED BIOL, V406, P119; NAGATA S, 1994, ADV IMMUNOL, V57, P129, DOI 10.1016/S0065-2776(08)60672-0; Newsom-Davis T, 2009, APOPTOSIS, V14, P607, DOI 10.1007/s10495-009-0321-2; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Roederer M, 2001, CYTOMETRY, V45, P37, DOI 10.1002/1097-0320(20010901)45:1<37::AID-CYTO1142>3.0.CO;2-E; RUSSELL JH, 1995, CURR OPIN IMMUNOL, V7, P382, DOI 10.1016/0952-7915(95)80114-6; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Sheikh MS, 1998, CANCER RES, V58, P1593; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; Stary G, 2009, BLOOD, V114, P3854, DOI 10.1182/blood-2009-04-217927; Tecchio C, 2004, BLOOD, V103, P3837, DOI 10.1182/blood-2003-08-2806; Wahl H, 2007, GYNECOL ONCOL, V105, P104, DOI 10.1016/j.ygyno.2006.10.050; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141	43	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32874	10.1371/journal.pone.0032874	http://dx.doi.org/10.1371/journal.pone.0032874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412938	gold, Green Published, Green Submitted			2022-12-25	WOS:000303021100036
J	Bozinovski, S; Seow, HJ; Crack, PJ; Anderson, GP; Vlahos, R				Bozinovski, Steven; Seow, Huei Jiunn; Crack, Peter J.; Anderson, Gary P.; Vlahos, Ross			Glutathione Peroxidase-1 Primes Pro-Inflammatory Cytokine Production after LPS Challenge In Vivo	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; INDUCED LUNG INFLAMMATION; FACTOR GM-CSF; MOUSE LUNG; OXIDATIVE STRESS; ALVEOLAR MACROPHAGES; HYDROGEN-PEROXIDE; INNATE IMMUNITY	Reactive oxygen species produced during the innate immune response to LPS are important agents of anti-pathogen defence but may also cause oxidative lung damage. Glutathione peroxidase-1 (gpx-1) is an anti-oxidant enzyme that may protect lungs from such damage. We assessed the in vivo importance of gpx-1 in LPS-induced lung inflammation. Male wild-type (WT) or gpx-1 deficient (gpx-1(-/-)) mice were treated intranasally with PBS or 10 mu g LPS and killed 3 and 24 h post LPS. Lungs were lavaged with PBS and then harvested for inflammatory marker expression. LPS caused an intense neutrophilia in WT BALF evident 3 and 24 h post challenge that was reduced in gpx-1(-/-) mice. In addition, LPS-treated gpx-1(-/-) mice had significantly fewer macrophages than LPS-treated WT mice. To understand the basis for this paradoxical reduction we assessed inflammatory cytokines and proteases at protein and transcript levels. MMP-9 expression and net gelatinase activity in BALF of gpx-1(-/-) mice treated with LPS for 3 and 24 h was no different to that found in LPS-treated WT mice. BALF from LPS-treated gpx-1(-/-) mice (3 h) had less TNF-alpha, MIP-2 and GM-CSF protein than LPS-treated WT mice. In contrast, LPS-induced increases in TNF-alpha, MIP-2 and GM-CSF mRNA expression in WT mice were similar to those observed in gpx-1(-/-) mice. These attenuated protein levels were unexpectedly not mirrored by reduced mRNA transcripts but were associated with increased 20S proteasome expression. Thus, these data suggest that gpx-1 primes pro-inflammatory cytokine production after LPS challenge in vivo.	[Bozinovski, Steven; Seow, Huei Jiunn; Crack, Peter J.; Anderson, Gary P.; Vlahos, Ross] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	University of Melbourne	Bozinovski, S (corresponding author), Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia.	rossv@unimelb.edu.au	Vlahos, Ross/AAM-3837-2020; Crack, Peter/ABE-2065-2020	Vlahos, Ross/0000-0001-8443-7071; Crack, Peter/0000-0002-5030-0330; Bozinovski, Steven/0000-0001-6533-8641; Seow, Huei/0000-0002-4790-4811; Anderson, Gary/0000-0001-6580-3398	National Health and Medical Research Council of Australia (NHMRC) [I.D. 509226]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The National Health and Medical Research Council of Australia (NHMRC, http://www.nhmrc.gov.au) financially supported this study (Project Grant I.D. 509226). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avissar N, 1996, AM J PHYSIOL-LUNG C, V270, pL173, DOI 10.1152/ajplung.1996.270.2.L173; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; Brass DM, 2008, AM J RESP CELL MOL, V39, P584, DOI 10.1165/rcmb.2007-0448OC; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; deMoraes VLG, 1996, BRIT J PHARMACOL, V117, P1792; Dubin W, 1996, AM J PHYSIOL-LUNG C, V270, pL736, DOI 10.1152/ajplung.1996.270.5.L736; Duong C, 2010, AM J PHYSIOL-LUNG C, V299, pL425, DOI 10.1152/ajplung.00038.2010; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Hutchison ML, 2000, FEMS IMMUNOL MED MIC, V27, P73, DOI 10.1111/j.1574-695X.2000.tb01414.x; Jagielo PJ, 1996, CHEST, V110, P263, DOI 10.1378/chest.110.1.263; Knorpp T, 2006, J NEURAL TRANSM, V113, P1145, DOI 10.1007/s00702-005-0389-y; Koppelman GH, 2001, AM J RESP CRIT CARE, V163, P965, DOI 10.1164/ajrccm.163.4.2004164; Koyama H, 1998, THORAX, V53, pS10, DOI 10.1136/thx.53.2008.S10; Kretz-Remy C, 2003, BIOL CHEM, V384, P589, DOI 10.1515/BC.2003.066; Lefort J, 2001, AM J RESP CELL MOL, V24, P345, DOI 10.1165/ajrcmb.24.3.4289; Lei XF, 1998, CLIN EXP IMMUNOL, V113, P157; Lorne E, 2008, AM J PHYSIOL-CELL PH, V294, pC985, DOI 10.1152/ajpcell.00454.2007; Maus U, 2001, AM J RESP CRIT CARE, V164, P406, DOI 10.1164/ajrccm.164.3.2009055; Maus U, 2001, AM J PHYSIOL-LUNG C, V280, pL58, DOI 10.1152/ajplung.2001.280.1.L58; Meja KK, 2000, BRIT J PHARMACOL, V131, P1143, DOI 10.1038/sj.bjp.0703684; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; NAKATA K, 1991, J IMMUNOL, V147, P1266; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; SANDSTROM T, 1992, EUR RESPIR J, V5, P992; SILBERSTEIN DS, 1986, J IMMUNOL, V137, P3290; STOLK J, 1992, J PATHOL, V167, P349, DOI 10.1002/path.1711670314; Strassheim D, 2004, AM J PHYSIOL-CELL PH, V286, pC683, DOI 10.1152/ajpcell.00296.2003; Vernooy JHJ, 2002, AM J RESP CELL MOL, V26, P152, DOI 10.1165/ajrcmb.26.1.4652; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Vlahos R, 2006, PHARM THER; Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Wong CHY, 2008, J NEUROCHEM, V107, P241, DOI 10.1111/j.1471-4159.2008.05605.x; Xing Z, 1996, J CLIN INVEST, V97, P1102, DOI 10.1172/JCI118503; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006	40	24	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e33172	10.1371/journal.pone.0033172	http://dx.doi.org/10.1371/journal.pone.0033172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412999	Green Published, gold			2022-12-25	WOS:000303021100054
J	Eskra, L; Covert, J; Glasner, J; Splitter, G				Eskra, Linda; Covert, Jill; Glasner, Jeremy; Splitter, Gary			Differential Expression of Iron Acquisition Genes by Brucella melitensis and Brucella canis during Macrophage Infection	PLOS ONE			English	Article							SIDEROPHORE 2,3-DIHYDROXYBENZOIC ACID; STRESS-RESPONSE PROTEASE; WILD-TYPE VIRULENCE; INTRACELLULAR SURVIVAL; ABORTUS; GROWTH; TONB; SYSTEM; TRANSCRIPTS; TRANSPORTER	Brucella spp. cause chronic zoonotic disease often affecting individuals and animals in impoverished economic or public health conditions; however, these bacteria do not have obvious virulence factors. Restriction of iron availability to pathogens is an effective strategy of host defense. For brucellae, virulence depends on the ability to survive and replicate within the host cell where iron is an essential nutrient for the growth and survival of both mammalian and bacterial cells. Iron is a particularly scarce nutrient for bacteria with an intracellular lifestyle. Brucella melitensis and Brucella canis share similar to 99% of their genomes but differ in intracellular lifestyles. To identify differences, gene transcription of these two pathogens was examined during infection of murine macrophages and compared to broth grown bacteria. Transcriptome analysis of B. melitensis and B. canis revealed differences of genes involved in iron transport. Gene transcription of the TonB, enterobactin, and ferric anguibactin transport systems was increased in B. canis but not B. melitensis during infection of macrophages. The data suggest differences in iron requirements that may contribute to differences observed in the lifestyles of these closely related pathogens. The initial importance of iron for B. canis but not for B. melitensis helps elucidate differing intracellular survival strategies for two closely related bacteria and provides insight for controlling these pathogens.	[Eskra, Linda; Splitter, Gary] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Covert, Jill] Univ Calif Davis, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Glasner, Jeremy] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison	Eskra, L (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	splitter@svm.vetmed.wisc.edu			Region V 'Great Lakes' RCE (National Institutes of Health [NIH] [1-U54-AI-057153]; BARD [US-4378-11]; NIH [1R01AI073558]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073558, R21AI088038, U54AI057153] Funding Source: NIH RePORTER	Region V 'Great Lakes' RCE (National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BARD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Region V 'Great Lakes' RCE (National Institutes of Health [NIH] award 1-U54-AI-057153), BARD grant US-4378-11, and NIH 1R01AI073558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ES, 2008, J BACTERIOL, V190, P1838, DOI 10.1128/JB.01551-07; Beckett D, 2005, J NUTR BIOCHEM, V16, P411, DOI 10.1016/j.jnutbio.2005.03.019; Bellaire BH, 1999, INFECT IMMUN, V67, P2615, DOI 10.1128/IAI.67.5.2615-2618.1999; Bellaire BH, 2003, INFECT IMMUN, V71, P1794, DOI 10.1128/IAI.71.4.1794-1803.2003; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Brickman TJ, 2001, J BACTERIOL, V183, P483, DOI 10.1128/JB.183.2.483-489.2001; CARON E, 1994, J LEUKOCYTE BIOL, V56, P174, DOI 10.1002/jlb.56.2.174; Carrero MIG, 2002, MICROBIOL-SGM, V148, P353, DOI 10.1099/00221287-148-2-353; Danese I, 2004, INFECT IMMUN, V72, P5783, DOI 10.1128/IAI.72.10.5783-5790.2004; DETILLEUX PG, 1990, VET PATHOL, V27, P317, DOI 10.1177/030098589002700503; Ekaza E, 2000, MICROBIOL-UK, V146, P1605, DOI 10.1099/00221287-146-7-1605; Eschenbrenner M, 2006, J PROTEOME RES, V5, P1731, DOI 10.1021/pr060135p; Eskra L, 2001, INFECT IMMUN, V69, P7736, DOI 10.1128/IAI.69.12.7736-7742.2001; Gandara B, 2001, J CLIN MICROBIOL, V39, P235, DOI 10.1128/JCM.39.1.235-240.2001; Herrou J, 2010, MOL MICROBIOL, V78, P290, DOI 10.1111/j.1365-2958.2010.07323.x; Hibbing ME, 2011, J BACTERIOL, V193, P3461, DOI 10.1128/JB.00317-11; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Iwanczyk J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018944; Jain N, 2011, FEMS MICROBIOL LETT, V316, P1, DOI 10.1111/j.1574-6968.2010.02186.x; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kohler S, 2002, INFECT IMMUN, V70, P1631, DOI 10.1128/IAI.70.3.1631-1634.2002; Koprivnjak T, 2011, CELL MOL LIFE S 0511, V11; Lamontagne J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-300; Lapaque N, 2006, CELL MICROBIOL, V8, P197, DOI 10.1111/j.1462-5822.2005.00609.x; LOPEZGONI I, 1992, INFECT IMMUN, V60, P4496; Lourenco RF, 2011, MOL MICROBIOL, V80, P1598, DOI 10.1111/j.1365-2958.2011.07668.x; Martinez M, 2006, MICROBIOL-SGM, V152, P2591, DOI 10.1099/mic.0.28782-0; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Parent MA, 2002, MICROB PATHOGENESIS, V32, P239, DOI 10.1006/mpat.2002.0500; Paulley JT, 2007, INFECT IMMUN, V75, P5248, DOI 10.1128/IAI.00460-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips RW, 2001, INFECT IMMUN, V69, P5911, DOI 10.1128/IAI.69.9.5911-5913.2001; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI 10.1128/jb.186.15.5040-5051.2004; Reeves SA, 2000, INFECT IMMUN, V68, P6329, DOI 10.1128/IAI.68.11.6329-6336.2000; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Roop RM, 2001, VET MICROBIOL, V82, P91, DOI 10.1016/S0378-1135(01)00380-7; Sathiyaseelan J, 2000, CLIN EXP IMMUNOL, V121, P289, DOI 10.1046/j.1365-2249.2000.01295.x; Singh V, 2011, MICROBIOL-SGM, V157, P38, DOI 10.1099/mic.0.042358-0; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Staron A, 2010, MOL MICROBIOL, V78, P271, DOI 10.1111/j.1365-2958.2010.07336.x; Steele KH, 2010, J BACTERIOL, V192, P4912, DOI 10.1128/JB.00231-10; Supuran CT, 2002, MED RES REV, V22, P329, DOI 10.1002/med.10007; Talaat AM, 2000, NAT BIOTECHNOL, V18, P679, DOI 10.1038/76543; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tsolis RM, 1996, INFECT IMMUN, V64, P4549, DOI 10.1128/IAI.64.11.4549-4556.1996; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; VERGER JM, 1985, INT J SYST BACTERIOL, V35, P292, DOI 10.1099/00207713-35-3-292; Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	52	15	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31747	10.1371/journal.pone.0031747	http://dx.doi.org/10.1371/journal.pone.0031747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403618	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700015
J	Nieto, JC; Canto, E; Zamora, C; Ortiz, MA; Juarez, C; Vidal, S				Nieto, Juan C.; Canto, Elisabet; Zamora, Carlos; Angels Ortiz, M.; Juarez, Candido; Vidal, Silvia			Selective Loss of Chemokine Receptor Expression on Leukocytes after Cell Isolation	PLOS ONE			English	Article							HUMAN MONOCYTES; FLOW-CYTOMETRY; WHOLE-BLOOD; CCR2; DIFFERENTIATION; MODULATION; SUBSETS; TISSUES; CXCR4	Chemokine receptors are distinctively exposed on cells to characterize their migration pattern. However, little is known about factors that may regulate their expression. To determine the optimal conditions for an accurate analysis of chemokine receptors, we compared the expression of CCR2, CCR4, CCR5, CCR6, CXCR3 and CXCR4 on different leukocyte subsets using whole blood (WB) plus erythrocyte lysis and density gradient isolation (Ficoll). Most WB monocytes were CCR2+ (93.5 +/- 2.9%) whereas 32.8 +/- 6.0% of monocytes from Ficoll-PBMC expressed CCR2 (p<0.001). Significant reductions of CCR6 and CXCR3 on monocytes were also observed after Ficoll isolation (WB: 46.4 +/- 7.5% and 57.1 +/- 5.5%; Ficoll: 29.5 +/- 2.2% and 5.4 +/- 4.3% respectively) (p<0.01). Although comparable percentages of WB and Ficoll-PBMC monocytes expressed CCR4, CCR5 and CXCR4, Ficoll isolation significantly reduced the levels of CXCR4 (WB: MFI 5 +/- 0.4 and Ficoll: MFI 3.3 +/- 0.1) (p<0.05). Similarly to monocytes, CCR2, CXCR3 and CXCR4 were also reduced on lymphocytes. In addition, Ficoll isolation significantly reduced the percentage of CCR4 positive lymphocytes (WB: 90.2 +/- 4.5% and Ficoll: 55 +/- 4.1%) (p<0.01). The loss of expression of chemokine receptors after isolation of monocytes was not dependent on either the anticoagulant or the density gradient method. It was irreversible and could not be restored by LPS activation or in vitro macrophage differentiation. Experiments tagged with anti-CCR2 antibodies prior to density gradient isolation demonstrated that Ficoll internalized chemokine receptors. The method for cell isolation may alter not only the expression of certain chemokine receptors but also the respective functional migration assay. The final choice to analyze their expression should therefore depend on the receptor to be measured.	[Nieto, Juan C.; Canto, Elisabet; Zamora, Carlos; Angels Ortiz, M.; Vidal, Silvia] Inst Recerca Hosp St Pau, Dept Immunol, Barcelona, Spain; [Juarez, Candido] Hosp Santa Creu & Sant Pau, Barcelona, Spain	Hospital of Santa Creu i Sant Pau	Nieto, JC (corresponding author), Inst Recerca Hosp St Pau, Dept Immunol, Barcelona, Spain.	svidal@santpau.cat		CANTO, ELISABET/0000-0002-1782-1855; zamora, carlos/0000-0003-2962-678X; Nieto Sachica, Juan Camilo/0000-0002-3400-1488; Juarez, Candido/0000-0003-2235-9893; Vidal, Silvia/0000-0002-3909-6682	Department of Education and Science [BFU06/15063]; Fondo Investigaciones Sanitarias [PS09/132]	Department of Education and Science; Fondo Investigaciones Sanitarias(Instituto de Salud Carlos III)	This research was supported by the Department of Education and Science (BFU06/15063) and Fondo Investigaciones Sanitarias (PS09/132). S.V. was supported by Fondo Investigaciones Sanitarias and a participant in the Program for Stabilization of Investigators from the Direction of Strategy and Coordination of Health Department of Generalitat Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AR, 2008, STROKE, V39, P1972, DOI 10.1161/STROKEAHA.107.504381; ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; Arias MA, 2006, IMMUNOLOGY, V118, P171, DOI 10.1111/j.1365-2567.2006.02352.x; Berhanu D, 2003, J IMMUNOL METHODS, V279, P199, DOI 10.1016/S0022-1759(03)00186-8; Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; Fantuzzi L, 1999, BLOOD, V94, P875, DOI 10.1182/blood.V94.3.875.415k28_875_883; FEARON DT, 1983, J IMMUNOL, V130, P370; Fung E, 2010, NAT PROTOC, V5, P357, DOI 10.1038/nprot.2009.246; Hernandez-Campo PM, 2002, CYTOMETRY, V50, P191, DOI 10.1002/cyto.10072; Juffermans NP, 2002, J INFECT DIS, V185, P986, DOI 10.1086/339606; Liao F, 1999, J IMMUNOL, V162, P186; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; Murphy PM, 2002, PHARMACOL REV, V54, P227, DOI 10.1124/pr.54.2.227; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Newhall KJ, 2010, CLIN CHEM, V56, P1483, DOI 10.1373/clinchem.2006.144618; Panaro MA, 1999, IMMUNOPHARM IMMUNOT, V21, P397, DOI 10.3109/08923979909007117; Penton-Rol G, 1998, J IMMUNOL, V160, P3869; Phillips Roderick J, 2005, J Inflamm (Lond), V2, P14, DOI 10.1186/1476-9255-2-14; Rossol M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2733; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; TAMUL KR, 1995, CLIN DIAGN LAB IMMUN, V2, P337, DOI 10.1128/CDLI.2.3.337-342.1995; Tuttle DL, 1998, J VIROL, V72, P4962, DOI 10.1128/JVI.72.6.4962-4969.1998; Xu L, 1997, J LEUKOCYTE BIOL, V62, P653, DOI 10.1002/jlb.62.5.653; Xu LL, 2000, EUR J IMMUNOL, V30, P227, DOI 10.1002/1521-4141(200001)30:1<227::AID-IMMU227>3.0.CO;2-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	29	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31297	10.1371/journal.pone.0031297	http://dx.doi.org/10.1371/journal.pone.0031297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403612	Green Published, Green Submitted, gold			2022-12-25	WOS:000303017700009
J	Tiv, M; Viel, JF; Mauny, F; Eschwege, E; Weill, A; Fournier, C; Fagot-Campagna, A; Penfornis, A				Tiv, Michel; Viel, Jean-Francois; Mauny, Frederic; Eschwege, Eveline; Weill, Alain; Fournier, Cecile; Fagot-Campagna, Anne; Penfornis, Alfred			Medication Adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study	PLOS ONE			English	Article							RACIAL-DIFFERENCES; METABOLIC-CONTROL; DRUG-THERAPY; PATIENT; CARE; QUALITY; IMPACT; CONSEQUENCES; HYPERTENSION; IMPROVEMENTS	Background: Adherence to prescribed medications is a key dimension of healthcare quality. The aim of this large population-based study was to evaluate self-reported medication adherence and to identify factors linked with poor adherence in patients with type 2 diabetes in France. Methodology: The ENTRED study 2007, a French national survey of people treated for diabetes, was based on a representative sample of patients who claimed reimbursement for oral hypoglycaemic agents and/or insulin at least three times between August 2006 and July 2007, and who were randomly selected from the database of the two main National Health Insurance Systems. Medication adherence was determined using a six-item self-administered questionnaire. A multinomial polychotomous logistic regression model was used to identify factors associated with medication adherence in the 3,637 persons with type 2 diabetes. Principal Findings: Thirty nine percent of patients reported good medication adherence, 49% medium adherence and 12% poor adherence. The factors significantly associated with poor adherence in multivariate analysis were socio-demographic factors: age <45 years, non-European geographical origin, financial difficulties and being professionally active; disease and therapy-related factors: HbA(1c) > 8% and existing diabetes complications; and health care-related factors: difficulties for taking medication alone, decision making by the patient only, poor acceptability of medical recommendations, lack of family or social support, need for information on treatment, reporting no confidence in the future, need for medical support and follow-up by a specialist physician. Conclusions: In a country with a high level of access to healthcare, our study demonstrated a substantial low level of medication adherence in type 2 diabetic patients. Better identification of those with poor adherence and individualised suitable recommendations remain essential for better healthcare management.	[Tiv, Michel; Viel, Jean-Francois; Mauny, Frederic] Univ Hosp Besancon, Dept Med Informat, Besancon, France; [Eschwege, Eveline] INSERM, Villejuif, France; [Weill, Alain] French Natl Hlth Insurance Fund Salaried Workers, Paris, France; [Fournier, Cecile] Inst Hlth Prevent & Educ Inpes, St Denis, France; [Fagot-Campagna, Anne] Inst Publ Hlth Surveillance InVS, St Maurice, France; [Penfornis, Alfred] Univ Franche Comte, Dept Endocrinol Metab & Diabetol Nutr, Jean Minjoz Hosp, F-25030 Besancon, France	Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm); Institute of Public Health Surveillance; Universite de Franche-Comte; CHU Besancon	Tiv, M (corresponding author), Univ Hosp Besancon, Dept Med Informat, Besancon, France.	alfred.penfornis@univ-fcomte.fr	Viel, Jean-Francois/K-2224-2015; Mauny, Fred/G-2469-2018	Viel, Jean-Francois/0000-0002-6716-7468; Mauny, Fred/0000-0002-8512-2693; Weill, Alain/0000-0001-8687-9092	Institut de Veille Sanitaire; Institut national de prevention et d'education pour la sante; Regime general de l'assurance maladie; Regime des salaries independants; Haute autorite de sante	Institut de Veille Sanitaire; Institut national de prevention et d'education pour la sante; Regime general de l'assurance maladie; Regime des salaries independants; Haute autorite de sante	The Entred study was financially supported by the Institut de Veille Sanitaire, the Institut national de prevention et d'education pour la sante, the Regime general de l'assurance maladie, the Regime des salaries independants, and the Haute autorite de sante. These five public institutions planned the study design, organised data collection, and provided their authorizations for publication.	Adams AS, 2008, DIABETES CARE, V31, P916, DOI 10.2337/dc07-1924; [Anonymous], 2007, DIABETES METAB, V33, p1S7; Brown JB, 1999, CLIN THER, V21, P1045, DOI 10.1016/S0149-2918(99)80023-X; Campbell SM, 2005, BMJ-BRIT MED J, V331, P1121, DOI 10.1136/bmj.38632.611123.AE; Cegala DJ, 2000, ARCH FAM MED, V9, P57, DOI 10.1001/archfami.9.1.57; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Ciechanowski PS, 2001, AM J PSYCHIAT, V158, P29, DOI 10.1176/appi.ajp.158.1.29; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Dezii CM, 2002, SOUTH MED J, V95, P68; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Garber MC, 2004, MED CARE, V42, P649, DOI 10.1097/01.mlr.0000129496.05898.02; Girerd X, 2001, PRESSE MED, V30, P1044; Grant RW, 2003, ANN PHARMACOTHER, V37, P962, DOI 10.1345/aph.1C452; Grant RW, 2003, DIABETES CARE, V26, P1408, DOI 10.2337/diacare.26.5.1408; Guillausseau PJ, 2003, DIABETES METAB, V29, P79, DOI 10.1016/S1262-3636(07)70011-3; Lawton J, 2008, DIABETIC MED, V25, P491, DOI 10.1111/j.1464-5491.2008.02400.x; Lee Won Chan, 2006, Manag Care Interface, V19, P31; Lepkowski James M, 2006, Vital Health Stat 2, P1; Little RJ, 2003, STAT MED, V22, P1589, DOI 10.1002/sim.1513; Magadza C, 2009, RES SOC ADMIN PHARM, V5, P363, DOI 10.1016/j.sapharm.2009.01.004; Mann DM, 2009, J BEHAV MED, V32, P278, DOI 10.1007/s10865-009-9202-y; Melikian C, 2002, CLIN THER, V24, P460, DOI 10.1016/S0149-2918(02)85047-0; Moreau A, 2009, EUR J GEN PRACT, V15, P147, DOI 10.3109/13814780903329510; Mosnier-Pudar H, 2009, DIABETES METAB, V35, P220, DOI 10.1016/j.diabet.2009.02.001; Nagasawa M, 1990, Diabetes Educ, V16, P192, DOI 10.1177/014572179001600309; National Institute of Health and Clinical Excellence, 2008, NICE CLIN GUID 66 TY; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Paes AHP, 1997, DIABETES CARE, V20, P1512, DOI 10.2337/diacare.20.10.1512; Parchman ML, 2010, ANN FAM MED, V8, P410, DOI 10.1370/afm.1161; Park Kyung-Ae, 2010, Korean Diabetes J, V34, P55, DOI 10.4093/kdj.2010.34.1.55; Penfornis A, 2003, DIABETES METAB, V29, pS31; Pollack MF, 2010, DIABETES RES CLIN PR, V87, P204, DOI 10.1016/j.diabres.2009.11.023; Pornet C, 2011, DIABETES METAB, V37, P152, DOI 10.1016/j.diabet.2011.02.001; Rosen MI, 2003, J BEHAV MED, V26, P349, DOI 10.1023/A:1024257027839; Rothenbacher D, 2003, BRIT J GEN PRACT, V53, P389; Schechter CB, 2002, DIABETES SPECTRUM, V15, P170, DOI DOI 10.2337/DIASPECT.15.3.170; Schectman JM, 2002, DIABETES CARE, V25, P1015, DOI 10.2337/diacare.25.6.1015; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Trinacty CM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-24; van Bruggen R, 2009, PHARMACOEPIDEM DR S, V18, P983, DOI 10.1002/pds.1810; Venturini F, 1999, ANN PHARMACOTHER, V33, P281, DOI 10.1345/aph.18198; Walker EA, 2006, DIABETES CARE, V29, P1997, DOI 10.2337/dc06-0454; WHO, 2003, ADH LONG TERM THER T; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	45	137	138	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32412	10.1371/journal.pone.0032412	http://dx.doi.org/10.1371/journal.pone.0032412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403654	Green Published, gold			2022-12-25	WOS:000303017700051
J	Yoshida, CA; Komori, H; Maruyama, Z; Miyazaki, T; Kawasaki, K; Furuichi, T; Fukuyama, R; Mori, M; Yamana, K; Nakamura, K; Liu, WG; Toyosawa, S; Moriishi, T; Kawaguchi, H; Takada, K; Komori, T				Yoshida, Carolina A.; Komori, Hisato; Maruyama, Zenjiro; Miyazaki, Toshihiro; Kawasaki, Keishi; Furuichi, Tatsuya; Fukuyama, Ryo; Mori, Masako; Yamana, Kei; Nakamura, Kouhei; Liu, Wenguang; Toyosawa, Satoru; Moriishi, Takeshi; Kawaguchi, Hiroshi; Takada, Kenji; Komori, Toshihisa			SP7 Inhibits Osteoblast Differentiation at a Late Stage in Mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; MESENCHYMAL STEM-CELLS; BONE-FORMATION; IN-VITRO; TARGETED DISRUPTION; TRANSGENIC MICE; EXPRESSION; GENE; OVEREXPRESSION; CBFA1	RUNX2 and SP7 are essential transcription factors for osteoblast differentiation at an early stage. Although RUNX2 inhibits osteoblast differentiation at a late stage, the function of SP7 at the late stage of osteoblast differentiation is not fully elucidated. Thus, we pursued the function of SP7 in osteoblast differentiation. RUNX2 induced Sp7 expression in Runx2(-/-) calvarial cells. Adenoviral transfer of sh-Sp7 into primary osteoblasts reduced the expression of Alpl, Col1a1, and Bglap2 and mineralization, whereas that of Sp7 reduced Bglap2 expression and mineralization at a late stage of osteoblast differentiation. Sp7 transgenic mice under the control of 2.3 kb Col1a1 promoter showed osteopenia and woven-bone like structure in the cortical bone, which was thin and less mineralized, in a dose-dependent manner. Further, the number of processes in the osteoblasts and osteocytes was reduced. Although the osteoblast density was increased, the bone formation was reduced. The frequency of BrdU incorporation was increased in the osteoblastic cells, while the expression of Col1a1, Spp1, Ibsp, and Bglap2 was reduced. Further, the osteopenia in Sp7 or Runx2 transgenic mice was worsened in Sp7/Runx2 double transgenic mice and the expression of Col1a1 and Bglap2 was reduced. The expression of Sp7 and Runx2 was not increased in Runx2 and Sp7 transgenic mice, respectively. The expression of endogenous Sp7 was increased in Sp7 transgenic mice and Sp7-transduced cells; the introduction of Sp7 activated and sh-Sp7 inhibited Sp7 promoter; and ChIP assay showed the binding of endogenous SP7 in the proximal region of Sp7 promoter. These findings suggest that SP7 and RUNX2 inhibit osteoblast differentiation at a late stage in a manner independent of RUNX2 and SP7, respectively, and SP7 positively regulates its own promoter.	[Yoshida, Carolina A.; Komori, Hisato; Maruyama, Zenjiro; Miyazaki, Toshihiro; Kawasaki, Keishi; Furuichi, Tatsuya; Mori, Masako; Nakamura, Kouhei; Liu, Wenguang; Moriishi, Takeshi; Komori, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan; [Maruyama, Zenjiro; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Kawasaki, Keishi; Takada, Kenji] Osaka Univ, Dept Orthodont & Dentofacial Orthoped, Grad Sch Dent, Suita, Osaka, Japan; [Fukuyama, Ryo] Hiroshima Int Univ, Fac Pharmaceut Sci, Pharmacol Lab, Kure, Japan; [Yamana, Kei] Teijin Inst Biomed Res, Tokyo, Japan; [Nakamura, Kouhei] Nagasaki Univ, Grad Sch Biomed Sci, Dept Periodontol, Nagasaki 852, Japan; [Toyosawa, Satoru] Osaka Univ, Grad Sch Dent, Dept Oral Pathol, Suita, Osaka, Japan	Nagasaki University; University of Tokyo; Osaka University; Nagasaki University; Osaka University	Yoshida, CA (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan.	komorit@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Uehara Memorial Foundation; Nagasaki University	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Nagasaki University	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, the Uehara Memorial Foundation, and the President's Discretionary Fund of Nagasaki University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin EJ, 2002, PRINCIPLES BONE BIOL, P59; Baek WY, 2010, BONE, V46, P920, DOI 10.1016/j.bone.2009.12.007; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; EJIRI S, 1982, ARCH HISTOL JAPON, V45, P399, DOI 10.1679/aohc.45.399; Fu HH, 2007, J BIOMED MATER RES A, V83A, P770, DOI 10.1002/jbm.a.31356; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; Karner E, 2009, J CELL PHYSIOL, V218, P323, DOI 10.1002/jcp.21605; Kim YJ, 2006, GENE, V366, P145, DOI 10.1016/j.gene.2005.08.021; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kurata H, 2007, TISSUE ENG, V13, P1513, DOI 10.1089/ten.2006.0374; Kusuzaki K, 2000, BONE, V27, P655, DOI 10.1016/S8756-3282(00)00383-5; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Maehata Y, 2006, MATRIX BIOL, V25, P47, DOI 10.1016/j.matbio.2005.09.001; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Nampei A, 2004, J BONE MINER METAB, V22, P176, DOI 10.1007/s00774-003-0468-9; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Odgren PR, 2002, PRINCIPLES BONE BIOL, P3, DOI DOI 10.1016/B978-012098652-1.50103-7; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Sun S, 2008, INT J ORAL MAX SURG, V37, P350, DOI 10.1016/j.ijom.2007.11.024; Tai GP, 2004, TISSUE ENG, V10, P1456, DOI 10.1089/1076327042500300; Tominaga H, 2009, J BONE MINER METAB, V27, P36, DOI 10.1007/s00774-008-0003-0; Tu QS, 2006, BIOCHEM BIOPH RES CO, V341, P1257, DOI 10.1016/j.bbrc.2006.01.092; Wu L, 2007, MOL CELL BIOCHEM, V301, P83, DOI 10.1007/s11010-006-9399-9; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	36	60	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32364	10.1371/journal.pone.0032364	http://dx.doi.org/10.1371/journal.pone.0032364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396760	gold, Green Published, Green Submitted			2022-12-25	WOS:000303006500015
J	Palma, RE; Boric-Bargetto, D; Torres-Perez, F; Hernandez, CE; Yates, TL				Eduardo Palma, R.; Boric-Bargetto, Dusan; Torres-Perez, Fernando; Hernandez, Cristian E.; Yates, Terry L.			Glaciation Effects on the Phylogeographic Structure of Oligoryzomys longicaudatus (Rodentia: Sigmodontinae) in the Southern Andes	PLOS ONE			English	Article							HANTAVIRUS PULMONARY SYNDROME; PYGMY RICE RATS; PHYLOGENETIC-RELATIONSHIPS; GENETIC DIVERSITY; POSTGLACIAL EXPANSION; POPULATION-GENETICS; LATE-PLEISTOCENE; HISTORY; CHILE; AMERICA	The long-tailed pygmy rice rat Oligoryzomys longicaudatus (Sigmodontinae), the major reservoir of Hantavirus in Chile and Patagonian Argentina, is widely distributed in the Mediterranean, Temperate and Patagonian Forests of Chile, as well as in adjacent areas in southern Argentina. We used molecular data to evaluate the effects of the last glacial event on the phylogeographic structure of this species. We examined if historical Pleistocene events had affected genetic variation and spatial distribution of this species along its distributional range. We sampled 223 individuals representing 47 localities along the species range, and sequenced the hypervariable domain I of the mtDNA control region. Aligned sequences were analyzed using haplotype network, Bayesian population structure and demographic analyses. Analysis of population structure and the haplotype network inferred three genetic clusters along the distribution of O. longicaudatus that mostly agreed with the three major ecogeographic regions in Chile: Mediterranean, Temperate Forests and Patagonian Forests. Bayesian Skyline Plots showed constant population sizes through time in all three clusters followed by an increase after and during the Last Glacial Maximum (LGM; between 26,000-13,000 years ago). Neutrality tests and the "g" parameter also suggest that populations of O. longicaudatus experienced demographic expansion across the species entire range. Past climate shifts have influenced population structure and lineage variation of O. longicaudatus. This species remained in refugia areas during Pleistocene times in southern Temperate Forests (and adjacent areas in Patagonia). From these refugia, O. longicaudatus experienced demographic expansions into Patagonian Forests and central Mediterranean Chile using glacial retreats.	[Eduardo Palma, R.; Boric-Bargetto, Dusan; Torres-Perez, Fernando] Pontificia Univ Catolica Chile, CASEB, Ctr Estudios Avanzados Ecol & Biodiversidad, Santiago, Chile; [Eduardo Palma, R.; Boric-Bargetto, Dusan; Torres-Perez, Fernando] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Boric-Bargetto, Dusan; Hernandez, Cristian E.] Univ Concepcion, Dept Zool, Fac Ciencias Nat & Oceanog, Concepcion, Chile; [Torres-Perez, Fernando] Pontificia Univ Catolica Valparaiso, Inst Biol, Valparaiso, Chile; [Yates, Terry L.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Yates, Terry L.] Univ New Mexico, Museum SW Biol, Albuquerque, NM 87131 USA	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Concepcion; Pontificia Universidad Catolica de Valparaiso; University of New Mexico; University of New Mexico	Palma, RE (corresponding author), Pontificia Univ Catolica Chile, CASEB, Ctr Estudios Avanzados Ecol & Biodiversidad, Alameda 340, Santiago, Chile.	epalma@bio.puc.cl	Torres-Perez, Fernando/B-5002-2008; Hernández, Cristián E./C-4414-2012; Palma, Eduardo/N-1416-2014; Hernández, Cristián E./GLS-1111-2022; Hernández, Cristián E./AAS-1286-2020	Torres-Perez, Fernando/0000-0001-8655-7288; Hernández, Cristián E./0000-0002-9811-2881; Hernández, Cristián E./0000-0002-9811-2881; Boric-Bargetto, Dusan/0000-0002-4568-8828	NIH [NIH U01 AI045452, NIH-ICDR I U19 AI-45452-01]; FONDECYT [1110664, 1070331, 11080110, 1100558]; FONDECYT CASEB [1501-0001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI045452, U01AI045452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT CASEB(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: NIH: NIH U01 AI045452, NIH-ICDR I U19 AI-45452-01 http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-04-017.html. FONDECYT grants 1110664, 1070331, 11080110, 1100558; FONDECYT CASEB 1501-0001. http://www.fondecyt.cl/578/channel.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armesto JJ, 1995, ECOLOGY SO CONIFERS, P120; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; BARTON NH, 1995, PHILOS T ROY SOC B, V349, P49, DOI 10.1098/rstb.1995.0090; Belmar-Lucero S, 2009, REV CHIL HIST NAT, V82, P265, DOI 10.4067/S0716-078X2009000200008; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Carleton MD, 1989, B AM MUS NAT HIST, V191, P1; Conroy CJ, 2000, MOL ECOL, V9, P165, DOI 10.1046/j.1365-294x.2000.00846.x; Cook JA, 2006, BIOL CONSERV, V133, P1, DOI 10.1016/j.biocon.2006.05.026; Cope JM, 2004, CAN J FISH AQUAT SCI, V61, P332, DOI 10.1139/F04-008; Cosacov A, 2010, J BIOGEOGR, V37, P1463, DOI 10.1111/j.1365-2699.2010.02307.x; Dragoo JW, 2006, J GEN VIROL, V87, P1997, DOI 10.1099/vir.0.81576-0; Dress AWM, 2004, IEEE ACM T COMPUT BI, V1, P109, DOI 10.1109/TCBB.2004.27; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Palma RE, 2010, ZOOL J LINN SOC-LOND, V160, P551, DOI 10.1111/j.1096-3642.2009.00621.x; Palma RE, 2010, J MAMMAL, V91, P1102, DOI 10.1644/10-MAMM-A-031.1; Fedorov VB, 2008, MOL ECOL, V17, P598, DOI 10.1111/j.1365-294X.2007.03595.x; Fu YX, 1997, GENETICS, V147, P915; GALLARDO MH, 1990, J MAMMAL, V71, P333, DOI 10.2307/1381943; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gelman A., 2003, BAYESIAN DATA ANAL; Glasser NF, 2008, QUATERNARY SCI REV, V27, P365, DOI 10.1016/j.quascirev.2007.11.011; Gonzalez-Ittig RE, 2010, CAN J ZOOL, V88, P23, DOI 10.1139/Z09-115; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Harrison S, 2004, DEV QUA SCI, V2, P89; Hein J., 2005, GENE GENEALOGIES VAR; HEUSSER CJ, 1972, B TORREY BOT CLUB, V99, P178, DOI 10.2307/2484572; HEUSSER CJ, 1983, SCIENCE, V219, P1429, DOI 10.1126/science.219.4591.1429; HEUSSER CJ, 1993, QUATERNARY SCI REV, V12, P345, DOI 10.1016/0277-3791(93)90042-K; HEUSSER CJ, 1982, QUATERNARY RES, V17, P71, DOI 10.1016/0033-5894(82)90046-1; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Himes CMT, 2008, J BIOGEOGR, V35, P1415, DOI 10.1111/j.1365-2699.2008.01895.x; Hjelle B, 2010, VIRUSES-BASEL, V2, P2559, DOI 10.3390/v2122559; HOLLIN JT, 1981, LAST GREAT ICE SHEET, P179; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; Kim I, 1998, MOL ECOL, V7, P667, DOI 10.1046/j.1365-294x.1998.00369.x; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lessa EP, 2010, MOL ECOL, V19, P3031, DOI 10.1111/j.1365-294X.2010.04734.x; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez N, 1996, VIROLOGY, V220, P223, DOI 10.1006/viro.1996.0305; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Mann G, 1978, GAYANA ZOOL, V40; Mathiasen P, 2010, MOL ECOL, V19, P371, DOI 10.1111/j.1365-294X.2009.04456.x; Medina RA, 2009, J VIROL, V83, P2446, DOI 10.1128/JVI.01057-08; MERCER JH, 1983, ANNU REV EARTH PL SC, V11, P99, DOI 10.1146/annurev.ea.11.050183.000531; MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742; Muellner AN, 2005, MOL ECOL, V14, P203, DOI 10.1111/j.1365-294X.2004.02386.x; MURUA R, 1986, J ANIM ECOL, V55, P281, DOI 10.2307/4708; Nei M., 1987, MOL EVOLUTIONARY GEN; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Orme A.R., 2007, PHYS GEOGRAPHY S AM, P184; Osgood W.H., 1943, FIELD MUSEUM NATURAL; Padula PJ, 1998, VIROLOGY, V241, P323, DOI 10.1006/viro.1997.8976; Palma RE, 2005, J MAMMAL, V86, P191, DOI 10.1644/1545-1542(2005)086<0191:POOLRS>2.0.CO;2; Palma RE, 1987, SISTEMATICA EVOLUTIV; Palma RE, 2007, QUINTESSENTIAL NATUR, P671; Pastorino MJ, 2002, J BIOGEOGR, V29, P1167, DOI 10.1046/j.1365-2699.2002.00731.x; PATTON JL, 1992, EVOLUTION, V46, P174, DOI 10.1111/j.1558-5646.1992.tb01992.x; PEREZ C, 1985, REV CHIL HIST NAT, V58, P157; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; PORTER SC, 1981, QUATERNARY RES, V16, P263, DOI 10.1016/0033-5894(81)90013-2; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potts Richard, 1992, P419; Premoli AC, 2000, J BIOGEOGR, V27, P251, DOI 10.1046/j.1365-2699.2000.00402.x; RABASSA J, 1990, QUATERNARY SCI REV, V9, P153, DOI 10.1016/0277-3791(90)90016-4; Rabassa J, 2008, DEV QUATER SCI, V11, P151, DOI 10.1016/S1571-0866(07)10008-7; Rajabi-Maham H, 2008, MOL ECOL, V17, P627, DOI 10.1111/j.1365-294X.2007.03601.x; Rambaut A, 2009, TRACER V1 5; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Redford K.H., 1992, MAMMALS NEOTROPICS S; Rivera PC, 2007, ZOOL SCR, V36, P231, DOI 10.1111/j.1463-6409.2007.00273.x; Rodriguez-Serrano E, 2008, MAMM BIOL, V73, P309, DOI 10.1016/j.mambio.2007.10.003; Rodriguez-Serrano E, 2006, J MAMMAL, V87, P971, DOI 10.1644/05-MAMM-A-393R2.1; Runck AM, 2005, MOL ECOL, V14, P1445, DOI 10.1111/j.1365-294X.2005.02501.x; Ruzzante DE, 2006, MOL ECOL, V15, P2949, DOI 10.1111/j.1365-294X.2006.03010.x; Smith MF, 2001, MOL ECOL, V10, P397, DOI 10.1046/j.1365-294x.2001.01183.x; Soltis DE, 1997, PLANT SYST EVOL, V206, P353, DOI 10.1007/BF00987957; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; TAJIMA F, 1989, GENETICS, V123, P597; TEMPLETON AR, 1995, GENETICS, V140, P767; Toro J, 1998, EMERG INFECT DIS, V4, P687, DOI 10.3201/eid0404.980425; Torres-Perez F, 2004, AM J TROP MED HYG, V70, P305, DOI 10.4269/ajtmh.2004.70.305; Torres-Perez F, 2011, MOL ECOL, V20, P4109, DOI 10.1111/j.1365-294X.2011.05241.x; Torres-Perez F, 2010, INFECT GENET EVOL, V10, P820, DOI 10.1016/j.meegid.2009.07.004; Trucchi E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-109; Vendramin GG, 1998, THEOR APPL GENET, V97, P456, DOI 10.1007/s001220050917; Victoriano PF, 2008, MOL ECOL, V17, P2397, DOI 10.1111/j.1365-294X.2008.03741.x; Villagran C, 1997, REV CHIL HIST NAT, V70, P241; VILLAGRAN C, 1988, QUATERNARY RES, V30, P304, DOI 10.1016/0033-5894(88)90006-3; VILLAGRAN C, 1988, QUATERNARY RES, V29, P294, DOI 10.1016/0033-5894(88)90037-3; VILLAGRAN C, 1991, REV CHIL HIST NAT, V64, P447; Villagran C., 2005, REGIONALIZACION BIOG, P551; VILLAGRAN C, 1996, ECOLOGIA BOSQUES NAT, P51; Wares JP, 2001, EVOLUTION, V55, P2455; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Xu J, 2009, MOL ECOL; Zemlak TS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-67	111	32	35	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32206	10.1371/journal.pone.0032206	http://dx.doi.org/10.1371/journal.pone.0032206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396751	Green Submitted, gold, Green Published			2022-12-25	WOS:000303005000017
J	Shakeri, R; Kamangar, F; Nasrollahzadeh, D; Nouraie, M; Khademi, H; Etemadi, A; Islami, F; Marjani, H; Fahimi, S; Sepehr, A; Rahmati, A; Abnet, CC; Dawsey, SM; Brennan, P; Boffetta, P; Malekzadeh, R; Majdzadeh, R				Shakeri, Ramin; Kamangar, Farin; Nasrollahzadeh, Dariush; Nouraie, Mehdi; Khademi, Hooman; Etemadi, Arash; Islami, Farhad; Marjani, Hajiamin; Fahimi, Saman; Sepehr, Alireza; Rahmati, Atieh; Abnet, Christian C.; Dawsey, Sanford M.; Brennan, Paul; Boffetta, Paolo; Malekzadeh, Reza; Majdzadeh, Reza			Is Opium a Real Risk Factor for Esophageal Cancer or Just a Methodological Artifact? Hospital and Neighborhood Controls in Case-Control Studies	PLOS ONE			English	Article							POPULATION-CONTROLS; GOLESTAN COHORT; NORTHERN IRAN; ALCOHOL; SELECTION; QUESTION; TOBACCO; TRACT; AREA; DIET	Background: Control selection is a major challenge in epidemiologic case-control studies. The aim of our study was to evaluate using hospital versus neighborhood control groups in studying risk factors of esophageal squamous cell carcinoma (ESCC). Methodology/Principal Findings: We compared the results of two different case-control studies of ESCC conducted in the same region by a single research group. Case definition and enrollment were the same in the two studies, but control selection differed. In the first study, we selected two age-and sex-matched controls from inpatient subjects in hospitals, while for the second we selected two age-and sex-matched controls from each subject's neighborhood of residence. We used the test of heterogeneity to compare the results of the two studies. We found no significant differences in exposure data for tobacco-related variables such as cigarette smoking, chewing Nass (a tobacco product) and hookah (water pipe) usage, but the frequency of opium usage was significantly different between hospital and neighborhood controls. Consequently, the inference drawn for the association between ESCC and tobacco use did not differ between the studies, but it did for opium use. In the study using neighborhood controls, opium use was associated with a significantly increased risk of ESCC (adjusted OR 1.77, 95% CI 1.17-2.68), while in the study using hospital controls, this was not the case (OR 1.09, 95% CI 0.63-1.87). Comparing the prevalence of opium consumption in the two control groups and a cohort enrolled from the same geographic area suggested that the neighborhood controls were more representative of the study base population for this exposure. Conclusions/Significance: Hospital and neighborhood controls did not lead us to the same conclusion for a major hypothesized risk factor for ESCC in this population. Our results show that control group selection is critical in drawing appropriate conclusions in observational studies.	[Shakeri, Ramin; Kamangar, Farin; Nasrollahzadeh, Dariush; Nouraie, Mehdi; Khademi, Hooman; Etemadi, Arash; Islami, Farhad; Marjani, Hajiamin; Fahimi, Saman; Sepehr, Alireza; Rahmati, Atieh; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Shakeri, Ramin; Kamangar, Farin; Etemadi, Arash; Abnet, Christian C.; Dawsey, Sanford M.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA; [Nasrollahzadeh, Dariush] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Nouraie, Mehdi] Howard Univ, Dept Internal Med, Washington, DC 20059 USA; [Nouraie, Mehdi] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; [Khademi, Hooman; Islami, Farhad; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Fahimi, Saman] Univ Cambridge, Cambridge, England; [Sepehr, Alireza] Harvard Univ, Sch Med, Dept Pathol, BIDMC, Boston, MA 02115 USA; [Rahmati, Atieh] Univ Tehran Med Sci, Firoozgar Hosp, Gastrointestinal & Liver Dis Res Ctr, Tehran, Iran; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Majdzadeh, Reza] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Majdzadeh, Reza] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Morgan State University; Karolinska Institutet; Howard University; Howard University; World Health Organization; International Agency for Research on Cancer (IARC); University of Cambridge; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tehran University of Medical Sciences; Icahn School of Medicine at Mount Sinai; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Shakeri, R (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran.	rezamajd@tums.ac.ir	Etemadi, Arash/C-1386-2016; Abnet, Christian C/C-4111-2015; Boffetta, Paolo/AAI-7767-2021; Nouraie, Seyed Mehdi/O-4071-2018; Khademi, Hooman/AAZ-8798-2020; Etemadi, Arash/Y-7082-2018; Malekzadeh, Reza/U-1382-2017	Etemadi, Arash/0000-0002-3458-1072; Abnet, Christian C/0000-0002-3008-7843; Boffetta, Paolo/0000-0002-3811-2791; Nouraie, Seyed Mehdi/0000-0001-7465-0581; Etemadi, Arash/0000-0002-3458-1072; Malekzadeh, Reza/0000-0002-9820-6335; Islami, Farhad/0000-0002-7357-5994; , Ramin/0000-0003-0487-3629; Malekzadeh, Reza/0000-0003-1043-3814	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036120] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abnet CC, 2004, CANCER EPIDEM BIOMAR, V13, P1068; Carman S, 2009, INT J CANCER, V125, P165, DOI 10.1002/ijc.24342; Freedman ND, 2007, INT J CANCER, V121, P2753, DOI 10.1002/ijc.22993; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; Infante-Rivard C, 2003, AM J EPIDEMIOL, V157, P176, DOI 10.1093/aje/kwf174; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Islami F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b929; JAIN M, 1980, INT J CANCER, V26, P757, DOI 10.1002/ijc.2910260609; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Majdzadeh R, 2009, TRAFFIC INJ PREV, V10, P325, DOI 10.1080/15389580902995380; Matzkin H, 1996, PROSTATE, V29, P42, DOI 10.1002/(SICI)1097-0045(199607)29:1<42::AID-PROS6>3.0.CO;2-K; MILLER AB, 1994, PREV MED, V23, P263, DOI 10.1006/pmed.1994.1037; MILLER AB, 1984, J CHRON DIS, V37, P337, DOI 10.1016/0021-9681(84)90097-3; Nasrollahzadeh D, 2008, BRIT J CANCER, V98, P1857, DOI 10.1038/sj.bjc.6604369; Pourshams A, 2005, BRIT J CANCER, V92, P176, DOI 10.1038/sj.bjc.6602249; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Sadetzki S, 2003, EUR J EPIDEMIOL, V18, P1127, DOI 10.1023/B:EJEP.0000006634.49205.c5; Sorensen LT, 2005, ARCH SURG-CHICAGO, V140, P119, DOI 10.1001/archsurg.140.2.119; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; Weikert C, 2009, INT J CANCER, V125, P406, DOI 10.1002/ijc.24393; WEST DW, 1984, INT J EPIDEMIOL, V13, P235, DOI 10.1093/ije/13.2.235	23	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32711	10.1371/journal.pone.0032711	http://dx.doi.org/10.1371/journal.pone.0032711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396792	gold, Green Submitted, Green Published			2022-12-25	WOS:000303005000036
J	Ajelli, M; Merler, S				Ajelli, Marco; Merler, Stefano			The Impact of the Unstructured Contacts Component in Influenza Pandemic Modeling	PLOS ONE			English	Article							TRANSMISSION; STRATEGIES	Individual based models have become a valuable tool for modeling the spatiotemporal dynamics of epidemics, e. g. influenza pandemic, and for evaluating the effectiveness of intervention strategies. While specific contacts among individuals into diverse environments (family, school/workplace) can be modeled in a standard way by employing available socio-demographic data, all the other (unstructured) contacts can be dealt with by adopting very different approaches. This can be achieved for instance by employing distance-based models or by choosing unstructured contacts in the local communities or by employing commuting data. Methods/Results. Here we show how diverse choices can lead to different model outputs and thus to a different evaluation of the effectiveness of the containment/mitigation strategies. Sensitivity analysis has been conducted for different values of the first generation index G(0), which is the average number of secondary infections generated by the first infectious individual in a completely susceptible population and by varying the seeding municipality. Among the different considered models, attack rate ranges from 19.1% to 25.7% for G(0)= 1.1, from 47.8% to 50.7% for G(0)= 1.4 and from 62.4% to 67.8% for G(0)= 1.7. Differences of about 15 to 20 days in the peak day have been observed. As regards spatial diffusion, a difference of about 100 days to cover 200 km for different values of G(0) has been observed. Conclusion. To reduce uncertainty in the models it is thus important to employ data, which start being available, on contacts on neglected but important activities (leisure time, sport mall, restaurants, etc.) and time-use data for improving the characterization of the unstructured contacts. Moreover, all the possible effects of different assumptions should be considered for taking public health decisions: not only sensitivity analysis to various model parameters should be performed, but intervention options should be based on the analysis and comparison of different modeling choices.	[Ajelli, Marco; Merler, Stefano] Fdn Bruno Kessler, Trento, Italy; [Ajelli, Marco] Univ Trento, Inform Engn & Comp Sci Dept, Trento, Italy	Fondazione Bruno Kessler; University of Trento	Ajelli, M (corresponding author), Fdn Bruno Kessler, Trento, Italy.	ajelli@fbk.eu	merler, stefano/I-3557-2017; Ajelli, Marco/AAX-1113-2020	merler, stefano/0000-0002-5117-0611; Ajelli, Marco/0000-0003-1753-4749	EPICO projoect	EPICO projoect	This work was partially funded by the EPICO project.	ANDERSON R M, 1991; Breban R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000282; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; DIEKMANN O, 2000, MATH EPIDEMIOLOGY IN, P73; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Lenth R., 2019, Journal of Statistical Software, V60, P1; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Riley S, 2006, P NATL ACAD SCI USA, V103, P12637, DOI 10.1073/pnas.0510873103; Viboud C, 2006, PLOS MED, V3, P2159, DOI 10.1371/journal.pmed.0030503	17	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1519	10.1371/journal.pone.0001519	http://dx.doi.org/10.1371/journal.pone.0001519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	22423310	Green Published, Green Submitted, gold			2022-12-25	WOS:000260504200031
J	Paccez, JD; Vasques, GJ; Correa, RG; Vasconcellos, JF; Duncan, K; Gu, X; Bhasin, M; Libermann, TA; Zerbini, LF				Paccez, J. D.; Vasques, G. J.; Correa, R. G.; Vasconcellos, J. F.; Duncan, K.; Gu, X.; Bhasin, M.; Libermann, T. A.; Zerbini, L. F.			The receptor tyrosine kinase Ax1 is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target	ONCOGENE			English	Article						tyrosine kinase receptor; Ax1; prostate cancer; proliferation; NF-kappa B; IL-6	NF-KAPPA-B; ARREST-SPECIFIC GENE-6; BREAST-CANCER; PROLONGS SURVIVAL; ENDOTHELIAL-CELLS; CARCINOMA CELLS; ACTIVATION; PATHWAY; EXPRESSION; GAS6	Deregulation of the receptor tyrosine kinase Ax1 has been implicated in the progression of several human cancers. However, the role of Ax1 in prostate cancer remains poorly understood, and the therapeutic efficacy of Ax1 targeting remains untested. In this report we identified Ax1 as a new therapeutic target for prostate cancer. Ax1 is consistently overexpressed in prostate cancer cell lines and human prostate tumors. Interestingly, the blockage of Ax1 gene expression strongly inhibits proliferation, migration, invasion and tumor growth. Furthermore, inhibition of Ax1 expression by small interfering RNA regulates a transcriptional program of genes involved in cell survival, strikingly all connected to the nuclear factor-kappa B pathway. Additionally, blockage of Ax1 expression leads to inhibition of Akt, IKK alpha and I kappa B alpha phosphorylation, increasing I kappa B alpha expression and stability. Furthermore, induction of Akt phosphorylation by insulin-like growth factor 1 in Ax1 knockdown cells restores Akt activity and proliferation. Taken together, our results establish an unambiguous role for Ax1 in prostate cancer tumorigenesis with implications for prostate cancer treatment. Oncogene (2013) 32, 689-698; doi:10.1038/onc.2012.89; published online 12 March 2012	[Paccez, J. D.; Vasques, G. J.; Duncan, K.; Zerbini, L. F.] Int Ctr Genet Engn & Biotechnol, Canc Genom Grp, Cape Town, South Africa; [Paccez, J. D.; Zerbini, L. F.] Univ Cape Town, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Correa, R. G.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Vasconcellos, J. F.; Gu, X.; Bhasin, M.; Libermann, T. A.] Beth Israel Deaconess Med Ctr, BIDMC Genom & Prote Ctr, Boston, MA 02215 USA; [Vasconcellos, J. F.; Gu, X.; Bhasin, M.; Libermann, T. A.] Harvard Univ, Sch Med, Boston, MA USA	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Zerbini, LF (corresponding author), Int Ctr Genet Engn & Biotechnol, Canc Genom Grp, Cape Town, South Africa.	luiz.zerbini@uct.ac.za	Correa, Ricardo G/G-7613-2012; Zerbini, Luiz/B-7720-2015; Paccez, Juliano/K-8560-2012	Correa, Ricardo G/0000-0001-6940-7034; Zerbini, Luiz/0000-0003-0736-9508; Paccez, Juliano/0000-0002-1086-4588; Ferreira de Vasconcellos, Jaira/0000-0001-5011-4493; Libermann, Towia/0000-0002-4006-8179; Bhasin, Manoj/0000-0001-5172-420X	ICGEB post-doctoral fellowship; CAPES international fellowship; Department of Defense [PC051217]; NIH [1RO1 CA85467]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA085467] Funding Source: NIH RePORTER	ICGEB post-doctoral fellowship; CAPES international fellowship; Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JDP is recipient of the ICGEB post-doctoral fellowship. JFV is recipient of CAPES international fellowship. This study was supported by the Department of Defense grant PC051217 (LFZ), NIH grants 1RO1 CA85467 (TAL) and the Prostate Cancer Foundation (TAL).	Begley LA, 2008, NEOPLASIA, V10, P244, DOI 10.1593/neo.07976; BELLOSTA P, 1995, MOL CELL BIOL, V15, P614; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Gallicchio M, 2005, BLOOD, V105, P1970, DOI 10.1182/blood-2004-04-1469; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Goruppi S, 1997, MOL CELL BIOL, V17, P4442, DOI 10.1128/MCB.17.8.4442; Goruppi S, 2001, MOL CELL BIOL, V21, P902, DOI 10.1128/MCB.21.3.902-915.2001; Grall F, 2003, ARTHRITIS RHEUM, V48, P1249, DOI 10.1002/art.10942; Haas GP, 2008, CAN J UROL, V15, P3866; Harwood FG, 2000, J BIOL CHEM, V275, P10023, DOI 10.1074/jbc.275.14.10023; Hasanbasic I, 2004, AM J PHYSIOL-HEART C, V287, pH1207, DOI 10.1152/ajpheart.00020.2004; Healy AM, 2001, AM J PHYSIOL-LUNG C, V280, pL1273, DOI 10.1152/ajplung.2001.280.6.L1273; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jacob ANK, 1999, CANCER DETECT PREV, V23, P325; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Koch AE, 2005, ARTHRITIS RHEUM, V52, P710, DOI 10.1002/art.20932; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Lay JD, 2007, CANCER RES, V67, P3878, DOI 10.1158/0008-5472.CAN-06-3191; Lee WP, 2002, ONCOGENE, V21, P329, DOI 10.1038/sj.onc.1205066; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Okamoto M, 1997, CANCER RES, V57, P141; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Sawabu T, 2007, MOL CARCINOGEN, V46, P155, DOI 10.1002/mc.20211; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Tsai KC, 2009, BIOORG MED CHEM LETT, V19, P5665, DOI 10.1016/j.bmcl.2009.08.021; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Walz A, 1997, J LEUKOCYTE BIOL, V62, P604, DOI 10.1002/jlb.62.5.604; Wimmel A, 2001, EUR J CANCER, V37, P2264, DOI 10.1016/S0959-8049(01)00271-4; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101; Zerbini LF, 2003, CANCER RES, V63, P2206; Zerbini LF, 2006, CANCER RES, V66, P11922, DOI 10.1158/0008-5472.CAN-06-2068; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zheng WH, 2002, MOL PHARMACOL, V62, P225, DOI 10.1124/mol.62.2.225	50	88	94	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 7	2013	32	6					689	698		10.1038/onc.2012.89	http://dx.doi.org/10.1038/onc.2012.89			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	101AF	22410775	Green Accepted			2022-12-25	WOS:000315746700003
J	Chung, S; Yao, J; Suyama, K; Bajaj, S; Qian, X; Loudig, OD; Eugenin, EA; Phillips, GR; Hazan, RB				Chung, S.; Yao, J.; Suyama, K.; Bajaj, S.; Qian, X.; Loudig, O. D.; Eugenin, E. A.; Phillips, G. R.; Hazan, R. B.			N-cadherin regulates mammary tumor cell migration through Akt3 suppression	ONCOGENE			English	Article						adhesion; motility; Akt isoforms; Akt3; breast cancer	BREAST-CANCER; FGF-RECEPTOR; SIGNALING PATHWAY; METASTASIS; ACTIVATION; EXPRESSION; PROGRESSION; PROLIFERATION; ISOFORMS; PROTEIN	N-cadherin is a cell-cell adhesion molecule that plays a role in breast cancer metastasis. Here, we show that in vivo expression of N-cadherin in the PyMT mouse model, which enhances mammary tumor metastasis, results in selective inhibition of Akt3 expression and phosphorylation. Similarly, exogenous expression of N-cadherin in PyMT or MCF-7 mammary tumor cells enhanced cell motility and caused a dramatic reduction in Akt3 expression and phosphorylation. Moreover, knockdown of Akt3 in PyMT tumor cells increased cell motility and disrupted mammary morphogenesis, but had no effect on cell proliferation. Conversely, overexpression of wild-type Akt3 in PyMT-N-cadherin cells inhibited cell motility promoted by N-cadherin. Taken altogether, these findings demonstrate that N-cadherin suppresses Akt3 to promote cell motility and highlight the intricate regulation of Akt isoforms by N-cadherin during metastasis. Oncogene (2013) 32, 422-430; doi:10.1038/onc.2012.65; published online 12 March 2012	[Chung, S.; Yao, J.; Suyama, K.; Bajaj, S.; Qian, X.; Loudig, O. D.; Eugenin, E. A.; Hazan, R. B.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Phillips, G. R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai	Hazan, RB (corresponding author), Albert Einstein Coll Med, Dept Pathol, F529S,1300 Morris Pk Ave, Bronx, NY 10461 USA.	Rachel.hazan@einstein.yu.edu	qian, xia/L-1616-2013; Qian, Xia/D-8255-2014		National Cancer Institute [1R01 CA135061-01A1]; NIH; Breast Cancer Research Foundation; Training Program in Cellular and Molecular Biology and Genetics [T32 GM007491]; NATIONAL CANCER INSTITUTE [R01CA090872, R01CA135061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096625, K01MH076679] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Training Program in Cellular and Molecular Biology and Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grants from National Cancer Institute (Grant 1R01 CA135061-01A1) the NIH and Breast Cancer Research Foundation (to RB Hazan). Su Chung was partly supported by the Training Program in Cellular and Molecular Biology and Genetics (T32 GM007491).	Agiostratidou G, 2007, J MAMMARY GLAND BIOL, V12, P127, DOI 10.1007/s10911-007-9044-6; Agiostratidou G, 2009, CANCER RES, V69, P5030, DOI 10.1158/0008-5472.CAN-08-4007; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cavallaro Ugo, 2004, Curr Opin Investig Drugs, V5, P1274; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hazan RB, 1996, CELL ADHES COMMUN, V4, P399, DOI 10.3109/15419069709004457; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Nagi C, 2005, BREAST CANCER RES TR, V94, P225, DOI 10.1007/s10549-005-7727-5; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Nogueira C, 2010, ONCOGENE, V29, P6222, DOI 10.1038/onc.2010.349; Roccaro AM, 2009, BLOOD, V113, P6669, DOI 10.1182/blood-2009-01-198408; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135	27	37	38	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 24	2013	32	4					422	430		10.1038/onc.2012.65	http://dx.doi.org/10.1038/onc.2012.65			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	098LR	22410780	Green Accepted			2022-12-25	WOS:000315551300003
J	Smits, M; Wurdinger, T; van het Hof, B; Drexhage, JAR; Geerts, D; Wesseling, P; Noske, DP; Vandertop, WP; de Vries, HE; Reijerkerk, A				Smits, Michiel; Wurdinger, Thomas; van het Hof, Bert; Drexhage, Joost A. R.; Geerts, Dirk; Wesseling, Pieter; Noske, David P.; Vandertop, W. Peter; de Vries, Helga E.; Reijerkerk, Arie			Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma	FASEB JOURNAL			English	Article						brain cancer; brain endothelial cell	ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER CELLS; SAF-1 TRANSCRIPTION FACTOR; GENE-EXPRESSION; FUNCTIONAL COOPERATION; SIGNALING PATHWAY; SYNOVIOCYTE CELLS; BRAIN-TUMORS; FACTOR-I; INDUCTION	In patients with glioblastomas, vascular endothelial growth factor (VEGF) is a key mediator of tumor-associated angiogenesis. Glioblastomas are notorious for their capacity to induce neovascularization, driving continued tumor growth. Here we report that miR-125b is down-regulated in glioblastoma-associated endothelial cells, resulting in increased expression of its target, myc-associated zinc finger protein (MAZ), a transcription factor that regulates VEGF. The down-regulation of miR-125b was also observed on exposure of endothelial cells to glioblastoma-conditioned medium or VEGF, resulting in increased MAZ expression. Further analysis revealed that inhibition of MAZ accumulation by miR-125b, or by MAZ-specific shRNAs, attenuated primary human brain endothelial cell migration and tubule formation in vitro, phenomena considered to mimick angiogenic processes in vitro. Moreover, MAZ expression was elevated in brain blood vessels of glioblastoma patients. Altogether these results demonstrate a functional feed-forward loop in glioblastoma-related angiogenesis, in which VEGF inhibits the expression of miR-125b, resulting in increased expression of MAZ, which in its turn causes transcriptional activation of VEGF. This loop is functionally impeded by the VEGF receptor inhibitor vandetanib, and our results may contribute to the further development of inhibitors of tumor-angiogenesis.-Smits, M., Wurdinger, T., van het Hof, B., Drexhage, J. A. R., Geerts, D., Wesseling, P., Noske, D. P., Vandertop, W. P., de Vries, H. E., Reijerkerk, A. Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. FASEB J. 26, 2639-2647 (2012). www.fasebj.org	[van het Hof, Bert; Drexhage, Joost A. R.; de Vries, Helga E.; Reijerkerk, Arie] Vrije Univ Med Ctr, Blood Brain Barrier Res Grp, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands; [Smits, Michiel; Wurdinger, Thomas; Noske, David P.; Vandertop, W. Peter] Vrije Univ Med Ctr, Neurooncol Res Grp, Dept Neurosurg, Canc Ctr Amsterdam, NL-1007 MB Amsterdam, Netherlands; [Wesseling, Pieter] Vrije Univ Med Ctr, Neurooncol Res Grp, Dept Pathol, NL-1007 MB Amsterdam, Netherlands; [Wurdinger, Thomas] Harvard Univ, Sch Med, Dept Neurol, Mol Neurogenet Unit,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wurdinger, Thomas] Harvard Univ, Sch Med, Dept Radiol, Mol Neurogenet Unit,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wurdinger, Thomas] Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; [Geerts, Dirk] Erasmus Univ, Dept Pediat Oncol & Hematol, Sophia Childrens Hosp, Med Ctr, Rotterdam, Netherlands; [Wesseling, Pieter] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vandertop, W. Peter] Univ Amsterdam, Acad Med Ctr, Neurosurg Ctr Amsterdam, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Reijerkerk, A (corresponding author), Vrije Univ Med Ctr, Blood Brain Barrier Res Grp, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands.	t.wurdinger@vumc.nl; a.reijerkerk@vumc.nl	Wesseling, P./H-8114-2014; Vandertop, William P./K-9288-2018; Wurdinger, Thomas/AAA-5645-2022; Geerts, Dirk/K-8260-2015	Wesseling, P./0000-0001-5453-5201; Geerts, Dirk/0000-0002-6386-8187; Vandertop, William/0000-0001-5417-0265; de Vries, Helga/0000-0001-7904-7124; Noske, David/0000-0001-5992-4468	Stichting Translational Research Cancer Center Amsterdam/Vrije Universiteit Medical Center; Nederlandse Organisatie voor Wetenschappelijk Onderzoek-VIDI; Netherlands Genomics Initiative	Stichting Translational Research Cancer Center Amsterdam/Vrije Universiteit Medical Center; Nederlandse Organisatie voor Wetenschappelijk Onderzoek-VIDI(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative	This work was supported by Stichting Translational Research Cancer Center Amsterdam/Vrije Universiteit Medical Center and Nederlandse Organisatie voor Wetenschappelijk Onderzoek-VIDI (T. W.) and Netherlands Genomics Initiative (A. R. and J. A. R. D.). M. S., T. W., and A. R. performed the expression analysis, target analysis, endothelial migration, and Matrigel experiments, wrote the manuscript, and designed the experiments; D. G. provided the shRNA constructs; P. W., D. P. N., W. P. V., and H. E. V. assisted in concept design and writing.	Alpini G, 2011, J HEPATOL, V55, P1339, DOI 10.1016/j.jhep.2011.04.015; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; DANGELO G, 1995, P NATL ACAD SCI USA, V92, P6374, DOI 10.1073/pnas.92.14.6374; Dudas J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-92; Fischer I, 2005, BRAIN PATHOL, V15, P297; Giannopoulos K, 2006, INT J ONCOL, V29, P95; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hennequin LF, 2002, J MED CHEM, V45, P1300, DOI 10.1021/jm011022e; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; KENNEDY GC, 1992, P NATL ACAD SCI USA, V89, P11498, DOI 10.1073/pnas.89.23.11498; Knowles Jonathan, 2005, Current Vascular Pharmacology, V3, P309, DOI 10.2174/157016105774329462; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee OH, 2008, ONCOGENE, V27, P1310, DOI 10.1038/sj.onc.1210731; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Miebach S, 2006, J NEURO-ONCOL, V76, P39, DOI 10.1007/s11060-005-3674-6; Parks CL, 1996, J BIOL CHEM, V271, P4417; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Ray A, 1999, J BIOL CHEM, V274, P4300, DOI 10.1074/jbc.274.7.4300; Ray A, 2005, J IMMUNOL, V175, P4039, DOI 10.4049/jimmunol.175.6.4039; Ray A, 2003, ARTHRITIS RHEUM, V48, P134, DOI 10.1002/art.10706; Ray A, 2003, J BIOL CHEM, V278, P22586, DOI 10.1074/jbc.M300705200; Ray A, 2002, MOL CELL BIOL, V22, P1027, DOI 10.1128/MCB.22.4.1027-1035.2002; Ray A, 2000, J BIOL CHEM, V275, P39727, DOI 10.1074/jbc.M007907200; Ray A, 2011, MOL CANCER RES, V9, P1030, DOI 10.1158/1541-7786.MCR-10-0598; Ray BK, 2007, J IMMUNOL, V178, P1774, DOI 10.4049/jimmunol.178.3.1774; Ray BK, 2004, CIRC RES, V95, P1082, DOI 10.1161/01.RES.0000150046.48115.80; Reardon DA, 2011, J NATL COMPR CANC NE, V9, P414, DOI 10.6004/jnccn.2011.0038; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; Schaefer LK, 2002, ONCOGENE, V21, P2058, DOI 10.1038/sj.onc.1205263; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Smits M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016282; Sohl M, 2009, GENE, V437, P54, DOI 10.1016/j.gene.2009.02.017; Song J, 1998, J BIOL CHEM, V273, P20603, DOI 10.1074/jbc.273.32.20603; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang X, 2008, BREAST CANCER RES TR, V111, P103, DOI 10.1007/s10549-007-9765-7; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Wurdinger T, 2009, CELL ADHES MIGR, V3, P230, DOI 10.4161/cam.3.2.7910; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yin JH, 2000, BIOCHEM BIOPH RES CO, V279, P30, DOI 10.1006/bbrc.2000.3896; Zaytseva YY, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-90; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337; Zundel W, 2000, GENE DEV, V14, P391	50	76	76	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2639	2647		10.1096/fj.11-202820	http://dx.doi.org/10.1096/fj.11-202820			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22415301				2022-12-25	WOS:000305017200039
J	Omae, Y; Sekimizu, K; Kaito, C				Omae, Yosuke; Sekimizu, Kazuhisa; Kaito, Chikara			Inhibition of Colony-spreading Activity of Staphylococcus aureus by Secretion of delta-Hemolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL DNA-REPLICATION; GENE REGULATOR AGR; MYCOBACTERIUM-SMEGMATIS; VIRULENCE DETERMINANTS; BACILLUS-SUBTILIS; SLIDING MOTILITY; VIBRIO-CHOLERAE; POTASSIUM-ION; IDENTIFICATION; BACTERIA	Staphylococcus aureus spreads on the surface of soft agar, a phenomenon we termed "colony spreading." Here, we found that S. aureus culture supernatant inhibited colony spreading. We purified delta-hemolysin (Hld, delta-toxin), a major protein secreted from S. aureus, as a compound that inhibits colony spreading. The culture supernatants of hld-disrupted mutants had 30-fold lower colony-spreading inhibitory activity than those of the parent strain. Furthermore, hld-disrupted mutants had higher colony-spreading ability than the parent strain. These results suggest that S. aureus negatively regulates colony spreading by secreting delta-hemolysin.	[Omae, Yosuke; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/G-1248-2017; Kaito, Chikara/W-1815-2019	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	Naito Foundation; National Institute of Biomedical Innovation; Genome Pharmaceuticals Institute	Naito Foundation(Naito Memorial Foundation); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Genome Pharmaceuticals Institute	This work was supported by grants-in-aid for scientific research and in part by the Naito Foundation, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and the Genome Pharmaceuticals Institute.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BIRKBECK TH, 1988, METHOD ENZYMOL, V165, P16; Brown II, 2001, J BACTERIOL, V183, P3784, DOI 10.1128/JB.183.12.3784-3790.2001; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; FITTON JE, 1980, FEBS LETT, V115, P209, DOI 10.1016/0014-5793(80)81170-7; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; JAIN DK, 1991, J MICROBIOL METH, V13, P271, DOI 10.1016/0167-7012(91)90064-W; JANZON L, 1990, EMBO J, V9, P1391, DOI 10.1002/j.1460-2075.1990.tb08254.x; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003921; Kinsinger RF, 2005, J BACTERIOL, V187, P8462, DOI 10.1128/JB.187.24.8462-8469.2005; Kinsinger RF, 2003, J BACTERIOL, V185, P5627, DOI 10.1128/JB.185.18.5627-5631.2003; KREGER AS, 1971, INFECT IMMUN, V3, P449, DOI 10.1128/IAI.3.3.449-465.1971; Krukonis ES, 2003, CURR OPIN MICROBIOL, V6, P186, DOI 10.1016/S1369-5274(03)00032-8; LEE KH, 1987, BIOCHIM BIOPHYS ACTA, V911, P144, DOI 10.1016/0167-4838(87)90003-3; Li SL, 1997, BIOTECHNIQUES, V23, P588, DOI 10.2144/97234bm05; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8; Sambrook J, 2001, MOL CLONING LAB MANU; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; SMITH JM, 1956, J EXP MED, V103, P87, DOI 10.1084/jem.103.1.87; TAPPIN MJ, 1988, BIOCHEMISTRY-US, V27, P1643, DOI 10.1021/bi00405a038; Tsompanidou E, 2011, J BACTERIOL, V193, P1267, DOI 10.1128/JB.01276-10; Ueda T, 2011, MICROB PATHOGENESIS, V51, P178, DOI 10.1016/j.micpath.2011.04.003; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656	42	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15570	15579		10.1074/jbc.M112.357848	http://dx.doi.org/10.1074/jbc.M112.357848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411996	Green Published, hybrid			2022-12-25	WOS:000304006300037
J	Boden, L; Handel, I; Hawkins, N; Houston, F; Fryer, H; Kao, R				Boden, Lisa; Handel, Ian; Hawkins, Neil; Houston, Fiona; Fryer, Helen; Kao, Rowland			An Economic Evaluation of Preclinical Testing Strategies Compared to the Compulsory Scrapie Flock Scheme in the Control of Classical Scrapie	PLOS ONE			English	Article							BENEFIT-COST-ANALYSIS; GREAT-BRITAIN; ERADICATION PROGRAM; MOUTH-DISEASE; SHEEP FLOCK; BSE; DYNAMICS; UK; TRANSMISSION; VACCINATION	Cost-benefit is rarely combined with nonlinear dynamic models when evaluating control options for infectious diseases. The current strategy for scrapie in Great Britain requires that all genetically susceptible livestock in affected flocks be culled (Compulsory Scrapie Flock Scheme or CSFS). However, this results in the removal of many healthy sheep, and a recently developed pre-clinical test for scrapie now offers a strategy based on disease detection. We explore the flock level cost-effectiveness of scrapie control using a deterministic transmission model and industry estimates of costs associated with genotype testing, pre-clinical tests and the value of a sheep culled. Benefit was measured in terms of the reduction in the number of infected sheep sold on, compared to a baseline strategy of doing nothing, using Incremental Cost Effectiveness analysis to compare across strategies. As market data was not available for pre-clinical testing, a threshold analysis was used to set a unit-cost giving equal costs for CSFS and multiple pre-clinical testing (MT, one test each year for three consecutive years). Assuming a 40% within-flock proportion of susceptible genotypes and a test sensitivity of 90%, a single test (ST) was cheaper but less effective than either the CSFS or MT strategies (30 infected-sales-averted over the lifetime of the average epidemic). The MT strategy was slightly less effective than the CSFS and would be a dominated strategy unless preclinical testing was cheaper than the threshold price of (sic)6.28, but may be appropriate for flocks with particularly valuable livestock. Though the ST is not currently recommended, the proportion of susceptible genotypes in the national flock is likely to continue to decrease; this may eventually make it a cost-effective alternative to the MT or CSFS.	[Boden, Lisa; Houston, Fiona; Kao, Rowland] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Handel, Ian] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland; [Handel, Ian] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Hawkins, Neil] Oxford Outcomes, Oxford, England; [Fryer, Helen] Univ Oxford, Oxford Martin Sch, Inst Emerging Infect, Dept Zool, Oxford OX1 2JD, England	University of Glasgow; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Oxford	Boden, L (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.	rowland.kao@glasgow.ac.uk		Boden, Lisa/0000-0002-9317-4741; Hawkins, Neil/0000-0003-3199-221X; Kao, Rowland/0000-0003-0919-6401	Defra (Department of Farming and Rural Affairs) [SE0250]; BBSRC (Biotechnology and Biological Sciences Research Council) [338BDD RA0762]; Wellcome Trust; BBSRC [BBS/E/D/20251968] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251968] Funding Source: researchfish	Defra (Department of Farming and Rural Affairs); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LB is funded by Defra project (Department of Farming and Rural Affairs) SE0250. IH is funded by BBSRC (Biotechnology and Biological Sciences Research Council) institutional strategic programme grant 338BDD RA0762. RRK is funded by a Wellcome Trust Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EC2001999; Arnold M, 2002, PREV VET MED, V56, P227, DOI 10.1016/S0167-5877(02)00159-9; Bates TW, 2003, AM J VET RES, V64, P805, DOI 10.2460/ajvr.2003.64.805; Baylis M, 2002, TRENDS MICROBIOL, V10, P563, DOI 10.1016/S0966-842X(02)02477-0; Berentsen PBM, 1992, PREV VET MED, V12, P227; Boden LA, 2010, J GEN VIROL, V91, P2642, DOI 10.1099/vir.0.022566-0; Brisson M, 2003, ARCH DIS CHILD, V88, P862, DOI 10.1136/adc.88.10.862; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CANTOR SB, 1994, MED DECIS MAKING, V14, P259, DOI 10.1177/0272989X9401400308; Caughey B, 1997, TRENDS CELL BIOL, V7, P56, DOI 10.1016/S0962-8924(96)10054-4; *DEFR, 2007, 9 DEFR; Disney WT, 2001, REV SCI TECH OIE, V20, P385, DOI 10.20506/rst.20.2.1277; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Durand B, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-16; EC, 2003, OFF J EUR UNION L, VL283, P29; European Commission, 2003, OFF J EUR UNION L, V41, P41; Fediaevsky A, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-14; Fediaevsky A, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-9; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Fryer HR, 2007, P R SOC B, V274, P1497, DOI 10.1098/rspb.2007.0353; Gonzalez L, 2008, VET REC, V162, P397, DOI 10.1136/vr.162.13.397; Gravenor MB, 2001, P ROY SOC B-BIOL SCI, V268, P587, DOI 10.1098/rspb.2000.1462; Green DM, 2007, J GEN VIROL, V88, P3486, DOI 10.1099/vir.0.83225-0; Gubbins S, 2005, PREV VET MED, V69, P175, DOI 10.1016/j.prevetmed.2004.12.009; Hagenaars TJ, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-25; Hagenaars TJ, 2000, MATH BIOSCI, V168, P117, DOI 10.1016/S0025-5564(00)00048-1; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; James A, 2005, PREV VET MED, V67, P91, DOI 10.1016/j.prevetmed.2004.11.003; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Kao RR, 2001, MATH BIOSCI, V174, P61, DOI 10.1016/S0025-5564(01)00082-7; McIntyre KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003994; Miller GY, 1996, J AM VET MED ASSOC, V208, P208; Sivam SK, 2006, VET REC, V158, P501, DOI 10.1136/vr.158.15.501; Stringer SM, 1998, MATH BIOSCI, V153, P79, DOI 10.1016/S0025-5564(98)10036-6; Truscott JE, 2009, EPIDEMIOL INFECT, V137, P775, DOI 10.1017/S0950268808001064	36	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32884	10.1371/journal.pone.0032884	http://dx.doi.org/10.1371/journal.pone.0032884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412943	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000303060800059
J	Diaz-Balzac, CA; Lazaro-Pena, MI; Garcia-Rivera, EM; Gonzalez, CI; Garcia-Arraras, JE				Diaz-Balzac, Carlos A.; Lazaro-Pena, Maria I.; Garcia-Rivera, Enrique M.; Gonzalez, Carlos I.; Garcia-Arraras, Jose E.			Calbindin-D32k Is Localized to a Subpopulation of Neurons in the Nervous System of the Sea Cucumber Holothuria glaberrima (Echinodermata)	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; URCHIN STRONGYLOCENTROTUS-PURPURATUS; IMMUNOHISTOCHEMICAL LOCALIZATION; CA2+-BINDING PROTEIN; BRAIN-STEM; TUBE FEET; PARVALBUMIN; CALRETININ; EXPRESSION; CELLS	Members of the calbindin subfamily serve as markers of subpopulations of neurons within the vertebrate nervous system. Although markers of these proteins are widely available and used, their application to invertebrate nervous systems has been very limited. In this study we investigated the presence and distribution of members of the calbindin subfamily in the sea cucumber Holothuria glaberrima (Selenka, 1867). Immunohistological experiments with antibodies made against rat calbindin 1, parvalbumin, and calbindin 2, showed that these antibodies labeled cells and fibers within the nervous system of H. glaberrima. Most of the cells and fibers were co-labeled with the neural-specific marker RN1, showing their neural specificity. These were distributed throughout all of the nervous structures, including the connective tissue plexi of the body wall and podia. Bioinformatics analyses of the possible antigen recognized by these markers showed that a calbindin 2-like protein present in the sea urchin Strongylocentrotus purpuratus, corresponded to the calbindin-D32k previously identified in other invertebrates. Western blots with anti-calbindin 1 and anti-parvalbumin showed that these markers recognized an antigen of approximately 32 kDa in homogenates of radial nerve cords of H. glaberrima and Lytechinus variegatus. Furthermore, immunoreactivity with anti-calbindin 1 and anti-parvalbumin was obtained to a fragment of calbindin-D32k of H. glaberrima. Our findings suggest that calbindin-D32k is present in invertebrates and its sequence is more similar to the vertebrate calbindin 2 than to calbindin 1. Thus, characterization of calbindin-D32k in echinoderms provides an important view of the evolution of this protein family and represents a valuable marker to study the nervous system of invertebrates.	[Diaz-Balzac, Carlos A.; Lazaro-Pena, Maria I.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Diaz-Balzac, Carlos A.; Lazaro-Pena, Maria I.; Garcia-Rivera, Enrique M.; Gonzalez, Carlos I.; Garcia-Arraras, Jose E.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA	Yeshiva University; Albert Einstein College of Medicine; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Diaz-Balzac, CA (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	jegarcia@hpcf.upr.edu	Gonzalez, Carlos/V-7628-2019	Lazaro-Pena, Maria I./0000-0002-3061-8835; Garcia-Rivera, Enrique/0000-0003-1203-2918; Diaz-Balzac, Carlos A./0000-0002-4723-1282	National Science Foundation [IOS-0842870]; National Institutes of Health (NIH) [1SC1GM084770-01, 1R03NS065275-01]; University of Puerto Rico Rio Piedras Campus (UPR-RP) [5T34GM007821, 2R25GM061151]; NIH Research Centers in Minority Institutions (NIH-RCMI) [RRO-3641-01]; University of Puerto Rico; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM084770, T34GM007821, R25GM061151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS065275] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico Rio Piedras Campus (UPR-RP); NIH Research Centers in Minority Institutions (NIH-RCMI); University of Puerto Rico; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Science Foundation (IOS-0842870) and the National Institutes of Health (NIH, 1SC1GM084770-01 and 1R03NS065275-01). CADB and EMGR were funded by the University of Puerto Rico Rio Piedras Campus (UPR-RP) Minority Access to Research Career (MARC) Program (5T34GM007821) and MILP by the UPR-RP Research Initiative for Scientific Enhancement (RISE) Program (2R25GM061151). We also acknowledge partial support from NIH Research Centers in Minority Institutions (NIH-RCMI, RRO-3641-01) and the University of Puerto Rico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2011, J COMP NEUROL, V519, P3566, DOI 10.1002/cne.22724; ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; BENNETTCLARKE CA, 1992, J COMP NEUROL, V320, P323, DOI 10.1002/cne.903200305; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CELIO MR, 1981, NATURE, V293, P300, DOI 10.1038/293300a0; CHRISTAKOS S, 1987, J NEUROCHEM, V49, P1427, DOI 10.1111/j.1471-4159.1987.tb01010.x; DALILTHINEY N, 1994, J COMP NEUROL, V340, P140, DOI 10.1002/cne.903400110; DECLERCQ JP, 1991, J MOL BIOL, V220, P1017, DOI 10.1016/0022-2836(91)90369-H; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; Diaz-Balzac CA, 2007, BIOL BULL-US, V213, P28, DOI 10.2307/25066616; Diaz-Balzac CA, 2010, ZOOMORPHOLOGY, V129, P99, DOI 10.1007/s00435-010-0103-y; Diaz-Balzac CA, 2010, ZOOMORPHOLOGY, V129, P33, DOI 10.1007/s00435-009-0098-4; DIAZMIRANDA L, 1995, J COMP NEUROL, V352, P626, DOI 10.1002/cne.903520410; DiazMiranda L, 1996, CELL TISSUE RES, V286, P385, DOI 10.1007/s004410050708; Drummond AJ, 2011, GENEIOUS 5; Friedberg F, 2005, MOL BIOL REP, V32, P167, DOI 10.1007/s11033-005-2334-4; Garcia-Arraras J.E., 1993, HDB ENDOCRINE RES TR, P207; Gartner W, 2001, CEREB CORTEX, V11, P1161, DOI 10.1093/cercor/11.12.1161; Hsiao Chung-Der, 2002, Gene Expression Patterns, V2, P163, DOI 10.1016/S0925-4773(02)00340-4; Huesa G, 2002, CELL TISSUE RES, V309, P355, DOI 10.1007/s00441-002-0608-x; HUTTICHER A, 1995, CELL MOL NEUROBIOL, V15, P401, DOI 10.1007/BF02071876; Hyman LH, 1955, INVERTEBRATES ECHINO; Lee SJ, 2007, J EXP ZOOL PART A, V307A, P51, DOI 10.1002/jez.a.345; Magnusson A, 1996, NEUROSCIENCE, V73, P497, DOI 10.1016/0306-4522(96)00044-9; Morona R, 2009, J COMP NEUROL, V515, P503, DOI 10.1002/cne.22060; REIFEGERSTE R, 1993, J NEUROSCI, V13, P2186; REN K, 1994, BRAIN RES REV, V19, P163, DOI 10.1016/0165-0173(94)90010-8; Revett SP, 1997, PROTEIN SCI, V6, P2397; ROGERS JH, 1987, J CELL BIOL, V105, P1343, DOI 10.1083/jcb.105.3.1343; Rojas-Cartagena C, 2007, PHYSIOL GENOMICS, V31, P203, DOI 10.1152/physiolgenomics.00228.2006; Roux MM, 2006, DEV BIOL, V300, P416, DOI 10.1016/j.ydbio.2006.09.006; Schwaller B., 2007, HDB NEUROCHEMISTRY M, P197, DOI 10.1007/978-0-387-30379-6_5.; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; SMILEY S, 1994, MICROSCOPIC ANATOMY, V14, P401; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Subramaniam S, 1998, PROTEINS, V32, P1; TROTTER JA, 1995, J EXP BIOL, V198, P1951; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Vega IE, 2008, J NEUROCHEM, V106, P96, DOI 10.1111/j.1471-4159.2008.05339.x; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; WILKIE IC, 1979, CELL TISSUE RES, V197, P515; WILKIE IC, 1978, MAR BEHAV PHYSIOL, V5, P289, DOI 10.1080/10236247809378544	43	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32689	10.1371/journal.pone.0032689	http://dx.doi.org/10.1371/journal.pone.0032689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412907	Green Published, Green Submitted, gold			2022-12-25	WOS:000303060800042
J	Kurt, S; Fisher, SE; Ehret, G				Kurt, Simone; Fisher, Simon E.; Ehret, Guenter			Foxp2 Mutations Impair Auditory-Motor Association Learning	PLOS ONE			English	Article							BASAL GANGLIA; SEVERE SPEECH; LANGUAGE; GENE; MICE; EXPRESSION; VOCALIZATIONS; IDENTIFICATION; TARGETS; CALLS	Heterozygous mutations of the human FOXP2 transcription factor gene cause the best-described examples of monogenic speech and language disorders. Acquisition of proficient spoken language involves auditory-guided vocal learning, a specialized form of sensory-motor association learning. The impact of etiological Foxp2 mutations on learning of auditory-motor associations in mammals has not been determined yet. Here, we directly assess this type of learning using a newly developed conditioned avoidance paradigm in a shuttle-box for mice. We show striking deficits in mice heterozygous for either of two different Foxp2 mutations previously implicated in human speech disorders. Both mutations cause delays in acquiring new motor skills. The magnitude of impairments in association learning, however, depends on the nature of the mutation. Mice with a missense mutation in the DNA-binding domain are able to learn, but at a much slower rate than wild type animals, while mice carrying an early nonsense mutation learn very little. These results are consistent with expression of Foxp2 in distributed circuits of the cortex, striatum and cerebellum that are known to play key roles in acquisition of motor skills and sensory-motor association learning, and suggest differing in vivo effects for distinct variants of the Foxp2 protein. Given the importance of such networks for the acquisition of human spoken language, and the fact that similar mutations in human FOXP2 cause problems with speech development, this work opens up a new perspective on the use of mouse models for understanding pathways underlying speech and language disorders.	[Kurt, Simone; Ehret, Guenter] Univ Ulm, Inst Neurobiol, Ulm, Germany; [Fisher, Simon E.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Fisher, Simon E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Fisher, Simon E.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Ulm University; Max Planck Society; Radboud University Nijmegen; University of Oxford; Wellcome Centre for Human Genetics	Kurt, S (corresponding author), Univ Ulm, Inst Neurobiol, Ulm, Germany.	guenter.ehret@uni-ulm.de	Kurt, Simone/I-2927-2012; Fisher, Simon E./E-9130-2012	Fisher, Simon E./0000-0002-3132-1996; Kurt, Simone/0000-0002-1820-2597	Wellcome Trust [080971, 075491]; Royal Society (United Kingdom); Max Planck Society	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society (United Kingdom)(Royal Society of London); Max Planck Society(Max Planck SocietyFoundation CELLEX)	The contribution of Dr. Fisher was supported by the Wellcome Trust (grants 080971 and 075491, the Royal Society (United Kingdom) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 2008, TRENDS NEUROSCI, V31, P265, DOI 10.1016/j.tins.2008.02.011; BELL RW, 1972, BEHAV BIOL, V7, P805, DOI 10.1016/S0091-6773(72)80172-X; Campbell P, 2009, J COMP NEUROL, V512, P84, DOI 10.1002/cne.21881; DUDINE B, 1982, BEHAV NEURAL BIOL, V36, P197, DOI 10.1016/S0163-1047(82)90189-3; EHRET G, 1975, J COMP PHYSIOL, V102, P321, DOI 10.1007/BF01464344; EHRET G, 1979, ACTA OTO-LARYNGOL, V87, P28, DOI 10.3109/00016487909126384; EHRET G, 1980, ADV STUD BEHAV, V11, P179, DOI 10.1016/S0065-3454(08)60118-7; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hahn ME, 2002, BEHAV GENET, V32, P267, DOI 10.1023/A:1019728813891; Jurgens U, 2009, J VOICE, V23, P1, DOI 10.1016/j.jvoice.2007.07.005; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Kurt S, 2010, P NATL ACAD SCI USA, V107, P8481, DOI 10.1073/pnas.0912357107; Kurt S, 2009, BRAIN RES, V1289, P30, DOI 10.1016/j.brainres.2009.06.092; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Macmillan N. A., 1991, DETECTION THEORY USE; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mizutani A, 2007, BIOCHEM BIOPH RES CO, V353, P869, DOI 10.1016/j.bbrc.2006.12.130; Reimers-Kipping S, 2011, NEUROSCIENCE, V175, P75, DOI 10.1016/j.neuroscience.2010.11.042; Roubertoux PL, 1996, BEHAV GENET, V26, P427, DOI 10.1007/BF02359487; Schulze K, 2011, PHONOLOGICAL WORKING, P88; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Takahashi K, 2008, J COMP NEUROL, V509, P180, DOI 10.1002/cne.21740; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Thornton LM, 2005, BEHAV GENET, V35, P73, DOI 10.1007/s10519-004-0857-4; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Vernes SC, 2009, BIOCHEM SOC T, V37, P1263, DOI 10.1042/BST0371263; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057	41	51	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33130	10.1371/journal.pone.0033130	http://dx.doi.org/10.1371/journal.pone.0033130			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412993	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800082
J	Li, YW; Kong, DJ; Ahmad, A; Bao, B; Sarkar, FH				Li, Yiwei; Kong, Dejuan; Ahmad, Aamir; Bao, Bin; Sarkar, Fazlul H.			Targeting Bone Remodeling by Isoflavone and 3,3 '-Diindolylmethane in the Context of Prostate Cancer Bone Metastasis	PLOS ONE			English	Article							FACTOR-KAPPA-B; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; CLINICAL-IMPLICATIONS; CELL-PROLIFERATION; INHIBITION; ACTIVATION; GENISTEIN; RECEPTOR	Prostate cancer (PCa) bone metastases have long been believed to be osteoblastic because of bone remodeling leading to the formation of new bone. However, recent studies have shown increased osteolytic activity in the beginning stages of PCa bone metastases, suggesting that targeting both osteolytic and osteoblastic mediators would likely inhibit bone remodeling and PCa bone metastasis. In this study, we found that PCa cells could stimulate differentiation of osteoclasts and osteoblasts through the up-regulation of RANKL, RUNX2 and osteopontin, promoting bone remodeling. Interestingly, we found that formulated isoflavone and 3,3'-diindolylmethane (BR-DIM) were able to inhibit the differentiation of osteoclasts and osteoblasts through the inhibition of cell signal transduction in RANKL, osteoblastic, and PCa cell signaling. Moreover, we found that isoflavone and BR-DIM down-regulated the expression of miR-92a, which is known to be associated with RANKL signaling, EMT and cancer progression. By pathway and network analysis, we also observed the regulatory effects of isoflavone and BR-DIM on multiple signaling pathways such as AR/PSA, NKX3-1/Akt/p27, MITF, etc. Therefore, isoflavone and BR-DIM with their multi-targeted effects could be useful for the prevention of PCa progression, especially by attenuating bone metastasis mechanisms.	[Li, Yiwei; Kong, Dejuan; Ahmad, Aamir; Bao, Bin; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Oncol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Li, YW (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723	National Cancer Institute; National Institutes of Health [5R01CA083695, 5R01CA108535, 5R01CA132794, 5R01CA131151]; Puschelberg and Guido foundations; NATIONAL CANCER INSTITUTE [R01CA108535, R01CA131151, R01CA083695, R01CA132794] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Puschelberg and Guido foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from the National Cancer Institute, National Institutes of Health (5R01CA083695, 5R01CA108535, 5R01CA132794, and 5R01CA131151 awarded to FHS). The authors thank Puschelberg and Guido foundations for their generous financial contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Aamir, 2011, Cancers (Basel), V3, P2955, DOI 10.3390/cancers3032955; Ali S, 2010, J CELL BIOCHEM, V110, P171, DOI 10.1002/jcb.22523; Anderton MJ, 2004, DRUG METAB DISPOS, V32, P632, DOI 10.1124/dmd.32.6.632; Bhuiyan MMR, 2006, CANCER RES, V66, P10064, DOI 10.1158/0008-5472.CAN-06-2011; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Chen ZL, 2011, J BIOL CHEM, V286, P10725, DOI 10.1074/jbc.M110.165654; Clezardin P, 2011, B CANCER, V98, P837, DOI 10.1684/bdc.2011.1398; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Graham TR, 2010, CANCER SCI, V101, P103, DOI 10.1111/j.1349-7006.2009.01356.x; Haug BH, 2011, CARCINOGENESIS, V32, P1005, DOI 10.1093/carcin/bgr073; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ito Y, 2011, BIOCHEM BIOPH RES CO, V407, P225, DOI 10.1016/j.bbrc.2011.03.003; Jin JK, 2011, INT J CANCER, V128, P2545, DOI 10.1002/ijc.26024; Kanakis I, 2004, J PHARMACEUT BIOMED, V34, P827, DOI 10.1016/S0731-7085(03)00567-3; Kanno Y, 2011, J BIOL CHEM, V286, P8952, DOI 10.1074/jbc.M110.152181; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li YW, 2006, CANCER RES, V66, P4816, DOI 10.1158/0008-5472.CAN-05-3752; Li YW, 2005, CANCER RES, V65, P6934, DOI 10.1158/0008-5472.CAN-04-4604; Li YW, 2004, NEOPLASIA, V6, P354, DOI 10.1593/neo.03478; Li YW, 2002, CLIN CANCER RES, V8, P2369; Miclea RL, 2011, EXP CELL RES, V317, P1411, DOI 10.1016/j.yexcr.2011.03.007; Morrissey C, 2010, PROSTATE, V70, P412, DOI 10.1002/pros.21075; Nadiminty N, 2006, CLIN CANCER RES, V12, P1420, DOI 10.1158/1078-0432.CCR-05-1849; Roato I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003627; Sato S, 2008, CANCER SCI, V99, P316, DOI 10.1111/j.1349-7006.2007.00690.x; Shruti K, 2011, BIOCHEM BIOPH RES CO, V407, P445, DOI 10.1016/j.bbrc.2011.03.058; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song H, 2012, EMBO J; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Suva LJ, 2011, NAT REV ENDOCRINOL, V7, P208, DOI 10.1038/nrendo.2010.227; Tanaka H, 2011, BIOCH BIOPHYS RES CO; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Vessella RL, 2006, CLIN CANCER RES, V12, p6285S, DOI 10.1158/1078-0432.CCR-06-0813; Wittrant Y, 2004, BBA-REV CANCER, V1704, P49, DOI 10.1016/j.bbcan.2004.05.002; Wittrant Y, 2003, BIOCHEM BIOPH RES CO, V310, P774, DOI 10.1016/j.bbrc.2003.09.084; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	39	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e33011	10.1371/journal.pone.0033011	http://dx.doi.org/10.1371/journal.pone.0033011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412975	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800076
J	Teklenburg, G; Weimar, CHE; Fauser, BCJM; Macklon, N; Geijsen, N; Heijnen, CJ; Lopes, SMCD; Kuijk, EW				Teklenburg, Gijs; Weimar, Charlotte H. E.; Fauser, Bart C. J. M.; Macklon, Nick; Geijsen, Niels; Heijnen, Cobi J.; Lopes, Susana M. Chuva de Sousa; Kuijk, Ewart W.			Cell Lineage Specific Distribution of H3K27 Trimethylation Accumulation in an In Vitro Model for Human Implantation	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; ENDOMETRIAL STROMAL CELLS; TRANSCRIPTION FACTOR; MOUSE DEVELOPMENT; STEM-CELLS; EMBRYO; EXPRESSION; NANOG; PLURIPOTENCY; ENDODERM	Female mammals inactivate one of their two X-chromosomes to compensate for the difference in gene-dosage with males that have just one X-chromosome. X-chromosome inactivation is initiated by the expression of the non-coding RNA Xist, which coats the X-chromosome in cis and triggers gene silencing. In early mouse development the paternal X-chromosome is initially inactivated in all cells of cleavage stage embryos (imprinted X-inactivation) followed by reactivation of the inactivated paternal X-chromosome exclusively in the epiblast precursors of blastocysts, resulting temporarily in the presence of two active X-chromosomes in this specific lineage. Shortly thereafter, epiblast cells randomly inactivate either the maternal or the paternal X-chromosome. XCI is accompanied by the accumulation of histone 3 lysine 27 trimethylation (H3K27me3) marks on the condensed X-chromosome. It is still poorly understood how XCI is regulated during early human development. Here we have investigated lineage development and the distribution of H3K27me3 foci in human embryos derived from an in-vitro model for human implantation. In this system, embryos are co-cultured on decidualized endometrial stromal cells up to day 8, which allows the culture period to be extended for an additional two days. We demonstrate that after the co-culture period, the inner cell masses have relatively high cell numbers and that the GATA4-positive hypoblast lineage and OCT4-positive epiblast cell lineage in these embryos have segregated. H3K27me3 foci were observed in,25% of the trophectoderm cells and in similar to 7.5% of the hypoblast cells, but not in epiblast cells. In contrast with day 8 embryos derived from the co-cultures, foci of H3K27me3 were not observed in embryos at day 5 of development derived from regular IVF-cultures. These findings indicate that the dynamics of H3K27me3 accumulation on the X-chromosome in human development is regulated in a lineage specific fashion.	[Teklenburg, Gijs; Weimar, Charlotte H. E.; Fauser, Bart C. J. M.; Macklon, Nick; Kuijk, Ewart W.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynaecol, Utrecht, Netherlands; [Weimar, Charlotte H. E.; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis NIDOD, Utrecht, Netherlands; [Macklon, Nick] Univ Southampton, Princess Anne Hosp, Dept Obstet & Gynaecol, Div Dev Origins Adult Dis, Southampton, Hants, England; [Geijsen, Niels; Kuijk, Ewart W.] Hubrecht Inst KNAW, Utrecht, Netherlands; [Geijsen, Niels] Univ Utrecht, Sch Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Lopes, Susana M. Chuva de Sousa] Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Southampton; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Teklenburg, G (corresponding author), Univ Med Ctr Utrecht, Dept Reprod Med & Gynaecol, Utrecht, Netherlands.	E.Kuijk@hubrecht.eu	Kuijk, Ewart/I-2569-2019	Kuijk, Ewart/0000-0002-1385-6516	Netherlands Organization for Scientific Research (NWO) [916.76.015]; AGIKO Stipendium [92003393]; National Institutes of Health (NIH); Hubrecht Imaging Center; IVF-clinic at the UMC Utrecht	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); AGIKO Stipendium(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hubrecht Imaging Center; IVF-clinic at the UMC Utrecht	This work was supported by funding from the Netherlands Organization for Scientific Research (NWO) to SCDSL (VENI 916.76.015 grant), GT (AGIKO Stipendium 92003393), and NG. NG was also supported by the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the support of Anko the Graaff from the Hubrecht Imaging Center and the support of Anneke de Vreede from the IVF-clinic at the UMC Utrecht.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Carver J, 2003, HUM REPROD, V18, P283, DOI 10.1093/humrep/deg072; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; de Jong D, 2002, J ASSIST REPROD GEN, V19, P561, DOI 10.1023/A:1021211115337; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Heijnen EMEW, 2007, LANCET, V369, P743, DOI 10.1016/S0140-6736(07)60360-2; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; O'Leary T, 2011, STEM CELLS DEV, V20, P785, DOI 10.1089/scd.2010.0338; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TANG BQ, 1994, ANN NY ACAD SCI, V734, P19, DOI 10.1111/j.1749-6632.1994.tb21731.x; Teklenburg G, 2009, REPROD SCI, V16, P811, DOI 10.1177/1933719109334966; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yeom YI, 1996, DEVELOPMENT, V122, P881	34	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32701	10.1371/journal.pone.0032701	http://dx.doi.org/10.1371/journal.pone.0032701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412909	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000303060800043
J	Chuang, JY; Lee, CW; Shih, YH; Yang, TT; Yu, L; Kuo, YM				Chuang, Jia-Ying; Lee, Chu-Wan; Shih, Yao-Hsiang; Yang, Tingting; Yu, Lung; Kuo, Yu-Min			Interactions between Amyloid-beta and Hemoglobin: Implications for Amyloid Plaque Formation in Alzheimer's Disease	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SENILE PLAQUES; A-BETA; DIFFERENTIAL EXPRESSION; MICROVASCULAR PATHOLOGY; CEREBROSPINAL-FLUID; PROTEIN-PRECURSOR; APOLIPOPROTEIN-E; MOUSE MODEL; RAT-BRAIN	Accumulation of amyloid-beta (A beta) peptides in the brain is one of the central pathogenic events in Alzheimer's disease (AD). However, why and how A beta aggregates within the brain of AD patients remains elusive. Previously, we demonstrated hemoglobin (Hb) binds to A beta and co-localizes with the plaque and vascular amyloid deposits in post-mortem AD brains. In this study, we further characterize the interactions between Hb and A beta in vitro and in vivo and report the following observations: 1) the binding of Hb to A beta required iron-containing heme; 2) other heme-containing proteins, such as myoglobin and cytochrome C, also bound to A beta; 3) hemin-induced cytotoxicity was reduced in neuroblastoma cells by low levels of A beta; 4) Hb was detected in neurons and glial cells of post-mortem AD brains and was up-regulated in aging and APP/PS1 transgenic mice; 5) microinjection of human Hb into the dorsal hippocampi of the APP/PS1 transgenic mice induced the formation of an envelope-like structure composed of A beta surrounding the Hb droplets. Our results reveal an enhanced endogenous expression of Hb in aging brain cells, probably serving as a compensatory mechanism against hypoxia. In addition, A beta binds to Hb and other hemoproteins via the iron-containing heme moiety, thereby reducing Hb/heme/iron-induced cytotoxicity. As some of the brain Hb could be derived from the peripheral circulation due to a compromised blood-brain barrier frequently observed in aged and AD brains, our work also suggests the genesis of some plaques may be a consequence of sustained amyloid accretion at sites of vascular injury.	[Chuang, Jia-Ying; Lee, Chu-Wan; Shih, Yao-Hsiang; Yu, Lung; Kuo, Yu-Min] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Yang, Tingting] I Shou Univ, Sch Chinese Med Postbaccalaureate, Div Neurosci & Neuropathol, Kaohsiung, Taiwan; [Yu, Lung] Natl Cheng Kung Univ, Inst Behav Med, Tainan 70101, Taiwan; [Kuo, Yu-Min] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 70101, Taiwan	National Cheng Kung University; I Shou University; National Cheng Kung University; National Cheng Kung University	Chuang, JY (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan.	lungyu@mail.ncku.edu.tw; kuoym@mail.ncku.edu.tw	施, 耀翔/AIF-3153-2022; Ting-Ting, YANG/E-6009-2010; Kuo, Yu-Min/A-9050-2013	施, 耀翔/0000-0001-9145-7492; Ting-Ting, YANG/0000-0001-5975-8359; Kuo, Yu-Min/0000-0003-4867-2482	National Science council (NSC) of Taiwan [99-2320-B-006-017-MY3, NSC99-2321-B-006-003, NSC97-2410-H-006-074-MY3]	National Science council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science council (NSC 99-2320-B-006-017-MY3, NSC99-2321-B-006-003, NSC97-2410-H-006-074-MY3) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli F, 1981, Methods Enzymol, V76, P72; Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Atamna H, 2004, P NATL ACAD SCI USA, V101, P11153, DOI 10.1073/pnas.0404349101; Atwood CS, 2003, BRAIN RES REV, V43, P164, DOI 10.1016/S0165-0173(03)00206-6; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Bishop GM, 2004, BRAIN PATHOL, V14, P448; Bishop GM, 2003, J NEUROSCI RES, V73, P316, DOI 10.1002/jnr.10661; Blalock EM, 2003, J NEUROSCI, V23, P3807; Buee L, 1997, ANN NY ACAD SCI, V826, P7, DOI 10.1111/j.1749-6632.1997.tb48457.x; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; ERIKSSON S, 1995, P NATL ACAD SCI USA, V92, P2313, DOI 10.1073/pnas.92.6.2313; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Evin G, 2002, PEPTIDES, V23, P1285, DOI 10.1016/S0196-9781(02)00063-3; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Grammas P, 2002, J ALZHEIMERS DIS, V4, P217, DOI 10.3233/JAD-2002-4311; HALL ED, 1995, EXP NEUROL, V135, P17, DOI 10.1006/exnr.1995.1062; HAMAZAKI H, 1995, BIOCHEM BIOPH RES CO, V211, P349, DOI 10.1006/bbrc.1995.1819; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HARDY JA, 1986, NEUROBIOL AGING, V7, P489, DOI 10.1016/0197-4580(86)90086-2; Hardy J, 2006, J ALZHEIMERS DIS, V9, P151; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; He YD, 2009, J CEREBR BLOOD F MET, V29, P596, DOI 10.1038/jcbfm.2008.145; Holcomb LA, 2000, MECH AGEING DEV, V112, P135, DOI 10.1016/S0047-6374(99)00086-X; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Jendroska K, 1997, Ann N Y Acad Sci, V826, P401, DOI 10.1111/j.1749-6632.1997.tb48492.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; KARELIN AA, 1994, BIOCHEM BIOPH RES CO, V202, P410, DOI 10.1006/bbrc.1994.1943; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khan S, 2008, CAN MED ASSOC J, V178, P1687, DOI 10.1503/cmaj.1080038; Kokjohn TA, 2011, IS ALZHEIMERS DIS AM; Kontush A, 2001, FREE RADICAL BIO MED, V30, P119, DOI 10.1016/S0891-5849(00)00458-5; KOO EH, 1990, NEURON, V4, P97, DOI 10.1016/0896-6273(90)90446-M; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Kuo YM, 1999, BIOCHEM BIOPH RES CO, V257, P787, DOI 10.1006/bbrc.1999.0552; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; MASLIAH E, 1994, ACTA NEUROPATHOL, V87, P135; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Meyer EP, 2008, P NATL ACAD SCI USA, V105, P3587, DOI 10.1073/pnas.0709788105; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; MIYAKAWA T, 1979, ACTA NEUROPATHOL, V48, P153, DOI 10.1007/BF00691158; MIYAKAWA T, 1982, VIRCHOWS ARCH B, V40, P121, DOI 10.1007/BF02932857; ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431; OYAMA F, 1991, J NEUROPATH EXP NEUR, V50, P560, DOI 10.1097/00005072-199109000-00004; Oyama R, 2000, BBA-PROTEIN STRUCT M, V1479, P91, DOI 10.1016/S0167-4838(00)00057-1; Paris D, 2000, NEUROBIOL AGING, V21, P183, DOI 10.1016/S0197-4580(99)00111-6; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Raby CA, 1998, J NEUROCHEM, V71, P2505; Raymackers J, 2000, ELECTROPHORESIS, V21, P2266, DOI 10.1002/1522-2683(20000601)21:11<2266::AID-ELPS2266>3.0.CO;2-Z; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; Schonberger SJ, 2001, PROTEOMICS, V1, P1519, DOI 10.1002/1615-9861(200111)1:12<1519::AID-PROT1519>3.0.CO;2-L; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SLEMMON JR, 1994, J NEUROSCI, V14, P2225; Stone J, 2008, MED HYPOTHESES, V71, P347, DOI 10.1016/j.mehy.2008.04.007; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wu CW, 2007, J NEUROCHEM, V103, P2471, DOI 10.1111/j.1471-4159.2007.04987.x; Wu CW, 2004, NEUROBIOL DIS, V17, P367, DOI 10.1016/j.nbd.2004.08.014; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yeh SR, 1998, NAT STRUCT BIOL, V5, P222, DOI 10.1038/nsb0398-222; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002	78	65	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e33120	10.1371/journal.pone.0033120	http://dx.doi.org/10.1371/journal.pone.0033120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412990	gold, Green Published, Green Submitted			2022-12-25	WOS:000303021100049
J	Cheever, TR; Li, B; Ervasti, JM				Cheever, Thomas R.; Li, Bin; Ervasti, James M.			Restricted Morphological and Behavioral Abnormalities following Ablation of beta-Actin in the Brain	PLOS ONE			English	Article							ZIPCODE-BINDING-PROTEIN; MESSENGER-RNA; CORPUS-CALLOSUM; LOCOMOTOR-ACTIVITY; AXON GUIDANCE; TRANSLATION; ISOFORMS; MOUSE; PHOSPHORYLATION; LOCALIZATION	The local translation of beta-actin is one mechanism proposed to regulate spatially-restricted actin polymerization crucial for nearly all aspects of neuronal development and function. However, the physiological significance of localized bactin translation in neurons has not yet been demonstrated in vivo. To investigate the role of b-actin in the mammalian central nervous system (CNS), we characterized brain structure and function in a CNS-specific beta-actin knock-out mouse (CNS-ActbKO). beta-actin was rapidly ablated in the embryonic mouse brain, but total actin levels were maintained through upregulation of other actin isoforms during development. CNS-ActbKO mice exhibited partial perinatal lethality while survivors presented with surprisingly restricted histological abnormalities localized to the hippocampus and cerebellum. These tissue morphology defects correlated with profound hyperactivity as well as cognitive and maternal behavior impairments. Finally, we also identified localized defects in axonal crossing of the corpus callosum in CNS-ActbKO mice. These restricted defects occurred despite the fact that primary neurons lacking beta-actin in culture were morphologically normal. Altogether, we identified novel roles for beta-actin in promoting complex CNS tissue architecture while also demonstrating that distinct functions for the ubiquitously expressed beta-actin are surprisingly restricted in vivo.	[Cheever, Thomas R.; Li, Bin; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Cheever, TR (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	jervasti@umn.edu	Ervasti, James/AAZ-4786-2020		National Institutes of Health [AR049899, AR007612]; University of Minnesota; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612, R01AR049899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the National Institutes of Health (AR049899). T. R. C. was supported by a University of Minnesota Doctoral Dissertation Fellowship with additional support from the National Institutes of Health Training Program in Muscle Research (AR007612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PG, 1996, BIOCHEMISTRY-US, V35, P14062, DOI 10.1021/bi961326g; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bergeron SE, 2010, J BIOL CHEM, V285, P16087, DOI 10.1074/jbc.M110.110130; Cheever TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017768; CHOO QL, 1978, J NEUROCHEM, V31, P217, DOI 10.1111/j.1471-4159.1978.tb12451.x; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Devineni N, 1999, BRAIN RES, V823, P129, DOI 10.1016/S0006-8993(99)01147-6; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; ECKENHOFF MF, 1984, J COMP NEUROL, V223, P1, DOI 10.1002/cne.902230102; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hanft LM, 2006, P NATL ACAD SCI USA, V103, P5385, DOI 10.1073/pnas.0600980103; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; HILL MA, 1993, J CELL BIOL, V122, P825, DOI 10.1083/jcb.122.4.825; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Livy DJ, 1997, HIPPOCAMPUS, V7, P2, DOI 10.1002/(SICI)1098-1063(1997)7:1<2::AID-HIPO2>3.0.CO;2-R; Martin AC, 2010, DEV BIOL, V341, P114, DOI 10.1016/j.ydbio.2009.10.031; Maruthamuthu V, 2010, CURR OPIN CELL BIOL, V22, P583, DOI 10.1016/j.ceb.2010.07.010; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mignogna P, 2010, PHYSIOL BEHAV, V99, P618, DOI 10.1016/j.physbeh.2010.01.026; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; OTEY CA, 1987, J CELL BIOCHEM, V34, P113, DOI 10.1002/jcb.240340205; Perrin BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001158; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; SMART IHM, 1982, J ANAT, V135, P763; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yisraeli JK, 2005, BIOL CELL, V97, P87	44	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32970	10.1371/journal.pone.0032970	http://dx.doi.org/10.1371/journal.pone.0032970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403730	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700127
J	van Haren, H; Gostiaux, L; Laan, M; van Haren, M; van Haren, E; Gerringa, LJA				van Haren, Hans; Gostiaux, Louis; Laan, Martin; van Haren, Martijn; van Haren, Eva; Gerringa, Loes J. A.			Internal Wave Turbulence Near a Texel Beach	PLOS ONE			English	Article							COASTAL WATERS; TEMPERATURE; SEA; SENSITIVITY; DISSIPATION; SCALES	A summer bather entering a calm sea from the beach may sense alternating warm and cold water. This can be felt when moving forward into the sea ('vertically homogeneous' and 'horizontally different'), but also when standing still between one's feet and body ('vertically different'). On a calm summer-day, an array of high-precision sensors has measured fast temperature-changes up to 1 degrees C near a Texel-island (NL) beach. The measurements show that sensed variations are in fact internal waves, fronts and turbulence, supported in part by vertical stable stratification in density (temperature). Such motions are common in the deep ocean, but generally not in shallow seas where turbulent mixing is expected strong enough to homogenize. The internal beach-waves have amplitudes ten-times larger than those of the small surface wind waves. Quantifying their turbulent mixing gives diffusivity estimates of 10(-4)-10(-3) m(2) s(-1), which are larger than found in open-ocean but smaller than wave breaking above deep sloping topography.	[van Haren, Hans; Laan, Martin; Gerringa, Loes J. A.] Royal Netherlands Inst Sea Res, Den Burg, Netherlands; [Gostiaux, Louis] UJF Grenoble 1, CNRS, Grenoble INP, Lab Ecoulements & Geophys & Ind, Grenoble, France; [van Haren, Martijn; van Haren, Eva] OSG Hogeberg, Den Burg, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	van Haren, H (corresponding author), Royal Netherlands Inst Sea Res, Den Burg, Netherlands.	hans.van.haren@nioz.nl		Gostiaux, Louis/0000-0001-9683-4461				Arthur RS, 1954, DEEP-SEA RES, V2, P129; CAIRNS JL, 1967, J GEOPHYS RES, V72, P3563, DOI 10.1029/JZ072i014p03563; DILLON TM, 1982, J GEOPHYS RES-OCEANS, V87, P9601, DOI 10.1029/JC087iC12p09601; Divert V E, 2001, Int J Circumpolar Health, V60, P305; Ganzevles SPM, 2009, NATURWISSENSCHAFTEN, V96, P449, DOI 10.1007/s00114-008-0493-6; GREGG MC, 1989, J GEOPHYS RES-OCEANS, V94, P9686, DOI 10.1029/JC094iC07p09686; Hardy JD, 1937, J CLIN INVEST, V16, P533, DOI 10.1172/JCI100879; KENSHALO DR, 1968, PERCEPT PSYCHOPHYS, V3, P81, DOI 10.3758/BF03212769; Kuhtz-Buschbeck JP, 2010, ADV PHYSIOL EDUC, V34, P25, DOI 10.1152/advan.00002.2010; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Lin S.D., 2007, WATER WASTEWATER CAL; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Pingree RD, 1978, J GEOPHYS RES, V83, P329; SIMPSON JH, 1974, NATURE, V250, P404, DOI 10.1038/250404a0; THORPE SA, 1987, J GEOPHYS RES-OCEANS, V92, P5231, DOI 10.1029/JC092iC05p05231; THORPE SA, 1977, PHILOS T R SOC A, V286, P125, DOI 10.1098/rsta.1977.0112; van Aken HM, 2008, J SEA RES, V60, P227, DOI 10.1016/j.seares.2008.09.001; van Haren H, 1999, GEOPHYS RES LETT, V26, P2993, DOI 10.1029/1999GL002352; van Haren H, 2011, J MAR RES IN PRESS; van Haren H, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041890; van Haren H, 2009, IEEE J OCEANIC ENG, V34, P315, DOI 10.1109/JOE.2009.2021237; WINANT CD, 1974, J GEOPHYS RES, V79, P4523, DOI 10.1029/JC079i030p04523	22	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32535	10.1371/journal.pone.0032535	http://dx.doi.org/10.1371/journal.pone.0032535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403671	gold, Green Published, Green Submitted			2022-12-25	WOS:000303017700068
J	Cariani, E; Pilli, M; Zerbini, A; Rota, C; Olivani, A; Pelosi, G; Schianchi, C; Soliani, P; Campanini, N; Silini, EM; Trenti, T; Ferrari, C; Missale, G				Cariani, Elisabetta; Pilli, Massimo; Zerbini, Alessandro; Rota, Cristina; Olivani, Andrea; Pelosi, Guido; Schianchi, Claudia; Soliani, Paolo; Campanini, Nicoletta; Silini, Enrico Maria; Trenti, Tommaso; Ferrari, Carlo; Missale, Gabriele			Immunological and Molecular Correlates of Disease Recurrence after Liver Resection for Hepatocellular Carcinoma	PLOS ONE			English	Article							REGULATORY T-CELLS; POSTOPERATIVE RECURRENCE; GENE-EXPRESSION; TUMOR; SURVIVAL; CANCER; CLASSIFICATION; PROGNOSIS; MICROENVIRONMENT; OVEREXPRESSION	The definition of the risk of hepatocellular carcinoma (HCC) recurrence after resection represents a central issue to improve the clinical management of patients. In this study we examined the prognostic relevance of infiltrating immune cell subsets in the tumor (TIL) and in nontumorous (NT) liver (LIL), and the expression of immune-related and lineage-specific mRNAs in HCC and NT liver derived from 42 patients. The phenotype of infiltrating cells was analyzed by flow cytometry, and mRNA expression in liver tissue was examined by real-time reverse transcription (RT)-PCR. The tumor immune microenvironment was enriched in inhibitory and dysfunctional cell subsets. Enrichment in CD4+ T-cells and in particular CD4 and CD8+ memory subsets within TIL was predictive of better overall survival (OS) and time to recurrence (TTR). Increased programmed death ligand 1 (PDL1) mRNA content and higher prevalence of invariant NKT (iNKT) cells were associated with shorter OS and TTR, respectively. By combined evaluation of infiltrating cell subsets along with mRNA profiling of immune and tumor related genes, we identified the intratumoral frequency of memory T-cells and iNKT-cells as well as PDL1 expression as the best predictors of clinical outcome. HCC infiltrate is characterized by the expression of molecules with negative regulatory function that may favor tumor recurrence and poor survival.	[Cariani, Elisabetta; Rota, Cristina; Trenti, Tommaso] Osped S Agostino Estense, Clin Pathol Toxicol, Modena, Italy; [Pilli, Massimo; Olivani, Andrea; Pelosi, Guido; Schianchi, Claudia; Ferrari, Carlo; Missale, Gabriele] Azienda Osped Univ Parma, Unit Infect Dis & Hepatol, Parma, Italy; [Zerbini, Alessandro] Azienda Osped ASMN, Ist Ricovero & Cura Carattere Sci, Dept Lab Med, Clin Microbiol Lab, Reggio Emilia, Italy; [Soliani, Paolo] Osped Santa Maria delle Croci, Dept Gen Surg, Ravenna, Italy; [Campanini, Nicoletta; Silini, Enrico Maria] Univ Parma, Dept Pathol & Lab Med, Pathol Sect, I-43100 Parma, Italy	University of Parma; University Hospital of Parma; IRCCS Arcispedale S. Maria Nuova; University of Parma; University Hospital of Parma	Cariani, E (corresponding author), Osped S Agostino Estense, Clin Pathol Toxicol, Modena, Italy.	missale@tin.it	SILINI, ENRICO MARIA/AAB-8747-2019; Cariani, Elisabetta/J-6877-2016; Zerbini, Alessandro/J-5486-2016; Ferrari, Carlo/D-5663-2017; Missale, Gabriele/J-6083-2016; Trenti, Tommaso/K-8457-2016	SILINI, ENRICO MARIA/0000-0003-2578-3059; Cariani, Elisabetta/0000-0002-1887-6954; Zerbini, Alessandro/0000-0001-7378-0675; Ferrari, Carlo/0000-0002-5461-6842; Missale, Gabriele/0000-0001-6691-8701; Rota, Cristina/0000-0002-4392-4700; Trenti, Tommaso/0000-0001-8093-4011; Ferrari, Carlo/0000-0002-7843-4963; Olivani, Andrea/0000-0002-6199-1819	Italian Ministry of Health, Programma Straordinario Ricerca Oncologica	Italian Ministry of Health, Programma Straordinario Ricerca Oncologica	This work was supported by the Italian Ministry of Health, Programma Straordinario Ricerca Oncologica 2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Breuhahn K, 2004, CANCER RES, V64, P6058, DOI 10.1158/0008-5472.CAN-04-0292; Bricard G, 2009, J IMMUNOL, V182, P5140, DOI 10.4049/jimmunol.0711086; Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Chew V, 2010, J HEPATOL, V52, P370, DOI 10.1016/j.jhep.2009.07.013; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Gehring AJ, 2009, GASTROENTEROLOGY, V137, P682, DOI 10.1053/j.gastro.2009.04.045; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Sakai Y, 2008, CANCER RES, V68, P10267, DOI 10.1158/0008-5472.CAN-08-0911; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Thorgeirsson SS, 2006, J HEPATOL, V44, P798, DOI 10.1016/j.jhep.2006.01.008; Unitt E, 2006, J HEPATOL, V45, P246, DOI 10.1016/j.jhep.2005.12.027; Villanueva A, 2010, CLIN CANCER RES, V16, P4688, DOI 10.1158/1078-0432.CCR-09-1811; Wada Y, 1998, HEPATOLOGY, V27, P407, DOI 10.1002/hep.510270214; Wilke CM, 2010, INT J CANCER, V127, P748, DOI 10.1002/ijc.25464; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yang XH, 2006, J HEPATOL, V45, P254, DOI 10.1016/j.jhep.2006.01.036; Zhou J, 2009, INT J CANCER, V125, P1640, DOI 10.1002/ijc.24556	32	59	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32493	10.1371/journal.pone.0032493	http://dx.doi.org/10.1371/journal.pone.0032493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396772	Green Published, gold, Green Submitted			2022-12-25	WOS:000303006500023
J	Mateo, RG; Felicisimo, AM; Pottier, J; Guisan, A; Munoz, J				Mateo, Ruben G.; Felicisimo, Angel M.; Pottier, Julien; Guisan, Antoine; Munoz, Jesus			Do Stacked Species Distribution Models Reflect Altitudinal Diversity Patterns?	PLOS ONE			English	Article							ELEVATIONAL GRADIENT; CLIMATE-CHANGE; ECOLOGICAL THEORY; RICHNESS; PREDICTION; BIODIVERSITY; UNCERTAINTY; ABSENCES; IMPROVE; NUMBERS	The objective of this study was to evaluate the performance of stacked species distribution models in predicting the alpha and gamma species diversity patterns of two important plant clades along elevation in the Andes. We modelled the distribution of the species in the Anthurium genus (53 species) and the Bromeliaceae family (89 species) using six modelling techniques. We combined all of the predictions for the same species in ensemble models based on two different criteria: the average of the rescaled predictions by all techniques and the average of the best techniques. The rescaled predictions were then reclassified into binary predictions (presence/absence). By stacking either the original predictions or binary predictions for both ensemble procedures, we obtained four different species richness models per taxa. The gamma and alpha diversity per elevation band (500 m) was also computed. To evaluate the prediction abilities for the four predictions of species richness and gamma diversity, the models were compared with the real data along an elevation gradient that was independently compiled by specialists. Finally, we also tested whether our richness models performed better than a null model of altitudinal changes of diversity based on the literature. Stacking of the ensemble prediction of the individual species models generated richness models that proved to be well correlated with the observed alpha diversity richness patterns along elevation and with the gamma diversity derived from the literature. Overall, these models tend to overpredict species richness. The use of the ensemble predictions from the species models built with different techniques seems very promising for modelling of species assemblages. Stacking of the binary models reduced the over-prediction, although more research is needed. The randomisation test proved to be a promising method for testing the performance of the stacked models, but other implementations may still be developed.	[Mateo, Ruben G.] Univ Liege, Inst Bot, Liege, Belgium; [Mateo, Ruben G.; Munoz, Jesus] Real Jardin Bot CSIC, Madrid, Spain; [Felicisimo, Angel M.] Univ Extremadura, Escuela Politecn, Caceres, Spain; [Pottier, Julien; Guisan, Antoine] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Liege; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Universidad de Extremadura; University of Lausanne	Mateo, RG (corresponding author), Univ Liege, Inst Bot, Liege, Belgium.	rubeng.mateo@gmail.com	Munoz, Jesus/B-7809-2008; Felicisimo, Angel/B-4138-2008; Guisan, Antoine/A-1057-2011; Mateo, Rubén/M-3545-2015	Felicisimo, Angel/0000-0002-9953-8614; Guisan, Antoine/0000-0002-3998-4815; Mateo, Rubén/0000-0001-8577-001X; Munoz, Jesus/0000-0002-9266-2268	The foundation of the "Banco Banco Bilbao Vizcaya Argentaria''; European Commission; Swiss National Science Foundation; Ministry of Science and Technology of Spain [CGL2009-09530-BOS]	The foundation of the "Banco Banco Bilbao Vizcaya Argentaria''; European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The foundation of the "Banco Banco Bilbao Vizcaya Argentaria'' gave the financial support. The Center for Conservation and Sustainable Development (Missouri Botanical Garden) generously provided the data on the distribution of plants. AG and JP received support from the European Commission (ECOCHANGE project) and from the Swiss National Science Foundation (project BIOASSEMBLE), and JM was also funded by grant CGL2009-09530-BOS of the Ministry of Science and Technology of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Peng C, 2007, DIVERS DISTRIB, V13, P654, DOI 10.1111/j.1472-4642.2007.00393.x; Algar AC, 2009, ECOGRAPHY, V32, P22, DOI 10.1111/j.1600-0587.2009.05832.x; Anderson RP, 2003, J BIOGEOGR, V30, P591, DOI 10.1046/j.1365-2699.2003.00867.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, BIOSCIENCE, V11, P1504; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Baselga A, 2010, J BIOGEOGR, V37, P1842, DOI 10.1111/j.1365-2699.2010.02341.x; Becker A, 2007, MT RES DEV, V27, P58, DOI 10.1659/0276-4741(2007)27[58:EALUSA]2.0.CO;2; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Dubuis A, DIVERS DIST IN PRESS; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Engler R, 2009, ECOGRAPHY, V32, P34, DOI 10.1111/j.1600-0587.2009.05789.x; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fleishman E, 2000, J BIOGEOGR, V27, P1209, DOI 10.1046/j.1365-2699.2000.00455.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Heaney LR, 2001, GLOBAL ECOL BIOGEOGR, V10, P15, DOI 10.1046/j.1466-822x.2001.00227.x; Hijmans R.J., 2004, DIVA GIS VERSION 4 G; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hortal J, 2008, J BIOGEOGR, V35, P1335, DOI 10.1111/j.1365-2699.2008.01955.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Jorgensen PM, 1999, MISOURI BOTANICAL GA; Kessler M, 2002, J BIOGEOGR, V29, P1159, DOI 10.1046/j.1365-2699.2002.00773.x; Kessler M, 2001, BIODIVERS CONSERV, V10, P1897, DOI 10.1023/A:1013130902993; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Mateo RG, 2008, MODELOS PREDICTIVOS; Mateo RG, 2010, J VEG SCI, V21, P908, DOI 10.1111/j.1654-1103.2010.01198.x; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCullagh P, 1989, GEN LINEAR MODELS; Munoz J, 2004, J VEG SCI, V15, P285, DOI 10.1111/j.1654-1103.2004.tb02263.x; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pellissier L, ECOGRAPHY; Pellissier L, 2010, ECOGRAPHY, V33, P1004, DOI 10.1111/j.1600-0587.2010.06386.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pineda E, 2009, J ANIM ECOL, V78, P182, DOI 10.1111/j.1365-2656.2008.01471.x; Pottier J, GLOBAL ECOL BIOGEOGR; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Rickart EA, 2001, GLOBAL ECOL BIOGEOGR, V10, P77, DOI 10.1046/j.1466-822x.2001.00223.x; Romdal TS, 2007, ECOGRAPHY, V30, P440, DOI [10.1111/j.2007.0906-7590.04954.x, 10.1111/j.0906-7590.2007.04954.x]; Rowe RJ, 2005, J BIOGEOGR, V32, P1883, DOI 10.1111/j.1365-2699.2005.01346.x; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Titeux N, 2006, MODELLING SPECIES DI; Trotta-Moreu N, 2010, ENVIRON ENTOMOL, V39, P42, DOI 10.1603/EN08179; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004	64	56	57	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32586	10.1371/journal.pone.0032586	http://dx.doi.org/10.1371/journal.pone.0032586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396782	gold, Green Published, Green Submitted			2022-12-25	WOS:000303006500028
J	McKay, BR; Ogborn, DI; Bellamy, LM; Tarnopolsky, MA; Parise, G				McKay, Bryon R.; Ogborn, Daniel I.; Bellamy, Leeann M.; Tarnopolsky, Mark A.; Parise, Gianni			Myostatin is associated with age-related human muscle stem cell dysfunction	FASEB JOURNAL			English	Article						Pax7; GDF-8; aging; fiber type-specific	SKELETAL-MUSCLE; SATELLITE-CELL; OLDER MEN; GENE-EXPRESSION; FLOW-CYTOMETRY; YOUNG; SARCOPENIA; WOMEN; MICE; MASS	Human aging is accompanied by a progressive loss of muscle mass (sarcopenia). We tested the hypothesis that older males (OMs, 70 +/- 4 yr, n = 9) would have a blunted myogenic response to a physiological stimulus compared to younger controls (21 +/- 3 yr, n = 9). Subjects completed an acute bout of intense unilateral muscle loading. Young healthy males matched for body mass and activity level served as the control group. Muscle biopsies and blood were obtained before and at 3, 24, and 48 h after muscle loading. The muscle stem cell response was analyzed using flow cytometry, immunofluorescent microscopy, and standard protein and mRNA analysis. OMs had 35% fewer basal stem cells and a type II fiber-specific impairment in stem cell content and proliferation. Myogenic determination factor staining and cell cycle analysis illustrated a severely blunted progression through the myogenic program. Myostatin protein and mRNA were 2-fold higher in OMs. Stem cell-specific myostatin levels were not different at baseline; however, there were 67% more myostatin-positive type II-associated stem cells in OMs at 24 h. These data illustrate an age-related impairment of stem cell function in a fiber type-specific manner. The greater colocalization of myostatin with stem cells provides a mechanism for the impaired myogenic capacity of aged muscle.-McKay, B. R., Ogborn, D. I., Bellamy, L. M., Tarnopolsky, M. A., Parise, G. Myostatin is associated with age-related human muscle stem cell dysfunction. FASEB J. 26, 2509-2521 (2012). www.fasebj.org	[McKay, Bryon R.; Bellamy, Leeann M.; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada; [Ogborn, Daniel I.] McMaster Univ, Dept Hlth Sci, Hamilton, ON L8S 4L8, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat & Med Phys, Hamilton, ON L8S 4L8, Canada; [Parise, Gianni] McMaster Univ, Dept Appl Radiat Sci, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Parise, G (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada.	pariseg@mcmaster.ca			National Institute of Child Health and Human Development	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors acknowledge Nicole MacFarlane and Dr. Doug Boreham for their technical assistance with the flow cytometry. The Pax7 hybridoma cells, developed by Dr. A. Kawakami, and the A4.951 and 5.1H11 hybridoma cells, developed by Dr. H. Blau, were obtained from the Developmental Studies Hybridoma Bank under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa, Department of Biology (Iowa City, IA, USA). Contributions: B. R. M. and G. P. conceived the project; B. R. M., D. I. O., M. A. T., and G. P. contributed to the experimental design, exercise testing, and tissue collection; B. R. M. was responsible for IHC/IF, RNA, and primary myoblast experiments; D. I. O. and L. M. B. were responsible for RNA isolation and RT reactions; D. I. O. was responsible for the protein analysis. The manuscript was largely written by B. R. M. and G. P. All authors were involved with the writing and final approval of the manuscript.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Bish LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010230; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Huang ZQ, 2011, CELL SIGNAL, V23, P1441, DOI 10.1016/j.cellsig.2011.05.003; Jejurikar SS, 2006, EXP GERONTOL, V41, P828, DOI 10.1016/j.exger.2006.06.053; Jespersen JG, 2011, SCAND J MED SCI SPOR, V21, P215, DOI 10.1111/j.1600-0838.2009.01044.x; Kadi F, 2004, MUSCLE NERVE, V29, P120, DOI 10.1002/mus.10510; Kim JS, 2005, J APPL PHYSIOL, V99, P2149, DOI 10.1152/japplphysiol.00513.2005; Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Leger B, 2008, REJUV RES, V11, P163, DOI 10.1089/rej.2007.0588; LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809; Lindstrom M, 2009, HISTOCHEM CELL BIOL, V132, P141, DOI 10.1007/s00418-009-0606-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Melton LJ, 2000, J AM GERIATR SOC, V48, P625; Morissette MR, 2009, AGING CELL, V8, P573, DOI 10.1111/j.1474-9726.2009.00508.x; Raue U, 2006, J APPL PHYSIOL, V101, P53, DOI 10.1152/japplphysiol.01616.2005; Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6; Roubenoff R, 1999, J NUTR, V129, p256S, DOI 10.1093/jn/129.1.256S; Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179, DOI 10.1177/002215540405200205; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Siriett V, 2006, J CELL PHYSIOL, V209, P866, DOI 10.1002/jcp.20778; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006; Yarasheski K E, 2002, J Nutr Health Aging, V6, P343; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	44	117	118	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2509	2521		10.1096/fj.11-198663	http://dx.doi.org/10.1096/fj.11-198663			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22403007				2022-12-25	WOS:000305017200027
J	Melas, PA; Rogdaki, M; Osby, U; Schalling, M; Lavebratt, C; Ekstrom, TJ				Melas, Philippe A.; Rogdaki, Maria; Osby, Urban; Schalling, Martin; Lavebratt, Catharina; Ekstrom, Tomas J.			Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset	FASEB JOURNAL			English	Article						COMT; haloperidol; SERT	LUMINOMETRIC METHYLATION; BIPOLAR DISORDER; MESSENGER-RNA; COMT PROMOTER; HYPOMETHYLATION; EXPRESSION; PSYCHOSIS; DIAGNOSIS; GENETICS; ASSAY	Even though schizophrenia has a strong hereditary component, departures from simple genetic transmission are prominent. DNA methylation has emerged as an epigenetic explanatory candidate of schizophrenia's nonmendelian characteristics. To investigate this assumption, we examined genome-wide (global) and gene-specific DNA methylation levels, which are associated with genomic stability and gene expression activity, respectively. Analyses were conducted using DNA from leukocytes of patients with schizophrenia and controls. Global methylation results revealed a highly significant hypomethylation in patients with schizophrenia (P<2.0 x 10(-6)) and linear regression among patients generated a model in which antipsychotic treatment and disease onset explained 11% of the global methylation variance (adjusted R-2=0.11, ANOVA P<0.001). Specifically, haloperidol was associated with higher ("control-like") methylation (P=0.001), and early onset (a putative marker of schizophrenia severity) was associated with lower methylation (P=0.002). With regard to the gene-specific methylation analyses, and in accordance with the dopamine hypothesis of psychosis, we found that the analyzed region of S-COMT was hypermethylated in patients with schizophrenia (P=0.004). In summary, these data support the notion of a dysregulated epigenome in schizophrenia, which, at least globally, is more pronounced in early-onset patients and can be partly rescued by antipsychotic medication. In addition, blood DNA-methylation signatures show promise of serving as a schizophrenia biomarker in the future.-Melas, P. A., Rogdaki, M., sby, U., Schalling, M., Lavebratt, C., Ekstrom, T. J. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J. 26, 2712-2718 (2012). www.fasebj.org	[Lavebratt, Catharina] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Mol Med & Surg,Neurogenet Unit, S-17176 Stockholm, Sweden; [Ekstrom, Tomas J.] Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med, S-17176 Stockholm, Sweden; [Osby, Urban] Tiohundra AB, Dept Psychiat, Norrtalje, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Lavebratt, C (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Mol Med & Surg,Neurogenet Unit, L8 00, S-17176 Stockholm, Sweden.	catharina.lavebratt@ki.se	Schalling, Martin/F-1518-2015; Ekström, Tomas/B-7764-2013	Schalling, Martin/0000-0001-5011-2922; , Maria/0000-0003-2685-1789; Lavebratt, Catharina/0000-0003-4987-2718; Melas, Philippe/0000-0002-7889-9250	Swedish Cancer Society; Karolinska Institute; Bodossaki Foundation; Swedish Research Council; ALF from Stockholm County Council [20060100, 20080022]; Department of Drug Management and Informatics, Stockholm County Council; Soderstrom-Konigska Hospital; Bristol-Myers Squibb; Janssen-Cilag	Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Bodossaki Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF from Stockholm County Council; Department of Drug Management and Informatics, Stockholm County Council(Stockholm County Council); Soderstrom-Konigska Hospital; Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was supported by funds from the Swedish Cancer Society, the Karolinska Institute Faculty Funds (KID), the Bodossaki Foundation, and Swedish Research Council grants. The Swedish Study of Metabolic Risks in Psychosis (SSMP) was supported by ALF Grants 20060100 and 20080022 from Stockholm County Council and Karolinska Institutet, and by grants from the Department of Drug Management and Informatics, Stockholm County Council, and from Soderstrom-Konigska Hospital. None of the funding sources were involved in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, and in the decision to submit the paper for publication. The authors also thank Dr. Nimrod Kiss and Dr. Mohsen Karimi Arzenani for experimental support and expertise, and Carina Schmidt for work with the patient sample. U.O. has received honoraria as a speaker or advisor or for attending congresses from AstraZeneca, Bristol-Myers Squibb, Janssen-Cilag, Eli Lilly, and Pfizer, and grant support from Bristol-Myers Squibb and Janssen-Cilag. The other authors declare no conflicts of interest.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; American Academy of Child and Adolescent Psychiatry, 2001, J AM ACAD CHILD ADOL, V40, p4S; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Ban TA, 2004, PROG NEURO-PSYCHOPH, V28, P753, DOI 10.1016/j.pnpbp.2004.05.021; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Dempster EL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-10; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Frazier JA, 2007, J AM ACAD CHILD PSY, V46, P979, DOI 10.1097/chi.0b013e31807083fd; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Karimi M, 2011, METHODS MOL BIOL, V791, P135, DOI 10.1007/978-1-61779-316-5_11; Kyriakopoulos M, 2007, INT REV PSYCHIATR, V19, P315, DOI 10.1080/09540260701486258; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Melas PA, 2011, INT J NEUROPSYCHOPH, P1, DOI DOI 10.1017/S1461145711000940; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Murphy BC, 2005, AM J MED GENET B, V133B, P37, DOI 10.1002/ajmg.b.30134; Nohesara S, 2011, J PSYCHIATR RES, V45, P1432, DOI 10.1016/j.jpsychires.2011.06.013; Petronis A, 2004, BIOL PSYCHIAT, V55, P965, DOI 10.1016/j.biopsych.2004.02.005; Petronis A, 2003, SCHIZOPHRENIA BULL, V29, P169, DOI 10.1093/oxfordjournals.schbul.a006988; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Pidsley R, 2011, BIOL PSYCHIAT, V69, P146, DOI 10.1016/j.biopsych.2010.03.029; Shimabukuro M, 2007, J PSYCHIATR RES, V41, P1042, DOI 10.1016/j.jpsychires.2006.08.006; Shin JK, 2011, CURR MED CHEM, V18, P1380; SNYDER SH, 1976, AM J PSYCHIAT, V133, P197; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132	31	145	150	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2712	2718		10.1096/fj.11-202069	http://dx.doi.org/10.1096/fj.11-202069			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22426120				2022-12-25	WOS:000305017200046
J	Romes, EM; Tripathy, A; Slep, KC				Romes, Erin M.; Tripathy, Ashutosh; Slep, Kevin C.			Structure of a Yeast Dyn2-Nup159 Complex and Molecular Basis for Dynein Light Chain-Nuclear Pore Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; SPLICED EXON-B; INTERMEDIATE CHAIN; FUNCTIONAL INTERACTION; ESSENTIAL NUCLEOPORIN; MYOSIN VA; BINDING; ARCHITECTURE; NUP159; DBP5	The nuclear pore complex gates nucleocytoplasmic transport through a massive, eight-fold symmetric channel capped by a nucleoplasmic basket and structurally unique, cytoplasmic fibrils whose tentacles bind and regulate asymmetric traffic. The conserved Nup82 complex, composed of Nsp1, Nup82, and Nup159, forms the unique cytoplasmic fibrils that regulate mRNA nuclear export. Although the nuclear pore complex plays a fundamental, conserved role in nuclear trafficking, structural information about the cytoplasmic fibrils is limited. Here, we investigate the structural and biochemical interactions between Saccharomyces cerevisiae Nup159 and the nucleoporin, Dyn2. We find that Dyn2 is predominantly a homodimer and binds arrayed sites on Nup159, promoting the Nup159 parallel homodimerization. We present the first structure of Dyn2, determined at 1.85 angstrom resolution, complexed with a Nup159 target peptide. Dyn2 resembles homologous metazoan dynein light chains, forming homodimeric composite substrate binding sites that engage two independent 10-residue target motifs, imparting a beta-strand structure to each peptide via antiparallel extension of the Dyn2 core beta-sandwich. Dyn2 recognizes a highly conserved QT motif while allowing sequence plasticity in the flanking residues of the peptide. Isothermal titration calorimetric analysis of the comparative binding of Dyn2 to two Nup159 target sites shows similar affinities (18 and 13 mu M), but divergent thermal binding modes. Dyn2 homodimers are arrayed in the crystal lattice, likely mimicking the arrayed architecture of Dyn2 on the Nup159 multivalent binding sites. Crystallographic interdimer interactions potentially reflect a cooperative basis for Dyn2-Nup159 complex formation. Our data highlight the determinants that mediate oligomerization of the Nup82 complex and promote a directed, elongated cytoplasmic fibril architecture.	[Slep, Kevin C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Romes, Erin M.; Tripathy, Ashutosh] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Romes, Erin M.] Univ N Carolina, Grad Program Mol Biophys & Biochem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Slep, KC (corresponding author), Univ N Carolina, Dept Biol, 402 Fordham Hall,Campus Box 3280, Chapel Hill, NC 27599 USA.	kslep@bio.unc.edu			National Institutes of Health [1R01GM094415]; March of Dimes [1-FY11-434]; University Research Council, University of North Carolina at Chapel Hill; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); University Research Council, University of North Carolina at Chapel Hill; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM094415 (to K. C. S.). This work was also supported by March of Dimes Grant 1-FY11-434 to K. C. S.) and a research grant from the University Research Council, University of North Carolina at Chapel Hill (to K. C. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Allen NPC, 2002, MOL CELL PROTEOMICS, V1, P930, DOI 10.1074/mcp.T200012-MCP200; Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Del Priore V, 1997, J CELL SCI, V110, P2987; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939; Hodge CA, 2011, GENE DEV, V25, P1052, DOI 10.1101/gad.2041611; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; KRAEMER DM, 1995, J BIOL CHEM, V270, P19017, DOI 10.1074/jbc.270.32.19017; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; MAUL GG, 1971, J CELL BIOL, V51, P558, DOI 10.1083/jcb.51.2.558; McCauley SD, 2007, LIFE SCI, V80, P959, DOI 10.1016/j.lfs.2006.11.025; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Nyarko A, 2011, BIOPHYS CHEM, V159, P41, DOI 10.1016/j.bpc.2011.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radnai L, 2010, J BIOL CHEM, V285, P38649, DOI 10.1074/jbc.M110.165894; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Stuchell-Brereton MD, 2011, MOL BIOL CELL, V22, P2690, DOI 10.1091/mbc.E11-01-0075; Tcheperegine SE, 1999, J BIOL CHEM, V274, P5252, DOI 10.1074/jbc.274.8.5252; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yoshida K, 2011, P NATL ACAD SCI USA, V108, P16571, DOI 10.1073/pnas.1112846108	42	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15862	15873		10.1074/jbc.M111.336172	http://dx.doi.org/10.1074/jbc.M111.336172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411995	hybrid, Green Published			2022-12-25	WOS:000304006300065
J	Sontag, JM; Nunbhakdi-Craig, V; White, CL; Halpain, S; Sontag, E				Sontag, Jean-Marie; Nunbhakdi-Craig, Viyada; White, Charles L., III; Halpain, Shelley; Sontag, Estelle			The Protein Phosphatase PP2A/B alpha Binds to the Microtubule-associated Proteins Tau and MAP2 at a Motif Also Recognized by the Kinase Fyn IMPLICATIONS FOR TAUOPATHIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; HYPERPHOSPHORYLATED-TAU; PHOSPHORYLATION STATE; CATALYTIC SUBUNIT; DOWN-REGULATION; 2A; BRAIN; ALPHA; EXPRESSION; ENZYME	The predominant brain microtubule-associated proteins MAP2 and tau play a critical role in microtubule cytoskeletal organization and function. We have previously reported that PP2A/B alpha, a major protein phosphatase 2A (PP2A) holoenzyme, binds to and dephosphorylates tau, and regulates microtubule stability. Here, we provide evidence that MAP2 co-purifies with and is dephosphorylated by endogenous PP2A/B alpha in bovine gray matter. It co-localizes with PP2A/B alpha in immature and mature human neuronal cell bodies. PP2A co-immunoprecipitates with and directly interacts with MAP2. Using in vitro binding assays, we show that PP2A/B alpha binds to MAP2c isoforms through a region encompassing the microtubule-binding domain and upstream proline-rich region. Tau and MAP2 compete for binding to and dephosphorylation by PP2A/B alpha. Remarkably, the protein-tyrosine kinase Fyn, which binds to the proline-rich RTPPKSP motif conserved in both MAP2 and tau, inhibits the interaction of PP2A/B alpha with either tau or MAP2c. The corresponding synthetic RTPPKSP peptide, but not the phosphorylated RpTPPKSP version, competes with Tau and MAP2c for binding to PP2A/B alpha. Significantly, down-regulation of PP2A/B alpha and deregulation of Fyn-Tau protein interactions have been linked to enhanced tau phosphorylation in Alzheimer disease. Together, our results suggest that PP2A/B alpha is part of segregated MAP2 and tau signaling scaffolds that can coordinate the action of key kinases and phosphatases involved in modulating neuronal plasticity. Deregulation of these compartmentalized multifunctional protein complexes is likely to contribute to tau deregulation, microtubule disruption, and altered signaling in tauopathies.	[Sontag, Jean-Marie; Sontag, Estelle] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Sontag, Jean-Marie; Nunbhakdi-Craig, Viyada; White, Charles L., III; Sontag, Estelle] UT SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; [Halpain, Shelley] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA	University of Newcastle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Sontag, E (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	Estelle.Sontag@newcastle.edu.au	White, Charles L/AAJ-1858-2021; SONTAG, ESTELLE/AAE-9805-2020	White, Charles L/0000-0002-3870-2804; 	National Institutes of Health [AG18883]; French Foundation for Alzheimer research [AG12300, MH50861]; NHMRC Australia; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH050861, R01MH087823, R01MH050861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018883, P30AG012300, R56AG018883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Foundation for Alzheimer research; NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants AG18883 (to E. S.), French Foundation for Alzheimer research (to E. S.), AG12300 (to E. S. and C. W.) and MH50861 (to S. H.), and NHMRC Australia grant (to E. S. and J. M. S.).	Alexa A, 2002, BIOCHEMISTRY-US, V41, P12427, DOI 10.1021/bi025916s; Arendt T, 2001, NEUROSCIENCE, V102, P723, DOI 10.1016/S0306-4522(00)00516-9; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; DEANCOS JG, 1993, BIOCHEM J, V296, P351, DOI 10.1042/bj2960351; Dehmelt L, 2005, GENOME BIOL, V6; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; Evan BJ, 2008, BIOCHEM BIOPH RES CO, V377, P1067, DOI 10.1016/j.bbrc.2008.10.108; Fan QW, 2002, J NEUROCHEM, V80, P178, DOI 10.1046/j.0022-3042.2001.00686.x; Farah CA, 2008, CELL MOTIL CYTOSKEL, V65, P515, DOI 10.1002/cm.20284; Goedert M, 2000, J NEUROCHEM, V75, P2155, DOI 10.1046/j.1471-4159.2000.0752155.x; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gong CX, 2000, BRAIN RES, V853, P299, DOI 10.1016/S0006-8993(99)02294-5; Gotz J, 2006, J NEUROCHEM, V98, P993, DOI 10.1111/j.1471-4159.2006.03955.x; Hiraga A, 2000, BIOCHEM J, V346, P433, DOI 10.1042/0264-6021:3460433; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Iqbal K, 2008, J ALZHEIMERS DIS, V14, P365; Ittner A, 2011, IUBMB LIFE, V63, P495, DOI 10.1002/iub.467; JOLY JC, 1989, J CELL BIOL, V109, P2289, DOI 10.1083/jcb.109.5.2289; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; Landrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021521; Lee G, 1998, J CELL SCI, V111, P3167; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lim RWL, 2000, J BIOL CHEM, V275, P20578, DOI 10.1074/jbc.M001887200; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sanchez C, 1996, EUR J BIOCHEM, V241, P765, DOI 10.1111/j.1432-1033.1996.00765.x; Sanchez M. C., 1998, NEUROSCIENCE, V87, P861; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag JM, 2008, J NEUROSCI, V28, P11477, DOI 10.1523/JNEUROSCI.2816-08.2008; Sontag JM, 2010, J NEUROCHEM, V115, P1455, DOI 10.1111/j.1471-4159.2010.07049.x; SURRIDGE CD, 1994, BIOCHEMISTRY-US, V33, P8051, DOI 10.1021/bi00192a009; Turowski P, 1997, EUR J BIOCHEM, V248, P200, DOI 10.1111/j.1432-1033.1997.t01-1-00200.x; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Zamora-Leon SP, 2001, J BIOL CHEM, V276, P39950, DOI 10.1074/jbc.M107807200	52	56	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14984	14993		10.1074/jbc.M111.338681	http://dx.doi.org/10.1074/jbc.M111.338681			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403409	hybrid, Green Published			2022-12-25	WOS:000304003200060
J	Xie, CQ; Guo, YH; Zhu, TQ; Zhang, JF; Ma, PX; Chen, YE				Xie, Changqing; Guo, Yanhong; Zhu, Tianqing; Zhang, Jifeng; Ma, Peter X.; Chen, Y. Eugene			Yap1 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; ORGAN SIZE CONTROL; GENE-EXPRESSION; HIPPO PATHWAY; ALPHA-ACTIN; CARDIOMYOCYTE PROLIFERATION; DIFFERENTIATION; GROWTH; TRANSCRIPTION; INHIBITION	The Hippo-Yap (Yes-associated protein) signaling pathway has emerged as one of the critical pathways regulating cell proliferation, differentiation, and apoptosis in response to environmental and developmental cues. However, Yap1 roles in vascular smooth muscle cell (VSMC) biology have not been investigated. VSMCs undergo phenotypic switch, a process characterized by decreased gene expression of VSMC contractile markers and increased proliferation, migration, and matrix synthesis. The goals of the present studies were to investigate the relationship between Yap1 and VSMC phenotypic switch and to determine the molecular mechanisms by which Yap1 affects this essential process in VSMC biology. Results demonstrated that the expression of Yap1 was rapidly up-regulated by stimulation with PDGF-BB (a known inducer of phenotypic switch in VSMCs) and in the injured vessel wall. Knockdown of Yap1 impaired VSMC proliferation in vitro and enhanced the expression of VSMC contractile genes as well by increasing serum response factor binding to CArG-containing regions of VSMC-specific contractile genes within intact chromatin. Conversely, the interaction between serum response factor and its co-activator myocardin was reduced by overexpression of Yap1 in a dose-dependent manner. Taken together, these results indicate that down-regulation of Yap1 promotes VSMC contractile phenotype by both up-regulating myocardin expression and promoting the association of the serum response factor-myocardin complex with VSMC contractile gene promoters and suggest that the Yap1 signaling pathway is a central regulator of phenotypic switch of VSMCs.	[Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Cardiovasc Ctr, Ann Arbor, MI 48109 USA; [Ma, Peter X.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chen, YE (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Cardiovasc Ctr, MSRB 3 7200,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	echenum@umich.edu	GUO, Yanhong/B-5325-2012; X, Peter/E-4895-2011; Guo, Yanhong/D-9764-2012		National Institutes of Health [HL105114, HL068878, HL89544]; American Heart Association [0835237N, 09SDG2260023, 0840025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105114, R01HL089544, R01HL068878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL105114, HL068878, and HL89544 (to Y. E. C.).; Supported by American Heart Association National Career Development Grants 0835237N (to J. Z.) and 09SDG2260023 (to C. X.).; An American Heart Association Established Investigator (Grant 0840025N).	Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Chen J, 2011, ARTERIOSCL THROM VAS, V31, P368, DOI 10.1161/ATVBAHA.110.218149; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen LM, 2010, PROTEIN CELL, V1, P1073, DOI 10.1007/s13238-010-0138-3; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Fan YB, 2011, J BIOL CHEM, V286, P40584, DOI 10.1074/jbc.M111.232918; Faxon DP, 1997, PROG CARDIOVASC DIS, V40, P129, DOI 10.1016/S0033-0620(97)80005-9; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Itoh S, 2001, J MOL CELL CARDIOL, V33, P95, DOI 10.1006/jmcc.2000.1279; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Nishida W, 2002, J BIOL CHEM, V277, P7308, DOI 10.1074/jbc.M111824200; Ono H, 2005, ARTERIOSCL THROM VAS, V25, P1871, DOI 10.1161/01.ATV.0000174588.50971.1a; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Rensen SSM, 2006, CARDIOVASC RES, V70, P136, DOI 10.1016/j.cardiores.2005.12.018; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Swartz EA, 1998, AM J PHYSIOL-CELL PH, V275, pC608, DOI 10.1152/ajpcell.1998.275.2.C608; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Xie CQ, 2011, ARTERIOSCL THROM VAS, V31, P1485, DOI 10.1161/ATVBAHA.110.221101; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005	62	75	87	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14598	14605		10.1074/jbc.M111.329268	http://dx.doi.org/10.1074/jbc.M111.329268			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22411986	Green Published, hybrid			2022-12-25	WOS:000304003200026
J	Zanou, N; Schakman, O; Louis, P; Ruegg, UT; Dietrich, A; Birnbaumer, L; Gailly, P				Zanou, Nadege; Schakman, Olivier; Louis, Pierre; Ruegg, Urs T.; Dietrich, Alexander; Birnbaumer, Lutz; Gailly, Philippe			Trpc1 Ion Channel Modulates Phosphatidylinositol 3-Kinase/Akt Pathway during Myoblast Differentiation and Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; CELL-CYCLE ARREST; HELIX-LOOP-HELIX; SKELETAL-MUSCLE; MYOGENIN EXPRESSION; IGF-I; MYOD; ACTIVATION; HYPERTROPHY; TARGET	We previously showed in vitro that calcium entry through Trpc1 ion channels regulates myoblast migration and differentiation. In the present work, we used primary cell cultures and isolated muscles from Trpc1(-/-) and Trpc1(+/+) murine model to investigate the role of Trpc1 in myoblast differentiation and in muscle regeneration. In these models, we studied regeneration consecutive to cardiotoxin-induced muscle injury and observed a significant hypotrophy and a delayed regeneration in Trpc1(-/-) muscles consisting in smaller fiber size and increased proportion of centrally nucleated fibers. This was accompanied by a decreased expression of myogenic factors such as MyoD, Myf5, and myogenin and of one of their targets, the developmental MHC (MHCd). Consequently, muscle tension was systematically lower in muscles from Trpc1(-/-) mice. Importantly, the PI3K/Akt/mTOR/p70S6K pathway, which plays a crucial role in muscle growth and regeneration, was down-regulated in regenerating Trpc1(-/-) muscles. Indeed, phosphorylation of both Akt and p70S6K proteins was decreased as well as the activation of PI3K, the main upstream regulator of the Akt. This effect was independent of insulin-like growth factor expression. Akt phosphorylation also was reduced in Trpc1(-/-) primary myoblasts and in control myoblasts differentiated in the absence of extracellular Ca2+ or pretreated with EGTA-AM or wortmannin, suggesting that the entry of Ca2+ through Trpc1 channels enhanced the activity of PI3K. Our results emphasize the involvement of Trpc1 channels in skeletal muscle development in vitro and in vivo, and identify a Ca2+-dependent activation of the PI3K/Akt/mTOR/p70S6K pathway during myoblast differentiation and muscle regeneration.	[Zanou, Nadege; Schakman, Olivier; Louis, Pierre; Gailly, Philippe] Catholic Univ Louvain, Lab Cell Physiol, Inst Neurosci, B-1200 Brussels, Belgium; [Ruegg, Urs T.] Univ Geneva, Geneva Lausanne Sch Pharmaceut Sci, Pharmacol Lab, CH-1211 Geneva 4, Switzerland; [Dietrich, Alexander] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany; [Birnbaumer, Lutz] Natl Inst Environm Hlth Sci, Neurobiol Lab, Res Triangle Pk, NC 27709 USA	Universite Catholique Louvain; University of Geneva; University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zanou, N (corresponding author), Catholic Univ Louvain, Lab Cell Physiol, Inst Neurosci, 55-40 Av Hippocrate, B-1200 Brussels, Belgium.	nadege.zanou@uclouvain.be; philippe.gailly@uclouvain.be	Dietrich, Alexander/G-8619-2013	Dietrich, Alexander/0000-0002-1168-8707; RUEGG, Urs/0000-0001-6078-8280	National Institutes of Health [Z01-101684]; Association francaise contre les myopathies; Association Belge contre les Maladies Neuro-musculaires; General Direction of Scientific Research of the French Community of Belgium [ARC 10/15-029]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association francaise contre les myopathies(Association Francaise contre les Myopathies); Association Belge contre les Maladies Neuro-musculaires; General Direction of Scientific Research of the French Community of Belgium; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health Z01-101684 (to L. B.). This work was also supported by the "Association francaise contre les myopathies", the "Association Belge contre les Maladies Neuro-musculaires", by Grant ARC 10/15-029 from the General Direction of Scientific Research of the French Community of Belgium.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Beylkin DH, 2006, DEV BIOL, V294, P541, DOI 10.1016/j.ydbio.2006.02.049; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Gailly P, 1996, J PHYSIOL-LONDON, V491, P635, DOI 10.1113/jphysiol.1996.sp021245; Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; LeRoith D, 2000, ENDOCRINOLOGY, V141, P1287, DOI 10.1210/en.141.4.1287; Louis M, 2004, FEBS LETT, V557, P243, DOI 10.1016/S0014-5793(03)01504-7; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Ma R, 2003, J BIOL CHEM, V278, P52763, DOI 10.1074/jbc.M309610200; MARECHAL G, 1993, PFLUG ARCH EUR J PHY, V424, P478, DOI 10.1007/BF00374911; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; Miyabara EH, 2010, MUSCLE NERVE, V42, P778, DOI 10.1002/mus.21754; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; OTT MO, 1991, DEVELOPMENT, V111, P1097; PRZYBYLSKI RJ, 1994, CELL CALCIUM, V15, P132, DOI 10.1016/0143-4160(94)90052-3; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; SCHMID A, 1984, J BIOL CHEM, V259, P1366; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; TAPSCOTT SJ, 1990, ADV EXP MED BIOL, V280, P3; Vernon AE, 2003, DEVELOPMENT, V130, P71, DOI 10.1242/dev.00180; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Whitehead JP, 2000, CURR OPIN CELL BIOL, V12, P222, DOI 10.1016/S0955-0674(99)00079-4; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009	50	48	48	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14524	14534		10.1074/jbc.M112.341784	http://dx.doi.org/10.1074/jbc.M112.341784			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399301	Green Published, hybrid			2022-12-25	WOS:000304003200019
J	Rudolph, M; Docke, WD; Muller, A; Menning, A; Rose, L; Zollner, TM; Gashaw, I				Rudolph, Marion; Doecke, Wolf-Dietrich; Mueller, Andrea; Menning, Astrid; Roese, Lars; Zollner, Thomas Matthias; Gashaw, Isabella			Induction of Overt Menstruation in Intact Mice	PLOS ONE			English	Article							PROGESTOGEN-ONLY CONTRACEPTIVES; ENDOTHELIAL GROWTH-FACTOR; HUMAN ENDOMETRIUM; DECIDUALIZED ENDOMETRIUM; HEME OXYGENASE; MESSENGER-RNA; MOUSE MODEL; EXPRESSION; CYCLE; IDENTIFICATION	The complex tissue remodeling process of menstruation is experienced by humans and some primates, whereas most placental mammals, including mice, go through an estrous cycle. How menstruation and the underlying mechanisms evolved is still unknown. Here we demonstrate that the process of menstruation is not just species-specific but also depends on factors which can be induced experimentally. In intact female mice endogenous progesterone levels were raised by the induction of pseudopregnancy. Following an intrauterine oil injection, the decidualization of the endometrium was reliably induced as a prerequisite for menstruation. The natural drop of endogenous progesterone led to spontaneous breakdown of endometrial tissue within an average of 3 days post induction of decidualization. Interestingly, morphological changes such as breakdown and repair of the endometrial layer occurred in parallel in the same uterine horn. Most importantly, endometrial breakdown was accompanied by vaginally visible (overt) bleeding and flushing out of shed tissue comparable to human menstruation. Real-time PCR data clearly showed temporal changes in the expression of multiple factors participating in inflammation, angiogenesis, tissue modulation, proliferation, and apoptosis, as has been described for human menstruating endometrium. In conclusion, human menstruation can be mimicked in terms of extravaginally visible bleeding, tissue remodeling, and gene regulation in naturally non-menstruating species such as intact female mice without the need for an exogenous hormone supply.	[Rudolph, Marion; Doecke, Wolf-Dietrich; Mueller, Andrea; Zollner, Thomas Matthias; Gashaw, Isabella] Bayer HealthCare, Global Drug Discovery, Target Discovery, Berlin, Germany; [Menning, Astrid; Roese, Lars] Bayer HealthCare, Global Drug Discovery, Target Res Grp Womens Healthcare, Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Rudolph, M (corresponding author), Bayer HealthCare, Global Drug Discovery, Target Discovery, Berlin, Germany.	marion.rudolph@bayer.com		Gashaw, Isabella/0000-0001-5984-576X				Brasted M, 2003, BIOL REPROD, V69, P1273, DOI 10.1095/biolreprod.103.016550; Casanas-Roux F, 2002, FERTIL STERIL, V78, P1327, DOI 10.1016/S0015-0282(02)04395-9; Casslen B, 1998, BIOL REPROD, V58, P1343, DOI 10.1095/biolreprod58.6.1343; Catalano RD, 2011, MOL HUM REPROD, V17, P182, DOI 10.1093/molehr/gaq094; CHARNOCKJONES DS, 1993, BIOL REPROD, V48, P1120, DOI 10.1095/biolreprod48.5.1120; Chevronnay HPG, 2008, ENDOCRINOLOGY, V149, P1015, DOI 10.1210/en.2007-0849; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; Critchley HOD, 2001, CLIN ENDOCRINOL, V55, P701, DOI 10.1046/j.1365-2265.2001.01432.x; DeSouza L, 2005, PROTEOMICS, V5, P270, DOI 10.1002/pmic.200400920; FINN CA, 1984, J ENDOCRINOL, V100, P295, DOI 10.1677/joe.0.1000295; GERDES J, 1984, J IMMUNOL, V133, P1710; Graubert MD, 2001, AM J PATHOL, V158, P1399, DOI 10.1016/S0002-9440(10)64091-6; Henriet P, 2011, MOL CELL ENDOCRINOL; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Kaitu'u-Lino TJ, 2010, ENDOCRINOLOGY, V151, P3386, DOI 10.1210/en.2009-1334; Kitaya K, 2004, J CLIN ENDOCR METAB, V89, P2470, DOI 10.1210/jc.2003-031293; Kitaya K, 2000, BIOL REPROD, V63, P683, DOI 10.1095/biolreprod63.3.683; Laird SM, 2011, HUM REPROD, V26, P1144, DOI 10.1093/humrep/der043; MAHONEY CJ, 1970, J REPROD FERTIL, V21, P153; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Morison NB, 2008, REPRODUCTION, V136, P267, DOI 10.1530/REP-08-0076; Morison NB, 2007, REPRODUCTION, V133, P309, DOI 10.1530/rep.1.01171; Murakami Y, 2005, J REPROD DEVELOP, V51, P639, DOI 10.1262/jrd.17029; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; OTSUKI Y, 1994, LANCET, V344, P28; PROFET M, 1993, Q REV BIOL, V68, P335, DOI 10.1086/418170; RASWEILER JJ, 1991, AM J ANAT, V191, P1, DOI 10.1002/aja.1001910102; Shiozawa T, 1996, MOL HUM REPROD, V2, P745, DOI 10.1093/molehr/2.10.745; Strassmann BI, 1996, Q REV BIOL, V71, P181, DOI 10.1086/419369; TABIBZADEH S, 1992, HUM REPROD, V7, P1214, DOI 10.1093/oxfordjournals.humrep.a137829; TAWIA SA, 1993, HUM REPROD, V8, P175; Van der HORST C. J., 1954, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V238, P27, DOI 10.1098/rstb.1954.0005; WHITTEN WK, 1968, SCIENCE, V161, P584, DOI 10.1126/science.161.3841.584; Xu XB, 2007, HUM REPROD, V22, P3184, DOI 10.1093/humrep/dem312; Yoshiki N, 2001, J CLIN ENDOCR METAB, V86, P5033, DOI 10.1210/jc.86.10.5033; Yoshino O, 2001, MOL HUM REPROD, V7, P649, DOI 10.1093/molehr/7.7.649; ZHU HH, 1992, HUM REPROD, V7, P141, DOI 10.1093/oxfordjournals.humrep.a137606; Zygmunt M, 2003, EUR J OBSTET GYN R B, V110, pS10, DOI 10.1016/S0301-2115(03)00168-4	38	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2012	7	3							e32922	10.1371/journal.pone.0032922	http://dx.doi.org/10.1371/journal.pone.0032922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KK	22412950	gold, Green Published, Green Submitted			2022-12-25	WOS:000303060800063
J	Konig, K; Gatidou, D; Granja, T; Meier, J; Rosenberger, P; Mirakaj, V				Koenig, Klemens; Gatidou, Dimitra; Granja, Tiago; Meier, Jens; Rosenberger, Peter; Mirakaj, Valbona			The Axonal Guidance Receptor Neogenin Promotes Acute Inflammation	PLOS ONE			English	Article							INHIBITS LEUKOCYTE MIGRATION; ISCHEMIA-REPERFUSION INJURY; REPULSIVE GUIDANCE; IN-VIVO; NEURONAL DIFFERENTIATION; NETRIN-1; MOLECULE; RGMA; DCC; EMBRYOGENESIS	Neuronal guidance proteins (NGP) were originally described in the context of axonal growth and migration. Yet recent work has demonstrated that NGPs also serve as guidance cues for immune competent cells. A crucial target receptor for NGPs during embryonic development is the neogenin receptor, however its role during acute inflammation is unknown. We report here that neogenin is abundantly expressed outside the nervous system and that animals with endogenous repression of neogenin (Neo1(-/-)) demonstrate attenuated changes of acute inflammation. Studies using functional inhibition of neogenin resulted in a significant attenuation of inflammatory peritonitis. In studies employing bone marrow chimeric animals we found the hematopoietic presence of Neo1(-/-) to be responsible for the attenuated inflammatory response. Taken together our studies suggest that the guidance receptor neogenin holds crucial importance for the propagation of an acute inflammatory response and further define mechanisms shared between the nervous and the immune system.	[Koenig, Klemens; Gatidou, Dimitra; Granja, Tiago; Meier, Jens; Rosenberger, Peter; Mirakaj, Valbona] Univ Tubingen, Tubingen Univ Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Koenig, Klemens; Granja, Tiago; Meier, Jens] Goethe Univ Frankfurt, Univ Hosp Frankfurt Main, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Konig, K (corresponding author), Univ Tubingen, Tubingen Univ Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	peter.rosenberger@med.uni-tuebingen.de; valbona.mirakaj@med.uni-tuebingen.de	Granja, Tiago/O-2597-2019	Granja, Tiago/0000-0002-8137-1449; Mirakaj, Valbona/0000-0002-6907-6455	Deutsche Forschungsgemeinschaft (DFG) [DFG-RO 3671/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) DFG-RO 3671/5-1 to PR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae GU, 2009, MOL BIOL CELL, V20, P4920, DOI 10.1091/mbc.E09-06-0491; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Henes J, 2009, FASEB J, V23, P4244, DOI 10.1096/fj.09-138693; Kanellis J, 2004, AM J PATHOL, V165, P341, DOI 10.1016/S0002-9440(10)63301-9; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; Koeberle PD, 2010, NEUROSCIENCE; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Okamura Y, 2009, NEUROSCI RES, V65, pS158, DOI 10.1016/j.neures.2009.09.813; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Rao Y, 2002, GENE DEV, V16, P2973, DOI 10.1101/gad.1005802; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	32	17	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e32145	10.1371/journal.pone.0032145	http://dx.doi.org/10.1371/journal.pone.0032145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412855	Green Published, Green Submitted, gold			2022-12-25	WOS:000303021100012
J	Kumar, S; Quinn, SC; Kim, KH; Hilyard, KM				Kumar, Supriya; Quinn, Sandra Crouse; Kim, Kevin H.; Hilyard, Karen M.			US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic	PLOS ONE			English	Article								Background: During the 2009 H1N1 pandemic, the global health community sought to make vaccine available "in developing nations in the same timeframe as developed nations.'' However, richer nations placed advance orders with manufacturers, leaving poorer nations dependent on the quantity and timing of vaccine donations by manufacturers and rich nations. Knowledge of public support for timely donations could be important to policy makers during the next pandemic. We explored what the United States (US) public believes about vaccine donation by its country to poorer countries. Methods and Findings: We surveyed 2079 US adults between January 22nd and February 1st 2010 about their beliefs regarding vaccine donation to poorer countries. Income (p = 0.014), objective priority status (p = 0.005), nativity, party affiliation, and political ideology (p < 0.001) were significantly related to views on the amount of vaccine to be donated. Though party affiliation and political ideology were related to willingness to donate vaccine (p < 0.001), there was bipartisan support for timely donations of 10% of the US vaccine supply so that those "at risk in poorer countries can get the vaccine at the same time'' as those at risk in the US. Conclusions: We suggest that the US and other developed nations would do well to bolster support with education and public discussion on this issue prior to an emerging pandemic when emotional reactions could potentially influence support for donation. We conclude that given our evidence for bipartisan support for timely donations, it may be necessary to design multiple arguments, from utilitarian to moral, to strengthen public and policy makers' support for donations.	[Kumar, Supriya] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Quinn, Sandra Crouse] Univ Maryland, Sch Publ Hlth, Dept Family Sci, College Pk, MD 20742 USA; [Kim, Kevin H.] Univ Pittsburgh, Sch Educ, Pittsburgh, PA 15260 USA; [Hilyard, Karen M.] Univ Georgia, Coll Publ Hlth, Dept Hlth Promot & Behav, Athens, GA 30602 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; University of Georgia	Kumar, S (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.	supriya@pitt.edu		Kumar, Supriya/0000-0001-8373-105X	Center for Public Health Practice by the Centers for Disease Control and Prevention [1P01TP000304-01]	Center for Public Health Practice by the Centers for Disease Control and Prevention	This study was funded through the Center for Public Health Practice by the Centers for Disease Control and Prevention cooperative agreement number 1P01TP000304-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CanPREP, 2009, ETH PAND INFL WHIT P; Chan M, COMMUNICATION; CNN Saturday Morning News transcript October 31st 2009, 2009, CNN SATURDAY MO 1031; Enserink M, 2009, SCIENCE, V326, P782, DOI 10.1126/science.326_782; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Garrett L, 2009, NEWSWEEK        1207; Robert Wood Johnson Foundation, 2010, NEW WAY TALK SOC DET; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Sen AK, 1993, LA CALIDAD DE VIDA; Singleton J. A., 2010, Morbidity and Mortality Weekly Report, V59, P44; WHO (World Health Organization), 2010, PAND INFL PREP SHAR; Woodle D, 2000, HEALTH POLICY PLANN, V15, P121, DOI 10.1093/heapol/15.2.121; Yamada T, 2009, NEW ENGL J MED, V361, P1129, DOI 10.1056/NEJMp0906972	13	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e33025	10.1371/journal.pone.0033025	http://dx.doi.org/10.1371/journal.pone.0033025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412979	Green Published, Green Submitted, gold			2022-12-25	WOS:000303021100047
J	Chauhan, A; Zubair, S; Sherwani, A; Owais, M				Chauhan, Arun; Zubair, Swaleha; Sherwani, Asif; Owais, Mohammad			Aloe vera Induced Biomimetic Assemblage of Nucleobase into Nanosized Particles	PLOS ONE			English	Article							CELL-CYCLE; SILVER NANOPARTICLES; GOLD NANOPARTICLES; CRYSTAL-STRUCTURE; CARCINOMA-CELLS; IN-SITU; 5-FLUOROURACIL; P53; MECHANISM; APOPTOSIS	Aim: Biomimetic nano-assembly formation offers a convenient and bio friendly approach to fabricate complex structures from simple components with sub-nanometer precision. Recently, biomimetic (employing microorganism/plants) synthesis of metal and inorganic materials nano-particles has emerged as a simple and viable strategy. In the present study, we have extended biological synthesis of nano-particles to organic molecules, namely the anticancer agent 5-fluorouracil (5-FU), using Aloe vera leaf extract. Methodology: The 5-FU nano-particles synthesized by using Aloe vera leaf extract were characterized by UV, FT-IR and fluorescence spectroscopic techniques. The size and shape of the synthesized nanoparticles were determined by TEM, while crystalline nature of 5-FU particles was established by X-ray diffraction study. The cytotoxic effects of 5-FU nanoparticles were assessed against HT-29 and Caco-2 (human adenocarcinoma colorectal) cell lines. Results: Transmission electron microscopy and atomic force microscopic techniques confirmed nano-size of the synthesized particles. Importantly, the nano-assembled 5-FU retained its anticancer action against various cancerous cell lines. Conclusion: In the present study, we have explored the potential of biomimetic synthesis of nanoparticles employing organic molecules with the hope that such developments will be helpful to introduce novel nano-particle formulations that will not only be more effective but would also be devoid of nano-particle associated putative toxicity constraints.	[Chauhan, Arun; Sherwani, Asif; Owais, Mohammad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Zubair, Swaleha] Aligarh Muslim Univ, Womens Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Chauhan, A (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	owais_lakhnawi@yahoo.com	Sherwani, Mohammad Asif/AAQ-2949-2021; Sherwani, Mohammad/AAR-6089-2021	Sherwani, Mohammad Asif/0000-0001-5317-1557; Mohammad, Owais/0000-0001-7377-7388	Department of Biotechnology, Government of India, New Delhi	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	Funding was provided by the Department of Biotechnology, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis B, 2007, NANO LETT, V7, P1723, DOI 10.1021/nl0707149; Alkhalaf M, 2003, J ENDOCRINOL, V179, P55, DOI 10.1677/joe.0.1790055; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Chandran SP, 2006, BIOTECHNOL PROGR, V22, P577, DOI 10.1021/bp0501423; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; CHEN RF, 1988, ANAL BIOCHEM, V172, P61, DOI 10.1016/0003-2697(88)90412-5; Choi YH, 2001, ONCOL REP, V8, P1091; Costantini P, 2002, CELL DEATH DIFFER, V9, P82, DOI 10.1038/sj.cdd.4400932; FALLON L, 1973, ACTA CRYSTALLOGR B, V29, P2549, DOI 10.1107/S0567740873006989; Gardea-Torresdey JL, 2002, NANO LETT, V2, P397, DOI 10.1021/nl015673+; Germain V, 2003, J PHYS CHEM B, V107, P8717, DOI 10.1021/jp0303826; Glimcher J, 1981, CHEM BIOL MINERALIZE, P617; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gustavsson T, 2006, J AM CHEM SOC, V128, P607, DOI 10.1021/ja056181s; Hamman JH, 2008, MOLECULES, V13, P1599, DOI 10.3390/molecules13081599; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hulme AT, 2005, J AM CHEM SOC, V127, P1116, DOI 10.1021/ja044336a; Imhof A, 1999, J PHYS CHEM B, V103, P1408, DOI 10.1021/jp983241q; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Ji XH, 2007, J AM CHEM SOC, V129, P13939, DOI 10.1021/ja074447k; Jiang M, 2003, GENE DEV, V17, P832, DOI 10.1101/gad.252603; Johnson KR, 1997, CLIN CANCER RES, V3, P1739; Kagawa S, 2000, CANCER RES, V60, P1157; KARLSSON JO, 1994, ANAL BIOCHEM, V219, P144, DOI 10.1006/abio.1994.1243; Kawasaki H, 2007, J PHYS CHEM C, V111, P2683, DOI 10.1021/jp066963n; Kelly C, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/727241; Khan A, 2007, MOL MED, V13, P266, DOI 10.2119/2007-00018.Khan; Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w; Kompella U. B., 2006, NANOPARTICLE TECHNOL, P1; Lee JH, 2008, CRYST GROWTH DES, V8, P2638, DOI 10.1021/cg0702075; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lobenberg R, 1996, AIDS RES HUM RETROV, V12, P1709, DOI 10.1089/aid.1996.12.1709; Lofton C, 2005, ADV FUNCT MATER, V15, P1197, DOI 10.1002/adfm.200400091; Elechiguerra JL, 2006, J MATER CHEM, V16, P3906, DOI 10.1039/b607128g; MIYASHITA T, 1995, CELL, V80, P293; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukherjee P, 2001, NANO LETT, V1, P515, DOI 10.1021/nl0155274; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Polte J, 2010, J AM CHEM SOC, V132, P1296, DOI 10.1021/ja906506j; Pong BK, 2007, J PHYS CHEM C, V111, P6281, DOI 10.1021/jp068666o; Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5; ROZENMAN Y, 1995, INT J CARDIOL, V49, P282, DOI 10.1016/0167-5273(95)02314-M; Santoro F, 2006, J AM CHEM SOC, V128, P16312, DOI 10.1021/ja0657861; Santra S, 2001, J BIOMED OPT, V6, P160, DOI 10.1117/1.1353590; Schmidt JJ, 2002, DRUG DISCOV TODAY, V7, P500, DOI 10.1016/S1359-6446(02)02174-8; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Scorates G, INFRARED CHARACTERIS; Selvaraj V, 2007, INT J PHARMACEUT, V337, P275, DOI 10.1016/j.ijpharm.2006.12.027; Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003; Singh P, 2009, DRUG TEST ANAL, V1, P240, DOI 10.1002/dta.41; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; STEWART RF, 1967, ACTA CRYSTALLOGR, V23, P1102, DOI 10.1107/S0365110X67004360; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Verma AK, 2005, CURR PHARM BIOTECHNO, V6, P121, DOI 10.2174/1389201053642349; Wang ZL, 2000, J PHYS CHEM B, V104, P1153, DOI 10.1021/jp993593c; Wangoo N, 2008, ANAL CHIM ACTA, V610, P142, DOI 10.1016/j.aca.2008.01.033; Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006; Wiley B, 2005, CHEM-EUR J, V11, P454, DOI 10.1002/chem.200400927; Wilkinson J M, 2003, Med Device Technol, V14, P29; Yoneda K, 1998, ORAL ONCOL, V34, P529, DOI 10.1016/S1368-8375(98)00036-0; Yoshikawa R, 2001, CANCER RES, V61, P1029; Zoli W, 2005, BREAST CANCER RES, V7, pR681, DOI 10.1186/bcr1274	67	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32049	10.1371/journal.pone.0032049	http://dx.doi.org/10.1371/journal.pone.0032049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403622	gold, Green Submitted, Green Published			2022-12-25	WOS:000303017700019
J	Lahaye, LL; Wouda, RR; de Jong, AWM; Fradkin, LG; Noordermeer, JN				Lahaye, Liza L.; Wouda, Rene R.; de Jong, Anja W. M.; Fradkin, Lee G.; Noordermeer, Jasprina N.			WNT5 Interacts with the Ryk Receptors Doughnut and Derailed to Mediate Muscle Attachment Site Selection in Drosophila melanogaster	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DIRECT FLIGHT MUSCLES; MYOTUBE GUIDANCE; EMBRYONIC-DEVELOPMENT; SIGNALING PATHWAY; MYOBLAST FUSION; GENE-EXPRESSION; AXON GUIDANCE; CELLS; HOMOLOG	In recent years a number of the genes that regulate muscle formation and maintenance in higher organisms have been identified. Studies employing invertebrate and vertebrate model organisms have revealed that many of the genes required for early mesoderm specification are highly conserved throughout evolution. Less is known about the molecules that mediate the steps subsequent to myogenesis, e. g. myotube guidance and attachment to tendon cells. We use the stereotypic pattern of the Drosophila embryonic body wall musculature in genetic approaches to identify novel factors required for muscle attachment site selection. Here, we show that Wnt5 is needed in this process. The lateral transverse muscles frequently overshoot their target attachment sites and stably attach at novel epidermal sites in Wnt5 mutant embryos. Restoration of WNT5 expression in either the muscle or the tendon cell rescues the mutant phenotype. Surprisingly, the novel attachment sites in Wnt5 mutants frequently do not express the Stripe (SR) protein which has been shown to be required for terminal tendon cell differentiation. A muscle bypass phenotype was previously reported for embryos lacking the WNT5 receptor Derailed (DRL). drl and Wnt5 mutant embryos also exhibit axon path finding errors. DRL belongs to the conserved Ryk receptor tyrosine kinase family which includes two other Drosophila orthologs, the Doughnut on 2 (DNT) and Derailed-2 (DRL-2) proteins. We generated a mutant allele of dnt and find that dnt, but not Drl-2, mutant embryos also show a muscle bypass phenotype. Genetic interaction experiments indicate that drl and dnt act together, likely as WNT5 receptors, to control muscle attachment site selection. These results extend previous findings that at least some of the molecular pathways that guide axons towards their targets are also employed for guidance of muscle fibers to their appropriate attachment sites.	[Lahaye, Liza L.; Wouda, Rene R.; de Jong, Anja W. M.; Fradkin, Lee G.; Noordermeer, Jasprina N.] Leiden Univ, Dept Mol & Cell Biol, Med Ctr, Dev Neurobiol Lab, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lahaye, LL (corresponding author), Leiden Univ, Dept Mol & Cell Biol, Med Ctr, Dev Neurobiol Lab, Leiden, Netherlands.	l.g.fradkin@lumc.nl; j.n.noordermeer@lumc.nl		de Jong, Anja/0000-0001-8110-8520	Nederlandse Organisatie voor Wetenschappelijk Onderzoek, N.W.O. [900-02-003, 050.10.155, 40-00812-98-10058]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek, N.W.O.(Netherlands Organization for Scientific Research (NWO))	This work was funded by grants 900-02-003, 050.10.155 and 40-00812-98-10058 from the 'Nederlandse Organisatie voor Wetenschappelijk Onderzoek, N.W.O.' (www.nwo.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABMAYR SM, 1995, TRENDS GENET, V11, P153, DOI 10.1016/S0168-9525(00)89030-7; Abmayr SM, 2003, INT REV CYTOL, V225, P33, DOI 10.1016/S0074-7696(05)25002-7; BATE M, 1990, DEVELOPMENT, V110, P791; Bate M, DEV DROSOPHILA MELAN; Becker S, 1997, DEVELOPMENT, V124, P2615; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1991, DEVELOPMENT, V113, P103; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Callahan CA, 1996, DEVELOPMENT, V122, P2761; Chanana B, 2007, MECH DEVELOP, V124, P463, DOI 10.1016/j.mod.2007.03.005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conti FJ, 2009, DEVELOPMENT, V136, P3597, DOI 10.1242/dev.035857; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Fradkin LG, 2010, TRENDS NEUROSCI, V33, P84, DOI 10.1016/j.tins.2009.11.005; Fradkin LG, 2004, DEV BIOL, V272, P362, DOI 10.1016/j.ydbio.2004.04.034; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; Ganguly A, 2005, DEVELOPMENT, V132, P3419, DOI 10.1242/dev.01903; Ghazi A, 2000, DEVELOPMENT, V127, P5309; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; Grillenzoni N, 2007, DEVELOPMENT, V134, P3089, DOI 10.1242/dev.02876; Haralalka S, 2010, EXP CELL RES, V316, P3007, DOI 10.1016/j.yexcr.2010.05.018; Harris KE, 2007, DEVELOPMENT, V134, P2017, DOI 10.1242/dev.001164; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013; Janson K, 2001, MECH DEVELOP, V103, P117, DOI 10.1016/S0925-4773(01)00323-9; Kozopas KM, 2002, DEV BIOL, V243, P312, DOI 10.1006/dbio.2002.0572; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Oates AC, 1998, MECH DEVELOP, V78, P165, DOI 10.1016/S0925-4773(98)00167-1; Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Sakurai M, 2009, J NEUROSCI, V29, P4972, DOI 10.1523/JNEUROSCI.2821-08.2009; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Savant-Bhonsale S, 1999, GENE, V231, P155, DOI 10.1016/S0378-1119(99)00061-X; Schnorrer F, 2004, DEV CELL, V7, P9, DOI 10.1016/j.devcel.2004.06.010; Schnorrer F, 2007, DEV CELL, V12, P751, DOI 10.1016/j.devcel.2007.02.017; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Shimizu K, 2011, J NEUROSCI, V31, P4944, DOI 10.1523/JNEUROSCI.0154-11.2011; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; STACKER SA, 1993, ONCOGENE, V8, P1347; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Subramanian A, 2007, DEVELOPMENT, V134, P1269, DOI 10.1242/dev.000406; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; TOWER J, 1993, GENETICS, V133, P347; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; VOLK T, 1994, DEVELOPMENT, V120, P59; Vorbruggen G, 1997, P NATL ACAD SCI USA, V94, P8606, DOI 10.1073/pnas.94.16.8606; Wayburn B, 2009, DEVELOPMENT, V136, P3607, DOI 10.1242/dev.040329; Wouda RR, 2008, DEVELOPMENT, V135, P2277, DOI 10.1242/dev.017319; Yarnitzky T, 1997, GENE DEV, V11, P2691, DOI 10.1101/gad.11.20.2691; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yoshikawa S, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-01-j0002.2001	61	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32297	10.1371/journal.pone.0032297	http://dx.doi.org/10.1371/journal.pone.0032297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403643	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700040
J	Ru, ZT; Xiao, WJ; Pajot, A; Kou, ZH; Sun, SH; Maillere, B; Zhao, GY; Ojcius, DM; Lone, YC; Zhou, YS				Ru, Zhitao; Xiao, Wenjun; Pajot, Anthony; Kou, Zhihua; Sun, Shihui; Maillere, Bernard; Zhao, Guangyu; Ojcius, David M.; Lone, Yu-chun; Zhou, Yusen			Development of a Humanized HLA-A2.1/DP4 Transgenic Mouse Model and the Use of This Model to Map HLA-DP4-Restricted Epitopes of HBV Envelope Protein	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; T-CELL EPITOPES; SURFACE-ANTIGEN; IMMUNE-RESPONSES; BINDING-SPECIFICITY; HLA-DP4 MOLECULES; KNOCKOUT MICE; HLA-DR; PEPTIDE; INFECTION	A new homozygous humanized transgenic mouse strain, HLA-A2.1(+/+)HLA-DP4(+/+) hCD4(+/+)mCD4(-/-)IA beta(-/-beta)2m(-/-) (HLA-A2/DP4), was obtained by crossing the previously characterized HLA-A2(+/+beta)2m(-/-) (A2) mouse and our previously created HLA-DP4(+/+) hCD4(+/+)mCD4(-/-)IA beta(-/-) (DP4) mouse. We confirmed that the transgenes (HLA-A2, HLA-DP4, hCD4) inherited from the parental A2 and DP4 mice are functional in the HLA-A2/DP4 mice. After immunizing HLA-A2/DP4 mice with a hepatitis B DNA vaccine, hepatitis B virus-specific antibodies, HLA-A2-restricted and HLA-DP4-restricted responses were observed to be similar to those in naturally infected humans. Therefore, the present study demonstrated that HLA-A2/DP4 transgenic mice can faithfully mimic human cellular responses. Furthermore, we reported four new HLA-DP4-restricted epitopes derived from HBsAg that were identified in both vaccinated HLA-A2/DP4 mice and HLA-DP4-positive human individuals. The HLA-A2/DP4 mouse model is a promising preclinical animal model carrying alleles present to more than a quarter of the human population. This model should facilitate the identification of novel HLA-A2- and HLA-DP4-restricted epitopes and vaccine development as well as the characterization of HLA-DP4-restricted responses against infection in humans.	[Ru, Zhitao; Xiao, Wenjun; Kou, Zhihua; Sun, Shihui; Zhao, Guangyu; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China; [Ru, Zhitao; Pajot, Anthony; Lone, Yu-chun] Univ Paris Sud, INSERM, Hop Paul Brousse, U1014,Ex U542, Villejuif, France; [Maillere, Bernard] Commissariat Energie Atom Saclay, Inst Biol & Technol, Serv Ingn Mol Prot, Gif Sur Yvette, France; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA	Beijing Institute of Microbiology & Epidemiology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Merced; University of California System; University of California Merced	Ru, ZT (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	yu-chun.lone@inserm.fr; yszhou@nic.bmi.ac.cn	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; LONE, Yu Chun/0000-0002-7417-4930; Xiao, Wenjun/0000-0002-6670-2203	National Program of Infectious Diseases [2012ZX10004-502]; The 973 program of China [2011CB 504706]; Institut National du Cancer [PL06_106]; Canceropole-Region Ile de France	National Program of Infectious Diseases; The 973 program of China(National Basic Research Program of China); Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole-Region Ile de France(Region Ile-de-France)	Funding provided by the National Program of Infectious Diseases: 2012ZX10004-502, The 973 program of China (2011CB 504706), the Institut National du Cancer (PL06_106), and Canceropole-Region Ile de France (Project HPVCanORL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baschal EE, 2007, DIABETES, V56, P2405, DOI 10.2337/db07-0029; Botten J, 2010, J VIROL, V84, P9947, DOI 10.1128/JVI.00672-10; Busson M, 2006, J IMMUNOL METHODS, V317, P144, DOI 10.1016/j.jim.2006.10.002; Castelli FA, 2002, J IMMUNOL, V169, P6928, DOI 10.4049/jimmunol.169.12.6928; CELIS E, 1989, J VIROL, V63, P747, DOI 10.1128/JVI.63.2.747-752.1989; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; de Graaff PMA, 2004, VIROLOGY, V326, P220, DOI 10.1016/j.virol.2004.06.008; de Waal L, 2004, J VIROL, V78, P1775, DOI 10.1128/JVI.78.4.1775-1781.2004; Deng Q, 2009, HEPATOLOGY, V50, P1380, DOI 10.1002/hep.23150; Francois V, 2009, CANCER RES, V69, P4335, DOI 10.1158/0008-5472.CAN-08-3726; Gao DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014237; Gaschet J, 1996, J CLIN INVEST, V98, P100, DOI 10.1172/JCI118753; Gelder C, 1998, INT IMMUNOL, V10, P211, DOI 10.1093/intimm/10.2.211; GENG L, 1995, TISSUE ANTIGENS, V46, P111, DOI 10.1111/j.1399-0039.1995.tb02486.x; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Guo X, 2004, HEPATOLOGY, V40, P318; Healey GD, 2005, INFECT IMMUN, V73, P5945, DOI 10.1128/IAI.73.9.5945-5951.2005; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Lacey SF, 2003, HUM IMMUNOL, V64, P440, DOI 10.1016/S0198-8859(03)00028-4; LAW YM, 1994, J EXP MED, V179, P1233, DOI 10.1084/jem.179.4.1233; Leen AM, 2008, J VIROL, V82, P546, DOI 10.1128/JVI.01689-07; Lone YC, 2006, Patent publication, Patent No. [WO 2006/092515 A1, 2006092515]; Maini MK, 1999, GASTROENTEROLOGY, V117, P1386, DOI 10.1016/S0016-5085(99)70289-1; Mandic M, 2005, J IMMUNOL, V174, P1751, DOI 10.4049/jimmunol.174.3.1751; MICHEL ML, 1995, P NATL ACAD SCI USA, V92, P5307, DOI 10.1073/pnas.92.12.5307; NAYERSINA R, 1993, J IMMUNOL, V150, P4659; ODUM N, 1989, J IMMUNOGENET, V16, P467; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Pajot A, 2007, EUR J IMMUNOL, V37, P2635, DOI 10.1002/eji.200636819; Pascolo S, 2005, EXPERT OPIN BIOL TH, V5, P919, DOI 10.1517/14712598.5.7.919; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Schirmbeck R, 1998, EUR J IMMUNOL, V28, P4149, DOI 10.1002/(SICI)1521-4141(199812)28:12<4149::AID-IMMU4149>3.0.CO;2-D; Schultz ES, 2000, CANCER RES, V60, P6272; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; SPRENT J, 1990, SCIENCE, V248, P1357, DOI 10.1126/science.1694041; Stern JNH, 2005, P NATL ACAD SCI USA, V102, P1620, DOI 10.1073/pnas.0409022102; Taneja V, 1998, J CLIN INVEST, V101, P921, DOI 10.1172/JCI2860; Tang J, 2004, GENE THER, V22, P1; TUSSEY LG, 1995, IMMUNITY, V3, P65, DOI 10.1016/1074-7613(95)90159-0; Viret C, 1999, Rev Immunogenet, V1, P91; Wang QM, 2004, SCAND J IMMUNOL, V60, P219, DOI 10.1111/j.0300-9475.2004.01442.x; Wang XF, 2007, CANCER IMMUNOL IMMUN, V56, P807, DOI 10.1007/s00262-006-0230-y; Zhou WY, 2009, VACCINE, V27, P5013, DOI 10.1016/j.vaccine.2009.05.009	46	15	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32247	10.1371/journal.pone.0032247	http://dx.doi.org/10.1371/journal.pone.0032247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403638	Green Published, gold, Green Submitted			2022-12-25	WOS:000303017700035
J	de Ronde, H; Alonso, PG; van Soolingen, D; Klatser, PR; Anthony, RM				de Ronde, Hans; Alonso, Paula Gonzalez; van Soolingen, Dick; Klatser, Paul R.; Anthony, Richard M.			Bead Array Direct rRNA Capture Assay (rCapA) for Amplification Free Speciation of Mycobacterium Cultures	PLOS ONE			English	Article							TUBERCULOSIS COMPLEX; CLINICAL-RELEVANCE; IDENTIFICATION; HYBRIDIZATION; RESISTANCE; MALMOENSE; DIAGNOSIS; KANSASII; IMPACT; CELLS	Mycobacterium cultures, from patients suspected of tuberculosis or nontuberculous mycobacteria (NTM) infection, need to be identified. It is most critical to identify cultures belonging to the Mycobacterium tuberculosis complex, but also important to recognize clinically irrelevant or important NTM to allow appropriate patient management. Identification of M. tuberculosis can be achieved by a simple and cheap lateral flow assay, but identification of other Mycobacterium spp. generally requires more complex molecular methods. Here we demonstrate that a paramagnetic liquid bead array method can be used to capture mycobacterial rRNA in crude lysates of positive cultures and use a robust reader to identify the species in a direct and sensitive manner. We developed an array composed of paramagnetic beads coupled to oligonucleotides to capture 16 rRNA from eight specific Mycobacterium species and a single secondary biotinilated reporter probe to allow the captured rRNA to be detected. A ninth less specific bead and its associated reporter probe, designed to capture 23S rRNA from mycobacteria and related genera, is included as an internal control to confirm the presence of bacterial rRNA from a GC rich Gram variable genera. Using this rRNA capture assay (rCapA) with the array developed we were already able to confirm the presence of members of the M. tuberculosis complex and to discriminate a range of NTM species. This approach is not based on DNA amplification and therefore does not require precautions to avoid amplicon contamination. Moreover, the new generation of stable and cost effective liquid bead readers provides the necessary multiplexing potential to develop a robust and highly discriminatory assay.	[de Ronde, Hans; Klatser, Paul R.; Anthony, Richard M.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Alonso, Paula Gonzalez] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Mol Cell Biol, Amsterdam, Netherlands; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, TB Reference Lab, Bilthoven, Netherlands	Vrije Universiteit Amsterdam; Netherlands National Institute for Public Health & the Environment	de Ronde, H (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	r.anthony@kit.nl	González-Alonso, Paula/ABH-1757-2020; Anthony, Richard/AAP-3406-2020; Anthony, Richard M/G-5654-2010	González-Alonso, Paula/0000-0002-5343-8300; Anthony, Richard/0000-0002-0550-5273; Anthony, Richard M/0000-0002-0550-5273; Klatser, Paul/0000-0003-2127-9138; Klatser, Paul/0000-0003-3868-2409	MicronNed; NanoNextNL; ZonMW	MicronNed; NanoNextNL; ZonMW(Netherlands Organization for Health Research and Development)	MicronNed and NanoNextNL (http://www.nanonextnl.nl/) partially funded this work, and access to the MAGPIX device was partially funded by a ZonMW grant (http://www.zonmw.nl/). The funders are non profit bodies and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abadia E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-110; Anthony RM, 2009, INT J TUBERC LUNG D, V13, P1051; Anthony Richard M, 2005, Ann Clin Microbiol Antimicrob, V4, P9, DOI 10.1186/1476-0711-4-9; Anthony RM, 2005, J MICROBIOL METH, V60, P47, DOI 10.1016/j.mimet.2004.08.009; Anthony RM, 2000, J CLIN MICROBIOL, V38, P781, DOI 10.1128/JCM.38.2.781-788.2000; Bergval I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029108; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brown TJ, 2006, J MICROBIOL METH, V65, P294, DOI 10.1016/j.mimet.2005.08.002; Brown TJ, 2000, J MICROBIOL METH, V42, P203, DOI 10.1016/S0167-7012(00)00175-5; Corbett EL, 1999, AM J RESP CRIT CARE, V160, P10, DOI 10.1164/ajrccm.160.1.9808052; DEBEENHOUWER H, 1995, TUBERCLE LUNG DIS, V76, P425, DOI 10.1016/0962-8479(95)90009-8; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1409; Hoefsloot W, 2008, INT J TUBERC LUNG D, V12, P987; KOX LFF, 1995, J CLIN MICROBIOL, V33, P3225, DOI 10.1128/JCM.33.12.3225-3233.1995; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; OBRIEN RJ, 1987, AM REV RESPIR DIS, V135, P1007; REISNER BS, 1994, J CLIN MICROBIOL, V32, P2995, DOI 10.1128/JCM.32.12.2995-2998.1994; Richter E, 2006, J CLIN MICROBIOL, V44, P1769, DOI 10.1128/JCM.44.5.1769-1775.2006; SCHRODER KH, 1977, INT J SYST BACTERIOL, V27, P241, DOI 10.1099/00207713-27-3-241; Small J, 2001, APPL ENVIRON MICROB, V67, P4708, DOI 10.1128/AEM.67.10.4708-4716.2001; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; Vandeventer PE, 2011, J CLIN MICROBIOL, V49, P2533, DOI 10.1128/JCM.02171-10	24	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32575	10.1371/journal.pone.0032575	http://dx.doi.org/10.1371/journal.pone.0032575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396779	Green Published, gold, Green Submitted			2022-12-25	WOS:000303006500025
J	Girdhar, G; Xenos, M; Alemu, Y; Chiu, WC; Lynch, BE; Jesty, J; Einav, S; Slepian, MJ; Bluestein, D				Girdhar, Gaurav; Xenos, Michalis; Alemu, Yared; Chiu, Wei-Che; Lynch, Bryan E.; Jesty, Jolyon; Einav, Shmuel; Slepian, Marvin J.; Bluestein, Danny			Device Thrombogenicity Emulation: A Novel Method for Optimizing Mechanical Circulatory Support Device Thromboresistance	PLOS ONE			English	Article							INDUCED PLATELET ACTIVATION; BLADE TIP CLEARANCE; DAMAGE ACCUMULATION; CLINICAL-EXPERIENCE; HEART-VALVE; BLOOD PUMP; OPTIMIZATION; SIMULATION; IMPELLER; BRIDGE	Mechanical circulatory support (MCS) devices provide both short and long term hemodynamic support for advanced heart failure patients. Unfortunately these devices remain plagued by thromboembolic complications associated with chronic platelet activation - mandating complex, lifelong anticoagulation therapy. To address the unmet need for enhancing the thromboresistance of these devices to extend their long term use, we developed a universal predictive methodology entitled Device Thrombogenicity Emulation (DTE) that facilitates optimizing the thrombogenic performance of any MCS device - ideally to a level that may obviate the need for mandatory anticoagulation. DTE combines in silico numerical simulations with in vitro measurements by correlating device hemodynamics with platelet activity coagulation markers before and after iterative design modifications aimed at achieving optimized thrombogenic performance. DTE proof-of-concept is demonstrated by comparing two rotary Left Ventricular Assist Devices (LVADs) (DeBakey vs HeartAssist 5, Micromed Houston, TX), the latter a version of the former following optimization of geometrical features implicated in device thrombogenicity. Cumulative stresses that may drive platelets beyond their activation threshold were calculated along multiple flow trajectories and collapsed into probability density functions (PDFs) representing the device 'thrombogenic footprint', indicating significantly reduced thrombogenicity for the optimized design. Platelet activity measurements performed in the actual pump prototypes operating under clinical conditions in circulation flow loops - before and after the optimization with the DTE methodology, show an order of magnitude lower platelet activity rate for the optimized device. The robust capability of this predictive technology - demonstrated here for attaining safe and cost-effective pre-clinical MCS thrombo-optimization - indicates its potential for reducing device thrombogenicity to a level that may significantly limit the extent of concomitant antithrombotic pharmacotherapy needed for safe clinical device use.	[Girdhar, Gaurav; Xenos, Michalis; Alemu, Yared; Chiu, Wei-Che; Einav, Shmuel; Bluestein, Danny] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Jesty, Jolyon] SUNY Stony Brook, Dept Hematol, Stony Brook, NY 11794 USA; [Lynch, Bryan E.] MicroMed Cardiovasc Inc, Houston, TX USA; [Slepian, Marvin J.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Arizona	Girdhar, G (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	danny.bluestein@sunysb.edu	Chiu, Wei-Che/H-3959-2017; Bluestein, Danny/P-4073-2014; Slepian, Marvin/ABG-8305-2020	Chiu, Wei-Che/0000-0002-2830-8184; Slepian, Marvin/0000-0002-7864-6691; Xenos, Michalis/0000-0001-8441-1306	National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health [I R01, EB008004-01, II-1U01EB012487-0]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008004, U01EB012487] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This project was supported by grants from the National Institute of Biomedical Imaging and Bioengineering from the National Institutes of Health: Quantum Award Phase I R01, EB008004-01 (DB), and Quantum Award: Implementation Phase II-1U01EB012487-0 (DB). The funders (NIH) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu Y, 2007, ARTIF ORGANS, V31, P677, DOI 10.1111/j.1525-1594.2007.00446.x; Alemu Y, 2010, ASAIO J, V56, P389, DOI 10.1097/MAT.0b013e3181e65bf9; Antaki JF, 2008, P I MECH ENG H, V222, P573, DOI 10.1243/09544119JEIM352; Apel J, 2001, ARTIF ORGANS, V25, P341, DOI 10.1046/j.1525-1594.2001.025005341.x; Baldwin JT, 2004, NEXT GENERATION VENT; Bluestein D, 2004, J HEART VALVE DIS, V13, P501; Chan WK, 2005, ARTIF ORGANS, V29, P250, DOI 10.1111/j.1525-1594.2005.29046.x; Claiborne TE, 2011, ASAIO J, V57, P26, DOI 10.1097/MAT.0b013e3181fcbd86; Copeland Jack G., 2003, Cardiology Clinics, V21, P101, DOI 10.1016/S0733-8651(02)00136-4; Fossum TW, 2001, ASAIO J, V47, P288, DOI 10.1097/00002480-200105000-00026; Frazier OH, 2007, CARDIOL CLIN, V25, P553, DOI 10.1016/j.ccl.2007.09.001; Goldstein DJ, 2003, CIRCULATION, V108, P272, DOI 10.1161/01.cir.0000087387.02218.7e; GOSMAN AD, 1983, J ENERGY, V7, P482, DOI 10.2514/3.62687; HELLUMS J, 1987, STUDIES MECH SHEAR I; HELLUMS JD, 1994, ANN BIOMED ENG, V22, P445, DOI 10.1007/BF02367081; Jesty J, 1999, ANAL BIOCHEM, V272, P64, DOI 10.1006/abio.1999.4148; Kawahito K, 1997, ARTIF ORGANS, V21, P339; Kawahito K, 1996, ARTIF ORGANS, V20, P47, DOI 10.1111/j.1525-1594.1996.tb04417.x; Kim NJ, 2009, ARTIF ORGANS, V33, P468, DOI 10.1111/j.1525-1594.2009.00754.x; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Nobili M, 2008, ASAIO J, V54, P64, DOI 10.1097/MAT.0b013e31815d6898; Noon GP, 2000, CURR OPIN CARDIOL, V15, P166, DOI 10.1097/00001573-200005000-00008; Noon GP, 2001, ANN THORAC SURG, V71, pS133, DOI 10.1016/S0003-4975(00)02634-5; RAMSTACK JM, 1979, J BIOMECH, V12, P113, DOI 10.1016/0021-9290(79)90150-7; Snyder TA, 2002, ANN THORAC SURG, V73, P1933, DOI 10.1016/S0003-4975(02)03549-X; Wieselthaler GM, 2000, CIRCULATION, V101, P356, DOI 10.1161/01.CIR.101.4.356; WILCOX DC, 1994, AIAA J, V32, P247, DOI 10.2514/3.59994; Wu JS, 2011, ANN BIOMED ENG, V39, P897, DOI 10.1007/s10439-010-0184-2; Xenos M, 2010, J BIOMECH, V43, P2400, DOI 10.1016/j.jbiomech.2010.04.020; Zhu LL, 2010, ARTIF ORGANS, V34, P185, DOI 10.1111/j.1525-1594.2009.00799.x	30	72	76	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2012	7	3							e32463	10.1371/journal.pone.0032463	http://dx.doi.org/10.1371/journal.pone.0032463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TC	22396768	Green Published, gold			2022-12-25	WOS:000303006500020
J	Barrientos, R; Ponce, C; Palacin, C; Martin, CA; Martin, B; Alonso, JC				Barrientos, Rafael; Ponce, Carlos; Palacin, Carlos; Martin, Carlos A.; Martin, Beatriz; Alonso, Juan Carlos			Wire Marking Results in a Small but Significant Reduction in Avian Mortality at Power Lines: A BACI Designed Study	PLOS ONE			English	Article							BIRD COLLISIONS; POPULATION	Background: Collision with electric power lines is a conservation problem for many bird species. Although the implementation of flight diverters is rapidly increasing, few well-designed studies supporting the effectiveness of this costly conservation measure have been published. Methodology/Principal Findings: We provide information on the largest worldwide marking experiment to date, including carcass searches at 35 (15 experimental, 20 control) power lines totalling 72.5 km, at both transmission (220 kV) and distribution (15 kV-45 kV) lines. We found carcasses of 45 species, 19 of conservation concern. Numbers of carcasses found were corrected to account for carcass losses due to removal by scavengers or being overlooked by researchers, resulting in an estimated collision rate of 8.2 collisions per km per month. We observed a small (9.6%) but significant decrease in the number of casualties after line marking compared to before line marking in experimental lines. This was not observed in control lines. We found no influence of either marker size (large vs. small spirals, sample of distribution lines only) or power line type (transmission vs. distribution, sample of large spirals only) on the collision rate when we analyzed all species together. However, great bustard mortality was slightly lower when lines were marked with large spirals and in transmission lines after marking. Conclusions: Our results confirm the overall effectiveness of wire marking as a way to reduce, but not eliminate, bird collisions with power lines. If raw field data are not corrected by carcass losses due to scavengers and missed observations, findings may be biased. The high cost of this conservation measure suggests a need for more studies to improve its application, including wire marking with non-visual devices. Our findings suggest that different species may respond differently to marking, implying that species-specific patterns should be explored, at least for species of conservation concern.	[Barrientos, Rafael; Ponce, Carlos; Palacin, Carlos; Martin, Carlos A.; Martin, Beatriz; Alonso, Juan Carlos] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Barrientos, R (corresponding author), Univ Castilla La Mancha, Fac Ciencias Medio Ambiente, Dept Ciencias Ambientales, Area Zool, Toledo, Spain.	rafael.barrientos@uclm.es	Palacín, Carlos/F-1547-2018; Alonso, Juan Carlos/C-9974-2012; Martín, Carlos A./O-9520-2016; Martin, Beatriz/E-8478-2016; Barrientos, Rafael/I-2102-2015	Palacín, Carlos/0000-0002-6653-9207; Alonso, Juan Carlos/0000-0003-0450-7434; Martín, Carlos A./0000-0002-6865-9376; Martin, Beatriz/0000-0001-6893-2187; Barrientos, Rafael/0000-0002-1677-3214	Direccion General de Investigacion, Spanish Ministry of Science and Innovation [CGL2008-02567]; Junta de Comunidades de Castilla-La Mancha; CSIC-HENARSA; HENARSA-CSIC	Direccion General de Investigacion, Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); CSIC-HENARSA; HENARSA-CSIC	RB was contracted within the project CGL2008-02567 of the Direccion General de Investigacion, Spanish Ministry of Science and Innovation and later supported by a postdoctoral grant from Junta de Comunidades de Castilla-La Mancha. C. Ponce, C. Palacin, CM and BM were supported by contracts CSIC-HENARSA. This study was carried out within the "Preventive, corrective and compensatory measures to balance the impact of the M-50 and R-2 highways on the population of great bustards and other steppe-land birds in the Important Bird Area Talamanca-Camarma and the Site of Community Importance Cuenca de los rios Jarama y Henares", supported by a contract HENARSA-CSIC. Additional financial support was provided by project CGL2008-02567 of the Direccion General de Investigacion, Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO JC, 1994, BIOL CONSERV, V67, P129, DOI 10.1016/0006-3207(94)90358-1; Alonso JC, 2003, ARDEOLA, V50, P21; Alonso JC, 2005, PROYECTO MEDIDAS PRE; Anderson MD, 2002, EFFECTIVENESS 2 DIFF; APLIC (Avian Power Line Interaction Committee), 1994, MIT BIRD COLL POW LI; Avian Powerline Interaction Committee [APLIC], 2006, SUGG PRACT AV PROT P; Barrientos R, 2011, CONSERV BIOL, V25, P893, DOI 10.1111/j.1523-1739.2011.01699.x; Beaulaurier DL, 1981, MITIGATION BIRD COLL; Bevanger K, 1998, BIOL CONSERV, V86, P67, DOI 10.1016/S0006-3207(97)00176-6; Bevanger K, 1995, J APPL ECOL, V32, P745, DOI 10.2307/2404814; Bevanger K, 2001, BIOL CONSERV, V99, P341, DOI 10.1016/S0006-3207(00)00217-2; Bevanger K, 1999, BIRDS POWER LINES CO, P29; Biewener AA., 2003, ANIMAL LOCOMOTION; BirdLife International, 2004, BIRDS POP EST TRENDS; Calabuig C.P, 2009, ANALISIS EFICACIA VI; Castellan NJ, 1988, NONPARAMETRIC STAT B; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; Garcia de la Morena E. L., 2006, SISON COMUN ESPANA; Hebert E, PUBLICATION; Hunting K, 2002, P50002071F CAL EN CO; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Janss GFE, 2000, BIOL CONSERV, V95, P353, DOI 10.1016/S0006-3207(00)00021-5; Jenkins AR, 2010, BIRD CONSERV INT, V20, P263, DOI 10.1017/S0959270910000122; Koops FBJ, 1982, ELECTROTECHNIEK, V60, P641; Koops FBJ, 1994, RED ELECT ESPANOLA, P51; Kruger R, 2001, AVIAN INTERACTIONS U, P229; MANVILLE AM, 2009, TUNDRA TROPICS CONNE, P00262; Manville II AM, 1999, AVIAN INTERACTIONS U, P85; Martin B., 2008, THESIS U COMPLUTENSE; Martin CA, 2011, ABUNDANCIA IN PRESS; Martin GR, 2010, BIOL CONSERV, V143, P2695, DOI 10.1016/j.biocon.2010.07.014; Martin GR, 2011, IBIS, V153, P239, DOI 10.1111/j.1474-919X.2011.01117.x; MORKILL AE, 1991, WILDLIFE SOC B, V19, P442; Norberg U. M., 1990, ZOOPHYSIOLOGY SERIES, V27; Ponce C, 2010, ANIM CONSERV, V13, P603, DOI 10.1111/j.1469-1795.2010.00387.x; Ponce C, 2011, AGR ECOSYST ENVIRON, V141, P193, DOI 10.1016/j.agee.2011.02.030; Quinn M, 2011, J ENVIRON INFORM, V18, P12, DOI 10.3808/jei.201100194; R Development Core Team, 2009, R FDN STAT COMP; Sastre P, 2009, EUR J WILDLIFE RES, V55, P425, DOI 10.1007/s10344-009-0254-7; Savereno AJ, 1996, WILDLIFE SOC B, V24, P636; Schaub M, 2004, ECOLOGY, V85, P930, DOI 10.1890/03-0012; Shaw JM, 2009, THESIS U CAPE TOWN C; Silva JP, 2010, ECOL MODEL, V221, P1954, DOI 10.1016/j.ecolmodel.2010.03.027; Virgos E, 2005, BIODIVERS CONSERV, V14, P3475, DOI 10.1007/s10531-004-0823-8	44	48	51	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32569	10.1371/journal.pone.0032569	http://dx.doi.org/10.1371/journal.pone.0032569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396776	Green Published, gold, Green Submitted			2022-12-25	WOS:000303005000030
J	Mar, KU; Lahdenpera, M; Lummaa, V				Mar, Khyne U.; Lahdenpera, Mirkka; Lummaa, Virpi			Causes and Correlates of Calf Mortality in Captive Asian Elephants (Elephas maximus)	PLOS ONE			English	Article							POPULATION VIABILITY; LOXODONTA-AFRICANA; ZOO ELEPHANTS; INVESTMENT; DEMOGRAPHY; RESPONSES; BIOLOGY	Juvenile mortality is a key factor influencing population growth rate in density-independent, predation-free, well-managed captive populations. Currently at least a quarter of all Asian elephants live in captivity, but both the wild and captive populations are unsustainable with the present fertility and calf mortality rates. Despite the need for detailed data on calf mortality to manage effectively populations and to minimize the need for capture from the wild, very little is known of the causes and correlates of calf mortality in Asian elephants. Here we use the world's largest multigenerational demographic dataset on a semi-captive population of Asian elephants compiled from timber camps in Myanmar to investigate the survival of calves (n = 1020) to age five born to captive-born mothers (n = 391) between 1960 and 1999. Mortality risk varied significantly across different ages and was higher for males at any age. Maternal reproductive history was associated with large differences in both stillbirth and liveborn mortality risk: first-time mothers had a higher risk of calf loss as did mothers producing another calf soon (<3.7 years) after a previous birth, and when giving birth at older age. Stillbirth (4%) and pre-weaning mortality (25.6%) were considerably lower than those reported for zoo elephants and used in published population viability analyses. A large proportion of deaths were caused by accidents and lack of maternal milk/calf weakness which both might be partly preventable by supplementary feeding of mothers and calves and work reduction of high-risk mothers. Our results on Myanmar timber elephants with an extensive keeping system provide an important comparison to compromised survivorship reported in zoo elephants. They have implications for improving captive working elephant management systems in range countries and for refining population viability analyses with realistic parameter values in order to predict future population size of the Asian elephant.	[Mar, Khyne U.; Lummaa, Virpi] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Lahdenpera, Mirkka] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Lummaa, Virpi] Wissensch Kolleg Berlin, Inst Adv Study, Berlin, Germany	University of Sheffield; University of Turku	Mar, KU (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	v.lummaa@sheffield.ac.uk	Lummaa, Virpi/AHB-0181-2022; U Mar, Khyne/AAO-8806-2021	Lahdenpera, Mirkka/0000-0003-0062-6284	National Environmental Research Council, UK; Royal Society of London; Nando Peretti Foundation; Rufford Small Grant for Nature; International Foundation for Science; Finnish Cultural Foundation; Kone Foundation; NERC [NE/G007330/1] Funding Source: UKRI; Natural Environment Research Council [NE/G007330/1] Funding Source: researchfish	National Environmental Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society of London(Royal Society of London); Nando Peretti Foundation; Rufford Small Grant for Nature; International Foundation for Science(International Foundation for Science); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Kone Foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was financially supported by the National Environmental Research Council, UK (VL), Royal Society of London (VL), Nando Peretti Foundation (VL), Rufford Small Grant for Nature (KUM), International Foundation for Science (KUM), Finnish Cultural Foundation (ML), and Kone Foundation (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung TU, 2001, GIANTS OUR HANDS, P89; Brown JL, 2010, ZOO BIOL, V29, P274, DOI 10.1002/zoo.20268; Brown JL, 2003, BIOL REPROD, V68, P95; Clubb R, 2009, ANIM WELFARE, V18, P237; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Dale RHI, 2010, ZOO BIOL, V29, P87, DOI 10.1002/zoo.20234; Fowler M, 2006, BIOL MED SURG ELEPHA; Hamel S, 2010, ECOLOGY, V91, P2034, DOI 10.1890/09-1311.1; Hermes R, 2008, THERIOGENOLOGY, V70, P131, DOI 10.1016/j.theriogenology.2008.04.003; Hildebrandt T. B., 2006, International Zoo Yearbook, V40, P20, DOI 10.1111/j.1748-1090.2006.00020.x; Kurt F, 1996, Z SAUGETIERKD, V61, P155; Kurt Fred, 2008, P327; Lair R.C., 1997, GONE ASTRAY CARE MAN; LEE PC, 1986, BEHAV ECOL SOCIOBIOL, V18, P353, DOI 10.1007/BF00299666; LEE PC, 1987, ANIM BEHAV, V35, P278, DOI 10.1016/S0003-3472(87)80234-8; Leimgruber P, 2008, ANIM CONSERV, V11, P198, DOI 10.1111/j.1469-1795.2008.00172.x; Mar KU, 2007, THESIS U COLL LONDON; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; Mason GJ, 2010, ZOO BIOL, V29, P237, DOI 10.1002/zoo.20256; McComb K, 2011, P R SOC LON IN PRESS; Mellen J, 1994, MED MANAGEMENT ELEPH, P19; Moss C.J., 2011, AMBOSELI ELEPHANTS L, DOI DOI 10.7208/CHICAGO/9780226542263.001.0001; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Myint MU, 2009, ANAL STATUS CARE MAN; Ramanathan A, 2008, J ZOO WILDLIFE MED, V39, P148, DOI 10.1638/2007-0008R1.1; RAPAPORT L, 1987, J MAMMAL, V68, P438, DOI 10.2307/1381494; Saragusty J, 2009, ANIM REPROD SCI, V115, P247, DOI 10.1016/j.anireprosci.2008.10.019; Schmid Jeannette, 1998, IZN (International Zoo News), V45, P341; Schmidt Michael J., 1996, Gajah, V16, P23; Shrader AM, 2010, BIODIVERS CONSERV, V19, P2235, DOI 10.1007/s10531-010-9836-7; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Sukumar R, 1997, ZOO BIOL, V16, P263, DOI 10.1002/(SICI)1098-2361(1997)16:3<263::AID-ZOO6>3.3.CO;2-A; Sukumar R., 2006, International Zoo Yearbook, V40, P1, DOI 10.1111/j.1748-1090.2006.00001.x; Sukumar R., 1993, GAJAH, V11, P59; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sukumar R, 1998, ASIAN ELEPHANT PRIOR; Taylor VJ, 1998, ZOO BIOL, V17, P311, DOI 10.1002/(SICI)1098-2361(1998)17:4&lt;311::AID-ZOO5&gt;3.0.CO;2-C; Tilson R, 1994, ASIAN ELEPHANT SUMAT; Toke Gale U, 1971, BURMESE TIMBER ELEPH; Wiese RJ, 2000, ZOO BIOL, V19, P299, DOI 10.1002/1098-2361(2000)19:5<299::AID-ZOO2>3.0.CO;2-Z	43	44	45	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2012	7	3							e32335	10.1371/journal.pone.0032335	http://dx.doi.org/10.1371/journal.pone.0032335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SU	22396757	Green Published, Green Accepted, gold			2022-12-25	WOS:000303005000020
J	Abdgawad, M; Pettersson, A; Gunnarsson, L; Bengtsson, AA; Geborek, P; Nilsson, L; Segelmark, M; Hellmark, T				Abdgawad, Mohamed; Pettersson, Asa; Gunnarsson, Lena; Bengtsson, Anders A.; Geborek, Pierre; Nilsson, Lars; Segelmark, Marten; Hellmark, Thomas			Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INFLAMMATORY-BOWEL-DISEASE; GRANULOCYTE-MACROPHAGE; FACTOR-RECEPTOR; WEGENERS-GRANULOMATOSIS; CIRCULATING NEUTROPHILS; LUPUS-ERYTHEMATOSUS; ENDOTHELIAL-CELLS; TARGET-CELLS; PU.1 SPI-1	Background: ANCA-Associated Systemic Vasculitis (AASV) is characterized by leukocytoclasis, accumulation of unscavenged apoptotic and necrotic neutrophils in perivascular tissues. Dysregulation of neutrophil cell death may contribute directly to the pathogenesis of AASV. Methods: Neutrophils from Healthy Blood Donors (HBD), patients with AASV most in complete remission, Polycythemia Vera (PV), Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA) and renal transplant recipients (TP) were incubated in vitro, and the rate of spontaneous apoptosis was measured by FACS. Plasma levels of cytokines and sFAS were measured with cytometric bead array and ELISA. Expression of pro/anti-apoptotic factors, transcription factors C/EBP-alpha, C/EBP-beta and PU.1 and inhibitors of survival/JAK2-pathway were measured by real-time-PCR. Results: AASV, PV and RA neutrophils had a significantly lower rate of apoptosis compared to HBD neutrophils (AASV 50 +/- 14% vs. HBD 64 +/- 11%, p < 0.0001). In RA but not in AASV and PV, low apoptosis rate correlated with increased plasma levels of GM-CSF and high mRNA levels of anti-apoptotic factors Bcl-2A1 and Mcl-1. AASV patients had normal levels of G-CSF, GM-CSF and IL-3. Both C/EBP-alpha, C/EBP-beta were significantly higher in neutrophils from AASV patients than HBD. Levels of sFAS were significantly higher in AASV compared to HBD. Conclusion: Neutrophil apoptosis rates in vitro are decreased in AASV, RA and PV but mechanisms seem to differ. Increased mRNA levels of granulopoiesis-associated transcription factors and increased levels of sFAS in plasma were observed in AASV. Additional studies are required to define the mechanisms behind the decreased apoptosis rates, and possible connections with accumulation of dying neutrophils in regions of vascular lesions in AASV patients.	[Abdgawad, Mohamed; Pettersson, Asa; Gunnarsson, Lena; Segelmark, Marten; Hellmark, Thomas] Lund Univ, Dept Nephrol, S-22101 Lund, Sweden; [Bengtsson, Anders A.; Geborek, Pierre] Lund Univ, Dept Rheumatol, S-22101 Lund, Sweden; [Nilsson, Lars] Lund Univ, Dept Haematol, S-22101 Lund, Sweden; [Segelmark, Marten] Linkoping Univ, Dept Hlth & Med, Linkoping, Sweden	Lund University; Lund University; Lund University; Linkoping University	Abdgawad, M (corresponding author), Lund Univ, Dept Nephrol, S-22101 Lund, Sweden.	Mohamed.Abdgawad@med.lu.se	Hellmark, Thomas/U-6289-2017	Hellmark, Thomas/0000-0002-2952-1155; Segelmark, Marten/0000-0002-1221-0772; Phillipson, Mia/0000-0002-2387-0266	Swedish Research Council [71X-15152]; Crafoord Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation	This study was supported by Swedish Research Council (grant 71X-15152) and the Crafoord Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIETTA M, 1993, STEM CELLS, V11, P83; AGLIETTA M, 1993, BLOOD, V82, P2054; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Bijl M, 1998, J AUTOIMMUN, V11, P457, DOI 10.1006/jaut.1998.0233; Brannigan AE, 2000, SHOCK, V13, P361, DOI 10.1097/00024382-200005000-00003; Christensson M, 2002, J CLIN IMMUNOL, V22, P220, DOI 10.1023/A:1016040925295; Christensson M, 2000, CLIN NEPHROL, V54, P435; Chuang PI, 1998, BIOCHEM BIOPH RES CO, V249, P361, DOI 10.1006/bbrc.1998.9155; DAI CH, 1992, BLOOD, V80, P891; Dale DC, 1998, AM J HEMATOL, V57, P7, DOI 10.1002/(SICI)1096-8652(199801)57:1<7::AID-AJH2>3.0.CO;2-0; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Durant S, 2004, J LEUKOCYTE BIOL, V75, P87, DOI 10.1189/jlb.0203079; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; Fujimori K, 2008, GRAEF ARCH CLIN EXP, V246, P285, DOI 10.1007/s00417-007-0659-5; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Goldstein JI, 2011, GASTROENTEROLOGY, V141, P208, DOI 10.1053/j.gastro.2011.03.060; Harper L, 2001, KIDNEY INT, V59, P1729, DOI 10.1046/j.1523-1755.2001.0590051729.x; Harper Lorraine, 2006, Expert Rev Clin Immunol, V2, P237, DOI 10.1586/1744666X.2.2.237; Hasegawa T, 2003, BLOOD, V101, P1164, DOI 10.1182/blood-2002-05-1505; HENSHAW TJ, 1994, ARTHRITIS RHEUM, V37, P104, DOI 10.1002/art.1780370116; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Jimenez MF, 1997, ARCH SURG-CHICAGO, V132, P1263; Kallenberg CGM, 2002, KIDNEY INT, V61, P758, DOI 10.1046/j.1523-1755.2002.00179.x; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505; LUQMANI RA, 1994, Q J MED, V87, P671; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; MOUNTZ JD, 1994, ARTHRITIS RHEUM, V37, P1415, DOI 10.1002/art.1780371002; NAKABAYASHI I, 1993, CLIN NEPHROL, V40, P265; Ohlsson S, 2003, CLIN EXP IMMUNOL, V131, P528, DOI 10.1046/j.1365-2249.2003.02083.x; Patry YC, 2001, J AM SOC NEPHROL, V12, P1764, DOI 10.1681/ASN.V1281764; Pederzoli M, 2005, J IMMUNOL, V174, P6381, DOI 10.4049/jimmunol.174.10.6381; Pendergraft WF, 2000, KIDNEY INT, V57, P1981, DOI 10.1046/j.1523-1755.2000.00048.x; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; SAVILL J, 1995, SEMIN CELL BIOL, V6, P385, DOI 10.1016/S1043-4682(05)80009-1; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; TRAVIS WD, 1991, AM J SURG PATHOL, V15, P315, DOI 10.1097/00000478-199104000-00001; Tsujimoto H, 2001, CLIN EXP IMMUNOL, V126, P355, DOI 10.1046/j.1365-2249.2001.01675.x; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Weinmann P, 2007, CLIN EXP RHEUMATOL, V25, P885; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Yang JJ, 1996, AM J PATHOL, V149, P1617; Yang JJ, 2000, CLIN EXP IMMUNOL, V121, P165, DOI 10.1046/j.1365-2249.2000.01228.x	51	228	229	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32439	10.1371/journal.pone.0032439	http://dx.doi.org/10.1371/journal.pone.0032439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403660	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700057
J	Zhang, SP; Chen, LG; Cui, B; Chuang, HY; Yu, JQ; Wang-Rodriguez, J; Tang, L; Chen, G; Basak, GW; Kipps, TJ				Zhang, Suping; Chen, Liguang; Cui, Bing; Chuang, Han-Yu; Yu, Jianqiang; Wang-Rodriguez, Jessica; Tang, Li; Chen, George; Basak, Grzegorz W.; Kipps, Thomas J.			ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; ELEMENT-BINDING PROTEIN; BRACHYDACTYLY TYPE-B; RNAI SCREEN; I-EPSILON; CREB; THERAPY; TARGET; GENE	Receptor-tyrosine-kinase-like orphan receptor 1 (ROR1) is expressed during embryogenesis and by certain leukemias, but not by normal adult tissues. Here we show that the neoplastic cells of many human breast cancers express the ROR1 protein and high-level expression of ROR1 in breast adenocarcinoma was associated with aggressive disease. Silencing expression of ROR1 in human breast cancer cell lines found to express this protein impaired their growth in vitro and also in immune-deficient mice. We found that ROR1 could interact with casein kinase 1 epsilon (CK1 epsilon) to activate phosphoinositide 3-kinase-mediated AKT phosphorylation and cAMP-response-element-binding protein (CREB), which was associated with enhanced tumor-cell growth. Wnt5a, a ligand of ROR1, could induce ROR1-dependent signaling and enhance cell growth. This study demonstrates that ROR1 is expressed in human breast cancers and has biological and clinical significance, indicating that it may be a potential target for breast cancer therapy.	[Zhang, Suping; Chen, Liguang; Cui, Bing; Chuang, Han-Yu; Yu, Jianqiang; Wang-Rodriguez, Jessica; Tang, Li; Chen, George; Basak, Grzegorz W.; Kipps, Thomas J.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Zhang, SP (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	tkipps@ucsd.edu	Cui, Bing/F-3599-2018	Cui, Bing/0000-0001-8374-7801; zhang, Si/0000-0002-5682-4995; Chen, George/0000-0002-1342-0835	National Institutes of Health [PO1-CA081534]; Leukemia and Lymphoma Society of America; NATIONAL CANCER INSTITUTE [P01CA081534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant PO1-CA081534 (to TJK) and a Specialized Centers of Research grant (to TJK) from the Leukemia and Lymphoma Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Chhabra A, 2007, ONCOL REP, V18, P953; Chicha L, 2005, ANN NY ACAD SCI, V1044, P236, DOI 10.1196/annals.1349.029; Choudhury A, 2010, BR J HAEMATOL; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; IOZZO RV, 1995, CANCER RES, V55, P3495; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Katoh M, 2005, INT J MOL MED, V15, P533; LEJEUNE S, 1995, CLIN CANCER RES, V1, P215; Linnerth NM, 2008, INT J GYNECOL CANCER, V18, P1248, DOI 10.1111/j.1525-1438.2007.01177.x; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MCGUIRE WL, 1975, CANCER, V36, P638; Modak C, 2008, BIOCHEM BIOPH RES CO, V368, P801, DOI 10.1016/j.bbrc.2008.02.001; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Shabani M, 2007, TUMOR BIOL, V28, P318, DOI 10.1159/000121405; STOLL BA, 1979, PRACTITIONER, V222, P211; Sun CX, 2005, J CLIN INVEST, V115, P35, DOI 10.1172/JCI200522656; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WILSON C, 1993, P NATL ACAD SCI USA, V90, P7109, DOI 10.1073/pnas.90.15.7109; Xiao X, 2010, CURR CANCER DRUG TAR, V10, P384, DOI 10.2174/156800910791208535; Yang WS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r92; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	45	173	194	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31127	10.1371/journal.pone.0031127	http://dx.doi.org/10.1371/journal.pone.0031127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403610	Green Submitted, gold, Green Published			2022-12-25	WOS:000303017700007
J	Zhang, Y; Luo, Y; Deng, YH; Mu, YG; Wei, GH				Zhang, Yun; Luo, Yin; Deng, Yonghua; Mu, Yuguang; Wei, Guanghong			Lipid Interaction and Membrane Perturbation of Human Islet Amyloid Polypeptide Monomer and Dimer by Molecular Dynamics Simulations	PLOS ONE			English	Article							FIBER FORMATION; HUMAN AMYLIN; MECHANISM; BILAYERS; AGGREGATION; RECOGNITION; DISRUPTION; OLIGOMERS; TOXICITY; PEPTIDE	The aggregation of human islet amyloid polypeptide (hIAPP or amylin) is associated with the pathogenesis of type 2 diabetes mellitus. Increasing evidence suggests that the interaction of hIAPP with beta-cell membranes plays a crucial role in cytotoxicity. However, the hIAPP-lipid interaction and subsequent membrane perturbation is not well understood at atomic level. In this study, as a first step to gain insight into the mechanism of hIAPP-induced cytotoxicity, we have investigated the detailed interactions of hIAPP monomer and dimer with anionic palmitoyloleolyophosphatidylglycerol (POPG) bilayer using all-atom molecular dynamics (MD) simulations. Multiple MD simulations have been performed by employing the initial configurations where the N-terminal region of hIAPP is pre-inserted in POPG bilayer. Our simulations show that electrostatic interaction between hIAPP and POPG bilayer plays a major role in peptide-lipid interaction. In particular, the N-terminal positively-charged residues Lys1 and Arg11 make a dominant contribution to the interaction. During peptide-lipid interaction process, peptide dimerization occurs mostly through the C-terminal 20-37 region containing the amyloidogenic 20-29-residue segment. Membrane-bound hIAPP dimers display a pronounced ability of membrane perturbation than monomers. The higher bilayer perturbation propensity of hIAPP dimer likely results from the cooperativity of the peptide-peptide interaction (or peptide aggregation). This study provides insight into the hIAPP-membrane interaction and the molecular mechanism of membrane disruption by hIAPP oligomers.	[Zhang, Yun; Luo, Yin; Deng, Yonghua; Wei, Guanghong] Fudan Univ, State Key Lab Surface Phys, Key Lab Computat Phys Sci MOE, Shanghai 200433, Peoples R China; [Zhang, Yun; Luo, Yin; Deng, Yonghua; Wei, Guanghong] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; [Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Fudan University; Fudan University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhang, Y (corresponding author), Fudan Univ, State Key Lab Surface Phys, Key Lab Computat Phys Sci MOE, Shanghai 200433, Peoples R China.	ghwei@fudan.edu.cn		Wei, Guanghong/0000-0001-5814-3328; Yao, Dezhong/0000-0002-8042-879X; Zhang, Yangsong/0000-0002-6764-3567	National Natural Science Foundation of China [11074047]; Research Fund for the Doctoral Program of Higher Education of China [RFDP-20100071110006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 11074047) and Research Fund for the Doctoral Program of Higher Education of China (RFDP-20100071110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MN, 2011, BIOPHYS CHEM, V156, P43, DOI 10.1016/j.bpc.2010.12.007; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Chang ZW, 2011, J PHYS CHEM B, V115, P1165, DOI 10.1021/jp107558e; Colombo G, 2005, PROTEINS, V59, P519, DOI 10.1002/prot.20426; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Elmore DE, 2006, FEBS LETT, V580, P144, DOI 10.1016/j.febslet.2005.11.064; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jaud S, 2009, P NATL ACAD SCI USA, V106, P11588, DOI 10.1073/pnas.0900638106; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Jiang P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000357; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Laghaei R, 2010, J PHYS CHEM B, V114, P7071, DOI 10.1021/jp100205w; Last NB, 2011, P NATL ACAD SCI USA, V108, P9460, DOI 10.1073/pnas.1102356108; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mo YX, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3097982; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Rivera E, 2009, BIOPHYS J, V96, P4552, DOI 10.1016/j.bpj.2009.03.039; Sciacca MFM, 2010, NEW J CHEM, V34, P200, DOI 10.1039/b9nj00253g; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; Tolokh IS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031911; van Gunsteren WF, GROMOS 87 MANUAL; Vermeer LS, 2007, EUR BIOPHYS J BIOPHY, V36, P919, DOI 10.1007/s00249-007-0192-9; Wei L, 2011, J BIOL CHEM, V286, P6291, DOI 10.1074/jbc.M110.166678; WIEDMANN T, 1993, BIOCHIM BIOPHYS ACTA, V1167, P114, DOI 10.1016/0005-2760(93)90150-8; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Yu X, 2011, J MOL BIOL, DOI [10.1016/j.jmb.2011.1011.1006, DOI 10.1016/J.JMB.2011.1011.1006]	54	89	97	9	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38191	10.1371/journal.pone.0038191	http://dx.doi.org/10.1371/journal.pone.0038191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22412829	Green Published, gold			2022-12-25	WOS:000305338500105
J	Zhang, YS; Xu, P; Liu, TJ; Hu, J; Zhang, R; Yao, DZ				Zhang, Yangsong; Xu, Peng; Liu, Tiejun; Hu, Jun; Zhang, Rui; Yao, Dezhong			Multiple Frequencies Sequential Coding for SSVEP-Based Brain-Computer Interface	PLOS ONE			English	Article							FLICKER	Background: Steady-state visual evoked potential (SSVEP)-based brain-computer interface (BCI) has become one of the most promising modalities for a practical noninvasive BCI system. Owing to both the limitation of refresh rate of liquid crystal display (LCD) or cathode ray tube (CRT) monitor, and the specific physiological response property that only a very small number of stimuli at certain frequencies could evoke strong SSVEPs, the available frequencies for SSVEP stimuli are limited. Therefore, it may not be enough to code multiple targets with the traditional frequencies coding protocols, which poses a big challenge for the design of a practical SSVEP-based BCI. This study aimed to provide an innovative coding method to tackle this problem. Methodology/Principal Findings: In this study, we present a novel protocol termed multiple frequencies sequential coding (MFSC) for SSVEP-based BCI. In MFSC, multiple frequencies are sequentially used in each cycle to code the targets. To fulfill the sequential coding, each cycle is divided into several coding epochs, and during each epoch, certain frequency is used. Obviously, different frequencies or the same frequency can be presented in the coding epochs, and the different epoch sequence corresponds to the different targets. To show the feasibility of MFSC, we used two frequencies to realize four targets and carried on an offline experiment. The current study shows that: 1) MFSC is feasible and efficient; 2) the performance of SSVEP-based BCI based on MFSC can be comparable to some existed systems. Conclusions/Significance: The proposed protocol could potentially implement much more targets with the limited available frequencies compared with the traditional frequencies coding protocol. The efficiency of the new protocol was confirmed by real data experiment. We propose that the SSVEP-based BCI under MFSC might be a promising choice in the future.	[Zhang, Yangsong; Xu, Peng; Liu, Tiejun; Hu, Jun; Zhang, Rui; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Zhang, YS (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	xupeng@uestc.edu.cn; dyao@uestc.edu.cn		Wei, Guanghong/0000-0001-5814-3328; Yao, Dezhong/0000-0002-8042-879X; Zhang, Yangsong/0000-0002-6764-3567	National Natural Science Foundation of China [31070881]; Program for Changjiang Scholars and Innovative Research Team in University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China under Grant No. 31070881, and in part by the project of the Program for Changjiang Scholars and Innovative Research Team in University. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Cecotti H, 2010, C COMP NEUR, P215; Cecotti H, 2010, IEEE T NEUR SYS REH, V18, P127, DOI 10.1109/TNSRE.2009.2039594; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Friman O, 2001, MAGNET RESON MED, V45, P323, DOI 10.1002/1522-2594(200102)45:2<323::AID-MRM1041>3.0.CO;2-#; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Lin ZL, 2006, IEEE T BIO-MED ENG, V53, P2610, DOI 10.1109/TBME.2006.886577; Melzer T, 2003, PATTERN RECOGN, V36, P1961, DOI 10.1016/S0031-3203(03)00058-X; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Mukesh TMS, 2006, PHYSIOL MEAS, V27, P61, DOI 10.1088/0967-3334/27/1/006; Panicker R, 2011, IEEE T BIOMED ENG; Parkhomenko E, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1406; Pfurtscheller G, 2010, FRONTIERS NEUROSCIEN, V4; Pfurtscheller G, 2010, IEEE T NEUR SYS REH, V18, P409, DOI 10.1109/TNSRE.2010.2040837; Regan D., 1989, HUMAN BRAIN ELECTROP; Shyu KK, 2010, NEUROSCI LETT, V483, P28, DOI 10.1016/j.neulet.2010.07.043; Teng F, 2010, P 48 ACM SE C, P50; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YJ, 2008, IEEE ENG MED BIOL, V27, P64, DOI 10.1109/MEMB.2008.923958; Wang YT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025018; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu ZH, 2008, MED ENG PHYS, V30, P1079, DOI 10.1016/j.medengphy.2008.01.004; Wu ZH, 2008, J NEURAL ENG, V5, P36, DOI 10.1088/1741-2560/5/1/004; Xu Peng, 2011, PLoS One, V6, pe14634, DOI 10.1371/journal.pone.0014634; Yan Z, 2011, NEUROSCIENCE LETT; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	35	89	97	9	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2012	7	3							e29519	10.1371/journal.pone.0029519	http://dx.doi.org/10.1371/journal.pone.0029519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928XD	22412829	Green Published, gold, Green Submitted			2022-12-25	WOS:000303021100001
